data_2loy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2loy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.436 ' HG3' ' HB3' ' A' ' 181' ' ' CYS . 12.6 tpt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.965 -0.383 . . . . 72.44 109.965 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 180' ' ' LYS . 73.5 mt -132.51 134.08 44.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.969 0.908 . . . . 75.25 109.341 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 68.7 mt -103.0 120.94 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.275 -1.379 . . . . 63.13 107.275 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.734 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 74.6 m-85 -105.08 135.88 45.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.534 -0.543 . . . . 75.13 109.534 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.557 ' HZ1' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -137.48 146.25 44.02 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.714 0.806 . . . . 74.42 110.12 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.408 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 27.0 t70 -106.35 172.4 6.83 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.903 1.281 . . . . 53.13 107.827 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.534 HD11 HD22 ' A' ' 98' ' ' ASN . 72.5 mt -64.81 -35.84 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 O-C-N 121.458 -0.776 . . . . 72.12 111.437 175.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.82 -43.18 3.85 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.333 1.053 . . . . 74.32 110.903 -167.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -98.32 20.25 12.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 75.24 111.003 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 12.6 t70 -45.45 -43.03 11.09 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.523 1.929 . . . . 63.14 113.443 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -49.51 -61.68 1.97 Allowed 'General case' 0 N--CA 1.476 0.87 0 O-C-N 125.626 1.829 . . . . 64.53 112.626 -166.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.3 21.76 7.9 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.779 0.659 . . . . 72.23 112.779 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 tp -49.12 -65.37 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 112.578 0.584 . . . . 70.11 112.578 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.734 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 22.7 t -158.19 173.46 16.67 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.759 0.424 . . . . 73.13 110.282 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 35.8 p 172.88 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.078 0.951 . . . . 71.31 111.205 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.526 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.8 t70 -174.0 167.93 4.22 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.899 1.28 . . . . 73.41 109.026 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 m -68.88 65.11 0.13 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.297 1.039 . . . . 61.3 112.448 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 60.4 m-85 -87.9 134.07 36.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 122.976 0.51 . . . . 73.22 109.672 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.482 ' HG2' ' HB3' ' A' ' 31' ' ' LYS . 52.6 Cg_endo -67.32 121.09 8.18 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.121 1.881 . . . . 75.12 110.401 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.66 147.02 52.33 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.082 -0.508 . . . . 71.52 110.633 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.654 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 26.2 mtpp -131.69 158.71 40.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.168 . . . . 73.44 108.53 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.63 110.88 18.44 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.673 -1.232 . . . . 75.12 107.673 167.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.17 139.13 20.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.907 0.883 . . . . 64.53 109.38 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 62.73 10.45 4.22 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.425 1.09 . . . . 75.41 112.926 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.5 t70 51.27 38.66 22.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.402 1.081 . . . . 64.03 110.622 -167.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 120' ' ' ILE . 39.2 tp -134.74 -50.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.943 -0.571 . . . . 73.34 111.469 -172.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.9 t -125.11 138.29 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.341 0.657 . . . . 72.43 110.527 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 36.0 m-85 -86.1 119.96 26.96 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.077 0.951 . . . . 74.4 110.186 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.654 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 25.5 mm-40 -88.56 103.5 15.96 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 124.52 1.138 . . . . 75.43 108.569 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 25.0 t80 -109.74 103.92 12.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.423 -1.695 . . . . 72.44 106.423 -174.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 42.1 tttm -85.04 145.0 27.91 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.103 0.477 . . . . 73.23 111.048 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -133.78 -163.41 10.37 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 114.989 -1.005 . . . . 73.11 111.878 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -144.21 143.15 30.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.639 0.776 . . . . 73.31 109.224 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -74.25 121.53 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.468 -0.567 . . . . 74.42 109.468 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 72' ' ' LEU . 18.4 m -146.44 166.66 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.635 0.774 . . . . 72.31 109.163 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -128.84 139.69 51.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.225 -1.028 . . . . 75.43 108.225 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.698 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 17.9 tpt180 -100.13 108.41 20.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.364 -1.347 . . . . 74.34 107.364 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.659 ' HG2' HG21 ' A' ' 64' ' ' VAL . 5.6 tmtm? -124.72 106.39 10.04 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.12 -2.178 . . . . 73.24 105.12 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -72.67 79.58 1.1 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 121.742 0.782 . . . . 61.32 110.249 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.67 -35.76 0.34 Allowed Glycine 0 C--O 1.237 0.332 0 CA-C-N 114.693 -1.14 . . . . 73.33 111.92 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -174.9 105.0 0.09 Allowed 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.577 -0.527 . . . . 74.54 109.577 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.7 tt . . . . . 0 CA--C 1.554 1.111 0 CA-C-O 121.5 0.667 . . . . 74.01 110.743 179.789 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.659 HG21 ' HG2' ' A' ' 38' ' ' LYS . 18.3 t . . . . . 0 C--O 1.241 0.607 0 N-CA-C 108.657 -0.868 . . . . 65.15 108.657 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.1 mp0 -69.62 74.52 0.4 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.137 -1.061 . . . . 72.31 108.137 166.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 -75.96 134.43 40.2 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.636 1.175 . . . . 74.24 110.617 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.0 -141.38 6.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 112.089 -0.404 . . . . 61.21 112.089 170.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 18.4 pt -111.18 158.72 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.799 0.44 . . . . 74.34 110.125 170.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.94 -30.48 71.6 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 75.24 111.915 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.2 mt -59.75 -52.61 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.375 1.07 . . . . 63.45 109.955 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.24 -48.04 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 114.251 -1.34 . . . . 75.31 111.443 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.467 HD13 HG21 ' A' ' 35' ' ' VAL . 79.3 mt -67.45 -23.25 65.5 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.577 0.751 . . . . 72.51 112.071 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -53.61 -53.84 46.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.181 0.992 . . . . 74.54 110.893 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -114.69 -1.61 13.25 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.436 -0.802 . . . . 75.44 112.427 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 66.71 70.14 0.4 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.448 1.099 . . . . 74.41 109.427 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.7 133.69 33.8 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.397 -0.964 . . . . 75.12 108.397 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.68 129.55 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.678 0.391 . . . . 75.34 110.369 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.42 147.04 46.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.477 0.711 . . . . 71.54 112.483 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.3 mtp -148.03 143.97 27.59 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.515 1.926 . . . . 73.33 106.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.0 m-80 -126.97 124.04 38.54 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.211 -1.033 . . . . 75.14 108.211 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.53 ' SG ' ' HD3' ' A' ' 130' ' ' LYS . 16.9 p -58.96 -15.27 12.13 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.844 0.857 . . . . 73.23 112.624 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.406 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 98.4 m-85 -57.29 -48.7 78.23 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.237 1.015 . . . . 72.44 111.545 174.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.81 -39.16 6.4 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.396 0.678 . . . . 73.23 110.543 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.76 20.11 1.22 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.61 1.164 . . . . 74.52 112.516 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.97 49.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.929 0.891 . . . . 72.45 112.876 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.3 m -68.33 -50.68 51.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.025 0.53 . . . . 74.52 112.105 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.3 mmm -60.26 -47.49 85.78 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.93 0.892 . . . . 72.03 111.44 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -64.04 -36.22 83.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.587 -1.188 . . . . 75.53 111.095 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.7 -37.44 87.36 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.109 0.564 . . . . 75.55 110.697 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 94' ' ' LYS . . . -61.51 -48.99 78.54 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.001 -0.545 . . . . 73.2 109.986 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -65.24 -32.23 73.8 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.958 0.725 . . . . 75.43 112.958 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 mm -66.19 -41.19 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.239 0.616 . . . . 75.54 111.575 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.98 -36.42 82.14 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.622 0.249 . . . . 72.2 110.786 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.692 ' HD3' ' HA ' ' A' ' 150' ' ' ASN . 96.6 mttt -64.43 -47.05 80.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.733 0.813 . . . . 75.04 109.83 174.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -53.76 -62.41 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.964 1.706 . . . . 72.53 111.858 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.3 ptm -62.3 -38.15 88.28 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.411 0.444 . . . . 70.22 111.269 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -66.21 -42.26 89.0 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 110.286 -0.264 . . . . 75.13 110.286 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.534 HD22 HD11 ' A' ' 7' ' ' ILE . 7.9 t30 -65.59 -54.11 32.43 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.808 0.843 . . . . 74.11 111.445 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.483 HG11 HG13 ' A' ' 172' ' ' VAL . 17.8 m -67.4 -40.17 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.114 0.566 . . . . 74.13 112.173 -171.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 86.6 mt -69.4 -45.68 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 109.626 -0.509 . . . . 75.11 109.626 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.81 -35.23 80.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.371 0.668 . . . . 71.13 111.608 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -59.4 -47.35 85.77 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.878 . . . . 73.33 109.065 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.48 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.6 tpt -71.37 -28.32 63.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.631 -1.168 . . . . 65.13 111.178 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HA ' HG13 ' A' ' 113' ' ' VAL . 29.6 mm-40 -67.43 -23.49 65.54 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.035 0.534 . . . . 73.23 111.394 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -86.02 -30.64 22.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.774 -0.648 . . . . 73.41 109.76 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.31 -36.58 58.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.333 0.653 . . . . 73.22 111.622 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.405 ' HB3' HG11 ' A' ' 113' ' ' VAL . 8.7 t-20 -118.46 -66.68 1.05 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.83 0.852 . . . . 74.14 109.438 -170.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 74.86 -30.49 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.053 1.341 . . . . 73.24 112.892 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.89 -16.86 63.87 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.034 1.334 . . . . 63.51 113.671 -166.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HA ' HG23 ' A' ' 113' ' ' VAL . 40.4 mmtm 79.99 -2.55 2.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.237 1.415 . . . . 72.53 112.299 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.05 -60.36 2.9 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.921 0.488 . . . . 74.12 110.856 171.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -91.11 -34.34 15.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.728 -0.669 . . . . 63.03 111.592 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 103' ' ' MET . 26.9 m -68.96 -44.84 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 112.135 0.42 . . . . 74.55 112.135 -175.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 24.0 t70 -72.51 -32.91 66.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.558 0.743 . . . . 72.31 110.203 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -65.47 -53.08 47.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.772 0.67 . . . . 61.41 109.789 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -56.82 -37.63 71.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.618 -1.174 . . . . 72.23 110.603 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.1 -44.34 92.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.403 1.081 . . . . 75.44 111.158 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 46.0 mmtm -63.37 -38.5 91.38 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.566 0.541 . . . . 73.22 110.609 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 13.9 mmmm -71.73 -49.47 38.98 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.774 -0.648 . . . . 74.55 111.084 -176.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.413 ' HB ' HD13 ' A' ' 26' ' ' LEU . 9.3 tp -74.02 -37.58 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 123.285 0.366 . . . . 74.23 110.732 -173.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.35 -45.53 72.59 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.678 -0.86 . . . . 73.44 108.678 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.99 97.34 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.007 -0.542 . . . . 72.33 112.271 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -64.25 -50.71 66.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.695 0.798 . . . . 71.53 110.441 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.1 m -67.57 -38.24 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 O-C-N 123.782 0.676 . . . . 73.32 111.198 -175.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.97 -39.93 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.081 0.401 . . . . 64.05 110.538 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.7 t -70.61 -45.35 65.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.476 -0.329 . . . . 70.14 110.179 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.66 -32.03 73.37 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.897 1.279 . . . . 74.4 111.89 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 59.2 mt -88.47 3.12 51.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.052 0.541 . . . . 73.03 111.827 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.19 92.49 6.9 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.004 0.522 . . . . 52.52 109.714 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.53 ' HD3' ' SG ' ' A' ' 81' ' ' CYS . 48.0 mtmt -60.4 -9.2 3.28 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.088 1.355 . . . . 74.15 114.266 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -53.62 -47.65 70.05 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 73.25 110.472 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.457 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -111.9 -34.4 6.01 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.101 -0.954 . . . . 74.1 110.767 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -73.29 -0.31 14.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.633 1.345 . . . . 74.24 114.633 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.1 ptmt -50.56 -9.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.676 1.362 . . . . 73.51 114.676 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -81.92 6.77 14.82 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.735 0.814 . . . . 74.42 111.732 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 157' ' ' GLU . 90.6 mt -89.41 140.99 28.96 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.355 0.662 . . . . 73.13 109.688 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.57 113.35 15.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.87 -1.9 . . . . 75.35 105.87 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.448 ' HE2' ' SG ' ' A' ' 81' ' ' CYS . 65.0 m-85 -87.61 136.51 32.92 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.631 -0.507 . . . . 71.33 109.631 -172.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -135.44 153.28 51.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.012 -1.107 . . . . 72.22 108.012 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.2 tt -139.01 145.35 27.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 108.945 -0.761 . . . . 70.24 108.945 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.68 131.27 51.33 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.267 0.979 . . . . 73.53 112.222 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.98 -33.68 3.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.262 1.425 . . . . 75.03 112.522 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -73.48 -49.34 27.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.23 1.012 . . . . 73.14 110.563 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.7 78.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.566 0.746 . . . . 62.01 111.72 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.72 -8.94 59.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.693 -0.685 . . . . 54.33 112.764 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -89.01 -41.83 12.12 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.058 0.456 . . . . 65.2 109.85 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -100.7 5.09 56.64 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.64 -0.709 . . . . 72.03 113.672 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 60.45 34.74 20.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.833 0.853 . . . . 75.42 110.568 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -63.18 178.37 0.51 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.719 1.208 . . . . 64.33 112.996 -173.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.692 ' HA ' ' HD3' ' A' ' 94' ' ' LYS . 4.2 t30 -88.11 8.17 28.12 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.716 -1.129 . . . . 74.11 109.614 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.25 144.65 48.71 Favored Glycine 0 C--N 1.359 1.853 0 CA-C-N 115.952 -0.567 . . . . 73.45 113.01 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.451 ' NE2' HD21 ' A' ' 171' ' ' LEU . 8.9 pt20 -85.0 162.74 19.24 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.672 0.789 . . . . 74.43 110.916 -174.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.15 125.36 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.814 -1.085 . . . . 75.14 110.015 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.16 107.95 3.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.383 1.073 . . . . 75.13 109.36 169.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.6 mt -90.94 102.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.422 -0.585 . . . . 75.45 109.422 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.22 148.03 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.939 -0.763 . . . . 74.3 108.939 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.621 ' HB3' HD21 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -139.17 147.41 41.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.735 0.814 . . . . 74.41 108.942 169.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -98.24 134.37 41.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.195 -1.039 . . . . 71.05 108.195 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 23.7 ttm180 -124.83 153.14 42.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.051 0.94 . . . . 70.23 108.849 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.76 93.99 4.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.941 0.337 . . . . 64.32 110.491 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.3 p -119.37 123.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.716 0.806 . . . . 74.33 110.166 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 55.75 32.57 19.72 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.516 1.126 . . . . 74.44 112.612 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.01 68.89 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.181 -0.463 . . . . 74.45 113.422 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 m -128.05 125.8 40.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.254 0.622 . . . . 74.0 110.257 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 9.5 pt-20 -73.48 112.89 9.98 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.461 0.704 . . . . 75.15 109.267 169.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.93 106.89 46.91 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.483 0.713 . . . . 74.35 109.348 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.7 Cg_exo -76.16 117.05 4.52 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 122.675 2.25 . . . . 71.22 111.154 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.2 m -116.1 124.23 49.86 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.153 -0.684 . . . . 75.31 109.153 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 29.3 tp -76.99 137.7 39.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.395 1.078 . . . . 72.41 109.937 171.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 74.2 mtp -117.63 122.72 44.34 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.344 -1.354 . . . . 73.12 107.344 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.451 HD21 ' NE2' ' A' ' 152' ' ' GLN . 80.1 mt -136.33 147.85 47.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.076 -1.083 . . . . 73.41 108.076 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.483 HG13 HG11 ' A' ' 99' ' ' VAL . 10.0 p -75.46 144.65 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 109.464 -0.569 . . . . 74.35 109.464 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.44 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 12.8 ptmm? -57.0 -32.79 66.48 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.642 0.777 . . . . 65.55 112.188 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -85.82 1.1 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.809 0.844 . . . . 74.11 113.046 -165.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.46 -1.01 6.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.46 0.304 . . . . 70.52 111.637 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.24 141.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.624 0.77 . . . . 74.21 109.501 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.527 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.1 mm -126.88 114.0 35.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.214 -1.402 . . . . 72.32 107.214 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -84.47 127.0 33.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.235 -0.654 . . . . 63.11 109.235 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -116.3 101.78 8.98 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.075 -0.713 . . . . 75.54 109.075 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.417 ' HA ' HD22 ' A' ' 2' ' ' LEU . 36.0 ttpt -68.51 137.76 54.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.412 0.685 . . . . 73.42 110.539 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.436 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 21.8 t -131.87 88.3 2.55 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.623 -0.88 . . . . 72.44 108.623 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.3 mt -131.2 100.8 5.32 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.672 1.189 . . . . 71.53 108.257 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.559 1.298 0 C-N-CA 123.808 0.843 . . . . 73.41 110.718 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 108.772 -0.825 . . . . 72.11 108.772 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.0 mt -94.53 115.41 27.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.117 0.484 . . . . 74.3 110.497 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 49.8 mt -99.04 132.48 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.091 -1.077 . . . . 72.14 108.091 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 64.5 m-85 -121.76 132.39 54.59 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.484 -0.932 . . . . 73.3 108.484 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.561 ' NZ ' ' HB2' ' A' ' 179' ' ' GLU . 3.5 mppt? -120.67 120.18 34.97 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.415 0.686 . . . . 75.42 110.877 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 21.5 t70 -69.05 177.87 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.195 0.998 . . . . 73.14 108.797 170.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 pt -81.88 -29.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.838 -1.164 . . . . 75.11 111.62 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.05 -38.71 4.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.605 0.762 . . . . 72.22 110.64 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 m -96.28 15.81 20.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.833 -1.076 . . . . 70.21 109.686 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.575 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 4.2 p-10 -54.62 -33.85 61.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.214 1.406 . . . . 73.22 113.253 -172.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.61 -57.39 8.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.382 1.676 . . . . 74.54 112.131 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -123.83 24.34 8.39 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.766 0.654 . . . . 74.53 112.766 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 tm? -60.28 -61.14 2.82 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.572 0.349 . . . . 73.51 110.552 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.624 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 35.6 t -155.21 161.27 41.23 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 110.048 -0.353 . . . . 62.42 110.048 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 23.0 t 172.3 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.455 1.097 . . . . 74.31 109.838 -168.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.479 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 23.4 t70 -177.8 165.24 2.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.802 1.241 . . . . 63.51 109.145 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 p -67.8 88.35 0.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.414 -0.588 . . . . 72.43 109.414 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 23.4 m-85 -109.83 151.67 42.5 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.915 -1.039 . . . . 64.1 111.514 -175.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.66 120.74 7.11 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.913 1.742 . . . . 53.23 110.982 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.9 135.96 34.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.47 -0.937 . . . . 65.12 108.47 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 8.6 mmmm -141.82 107.32 5.05 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.219 -1.4 . . . . 75.24 107.219 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.6 tp -109.29 133.65 52.78 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.809 -0.812 . . . . 74.24 108.809 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.92 137.13 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.826 0.851 . . . . 72.24 109.083 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.5 t70 66.42 4.32 3.21 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.401 1.08 . . . . 75.42 112.263 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.8 t70 59.47 11.68 2.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.904 1.281 . . . . 74.21 112.57 -167.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.3 tp -113.03 -41.51 3.72 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.686 -0.634 . . . . 74.3 110.158 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.47 130.94 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.089 0.556 . . . . 73.21 109.656 -167.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -93.61 117.77 30.52 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.561 -0.903 . . . . 72.44 108.561 171.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 7.0 pt-20 -97.42 119.56 36.19 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.479 0.712 . . . . 70.41 109.728 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.595 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 23.3 t80 -110.76 106.21 15.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.25 -1.019 . . . . 75.34 108.25 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.05 113.5 4.51 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.21 0.204 . . . . 73.51 111.19 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.13 165.4 22.85 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 110.825 -0.91 . . . . 75.1 110.825 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.643 ' HG2' ' HB2' ' A' ' 69' ' ' ASP . 18.2 ptpt -94.37 125.38 38.97 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.65 0.725 . . . . 74.33 109.673 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.59 ' HB3' ' HG3' ' A' ' 167' ' ' PRO . 0.3 OUTLIER -73.63 106.84 5.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.158 0.583 . . . . 73.21 109.436 177.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.476 ' HB ' HD12 ' A' ' 42' ' ' ILE . 9.9 m -139.24 162.24 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.675 0.79 . . . . 75.51 110.786 -170.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 m -109.56 124.01 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.197 -0.94 . . . . 72.15 109.422 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.405 ' HB2' HD13 ' A' ' 72' ' ' LEU . 16.7 tpt180 -132.7 108.09 8.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.013 -0.365 . . . . 75.13 110.013 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -129.65 160.46 33.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.281 1.032 . . . . 72.25 108.526 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 50.73 -76.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.635 1.974 . . . . 74.52 113.497 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.31 32.35 0.11 Allowed Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.676 -0.57 . . . . 64.23 111.676 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -147.39 146.67 29.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.356 0.662 . . . . 73.45 110.322 -175.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.476 HD12 ' HB ' ' A' ' 35' ' ' VAL . 5.9 tp . . . . . 0 CA--C 1.555 1.153 0 C-N-CA 124.796 1.238 . . . . 75.23 109.063 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--O 1.236 0.358 0 N-CA-C 105.012 -2.218 . . . . 65.53 105.012 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.74 ' HG3' ' HG2' ' A' ' 66' ' ' ARG 0.25 10.4 pt-20 65.15 -36.08 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 127.612 2.365 . . . . 70.04 115.632 164.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.74 ' HG2' ' HG3' ' A' ' 65' ' ' GLU . 18.1 mmt180 -132.66 110.92 10.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 104.76 -2.311 . . . . 65.12 104.76 -174.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.6 37.83 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.468 -0.653 . . . . 72.23 111.468 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 34' ' ' HIS . 30.9 pt -109.6 160.07 8.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.143 -0.688 . . . . 73.35 109.143 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.643 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . 24.1 t70 -39.15 -40.53 0.73 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.26 1.024 . . . . 75.14 113.038 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mm -56.54 -42.36 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.461 -0.791 . . . . 73.3 111.125 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.8 t -85.28 -49.52 15.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 C-N-CA 123.56 0.744 . . . . 74.31 111.717 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' A' ' 37' ' ' ARG . 33.8 mt -72.13 -49.0 39.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.217 0.607 . . . . 73.24 111.919 -169.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -69.79 -26.0 64.06 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 73.12 111.274 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -103.42 -14.95 16.05 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.027 0.381 . . . . 71.13 112.027 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? 60.07 69.97 0.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.516 1.126 . . . . 73.34 110.759 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 mt -96.57 142.13 29.0 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.402 -1.272 . . . . 72.44 109.113 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.04 124.22 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 108.794 -0.817 . . . . 73.0 108.794 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.35 151.08 5.72 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.482 1.113 . . . . 73.35 113.811 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.7 tpt -147.03 103.64 3.62 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 113.839 -1.528 . . . . 75.24 107.271 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -94.24 93.95 8.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.111 -1.441 . . . . 72.52 107.111 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 30.1 p -68.91 -31.02 69.64 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.508 0.67 . . . . 75.2 110.111 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.09 -21.18 61.53 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.42 -1.263 . . . . 73.54 111.711 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -105.18 -16.72 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.509 0.724 . . . . 63.23 112.197 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.39 23.53 6.37 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.301 0.64 . . . . 73.21 110.596 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.18 -28.94 3.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.014 1.725 . . . . 63.22 114.823 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.3 m -62.25 -59.18 5.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 118.109 0.413 . . . . 73.34 111.503 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.2 mmm -64.74 -39.25 93.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.489 0.716 . . . . 73.32 110.233 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -61.1 -46.23 91.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.037 -0.983 . . . . 74.31 112.076 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -61.33 -35.28 76.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.924 0.765 . . . . 74.42 110.106 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.57 82.41 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.746 -0.661 . . . . 71.03 111.323 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -67.37 -43.72 80.74 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.536 0.334 . . . . 72.43 111.498 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -64.08 -33.52 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.604 1.162 . . . . 71.25 111.449 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.87 -47.08 86.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.415 0.686 . . . . 73.13 109.851 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -72.82 -40.46 65.79 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.533 -0.758 . . . . 75.11 110.902 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.08 -54.92 36.94 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.657 1.583 . . . . 75.3 112.069 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttt -59.7 -46.14 89.97 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.738 0.648 . . . . 74.43 110.115 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -58.23 -44.91 88.46 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 115.659 -0.7 . . . . 75.5 109.535 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -62.59 -50.37 71.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.316 1.046 . . . . 72.33 111.144 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.541 HG13 ' HB1' ' A' ' 175' ' ' ALA . 26.4 m -67.93 -39.17 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.275 0.63 . . . . 74.12 112.566 -174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.5 mt -73.39 -38.48 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.495 -0.557 . . . . 74.13 109.495 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.34 -27.19 66.93 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.813 1.245 . . . . 70.35 111.162 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -63.55 -57.92 8.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.952 0.901 . . . . 63.33 109.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.531 ' HG3' HG12 ' A' ' 113' ' ' VAL . 23.2 ptm -73.89 -19.74 60.62 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.86 0.725 . . . . 75.44 111.575 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 26.6 tt0 -53.8 -55.77 23.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.014 0.926 . . . . 74.33 110.759 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -24.34 66.14 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.825 0.703 . . . . 73.45 111.317 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -94.35 -16.43 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.2 1.0 . . . . 72.54 110.787 -173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -129.11 -83.43 0.57 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.83 0.852 . . . . 73.3 110.316 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 94.2 mtt180 53.56 20.9 2.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.751 1.019 . . . . 75.25 113.751 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.19 -21.96 59.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.397 0.679 . . . . 73.53 109.44 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.626 ' HB2' ' HZ3' ' A' ' 110' ' ' LYS . 9.7 mtmp? 86.53 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.415 1.886 . . . . 75.14 112.238 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.47 -44.39 91.2 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.878 0.325 . . . . 72.35 111.878 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.9 -41.46 36.48 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.46 0.704 . . . . 72.11 110.654 -171.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.531 HG12 ' HG3' ' A' ' 103' ' ' MET . 33.4 m -70.71 -28.6 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 115.818 -0.628 . . . . 71.14 110.858 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 29.9 t70 -68.1 -47.79 67.24 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.124 0.57 . . . . 71.34 110.465 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.09 -38.28 90.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.785 0.678 . . . . 62.11 110.082 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -65.36 -49.57 68.86 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.232 -0.894 . . . . 70.41 111.348 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.588 ' HA ' HG21 ' A' ' 120' ' ' ILE . 21.9 pttp -67.46 -25.84 66.09 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.177 0.298 . . . . 72.32 110.894 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -61.91 -51.19 69.16 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.822 0.701 . . . . 74.45 110.566 169.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.83 -36.5 59.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.848 0.685 . . . . 73.22 112.848 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 117' ' ' LYS . 10.6 tp -73.18 -37.18 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 118.538 0.608 . . . . 73.44 109.682 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -48.12 69.38 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.001 0.521 . . . . 74.21 110.091 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.28 94.31 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.63 0.581 . . . . 64.13 112.331 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.41 -55.26 22.18 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 123.513 0.725 . . . . 74.1 110.232 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.1 m -66.05 -41.72 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 118.721 -0.656 . . . . 75.5 111.482 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.79 -40.03 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.686 0.676 . . . . 72.12 110.419 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -73.19 -32.81 65.04 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.067 0.547 . . . . 72.34 111.51 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.667 HD22 HG22 ' A' ' 155' ' ' ILE . 31.0 tp -77.29 -31.2 54.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.567 0.747 . . . . 75.43 110.992 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 56.2 mt -84.0 3.64 33.43 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.855 0.862 . . . . 72.43 111.246 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.04 84.01 0.98 Allowed 'General case' 0 C--N 1.357 0.935 0 N-CA-C 109.263 -0.643 . . . . 71.34 109.263 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 17.8 ptpt -66.09 -14.84 62.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.863 1.431 . . . . 75.43 114.863 -163.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.61 -36.4 80.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.208 0.527 . . . . 71.14 110.489 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.1 mtp-105 -105.76 -39.15 6.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.168 0.987 . . . . 74.31 110.42 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -81.67 -1.43 46.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.383 1.073 . . . . 74.45 113.784 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 24.5 pttm -47.64 -10.85 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.958 1.466 . . . . 74.34 114.958 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -82.01 6.21 16.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.808 0.843 . . . . 72.04 111.66 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 157' ' ' GLU . 96.3 mt -91.69 154.31 19.08 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.286 0.634 . . . . 75.43 110.002 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.62 125.65 18.42 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.793 -1.558 . . . . 73.14 106.793 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -98.68 153.05 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.284 -1.006 . . . . 72.41 108.284 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -143.58 171.15 14.56 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.642 0.777 . . . . 72.11 109.074 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.99 149.12 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.929 -1.137 . . . . 73.53 107.929 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.81 132.79 44.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.474 -0.626 . . . . 75.2 112.23 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.53 -42.65 99.14 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.761 -0.459 . . . . 73.42 109.761 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -65.71 -33.71 76.52 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.5 -0.773 . . . . 73.42 111.931 172.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.51 -44.24 75.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.192 0.597 . . . . 74.41 110.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.06 65.75 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.246 0.966 . . . . 60.34 110.875 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -57.36 -36.57 71.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.369 1.067 . . . . 74.35 111.513 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.6 -52.92 23.0 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.361 -0.836 . . . . 60.21 111.137 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -167.72 154.78 8.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.555 0.742 . . . . 75.54 109.944 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.11 10.05 9.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.3 0.24 . . . . 72.53 110.97 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -88.88 -3.89 58.62 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.585 0.754 . . . . 74.3 110.601 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.66 151.54 24.38 Favored Glycine 0 C--N 1.356 1.642 0 O-C-N 123.963 0.79 . . . . 55.31 113.697 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -79.52 135.52 36.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.029 0.532 . . . . 73.51 111.33 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.41 112.07 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.202 -0.908 . . . . 74.42 110.527 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.88 115.48 14.52 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.415 1.086 . . . . 72.43 109.964 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.667 HG22 HD22 ' A' ' 127' ' ' LEU . 54.4 mt -92.8 115.21 31.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 122.922 0.489 . . . . 74.44 109.932 -171.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 68' ' ' ILE . 35.1 mm -98.81 116.22 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 118.441 0.564 . . . . 64.42 110.562 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 159' ' ' ARG . 46.0 tt0 -97.22 101.46 13.03 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.259 1.023 . . . . 75.31 109.554 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -75.62 89.7 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.564 -1.273 . . . . 74.01 107.564 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.451 ' HB2' ' HG2' ' A' ' 157' ' ' GLU . 39.0 ttt85 -99.52 149.7 22.96 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.808 -0.812 . . . . 72.42 108.808 -172.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -122.47 130.56 53.19 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.592 -0.892 . . . . 74.32 108.592 167.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.1 109.37 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.362 -0.977 . . . . 73.45 108.362 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 60.1 28.84 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.498 1.119 . . . . 75.32 110.568 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.54 -17.08 59.92 Favored Glycine 0 C--N 1.357 1.743 0 CA-C-N 115.548 -0.751 . . . . 71.43 113.432 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.7 m -81.32 112.24 18.44 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.238 0.519 . . . . 75.54 110.42 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -71.84 103.33 3.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.501 0.72 . . . . 51.24 110.09 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.05 92.67 15.67 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 125.12 1.368 . . . . 75.55 109.224 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 34' ' ' HIS . 72.1 Cg_endo -75.26 116.53 4.56 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.395 2.063 . . . . 73.3 111.645 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 31.1 p -117.22 135.6 53.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.282 1.033 . . . . 64.03 110.605 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.4 tp -77.18 114.05 15.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.131 0.972 . . . . 75.21 108.895 170.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 66.6 mmm -102.67 121.49 42.52 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.259 -1.386 . . . . 64.55 107.259 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.1 mt -136.0 147.12 47.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 106.966 -1.494 . . . . 74.44 106.966 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.446 HG13 HG11 ' A' ' 99' ' ' VAL . 7.5 p -73.05 131.17 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.55 -0.907 . . . . 71.54 108.55 173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.61 -34.82 59.83 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.38 1.472 . . . . 74.14 111.634 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.17 -18.45 65.31 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 75.15 112.2 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.541 ' HB1' HG13 ' A' ' 99' ' ' VAL . . . -127.36 15.95 7.15 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.428 0.691 . . . . 71.02 111.74 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.5 tp -131.49 119.01 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 N-CA-C 108.199 -1.038 . . . . 71.5 108.199 165.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.43 113.74 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.644 -0.502 . . . . 74.34 109.644 -168.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -70.61 154.51 41.8 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.192 0.997 . . . . 64.35 111.244 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.574 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.4 tp10 -147.51 101.6 3.37 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.36 -0.607 . . . . 75.12 109.36 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -83.46 94.55 8.03 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.908 -0.404 . . . . 74.24 109.908 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 44.0 t -96.49 89.73 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.93 -1.137 . . . . 74.12 107.93 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.92 172.83 16.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.741 -0.663 . . . . 74.23 111.134 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 CA--C 1.559 1.324 0 C-N-CA 124.556 1.142 . . . . 64.53 110.793 -171.505 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.64 ' HG3' ' HG ' ' A' ' 2' ' ' LEU . 20.9 ptt? . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 112.997 0.74 . . . . 73.32 112.997 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.64 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 87.0 mt -136.03 161.51 35.47 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 123.327 0.651 . . . . 74.54 110.815 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 57.1 mt -96.65 120.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.351 -1.351 . . . . 63.55 107.351 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.592 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 22.7 m-85 -112.54 96.95 6.28 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.518 -1.66 . . . . 73.3 106.518 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 14.0 ptmm? -107.41 127.24 53.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.272 -0.876 . . . . 74.51 110.898 -173.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 25.1 t70 -74.2 178.16 5.29 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.59 -1.186 . . . . 65.04 109.807 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.464 HD13 HD22 ' A' ' 98' ' ' ASN . 62.0 mt -76.22 -38.66 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.578 -0.701 . . . . 72.3 110.732 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.7 -50.84 2.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.251 1.02 . . . . 70.45 109.867 -172.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -90.25 17.65 6.89 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.095 -0.957 . . . . 75.14 111.106 -171.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 9.0 p-10 -55.19 -26.57 39.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.773 1.629 . . . . 74.21 113.657 -170.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -49.46 -62.19 1.68 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 125.178 1.549 . . . . 74.14 112.493 -170.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -123.6 24.08 8.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.273 -0.876 . . . . 71.31 111.901 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 1.8 tm? -59.43 -73.58 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.993 0.517 . . . . 73.1 109.648 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 27.1 m -149.73 151.94 34.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.968 -1.123 . . . . 70.44 107.968 167.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 m -155.76 111.9 3.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.098 0.559 . . . . 72.52 110.359 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.269 4.1 p-10 51.88 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.31 1.844 . . . . 74.02 112.33 172.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.1 p -60.71 5.85 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.435 1.642 . . . . 72.03 115.435 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.41 146.94 32.87 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.777 0.831 . . . . 70.52 109.935 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -91.38 173.09 2.75 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.348 2.699 . . . . 74.12 114.312 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.646 ' HA ' ' HE1' ' A' ' 28' ' ' TYR . 23.8 ptt? -114.09 151.68 32.21 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.898 -1.046 . . . . 73.12 109.799 169.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -149.39 97.53 2.66 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 106.818 -1.549 . . . . 74.22 106.818 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.0 tp -91.72 122.03 33.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.812 -0.81 . . . . 73.01 108.812 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.96 134.32 53.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 C-N-CA 123.693 0.797 . . . . 74.31 108.954 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.31 21.72 8.57 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.848 0.859 . . . . 71.44 111.764 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 68.15 -9.29 0.5 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.824 1.249 . . . . 73.22 113.756 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.6 tp -102.76 -52.56 3.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.516 -0.74 . . . . 73.52 111.448 -167.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -103.71 129.08 56.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.043 -0.981 . . . . 71.42 109.586 -164.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HE1' ' HA ' ' A' ' 20' ' ' MET . 17.2 t80 -83.35 112.83 20.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.38 -1.341 . . . . 75.11 107.38 170.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.8 121.64 38.87 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.528 -1.214 . . . . 71.01 108.196 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -113.13 136.58 52.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.459 0.704 . . . . 72.01 109.548 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 136.15 57.88 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.374 1.07 . . . . 75.05 113.314 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.62 146.21 14.07 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 110.58 -1.008 . . . . 73.43 110.58 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.79 151.83 40.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.266 0.533 . . . . 72.34 109.69 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -74.97 124.34 26.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.715 -0.476 . . . . 75.43 109.715 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.53 160.58 16.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 124.407 1.083 . . . . 74.42 109.454 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.496 HG13 ' HG3' ' A' ' 66' ' ' ARG . 16.1 m -120.14 103.55 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.791 -1.559 . . . . 63.44 106.791 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.589 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.5 mtp180 -101.06 155.74 17.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.812 -1.085 . . . . 74.34 108.315 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 20.6 ttpp -135.5 161.83 34.38 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.627 -1.249 . . . . 74.32 107.627 170.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -43.37 -32.41 0.83 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.465 1.506 . . . . 75.23 113.927 -172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.83 54.83 0.53 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.448 -0.661 . . . . 55.2 111.448 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.678 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.8 tt0 -163.97 150.67 11.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.34 0.656 . . . . 72.24 110.939 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 124.841 1.256 . . . . 74.25 107.799 168.571 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 107.479 -1.304 . . . . 64.42 107.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.3 mt-10 -85.59 70.5 10.75 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.518 -1.29 . . . . 72.33 107.518 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.496 ' HG3' HG13 ' A' ' 36' ' ' VAL . 18.7 ttp180 -96.55 139.18 33.02 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.465 0.65 . . . . 73.35 111.025 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.69 -131.99 5.22 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 114.858 -1.065 . . . . 63.34 111.374 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.741 HD13 ' HB2' ' A' ' 167' ' ' PRO . 0.8 OUTLIER -99.87 133.97 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.184 0.594 . . . . 72.23 110.755 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -36.79 -48.32 0.72 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.835 2.054 . . . . 65.32 114.186 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.7 mm -50.31 -53.33 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 124.164 0.915 . . . . 73.1 111.436 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.545 HG12 ' HB2' ' A' ' 76' ' ' LEU . 57.7 t -80.84 -23.17 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.615 0.766 . . . . 73.51 111.299 -170.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 60.7 mt -77.47 -38.13 49.89 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.905 0.482 . . . . 72.24 110.578 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.52 -49.38 12.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.81 0.844 . . . . 75.31 110.819 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.89 -21.39 34.27 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.555 0.342 . . . . 64.35 111.094 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm 63.11 66.97 0.7 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 124.632 1.173 . . . . 73.34 110.85 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.545 ' HB2' HG12 ' A' ' 71' ' ' VAL . 40.5 mt -93.18 162.72 13.91 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.442 -1.254 . . . . 65.13 109.587 174.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.12 135.65 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.636 0.775 . . . . 73.11 109.912 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.11 152.85 44.87 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.493 0.923 . . . . 62.32 113.493 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 59.8 mtm -146.06 104.93 3.87 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.106 1.762 . . . . 75.54 106.434 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.68 124.58 25.05 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.202 -0.666 . . . . 75.32 109.202 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.418 ' SG ' ' CD2' ' A' ' 138' ' ' PHE . 3.8 m -56.31 -30.89 63.14 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.848 0.859 . . . . 73.11 111.612 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -69.49 -45.54 68.71 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 113.592 -1.64 . . . . 74.22 112.86 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -97.73 -28.23 13.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.883 0.473 . . . . 74.14 111.914 -173.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.97 19.5 18.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.151 0.98 . . . . 71.1 111.132 -169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.76 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.264 1.025 . . . . 71.04 113.743 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -72.79 -55.51 6.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.037 0.935 . . . . 72.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.6 mtt -64.07 -37.2 86.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.055 0.542 . . . . 75.35 110.403 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.608 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 14.9 t80 -54.04 -49.07 69.78 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.747 1.219 . . . . 74.51 111.03 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.622 ' HB3' ' HZ2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -64.61 -34.9 79.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 74.34 110.093 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.46 81.14 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.328 0.392 . . . . 72.44 111.005 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -67.67 -32.7 73.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.504 0.722 . . . . 72.34 112.505 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.9 mm -67.31 -44.71 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.468 0.707 . . . . 74.4 111.245 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.6 -40.61 92.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.914 0.486 . . . . 74.45 109.827 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -63.28 -50.22 70.97 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.262 -0.881 . . . . 71.12 109.435 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -56.51 -51.01 70.13 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.243 1.417 . . . . 75.53 112.12 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.5 -40.27 85.2 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.344 0.402 . . . . 71.21 110.993 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -68.43 -38.68 81.4 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.875 -0.417 . . . . 72.35 109.875 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.464 HD22 HD13 ' A' ' 7' ' ' ILE . 30.2 t30 -58.45 -55.69 31.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 63.43 110.625 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.469 HG13 HG11 ' A' ' 172' ' ' VAL . 22.3 m -71.41 -39.98 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 114.969 -1.014 . . . . 71.04 112.865 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.25 -45.82 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 110.014 -0.365 . . . . 72.33 110.014 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -56.03 -38.47 70.6 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.474 0.71 . . . . 71.14 110.8 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -56.33 -58.11 9.37 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.152 0.907 . . . . 74.34 110.197 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.4 mmm -70.28 -26.74 63.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.535 -0.302 . . . . 72.33 111.138 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HA ' HG12 ' A' ' 113' ' ' VAL . 40.5 tt0 -64.35 -45.91 85.72 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.359 1.064 . . . . 72.01 110.681 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -89.29 -9.61 49.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.273 0.471 . . . . 74.15 112.273 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.25 -22.9 21.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.508 0.559 . . . . 70.44 112.508 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -124.86 -43.95 1.96 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.573 0.349 . . . . 74.51 111.16 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.96 25.62 14.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.718 0.807 . . . . 72.33 111.234 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -119.13 126.59 51.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.032 0.933 . . . . 74.54 109.361 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -62.24 -36.0 80.67 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.748 0.819 . . . . 75.52 111.85 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.34 60.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.783 0.433 . . . . 72.51 110.889 -172.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.11 -60.64 2.21 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.445 -0.576 . . . . 72.32 109.445 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 104' ' ' GLU . 30.3 m -67.45 -35.52 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.737 -1.12 . . . . 74.41 112.875 -167.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.54 -33.9 35.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.458 0.703 . . . . 75.43 110.324 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.26 64.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.706 -0.479 . . . . 74.3 109.706 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.419 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 42.0 t80 -71.49 -40.62 70.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.972 -1.013 . . . . 72.23 110.129 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -62.31 -38.62 90.11 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.685 0.794 . . . . 75.15 110.207 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.81 -40.42 88.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.557 -1.201 . . . . 74.5 109.698 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -71.71 -37.18 70.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.627 0.771 . . . . 74.12 109.927 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 172' ' ' VAL . 8.3 mm -65.05 -47.81 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.655 0.782 . . . . 72.25 109.2 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.11 -37.83 81.16 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.784 0.678 . . . . 75.35 110.577 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.52 58.62 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 115.83 -0.623 . . . . 53.33 112.393 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.79 -51.19 61.08 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.053 0.502 . . . . 75.32 110.762 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.0 m -70.87 -41.71 77.25 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.966 0 CA-C-O 118.546 -0.74 . . . . 73.2 111.071 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.57 -32.28 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 119.727 1.149 . . . . 72.2 110.619 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.6 t -70.63 -32.58 69.95 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.522 0.329 . . . . 71.22 110.597 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.653 ' HA ' ' HD2' ' A' ' 132' ' ' ARG . 37.8 tp -76.03 -40.43 53.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.004 0.922 . . . . 74.1 111.174 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.608 HD22 ' HZ ' ' A' ' 88' ' ' PHE . 47.6 mt -77.65 1.7 18.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.1 0.96 . . . . 75.32 111.142 -170.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.23 130.04 39.36 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.364 -1.347 . . . . 74.13 107.364 168.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.62 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 50.3 mtmt -68.06 -6.46 22.84 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.467 0.914 . . . . 65.31 113.467 -173.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 22.7 t70 -68.52 -30.34 69.13 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.763 0.825 . . . . 71.25 109.764 171.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.653 ' HD2' ' HA ' ' A' ' 127' ' ' LEU . 42.6 mtt180 -81.34 -33.2 32.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.992 -0.443 . . . . 72.24 110.515 171.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.626 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.1 m-85 -67.0 -20.23 65.85 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.549 0.739 . . . . 74.04 111.866 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 131' ' ' ASP . 24.3 pttm -61.98 -30.9 71.24 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.582 0.551 . . . . 72.14 110.577 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -127.56 25.5 6.06 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.332 1.053 . . . . 74.11 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.626 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 24.2 mt -100.27 144.28 29.47 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.585 0.707 . . . . 73.32 111.341 168.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.4 121.06 15.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.523 -1.658 . . . . 74.02 106.523 167.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.486 ' HB3' HG12 ' A' ' 153' ' ' VAL . 66.4 m-85 -93.57 134.31 35.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.747 -0.464 . . . . 72.53 109.747 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.06 140.96 50.77 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 75.43 109.452 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.4 tt -120.89 159.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.994 -1.484 . . . . 74.01 106.994 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.23 129.72 49.9 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.177 -0.791 . . . . 74.21 111.53 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.29 -41.49 79.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.526 0.731 . . . . 72.33 110.049 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -69.51 -38.55 77.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.861 -1.063 . . . . 73.21 110.666 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.34 -31.44 72.57 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.448 0.699 . . . . 70.41 110.58 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 5.43 12.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.711 0.804 . . . . 71.34 112.049 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.83 -10.28 45.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 71.23 110.403 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.62 -55.51 0.01 OUTLIER Glycine 0 C--N 1.352 1.42 0 N-CA-C 112.016 -0.433 . . . . 72.21 112.016 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.82 83.31 2.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.452 0.701 . . . . 74.13 110.649 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.92 -2.23 50.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.124 0.97 . . . . 74.52 111.22 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.11 78.75 1.83 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.208 -1.775 . . . . 70.01 106.208 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -123.89 -166.58 12.56 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-N 113.797 -1.547 . . . . 34.2 111.733 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -101.58 142.1 33.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.002 -0.74 . . . . 72.21 109.002 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 138' ' ' PHE . 75.8 t -109.4 131.92 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.259 0.624 . . . . 74.23 112.058 -171.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.425 ' HA ' HD23 ' A' ' 171' ' ' LEU . . . -69.67 109.53 4.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.265 -1.334 . . . . 75.24 109.558 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 71.5 mt -85.56 105.5 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.966 -0.753 . . . . 75.21 108.966 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 169' ' ' LEU . 40.9 mm -103.58 119.61 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.008 -0.738 . . . . 75.03 109.008 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.94 127.81 47.64 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.827 0.346 . . . . 74.34 110.482 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -75.97 110.63 10.6 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 115.106 -0.952 . . . . 73.21 109.341 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.491 ' HB2' HG12 ' A' ' 166' ' ' VAL . 22.6 mmt85 -101.86 172.8 6.72 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.357 -0.979 . . . . 74.44 108.357 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -122.58 119.06 29.71 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.128 0.571 . . . . 73.33 110.603 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.73 118.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.021 0.528 . . . . 65.44 109.903 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 67.83 -67.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.899 1.68 . . . . 71.12 110.9 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.79 35.68 0.11 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.211 -0.756 . . . . 63.12 111.211 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.6 t -141.86 158.17 44.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.088 0.555 . . . . 64.53 110.863 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -78.75 114.46 17.69 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.748 0.819 . . . . 71.04 111.103 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 159' ' ' ARG . 5.8 p -117.73 89.14 32.33 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 109.11 -0.7 . . . . 74.24 109.11 175.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.741 ' HB2' HD13 ' A' ' 68' ' ' ILE . 1.3 Cg_endo -82.61 122.53 3.56 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 122.342 2.028 . . . . 75.35 110.159 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -105.42 140.0 39.2 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.727 0.811 . . . . 71.44 109.73 -168.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 156' ' ' ILE . 30.8 tp -82.36 123.34 29.01 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.917 0.76 . . . . 73.53 109.635 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.99 123.09 48.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.945 0.898 . . . . 75.41 108.882 174.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.435 HD11 HD13 ' A' ' 176' ' ' ILE . 79.7 mt -140.97 145.51 36.09 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.987 -1.486 . . . . 72.51 106.987 172.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.469 HG11 HG13 ' A' ' 99' ' ' VAL . 7.1 p -76.76 134.88 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 109.427 -0.583 . . . . 73.34 109.427 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.479 ' HZ1' ' HB3' ' A' ' 173' ' ' LYS . 6.0 ttpm? -56.75 -36.76 70.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.511 1.124 . . . . 71.01 111.871 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -68.48 -25.91 65.21 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.901 0.881 . . . . 52.22 112.5 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 99' ' ' VAL . . . -97.59 -1.91 42.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.816 0.446 . . . . 74.32 110.336 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.435 HD13 HD11 ' A' ' 171' ' ' LEU . 48.9 mm -102.55 132.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.362 -0.977 . . . . 74.32 108.362 174.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 44.3 mm -93.22 111.8 25.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.302 -0.999 . . . . 74.41 108.302 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.35 104.34 6.82 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.402 -0.962 . . . . 75.24 108.402 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.515 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.7 tp10 -104.04 111.06 23.47 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.966 -1.124 . . . . 72.04 107.966 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 180' ' ' LYS . 0.1 OUTLIER -79.44 129.66 34.68 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.806 -0.442 . . . . 75.4 109.806 -178.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.4 t -100.81 104.35 15.59 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.734 -0.667 . . . . 74.11 110.417 -171.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.35 161.66 26.51 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.285 1.034 . . . . 74.12 109.399 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 C--O 1.252 1.219 0 CA-C-N 115.104 -0.953 . . . . 73.42 108.553 178.272 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.067 0.46 . . . . 72.05 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.2 mt -84.33 123.82 30.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.849 -0.797 . . . . 71.02 108.849 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.519 HG23 ' HB3' ' A' ' 15' ' ' SER . 33.3 pt -99.39 128.58 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.535 0.734 . . . . 72.54 109.251 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.495 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 12.9 m-85 -122.95 124.22 42.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.947 1.299 . . . . 74.32 107.807 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -145.85 147.12 31.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.083 0.856 . . . . 74.35 112.239 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 14.9 t70 -101.25 124.08 46.39 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.899 0.88 . . . . 70.22 109.996 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.606 HG12 ' HA ' ' A' ' 175' ' ' ALA . 43.4 pt -66.56 -26.85 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.68 0.622 . . . . 72.41 112.68 -164.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.61 -60.97 2.11 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.293 0.568 . . . . 75.42 111.587 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 m -125.53 -46.48 1.75 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.91 -1.041 . . . . 75.24 111.737 -159.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 2.8 t0 -101.4 24.05 10.17 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.99 0.916 . . . . 74.02 110.486 -166.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -50.81 -2.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.016 2.228 . . . . 72.05 117.016 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -99.59 -41.52 7.3 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.645 1.111 . . . . 75.03 109.86 167.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 26.6 tp 36.51 -88.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.79 2.036 . . . . 74.0 113.655 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.5 m -157.3 134.48 10.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.802 0.841 . . . . 74.24 109.477 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.519 ' HB3' HG23 ' A' ' 3' ' ' ILE . 50.4 m -130.73 97.93 4.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.487 0.715 . . . . 74.44 109.149 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.45 ' HB3' ' HE1' ' A' ' 18' ' ' PHE . 24.3 t70 -166.52 -90.64 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.185 0.594 . . . . 75.2 110.258 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 m -170.2 78.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.463 1.105 . . . . 73.15 108.874 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.45 ' HE1' ' HB3' ' A' ' 16' ' ' ASP . 53.9 m-85 -112.43 139.12 22.26 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.744 0.817 . . . . 73.43 110.213 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' HE1' ' A' ' 30' ' ' PHE . 57.9 Cg_exo -53.8 117.57 4.0 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.202 1.935 . . . . 74.12 111.495 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.92 134.26 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.364 -0.835 . . . . 74.42 109.507 -172.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 39.1 ttmt -137.2 140.17 41.57 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.738 -1.208 . . . . 74.22 107.738 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 tp -131.75 108.07 9.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.831 -1.174 . . . . 74.15 107.831 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.35 133.64 42.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.848 0.859 . . . . 71.5 110.017 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.92 14.65 4.41 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.749 1.22 . . . . 63.12 112.763 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.7 t70 58.23 10.36 1.25 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.641 1.177 . . . . 73.35 111.987 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD23 ' HB3' ' A' ' 119' ' ' LYS . 51.8 tp -103.9 -47.1 4.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.01 0.924 . . . . 70.0 111.333 -167.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -126.93 131.54 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 115.835 -0.621 . . . . 74.33 110.077 -172.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.429 ' HB2' HG21 ' A' ' 176' ' ' ILE . 82.1 t80 -85.24 135.11 34.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.41 1.084 . . . . 72.53 108.439 169.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 32.5 tt0 -117.98 144.99 45.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.362 0.665 . . . . 74.23 109.286 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.605 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.5 t80 -131.97 138.45 48.3 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.91 1.284 . . . . 74.43 107.683 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.33 153.94 39.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.647 0.379 . . . . 64.2 110.714 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.1 159.72 30.61 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.977 -0.556 . . . . 63.23 112.124 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -134.83 138.88 44.62 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.01 0.924 . . . . 74.44 109.244 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -70.57 120.46 16.23 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.543 -1.28 . . . . 73.52 107.543 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.84 -178.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.477 0.711 . . . . 75.03 109.941 -168.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.9 156.05 42.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.305 1.042 . . . . 72.45 108.578 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 38.1 ttm180 -140.06 132.64 28.74 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.282 0.563 . . . . 72.41 109.977 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.564 ' HD2' ' HB2' ' A' ' 41' ' ' GLU . 65.0 mttp -133.38 156.17 48.14 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.142 1.377 . . . . 73.03 107.456 164.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.09 -38.62 83.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 75.4 112.019 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.85 -44.04 1.58 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.951 -0.568 . . . . 75.43 113.16 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.564 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 24.6 mm-40 -95.9 163.35 13.19 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.296 0.638 . . . . 71.22 111.836 -171.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 tp . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 124.889 1.276 . . . . 73.03 108.407 178.467 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.51 HG22 ' HE3' ' A' ' 38' ' ' LYS . 37.7 t . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 108.894 -0.78 . . . . 73.44 108.894 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 9.4 mp0 -75.27 73.91 2.38 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.977 -1.49 . . . . 74.04 106.977 171.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -92.22 135.5 33.95 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.846 -1.07 . . . . 74.25 110.693 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.44 -154.43 25.52 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.836 -1.306 . . . . 73.35 109.836 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -94.62 153.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.684 0.742 . . . . 73.43 111.496 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -42.88 -46.66 5.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.888 1.675 . . . . 65.54 113.097 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 169' ' ' LEU . 45.1 mt -60.42 -47.97 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.919 1.288 . . . . 73.11 110.877 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -72.83 -42.56 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 114.604 -1.18 . . . . 74.43 112.195 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.49 -36.27 80.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.917 0.487 . . . . 71.24 110.768 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -59.58 -61.97 2.23 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.364 0.666 . . . . 64.44 110.634 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.486 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 59.6 t-80 -81.57 -17.7 47.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.264 -0.426 . . . . 72.34 112.1 -170.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 64.37 61.12 0.89 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.736 1.255 . . . . 75.23 108.427 -167.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 95.7 mt -82.07 133.46 35.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.066 -1.424 . . . . 74.43 109.399 174.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 145' ' ' ALA . 7.3 p -91.93 138.38 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.325 0.65 . . . . 74.12 109.386 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.33 147.41 53.0 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.994 0.902 . . . . 74.42 111.519 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -132.64 103.12 5.97 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 103.081 -2.933 . . . . 72.03 103.081 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 12.2 t-20 -69.14 116.54 9.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.515 1.126 . . . . 72.4 111.104 -172.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.5 p -63.99 -28.77 70.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.59 0.756 . . . . 74.51 111.843 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -73.3 -58.89 2.99 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.493 -1.231 . . . . 64.33 112.157 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -103.51 -6.73 21.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.922 0.712 . . . . 71.53 112.922 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 16.1 m-20 -121.2 22.69 10.81 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.647 0.779 . . . . 74.42 111.266 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.56 -35.21 40.17 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.835 0.854 . . . . 74.15 112.399 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.6 m -64.11 -38.27 90.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.442 0.697 . . . . 75.05 111.353 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 mtt -60.18 -45.84 91.74 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.627 -0.508 . . . . 75.34 109.627 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 46.1 t80 -63.09 -35.42 80.19 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.889 0.743 . . . . 75.53 111.245 -176.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.9 -25.34 55.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.196 0.598 . . . . 71.21 111.47 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.29 -45.89 75.23 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 109.576 -0.527 . . . . 72.13 109.576 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 76.4 m-85 -54.15 -54.54 38.27 Favored 'General case' 0 C--O 1.202 -1.444 0 CA-C-N 114.71 -1.132 . . . . 73.41 109.473 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.02 -42.46 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.093 0.957 . . . . 71.14 112.088 -172.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -59.75 -55.64 31.76 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 122.442 0.297 . . . . 64.42 111.167 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -37.78 76.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 123.526 0.516 . . . . 74.3 110.386 -174.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -55.95 -57.01 13.91 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.838 1.655 . . . . 74.45 111.434 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.4 ttm -67.86 -40.09 83.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.847 0.717 . . . . 71.31 111.56 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -61.7 -44.68 96.47 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.376 0.422 . . . . 73.33 110.323 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -70.6 -45.2 65.75 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 124.16 0.913 . . . . 71.22 111.235 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.56 -40.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.202 0.314 . . . . 74.51 111.758 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.8 mt -73.43 -39.47 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 117.983 0.356 . . . . 74.54 110.746 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.19 -38.72 85.86 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.709 0.804 . . . . 74.55 110.974 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.87 -44.78 54.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.562 -0.744 . . . . 73.41 110.129 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.533 ' SD ' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -58.61 -40.37 83.08 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.642 0.777 . . . . 71.32 109.735 177.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.518 ' HA ' HG11 ' A' ' 113' ' ' VAL . 40.9 tt0 -65.7 -29.73 70.32 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.302 1.041 . . . . 74.44 111.374 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -75.1 -40.15 60.15 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.335 0.654 . . . . 74.35 110.131 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -73.2 -34.52 66.01 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.22 1.008 . . . . 73.45 111.86 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.686 HD22 ' HB3' ' A' ' 112' ' ' ASP . 42.5 t30 -100.59 -45.96 5.35 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.868 0.867 . . . . 70.3 111.639 -171.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 77.82 -17.17 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.241 1.416 . . . . 75.52 112.532 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 113' ' ' VAL . 23.9 t70 -96.6 126.27 41.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.14 109.657 -174.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -77.65 -27.15 50.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.161 0.584 . . . . 75.4 112.118 -174.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.56 89.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.731 0.412 . . . . 72.22 111.804 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.686 ' HB3' HD22 ' A' ' 107' ' ' ASN . 30.0 t70 -85.6 -33.54 21.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.629 0.772 . . . . 75.35 111.354 -174.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.581 HG12 HD21 ' A' ' 107' ' ' ASN . 16.9 m -78.99 -28.07 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 117.944 0.338 . . . . 72.44 111.833 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.99 -42.13 85.6 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.888 0.475 . . . . 73.54 109.84 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.39 -45.86 78.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.593 -0.73 . . . . 72.12 110.052 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.423 ' HZ ' ' HB2' ' A' ' 174' ' ' GLU . 81.1 t80 -56.31 -45.83 80.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.437 1.095 . . . . 71.24 111.119 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -57.35 -47.86 80.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 72.44 110.667 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -69.04 -26.53 65.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.703 0.801 . . . . 70.42 111.411 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.449 ' HB3' HD23 ' A' ' 26' ' ' LEU . 32.5 mmtp -78.14 -35.51 48.88 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.344 0.658 . . . . 71.24 110.644 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.2 mm -69.66 -44.22 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.635 0.374 . . . . 73.15 110.046 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -58.42 -46.53 86.29 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.96 0.904 . . . . 74.41 109.614 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.39 99.22 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 124.194 0.934 . . . . 65.33 112.925 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -64.62 -51.51 62.29 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.301 0.64 . . . . 75.21 110.174 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.9 m -70.99 -41.22 76.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 0 CA-C-O 118.309 -0.853 . . . . 73.53 111.096 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.41 -33.04 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 119.486 1.039 . . . . 73.02 110.218 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.2 t -72.3 -42.15 65.81 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.437 0.695 . . . . 70.44 110.616 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.561 ' HA ' ' HG3' ' A' ' 132' ' ' ARG . 34.8 tp -79.09 -20.05 49.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.432 1.093 . . . . 74.11 111.952 -173.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -83.39 4.07 29.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.005 0.922 . . . . 74.44 112.206 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.32 38.98 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.009 0.524 . . . . 74.31 110.723 172.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.551 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 4.3 ttpm? -62.33 -45.03 95.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.027 0.931 . . . . 74.43 112.289 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.53 -24.49 64.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.146 0.578 . . . . 64.44 111.425 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.561 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 30.0 mmt180 -68.72 -54.49 15.82 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.059 -0.719 . . . . 73.42 109.059 170.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.591 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.0 m-85 -59.92 -22.5 62.5 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.416 1.086 . . . . 75.12 113.783 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -66.64 -27.84 68.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 73.51 110.137 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -115.78 0.08 13.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.35 0.66 . . . . 72.32 111.263 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 60.8 mt -89.36 132.38 34.98 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.58 0.627 . . . . 72.52 109.677 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.51 117.03 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.225 -2.139 . . . . 64.42 105.225 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.552 ' HB3' HG13 ' A' ' 153' ' ' VAL . 33.6 m-85 -90.36 143.45 26.75 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.759 -0.83 . . . . 71.13 108.759 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.609 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 82.9 m-85 -140.7 152.93 45.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.138 0.575 . . . . 73.43 110.598 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.0 pt -144.89 172.96 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.05 1.34 . . . . 73.22 107.635 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.86 134.23 51.08 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.708 -1.051 . . . . 74.31 111.103 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -40.65 -48.14 2.88 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.337 1.236 . . . . 74.34 114.337 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -64.02 -28.56 69.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.835 0.854 . . . . 64.14 112.543 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.46 -14.46 62.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.683 0.793 . . . . 74.22 111.999 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.669 ' HB2' HG12 ' A' ' 77' ' ' VAL . . . -75.36 -2.92 30.68 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.229 0.611 . . . . 65.14 112.313 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -81.47 -33.12 32.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 74.35 110.137 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.11 -2.06 0.03 OUTLIER Glycine 0 C--N 1.357 1.727 0 N-CA-C 115.834 1.094 . . . . 65.1 115.834 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.12 75.11 9.49 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.717 1.258 . . . . 64.43 110.725 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.56 -0.53 57.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.245 1.018 . . . . 74.45 111.479 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -130.61 79.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.22 -1.03 . . . . 72.42 108.22 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -147.72 -148.55 4.77 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.067 -1.213 . . . . 51.04 110.067 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.96 152.92 22.1 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.328 -0.99 . . . . 72.11 108.328 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 138' ' ' PHE . 93.8 t -113.25 132.16 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.755 0.822 . . . . 75.44 110.445 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.74 101.38 3.67 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.338 -0.986 . . . . 72.41 108.338 166.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.437 HG21 HD21 ' A' ' 127' ' ' LEU . 67.1 mt -89.54 120.35 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.632 -0.507 . . . . 75.24 109.632 -170.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 169' ' ' LEU . 48.4 mm -105.63 119.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.839 0.455 . . . . 74.54 110.488 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -103.88 111.7 24.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.76 1.224 . . . . 70.32 109.48 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -75.61 89.82 2.77 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.443 -0.947 . . . . 74.15 108.443 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -89.61 164.67 14.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.217 1.007 . . . . 74.42 109.332 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -122.51 115.2 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.197 0.599 . . . . 74.32 110.151 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -120.43 97.88 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.821 0.849 . . . . 74.34 109.585 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 65.56 11.59 7.57 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.089 1.356 . . . . 54.52 112.583 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 118.85 -14.33 11.43 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.748 -0.473 . . . . 65.24 113.039 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.7 m -88.7 111.49 22.02 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 117.23 0.515 . . . . 72.24 109.804 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.68 114.39 9.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.289 -0.869 . . . . 74.23 109.167 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 13.2 m -123.5 98.16 41.23 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.746 1.218 . . . . 75.01 110.004 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 166' ' ' VAL . 38.7 Cg_endo -65.62 112.8 2.28 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.478 2.119 . . . . 73.43 111.163 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 p -113.96 134.19 54.99 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.141 0.976 . . . . 71.4 109.375 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 39.3 tp -77.33 140.91 40.09 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.493 0.717 . . . . 73.42 109.621 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 25.3 ptp -131.85 129.36 40.31 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 108.124 -1.065 . . . . 74.45 108.124 169.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -130.96 137.44 49.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.803 1.641 . . . . 74.42 106.903 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 174' ' ' GLU . 7.6 p -72.12 143.14 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.419 0.287 . . . . 72.52 111.455 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -32.6 -50.35 0.25 Allowed 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 126.951 2.1 . . . . 74.31 113.397 171.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.423 ' HB2' ' HZ ' ' A' ' 116' ' ' PHE . 1.4 tm-20 -68.85 -38.94 80.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.57 -1.195 . . . . 72.44 110.455 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.606 ' HA ' HG12 ' A' ' 7' ' ' ILE . . . -98.06 -6.46 31.74 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.99 -0.528 . . . . 63.42 111.123 -172.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 28' ' ' TYR . 8.6 tp -108.41 136.64 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.767 -1.198 . . . . 73.51 107.767 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.0 mm -125.81 118.37 51.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.401 -1.703 . . . . 74.53 106.401 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.69 123.54 42.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.788 -1.19 . . . . 73.24 107.788 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -141.2 149.49 41.47 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.501 0.72 . . . . 72.14 109.274 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -98.7 96.82 8.18 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.231 -0.655 . . . . 75.33 109.231 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.59 93.92 4.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.294 0.638 . . . . 75.22 110.763 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 117.25 17.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.555 0.742 . . . . 74.1 109.201 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 . . . . . 0 CA--C 1.554 1.109 0 CA-C-O 118.909 -0.567 . . . . 64.01 110.076 175.818 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 17' ' ' SER . 22.4 mmt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 110.031 -0.359 . . . . 73.11 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.11 135.13 51.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.026 0.531 . . . . 70.14 109.656 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 5.1 tt -95.14 120.21 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.23 -0.656 . . . . 72.21 109.23 173.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HB3' HD13 ' A' ' 176' ' ' ILE . 27.2 m-85 -105.92 125.99 51.65 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.389 -1.337 . . . . 73.12 107.389 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.586 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 48.5 pttt -151.25 159.52 44.32 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 123.559 0.537 . . . . 75.34 111.909 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.595 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 8.3 t70 -87.23 144.87 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.86 -0.793 . . . . 73.12 108.86 173.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 pt -66.63 -11.56 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 113.218 0.822 . . . . 61.22 113.218 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.17 -59.46 1.85 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.77 0.714 . . . . 73.21 112.527 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -125.99 -32.54 2.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.745 1.387 . . . . 63.0 114.745 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.595 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 19.0 m-20 -81.85 21.88 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.798 0.726 . . . . 75.23 111.539 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 7.5 m-20 -48.45 -20.99 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.305 1.224 . . . . 73.21 114.305 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.78 28.11 9.02 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 123.829 0.851 . . . . 74.14 110.212 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.596 ' HA ' ' HD2' ' A' ' 74' ' ' HIS . 41.3 tp -57.42 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.784 1.234 . . . . 73.34 112.107 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.7 m -155.62 126.74 7.1 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.83 -0.433 . . . . 74.41 109.83 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 29.2 p -133.77 102.03 5.31 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.064 0.546 . . . . 72.33 109.895 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -172.67 -176.35 1.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.038 -1.097 . . . . 74.04 108.038 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.409 ' N ' ' SD ' ' A' ' 1' ' ' MET . 58.9 m -79.71 84.88 5.47 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.425 -0.954 . . . . 64.33 108.425 172.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.417 ' HB2' ' HE2' ' A' ' 4' ' ' TYR . 73.6 m-85 -102.25 129.74 25.6 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.581 -0.896 . . . . 75.04 108.581 175.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 11.9 Cg_endo -56.19 122.07 11.13 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.026 2.484 . . . . 54.44 112.429 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.4 mtm -83.82 144.14 29.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.307 -0.861 . . . . 75.41 109.9 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -143.06 101.74 3.88 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.249 -1.389 . . . . 73.24 107.249 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.5 tp -103.67 126.43 50.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.502 0.721 . . . . 72.11 109.358 -174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.7 129.19 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.264 0.626 . . . . 64.41 109.8 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 64.48 12.0 7.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.659 1.183 . . . . 75.53 113.454 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 55.59 11.17 0.59 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.362 1.065 . . . . 54.13 113.102 -166.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.4 tp -105.66 -44.19 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.08 0.952 . . . . 73.32 110.394 -168.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.557 HG12 ' HE3' ' A' ' 170' ' ' MET . 46.8 t -124.56 130.01 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.283 -0.871 . . . . 74.55 109.473 -171.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -90.21 117.59 29.08 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.692 -0.855 . . . . 71.24 108.692 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -92.75 126.34 37.78 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.158 0.983 . . . . 74.22 109.627 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.784 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 80.3 t80 -107.52 127.92 54.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.852 1.261 . . . . 73.03 108.024 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HG3' ' HG2' ' A' ' 19' ' ' PRO . 72.4 mmtt -68.23 145.23 54.48 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 75.04 111.916 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.27 162.24 35.14 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.608 0.568 . . . . 64.23 112.021 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.38 142.96 50.68 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.027 0.931 . . . . 72.33 109.138 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -67.91 117.54 9.92 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.115 -0.698 . . . . 73.02 109.115 173.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.41 162.93 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.521 0.728 . . . . 73.12 110.626 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.56 131.89 72.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 108.64 -0.874 . . . . 75.34 108.64 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.694 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 73.2 mtp180 -105.31 108.13 19.48 Favored 'General case' 0 C--O 1.255 1.38 0 N-CA-C 108.504 -0.924 . . . . 73.41 108.504 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.615 ' HZ2' HG21 ' A' ' 64' ' ' VAL . 62.9 mmtt -134.3 148.37 50.76 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.099 1.759 . . . . 73.53 108.415 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.06 -7.08 43.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.936 0.894 . . . . 71.41 112.014 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.52 33.44 0.32 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.086 0.394 . . . . 61.42 114.086 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 39.7 tt0 -156.52 141.47 17.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.555 -0.535 . . . . 71.23 109.555 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 CA--C 1.563 1.474 0 CA-C-O 121.893 0.854 . . . . 74.5 110.423 -170.194 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.615 HG21 ' HZ2' ' A' ' 38' ' ' LYS . 12.7 t . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 107.897 -1.149 . . . . 74.42 107.897 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.694 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.2 mm-40 -98.72 66.78 1.67 Allowed 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.597 0.713 . . . . 72.32 109.16 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -89.15 143.38 26.88 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.609 -0.723 . . . . 65.54 110.006 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.07 -133.01 3.85 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.508 -1.037 . . . . 63.43 110.508 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 4.7 pt -111.26 154.08 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 122.508 0.323 . . . . 73.13 110.858 172.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.59 -39.23 73.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.454 1.101 . . . . 73.14 113.099 -173.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.04 -48.88 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.99 0.916 . . . . 72.33 110.527 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.407 HG12 ' HB2' ' A' ' 76' ' ' LEU . 55.0 t -67.85 -43.48 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 114.999 -1.0 . . . . 75.04 111.099 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 75.9 mt -72.76 -21.97 60.92 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.183 0.593 . . . . 74.13 111.841 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -70.71 -53.59 15.05 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.362 0.665 . . . . 74.31 109.511 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.596 ' HD2' ' HA ' ' A' ' 13' ' ' LEU . 48.9 t-80 -86.55 -21.14 27.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.19 0.596 . . . . 75.35 111.101 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 7.5 mtpm? 65.67 71.13 0.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.871 1.268 . . . . 74.42 109.727 -170.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 91.1 mt -91.44 145.68 24.43 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.969 -1.014 . . . . 74.44 110.151 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 129.17 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.564 0.746 . . . . 74.34 109.855 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.77 153.56 32.44 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.615 0.969 . . . . 74.11 113.615 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.6 ttm -150.16 112.11 4.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.799 2.039 . . . . 73.44 106.078 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.66 152.33 29.12 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.979 0.809 . . . . 73.53 111.702 -172.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.546 ' SG ' ' HE2' ' A' ' 138' ' ' PHE . 85.6 m -65.96 -16.63 64.05 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.402 0.89 . . . . 60.41 113.402 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -71.3 -55.23 8.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.973 0.509 . . . . 74.51 110.367 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.36 -40.63 5.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.231 0.612 . . . . 71.0 112.061 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.83 20.55 3.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.628 0.771 . . . . 65.54 112.854 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.77 85.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.293 0.637 . . . . 75.51 112.29 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -77.35 -31.31 54.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.348 0.659 . . . . 63.21 111.711 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.9 mmt -64.42 -50.92 65.71 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.319 -0.622 . . . . 54.04 109.319 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.86 -23.41 62.31 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.141 -0.936 . . . . 75.41 110.725 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -68.97 -37.64 78.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.291 0.636 . . . . 75.03 109.93 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.4 83.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.18 0.592 . . . . 72.11 110.238 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -69.39 -32.9 72.21 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 123.409 0.684 . . . . 73.34 112.499 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mm -65.87 -33.6 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 117.898 0.317 . . . . 75.34 110.644 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -63.11 -45.65 91.03 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 122.314 0.246 . . . . 73.0 110.571 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -61.6 -54.45 42.85 Favored 'General case' 0 C--N 1.36 1.058 0 N-CA-C 109.227 -0.657 . . . . 72.05 109.227 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HD2' ' HG2' ' A' ' 152' ' ' GLN . 60.1 t80 -44.4 -68.53 0.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.792 2.037 . . . . 73.22 111.603 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 40.9 ttp -57.35 -50.38 73.13 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 124.127 0.971 . . . . 74.45 111.595 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -56.82 -50.04 73.59 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.111 0.882 . . . . 73.43 110.537 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -71.93 -48.01 48.41 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.74 -0.664 . . . . 75.33 111.604 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.514 HG13 HG13 ' A' ' 172' ' ' VAL . 23.8 m -66.25 -38.9 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 112.396 0.517 . . . . 60.25 112.396 -172.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.0 mt -77.91 -42.14 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 120.439 0.161 . . . . 70.32 110.921 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.05 -45.41 85.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.617 0.767 . . . . 73.34 111.355 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -67.14 -40.26 86.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.15 0.58 . . . . 70.23 109.959 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.36 -51.48 69.76 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 123.842 0.714 . . . . 73.23 110.62 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.81 -23.66 66.74 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.291 0.637 . . . . 75.35 111.257 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 31.8 ttmt -75.07 -24.47 58.21 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.338 0.655 . . . . 74.45 110.87 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -114.5 -13.39 12.2 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.2 0.6 . . . . 72.23 112.18 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -100.74 -46.06 5.28 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.717 0.807 . . . . 74.14 109.399 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 66.29 18.29 10.88 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.068 1.347 . . . . 75.13 113.144 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.18 111.13 19.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.64 -1.245 . . . . 62.03 107.64 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -69.5 -29.69 67.38 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.595 0.559 . . . . 75.44 111.632 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.34 -32.15 66.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 60.45 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.22 -47.55 56.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.686 0.794 . . . . 74.05 109.492 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.7 m -79.28 -17.82 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 115.237 -0.892 . . . . 73.53 111.935 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.08 -35.35 74.13 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.013 -0.736 . . . . 72.31 109.013 170.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.31 73.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.192 -0.913 . . . . 73.33 110.09 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -62.25 -41.61 98.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.0 0.52 . . . . 74.22 110.391 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.24 -34.86 77.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.598 0.759 . . . . 74.43 110.589 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -66.4 -43.25 86.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.51 -0.768 . . . . 75.22 110.411 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -46.76 71.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.781 -0.645 . . . . 73.44 111.441 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.96 -33.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.606 0.363 . . . . 70.54 110.944 -168.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -41.06 95.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.082 -1.081 . . . . 72.0 108.082 171.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.8 -40.98 97.4 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.832 0.708 . . . . 63.04 113.013 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -67.88 -48.0 67.29 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 122.656 0.382 . . . . 74.51 111.003 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.413 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 31.4 m -70.5 -38.37 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 118.997 -0.525 . . . . 63.45 111.796 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.39 -32.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 118.683 0.674 . . . . 73.52 110.194 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -69.43 -42.03 75.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.453 0.701 . . . . 74.31 110.581 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.51 HD21 HG21 ' A' ' 155' ' ' ILE . 14.4 tp -74.8 -30.89 61.56 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.247 1.019 . . . . 72.52 111.076 -170.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 86.5 mt -86.09 1.93 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.923 0.889 . . . . 72.42 110.78 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.04 67.03 8.94 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 122.08 0.943 . . . . 73.55 108.701 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.74 -6.22 30.48 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 114.191 -1.368 . . . . 74.54 113.593 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.73 -33.76 74.62 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.25 0.62 . . . . 71.51 110.449 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -105.44 -39.18 6.22 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.429 1.092 . . . . 73.11 109.527 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -80.33 0.67 31.98 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.112 1.365 . . . . 72.15 114.203 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -14.6 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 N-CA-C 114.288 1.218 . . . . 75.02 114.288 175.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.419 ' ND2' ' HG3' ' A' ' 157' ' ' GLU . 4.9 p-10 -79.44 13.63 1.9 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.026 0.93 . . . . 74.21 112.024 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.26 146.47 24.2 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.496 0.719 . . . . 74.14 109.425 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -139.06 112.49 8.21 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.72 -1.956 . . . . 74.43 105.72 169.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.638 ' HB3' HG12 ' A' ' 153' ' ' VAL . 37.1 m-85 -85.75 145.24 27.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.445 -0.946 . . . . 73.33 108.445 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 69.5 m-85 -139.41 143.79 37.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.349 0.66 . . . . 73.35 109.461 -176.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.6 pt -131.51 177.01 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.615 -0.883 . . . . 73.33 108.615 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.56 120.94 23.66 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 123.656 0.597 . . . . 74.32 111.621 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.39 -36.17 61.15 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.864 1.266 . . . . 75.43 110.24 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.54 -45.85 71.08 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.878 -1.055 . . . . 72.24 111.298 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.438 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . . . -65.63 -25.74 67.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.519 0.728 . . . . 75.24 111.947 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.24 -7.66 56.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.894 0.877 . . . . 71.11 112.239 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -85.28 -40.39 16.64 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.535 -0.543 . . . . 74.51 109.535 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.09 52.03 0.05 OUTLIER Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.996 -0.547 . . . . 61.22 112.489 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.438 ' HB1' ' HA ' ' A' ' 144' ' ' ALA . . . -145.35 -179.49 6.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.828 0.851 . . . . 72.42 109.592 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -119.99 121.63 39.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.878 0.871 . . . . 72.31 108.72 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -91.27 -26.68 18.87 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.756 -0.461 . . . . 75.44 109.756 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.73 -68.16 2.23 Favored Glycine 0 C--N 1.342 0.879 0 O-C-N 124.593 1.183 . . . . 70.23 113.656 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.492 ' HG2' ' HD2' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -100.47 133.16 45.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.247 -1.39 . . . . 75.53 107.247 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.638 HG12 ' HB3' ' A' ' 138' ' ' PHE . 71.5 t -94.02 141.63 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.768 0.827 . . . . 74.34 111.572 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.657 ' HA ' HD22 ' A' ' 171' ' ' LEU . . . -72.32 97.2 1.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.891 0.876 . . . . 72.33 109.6 169.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.51 HG21 HD21 ' A' ' 127' ' ' LEU . 85.6 mt -89.84 104.65 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.342 -0.614 . . . . 73.42 109.342 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.422 HD12 HD12 ' A' ' 68' ' ' ILE . 41.3 mm -93.59 125.63 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.039 -0.726 . . . . 74.33 109.039 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.419 ' HG3' ' ND2' ' A' ' 135' ' ' ASN . 21.7 tt0 -129.2 112.12 13.6 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.703 -0.851 . . . . 73.12 108.703 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.578 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 54.1 p90 -81.22 99.31 8.51 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 106.76 -1.57 . . . . 72.42 106.76 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -83.46 143.18 30.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.047 -0.979 . . . . 64.34 110.769 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.77 120.78 21.61 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.123 0.487 . . . . 70.13 109.718 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.11 95.37 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 125.336 1.454 . . . . 73.34 107.951 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.62 17.66 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.185 0.994 . . . . 72.53 112.11 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.31 6.93 47.18 Favored Glycine 0 C--N 1.353 1.521 0 C-N-CA 123.146 0.403 . . . . 75.11 113.545 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 m -111.94 156.42 22.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.242 1.017 . . . . 73.53 109.516 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 12.8 pt-20 -84.51 138.51 32.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.903 0.481 . . . . 75.41 110.156 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.54 99.37 18.98 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.783 0.833 . . . . 72.22 108.8 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.04 114.11 1.87 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.902 2.401 . . . . 74.2 113.195 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.3 p -115.75 121.23 41.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.875 0.87 . . . . 63.35 108.714 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.784 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 30.7 tp -76.76 107.4 9.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.467 -0.938 . . . . 73.13 108.467 172.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.557 ' HE3' HG12 ' A' ' 27' ' ' VAL . 73.7 mtp -94.96 122.69 37.86 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 107.875 -1.157 . . . . 65.41 107.875 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 154' ' ' ALA . 85.3 mt -134.7 145.04 48.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.558 1.543 . . . . 72.34 107.081 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.514 HG13 HG13 ' A' ' 99' ' ' VAL . 7.5 p -73.6 141.66 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.618 -0.882 . . . . 74.33 108.618 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.544 ' HA ' HG23 ' A' ' 176' ' ' ILE . 61.6 tttp -57.86 -30.02 65.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.004 0.922 . . . . 74.42 111.758 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.65 2.16 42.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.822 0.849 . . . . 74.43 112.267 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.98 -9.03 4.88 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.472 0.709 . . . . 74.15 111.375 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.544 HG23 ' HA ' ' A' ' 173' ' ' LYS . 8.6 tp -97.8 133.85 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 107.141 -1.429 . . . . 74.41 107.141 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.2 mm -104.57 110.53 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 106.864 -1.532 . . . . 64.41 106.864 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.89 90.31 3.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.012 1.325 . . . . 74.31 107.582 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 3' ' ' ILE . 12.2 tp10 -106.13 144.02 33.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.817 -0.808 . . . . 71.12 108.817 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.564 ' HE2' HD11 ' A' ' 182' ' ' LEU . 13.8 ptmt -100.27 123.92 45.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.681 0.792 . . . . 73.32 110.134 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.26 87.4 7.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.597 -0.89 . . . . 73.45 108.597 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.564 HD11 ' HE2' ' A' ' 180' ' ' LYS . 82.8 mt -90.31 87.93 7.01 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.741 -0.837 . . . . 72.21 108.741 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 C--O 1.254 1.336 0 N-CA-C 107.263 -1.384 . . . . 71.42 107.263 178.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.501 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 86.1 mmm . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.701 0.286 . . . . 72.14 110.441 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 180' ' ' LYS . 62.3 mt -120.52 155.74 32.99 Favored 'General case' 0 C--O 1.25 1.087 0 C-N-CA 123.781 0.832 . . . . 61.43 109.742 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 60.3 mt -96.85 120.25 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.373 -0.973 . . . . 71.54 108.373 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -110.33 99.41 8.44 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.265 -1.383 . . . . 75.52 107.265 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.533 ' HD2' ' HB2' ' A' ' 10' ' ' ASP . 55.2 pttt -129.53 165.3 21.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.314 -0.403 . . . . 73.43 110.054 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 10.3 m-20 -85.89 -177.94 6.46 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.839 0.828 . . . . 74.21 110.207 174.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.6 mt -84.19 -24.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 114.87 -1.059 . . . . 71.24 110.041 157.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -107.11 -59.76 1.77 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.788 0.835 . . . . 73.24 112.267 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -96.82 17.56 16.42 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.013 0.925 . . . . 73.24 110.439 -174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.533 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 5.3 p-10 -52.42 -29.21 23.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.111 1.364 . . . . 72.24 113.212 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -48.62 72.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.765 1.291 . . . . 74.43 111.323 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -120.3 17.87 12.25 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.688 -0.687 . . . . 73.25 112.268 -168.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -78.23 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.261 0.937 . . . . 74.1 109.176 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -143.78 122.79 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 120.741 1.61 . . . . 73.51 112.617 -168.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.492 ' HB3' HG22 ' A' ' 3' ' ' ILE . 35.7 p -116.12 104.87 11.98 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.865 0.866 . . . . 74.13 108.995 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 1' ' ' MET . 37.4 t70 -160.64 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 110.141 -0.318 . . . . 74.32 110.141 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.9 p -127.69 71.5 1.36 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.027 -0.731 . . . . 70.12 109.027 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -120.67 93.9 48.68 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.004 -0.739 . . . . 72.31 109.004 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.54 135.74 66.58 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.638 2.225 . . . . 54.43 111.622 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 180' ' ' LYS . 24.2 ptt? -83.48 138.98 33.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.928 -0.767 . . . . 74.22 108.928 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -152.4 122.74 7.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.035 -1.098 . . . . 74.42 108.035 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -130.64 122.89 28.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.64 0.776 . . . . 74.44 109.039 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.13 142.86 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.322 0.649 . . . . 73.55 110.327 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 59.39 8.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.34 1.456 . . . . 73.52 113.515 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 51.72 39.28 25.01 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.243 1.017 . . . . 72.4 110.587 -168.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.0 tp -134.99 -51.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.794 . . . . 71.25 110.532 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.28 125.9 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.58 0.752 . . . . 72.24 110.299 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.4 ' HH ' ' HD2' ' A' ' 30' ' ' PHE . 81.8 t80 -83.6 119.96 25.37 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.981 -1.118 . . . . 74.42 107.981 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 6.7 pt-20 -111.51 141.65 44.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.176 0.591 . . . . 65.23 109.833 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.4 ' HD2' ' HH ' ' A' ' 28' ' ' TYR . 33.2 t80 -136.76 140.28 42.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.997 -1.112 . . . . 74.04 107.997 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.8 97.05 8.96 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.088 0.555 . . . . 73.21 110.061 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.98 130.6 11.6 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.942 -0.572 . . . . 70.0 111.706 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -97.62 124.04 41.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.367 0.583 . . . . 73.14 109.454 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -64.72 114.27 4.33 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 108.783 -0.821 . . . . 73.4 108.783 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.453 HG22 HD11 ' A' ' 72' ' ' LEU . 15.4 m -148.47 161.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.208 1.003 . . . . 74.22 108.88 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.42 143.78 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.183 -1.043 . . . . 73.25 108.183 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -91.74 116.08 28.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.404 -1.702 . . . . 73.15 106.404 169.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -119.46 145.48 46.25 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.87 -1.53 . . . . 71.02 106.87 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -62.8 89.02 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.432 0.634 . . . . 72.15 111.548 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.32 52.02 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 114.639 -1.164 . . . . 62.23 113.998 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -159.85 -174.59 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.899 0.48 . . . . 73.0 110.757 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tt . . . . . 0 N--CA 1.469 0.476 0 C-N-CA 123.687 0.795 . . . . 73.33 109.483 176.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 31.7 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 107.852 -1.166 . . . . 75.33 107.852 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 39.5 mt-10 -75.32 77.18 2.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.718 -1.216 . . . . 72.23 107.718 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -76.59 135.63 39.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.89 -1.05 . . . . 74.54 110.545 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.44 -136.84 4.53 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.443 -0.663 . . . . 63.34 111.443 173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 pt -110.22 155.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.509 0.324 . . . . 75.02 110.779 172.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.75 -39.27 70.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.382 1.073 . . . . 74.52 112.391 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.3 mt -55.29 -44.87 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 124.104 0.962 . . . . 73.42 110.47 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.74 -55.08 19.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 CA-C-N 114.011 -1.449 . . . . 74.42 110.656 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.453 HD11 HG22 ' A' ' 35' ' ' VAL . 18.2 mt -67.94 -30.37 69.66 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.726 -0.67 . . . . 73.41 111.088 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.65 -52.38 38.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.838 -1.073 . . . . 75.13 110.95 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -89.37 -13.56 37.53 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.106 -0.497 . . . . 74.54 111.798 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt 68.42 66.32 0.32 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.24 1.016 . . . . 75.51 109.437 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 94.9 mt -86.57 131.36 34.19 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.96 -1.018 . . . . 75.2 108.677 173.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.785 HG11 ' HB3' ' A' ' 145' ' ' ALA . 4.4 p -86.42 129.89 37.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.524 0.73 . . . . 74.04 109.424 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.56 151.67 37.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 123.663 0.785 . . . . 74.45 112.247 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 39.5 tpp -149.5 140.28 22.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.347 -1.353 . . . . 72.45 107.347 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.639 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 29.7 m-80 -130.06 123.18 29.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.066 0.546 . . . . 73.43 110.334 -169.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 28.0 p -67.73 -16.26 64.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.014 0.526 . . . . 70.35 111.72 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.639 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 97.5 m-85 -45.88 -60.76 2.06 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.287 1.035 . . . . 73.24 111.319 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -105.23 -33.31 8.27 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.244 1.018 . . . . 72.13 111.255 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -93.02 19.98 7.23 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.002 0.521 . . . . 65.34 111.728 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.97 27.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.85 0.86 . . . . 70.53 113.203 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -77.96 -50.74 11.57 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.515 0.726 . . . . 61.35 112.25 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -72.91 -33.48 66.01 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.1 0.56 . . . . 71.13 110.971 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.516 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 35.0 t80 -64.91 -42.92 94.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.103 0.561 . . . . 75.42 110.568 170.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.571 ' HZ1' ' HB2' ' A' ' 89' ' ' LYS . 4.6 ttmp? -63.46 -27.62 69.41 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 120.678 0.275 . . . . 73.55 110.564 175.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.2 -36.72 74.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.192 0.597 . . . . 65.41 110.571 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.516 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 34.8 m-85 -63.83 -35.85 81.97 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.654 0.382 . . . . 74.14 110.526 170.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mm -65.61 -36.5 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.453 0.701 . . . . 75.43 111.459 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.36 -44.82 96.51 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.579 0.352 . . . . 75.24 110.699 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -68.09 -42.81 79.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.909 -0.587 . . . . 74.24 109.886 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -48.86 -66.63 0.37 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.625 1.57 . . . . 74.23 111.07 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.1 ptm -60.46 -40.61 91.83 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.507 0.504 . . . . 72.11 111.19 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -62.93 -45.59 91.74 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 122.68 0.392 . . . . 71.52 110.379 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -72.9 -48.72 34.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.346 0.658 . . . . 74.34 111.206 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -66.41 -38.06 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 123.541 0.525 . . . . 70.32 112.188 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.411 HD13 ' HE3' ' A' ' 117' ' ' LYS . 63.8 mt -77.89 -40.18 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 122.969 0.508 . . . . 72.51 110.148 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.52 -42.71 99.69 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.134 0.974 . . . . 73.22 111.83 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -66.96 -45.03 78.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.297 -0.865 . . . . 73.13 109.104 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.435 ' HA ' HD22 ' A' ' 106' ' ' ASN . 26.9 ttt -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 124.349 1.031 . . . . 74.4 110.692 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.23 -41.29 79.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.258 1.023 . . . . 73.44 112.174 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.58 -19.22 62.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.797 0.666 . . . . 75.1 112.797 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 103' ' ' MET . 9.5 p30 -114.37 0.9 14.25 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.386 0.539 . . . . 75.45 111.891 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.56 -48.06 2.88 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.754 -0.832 . . . . 74.52 108.754 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 57.37 8.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 126.848 2.059 . . . . 75.23 113.996 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -113.91 115.13 27.2 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.987 -0.746 . . . . 72.12 108.987 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -64.6 -32.85 74.68 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.026 0.829 . . . . 75.11 111.833 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.58 68.24 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.791 0.329 . . . . 73.04 110.603 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.19 -54.59 6.32 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.976 -0.75 . . . . 61.25 108.976 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.9 -22.22 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 115.932 -0.576 . . . . 60.44 111.677 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.05 -41.73 97.27 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.303 0.641 . . . . 74.54 110.221 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.053 0.845 . . . . 73.25 110.172 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -57.64 -61.12 2.74 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.173 0.92 . . . . 75.25 111.733 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.411 ' HE3' HD13 ' A' ' 100' ' ' ILE . 21.8 ptmt -73.19 -15.38 61.45 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.615 0.572 . . . . 65.43 111.858 -173.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -68.14 -51.49 45.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.55 -0.907 . . . . 74.21 108.55 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.12 -32.86 72.55 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.081 -1.418 . . . . 71.51 111.878 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mm -67.98 -47.62 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.068 0.547 . . . . 72.32 110.262 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.35 -49.53 75.85 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.91 0.756 . . . . 73.03 109.499 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.59 98.76 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 123.819 0.7 . . . . 75.13 112.981 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -62.45 -50.5 71.2 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.696 0.799 . . . . 74.54 109.79 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.5 m -70.79 -42.14 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 118.503 -0.76 . . . . 73.02 111.816 -173.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.55 -32.16 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 119.221 0.919 . . . . 73.4 110.757 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.2 t -73.97 -38.96 64.03 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 120.907 0.384 . . . . 73.4 110.081 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.653 HD23 HG21 ' A' ' 155' ' ' ILE . 28.4 tp -73.88 -26.94 60.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.929 1.292 . . . . 74.51 111.867 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 64.8 mt -88.42 2.24 53.12 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.852 0.861 . . . . 75.31 111.822 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 93.87 6.77 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.209 0.528 . . . . 72.35 109.586 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 50.9 mtpt -67.07 -5.38 12.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.331 1.234 . . . . 72.42 114.331 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -47.15 83.08 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 118.231 0.469 . . . . 73.25 110.794 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -109.06 -37.64 5.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.768 0.827 . . . . 74.12 110.547 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.37 -1.79 38.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.714 1.206 . . . . 73.32 114.148 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 37.3 ttpt -55.26 -15.54 2.52 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.705 0.631 . . . . 71.22 112.705 172.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -83.68 6.72 19.95 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.598 0.759 . . . . 72.02 111.276 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.63 129.18 34.96 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.415 0.686 . . . . 64.31 109.309 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.85 120.17 39.75 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.658 -1.238 . . . . 75.25 107.658 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.45 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 65.1 m-85 -102.7 141.91 34.73 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.422 -0.585 . . . . 75.5 109.422 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.618 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 95.1 m-85 -139.65 149.76 44.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.239 -0.652 . . . . 73.43 109.239 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.4 pt -133.66 168.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.892 -0.781 . . . . 75.33 108.892 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.61 143.93 48.99 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.821 -0.433 . . . . 63.41 112.227 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -44.86 -39.31 5.25 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.698 0.799 . . . . 75.3 111.993 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -62.77 -38.53 90.95 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 74.02 111.898 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -68.59 -29.74 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.267 0.627 . . . . 62.34 111.727 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.785 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -84.53 -25.33 28.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.575 0.35 . . . . 74.53 111.215 173.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -65.81 -29.89 70.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.499 0.72 . . . . 72.23 110.55 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.53 0.01 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.074 -0.81 . . . . 71.41 111.074 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -159.41 -170.69 3.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.165 0.586 . . . . 73.42 111.134 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.95 -173.01 0.9 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 75.32 108.858 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 79.21 -20.82 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.521 1.528 . . . . 75.15 111.963 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.13 146.72 47.78 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.908 -0.477 . . . . 72.35 111.908 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -67.62 134.23 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.397 0.679 . . . . 75.53 111.52 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.437 HG13 ' HE1' ' A' ' 88' ' ' PHE . 59.9 t -83.36 117.96 30.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.699 -0.682 . . . . 72.12 109.679 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -67.01 101.5 0.86 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.828 0.851 . . . . 75.04 109.525 168.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.653 HG21 HD23 ' A' ' 127' ' ' LEU . 67.1 mt -90.78 105.88 16.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.22 -1.03 . . . . 74.25 108.22 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -94.84 96.35 5.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.333 -0.617 . . . . 74.52 109.333 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -81.47 157.23 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.732 -1.122 . . . . 73.44 108.011 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.1 p90 -120.45 139.24 53.14 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.021 -1.103 . . . . 72.31 108.021 175.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.407 ' HB2' HG23 ' A' ' 166' ' ' VAL . 24.1 mmt180 -118.98 161.27 20.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.263 -0.643 . . . . 72.33 109.263 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -115.84 119.84 37.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.489 0.716 . . . . 70.51 110.403 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.88 97.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.296 1.038 . . . . 72.34 108.773 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 61.94 18.06 9.51 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.446 1.098 . . . . 75.14 113.777 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.84 1.37 22.7 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 120.122 -0.266 . . . . 75.52 113.194 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.9 m -110.11 134.37 52.25 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.954 0.901 . . . . 75.41 109.634 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.91 120.66 23.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.878 -1.156 . . . . 75.42 107.878 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.407 HG23 ' HB2' ' A' ' 159' ' ' ARG . 2.7 m -117.84 89.33 33.39 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.495 -1.298 . . . . 74.14 107.495 169.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 84.3 Cg_exo -54.19 126.25 21.5 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.006 2.47 . . . . 73.32 113.269 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -103.58 107.22 17.98 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.105 -1.072 . . . . 73.52 108.105 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 16.5 tp -75.17 112.42 11.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.676 -1.231 . . . . 74.43 107.676 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ptp -105.83 136.11 46.05 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 122.07 0.938 . . . . 73.14 108.945 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 154' ' ' ALA . 68.1 mt -141.77 158.33 43.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 112.963 -1.926 . . . . 75.43 106.534 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 174' ' ' GLU . 10.6 p -86.73 140.65 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.363 -0.977 . . . . 74.54 108.363 168.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -57.77 -27.33 62.97 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.537 0.735 . . . . 73.34 111.722 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.407 ' H ' HG22 ' A' ' 172' ' ' VAL . 17.0 mm-40 -90.12 13.58 14.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.594 0.757 . . . . 72.31 112.858 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.92 -1.14 7.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.588 0.755 . . . . 71.03 110.921 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.412 HG13 HD11 ' A' ' 171' ' ' LEU . 36.3 mm -132.0 137.0 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.047 0.939 . . . . 71.04 109.55 -174.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.94 109.81 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.854 -1.165 . . . . 74.42 107.854 171.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.05 106.15 18.35 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.403 -1.332 . . . . 72.12 107.403 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.643 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 43.3 mt-10 -92.78 98.11 11.19 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.425 -1.324 . . . . 74.13 107.425 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.581 ' HA ' HD23 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -72.97 96.43 2.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 113.794 -1.548 . . . . 74.33 109.403 179.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.91 87.78 2.89 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.272 -1.01 . . . . 72.43 108.272 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 97.5 mt -83.33 110.61 18.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.194 -0.912 . . . . 64.42 110.459 -171.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 108.031 -1.1 . . . . 74.22 108.031 175.43 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.826 -0.435 . . . . 71.32 109.826 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.9 mt -95.35 127.7 41.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.07 -0.715 . . . . 72.34 109.07 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.575 ' HB ' ' HG3' ' A' ' 179' ' ' GLU . 45.9 mt -97.4 127.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.332 0.653 . . . . 73.32 109.482 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.42 ' OH ' ' HB3' ' A' ' 20' ' ' MET . 31.1 m-85 -121.72 114.42 21.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.842 1.257 . . . . 75.23 107.792 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -123.11 150.72 42.86 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.342 0.657 . . . . 74.21 110.02 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.15 134.19 34.74 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.89 -1.152 . . . . 63.2 107.89 166.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.2 pt -68.71 -27.66 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.786 0.661 . . . . 73.51 112.786 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 98' ' ' ASN . 74.8 m-85 -85.61 -63.31 1.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.079 0.399 . . . . 75.34 112.068 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -131.33 -33.82 1.45 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.522 0.564 . . . . 74.15 112.522 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.83 24.03 5.77 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.05 0.94 . . . . 64.1 112.721 -156.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.19 -29.07 1.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.866 1.266 . . . . 73.1 113.605 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -84.42 24.68 0.95 Allowed 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 113.2 0.815 . . . . 74.33 113.2 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.4 mt -45.28 -76.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.534 1.134 . . . . 65.12 112.564 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 p -160.79 134.87 7.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.154 0.581 . . . . 71.21 110.359 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.9 p -141.53 99.91 3.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.091 0.86 . . . . 42.3 109.655 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' HB3' ' HD2' ' A' ' 18' ' ' PHE . 25.9 t70 -163.85 169.66 17.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.711 0.805 . . . . 70.32 109.364 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -80.99 9.49 6.47 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.862 0.865 . . . . 74.22 113.13 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.511 ' HD2' ' HB3' ' A' ' 16' ' ' ASP . 51.4 p90 -54.49 141.82 52.96 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 118.34 0.518 . . . . 73.14 111.787 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.38 119.82 7.22 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 123.008 2.472 . . . . 72.24 113.258 -164.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.42 ' HB3' ' OH ' ' A' ' 4' ' ' TYR . 24.2 ptt? -101.94 151.81 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.977 -0.556 . . . . 75.44 110.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -135.91 145.96 46.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.181 -1.415 . . . . 73.33 107.181 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.0 tp -134.32 118.52 17.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.271 -1.011 . . . . 73.1 108.271 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.51 133.88 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.056 0.942 . . . . 63.32 109.278 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 58.44 10.46 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.131 1.373 . . . . 64.33 114.55 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 50.72 25.08 1.93 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.723 0.809 . . . . 73.4 112.362 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 119' ' ' LYS . 63.3 tp -109.15 -46.14 3.63 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.1 t -124.44 124.4 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 122.673 0.389 . . . . 74.14 110.822 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -84.63 114.42 21.99 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.604 -1.258 . . . . 73.44 107.604 167.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 47.3 mt-10 -106.97 135.01 49.26 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.227 -0.897 . . . . 65.5 110.44 176.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 27.7 t80 -127.11 133.59 50.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.215 1.006 . . . . 74.33 108.984 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.73 139.55 30.41 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.019 0.438 . . . . 74.23 109.828 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -172.59 12.97 Favored Glycine 0 CA--C 1.508 -0.372 0 N-CA-C 110.538 -1.025 . . . . 65.4 110.538 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -144.84 144.55 31.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 74.43 109.992 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -65.03 117.37 7.56 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.121 -1.066 . . . . 74.34 108.121 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.71 163.61 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.854 1.261 . . . . 73.12 109.382 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 2.9 m -119.54 104.86 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.241 -1.022 . . . . 73.55 108.241 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.696 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 13.5 tpt180 -80.73 106.62 12.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.772 -1.195 . . . . 73.41 107.772 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 87.5 tttt -135.04 154.11 51.82 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.818 -1.083 . . . . 73.54 109.579 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -51.63 -26.76 9.57 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.003 1.321 . . . . 73.13 112.836 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.88 27.83 1.29 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.667 -0.518 . . . . 53.24 114.197 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 39.6 mm-40 -146.08 152.45 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.734 0.813 . . . . 75.43 109.352 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 6.4 tp . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 123.599 0.76 . . . . 74.4 110.194 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.238 0.477 0 N-CA-C 106.868 -1.531 . . . . 74.3 106.868 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 48.1 mt-10 -67.36 80.86 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.849 0.833 . . . . 75.12 109.091 170.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -75.55 132.42 40.7 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.785 -1.098 . . . . 71.23 110.011 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.06 -141.45 7.73 Favored Glycine 0 CA--C 1.498 -0.982 0 N-CA-C 110.048 -1.221 . . . . 73.04 110.048 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 30.1 pt -111.5 147.41 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.426 0.613 . . . . 74.41 110.63 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.7 -24.33 65.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.438 0.695 . . . . 75.22 112.846 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.491 HG21 ' HB2' ' A' ' 169' ' ' LEU . 52.9 mt -60.16 -40.39 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.609 0.719 . . . . 74.42 110.165 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.17 -51.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.351 -0.841 . . . . 74.34 111.625 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 65' ' ' GLU . 24.1 mt -64.88 -45.62 85.23 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.079 0.862 . . . . 74.02 111.492 -169.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -80.62 -18.03 49.45 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.559 -0.746 . . . . 72.23 111.854 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -107.79 -1.45 20.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.791 -0.568 . . . . 72.24 111.357 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 55.95 56.69 5.75 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.226 1.011 . . . . 74.33 111.726 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 62.8 mt -95.13 138.3 33.03 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.016 -0.993 . . . . 73.23 109.73 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.4 134.48 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.922 -0.77 . . . . 74.3 108.922 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.26 141.45 57.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.143 -0.935 . . . . 64.34 112.928 -174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 ptm -140.81 109.96 6.18 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 107.136 -1.431 . . . . 64.44 107.136 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.45 152.98 20.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.703 -0.681 . . . . 65.41 110.306 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.432 ' SG ' ' HE1' ' A' ' 138' ' ' PHE . 64.8 m -67.34 -3.56 8.47 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.045 1.128 . . . . 74.44 114.045 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -94.13 -60.24 1.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.796 0.439 . . . . 74.4 110.018 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -78.36 -43.62 27.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.862 0.865 . . . . 75.41 110.273 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.13 20.56 8.94 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.842 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.81 -53.82 22.99 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.416 1.086 . . . . 65.32 113.904 -174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.0 m -68.33 -40.59 81.58 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.5 0.667 . . . . 74.11 110.996 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.425 ' HG3' ' CE2' ' A' ' 91' ' ' TYR . 14.2 tpt -68.59 -29.07 67.52 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.179 -0.919 . . . . 74.41 110.245 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -66.46 -42.12 88.04 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.355 1.462 . . . . 74.43 110.063 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.78 -41.65 82.47 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.86 0.725 . . . . 71.43 110.167 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.88 -45.42 86.07 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.394 0.678 . . . . 74.15 112.389 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.558 ' HE1' HD13 ' A' ' 140' ' ' ILE . 30.3 m-85 -55.17 -48.21 74.08 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.456 0.702 . . . . 71.32 112.151 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.13 -41.33 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.802 0.689 . . . . 74.13 112.614 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -52.63 -47.76 66.82 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.361 0.528 . . . . 73.25 111.334 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -70.24 -45.35 66.66 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.162 -0.926 . . . . 72.34 110.996 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -49.83 -51.42 40.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.631 1.172 . . . . 75.42 110.63 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.4 ttt -58.09 -54.64 44.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.764 1.226 . . . . 73.01 111.392 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.3 -24.17 62.98 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.316 -0.402 . . . . 74.2 111.901 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 8' ' ' PHE . 99.5 m-20 -88.12 -40.63 13.62 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.542 0.737 . . . . 73.4 112.264 -174.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 120' ' ' ILE . 29.5 m -66.8 -36.96 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 110.14 -0.318 . . . . 74.0 110.14 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.09 -31.23 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 122.438 0.295 . . . . 75.11 110.543 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.24 -52.93 61.81 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.853 0.461 . . . . 74.41 111.028 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -66.32 -38.29 87.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.913 -0.585 . . . . 73.41 111.391 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.629 ' SD ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -67.26 -58.14 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.671 0.389 . . . . 74.4 110.741 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.13 -42.2 80.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.352 1.061 . . . . 64.21 112.337 -168.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -68.65 -22.09 64.42 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.094 0.558 . . . . 74.35 111.433 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.417 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.8 OUTLIER -101.09 -17.95 16.45 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.278 0.631 . . . . 74.23 111.446 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -105.31 -52.17 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.061 0.545 . . . . 75.32 111.004 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 81.38 -21.45 0.31 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.457 1.503 . . . . 74.25 113.066 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -79.52 127.35 32.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.354 0.525 . . . . 64.33 110.516 -172.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -43.39 81.08 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 124.55 1.156 . . . . 72.1 112.454 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.03 -30.65 39.55 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.143 0.577 . . . . 74.22 112.52 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.06 -36.62 22.91 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.574 0.35 . . . . 55.22 110.542 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.629 HG11 ' SD ' ' A' ' 103' ' ' MET . 23.4 m -69.91 -29.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.729 0.299 . . . . 75.15 110.385 172.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.76 -31.82 68.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.679 0.791 . . . . 75.41 109.921 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.2 -53.81 26.87 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.456 0.702 . . . . 65.21 109.689 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -55.82 -43.27 76.8 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 123.878 0.736 . . . . 73.44 110.465 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.37 -43.94 79.7 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 124.579 1.174 . . . . 74.55 111.181 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 74.54 110.204 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.5 mptm? -66.92 -45.2 78.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.204 0.602 . . . . 74.24 111.142 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 99' ' ' VAL . 10.8 tp -73.03 -39.15 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 122.794 0.438 . . . . 71.21 110.301 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -67.11 -44.79 79.04 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.217 0.607 . . . . 72.05 109.885 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.24 99.76 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.91 0.756 . . . . 61.44 111.887 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . 0.514 ' HZ2' ' HB3' ' A' ' 170' ' ' MET . 34.1 t90 -63.11 -50.99 68.33 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.826 0.85 . . . . 72.33 110.434 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.484 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.8 m -68.62 -47.64 75.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 CA-C-O 118.9 -0.571 . . . . 72.43 111.019 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.8 m -62.1 -31.23 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.09 0.859 . . . . 74.44 111.509 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 m -76.37 -43.68 39.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.032 0.533 . . . . 73.32 111.219 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.8 tp -77.07 -33.86 57.07 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 123.237 0.615 . . . . 74.12 111.704 -170.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.3 mt -80.54 4.04 19.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.596 0.759 . . . . 74.34 112.248 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.67 108.38 0.73 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.916 0.886 . . . . 64.41 111.434 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.436 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -73.61 -5.49 40.69 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.745 1.017 . . . . 75.54 113.745 -170.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -97.45 -45.17 6.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.865 0.466 . . . . 73.23 111.151 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -100.4 -47.88 4.76 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.198 0.999 . . . . 72.32 110.508 -172.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.492 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 39.2 m-85 -86.24 -2.66 58.58 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.075 0.95 . . . . 73.21 112.402 -173.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -52.57 2.53 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.158 1.91 . . . . 75.21 116.158 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -83.3 17.31 2.13 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 74.53 110.82 167.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' A' ' 157' ' ' GLU . 87.6 mt -89.82 151.01 22.0 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.426 0.632 . . . . 73.52 110.489 175.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.32 119.36 17.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.109 -1.811 . . . . 74.21 106.109 169.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.432 ' HE1' ' SG ' ' A' ' 81' ' ' CYS . 91.1 m-85 -93.59 149.31 21.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.178 -1.045 . . . . 75.42 108.178 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.662 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . 82.3 m-85 -138.78 161.62 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.354 -0.609 . . . . 74.22 109.354 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.558 HD13 ' HE1' ' A' ' 91' ' ' TYR . 4.7 tt -136.4 143.29 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.648 -1.241 . . . . 70.1 107.648 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.72 150.47 49.84 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.525 0.516 . . . . 73.13 112.997 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.91 -47.84 52.0 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.495 1.518 . . . . 72.23 114.367 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -42.17 73.83 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.235 0.614 . . . . 74.43 110.684 -171.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.04 60.57 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.287 1.035 . . . . 75.1 110.872 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.46 -5.37 42.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.993 0.917 . . . . 73.21 112.583 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.83 -5.0 56.71 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.583 0.353 . . . . 75.25 111.028 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.67 42.94 1.28 Allowed Glycine 0 C--N 1.345 1.041 0 C-N-CA 122.876 0.274 . . . . 73.1 112.666 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.95 -67.48 0.85 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.104 -0.702 . . . . 73.21 109.104 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -159.16 173.37 16.5 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 74.14 109.558 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -54.96 -27.59 44.98 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.565 1.146 . . . . 72.34 112.547 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.85 -153.46 41.21 Favored Glycine 0 C--N 1.357 1.726 0 O-C-N 123.793 0.683 . . . . 60.31 111.446 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.541 ' HG3' HD22 ' A' ' 171' ' ' LEU . 50.3 tp60 -87.28 120.16 28.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.616 -0.883 . . . . 73.44 108.616 162.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.77 116.24 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 109.297 -0.631 . . . . 72.13 109.297 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 139' ' ' PHE . . . -76.65 99.97 5.21 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.159 -0.928 . . . . 75.31 110.494 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -91.47 108.58 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.476 -0.784 . . . . 75.13 109.628 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 49.9 mm -99.0 109.63 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.667 0.387 . . . . 74.35 110.71 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.497 ' HA ' HD21 ' A' ' 136' ' ' LEU . 45.7 tt0 -86.94 107.41 18.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.317 -0.623 . . . . 75.25 109.317 171.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -75.0 87.91 2.36 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.378 -1.341 . . . . 72.4 107.378 169.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.525 ' HB3' HG21 ' A' ' 166' ' ' VAL . 8.0 tpt180 -85.92 119.83 26.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.048 -0.978 . . . . 74.24 108.62 -170.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.73 97.62 10.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.758 0.423 . . . . 71.25 109.957 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 p -96.41 97.64 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.606 0.763 . . . . 73.01 109.306 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 64.7 17.38 10.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.415 1.086 . . . . 73.2 112.916 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 115.5 -10.13 19.47 Favored Glycine 0 N--CA 1.475 1.245 0 CA-C-O 120.156 -0.247 . . . . 75.03 113.335 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.4 m -97.38 128.61 44.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.332 0.653 . . . . 74.52 109.974 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.52 120.85 22.3 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.422 -0.955 . . . . 72.1 108.422 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 159' ' ' ARG . 12.4 m -115.88 95.72 44.89 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.624 -1.25 . . . . 74.53 107.624 171.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 123.91 14.97 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.451 2.767 . . . . 75.21 112.366 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 157' ' ' GLU . 26.5 m -117.89 110.45 17.76 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.569 -0.901 . . . . 72.34 108.569 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 62.8 tp -76.24 117.43 17.92 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.633 -0.877 . . . . 73.31 108.633 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.514 ' HB3' ' HZ2' ' A' ' 123' ' ' TRP . 63.5 mtt -112.26 120.92 43.41 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.957 -1.127 . . . . 74.25 107.957 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.541 HD22 ' HG3' ' A' ' 152' ' ' GLN . 78.5 mt -131.73 145.49 51.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.017 -1.475 . . . . 75.31 107.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.43 HG11 ' OE1' ' A' ' 152' ' ' GLN . 14.7 p -82.67 137.91 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.796 -0.816 . . . . 74.44 108.796 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -57.18 -22.19 38.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.858 1.263 . . . . 74.21 111.687 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -78.48 -36.91 44.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.4 0.519 . . . . 74.14 112.4 -174.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.422 ' HB1' HG12 ' A' ' 99' ' ' VAL . . . -97.64 -0.78 45.03 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.738 0.304 . . . . 72.03 110.597 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 41.3 mm -121.96 133.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 C-N-CA 124.131 0.972 . . . . 73.01 109.337 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.3 mm -99.0 109.73 24.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.418 -0.956 . . . . 74.24 108.418 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -95.68 123.45 39.25 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.464 -1.31 . . . . 72.1 107.464 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.575 ' HG3' ' HB ' ' A' ' 3' ' ' ILE . 8.1 pt-20 -146.98 125.04 12.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.218 -0.66 . . . . 63.12 109.218 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -81.49 95.81 7.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.59 -0.732 . . . . 74.5 109.324 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.37 88.8 6.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.38 -0.97 . . . . 74.14 108.38 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 67.1 mt -71.46 143.14 50.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.233 -0.894 . . . . 73.31 109.909 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.773 -0.632 . . . . 75.03 109.468 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.669 -0.493 . . . . 73.54 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.27 161.59 20.15 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.575 -0.898 . . . . 71.43 108.575 173.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.408 HD12 ' HD3' ' A' ' 5' ' ' LYS . 12.7 tt -133.66 118.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 71.22 109.802 172.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 177' ' ' ILE . 21.5 p90 -122.58 124.09 42.7 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.899 -1.148 . . . . 73.13 107.899 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 22.2 pttp -153.29 171.24 18.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.381 0.673 . . . . 72.31 109.995 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -105.09 142.77 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 72.11 108.812 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.412 HG22 HG12 ' A' ' 177' ' ' ILE . 22.1 pt -79.68 -9.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.293 0.637 . . . . 75.44 112.603 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -107.76 -60.21 1.74 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.708 0.29 . . . . 74.44 111.657 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -125.32 -49.49 1.68 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.837 0.68 . . . . 75.14 112.837 -164.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.488 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -87.31 21.84 2.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 71.44 111.181 -172.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 16.7 t70 -48.24 -21.68 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.013 1.325 . . . . 72.25 112.814 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.95 25.33 2.14 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.823 1.249 . . . . 72.5 112.722 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.494 HD23 ' HD1' ' A' ' 74' ' ' HIS . 40.9 mt -62.99 -92.3 0.0 OUTLIER 'General case' 0 C--N 1.371 1.542 0 CA-C-N 119.128 0.877 . . . . 75.13 110.378 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.403 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 68.1 m -154.65 129.97 9.73 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.994 0.815 . . . . 70.04 112.258 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.7 t -109.67 81.93 1.51 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.224 1.009 . . . . 74.5 108.795 163.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -162.2 166.92 24.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.083 0.953 . . . . 71.15 109.301 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.3 80.91 0.74 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.595 0.712 . . . . 75.54 110.93 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 61.7 m-85 -114.2 139.65 24.02 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.913 1.285 . . . . 75.44 108.98 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 16.5 Cg_exo -68.45 119.86 6.84 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.488 2.125 . . . . 54.3 112.092 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.08 144.13 27.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.637 0.775 . . . . 73.53 109.786 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.19 146.74 47.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.969 -0.752 . . . . 74.05 108.969 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.73 138.67 53.88 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.882 -0.785 . . . . 73.2 108.882 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.35 128.43 63.89 Favored 'Isoleucine or valine' 0 C--O 1.266 1.932 0 N-CA-C 109.001 -0.74 . . . . 61.22 109.001 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 72.78 -85.53 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.933 1.693 . . . . 74.01 108.741 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.5 t70 172.14 28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.575 1.95 . . . . 51.03 106.788 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 tp -135.15 -52.16 0.78 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.485 -0.779 . . . . 71.25 110.712 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.1 t -118.21 131.28 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.088 -0.505 . . . . 64.33 109.783 -168.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -83.62 135.49 34.58 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.122 -1.066 . . . . 74.54 108.122 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.87 155.76 47.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.42 0.629 . . . . 70.45 110.673 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.3 t80 -139.99 147.86 41.05 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.14 -0.936 . . . . 74.32 109.259 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.58 154.02 39.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.712 0.805 . . . . 75.33 111.892 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 156.46 28.42 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.722 -0.275 . . . . 75.02 112.858 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -154.37 159.24 41.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.836 0.854 . . . . 71.44 109.935 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -70.21 120.41 15.86 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.371 -0.603 . . . . 71.12 109.371 169.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.75 168.11 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.896 1.278 . . . . 64.32 108.473 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.97 145.32 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.722 -0.844 . . . . 73.21 108.722 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.741 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 27.2 mmt180 -134.33 109.16 8.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.06 -1.83 . . . . 75.22 106.06 174.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -133.07 97.32 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.761 -0.459 . . . . 74.2 109.761 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 39.95 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 126.616 1.966 . . . . 74.3 115.132 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.75 49.77 0.82 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.787 -0.925 . . . . 75.01 110.787 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -170.78 152.55 3.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.551 1.141 . . . . 73.14 109.0 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tt . . . . . 0 CA--C 1.547 0.835 0 C-N-CA 123.601 0.76 . . . . 70.02 109.694 172.407 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.008 -1.108 . . . . 73.51 108.008 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.741 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 3.3 mp0 -72.58 80.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.81 -0.811 . . . . 75.03 108.81 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.37 146.54 24.32 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.084 0.954 . . . . 70.14 109.416 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.65 -143.93 15.07 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.551 -1.019 . . . . 64.3 110.551 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.578 HD12 HD13 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -83.7 122.04 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 117.595 0.698 . . . . 74.22 109.413 -175.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.44 -47.52 9.91 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.756 2.022 . . . . 65.32 113.824 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 169' ' ' LEU . 66.4 mt -51.81 -48.45 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.82 1.248 . . . . 74.43 110.457 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 76' ' ' LEU . 56.0 t -70.56 -41.55 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.816 -1.084 . . . . 73.02 111.75 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 43.8 mt -64.08 -39.77 94.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.564 0.746 . . . . 74.33 111.341 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.25 -38.14 63.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.966 0.906 . . . . 75.1 111.128 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.494 ' HD1' HD23 ' A' ' 13' ' ' LEU . 28.5 m170 -92.07 -11.97 34.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.371 0.669 . . . . 72.43 111.555 -172.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 28.0 mtpp 62.44 46.7 5.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.897 1.279 . . . . 74.1 111.137 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.503 ' HB2' HG13 ' A' ' 71' ' ' VAL . 63.1 mt -80.43 130.79 35.39 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.376 -0.602 . . . . 74.24 109.376 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.8 135.42 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.214 -0.661 . . . . 72.23 109.214 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.45 148.01 24.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 75.42 113.325 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -146.64 103.54 3.67 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 106.307 -1.738 . . . . 74.23 106.307 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -92.6 118.12 30.69 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.931 -0.766 . . . . 75.45 108.931 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.4 p -63.64 -27.85 69.51 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.907 0.483 . . . . 74.21 111.188 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -68.03 -41.62 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.619 -1.173 . . . . 75.44 111.582 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.16 -22.88 13.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.628 0.771 . . . . 72.32 111.998 -170.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -116.66 21.0 13.73 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.456 1.102 . . . . 61.34 110.753 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.97 13.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.89 1.276 . . . . 71.13 113.779 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.9 m -61.45 -56.72 17.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.588 0.755 . . . . 75.34 111.26 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.6 mtp -59.92 -36.71 77.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.882 0.473 . . . . 73.2 111.072 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.42 -39.29 91.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.0 0.52 . . . . 75.15 111.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.06 -38.54 89.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.007 0.523 . . . . 74.34 109.974 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.38 94.11 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.072 -0.967 . . . . 61.52 110.739 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 95' ' ' PHE . 54.2 m-85 -59.28 -50.4 74.15 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 119.0 -0.524 . . . . 73.41 111.107 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mm -55.65 -44.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.453 0.701 . . . . 74.22 111.886 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -64.4 -56.2 15.9 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.099 0.56 . . . . 75.24 109.722 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -65.11 -55.85 16.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.537 0.523 . . . . 75.34 110.069 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 8.4 t80 -45.34 -61.13 1.79 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.325 1.45 . . . . 72.51 112.962 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.619 ' HE2' HG23 ' A' ' 120' ' ' ILE . 28.6 ttt -64.19 -41.27 97.15 Favored 'General case' 0 C--O 1.248 0.984 0 O-C-N 123.415 0.447 . . . . 74.42 111.449 -171.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -62.66 -41.35 99.01 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.139 -0.482 . . . . 74.11 110.683 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.44 -48.62 74.63 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.044 0.84 . . . . 74.33 111.373 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 103' ' ' MET . 29.2 m -62.24 -48.75 86.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.565 0.541 . . . . 75.14 110.433 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.475 HD11 ' HG3' ' A' ' 117' ' ' LYS . 47.0 mt -69.73 -43.01 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 O-C-N 123.308 0.38 . . . . 74.35 110.953 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.06 -37.83 81.04 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.732 0.813 . . . . 73.23 111.877 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -70.84 -41.23 71.76 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.83 0.706 . . . . 65.34 110.608 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.565 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 79.4 mmm -64.81 -36.52 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.079 -0.712 . . . . 75.25 109.079 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.45 -37.54 71.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.129 1.371 . . . . 74.43 110.462 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.619 ' HZ2' ' HB2' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -76.12 -12.82 60.18 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 74.32 111.194 -175.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -104.37 -6.02 21.17 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.211 1.005 . . . . 75.33 109.801 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 47.02 77.29 0.09 Allowed 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.13 1.772 . . . . 73.11 112.225 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.549 ' HG3' ' HE2' ' A' ' 103' ' ' MET . 5.3 mmm180 -61.12 -36.24 79.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.438 -0.801 . . . . 74.22 108.88 166.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.5 t70 152.06 147.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 128.503 2.721 . . . . 74.41 106.063 172.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.6 ' HZ1' ' HB3' ' A' ' 110' ' ' LYS . 7.0 ttpm? -58.0 -51.88 67.84 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.684 0.794 . . . . 72.03 110.99 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.28 -22.37 61.96 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.761 -0.654 . . . . 74.04 111.547 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -80.28 -42.55 22.89 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.107 0.563 . . . . 64.13 111.017 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.21 -27.66 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.965 0.506 . . . . 71.53 110.278 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.29 -36.1 63.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.822 0.849 . . . . 65.43 110.856 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.43 -40.94 76.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.229 0.612 . . . . 64.11 110.147 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -64.62 -40.03 94.76 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.0 0.92 . . . . 72.24 109.588 172.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HG3' HD11 ' A' ' 100' ' ' ILE . 29.1 ttpp -63.56 -33.16 74.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.464 0.705 . . . . 75.14 110.721 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -74.93 -39.22 61.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.566 0.746 . . . . 73.23 110.819 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -66.85 -46.9 73.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 64.22 111.447 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.619 HG23 ' HE2' ' A' ' 96' ' ' MET . 10.9 tp -74.01 -32.47 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.182 0.593 . . . . 75.45 109.624 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -62.36 -48.09 81.32 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 122.892 0.477 . . . . 74.21 110.008 172.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.67 98.74 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 124.454 1.096 . . . . 65.03 112.403 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -65.39 -48.95 71.12 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.204 0.602 . . . . 75.44 110.191 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -70.2 -41.81 78.91 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.462 0 CA-C-O 118.216 -0.897 . . . . 71.44 111.133 -174.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 m -71.88 -21.5 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 120.061 1.3 . . . . 74.44 111.507 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.2 t -73.72 -43.24 59.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.246 0.546 . . . . 72.24 109.605 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 34.7 tp -73.04 -36.0 66.84 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.459 1.103 . . . . 75.14 111.405 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.487 ' HA ' ' CE1' ' A' ' 133' ' ' PHE . 77.0 mt -79.83 4.02 17.85 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.587 1.155 . . . . 72.12 112.684 -171.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.13 141.56 49.14 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.486 -0.561 . . . . 62.01 109.486 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.639 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 99.8 mttt -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.561 0.745 . . . . 72.51 111.715 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.28 -16.41 63.01 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.816 0.846 . . . . 70.01 110.64 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.497 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 8.9 tpt180 -96.9 -41.59 8.35 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.324 1.049 . . . . 74.03 109.188 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.639 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.7 m-85 -62.82 -12.85 27.27 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.742 1.217 . . . . 72.14 113.146 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -50.21 -30.31 11.25 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.878 0.736 . . . . 75.44 112.618 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -131.4 17.87 4.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.704 0.801 . . . . 75.05 112.177 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.618 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 26.1 mt -96.12 128.94 43.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.201 0.525 . . . . 74.2 111.381 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.422 ' HB3' ' HE1' ' A' ' 158' ' ' TYR . . . -124.79 139.08 54.18 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 105.362 -2.088 . . . . 74.0 105.362 172.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.479 ' HB3' HG11 ' A' ' 153' ' ' VAL . 98.1 m-85 -116.0 148.03 40.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.501 -0.926 . . . . 72.32 108.501 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -146.56 136.4 23.3 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 107.716 -1.216 . . . . 71.15 107.716 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -127.57 148.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.044 -1.095 . . . . 74.01 108.044 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -51.85 145.49 15.16 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.343 0.497 . . . . 75.2 114.343 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 10.9 tp10 -52.05 -54.97 23.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.743 0.817 . . . . 64.32 111.107 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -72.15 -15.28 61.97 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.898 0.879 . . . . 74.25 111.567 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.96 -34.88 43.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.586 0.755 . . . . 73.32 110.445 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.45 7.57 4.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.078 0.951 . . . . 74.55 112.032 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -73.48 -20.32 60.71 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.861 0.864 . . . . 75.04 109.813 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.01 30.32 0.81 Allowed Glycine 0 C--N 1.356 1.647 0 C-N-CA 123.739 0.685 . . . . 74.42 112.363 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.85 90.27 5.28 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 72.2 110.367 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.35 163.27 25.52 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.026 0.931 . . . . 73.24 112.391 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 79.97 7.34 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.769 1.628 . . . . 74.21 111.495 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.64 -177.61 36.86 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 116.137 1.215 . . . . 63.12 116.137 -170.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -111.95 152.27 28.25 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.825 1.65 . . . . 70.5 109.866 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 138' ' ' PHE . 92.7 t -108.22 136.04 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.935 0.894 . . . . 72.13 108.632 173.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.636 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -64.62 114.44 4.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.098 0.959 . . . . 53.22 110.27 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 170' ' ' MET . 61.3 mt -87.03 107.67 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.99 0.916 . . . . 72.54 108.864 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.48 121.56 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 72.3 110.092 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.62 98.2 7.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.264 1.426 . . . . 74.54 108.974 -166.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.422 ' HE1' ' HB3' ' A' ' 137' ' ' ALA . 57.5 m-85 -82.86 118.65 23.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.761 0.424 . . . . 74.53 110.705 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -125.31 -179.32 4.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.101 0.96 . . . . 75.42 109.436 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -123.86 110.83 15.35 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.215 0.606 . . . . 61.25 110.941 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.95 102.12 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.226 1.01 . . . . 74.0 108.31 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.95 31.55 19.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.239 1.016 . . . . 74.45 110.841 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.57 65.63 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.044 -0.525 . . . . 74.52 113.817 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.7 m -90.42 131.39 36.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.202 0.601 . . . . 74.3 109.841 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -71.14 123.11 21.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.509 0.724 . . . . 72.22 109.979 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.96 102.49 31.4 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.492 1.117 . . . . 75.24 110.21 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.563 ' HB2' HD11 ' A' ' 68' ' ' ILE . 72.3 Cg_endo -85.83 118.33 1.77 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.79 2.327 . . . . 72.3 112.236 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.1 m -103.78 141.91 35.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.991 0.916 . . . . 54.42 109.991 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.657 ' HB2' HD12 ' A' ' 70' ' ' ILE . 46.4 tp -77.22 130.35 37.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.086 -1.079 . . . . 74.21 108.086 171.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 155' ' ' ILE . 33.2 tpp -131.4 122.48 26.39 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.863 -1.532 . . . . 74.44 106.863 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' A' ' 154' ' ' ALA . 48.8 mt -159.76 145.65 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.696 1.198 . . . . 74.41 108.107 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 176' ' ' ILE . 14.6 p -80.24 134.43 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.355 0.98 . . . . 75.42 109.795 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -55.27 -30.39 60.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.869 1.268 . . . . 64.03 112.975 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.498 ' HG3' ' HE3' ' A' ' 103' ' ' MET . 6.2 mp0 -71.13 -25.99 62.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.264 0.625 . . . . 74.22 111.713 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.01 -1.5 42.5 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.997 0.519 . . . . 64.04 111.008 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 171' ' ' LEU . 42.7 mm -112.5 138.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.039 0.535 . . . . 73.33 110.703 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 38.0 mm -96.62 109.46 23.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 105.96 -1.867 . . . . 75.03 105.96 167.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.6 99.29 6.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.599 -1.63 . . . . 75.21 106.599 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -126.75 155.72 42.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.011 0.924 . . . . 72.51 110.081 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -106.63 113.74 27.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.262 1.025 . . . . 73.23 109.725 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 46.7 m -95.88 91.15 5.89 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.462 -0.79 . . . . 71.41 109.085 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.64 168.81 18.87 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.013 0.525 . . . . 63.45 110.584 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.056 0 N-CA-C 108.853 -0.795 . . . . 75.12 108.853 -178.22 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.854 -0.424 . . . . 75.52 109.854 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.73 130.64 53.17 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.927 0.491 . . . . 72.12 111.538 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 tt -99.15 118.92 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 N-CA-C 107.662 -1.236 . . . . 61.0 107.662 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -125.11 115.1 19.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.426 0.69 . . . . 72.1 110.902 -163.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.723 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 1.5 mptp? -121.3 153.14 38.11 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.49 0.716 . . . . 73.43 110.57 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.35 148.63 22.19 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.454 -0.943 . . . . 75.41 108.454 159.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 175' ' ' ALA . 47.2 pt -83.27 -24.58 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 112.563 0.579 . . . . 73.41 112.563 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -86.99 -64.0 1.22 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.796 0.665 . . . . 74.33 112.796 -169.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 144' ' ' ALA . 6.3 m -132.3 -34.73 1.21 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.877 0.695 . . . . 74.32 112.877 -172.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -92.5 21.79 5.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.941 1.296 . . . . 65.5 110.934 -164.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -46.78 -28.27 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.556 1.542 . . . . 61.22 112.891 -172.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.93 26.26 1.87 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.763 0.825 . . . . 72.32 112.596 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 10' ' ' ASP . 18.2 mt -44.93 -93.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.974 1.31 . . . . 74.34 112.557 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.3 m -156.28 152.26 27.48 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.965 -0.46 . . . . 64.21 110.917 -167.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -140.13 98.81 3.52 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.144 -1.058 . . . . 64.12 108.144 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -161.5 -176.2 5.21 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 110.267 -0.271 . . . . 74.42 110.267 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -68.33 92.82 0.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.36 1.064 . . . . 71.21 110.097 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.443 ' HB3' ' HE2' ' A' ' 30' ' ' PHE . 41.2 m-85 -109.29 139.5 21.11 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 123.486 0.714 . . . . 75.11 111.18 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.36 119.08 6.05 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.197 1.931 . . . . 75.15 110.872 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.0 ttp -126.42 123.2 37.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.469 -0.787 . . . . 75.44 109.184 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.59 131.03 22.32 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.892 -1.521 . . . . 74.25 106.892 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.7 tp -101.77 124.06 46.77 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.81 -0.811 . . . . 74.25 108.81 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.39 140.05 38.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 124.424 1.089 . . . . 74.41 108.551 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 64.29 12.99 7.63 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.006 0.922 . . . . 73.45 112.453 173.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 58.38 21.84 8.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.31 1.044 . . . . 75.25 111.966 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.3 tp -130.74 -52.83 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.758 0.423 . . . . 74.21 110.686 -167.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -117.56 141.61 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.395 0.678 . . . . 64.24 111.239 -167.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' A' ' 178' ' ' GLU . 46.6 m-85 -88.7 118.15 28.17 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.128 0.971 . . . . 74.45 109.936 168.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -85.69 104.41 15.38 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.462 -1.245 . . . . 74.11 107.885 167.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.558 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.7 t80 -100.58 106.81 18.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.419 -1.326 . . . . 74.24 107.419 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.83 154.36 27.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.103 0.477 . . . . 74.11 110.964 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.01 -172.2 23.96 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.094 -0.802 . . . . 73.43 111.094 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -135.21 137.34 42.54 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.468 0.634 . . . . 74.02 110.717 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -74.18 118.67 17.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.796 0.839 . . . . 74.11 109.198 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.561 ' HB ' HD11 ' A' ' 42' ' ' ILE . 12.6 m -141.63 168.67 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.705 1.202 . . . . 72.53 110.69 -165.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.97 114.01 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.765 0.793 . . . . 70.34 109.235 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.785 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 35.8 ttm180 -92.71 111.04 22.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.282 -1.007 . . . . 74.54 108.282 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -120.81 149.31 42.77 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.083 0.953 . . . . 75.34 109.361 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -72.45 81.83 1.07 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.728 -0.841 . . . . 65.23 108.728 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.83 -62.19 0.18 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 114.365 -1.289 . . . . 73.23 110.259 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -172.17 157.95 4.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.634 0.774 . . . . 75.54 110.163 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.561 HD11 ' HB ' ' A' ' 35' ' ' VAL . 6.5 tp . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 108.092 -1.077 . . . . 73.14 108.092 169.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 C--O 1.24 0.56 0 N-CA-C 106.346 -1.724 . . . . 65.31 106.346 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.785 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 13.2 mm-40 -75.74 69.41 2.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.032 -1.099 . . . . 73.23 108.032 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -82.28 122.26 27.72 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.552 -1.204 . . . . 74.51 108.026 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.78 -164.82 37.64 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.057 -1.617 . . . . 74.34 109.057 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.45 HD13 HD13 ' A' ' 70' ' ' ILE . 37.2 pt -96.65 148.82 5.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 117.471 0.636 . . . . 75.21 110.33 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.69 -30.85 63.87 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.746 1.218 . . . . 71.11 112.312 -174.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.45 HD13 HD13 ' A' ' 68' ' ' ILE . 61.1 mt -56.52 -51.24 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.022 1.329 . . . . 75.01 110.613 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 76' ' ' LEU . 47.2 t -78.65 -44.11 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 114.451 -1.25 . . . . 73.32 111.21 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.58 -18.17 65.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.666 0.786 . . . . 72.42 112.089 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -48.52 -58.52 4.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.331 1.052 . . . . 74.13 110.681 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.04 -7.72 16.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.819 -0.628 . . . . 64.43 112.598 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttp 62.21 69.88 0.6 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.558 1.161 . . . . 73.34 109.052 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' A' ' 71' ' ' VAL . 64.3 mt -75.16 157.03 35.27 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.54 -0.755 . . . . 71.15 109.57 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.51 127.84 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.276 -0.638 . . . . 75.12 109.276 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.87 152.07 20.19 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.939 0.876 . . . . 73.52 112.887 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.587 ' HE3' ' HE2' ' A' ' 91' ' ' TYR . 86.0 mmm -143.83 137.22 27.82 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 104.72 -2.326 . . . . 70.13 104.72 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 140.42 35.64 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.327 0.512 . . . . 71.31 109.788 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.43 ' SG ' ' HG3' ' A' ' 134' ' ' LYS . 24.9 p -58.96 -14.81 10.28 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.504 0.722 . . . . 62.54 112.907 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -66.3 -59.09 4.04 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.4 0.68 . . . . 75.54 112.197 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -98.21 -38.24 9.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.846 0.458 . . . . 73.14 110.728 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -92.5 21.59 5.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.622 0.769 . . . . 73.34 112.681 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.2 -53.2 29.67 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.759 0.824 . . . . 63.0 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 m -72.84 -37.72 67.34 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.774 0.83 . . . . 73.14 111.6 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.5 mpt? -66.5 -45.87 78.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.237 1.015 . . . . 74.33 110.3 -176.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.448 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 36.2 t80 -63.38 -47.18 83.12 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.376 -1.284 . . . . 75.43 111.236 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 37.1 ttmt -65.39 -28.83 69.54 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.349 0.405 . . . . 72.53 110.701 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.55 93.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.425 0.69 . . . . 65.43 110.7 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.587 ' HE2' ' HE3' ' A' ' 79' ' ' MET . 31.2 m-85 -61.09 -40.04 92.24 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 115.961 -0.563 . . . . 73.22 111.115 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.0 mm -65.19 -32.54 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.731 0.812 . . . . 75.43 111.675 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 89' ' ' LYS . 96.4 mttt -61.53 -47.45 85.51 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.066 0.547 . . . . 65.0 111.437 171.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -66.91 -42.28 85.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.098 0.559 . . . . 75.44 110.675 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.451 ' O ' HG12 ' A' ' 99' ' ' VAL . 79.0 t80 -51.86 -60.79 2.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.117 1.767 . . . . 73.23 111.035 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.9 ttp -61.04 -40.92 95.45 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.731 0.645 . . . . 71.32 111.018 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -56.02 -55.73 29.27 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.214 0.606 . . . . 74.42 110.684 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -72.27 -36.68 69.06 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.496 0.498 . . . . 62.43 111.854 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 95' ' ' PHE . 18.1 m -67.77 -38.78 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.432 0.53 . . . . 63.12 112.432 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.05 -35.93 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 121.001 0.429 . . . . 75.41 110.529 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.78 -47.83 84.54 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.074 0.95 . . . . 71.22 110.765 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -66.56 -44.34 82.58 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.617 -1.174 . . . . 50.33 110.061 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.493 ' HE3' ' HB2' ' A' ' 116' ' ' PHE . 15.4 tpt -55.53 -53.35 57.52 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.118 0.886 . . . . 74.43 111.724 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.443 ' HA ' HG11 ' A' ' 113' ' ' VAL . 41.1 tt0 -65.2 -27.09 68.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.568 0.542 . . . . 73.2 111.579 -172.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.58 -45.28 76.01 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.201 0.524 . . . . 75.12 110.616 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -83.82 -29.54 27.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.081 0.953 . . . . 75.22 111.388 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -99.57 -50.66 4.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.632 0.773 . . . . 72.55 109.938 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 73.29 -13.3 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.146 1.379 . . . . 72.54 113.611 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.22 122.6 33.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.564 -0.902 . . . . 75.32 108.564 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.07 -37.48 85.91 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.189 0.596 . . . . 70.33 112.591 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.8 -30.26 66.68 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.611 0.364 . . . . 74.04 111.834 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.08 -30.92 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.598 0.359 . . . . 70.11 110.317 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 103' ' ' MET . 27.0 m -80.65 -25.68 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 121.903 0.081 . . . . 72.21 110.974 173.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.25 -39.29 94.19 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.649 0.779 . . . . 72.31 109.64 167.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.31 -40.87 67.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.688 -1.142 . . . . 73.01 110.435 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.493 ' HB2' ' HE3' ' A' ' 103' ' ' MET . 78.6 t80 -63.37 -44.95 93.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.805 0.442 . . . . 74.4 111.188 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.401 ' HA ' HG23 ' A' ' 120' ' ' ILE . 15.6 pttp -65.58 -35.75 81.74 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.904 -0.406 . . . . 74.33 109.904 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.28 -36.89 85.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.929 0.892 . . . . 75.41 111.045 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.44 -52.84 22.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.236 0.614 . . . . 74.44 110.633 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.431 HG12 HG22 ' A' ' 99' ' ' VAL . 8.5 tp -73.89 -40.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.164 0.29 . . . . 75.15 110.986 -169.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -68.18 -35.27 77.75 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.283 -0.636 . . . . 75.2 109.283 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.19 94.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.643 -0.708 . . . . 72.33 113.342 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -66.33 -47.89 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.903 -0.776 . . . . 73.54 108.903 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.0 m -74.49 -30.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-N 115.582 -0.736 . . . . 70.44 111.88 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.47 -25.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 119.118 0.872 . . . . 73.15 110.068 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -81.77 -42.2 20.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.022 0.529 . . . . 74.41 111.232 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.524 HD21 HG23 ' A' ' 155' ' ' ILE . 54.7 tp -79.31 -23.95 43.17 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.124 0.969 . . . . 74.54 112.118 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.3 mt -93.4 4.4 54.03 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.841 0.456 . . . . 72.14 111.63 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 99.75 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.331 0.652 . . . . 74.22 111.141 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 13.4 ptmm? -51.68 -39.8 58.93 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.863 1.801 . . . . 74.51 115.863 -162.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.31 -29.53 66.28 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.891 0.7 . . . . 74.41 112.891 -163.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -111.51 -29.75 7.64 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.401 0.519 . . . . 72.34 112.401 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.48 -2.22 58.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.495 0.924 . . . . 73.23 113.495 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HG3' ' SG ' ' A' ' 81' ' ' CYS . 26.5 ttpp -51.07 -24.63 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 112.546 0.573 . . . . 74.31 112.546 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.15 25.94 3.99 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.152 0.981 . . . . 75.53 111.66 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.08 142.07 28.19 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.424 -0.954 . . . . 74.43 108.424 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.28 110.51 22.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.341 -1.355 . . . . 73.33 107.341 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.36 143.11 26.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.717 -1.216 . . . . 71.51 107.717 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -137.48 137.38 38.63 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.765 -0.828 . . . . 74.12 108.765 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 tt -109.9 148.15 13.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.355 0 N-CA-C 106.73 -1.582 . . . . 72.12 106.73 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.64 ' HA2' HD21 ' A' ' 76' ' ' LEU . . . -48.37 130.48 20.23 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 124.386 1.053 . . . . 71.34 112.766 175.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 11.0 tp10 -56.98 -38.28 72.79 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.21 0.604 . . . . 73.13 110.923 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -71.54 -35.25 70.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.959 0.904 . . . . 73.23 109.259 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' A' ' 9' ' ' THR . . . -65.12 -42.76 93.62 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.255 -0.884 . . . . 63.3 110.628 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -19.52 65.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.287 0.635 . . . . 73.13 112.593 -176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 49.8 mt-10 -79.75 -23.12 42.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.942 0.497 . . . . 63.23 111.928 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.86 49.06 0.08 OUTLIER Glycine 0 C--N 1.348 1.243 0 C-N-CA 121.288 -0.482 . . . . 71.22 113.867 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.96 98.53 0.29 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.858 0.863 . . . . 72.34 110.731 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.57 14.39 4.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.479 0.711 . . . . 73.22 111.221 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.61 -3.78 29.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.281 1.032 . . . . 75.24 111.006 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.68 163.83 35.74 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.891 0.744 . . . . 73.31 114.871 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -78.77 141.62 37.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.043 0.937 . . . . 73.13 112.479 -172.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.05 111.03 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 123.347 0.659 . . . . 73.12 110.028 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.53 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.54 111.36 5.32 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.849 -1.069 . . . . 60.12 108.78 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.524 HG23 HD21 ' A' ' 127' ' ' LEU . 63.0 mt -92.77 124.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.44 -0.948 . . . . 75.23 108.44 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 68' ' ' ILE . 49.7 mm -109.39 111.29 35.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 109.362 -0.607 . . . . 75.51 109.362 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.26 116.15 26.26 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.726 0.641 . . . . 74.13 109.831 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -69.86 88.54 0.56 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.669 1.187 . . . . 74.35 109.304 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -94.65 134.06 37.63 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.149 -0.97 . . . . 73.25 109.816 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.4 102.71 15.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.909 0.484 . . . . 65.02 110.109 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.8 p -90.19 92.31 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 N-CA-C 108.295 -1.002 . . . . 75.21 108.295 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.68 -66.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.914 1.685 . . . . 54.43 111.514 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -163.89 29.05 0.23 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.764 -0.934 . . . . 75.3 110.764 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 98.5 m -135.73 148.08 48.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.583 1.153 . . . . 74.34 108.032 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.53 136.44 36.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.286 0.494 . . . . 73.33 110.054 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.29 112.75 18.22 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.342 1.057 . . . . 73.33 108.271 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 115.4 3.62 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.183 1.922 . . . . 53.42 111.666 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.4 p -111.35 108.66 18.32 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.095 -1.076 . . . . 74.11 108.095 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 19.5 tp -75.96 120.37 21.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.719 0.807 . . . . 75.31 109.538 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.5 mtt -100.1 122.2 42.6 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 123.783 0.833 . . . . 73.45 109.117 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 154' ' ' ALA . 42.6 mt -141.07 140.16 34.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.353 1.461 . . . . 73.45 107.487 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.445 HG12 HG11 ' A' ' 99' ' ' VAL . 10.5 p -81.77 147.59 6.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.395 -0.594 . . . . 71.51 109.395 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -51.06 -44.93 61.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.813 1.245 . . . . 75.02 112.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -82.29 3.65 26.83 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.419 0.896 . . . . 74.31 113.419 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.414 ' HA ' HD13 ' A' ' 7' ' ' ILE . . . -105.93 -5.0 19.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.212 0.605 . . . . 63.21 111.474 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 171' ' ' LEU . 48.2 mm -122.79 143.97 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.448 0.699 . . . . 74.1 110.006 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.723 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 41.3 mm -98.62 109.68 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 N-CA-C 106.905 -1.517 . . . . 75.53 106.905 168.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.447 ' HG2' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -130.19 116.68 18.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.873 0.869 . . . . 74.24 109.575 -171.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -141.28 132.4 26.31 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.191 0.597 . . . . 70.3 109.872 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -76.94 102.8 6.55 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.999 -0.741 . . . . 74.11 108.999 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.7 t -77.73 87.67 3.99 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.403 0.621 . . . . 73.45 110.082 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.9 mt -87.35 92.66 9.15 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.514 -0.921 . . . . 74.11 108.514 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.467 0.707 . . . . 71.12 109.206 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 49.9 ttm . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 108.279 -1.008 . . . . 74.21 108.279 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 mt -91.87 139.77 30.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.442 -0.577 . . . . 73.51 109.442 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.652 HG23 ' HB3' ' A' ' 179' ' ' GLU . 4.0 tt -110.09 117.88 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.448 -0.945 . . . . 74.3 108.448 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.493 ' HD1' ' HB2' ' A' ' 14' ' ' SER . 0.9 OUTLIER -103.09 123.0 45.83 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.309 -1.737 . . . . 72.0 106.309 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -124.14 151.86 43.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.572 0.749 . . . . 75.13 109.899 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 38.8 t70 -99.5 174.67 6.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.577 -0.897 . . . . 64.51 108.577 173.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 98' ' ' ASN . 20.6 tt -72.99 -34.73 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.356 0.662 . . . . 72.33 110.995 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.4 -48.45 2.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.093 0.957 . . . . 74.24 109.872 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -88.33 16.37 6.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.143 -1.39 . . . . 73.45 111.394 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 5.8 p-10 -52.7 -39.01 61.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.312 1.045 . . . . 74.22 112.841 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.23 -25.86 67.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.177 -0.919 . . . . 74.45 111.502 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -105.8 -1.61 24.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.599 0.759 . . . . 74.33 112.469 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mt -84.96 -154.45 0.18 Allowed 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.453 1.024 . . . . 74.04 110.309 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.493 ' HB2' ' HD1' ' A' ' 4' ' ' TYR . 15.1 m -115.45 124.54 51.4 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.248 0.462 . . . . 71.54 112.248 -158.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -116.5 85.2 2.26 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.206 -0.665 . . . . 64.2 109.206 168.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB3' ' HE1' ' A' ' 18' ' ' PHE . 26.3 t70 -166.03 -105.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.529 -0.76 . . . . 72.23 109.388 -172.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 p -177.91 84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.08 0.952 . . . . 55.04 108.642 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.404 ' HE1' ' HB3' ' A' ' 16' ' ' ASP . 78.0 m-85 -115.75 129.5 25.11 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.315 1.046 . . . . 74.22 109.264 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.87 135.81 43.2 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.078 2.518 . . . . 72.12 112.188 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.28 162.78 37.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.047 -0.524 . . . . 71.32 111.042 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.518 ' HB2' ' HZ3' ' A' ' 21' ' ' LYS . 4.8 ttmp? -144.89 159.56 42.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.784 0.833 . . . . 74.32 109.389 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.23 128.58 50.2 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.325 -0.991 . . . . 75.42 108.325 168.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -120.54 146.15 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.901 0.88 . . . . 73.41 109.817 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 t70 67.52 5.72 4.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.576 1.15 . . . . 73.14 113.153 167.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.56 18.35 6.93 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.597 1.159 . . . . 74.0 111.294 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 119' ' ' LYS . 52.8 tp -129.54 -50.03 1.16 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.004 -0.544 . . . . 73.14 111.131 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.3 t -110.79 124.12 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.4 0.619 . . . . 74.45 110.47 -172.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -85.34 115.8 23.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 114.816 -1.083 . . . . 64.44 108.598 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 21' ' ' LYS . 42.0 mt-10 -89.33 149.34 23.07 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.882 0.873 . . . . 64.34 110.534 173.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.737 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 35.9 t80 -139.84 142.5 36.6 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.875 -1.157 . . . . 75.23 107.875 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.02 120.72 14.13 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.273 0.358 . . . . 74.42 111.672 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.8 157.71 14.78 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.201 -1.16 . . . . 73.42 110.201 166.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -144.9 147.32 32.64 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.598 -0.89 . . . . 74.52 108.598 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -87.59 109.18 19.46 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.624 -0.88 . . . . 65.43 108.624 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG22 HD11 ' A' ' 72' ' ' LEU . 18.5 m -145.22 174.3 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.612 1.165 . . . . 74.54 109.876 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' A' ' 66' ' ' ARG . 25.7 m -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.339 -0.615 . . . . 71.43 109.339 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -120.05 107.58 13.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.591 -0.892 . . . . 71.14 108.591 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HD2' HG23 ' A' ' 64' ' ' VAL . 63.9 tttp -134.83 96.19 3.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.143 -1.058 . . . . 74.32 108.143 166.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 60.02 -66.36 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.564 1.546 . . . . 75.44 112.2 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.02 43.89 0.19 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.662 -0.975 . . . . 75.34 110.662 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -113.93 100.15 8.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.065 0.946 . . . . 74.33 109.448 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 CA--C 1.554 1.119 0 CA-C-O 122.823 1.297 . . . . 75.0 110.335 -177.121 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG23 ' HD2' ' A' ' 38' ' ' LYS . 58.0 t . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 108.061 -1.088 . . . . 71.01 108.061 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -88.0 70.76 9.42 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.231 -0.895 . . . . 65.2 108.612 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.472 ' HA ' HG13 ' A' ' 36' ' ' VAL . 8.1 ptp180 -85.14 139.05 32.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.677 -0.692 . . . . 75.54 110.936 172.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.36 -126.68 2.75 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.289 -0.414 . . . . 62.41 112.152 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 34.6 pt -113.83 142.41 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.383 0.673 . . . . 70.21 112.763 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.6 -46.61 2.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.989 2.116 . . . . 72.33 114.402 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 156' ' ' ILE . 29.5 mm -54.3 -43.19 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.937 0.875 . . . . 75.22 111.023 -176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.6 t -83.2 -40.36 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.388 -1.278 . . . . 75.51 112.402 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 16.5 mt -74.22 -32.33 62.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.063 0.459 . . . . 74.53 110.572 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -78.25 -24.37 46.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.642 0.777 . . . . 75.41 111.535 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -122.47 -6.71 8.69 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.816 0.673 . . . . 62.53 112.816 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.0 tptt 54.63 70.32 0.63 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.111 1.364 . . . . 73.04 110.928 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -96.04 139.35 32.34 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.215 -0.902 . . . . 71.3 109.038 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.636 HG11 HG21 ' A' ' 140' ' ' ILE . 4.0 p -89.85 133.61 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.049 -0.723 . . . . 71.23 109.049 174.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.427 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 pt-20 -56.54 152.48 11.71 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.933 0.893 . . . . 73.02 113.274 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.7 tpt -148.44 144.6 27.53 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 125.206 1.402 . . . . 74.12 107.481 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -137.52 151.48 48.47 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.207 0.527 . . . . 74.52 111.327 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.422 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 26.0 p -88.86 -2.16 58.45 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.143 -0.935 . . . . 73.43 111.327 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -75.52 -61.81 1.79 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.022 0.749 . . . . 74.42 113.022 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -103.96 -35.04 8.27 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.389 0.676 . . . . 75.14 110.439 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.29 20.6 2.32 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 71.11 112.094 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 81' ' ' CYS . . . -55.01 -35.35 64.31 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.38 1.072 . . . . 75.24 113.252 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.1 m -70.03 -44.68 68.75 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 73.4 111.058 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -70.43 -42.1 72.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.42 109.855 -176.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' HE2' HD21 ' A' ' 128' ' ' LEU . 53.2 t80 -68.48 -32.44 72.43 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.463 -1.244 . . . . 74.51 111.36 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 89' ' ' LYS . 4.4 ttmp? -64.14 -34.92 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.888 0.475 . . . . 72.41 110.522 173.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -39.4 88.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.696 -0.683 . . . . 72.24 109.855 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -69.11 -33.54 73.66 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.765 0.654 . . . . 73.43 112.765 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -62.91 -41.24 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.957 0.503 . . . . 72.03 110.788 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -59.21 -44.66 92.25 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.653 0.595 . . . . 75.52 110.15 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' HA ' ' HZ3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -61.41 -60.25 4.01 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 114.87 -1.059 . . . . 74.13 109.619 177.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -49.25 -62.5 1.5 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.925 1.69 . . . . 62.03 112.955 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.55 -44.64 90.14 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.559 0.537 . . . . 75.11 111.618 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -66.77 -36.11 81.65 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 118.296 0.498 . . . . 75.14 110.674 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.49 HD22 HD12 ' A' ' 7' ' ' ILE . 25.2 t30 -61.26 -53.21 59.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.103 0.961 . . . . 53.32 110.47 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.3 m -78.69 -29.66 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.341 -0.845 . . . . 71.43 112.186 -170.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.55 -40.67 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.787 -0.449 . . . . 75.25 109.787 172.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.32 -36.88 79.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.79 0.836 . . . . 72.24 111.227 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -66.09 -42.57 89.13 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.257 0.623 . . . . 73.33 109.563 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.576 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 27.0 ttt -66.32 -37.06 84.49 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 116.009 -0.541 . . . . 72.33 111.154 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.649 0.78 . . . . 73.33 111.458 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -84.17 -37.63 21.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.35 0.26 . . . . 73.3 111.372 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.576 ' ND2' ' HA ' ' A' ' 103' ' ' MET . 6.0 p30 -96.78 5.25 50.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.173 -0.329 . . . . 74.04 111.823 -175.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -129.85 -50.3 1.14 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.656 0.782 . . . . 74.14 109.742 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 49.28 21.67 0.57 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.868 1.667 . . . . 74.13 112.994 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.2 131.47 51.47 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.686 1.195 . . . . 75.31 108.354 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -63.65 -45.06 91.9 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.281 0.988 . . . . 74.53 111.843 -173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.55 76.19 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.04 0.536 . . . . 73.22 112.115 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.81 -45.37 51.81 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.846 0.459 . . . . 72.2 111.22 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.67 -30.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 123.655 0.597 . . . . 74.42 111.338 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -41.78 76.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.325 0.65 . . . . 74.31 111.072 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.78 -42.45 86.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.01 0.433 . . . . 74.35 110.2 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.424 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 88.3 t80 -67.0 -42.13 85.54 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.036 -0.984 . . . . 64.44 110.762 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 64.3 tttp -53.87 -47.08 71.4 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.996 0.81 . . . . 74.24 110.102 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -65.88 -39.54 90.76 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.736 1.273 . . . . 75.3 109.789 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.525 ' HB3' HD11 ' A' ' 26' ' ' LEU . 8.8 tptp -69.22 -49.17 58.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.287 0.635 . . . . 75.33 109.638 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 tp -74.56 -42.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.991 -0.55 . . . . 64.5 110.874 -170.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 12.5 pt20 -66.07 -39.47 90.08 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 109.572 -0.529 . . . . 73.51 109.572 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.73 99.23 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.501 0.5 . . . . 71.21 112.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -67.82 -50.99 53.71 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 118.98 -0.534 . . . . 71.45 109.935 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.513 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.7 m -68.32 -43.3 84.5 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 O-C-N 123.654 0.596 . . . . 73.44 111.299 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 -25.56 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.083 0.553 . . . . 74.41 110.894 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -77.67 -40.52 41.29 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.878 0.471 . . . . 73.02 110.575 167.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.555 HD21 HG22 ' A' ' 155' ' ' ILE . 41.0 tp -73.71 -28.42 61.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.917 1.287 . . . . 73.35 111.5 -171.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 83.9 mt -84.37 1.55 44.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.722 0.809 . . . . 75.24 111.082 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.83 85.37 2.2 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 123.455 0.702 . . . . 75.31 109.416 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -55.67 -29.49 59.41 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.679 1.592 . . . . 75.2 114.556 -166.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.33 -22.8 61.12 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.349 0.5 . . . . 72.14 112.349 -171.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -103.18 -51.34 3.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.071 0.948 . . . . 72.24 108.806 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -76.96 0.24 21.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.697 1.599 . . . . 73.4 114.9 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -46.25 -7.44 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.435 1.642 . . . . 64.35 115.435 171.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -82.18 9.76 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.955 0.902 . . . . 71.3 111.339 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.02 148.07 23.29 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.736 0.814 . . . . 73.31 109.089 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.425 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . . . -138.92 116.07 11.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.19 -1.781 . . . . 75.24 106.19 170.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -89.15 147.63 24.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.29 -1.004 . . . . 65.33 108.29 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 78' ' ' GLU . 75.7 m-85 -141.27 143.15 33.95 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.389 -0.597 . . . . 73.05 109.389 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.636 HG21 HG11 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -123.61 138.01 54.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 105.174 -2.158 . . . . 74.33 105.174 176.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.92 126.28 39.68 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.125 -0.82 . . . . 62.31 111.336 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -56.75 -38.56 72.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 75.4 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -57.26 -47.09 82.3 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.628 1.171 . . . . 74.21 111.253 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.43 84.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.325 0.65 . . . . 72.42 111.149 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.0 -3.59 16.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.653 -0.703 . . . . 72.12 112.237 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -104.9 -18.02 14.35 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.319 1.048 . . . . 64.51 110.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.71 -74.32 0.01 OUTLIER Glycine 0 C--N 1.355 1.594 0 O-C-N 122.307 -0.246 . . . . 64.14 112.778 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.25 80.24 9.13 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.534 0.734 . . . . 70.43 109.809 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.01 1.56 2.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.29 1.036 . . . . 73.05 113.587 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -97.89 9.06 43.66 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.983 0.913 . . . . 75.14 110.624 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.04 154.62 43.76 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.796 0.685 . . . . 52.43 112.718 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.61 143.91 28.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 74.21 111.077 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.14 116.34 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.295 0.638 . . . . 73.32 110.636 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' A' ' 171' ' ' LEU . . . -69.35 113.95 7.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.745 1.218 . . . . 74.3 109.721 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.555 HG22 HD21 ' A' ' 127' ' ' LEU . 75.1 mt -91.59 109.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.217 -0.66 . . . . 71.14 109.217 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 169' ' ' LEU . 40.0 mm -96.71 144.7 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.431 -0.581 . . . . 74.5 109.431 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.99 109.66 9.71 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.251 -1.018 . . . . 61.32 108.251 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 6.2 p90 -83.4 91.96 7.46 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.352 -1.351 . . . . 74.42 107.352 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.499 ' HB3' HG12 ' A' ' 166' ' ' VAL . 7.5 tpt180 -74.4 91.61 2.24 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.158 -1.383 . . . . 74.44 108.72 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.35 112.44 5.22 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.21 -0.905 . . . . 75.12 110.904 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.48 92.08 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.526 1.13 . . . . 64.34 108.581 168.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 t70 46.35 61.87 2.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.568 1.547 . . . . 75.1 112.515 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.92 -12.8 68.68 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-N 115.515 -0.766 . . . . 73.34 113.441 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.18 106.97 17.71 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.004 -0.739 . . . . 74.33 109.004 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 14.4 pt-20 -73.31 141.09 47.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.484 -0.561 . . . . 75.21 109.484 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 159' ' ' ARG . 3.7 p -127.27 91.29 46.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 108.199 -1.037 . . . . 74.23 108.199 166.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 52.1 Cg_exo -56.24 143.51 84.99 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.148 2.565 . . . . 61.33 112.663 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.1 m -145.87 126.47 14.21 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 74.03 108.576 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.7 tp -77.35 130.33 37.0 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.416 -0.957 . . . . 64.21 108.416 170.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.6 mtt -128.85 123.8 33.67 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.188 0.995 . . . . 75.23 108.622 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 154' ' ' ALA . 79.7 mt -141.32 170.89 14.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.878 1.671 . . . . 74.24 106.512 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.42 147.22 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 108.836 -0.802 . . . . 72.11 108.836 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.91 -27.55 43.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.909 0.884 . . . . 74.22 112.456 175.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 12.8 tp10 -85.56 -2.44 58.15 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.768 0.827 . . . . 73.4 111.574 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.99 -11.99 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.859 0.864 . . . . 74.5 110.159 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.2 mm -108.81 140.88 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.286 0.565 . . . . 73.24 110.879 -174.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.1 mm -124.08 109.19 22.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.444 1.498 . . . . 74.34 107.192 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.68 121.02 31.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.568 -0.901 . . . . 74.44 108.568 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.652 ' HB3' HG23 ' A' ' 3' ' ' ILE . 33.6 tt0 -121.92 116.01 23.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.185 -1.043 . . . . 74.33 108.185 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.521 ' HB3' ' HZ2' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -100.04 109.85 22.16 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.166 0.508 . . . . 71.24 111.609 -170.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 1' ' ' MET . 47.7 t -100.88 95.43 6.61 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.729 -0.841 . . . . 74.1 108.729 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.28 -35.35 0.55 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.137 0.975 . . . . 74.13 110.583 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 C--O 1.248 0.992 0 C-N-CA 123.736 0.814 . . . . 75.53 109.368 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttm . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.037 -0.727 . . . . 75.21 109.037 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 99.0 mt -123.21 133.92 54.18 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.365 0.266 . . . . 72.4 110.51 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 61.8 mt -106.55 117.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.668 -1.234 . . . . 74.51 107.668 170.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.603 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 91.5 m-85 -89.71 122.16 32.55 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.507 -0.923 . . . . 75.23 108.507 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.19 131.4 53.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.628 0.771 . . . . 71.31 110.776 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.551 ' HA ' HG12 ' A' ' 176' ' ' ILE . 25.0 t70 -90.34 174.44 7.58 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.334 1.021 . . . . 64.01 108.433 172.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 7' ' ' ILE . 8.3 mt -53.74 -58.97 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.184 0.594 . . . . 63.52 110.967 171.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -112.7 -23.1 10.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 73.21 111.517 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -98.24 14.12 28.91 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.998 0.919 . . . . 74.43 110.563 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.3 p-10 -48.28 -33.08 8.21 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 124.245 1.018 . . . . 63.41 113.422 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.56 -42.93 64.1 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.194 -0.912 . . . . 70.31 110.97 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.618 ' HB2' ' HG2' ' A' ' 143' ' ' ARG . 5.0 tp10 -121.25 24.72 9.89 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.188 0.595 . . . . 74.11 111.581 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 2.6 tm? -77.19 -81.88 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.11 -0.7 . . . . 75.53 109.11 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 53.1 m -157.4 -178.35 7.28 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.154 0.982 . . . . 71.43 110.386 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 73.4 p 177.3 -177.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.276 1.03 . . . . 72.24 111.397 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 85.91 -109.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.188 1.795 . . . . 71.14 111.634 165.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -144.04 42.39 1.42 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.86 -0.793 . . . . 75.13 108.86 -163.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -108.31 98.89 29.47 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.352 -0.84 . . . . 71.53 109.372 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.36 134.81 9.13 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 124.153 3.235 . . . . 72.42 114.978 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.15 146.55 42.18 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.125 -0.943 . . . . 71.13 108.596 174.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 66.6 mttm -110.66 157.45 19.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.198 -1.408 . . . . 74.25 107.198 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -130.73 108.06 9.61 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.629 -0.878 . . . . 75.35 108.629 175.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.48 127.46 50.98 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 109.018 -0.734 . . . . 75.31 109.018 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.2 t70 56.24 25.37 9.17 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.417 1.073 . . . . 74.45 112.485 175.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 53.11 16.02 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.063 1.135 . . . . 71.42 114.063 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 119' ' ' LYS . 34.5 tp -105.07 -51.48 3.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.947 0.499 . . . . 73.51 110.201 -174.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.472 HG13 ' SD ' ' A' ' 170' ' ' MET . 21.6 t -123.49 133.72 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 116.547 -0.297 . . . . 73.35 111.376 -168.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 m-85 -84.76 120.12 26.06 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.576 -0.898 . . . . 53.13 108.576 167.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 40.2 tt0 -99.06 103.18 15.09 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.696 -1.224 . . . . 74.04 107.696 170.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.718 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 30.7 t80 -94.21 141.2 28.83 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.848 1.259 . . . . 75.4 109.307 -169.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -71.49 139.88 49.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.837 0.855 . . . . 71.21 112.718 -169.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.29 149.73 17.13 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 114.768 -1.106 . . . . 64.04 111.257 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -126.93 161.41 28.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.961 0.904 . . . . 75.41 108.658 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -75.19 120.67 21.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.603 -0.517 . . . . 70.53 109.603 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.492 HG22 HD12 ' A' ' 72' ' ' LEU . 4.1 m -145.06 164.58 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.442 0.697 . . . . 74.03 110.486 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -94.89 160.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.217 -0.447 . . . . 72.44 110.765 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -142.74 112.44 6.87 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.912 -0.403 . . . . 72.41 109.912 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -125.27 140.21 53.03 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.468 -0.938 . . . . 75.44 108.468 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -26.41 65.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 123.388 0.43 . . . . 74.11 111.699 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.0 -61.7 4.44 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.657 0.598 . . . . 74.14 111.802 172.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.8 152.09 0.94 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.137 0.975 . . . . 73.35 108.719 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 CA--C 1.55 0.962 0 CA-C-O 121.397 0.618 . . . . 63.15 109.682 174.53 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.558 -0.164 . . . . 72.13 110.558 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 73.53 -57.71 0.62 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.327 1.851 . . . . 73.33 111.604 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -116.13 129.28 56.25 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.285 1.034 . . . . 75.1 109.082 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.08 -165.02 29.4 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.234 -0.984 . . . . 73.44 113.287 166.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.51 HD11 HG23 ' A' ' 156' ' ' ILE . 26.4 pt -104.12 146.89 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 113.914 -1.143 . . . . 72.54 110.988 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.2 -47.16 35.61 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.312 1.445 . . . . 71.52 112.614 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 169' ' ' LEU . 67.6 mt -52.73 -45.65 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.073 -1.421 . . . . 74.12 111.333 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 76' ' ' LEU . 53.7 t -94.04 -28.56 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.017 0.527 . . . . 74.21 112.063 -173.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.492 HD12 HG22 ' A' ' 35' ' ' VAL . 84.2 mt -75.66 -18.67 59.57 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 122.227 -0.296 . . . . 72.23 110.31 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -95.37 -55.82 2.92 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.388 0.675 . . . . 75.52 110.638 172.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -86.79 3.32 45.65 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.755 0.422 . . . . 71.31 112.1 -171.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.683 ' HE3' ' HG3' ' A' ' 142' ' ' GLU . 34.4 ttpt 58.03 35.36 25.15 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.897 0.856 . . . . 75.35 111.682 165.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.549 ' HB2' HG23 ' A' ' 71' ' ' VAL . 59.2 mt -74.52 141.59 44.85 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.021 -0.536 . . . . 75.32 110.438 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.184 0.594 . . . . 74.15 110.36 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.26 145.27 42.05 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.75 1.389 . . . . 74.24 114.75 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.519 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 80.3 mtp -141.91 134.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.616 1.966 . . . . 73.34 105.813 171.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.537 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.2 m-80 -93.77 138.17 32.24 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.915 0.325 . . . . 72.04 110.204 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.426 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 29.7 p -67.08 -21.7 65.86 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.528 0.331 . . . . 44.15 111.28 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.537 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 64.0 m-85 -58.23 -52.75 64.27 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.978 -1.01 . . . . 73.14 110.567 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -105.28 -36.85 7.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.147 0.979 . . . . 73.55 112.847 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -91.91 18.95 7.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.596 0.759 . . . . 75.15 112.701 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.07 98.87 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.45 0.568 . . . . 71.2 111.194 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -65.63 -45.25 83.76 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.265 1.026 . . . . 73.25 111.467 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.09 -38.8 92.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.562 -0.745 . . . . 71.35 110.797 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 86.1 t80 -75.99 -28.91 58.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.956 0.902 . . . . 75.42 111.035 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -68.59 -38.38 80.62 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.497 -0.557 . . . . 64.25 109.497 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.4 98.89 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.778 -1.101 . . . . 70.22 110.477 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.45 ' HE2' ' HE1' ' A' ' 79' ' ' MET . 20.3 m-85 -59.09 -45.63 90.35 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.547 -0.751 . . . . 73.41 110.616 173.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.47 -40.37 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.699 . . . . 71.32 111.688 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -63.29 -45.42 91.49 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.627 0.371 . . . . 75.25 111.531 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.495 ' HB3' ' HZ1' ' A' ' 94' ' ' LYS . 8.7 mtpm? -73.08 -47.06 47.78 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.73 -0.668 . . . . 74.41 110.893 -177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -53.51 -44.82 69.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.032 1.733 . . . . 75.24 111.201 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.1 ttm -59.04 -53.58 56.8 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.079 0.862 . . . . 72.32 110.521 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HZ3' ' HB2' ' A' ' 101' ' ' ASP . 24.7 tptp -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.173 -0.921 . . . . 74.11 110.933 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.82 -47.47 46.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.572 0.749 . . . . 72.42 112.254 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 175' ' ' ALA . 31.0 m -69.54 -34.06 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.044 0.538 . . . . 54.45 112.14 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.52 -35.14 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 123.168 0.292 . . . . 72.22 110.585 176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.464 ' HB2' ' HZ3' ' A' ' 97' ' ' LYS . 27.2 t70 -58.92 -46.16 88.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.471 0.709 . . . . 74.21 110.077 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -62.51 -48.86 77.71 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.51 -0.768 . . . . 71.33 110.687 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.531 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.7 tpt -61.93 -38.75 89.6 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.717 0.807 . . . . 61.51 111.053 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.597 ' HA ' HG13 ' A' ' 113' ' ' VAL . 43.4 tt0 -71.88 -38.89 69.94 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.274 1.03 . . . . 74.34 110.27 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -80.51 -27.45 37.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.59 0.356 . . . . 74.31 111.609 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.28 -36.29 27.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.018 0.527 . . . . 72.43 110.839 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -101.13 -49.26 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.196 0.598 . . . . 73.45 110.945 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 70.24 4.24 4.78 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.37 1.248 . . . . 71.54 114.37 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -99.44 117.89 34.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.984 -0.747 . . . . 74.13 108.984 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -50.76 -45.17 58.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.991 1.316 . . . . 70.04 112.189 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.45 66.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.017 0.527 . . . . 75.22 112.417 -173.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.99 -45.26 18.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.67 0.388 . . . . 73.4 110.137 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 104' ' ' GLU . 33.7 m -71.65 -23.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 116.368 -0.378 . . . . 74.43 111.248 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.05 -43.89 91.74 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.51 0.724 . . . . 71.32 110.534 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.44 -46.3 76.91 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.902 0.751 . . . . 73.31 110.164 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -57.6 -48.13 80.26 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.34 0.656 . . . . 71.1 111.787 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.67 -30.65 67.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.648 -0.501 . . . . 74.14 109.648 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -61.16 -45.1 96.02 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.735 -0.839 . . . . 73.5 108.735 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.421 ' HB3' HD21 ' A' ' 26' ' ' LEU . 3.1 mptm? -65.52 -46.46 79.51 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 75.21 110.875 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.484 HD12 HG23 ' A' ' 172' ' ' VAL . 26.7 mm -66.83 -42.06 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 119.319 -0.372 . . . . 73.25 110.495 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -54.77 -57.29 12.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.776 0.831 . . . . 62.14 109.999 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.7 -38.35 95.76 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.748 0.655 . . . . 64.22 113.259 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -64.69 -53.28 49.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.904 0.882 . . . . 75.41 110.442 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 120' ' ' ILE . 34.0 m -70.57 -30.48 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 119.276 -0.392 . . . . 74.31 111.553 -177.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.53 -41.46 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 118.501 0.591 . . . . 62.43 110.328 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.6 t -65.84 -43.5 88.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 120.96 0.41 . . . . 64.54 109.922 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 155' ' ' ILE . 21.1 tp -73.11 -30.08 63.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.662 1.185 . . . . 73.34 112.221 -169.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.55 3.07 45.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.448 0.699 . . . . 73.52 111.951 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -67.62 150.97 48.07 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.458 0.703 . . . . 73.24 111.217 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 17.3 ptpt -93.45 -28.7 15.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.086 1.143 . . . . 74.2 114.086 -175.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.08 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.117 0.872 . . . . 74.35 113.267 -165.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -110.81 -32.87 6.7 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.213 0.605 . . . . 72.41 111.296 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 98.1 m-85 -78.17 -1.23 31.7 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.489 0.716 . . . . 73.54 112.038 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.2 pttp -55.59 -20.99 15.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.167 -0.333 . . . . 75.41 111.133 160.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -82.48 17.28 1.79 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.704 1.201 . . . . 74.15 110.856 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 156' ' ' ILE . 93.3 mt -89.8 148.05 23.44 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.079 -0.711 . . . . 71.3 109.079 170.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.75 126.45 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.739 -1.578 . . . . 70.22 106.739 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 11.1 m-85 -91.37 134.12 34.87 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.617 -0.512 . . . . 75.12 109.617 -171.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.27 151.91 50.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.298 0.639 . . . . 71.11 109.293 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.4 pt -137.16 170.7 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.317 -0.994 . . . . 74.41 108.317 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.64 44.42 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.872 -0.491 . . . . 71.22 111.872 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.683 ' HG3' ' HE3' ' A' ' 75' ' ' LYS . 10.7 mm-40 -53.24 -43.15 67.11 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.32 1.048 . . . . 75.22 112.259 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.618 ' HG2' ' HB2' ' A' ' 12' ' ' GLU . 3.0 mmt180 -65.67 -37.37 86.32 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.332 0.653 . . . . 75.12 110.353 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -59.86 -58.6 7.85 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.044 0.84 . . . . 73.34 109.136 173.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.85 -17.96 63.67 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.997 0.919 . . . . 72.11 113.084 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.49 -41.03 40.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 70.44 110.997 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.67 -26.43 0.03 OUTLIER Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.369 -0.378 . . . . 74.52 113.591 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -72.86 177.11 5.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.062 0.431 . . . . 71.14 111.229 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.09 -172.61 2.31 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 122.153 -0.342 . . . . 74.33 110.68 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.34 -49.95 12.67 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.14 0.793 . . . . 62.12 113.14 -161.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.09 -98.58 0.17 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.235 -0.746 . . . . 75.15 111.235 -156.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -121.93 144.09 49.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.155 0.582 . . . . 74.22 110.104 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 155' ' ' ILE . 89.2 t -75.96 133.09 31.91 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 108.433 -0.951 . . . . 72.43 108.433 166.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.43 97.16 0.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.645 -0.872 . . . . 75.24 108.645 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 127' ' ' LEU . 55.3 mt -85.87 101.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 108.515 -0.92 . . . . 72.32 108.515 -171.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.51 HG23 HD11 ' A' ' 68' ' ' ILE . 36.1 mm -91.85 140.22 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.036 -0.727 . . . . 74.11 109.036 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.41 105.47 7.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.232 -1.025 . . . . 73.14 108.232 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 12.2 p90 -73.5 88.77 1.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.396 -0.964 . . . . 63.2 108.396 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -92.68 174.14 7.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.425 1.49 . . . . 74.12 108.85 -165.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.75 138.73 54.54 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.258 0.623 . . . . 74.43 110.575 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.32 102.63 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 124.401 1.081 . . . . 75.33 109.302 169.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.5 t70 62.46 24.96 14.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 124.266 1.026 . . . . 73.42 112.474 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.12 -14.02 33.85 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 121.797 -0.564 . . . . 72.13 113.008 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -94.78 122.23 37.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.524 0.729 . . . . 74.11 110.336 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.94 116.18 13.14 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-O 121.151 0.5 . . . . 74.51 110.047 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.21 93.68 46.42 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 115.07 -0.968 . . . . 73.41 110.523 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 11.4 Cg_endo -52.48 121.52 9.2 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.623 2.882 . . . . 75.3 112.498 167.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.6 p -107.99 117.13 33.34 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.374 1.07 . . . . 72.33 108.429 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 17.4 tp -80.17 117.57 21.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.416 -0.587 . . . . 75.33 109.416 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.472 ' SD ' HG13 ' A' ' 27' ' ' VAL . 30.7 tpp -100.96 120.82 40.73 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 107.205 -1.406 . . . . 74.42 107.205 -175.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.438 HD22 HD11 ' A' ' 176' ' ' ILE . 84.0 mt -143.77 143.87 31.56 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.656 1.182 . . . . 74.13 109.207 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.484 HG23 HD12 ' A' ' 120' ' ' ILE . 15.0 p -91.07 138.32 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.972 0.805 . . . . 74.53 109.763 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.54 -26.45 67.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.323 1.449 . . . . 74.24 112.011 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -86.14 -0.97 56.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.134 0.574 . . . . 64.22 112.343 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 99' ' ' VAL . . . -120.0 -18.75 8.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.605 0.762 . . . . 62.45 110.553 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.551 HG12 ' HA ' ' A' ' 6' ' ' ASP . 3.3 mt -136.64 139.58 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.336 0.654 . . . . 71.14 110.219 -172.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 30.8 mm -142.17 139.59 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.449 1.1 . . . . 71.24 108.114 -171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.02 143.01 34.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.27 0.557 . . . . 74.54 109.992 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.7 tp10 -101.33 109.39 21.23 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.098 -1.075 . . . . 74.21 108.098 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -69.84 98.04 1.18 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.886 0.741 . . . . 73.13 109.951 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.7 t -108.16 91.63 3.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.274 -1.01 . . . . 73.11 108.274 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.36 173.8 14.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.037 0.535 . . . . 75.41 110.634 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.254 1.332 0 CA-C-N 114.923 -1.035 . . . . 74.14 108.552 178.822 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.516 ' HG3' ' SG ' ' A' ' 181' ' ' CYS . 26.2 ptt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.946 0.403 . . . . 70.53 110.212 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 180' ' ' LYS . 95.6 mt -118.72 159.82 22.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.505 0.722 . . . . 72.42 110.067 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 56.3 mt -126.8 118.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 106.996 -1.483 . . . . 65.25 106.996 171.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.756 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 5.6 t80 -101.4 113.94 27.48 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.015 -1.106 . . . . 73.13 108.015 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -125.59 117.13 22.9 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.131 0.972 . . . . 75.33 110.295 -167.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.87 134.83 48.36 Favored 'General case' 0 C--O 1.205 -1.285 0 N-CA-C 108.344 -0.984 . . . . 71.42 108.344 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 pt -66.39 -5.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 113.293 0.849 . . . . 75.43 113.293 -170.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -107.94 -46.72 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.736 -0.838 . . . . 71.41 108.736 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 p -111.82 18.66 18.71 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.827 1.251 . . . . 74.0 112.456 -173.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -46.94 -42.22 17.4 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.183 1.793 . . . . 72.54 113.545 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -55.95 -39.13 71.29 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.89 1.369 . . . . 73.54 112.543 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -120.61 11.32 11.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.176 0.591 . . . . 74.42 111.458 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -95.9 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 112.871 0.693 . . . . 73.13 112.871 -163.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.756 ' HB3' ' HB3' ' A' ' 4' ' ' TYR . 35.5 t -158.21 178.44 10.18 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.93 0.787 . . . . 64.21 111.367 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 33.0 p 163.32 104.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.691 1.597 . . . . 74.51 109.377 -168.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -171.59 161.07 6.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.572 0.749 . . . . 73.43 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -68.87 83.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.391 0.676 . . . . 72.41 111.316 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.598 ' HZ ' ' HB2' ' A' ' 4' ' ' TYR . 3.8 p90 -127.18 159.09 66.93 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.906 0.882 . . . . 71.13 110.275 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.97 120.86 3.08 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.134 1.89 . . . . 70.32 112.883 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.587 ' HB2' ' HE2' ' A' ' 28' ' ' TYR . 17.8 ptm -87.71 157.88 18.95 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.052 0.541 . . . . 73.21 110.527 174.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -152.03 145.63 24.95 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.038 -0.727 . . . . 73.33 109.038 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.55 125.78 52.88 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.502 -0.925 . . . . 71.33 108.502 173.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.19 129.81 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.281 0.632 . . . . 71.32 110.268 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.92 23.74 6.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.151 1.38 . . . . 74.22 113.992 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 t70 54.76 26.83 8.04 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.829 0.852 . . . . 71.23 112.054 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' HE2' ' A' ' 119' ' ' LYS . 64.7 tp -135.1 -51.17 0.77 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.991 0.901 . . . . 75.51 110.483 -170.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -120.41 148.7 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.888 -1.506 . . . . 74.5 107.885 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.587 ' HE2' ' HB2' ' A' ' 20' ' ' MET . 44.6 t80 -86.18 139.39 31.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.244 -1.021 . . . . 75.35 108.244 170.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -123.61 129.37 51.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.805 0.842 . . . . 74.42 109.695 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.713 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 48.8 t80 -114.31 124.68 52.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.128 0.571 . . . . 74.03 109.473 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.46 95.74 8.36 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.942 -0.762 . . . . 75.43 108.942 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.3 176.56 46.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.751 -0.659 . . . . 72.32 112.464 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -125.13 158.06 34.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.355 0.662 . . . . 74.25 109.629 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -90.59 117.57 29.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.194 -0.669 . . . . 73.21 109.194 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 72' ' ' LEU . 19.7 m -143.49 153.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.494 0.664 . . . . 73.42 110.098 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.6 127.53 66.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.544 -1.28 . . . . 72.34 107.544 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 10.7 tpt180 -105.3 108.55 20.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 106.677 -1.601 . . . . 73.23 106.677 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -106.26 96.59 6.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.895 -0.78 . . . . 73.52 108.895 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 46.64 58.46 4.63 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.087 1.355 . . . . 73.23 111.962 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.97 -33.09 3.86 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.937 -1.029 . . . . 74.34 113.657 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -93.19 116.16 28.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.45 1.1 . . . . 74.42 110.033 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.1 tt . . . . . 0 CA--C 1.55 0.947 0 N-CA-C 109.048 -0.723 . . . . 75.22 109.048 172.525 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 107.682 -1.229 . . . . 71.14 107.682 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.626 ' HB3' HD22 ' A' ' 72' ' ' LEU . 40.9 mt-10 -94.16 62.07 2.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.51 -0.768 . . . . 73.53 109.538 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -74.93 127.7 33.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.136 -0.938 . . . . 74.15 109.301 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.29 -134.74 3.65 Favored Glycine 0 C--N 1.343 0.919 0 O-C-N 123.512 0.508 . . . . 72.22 112.416 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 27.0 pt -111.9 151.75 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.86 0.864 . . . . 75.45 110.906 177.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.11 -35.1 74.5 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.366 1.066 . . . . 73.31 112.73 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 169' ' ' LEU . 47.7 mt -53.88 -46.53 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.56 1.144 . . . . 73.32 110.497 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' A' ' 76' ' ' LEU . 55.1 t -75.97 -44.32 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 113.898 -1.501 . . . . 70.43 111.888 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.626 HD22 ' HB3' ' A' ' 65' ' ' GLU . 55.5 mt -66.16 -32.04 73.25 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.642 0.589 . . . . 71.32 111.18 -175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -58.94 -52.36 66.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.278 1.031 . . . . 75.51 111.846 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -89.42 -22.85 22.33 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 116.18 -0.463 . . . . 75.23 111.663 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.588 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 4.6 mmmp? 69.28 70.36 0.26 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.225 1.01 . . . . 75.32 109.836 -166.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.661 ' HB2' HG12 ' A' ' 71' ' ' VAL . 76.0 mt -85.66 151.74 23.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.8 -1.091 . . . . 73.31 109.269 173.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.603 HG13 ' HB3' ' A' ' 145' ' ' ALA . 11.3 p -90.54 138.43 19.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 N-CA-C 109.111 -0.7 . . . . 73.05 109.111 170.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.43 138.85 57.93 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.074 0.859 . . . . 74.11 109.922 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 33.7 tpp -132.42 103.03 5.98 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 105.572 -2.01 . . . . 73.03 105.572 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 82' ' ' TYR . 20.7 t-20 -63.89 113.59 3.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.183 -1.826 . . . . 75.52 111.18 -170.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.407 ' SG ' ' CD2' ' A' ' 133' ' ' PHE . 41.5 t -59.05 -33.51 70.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.431 1.092 . . . . 72.33 111.345 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.437 ' HB2' ' OD1' ' A' ' 80' ' ' ASN . 60.8 m-85 -68.13 -29.65 68.61 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 113.919 -1.491 . . . . 75.14 110.75 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -104.87 -33.11 8.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.935 0.894 . . . . 74.25 112.445 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.32 19.52 15.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.314 0.646 . . . . 75.51 111.791 -162.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.59 72.52 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 112.205 0.446 . . . . 73.13 112.205 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.2 m -72.49 -43.89 63.03 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.275 0.63 . . . . 71.53 111.292 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 mmt -70.75 -29.72 66.03 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.463 0.305 . . . . 74.45 110.514 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.586 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 81.0 t80 -67.52 -32.67 73.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 74.0 110.172 173.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -64.61 -36.9 85.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.792 0.437 . . . . 74.21 110.002 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.12 82.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.065 0.546 . . . . 63.34 111.153 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.586 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 54.1 m-85 -69.85 -34.59 73.83 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 118.914 -0.565 . . . . 74.23 111.998 173.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.588 HG13 HD21 ' A' ' 128' ' ' LEU . 35.7 mm -66.11 -36.16 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.294 0.638 . . . . 74.2 110.577 174.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -57.52 -46.83 83.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.354 0.662 . . . . 73.0 111.11 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.58 -44.95 73.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.053 0.541 . . . . 71.33 110.704 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -47.78 -65.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.49 1.916 . . . . 73.43 111.078 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.558 ' HE2' HG21 ' A' ' 120' ' ' ILE . 70.9 mtp -63.09 -44.06 96.76 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.728 0.811 . . . . 74.15 111.384 -174.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -57.85 -49.9 75.11 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.656 0.597 . . . . 72.15 110.97 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.08 -43.84 70.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.856 -1.066 . . . . 74.11 111.283 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.495 HG13 HG12 ' A' ' 172' ' ' VAL . 34.3 m -69.18 -38.93 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 112.862 0.689 . . . . 72.41 112.862 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.45 -43.19 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.421 -0.585 . . . . 74.31 109.421 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 14.7 t70 -56.83 -41.09 77.25 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.231 0.957 . . . . 74.22 109.939 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -58.87 -48.07 82.7 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.386 1.074 . . . . 70.31 109.724 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.58 ' HB3' HG11 ' A' ' 113' ' ' VAL . 96.0 mmm -62.42 -36.18 81.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.338 -0.846 . . . . 74.33 111.263 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.07 -24.84 62.41 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.428 0.691 . . . . 73.21 111.494 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 29.5 mtpp -81.39 -49.89 10.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.923 0.489 . . . . 74.11 110.431 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -84.2 -14.03 51.16 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.302 0.641 . . . . 72.34 112.659 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -140.05 -59.64 0.54 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.108 0.413 . . . . 74.04 111.063 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 69.35 15.64 8.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.756 1.222 . . . . 75.44 112.479 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.16 114.58 19.17 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.473 -0.936 . . . . 63.55 108.473 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -57.24 -42.68 81.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.112 0.965 . . . . 73.32 112.249 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.17 87.87 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.571 0.544 . . . . 74.04 111.234 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.91 -42.44 48.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.32 0.648 . . . . 71.24 110.766 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 103' ' ' MET . 33.0 m -72.83 -28.55 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.05 0.54 . . . . 73.43 110.67 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 26.5 t70 -67.95 -43.92 77.95 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 123.6 0.562 . . . . 75.53 109.889 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -42.51 94.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.698 0.624 . . . . 75.13 109.946 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -44.12 97.78 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.849 0.86 . . . . 72.2 110.918 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -39.02 85.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.07 0.948 . . . . 75.0 110.504 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 57.5 mtpt -71.87 -36.9 70.24 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.886 0.741 . . . . 74.22 110.885 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.534 ' HE2' HD12 ' A' ' 26' ' ' LEU . 60.1 mtpt -64.28 -44.45 91.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.045 0.538 . . . . 62.24 109.992 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.558 HG21 ' HE2' ' A' ' 96' ' ' MET . 22.6 mm -65.0 -44.56 96.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 C-N-CA 123.732 0.813 . . . . 75.21 109.897 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.43 ' O ' HG21 ' A' ' 125' ' ' VAL . 7.2 tp-100 -56.35 -51.11 69.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.022 0.929 . . . . 71.41 110.649 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.58 98.2 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.14 0.9 . . . . 61.21 113.264 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -62.91 -49.92 72.88 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.867 0.467 . . . . 75.24 109.746 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 32.9 m -67.21 -49.03 76.4 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.338 0 CA-C-O 117.531 -1.223 . . . . 74.12 110.488 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 121' ' ' GLN . 33.4 m -64.16 -31.16 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 120.107 1.321 . . . . 74.31 112.002 -176.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.7 m -72.09 -37.54 69.55 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.672 0.389 . . . . 71.12 110.361 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.555 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 40.5 tp -77.32 -26.06 51.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.316 1.046 . . . . 72.01 111.171 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.588 HD21 HG13 ' A' ' 92' ' ' ILE . 95.0 mt -85.45 2.51 44.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.39 1.076 . . . . 75.13 111.447 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.87 147.8 40.73 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.143 -0.688 . . . . 72.13 109.143 170.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.63 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 40.7 ttmt -69.29 -13.4 62.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.081 0.552 . . . . 75.42 111.212 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.2 -45.57 87.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.493 0.717 . . . . 62.43 110.068 168.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.555 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 5.1 mpt_? -78.38 -47.45 17.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.061 -0.972 . . . . 74.35 110.413 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.63 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.2 m-85 -57.84 -25.97 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.746 0.818 . . . . 72.24 112.673 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.12 -36.06 78.72 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.607 0.763 . . . . 64.23 110.905 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -104.62 -7.96 19.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.918 1.287 . . . . 73.52 111.281 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 63.1 mt -88.54 139.59 30.33 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.649 0.737 . . . . 72.34 110.939 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.66 124.81 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 105.798 -1.926 . . . . 72.32 105.798 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.572 ' HB3' HG11 ' A' ' 153' ' ' VAL . 21.8 m-85 -95.88 140.5 30.56 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.818 -0.808 . . . . 70.42 108.818 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -138.34 138.44 38.32 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.411 -0.589 . . . . 74.31 109.411 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.21 175.66 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.562 -0.903 . . . . 75.02 108.562 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.1 120.04 20.43 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.222 -0.751 . . . . 54.31 111.222 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.37 -18.31 16.9 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.312 0.856 . . . . 63.11 113.312 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -68.7 -40.42 80.0 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.376 0.671 . . . . 75.24 109.656 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 149' ' ' GLU . . . -80.41 -6.03 57.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.165 0.986 . . . . 71.32 112.491 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 77' ' ' VAL . . . -70.16 2.17 3.97 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.698 0.799 . . . . 74.04 112.484 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -24.59 61.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.026 0.93 . . . . 74.32 110.448 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.01 -64.31 0.01 OUTLIER Glycine 0 C--N 1.354 1.579 0 CA-C-N 116.113 -0.494 . . . . 71.43 112.221 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -163.27 146.02 10.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.949 0.5 . . . . 75.01 110.628 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 144' ' ' ALA . 10.9 tp10 -71.18 -41.29 70.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.115 0.566 . . . . 65.0 110.557 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.525 ' H ' ' HE1' ' A' ' 91' ' ' TYR . 80.0 m-20 59.99 44.12 13.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.016 0.926 . . . . 73.14 110.805 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.34 -150.9 5.77 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.03 -0.986 . . . . 63.33 110.827 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.63 140.36 31.35 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.716 -0.846 . . . . 75.44 108.716 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 138' ' ' PHE . 94.0 t -87.18 142.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.82 0.848 . . . . 73.53 109.897 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.413 ' HA ' HD22 ' A' ' 171' ' ' LEU . . . -63.79 97.51 0.16 Allowed 'General case' 0 C--O 1.245 0.821 0 N-CA-C 108.942 -0.762 . . . . 62.14 108.942 168.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 75.9 mt -85.31 101.58 9.94 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.916 -1.142 . . . . 73.23 107.916 -173.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.57 114.16 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.237 0.615 . . . . 75.42 109.39 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -112.23 103.77 11.94 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.459 -0.941 . . . . 74.42 108.459 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 6.5 p90 -81.73 94.45 7.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.754 -0.832 . . . . 74.42 108.754 -174.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -90.28 155.06 19.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.257 -0.645 . . . . 74.25 109.257 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -103.95 123.76 47.75 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 110.106 -0.331 . . . . 70.11 110.106 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.71 116.21 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.592 -0.892 . . . . 74.02 108.592 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.18 15.16 7.25 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.213 1.005 . . . . 63.24 112.285 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 94.78 25.33 15.37 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 121.887 -0.508 . . . . 74.53 112.892 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.3 m -121.74 130.61 53.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.497 0.719 . . . . 73.53 110.431 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.76 98.62 7.85 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.808 -0.812 . . . . 75.41 108.808 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.46 95.62 19.71 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.823 0.849 . . . . 74.31 109.796 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 59.9 Cg_endo -68.2 129.54 19.52 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 122.538 2.159 . . . . 62.1 111.389 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.8 p -109.85 110.2 21.09 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.797 -0.816 . . . . 73.12 108.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -79.1 112.54 16.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.456 -0.793 . . . . 75.42 109.382 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.456 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.0 mtt -100.83 122.32 43.22 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 107.876 -1.157 . . . . 73.14 107.876 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 154' ' ' ALA . 59.5 mt -141.62 130.93 23.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.544 -1.65 . . . . 72.31 106.544 172.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.495 HG12 HG13 ' A' ' 99' ' ' VAL . 3.9 p -69.09 137.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.005 0.522 . . . . 71.15 110.431 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.401 ' HA ' HG21 ' A' ' 176' ' ' ILE . 1.5 tmpt? -60.27 -35.48 75.61 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 74.54 111.827 -172.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -70.32 -6.01 32.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.429 0.9 . . . . 72.13 113.429 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.08 -6.37 6.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.223 0.609 . . . . 72.33 111.933 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 173' ' ' LYS . 10.6 tp -124.98 143.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.433 0.635 . . . . 71.34 110.128 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 40.6 mm -130.93 110.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.449 -1.315 . . . . 74.53 107.449 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.87 127.46 42.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.138 -1.06 . . . . 64.42 108.138 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 23.5 mm-40 -115.04 114.75 25.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.382 0.673 . . . . 74.14 111.568 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.48 ' HA ' HD22 ' A' ' 2' ' ' LEU . 33.2 mtmm -83.4 96.68 8.62 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.465 0.706 . . . . 74.33 109.915 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.516 ' SG ' ' HG3' ' A' ' 1' ' ' MET . 9.3 p -108.84 88.95 2.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.959 -0.756 . . . . 63.25 108.959 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.17 -68.18 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.153 -0.93 . . . . 74.15 109.301 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 CA--C 1.552 1.02 0 C-N-CA 123.47 0.708 . . . . 71.12 110.204 -174.8 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.584 ' HB3' ' HA ' ' A' ' 16' ' ' ASP . 65.5 mtt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 73.32 109.471 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 180' ' ' LYS . 43.1 mt -115.42 146.92 41.16 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.3 0.64 . . . . 74.22 109.988 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 57.3 mt -95.8 119.61 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.242 -0.651 . . . . 75.04 109.242 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.0 m-85 -118.91 129.09 55.0 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.422 -1.325 . . . . 74.43 107.422 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HZ1' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -144.38 155.07 43.61 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.557 0.343 . . . . 73.52 111.08 -178.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 10.3 t70 -101.14 144.62 29.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.597 0.759 . . . . 71.54 109.743 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.5 pt -81.33 -6.42 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 112.752 0.649 . . . . 74.15 112.752 -171.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -106.7 -64.02 1.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.172 0.804 . . . . 61.31 113.172 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.0 m -130.06 -25.33 2.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.828 0.677 . . . . 74.31 112.828 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 12.9 t0 -99.9 25.87 6.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.538 0.735 . . . . 71.24 110.759 -170.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.63 -20.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.101 1.519 . . . . 75.12 115.101 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.85 -37.61 19.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.258 -0.901 . . . . 72.52 111.052 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 31.5 tp 28.55 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.001 2.12 . . . . 74.53 114.243 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.438 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 67.6 m -157.94 121.88 4.12 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 72.44 109.58 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 45.3 p -113.7 67.46 0.67 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.776 0.798 . . . . 55.11 109.65 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.584 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 37.6 t70 -159.49 177.28 11.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.992 -1.004 . . . . 70.52 109.852 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 m -84.54 76.29 10.19 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.056 -0.72 . . . . 74.31 109.056 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 14' ' ' SER . 15.7 m-85 -100.58 139.16 20.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 115.276 -0.874 . . . . 72.44 110.748 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.9 118.7 5.66 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.693 2.262 . . . . 74.11 112.14 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -129.25 162.69 27.31 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.169 -0.923 . . . . 75.01 111.042 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -151.2 115.26 5.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.972 1.309 . . . . 75.42 107.649 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.8 113.28 24.17 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.624 -1.621 . . . . 65.0 106.624 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.87 132.12 51.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 C-N-CA 123.111 0.564 . . . . 65.42 110.056 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.0 t0 55.04 22.96 4.78 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 125.064 1.346 . . . . 70.21 112.719 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 t70 59.81 12.38 2.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.681 1.592 . . . . 71.04 112.65 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.735 HD22 ' HG3' ' A' ' 119' ' ' LYS . 55.3 tp -109.49 -51.88 2.83 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.523 -0.736 . . . . 71.43 111.214 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.64 126.03 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.571 -0.741 . . . . 73.43 109.987 -167.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -83.31 114.87 21.71 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.408 -1.33 . . . . 74.41 107.408 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 35.2 tt0 -112.68 119.49 38.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 65.15 110.316 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -105.4 107.12 17.93 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.999 -1.112 . . . . 75.22 107.999 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -77.06 153.13 34.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.616 0.366 . . . . 71.01 111.13 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.19 -163.88 12.1 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.285 -0.726 . . . . 74.21 111.285 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.02 136.72 34.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.356 0.663 . . . . 74.05 109.404 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 4.2 t60 -69.07 128.47 36.79 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.762 -0.829 . . . . 72.5 108.762 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.518 HG22 HD13 ' A' ' 72' ' ' LEU . 13.9 m -147.28 178.57 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.407 0 C-N-CA 124.345 1.058 . . . . 74.14 109.711 -174.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 21.8 m -125.4 141.44 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 116.263 -0.426 . . . . 74.53 111.526 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.436 ' HD3' HD12 ' A' ' 72' ' ' LEU . 9.6 mpt_? -105.23 105.54 15.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.368 -1.345 . . . . 64.3 107.368 165.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -127.45 125.23 40.15 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.864 -0.791 . . . . 74.14 108.864 -165.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.45 84.39 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.28 . . . . 73.23 111.406 -174.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -48.96 0.59 Allowed Glycine 0 C--O 1.239 0.46 0 CA-C-N 114.692 -1.14 . . . . 54.34 111.638 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -166.51 129.21 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.289 0.636 . . . . 73.55 110.158 -173.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tt . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 109.265 -0.643 . . . . 74.14 109.265 174.409 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 119.435 -0.317 . . . . 71.42 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 36' ' ' VAL 0.298 8.4 pt-20 51.39 -70.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.336 2.254 . . . . 74.03 113.178 -163.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -74.16 111.6 9.49 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.702 0.801 . . . . 74.31 110.974 -161.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.16 -172.28 45.15 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.316 -0.945 . . . . 74.15 111.69 160.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 16.4 pt -96.06 150.65 4.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.004 -0.739 . . . . 74.24 109.004 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -56.06 -34.07 65.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 64.3 112.362 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.432 HD13 HD12 ' A' ' 68' ' ' ILE . 61.8 mt -55.06 -51.37 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.389 1.076 . . . . 74.12 110.16 176.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 76' ' ' LEU . 30.6 t -75.02 -46.26 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.604 1.161 . . . . 64.12 112.224 -175.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.518 HD13 HG22 ' A' ' 35' ' ' VAL . 80.5 mt -63.19 -37.17 86.19 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.046 0.841 . . . . 75.22 111.088 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -68.21 -47.0 69.05 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.986 -1.007 . . . . 73.11 109.204 174.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -80.55 -17.66 50.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.045 0.938 . . . . 74.34 111.957 -166.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 62.82 61.66 1.14 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.281 1.433 . . . . 71.43 111.044 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.614 ' HB2' HG13 ' A' ' 71' ' ' VAL . 83.8 mt -101.28 140.15 35.97 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.378 -0.828 . . . . 73.23 110.483 174.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.57 137.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.478 0.711 . . . . 75.11 109.219 171.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.45 157.06 24.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.454 1.121 . . . . 73.1 113.685 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 ttm -147.28 104.21 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.172 -2.159 . . . . 72.25 105.172 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.592 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 80.1 m-20 -101.87 124.94 48.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.331 -0.618 . . . . 63.44 109.331 -171.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.592 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 20.6 p -61.4 -11.14 9.12 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.109 0.964 . . . . 71.21 112.522 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.592 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 90.9 m-85 -53.5 -48.85 68.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.386 1.074 . . . . 73.22 111.461 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.95 -39.22 6.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.604 0.762 . . . . 75.45 110.571 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.16 20.39 3.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.408 1.083 . . . . 75.42 113.336 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.47 69.73 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.154 0.582 . . . . 65.21 111.614 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t -65.93 -38.72 89.39 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.972 0.909 . . . . 74.21 110.725 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.472 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.2 mpt? -69.25 -40.62 77.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.174 -0.921 . . . . 73.11 110.658 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -70.61 -31.9 69.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.571 0.748 . . . . 75.0 110.466 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -67.42 -35.23 78.85 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 61.14 111.113 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.27 95.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.202 0.601 . . . . 64.11 110.154 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.57 -34.37 74.07 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-N 115.567 -0.742 . . . . 73.34 111.79 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.78 -34.05 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.629 0.772 . . . . 72.23 111.281 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.01 -47.6 82.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.731 0.413 . . . . 75.02 110.607 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.63 -46.7 78.27 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.975 0.797 . . . . 71.5 109.681 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' O ' HG22 ' A' ' 99' ' ' VAL . 72.7 t80 -48.26 -64.84 0.68 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.011 1.724 . . . . 74.44 111.755 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 27.6 ttt -58.08 -48.61 79.61 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.409 1.068 . . . . 75.11 110.765 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -58.35 -51.43 69.85 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.035 0.835 . . . . 73.24 111.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -73.72 -39.32 64.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.659 0.599 . . . . 74.12 111.82 -168.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.0 m -67.2 -37.79 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 111.857 0.317 . . . . 71.03 111.857 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.505 HG23 ' HB ' ' A' ' 113' ' ' VAL . 81.7 mt -71.6 -54.24 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.627 -0.509 . . . . 72.02 109.627 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.91 -33.18 70.26 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.533 1.533 . . . . 63.13 112.357 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -81.56 -52.63 7.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.262 0.625 . . . . 74.22 110.65 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.425 ' HG2' ' HG3' ' A' ' 174' ' ' GLU . 11.7 tpt -72.2 -31.47 65.92 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.85 0.315 . . . . 73.24 111.85 -167.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.36 -55.46 21.44 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.626 0.77 . . . . 75.54 112.351 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -82.32 -0.03 43.8 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.087 0.47 . . . . 75.12 110.412 -166.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -101.59 -36.35 8.8 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.174 0.99 . . . . 75.15 110.041 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -92.69 -78.66 0.41 Allowed 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.422 -0.808 . . . . 62.31 111.767 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 112' ' ' ASP . 63.1 ttt180 -153.47 13.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.6 0.714 . . . . 73.53 112.337 -169.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.6 t70 68.94 -74.13 0.08 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.275 1.43 . . . . 75.45 113.059 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.04 -66.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 112.518 0.562 . . . . 75.34 112.518 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.87 87.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.087 1.143 . . . . 75.12 114.087 -162.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -73.53 -46.44 47.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.297 -0.41 . . . . 73.01 111.095 -170.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.634 ' HA ' ' HB3' ' A' ' 116' ' ' PHE . 13.6 m -76.24 -22.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 119.241 -0.409 . . . . 74.33 111.506 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.59 -55.09 34.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.165 0.586 . . . . 64.41 110.507 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.99 88.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.14 0.9 . . . . 75.0 110.244 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.634 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 18.9 t80 -61.96 -41.9 98.52 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.444 -1.253 . . . . 71.11 111.496 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -64.6 -41.47 96.21 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.906 0.482 . . . . 73.34 110.62 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.45 -42.79 95.77 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.088 0.868 . . . . 70.24 110.285 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.735 ' HG3' HD22 ' A' ' 26' ' ' LEU . 17.9 tppt? -72.91 -40.18 65.71 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.473 1.109 . . . . 71.33 111.755 -174.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.4 tp -76.45 -34.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.292 0.637 . . . . 74.45 109.51 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -61.37 -44.46 97.13 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 124.119 0.887 . . . . 73.45 109.138 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.34 -41.39 99.47 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.803 0.689 . . . . 64.32 112.836 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.63 -53.05 57.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.424 0.69 . . . . 75.13 110.703 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 18.7 m -63.61 -44.76 98.68 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.17 0 CA-C-O 118.298 -0.858 . . . . 75.14 111.432 -175.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.6 -38.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 119.205 0.911 . . . . 74.21 111.39 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 m -71.81 -31.09 66.19 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.901 0.48 . . . . 73.33 111.399 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.679 HD23 HG21 ' A' ' 155' ' ' ILE . 28.9 tp -82.96 -18.99 38.02 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 71.33 110.584 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.8 mt -91.95 3.24 55.64 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.895 0.878 . . . . 72.42 111.069 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.12 88.31 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.796 0.838 . . . . 71.3 110.474 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -58.24 -19.81 37.0 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.886 1.439 . . . . 61.2 114.886 -163.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.48 -40.77 95.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.636 0.774 . . . . 72.12 112.133 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -108.19 -37.2 6.09 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.348 0.594 . . . . 72.5 110.872 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.1 -2.36 48.0 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.187 0.995 . . . . 74.51 113.453 -168.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.34 -15.8 18.52 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 112.259 0.466 . . . . 72.45 112.259 163.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -103.31 26.72 8.0 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.785 0.834 . . . . 74.24 110.32 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.5 mt -86.63 133.18 33.72 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.862 -1.162 . . . . 75.33 107.862 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.73 109.3 21.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.723 -1.584 . . . . 72.3 106.723 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.592 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 42.5 m-85 -92.24 145.89 24.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.058 -1.09 . . . . 75.25 108.058 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 78.6 m-85 -140.51 146.36 38.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.21 0.529 . . . . 75.23 110.659 -175.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.98 163.18 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.257 -1.757 . . . . 74.31 106.257 167.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.7 147.29 50.89 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.885 -0.886 . . . . 74.23 110.885 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.44 -25.32 50.17 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.92 0.86 . . . . 74.21 112.714 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -36.36 80.48 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.538 1.135 . . . . 74.2 111.129 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 150' ' ' ASN . . . -68.14 -42.69 79.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.985 0.914 . . . . 64.31 110.634 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.57 -0.69 47.98 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.252 -0.886 . . . . 75.01 112.36 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -90.89 -19.0 23.83 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.417 1.087 . . . . 71.44 109.922 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.74 45.89 1.17 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.006 -0.543 . . . . 61.35 111.811 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -156.7 108.44 2.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.462 0.705 . . . . 73.45 109.283 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 49.29 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.566 1.546 . . . . 74.45 113.712 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 144' ' ' ALA . 17.6 m120 -61.25 -43.03 99.54 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.783 0.833 . . . . 71.2 111.282 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 58.53 -148.77 37.51 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 115.421 0.928 . . . . 51.01 115.421 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 138.64 31.31 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.011 0.924 . . . . 64.53 109.266 -174.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.0 t -82.73 123.91 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.134 0.574 . . . . 72.02 110.977 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.68 105.3 6.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.381 1.072 . . . . 70.21 109.294 170.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.679 HG21 HD23 ' A' ' 127' ' ' LEU . 74.9 mt -91.75 121.26 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.297 -0.631 . . . . 75.24 109.297 -173.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.08 114.84 47.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 110.048 -0.352 . . . . 74.22 110.048 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.89 118.27 36.59 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 124.244 0.965 . . . . 75.43 108.641 170.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 16.1 p90 -79.96 112.52 17.33 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.669 -1.604 . . . . 74.13 106.669 170.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.408 ' O ' HG13 ' A' ' 166' ' ' VAL . 38.4 ttm180 -103.01 128.49 49.83 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.628 -0.508 . . . . 72.12 109.628 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.18 120.23 22.69 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.556 0.342 . . . . 72.53 110.872 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.23 107.17 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.422 1.489 . . . . 63.33 108.824 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 61.92 23.64 13.95 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.811 1.244 . . . . 65.55 112.783 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.22 65.3 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 113.867 0.307 . . . . 73.01 113.867 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.1 m -110.87 137.54 48.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.285 1.034 . . . . 74.31 108.834 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 9.0 pt-20 -72.95 145.61 46.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.167 0.439 . . . . 74.13 110.405 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 159' ' ' ARG . 5.5 p -128.4 101.16 21.83 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 107.645 -1.242 . . . . 74.12 107.645 167.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.75 128.52 20.13 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.401 2.067 . . . . 74.11 112.299 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 53.1 p -121.0 118.43 29.82 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.227 -1.027 . . . . 72.42 108.227 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 tp -77.23 111.73 13.17 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.936 -0.764 . . . . 75.24 108.936 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 57.5 mtt -101.63 122.53 44.03 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.657 -0.868 . . . . 73.13 108.657 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.0 mt -136.65 143.43 43.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.752 -1.944 . . . . 74.23 105.752 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.93 138.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.063 0.847 . . . . 64.44 109.976 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.637 ' HZ1' ' HB3' ' A' ' 173' ' ' LYS . 4.3 ttpm? -58.38 -29.16 65.8 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.904 1.282 . . . . 75.01 112.272 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.425 ' HG3' ' HG2' ' A' ' 103' ' ' MET . 11.1 mp0 -70.1 -26.32 63.93 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.606 0.763 . . . . 75.34 111.217 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.47 0.43 50.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 75.03 110.723 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 46.6 mm -121.16 125.05 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.301 0.64 . . . . 72.14 109.597 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mm -99.2 108.36 22.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.362 -1.347 . . . . 72.35 107.362 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.84 116.18 26.93 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.0 -1.482 . . . . 73.33 107.0 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -126.31 106.09 9.27 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.253 -1.388 . . . . 62.01 107.253 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.559 ' HA ' HD23 ' A' ' 2' ' ' LEU . 56.4 pttt -88.3 119.79 29.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.951 0.5 . . . . 73.31 110.904 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 34.6 t -78.25 89.84 4.32 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.803 0.841 . . . . 74.41 109.834 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.23 129.83 39.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.667 0.787 . . . . 75.0 110.516 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.883 0.873 . . . . 75.53 108.822 -179.476 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtm . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 120.656 0.265 . . . . 65.13 110.324 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 180' ' ' LYS . 32.6 mt -115.63 161.78 18.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.567 0.747 . . . . 74.44 110.969 -166.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.424 HG22 ' HB3' ' A' ' 179' ' ' GLU . 8.3 tt -105.75 130.16 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.962 -1.125 . . . . 74.42 107.962 169.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 9.1 m-30 -97.83 136.7 37.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.452 0.644 . . . . 75.01 111.711 -174.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.411 ' HG3' ' HB ' ' A' ' 177' ' ' ILE . 15.3 ptmt -138.47 136.42 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.068 -1.424 . . . . 73.41 108.945 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.764 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 29.9 t70 -109.17 177.21 4.82 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.574 1.55 . . . . 62.32 110.54 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 pt -65.73 -43.07 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 123.921 0.888 . . . . 73.42 112.511 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -111.42 -51.67 2.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.368 1.067 . . . . 74.24 109.26 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -84.25 19.05 1.96 Allowed 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.026 -1.443 . . . . 73.41 110.666 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.764 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 13.0 t70 -44.37 -42.8 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.319 1.847 . . . . 64.22 113.608 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.25 -47.3 80.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.805 -1.543 . . . . 63.03 111.774 -173.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -124.41 27.35 7.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.634 0.774 . . . . 71.31 112.033 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.668 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 3.0 tm? -64.63 -79.68 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.079 -0.388 . . . . 74.01 110.327 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 75.1 m -153.32 -176.17 5.67 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.764 0.792 . . . . 74.51 111.348 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 t -151.34 95.12 2.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.943 -1.503 . . . . 75.22 106.943 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.94 95.65 0.06 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.206 1.402 . . . . 73.32 110.633 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 p -120.46 25.1 10.0 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.977 -1.49 . . . . 71.5 106.977 158.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -135.52 155.33 78.49 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.446 -1.252 . . . . 75.04 109.987 -171.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.08 120.11 7.27 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.843 1.695 . . . . 73.31 112.726 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.75 149.93 20.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.551 0.741 . . . . 74.24 110.324 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -136.18 144.97 45.25 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.508 0.723 . . . . 75.54 109.417 -173.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.0 tp -130.71 145.05 51.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.591 0.756 . . . . 72.03 109.485 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.98 133.87 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.468 0.707 . . . . 72.03 109.689 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 58.82 16.23 4.36 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.211 1.404 . . . . 72.53 113.681 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 47.25 26.56 0.71 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.536 1.135 . . . . 73.53 112.616 -167.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 119' ' ' LYS . 37.1 tp -119.94 -46.69 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.179 0.992 . . . . 74.34 109.937 -174.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.81 126.54 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.115 0.566 . . . . 74.1 110.395 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.15 122.74 29.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.491 -1.3 . . . . 73.3 107.491 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 5.1 pt-20 -112.73 147.03 37.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.197 0.522 . . . . 74.22 110.118 170.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -131.49 105.08 7.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.369 -1.345 . . . . 74.45 107.369 166.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 167' ' ' PRO . 15.2 ptmt -82.01 103.64 11.79 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.11 -0.7 . . . . 74.51 109.11 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.82 -157.4 19.46 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.042 -0.981 . . . . 75.43 112.09 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -124.12 161.3 25.92 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.806 0.842 . . . . 75.42 109.913 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -93.13 118.09 30.82 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.156 -1.053 . . . . 73.01 108.156 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 m -146.98 159.8 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.331 0.586 . . . . 62.11 111.42 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 m -133.88 132.57 56.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.181 -1.044 . . . . 74.35 108.181 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.62 149.67 43.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.132 -1.433 . . . . 75.44 107.132 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -133.86 132.06 39.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.628 -0.878 . . . . 74.43 108.628 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 65.17 12.49 8.03 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.097 1.359 . . . . 70.51 113.503 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.8 21.24 26.55 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 123.051 0.358 . . . . 24.2 112.481 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.44 127.27 43.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.271 1.028 . . . . 75.12 109.175 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp . . . . . 0 CA--C 1.556 1.19 0 N-CA-C 109.282 -0.636 . . . . 75.32 109.282 176.627 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 108.132 -1.062 . . . . 74.32 108.132 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.4 73.31 3.16 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.959 -1.126 . . . . 72.01 107.959 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -91.97 137.28 32.49 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.952 -0.567 . . . . 72.13 109.54 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.18 -122.72 2.75 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 112.15 -0.38 . . . . 65.41 112.15 170.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 42.2 pt -112.5 138.8 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.308 0.643 . . . . 64.45 111.648 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -47.8 -46.87 31.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.209 1.404 . . . . 55.44 113.765 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 169' ' ' LEU . 57.6 mt -50.41 -46.13 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.382 1.073 . . . . 73.31 111.705 -174.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.25 -47.11 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.289 -0.869 . . . . 74.14 111.216 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 17.2 mt -64.2 -36.12 83.03 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.214 0.946 . . . . 73.42 110.517 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -60.98 -37.06 81.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.879 1.672 . . . . 63.42 110.803 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.544 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 26.3 m170 -106.89 -13.33 15.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.974 -1.012 . . . . 75.3 111.99 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 55.02 57.47 5.57 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.532 1.133 . . . . 72.22 111.488 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' ' 74' ' ' HIS . 79.5 mt -84.64 146.13 27.64 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.651 0.78 . . . . 71.5 110.431 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.84 123.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 109.538 -0.541 . . . . 70.21 109.538 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -70.6 147.36 49.31 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.704 -1.135 . . . . 45.23 112.876 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 70.4 mtp -143.74 122.35 12.52 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.015 -2.217 . . . . 61.03 105.015 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -101.0 152.86 20.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.772 -0.58 . . . . 73.44 112.007 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 20.4 p -66.88 -23.97 66.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.616 0.766 . . . . 70.24 113.058 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -72.14 -43.67 64.32 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.922 0.489 . . . . 45.21 111.575 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.73 -48.19 3.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.333 0.653 . . . . 64.34 111.395 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.41 21.0 3.04 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.122 0.969 . . . . 73.32 112.432 -171.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.4 74.83 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.591 0.757 . . . . 73.51 112.584 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.6 t -74.04 -41.22 62.13 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.812 0.845 . . . . 73.04 110.794 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -61.55 -43.99 97.84 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.06 0.544 . . . . 71.54 110.049 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.615 ' HD1' HG22 ' A' ' 153' ' ' VAL . 46.5 t80 -58.83 -42.91 90.39 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.381 1.472 . . . . 74.23 111.086 176.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -58.93 -41.45 87.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.624 0.77 . . . . 73.2 110.369 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.36 88.84 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.349 0.66 . . . . 75.42 111.277 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.504 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 63.8 m-85 -59.6 -45.24 92.49 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.737 0.415 . . . . 74.45 111.371 171.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.457 HG22 ' HE3' ' A' ' 96' ' ' MET . 34.4 mm -59.43 -38.31 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.814 0.846 . . . . 75.14 111.0 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -58.18 -47.74 82.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.972 0.509 . . . . 74.31 111.476 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -65.71 -51.04 62.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.545 0.738 . . . . 74.34 110.656 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -49.98 -62.29 1.65 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.941 2.097 . . . . 74.15 111.655 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.457 ' HE3' HG22 ' A' ' 92' ' ' ILE . 48.2 mtm -64.6 -33.98 77.19 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.634 0.584 . . . . 71.12 111.04 -177.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -60.58 -47.03 88.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.836 0.454 . . . . 75.52 110.076 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.31 -48.9 16.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.486 0.714 . . . . 73.21 110.57 -172.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.45 -40.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.363 0.265 . . . . 75.54 111.069 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 77.0 mt -71.19 -45.68 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 119.016 -0.516 . . . . 72.15 109.723 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 26.5 t70 -53.59 -47.69 69.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 123.882 0.873 . . . . 65.21 112.634 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -65.36 -43.18 91.6 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.757 0.423 . . . . 71.22 110.143 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.455 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 7.6 tpt -68.84 -26.07 64.97 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.653 -0.703 . . . . 72.33 110.048 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.64 ' HA ' HG12 ' A' ' 113' ' ' VAL . 1.7 tm-20 -76.4 -38.04 56.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.856 1.263 . . . . 75.23 109.787 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 64.7 mttm -67.15 -25.92 66.4 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.698 0.399 . . . . 73.12 110.61 174.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.17 0.68 53.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.087 0.955 . . . . 73.01 111.701 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -130.42 -53.43 1.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.439 0.695 . . . . 71.31 110.168 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 56.82 23.06 7.62 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.042 2.137 . . . . 73.23 112.854 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.48 -89.0 0.61 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.81 0.844 . . . . 72.32 109.564 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttp 173.13 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.648 1.179 . . . . 74.22 109.782 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.13 92.14 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.731 0.641 . . . . 54.43 112.731 -164.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.29 -48.54 17.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.765 0.426 . . . . 73.51 109.95 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 104' ' ' GLU . 35.0 m -70.39 -24.09 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.723 -0.671 . . . . 74.32 112.22 -174.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 23.0 t70 -65.43 -37.48 87.03 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.376 0.67 . . . . 73.54 109.865 172.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' A' ' 119' ' ' LYS . . . -72.62 -49.49 31.64 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.876 0.735 . . . . 74.2 109.935 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -55.16 -47.92 74.48 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.885 0.474 . . . . 75.22 110.418 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -60.7 -46.59 89.82 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.387 1.054 . . . . 74.54 110.944 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -61.25 -43.89 98.14 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.009 0.818 . . . . 72.44 110.248 -174.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.47 ' HB3' HD23 ' A' ' 26' ' ' LEU . 5.1 mptp? -79.28 -36.91 39.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.501 -0.772 . . . . 75.43 111.337 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.1 tp -73.99 -38.22 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 118.751 0.705 . . . . 74.22 110.324 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.46 ' HA ' HG23 ' A' ' 124' ' ' VAL . 23.4 tm0? -72.32 -39.34 68.28 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 176.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.63 -39.21 97.08 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.513 0.508 . . . . 72.13 112.28 174.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -65.13 -51.42 61.33 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.504 0.722 . . . . 73.32 109.616 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.529 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.8 m -68.77 -42.12 82.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-O 118.936 -0.554 . . . . 75.22 111.04 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.1 -29.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 118.85 0.75 . . . . 74.13 110.605 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.3 t -77.81 -39.17 44.69 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.201 0.6 . . . . 71.23 110.882 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.684 HD21 HG23 ' A' ' 155' ' ' ILE . 35.0 tp -72.48 -29.45 63.65 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.521 1.128 . . . . 74.22 111.509 -174.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 38.0 mt -86.75 0.3 54.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.195 0.598 . . . . 75.44 111.123 -177.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.31 81.05 4.69 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.076 -0.713 . . . . 74.0 109.076 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 61.7 pttt -61.56 -6.1 2.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.875 1.27 . . . . 74.15 113.819 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -54.44 -42.72 70.9 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.955 0.902 . . . . 72.32 110.838 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -109.17 -37.98 5.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.285 1.034 . . . . 73.11 109.637 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.445 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 56.7 m-85 -79.26 -1.54 37.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.796 1.238 . . . . 72.14 114.15 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 30.3 ttmt -50.64 -12.74 0.11 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.1 1.148 . . . . 72.34 114.1 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 77.4 m-20 -82.29 22.09 0.86 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.745 0.818 . . . . 71.12 111.467 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 72.8 mt -89.23 136.95 32.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.171 0.588 . . . . 74.53 109.598 172.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.47 122.95 25.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.661 -1.607 . . . . 44.54 106.661 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -99.39 129.44 45.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.937 0.495 . . . . 74.55 109.8 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.429 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 96.6 m-85 -130.33 146.12 51.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.826 0.451 . . . . 74.52 110.525 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.37 170.26 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.933 0.493 . . . . 65.31 109.751 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.54 138.84 22.27 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.658 -0.701 . . . . 55.12 112.353 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -59.86 -47.47 85.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.7 1.2 . . . . 71.51 109.833 171.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -38.35 68.35 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.795 1.238 . . . . 75.32 111.206 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.02 -46.34 68.22 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.923 -1.035 . . . . 74.54 110.292 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.01 -3.25 51.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.352 0.661 . . . . 72.01 112.429 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.94 -41.66 14.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.258 0.623 . . . . 73.32 111.726 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.62 46.37 0.1 OUTLIER Glycine 0 N--CA 1.469 0.867 0 C-N-CA 121.271 -0.49 . . . . 73.25 112.839 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.93 -165.2 1.68 Allowed 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.154 0.982 . . . . 63.4 108.826 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -55.09 122.56 11.23 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.792 -0.818 . . . . 74.42 108.792 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -50.38 -31.04 13.68 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.957 1.411 . . . . 75.23 111.621 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 123.87 -174.39 16.77 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.797 -0.638 . . . . 53.0 112.902 172.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.4 164.79 16.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.926 1.291 . . . . 63.24 108.072 167.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.615 HG22 ' HD1' ' A' ' 88' ' ' PHE . 41.9 t -79.15 116.94 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.585 0.707 . . . . 74.14 111.77 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.35 106.17 5.85 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.071 -1.422 . . . . 62.4 107.908 161.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.684 HG23 HD21 ' A' ' 127' ' ' LEU . 54.8 mt -90.41 106.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.534 0.733 . . . . 74.42 110.236 -165.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 169' ' ' LEU . 44.9 mm -96.05 115.98 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.033 -0.358 . . . . 72.42 110.033 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -100.51 121.4 41.51 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.09 0.556 . . . . 74.53 110.0 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.511 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 32.6 m-85 -83.43 98.34 9.45 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.633 -0.877 . . . . 73.33 108.633 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -90.74 131.88 36.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.686 -0.857 . . . . 74.22 108.686 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.79 108.38 19.95 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.166 -0.679 . . . . 71.31 109.166 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.03 111.47 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 108.978 -0.749 . . . . 74.41 108.978 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.33 21.5 11.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.428 1.091 . . . . 71.43 112.826 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.19 31.17 14.83 Favored Glycine 0 C--N 1.347 1.144 0 C-N-CA 121.908 -0.187 . . . . 64.03 112.909 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -133.71 121.71 22.34 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.881 0.872 . . . . 71.4 109.326 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.92 126.65 30.45 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.545 0.528 . . . . 75.23 109.634 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.01 107.22 37.99 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 108.221 -1.029 . . . . 74.42 108.221 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 57.8 Cg_endo -68.15 127.57 16.14 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.677 2.252 . . . . 75.34 111.178 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 20.8 m -118.06 104.79 11.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.184 0.594 . . . . 71.25 109.845 -171.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 56.2 tp -78.01 106.19 9.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.621 0.769 . . . . 74.31 109.674 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.509 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.3 mtt -103.28 122.81 45.56 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.571 0.748 . . . . 73.41 109.139 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.9 mt -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.937 -1.875 . . . . 74.44 105.937 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.0 p -83.09 143.71 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 108.047 -1.094 . . . . 65.41 108.047 173.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -48.56 -37.58 18.24 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.501 1.52 . . . . 74.54 111.707 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.455 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 8.7 tp10 -83.72 -0.52 51.18 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.688 0.795 . . . . 74.13 112.191 -175.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -104.73 -33.29 8.5 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.545 0.738 . . . . 72.43 110.373 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.66 133.48 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.33 0.586 . . . . 74.31 110.285 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.411 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.8 mm -127.9 131.94 69.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 107.385 -1.339 . . . . 73.02 107.385 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' HB2' HD11 ' A' ' 2' ' ' LEU . 10.5 pt-20 -95.06 124.8 39.31 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.245 -0.65 . . . . 70.43 109.245 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.424 ' HB3' HG22 ' A' ' 3' ' ' ILE . 15.9 tp10 -108.4 125.54 51.85 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.841 -0.8 . . . . 65.54 108.841 175.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.457 ' HA ' HD21 ' A' ' 2' ' ' LEU . 13.8 mptt -71.28 154.25 41.78 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.746 0.818 . . . . 72.12 110.621 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 39.8 m -133.3 86.41 2.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.492 -0.559 . . . . 71.01 109.492 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -170.08 0.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.085 0.954 . . . . 71.51 112.149 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 . . . . . 0 CA--C 1.552 1.026 0 C-N-CA 123.573 0.749 . . . . 73.42 109.152 -178.679 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' HA ' ' A' ' 16' ' ' ASP . 25.0 ptp . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.933 -0.395 . . . . 73.42 109.933 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.16 123.32 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.649 -0.871 . . . . 71.11 108.649 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.591 HG22 ' HB3' ' A' ' 179' ' ' GLU . 9.7 tt -96.82 119.95 45.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.6 0.714 . . . . 74.01 110.068 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -102.71 110.83 22.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.717 -1.957 . . . . 63.54 105.717 173.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -131.24 134.95 46.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.068 0.547 . . . . 74.42 111.736 -167.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.409 ' HA ' HD13 ' A' ' 176' ' ' ILE . 27.7 t70 -81.65 131.2 35.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.71 0.804 . . . . 71.32 109.751 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 175' ' ' ALA . 25.9 pt -77.94 -11.55 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 74.53 112.752 -171.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.571 ' HE1' ' HB2' ' A' ' 175' ' ' ALA . 9.0 m-85 -94.15 -64.68 1.05 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.082 0.401 . . . . 73.43 110.619 -172.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.481 HG22 ' HB3' ' A' ' 149' ' ' GLU . 3.2 p -132.08 -37.68 1.12 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.385 1.074 . . . . 72.5 113.702 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.34 23.56 8.26 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.048 0.939 . . . . 71.22 111.854 -162.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -46.35 -26.32 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 126.014 1.726 . . . . 74.11 115.027 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.91 27.58 0.87 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.367 1.067 . . . . 74.41 111.16 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.63 -73.69 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.735 1.614 . . . . 75.5 112.39 -173.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 m -152.15 131.87 13.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.973 0.509 . . . . 61.14 109.85 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 34.5 p -131.34 91.79 3.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.037 0.935 . . . . 75.41 108.942 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.42 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.0 t70 -168.31 177.55 5.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.594 0.757 . . . . 74.45 109.628 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 p -83.39 81.55 8.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.589 0.756 . . . . 74.04 109.344 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 36.9 m-85 -103.19 152.79 38.68 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 115.188 -0.915 . . . . 74.33 109.57 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -46.98 119.12 3.16 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.872 2.381 . . . . 64.34 112.83 173.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.4 ' HE3' ' HB2' ' A' ' 22' ' ' LEU . 17.7 tpt -112.26 120.93 43.44 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.224 -1.028 . . . . 74.22 108.224 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -142.44 116.62 9.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.764 -1.569 . . . . 75.43 106.764 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.4 ' HB2' ' HE3' ' A' ' 20' ' ' MET . 57.9 tp -123.64 113.91 19.28 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.104 0.962 . . . . 73.12 108.606 -172.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.25 137.0 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.08 0.952 . . . . 63.14 109.649 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 56.09 18.98 3.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 125.417 1.487 . . . . 71.34 113.315 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.62 14.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.371 1.068 . . . . 73.23 112.113 -172.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 119' ' ' LYS . 37.2 tp -112.74 -51.28 2.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.62 0.768 . . . . 73.52 110.636 -168.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -116.15 122.09 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.534 -0.757 . . . . 72.13 109.708 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.59 113.06 21.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.851 -1.166 . . . . 71.42 107.851 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -103.99 107.62 18.6 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.016 0.926 . . . . 73.34 109.032 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.581 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 45.9 t80 -90.2 112.62 24.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.595 1.158 . . . . 74.4 109.159 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HE2' HG11 ' A' ' 166' ' ' VAL . 62.5 tttm -69.2 143.5 53.99 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.067 0.547 . . . . 72.33 110.546 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.19 -174.54 33.2 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 110.822 -0.911 . . . . 72.11 110.822 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 20.2 ptmt -134.43 151.56 51.26 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.477 0.639 . . . . 73.52 111.088 -173.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -75.39 125.21 28.53 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.303 -0.629 . . . . 73.52 109.303 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.446 HG22 HD12 ' A' ' 72' ' ' LEU . 4.7 m -150.85 155.99 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.211 1.404 . . . . 74.22 108.962 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.5 m -133.27 161.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.847 -0.798 . . . . 71.12 108.847 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -138.12 110.22 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.631 -0.877 . . . . 75.22 108.631 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -117.29 147.36 42.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.285 -1.005 . . . . 75.53 108.285 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -59.43 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.739 1.216 . . . . 63.43 111.106 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.25 -52.42 0.65 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.085 -1.416 . . . . 70.43 111.722 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -165.31 2.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.526 0.731 . . . . 74.54 112.122 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 tt . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 124.054 0.942 . . . . 74.24 110.51 -179.381 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 107.211 -1.403 . . . . 74.41 107.211 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HG2' HD21 ' A' ' 72' ' ' LEU . 37.4 tt0 -93.34 75.5 4.54 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 107.795 -1.187 . . . . 64.4 107.795 172.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -89.01 144.76 25.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.553 -1.203 . . . . 72.32 110.589 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.01 -130.54 3.13 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.099 -0.8 . . . . 73.32 111.099 164.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.488 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.4 pt -112.73 150.06 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 122.881 0.472 . . . . 74.14 111.212 168.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -41.17 -41.32 1.77 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 127.122 2.169 . . . . 72.35 113.146 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 169' ' ' LEU . 66.9 mt -57.58 -55.32 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 124.336 1.023 . . . . 75.14 110.352 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 76' ' ' LEU . 40.3 t -60.56 -44.91 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 114.407 -1.269 . . . . 73.31 111.215 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.49 HD21 ' HG2' ' A' ' 65' ' ' GLU . 19.1 mt -72.34 -35.8 68.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.418 -0.81 . . . . 72.1 111.127 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -72.04 -33.88 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.757 0.823 . . . . 75.35 110.83 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -97.7 -5.68 34.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.417 0.687 . . . . 74.11 111.64 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt 55.5 63.13 2.17 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.937 1.295 . . . . 73.24 110.683 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.526 ' HB2' HG11 ' A' ' 71' ' ' VAL . 58.0 mt -100.52 135.35 42.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.713 -1.131 . . . . 72.4 109.367 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.75 130.35 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.519 -0.548 . . . . 75.1 109.519 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.98 134.32 43.08 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.804 -1.089 . . . . 73.03 111.902 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.4 mtp -145.56 103.84 3.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.853 1.661 . . . . 74.5 107.273 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.471 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 95.6 m-20 -86.05 149.98 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.522 -0.736 . . . . 74.52 109.691 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.406 ' HB2' ' HE2' ' A' ' 138' ' ' PHE . 37.0 t -60.72 -20.38 61.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.625 -0.716 . . . . 74.24 111.812 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.471 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 95.1 m-85 -58.28 -57.72 11.65 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.331 1.053 . . . . 74.44 110.925 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -74.24 -35.14 63.83 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.274 -0.876 . . . . 73.2 111.851 -174.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -121.44 19.37 11.31 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 112.208 0.447 . . . . 72.25 112.208 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.39 -39.6 7.11 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.681 0.993 . . . . 51.42 113.681 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.0 m -65.98 -60.18 3.1 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.507 0.723 . . . . 70.31 111.378 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.2 mtt -76.75 -14.54 59.93 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.988 -0.551 . . . . 75.22 111.431 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.672 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 40.5 t80 -70.1 -38.51 75.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.21 0.604 . . . . 73.43 109.862 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -70.07 -26.15 63.88 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 110.216 -0.291 . . . . 75.04 110.216 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.3 72.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.012 -0.54 . . . . 70.12 110.785 170.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.672 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 33.1 m-85 -58.48 -44.86 89.53 Favored 'General case' 0 C--N 1.367 1.346 0 C-N-CA 123.205 0.602 . . . . 72.42 109.784 170.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm -64.15 -38.78 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.843 0.857 . . . . 63.11 111.613 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -60.02 -46.92 87.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.935 0.494 . . . . 73.22 111.713 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -66.49 -44.89 81.38 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 71.02 110.395 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -50.41 -59.31 4.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.204 1.802 . . . . 73.11 110.85 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 64.0 mtt -57.26 -57.45 12.57 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.164 0.915 . . . . 73.54 111.022 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.17 -30.69 71.23 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.285 0.366 . . . . 72.22 111.639 -173.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -78.34 -45.15 23.28 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.74 0.416 . . . . 72.25 110.991 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.472 HG12 ' HB1' ' A' ' 175' ' ' ALA . 32.4 m -68.27 -28.8 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 123.196 0.31 . . . . 74.3 110.583 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.486 ' HA ' ' HE1' ' A' ' 103' ' ' MET . 52.6 mt -75.04 -45.36 42.68 Favored 'Isoleucine or valine' 0 C--N 1.359 0.978 0 C-N-CA 123.431 0.692 . . . . 73.53 110.307 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.63 -31.87 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.444 0.698 . . . . 73.05 111.337 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -69.78 -61.35 1.82 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.984 0.914 . . . . 73.24 109.811 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.486 ' HE1' ' HA ' ' A' ' 100' ' ' ILE . 21.9 ptt? -64.5 -50.31 67.89 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.66 0.6 . . . . 55.23 111.444 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.82 -20.93 66.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.348 0.659 . . . . 71.43 111.991 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -72.64 -25.73 61.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.387 0.675 . . . . 75.22 110.388 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.57 0.09 12.58 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.799 0.84 . . . . 62.43 111.538 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -120.02 -74.11 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.158 0.583 . . . . 65.51 110.206 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 50.08 18.78 0.41 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.548 1.939 . . . . 72.44 115.131 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.86 -22.64 49.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.249 0.62 . . . . 75.51 110.001 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HA ' HG21 ' A' ' 113' ' ' VAL . 86.0 tttt 84.15 -38.76 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.148 1.779 . . . . 75.44 111.73 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.89 62.79 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.227 0.467 . . . . 75.3 110.637 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -86.2 -44.55 12.09 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.938 0.895 . . . . 74.3 111.742 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 110' ' ' LYS . 33.5 m -78.03 -34.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.139 -0.482 . . . . 73.44 111.564 -174.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.72 -25.3 56.49 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.701 -0.481 . . . . 72.12 109.701 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.7 -47.98 57.01 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.351 0.66 . . . . 73.35 109.691 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -61.85 -47.69 83.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.216 1.006 . . . . 74.24 110.828 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.56 -36.18 79.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.195 0.998 . . . . 72.32 110.786 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.72 -46.17 83.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.66 0.784 . . . . 73.43 109.939 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HB3' HD21 ' A' ' 26' ' ' LEU . 34.4 mmtp -66.49 -37.75 85.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.465 -0.789 . . . . 72.55 111.107 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.7 mm -73.24 -36.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.82 0.848 . . . . 72.31 110.682 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -61.32 -52.51 64.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.744 -0.835 . . . . 73.1 108.744 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.67 -37.44 94.37 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.66 -0.7 . . . . 65.23 112.325 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -62.51 -55.32 28.57 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.1 0.96 . . . . 74.35 110.743 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -67.23 -41.15 86.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-O 118.402 -0.809 . . . . 75.12 111.151 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.3 -42.52 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.095 0.861 . . . . 74.2 110.787 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -70.24 -31.4 68.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.883 0.473 . . . . 61.15 111.311 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.653 HD22 HG21 ' A' ' 155' ' ' ILE . 31.9 tp -84.03 -21.65 31.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.058 0.943 . . . . 75.24 111.342 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -92.88 -0.37 57.25 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.694 0.797 . . . . 71.23 111.589 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.82 101.32 0.19 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.09 0.556 . . . . 51.45 110.487 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 15.3 ptmm? -61.77 -12.41 16.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.962 1.305 . . . . 71.32 114.432 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.68 -46.46 82.33 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.829 0.452 . . . . 63.15 111.113 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -110.13 -40.36 4.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.242 1.017 . . . . 75.35 109.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -81.58 -3.47 53.39 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.233 1.013 . . . . 73.43 112.608 -167.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 61.1 tttm -46.09 -31.01 2.11 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.423 1.089 . . . . 75.2 111.895 160.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -97.57 26.66 4.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.332 1.053 . . . . 54.13 111.596 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 mt -88.69 140.61 29.28 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.214 -0.662 . . . . 64.54 109.214 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.55 112.34 25.03 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.401 -1.333 . . . . 71.35 107.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.406 ' HE2' ' HB2' ' A' ' 81' ' ' CYS . 76.7 m-85 -99.71 140.35 34.05 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.579 -0.897 . . . . 75.55 108.579 -175.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.521 ' HB2' ' HB1' ' A' ' 154' ' ' ALA . 45.5 m-85 -131.84 150.04 52.27 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.953 -1.128 . . . . 74.24 107.953 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.2 tt -124.13 141.05 45.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 107.948 -1.13 . . . . 75.11 107.948 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.32 138.61 47.69 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.014 0.822 . . . . 71.12 111.904 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 49.0 tt0 -43.31 -54.21 4.77 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.178 0.991 . . . . 74.4 112.18 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -64.24 -38.35 90.74 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.9 0.75 . . . . 74.42 111.29 -172.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.25 97.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.717 0.807 . . . . 74.42 110.924 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 -16.28 56.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.401 1.08 . . . . 64.11 113.215 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 42.3 mt-10 -64.27 -31.41 72.61 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.775 0.43 . . . . 73.32 111.693 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.19 51.86 0.03 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.739 -0.944 . . . . 60.13 110.739 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.72 -170.18 2.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.778 0.831 . . . . 74.54 110.314 -173.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.481 ' HB3' HG22 ' A' ' 9' ' ' THR . 12.7 tp10 -51.18 142.83 11.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.461 1.104 . . . . 74.32 111.53 173.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -50.98 -26.46 6.04 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.779 1.77 . . . . 71.12 115.779 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.66 176.54 21.43 Favored Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.051 0.219 . . . . 73.45 112.902 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.07 127.16 33.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 106.758 -1.571 . . . . 70.03 106.758 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 155' ' ' ILE . 67.9 t -74.63 113.7 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.322 -0.622 . . . . 65.22 109.322 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 139' ' ' PHE . . . -64.81 97.09 0.2 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.62 1.168 . . . . 73.24 109.654 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.653 HG21 HD22 ' A' ' 127' ' ' LEU . 85.2 mt -88.15 102.73 12.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 108.538 -0.912 . . . . 75.13 108.538 -172.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 68' ' ' ILE . 41.0 mm -95.56 114.29 31.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 116.255 -0.43 . . . . 75.52 109.967 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.71 130.18 54.89 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.406 -1.27 . . . . 74.2 108.313 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.3 p90 -83.12 124.41 30.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.992 -1.484 . . . . 62.44 106.992 173.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -116.14 135.74 53.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.635 -1.246 . . . . 75.21 107.635 -171.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.11 115.39 28.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.032 -0.729 . . . . 74.04 109.032 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.6 107.64 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.952 -0.759 . . . . 74.43 108.952 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 63.97 30.63 14.1 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.416 1.086 . . . . 64.12 110.734 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.94 25.03 75.71 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.59 -0.732 . . . . 61.02 113.038 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.1 m -108.34 134.85 50.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.612 0.765 . . . . 73.1 109.129 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -73.14 111.43 8.25 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.888 -0.782 . . . . 73.44 108.888 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.436 HG11 ' HE2' ' A' ' 31' ' ' LYS . 27.0 m -128.63 88.07 53.16 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 121.845 0.831 . . . . 74.15 108.98 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 80.6 Cg_exo -55.37 121.4 9.86 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.788 2.325 . . . . 71.4 111.989 168.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.6 t -115.28 140.07 49.42 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.347 1.059 . . . . 71.24 109.098 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.7 tp -91.75 114.54 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.712 1.205 . . . . 73.41 108.967 176.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 81.1 mtp -93.84 123.04 36.93 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 107.568 -1.271 . . . . 74.34 107.568 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.557 HD12 HG23 ' A' ' 176' ' ' ILE . 94.0 mt -132.84 141.26 48.36 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.629 1.572 . . . . 73.13 107.511 -177.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.2 p -80.87 133.7 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.471 -0.937 . . . . 73.12 108.471 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -66.29 -19.62 65.87 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.431 0.692 . . . . 75.41 112.254 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.38 -30.43 47.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.768 0.318 . . . . 73.4 111.48 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.571 ' HB2' ' HE1' ' A' ' 8' ' ' PHE . . . -104.21 -10.16 18.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.092 0.557 . . . . 72.31 111.678 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 171' ' ' LEU . 36.1 mm -126.25 108.34 19.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.787 -1.561 . . . . 64.11 106.787 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.2 mm -95.04 113.18 28.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.288 -0.869 . . . . 74.31 109.596 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.37 135.84 44.31 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.434 -1.321 . . . . 75.23 107.434 166.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.591 ' HB3' HG22 ' A' ' 3' ' ' ILE . 36.9 tt0 -149.19 134.74 18.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.818 0.342 . . . . 73.12 110.235 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.582 ' HE3' HD13 ' A' ' 182' ' ' LEU . 37.8 tttp -81.14 112.42 18.48 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.45 -0.945 . . . . 75.12 108.45 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.75 92.36 3.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.887 -0.783 . . . . 74.41 108.887 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.582 HD13 ' HE3' ' A' ' 180' ' ' LYS . 48.1 mt -98.74 152.96 19.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.094 0.558 . . . . 65.22 110.88 -174.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 CA--C 1.557 1.222 0 C-N-CA 122.892 0.477 . . . . 75.32 110.389 178.577 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.924 -0.769 . . . . 75.24 108.924 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.496 HD11 ' SD ' ' A' ' 20' ' ' MET . 84.0 mt -133.16 153.07 51.86 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.143 -0.688 . . . . 74.04 109.143 175.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' A' ' 179' ' ' GLU . 4.4 tt -114.49 116.74 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.906 -1.516 . . . . 71.42 106.906 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.421 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 5.2 m-85 -100.97 130.93 47.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.26 -1.385 . . . . 73.3 107.26 -174.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.96 161.7 19.76 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.289 1.036 . . . . 71.32 109.638 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 35.3 t70 -116.02 178.06 4.46 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.383 1.073 . . . . 74.13 109.743 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.96 -39.27 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 CA-C-O 121.348 0.594 . . . . 73.31 110.306 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -110.93 -55.25 2.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.679 1.192 . . . . 65.43 110.002 -168.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.446 ' HB ' HD21 ' A' ' 13' ' ' LEU . 3.7 m -90.06 15.74 9.6 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 113.755 -1.566 . . . . 72.44 111.234 -168.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.7 p-10 -63.2 -7.11 5.21 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 114.603 1.334 . . . . 75.35 114.603 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -48.82 -50.98 31.93 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.403 1.064 . . . . 72.23 111.393 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -123.35 -40.54 2.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.017 0.927 . . . . 74.32 109.144 164.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD21 ' HB ' ' A' ' 9' ' ' THR . 2.0 tm? 42.9 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.294 1.837 . . . . 73.54 111.67 -167.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 4' ' ' TYR . 67.1 p -155.26 154.49 32.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.66 0.784 . . . . 74.41 110.783 175.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.449 ' HG ' HG13 ' A' ' 3' ' ' ILE . 48.1 m -163.16 96.35 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.959 0.904 . . . . 73.21 110.468 -171.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -179.16 172.77 1.21 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.612 1.165 . . . . 70.31 108.912 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -38.8 -55.1 1.55 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.466 1.106 . . . . 73.21 111.355 165.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 43.07 108.29 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 125.924 1.69 . . . . 71.43 114.84 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.92 121.04 9.29 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 121.951 1.767 . . . . 75.11 110.951 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.496 ' SD ' HD11 ' A' ' 2' ' ' LEU . 44.4 mtm -101.28 150.45 22.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.128 0.971 . . . . 72.42 109.718 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -156.76 134.27 10.74 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.113 -0.699 . . . . 74.54 109.113 171.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.73 122.55 47.44 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.18 -1.045 . . . . 73.43 108.18 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.52 135.19 52.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.465 0.706 . . . . 75.31 110.082 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 60.5 14.18 4.66 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.678 1.191 . . . . 71.15 112.536 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 48.58 33.84 4.47 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.547 1.139 . . . . 74.24 111.67 -171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 119' ' ' LYS . 32.8 tp -125.81 -52.47 1.56 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.236 -0.893 . . . . 72.24 109.632 -175.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.1 t -114.13 128.9 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.281 -0.872 . . . . 74.03 109.226 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.88 112.84 21.52 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 106.829 -1.545 . . . . 65.22 106.829 166.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -104.43 145.06 30.81 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.175 -0.676 . . . . 72.42 109.175 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -142.93 105.48 4.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.484 1.114 . . . . 73.11 108.411 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.67 149.22 26.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.348 0.659 . . . . 74.11 110.415 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.97 -161.76 9.53 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.88 -1.055 . . . . 74.14 111.262 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 139.83 51.02 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.76 0.824 . . . . 74.4 109.891 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -73.76 115.81 13.63 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.71 -1.132 . . . . 74.51 109.236 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -147.45 -175.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.721 1.208 . . . . 71.33 109.792 -170.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 26.0 m -113.16 161.05 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.448 0.699 . . . . 72.31 110.909 173.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 60.6 ttt180 -136.3 112.18 9.55 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.666 1.186 . . . . 75.44 108.366 174.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HD2' HG21 ' A' ' 64' ' ' VAL . 52.0 tttm -135.66 96.73 3.5 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.521 -0.918 . . . . 75.43 108.521 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 47.7 -81.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 126.326 1.851 . . . . 74.52 112.987 -173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.15 26.13 0.31 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.856 -0.898 . . . . 71.41 110.856 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.32 98.14 4.02 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.689 1.596 . . . . 63.2 107.182 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.7 pt . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 121.215 0.531 . . . . 71.23 110.99 -176.026 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.402 HG21 ' HD2' ' A' ' 38' ' ' LYS . 46.2 t . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.157 -0.683 . . . . 74.03 109.157 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.8 mp0 -78.26 82.06 4.59 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.313 -0.995 . . . . 73.34 108.313 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 6.9 tmm_? -76.11 146.37 39.33 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.982 -0.747 . . . . 75.34 108.982 168.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.33 -136.7 5.54 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.644 -0.582 . . . . 61.21 111.644 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.712 HD11 HD13 ' A' ' 70' ' ' ILE . 2.1 tt -104.31 126.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.627 1.171 . . . . 73.02 109.026 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.26 -29.46 33.06 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.188 1.395 . . . . 64.03 113.502 -172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.712 HD13 HD11 ' A' ' 68' ' ' ILE . 56.5 mt -61.53 -44.87 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.428 1.091 . . . . 74.13 110.048 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 76' ' ' LEU . 44.0 t -74.68 -41.79 47.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-N 114.179 -1.373 . . . . 73.14 110.268 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 35.2 mt -67.2 -24.09 65.81 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.668 0.605 . . . . 75.44 110.914 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -62.36 -61.11 2.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.635 1.174 . . . . 71.01 110.513 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -87.01 -20.17 27.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.729 0.812 . . . . 72.32 111.227 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 41.2 ttmt 66.38 69.62 0.42 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.042 1.337 . . . . 75.34 109.124 -168.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HB2' HG13 ' A' ' 71' ' ' VAL . 70.4 mt -80.44 136.34 36.32 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.255 -1.017 . . . . 73.1 108.255 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.91 130.28 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.09 -0.707 . . . . 74.51 109.09 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.47 148.54 37.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.039 . . . . 73.3 112.59 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.54 ' HE1' HG21 ' A' ' 153' ' ' VAL . 56.2 ttp -148.69 134.42 18.85 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.239 -1.346 . . . . 74.43 107.657 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -119.09 142.69 47.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.091 0.556 . . . . 60.03 109.645 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.6 -11.92 48.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.711 0.805 . . . . 73.44 111.753 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -80.25 -34.63 36.95 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.973 0.909 . . . . 70.44 111.424 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -103.06 -37.22 7.86 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.172 0.511 . . . . 70.13 110.635 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.4 20.4 16.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.315 1.046 . . . . 72.55 111.925 -169.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -44.77 -43.48 8.61 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.748 1.219 . . . . 71.12 113.57 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.3 t -65.62 -52.04 55.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.057 0.943 . . . . 73.02 111.353 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.1 mpt? -68.63 -42.29 78.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.967 0.907 . . . . 73.33 110.688 -173.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.465 ' HE1' HG13 ' A' ' 153' ' ' VAL . 51.5 t80 -63.04 -41.87 99.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.766 1.226 . . . . 75.44 111.236 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -65.28 -36.56 84.47 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.212 0.605 . . . . 73.41 110.637 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.79 87.52 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.787 -0.642 . . . . 74.44 110.307 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -65.03 -45.63 84.66 Favored 'General case' 0 C--O 1.193 -1.874 0 CA-C-O 118.571 -0.728 . . . . 75.31 110.808 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.25 -43.08 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.36 0.664 . . . . 64.44 111.67 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.81 -49.07 78.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.702 0.801 . . . . 72.04 111.26 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -79.5 -38.25 34.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.256 0.622 . . . . 74.13 111.173 -173.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -50.99 -53.75 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.632 1.573 . . . . 74.52 110.387 170.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.9 ttp -53.79 -55.87 22.62 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 124.184 0.927 . . . . 74.4 110.14 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.36 -36.67 66.57 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.48 1.112 . . . . 73.53 112.186 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.09 -41.53 18.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.026 0.931 . . . . 71.41 111.936 -169.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -76.88 -27.74 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.673 0.389 . . . . 75.11 111.916 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.459 HD12 ' HG3' ' A' ' 117' ' ' LYS . 84.8 mt -73.05 -36.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.312 0.645 . . . . 72.51 109.303 171.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.59 -44.89 95.19 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.892 0.877 . . . . 65.23 110.562 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -63.2 -44.44 95.36 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.666 -0.697 . . . . 74.33 110.106 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.485 ' SD ' ' CG ' ' A' ' 116' ' ' PHE . 22.9 ttt -66.82 -40.05 87.91 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.258 -0.883 . . . . 73.2 111.329 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.564 ' HA ' HG11 ' A' ' 113' ' ' VAL . 7.6 tp10 -55.27 -40.67 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.563 1.145 . . . . 72.14 111.556 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -37.3 74.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.085 -0.961 . . . . 74.44 111.439 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -115.07 0.74 13.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.16 0.584 . . . . 71.24 111.62 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.481 ' HB2' ' HG2' ' A' ' 103' ' ' MET . 18.3 m120 -148.7 41.99 0.96 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.257 1.023 . . . . 70.24 109.22 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.73 10.68 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.697 1.599 . . . . 71.44 113.632 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.69 -24.37 21.64 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.934 1.294 . . . . 72.45 112.005 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? 89.72 -58.01 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.666 1.986 . . . . 74.4 112.483 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.91 63.18 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.1 0.409 . . . . 55.1 110.933 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.01 -45.89 25.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.09 0.956 . . . . 73.15 111.049 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 104' ' ' GLU . 8.0 m -76.03 -26.92 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.716 0.406 . . . . 74.42 111.571 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.43 -36.37 73.93 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.447 0.699 . . . . 75.13 110.345 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.93 81.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.701 -0.681 . . . . 74.34 110.399 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.485 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 79.3 t80 -63.07 -41.99 99.57 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.444 1.098 . . . . 65.01 110.331 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' HD12 ' A' ' 100' ' ' ILE . 35.5 ttpt -63.9 -38.29 90.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.133 0.973 . . . . 75.43 110.478 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -67.19 -41.5 85.75 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.884 0.874 . . . . 74.01 110.005 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.576 ' HB3' HD22 ' A' ' 26' ' ' LEU . 87.9 mttt -67.24 -39.8 86.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.415 -0.811 . . . . 75.24 111.034 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 124' ' ' VAL . 23.3 mm -67.72 -47.05 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.468 0.707 . . . . 73.41 109.731 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -51.9 -51.83 54.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.666 1.186 . . . . 75.4 110.41 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.76 -38.12 89.35 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.776 -1.102 . . . . 75.12 113.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -65.43 -54.83 22.9 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.354 0.662 . . . . 71.42 110.463 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.5 m -66.5 -42.04 89.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 118.35 -0.833 . . . . 70.13 111.208 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.47 -35.98 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 119.505 1.048 . . . . 72.24 110.871 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.1 t -74.3 -38.01 63.49 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 123.481 0.712 . . . . 64.35 110.956 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.39 -19.04 39.9 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.787 0.835 . . . . 75.13 111.128 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.4 mt -93.7 2.22 56.35 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.142 0.577 . . . . 74.41 111.398 174.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 91.58 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.326 0.584 . . . . 65.52 109.843 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -59.12 -8.28 1.47 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.336 1.455 . . . . 75.22 114.685 -168.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.32 -46.59 72.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.928 0.891 . . . . 75.55 110.333 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -109.29 -39.09 5.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.964 0.906 . . . . 75.1 110.435 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -79.23 -1.89 38.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.595 1.158 . . . . 73.54 113.248 -163.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -51.89 -24.75 6.71 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 122.858 0.463 . . . . 74.32 111.615 160.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -93.92 29.63 2.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.753 1.221 . . . . 64.55 110.351 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.3 mt -94.02 153.43 18.18 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.919 -0.771 . . . . 74.52 108.919 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.58 117.42 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.272 -1.381 . . . . 72.12 107.272 172.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.568 ' HD1' HG23 ' A' ' 155' ' ' ILE . 50.1 m-85 -94.12 140.78 29.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.142 -1.058 . . . . 71.1 108.142 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.456 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 83.6 m-85 -136.46 153.81 50.95 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.774 -0.454 . . . . 74.32 109.774 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 tt -143.71 149.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.857 -1.164 . . . . 75.33 107.857 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.08 123.94 34.15 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.293 -0.723 . . . . 73.31 111.293 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -55.22 -34.01 63.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.825 0.85 . . . . 71.54 112.499 -177.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -66.39 -43.13 86.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.963 0.905 . . . . 75.21 110.196 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.717 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -63.24 -35.62 80.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.312 -0.858 . . . . 74.31 110.189 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.46 -12.43 57.84 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 72.11 112.143 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -95.63 -40.74 9.26 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.356 0.662 . . . . 71.54 111.065 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.18 49.62 0.28 Allowed Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.126 -0.488 . . . . 74.32 112.588 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 144' ' ' ALA . . . -158.22 -179.77 8.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.696 0.798 . . . . 71.55 109.91 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.7 155.35 48.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.102 0.561 . . . . 71.35 111.055 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 67.61 20.38 9.65 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.078 1.351 . . . . 65.43 113.315 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.72 144.73 33.87 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.118 0.261 . . . . 72.5 112.868 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -69.93 139.55 52.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.767 0.827 . . . . 65.15 112.302 -168.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.54 HG21 ' HE1' ' A' ' 79' ' ' MET . 31.7 t -88.51 94.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.578 -0.737 . . . . 75.12 109.544 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.406 ' HA ' HD22 ' A' ' 171' ' ' LEU . . . -67.15 104.24 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.158 -0.928 . . . . 75.41 108.588 169.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.568 HG23 ' HD1' ' A' ' 138' ' ' PHE . 1.1 pt -95.12 113.68 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.421 0.629 . . . . 64.0 109.919 -168.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 169' ' ' LEU . 50.8 mm -107.09 133.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.8 -1.091 . . . . 72.34 110.207 -170.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 45.7 mt-10 -94.41 142.26 27.63 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.861 -0.792 . . . . 62.33 108.861 166.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -119.92 87.15 2.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.004 -1.85 . . . . 70.14 106.004 155.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 17.9 ttt180 -95.32 170.2 9.54 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 113.9 -1.5 . . . . 74.42 109.06 -171.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -98.12 124.97 42.93 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.552 1.069 . . . . 75.11 111.956 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.88 105.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.611 1.164 . . . . 75.13 108.466 167.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.4 t70 63.68 5.52 2.25 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.729 1.212 . . . . 75.5 112.695 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.35 -18.16 8.88 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.449 -0.639 . . . . 74.53 114.077 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 t -101.11 167.33 10.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 117.789 0.794 . . . . 71.45 109.609 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 1.2 pm0 -94.72 126.79 40.26 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.99 0.516 . . . . 74.53 112.105 -172.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 t -78.79 107.54 6.18 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 72.35 108.979 166.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.0 Cg_endo -87.97 112.5 0.77 Allowed 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 122.712 2.275 . . . . 65.3 109.988 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.3 m -126.31 118.21 24.61 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.811 0.444 . . . . 74.54 111.037 -174.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 156' ' ' ILE . 53.0 tp -78.92 134.28 36.88 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.109 -0.7 . . . . 71.43 109.109 166.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' MET . . . . . 0.512 ' HB2' HG13 ' A' ' 155' ' ' ILE . 65.7 mtt -124.37 138.44 54.37 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.885 -1.154 . . . . 74.12 107.885 165.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 176' ' ' ILE . 53.5 mt -152.16 150.85 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.098 1.759 . . . . 73.42 106.789 169.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.8 p -78.76 149.1 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.599 -0.889 . . . . 73.54 108.599 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -63.6 -31.58 72.79 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.321 0.649 . . . . 75.11 110.214 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 103' ' ' MET . 67.6 mm-40 -76.97 -3.37 38.54 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.504 0.928 . . . . 73.31 113.504 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.72 -25.13 14.78 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.965 0.506 . . . . 55.04 110.065 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.454 HD12 HD11 ' A' ' 171' ' ' LEU . 48.3 mm -106.52 125.28 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.422 0.689 . . . . 65.43 110.866 -170.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.0 mm -110.22 109.36 28.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.59 -1.263 . . . . 74.33 107.59 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.61 111.5 19.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.068 -0.969 . . . . 70.41 108.657 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.6 ' HB3' HG22 ' A' ' 3' ' ' ILE . 8.8 tp10 -95.11 130.44 41.81 Favored 'General case' 0 C--O 1.248 0.98 0 N-CA-C 109.394 -0.595 . . . . 71.41 109.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -71.87 108.58 5.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.141 -0.936 . . . . 74.22 109.797 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.9 t -94.32 89.82 6.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.465 0.706 . . . . 75.12 110.011 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.86 -61.18 1.46 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.022 0.929 . . . . 54.45 109.267 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 123.846 0.858 . . . . 74.33 109.597 -178.818 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.633 ' SD ' ' HA ' ' A' ' 16' ' ' ASP . 45.2 tpp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.438 -0.579 . . . . 74.44 109.438 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 18' ' ' PHE . 79.3 mt -118.47 152.96 34.93 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.689 -0.856 . . . . 74.11 108.689 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.0 pt -131.99 121.08 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 108.563 -0.903 . . . . 75.54 108.563 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 23.1 p90 -122.15 135.58 54.8 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 121.58 -0.7 . . . . 74.24 109.946 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 46.4 mtpt -137.72 135.09 36.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.839 -1.528 . . . . 71.3 109.448 -159.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.94 144.32 36.92 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.298 -0.631 . . . . 63.54 109.298 173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.23 -26.42 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 113.475 0.917 . . . . 74.12 113.475 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -96.72 -67.85 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 114.238 1.199 . . . . 74.2 114.238 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -130.38 -22.45 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.462 0.912 . . . . 74.52 113.462 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.57 23.15 13.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.458 1.103 . . . . 60.52 109.74 -169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.26 -15.29 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.574 1.55 . . . . 74.44 114.286 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -76.24 -40.45 51.99 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 121.55 -0.718 . . . . 75.34 111.78 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 37.4 mt 21.18 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 126.455 1.902 . . . . 73.05 113.813 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.5 m -152.14 123.03 7.5 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.782 0.289 . . . . 72.42 111.782 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.6 m -113.01 94.66 5.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.595 1.158 . . . . 73.22 110.538 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.633 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 26.7 t70 -168.97 166.17 11.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.95 0.9 . . . . 71.23 109.668 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -70.32 78.43 0.54 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.527 0.731 . . . . 74.34 110.334 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 32.1 m-85 -104.21 146.7 33.06 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 124.784 1.233 . . . . 73.23 110.673 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.38 118.9 5.91 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.52 2.147 . . . . 73.34 112.603 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.7 ptm -113.4 145.68 40.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.342 0.657 . . . . 75.13 109.927 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.557 ' HB2' ' HZ1' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -151.47 137.64 18.35 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.235 -0.654 . . . . 75.23 109.235 174.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.53 148.53 24.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.386 1.074 . . . . 75.44 108.232 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.11 134.25 47.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 C-N-CA 124.074 0.95 . . . . 71.13 109.375 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 59.51 16.47 5.29 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.945 1.298 . . . . 64.42 112.53 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 54.61 32.73 17.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.509 1.523 . . . . 74.34 112.542 -174.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 119' ' ' LYS . 55.2 tp -132.23 -50.97 0.94 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.226 0.61 . . . . 74.02 111.033 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.39 141.92 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.319 0.648 . . . . 71.34 109.819 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.69 113.24 24.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.586 -0.894 . . . . 72.12 108.586 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HG3' ' HB3' ' A' ' 21' ' ' LYS . 6.0 pt-20 -82.88 104.08 12.83 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.007 -1.479 . . . . 61.34 107.007 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.0 t80 -88.88 112.67 23.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.94 -1.504 . . . . 73.42 106.94 177.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.484 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 2.2 mmmp? -67.2 148.88 51.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.912 0.885 . . . . 72.33 110.969 -171.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 157.78 27.51 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.496 0.497 . . . . 72.43 113.575 -174.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -121.26 140.23 52.34 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.311 -0.996 . . . . 73.11 108.311 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -74.33 116.78 15.39 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.001 -1.481 . . . . 74.45 107.001 167.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.48 HG22 HD12 ' A' ' 72' ' ' LEU . 34.4 m -131.08 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 124.545 1.138 . . . . 75.42 108.398 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 m -125.86 153.93 34.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.814 0.846 . . . . 75.33 109.655 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.503 ' HB2' HD11 ' A' ' 72' ' ' LEU . 12.9 ttp180 -141.53 110.26 6.1 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.071 0.462 . . . . 74.55 110.945 170.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -133.94 137.99 45.2 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 107.585 -1.265 . . . . 75.42 107.585 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -9.89 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.039 0.755 . . . . 65.3 113.039 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.83 -38.65 2.15 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.303 -0.319 . . . . 60.43 112.303 170.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -121.27 138.3 54.3 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.179 0.592 . . . . 74.13 112.321 -167.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.488 1.474 0 C-N-CA 123.927 0.891 . . . . 63.54 110.405 177.036 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 107.233 -1.395 . . . . 64.34 107.233 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . 0.252 2.1 pt-20 68.7 -45.85 0.54 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.694 2.398 . . . . 74.52 113.528 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -134.15 146.35 50.12 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 108.398 -0.964 . . . . 73.42 108.398 -173.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.57 44.65 Favored Glycine 0 N--CA 1.447 -0.58 0 O-C-N 123.604 0.565 . . . . 72.45 112.259 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 70' ' ' ILE . 1.8 tt -94.82 130.1 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.219 -1.03 . . . . 73.01 108.219 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -47.97 -40.67 23.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.753 1.621 . . . . 71.23 113.416 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 68' ' ' ILE . 62.4 mt -55.36 -47.88 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.741 1.216 . . . . 75.24 110.666 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.1 -48.63 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.405 0.682 . . . . 75.11 111.713 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 37' ' ' ARG . 63.0 mt -60.83 -33.91 73.75 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.094 0.871 . . . . 74.51 111.092 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -79.35 -48.65 13.68 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.169 0.987 . . . . 75.43 111.16 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -87.15 1.78 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.91 0.484 . . . . 75.03 111.612 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 70.5 mmtt 64.38 34.86 10.11 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.833 1.253 . . . . 74.35 111.165 173.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.51 132.71 40.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.205 -0.665 . . . . 71.03 109.205 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 p -84.64 133.46 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 N-CA-C 109.883 -0.414 . . . . 72.43 109.883 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.79 140.34 45.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.157 1.383 . . . . 73.01 112.677 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -148.06 131.55 16.72 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.505 -0.924 . . . . 71.43 108.505 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 45.2 m-80 -88.0 137.57 32.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.816 0.446 . . . . 71.2 110.491 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 133' ' ' PHE . 9.1 p -57.74 -30.75 65.83 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.501 1.521 . . . . 74.43 111.204 172.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.433 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 47.1 m-85 -59.51 -34.58 72.8 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.673 -1.603 . . . . 73.24 110.832 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.46 -18.59 14.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.752 0.821 . . . . 75.13 111.829 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.69 14.98 20.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.261 0.624 . . . . 72.24 112.143 -169.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.89 -53.96 50.86 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.563 0.62 . . . . 75.52 112.213 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.7 t -70.5 -36.54 73.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.345 0.658 . . . . 65.31 110.745 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.0 mmm -62.39 -38.39 89.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.273 0.629 . . . . 73.43 110.846 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.412 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 76.4 t80 -78.95 -25.45 43.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.707 0.803 . . . . 72.32 110.627 -176.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -62.94 -41.79 99.6 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.951 -0.759 . . . . 75.03 108.951 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.4 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 74.32 111.05 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 23.2 m-85 -61.37 -37.98 85.34 Favored 'General case' 0 C--N 1.364 1.205 0 CA-C-O 119.506 -0.283 . . . . 74.43 110.48 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.766 HG21 HD12 ' A' ' 128' ' ' LEU . 14.8 mm -66.47 -41.67 89.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 124.061 0.851 . . . . 74.14 111.876 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -61.88 -38.4 88.16 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.89 0.768 . . . . 75.33 110.204 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.82 -45.22 68.35 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.457 -0.792 . . . . 72.23 110.431 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . 84.6 t80 -55.76 -57.31 12.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.738 1.615 . . . . 70.31 111.621 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.2 ptm -63.97 -31.64 72.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.493 0.717 . . . . 70.52 110.693 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -61.5 -58.55 7.72 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.867 -0.42 . . . . 73.13 109.867 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.5 -27.38 62.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.336 -0.847 . . . . 74.04 112.223 -168.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 174' ' ' GLU . 22.5 m -75.2 -38.46 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 117.697 0.226 . . . . 72.21 111.326 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.577 ' HA ' ' HE1' ' A' ' 103' ' ' MET . 55.4 mt -69.31 -38.05 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 110.324 -0.25 . . . . 73.54 110.324 176.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 -46.4 88.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.017 0.527 . . . . 74.44 110.685 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.518 ' HD1' ' HG3' ' A' ' 174' ' ' GLU . 49.3 t-80 -53.23 -56.01 19.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.129 0.971 . . . . 75.2 111.057 -176.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.577 ' HE1' ' HA ' ' A' ' 100' ' ' ILE . 19.4 ptt? -64.63 -45.49 86.61 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.086 0.866 . . . . 74.02 111.346 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.142 0.977 . . . . 75.55 111.529 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -62.8 -27.1 69.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.993 0.917 . . . . 74.05 113.177 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -116.26 -6.91 11.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.139 0.422 . . . . 72.02 112.139 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.83 -64.67 1.04 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.52 -0.919 . . . . 72.42 108.52 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 74.35 -26.99 0.19 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.09 1.356 . . . . 74.21 112.166 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.65 125.8 29.87 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.658 0.783 . . . . 64.23 109.747 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.94 -23.31 66.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.521 1.128 . . . . 74.32 111.248 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.18 73.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.961 0.904 . . . . 64.42 111.483 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.48 -48.69 6.01 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.584 0.754 . . . . 62.34 110.031 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.9 -34.08 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 113.19 0.811 . . . . 72.34 113.19 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.21 -38.98 89.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 118.702 0.683 . . . . 74.22 110.254 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.98 -45.49 73.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.016 -0.993 . . . . 75.55 110.786 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.36 -42.03 96.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.74 0.416 . . . . 73.24 110.291 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.78 -38.58 75.71 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.727 0.811 . . . . 63.33 110.824 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -68.36 -43.07 78.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.411 0.685 . . . . 74.44 110.52 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.413 ' HB3' HD22 ' A' ' 26' ' ' LEU . 70.3 mmtt -60.12 -55.85 28.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.73 0.812 . . . . 75.13 111.134 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.49 HD13 HG22 ' A' ' 172' ' ' VAL . 10.5 tp -66.97 -31.18 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.488 0.715 . . . . 73.42 110.232 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.62 -62.76 1.47 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 123.041 0.536 . . . . 74.41 110.123 168.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.77 -27.45 66.6 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.606 0.567 . . . . 52.02 113.77 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -73.88 -45.17 52.55 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.152 0.581 . . . . 75.24 111.009 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.67 -25.34 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 122.989 0.181 . . . . 73.14 110.892 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.08 -27.58 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.879 -0.513 . . . . 74.41 109.803 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -76.68 -50.97 12.4 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.367 0.667 . . . . 70.43 110.375 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.503 HD23 HG23 ' A' ' 155' ' ' ILE . 36.8 tp -75.15 -33.02 61.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.296 1.039 . . . . 64.51 112.766 -166.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.766 HD12 HG21 ' A' ' 92' ' ' ILE . 95.9 mt -79.07 2.89 19.08 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.86 0.689 . . . . 70.24 112.86 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.55 143.11 48.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.254 -1.017 . . . . 73.32 108.254 170.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 25.8 pttm -57.75 -27.36 62.95 Favored 'General case' 0 C--O 1.212 -0.87 0 O-C-N 124.1 0.875 . . . . 74.31 111.89 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -46.1 87.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.229 1.412 . . . . 72.41 110.59 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.461 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 1.5 mpp_? -67.85 -44.33 77.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.596 -1.183 . . . . 75.45 110.115 175.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.492 ' O ' ' SG ' ' A' ' 81' ' ' CYS . 7.2 m-85 -61.53 -25.76 67.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.831 0.853 . . . . 73.33 113.029 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 25.2 mtpp -64.88 -20.43 66.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.859 0.464 . . . . 74.51 111.382 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -132.57 17.09 4.36 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.375 0.67 . . . . 74.44 112.154 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 44.1 mt -93.07 139.38 30.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.277 0.489 . . . . 73.23 110.272 172.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -122.16 123.38 41.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.69 -1.226 . . . . 62.23 107.69 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -95.38 128.75 42.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.218 0.532 . . . . 75.42 109.684 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -130.65 151.86 50.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.19 -1.041 . . . . 73.2 108.19 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.3 pt -134.0 167.94 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 108.324 -0.991 . . . . 73.55 108.324 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.81 144.65 48.2 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.761 -0.536 . . . . 53.45 111.761 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 36.7 tt0 -52.9 -42.71 65.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.113 0.565 . . . . 74.24 110.735 173.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.678 HH11 ' HB2' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -60.76 -42.62 97.81 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.309 1.444 . . . . 75.3 110.319 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.677 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . . . -56.09 -51.68 67.02 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.951 0.9 . . . . 75.43 111.59 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.86 -29.16 61.96 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.455 -0.793 . . . . 73.04 112.4 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -74.26 -41.74 60.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.553 . . . . 72.13 110.856 -171.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.23 62.63 0.08 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.15 -0.78 . . . . 71.35 111.15 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.678 ' HB2' HH11 ' A' ' 143' ' ' ARG . . . -157.59 175.6 13.72 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.155 0.582 . . . . 73.32 110.865 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.82 170.56 13.38 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.896 0.878 . . . . 73.33 113.16 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -86.09 67.19 9.9 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.722 1.209 . . . . 74.31 108.003 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.09 -112.0 0.01 OUTLIER Glycine 0 CA--C 1.54 1.625 0 CA-C-N 113.229 -1.805 . . . . 75.44 114.39 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.38 155.99 17.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.202 0.601 . . . . 73.52 109.558 169.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 85.4 t -103.01 126.55 57.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.817 -0.808 . . . . 75.44 108.817 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.09 103.84 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.127 0.971 . . . . 73.12 109.113 170.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.503 HG23 HD23 ' A' ' 127' ' ' LEU . 63.2 mt -90.68 110.6 22.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.171 -0.677 . . . . 75.04 109.171 -171.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.4 HD13 HD12 ' A' ' 68' ' ' ILE . 51.2 mm -96.91 98.96 8.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.215 0.531 . . . . 74.42 110.001 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.43 96.51 5.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.894 -1.15 . . . . 74.31 107.894 169.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 45.0 p90 -107.02 129.12 54.85 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.411 -0.588 . . . . 73.4 109.411 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.16 -177.36 6.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.473 1.109 . . . . 72.41 109.09 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.19 137.52 54.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.43 0.292 . . . . 72.11 110.28 171.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.7 p -111.03 111.95 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 N-CA-C 108.22 -1.029 . . . . 72.42 108.22 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 63.49 17.43 10.34 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.828 1.251 . . . . 73.34 112.367 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.18 -19.03 30.22 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.113 -0.271 . . . . 65.23 112.719 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.4 m -82.28 106.94 14.57 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.3 0.55 . . . . 72.01 109.537 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -71.97 101.61 2.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 74.22 109.922 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.7 m -105.6 101.19 30.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 113.627 -1.624 . . . . 74.43 109.348 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.597 ' HB2' HD13 ' A' ' 68' ' ' ILE . 92.0 Cg_endo -92.15 118.36 0.45 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.95 2.433 . . . . 75.23 111.703 172.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 28.1 m -114.43 135.53 54.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.129 0.972 . . . . 74.11 109.565 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 38.6 tp -79.61 146.24 32.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.803 -0.814 . . . . 74.31 108.803 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.0 ptp -141.05 132.5 26.86 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.428 0.632 . . . . 65.21 109.635 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 154' ' ' ALA . 94.8 mt -139.14 149.83 44.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.482 1.913 . . . . 74.34 107.032 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.49 HG22 HD13 ' A' ' 120' ' ' ILE . 6.2 p -83.14 146.54 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.476 -0.935 . . . . 72.31 108.476 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.595 ' HB3' ' HZ2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -52.14 -25.42 8.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.754 1.621 . . . . 75.21 112.585 -177.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . 2.0 tp10 -89.22 -27.07 20.87 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.085 0.954 . . . . 64.4 112.583 -172.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.37 -6.51 37.4 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.949 0.5 . . . . 71.14 110.77 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 172' ' ' VAL . 10.5 tp -118.12 151.4 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.053 0.941 . . . . 73.34 108.72 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 47.3 mm -124.55 107.97 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.1 -1.444 . . . . 74.42 107.1 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 140.59 46.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.675 -0.491 . . . . 75.21 109.675 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.88 124.82 13.49 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.294 -1.002 . . . . 71.45 108.294 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.49 ' HG2' HD23 ' A' ' 182' ' ' LEU . 36.2 ttpt -80.72 103.99 10.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.405 0.682 . . . . 75.44 109.602 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.31 90.0 8.14 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.395 0.678 . . . . 74.32 109.457 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.49 HD23 ' HG2' ' A' ' 180' ' ' LYS . 2.6 pt? -118.9 175.07 5.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.443 0.697 . . . . 73.52 109.855 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.562 1.409 0 C-N-CA 123.546 0.738 . . . . 73.24 110.078 -179.049 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 63.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 110.204 -0.295 . . . . 70.11 110.204 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mt -104.43 137.76 41.82 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.444 0.698 . . . . 72.43 109.882 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.428 HG22 ' HB2' ' A' ' 15' ' ' SER . 21.1 pt -121.43 122.23 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 109.498 -0.556 . . . . 74.42 109.498 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.731 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 18.6 p90 -124.3 114.88 20.15 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.85 0.86 . . . . 73.41 110.061 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 169.14 14.37 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.836 0.854 . . . . 73.31 110.438 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -114.67 175.34 5.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.425 0.69 . . . . 71.33 109.432 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.28 -28.33 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 112.918 0.71 . . . . 70.02 112.918 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.58 -59.88 1.89 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.488 0.715 . . . . 74.21 110.295 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -84.41 19.8 1.83 Allowed 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.147 -0.933 . . . . 75.32 110.8 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -45.35 -35.87 3.84 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.194 2.197 . . . . 61.33 114.012 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.07 -9.76 42.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.338 0.655 . . . . 71.41 112.375 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -121.17 16.5 11.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.668 0.787 . . . . 72.42 111.287 -172.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.403 ' HB3' ' H ' ' A' ' 14' ' ' SER . 4.6 mm? -105.27 -164.54 1.04 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 75.3 108.468 177.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 13' ' ' LEU . 32.5 t -151.64 152.28 32.62 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.212 0.529 . . . . 71.24 111.712 -168.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.428 ' HB2' HG22 ' A' ' 3' ' ' ILE . 59.9 p -137.18 101.39 4.53 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.08 0.952 . . . . 72.14 109.124 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.2 t70 -157.37 -84.11 0.05 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.782 0.433 . . . . 75.21 110.273 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 m 177.69 86.77 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.264 1.826 . . . . 71.32 107.383 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.08 148.19 64.83 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.028 -0.987 . . . . 71.13 108.341 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.86 118.46 5.63 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.87 1.713 . . . . 74.12 112.559 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.731 ' SD ' ' HB3' ' A' ' 4' ' ' TYR . 58.4 mtm -114.34 144.66 42.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.746 0.818 . . . . 72.53 109.353 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -131.32 156.56 45.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.933 . . . . 73.34 108.896 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.541 HD11 ' HD3' ' A' ' 173' ' ' LYS . 28.3 tp -127.97 139.57 52.49 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.472 -0.936 . . . . 72.34 108.472 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.84 145.56 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 C-N-CA 123.213 0.605 . . . . 65.24 109.721 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 67.72 2.51 3.05 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.579 1.152 . . . . 72.2 112.356 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 55.49 29.08 12.67 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.112 0.965 . . . . 73.53 110.827 -167.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 119' ' ' LYS . 49.8 tp -134.45 -51.32 0.81 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.543 0.687 . . . . 74.25 110.483 -175.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.2 t -107.23 127.18 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.728 -1.123 . . . . 72.24 109.834 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -83.02 134.09 35.06 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.405 -0.961 . . . . 75.2 108.405 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.4 tt0 -130.17 104.7 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.076 -0.965 . . . . 74.55 109.056 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.6 t80 -90.59 124.36 34.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.099 -0.704 . . . . 73.32 109.099 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -80.15 138.59 36.92 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.745 -0.465 . . . . 75.41 109.745 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.99 151.5 20.05 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.517 -0.633 . . . . 55.25 111.517 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -93.58 150.25 20.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.191 0.596 . . . . 73.35 110.265 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -83.16 106.04 14.63 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.115 -1.069 . . . . 74.41 108.115 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.417 HG23 HD11 ' A' ' 72' ' ' LEU . 16.8 m -141.83 162.89 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.508 0.723 . . . . 71.43 109.583 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.419 HG21 HD13 ' A' ' 42' ' ' ILE . 11.4 m -127.04 151.31 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.946 -0.39 . . . . 60.34 109.946 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.6 107.59 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.352 -1.351 . . . . 74.44 107.352 160.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -123.64 95.02 4.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.525 -1.287 . . . . 73.51 107.525 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 49.2 -77.33 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 126.392 1.877 . . . . 64.42 113.161 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.8 45.71 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.779 -0.928 . . . . 72.3 110.779 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.74 137.23 16.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.294 1.038 . . . . 71.31 110.15 -173.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 36' ' ' VAL . 5.9 tp . . . . . 0 CA--C 1.56 1.354 0 C-N-CA 123.948 0.899 . . . . 74.33 110.062 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 108.266 -1.013 . . . . 74.31 108.266 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.51 67.91 10.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.611 -1.255 . . . . 72.44 107.611 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -91.88 157.01 17.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.853 -1.067 . . . . 74.22 112.089 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.3 -124.48 1.95 Allowed Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.151 -0.477 . . . . 64.41 112.336 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 12.6 pt -112.47 154.68 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.344 0.658 . . . . 75.43 111.153 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -53.83 -42.05 68.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.745 1.218 . . . . 73.33 112.7 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.6 mt -58.27 -45.99 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.711 1.204 . . . . 72.01 110.106 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 76' ' ' LEU . 75.8 t -72.63 -49.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 114.239 -1.346 . . . . 64.53 112.093 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 57.2 mt -67.94 -33.18 74.18 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.661 0.601 . . . . 71.24 112.404 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.56 -29.55 70.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.613 0.571 . . . . 74.32 111.304 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -115.52 -19.74 10.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.696 0.998 . . . . 73.25 113.696 -170.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HB2' ' HZ2' ' A' ' 75' ' ' LYS . 8.0 mtmp? 68.56 59.85 0.39 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.887 0.875 . . . . 71.31 109.195 -170.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.439 ' HB2' HG13 ' A' ' 71' ' ' VAL . 87.2 mt -77.42 125.5 29.43 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 107.506 -1.294 . . . . 74.53 107.506 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.34 124.85 39.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 109.114 -0.698 . . . . 73.04 109.114 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.11 158.9 33.95 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 122.0 0.905 . . . . 55.03 112.48 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.55 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 3.2 tpt -147.38 112.17 5.38 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 105.744 -1.947 . . . . 71.02 105.744 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 15.6 m120 -100.42 128.3 46.52 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.192 0.597 . . . . 55.33 110.139 -171.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.98 -12.85 12.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.804 1.641 . . . . 72.53 113.054 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.427 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 69.1 m-85 -73.88 -38.07 64.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.048 1.339 . . . . 71.23 111.085 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.04 -38.15 6.4 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.414 0.686 . . . . 75.42 112.614 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.55 ' HB3' ' HE2' ' A' ' 79' ' ' MET . 44.0 p30 -66.96 -3.13 6.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.025 1.861 . . . . 64.21 116.025 -159.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -30.12 -63.77 0.13 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.843 1.657 . . . . 63.15 114.815 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.8 m -64.33 -42.76 96.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.903 0.481 . . . . 75.25 111.693 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 85.2 mmm -71.67 -50.93 26.01 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.474 0.484 . . . . 74.31 111.907 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HE2' HD22 ' A' ' 128' ' ' LEU . 58.2 t80 -65.71 -40.0 91.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.599 0.76 . . . . 75.22 111.527 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.28 -35.13 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.78 0.432 . . . . 74.44 110.542 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 94' ' ' LYS . . . -64.26 -42.7 96.35 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 123.296 0.373 . . . . 64.3 110.184 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -67.92 -33.98 75.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.654 0.782 . . . . 75.44 112.033 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.25 -38.87 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.187 0.595 . . . . 62.51 110.641 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -41.3 98.54 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.112 -0.699 . . . . 72.43 109.112 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mmtt -61.97 -60.75 3.16 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.508 -0.923 . . . . 71.12 108.508 175.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -43.6 -60.85 1.59 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.132 1.773 . . . . 74.2 111.493 -177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 42.5 ttp -56.51 -60.64 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.134 0.974 . . . . 71.24 110.631 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -60.12 -41.62 93.01 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.422 0.451 . . . . 74.13 111.322 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -72.47 -39.8 67.46 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 119.124 -0.465 . . . . 52.02 111.63 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' A' ' 175' ' ' ALA . 22.2 m -70.71 -37.27 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 117.823 0.283 . . . . 75.44 111.375 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.89 -43.24 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.074 0.464 . . . . 75.21 109.797 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.05 -30.21 68.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.284 1.034 . . . . 73.34 111.335 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -62.53 -48.77 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.55 0.74 . . . . 75.22 109.463 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.408 ' HG3' ' HG3' ' A' ' 174' ' ' GLU . 16.1 mmt -78.28 -21.02 50.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.741 -0.663 . . . . 73.41 112.064 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.29 -30.29 62.02 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.773 -0.579 . . . . 75.33 109.868 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -75.01 -31.58 61.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.509 0.723 . . . . 73.51 110.71 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -99.12 -29.68 12.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.252 0.621 . . . . 72.54 112.613 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -103.18 -43.68 5.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 74.01 108.686 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 64.68 19.82 11.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.692 1.197 . . . . 75.32 112.433 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m-20 -94.85 103.74 15.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.301 -1.0 . . . . 75.23 108.301 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.25 -37.89 81.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.07 0.948 . . . . 74.54 111.827 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.29 74.61 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.416 0.686 . . . . 74.45 111.52 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 109' ' ' ASP . 3.6 t70 -75.42 -49.84 17.68 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.059 0.943 . . . . 75.42 110.712 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.94 -23.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.468 -0.787 . . . . 74.34 111.659 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.15 -35.45 61.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.873 0.469 . . . . 72.24 110.203 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 118' ' ' LYS . . . -69.64 -39.42 77.15 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.482 -0.562 . . . . 75.13 109.482 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -65.63 -38.54 89.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.181 0.993 . . . . 73.31 110.771 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.35 -33.86 73.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.237 1.015 . . . . 74.45 110.798 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 18.0 tppt? -64.92 -48.96 72.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.509 0.724 . . . . 74.31 110.32 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HB3' HD22 ' A' ' 26' ' ' LEU . 13.5 mptt -63.93 -40.12 95.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.415 0.286 . . . . 74.2 111.63 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 172' ' ' VAL . 17.6 mm -70.27 -48.26 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 118.994 -0.527 . . . . 74.54 111.095 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.24 -46.08 83.32 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.081 -0.711 . . . . 75.0 109.081 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.13 94.54 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.285 0.991 . . . . 71.31 113.292 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.3 -52.09 56.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 122.992 0.517 . . . . 74.45 109.861 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 25.8 m -70.85 -37.3 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 123.644 0.59 . . . . 75.13 111.727 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.89 -32.83 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.81 0.732 . . . . 73.31 109.784 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -74.98 -40.96 60.43 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.875 -0.602 . . . . 64.2 111.497 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.3 tp -78.87 -19.35 52.15 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.305 1.042 . . . . 73.42 112.307 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 47.4 mt -93.64 2.65 56.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.271 0.628 . . . . 75.31 111.49 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.3 91.15 2.16 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.746 0.418 . . . . 53.31 109.933 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -63.16 -6.72 4.56 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.745 1.218 . . . . 75.2 113.778 -170.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.26 -41.68 76.2 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.14 0.576 . . . . 74.44 110.194 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -108.74 -48.44 3.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.969 1.308 . . . . 74.33 110.558 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -81.37 -1.12 44.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.268 1.427 . . . . 73.24 114.491 -164.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -57.19 -16.89 9.07 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.053 0.541 . . . . 74.52 111.237 165.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.98 15.31 10.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.246 1.018 . . . . 75.33 111.089 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.61 148.65 23.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.56 -0.904 . . . . 71.43 108.56 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.53 111.68 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.599 -1.63 . . . . 75.21 106.599 175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.448 ' HB3' HG11 ' A' ' 153' ' ' VAL . 46.1 m-85 -90.21 142.11 28.04 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.731 -0.84 . . . . 74.24 108.731 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -137.82 155.79 48.63 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.922 0.889 . . . . 73.41 108.735 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.38 143.2 20.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.011 -1.477 . . . . 72.34 107.011 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.46 134.89 49.97 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 118.992 -0.893 . . . . 63.41 113.073 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -55.25 -38.27 68.3 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.139 0.975 . . . . 73.45 111.355 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -65.63 -44.42 86.53 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.204 -0.907 . . . . 75.3 111.659 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.93 -21.42 51.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.049 0.54 . . . . 74.14 111.647 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.89 0.18 51.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.744 0.817 . . . . 61.23 110.942 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.04 -24.04 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.799 0.84 . . . . 71.44 110.62 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.48 47.77 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.748 -0.205 . . . . 30.31 113.361 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.75 78.32 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.06 0.544 . . . . 74.45 110.586 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.12 -3.43 32.76 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.505 0.722 . . . . 71.31 111.828 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.25 -18.64 55.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.574 0.75 . . . . 75.14 109.667 169.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.86 150.4 50.08 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 124.376 1.047 . . . . 64.44 113.373 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -96.16 155.5 16.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.479 0.711 . . . . 75.41 110.088 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 138' ' ' PHE . 53.3 t -88.13 129.34 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.565 0.746 . . . . 75.53 111.296 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.18 111.5 10.48 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.487 1.115 . . . . 75.41 109.33 170.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.4 mt -93.78 113.02 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.437 0.695 . . . . 74.13 109.398 -170.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 169' ' ' LEU . 45.7 mm -98.7 123.7 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.955 -0.465 . . . . 73.45 109.984 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.29 128.88 49.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.802 1.241 . . . . 74.02 108.889 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -81.21 114.5 20.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.814 -1.18 . . . . 75.12 107.814 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.574 ' HB3' HG12 ' A' ' 166' ' ' VAL . 18.2 tpp85 -88.68 141.25 28.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.459 0.704 . . . . 72.3 109.646 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -100.68 124.43 46.28 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.694 -0.484 . . . . 65.35 109.694 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.562 HG11 ' HB ' ' A' ' 164' ' ' THR . 3.1 p -125.77 90.67 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.056 0.942 . . . . 74.55 109.273 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 62.23 17.5 9.32 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.063 1.345 . . . . 71.35 113.31 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.23 -14.69 9.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 120.027 -0.318 . . . . 71.1 113.382 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.562 ' HB ' HG11 ' A' ' 161' ' ' VAL . 80.5 m -88.2 138.66 31.24 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.263 0.625 . . . . 74.41 110.112 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 112.16 24.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.513 0.725 . . . . 64.13 109.296 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 159' ' ' ARG . 2.6 p -119.75 104.02 45.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.46 1.104 . . . . 75.14 109.293 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.27 130.45 39.44 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.597 2.198 . . . . 71.25 112.574 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.1 p -137.02 131.07 32.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.048 0.539 . . . . 74.5 110.587 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 28.7 tp -76.43 137.96 40.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 64.52 109.477 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.8 ttm -123.95 122.25 37.45 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.67 -1.233 . . . . 75.24 107.67 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 34.5 mt -151.8 167.9 26.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.65 1.58 . . . . 72.43 106.76 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.443 HG21 HD11 ' A' ' 120' ' ' ILE . 12.3 p -88.35 139.92 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 118.593 0.633 . . . . 63.43 109.596 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.541 ' HD3' HD11 ' A' ' 22' ' ' LEU . 58.7 pttt -69.21 -24.1 63.99 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.943 0.497 . . . . 75.44 112.147 -173.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.408 ' HG3' ' HG3' ' A' ' 103' ' ' MET . 11.2 mp0 -64.87 -23.89 67.37 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.797 0.839 . . . . 63.32 112.045 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' A' ' 99' ' ' VAL . . . -96.82 -10.38 26.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.487 0.715 . . . . 61.41 111.358 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 42.5 mm -107.02 147.53 12.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.355 0.662 . . . . 71.23 109.555 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.71 108.2 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.13 -1.433 . . . . 72.41 107.13 170.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -109.49 117.93 35.27 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.601 -1.259 . . . . 71.32 107.601 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -144.66 135.6 24.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.592 -0.892 . . . . 75.34 108.592 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -124.44 109.01 12.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 74.44 109.164 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -96.64 91.89 5.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.786 0.834 . . . . 71.12 109.724 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.47 -46.92 4.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 74.34 109.828 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.617 -0.883 . . . . 74.01 108.617 -178.638 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.031 0.443 . . . . 71.43 110.087 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.6 mt -105.39 161.67 14.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.054 0.942 . . . . 73.51 108.755 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 62.0 mt -115.97 118.72 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.701 -0.852 . . . . 75.21 108.701 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -104.57 96.26 6.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.829 -0.804 . . . . 65.13 108.829 -174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 68.3 mttm -122.34 152.17 40.42 Favored 'General case' 0 C--O 1.21 -0.992 0 C-N-CA 123.859 0.864 . . . . 73.2 109.213 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.428 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 7.2 t70 -114.02 143.21 45.13 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 106.955 -1.498 . . . . 74.15 106.955 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -52.84 -20.6 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.823 1.045 . . . . 73.31 113.823 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -107.13 -42.49 4.86 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.189 0.996 . . . . 74.53 110.5 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 6' ' ' ASP . 33.2 p -104.93 18.43 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.816 0.847 . . . . 75.44 112.098 -172.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 8.7 p-10 -60.75 -11.92 9.03 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.511 1.524 . . . . 73.33 113.784 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.31 -58.26 4.83 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 125.133 1.521 . . . . 54.52 110.53 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -122.91 -38.17 2.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.416 -0.811 . . . . 64.44 111.473 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.7 tp 5.54 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.885 2.074 . . . . 74.13 114.203 -163.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.49 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 70.6 m -156.95 146.0 20.16 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.95 0.5 . . . . 54.13 110.779 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 p -148.6 103.64 3.42 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 118.833 0.742 . . . . 74.31 110.957 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -168.28 176.34 5.98 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.343 1.457 . . . . 64.5 108.196 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -72.83 75.37 1.15 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.185 0.517 . . . . 72.11 110.116 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 14' ' ' SER . 64.2 m-85 -87.32 147.28 41.84 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.722 0.809 . . . . 74.4 110.769 -177.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.15 117.7 2.71 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.716 2.278 . . . . 75.44 112.737 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.588 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 60.6 ttp -119.35 114.43 22.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.605 1.162 . . . . 74.22 109.399 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.34 136.61 33.36 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.779 -1.193 . . . . 73.44 107.779 171.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.401 HD21 ' HA ' ' A' ' 25' ' ' ASP . 59.9 tp -113.15 142.54 45.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.132 -1.062 . . . . 64.32 108.132 174.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.25 130.76 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.148 -0.686 . . . . 73.33 109.148 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.99 12.74 4.1 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.902 1.281 . . . . 74.12 112.811 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' HA ' HD21 ' A' ' 22' ' ' LEU . 8.6 m-20 53.37 12.11 0.32 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.638 1.175 . . . . 72.03 113.418 -167.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.689 HD23 ' HG3' ' A' ' 119' ' ' LYS . 45.5 tp -107.08 -45.59 4.11 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.774 0.83 . . . . 74.25 110.027 -171.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 t -120.3 131.38 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.473 -0.785 . . . . 74.01 109.446 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.588 ' HE1' ' HG3' ' A' ' 20' ' ' MET . 82.0 t80 -98.07 126.7 43.62 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.897 -1.149 . . . . 73.53 107.897 171.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 154.6 30.8 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.415 0.626 . . . . 73.01 110.811 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 50.7 t80 -136.42 129.92 31.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.268 1.427 . . . . 74.33 108.655 -171.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -78.98 153.71 30.12 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.154 0.502 . . . . 74.13 110.976 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.37 172.58 39.36 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.312 -0.858 . . . . 73.31 111.004 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 47.4 mtmt -128.28 154.29 46.05 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.569 -0.901 . . . . 74.2 108.569 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 6.4 p-80 -73.98 130.15 39.28 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.5 -1.296 . . . . 75.32 107.5 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.591 ' HB ' HD13 ' A' ' 42' ' ' ILE . 15.9 m -139.73 149.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.54 0.736 . . . . 75.21 109.305 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.504 ' HB ' ' HG2' ' A' ' 66' ' ' ARG . 7.4 m -123.3 120.32 59.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.299 -1.371 . . . . 73.53 107.299 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 59.3 ttt180 -138.53 117.43 12.41 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.531 -0.759 . . . . 75.43 108.96 -169.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -133.08 118.6 18.94 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.038 -0.727 . . . . 75.43 109.038 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 64.43 24.68 13.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.422 1.089 . . . . 75.24 112.028 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -27.07 18.74 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-O 120.019 -0.323 . . . . 74.45 113.008 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.23 123.17 24.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.231 0.612 . . . . 74.43 110.204 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.591 HD13 ' HB ' ' A' ' 35' ' ' VAL . 5.5 tp . . . . . 0 CA--C 1.547 0.851 0 C-N-CA 123.659 0.783 . . . . 75.11 109.897 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.241 0.622 0 N-CA-C 105.647 -1.983 . . . . 73.3 105.647 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.489 ' HA ' HD22 ' A' ' 72' ' ' LEU . 51.8 mt-10 -82.52 62.64 6.27 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.505 0.669 . . . . 75.34 111.324 -174.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.504 ' HG2' ' HB ' ' A' ' 36' ' ' VAL . 49.0 mtt180 -108.69 120.51 42.68 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.153 -1.055 . . . . 74.41 108.153 173.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.28 -136.08 4.6 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 109.703 -1.359 . . . . 70.11 109.703 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 24.2 pt -110.4 143.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 117.354 0.577 . . . . 75.55 110.5 173.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.96 -34.48 59.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.152 1.381 . . . . 72.51 112.223 -176.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.482 HG21 ' HB2' ' A' ' 169' ' ' LEU . 60.1 mt -56.46 -51.04 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.924 0.89 . . . . 75.34 110.637 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 76' ' ' LEU . 63.1 t -70.26 -49.32 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.887 -1.051 . . . . 73.45 111.518 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 65' ' ' GLU . 33.4 mt -63.28 -39.85 95.73 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.814 0.846 . . . . 74.14 111.069 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.96 -32.93 73.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.31 1.044 . . . . 75.02 111.579 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.16 -6.69 21.91 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.247 0.619 . . . . 73.21 112.44 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.98 61.54 3.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.906 1.283 . . . . 75.2 111.383 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.491 ' HB2' HG11 ' A' ' 71' ' ' VAL . 59.1 mt -93.95 132.05 38.79 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.371 -0.831 . . . . 73.21 109.945 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 p -79.4 136.88 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.445 0.698 . . . . 71.22 109.881 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.69 144.46 10.92 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.829 1.652 . . . . 74.35 113.58 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.7 mmm -147.95 104.18 3.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 106.346 -1.724 . . . . 74.42 106.346 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -93.01 136.58 33.14 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.9 -0.778 . . . . 74.32 108.9 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 85' ' ' ALA . 52.1 t -65.56 -14.22 60.62 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.618 0.767 . . . . 72.01 110.842 173.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -75.75 -47.62 25.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.941 . . . . 72.0 110.617 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.17 -33.2 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.137 -0.938 . . . . 73.13 110.703 -175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.49 22.44 12.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.632 1.173 . . . . 70.34 111.704 -166.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 81' ' ' CYS . . . -49.82 -56.41 10.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.453 0.701 . . . . 73.13 112.284 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.8 m -70.39 -33.68 71.67 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.397 -0.82 . . . . 75.13 111.018 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 42.5 tpp -66.08 -36.86 84.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.059 0.944 . . . . 74.34 110.55 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.522 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 64.1 t80 -72.85 -29.21 63.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.82 0.848 . . . . 74.13 110.576 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -40.91 98.92 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.398 -0.593 . . . . 75.54 109.398 170.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.84 93.97 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.922 -0.581 . . . . 61.2 110.695 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.522 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 58.1 m-85 -60.61 -52.64 64.3 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-O 118.777 -0.63 . . . . 74.1 110.797 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mm -58.47 -37.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.641 0.776 . . . . 73.24 111.56 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -65.17 -49.28 70.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.956 0.502 . . . . 74.44 111.42 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -47.12 83.44 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.612 -0.884 . . . . 74.03 108.612 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 152' ' ' GLN . 22.6 t80 -52.55 -56.61 14.03 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.888 2.075 . . . . 70.45 112.195 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.1 ttt -59.17 -50.81 72.6 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.985 0.803 . . . . 72.25 109.773 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -61.68 -36.05 79.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.672 -0.694 . . . . 65.43 111.338 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.11 -52.88 29.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.015 0.926 . . . . 74.0 111.525 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.93 -31.88 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.163 0.585 . . . . 74.05 112.563 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.15 -43.15 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.492 -0.559 . . . . 74.53 109.492 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.93 -38.83 87.17 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.912 0.885 . . . . 74.14 110.622 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -63.22 -50.88 68.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.206 1.002 . . . . 73.31 109.998 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ttt -63.52 -43.13 98.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.118 -0.946 . . . . 74.25 110.725 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -74.21 -23.01 59.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.845 0.858 . . . . 74.1 111.837 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.45 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 29.0 ttmt -70.5 -20.51 62.84 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.708 . . . . 74.43 109.783 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -112.83 1.21 15.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.469 1.108 . . . . 62.14 111.218 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.35 -68.97 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.005 0.522 . . . . 71.54 110.711 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.88 11.88 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.487 1.915 . . . . 74.01 115.079 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -83.51 -8.75 59.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.909 . . . . 73.03 110.581 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 80.01 -45.21 0.29 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.774 1.63 . . . . 75.42 113.974 169.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.01 71.77 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.477 0.58 . . . . 74.23 112.493 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.83 -44.79 22.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.378 0.671 . . . . 65.34 109.791 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.09 -23.53 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.299 -0.864 . . . . 74.24 111.242 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.64 -47.75 74.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.497 1.119 . . . . 73.22 110.172 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.31 95.36 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 124.098 0.874 . . . . 72.11 110.078 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.47 -45.21 80.45 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.259 0.974 . . . . 73.25 111.752 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.43 -45.88 84.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.341 0.656 . . . . 73.34 110.616 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -65.15 -39.55 93.14 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.255 -1.339 . . . . 72.22 110.47 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.689 ' HG3' HD23 ' A' ' 26' ' ' LEU . 14.0 tppt? -69.07 -49.58 56.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.598 0.759 . . . . 71.42 110.43 -173.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.444 ' HA ' HD21 ' A' ' 26' ' ' LEU . 8.5 tp -72.4 -37.75 58.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 123.374 0.669 . . . . 71.4 110.978 -174.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -66.86 -39.96 87.73 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.184 -0.673 . . . . 75.12 109.184 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.3 99.92 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.648 0.592 . . . . 65.21 112.414 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -66.04 -47.36 74.64 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.138 0.575 . . . . 70.43 110.203 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.488 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -69.7 -40.73 79.63 Favored 'Isoleucine or valine' 0 C--N 1.361 1.104 0 CA-C-O 118.476 -0.773 . . . . 71.44 111.565 -174.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.15 -33.22 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 119.495 1.043 . . . . 74.41 110.272 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -72.38 -34.06 67.66 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.9 0.88 . . . . 73.01 110.769 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 155' ' ' ILE . 28.7 tp -81.54 -26.28 35.19 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.361 1.064 . . . . 74.22 111.197 -174.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.0 mt -88.24 4.47 45.67 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.834 0.854 . . . . 74.13 111.461 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.55 85.84 0.3 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 123.632 0.773 . . . . 71.43 110.284 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -62.22 -6.83 3.41 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.194 1.398 . . . . 74.2 114.753 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.97 -47.07 84.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.028 0.931 . . . . 74.44 110.865 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . 0.465 ' H ' ' HD3' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -112.22 -31.77 6.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.625 1.17 . . . . 75.22 110.873 174.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.73 -1.93 36.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.017 0.927 . . . . 71.31 113.218 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -10.88 4.45 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.474 0.579 . . . . 71.01 112.311 171.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.5 21.71 4.43 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.098 0.959 . . . . 73.24 110.788 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.57 137.71 32.09 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.636 -0.505 . . . . 75.2 109.636 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -111.15 145.83 37.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.654 -1.61 . . . . 73.23 106.654 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.424 ' HB3' HG12 ' A' ' 153' ' ' VAL . 59.9 m-85 -125.32 141.11 52.27 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.296 -1.002 . . . . 74.41 108.296 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -149.32 147.98 28.99 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 124.165 0.986 . . . . 75.42 108.394 -175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.522 ' HB ' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -150.97 147.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.065 -1.087 . . . . 73.3 108.065 -177.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.78 139.04 42.66 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.385 -1.086 . . . . 72.31 110.385 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.65 -21.16 28.53 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.505 0.653 . . . . 75.21 109.978 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.75 -46.41 75.49 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.422 -0.955 . . . . 73.34 108.422 164.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.58 98.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.173 -1.376 . . . . 71.51 111.668 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.92 -46.38 52.96 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.262 0.625 . . . . 73.11 111.649 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.48 -41.32 93.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.188 0.595 . . . . 75.11 111.148 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -63.76 -58.45 11.04 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.245 -0.742 . . . . 55.43 111.245 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 176.63 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.389 1.076 . . . . 53.21 108.548 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -41.41 118.84 1.11 Allowed 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.917 0.887 . . . . 61.0 113.267 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -38.71 -41.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.258 1.423 . . . . 73.25 112.73 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.72 -34.8 4.59 Favored Glycine 0 CA--C 1.502 -0.773 0 CA-C-N 114.681 -1.145 . . . . 72.05 112.224 -175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.433 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 20.5 pm0 -98.1 156.59 16.59 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.702 -0.851 . . . . 71.02 108.702 173.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.522 HG13 ' HB ' ' A' ' 140' ' ' ILE . 24.9 t -109.24 143.96 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 107.123 -1.436 . . . . 75.31 107.123 171.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . 0.428 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -63.28 108.79 1.38 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.73 0.812 . . . . 73.33 109.657 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.62 HG21 HD21 ' A' ' 127' ' ' LEU . 58.9 mt -86.5 104.38 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.746 0.818 . . . . 75.11 109.337 -170.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 44.2 mm -89.51 100.11 10.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.451 -0.795 . . . . 74.2 110.048 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.35 95.14 7.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.939 -1.134 . . . . 62.21 107.939 170.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 36.9 p90 -85.56 109.32 18.45 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.627 -0.879 . . . . 73.43 108.627 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -100.43 -179.48 4.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.855 1.262 . . . . 72.51 108.747 -172.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -124.08 120.59 32.81 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.801 0.728 . . . . 75.34 110.408 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -90.08 89.49 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.393 -1.336 . . . . 74.14 107.393 170.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.56 33.78 20.4 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.624 -1.171 . . . . 64.5 111.926 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 111.54 -23.76 17.03 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.753 -0.471 . . . . 73.32 113.28 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.6 m -86.0 125.24 33.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.685 -0.857 . . . . 73.05 108.685 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 20.5 tt0 -72.08 121.96 20.13 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.433 0.56 . . . . 73.1 109.723 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.0 p -117.46 90.25 34.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.892 1.277 . . . . 75.11 109.037 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 98.4 Cg_exo -50.2 125.92 16.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.226 2.617 . . . . 74.25 112.473 167.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.0 m -123.82 115.06 20.72 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.904 -0.776 . . . . 74.52 108.904 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp -76.51 130.7 38.3 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.054 0.942 . . . . 72.35 108.909 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.2 ttp -128.14 123.0 33.35 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.06 0.944 . . . . 73.32 109.174 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' A' ' 154' ' ' ALA . 95.2 mt -139.11 157.58 45.72 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.341 1.456 . . . . 73.52 107.614 176.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.6 p -78.25 131.97 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.891 -0.781 . . . . 64.41 108.891 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -52.22 -28.77 19.77 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.637 1.575 . . . . 75.4 111.983 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -67.15 -34.95 78.65 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.243 1.017 . . . . 74.11 111.844 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.18 -13.43 15.43 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.224 0.61 . . . . 74.22 112.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 28' ' ' TYR . 11.0 tp -108.93 161.91 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.084 -1.45 . . . . 72.3 107.084 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 42.3 mm -135.79 132.26 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.092 0.957 . . . . 71.34 108.593 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.3 96.95 5.29 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.129 -1.063 . . . . 63.43 108.129 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 41.4 tt0 -99.19 102.07 13.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.482 -0.933 . . . . 71.42 108.482 -174.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.17 134.08 45.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.549 0.74 . . . . 75.15 110.546 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.7 t -117.76 96.15 5.25 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.239 -1.023 . . . . 65.31 108.239 173.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.07 153.62 42.95 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.312 0.645 . . . . 74.34 109.919 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.253 1.265 0 CA-C-N 115.456 -0.793 . . . . 71.11 108.988 177.258 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.598 0.713 . . . . 74.12 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.47 160.59 29.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.106 0.962 . . . . 73.12 108.431 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 28.1 mt -116.74 118.9 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.573 -1.269 . . . . 73.45 107.573 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -97.92 97.23 8.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.362 -0.977 . . . . 71.1 108.362 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -111.43 110.29 20.67 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.199 0.6 . . . . 75.22 109.679 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 9.8 t70 -83.85 135.93 34.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.643 -1.614 . . . . 73.32 106.643 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.7 pt -64.04 -17.87 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 118.542 0.61 . . . . 71.31 112.232 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -113.98 -52.07 2.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.383 1.073 . . . . 74.22 110.47 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -90.05 17.46 6.89 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.622 -1.172 . . . . 73.02 111.634 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 29.0 t70 -46.91 -43.84 19.24 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.034 1.333 . . . . 74.42 112.671 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.24 -19.3 65.78 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.117 -1.401 . . . . 71.31 111.906 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.571 ' HG3' ' HA3' ' A' ' 141' ' ' GLY . 6.9 mm-40 -120.8 12.5 11.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.808 1.243 . . . . 74.44 111.403 -174.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.96 -148.34 0.34 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.433 0.693 . . . . 73.42 109.794 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -150.07 160.14 43.87 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.435 0.562 . . . . 75.45 111.388 -163.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 60.0 p -124.38 -160.77 0.95 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.026 0.93 . . . . 73.24 109.573 165.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 74.11 -162.86 0.08 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.073 0.949 . . . . 74.25 110.905 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -96.98 58.01 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.549 0.69 . . . . 73.33 110.307 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.9 149.27 62.99 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 115.427 -0.806 . . . . 74.0 109.007 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 16.5 Cg_exo -68.02 117.6 5.03 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 121.684 1.589 . . . . 71.25 112.025 -176.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.457 ' SD ' ' CD1' ' A' ' 28' ' ' TYR . 12.6 tmm? -148.98 139.44 22.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.042 0.937 . . . . 74.31 109.69 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -139.45 158.28 44.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.269 1.028 . . . . 75.53 109.147 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.12 119.76 37.33 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.469 -0.938 . . . . 74.21 108.469 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.23 136.15 43.34 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 123.808 0.843 . . . . 74.21 108.93 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 65.51 8.3 4.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.269 1.028 . . . . 71.22 113.044 171.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 55.42 30.49 15.08 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.265 1.026 . . . . 65.14 111.626 -171.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.457 HD12 ' HB ' ' A' ' 120' ' ' ILE . 21.3 tp -132.93 -44.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.881 -0.6 . . . . 73.03 111.076 -172.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.08 140.6 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.967 0.507 . . . . 75.24 109.988 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.457 ' CD1' ' SD ' ' A' ' 20' ' ' MET . 30.2 m-85 -92.47 115.09 27.78 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 109.179 -0.675 . . . . 75.33 109.179 168.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.13 126.99 31.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.747 -1.205 . . . . 74.41 107.747 166.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.612 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.5 t80 -117.06 104.93 11.74 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.973 -1.491 . . . . 74.54 106.973 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 41.0 mmtm -79.48 143.38 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.377 0.671 . . . . 75.22 111.374 -175.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -139.77 -168.55 11.35 Favored Glycine 0 C--O 1.241 0.582 0 CA-C-N 114.677 -1.147 . . . . 74.45 110.51 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -118.97 150.85 39.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.36 0.664 . . . . 74.43 110.913 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -80.3 107.73 13.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.639 -1.245 . . . . 65.34 107.639 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.96 155.8 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.773 0.829 . . . . 74.42 109.159 -173.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.09 141.14 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.446 -0.576 . . . . 64.32 109.446 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.707 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -142.13 110.08 5.86 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.604 -1.258 . . . . 73.31 107.604 -178.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 15.6 tptm -89.23 161.66 16.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.942 0.897 . . . . 72.12 108.957 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -45.88 -38.62 7.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.64 0.978 . . . . 73.23 113.64 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.39 42.29 1.37 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.586 -0.279 . . . . 74.15 112.419 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 11.7 tp10 -164.52 142.51 6.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.55 . . . . 73.43 111.057 -176.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 tp . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.392 1.077 . . . . 70.03 108.507 172.659 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.516 -0.343 0 N-CA-C 104.179 -2.526 . . . . 63.44 104.179 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 77.0 -51.0 0.56 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 125.198 1.399 . . . . 75.22 113.339 157.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -139.15 158.37 44.29 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.552 0.741 . . . . 65.32 109.613 -164.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.4 -158.06 29.0 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 111.235 -0.746 . . . . 74.45 111.235 160.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 pt -110.14 147.3 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.375 0.67 . . . . 75.13 109.209 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.67 -26.84 68.85 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.885 0.874 . . . . 75.45 111.748 -174.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 169' ' ' LEU . 41.7 mm -54.01 -48.21 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.356 0.662 . . . . 54.4 110.205 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.5 t -80.71 -51.08 16.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.017 -0.992 . . . . 73.12 111.674 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.707 HD13 ' HB2' ' A' ' 37' ' ' ARG . 50.6 mt -64.49 -25.47 68.01 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.809 0.844 . . . . 71.31 112.353 -171.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -91.18 -43.68 9.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.571 0.748 . . . . 75.5 110.526 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 65.2 m80 -94.9 9.51 38.96 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.779 0.659 . . . . 73.21 112.779 -170.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? 64.02 33.77 11.93 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.991 0.807 . . . . 73.5 110.85 168.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 72.3 mt -78.5 120.74 23.64 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.543 -0.54 . . . . 71.52 109.543 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.18 136.37 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.697 0.799 . . . . 75.24 109.158 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.17 145.69 55.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.243 1.017 . . . . 75.14 113.194 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.9 mtt -133.06 102.9 5.78 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 105.211 -2.144 . . . . 75.11 105.211 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -68.45 125.4 26.36 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 108.892 -0.781 . . . . 72.23 108.892 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.6 -25.17 59.65 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.924 0.869 . . . . 74.41 111.071 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -70.01 -32.77 71.12 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 113.792 -1.549 . . . . 65.4 110.721 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -103.83 -39.72 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.347 0.659 . . . . 75.43 111.02 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.4 -11.89 39.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.063 0.945 . . . . 74.42 112.779 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -37.63 -51.85 1.21 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.391 1.626 . . . . 70.15 115.391 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.5 m -68.86 -45.14 71.83 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.074 0.464 . . . . 75.33 111.374 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 72.9 mtm -67.07 -27.99 67.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.177 -0.919 . . . . 74.54 110.432 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.461 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 81.0 t80 -70.79 -39.99 72.82 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.73 0.812 . . . . 74.44 110.78 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -66.13 -31.06 71.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.671 0.388 . . . . 75.42 110.657 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.7 82.63 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.945 -0.571 . . . . 74.24 110.257 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.461 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 19.4 m-85 -60.81 -41.69 96.2 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 109.669 -0.493 . . . . 73.32 109.669 173.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.73 -29.94 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.632 0.773 . . . . 73.32 110.625 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -62.79 -53.43 54.39 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.188 0.449 . . . . 74.54 111.381 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.11 -47.33 71.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.252 0.345 . . . . 62.42 110.389 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -45.74 -62.7 1.19 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.61 1.964 . . . . 75.25 112.054 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . 0.5 ' HE2' ' HE2' ' A' ' 97' ' ' LYS . 39.3 ttp -57.23 -47.99 79.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.583 1.153 . . . . 75.31 111.43 -175.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HE2' ' HE2' ' A' ' 96' ' ' MET . 72.8 mmtt -68.4 -35.7 78.05 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.783 -0.644 . . . . 74.12 111.896 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -47.31 63.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.525 0.73 . . . . 74.11 110.251 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 174' ' ' GLU . 19.6 m -71.53 -33.09 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.915 -0.584 . . . . 71.11 112.44 -173.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.26 -39.9 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.536 -0.542 . . . . 73.31 109.536 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.1 -46.62 75.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.023 0.929 . . . . 75.5 111.578 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.53 -43.98 92.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.501 0.72 . . . . 72.31 110.458 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.711 ' SD ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -62.81 -50.1 72.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.466 1.106 . . . . 74.21 112.604 -174.081 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.674 ' HA ' HG12 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -70.03 -32.72 71.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.435 0.294 . . . . 71.24 111.68 -172.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -58.47 -21.67 52.25 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.154 0.502 . . . . 72.12 111.596 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -106.55 -26.1 11.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.605 0.762 . . . . 54.24 111.831 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 112' ' ' ASP . 13.3 m120 -146.46 35.12 0.96 Allowed 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 123.11 0.564 . . . . 74.13 112.052 -167.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 31.1 ttp180 -69.83 7.55 0.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.006 0.922 . . . . 74.04 112.748 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.3 -21.88 26.9 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.136 0.974 . . . . 75.12 111.248 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.493 ' HA ' HG21 ' A' ' 113' ' ' VAL . 97.8 mttt 83.26 -8.84 1.1 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.685 1.594 . . . . 73.02 113.029 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.34 88.15 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.59 0.632 . . . . 64.44 110.004 168.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 107' ' ' ASN . 15.5 t0 -95.36 -44.54 7.52 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.072 -0.967 . . . . 73.33 110.69 -170.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.711 HG11 ' SD ' ' A' ' 103' ' ' MET . 35.8 m -76.37 -31.72 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 113.114 0.783 . . . . 73.41 113.114 -176.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.32 -40.12 95.3 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.163 0.438 . . . . 63.01 110.158 172.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.59 67.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.39 -0.823 . . . . 73.1 110.077 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.413 ' HB2' ' HE3' ' A' ' 103' ' ' MET . 90.0 t80 -56.99 -47.13 81.55 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.827 0.851 . . . . 75.11 111.605 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -63.83 -43.9 94.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.114 0.966 . . . . 74.11 110.434 -176.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.69 -45.73 91.22 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 123.753 0.658 . . . . 73.2 110.433 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.17 -39.31 68.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.256 -0.884 . . . . 74.22 111.559 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.457 ' HB ' HD12 ' A' ' 26' ' ' LEU . 10.8 tp -73.49 -38.78 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 117.95 0.341 . . . . 73.14 110.105 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -66.93 -44.0 81.81 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.041 0.536 . . . . 75.22 109.857 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.55 -38.23 95.47 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 124.088 0.867 . . . . 54.33 112.786 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.5 t90 -66.36 -52.69 44.4 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 123.874 0.87 . . . . 64.21 110.221 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.4 m -69.69 -36.9 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 119.152 -0.451 . . . . 74.44 111.842 -176.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.58 -33.95 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.606 0.639 . . . . 70.31 110.372 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.2 p -80.52 -34.06 35.92 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.497 0.319 . . . . 62.44 111.004 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.596 HD22 HG23 ' A' ' 155' ' ' ILE . 17.2 tp -69.53 -27.72 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.856 0.862 . . . . 73.32 110.623 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.3 mt -94.49 3.53 55.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.948 0.899 . . . . 75.11 111.438 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.01 95.0 4.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.046 -0.724 . . . . 61.03 109.046 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -58.3 -19.21 32.95 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.69 1.196 . . . . 75.44 113.774 -170.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.11 -45.91 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.315 1.046 . . . . 71.43 111.737 -173.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -108.58 -37.57 5.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 74.44 110.168 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -77.4 -1.84 32.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.664 1.186 . . . . 74.11 113.77 -170.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.05 -15.11 8.12 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 122.884 0.473 . . . . 74.21 111.179 164.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.22 26.09 6.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.019 0.927 . . . . 75.53 110.702 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -89.14 155.18 19.59 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.28 -1.007 . . . . 73.43 108.28 164.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.439 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -130.03 113.7 14.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.977 -1.49 . . . . 75.12 106.977 170.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.16 146.8 26.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.721 -0.844 . . . . 73.02 108.721 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.584 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 74.0 m-85 -143.47 162.49 35.66 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 123.405 0.682 . . . . 73.33 109.584 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.69 154.14 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.065 -1.457 . . . . 73.54 107.065 170.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.571 ' HA3' ' HG3' ' A' ' 12' ' ' GLU . . . -57.09 134.55 52.26 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-O 119.717 -0.49 . . . . 75.43 112.28 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 39.5 tt0 -61.57 -44.55 96.81 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.994 0.517 . . . . 72.34 110.26 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -57.16 -41.5 79.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 74.33 111.417 177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.567 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . . . -65.43 -35.14 80.03 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.431 -0.804 . . . . 74.44 111.15 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.77 4.04 48.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.555 1.142 . . . . 70.02 112.801 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 52.9 mt-10 -110.34 -42.14 4.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.427 0.691 . . . . 73.53 110.219 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.89 67.91 0.18 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.813 -0.631 . . . . 65.21 112.977 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.567 ' HB1' ' HA ' ' A' ' 144' ' ' ALA . . . -155.19 -92.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.405 0.682 . . . . 72.24 109.954 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -155.23 152.14 28.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.221 1.008 . . . . 75.35 109.763 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -70.89 -36.86 72.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.75 -0.659 . . . . 64.52 109.992 169.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 35.33 -119.73 0.4 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 125.516 1.76 . . . . 70.42 116.437 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -94.49 128.53 41.13 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.373 -0.602 . . . . 71.34 109.373 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.9 t -79.85 131.67 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.753 0.821 . . . . 74.54 109.422 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.3 100.19 2.09 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.209 1.004 . . . . 64.12 109.229 170.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.596 HG23 HD22 ' A' ' 127' ' ' LEU . 86.8 mt -92.11 113.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.555 -0.535 . . . . 74.44 109.555 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 137' ' ' ALA . 42.0 mm -101.73 125.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.624 0.37 . . . . 73.22 110.855 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.72 120.28 36.12 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.653 -1.24 . . . . 74.5 107.653 165.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 12.0 p90 -95.21 102.73 14.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.482 -1.303 . . . . 71.21 107.482 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.471 ' O ' HG22 ' A' ' 166' ' ' VAL . 11.3 tpt180 -87.39 102.52 14.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.387 0.675 . . . . 74.42 109.891 -166.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.61 109.11 2.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.385 1.074 . . . . 74.13 111.803 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.83 117.74 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 123.966 0.906 . . . . 73.41 109.624 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.3 t70 70.36 -62.13 0.44 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.346 1.858 . . . . 75.34 111.408 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -171.68 21.02 0.07 OUTLIER Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.013 -0.54 . . . . 73.23 112.513 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.9 m -136.26 127.75 28.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.743 0.817 . . . . 75.2 109.227 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 4.2 mp0 -81.17 137.7 35.89 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.098 0.559 . . . . 71.32 110.03 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 159' ' ' ARG . 34.2 m -109.42 113.19 58.59 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.4 0.68 . . . . 71.14 109.252 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.51 114.84 2.22 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.406 2.737 . . . . 74.5 112.361 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 m -120.68 103.9 9.49 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.127 -1.064 . . . . 74.31 108.127 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.3 tp -77.59 129.75 36.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 108.882 -0.784 . . . . 73.52 108.882 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.4 mtt -112.17 122.76 48.65 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.575 -0.898 . . . . 62.34 108.575 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -133.71 130.24 37.87 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 106.626 -1.62 . . . . 74.33 106.626 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 176' ' ' ILE . 14.8 p -66.25 133.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.617 -0.883 . . . . 74.01 108.617 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -63.29 -4.89 2.86 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.183 1.179 . . . . 71.22 114.183 -168.307 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.53 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . 42.0 mm-40 -95.68 -17.59 21.17 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.361 0.875 . . . . 75.3 113.361 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -108.62 -0.87 19.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.902 0.481 . . . . 64.53 110.49 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.474 HG21 ' O ' ' A' ' 172' ' ' VAL . 5.9 tp -126.88 119.79 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 106.653 -1.61 . . . . 74.01 106.653 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.8 mm -102.96 110.78 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.339 -0.846 . . . . 74.42 109.392 -172.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.52 96.06 1.89 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.061 -1.427 . . . . 73.34 109.518 172.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.599 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 10.5 tp10 -92.31 98.76 11.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.079 -1.452 . . . . 74.52 107.079 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -87.98 95.27 10.06 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.151 -0.932 . . . . 74.13 110.959 -165.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.2 t -92.79 88.88 6.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.261 -1.014 . . . . 74.13 108.261 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.33 54.43 0.73 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.464 1.106 . . . . 73.45 109.691 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.742 -1.117 . . . . 63.34 108.895 177.352 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HG3' ' HB3' ' A' ' 181' ' ' CYS . 12.6 tpt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.965 -0.383 . . . . 72.44 109.965 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 180' ' ' LYS . 73.5 mt -132.51 134.08 44.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.969 0.908 . . . . 75.25 109.341 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 68.7 mt -103.0 120.94 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.275 -1.379 . . . . 63.13 107.275 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.734 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 74.6 m-85 -105.08 135.88 45.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.534 -0.543 . . . . 75.13 109.534 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.557 ' HZ1' ' HB3' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -137.48 146.25 44.02 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.714 0.806 . . . . 74.42 110.12 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.408 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 27.0 t70 -106.35 172.4 6.83 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.903 1.281 . . . . 53.13 107.827 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.534 HD11 HD22 ' A' ' 98' ' ' ASN . 72.5 mt -64.81 -35.84 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 O-C-N 121.458 -0.776 . . . . 72.12 111.437 175.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.82 -43.18 3.85 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.333 1.053 . . . . 74.32 110.903 -167.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -98.32 20.25 12.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 75.24 111.003 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 12.6 t70 -45.45 -43.03 11.09 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.523 1.929 . . . . 63.14 113.443 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -49.51 -61.68 1.97 Allowed 'General case' 0 N--CA 1.476 0.87 0 O-C-N 125.626 1.829 . . . . 64.53 112.626 -166.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.3 21.76 7.9 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.779 0.659 . . . . 72.23 112.779 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 tp -49.12 -65.37 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 112.578 0.584 . . . . 70.11 112.578 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.734 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 22.7 t -158.19 173.46 16.67 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.759 0.424 . . . . 73.13 110.282 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 35.8 p 172.88 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.078 0.951 . . . . 71.31 111.205 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.526 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.8 t70 -174.0 167.93 4.22 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.899 1.28 . . . . 73.41 109.026 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 m -68.88 65.11 0.13 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.297 1.039 . . . . 61.3 112.448 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 60.4 m-85 -87.9 134.07 36.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 122.976 0.51 . . . . 73.22 109.672 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.482 ' HG2' ' HB3' ' A' ' 31' ' ' LYS . 52.6 Cg_endo -67.32 121.09 8.18 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.121 1.881 . . . . 75.12 110.401 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.66 147.02 52.33 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.082 -0.508 . . . . 71.52 110.633 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.654 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 26.2 mtpp -131.69 158.71 40.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.168 . . . . 73.44 108.53 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.63 110.88 18.44 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.673 -1.232 . . . . 75.12 107.673 167.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.17 139.13 20.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.907 0.883 . . . . 64.53 109.38 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 62.73 10.45 4.22 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.425 1.09 . . . . 75.41 112.926 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.5 t70 51.27 38.66 22.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.402 1.081 . . . . 64.03 110.622 -167.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.413 HD13 ' HB ' ' A' ' 120' ' ' ILE . 39.2 tp -134.74 -50.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.943 -0.571 . . . . 73.34 111.469 -172.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.9 t -125.11 138.29 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.341 0.657 . . . . 72.43 110.527 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.44 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 36.0 m-85 -86.1 119.96 26.96 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.077 0.951 . . . . 74.4 110.186 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.654 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 25.5 mm-40 -88.56 103.5 15.96 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 124.52 1.138 . . . . 75.43 108.569 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 25.0 t80 -109.74 103.92 12.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.423 -1.695 . . . . 72.44 106.423 -174.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 42.1 tttm -85.04 145.0 27.91 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.103 0.477 . . . . 73.23 111.048 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -133.78 -163.41 10.37 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 114.989 -1.005 . . . . 73.11 111.878 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -144.21 143.15 30.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.639 0.776 . . . . 73.31 109.224 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -74.25 121.53 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.468 -0.567 . . . . 74.42 109.468 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 72' ' ' LEU . 18.4 m -146.44 166.66 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.635 0.774 . . . . 72.31 109.163 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG13 ' OG ' ' A' ' 47' ' ' SER . 11.4 m -128.84 139.69 51.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.225 -1.028 . . . . 75.43 108.225 174.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.698 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 17.9 tpt180 -100.13 108.41 20.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.364 -1.347 . . . . 74.34 107.364 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.659 ' HG2' HG21 ' A' ' 64' ' ' VAL . 5.6 tmtm? -124.72 106.39 10.04 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.12 -2.178 . . . . 73.24 105.12 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -72.67 79.58 1.1 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 121.742 0.782 . . . . 61.32 110.249 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.67 -35.76 0.34 Allowed Glycine 0 C--O 1.237 0.332 0 CA-C-N 114.693 -1.14 . . . . 73.33 111.92 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.476 ' HG2' HG22 ' A' ' 43' ' ' VAL . 42.6 tt0 -174.9 105.0 0.09 Allowed 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.577 -0.527 . . . . 74.54 109.577 -174.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.7 tt -73.36 98.77 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-O 121.5 0.667 . . . . 74.01 110.743 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG22 ' HG2' ' A' ' 41' ' ' GLU . 61.4 t -128.37 116.74 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 108.255 -1.017 . . . . 75.44 108.255 172.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.69 -39.97 94.58 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.497 1.119 . . . . 75.22 111.305 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.88 -11.01 59.84 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.672 0.789 . . . . 55.32 111.43 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.95 66.21 2.53 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.095 -0.802 . . . . 74.24 111.095 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.424 ' OG ' HG13 ' A' ' 36' ' ' VAL . 46.4 m -136.84 158.41 44.53 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.098 0.959 . . . . 75.04 109.319 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -67.99 113.28 13.93 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.612 0.765 . . . . 74.11 110.338 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.57 92.49 0.36 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.782 2.321 . . . . 75.21 110.624 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.3 t -73.39 94.94 2.12 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.788 -0.642 . . . . 71.21 109.374 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.06 -59.45 3.46 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.725 0.81 . . . . 74.11 111.062 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -99.2 -70.32 0.73 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.302 -0.863 . . . . 75.02 109.929 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -127.31 -47.22 1.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.589 0.756 . . . . 72.34 110.961 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.36 28.02 68.68 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.114 -0.794 . . . . 73.41 111.114 -170.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.89 39.18 0.98 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.513 1.125 . . . . 63.32 111.047 -172.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 60' ' ' SER . 5.7 mm-40 -61.58 106.62 0.68 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.049 0.939 . . . . 73.25 108.531 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -53.36 -43.97 68.2 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 124.166 0.916 . . . . 73.11 112.361 -169.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -97.68 91.45 5.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.588 -0.893 . . . . 70.01 108.588 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.96 85.97 0.25 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.57 -0.741 . . . . 74.41 112.569 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 20.0 m -56.01 -34.98 66.31 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.906 0.882 . . . . 64.45 112.586 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -140.64 -169.02 2.7 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.719 1.208 . . . . 73.14 109.109 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -106.27 54.1 0.69 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.665 0.786 . . . . 72.15 109.225 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 60.66 32.95 20.38 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.591 1.156 . . . . 65.54 109.684 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.659 HG21 ' HG2' ' A' ' 38' ' ' LYS . 18.3 t -100.81 92.29 2.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.657 -0.868 . . . . 65.15 108.657 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.1 mp0 -69.62 74.52 0.4 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.137 -1.061 . . . . 72.31 108.137 166.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 -75.96 134.43 40.2 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.636 1.175 . . . . 74.24 110.617 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.0 -141.38 6.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 112.089 -0.404 . . . . 61.21 112.089 170.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 18.4 pt -111.18 158.72 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.799 0.44 . . . . 74.34 110.125 170.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.94 -30.48 71.6 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 75.24 111.915 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.2 mt -59.75 -52.61 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.375 1.07 . . . . 63.45 109.955 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.24 -48.04 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 114.251 -1.34 . . . . 75.31 111.443 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.467 HD13 HG21 ' A' ' 35' ' ' VAL . 79.3 mt -67.45 -23.25 65.5 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.577 0.751 . . . . 72.51 112.071 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -53.61 -53.84 46.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.181 0.992 . . . . 74.54 110.893 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -114.69 -1.61 13.25 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.436 -0.802 . . . . 75.44 112.427 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 66.71 70.14 0.4 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.448 1.099 . . . . 74.41 109.427 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.7 133.69 33.8 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.397 -0.964 . . . . 75.12 108.397 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.68 129.55 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.678 0.391 . . . . 75.34 110.369 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.42 147.04 46.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.477 0.711 . . . . 71.54 112.483 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.3 mtp -148.03 143.97 27.59 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.515 1.926 . . . . 73.33 106.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.406 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.0 m-80 -126.97 124.04 38.54 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.211 -1.033 . . . . 75.14 108.211 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.53 ' SG ' ' HD3' ' A' ' 130' ' ' LYS . 16.9 p -58.96 -15.27 12.13 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.844 0.857 . . . . 73.23 112.624 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.406 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 98.4 m-85 -57.29 -48.7 78.23 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.237 1.015 . . . . 72.44 111.545 174.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.81 -39.16 6.4 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.396 0.678 . . . . 73.23 110.543 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.76 20.11 1.22 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.61 1.164 . . . . 74.52 112.516 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.97 49.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.929 0.891 . . . . 72.45 112.876 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.3 m -68.33 -50.68 51.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.025 0.53 . . . . 74.52 112.105 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.3 mmm -60.26 -47.49 85.78 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.93 0.892 . . . . 72.03 111.44 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -64.04 -36.22 83.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.587 -1.188 . . . . 75.53 111.095 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.7 -37.44 87.36 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.109 0.564 . . . . 75.55 110.697 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 94' ' ' LYS . . . -61.51 -48.99 78.54 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.001 -0.545 . . . . 73.2 109.986 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -65.24 -32.23 73.8 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.958 0.725 . . . . 75.43 112.958 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 mm -66.19 -41.19 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.239 0.616 . . . . 75.54 111.575 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.98 -36.42 82.14 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.622 0.249 . . . . 72.2 110.786 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.692 ' HD3' ' HA ' ' A' ' 150' ' ' ASN . 96.6 mttt -64.43 -47.05 80.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.733 0.813 . . . . 75.04 109.83 174.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -53.76 -62.41 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.964 1.706 . . . . 72.53 111.858 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.3 ptm -62.3 -38.15 88.28 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.411 0.444 . . . . 70.22 111.269 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -66.21 -42.26 89.0 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 110.286 -0.264 . . . . 75.13 110.286 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.534 HD22 HD11 ' A' ' 7' ' ' ILE . 7.9 t30 -65.59 -54.11 32.43 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.808 0.843 . . . . 74.11 111.445 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.483 HG11 HG13 ' A' ' 172' ' ' VAL . 17.8 m -67.4 -40.17 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.114 0.566 . . . . 74.13 112.173 -171.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 86.6 mt -69.4 -45.68 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 109.626 -0.509 . . . . 75.11 109.626 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.81 -35.23 80.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.371 0.668 . . . . 71.13 111.608 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -59.4 -47.35 85.77 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.878 . . . . 73.33 109.065 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.48 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.6 tpt -71.37 -28.32 63.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.631 -1.168 . . . . 65.13 111.178 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' HA ' HG13 ' A' ' 113' ' ' VAL . 29.6 mm-40 -67.43 -23.49 65.54 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.035 0.534 . . . . 73.23 111.394 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -86.02 -30.64 22.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.774 -0.648 . . . . 73.41 109.76 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.31 -36.58 58.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.333 0.653 . . . . 73.22 111.622 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.405 ' HB3' HG11 ' A' ' 113' ' ' VAL . 8.7 t-20 -118.46 -66.68 1.05 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.83 0.852 . . . . 74.14 109.438 -170.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 74.86 -30.49 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.053 1.341 . . . . 73.24 112.892 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.89 -16.86 63.87 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.034 1.334 . . . . 63.51 113.671 -166.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.469 ' HA ' HG23 ' A' ' 113' ' ' VAL . 40.4 mmtm 79.99 -2.55 2.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.237 1.415 . . . . 72.53 112.299 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.05 -60.36 2.9 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.921 0.488 . . . . 74.12 110.856 171.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -91.11 -34.34 15.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.728 -0.669 . . . . 63.03 111.592 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 103' ' ' MET . 26.9 m -68.96 -44.84 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 112.135 0.42 . . . . 74.55 112.135 -175.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 24.0 t70 -72.51 -32.91 66.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.558 0.743 . . . . 72.31 110.203 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -65.47 -53.08 47.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.772 0.67 . . . . 61.41 109.789 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -56.82 -37.63 71.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.618 -1.174 . . . . 72.23 110.603 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.1 -44.34 92.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.403 1.081 . . . . 75.44 111.158 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 46.0 mmtm -63.37 -38.5 91.38 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.566 0.541 . . . . 73.22 110.609 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 13.9 mmmm -71.73 -49.47 38.98 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.774 -0.648 . . . . 74.55 111.084 -176.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.413 ' HB ' HD13 ' A' ' 26' ' ' LEU . 9.3 tp -74.02 -37.58 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 123.285 0.366 . . . . 74.23 110.732 -173.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.35 -45.53 72.59 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.678 -0.86 . . . . 73.44 108.678 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.99 97.34 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.007 -0.542 . . . . 72.33 112.271 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -64.25 -50.71 66.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.695 0.798 . . . . 71.53 110.441 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.487 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.1 m -67.57 -38.24 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 O-C-N 123.782 0.676 . . . . 73.32 111.198 -175.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.97 -39.93 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.081 0.401 . . . . 64.05 110.538 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.7 t -70.61 -45.35 65.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.476 -0.329 . . . . 70.14 110.179 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.66 -32.03 73.37 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.897 1.279 . . . . 74.4 111.89 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 59.2 mt -88.47 3.12 51.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.052 0.541 . . . . 73.03 111.827 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.19 92.49 6.9 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.004 0.522 . . . . 52.52 109.714 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.53 ' HD3' ' SG ' ' A' ' 81' ' ' CYS . 48.0 mtmt -60.4 -9.2 3.28 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.088 1.355 . . . . 74.15 114.266 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -53.62 -47.65 70.05 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 73.25 110.472 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.457 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -111.9 -34.4 6.01 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.101 -0.954 . . . . 74.1 110.767 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -73.29 -0.31 14.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.633 1.345 . . . . 74.24 114.633 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.1 ptmt -50.56 -9.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.676 1.362 . . . . 73.51 114.676 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -81.92 6.77 14.82 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.735 0.814 . . . . 74.42 111.732 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 157' ' ' GLU . 90.6 mt -89.41 140.99 28.96 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.355 0.662 . . . . 73.13 109.688 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.57 113.35 15.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.87 -1.9 . . . . 75.35 105.87 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.448 ' HE2' ' SG ' ' A' ' 81' ' ' CYS . 65.0 m-85 -87.61 136.51 32.92 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.631 -0.507 . . . . 71.33 109.631 -172.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -135.44 153.28 51.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.012 -1.107 . . . . 72.22 108.012 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.2 tt -139.01 145.35 27.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 108.945 -0.761 . . . . 70.24 108.945 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.68 131.27 51.33 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.267 0.979 . . . . 73.53 112.222 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.98 -33.68 3.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.262 1.425 . . . . 75.03 112.522 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -73.48 -49.34 27.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.23 1.012 . . . . 73.14 110.563 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.7 78.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.566 0.746 . . . . 62.01 111.72 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.72 -8.94 59.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.693 -0.685 . . . . 54.33 112.764 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -89.01 -41.83 12.12 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.058 0.456 . . . . 65.2 109.85 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -100.7 5.09 56.64 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.64 -0.709 . . . . 72.03 113.672 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 60.45 34.74 20.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.833 0.853 . . . . 75.42 110.568 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -63.18 178.37 0.51 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.719 1.208 . . . . 64.33 112.996 -173.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.692 ' HA ' ' HD3' ' A' ' 94' ' ' LYS . 4.2 t30 -88.11 8.17 28.12 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.716 -1.129 . . . . 74.11 109.614 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.25 144.65 48.71 Favored Glycine 0 C--N 1.359 1.853 0 CA-C-N 115.952 -0.567 . . . . 73.45 113.01 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.451 ' NE2' HD21 ' A' ' 171' ' ' LEU . 8.9 pt20 -85.0 162.74 19.24 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.672 0.789 . . . . 74.43 110.916 -174.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.15 125.36 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.814 -1.085 . . . . 75.14 110.015 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.16 107.95 3.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.383 1.073 . . . . 75.13 109.36 169.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.6 mt -90.94 102.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.422 -0.585 . . . . 75.45 109.422 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.2 mm -93.22 148.03 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.939 -0.763 . . . . 74.3 108.939 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.621 ' HB3' HD21 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -139.17 147.41 41.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.735 0.814 . . . . 74.41 108.942 169.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -98.24 134.37 41.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.195 -1.039 . . . . 71.05 108.195 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 23.7 ttm180 -124.83 153.14 42.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.051 0.94 . . . . 70.23 108.849 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.76 93.99 4.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.941 0.337 . . . . 64.32 110.491 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.3 p -119.37 123.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.716 0.806 . . . . 74.33 110.166 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 55.75 32.57 19.72 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.516 1.126 . . . . 74.44 112.612 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.01 68.89 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.181 -0.463 . . . . 74.45 113.422 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 m -128.05 125.8 40.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.254 0.622 . . . . 74.0 110.257 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 9.5 pt-20 -73.48 112.89 9.98 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.461 0.704 . . . . 75.15 109.267 169.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.93 106.89 46.91 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.483 0.713 . . . . 74.35 109.348 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.7 Cg_exo -76.16 117.05 4.52 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 122.675 2.25 . . . . 71.22 111.154 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.2 m -116.1 124.23 49.86 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.153 -0.684 . . . . 75.31 109.153 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 29.3 tp -76.99 137.7 39.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.395 1.078 . . . . 72.41 109.937 171.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 74.2 mtp -117.63 122.72 44.34 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.344 -1.354 . . . . 73.12 107.344 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.451 HD21 ' NE2' ' A' ' 152' ' ' GLN . 80.1 mt -136.33 147.85 47.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.076 -1.083 . . . . 73.41 108.076 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.483 HG13 HG11 ' A' ' 99' ' ' VAL . 10.0 p -75.46 144.65 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 109.464 -0.569 . . . . 74.35 109.464 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.44 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 12.8 ptmm? -57.0 -32.79 66.48 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.642 0.777 . . . . 65.55 112.188 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -85.82 1.1 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.809 0.844 . . . . 74.11 113.046 -165.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.46 -1.01 6.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.46 0.304 . . . . 70.52 111.637 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.24 141.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.624 0.77 . . . . 74.21 109.501 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.527 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.1 mm -126.88 114.0 35.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.214 -1.402 . . . . 72.32 107.214 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -84.47 127.0 33.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.235 -0.654 . . . . 63.11 109.235 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -116.3 101.78 8.98 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.075 -0.713 . . . . 75.54 109.075 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.417 ' HA ' HD22 ' A' ' 2' ' ' LEU . 36.0 ttpt -68.51 137.76 54.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.412 0.685 . . . . 73.42 110.539 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.436 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 21.8 t -131.87 88.3 2.55 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.623 -0.88 . . . . 72.44 108.623 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.3 mt -131.2 100.8 5.32 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.672 1.189 . . . . 71.53 108.257 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.559 1.298 0 C-N-CA 123.808 0.843 . . . . 73.41 110.718 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 108.772 -0.825 . . . . 72.11 108.772 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.0 mt -94.53 115.41 27.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.117 0.484 . . . . 74.3 110.497 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 49.8 mt -99.04 132.48 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.091 -1.077 . . . . 72.14 108.091 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 64.5 m-85 -121.76 132.39 54.59 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.484 -0.932 . . . . 73.3 108.484 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.561 ' NZ ' ' HB2' ' A' ' 179' ' ' GLU . 3.5 mppt? -120.67 120.18 34.97 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.415 0.686 . . . . 75.42 110.877 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.575 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 21.5 t70 -69.05 177.87 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.195 0.998 . . . . 73.14 108.797 170.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 pt -81.88 -29.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.838 -1.164 . . . . 75.11 111.62 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.05 -38.71 4.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.605 0.762 . . . . 72.22 110.64 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 m -96.28 15.81 20.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.833 -1.076 . . . . 70.21 109.686 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.575 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 4.2 p-10 -54.62 -33.85 61.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.214 1.406 . . . . 73.22 113.253 -172.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.61 -57.39 8.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.382 1.676 . . . . 74.54 112.131 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -123.83 24.34 8.39 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.766 0.654 . . . . 74.53 112.766 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.439 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 tm? -60.28 -61.14 2.82 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.572 0.349 . . . . 73.51 110.552 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.624 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 35.6 t -155.21 161.27 41.23 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 110.048 -0.353 . . . . 62.42 110.048 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 23.0 t 172.3 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.455 1.097 . . . . 74.31 109.838 -168.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.479 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 23.4 t70 -177.8 165.24 2.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.802 1.241 . . . . 63.51 109.145 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 p -67.8 88.35 0.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.414 -0.588 . . . . 72.43 109.414 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 23.4 m-85 -109.83 151.67 42.5 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.915 -1.039 . . . . 64.1 111.514 -175.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.66 120.74 7.11 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.913 1.742 . . . . 53.23 110.982 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.9 135.96 34.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.47 -0.937 . . . . 65.12 108.47 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 8.6 mmmm -141.82 107.32 5.05 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.219 -1.4 . . . . 75.24 107.219 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.6 tp -109.29 133.65 52.78 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.809 -0.812 . . . . 74.24 108.809 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.92 137.13 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.826 0.851 . . . . 72.24 109.083 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.5 t70 66.42 4.32 3.21 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.401 1.08 . . . . 75.42 112.263 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.8 t70 59.47 11.68 2.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.904 1.281 . . . . 74.21 112.57 -167.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.3 tp -113.03 -41.51 3.72 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.686 -0.634 . . . . 74.3 110.158 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.47 130.94 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.089 0.556 . . . . 73.21 109.656 -167.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -93.61 117.77 30.52 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.561 -0.903 . . . . 72.44 108.561 171.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 7.0 pt-20 -97.42 119.56 36.19 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.479 0.712 . . . . 70.41 109.728 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.595 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 23.3 t80 -110.76 106.21 15.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.25 -1.019 . . . . 75.34 108.25 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.05 113.5 4.51 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.21 0.204 . . . . 73.51 111.19 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.13 165.4 22.85 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 110.825 -0.91 . . . . 75.1 110.825 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.643 ' HG2' ' HB2' ' A' ' 69' ' ' ASP . 18.2 ptpt -94.37 125.38 38.97 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.65 0.725 . . . . 74.33 109.673 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.59 ' HB3' ' HG3' ' A' ' 167' ' ' PRO . 0.3 OUTLIER -73.63 106.84 5.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.158 0.583 . . . . 73.21 109.436 177.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.476 ' HB ' HD12 ' A' ' 42' ' ' ILE . 9.9 m -139.24 162.24 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.675 0.79 . . . . 75.51 110.786 -170.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 HG21 ' HA ' ' A' ' 44' ' ' LEU . 14.8 m -109.56 124.01 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.197 -0.94 . . . . 72.15 109.422 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.405 ' HB2' HD13 ' A' ' 72' ' ' LEU . 16.7 tpt180 -132.7 108.09 8.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.013 -0.365 . . . . 75.13 110.013 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -129.65 160.46 33.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.281 1.032 . . . . 72.25 108.526 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 50.73 -76.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.635 1.974 . . . . 74.52 113.497 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.31 32.35 0.11 Allowed Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.676 -0.57 . . . . 64.23 111.676 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -147.39 146.67 29.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.356 0.662 . . . . 73.45 110.322 -175.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.476 HD12 ' HB ' ' A' ' 35' ' ' VAL . 5.9 tp -106.16 104.07 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 124.796 1.238 . . . . 75.23 109.063 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.11 103.39 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.354 0.662 . . . . 73.33 109.29 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.529 ' HA ' HG21 ' A' ' 36' ' ' VAL . 2.8 mm? -56.54 86.3 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.125 1.37 . . . . 74.05 112.545 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.27 86.62 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 124.268 1.027 . . . . 75.33 110.39 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.57 -145.69 44.86 Favored Glycine 0 C--N 1.353 1.509 0 O-C-N 124.48 1.112 . . . . 64.33 114.687 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.8 m -88.36 86.02 6.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.742 0.817 . . . . 74.53 109.21 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -155.07 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 114.485 -1.234 . . . . 72.44 109.233 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -88.76 -171.06 0.54 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 121.844 1.696 . . . . 63.35 111.277 165.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.5 p -66.5 97.37 0.43 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.738 -0.664 . . . . 72.33 110.331 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.42 -30.77 71.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.547 1.139 . . . . 74.42 112.057 -172.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -91.48 22.57 3.9 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.593 0.757 . . . . 75.1 111.881 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -135.01 149.75 50.22 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 106.747 -1.575 . . . . 74.5 106.747 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.69 0.21 84.55 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 116.14 1.216 . . . . 73.41 116.14 -168.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 77.19 -52.9 0.56 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.32 1.448 . . . . 74.32 110.832 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.22 130.79 14.89 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.074 -1.084 . . . . 73.53 108.074 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -87.74 -34.75 18.24 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.575 0.75 . . . . 73.23 111.098 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.23 91.51 1.68 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.94 -1.133 . . . . 72.24 107.94 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.68 -25.61 5.57 Favored Glycine 0 N--CA 1.474 1.176 0 N-CA-C 111.147 -0.781 . . . . 73.14 111.147 -173.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.7 t -117.4 51.94 1.0 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.105 -1.442 . . . . 75.51 107.105 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.55 -51.03 25.61 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.183 -1.371 . . . . 74.42 109.886 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.63 -23.88 63.56 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.402 -0.817 . . . . 75.44 109.947 171.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 60.59 83.98 0.13 Allowed 'General case' 0 C--N 1.35 0.612 0 C-N-CA 124.727 1.211 . . . . 74.23 110.388 -170.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -74.14 -96.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 105.012 -2.218 . . . . 65.53 105.012 161.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.74 ' HG3' ' HG2' ' A' ' 66' ' ' ARG 0.25 10.4 pt-20 65.15 -36.08 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 127.612 2.365 . . . . 70.04 115.632 164.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.74 ' HG2' ' HG3' ' A' ' 65' ' ' GLU . 18.1 mmt180 -132.66 110.92 10.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 104.76 -2.311 . . . . 65.12 104.76 -174.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.6 37.83 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.468 -0.653 . . . . 72.23 111.468 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 34' ' ' HIS . 30.9 pt -109.6 160.07 8.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.143 -0.688 . . . . 73.35 109.143 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.643 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . 24.1 t70 -39.15 -40.53 0.73 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.26 1.024 . . . . 75.14 113.038 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.0 mm -56.54 -42.36 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.461 -0.791 . . . . 73.3 111.125 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.8 t -85.28 -49.52 15.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 C-N-CA 123.56 0.744 . . . . 74.31 111.717 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 HD13 ' HB2' ' A' ' 37' ' ' ARG . 33.8 mt -72.13 -49.0 39.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.217 0.607 . . . . 73.24 111.919 -169.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -69.79 -26.0 64.06 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 73.12 111.274 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -103.42 -14.95 16.05 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.027 0.381 . . . . 71.13 112.027 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? 60.07 69.97 0.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.516 1.126 . . . . 73.34 110.759 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 mt -96.57 142.13 29.0 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.402 -1.272 . . . . 72.44 109.113 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.04 124.22 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 108.794 -0.817 . . . . 73.0 108.794 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.35 151.08 5.72 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.482 1.113 . . . . 73.35 113.811 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.7 tpt -147.03 103.64 3.62 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 113.839 -1.528 . . . . 75.24 107.271 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -94.24 93.95 8.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.111 -1.441 . . . . 72.52 107.111 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 30.1 p -68.91 -31.02 69.64 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.508 0.67 . . . . 75.2 110.111 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.09 -21.18 61.53 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.42 -1.263 . . . . 73.54 111.711 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -105.18 -16.72 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.509 0.724 . . . . 63.23 112.197 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.39 23.53 6.37 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.301 0.64 . . . . 73.21 110.596 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.18 -28.94 3.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.014 1.725 . . . . 63.22 114.823 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.3 m -62.25 -59.18 5.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 118.109 0.413 . . . . 73.34 111.503 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.2 mmm -64.74 -39.25 93.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.489 0.716 . . . . 73.32 110.233 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -61.1 -46.23 91.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.037 -0.983 . . . . 74.31 112.076 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -61.33 -35.28 76.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.924 0.765 . . . . 74.42 110.106 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.57 82.41 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.746 -0.661 . . . . 71.03 111.323 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -67.37 -43.72 80.74 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.536 0.334 . . . . 72.43 111.498 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -64.08 -33.52 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.604 1.162 . . . . 71.25 111.449 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.87 -47.08 86.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.415 0.686 . . . . 73.13 109.851 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -72.82 -40.46 65.79 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.533 -0.758 . . . . 75.11 110.902 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.08 -54.92 36.94 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.657 1.583 . . . . 75.3 112.069 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttt -59.7 -46.14 89.97 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.738 0.648 . . . . 74.43 110.115 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -58.23 -44.91 88.46 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 115.659 -0.7 . . . . 75.5 109.535 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -62.59 -50.37 71.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.316 1.046 . . . . 72.33 111.144 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.541 HG13 ' HB1' ' A' ' 175' ' ' ALA . 26.4 m -67.93 -39.17 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.275 0.63 . . . . 74.12 112.566 -174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.5 mt -73.39 -38.48 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.495 -0.557 . . . . 74.13 109.495 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.34 -27.19 66.93 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.813 1.245 . . . . 70.35 111.162 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -63.55 -57.92 8.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.952 0.901 . . . . 63.33 109.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.531 ' HG3' HG12 ' A' ' 113' ' ' VAL . 23.2 ptm -73.89 -19.74 60.62 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.86 0.725 . . . . 75.44 111.575 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 26.6 tt0 -53.8 -55.77 23.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.014 0.926 . . . . 74.33 110.759 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -24.34 66.14 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.825 0.703 . . . . 73.45 111.317 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -94.35 -16.43 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.2 1.0 . . . . 72.54 110.787 -173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -129.11 -83.43 0.57 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.83 0.852 . . . . 73.3 110.316 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 104' ' ' GLU . 94.2 mtt180 53.56 20.9 2.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.751 1.019 . . . . 75.25 113.751 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.19 -21.96 59.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.397 0.679 . . . . 73.53 109.44 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.626 ' HB2' ' HZ3' ' A' ' 110' ' ' LYS . 9.7 mtmp? 86.53 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.415 1.886 . . . . 75.14 112.238 174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.47 -44.39 91.2 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.878 0.325 . . . . 72.35 111.878 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.9 -41.46 36.48 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.46 0.704 . . . . 72.11 110.654 -171.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.531 HG12 ' HG3' ' A' ' 103' ' ' MET . 33.4 m -70.71 -28.6 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 115.818 -0.628 . . . . 71.14 110.858 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 29.9 t70 -68.1 -47.79 67.24 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.124 0.57 . . . . 71.34 110.465 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.09 -38.28 90.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.785 0.678 . . . . 62.11 110.082 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -65.36 -49.57 68.86 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.232 -0.894 . . . . 70.41 111.348 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.588 ' HA ' HG21 ' A' ' 120' ' ' ILE . 21.9 pttp -67.46 -25.84 66.09 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.177 0.298 . . . . 72.32 110.894 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -61.91 -51.19 69.16 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.822 0.701 . . . . 74.45 110.566 169.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.83 -36.5 59.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.848 0.685 . . . . 73.22 112.848 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' A' ' 117' ' ' LYS . 10.6 tp -73.18 -37.18 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 118.538 0.608 . . . . 73.44 109.682 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -48.12 69.38 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.001 0.521 . . . . 74.21 110.091 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.28 94.31 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.63 0.581 . . . . 64.13 112.331 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.41 -55.26 22.18 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 123.513 0.725 . . . . 74.1 110.232 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.1 m -66.05 -41.72 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 118.721 -0.656 . . . . 75.5 111.482 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.79 -40.03 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.686 0.676 . . . . 72.12 110.419 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -73.19 -32.81 65.04 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.067 0.547 . . . . 72.34 111.51 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.667 HD22 HG22 ' A' ' 155' ' ' ILE . 31.0 tp -77.29 -31.2 54.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.567 0.747 . . . . 75.43 110.992 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 56.2 mt -84.0 3.64 33.43 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.855 0.862 . . . . 72.43 111.246 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.04 84.01 0.98 Allowed 'General case' 0 C--N 1.357 0.935 0 N-CA-C 109.263 -0.643 . . . . 71.34 109.263 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 17.8 ptpt -66.09 -14.84 62.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.863 1.431 . . . . 75.43 114.863 -163.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.61 -36.4 80.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.208 0.527 . . . . 71.14 110.489 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.1 mtp-105 -105.76 -39.15 6.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.168 0.987 . . . . 74.31 110.42 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -81.67 -1.43 46.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.383 1.073 . . . . 74.45 113.784 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 24.5 pttm -47.64 -10.85 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.958 1.466 . . . . 74.34 114.958 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -82.01 6.21 16.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.808 0.843 . . . . 72.04 111.66 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 157' ' ' GLU . 96.3 mt -91.69 154.31 19.08 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.286 0.634 . . . . 75.43 110.002 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.62 125.65 18.42 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.793 -1.558 . . . . 73.14 106.793 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -98.68 153.05 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.284 -1.006 . . . . 72.41 108.284 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -143.58 171.15 14.56 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.642 0.777 . . . . 72.11 109.074 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.99 149.12 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.929 -1.137 . . . . 73.53 107.929 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.81 132.79 44.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.474 -0.626 . . . . 75.2 112.23 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.53 -42.65 99.14 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.761 -0.459 . . . . 73.42 109.761 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.531 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -65.71 -33.71 76.52 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.5 -0.773 . . . . 73.42 111.931 172.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.51 -44.24 75.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.192 0.597 . . . . 74.41 110.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.06 65.75 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.246 0.966 . . . . 60.34 110.875 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -57.36 -36.57 71.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.369 1.067 . . . . 74.35 111.513 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.6 -52.92 23.0 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.361 -0.836 . . . . 60.21 111.137 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -167.72 154.78 8.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.555 0.742 . . . . 75.54 109.944 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.11 10.05 9.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.3 0.24 . . . . 72.53 110.97 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -88.88 -3.89 58.62 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.585 0.754 . . . . 74.3 110.601 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.66 151.54 24.38 Favored Glycine 0 C--N 1.356 1.642 0 O-C-N 123.963 0.79 . . . . 55.31 113.697 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -79.52 135.52 36.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.029 0.532 . . . . 73.51 111.33 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.41 112.07 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.202 -0.908 . . . . 74.42 110.527 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.88 115.48 14.52 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.415 1.086 . . . . 72.43 109.964 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.667 HG22 HD22 ' A' ' 127' ' ' LEU . 54.4 mt -92.8 115.21 31.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 122.922 0.489 . . . . 74.44 109.932 -171.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.498 HD11 HD11 ' A' ' 68' ' ' ILE . 35.1 mm -98.81 116.22 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 118.441 0.564 . . . . 64.42 110.562 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 159' ' ' ARG . 46.0 tt0 -97.22 101.46 13.03 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.259 1.023 . . . . 75.31 109.554 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -75.62 89.7 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.564 -1.273 . . . . 74.01 107.564 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.451 ' HB2' ' HG2' ' A' ' 157' ' ' GLU . 39.0 ttt85 -99.52 149.7 22.96 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.808 -0.812 . . . . 72.42 108.808 -172.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -122.47 130.56 53.19 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.592 -0.892 . . . . 74.32 108.592 167.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.1 109.37 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.362 -0.977 . . . . 73.45 108.362 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 60.1 28.84 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.498 1.119 . . . . 75.32 110.568 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.54 -17.08 59.92 Favored Glycine 0 C--N 1.357 1.743 0 CA-C-N 115.548 -0.751 . . . . 71.43 113.432 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.7 m -81.32 112.24 18.44 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.238 0.519 . . . . 75.54 110.42 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -71.84 103.33 3.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.501 0.72 . . . . 51.24 110.09 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.05 92.67 15.67 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 125.12 1.368 . . . . 75.55 109.224 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 34' ' ' HIS . 72.1 Cg_endo -75.26 116.53 4.56 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.395 2.063 . . . . 73.3 111.645 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 31.1 p -117.22 135.6 53.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.282 1.033 . . . . 64.03 110.605 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.4 tp -77.18 114.05 15.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.131 0.972 . . . . 75.21 108.895 170.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 66.6 mmm -102.67 121.49 42.52 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.259 -1.386 . . . . 64.55 107.259 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.1 mt -136.0 147.12 47.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 106.966 -1.494 . . . . 74.44 106.966 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.446 HG13 HG11 ' A' ' 99' ' ' VAL . 7.5 p -73.05 131.17 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.55 -0.907 . . . . 71.54 108.55 173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.61 -34.82 59.83 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.38 1.472 . . . . 74.14 111.634 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.17 -18.45 65.31 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 75.15 112.2 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.541 ' HB1' HG13 ' A' ' 99' ' ' VAL . . . -127.36 15.95 7.15 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.428 0.691 . . . . 71.02 111.74 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.5 tp -131.49 119.01 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 N-CA-C 108.199 -1.038 . . . . 71.5 108.199 165.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.43 113.74 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.644 -0.502 . . . . 74.34 109.644 -168.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -70.61 154.51 41.8 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.192 0.997 . . . . 64.35 111.244 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.574 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.4 tp10 -147.51 101.6 3.37 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.36 -0.607 . . . . 75.12 109.36 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -83.46 94.55 8.03 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.908 -0.404 . . . . 74.24 109.908 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 44.0 t -96.49 89.73 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.93 -1.137 . . . . 74.12 107.93 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.92 172.83 16.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.741 -0.663 . . . . 74.23 111.134 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 CA--C 1.559 1.324 0 C-N-CA 124.556 1.142 . . . . 64.53 110.793 -171.505 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.64 ' HG3' ' HG ' ' A' ' 2' ' ' LEU . 20.9 ptt? . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 112.997 0.74 . . . . 73.32 112.997 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.64 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 87.0 mt -136.03 161.51 35.47 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 123.327 0.651 . . . . 74.54 110.815 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 57.1 mt -96.65 120.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.351 -1.351 . . . . 63.55 107.351 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.592 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 22.7 m-85 -112.54 96.95 6.28 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.518 -1.66 . . . . 73.3 106.518 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 14.0 ptmm? -107.41 127.24 53.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.272 -0.876 . . . . 74.51 110.898 -173.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 25.1 t70 -74.2 178.16 5.29 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.59 -1.186 . . . . 65.04 109.807 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.464 HD13 HD22 ' A' ' 98' ' ' ASN . 62.0 mt -76.22 -38.66 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.578 -0.701 . . . . 72.3 110.732 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.7 -50.84 2.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.251 1.02 . . . . 70.45 109.867 -172.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -90.25 17.65 6.89 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.095 -0.957 . . . . 75.14 111.106 -171.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 9.0 p-10 -55.19 -26.57 39.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.773 1.629 . . . . 74.21 113.657 -170.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -49.46 -62.19 1.68 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 125.178 1.549 . . . . 74.14 112.493 -170.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -123.6 24.08 8.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.273 -0.876 . . . . 71.31 111.901 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 1.8 tm? -59.43 -73.58 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.993 0.517 . . . . 73.1 109.648 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 27.1 m -149.73 151.94 34.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.968 -1.123 . . . . 70.44 107.968 167.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 m -155.76 111.9 3.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.098 0.559 . . . . 72.52 110.359 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.269 4.1 p-10 51.88 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.31 1.844 . . . . 74.02 112.33 172.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.1 p -60.71 5.85 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.435 1.642 . . . . 72.03 115.435 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.41 146.94 32.87 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.777 0.831 . . . . 70.52 109.935 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -91.38 173.09 2.75 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.348 2.699 . . . . 74.12 114.312 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.646 ' HA ' ' HE1' ' A' ' 28' ' ' TYR . 23.8 ptt? -114.09 151.68 32.21 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.898 -1.046 . . . . 73.12 109.799 169.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -149.39 97.53 2.66 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 106.818 -1.549 . . . . 74.22 106.818 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.0 tp -91.72 122.03 33.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.812 -0.81 . . . . 73.01 108.812 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.96 134.32 53.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 C-N-CA 123.693 0.797 . . . . 74.31 108.954 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.31 21.72 8.57 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.848 0.859 . . . . 71.44 111.764 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 68.15 -9.29 0.5 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.824 1.249 . . . . 73.22 113.756 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.6 tp -102.76 -52.56 3.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.516 -0.74 . . . . 73.52 111.448 -167.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -103.71 129.08 56.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.043 -0.981 . . . . 71.42 109.586 -164.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.646 ' HE1' ' HA ' ' A' ' 20' ' ' MET . 17.2 t80 -83.35 112.83 20.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.38 -1.341 . . . . 75.11 107.38 170.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.8 121.64 38.87 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.528 -1.214 . . . . 71.01 108.196 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -113.13 136.58 52.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.459 0.704 . . . . 72.01 109.548 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 136.15 57.88 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.374 1.07 . . . . 75.05 113.314 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.62 146.21 14.07 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 110.58 -1.008 . . . . 73.43 110.58 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.79 151.83 40.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.266 0.533 . . . . 72.34 109.69 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -74.97 124.34 26.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.715 -0.476 . . . . 75.43 109.715 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.53 160.58 16.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 124.407 1.083 . . . . 74.42 109.454 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 44' ' ' LEU . 16.1 m -120.14 103.55 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.791 -1.559 . . . . 63.44 106.791 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.589 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.5 mtp180 -101.06 155.74 17.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.812 -1.085 . . . . 74.34 108.315 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 20.6 ttpp -135.5 161.83 34.38 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.627 -1.249 . . . . 74.32 107.627 170.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -43.37 -32.41 0.83 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.465 1.506 . . . . 75.23 113.927 -172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.83 54.83 0.53 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.448 -0.661 . . . . 55.2 111.448 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.678 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.8 tt0 -163.97 150.67 11.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.34 0.656 . . . . 72.24 110.939 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp -163.56 87.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 124.841 1.256 . . . . 74.25 107.799 168.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.11 -7.83 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.856 0.862 . . . . 71.15 111.903 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.505 ' HA ' HG23 ' A' ' 36' ' ' VAL . 3.4 mm? 58.03 75.51 0.38 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 124.194 0.997 . . . . 75.43 111.372 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.62 -13.52 17.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.705 0.802 . . . . 71.25 111.21 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.36 87.81 0.51 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.315 -0.714 . . . . 75.42 111.315 -174.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.468 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 31.2 t -76.89 84.51 3.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.646 0.778 . . . . 75.52 110.547 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -161.35 111.54 1.24 Allowed Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 109.332 -0.618 . . . . 75.23 109.332 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.79 -36.97 7.24 Favored 'Trans proline' 0 CA--C 1.555 1.563 0 C-N-CA 122.765 2.31 . . . . 62.44 112.775 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 p -167.06 -179.83 4.82 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.829 0.851 . . . . 64.24 110.069 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.27 92.68 0.58 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.466 0.707 . . . . 53.32 110.422 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -169.07 -167.94 0.79 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.924 1.29 . . . . 74.41 109.66 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.66 -39.26 88.13 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.338 0.655 . . . . 75.44 110.977 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.23 18.08 65.47 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 123.778 0.674 . . . . 73.35 112.346 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.69 87.04 6.76 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.895 -0.78 . . . . 74.1 108.895 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HB3' ' OG ' ' A' ' 60' ' ' SER . 8.5 tp10 -58.79 115.84 3.35 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.154 0.981 . . . . 75.2 110.426 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t70 62.6 45.78 5.9 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.773 1.295 . . . . 75.44 110.133 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 66.13 14.37 9.6 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.213 1.405 . . . . 74.34 112.856 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.74 -130.39 1.23 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 111.059 -0.816 . . . . 75.42 111.059 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.459 ' OG ' ' HB3' ' A' ' 56' ' ' GLU . 24.4 p 71.41 -23.36 0.18 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 126.401 1.88 . . . . 74.04 113.184 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -74.04 80.69 1.72 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.059 -1.089 . . . . 73.42 108.059 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -175.07 -52.79 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 104.552 -2.388 . . . . 72.33 104.552 -166.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -76.45 -47.28 23.55 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 107.196 -1.409 . . . . 74.32 107.196 166.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.24 97.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 107.479 -1.304 . . . . 64.42 107.479 162.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.3 mt-10 -85.59 70.5 10.75 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.518 -1.29 . . . . 72.33 107.518 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.496 ' HG3' HG13 ' A' ' 36' ' ' VAL . 18.7 ttp180 -96.55 139.18 33.02 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.465 0.65 . . . . 73.35 111.025 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.69 -131.99 5.22 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 114.858 -1.065 . . . . 63.34 111.374 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.741 HD13 ' HB2' ' A' ' 167' ' ' PRO . 0.8 OUTLIER -99.87 133.97 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.184 0.594 . . . . 72.23 110.755 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -36.79 -48.32 0.72 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.835 2.054 . . . . 65.32 114.186 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.7 mm -50.31 -53.33 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 124.164 0.915 . . . . 73.1 111.436 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.545 HG12 ' HB2' ' A' ' 76' ' ' LEU . 57.7 t -80.84 -23.17 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.615 0.766 . . . . 73.51 111.299 -170.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 60.7 mt -77.47 -38.13 49.89 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.905 0.482 . . . . 72.24 110.578 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.52 -49.38 12.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.81 0.844 . . . . 75.31 110.819 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.89 -21.39 34.27 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.555 0.342 . . . . 64.35 111.094 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm 63.11 66.97 0.7 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 124.632 1.173 . . . . 73.34 110.85 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.545 ' HB2' HG12 ' A' ' 71' ' ' VAL . 40.5 mt -93.18 162.72 13.91 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.442 -1.254 . . . . 65.13 109.587 174.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.12 135.65 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.636 0.775 . . . . 73.11 109.912 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.11 152.85 44.87 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.493 0.923 . . . . 62.32 113.493 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 59.8 mtm -146.06 104.93 3.87 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.106 1.762 . . . . 75.54 106.434 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.68 124.58 25.05 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.202 -0.666 . . . . 75.32 109.202 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.418 ' SG ' ' CD2' ' A' ' 138' ' ' PHE . 3.8 m -56.31 -30.89 63.14 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.848 0.859 . . . . 73.11 111.612 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -69.49 -45.54 68.71 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 113.592 -1.64 . . . . 74.22 112.86 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -97.73 -28.23 13.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.883 0.473 . . . . 74.14 111.914 -173.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.97 19.5 18.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.151 0.98 . . . . 71.1 111.132 -169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.76 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.264 1.025 . . . . 71.04 113.743 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -72.79 -55.51 6.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.037 0.935 . . . . 72.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.6 mtt -64.07 -37.2 86.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.055 0.542 . . . . 75.35 110.403 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.608 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 14.9 t80 -54.04 -49.07 69.78 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.747 1.219 . . . . 74.51 111.03 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.622 ' HB3' ' HZ2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -64.61 -34.9 79.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 74.34 110.093 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.46 81.14 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.328 0.392 . . . . 72.44 111.005 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -67.67 -32.7 73.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.504 0.722 . . . . 72.34 112.505 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.9 mm -67.31 -44.71 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.468 0.707 . . . . 74.4 111.245 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.6 -40.61 92.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.914 0.486 . . . . 74.45 109.827 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -63.28 -50.22 70.97 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.262 -0.881 . . . . 71.12 109.435 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -56.51 -51.01 70.13 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.243 1.417 . . . . 75.53 112.12 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.5 -40.27 85.2 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.344 0.402 . . . . 71.21 110.993 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -68.43 -38.68 81.4 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.875 -0.417 . . . . 72.35 109.875 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.464 HD22 HD13 ' A' ' 7' ' ' ILE . 30.2 t30 -58.45 -55.69 31.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 63.43 110.625 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.469 HG13 HG11 ' A' ' 172' ' ' VAL . 22.3 m -71.41 -39.98 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 114.969 -1.014 . . . . 71.04 112.865 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.25 -45.82 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 110.014 -0.365 . . . . 72.33 110.014 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -56.03 -38.47 70.6 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.474 0.71 . . . . 71.14 110.8 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -56.33 -58.11 9.37 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.152 0.907 . . . . 74.34 110.197 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.4 mmm -70.28 -26.74 63.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.535 -0.302 . . . . 72.33 111.138 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.538 ' HA ' HG12 ' A' ' 113' ' ' VAL . 40.5 tt0 -64.35 -45.91 85.72 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.359 1.064 . . . . 72.01 110.681 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -89.29 -9.61 49.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.273 0.471 . . . . 74.15 112.273 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.25 -22.9 21.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.508 0.559 . . . . 70.44 112.508 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -124.86 -43.95 1.96 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.573 0.349 . . . . 74.51 111.16 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.96 25.62 14.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.718 0.807 . . . . 72.33 111.234 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -119.13 126.59 51.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.032 0.933 . . . . 74.54 109.361 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -62.24 -36.0 80.67 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.748 0.819 . . . . 75.52 111.85 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.34 60.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.783 0.433 . . . . 72.51 110.889 -172.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.11 -60.64 2.21 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.445 -0.576 . . . . 72.32 109.445 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 104' ' ' GLU . 30.3 m -67.45 -35.52 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.737 -1.12 . . . . 74.41 112.875 -167.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.54 -33.9 35.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.458 0.703 . . . . 75.43 110.324 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.26 64.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.706 -0.479 . . . . 74.3 109.706 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.419 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 42.0 t80 -71.49 -40.62 70.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.972 -1.013 . . . . 72.23 110.129 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -62.31 -38.62 90.11 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.685 0.794 . . . . 75.15 110.207 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.81 -40.42 88.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.557 -1.201 . . . . 74.5 109.698 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -71.71 -37.18 70.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.627 0.771 . . . . 74.12 109.927 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 172' ' ' VAL . 8.3 mm -65.05 -47.81 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.655 0.782 . . . . 72.25 109.2 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.11 -37.83 81.16 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.784 0.678 . . . . 75.35 110.577 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.52 58.62 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 115.83 -0.623 . . . . 53.33 112.393 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.79 -51.19 61.08 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.053 0.502 . . . . 75.32 110.762 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.567 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.0 m -70.87 -41.71 77.25 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.966 0 CA-C-O 118.546 -0.74 . . . . 73.2 111.071 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.57 -32.28 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 119.727 1.149 . . . . 72.2 110.619 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.6 t -70.63 -32.58 69.95 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.522 0.329 . . . . 71.22 110.597 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.653 ' HA ' ' HD2' ' A' ' 132' ' ' ARG . 37.8 tp -76.03 -40.43 53.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.004 0.922 . . . . 74.1 111.174 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.608 HD22 ' HZ ' ' A' ' 88' ' ' PHE . 47.6 mt -77.65 1.7 18.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.1 0.96 . . . . 75.32 111.142 -170.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.23 130.04 39.36 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.364 -1.347 . . . . 74.13 107.364 168.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.62 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 50.3 mtmt -68.06 -6.46 22.84 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.467 0.914 . . . . 65.31 113.467 -173.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 22.7 t70 -68.52 -30.34 69.13 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.763 0.825 . . . . 71.25 109.764 171.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.653 ' HD2' ' HA ' ' A' ' 127' ' ' LEU . 42.6 mtt180 -81.34 -33.2 32.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.992 -0.443 . . . . 72.24 110.515 171.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.626 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.1 m-85 -67.0 -20.23 65.85 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.549 0.739 . . . . 74.04 111.866 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 131' ' ' ASP . 24.3 pttm -61.98 -30.9 71.24 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.582 0.551 . . . . 72.14 110.577 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -127.56 25.5 6.06 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.332 1.053 . . . . 74.11 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.626 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 24.2 mt -100.27 144.28 29.47 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.585 0.707 . . . . 73.32 111.341 168.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.4 121.06 15.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.523 -1.658 . . . . 74.02 106.523 167.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.486 ' HB3' HG12 ' A' ' 153' ' ' VAL . 66.4 m-85 -93.57 134.31 35.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.747 -0.464 . . . . 72.53 109.747 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.06 140.96 50.77 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 75.43 109.452 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.4 tt -120.89 159.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.994 -1.484 . . . . 74.01 106.994 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.23 129.72 49.9 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.177 -0.791 . . . . 74.21 111.53 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.29 -41.49 79.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.526 0.731 . . . . 72.33 110.049 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -69.51 -38.55 77.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.861 -1.063 . . . . 73.21 110.666 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.34 -31.44 72.57 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.448 0.699 . . . . 70.41 110.58 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 5.43 12.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.711 0.804 . . . . 71.34 112.049 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.83 -10.28 45.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 71.23 110.403 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.62 -55.51 0.01 OUTLIER Glycine 0 C--N 1.352 1.42 0 N-CA-C 112.016 -0.433 . . . . 72.21 112.016 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.82 83.31 2.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.452 0.701 . . . . 74.13 110.649 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.92 -2.23 50.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.124 0.97 . . . . 74.52 111.22 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.11 78.75 1.83 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.208 -1.775 . . . . 70.01 106.208 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -123.89 -166.58 12.56 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-N 113.797 -1.547 . . . . 34.2 111.733 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -101.58 142.1 33.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.002 -0.74 . . . . 72.21 109.002 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 138' ' ' PHE . 75.8 t -109.4 131.92 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.259 0.624 . . . . 74.23 112.058 -171.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.425 ' HA ' HD23 ' A' ' 171' ' ' LEU . . . -69.67 109.53 4.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.265 -1.334 . . . . 75.24 109.558 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 71.5 mt -85.56 105.5 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.966 -0.753 . . . . 75.21 108.966 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 169' ' ' LEU . 40.9 mm -103.58 119.61 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.008 -0.738 . . . . 75.03 109.008 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.94 127.81 47.64 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.827 0.346 . . . . 74.34 110.482 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -75.97 110.63 10.6 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 115.106 -0.952 . . . . 73.21 109.341 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.491 ' HB2' HG12 ' A' ' 166' ' ' VAL . 22.6 mmt85 -101.86 172.8 6.72 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.357 -0.979 . . . . 74.44 108.357 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -122.58 119.06 29.71 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.128 0.571 . . . . 73.33 110.603 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.73 118.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.021 0.528 . . . . 65.44 109.903 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 67.83 -67.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.899 1.68 . . . . 71.12 110.9 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.79 35.68 0.11 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.211 -0.756 . . . . 63.12 111.211 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.6 t -141.86 158.17 44.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.088 0.555 . . . . 64.53 110.863 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -78.75 114.46 17.69 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.748 0.819 . . . . 71.04 111.103 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 159' ' ' ARG . 5.8 p -117.73 89.14 32.33 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 109.11 -0.7 . . . . 74.24 109.11 175.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.741 ' HB2' HD13 ' A' ' 68' ' ' ILE . 1.3 Cg_endo -82.61 122.53 3.56 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 122.342 2.028 . . . . 75.35 110.159 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -105.42 140.0 39.2 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.727 0.811 . . . . 71.44 109.73 -168.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 156' ' ' ILE . 30.8 tp -82.36 123.34 29.01 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.917 0.76 . . . . 73.53 109.635 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.99 123.09 48.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.945 0.898 . . . . 75.41 108.882 174.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.435 HD11 HD13 ' A' ' 176' ' ' ILE . 79.7 mt -140.97 145.51 36.09 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.987 -1.486 . . . . 72.51 106.987 172.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.469 HG11 HG13 ' A' ' 99' ' ' VAL . 7.1 p -76.76 134.88 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 109.427 -0.583 . . . . 73.34 109.427 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.479 ' HZ1' ' HB3' ' A' ' 173' ' ' LYS . 6.0 ttpm? -56.75 -36.76 70.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.511 1.124 . . . . 71.01 111.871 -175.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -68.48 -25.91 65.21 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.901 0.881 . . . . 52.22 112.5 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.445 ' HB3' HG12 ' A' ' 99' ' ' VAL . . . -97.59 -1.91 42.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.816 0.446 . . . . 74.32 110.336 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.435 HD13 HD11 ' A' ' 171' ' ' LEU . 48.9 mm -102.55 132.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.362 -0.977 . . . . 74.32 108.362 174.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 44.3 mm -93.22 111.8 25.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.302 -0.999 . . . . 74.41 108.302 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.35 104.34 6.82 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.402 -0.962 . . . . 75.24 108.402 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.515 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.7 tp10 -104.04 111.06 23.47 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.966 -1.124 . . . . 72.04 107.966 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.444 ' HB3' ' HZ2' ' A' ' 180' ' ' LYS . 0.1 OUTLIER -79.44 129.66 34.68 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.806 -0.442 . . . . 75.4 109.806 -178.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.4 t -100.81 104.35 15.59 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.734 -0.667 . . . . 74.11 110.417 -171.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.35 161.66 26.51 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.285 1.034 . . . . 74.12 109.399 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 C--O 1.252 1.219 0 CA-C-N 115.104 -0.953 . . . . 73.42 108.553 178.272 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.067 0.46 . . . . 72.05 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.2 mt -84.33 123.82 30.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.849 -0.797 . . . . 71.02 108.849 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.519 HG23 ' HB3' ' A' ' 15' ' ' SER . 33.3 pt -99.39 128.58 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.535 0.734 . . . . 72.54 109.251 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.495 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 12.9 m-85 -122.95 124.22 42.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.947 1.299 . . . . 74.32 107.807 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -145.85 147.12 31.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.083 0.856 . . . . 74.35 112.239 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 14.9 t70 -101.25 124.08 46.39 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.899 0.88 . . . . 70.22 109.996 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.606 HG12 ' HA ' ' A' ' 175' ' ' ALA . 43.4 pt -66.56 -26.85 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.68 0.622 . . . . 72.41 112.68 -164.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.61 -60.97 2.11 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.293 0.568 . . . . 75.42 111.587 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 m -125.53 -46.48 1.75 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.91 -1.041 . . . . 75.24 111.737 -159.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 2.8 t0 -101.4 24.05 10.17 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.99 0.916 . . . . 74.02 110.486 -166.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -50.81 -2.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.016 2.228 . . . . 72.05 117.016 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -99.59 -41.52 7.3 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.645 1.111 . . . . 75.03 109.86 167.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 26.6 tp 36.51 -88.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.79 2.036 . . . . 74.0 113.655 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.5 m -157.3 134.48 10.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.802 0.841 . . . . 74.24 109.477 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.519 ' HB3' HG23 ' A' ' 3' ' ' ILE . 50.4 m -130.73 97.93 4.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.487 0.715 . . . . 74.44 109.149 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.45 ' HB3' ' HE1' ' A' ' 18' ' ' PHE . 24.3 t70 -166.52 -90.64 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.185 0.594 . . . . 75.2 110.258 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 m -170.2 78.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.463 1.105 . . . . 73.15 108.874 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.45 ' HE1' ' HB3' ' A' ' 16' ' ' ASP . 53.9 m-85 -112.43 139.12 22.26 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.744 0.817 . . . . 73.43 110.213 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' HE1' ' A' ' 30' ' ' PHE . 57.9 Cg_exo -53.8 117.57 4.0 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.202 1.935 . . . . 74.12 111.495 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.92 134.26 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.364 -0.835 . . . . 74.42 109.507 -172.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 39.1 ttmt -137.2 140.17 41.57 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.738 -1.208 . . . . 74.22 107.738 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 tp -131.75 108.07 9.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.831 -1.174 . . . . 74.15 107.831 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.35 133.64 42.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.848 0.859 . . . . 71.5 110.017 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.92 14.65 4.41 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.749 1.22 . . . . 63.12 112.763 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.7 t70 58.23 10.36 1.25 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.641 1.177 . . . . 73.35 111.987 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD23 ' HB3' ' A' ' 119' ' ' LYS . 51.8 tp -103.9 -47.1 4.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.01 0.924 . . . . 70.0 111.333 -167.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -126.93 131.54 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 115.835 -0.621 . . . . 74.33 110.077 -172.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.429 ' HB2' HG21 ' A' ' 176' ' ' ILE . 82.1 t80 -85.24 135.11 34.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.41 1.084 . . . . 72.53 108.439 169.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 32.5 tt0 -117.98 144.99 45.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.362 0.665 . . . . 74.23 109.286 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.605 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.5 t80 -131.97 138.45 48.3 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.91 1.284 . . . . 74.43 107.683 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.33 153.94 39.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.647 0.379 . . . . 64.2 110.714 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.1 159.72 30.61 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.977 -0.556 . . . . 63.23 112.124 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -134.83 138.88 44.62 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.01 0.924 . . . . 74.44 109.244 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -70.57 120.46 16.23 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.543 -1.28 . . . . 73.52 107.543 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.84 -178.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.477 0.711 . . . . 75.03 109.941 -168.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.9 156.05 42.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.305 1.042 . . . . 72.45 108.578 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 38.1 ttm180 -140.06 132.64 28.74 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.282 0.563 . . . . 72.41 109.977 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.564 ' HD2' ' HB2' ' A' ' 41' ' ' GLU . 65.0 mttp -133.38 156.17 48.14 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.142 1.377 . . . . 73.03 107.456 164.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.09 -38.62 83.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 75.4 112.019 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.85 -44.04 1.58 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.951 -0.568 . . . . 75.43 113.16 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.564 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 24.6 mm-40 -95.9 163.35 13.19 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.296 0.638 . . . . 71.22 111.836 -171.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 tp -161.25 104.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.889 1.276 . . . . 73.03 108.407 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -157.11 101.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 121.634 0.731 . . . . 72.23 110.715 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -93.74 -3.35 52.36 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.046 0.939 . . . . 71.43 111.017 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 94.18 0.36 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.992 0.917 . . . . 63.44 110.418 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.42 -86.16 0.05 OUTLIER Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.153 -1.179 . . . . 62.32 110.153 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -145.83 147.31 31.69 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.672 0.789 . . . . 73.32 109.941 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -62.63 -46.33 88.84 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.592 0.757 . . . . 64.23 109.76 170.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.07 94.4 0.89 Allowed 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 121.353 1.368 . . . . 75.35 110.248 165.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.4 m -77.03 1.32 18.26 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.422 0.689 . . . . 62.41 111.823 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . 65.8 14.44 9.55 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 124.713 1.205 . . . . 61.43 111.941 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.46 -11.12 60.71 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.571 1.148 . . . . 73.34 112.11 -169.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -94.26 106.65 18.63 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.786 0.834 . . . . 70.22 108.933 169.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.61 4.58 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 114.46 0.544 . . . . 75.4 114.46 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . . . -68.06 -29.01 67.87 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.9 0.88 . . . . 65.3 112.869 -170.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -85.82 114.33 22.67 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.16 -1.422 . . . . 75.32 107.16 165.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.89 137.57 57.76 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 124.09 0.869 . . . . 71.14 110.21 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.16 101.25 0.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.349 1.06 . . . . 62.13 110.248 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.04 6.7 55.8 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.498 -0.774 . . . . 62.54 113.515 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.8 t -101.23 92.32 4.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.663 0.785 . . . . 65.11 109.332 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.447 ' O ' HG21 ' A' ' 64' ' ' VAL . 6.3 p-10 -134.17 -3.77 2.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.29 1.036 . . . . 72.03 110.7 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 68.54 -72.02 0.11 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.883 1.673 . . . . 71.15 110.825 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -161.99 36.89 0.12 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.238 1.018 . . . . 72.0 108.521 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.51 HG22 ' HE3' ' A' ' 38' ' ' LYS . 37.7 t -100.28 114.53 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.894 -0.78 . . . . 73.44 108.894 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 9.4 mp0 -75.27 73.91 2.38 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.977 -1.49 . . . . 74.04 106.977 171.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -92.22 135.5 33.95 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.846 -1.07 . . . . 74.25 110.693 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.44 -154.43 25.52 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.836 -1.306 . . . . 73.35 109.836 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -94.62 153.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.684 0.742 . . . . 73.43 111.496 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -42.88 -46.66 5.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.888 1.675 . . . . 65.54 113.097 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 169' ' ' LEU . 45.1 mt -60.42 -47.97 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.919 1.288 . . . . 73.11 110.877 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -72.83 -42.56 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 114.604 -1.18 . . . . 74.43 112.195 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.49 -36.27 80.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.917 0.487 . . . . 71.24 110.768 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -59.58 -61.97 2.23 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.364 0.666 . . . . 64.44 110.634 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.486 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 59.6 t-80 -81.57 -17.7 47.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.264 -0.426 . . . . 72.34 112.1 -170.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 64.37 61.12 0.89 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.736 1.255 . . . . 75.23 108.427 -167.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 95.7 mt -82.07 133.46 35.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.066 -1.424 . . . . 74.43 109.399 174.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 145' ' ' ALA . 7.3 p -91.93 138.38 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.325 0.65 . . . . 74.12 109.386 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.33 147.41 53.0 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.994 0.902 . . . . 74.42 111.519 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -132.64 103.12 5.97 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 103.081 -2.933 . . . . 72.03 103.081 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 12.2 t-20 -69.14 116.54 9.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.515 1.126 . . . . 72.4 111.104 -172.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 26.5 p -63.99 -28.77 70.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.59 0.756 . . . . 74.51 111.843 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -73.3 -58.89 2.99 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.493 -1.231 . . . . 64.33 112.157 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -103.51 -6.73 21.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.922 0.712 . . . . 71.53 112.922 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 16.1 m-20 -121.2 22.69 10.81 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.647 0.779 . . . . 74.42 111.266 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.56 -35.21 40.17 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.835 0.854 . . . . 74.15 112.399 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.6 m -64.11 -38.27 90.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.442 0.697 . . . . 75.05 111.353 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 mtt -60.18 -45.84 91.74 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.627 -0.508 . . . . 75.34 109.627 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 46.1 t80 -63.09 -35.42 80.19 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.889 0.743 . . . . 75.53 111.245 -176.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.9 -25.34 55.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.196 0.598 . . . . 71.21 111.47 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.29 -45.89 75.23 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 109.576 -0.527 . . . . 72.13 109.576 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 76.4 m-85 -54.15 -54.54 38.27 Favored 'General case' 0 C--O 1.202 -1.444 0 CA-C-N 114.71 -1.132 . . . . 73.41 109.473 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.02 -42.46 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.093 0.957 . . . . 71.14 112.088 -172.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -59.75 -55.64 31.76 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 122.442 0.297 . . . . 64.42 111.167 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -37.78 76.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 123.526 0.516 . . . . 74.3 110.386 -174.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -55.95 -57.01 13.91 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.838 1.655 . . . . 74.45 111.434 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.4 ttm -67.86 -40.09 83.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.847 0.717 . . . . 71.31 111.56 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -61.7 -44.68 96.47 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.376 0.422 . . . . 73.33 110.323 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -70.6 -45.2 65.75 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 124.16 0.913 . . . . 71.22 111.235 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.56 -40.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.202 0.314 . . . . 74.51 111.758 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.8 mt -73.43 -39.47 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 117.983 0.356 . . . . 74.54 110.746 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.19 -38.72 85.86 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.709 0.804 . . . . 74.55 110.974 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.87 -44.78 54.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.562 -0.744 . . . . 73.41 110.129 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.533 ' SD ' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -58.61 -40.37 83.08 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.642 0.777 . . . . 71.32 109.735 177.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.518 ' HA ' HG11 ' A' ' 113' ' ' VAL . 40.9 tt0 -65.7 -29.73 70.32 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.302 1.041 . . . . 74.44 111.374 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -75.1 -40.15 60.15 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.335 0.654 . . . . 74.35 110.131 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -73.2 -34.52 66.01 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.22 1.008 . . . . 73.45 111.86 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.686 HD22 ' HB3' ' A' ' 112' ' ' ASP . 42.5 t30 -100.59 -45.96 5.35 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.868 0.867 . . . . 70.3 111.639 -171.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 77.82 -17.17 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.241 1.416 . . . . 75.52 112.532 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 113' ' ' VAL . 23.9 t70 -96.6 126.27 41.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.14 109.657 -174.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -77.65 -27.15 50.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.161 0.584 . . . . 75.4 112.118 -174.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.56 89.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.731 0.412 . . . . 72.22 111.804 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.686 ' HB3' HD22 ' A' ' 107' ' ' ASN . 30.0 t70 -85.6 -33.54 21.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.629 0.772 . . . . 75.35 111.354 -174.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.581 HG12 HD21 ' A' ' 107' ' ' ASN . 16.9 m -78.99 -28.07 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 117.944 0.338 . . . . 72.44 111.833 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.99 -42.13 85.6 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.888 0.475 . . . . 73.54 109.84 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.39 -45.86 78.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.593 -0.73 . . . . 72.12 110.052 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.423 ' HZ ' ' HB2' ' A' ' 174' ' ' GLU . 81.1 t80 -56.31 -45.83 80.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.437 1.095 . . . . 71.24 111.119 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -57.35 -47.86 80.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 72.44 110.667 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -69.04 -26.53 65.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.703 0.801 . . . . 70.42 111.411 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.449 ' HB3' HD23 ' A' ' 26' ' ' LEU . 32.5 mmtp -78.14 -35.51 48.88 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.344 0.658 . . . . 71.24 110.644 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.2 mm -69.66 -44.22 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.635 0.374 . . . . 73.15 110.046 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -58.42 -46.53 86.29 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.96 0.904 . . . . 74.41 109.614 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.39 99.22 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 124.194 0.934 . . . . 65.33 112.925 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -64.62 -51.51 62.29 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.301 0.64 . . . . 75.21 110.174 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.9 m -70.99 -41.22 76.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 0 CA-C-O 118.309 -0.853 . . . . 73.53 111.096 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.41 -33.04 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 119.486 1.039 . . . . 73.02 110.218 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.2 t -72.3 -42.15 65.81 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.437 0.695 . . . . 70.44 110.616 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.561 ' HA ' ' HG3' ' A' ' 132' ' ' ARG . 34.8 tp -79.09 -20.05 49.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.432 1.093 . . . . 74.11 111.952 -173.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -83.39 4.07 29.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.005 0.922 . . . . 74.44 112.206 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.32 38.98 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.009 0.524 . . . . 74.31 110.723 172.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.551 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 4.3 ttpm? -62.33 -45.03 95.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.027 0.931 . . . . 74.43 112.289 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.53 -24.49 64.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.146 0.578 . . . . 64.44 111.425 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.561 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 30.0 mmt180 -68.72 -54.49 15.82 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.059 -0.719 . . . . 73.42 109.059 170.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.591 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.0 m-85 -59.92 -22.5 62.5 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.416 1.086 . . . . 75.12 113.783 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -66.64 -27.84 68.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 73.51 110.137 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -115.78 0.08 13.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.35 0.66 . . . . 72.32 111.263 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 60.8 mt -89.36 132.38 34.98 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.58 0.627 . . . . 72.52 109.677 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.51 117.03 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.225 -2.139 . . . . 64.42 105.225 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.552 ' HB3' HG13 ' A' ' 153' ' ' VAL . 33.6 m-85 -90.36 143.45 26.75 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.759 -0.83 . . . . 71.13 108.759 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.609 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 82.9 m-85 -140.7 152.93 45.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.138 0.575 . . . . 73.43 110.598 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.0 pt -144.89 172.96 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.05 1.34 . . . . 73.22 107.635 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.86 134.23 51.08 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.708 -1.051 . . . . 74.31 111.103 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -40.65 -48.14 2.88 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.337 1.236 . . . . 74.34 114.337 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -64.02 -28.56 69.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.835 0.854 . . . . 64.14 112.543 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.46 -14.46 62.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.683 0.793 . . . . 74.22 111.999 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.669 ' HB2' HG12 ' A' ' 77' ' ' VAL . . . -75.36 -2.92 30.68 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.229 0.611 . . . . 65.14 112.313 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -81.47 -33.12 32.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 74.35 110.137 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.11 -2.06 0.03 OUTLIER Glycine 0 C--N 1.357 1.727 0 N-CA-C 115.834 1.094 . . . . 65.1 115.834 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.12 75.11 9.49 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.717 1.258 . . . . 64.43 110.725 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -88.56 -0.53 57.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.245 1.018 . . . . 74.45 111.479 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 -130.61 79.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.22 -1.03 . . . . 72.42 108.22 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -147.72 -148.55 4.77 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.067 -1.213 . . . . 51.04 110.067 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.96 152.92 22.1 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.328 -0.99 . . . . 72.11 108.328 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.552 HG13 ' HB3' ' A' ' 138' ' ' PHE . 93.8 t -113.25 132.16 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.755 0.822 . . . . 75.44 110.445 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.74 101.38 3.67 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.338 -0.986 . . . . 72.41 108.338 166.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.437 HG21 HD21 ' A' ' 127' ' ' LEU . 67.1 mt -89.54 120.35 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.632 -0.507 . . . . 75.24 109.632 -170.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 169' ' ' LEU . 48.4 mm -105.63 119.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.839 0.455 . . . . 74.54 110.488 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -103.88 111.7 24.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.76 1.224 . . . . 70.32 109.48 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -75.61 89.82 2.77 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.443 -0.947 . . . . 74.15 108.443 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -89.61 164.67 14.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.217 1.007 . . . . 74.42 109.332 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -122.51 115.2 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.197 0.599 . . . . 74.32 110.151 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -120.43 97.88 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.821 0.849 . . . . 74.34 109.585 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 65.56 11.59 7.57 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.089 1.356 . . . . 54.52 112.583 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 118.85 -14.33 11.43 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.748 -0.473 . . . . 65.24 113.039 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.7 m -88.7 111.49 22.02 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 117.23 0.515 . . . . 72.24 109.804 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.68 114.39 9.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.289 -0.869 . . . . 74.23 109.167 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 13.2 m -123.5 98.16 41.23 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.746 1.218 . . . . 75.01 110.004 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 166' ' ' VAL . 38.7 Cg_endo -65.62 112.8 2.28 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.478 2.119 . . . . 73.43 111.163 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 p -113.96 134.19 54.99 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.141 0.976 . . . . 71.4 109.375 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 39.3 tp -77.33 140.91 40.09 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.493 0.717 . . . . 73.42 109.621 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 25.3 ptp -131.85 129.36 40.31 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 108.124 -1.065 . . . . 74.45 108.124 169.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -130.96 137.44 49.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.803 1.641 . . . . 74.42 106.903 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 174' ' ' GLU . 7.6 p -72.12 143.14 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.419 0.287 . . . . 72.52 111.455 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -32.6 -50.35 0.25 Allowed 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 126.951 2.1 . . . . 74.31 113.397 171.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.423 ' HB2' ' HZ ' ' A' ' 116' ' ' PHE . 1.4 tm-20 -68.85 -38.94 80.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.57 -1.195 . . . . 72.44 110.455 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.606 ' HA ' HG12 ' A' ' 7' ' ' ILE . . . -98.06 -6.46 31.74 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.99 -0.528 . . . . 63.42 111.123 -172.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 28' ' ' TYR . 8.6 tp -108.41 136.64 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.767 -1.198 . . . . 73.51 107.767 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.0 mm -125.81 118.37 51.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.401 -1.703 . . . . 74.53 106.401 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.69 123.54 42.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.788 -1.19 . . . . 73.24 107.788 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -141.2 149.49 41.47 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.501 0.72 . . . . 72.14 109.274 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -98.7 96.82 8.18 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.231 -0.655 . . . . 75.33 109.231 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.59 93.92 4.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.294 0.638 . . . . 75.22 110.763 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 117.25 17.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.555 0.742 . . . . 74.1 109.201 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 . . . . . 0 CA--C 1.554 1.109 0 CA-C-O 118.909 -0.567 . . . . 64.01 110.076 175.818 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 17' ' ' SER . 22.4 mmt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 110.031 -0.359 . . . . 73.11 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.11 135.13 51.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.026 0.531 . . . . 70.14 109.656 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 5.1 tt -95.14 120.21 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.23 -0.656 . . . . 72.21 109.23 173.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HB3' HD13 ' A' ' 176' ' ' ILE . 27.2 m-85 -105.92 125.99 51.65 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.389 -1.337 . . . . 73.12 107.389 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.586 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 48.5 pttt -151.25 159.52 44.32 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 123.559 0.537 . . . . 75.34 111.909 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.595 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 8.3 t70 -87.23 144.87 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.86 -0.793 . . . . 73.12 108.86 173.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 pt -66.63 -11.56 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 113.218 0.822 . . . . 61.22 113.218 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.17 -59.46 1.85 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.77 0.714 . . . . 73.21 112.527 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -125.99 -32.54 2.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.745 1.387 . . . . 63.0 114.745 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.595 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 19.0 m-20 -81.85 21.88 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.798 0.726 . . . . 75.23 111.539 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 7.5 m-20 -48.45 -20.99 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.305 1.224 . . . . 73.21 114.305 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.78 28.11 9.02 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 123.829 0.851 . . . . 74.14 110.212 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.596 ' HA ' ' HD2' ' A' ' 74' ' ' HIS . 41.3 tp -57.42 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.784 1.234 . . . . 73.34 112.107 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.7 m -155.62 126.74 7.1 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.83 -0.433 . . . . 74.41 109.83 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 29.2 p -133.77 102.03 5.31 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.064 0.546 . . . . 72.33 109.895 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -172.67 -176.35 1.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.038 -1.097 . . . . 74.04 108.038 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.409 ' N ' ' SD ' ' A' ' 1' ' ' MET . 58.9 m -79.71 84.88 5.47 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.425 -0.954 . . . . 64.33 108.425 172.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.417 ' HB2' ' HE2' ' A' ' 4' ' ' TYR . 73.6 m-85 -102.25 129.74 25.6 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.581 -0.896 . . . . 75.04 108.581 175.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 11.9 Cg_endo -56.19 122.07 11.13 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.026 2.484 . . . . 54.44 112.429 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.4 mtm -83.82 144.14 29.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.307 -0.861 . . . . 75.41 109.9 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -143.06 101.74 3.88 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.249 -1.389 . . . . 73.24 107.249 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.5 tp -103.67 126.43 50.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.502 0.721 . . . . 72.11 109.358 -174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.7 129.19 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.264 0.626 . . . . 64.41 109.8 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 64.48 12.0 7.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.659 1.183 . . . . 75.53 113.454 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 55.59 11.17 0.59 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.362 1.065 . . . . 54.13 113.102 -166.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.4 tp -105.66 -44.19 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.08 0.952 . . . . 73.32 110.394 -168.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.557 HG12 ' HE3' ' A' ' 170' ' ' MET . 46.8 t -124.56 130.01 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.283 -0.871 . . . . 74.55 109.473 -171.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -90.21 117.59 29.08 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.692 -0.855 . . . . 71.24 108.692 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -92.75 126.34 37.78 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.158 0.983 . . . . 74.22 109.627 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.784 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 80.3 t80 -107.52 127.92 54.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.852 1.261 . . . . 73.03 108.024 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' HG3' ' HG2' ' A' ' 19' ' ' PRO . 72.4 mmtt -68.23 145.23 54.48 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 75.04 111.916 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.27 162.24 35.14 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.608 0.568 . . . . 64.23 112.021 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.38 142.96 50.68 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.027 0.931 . . . . 72.33 109.138 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -67.91 117.54 9.92 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.115 -0.698 . . . . 73.02 109.115 173.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.41 162.93 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.521 0.728 . . . . 73.12 110.626 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.56 131.89 72.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 108.64 -0.874 . . . . 75.34 108.64 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.694 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 73.2 mtp180 -105.31 108.13 19.48 Favored 'General case' 0 C--O 1.255 1.38 0 N-CA-C 108.504 -0.924 . . . . 73.41 108.504 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.615 ' HZ2' HG21 ' A' ' 64' ' ' VAL . 62.9 mmtt -134.3 148.37 50.76 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.099 1.759 . . . . 73.53 108.415 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.06 -7.08 43.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.936 0.894 . . . . 71.41 112.014 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.52 33.44 0.32 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.086 0.394 . . . . 61.42 114.086 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 39.7 tt0 -156.52 141.47 17.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.555 -0.535 . . . . 71.23 109.555 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp -140.32 35.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 CA-C-O 121.893 0.854 . . . . 74.5 110.423 -170.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.36 74.35 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 CA-C-O 122.267 1.032 . . . . 71.15 111.488 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pp -106.6 -4.8 19.22 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.428 0.899 . . . . 71.21 113.428 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.34 -19.63 46.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.026 0.531 . . . . 71.3 111.407 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.92 75.83 1.31 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 112.574 -0.211 . . . . 75.42 112.574 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.6 m -76.27 -29.05 57.29 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.287 0.635 . . . . 72.02 111.609 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -154.43 155.1 30.43 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.624 0.77 . . . . 75.14 110.39 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.72 94.78 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.586 2.191 . . . . 73.15 111.647 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -87.55 81.24 7.81 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.518 -0.765 . . . . 63.44 110.347 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.58 144.28 29.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.932 0.893 . . . . 74.12 109.193 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 143.74 41.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.423 1.089 . . . . 74.13 108.544 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -87.98 77.51 8.43 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.009 -0.737 . . . . 72.05 109.009 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.81 69.37 1.35 Allowed Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.657 -0.701 . . . . 74.44 112.186 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.61 98.78 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.522 1.529 . . . . 64.23 113.023 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.54 94.21 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.117 0.967 . . . . 74.42 111.091 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -143.75 -160.98 1.18 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.428 1.491 . . . . 73.12 108.078 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.8 -37.64 84.94 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.743 -0.836 . . . . 61.44 108.743 166.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.77 41.76 95.55 Favored Glycine 0 C--N 1.354 1.576 0 CA-C-N 115.35 -0.841 . . . . 63.32 111.2 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -144.88 -40.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.094 0.558 . . . . 71.33 111.503 -170.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -162.58 74.14 0.39 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.865 0.84 . . . . 73.34 110.364 -175.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -97.53 -16.76 19.95 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.15 -0.932 . . . . 71.13 110.314 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 64.61 17.17 10.76 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.613 1.165 . . . . 74.11 111.301 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.615 HG21 ' HZ2' ' A' ' 38' ' ' LYS . 12.7 t -106.8 84.17 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.575 0 N-CA-C 107.897 -1.149 . . . . 74.42 107.897 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.694 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.2 mm-40 -98.72 66.78 1.67 Allowed 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.597 0.713 . . . . 72.32 109.16 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -89.15 143.38 26.88 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.609 -0.723 . . . . 65.54 110.006 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.07 -133.01 3.85 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.508 -1.037 . . . . 63.43 110.508 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 4.7 pt -111.26 154.08 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 122.508 0.323 . . . . 73.13 110.858 172.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.59 -39.23 73.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.454 1.101 . . . . 73.14 113.099 -173.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.04 -48.88 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.99 0.916 . . . . 72.33 110.527 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.407 HG12 ' HB2' ' A' ' 76' ' ' LEU . 55.0 t -67.85 -43.48 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 114.999 -1.0 . . . . 75.04 111.099 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 75.9 mt -72.76 -21.97 60.92 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.183 0.593 . . . . 74.13 111.841 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -70.71 -53.59 15.05 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.362 0.665 . . . . 74.31 109.511 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.596 ' HD2' ' HA ' ' A' ' 13' ' ' LEU . 48.9 t-80 -86.55 -21.14 27.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.19 0.596 . . . . 75.35 111.101 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.467 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 7.5 mtpm? 65.67 71.13 0.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.871 1.268 . . . . 74.42 109.727 -170.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 91.1 mt -91.44 145.68 24.43 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.969 -1.014 . . . . 74.44 110.151 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 129.17 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.564 0.746 . . . . 74.34 109.855 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.77 153.56 32.44 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.615 0.969 . . . . 74.11 113.615 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 40.6 ttm -150.16 112.11 4.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.799 2.039 . . . . 73.44 106.078 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.66 152.33 29.12 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.979 0.809 . . . . 73.53 111.702 -172.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.546 ' SG ' ' HE2' ' A' ' 138' ' ' PHE . 85.6 m -65.96 -16.63 64.05 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.402 0.89 . . . . 60.41 113.402 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -71.3 -55.23 8.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.973 0.509 . . . . 74.51 110.367 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.36 -40.63 5.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.231 0.612 . . . . 71.0 112.061 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.83 20.55 3.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.628 0.771 . . . . 65.54 112.854 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.77 85.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.293 0.637 . . . . 75.51 112.29 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -77.35 -31.31 54.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.348 0.659 . . . . 63.21 111.711 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.9 mmt -64.42 -50.92 65.71 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.319 -0.622 . . . . 54.04 109.319 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.86 -23.41 62.31 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.141 -0.936 . . . . 75.41 110.725 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -68.97 -37.64 78.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.291 0.636 . . . . 75.03 109.93 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.4 83.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.18 0.592 . . . . 72.11 110.238 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -69.39 -32.9 72.21 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 123.409 0.684 . . . . 73.34 112.499 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mm -65.87 -33.6 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 117.898 0.317 . . . . 75.34 110.644 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -63.11 -45.65 91.03 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 122.314 0.246 . . . . 73.0 110.571 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -61.6 -54.45 42.85 Favored 'General case' 0 C--N 1.36 1.058 0 N-CA-C 109.227 -0.657 . . . . 72.05 109.227 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HD2' ' HG2' ' A' ' 152' ' ' GLN . 60.1 t80 -44.4 -68.53 0.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.792 2.037 . . . . 73.22 111.603 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 40.9 ttp -57.35 -50.38 73.13 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 124.127 0.971 . . . . 74.45 111.595 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -56.82 -50.04 73.59 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.111 0.882 . . . . 73.43 110.537 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -71.93 -48.01 48.41 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.74 -0.664 . . . . 75.33 111.604 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.514 HG13 HG13 ' A' ' 172' ' ' VAL . 23.8 m -66.25 -38.9 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 112.396 0.517 . . . . 60.25 112.396 -172.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.0 mt -77.91 -42.14 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 120.439 0.161 . . . . 70.32 110.921 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.05 -45.41 85.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.617 0.767 . . . . 73.34 111.355 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -67.14 -40.26 86.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.15 0.58 . . . . 70.23 109.959 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.36 -51.48 69.76 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 123.842 0.714 . . . . 73.23 110.62 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.81 -23.66 66.74 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.291 0.637 . . . . 75.35 111.257 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.438 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 31.8 ttmt -75.07 -24.47 58.21 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.338 0.655 . . . . 74.45 110.87 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -114.5 -13.39 12.2 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.2 0.6 . . . . 72.23 112.18 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -100.74 -46.06 5.28 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.717 0.807 . . . . 74.14 109.399 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 66.29 18.29 10.88 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.068 1.347 . . . . 75.13 113.144 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.18 111.13 19.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.64 -1.245 . . . . 62.03 107.64 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -69.5 -29.69 67.38 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.595 0.559 . . . . 75.44 111.632 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.34 -32.15 66.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 60.45 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.22 -47.55 56.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.686 0.794 . . . . 74.05 109.492 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.7 m -79.28 -17.82 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 115.237 -0.892 . . . . 73.53 111.935 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.08 -35.35 74.13 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.013 -0.736 . . . . 72.31 109.013 170.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.31 73.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.192 -0.913 . . . . 73.33 110.09 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -62.25 -41.61 98.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.0 0.52 . . . . 74.22 110.391 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -62.24 -34.86 77.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.598 0.759 . . . . 74.43 110.589 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -66.4 -43.25 86.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.51 -0.768 . . . . 75.22 110.411 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -46.76 71.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.781 -0.645 . . . . 73.44 111.441 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.96 -33.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.606 0.363 . . . . 70.54 110.944 -168.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -41.06 95.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.082 -1.081 . . . . 72.0 108.082 171.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.8 -40.98 97.4 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.832 0.708 . . . . 63.04 113.013 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -67.88 -48.0 67.29 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 122.656 0.382 . . . . 74.51 111.003 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.413 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 31.4 m -70.5 -38.37 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 118.997 -0.525 . . . . 63.45 111.796 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.39 -32.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 118.683 0.674 . . . . 73.52 110.194 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -69.43 -42.03 75.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.453 0.701 . . . . 74.31 110.581 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.51 HD21 HG21 ' A' ' 155' ' ' ILE . 14.4 tp -74.8 -30.89 61.56 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.247 1.019 . . . . 72.52 111.076 -170.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 86.5 mt -86.09 1.93 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.923 0.889 . . . . 72.42 110.78 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.04 67.03 8.94 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 122.08 0.943 . . . . 73.55 108.701 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.74 -6.22 30.48 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 114.191 -1.368 . . . . 74.54 113.593 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.73 -33.76 74.62 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.25 0.62 . . . . 71.51 110.449 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -105.44 -39.18 6.22 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.429 1.092 . . . . 73.11 109.527 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -80.33 0.67 31.98 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.112 1.365 . . . . 72.15 114.203 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -14.6 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 N-CA-C 114.288 1.218 . . . . 75.02 114.288 175.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.419 ' ND2' ' HG3' ' A' ' 157' ' ' GLU . 4.9 p-10 -79.44 13.63 1.9 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.026 0.93 . . . . 74.21 112.024 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.26 146.47 24.2 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.496 0.719 . . . . 74.14 109.425 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -139.06 112.49 8.21 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.72 -1.956 . . . . 74.43 105.72 169.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.638 ' HB3' HG12 ' A' ' 153' ' ' VAL . 37.1 m-85 -85.75 145.24 27.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.445 -0.946 . . . . 73.33 108.445 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 69.5 m-85 -139.41 143.79 37.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.349 0.66 . . . . 73.35 109.461 -176.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.6 pt -131.51 177.01 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.615 -0.883 . . . . 73.33 108.615 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.56 120.94 23.66 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 123.656 0.597 . . . . 74.32 111.621 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.39 -36.17 61.15 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.864 1.266 . . . . 75.43 110.24 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.54 -45.85 71.08 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.878 -1.055 . . . . 72.24 111.298 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.438 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . . . -65.63 -25.74 67.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.519 0.728 . . . . 75.24 111.947 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.24 -7.66 56.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.894 0.877 . . . . 71.11 112.239 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -85.28 -40.39 16.64 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.535 -0.543 . . . . 74.51 109.535 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.09 52.03 0.05 OUTLIER Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.996 -0.547 . . . . 61.22 112.489 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.438 ' HB1' ' HA ' ' A' ' 144' ' ' ALA . . . -145.35 -179.49 6.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.828 0.851 . . . . 72.42 109.592 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -119.99 121.63 39.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.878 0.871 . . . . 72.31 108.72 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -91.27 -26.68 18.87 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.756 -0.461 . . . . 75.44 109.756 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.73 -68.16 2.23 Favored Glycine 0 C--N 1.342 0.879 0 O-C-N 124.593 1.183 . . . . 70.23 113.656 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.492 ' HG2' ' HD2' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -100.47 133.16 45.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.247 -1.39 . . . . 75.53 107.247 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.638 HG12 ' HB3' ' A' ' 138' ' ' PHE . 71.5 t -94.02 141.63 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.768 0.827 . . . . 74.34 111.572 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.657 ' HA ' HD22 ' A' ' 171' ' ' LEU . . . -72.32 97.2 1.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.891 0.876 . . . . 72.33 109.6 169.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.51 HG21 HD21 ' A' ' 127' ' ' LEU . 85.6 mt -89.84 104.65 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.342 -0.614 . . . . 73.42 109.342 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.422 HD12 HD12 ' A' ' 68' ' ' ILE . 41.3 mm -93.59 125.63 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.039 -0.726 . . . . 74.33 109.039 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.419 ' HG3' ' ND2' ' A' ' 135' ' ' ASN . 21.7 tt0 -129.2 112.12 13.6 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.703 -0.851 . . . . 73.12 108.703 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.578 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 54.1 p90 -81.22 99.31 8.51 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 106.76 -1.57 . . . . 72.42 106.76 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -83.46 143.18 30.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.047 -0.979 . . . . 64.34 110.769 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.77 120.78 21.61 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.123 0.487 . . . . 70.13 109.718 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.11 95.37 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 125.336 1.454 . . . . 73.34 107.951 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.62 17.66 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.185 0.994 . . . . 72.53 112.11 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.31 6.93 47.18 Favored Glycine 0 C--N 1.353 1.521 0 C-N-CA 123.146 0.403 . . . . 75.11 113.545 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 m -111.94 156.42 22.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.242 1.017 . . . . 73.53 109.516 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 12.8 pt-20 -84.51 138.51 32.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.903 0.481 . . . . 75.41 110.156 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.54 99.37 18.98 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.783 0.833 . . . . 72.22 108.8 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.04 114.11 1.87 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.902 2.401 . . . . 74.2 113.195 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.3 p -115.75 121.23 41.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.875 0.87 . . . . 63.35 108.714 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.784 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 30.7 tp -76.76 107.4 9.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.467 -0.938 . . . . 73.13 108.467 172.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.557 ' HE3' HG12 ' A' ' 27' ' ' VAL . 73.7 mtp -94.96 122.69 37.86 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 107.875 -1.157 . . . . 65.41 107.875 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 154' ' ' ALA . 85.3 mt -134.7 145.04 48.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.558 1.543 . . . . 72.34 107.081 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.514 HG13 HG13 ' A' ' 99' ' ' VAL . 7.5 p -73.6 141.66 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.618 -0.882 . . . . 74.33 108.618 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.544 ' HA ' HG23 ' A' ' 176' ' ' ILE . 61.6 tttp -57.86 -30.02 65.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.004 0.922 . . . . 74.42 111.758 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.65 2.16 42.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.822 0.849 . . . . 74.43 112.267 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.98 -9.03 4.88 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.472 0.709 . . . . 74.15 111.375 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.544 HG23 ' HA ' ' A' ' 173' ' ' LYS . 8.6 tp -97.8 133.85 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 107.141 -1.429 . . . . 74.41 107.141 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.2 mm -104.57 110.53 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 106.864 -1.532 . . . . 64.41 106.864 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.89 90.31 3.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.012 1.325 . . . . 74.31 107.582 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 3' ' ' ILE . 12.2 tp10 -106.13 144.02 33.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.817 -0.808 . . . . 71.12 108.817 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.564 ' HE2' HD11 ' A' ' 182' ' ' LEU . 13.8 ptmt -100.27 123.92 45.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.681 0.792 . . . . 73.32 110.134 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.26 87.4 7.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.597 -0.89 . . . . 73.45 108.597 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.564 HD11 ' HE2' ' A' ' 180' ' ' LYS . 82.8 mt -90.31 87.93 7.01 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.741 -0.837 . . . . 72.21 108.741 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 C--O 1.254 1.336 0 N-CA-C 107.263 -1.384 . . . . 71.42 107.263 178.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.501 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 86.1 mmm . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.701 0.286 . . . . 72.14 110.441 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 180' ' ' LYS . 62.3 mt -120.52 155.74 32.99 Favored 'General case' 0 C--O 1.25 1.087 0 C-N-CA 123.781 0.832 . . . . 61.43 109.742 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 60.3 mt -96.85 120.25 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.373 -0.973 . . . . 71.54 108.373 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -110.33 99.41 8.44 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.265 -1.383 . . . . 75.52 107.265 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.533 ' HD2' ' HB2' ' A' ' 10' ' ' ASP . 55.2 pttt -129.53 165.3 21.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.314 -0.403 . . . . 73.43 110.054 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 10.3 m-20 -85.89 -177.94 6.46 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.839 0.828 . . . . 74.21 110.207 174.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.6 mt -84.19 -24.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 114.87 -1.059 . . . . 71.24 110.041 157.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -107.11 -59.76 1.77 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.788 0.835 . . . . 73.24 112.267 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -96.82 17.56 16.42 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.013 0.925 . . . . 73.24 110.439 -174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.533 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 5.3 p-10 -52.42 -29.21 23.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.111 1.364 . . . . 72.24 113.212 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -48.62 72.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.765 1.291 . . . . 74.43 111.323 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -120.3 17.87 12.25 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.688 -0.687 . . . . 73.25 112.268 -168.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -78.23 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.261 0.937 . . . . 74.1 109.176 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -143.78 122.79 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 120.741 1.61 . . . . 73.51 112.617 -168.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.492 ' HB3' HG22 ' A' ' 3' ' ' ILE . 35.7 p -116.12 104.87 11.98 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.865 0.866 . . . . 74.13 108.995 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 1' ' ' MET . 37.4 t70 -160.64 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 110.141 -0.318 . . . . 74.32 110.141 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.9 p -127.69 71.5 1.36 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.027 -0.731 . . . . 70.12 109.027 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -120.67 93.9 48.68 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.004 -0.739 . . . . 72.31 109.004 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.54 135.74 66.58 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.638 2.225 . . . . 54.43 111.622 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.436 ' SD ' ' HB3' ' A' ' 180' ' ' LYS . 24.2 ptt? -83.48 138.98 33.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.928 -0.767 . . . . 74.22 108.928 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -152.4 122.74 7.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.035 -1.098 . . . . 74.42 108.035 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -130.64 122.89 28.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.64 0.776 . . . . 74.44 109.039 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.13 142.86 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.322 0.649 . . . . 73.55 110.327 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 59.39 8.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.34 1.456 . . . . 73.52 113.515 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 51.72 39.28 25.01 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.243 1.017 . . . . 72.4 110.587 -168.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.0 tp -134.99 -51.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.794 . . . . 71.25 110.532 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.28 125.9 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.58 0.752 . . . . 72.24 110.299 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.4 ' HH ' ' HD2' ' A' ' 30' ' ' PHE . 81.8 t80 -83.6 119.96 25.37 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.981 -1.118 . . . . 74.42 107.981 171.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 6.7 pt-20 -111.51 141.65 44.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.176 0.591 . . . . 65.23 109.833 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.4 ' HD2' ' HH ' ' A' ' 28' ' ' TYR . 33.2 t80 -136.76 140.28 42.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.997 -1.112 . . . . 74.04 107.997 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.8 97.05 8.96 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.088 0.555 . . . . 73.21 110.061 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.98 130.6 11.6 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.942 -0.572 . . . . 70.0 111.706 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -97.62 124.04 41.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.367 0.583 . . . . 73.14 109.454 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -64.72 114.27 4.33 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 108.783 -0.821 . . . . 73.4 108.783 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.553 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 15.4 m -148.47 161.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.208 1.003 . . . . 74.22 108.88 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.538 HG13 ' HA ' ' A' ' 44' ' ' LEU . 3.3 m -128.42 143.78 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.183 -1.043 . . . . 73.25 108.183 173.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -91.74 116.08 28.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.404 -1.702 . . . . 73.15 106.404 169.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -119.46 145.48 46.25 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.87 -1.53 . . . . 71.02 106.87 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -62.8 89.02 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.432 0.634 . . . . 72.15 111.548 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.32 52.02 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 114.639 -1.164 . . . . 62.23 113.998 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -159.85 -174.59 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.899 0.48 . . . . 73.0 110.757 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tt -148.44 130.21 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.687 0.795 . . . . 73.33 109.483 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.18 79.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 107.95 -1.13 . . . . 71.11 107.95 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 35' ' ' VAL . 1.1 pp -69.99 -23.23 63.12 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.689 0.796 . . . . 71.32 112.36 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.59 160.88 22.43 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.588 0.755 . . . . 73.41 110.145 176.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.72 68.35 2.51 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.015 -0.834 . . . . 75.21 111.015 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.5 m -129.31 1.77 5.13 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.279 1.032 . . . . 72.5 110.507 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -76.11 108.32 5.93 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.513 -1.292 . . . . 72.03 107.513 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -82.61 42.89 1.38 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.96 2.44 . . . . 72.42 112.836 -173.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.2 t -158.23 177.79 10.89 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.15 0.98 . . . . 74.25 109.426 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB1' ' HA3' ' A' ' 59' ' ' GLY . . . 68.34 81.93 0.18 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.597 1.159 . . . . 63.31 112.193 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.46 -40.95 0.12 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.482 0.713 . . . . 74.2 111.397 173.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -172.65 -70.31 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.753 0.821 . . . . 73.4 109.666 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.78 -29.59 67.18 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 116.052 -0.522 . . . . 70.34 112.82 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.25 105.92 16.24 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.357 -1.349 . . . . 65.54 107.357 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -118.0 -48.33 2.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.415 0.686 . . . . 75.41 110.844 -171.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.53 -17.08 62.34 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 116.183 -0.462 . . . . 74.14 112.045 -172.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -109.52 130.7 55.49 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.302 -1.37 . . . . 74.1 107.302 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.483 ' HA3' ' HB1' ' A' ' 51' ' ' ALA . . . 85.46 26.78 34.8 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.216 -0.902 . . . . 73.52 112.026 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -74.17 122.23 22.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.556 0.742 . . . . 74.1 110.392 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' HB3' ' NH1' ' A' ' 66' ' ' ARG . 5.1 p-10 -67.77 -1.26 5.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.235 0.828 . . . . 74.0 113.235 -171.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -59.07 -57.16 14.27 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 123.877 0.871 . . . . 73.1 110.3 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -98.55 -25.36 14.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.763 0.425 . . . . 72.25 111.134 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 31.7 t -77.62 77.44 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.043 0 N-CA-C 107.852 -1.166 . . . . 75.33 107.852 168.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 39.5 mt-10 -75.32 77.18 2.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.718 -1.216 . . . . 72.23 107.718 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.418 ' NH1' ' HB3' ' A' ' 61' ' ' ASP . 6.1 ptp180 -76.59 135.63 39.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.89 -1.05 . . . . 74.54 110.545 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.44 -136.84 4.53 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.443 -0.663 . . . . 63.34 111.443 173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 pt -110.22 155.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.509 0.324 . . . . 75.02 110.779 172.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.75 -39.27 70.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.382 1.073 . . . . 74.52 112.391 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 41.3 mt -55.29 -44.87 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 124.104 0.962 . . . . 73.42 110.47 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.74 -55.08 19.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 CA-C-N 114.011 -1.449 . . . . 74.42 110.656 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.453 HD11 HG22 ' A' ' 35' ' ' VAL . 18.2 mt -67.94 -30.37 69.66 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.726 -0.67 . . . . 73.41 111.088 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.65 -52.38 38.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.838 -1.073 . . . . 75.13 110.95 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -89.37 -13.56 37.53 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.106 -0.497 . . . . 74.54 111.798 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt 68.42 66.32 0.32 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.24 1.016 . . . . 75.51 109.437 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 94.9 mt -86.57 131.36 34.19 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.96 -1.018 . . . . 75.2 108.677 173.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.785 HG11 ' HB3' ' A' ' 145' ' ' ALA . 4.4 p -86.42 129.89 37.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.524 0.73 . . . . 74.04 109.424 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.56 151.67 37.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 123.663 0.785 . . . . 74.45 112.247 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 39.5 tpp -149.5 140.28 22.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.347 -1.353 . . . . 72.45 107.347 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.639 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 29.7 m-80 -130.06 123.18 29.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.066 0.546 . . . . 73.43 110.334 -169.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 28.0 p -67.73 -16.26 64.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.014 0.526 . . . . 70.35 111.72 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.639 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 97.5 m-85 -45.88 -60.76 2.06 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.287 1.035 . . . . 73.24 111.319 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -105.23 -33.31 8.27 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.244 1.018 . . . . 72.13 111.255 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -93.02 19.98 7.23 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.002 0.521 . . . . 65.34 111.728 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.97 27.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.85 0.86 . . . . 70.53 113.203 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -77.96 -50.74 11.57 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.515 0.726 . . . . 61.35 112.25 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -72.91 -33.48 66.01 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.1 0.56 . . . . 71.13 110.971 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.516 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 35.0 t80 -64.91 -42.92 94.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.103 0.561 . . . . 75.42 110.568 170.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.571 ' HZ1' ' HB2' ' A' ' 89' ' ' LYS . 4.6 ttmp? -63.46 -27.62 69.41 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 120.678 0.275 . . . . 73.55 110.564 175.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.2 -36.72 74.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.192 0.597 . . . . 65.41 110.571 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.516 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 34.8 m-85 -63.83 -35.85 81.97 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.654 0.382 . . . . 74.14 110.526 170.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mm -65.61 -36.5 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.453 0.701 . . . . 75.43 111.459 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.36 -44.82 96.51 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.579 0.352 . . . . 75.24 110.699 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -68.09 -42.81 79.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.909 -0.587 . . . . 74.24 109.886 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -48.86 -66.63 0.37 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.625 1.57 . . . . 74.23 111.07 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.1 ptm -60.46 -40.61 91.83 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.507 0.504 . . . . 72.11 111.19 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -62.93 -45.59 91.74 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 122.68 0.392 . . . . 71.52 110.379 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -72.9 -48.72 34.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.346 0.658 . . . . 74.34 111.206 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -66.41 -38.06 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 123.541 0.525 . . . . 70.32 112.188 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.411 HD13 ' HE3' ' A' ' 117' ' ' LYS . 63.8 mt -77.89 -40.18 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 122.969 0.508 . . . . 72.51 110.148 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.52 -42.71 99.69 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.134 0.974 . . . . 73.22 111.83 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -66.96 -45.03 78.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.297 -0.865 . . . . 73.13 109.104 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.435 ' HA ' HD22 ' A' ' 106' ' ' ASN . 26.9 ttt -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 124.349 1.031 . . . . 74.4 110.692 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.23 -41.29 79.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.258 1.023 . . . . 73.44 112.174 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.58 -19.22 62.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.797 0.666 . . . . 75.1 112.797 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 103' ' ' MET . 9.5 p30 -114.37 0.9 14.25 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.386 0.539 . . . . 75.45 111.891 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.56 -48.06 2.88 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.754 -0.832 . . . . 74.52 108.754 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 57.37 8.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 126.848 2.059 . . . . 75.23 113.996 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -113.91 115.13 27.2 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.987 -0.746 . . . . 72.12 108.987 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -64.6 -32.85 74.68 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.026 0.829 . . . . 75.11 111.833 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.58 68.24 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.791 0.329 . . . . 73.04 110.603 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.19 -54.59 6.32 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.976 -0.75 . . . . 61.25 108.976 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.9 -22.22 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 115.932 -0.576 . . . . 60.44 111.677 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.05 -41.73 97.27 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.303 0.641 . . . . 74.54 110.221 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.053 0.845 . . . . 73.25 110.172 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -57.64 -61.12 2.74 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.173 0.92 . . . . 75.25 111.733 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.411 ' HE3' HD13 ' A' ' 100' ' ' ILE . 21.8 ptmt -73.19 -15.38 61.45 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.615 0.572 . . . . 65.43 111.858 -173.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -68.14 -51.49 45.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.55 -0.907 . . . . 74.21 108.55 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.12 -32.86 72.55 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.081 -1.418 . . . . 71.51 111.878 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mm -67.98 -47.62 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.068 0.547 . . . . 72.32 110.262 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.35 -49.53 75.85 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.91 0.756 . . . . 73.03 109.499 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.59 98.76 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 123.819 0.7 . . . . 75.13 112.981 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -62.45 -50.5 71.2 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.696 0.799 . . . . 74.54 109.79 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.469 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.5 m -70.79 -42.14 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 118.503 -0.76 . . . . 73.02 111.816 -173.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.55 -32.16 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 119.221 0.919 . . . . 73.4 110.757 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.2 t -73.97 -38.96 64.03 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 120.907 0.384 . . . . 73.4 110.081 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.653 HD23 HG21 ' A' ' 155' ' ' ILE . 28.4 tp -73.88 -26.94 60.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.929 1.292 . . . . 74.51 111.867 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 64.8 mt -88.42 2.24 53.12 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.852 0.861 . . . . 75.31 111.822 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 93.87 6.77 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.209 0.528 . . . . 72.35 109.586 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 50.9 mtpt -67.07 -5.38 12.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.331 1.234 . . . . 72.42 114.331 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -47.15 83.08 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 118.231 0.469 . . . . 73.25 110.794 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -109.06 -37.64 5.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.768 0.827 . . . . 74.12 110.547 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.37 -1.79 38.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.714 1.206 . . . . 73.32 114.148 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 37.3 ttpt -55.26 -15.54 2.52 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.705 0.631 . . . . 71.22 112.705 172.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -83.68 6.72 19.95 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.598 0.759 . . . . 72.02 111.276 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.63 129.18 34.96 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.415 0.686 . . . . 64.31 109.309 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.85 120.17 39.75 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.658 -1.238 . . . . 75.25 107.658 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.45 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 65.1 m-85 -102.7 141.91 34.73 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.422 -0.585 . . . . 75.5 109.422 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.618 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 95.1 m-85 -139.65 149.76 44.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.239 -0.652 . . . . 73.43 109.239 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.4 pt -133.66 168.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.892 -0.781 . . . . 75.33 108.892 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.61 143.93 48.99 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.821 -0.433 . . . . 63.41 112.227 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -44.86 -39.31 5.25 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.698 0.799 . . . . 75.3 111.993 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -62.77 -38.53 90.95 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 74.02 111.898 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -68.59 -29.74 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.267 0.627 . . . . 62.34 111.727 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.785 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -84.53 -25.33 28.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.575 0.35 . . . . 74.53 111.215 173.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -65.81 -29.89 70.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.499 0.72 . . . . 72.23 110.55 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.53 0.01 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.074 -0.81 . . . . 71.41 111.074 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -159.41 -170.69 3.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.165 0.586 . . . . 73.42 111.134 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.95 -173.01 0.9 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 75.32 108.858 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 79.21 -20.82 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.521 1.528 . . . . 75.15 111.963 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.13 146.72 47.78 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.908 -0.477 . . . . 72.35 111.908 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -67.62 134.23 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.397 0.679 . . . . 75.53 111.52 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.437 HG13 ' HE1' ' A' ' 88' ' ' PHE . 59.9 t -83.36 117.96 30.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.699 -0.682 . . . . 72.12 109.679 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -67.01 101.5 0.86 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.828 0.851 . . . . 75.04 109.525 168.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.653 HG21 HD23 ' A' ' 127' ' ' LEU . 67.1 mt -90.78 105.88 16.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.22 -1.03 . . . . 74.25 108.22 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -94.84 96.35 5.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.333 -0.617 . . . . 74.52 109.333 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -81.47 157.23 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.732 -1.122 . . . . 73.44 108.011 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.1 p90 -120.45 139.24 53.14 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.021 -1.103 . . . . 72.31 108.021 175.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.407 ' HB2' HG23 ' A' ' 166' ' ' VAL . 24.1 mmt180 -118.98 161.27 20.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.263 -0.643 . . . . 72.33 109.263 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -115.84 119.84 37.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.489 0.716 . . . . 70.51 110.403 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.88 97.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.296 1.038 . . . . 72.34 108.773 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 61.94 18.06 9.51 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.446 1.098 . . . . 75.14 113.777 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.84 1.37 22.7 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 120.122 -0.266 . . . . 75.52 113.194 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.9 m -110.11 134.37 52.25 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.954 0.901 . . . . 75.41 109.634 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.91 120.66 23.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.878 -1.156 . . . . 75.42 107.878 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.407 HG23 ' HB2' ' A' ' 159' ' ' ARG . 2.7 m -117.84 89.33 33.39 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.495 -1.298 . . . . 74.14 107.495 169.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.552 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 84.3 Cg_exo -54.19 126.25 21.5 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.006 2.47 . . . . 73.32 113.269 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -103.58 107.22 17.98 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.105 -1.072 . . . . 73.52 108.105 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 16.5 tp -75.17 112.42 11.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.676 -1.231 . . . . 74.43 107.676 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ptp -105.83 136.11 46.05 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 122.07 0.938 . . . . 73.14 108.945 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 154' ' ' ALA . 68.1 mt -141.77 158.33 43.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 112.963 -1.926 . . . . 75.43 106.534 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.407 HG22 ' H ' ' A' ' 174' ' ' GLU . 10.6 p -86.73 140.65 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.363 -0.977 . . . . 74.54 108.363 168.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -57.77 -27.33 62.97 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.537 0.735 . . . . 73.34 111.722 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.407 ' H ' HG22 ' A' ' 172' ' ' VAL . 17.0 mm-40 -90.12 13.58 14.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.594 0.757 . . . . 72.31 112.858 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.92 -1.14 7.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.588 0.755 . . . . 71.03 110.921 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.412 HG13 HD11 ' A' ' 171' ' ' LEU . 36.3 mm -132.0 137.0 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.047 0.939 . . . . 71.04 109.55 -174.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.94 109.81 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.854 -1.165 . . . . 74.42 107.854 171.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.05 106.15 18.35 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.403 -1.332 . . . . 72.12 107.403 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.643 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 43.3 mt-10 -92.78 98.11 11.19 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.425 -1.324 . . . . 74.13 107.425 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.581 ' HA ' HD23 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -72.97 96.43 2.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 113.794 -1.548 . . . . 74.33 109.403 179.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.91 87.78 2.89 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.272 -1.01 . . . . 72.43 108.272 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 97.5 mt -83.33 110.61 18.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.194 -0.912 . . . . 64.42 110.459 -171.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 108.031 -1.1 . . . . 74.22 108.031 175.43 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.826 -0.435 . . . . 71.32 109.826 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.9 mt -95.35 127.7 41.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.07 -0.715 . . . . 72.34 109.07 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.575 ' HB ' ' HG3' ' A' ' 179' ' ' GLU . 45.9 mt -97.4 127.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.332 0.653 . . . . 73.32 109.482 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.42 ' OH ' ' HB3' ' A' ' 20' ' ' MET . 31.1 m-85 -121.72 114.42 21.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.842 1.257 . . . . 75.23 107.792 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -123.11 150.72 42.86 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.342 0.657 . . . . 74.21 110.02 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.15 134.19 34.74 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.89 -1.152 . . . . 63.2 107.89 166.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.2 pt -68.71 -27.66 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.786 0.661 . . . . 73.51 112.786 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 98' ' ' ASN . 74.8 m-85 -85.61 -63.31 1.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.079 0.399 . . . . 75.34 112.068 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -131.33 -33.82 1.45 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.522 0.564 . . . . 74.15 112.522 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.83 24.03 5.77 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.05 0.94 . . . . 64.1 112.721 -156.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.19 -29.07 1.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.866 1.266 . . . . 73.1 113.605 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -84.42 24.68 0.95 Allowed 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 113.2 0.815 . . . . 74.33 113.2 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.4 mt -45.28 -76.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.534 1.134 . . . . 65.12 112.564 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 p -160.79 134.87 7.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.154 0.581 . . . . 71.21 110.359 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.9 p -141.53 99.91 3.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.091 0.86 . . . . 42.3 109.655 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' HB3' ' HD2' ' A' ' 18' ' ' PHE . 25.9 t70 -163.85 169.66 17.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.711 0.805 . . . . 70.32 109.364 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -80.99 9.49 6.47 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.862 0.865 . . . . 74.22 113.13 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.511 ' HD2' ' HB3' ' A' ' 16' ' ' ASP . 51.4 p90 -54.49 141.82 52.96 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 118.34 0.518 . . . . 73.14 111.787 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.38 119.82 7.22 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 123.008 2.472 . . . . 72.24 113.258 -164.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.42 ' HB3' ' OH ' ' A' ' 4' ' ' TYR . 24.2 ptt? -101.94 151.81 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.977 -0.556 . . . . 75.44 110.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -135.91 145.96 46.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.181 -1.415 . . . . 73.33 107.181 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.0 tp -134.32 118.52 17.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.271 -1.011 . . . . 73.1 108.271 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.51 133.88 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.056 0.942 . . . . 63.32 109.278 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 58.44 10.46 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.131 1.373 . . . . 64.33 114.55 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 50.72 25.08 1.93 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.723 0.809 . . . . 73.4 112.362 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 119' ' ' LYS . 63.3 tp -109.15 -46.14 3.63 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.1 t -124.44 124.4 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 122.673 0.389 . . . . 74.14 110.822 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -84.63 114.42 21.99 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.604 -1.258 . . . . 73.44 107.604 167.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 47.3 mt-10 -106.97 135.01 49.26 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.227 -0.897 . . . . 65.5 110.44 176.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 27.7 t80 -127.11 133.59 50.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.215 1.006 . . . . 74.33 108.984 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.73 139.55 30.41 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.019 0.438 . . . . 74.23 109.828 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -172.59 12.97 Favored Glycine 0 CA--C 1.508 -0.372 0 N-CA-C 110.538 -1.025 . . . . 65.4 110.538 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -144.84 144.55 31.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 74.43 109.992 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.405 ' O ' HD13 ' A' ' 44' ' ' LEU . 3.5 t-160 -65.03 117.37 7.56 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.121 -1.066 . . . . 74.34 108.121 169.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.71 163.61 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.854 1.261 . . . . 73.12 109.382 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.545 HG11 HD23 ' A' ' 44' ' ' LEU . 2.9 m -119.54 104.86 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.241 -1.022 . . . . 73.55 108.241 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.696 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 13.5 tpt180 -80.73 106.62 12.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.772 -1.195 . . . . 73.41 107.772 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 87.5 tttt -135.04 154.11 51.82 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.818 -1.083 . . . . 73.54 109.579 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -51.63 -26.76 9.57 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.003 1.321 . . . . 73.13 112.836 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.88 27.83 1.29 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.667 -0.518 . . . . 53.24 114.197 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.44 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 39.6 mm-40 -146.08 152.45 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.734 0.813 . . . . 75.43 109.352 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 6.4 tp -155.04 -43.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.599 0.76 . . . . 74.4 110.194 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.1 t -76.28 106.96 6.66 Favored 'Isoleucine or valine' 0 C--N 1.349 0.576 0 C-N-CA 123.735 0.814 . . . . 62.41 109.662 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.545 HD23 HG11 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -103.18 -162.89 0.94 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.783 0.833 . . . . 74.23 110.072 174.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.84 -172.78 3.01 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.394 1.078 . . . . 52.12 108.163 171.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.35 65.16 3.4 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.075 -0.81 . . . . 54.34 111.075 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.9 m -150.04 157.71 43.42 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.364 1.066 . . . . 54.21 109.77 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 m120 63.37 74.13 0.46 Allowed Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.681 1.192 . . . . 75.04 111.647 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.66 177.87 7.12 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.841 2.361 . . . . 71.45 111.413 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 p -72.04 102.15 2.91 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 109.77 -0.456 . . . . 75.25 109.77 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.45 155.76 34.49 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.58 0.752 . . . . 74.4 111.95 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.19 120.81 9.9 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.233 1.013 . . . . 74.32 109.524 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 69.34 77.42 0.22 Allowed 'General case' 0 CA--C 1.547 0.828 0 O-C-N 124.913 1.383 . . . . 75.31 109.464 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.47 43.69 2.19 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.825 -0.625 . . . . 73.03 112.423 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.06 -65.6 0.98 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.199 0.6 . . . . 74.1 109.79 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 51.97 49.59 20.38 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.161 1.384 . . . . 73.13 112.314 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 4.6 p-10 -65.26 -23.96 67.19 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.875 -0.602 . . . . 74.1 111.13 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -62.13 -37.27 84.5 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.552 0.741 . . . . 74.34 110.649 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.01 42.61 1.71 Allowed Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.907 -0.588 . . . . 72.4 111.683 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' A' ' 57' ' ' ASP . 44.4 p -73.51 93.65 2.02 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-O 121.331 0.586 . . . . 75.32 109.459 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -136.79 -63.53 0.61 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.484 -0.78 . . . . 74.15 109.555 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 64.13 33.77 11.66 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.225 1.01 . . . . 74.34 112.538 169.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -62.81 -25.1 68.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.497 0.665 . . . . 62.55 109.859 167.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t -92.86 90.38 3.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.868 -1.531 . . . . 74.3 106.868 164.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 48.1 mt-10 -67.36 80.86 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.849 0.833 . . . . 75.12 109.091 170.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -75.55 132.42 40.7 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.785 -1.098 . . . . 71.23 110.011 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.06 -141.45 7.73 Favored Glycine 0 CA--C 1.498 -0.982 0 N-CA-C 110.048 -1.221 . . . . 73.04 110.048 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 30.1 pt -111.5 147.41 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.426 0.613 . . . . 74.41 110.63 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.7 -24.33 65.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.438 0.695 . . . . 75.22 112.846 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.491 HG21 ' HB2' ' A' ' 169' ' ' LEU . 52.9 mt -60.16 -40.39 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.609 0.719 . . . . 74.42 110.165 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.17 -51.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.351 -0.841 . . . . 74.34 111.625 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 65' ' ' GLU . 24.1 mt -64.88 -45.62 85.23 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.079 0.862 . . . . 74.02 111.492 -169.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -80.62 -18.03 49.45 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.559 -0.746 . . . . 72.23 111.854 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -107.79 -1.45 20.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.791 -0.568 . . . . 72.24 111.357 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 55.95 56.69 5.75 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.226 1.011 . . . . 74.33 111.726 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 62.8 mt -95.13 138.3 33.03 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.016 -0.993 . . . . 73.23 109.73 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.4 134.48 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.922 -0.77 . . . . 74.3 108.922 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.26 141.45 57.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.143 -0.935 . . . . 64.34 112.928 -174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 ptm -140.81 109.96 6.18 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 107.136 -1.431 . . . . 64.44 107.136 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.45 152.98 20.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.703 -0.681 . . . . 65.41 110.306 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.432 ' SG ' ' HE1' ' A' ' 138' ' ' PHE . 64.8 m -67.34 -3.56 8.47 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.045 1.128 . . . . 74.44 114.045 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -94.13 -60.24 1.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.796 0.439 . . . . 74.4 110.018 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -78.36 -43.62 27.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.862 0.865 . . . . 75.41 110.273 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.13 20.56 8.94 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.842 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.81 -53.82 22.99 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.416 1.086 . . . . 65.32 113.904 -174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.0 m -68.33 -40.59 81.58 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.5 0.667 . . . . 74.11 110.996 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.425 ' HG3' ' CE2' ' A' ' 91' ' ' TYR . 14.2 tpt -68.59 -29.07 67.52 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.179 -0.919 . . . . 74.41 110.245 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -66.46 -42.12 88.04 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.355 1.462 . . . . 74.43 110.063 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.78 -41.65 82.47 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.86 0.725 . . . . 71.43 110.167 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.88 -45.42 86.07 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.394 0.678 . . . . 74.15 112.389 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.558 ' HE1' HD13 ' A' ' 140' ' ' ILE . 30.3 m-85 -55.17 -48.21 74.08 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.456 0.702 . . . . 71.32 112.151 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.13 -41.33 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.802 0.689 . . . . 74.13 112.614 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -52.63 -47.76 66.82 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.361 0.528 . . . . 73.25 111.334 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -70.24 -45.35 66.66 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.162 -0.926 . . . . 72.34 110.996 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -49.83 -51.42 40.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.631 1.172 . . . . 75.42 110.63 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.4 ttt -58.09 -54.64 44.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.764 1.226 . . . . 73.01 111.392 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.3 -24.17 62.98 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.316 -0.402 . . . . 74.2 111.901 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 8' ' ' PHE . 99.5 m-20 -88.12 -40.63 13.62 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.542 0.737 . . . . 73.4 112.264 -174.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.475 HG23 HG12 ' A' ' 120' ' ' ILE . 29.5 m -66.8 -36.96 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 110.14 -0.318 . . . . 74.0 110.14 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.09 -31.23 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 122.438 0.295 . . . . 75.11 110.543 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.24 -52.93 61.81 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.853 0.461 . . . . 74.41 111.028 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -66.32 -38.29 87.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.913 -0.585 . . . . 73.41 111.391 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.629 ' SD ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -67.26 -58.14 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.671 0.389 . . . . 74.4 110.741 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.13 -42.2 80.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.352 1.061 . . . . 64.21 112.337 -168.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -68.65 -22.09 64.42 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.094 0.558 . . . . 74.35 111.433 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.417 ' N ' HD21 ' A' ' 106' ' ' ASN . 0.8 OUTLIER -101.09 -17.95 16.45 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.278 0.631 . . . . 74.23 111.446 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -105.31 -52.17 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.061 0.545 . . . . 75.32 111.004 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 81.38 -21.45 0.31 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.457 1.503 . . . . 74.25 113.066 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -79.52 127.35 32.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.354 0.525 . . . . 64.33 110.516 -172.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -43.39 81.08 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 124.55 1.156 . . . . 72.1 112.454 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.03 -30.65 39.55 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.143 0.577 . . . . 74.22 112.52 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.06 -36.62 22.91 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.574 0.35 . . . . 55.22 110.542 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.629 HG11 ' SD ' ' A' ' 103' ' ' MET . 23.4 m -69.91 -29.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.729 0.299 . . . . 75.15 110.385 172.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.76 -31.82 68.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.679 0.791 . . . . 75.41 109.921 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.2 -53.81 26.87 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.456 0.702 . . . . 65.21 109.689 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -55.82 -43.27 76.8 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 123.878 0.736 . . . . 73.44 110.465 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.37 -43.94 79.7 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 124.579 1.174 . . . . 74.55 111.181 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 74.54 110.204 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.5 mptm? -66.92 -45.2 78.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.204 0.602 . . . . 74.24 111.142 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 99' ' ' VAL . 10.8 tp -73.03 -39.15 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 122.794 0.438 . . . . 71.21 110.301 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -67.11 -44.79 79.04 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.217 0.607 . . . . 72.05 109.885 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.24 99.76 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.91 0.756 . . . . 61.44 111.887 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.514 ' HZ2' ' HB3' ' A' ' 170' ' ' MET . 34.1 t90 -63.11 -50.99 68.33 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.826 0.85 . . . . 72.33 110.434 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.484 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.8 m -68.62 -47.64 75.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 CA-C-O 118.9 -0.571 . . . . 72.43 111.019 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.8 m -62.1 -31.23 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.09 0.859 . . . . 74.44 111.509 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 m -76.37 -43.68 39.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.032 0.533 . . . . 73.32 111.219 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.8 tp -77.07 -33.86 57.07 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 123.237 0.615 . . . . 74.12 111.704 -170.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.3 mt -80.54 4.04 19.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.596 0.759 . . . . 74.34 112.248 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.67 108.38 0.73 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.916 0.886 . . . . 64.41 111.434 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.436 ' HZ2' ' HB3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -73.61 -5.49 40.69 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.745 1.017 . . . . 75.54 113.745 -170.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -97.45 -45.17 6.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.865 0.466 . . . . 73.23 111.151 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -100.4 -47.88 4.76 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.198 0.999 . . . . 72.32 110.508 -172.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.492 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 39.2 m-85 -86.24 -2.66 58.58 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.075 0.95 . . . . 73.21 112.402 -173.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -52.57 2.53 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.158 1.91 . . . . 75.21 116.158 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -83.3 17.31 2.13 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 74.53 110.82 167.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' A' ' 157' ' ' GLU . 87.6 mt -89.82 151.01 22.0 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.426 0.632 . . . . 73.52 110.489 175.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.32 119.36 17.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.109 -1.811 . . . . 74.21 106.109 169.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.432 ' HE1' ' SG ' ' A' ' 81' ' ' CYS . 91.1 m-85 -93.59 149.31 21.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.178 -1.045 . . . . 75.42 108.178 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.662 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . 82.3 m-85 -138.78 161.62 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.354 -0.609 . . . . 74.22 109.354 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.558 HD13 ' HE1' ' A' ' 91' ' ' TYR . 4.7 tt -136.4 143.29 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.648 -1.241 . . . . 70.1 107.648 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.72 150.47 49.84 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.525 0.516 . . . . 73.13 112.997 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.91 -47.84 52.0 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.495 1.518 . . . . 72.23 114.367 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -42.17 73.83 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.235 0.614 . . . . 74.43 110.684 -171.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.04 60.57 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.287 1.035 . . . . 75.1 110.872 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.46 -5.37 42.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.993 0.917 . . . . 73.21 112.583 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.83 -5.0 56.71 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.583 0.353 . . . . 75.25 111.028 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.67 42.94 1.28 Allowed Glycine 0 C--N 1.345 1.041 0 C-N-CA 122.876 0.274 . . . . 73.1 112.666 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.95 -67.48 0.85 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.104 -0.702 . . . . 73.21 109.104 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -159.16 173.37 16.5 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 74.14 109.558 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -54.96 -27.59 44.98 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.565 1.146 . . . . 72.34 112.547 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.85 -153.46 41.21 Favored Glycine 0 C--N 1.357 1.726 0 O-C-N 123.793 0.683 . . . . 60.31 111.446 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.541 ' HG3' HD22 ' A' ' 171' ' ' LEU . 50.3 tp60 -87.28 120.16 28.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.616 -0.883 . . . . 73.44 108.616 162.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.77 116.24 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 109.297 -0.631 . . . . 72.13 109.297 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.662 ' HB3' ' HB2' ' A' ' 139' ' ' PHE . . . -76.65 99.97 5.21 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.159 -0.928 . . . . 75.31 110.494 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -91.47 108.58 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.476 -0.784 . . . . 75.13 109.628 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 49.9 mm -99.0 109.63 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.667 0.387 . . . . 74.35 110.71 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.497 ' HA ' HD21 ' A' ' 136' ' ' LEU . 45.7 tt0 -86.94 107.41 18.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.317 -0.623 . . . . 75.25 109.317 171.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -75.0 87.91 2.36 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.378 -1.341 . . . . 72.4 107.378 169.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.525 ' HB3' HG21 ' A' ' 166' ' ' VAL . 8.0 tpt180 -85.92 119.83 26.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.048 -0.978 . . . . 74.24 108.62 -170.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.73 97.62 10.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.758 0.423 . . . . 71.25 109.957 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 p -96.41 97.64 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.606 0.763 . . . . 73.01 109.306 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 64.7 17.38 10.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.415 1.086 . . . . 73.2 112.916 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 115.5 -10.13 19.47 Favored Glycine 0 N--CA 1.475 1.245 0 CA-C-O 120.156 -0.247 . . . . 75.03 113.335 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.4 m -97.38 128.61 44.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.332 0.653 . . . . 74.52 109.974 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.52 120.85 22.3 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.422 -0.955 . . . . 72.1 108.422 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 159' ' ' ARG . 12.4 m -115.88 95.72 44.89 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.624 -1.25 . . . . 74.53 107.624 171.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 123.91 14.97 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.451 2.767 . . . . 75.21 112.366 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 157' ' ' GLU . 26.5 m -117.89 110.45 17.76 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.569 -0.901 . . . . 72.34 108.569 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 62.8 tp -76.24 117.43 17.92 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.633 -0.877 . . . . 73.31 108.633 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.514 ' HB3' ' HZ2' ' A' ' 123' ' ' TRP . 63.5 mtt -112.26 120.92 43.41 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.957 -1.127 . . . . 74.25 107.957 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.541 HD22 ' HG3' ' A' ' 152' ' ' GLN . 78.5 mt -131.73 145.49 51.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.017 -1.475 . . . . 75.31 107.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.43 HG11 ' OE1' ' A' ' 152' ' ' GLN . 14.7 p -82.67 137.91 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.796 -0.816 . . . . 74.44 108.796 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -57.18 -22.19 38.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.858 1.263 . . . . 74.21 111.687 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -78.48 -36.91 44.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.4 0.519 . . . . 74.14 112.4 -174.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.422 ' HB1' HG12 ' A' ' 99' ' ' VAL . . . -97.64 -0.78 45.03 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.738 0.304 . . . . 72.03 110.597 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 41.3 mm -121.96 133.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 C-N-CA 124.131 0.972 . . . . 73.01 109.337 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.3 mm -99.0 109.73 24.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.418 -0.956 . . . . 74.24 108.418 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -95.68 123.45 39.25 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.464 -1.31 . . . . 72.1 107.464 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.575 ' HG3' ' HB ' ' A' ' 3' ' ' ILE . 8.1 pt-20 -146.98 125.04 12.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.218 -0.66 . . . . 63.12 109.218 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -81.49 95.81 7.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.59 -0.732 . . . . 74.5 109.324 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.37 88.8 6.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.38 -0.97 . . . . 74.14 108.38 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 67.1 mt -71.46 143.14 50.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.233 -0.894 . . . . 73.31 109.909 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.773 -0.632 . . . . 75.03 109.468 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.669 -0.493 . . . . 73.54 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.27 161.59 20.15 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.575 -0.898 . . . . 71.43 108.575 173.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.408 HD12 ' HD3' ' A' ' 5' ' ' LYS . 12.7 tt -133.66 118.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 71.22 109.802 172.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 177' ' ' ILE . 21.5 p90 -122.58 124.09 42.7 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.899 -1.148 . . . . 73.13 107.899 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.504 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 22.2 pttp -153.29 171.24 18.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.381 0.673 . . . . 72.31 109.995 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -105.09 142.77 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 72.11 108.812 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.412 HG22 HG12 ' A' ' 177' ' ' ILE . 22.1 pt -79.68 -9.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.293 0.637 . . . . 75.44 112.603 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -107.76 -60.21 1.74 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.708 0.29 . . . . 74.44 111.657 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 p -125.32 -49.49 1.68 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.837 0.68 . . . . 75.14 112.837 -164.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.488 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -87.31 21.84 2.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 71.44 111.181 -172.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 16.7 t70 -48.24 -21.68 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.013 1.325 . . . . 72.25 112.814 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.95 25.33 2.14 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.823 1.249 . . . . 72.5 112.722 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.494 HD23 ' HD1' ' A' ' 74' ' ' HIS . 40.9 mt -62.99 -92.3 0.0 OUTLIER 'General case' 0 C--N 1.371 1.542 0 CA-C-N 119.128 0.877 . . . . 75.13 110.378 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.403 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 68.1 m -154.65 129.97 9.73 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.994 0.815 . . . . 70.04 112.258 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.7 t -109.67 81.93 1.51 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.224 1.009 . . . . 74.5 108.795 163.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -162.2 166.92 24.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.083 0.953 . . . . 71.15 109.301 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.3 80.91 0.74 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.595 0.712 . . . . 75.54 110.93 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 61.7 m-85 -114.2 139.65 24.02 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.913 1.285 . . . . 75.44 108.98 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 16.5 Cg_exo -68.45 119.86 6.84 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.488 2.125 . . . . 54.3 112.092 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.08 144.13 27.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.637 0.775 . . . . 73.53 109.786 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.19 146.74 47.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.969 -0.752 . . . . 74.05 108.969 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.73 138.67 53.88 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.882 -0.785 . . . . 73.2 108.882 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.35 128.43 63.89 Favored 'Isoleucine or valine' 0 C--O 1.266 1.932 0 N-CA-C 109.001 -0.74 . . . . 61.22 109.001 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 72.78 -85.53 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.933 1.693 . . . . 74.01 108.741 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.5 t70 172.14 28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.575 1.95 . . . . 51.03 106.788 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 tp -135.15 -52.16 0.78 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.485 -0.779 . . . . 71.25 110.712 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.1 t -118.21 131.28 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.088 -0.505 . . . . 64.33 109.783 -168.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -83.62 135.49 34.58 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.122 -1.066 . . . . 74.54 108.122 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.87 155.76 47.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.42 0.629 . . . . 70.45 110.673 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.3 t80 -139.99 147.86 41.05 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.14 -0.936 . . . . 74.32 109.259 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.58 154.02 39.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.712 0.805 . . . . 75.33 111.892 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 156.46 28.42 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.722 -0.275 . . . . 75.02 112.858 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -154.37 159.24 41.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.836 0.854 . . . . 71.44 109.935 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -70.21 120.41 15.86 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.371 -0.603 . . . . 71.12 109.371 169.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.75 168.11 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.896 1.278 . . . . 64.32 108.473 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.97 145.32 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.722 -0.844 . . . . 73.21 108.722 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.741 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 27.2 mmt180 -134.33 109.16 8.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.06 -1.83 . . . . 75.22 106.06 174.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -133.07 97.32 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.761 -0.459 . . . . 74.2 109.761 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 39.95 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 126.616 1.966 . . . . 74.3 115.132 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.75 49.77 0.82 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.787 -0.925 . . . . 75.01 110.787 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -170.78 152.55 3.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.551 1.141 . . . . 73.14 109.0 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tt -156.65 105.73 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.601 0.76 . . . . 70.02 109.694 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -138.59 110.46 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.931 0.892 . . . . 65.24 109.258 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.18 7.05 16.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.918 0.887 . . . . 74.54 110.935 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.09 87.1 0.76 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.253 0.621 . . . . 61.32 109.815 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.36 5.56 4.13 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.78 -0.645 . . . . 73.3 112.839 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.3 p -71.37 90.19 0.94 Allowed 'General case' 0 C--O 1.245 0.851 0 N-CA-C 109.313 -0.625 . . . . 74.4 109.313 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -55.7 125.38 61.07 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.287 1.435 . . . . 71.3 111.048 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.15 104.88 0.12 Allowed 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 122.968 2.445 . . . . 74.52 111.392 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.4 m -81.38 28.02 0.4 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.183 0.993 . . . . 75.22 113.105 -166.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.34 -44.85 72.47 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.298 1.039 . . . . 72.23 110.948 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -137.41 92.5 2.71 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.155 -1.054 . . . . 73.41 108.155 168.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -104.04 -19.45 14.19 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.282 -0.872 . . . . 75.45 109.698 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.54 141.06 6.54 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 109.398 -1.481 . . . . 64.55 109.398 -169.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.45 72.57 4.98 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.702 0.801 . . . . 74.43 110.096 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -164.26 56.66 0.15 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 121.689 0.757 . . . . 63.24 109.901 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.98 139.64 50.63 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.7 -0.682 . . . . 74.13 109.692 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -146.47 93.74 2.34 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.084 -1.08 . . . . 73.42 108.084 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.31 50.23 3.58 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.781 -0.528 . . . . 65.44 111.781 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 27.6 t -86.12 45.14 1.19 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.245 1.018 . . . . 74.35 109.576 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -152.85 66.85 0.8 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.986 1.314 . . . . 62.02 108.462 -173.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.72 -24.03 63.5 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.689 -1.141 . . . . 73.22 111.409 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -88.74 5.86 41.39 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.745 0.818 . . . . 72.34 111.727 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.6 t -123.39 93.89 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.008 -1.108 . . . . 73.51 108.008 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.741 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 3.3 mp0 -72.58 80.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.81 -0.811 . . . . 75.03 108.81 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.37 146.54 24.32 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.084 0.954 . . . . 70.14 109.416 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.65 -143.93 15.07 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.551 -1.019 . . . . 64.3 110.551 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.578 HD12 HD13 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -83.7 122.04 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 117.595 0.698 . . . . 74.22 109.413 -175.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.44 -47.52 9.91 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.756 2.022 . . . . 65.32 113.824 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 169' ' ' LEU . 66.4 mt -51.81 -48.45 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.82 1.248 . . . . 74.43 110.457 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 76' ' ' LEU . 56.0 t -70.56 -41.55 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.816 -1.084 . . . . 73.02 111.75 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 43.8 mt -64.08 -39.77 94.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.564 0.746 . . . . 74.33 111.341 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.25 -38.14 63.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.966 0.906 . . . . 75.1 111.128 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.494 ' HD1' HD23 ' A' ' 13' ' ' LEU . 28.5 m170 -92.07 -11.97 34.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.371 0.669 . . . . 72.43 111.555 -172.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 28.0 mtpp 62.44 46.7 5.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.897 1.279 . . . . 74.1 111.137 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.503 ' HB2' HG13 ' A' ' 71' ' ' VAL . 63.1 mt -80.43 130.79 35.39 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.376 -0.602 . . . . 74.24 109.376 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.8 135.42 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.214 -0.661 . . . . 72.23 109.214 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.45 148.01 24.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 75.42 113.325 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -146.64 103.54 3.67 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 106.307 -1.738 . . . . 74.23 106.307 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -92.6 118.12 30.69 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.931 -0.766 . . . . 75.45 108.931 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.4 p -63.64 -27.85 69.51 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.907 0.483 . . . . 74.21 111.188 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -68.03 -41.62 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.619 -1.173 . . . . 75.44 111.582 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.16 -22.88 13.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.628 0.771 . . . . 72.32 111.998 -170.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -116.66 21.0 13.73 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.456 1.102 . . . . 61.34 110.753 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.97 13.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.89 1.276 . . . . 71.13 113.779 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.9 m -61.45 -56.72 17.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.588 0.755 . . . . 75.34 111.26 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.6 mtp -59.92 -36.71 77.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.882 0.473 . . . . 73.2 111.072 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.42 -39.29 91.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.0 0.52 . . . . 75.15 111.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.06 -38.54 89.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.007 0.523 . . . . 74.34 109.974 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.38 94.11 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.072 -0.967 . . . . 61.52 110.739 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 95' ' ' PHE . 54.2 m-85 -59.28 -50.4 74.15 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 119.0 -0.524 . . . . 73.41 111.107 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mm -55.65 -44.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.453 0.701 . . . . 74.22 111.886 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -64.4 -56.2 15.9 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.099 0.56 . . . . 75.24 109.722 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -65.11 -55.85 16.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.537 0.523 . . . . 75.34 110.069 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 8.4 t80 -45.34 -61.13 1.79 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.325 1.45 . . . . 72.51 112.962 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.619 ' HE2' HG23 ' A' ' 120' ' ' ILE . 28.6 ttt -64.19 -41.27 97.15 Favored 'General case' 0 C--O 1.248 0.984 0 O-C-N 123.415 0.447 . . . . 74.42 111.449 -171.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -62.66 -41.35 99.01 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.139 -0.482 . . . . 74.11 110.683 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.44 -48.62 74.63 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.044 0.84 . . . . 74.33 111.373 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 103' ' ' MET . 29.2 m -62.24 -48.75 86.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.565 0.541 . . . . 75.14 110.433 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.475 HD11 ' HG3' ' A' ' 117' ' ' LYS . 47.0 mt -69.73 -43.01 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 O-C-N 123.308 0.38 . . . . 74.35 110.953 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.06 -37.83 81.04 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.732 0.813 . . . . 73.23 111.877 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -70.84 -41.23 71.76 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.83 0.706 . . . . 65.34 110.608 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.565 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 79.4 mmm -64.81 -36.52 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.079 -0.712 . . . . 75.25 109.079 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.45 -37.54 71.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.129 1.371 . . . . 74.43 110.462 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.619 ' HZ2' ' HB2' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -76.12 -12.82 60.18 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 74.32 111.194 -175.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -104.37 -6.02 21.17 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.211 1.005 . . . . 75.33 109.801 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 47.02 77.29 0.09 Allowed 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.13 1.772 . . . . 73.11 112.225 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.549 ' HG3' ' HE2' ' A' ' 103' ' ' MET . 5.3 mmm180 -61.12 -36.24 79.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.438 -0.801 . . . . 74.22 108.88 166.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.5 t70 152.06 147.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 128.503 2.721 . . . . 74.41 106.063 172.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.6 ' HZ1' ' HB3' ' A' ' 110' ' ' LYS . 7.0 ttpm? -58.0 -51.88 67.84 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.684 0.794 . . . . 72.03 110.99 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.28 -22.37 61.96 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.761 -0.654 . . . . 74.04 111.547 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -80.28 -42.55 22.89 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.107 0.563 . . . . 64.13 111.017 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.21 -27.66 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.965 0.506 . . . . 71.53 110.278 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.29 -36.1 63.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.822 0.849 . . . . 65.43 110.856 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.43 -40.94 76.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.229 0.612 . . . . 64.11 110.147 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -64.62 -40.03 94.76 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.0 0.92 . . . . 72.24 109.588 172.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.475 ' HG3' HD11 ' A' ' 100' ' ' ILE . 29.1 ttpp -63.56 -33.16 74.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.464 0.705 . . . . 75.14 110.721 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -74.93 -39.22 61.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.566 0.746 . . . . 73.23 110.819 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -66.85 -46.9 73.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 64.22 111.447 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.619 HG23 ' HE2' ' A' ' 96' ' ' MET . 10.9 tp -74.01 -32.47 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.182 0.593 . . . . 75.45 109.624 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -62.36 -48.09 81.32 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 122.892 0.477 . . . . 74.21 110.008 172.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.67 98.74 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 124.454 1.096 . . . . 65.03 112.403 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -65.39 -48.95 71.12 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.204 0.602 . . . . 75.44 110.191 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -70.2 -41.81 78.91 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.462 0 CA-C-O 118.216 -0.897 . . . . 71.44 111.133 -174.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 m -71.88 -21.5 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 120.061 1.3 . . . . 74.44 111.507 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.2 t -73.72 -43.24 59.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.246 0.546 . . . . 72.24 109.605 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 34.7 tp -73.04 -36.0 66.84 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.459 1.103 . . . . 75.14 111.405 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.487 ' HA ' ' CE1' ' A' ' 133' ' ' PHE . 77.0 mt -79.83 4.02 17.85 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.587 1.155 . . . . 72.12 112.684 -171.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.13 141.56 49.14 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.486 -0.561 . . . . 62.01 109.486 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.639 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 99.8 mttt -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.561 0.745 . . . . 72.51 111.715 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.28 -16.41 63.01 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.816 0.846 . . . . 70.01 110.64 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.497 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 8.9 tpt180 -96.9 -41.59 8.35 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.324 1.049 . . . . 74.03 109.188 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.639 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.7 m-85 -62.82 -12.85 27.27 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.742 1.217 . . . . 72.14 113.146 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -50.21 -30.31 11.25 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.878 0.736 . . . . 75.44 112.618 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -131.4 17.87 4.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.704 0.801 . . . . 75.05 112.177 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.618 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 26.1 mt -96.12 128.94 43.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.201 0.525 . . . . 74.2 111.381 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.422 ' HB3' ' HE1' ' A' ' 158' ' ' TYR . . . -124.79 139.08 54.18 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 105.362 -2.088 . . . . 74.0 105.362 172.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.479 ' HB3' HG11 ' A' ' 153' ' ' VAL . 98.1 m-85 -116.0 148.03 40.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.501 -0.926 . . . . 72.32 108.501 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -146.56 136.4 23.3 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 107.716 -1.216 . . . . 71.15 107.716 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -127.57 148.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.044 -1.095 . . . . 74.01 108.044 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -51.85 145.49 15.16 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.343 0.497 . . . . 75.2 114.343 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 10.9 tp10 -52.05 -54.97 23.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.743 0.817 . . . . 64.32 111.107 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -72.15 -15.28 61.97 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.898 0.879 . . . . 74.25 111.567 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.96 -34.88 43.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.586 0.755 . . . . 73.32 110.445 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.45 7.57 4.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.078 0.951 . . . . 74.55 112.032 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -73.48 -20.32 60.71 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.861 0.864 . . . . 75.04 109.813 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.01 30.32 0.81 Allowed Glycine 0 C--N 1.356 1.647 0 C-N-CA 123.739 0.685 . . . . 74.42 112.363 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.85 90.27 5.28 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 72.2 110.367 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.35 163.27 25.52 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.026 0.931 . . . . 73.24 112.391 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 79.97 7.34 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.769 1.628 . . . . 74.21 111.495 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.64 -177.61 36.86 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 116.137 1.215 . . . . 63.12 116.137 -170.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -111.95 152.27 28.25 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.825 1.65 . . . . 70.5 109.866 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 138' ' ' PHE . 92.7 t -108.22 136.04 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.935 0.894 . . . . 72.13 108.632 173.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.636 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -64.62 114.44 4.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.098 0.959 . . . . 53.22 110.27 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 170' ' ' MET . 61.3 mt -87.03 107.67 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.99 0.916 . . . . 72.54 108.864 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.48 121.56 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 72.3 110.092 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.62 98.2 7.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.264 1.426 . . . . 74.54 108.974 -166.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.422 ' HE1' ' HB3' ' A' ' 137' ' ' ALA . 57.5 m-85 -82.86 118.65 23.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.761 0.424 . . . . 74.53 110.705 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -125.31 -179.32 4.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.101 0.96 . . . . 75.42 109.436 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -123.86 110.83 15.35 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.215 0.606 . . . . 61.25 110.941 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.95 102.12 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.226 1.01 . . . . 74.0 108.31 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.95 31.55 19.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.239 1.016 . . . . 74.45 110.841 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.57 65.63 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.044 -0.525 . . . . 74.52 113.817 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.7 m -90.42 131.39 36.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.202 0.601 . . . . 74.3 109.841 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -71.14 123.11 21.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.509 0.724 . . . . 72.22 109.979 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.96 102.49 31.4 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.492 1.117 . . . . 75.24 110.21 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.563 ' HB2' HD11 ' A' ' 68' ' ' ILE . 72.3 Cg_endo -85.83 118.33 1.77 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.79 2.327 . . . . 72.3 112.236 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.1 m -103.78 141.91 35.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.991 0.916 . . . . 54.42 109.991 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.657 ' HB2' HD12 ' A' ' 70' ' ' ILE . 46.4 tp -77.22 130.35 37.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.086 -1.079 . . . . 74.21 108.086 171.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.408 ' O ' ' HB ' ' A' ' 155' ' ' ILE . 33.2 tpp -131.4 122.48 26.39 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.863 -1.532 . . . . 74.44 106.863 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' A' ' 154' ' ' ALA . 48.8 mt -159.76 145.65 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.696 1.198 . . . . 74.41 108.107 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.404 ' O ' HG12 ' A' ' 176' ' ' ILE . 14.6 p -80.24 134.43 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.355 0.98 . . . . 75.42 109.795 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -55.27 -30.39 60.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.869 1.268 . . . . 64.03 112.975 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.498 ' HG3' ' HE3' ' A' ' 103' ' ' MET . 6.2 mp0 -71.13 -25.99 62.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.264 0.625 . . . . 74.22 111.713 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.01 -1.5 42.5 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.997 0.519 . . . . 64.04 111.008 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.42 HD11 HD12 ' A' ' 171' ' ' LEU . 42.7 mm -112.5 138.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.039 0.535 . . . . 73.33 110.703 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 38.0 mm -96.62 109.46 23.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 105.96 -1.867 . . . . 75.03 105.96 167.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.6 99.29 6.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.599 -1.63 . . . . 75.21 106.599 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -126.75 155.72 42.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.011 0.924 . . . . 72.51 110.081 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -106.63 113.74 27.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.262 1.025 . . . . 73.23 109.725 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 46.7 m -95.88 91.15 5.89 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.462 -0.79 . . . . 71.41 109.085 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.64 168.81 18.87 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.013 0.525 . . . . 63.45 110.584 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.056 0 N-CA-C 108.853 -0.795 . . . . 75.12 108.853 -178.22 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.854 -0.424 . . . . 75.52 109.854 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.73 130.64 53.17 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.927 0.491 . . . . 72.12 111.538 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 tt -99.15 118.92 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 N-CA-C 107.662 -1.236 . . . . 61.0 107.662 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -125.11 115.1 19.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.426 0.69 . . . . 72.1 110.902 -163.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.723 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 1.5 mptp? -121.3 153.14 38.11 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.49 0.716 . . . . 73.43 110.57 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.35 148.63 22.19 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.454 -0.943 . . . . 75.41 108.454 159.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 175' ' ' ALA . 47.2 pt -83.27 -24.58 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 112.563 0.579 . . . . 73.41 112.563 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -86.99 -64.0 1.22 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.796 0.665 . . . . 74.33 112.796 -169.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 144' ' ' ALA . 6.3 m -132.3 -34.73 1.21 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.877 0.695 . . . . 74.32 112.877 -172.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -92.5 21.79 5.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.941 1.296 . . . . 65.5 110.934 -164.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -46.78 -28.27 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.556 1.542 . . . . 61.22 112.891 -172.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.93 26.26 1.87 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.763 0.825 . . . . 72.32 112.596 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 10' ' ' ASP . 18.2 mt -44.93 -93.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.974 1.31 . . . . 74.34 112.557 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.3 m -156.28 152.26 27.48 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.965 -0.46 . . . . 64.21 110.917 -167.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -140.13 98.81 3.52 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.144 -1.058 . . . . 64.12 108.144 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -161.5 -176.2 5.21 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 110.267 -0.271 . . . . 74.42 110.267 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -68.33 92.82 0.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.36 1.064 . . . . 71.21 110.097 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.443 ' HB3' ' HE2' ' A' ' 30' ' ' PHE . 41.2 m-85 -109.29 139.5 21.11 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 123.486 0.714 . . . . 75.11 111.18 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.36 119.08 6.05 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.197 1.931 . . . . 75.15 110.872 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.0 ttp -126.42 123.2 37.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.469 -0.787 . . . . 75.44 109.184 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.59 131.03 22.32 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.892 -1.521 . . . . 74.25 106.892 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.7 tp -101.77 124.06 46.77 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.81 -0.811 . . . . 74.25 108.81 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.39 140.05 38.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 124.424 1.089 . . . . 74.41 108.551 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 64.29 12.99 7.63 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.006 0.922 . . . . 73.45 112.453 173.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 58.38 21.84 8.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.31 1.044 . . . . 75.25 111.966 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.3 tp -130.74 -52.83 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.758 0.423 . . . . 74.21 110.686 -167.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -117.56 141.61 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.395 0.678 . . . . 64.24 111.239 -167.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' A' ' 178' ' ' GLU . 46.6 m-85 -88.7 118.15 28.17 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.128 0.971 . . . . 74.45 109.936 168.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -85.69 104.41 15.38 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.462 -1.245 . . . . 74.11 107.885 167.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.558 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.7 t80 -100.58 106.81 18.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.419 -1.326 . . . . 74.24 107.419 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.83 154.36 27.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.103 0.477 . . . . 74.11 110.964 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.01 -172.2 23.96 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.094 -0.802 . . . . 73.43 111.094 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -135.21 137.34 42.54 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.468 0.634 . . . . 74.02 110.717 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -74.18 118.67 17.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.796 0.839 . . . . 74.11 109.198 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.561 ' HB ' HD11 ' A' ' 42' ' ' ILE . 12.6 m -141.63 168.67 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.705 1.202 . . . . 72.53 110.69 -165.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.97 114.01 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.765 0.793 . . . . 70.34 109.235 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.785 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 35.8 ttm180 -92.71 111.04 22.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.282 -1.007 . . . . 74.54 108.282 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -120.81 149.31 42.77 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.083 0.953 . . . . 75.34 109.361 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -72.45 81.83 1.07 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.728 -0.841 . . . . 65.23 108.728 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.83 -62.19 0.18 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 114.365 -1.289 . . . . 73.23 110.259 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -172.17 157.95 4.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.634 0.774 . . . . 75.54 110.163 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.561 HD11 ' HB ' ' A' ' 35' ' ' VAL . 6.5 tp -75.33 84.76 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 108.092 -1.077 . . . . 73.14 108.092 169.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.6 -25.53 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.245 -0.888 . . . . 75.44 112.787 -168.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 60.67 88.36 0.08 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.825 0.85 . . . . 75.11 110.112 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.47 4.23 11.19 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.301 1.04 . . . . 71.11 111.081 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.71 -107.57 1.92 Allowed Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.589 0.614 . . . . 64.2 113.373 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.8 m -133.15 96.9 3.85 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.168 0.987 . . . . 73.42 109.638 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -67.83 157.55 86.19 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.173 0.989 . . . . 74.41 110.932 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.6 84.9 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.326 2.018 . . . . 71.31 111.981 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -151.57 107.94 3.46 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.2 1.4 . . . . 74.32 108.116 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.04 -174.21 3.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.623 0.769 . . . . 62.01 110.968 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -77.25 85.17 3.7 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.301 0.572 . . . . 73.11 110.477 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.01 22.91 0.66 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.824 -1.08 . . . . 74.33 110.315 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 174.8 153.83 10.46 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.735 -0.546 . . . . 51.41 111.735 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.55 -1.15 44.59 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.04 0.936 . . . . 72.55 111.591 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.11 103.46 15.95 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.929 0.892 . . . . 72.13 111.191 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -91.09 133.78 35.05 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.223 -0.658 . . . . 73.32 109.223 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -111.51 22.3 15.23 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.583 0.753 . . . . 70.25 110.795 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.06 36.25 18.85 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 110.926 -0.87 . . . . 72.32 110.926 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.5 p -145.53 -57.12 0.32 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.834 0.854 . . . . 65.24 110.393 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.32 -33.4 74.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.238 1.015 . . . . 61.41 111.965 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -129.96 7.37 5.12 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.45 1.1 . . . . 74.15 110.927 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -128.71 -2.6 5.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.083 0.553 . . . . 74.13 112.461 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.99 100.36 2.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 106.346 -1.724 . . . . 65.31 106.346 161.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.785 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 13.2 mm-40 -75.74 69.41 2.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.032 -1.099 . . . . 73.23 108.032 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -82.28 122.26 27.72 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.552 -1.204 . . . . 74.51 108.026 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.78 -164.82 37.64 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.057 -1.617 . . . . 74.34 109.057 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.45 HD13 HD13 ' A' ' 70' ' ' ILE . 37.2 pt -96.65 148.82 5.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 117.471 0.636 . . . . 75.21 110.33 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.69 -30.85 63.87 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.746 1.218 . . . . 71.11 112.312 -174.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.45 HD13 HD13 ' A' ' 68' ' ' ILE . 61.1 mt -56.52 -51.24 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.022 1.329 . . . . 75.01 110.613 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.666 HG11 ' HB2' ' A' ' 76' ' ' LEU . 47.2 t -78.65 -44.11 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 114.451 -1.25 . . . . 73.32 111.21 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.58 -18.17 65.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.666 0.786 . . . . 72.42 112.089 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -48.52 -58.52 4.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.331 1.052 . . . . 74.13 110.681 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.04 -7.72 16.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.819 -0.628 . . . . 64.43 112.598 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttp 62.21 69.88 0.6 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.558 1.161 . . . . 73.34 109.052 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.666 ' HB2' HG11 ' A' ' 71' ' ' VAL . 64.3 mt -75.16 157.03 35.27 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.54 -0.755 . . . . 71.15 109.57 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.51 127.84 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.276 -0.638 . . . . 75.12 109.276 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.87 152.07 20.19 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.939 0.876 . . . . 73.52 112.887 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.587 ' HE3' ' HE2' ' A' ' 91' ' ' TYR . 86.0 mmm -143.83 137.22 27.82 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 104.72 -2.326 . . . . 70.13 104.72 177.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 140.42 35.64 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.327 0.512 . . . . 71.31 109.788 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.43 ' SG ' ' HG3' ' A' ' 134' ' ' LYS . 24.9 p -58.96 -14.81 10.28 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.504 0.722 . . . . 62.54 112.907 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -66.3 -59.09 4.04 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.4 0.68 . . . . 75.54 112.197 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -98.21 -38.24 9.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.846 0.458 . . . . 73.14 110.728 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -92.5 21.59 5.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.622 0.769 . . . . 73.34 112.681 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.2 -53.2 29.67 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.759 0.824 . . . . 63.0 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 m -72.84 -37.72 67.34 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.774 0.83 . . . . 73.14 111.6 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.5 mpt? -66.5 -45.87 78.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.237 1.015 . . . . 74.33 110.3 -176.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.448 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 36.2 t80 -63.38 -47.18 83.12 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.376 -1.284 . . . . 75.43 111.236 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 37.1 ttmt -65.39 -28.83 69.54 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.349 0.405 . . . . 72.53 110.701 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.55 93.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.425 0.69 . . . . 65.43 110.7 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.587 ' HE2' ' HE3' ' A' ' 79' ' ' MET . 31.2 m-85 -61.09 -40.04 92.24 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 115.961 -0.563 . . . . 73.22 111.115 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.0 mm -65.19 -32.54 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.731 0.812 . . . . 75.43 111.675 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 89' ' ' LYS . 96.4 mttt -61.53 -47.45 85.51 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.066 0.547 . . . . 65.0 111.437 171.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -66.91 -42.28 85.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.098 0.559 . . . . 75.44 110.675 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' O ' HG12 ' A' ' 99' ' ' VAL . 79.0 t80 -51.86 -60.79 2.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.117 1.767 . . . . 73.23 111.035 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.9 ttp -61.04 -40.92 95.45 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.731 0.645 . . . . 71.32 111.018 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -56.02 -55.73 29.27 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.214 0.606 . . . . 74.42 110.684 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -72.27 -36.68 69.06 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.496 0.498 . . . . 62.43 111.854 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 95' ' ' PHE . 18.1 m -67.77 -38.78 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.432 0.53 . . . . 63.12 112.432 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.05 -35.93 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 121.001 0.429 . . . . 75.41 110.529 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.78 -47.83 84.54 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.074 0.95 . . . . 71.22 110.765 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -66.56 -44.34 82.58 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.617 -1.174 . . . . 50.33 110.061 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.493 ' HE3' ' HB2' ' A' ' 116' ' ' PHE . 15.4 tpt -55.53 -53.35 57.52 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.118 0.886 . . . . 74.43 111.724 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.443 ' HA ' HG11 ' A' ' 113' ' ' VAL . 41.1 tt0 -65.2 -27.09 68.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.568 0.542 . . . . 73.2 111.579 -172.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.58 -45.28 76.01 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.201 0.524 . . . . 75.12 110.616 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -83.82 -29.54 27.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.081 0.953 . . . . 75.22 111.388 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -99.57 -50.66 4.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.632 0.773 . . . . 72.55 109.938 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 73.29 -13.3 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.146 1.379 . . . . 72.54 113.611 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.22 122.6 33.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.564 -0.902 . . . . 75.32 108.564 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.07 -37.48 85.91 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.189 0.596 . . . . 70.33 112.591 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.8 -30.26 66.68 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.611 0.364 . . . . 74.04 111.834 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.08 -30.92 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.598 0.359 . . . . 70.11 110.317 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 103' ' ' MET . 27.0 m -80.65 -25.68 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 121.903 0.081 . . . . 72.21 110.974 173.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.25 -39.29 94.19 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.649 0.779 . . . . 72.31 109.64 167.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.31 -40.87 67.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.688 -1.142 . . . . 73.01 110.435 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.493 ' HB2' ' HE3' ' A' ' 103' ' ' MET . 78.6 t80 -63.37 -44.95 93.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.805 0.442 . . . . 74.4 111.188 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.401 ' HA ' HG23 ' A' ' 120' ' ' ILE . 15.6 pttp -65.58 -35.75 81.74 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.904 -0.406 . . . . 74.33 109.904 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.28 -36.89 85.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.929 0.892 . . . . 75.41 111.045 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.44 -52.84 22.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.236 0.614 . . . . 74.44 110.633 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.431 HG12 HG22 ' A' ' 99' ' ' VAL . 8.5 tp -73.89 -40.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.164 0.29 . . . . 75.15 110.986 -169.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -68.18 -35.27 77.75 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.283 -0.636 . . . . 75.2 109.283 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.19 94.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.643 -0.708 . . . . 72.33 113.342 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -66.33 -47.89 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.903 -0.776 . . . . 73.54 108.903 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.0 m -74.49 -30.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-N 115.582 -0.736 . . . . 70.44 111.88 -176.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.47 -25.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 119.118 0.872 . . . . 73.15 110.068 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -81.77 -42.2 20.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.022 0.529 . . . . 74.41 111.232 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.524 HD21 HG23 ' A' ' 155' ' ' ILE . 54.7 tp -79.31 -23.95 43.17 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.124 0.969 . . . . 74.54 112.118 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 41.3 mt -93.4 4.4 54.03 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.841 0.456 . . . . 72.14 111.63 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 99.75 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.331 0.652 . . . . 74.22 111.141 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 13.4 ptmm? -51.68 -39.8 58.93 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.863 1.801 . . . . 74.51 115.863 -162.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.31 -29.53 66.28 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.891 0.7 . . . . 74.41 112.891 -163.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -111.51 -29.75 7.64 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.401 0.519 . . . . 72.34 112.401 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.48 -2.22 58.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.495 0.924 . . . . 73.23 113.495 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HG3' ' SG ' ' A' ' 81' ' ' CYS . 26.5 ttpp -51.07 -24.63 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 112.546 0.573 . . . . 74.31 112.546 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.15 25.94 3.99 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.152 0.981 . . . . 75.53 111.66 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.08 142.07 28.19 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.424 -0.954 . . . . 74.43 108.424 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.28 110.51 22.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.341 -1.355 . . . . 73.33 107.341 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.36 143.11 26.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.717 -1.216 . . . . 71.51 107.717 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -137.48 137.38 38.63 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.765 -0.828 . . . . 74.12 108.765 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 tt -109.9 148.15 13.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.355 0 N-CA-C 106.73 -1.582 . . . . 72.12 106.73 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.64 ' HA2' HD21 ' A' ' 76' ' ' LEU . . . -48.37 130.48 20.23 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 124.386 1.053 . . . . 71.34 112.766 175.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 11.0 tp10 -56.98 -38.28 72.79 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.21 0.604 . . . . 73.13 110.923 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -71.54 -35.25 70.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.959 0.904 . . . . 73.23 109.259 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.548 ' HA ' HG22 ' A' ' 9' ' ' THR . . . -65.12 -42.76 93.62 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.255 -0.884 . . . . 63.3 110.628 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -19.52 65.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.287 0.635 . . . . 73.13 112.593 -176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 49.8 mt-10 -79.75 -23.12 42.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.942 0.497 . . . . 63.23 111.928 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.86 49.06 0.08 OUTLIER Glycine 0 C--N 1.348 1.243 0 C-N-CA 121.288 -0.482 . . . . 71.22 113.867 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.96 98.53 0.29 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.858 0.863 . . . . 72.34 110.731 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.57 14.39 4.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.479 0.711 . . . . 73.22 111.221 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.61 -3.78 29.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.281 1.032 . . . . 75.24 111.006 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.68 163.83 35.74 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.891 0.744 . . . . 73.31 114.871 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -78.77 141.62 37.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.043 0.937 . . . . 73.13 112.479 -172.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.05 111.03 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 123.347 0.659 . . . . 73.12 110.028 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.53 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.54 111.36 5.32 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.849 -1.069 . . . . 60.12 108.78 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.524 HG23 HD21 ' A' ' 127' ' ' LEU . 63.0 mt -92.77 124.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.44 -0.948 . . . . 75.23 108.44 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 68' ' ' ILE . 49.7 mm -109.39 111.29 35.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 109.362 -0.607 . . . . 75.51 109.362 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.26 116.15 26.26 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.726 0.641 . . . . 74.13 109.831 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -69.86 88.54 0.56 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.669 1.187 . . . . 74.35 109.304 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -94.65 134.06 37.63 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.149 -0.97 . . . . 73.25 109.816 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.4 102.71 15.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.909 0.484 . . . . 65.02 110.109 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.8 p -90.19 92.31 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 N-CA-C 108.295 -1.002 . . . . 75.21 108.295 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.68 -66.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.914 1.685 . . . . 54.43 111.514 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -163.89 29.05 0.23 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.764 -0.934 . . . . 75.3 110.764 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 98.5 m -135.73 148.08 48.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.583 1.153 . . . . 74.34 108.032 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.53 136.44 36.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.286 0.494 . . . . 73.33 110.054 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.29 112.75 18.22 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.342 1.057 . . . . 73.33 108.271 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 115.4 3.62 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.183 1.922 . . . . 53.42 111.666 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.4 p -111.35 108.66 18.32 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.095 -1.076 . . . . 74.11 108.095 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 19.5 tp -75.96 120.37 21.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.719 0.807 . . . . 75.31 109.538 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.5 mtt -100.1 122.2 42.6 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 123.783 0.833 . . . . 73.45 109.117 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 154' ' ' ALA . 42.6 mt -141.07 140.16 34.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.353 1.461 . . . . 73.45 107.487 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.445 HG12 HG11 ' A' ' 99' ' ' VAL . 10.5 p -81.77 147.59 6.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.395 -0.594 . . . . 71.51 109.395 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -51.06 -44.93 61.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.813 1.245 . . . . 75.02 112.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -82.29 3.65 26.83 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.419 0.896 . . . . 74.31 113.419 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.414 ' HA ' HD13 ' A' ' 7' ' ' ILE . . . -105.93 -5.0 19.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.212 0.605 . . . . 63.21 111.474 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 171' ' ' LEU . 48.2 mm -122.79 143.97 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.448 0.699 . . . . 74.1 110.006 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.723 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 41.3 mm -98.62 109.68 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 N-CA-C 106.905 -1.517 . . . . 75.53 106.905 168.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.447 ' HG2' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -130.19 116.68 18.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.873 0.869 . . . . 74.24 109.575 -171.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -141.28 132.4 26.31 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.191 0.597 . . . . 70.3 109.872 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -76.94 102.8 6.55 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.999 -0.741 . . . . 74.11 108.999 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.7 t -77.73 87.67 3.99 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.403 0.621 . . . . 73.45 110.082 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.9 mt -87.35 92.66 9.15 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.514 -0.921 . . . . 74.11 108.514 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.467 0.707 . . . . 71.12 109.206 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 49.9 ttm . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 108.279 -1.008 . . . . 74.21 108.279 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 mt -91.87 139.77 30.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.442 -0.577 . . . . 73.51 109.442 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.652 HG23 ' HB3' ' A' ' 179' ' ' GLU . 4.0 tt -110.09 117.88 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.448 -0.945 . . . . 74.3 108.448 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.493 ' HD1' ' HB2' ' A' ' 14' ' ' SER . 0.9 OUTLIER -103.09 123.0 45.83 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.309 -1.737 . . . . 72.0 106.309 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -124.14 151.86 43.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.572 0.749 . . . . 75.13 109.899 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 38.8 t70 -99.5 174.67 6.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.577 -0.897 . . . . 64.51 108.577 173.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.49 HD12 HD22 ' A' ' 98' ' ' ASN . 20.6 tt -72.99 -34.73 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.356 0.662 . . . . 72.33 110.995 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.4 -48.45 2.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.093 0.957 . . . . 74.24 109.872 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -88.33 16.37 6.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.143 -1.39 . . . . 73.45 111.394 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 5.8 p-10 -52.7 -39.01 61.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.312 1.045 . . . . 74.22 112.841 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.23 -25.86 67.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.177 -0.919 . . . . 74.45 111.502 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -105.8 -1.61 24.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.599 0.759 . . . . 74.33 112.469 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mt -84.96 -154.45 0.18 Allowed 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.453 1.024 . . . . 74.04 110.309 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.493 ' HB2' ' HD1' ' A' ' 4' ' ' TYR . 15.1 m -115.45 124.54 51.4 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.248 0.462 . . . . 71.54 112.248 -158.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -116.5 85.2 2.26 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.206 -0.665 . . . . 64.2 109.206 168.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' HB3' ' HE1' ' A' ' 18' ' ' PHE . 26.3 t70 -166.03 -105.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.529 -0.76 . . . . 72.23 109.388 -172.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 p -177.91 84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.08 0.952 . . . . 55.04 108.642 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.404 ' HE1' ' HB3' ' A' ' 16' ' ' ASP . 78.0 m-85 -115.75 129.5 25.11 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.315 1.046 . . . . 74.22 109.264 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.87 135.81 43.2 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.078 2.518 . . . . 72.12 112.188 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.28 162.78 37.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.047 -0.524 . . . . 71.32 111.042 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.518 ' HB2' ' HZ3' ' A' ' 21' ' ' LYS . 4.8 ttmp? -144.89 159.56 42.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.784 0.833 . . . . 74.32 109.389 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.23 128.58 50.2 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.325 -0.991 . . . . 75.42 108.325 168.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -120.54 146.15 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.901 0.88 . . . . 73.41 109.817 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 t70 67.52 5.72 4.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.576 1.15 . . . . 73.14 113.153 167.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.56 18.35 6.93 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.597 1.159 . . . . 74.0 111.294 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 119' ' ' LYS . 52.8 tp -129.54 -50.03 1.16 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.004 -0.544 . . . . 73.14 111.131 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.3 t -110.79 124.12 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.4 0.619 . . . . 74.45 110.47 -172.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -85.34 115.8 23.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 114.816 -1.083 . . . . 64.44 108.598 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.505 ' HB2' ' HB3' ' A' ' 21' ' ' LYS . 42.0 mt-10 -89.33 149.34 23.07 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.882 0.873 . . . . 64.34 110.534 173.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.737 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 35.9 t80 -139.84 142.5 36.6 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.875 -1.157 . . . . 75.23 107.875 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.02 120.72 14.13 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.273 0.358 . . . . 74.42 111.672 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.8 157.71 14.78 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.201 -1.16 . . . . 73.42 110.201 166.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -144.9 147.32 32.64 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.598 -0.89 . . . . 74.52 108.598 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -87.59 109.18 19.46 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.624 -0.88 . . . . 65.43 108.624 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG22 HD11 ' A' ' 72' ' ' LEU . 18.5 m -145.22 174.3 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.612 1.165 . . . . 74.54 109.876 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' A' ' 66' ' ' ARG . 25.7 m -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.339 -0.615 . . . . 71.43 109.339 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -120.05 107.58 13.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.591 -0.892 . . . . 71.14 108.591 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HD2' HG23 ' A' ' 64' ' ' VAL . 63.9 tttp -134.83 96.19 3.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.143 -1.058 . . . . 74.32 108.143 166.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 60.02 -66.36 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.564 1.546 . . . . 75.44 112.2 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.02 43.89 0.19 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.662 -0.975 . . . . 75.34 110.662 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -113.93 100.15 8.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.065 0.946 . . . . 74.33 109.448 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.5 tp -92.15 77.24 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 CA-C-O 122.823 1.297 . . . . 75.0 110.335 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 m -120.14 85.78 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.476 -1.238 . . . . 74.42 109.317 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -103.87 156.8 17.55 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.434 -0.803 . . . . 72.22 112.223 -171.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.46 176.14 5.15 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.576 -1.193 . . . . 34.42 108.102 164.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.63 -141.51 9.28 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 121.771 -0.252 . . . . 73.34 113.177 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.0 m -62.02 135.52 57.57 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.513 0.725 . . . . 72.34 109.851 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 64.16 65.74 1.1 Allowed Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.4 1.08 . . . . 74.32 110.119 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -94.76 14.14 1.33 Allowed 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.471 2.781 . . . . 75.4 113.725 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.5 t 58.5 59.91 2.78 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.564 1.146 . . . . 72.22 110.36 -172.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.26 21.2 15.49 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.161 -0.927 . . . . 54.22 111.266 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.01 103.35 1.14 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.025 0.93 . . . . 63.11 109.856 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -89.59 -136.9 0.12 Allowed 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 123.665 0.786 . . . . 75.15 109.187 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.19 38.82 28.63 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 110.245 -1.142 . . . . 72.45 110.245 -169.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.98 70.51 0.5 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.758 1.223 . . . . 75.1 108.062 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -90.48 34.56 0.88 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.809 0.843 . . . . 75.42 111.365 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -91.02 153.04 20.43 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.835 -0.802 . . . . 63.05 108.835 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.2 -22.14 63.91 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.534 0.333 . . . . 71.41 111.532 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.02 -34.67 89.08 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.466 0.479 . . . . 74.53 112.843 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.2 m -89.36 -1.44 58.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.561 0.744 . . . . 73.11 111.001 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -101.48 115.2 29.98 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.853 0.461 . . . . 74.3 110.827 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.535 ' HG2' HG22 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -133.87 27.48 3.93 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.926 1.29 . . . . 64.14 108.085 166.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.7 m80 66.04 22.72 11.17 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.136 1.374 . . . . 72.53 113.011 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' A' ' 62' ' ' GLU . 58.0 t -78.81 80.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 108.061 -1.088 . . . . 71.01 108.061 168.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -88.0 70.76 9.42 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.231 -0.895 . . . . 65.2 108.612 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.472 ' HA ' HG13 ' A' ' 36' ' ' VAL . 8.1 ptp180 -85.14 139.05 32.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.677 -0.692 . . . . 75.54 110.936 172.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.36 -126.68 2.75 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.289 -0.414 . . . . 62.41 112.152 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.529 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 34.6 pt -113.83 142.41 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.383 0.673 . . . . 70.21 112.763 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.6 -46.61 2.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.989 2.116 . . . . 72.33 114.402 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 156' ' ' ILE . 29.5 mm -54.3 -43.19 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.937 0.875 . . . . 75.22 111.023 -176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.6 t -83.2 -40.36 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.388 -1.278 . . . . 75.51 112.402 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 16.5 mt -74.22 -32.33 62.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.063 0.459 . . . . 74.53 110.572 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -78.25 -24.37 46.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.642 0.777 . . . . 75.41 111.535 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -122.47 -6.71 8.69 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.816 0.673 . . . . 62.53 112.816 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.0 tptt 54.63 70.32 0.63 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.111 1.364 . . . . 73.04 110.928 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -96.04 139.35 32.34 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.215 -0.902 . . . . 71.3 109.038 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.636 HG11 HG21 ' A' ' 140' ' ' ILE . 4.0 p -89.85 133.61 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.049 -0.723 . . . . 71.23 109.049 174.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.427 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 pt-20 -56.54 152.48 11.71 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.933 0.893 . . . . 73.02 113.274 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.7 tpt -148.44 144.6 27.53 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 125.206 1.402 . . . . 74.12 107.481 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -137.52 151.48 48.47 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.207 0.527 . . . . 74.52 111.327 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.422 ' O ' ' HB1' ' A' ' 85' ' ' ALA . 26.0 p -88.86 -2.16 58.45 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.143 -0.935 . . . . 73.43 111.327 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -75.52 -61.81 1.79 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.022 0.749 . . . . 74.42 113.022 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -103.96 -35.04 8.27 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.389 0.676 . . . . 75.14 110.439 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.29 20.6 2.32 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 71.11 112.094 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 81' ' ' CYS . . . -55.01 -35.35 64.31 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.38 1.072 . . . . 75.24 113.252 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.1 m -70.03 -44.68 68.75 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 73.4 111.058 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -70.43 -42.1 72.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.42 109.855 -176.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' HE2' HD21 ' A' ' 128' ' ' LEU . 53.2 t80 -68.48 -32.44 72.43 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.463 -1.244 . . . . 74.51 111.36 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.464 ' HZ2' ' HB2' ' A' ' 89' ' ' LYS . 4.4 ttmp? -64.14 -34.92 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.888 0.475 . . . . 72.41 110.522 173.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -39.4 88.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.696 -0.683 . . . . 72.24 109.855 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -69.11 -33.54 73.66 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.765 0.654 . . . . 73.43 112.765 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -62.91 -41.24 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.957 0.503 . . . . 72.03 110.788 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -59.21 -44.66 92.25 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.653 0.595 . . . . 75.52 110.15 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' HA ' ' HZ3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -61.41 -60.25 4.01 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 114.87 -1.059 . . . . 74.13 109.619 177.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -49.25 -62.5 1.5 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.925 1.69 . . . . 62.03 112.955 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.55 -44.64 90.14 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.559 0.537 . . . . 75.11 111.618 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -66.77 -36.11 81.65 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 118.296 0.498 . . . . 75.14 110.674 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.49 HD22 HD12 ' A' ' 7' ' ' ILE . 25.2 t30 -61.26 -53.21 59.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.103 0.961 . . . . 53.32 110.47 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.3 m -78.69 -29.66 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.341 -0.845 . . . . 71.43 112.186 -170.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.55 -40.67 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.787 -0.449 . . . . 75.25 109.787 172.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.32 -36.88 79.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.79 0.836 . . . . 72.24 111.227 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -66.09 -42.57 89.13 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.257 0.623 . . . . 73.33 109.563 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.576 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 27.0 ttt -66.32 -37.06 84.49 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 116.009 -0.541 . . . . 72.33 111.154 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.649 0.78 . . . . 73.33 111.458 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -84.17 -37.63 21.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.35 0.26 . . . . 73.3 111.372 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.576 ' ND2' ' HA ' ' A' ' 103' ' ' MET . 6.0 p30 -96.78 5.25 50.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.173 -0.329 . . . . 74.04 111.823 -175.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -129.85 -50.3 1.14 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.656 0.782 . . . . 74.14 109.742 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 49.28 21.67 0.57 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.868 1.667 . . . . 74.13 112.994 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.2 131.47 51.47 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.686 1.195 . . . . 75.31 108.354 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -63.65 -45.06 91.9 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.281 0.988 . . . . 74.53 111.843 -173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.55 76.19 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.04 0.536 . . . . 73.22 112.115 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.81 -45.37 51.81 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.846 0.459 . . . . 72.2 111.22 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.67 -30.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 123.655 0.597 . . . . 74.42 111.338 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -41.78 76.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.325 0.65 . . . . 74.31 111.072 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.78 -42.45 86.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.01 0.433 . . . . 74.35 110.2 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.424 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 88.3 t80 -67.0 -42.13 85.54 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.036 -0.984 . . . . 64.44 110.762 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 64.3 tttp -53.87 -47.08 71.4 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.996 0.81 . . . . 74.24 110.102 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -65.88 -39.54 90.76 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.736 1.273 . . . . 75.3 109.789 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.525 ' HB3' HD11 ' A' ' 26' ' ' LEU . 8.8 tptp -69.22 -49.17 58.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.287 0.635 . . . . 75.33 109.638 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 tp -74.56 -42.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.991 -0.55 . . . . 64.5 110.874 -170.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 12.5 pt20 -66.07 -39.47 90.08 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 109.572 -0.529 . . . . 73.51 109.572 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.73 99.23 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.501 0.5 . . . . 71.21 112.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -67.82 -50.99 53.71 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 118.98 -0.534 . . . . 71.45 109.935 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.513 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.7 m -68.32 -43.3 84.5 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 O-C-N 123.654 0.596 . . . . 73.44 111.299 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 -25.56 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.083 0.553 . . . . 74.41 110.894 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -77.67 -40.52 41.29 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.878 0.471 . . . . 73.02 110.575 167.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.555 HD21 HG22 ' A' ' 155' ' ' ILE . 41.0 tp -73.71 -28.42 61.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.917 1.287 . . . . 73.35 111.5 -171.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 83.9 mt -84.37 1.55 44.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.722 0.809 . . . . 75.24 111.082 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.83 85.37 2.2 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 123.455 0.702 . . . . 75.31 109.416 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -55.67 -29.49 59.41 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.679 1.592 . . . . 75.2 114.556 -166.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.33 -22.8 61.12 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.349 0.5 . . . . 72.14 112.349 -171.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -103.18 -51.34 3.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.071 0.948 . . . . 72.24 108.806 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -76.96 0.24 21.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.697 1.599 . . . . 73.4 114.9 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -46.25 -7.44 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.435 1.642 . . . . 64.35 115.435 171.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -82.18 9.76 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.955 0.902 . . . . 71.3 111.339 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.02 148.07 23.29 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.736 0.814 . . . . 73.31 109.089 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.425 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . . . -138.92 116.07 11.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.19 -1.781 . . . . 75.24 106.19 170.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -89.15 147.63 24.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.29 -1.004 . . . . 65.33 108.29 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.427 ' CD1' ' HA ' ' A' ' 78' ' ' GLU . 75.7 m-85 -141.27 143.15 33.95 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.389 -0.597 . . . . 73.05 109.389 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.636 HG21 HG11 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -123.61 138.01 54.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 105.174 -2.158 . . . . 74.33 105.174 176.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.92 126.28 39.68 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.125 -0.82 . . . . 62.31 111.336 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -56.75 -38.56 72.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 75.4 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -57.26 -47.09 82.3 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.628 1.171 . . . . 74.21 111.253 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.43 84.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.325 0.65 . . . . 72.42 111.149 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.0 -3.59 16.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.653 -0.703 . . . . 72.12 112.237 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -104.9 -18.02 14.35 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.319 1.048 . . . . 64.51 110.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.71 -74.32 0.01 OUTLIER Glycine 0 C--N 1.355 1.594 0 O-C-N 122.307 -0.246 . . . . 64.14 112.778 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.25 80.24 9.13 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.534 0.734 . . . . 70.43 109.809 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.01 1.56 2.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.29 1.036 . . . . 73.05 113.587 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -97.89 9.06 43.66 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.983 0.913 . . . . 75.14 110.624 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.04 154.62 43.76 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.796 0.685 . . . . 52.43 112.718 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.61 143.91 28.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 74.21 111.077 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.14 116.34 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.295 0.638 . . . . 73.32 110.636 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.417 ' HA ' HD22 ' A' ' 171' ' ' LEU . . . -69.35 113.95 7.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.745 1.218 . . . . 74.3 109.721 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.555 HG22 HD21 ' A' ' 127' ' ' LEU . 75.1 mt -91.59 109.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.217 -0.66 . . . . 71.14 109.217 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 169' ' ' LEU . 40.0 mm -96.71 144.7 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.431 -0.581 . . . . 74.5 109.431 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.99 109.66 9.71 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.251 -1.018 . . . . 61.32 108.251 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 6.2 p90 -83.4 91.96 7.46 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.352 -1.351 . . . . 74.42 107.352 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.499 ' HB3' HG12 ' A' ' 166' ' ' VAL . 7.5 tpt180 -74.4 91.61 2.24 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.158 -1.383 . . . . 74.44 108.72 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.35 112.44 5.22 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.21 -0.905 . . . . 75.12 110.904 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.48 92.08 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.526 1.13 . . . . 64.34 108.581 168.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 t70 46.35 61.87 2.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.568 1.547 . . . . 75.1 112.515 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.92 -12.8 68.68 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-N 115.515 -0.766 . . . . 73.34 113.441 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.18 106.97 17.71 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.004 -0.739 . . . . 74.33 109.004 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.635 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 14.4 pt-20 -73.31 141.09 47.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.484 -0.561 . . . . 75.21 109.484 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 159' ' ' ARG . 3.7 p -127.27 91.29 46.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 108.199 -1.037 . . . . 74.23 108.199 166.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.568 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 52.1 Cg_exo -56.24 143.51 84.99 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.148 2.565 . . . . 61.33 112.663 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.1 m -145.87 126.47 14.21 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 74.03 108.576 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.7 tp -77.35 130.33 37.0 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.416 -0.957 . . . . 64.21 108.416 170.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.6 mtt -128.85 123.8 33.67 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.188 0.995 . . . . 75.23 108.622 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 154' ' ' ALA . 79.7 mt -141.32 170.89 14.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.878 1.671 . . . . 74.24 106.512 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.8 p -83.42 147.22 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 108.836 -0.802 . . . . 72.11 108.836 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.91 -27.55 43.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.909 0.884 . . . . 74.22 112.456 175.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 12.8 tp10 -85.56 -2.44 58.15 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.768 0.827 . . . . 73.4 111.574 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.99 -11.99 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.859 0.864 . . . . 74.5 110.159 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.2 mm -108.81 140.88 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.286 0.565 . . . . 73.24 110.879 -174.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.1 mm -124.08 109.19 22.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.444 1.498 . . . . 74.34 107.192 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.68 121.02 31.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.568 -0.901 . . . . 74.44 108.568 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.652 ' HB3' HG23 ' A' ' 3' ' ' ILE . 33.6 tt0 -121.92 116.01 23.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.185 -1.043 . . . . 74.33 108.185 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.521 ' HB3' ' HZ2' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -100.04 109.85 22.16 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.166 0.508 . . . . 71.24 111.609 -170.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 1' ' ' MET . 47.7 t -100.88 95.43 6.61 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.729 -0.841 . . . . 74.1 108.729 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.28 -35.35 0.55 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.137 0.975 . . . . 74.13 110.583 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 C--O 1.248 0.992 0 C-N-CA 123.736 0.814 . . . . 75.53 109.368 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttm . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.037 -0.727 . . . . 75.21 109.037 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 99.0 mt -123.21 133.92 54.18 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.365 0.266 . . . . 72.4 110.51 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 61.8 mt -106.55 117.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.668 -1.234 . . . . 74.51 107.668 170.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.603 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 91.5 m-85 -89.71 122.16 32.55 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.507 -0.923 . . . . 75.23 108.507 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.19 131.4 53.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.628 0.771 . . . . 71.31 110.776 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.551 ' HA ' HG12 ' A' ' 176' ' ' ILE . 25.0 t70 -90.34 174.44 7.58 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.334 1.021 . . . . 64.01 108.433 172.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 7' ' ' ILE . 8.3 mt -53.74 -58.97 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.184 0.594 . . . . 63.52 110.967 171.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -112.7 -23.1 10.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 73.21 111.517 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -98.24 14.12 28.91 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.998 0.919 . . . . 74.43 110.563 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.3 p-10 -48.28 -33.08 8.21 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 124.245 1.018 . . . . 63.41 113.422 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.56 -42.93 64.1 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.194 -0.912 . . . . 70.31 110.97 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.618 ' HB2' ' HG2' ' A' ' 143' ' ' ARG . 5.0 tp10 -121.25 24.72 9.89 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.188 0.595 . . . . 74.11 111.581 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 2.6 tm? -77.19 -81.88 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.11 -0.7 . . . . 75.53 109.11 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 53.1 m -157.4 -178.35 7.28 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.154 0.982 . . . . 71.43 110.386 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.675 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 73.4 p 177.3 -177.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.276 1.03 . . . . 72.24 111.397 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 85.91 -109.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.188 1.795 . . . . 71.14 111.634 165.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -144.04 42.39 1.42 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.86 -0.793 . . . . 75.13 108.86 -163.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -108.31 98.89 29.47 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.352 -0.84 . . . . 71.53 109.372 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.36 134.81 9.13 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 124.153 3.235 . . . . 72.42 114.978 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.15 146.55 42.18 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.125 -0.943 . . . . 71.13 108.596 174.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 66.6 mttm -110.66 157.45 19.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.198 -1.408 . . . . 74.25 107.198 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -130.73 108.06 9.61 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.629 -0.878 . . . . 75.35 108.629 175.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.48 127.46 50.98 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 109.018 -0.734 . . . . 75.31 109.018 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.2 t70 56.24 25.37 9.17 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.417 1.073 . . . . 74.45 112.485 175.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 53.11 16.02 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.063 1.135 . . . . 71.42 114.063 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 119' ' ' LYS . 34.5 tp -105.07 -51.48 3.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.947 0.499 . . . . 73.51 110.201 -174.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.472 HG13 ' SD ' ' A' ' 170' ' ' MET . 21.6 t -123.49 133.72 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 116.547 -0.297 . . . . 73.35 111.376 -168.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 m-85 -84.76 120.12 26.06 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.576 -0.898 . . . . 53.13 108.576 167.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 40.2 tt0 -99.06 103.18 15.09 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.696 -1.224 . . . . 74.04 107.696 170.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.718 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 30.7 t80 -94.21 141.2 28.83 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.848 1.259 . . . . 75.4 109.307 -169.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -71.49 139.88 49.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.837 0.855 . . . . 71.21 112.718 -169.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.29 149.73 17.13 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 114.768 -1.106 . . . . 64.04 111.257 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -126.93 161.41 28.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.961 0.904 . . . . 75.41 108.658 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -75.19 120.67 21.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.603 -0.517 . . . . 70.53 109.603 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.492 HG22 HD12 ' A' ' 72' ' ' LEU . 4.1 m -145.06 164.58 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.442 0.697 . . . . 74.03 110.486 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -94.89 160.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.217 -0.447 . . . . 72.44 110.765 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -142.74 112.44 6.87 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.912 -0.403 . . . . 72.41 109.912 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -125.27 140.21 53.03 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.468 -0.938 . . . . 75.44 108.468 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.776 ' HG3' ' HB3' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -59.73 -26.41 65.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 123.388 0.43 . . . . 74.11 111.699 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.0 -61.7 4.44 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.657 0.598 . . . . 74.14 111.802 172.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.8 152.09 0.94 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.137 0.975 . . . . 73.35 108.719 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tt -72.53 102.83 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 121.397 0.618 . . . . 63.15 109.682 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.4 t -109.32 81.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.277 1.031 . . . . 71.31 108.526 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -85.27 -18.85 32.7 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.964 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.16 127.06 55.46 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.183 0.993 . . . . 54.33 108.86 175.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.65 68.19 1.23 Allowed Glycine 0 C--N 1.346 1.107 0 O-C-N 123.403 0.439 . . . . 71.31 112.177 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.1 p -84.92 123.23 30.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.104 0.562 . . . . 73.0 109.892 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -67.01 151.65 96.89 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.295 0.638 . . . . 75.41 110.377 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.88 97.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.379 2.053 . . . . 75.31 111.218 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.7 t -58.64 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.345 1.058 . . . . 73.44 111.415 -174.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.11 94.24 7.03 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.934 -1.03 . . . . 75.33 109.814 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -77.38 88.06 3.77 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.621 0.724 . . . . 74.12 109.071 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -134.3 91.31 2.78 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.777 -1.101 . . . . 74.13 109.154 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.08 122.75 0.7 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.924 -1.034 . . . . 52.43 111.21 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.16 89.68 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.424 0.69 . . . . 75.02 111.258 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -73.38 100.67 3.26 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.775 -0.648 . . . . 73.55 109.274 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -76.78 145.69 38.36 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.182 0.993 . . . . 63.13 110.857 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -114.15 -4.0 13.17 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.633 0.773 . . . . 63.13 111.869 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.03 84.04 0.06 OUTLIER Glycine 0 CA--C 1.534 1.273 0 O-C-N 123.976 0.798 . . . . 45.13 114.169 -172.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.6 p -100.32 167.8 10.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.36 1.064 . . . . 63.43 110.394 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -73.54 -12.21 60.69 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.669 0.787 . . . . 71.14 111.893 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -53.13 -44.18 67.51 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.456 1.102 . . . . 74.02 109.935 167.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.776 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 34.0 p-80 -129.84 84.81 2.24 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.503 -1.226 . . . . 74.31 107.923 174.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.64 -31.36 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 122.628 0.371 . . . . 72.13 110.558 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 73.53 -57.71 0.62 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.327 1.851 . . . . 73.33 111.604 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -116.13 129.28 56.25 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.285 1.034 . . . . 75.1 109.082 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.08 -165.02 29.4 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.234 -0.984 . . . . 73.44 113.287 166.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.51 HD11 HG23 ' A' ' 156' ' ' ILE . 26.4 pt -104.12 146.89 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 113.914 -1.143 . . . . 72.54 110.988 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.2 -47.16 35.61 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.312 1.445 . . . . 71.52 112.614 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 169' ' ' LEU . 67.6 mt -52.73 -45.65 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.073 -1.421 . . . . 74.12 111.333 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 76' ' ' LEU . 53.7 t -94.04 -28.56 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.017 0.527 . . . . 74.21 112.063 -173.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.492 HD12 HG22 ' A' ' 35' ' ' VAL . 84.2 mt -75.66 -18.67 59.57 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 122.227 -0.296 . . . . 72.23 110.31 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -95.37 -55.82 2.92 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.388 0.675 . . . . 75.52 110.638 172.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -86.79 3.32 45.65 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.755 0.422 . . . . 71.31 112.1 -171.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.683 ' HE3' ' HG3' ' A' ' 142' ' ' GLU . 34.4 ttpt 58.03 35.36 25.15 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.897 0.856 . . . . 75.35 111.682 165.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.549 ' HB2' HG23 ' A' ' 71' ' ' VAL . 59.2 mt -74.52 141.59 44.85 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.021 -0.536 . . . . 75.32 110.438 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.184 0.594 . . . . 74.15 110.36 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.26 145.27 42.05 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.75 1.389 . . . . 74.24 114.75 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.519 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 80.3 mtp -141.91 134.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.616 1.966 . . . . 73.34 105.813 171.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.537 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.2 m-80 -93.77 138.17 32.24 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.915 0.325 . . . . 72.04 110.204 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.426 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 29.7 p -67.08 -21.7 65.86 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.528 0.331 . . . . 44.15 111.28 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.537 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 64.0 m-85 -58.23 -52.75 64.27 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.978 -1.01 . . . . 73.14 110.567 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -105.28 -36.85 7.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.147 0.979 . . . . 73.55 112.847 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -91.91 18.95 7.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.596 0.759 . . . . 75.15 112.701 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.07 98.87 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.45 0.568 . . . . 71.2 111.194 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -65.63 -45.25 83.76 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.265 1.026 . . . . 73.25 111.467 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.09 -38.8 92.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.562 -0.745 . . . . 71.35 110.797 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 86.1 t80 -75.99 -28.91 58.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.956 0.902 . . . . 75.42 111.035 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -68.59 -38.38 80.62 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.497 -0.557 . . . . 64.25 109.497 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.4 98.89 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.778 -1.101 . . . . 70.22 110.477 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.45 ' HE2' ' HE1' ' A' ' 79' ' ' MET . 20.3 m-85 -59.09 -45.63 90.35 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.547 -0.751 . . . . 73.41 110.616 173.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.47 -40.37 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.699 . . . . 71.32 111.688 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.479 ' HE2' ' HA ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -63.29 -45.42 91.49 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.627 0.371 . . . . 75.25 111.531 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.495 ' HB3' ' HZ1' ' A' ' 94' ' ' LYS . 8.7 mtpm? -73.08 -47.06 47.78 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.73 -0.668 . . . . 74.41 110.893 -177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -53.51 -44.82 69.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.032 1.733 . . . . 75.24 111.201 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.1 ttm -59.04 -53.58 56.8 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.079 0.862 . . . . 72.32 110.521 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HZ3' ' HB2' ' A' ' 101' ' ' ASP . 24.7 tptp -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.173 -0.921 . . . . 74.11 110.933 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.82 -47.47 46.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.572 0.749 . . . . 72.42 112.254 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.431 HG12 ' HB3' ' A' ' 175' ' ' ALA . 31.0 m -69.54 -34.06 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.044 0.538 . . . . 54.45 112.14 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.52 -35.14 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 123.168 0.292 . . . . 72.22 110.585 176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.464 ' HB2' ' HZ3' ' A' ' 97' ' ' LYS . 27.2 t70 -58.92 -46.16 88.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.471 0.709 . . . . 74.21 110.077 173.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -62.51 -48.86 77.71 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.51 -0.768 . . . . 71.33 110.687 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.531 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.7 tpt -61.93 -38.75 89.6 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.717 0.807 . . . . 61.51 111.053 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.597 ' HA ' HG13 ' A' ' 113' ' ' VAL . 43.4 tt0 -71.88 -38.89 69.94 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.274 1.03 . . . . 74.34 110.27 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -80.51 -27.45 37.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.59 0.356 . . . . 74.31 111.609 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.28 -36.29 27.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.018 0.527 . . . . 72.43 110.839 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -101.13 -49.26 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.196 0.598 . . . . 73.45 110.945 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 70.24 4.24 4.78 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.37 1.248 . . . . 71.54 114.37 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -99.44 117.89 34.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.984 -0.747 . . . . 74.13 108.984 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -50.76 -45.17 58.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.991 1.316 . . . . 70.04 112.189 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.45 66.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.017 0.527 . . . . 75.22 112.417 -173.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.99 -45.26 18.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.67 0.388 . . . . 73.4 110.137 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.597 HG13 ' HA ' ' A' ' 104' ' ' GLU . 33.7 m -71.65 -23.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 116.368 -0.378 . . . . 74.43 111.248 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.05 -43.89 91.74 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.51 0.724 . . . . 71.32 110.534 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.44 -46.3 76.91 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.902 0.751 . . . . 73.31 110.164 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -57.6 -48.13 80.26 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.34 0.656 . . . . 71.1 111.787 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.67 -30.65 67.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.648 -0.501 . . . . 74.14 109.648 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -61.16 -45.1 96.02 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.735 -0.839 . . . . 73.5 108.735 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.421 ' HB3' HD21 ' A' ' 26' ' ' LEU . 3.1 mptm? -65.52 -46.46 79.51 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 75.21 110.875 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.484 HD12 HG23 ' A' ' 172' ' ' VAL . 26.7 mm -66.83 -42.06 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 119.319 -0.372 . . . . 73.25 110.495 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -54.77 -57.29 12.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.776 0.831 . . . . 62.14 109.999 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.7 -38.35 95.76 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.748 0.655 . . . . 64.22 113.259 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -64.69 -53.28 49.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.904 0.882 . . . . 75.41 110.442 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 120' ' ' ILE . 34.0 m -70.57 -30.48 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 119.276 -0.392 . . . . 74.31 111.553 -177.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.53 -41.46 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 118.501 0.591 . . . . 62.43 110.328 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.6 t -65.84 -43.5 88.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 120.96 0.41 . . . . 64.54 109.922 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 155' ' ' ILE . 21.1 tp -73.11 -30.08 63.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.662 1.185 . . . . 73.34 112.221 -169.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.55 3.07 45.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.448 0.699 . . . . 73.52 111.951 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -67.62 150.97 48.07 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.458 0.703 . . . . 73.24 111.217 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 17.3 ptpt -93.45 -28.7 15.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.086 1.143 . . . . 74.2 114.086 -175.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.08 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.117 0.872 . . . . 74.35 113.267 -165.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -110.81 -32.87 6.7 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.213 0.605 . . . . 72.41 111.296 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 98.1 m-85 -78.17 -1.23 31.7 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.489 0.716 . . . . 73.54 112.038 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.2 pttp -55.59 -20.99 15.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.167 -0.333 . . . . 75.41 111.133 160.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -82.48 17.28 1.79 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.704 1.201 . . . . 74.15 110.856 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 156' ' ' ILE . 93.3 mt -89.8 148.05 23.44 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.079 -0.711 . . . . 71.3 109.079 170.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.75 126.45 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.739 -1.578 . . . . 70.22 106.739 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.519 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 11.1 m-85 -91.37 134.12 34.87 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.617 -0.512 . . . . 75.12 109.617 -171.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.27 151.91 50.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.298 0.639 . . . . 71.11 109.293 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.4 pt -137.16 170.7 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.317 -0.994 . . . . 74.41 108.317 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.64 44.42 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.872 -0.491 . . . . 71.22 111.872 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.683 ' HG3' ' HE3' ' A' ' 75' ' ' LYS . 10.7 mm-40 -53.24 -43.15 67.11 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.32 1.048 . . . . 75.22 112.259 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.618 ' HG2' ' HB2' ' A' ' 12' ' ' GLU . 3.0 mmt180 -65.67 -37.37 86.32 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.332 0.653 . . . . 75.12 110.353 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -59.86 -58.6 7.85 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.044 0.84 . . . . 73.34 109.136 173.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.85 -17.96 63.67 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.997 0.919 . . . . 72.11 113.084 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.49 -41.03 40.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 70.44 110.997 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.67 -26.43 0.03 OUTLIER Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.369 -0.378 . . . . 74.52 113.591 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -72.86 177.11 5.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.062 0.431 . . . . 71.14 111.229 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.09 -172.61 2.31 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 122.153 -0.342 . . . . 74.33 110.68 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.34 -49.95 12.67 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.14 0.793 . . . . 62.12 113.14 -161.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.09 -98.58 0.17 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.235 -0.746 . . . . 75.15 111.235 -156.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -121.93 144.09 49.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.155 0.582 . . . . 74.22 110.104 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 155' ' ' ILE . 89.2 t -75.96 133.09 31.91 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 108.433 -0.951 . . . . 72.43 108.433 166.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.43 97.16 0.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.645 -0.872 . . . . 75.24 108.645 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 127' ' ' LEU . 55.3 mt -85.87 101.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 108.515 -0.92 . . . . 72.32 108.515 -171.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.51 HG23 HD11 ' A' ' 68' ' ' ILE . 36.1 mm -91.85 140.22 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.036 -0.727 . . . . 74.11 109.036 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.41 105.47 7.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.232 -1.025 . . . . 73.14 108.232 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 12.2 p90 -73.5 88.77 1.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.396 -0.964 . . . . 63.2 108.396 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -92.68 174.14 7.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.425 1.49 . . . . 74.12 108.85 -165.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.75 138.73 54.54 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.258 0.623 . . . . 74.43 110.575 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.32 102.63 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 124.401 1.081 . . . . 75.33 109.302 169.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.5 t70 62.46 24.96 14.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 124.266 1.026 . . . . 73.42 112.474 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.12 -14.02 33.85 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 121.797 -0.564 . . . . 72.13 113.008 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -94.78 122.23 37.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.524 0.729 . . . . 74.11 110.336 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.94 116.18 13.14 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-O 121.151 0.5 . . . . 74.51 110.047 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.21 93.68 46.42 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 115.07 -0.968 . . . . 73.41 110.523 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 11.4 Cg_endo -52.48 121.52 9.2 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.623 2.882 . . . . 75.3 112.498 167.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.6 p -107.99 117.13 33.34 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.374 1.07 . . . . 72.33 108.429 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.718 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 17.4 tp -80.17 117.57 21.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.416 -0.587 . . . . 75.33 109.416 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.472 ' SD ' HG13 ' A' ' 27' ' ' VAL . 30.7 tpp -100.96 120.82 40.73 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 107.205 -1.406 . . . . 74.42 107.205 -175.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.438 HD22 HD11 ' A' ' 176' ' ' ILE . 84.0 mt -143.77 143.87 31.56 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.656 1.182 . . . . 74.13 109.207 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.484 HG23 HD12 ' A' ' 120' ' ' ILE . 15.0 p -91.07 138.32 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.972 0.805 . . . . 74.53 109.763 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.54 -26.45 67.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.323 1.449 . . . . 74.24 112.011 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -86.14 -0.97 56.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.134 0.574 . . . . 64.22 112.343 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.431 ' HB3' HG12 ' A' ' 99' ' ' VAL . . . -120.0 -18.75 8.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.605 0.762 . . . . 62.45 110.553 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.551 HG12 ' HA ' ' A' ' 6' ' ' ASP . 3.3 mt -136.64 139.58 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.336 0.654 . . . . 71.14 110.219 -172.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 30.8 mm -142.17 139.59 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.449 1.1 . . . . 71.24 108.114 -171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.02 143.01 34.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.27 0.557 . . . . 74.54 109.992 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.532 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.7 tp10 -101.33 109.39 21.23 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.098 -1.075 . . . . 74.21 108.098 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -69.84 98.04 1.18 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.886 0.741 . . . . 73.13 109.951 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.7 t -108.16 91.63 3.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.274 -1.01 . . . . 73.11 108.274 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.36 173.8 14.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.037 0.535 . . . . 75.41 110.634 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.254 1.332 0 CA-C-N 114.923 -1.035 . . . . 74.14 108.552 178.822 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HG3' ' SG ' ' A' ' 181' ' ' CYS . 26.2 ptt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.946 0.403 . . . . 70.53 110.212 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 180' ' ' LYS . 95.6 mt -118.72 159.82 22.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.505 0.722 . . . . 72.42 110.067 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 56.3 mt -126.8 118.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 106.996 -1.483 . . . . 65.25 106.996 171.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.756 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 5.6 t80 -101.4 113.94 27.48 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.015 -1.106 . . . . 73.13 108.015 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -125.59 117.13 22.9 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.131 0.972 . . . . 75.33 110.295 -167.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.87 134.83 48.36 Favored 'General case' 0 C--O 1.205 -1.285 0 N-CA-C 108.344 -0.984 . . . . 71.42 108.344 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 pt -66.39 -5.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 113.293 0.849 . . . . 75.43 113.293 -170.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -107.94 -46.72 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.736 -0.838 . . . . 71.41 108.736 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 p -111.82 18.66 18.71 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.827 1.251 . . . . 74.0 112.456 -173.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -46.94 -42.22 17.4 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.183 1.793 . . . . 72.54 113.545 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -55.95 -39.13 71.29 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.89 1.369 . . . . 73.54 112.543 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -120.61 11.32 11.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.176 0.591 . . . . 74.42 111.458 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -95.9 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 112.871 0.693 . . . . 73.13 112.871 -163.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.756 ' HB3' ' HB3' ' A' ' 4' ' ' TYR . 35.5 t -158.21 178.44 10.18 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.93 0.787 . . . . 64.21 111.367 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 33.0 p 163.32 104.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.691 1.597 . . . . 74.51 109.377 -168.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -171.59 161.07 6.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.572 0.749 . . . . 73.43 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -68.87 83.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.391 0.676 . . . . 72.41 111.316 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.598 ' HZ ' ' HB2' ' A' ' 4' ' ' TYR . 3.8 p90 -127.18 159.09 66.93 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.906 0.882 . . . . 71.13 110.275 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.97 120.86 3.08 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.134 1.89 . . . . 70.32 112.883 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.587 ' HB2' ' HE2' ' A' ' 28' ' ' TYR . 17.8 ptm -87.71 157.88 18.95 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.052 0.541 . . . . 73.21 110.527 174.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -152.03 145.63 24.95 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.038 -0.727 . . . . 73.33 109.038 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.55 125.78 52.88 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.502 -0.925 . . . . 71.33 108.502 173.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.19 129.81 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.281 0.632 . . . . 71.32 110.268 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.92 23.74 6.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.151 1.38 . . . . 74.22 113.992 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 t70 54.76 26.83 8.04 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.829 0.852 . . . . 71.23 112.054 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.534 HD12 ' HE2' ' A' ' 119' ' ' LYS . 64.7 tp -135.1 -51.17 0.77 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.991 0.901 . . . . 75.51 110.483 -170.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -120.41 148.7 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.888 -1.506 . . . . 74.5 107.885 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.587 ' HE2' ' HB2' ' A' ' 20' ' ' MET . 44.6 t80 -86.18 139.39 31.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.244 -1.021 . . . . 75.35 108.244 170.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -123.61 129.37 51.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.805 0.842 . . . . 74.42 109.695 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.713 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 48.8 t80 -114.31 124.68 52.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.128 0.571 . . . . 74.03 109.473 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.46 95.74 8.36 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.942 -0.762 . . . . 75.43 108.942 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.3 176.56 46.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.751 -0.659 . . . . 72.32 112.464 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -125.13 158.06 34.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.355 0.662 . . . . 74.25 109.629 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -90.59 117.57 29.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.194 -0.669 . . . . 73.21 109.194 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 72' ' ' LEU . 19.7 m -143.49 153.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.494 0.664 . . . . 73.42 110.098 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.6 127.53 66.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.544 -1.28 . . . . 72.34 107.544 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 10.7 tpt180 -105.3 108.55 20.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 106.677 -1.601 . . . . 73.23 106.677 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -106.26 96.59 6.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.895 -0.78 . . . . 73.52 108.895 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 46.64 58.46 4.63 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.087 1.355 . . . . 73.23 111.962 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.97 -33.09 3.86 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.937 -1.029 . . . . 74.34 113.657 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -93.19 116.16 28.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.45 1.1 . . . . 74.42 110.033 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.1 tt -80.83 115.88 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 109.048 -0.723 . . . . 75.22 109.048 172.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.03 90.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.462 1.105 . . . . 71.21 108.591 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 pp -101.89 173.09 6.56 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.954 0.901 . . . . 74.43 111.265 -177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.12 -43.01 0.06 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.875 -1.057 . . . . 75.25 108.698 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.24 135.1 2.04 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.546 -0.752 . . . . 64.01 111.556 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m -81.91 82.69 7.46 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 117.379 0.589 . . . . 73.34 109.923 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -55.73 -48.62 96.15 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.949 0.899 . . . . 74.4 111.558 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.14 149.03 45.43 Favored 'Trans proline' 0 C--N 1.391 2.795 0 CA-C-N 120.53 1.225 . . . . 72.24 111.307 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.0 m -77.01 171.33 14.98 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.529 -0.545 . . . . 64.53 109.529 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.72 86.0 0.92 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.192 0.52 . . . . 74.05 110.103 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.99 86.16 4.19 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.325 1.05 . . . . 72.44 109.589 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 15.8 mm-40 -94.47 70.73 3.67 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.62 0.768 . . . . 73.02 109.628 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.57 11.05 6.06 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.058 -0.973 . . . . 73.12 112.802 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.93 94.05 9.49 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.162 -0.681 . . . . 74.44 109.162 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -79.33 -36.86 38.85 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.681 0.793 . . . . 75.52 111.269 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -79.61 -23.39 42.67 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.3 -0.863 . . . . 64.43 110.954 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -137.09 126.66 25.22 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.724 0.81 . . . . 53.1 109.504 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.77 37.77 0.76 Allowed Glycine 0 N--CA 1.466 0.661 0 N-CA-C 111.375 -0.69 . . . . 72.1 111.375 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.5 p -80.02 138.17 36.96 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.177 0.591 . . . . 73.51 109.565 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -94.66 96.63 9.54 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.219 0.608 . . . . 75.51 109.529 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -76.16 -178.82 4.65 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.296 -0.631 . . . . 62.21 109.296 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -79.75 16.02 1.23 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.416 0.286 . . . . 75.41 111.281 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t -78.63 80.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.841 0 N-CA-C 107.682 -1.229 . . . . 71.14 107.682 166.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.626 ' HB3' HD22 ' A' ' 72' ' ' LEU . 40.9 mt-10 -94.16 62.07 2.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.51 -0.768 . . . . 73.53 109.538 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -74.93 127.7 33.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.136 -0.938 . . . . 74.15 109.301 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.29 -134.74 3.65 Favored Glycine 0 C--N 1.343 0.919 0 O-C-N 123.512 0.508 . . . . 72.22 112.416 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 27.0 pt -111.9 151.75 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.86 0.864 . . . . 75.45 110.906 177.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.11 -35.1 74.5 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.366 1.066 . . . . 73.31 112.73 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' A' ' 169' ' ' LEU . 47.7 mt -53.88 -46.53 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.56 1.144 . . . . 73.32 110.497 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.661 HG12 ' HB2' ' A' ' 76' ' ' LEU . 55.1 t -75.97 -44.32 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 113.898 -1.501 . . . . 70.43 111.888 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.626 HD22 ' HB3' ' A' ' 65' ' ' GLU . 55.5 mt -66.16 -32.04 73.25 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.642 0.589 . . . . 71.32 111.18 -175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -58.94 -52.36 66.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.278 1.031 . . . . 75.51 111.846 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -89.42 -22.85 22.33 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 116.18 -0.463 . . . . 75.23 111.663 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.588 ' HB3' ' HZ1' ' A' ' 75' ' ' LYS . 4.6 mmmp? 69.28 70.36 0.26 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.225 1.01 . . . . 75.32 109.836 -166.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.661 ' HB2' HG12 ' A' ' 71' ' ' VAL . 76.0 mt -85.66 151.74 23.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.8 -1.091 . . . . 73.31 109.269 173.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.603 HG13 ' HB3' ' A' ' 145' ' ' ALA . 11.3 p -90.54 138.43 19.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 N-CA-C 109.111 -0.7 . . . . 73.05 109.111 170.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.498 ' HG2' ' HG3' ' A' ' 53' ' ' GLU . 9.2 tp10 -60.43 138.85 57.93 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.074 0.859 . . . . 74.11 109.922 166.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 33.7 tpp -132.42 103.03 5.98 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 105.572 -2.01 . . . . 73.03 105.572 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 82' ' ' TYR . 20.7 t-20 -63.89 113.59 3.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.183 -1.826 . . . . 75.52 111.18 -170.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.407 ' SG ' ' CD2' ' A' ' 133' ' ' PHE . 41.5 t -59.05 -33.51 70.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.431 1.092 . . . . 72.33 111.345 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.437 ' HB2' ' OD1' ' A' ' 80' ' ' ASN . 60.8 m-85 -68.13 -29.65 68.61 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 113.919 -1.491 . . . . 75.14 110.75 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -104.87 -33.11 8.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.935 0.894 . . . . 74.25 112.445 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.32 19.52 15.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.314 0.646 . . . . 75.51 111.791 -162.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.59 72.52 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 112.205 0.446 . . . . 73.13 112.205 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.2 m -72.49 -43.89 63.03 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.275 0.63 . . . . 71.53 111.292 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 mmt -70.75 -29.72 66.03 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.463 0.305 . . . . 74.45 110.514 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.586 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 81.0 t80 -67.52 -32.67 73.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 74.0 110.172 173.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -64.61 -36.9 85.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.792 0.437 . . . . 74.21 110.002 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.12 82.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.065 0.546 . . . . 63.34 111.153 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.586 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 54.1 m-85 -69.85 -34.59 73.83 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 118.914 -0.565 . . . . 74.23 111.998 173.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.588 HG13 HD21 ' A' ' 128' ' ' LEU . 35.7 mm -66.11 -36.16 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.294 0.638 . . . . 74.2 110.577 174.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -57.52 -46.83 83.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.354 0.662 . . . . 73.0 111.11 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.58 -44.95 73.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.053 0.541 . . . . 71.33 110.704 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -47.78 -65.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.49 1.916 . . . . 73.43 111.078 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.558 ' HE2' HG21 ' A' ' 120' ' ' ILE . 70.9 mtp -63.09 -44.06 96.76 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.728 0.811 . . . . 74.15 111.384 -174.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -57.85 -49.9 75.11 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.656 0.597 . . . . 72.15 110.97 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.08 -43.84 70.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.856 -1.066 . . . . 74.11 111.283 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.495 HG13 HG12 ' A' ' 172' ' ' VAL . 34.3 m -69.18 -38.93 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 112.862 0.689 . . . . 72.41 112.862 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.45 -43.19 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.421 -0.585 . . . . 74.31 109.421 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.518 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 14.7 t70 -56.83 -41.09 77.25 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.231 0.957 . . . . 74.22 109.939 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -58.87 -48.07 82.7 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.386 1.074 . . . . 70.31 109.724 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.58 ' HB3' HG11 ' A' ' 113' ' ' VAL . 96.0 mmm -62.42 -36.18 81.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.338 -0.846 . . . . 74.33 111.263 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.07 -24.84 62.41 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.428 0.691 . . . . 73.21 111.494 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 29.5 mtpp -81.39 -49.89 10.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.923 0.489 . . . . 74.11 110.431 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -84.2 -14.03 51.16 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.302 0.641 . . . . 72.34 112.659 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -140.05 -59.64 0.54 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.108 0.413 . . . . 74.04 111.063 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 69.35 15.64 8.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.756 1.222 . . . . 75.44 112.479 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.16 114.58 19.17 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.473 -0.936 . . . . 63.55 108.473 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -57.24 -42.68 81.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.112 0.965 . . . . 73.32 112.249 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.17 87.87 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.571 0.544 . . . . 74.04 111.234 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.91 -42.44 48.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.32 0.648 . . . . 71.24 110.766 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 103' ' ' MET . 33.0 m -72.83 -28.55 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.05 0.54 . . . . 73.43 110.67 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 26.5 t70 -67.95 -43.92 77.95 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 123.6 0.562 . . . . 75.53 109.889 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -42.51 94.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.698 0.624 . . . . 75.13 109.946 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -44.12 97.78 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.849 0.86 . . . . 72.2 110.918 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -39.02 85.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.07 0.948 . . . . 75.0 110.504 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 57.5 mtpt -71.87 -36.9 70.24 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.886 0.741 . . . . 74.22 110.885 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.534 ' HE2' HD12 ' A' ' 26' ' ' LEU . 60.1 mtpt -64.28 -44.45 91.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.045 0.538 . . . . 62.24 109.992 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.558 HG21 ' HE2' ' A' ' 96' ' ' MET . 22.6 mm -65.0 -44.56 96.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 C-N-CA 123.732 0.813 . . . . 75.21 109.897 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.43 ' O ' HG21 ' A' ' 125' ' ' VAL . 7.2 tp-100 -56.35 -51.11 69.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.022 0.929 . . . . 71.41 110.649 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.58 98.2 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.14 0.9 . . . . 61.21 113.264 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -62.91 -49.92 72.88 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.867 0.467 . . . . 75.24 109.746 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.456 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 32.9 m -67.21 -49.03 76.4 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.338 0 CA-C-O 117.531 -1.223 . . . . 74.12 110.488 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 121' ' ' GLN . 33.4 m -64.16 -31.16 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 120.107 1.321 . . . . 74.31 112.002 -176.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.7 m -72.09 -37.54 69.55 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.672 0.389 . . . . 71.12 110.361 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.555 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 40.5 tp -77.32 -26.06 51.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.316 1.046 . . . . 72.01 111.171 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.588 HD21 HG13 ' A' ' 92' ' ' ILE . 95.0 mt -85.45 2.51 44.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.39 1.076 . . . . 75.13 111.447 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.87 147.8 40.73 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.143 -0.688 . . . . 72.13 109.143 170.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.63 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 40.7 ttmt -69.29 -13.4 62.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.081 0.552 . . . . 75.42 111.212 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.2 -45.57 87.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.493 0.717 . . . . 62.43 110.068 168.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.555 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 5.1 mpt_? -78.38 -47.45 17.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.061 -0.972 . . . . 74.35 110.413 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.63 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.2 m-85 -57.84 -25.97 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.746 0.818 . . . . 72.24 112.673 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.12 -36.06 78.72 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.607 0.763 . . . . 64.23 110.905 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -104.62 -7.96 19.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.918 1.287 . . . . 73.52 111.281 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 63.1 mt -88.54 139.59 30.33 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.649 0.737 . . . . 72.34 110.939 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.66 124.81 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 105.798 -1.926 . . . . 72.32 105.798 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.572 ' HB3' HG11 ' A' ' 153' ' ' VAL . 21.8 m-85 -95.88 140.5 30.56 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.818 -0.808 . . . . 70.42 108.818 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -138.34 138.44 38.32 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.411 -0.589 . . . . 74.31 109.411 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.21 175.66 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.562 -0.903 . . . . 75.02 108.562 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.1 120.04 20.43 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.222 -0.751 . . . . 54.31 111.222 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.37 -18.31 16.9 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.312 0.856 . . . . 63.11 113.312 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -68.7 -40.42 80.0 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.376 0.671 . . . . 75.24 109.656 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' A' ' 149' ' ' GLU . . . -80.41 -6.03 57.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.165 0.986 . . . . 71.32 112.491 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 77' ' ' VAL . . . -70.16 2.17 3.97 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.698 0.799 . . . . 74.04 112.484 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -24.59 61.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.026 0.93 . . . . 74.32 110.448 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.01 -64.31 0.01 OUTLIER Glycine 0 C--N 1.354 1.579 0 CA-C-N 116.113 -0.494 . . . . 71.43 112.221 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -163.27 146.02 10.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.949 0.5 . . . . 75.01 110.628 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 144' ' ' ALA . 10.9 tp10 -71.18 -41.29 70.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.115 0.566 . . . . 65.0 110.557 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.525 ' H ' ' HE1' ' A' ' 91' ' ' TYR . 80.0 m-20 59.99 44.12 13.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.016 0.926 . . . . 73.14 110.805 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.34 -150.9 5.77 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.03 -0.986 . . . . 63.33 110.827 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.63 140.36 31.35 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.716 -0.846 . . . . 75.44 108.716 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.572 HG11 ' HB3' ' A' ' 138' ' ' PHE . 94.0 t -87.18 142.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.82 0.848 . . . . 73.53 109.897 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.413 ' HA ' HD22 ' A' ' 171' ' ' LEU . . . -63.79 97.51 0.16 Allowed 'General case' 0 C--O 1.245 0.821 0 N-CA-C 108.942 -0.762 . . . . 62.14 108.942 168.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.456 ' HB ' ' HB2' ' A' ' 170' ' ' MET . 75.9 mt -85.31 101.58 9.94 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.916 -1.142 . . . . 73.23 107.916 -173.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.57 114.16 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.237 0.615 . . . . 75.42 109.39 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -112.23 103.77 11.94 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.459 -0.941 . . . . 74.42 108.459 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 6.5 p90 -81.73 94.45 7.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.754 -0.832 . . . . 74.42 108.754 -174.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -90.28 155.06 19.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.257 -0.645 . . . . 74.25 109.257 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -103.95 123.76 47.75 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 110.106 -0.331 . . . . 70.11 110.106 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.71 116.21 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.592 -0.892 . . . . 74.02 108.592 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.18 15.16 7.25 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.213 1.005 . . . . 63.24 112.285 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 94.78 25.33 15.37 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 121.887 -0.508 . . . . 74.53 112.892 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.3 m -121.74 130.61 53.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.497 0.719 . . . . 73.53 110.431 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.76 98.62 7.85 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.808 -0.812 . . . . 75.41 108.808 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.46 95.62 19.71 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.823 0.849 . . . . 74.31 109.796 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 59.9 Cg_endo -68.2 129.54 19.52 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 122.538 2.159 . . . . 62.1 111.389 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.8 p -109.85 110.2 21.09 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.797 -0.816 . . . . 73.12 108.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -79.1 112.54 16.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.456 -0.793 . . . . 75.42 109.382 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.456 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.0 mtt -100.83 122.32 43.22 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 107.876 -1.157 . . . . 73.14 107.876 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 154' ' ' ALA . 59.5 mt -141.62 130.93 23.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.544 -1.65 . . . . 72.31 106.544 172.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.495 HG12 HG13 ' A' ' 99' ' ' VAL . 3.9 p -69.09 137.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.005 0.522 . . . . 71.15 110.431 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.401 ' HA ' HG21 ' A' ' 176' ' ' ILE . 1.5 tmpt? -60.27 -35.48 75.61 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 74.54 111.827 -172.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -70.32 -6.01 32.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.429 0.9 . . . . 72.13 113.429 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.08 -6.37 6.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.223 0.609 . . . . 72.33 111.933 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.401 HG21 ' HA ' ' A' ' 173' ' ' LYS . 10.6 tp -124.98 143.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.433 0.635 . . . . 71.34 110.128 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 40.6 mm -130.93 110.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.449 -1.315 . . . . 74.53 107.449 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.87 127.46 42.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.138 -1.06 . . . . 64.42 108.138 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 23.5 mm-40 -115.04 114.75 25.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.382 0.673 . . . . 74.14 111.568 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.48 ' HA ' HD22 ' A' ' 2' ' ' LEU . 33.2 mtmm -83.4 96.68 8.62 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.465 0.706 . . . . 74.33 109.915 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.516 ' SG ' ' HG3' ' A' ' 1' ' ' MET . 9.3 p -108.84 88.95 2.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.959 -0.756 . . . . 63.25 108.959 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.17 -68.18 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.153 -0.93 . . . . 74.15 109.301 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 CA--C 1.552 1.02 0 C-N-CA 123.47 0.708 . . . . 71.12 110.204 -174.8 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.584 ' HB3' ' HA ' ' A' ' 16' ' ' ASP . 65.5 mtt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 73.32 109.471 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 180' ' ' LYS . 43.1 mt -115.42 146.92 41.16 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.3 0.64 . . . . 74.22 109.988 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 57.3 mt -95.8 119.61 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.242 -0.651 . . . . 75.04 109.242 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.0 m-85 -118.91 129.09 55.0 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.422 -1.325 . . . . 74.43 107.422 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HZ1' ' HB3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -144.38 155.07 43.61 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.557 0.343 . . . . 73.52 111.08 -178.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 10.3 t70 -101.14 144.62 29.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.597 0.759 . . . . 71.54 109.743 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.5 pt -81.33 -6.42 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 112.752 0.649 . . . . 74.15 112.752 -171.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -106.7 -64.02 1.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.172 0.804 . . . . 61.31 113.172 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.0 m -130.06 -25.33 2.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.828 0.677 . . . . 74.31 112.828 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 12.9 t0 -99.9 25.87 6.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.538 0.735 . . . . 71.24 110.759 -170.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.63 -20.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.101 1.519 . . . . 75.12 115.101 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.85 -37.61 19.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.258 -0.901 . . . . 72.52 111.052 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 31.5 tp 28.55 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.001 2.12 . . . . 74.53 114.243 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.438 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 67.6 m -157.94 121.88 4.12 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 72.44 109.58 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 45.3 p -113.7 67.46 0.67 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.776 0.798 . . . . 55.11 109.65 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.584 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 37.6 t70 -159.49 177.28 11.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.992 -1.004 . . . . 70.52 109.852 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 m -84.54 76.29 10.19 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.056 -0.72 . . . . 74.31 109.056 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.438 ' CD2' ' HB3' ' A' ' 14' ' ' SER . 15.7 m-85 -100.58 139.16 20.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 115.276 -0.874 . . . . 72.44 110.748 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.9 118.7 5.66 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.693 2.262 . . . . 74.11 112.14 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -129.25 162.69 27.31 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.169 -0.923 . . . . 75.01 111.042 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -151.2 115.26 5.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.972 1.309 . . . . 75.42 107.649 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.8 113.28 24.17 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.624 -1.621 . . . . 65.0 106.624 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.87 132.12 51.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 C-N-CA 123.111 0.564 . . . . 65.42 110.056 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.0 t0 55.04 22.96 4.78 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 125.064 1.346 . . . . 70.21 112.719 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 t70 59.81 12.38 2.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.681 1.592 . . . . 71.04 112.65 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.735 HD22 ' HG3' ' A' ' 119' ' ' LYS . 55.3 tp -109.49 -51.88 2.83 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.523 -0.736 . . . . 71.43 111.214 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.64 126.03 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.571 -0.741 . . . . 73.43 109.987 -167.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -83.31 114.87 21.71 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.408 -1.33 . . . . 74.41 107.408 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 35.2 tt0 -112.68 119.49 38.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 65.15 110.316 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -105.4 107.12 17.93 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.999 -1.112 . . . . 75.22 107.999 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -77.06 153.13 34.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.616 0.366 . . . . 71.01 111.13 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.19 -163.88 12.1 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.285 -0.726 . . . . 74.21 111.285 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.02 136.72 34.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.356 0.663 . . . . 74.05 109.404 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 4.2 t60 -69.07 128.47 36.79 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.762 -0.829 . . . . 72.5 108.762 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.518 HG22 HD13 ' A' ' 72' ' ' LEU . 13.9 m -147.28 178.57 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.407 0 C-N-CA 124.345 1.058 . . . . 74.14 109.711 -174.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 21.8 m -125.4 141.44 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 116.263 -0.426 . . . . 74.53 111.526 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.436 ' HD3' HD12 ' A' ' 72' ' ' LEU . 9.6 mpt_? -105.23 105.54 15.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.368 -1.345 . . . . 64.3 107.368 165.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -127.45 125.23 40.15 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.864 -0.791 . . . . 74.14 108.864 -165.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.45 84.39 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.28 . . . . 73.23 111.406 -174.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -48.96 0.59 Allowed Glycine 0 C--O 1.239 0.46 0 CA-C-N 114.692 -1.14 . . . . 54.34 111.638 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -166.51 129.21 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.289 0.636 . . . . 73.55 110.158 -173.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tt -72.2 106.52 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 109.265 -0.643 . . . . 74.14 109.265 174.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.63 88.28 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-O 121.824 0.821 . . . . 63.23 109.452 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -73.69 -19.35 60.84 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 115.415 -0.811 . . . . 74.33 111.398 -177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.42 -20.93 25.96 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.869 0.868 . . . . 72.44 110.621 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.48 70.1 2.89 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.349 0.406 . . . . 64.24 112.401 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.9 m -87.91 90.37 8.36 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.06 0.944 . . . . 74.51 109.097 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -61.87 -53.1 63.36 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 124.63 1.172 . . . . 72.41 113.28 -167.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.15 -2.16 11.86 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 121.976 1.784 . . . . 55.21 114.051 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m 59.99 21.08 10.17 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.226 1.011 . . . . 71.34 112.06 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -164.05 78.71 0.39 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.13 -1.433 . . . . 53.15 107.13 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.43 ' HG2' ' HD3' ' A' ' 66' ' ' ARG . 29.9 tt0 -68.96 -29.31 67.51 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.717 -1.129 . . . . 74.32 110.968 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -59.98 78.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.791 1.237 . . . . 74.32 111.683 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.09 -60.33 1.19 Allowed Glycine 0 C--N 1.342 0.882 0 N-CA-C 110.353 -1.099 . . . . 74.02 110.353 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.45 32.01 21.12 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.955 0.902 . . . . 71.44 111.956 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -166.17 100.24 0.63 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.142 0.977 . . . . 73.44 108.769 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.6 t70 77.72 -30.28 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.217 1.407 . . . . 75.33 113.27 170.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.94 -13.02 60.04 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.333 1.053 . . . . 74.42 112.26 -174.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.96 24.53 15.16 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 123.062 0.363 . . . . 74.42 112.787 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.7 t -66.37 153.28 43.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.404 1.081 . . . . 60.31 111.218 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.48 -21.48 66.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.042 0.937 . . . . 62.15 111.286 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.22 111.34 9.3 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.778 -1.193 . . . . 75.52 107.778 170.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.2 m80 76.41 -57.34 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.166 1.787 . . . . 75.02 111.953 -171.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t 72.26 -78.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.021 1.329 . . . . 71.42 111.202 -172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 36' ' ' VAL 0.298 8.4 pt-20 51.39 -70.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.336 2.254 . . . . 74.03 113.178 -163.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HD3' ' HG2' ' A' ' 52' ' ' GLU . 60.4 ttp85 -74.16 111.6 9.49 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.702 0.801 . . . . 74.31 110.974 -161.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.16 -172.28 45.15 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.316 -0.945 . . . . 74.15 111.69 160.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 16.4 pt -96.06 150.65 4.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.004 -0.739 . . . . 74.24 109.004 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -56.06 -34.07 65.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 64.3 112.362 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.432 HD13 HD12 ' A' ' 68' ' ' ILE . 61.8 mt -55.06 -51.37 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.389 1.076 . . . . 74.12 110.16 176.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 76' ' ' LEU . 30.6 t -75.02 -46.26 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.604 1.161 . . . . 64.12 112.224 -175.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.518 HD13 HG22 ' A' ' 35' ' ' VAL . 80.5 mt -63.19 -37.17 86.19 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.046 0.841 . . . . 75.22 111.088 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -68.21 -47.0 69.05 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.986 -1.007 . . . . 73.11 109.204 174.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -80.55 -17.66 50.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.045 0.938 . . . . 74.34 111.957 -166.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 62.82 61.66 1.14 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.281 1.433 . . . . 71.43 111.044 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.614 ' HB2' HG13 ' A' ' 71' ' ' VAL . 83.8 mt -101.28 140.15 35.97 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.378 -0.828 . . . . 73.23 110.483 174.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.57 137.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.478 0.711 . . . . 75.11 109.219 171.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.45 157.06 24.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.454 1.121 . . . . 73.1 113.685 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 ttm -147.28 104.21 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.172 -2.159 . . . . 72.25 105.172 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.592 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 80.1 m-20 -101.87 124.94 48.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.331 -0.618 . . . . 63.44 109.331 -171.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.592 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 20.6 p -61.4 -11.14 9.12 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.109 0.964 . . . . 71.21 112.522 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.592 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 90.9 m-85 -53.5 -48.85 68.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.386 1.074 . . . . 73.22 111.461 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.95 -39.22 6.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.604 0.762 . . . . 75.45 110.571 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.16 20.39 3.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.408 1.083 . . . . 75.42 113.336 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.47 69.73 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.154 0.582 . . . . 65.21 111.614 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t -65.93 -38.72 89.39 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.972 0.909 . . . . 74.21 110.725 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.472 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.2 mpt? -69.25 -40.62 77.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.174 -0.921 . . . . 73.11 110.658 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -70.61 -31.9 69.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.571 0.748 . . . . 75.0 110.466 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -67.42 -35.23 78.85 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 61.14 111.113 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.27 95.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.202 0.601 . . . . 64.11 110.154 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.57 -34.37 74.07 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-N 115.567 -0.742 . . . . 73.34 111.79 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.78 -34.05 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.629 0.772 . . . . 72.23 111.281 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.01 -47.6 82.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.731 0.413 . . . . 75.02 110.607 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.63 -46.7 78.27 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.975 0.797 . . . . 71.5 109.681 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' O ' HG22 ' A' ' 99' ' ' VAL . 72.7 t80 -48.26 -64.84 0.68 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.011 1.724 . . . . 74.44 111.755 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 27.6 ttt -58.08 -48.61 79.61 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.409 1.068 . . . . 75.11 110.765 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -58.35 -51.43 69.85 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.035 0.835 . . . . 73.24 111.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -73.72 -39.32 64.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.659 0.599 . . . . 74.12 111.82 -168.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.0 m -67.2 -37.79 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 111.857 0.317 . . . . 71.03 111.857 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.505 HG23 ' HB ' ' A' ' 113' ' ' VAL . 81.7 mt -71.6 -54.24 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.627 -0.509 . . . . 72.02 109.627 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.91 -33.18 70.26 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.533 1.533 . . . . 63.13 112.357 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -81.56 -52.63 7.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.262 0.625 . . . . 74.22 110.65 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.425 ' HG2' ' HG3' ' A' ' 174' ' ' GLU . 11.7 tpt -72.2 -31.47 65.92 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.85 0.315 . . . . 73.24 111.85 -167.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.36 -55.46 21.44 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.626 0.77 . . . . 75.54 112.351 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -82.32 -0.03 43.8 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.087 0.47 . . . . 75.12 110.412 -166.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -101.59 -36.35 8.8 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.174 0.99 . . . . 75.15 110.041 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -92.69 -78.66 0.41 Allowed 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.422 -0.808 . . . . 62.31 111.767 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 112' ' ' ASP . 63.1 ttt180 -153.47 13.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.6 0.714 . . . . 73.53 112.337 -169.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.6 t70 68.94 -74.13 0.08 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.275 1.43 . . . . 75.45 113.059 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.04 -66.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 112.518 0.562 . . . . 75.34 112.518 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.87 87.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.087 1.143 . . . . 75.12 114.087 -162.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -73.53 -46.44 47.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.297 -0.41 . . . . 73.01 111.095 -170.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.634 ' HA ' ' HB3' ' A' ' 116' ' ' PHE . 13.6 m -76.24 -22.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 119.241 -0.409 . . . . 74.33 111.506 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.59 -55.09 34.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.165 0.586 . . . . 64.41 110.507 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.99 88.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.14 0.9 . . . . 75.0 110.244 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.634 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 18.9 t80 -61.96 -41.9 98.52 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.444 -1.253 . . . . 71.11 111.496 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -64.6 -41.47 96.21 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.906 0.482 . . . . 73.34 110.62 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.45 -42.79 95.77 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.088 0.868 . . . . 70.24 110.285 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.735 ' HG3' HD22 ' A' ' 26' ' ' LEU . 17.9 tppt? -72.91 -40.18 65.71 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.473 1.109 . . . . 71.33 111.755 -174.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.4 tp -76.45 -34.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.292 0.637 . . . . 74.45 109.51 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -61.37 -44.46 97.13 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 124.119 0.887 . . . . 73.45 109.138 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.34 -41.39 99.47 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.803 0.689 . . . . 64.32 112.836 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.63 -53.05 57.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.424 0.69 . . . . 75.13 110.703 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.482 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 18.7 m -63.61 -44.76 98.68 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.17 0 CA-C-O 118.298 -0.858 . . . . 75.14 111.432 -175.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.6 -38.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 119.205 0.911 . . . . 74.21 111.39 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 m -71.81 -31.09 66.19 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.901 0.48 . . . . 73.33 111.399 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.679 HD23 HG21 ' A' ' 155' ' ' ILE . 28.9 tp -82.96 -18.99 38.02 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 71.33 110.584 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.8 mt -91.95 3.24 55.64 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.895 0.878 . . . . 72.42 111.069 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.12 88.31 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.796 0.838 . . . . 71.3 110.474 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -58.24 -19.81 37.0 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.886 1.439 . . . . 61.2 114.886 -163.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.48 -40.77 95.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.636 0.774 . . . . 72.12 112.133 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -108.19 -37.2 6.09 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.348 0.594 . . . . 72.5 110.872 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.1 -2.36 48.0 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.187 0.995 . . . . 74.51 113.453 -168.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.34 -15.8 18.52 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 112.259 0.466 . . . . 72.45 112.259 163.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -103.31 26.72 8.0 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.785 0.834 . . . . 74.24 110.32 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.5 mt -86.63 133.18 33.72 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.862 -1.162 . . . . 75.33 107.862 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.73 109.3 21.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.723 -1.584 . . . . 72.3 106.723 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.592 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 42.5 m-85 -92.24 145.89 24.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.058 -1.09 . . . . 75.25 108.058 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.445 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 78.6 m-85 -140.51 146.36 38.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.21 0.529 . . . . 75.23 110.659 -175.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.98 163.18 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.257 -1.757 . . . . 74.31 106.257 167.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.7 147.29 50.89 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.885 -0.886 . . . . 74.23 110.885 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.44 -25.32 50.17 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.92 0.86 . . . . 74.21 112.714 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -36.36 80.48 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.538 1.135 . . . . 74.2 111.129 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 150' ' ' ASN . . . -68.14 -42.69 79.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.985 0.914 . . . . 64.31 110.634 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.57 -0.69 47.98 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.252 -0.886 . . . . 75.01 112.36 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -90.89 -19.0 23.83 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.417 1.087 . . . . 71.44 109.922 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.74 45.89 1.17 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.006 -0.543 . . . . 61.35 111.811 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -156.7 108.44 2.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.462 0.705 . . . . 73.45 109.283 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 49.29 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.566 1.546 . . . . 74.45 113.712 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.532 ' HA ' ' HB3' ' A' ' 144' ' ' ALA . 17.6 m120 -61.25 -43.03 99.54 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.783 0.833 . . . . 71.2 111.282 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 58.53 -148.77 37.51 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 115.421 0.928 . . . . 51.01 115.421 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 138.64 31.31 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.011 0.924 . . . . 64.53 109.266 -174.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.0 t -82.73 123.91 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.134 0.574 . . . . 72.02 110.977 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.68 105.3 6.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.381 1.072 . . . . 70.21 109.294 170.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.679 HG21 HD23 ' A' ' 127' ' ' LEU . 74.9 mt -91.75 121.26 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.297 -0.631 . . . . 75.24 109.297 -173.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.7 mm -109.08 114.84 47.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 110.048 -0.352 . . . . 74.22 110.048 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.89 118.27 36.59 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 124.244 0.965 . . . . 75.43 108.641 170.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.453 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 16.1 p90 -79.96 112.52 17.33 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.669 -1.604 . . . . 74.13 106.669 170.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.408 ' O ' HG13 ' A' ' 166' ' ' VAL . 38.4 ttm180 -103.01 128.49 49.83 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.628 -0.508 . . . . 72.12 109.628 -173.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.18 120.23 22.69 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.556 0.342 . . . . 72.53 110.872 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.23 107.17 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.422 1.489 . . . . 63.33 108.824 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 61.92 23.64 13.95 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.811 1.244 . . . . 65.55 112.783 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.22 65.3 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 113.867 0.307 . . . . 73.01 113.867 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.1 m -110.87 137.54 48.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.285 1.034 . . . . 74.31 108.834 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 9.0 pt-20 -72.95 145.61 46.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.167 0.439 . . . . 74.13 110.405 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 159' ' ' ARG . 5.5 p -128.4 101.16 21.83 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 107.645 -1.242 . . . . 74.12 107.645 167.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.75 128.52 20.13 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.401 2.067 . . . . 74.11 112.299 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 53.1 p -121.0 118.43 29.82 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.227 -1.027 . . . . 72.42 108.227 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 tp -77.23 111.73 13.17 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.936 -0.764 . . . . 75.24 108.936 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 57.5 mtt -101.63 122.53 44.03 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.657 -0.868 . . . . 73.13 108.657 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 93.0 mt -136.65 143.43 43.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.752 -1.944 . . . . 74.23 105.752 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.93 138.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.063 0.847 . . . . 64.44 109.976 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.637 ' HZ1' ' HB3' ' A' ' 173' ' ' LYS . 4.3 ttpm? -58.38 -29.16 65.8 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.904 1.282 . . . . 75.01 112.272 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.425 ' HG3' ' HG2' ' A' ' 103' ' ' MET . 11.1 mp0 -70.1 -26.32 63.93 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.606 0.763 . . . . 75.34 111.217 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.47 0.43 50.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 75.03 110.723 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 46.6 mm -121.16 125.05 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.301 0.64 . . . . 72.14 109.597 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mm -99.2 108.36 22.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.362 -1.347 . . . . 72.35 107.362 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.84 116.18 26.93 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.0 -1.482 . . . . 73.33 107.0 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -126.31 106.09 9.27 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.253 -1.388 . . . . 62.01 107.253 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.559 ' HA ' HD23 ' A' ' 2' ' ' LEU . 56.4 pttt -88.3 119.79 29.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.951 0.5 . . . . 73.31 110.904 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 34.6 t -78.25 89.84 4.32 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.803 0.841 . . . . 74.41 109.834 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.23 129.83 39.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.667 0.787 . . . . 75.0 110.516 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.883 0.873 . . . . 75.53 108.822 -179.476 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtm . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 120.656 0.265 . . . . 65.13 110.324 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 180' ' ' LYS . 32.6 mt -115.63 161.78 18.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.567 0.747 . . . . 74.44 110.969 -166.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.424 HG22 ' HB3' ' A' ' 179' ' ' GLU . 8.3 tt -105.75 130.16 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.962 -1.125 . . . . 74.42 107.962 169.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 9.1 m-30 -97.83 136.7 37.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.452 0.644 . . . . 75.01 111.711 -174.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.411 ' HG3' ' HB ' ' A' ' 177' ' ' ILE . 15.3 ptmt -138.47 136.42 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.068 -1.424 . . . . 73.41 108.945 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.764 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 29.9 t70 -109.17 177.21 4.82 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.574 1.55 . . . . 62.32 110.54 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 pt -65.73 -43.07 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 123.921 0.888 . . . . 73.42 112.511 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -111.42 -51.67 2.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.368 1.067 . . . . 74.24 109.26 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -84.25 19.05 1.96 Allowed 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.026 -1.443 . . . . 73.41 110.666 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.764 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 13.0 t70 -44.37 -42.8 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.319 1.847 . . . . 64.22 113.608 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.25 -47.3 80.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.805 -1.543 . . . . 63.03 111.774 -173.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -124.41 27.35 7.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.634 0.774 . . . . 71.31 112.033 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.668 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 3.0 tm? -64.63 -79.68 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.079 -0.388 . . . . 74.01 110.327 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 75.1 m -153.32 -176.17 5.67 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.764 0.792 . . . . 74.51 111.348 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 t -151.34 95.12 2.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.943 -1.503 . . . . 75.22 106.943 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.94 95.65 0.06 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.206 1.402 . . . . 73.32 110.633 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 p -120.46 25.1 10.0 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.977 -1.49 . . . . 71.5 106.977 158.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -135.52 155.33 78.49 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.446 -1.252 . . . . 75.04 109.987 -171.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.08 120.11 7.27 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.843 1.695 . . . . 73.31 112.726 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.75 149.93 20.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.551 0.741 . . . . 74.24 110.324 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -136.18 144.97 45.25 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.508 0.723 . . . . 75.54 109.417 -173.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.0 tp -130.71 145.05 51.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.591 0.756 . . . . 72.03 109.485 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.98 133.87 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.468 0.707 . . . . 72.03 109.689 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 58.82 16.23 4.36 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.211 1.404 . . . . 72.53 113.681 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 47.25 26.56 0.71 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.536 1.135 . . . . 73.53 112.616 -167.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 119' ' ' LYS . 37.1 tp -119.94 -46.69 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.179 0.992 . . . . 74.34 109.937 -174.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.81 126.54 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.115 0.566 . . . . 74.1 110.395 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.15 122.74 29.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.491 -1.3 . . . . 73.3 107.491 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 5.1 pt-20 -112.73 147.03 37.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.197 0.522 . . . . 74.22 110.118 170.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -131.49 105.08 7.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.369 -1.345 . . . . 74.45 107.369 166.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 167' ' ' PRO . 15.2 ptmt -82.01 103.64 11.79 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.11 -0.7 . . . . 74.51 109.11 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.82 -157.4 19.46 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.042 -0.981 . . . . 75.43 112.09 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -124.12 161.3 25.92 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.806 0.842 . . . . 75.42 109.913 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -93.13 118.09 30.82 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.156 -1.053 . . . . 73.01 108.156 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 m -146.98 159.8 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.331 0.586 . . . . 62.11 111.42 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 44' ' ' LEU . 12.7 m -133.88 132.57 56.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.181 -1.044 . . . . 74.35 108.181 174.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.62 149.67 43.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.132 -1.433 . . . . 75.44 107.132 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -133.86 132.06 39.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.628 -0.878 . . . . 74.43 108.628 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 65.17 12.49 8.03 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.097 1.359 . . . . 70.51 113.503 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.8 21.24 26.55 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 123.051 0.358 . . . . 24.2 112.481 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.44 127.27 43.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.271 1.028 . . . . 75.12 109.175 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -72.04 118.86 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 N-CA-C 109.282 -0.636 . . . . 75.32 109.282 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.0 -46.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 112.775 0.657 . . . . 75.04 112.775 -169.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' HA ' HG23 ' A' ' 36' ' ' VAL . 3.2 mm? 51.38 81.44 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.269 1.028 . . . . 74.12 110.741 -168.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.56 20.18 5.65 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.895 0.878 . . . . 71.24 110.224 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.03 -135.67 28.16 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.538 -0.625 . . . . 73.33 111.538 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 38.6 m 61.1 29.53 18.93 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.511 1.124 . . . . 74.51 112.607 173.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -128.7 52.41 9.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 113.375 0.88 . . . . 72.05 113.375 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.14 -34.99 55.32 Favored 'Trans proline' 0 C--N 1.387 2.575 0 CA-C-N 120.631 1.261 . . . . 74.44 111.06 171.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.5 m -131.66 152.48 50.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.675 1.19 . . . . 74.53 109.377 175.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.22 82.09 1.54 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.011 0.924 . . . . 63.33 109.019 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.53 -29.88 30.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.877 0.871 . . . . 63.34 111.005 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 mp0 -80.91 75.04 7.87 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.334 0.654 . . . . 73.23 109.368 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.64 -63.06 2.84 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.739 -1.345 . . . . 74.44 109.739 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 179.32 -76.23 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.433 1.493 . . . . 74.32 108.899 167.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 59.44 -82.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 126.032 1.733 . . . . 74.15 113.441 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -168.94 -90.72 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.344 0.658 . . . . 74.14 109.685 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.799 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 1.4 m-20 -139.6 21.38 2.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 63.41 112.087 -169.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.83 -43.14 84.71 Favored Glycine 0 N--CA 1.473 1.139 0 N-CA-C 112.066 -0.414 . . . . 64.02 112.066 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.4 m -138.92 63.41 1.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.867 -1.161 . . . . 73.21 107.867 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.799 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 16.1 t70 -76.21 87.72 3.06 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.863 -1.062 . . . . 72.24 110.867 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HG2' HG22 ' A' ' 64' ' ' VAL . 26.9 tt0 -157.62 151.22 23.88 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.346 -0.983 . . . . 73.3 108.346 170.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -80.44 23.55 0.5 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.275 0.63 . . . . 71.24 112.286 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 62' ' ' GLU . 5.3 t -77.32 83.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.624 0 N-CA-C 108.132 -1.062 . . . . 74.32 108.132 170.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.4 73.31 3.16 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.959 -1.126 . . . . 72.01 107.959 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 47' ' ' SER . 15.3 ptp180 -91.97 137.28 32.49 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.952 -0.567 . . . . 72.13 109.54 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.18 -122.72 2.75 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 112.15 -0.38 . . . . 65.41 112.15 170.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 42.2 pt -112.5 138.8 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.308 0.643 . . . . 64.45 111.648 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -47.8 -46.87 31.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.209 1.404 . . . . 55.44 113.765 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 169' ' ' LEU . 57.6 mt -50.41 -46.13 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.382 1.073 . . . . 73.31 111.705 -174.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.25 -47.11 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.289 -0.869 . . . . 74.14 111.216 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 17.2 mt -64.2 -36.12 83.03 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.214 0.946 . . . . 73.42 110.517 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -60.98 -37.06 81.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.879 1.672 . . . . 63.42 110.803 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.544 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 26.3 m170 -106.89 -13.33 15.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.974 -1.012 . . . . 75.3 111.99 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 55.02 57.47 5.57 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.532 1.133 . . . . 72.22 111.488 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' ' 74' ' ' HIS . 79.5 mt -84.64 146.13 27.64 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.651 0.78 . . . . 71.5 110.431 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.84 123.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 109.538 -0.541 . . . . 70.21 109.538 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -70.6 147.36 49.31 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.704 -1.135 . . . . 45.23 112.876 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 70.4 mtp -143.74 122.35 12.52 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.015 -2.217 . . . . 61.03 105.015 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -101.0 152.86 20.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.772 -0.58 . . . . 73.44 112.007 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 20.4 p -66.88 -23.97 66.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.616 0.766 . . . . 70.24 113.058 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -72.14 -43.67 64.32 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.922 0.489 . . . . 45.21 111.575 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.73 -48.19 3.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.333 0.653 . . . . 64.34 111.395 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.41 21.0 3.04 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.122 0.969 . . . . 73.32 112.432 -171.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.4 74.83 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.591 0.757 . . . . 73.51 112.584 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.6 t -74.04 -41.22 62.13 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.812 0.845 . . . . 73.04 110.794 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -61.55 -43.99 97.84 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.06 0.544 . . . . 71.54 110.049 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.615 ' HD1' HG22 ' A' ' 153' ' ' VAL . 46.5 t80 -58.83 -42.91 90.39 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.381 1.472 . . . . 74.23 111.086 176.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -58.93 -41.45 87.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.624 0.77 . . . . 73.2 110.369 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.36 88.84 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.349 0.66 . . . . 75.42 111.277 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.504 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 63.8 m-85 -59.6 -45.24 92.49 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.737 0.415 . . . . 74.45 111.371 171.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.457 HG22 ' HE3' ' A' ' 96' ' ' MET . 34.4 mm -59.43 -38.31 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.814 0.846 . . . . 75.14 111.0 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -58.18 -47.74 82.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.972 0.509 . . . . 74.31 111.476 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -65.71 -51.04 62.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.545 0.738 . . . . 74.34 110.656 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -49.98 -62.29 1.65 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.941 2.097 . . . . 74.15 111.655 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.457 ' HE3' HG22 ' A' ' 92' ' ' ILE . 48.2 mtm -64.6 -33.98 77.19 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.634 0.584 . . . . 71.12 111.04 -177.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -60.58 -47.03 88.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.836 0.454 . . . . 75.52 110.076 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.31 -48.9 16.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.486 0.714 . . . . 73.21 110.57 -172.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.45 -40.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.363 0.265 . . . . 75.54 111.069 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 77.0 mt -71.19 -45.68 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 119.016 -0.516 . . . . 72.15 109.723 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 26.5 t70 -53.59 -47.69 69.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 123.882 0.873 . . . . 65.21 112.634 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -65.36 -43.18 91.6 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.757 0.423 . . . . 71.22 110.143 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.455 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 7.6 tpt -68.84 -26.07 64.97 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.653 -0.703 . . . . 72.33 110.048 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.64 ' HA ' HG12 ' A' ' 113' ' ' VAL . 1.7 tm-20 -76.4 -38.04 56.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.856 1.263 . . . . 75.23 109.787 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 64.7 mttm -67.15 -25.92 66.4 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.698 0.399 . . . . 73.12 110.61 174.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.17 0.68 53.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.087 0.955 . . . . 73.01 111.701 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -130.42 -53.43 1.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.439 0.695 . . . . 71.31 110.168 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 56.82 23.06 7.62 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.042 2.137 . . . . 73.23 112.854 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.48 -89.0 0.61 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.81 0.844 . . . . 72.32 109.564 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttp 173.13 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.648 1.179 . . . . 74.22 109.782 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.13 92.14 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.731 0.641 . . . . 54.43 112.731 -164.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.29 -48.54 17.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.765 0.426 . . . . 73.51 109.95 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 104' ' ' GLU . 35.0 m -70.39 -24.09 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.723 -0.671 . . . . 74.32 112.22 -174.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 23.0 t70 -65.43 -37.48 87.03 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.376 0.67 . . . . 73.54 109.865 172.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.408 ' O ' ' HD3' ' A' ' 119' ' ' LYS . . . -72.62 -49.49 31.64 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.876 0.735 . . . . 74.2 109.935 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -55.16 -47.92 74.48 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.885 0.474 . . . . 75.22 110.418 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -60.7 -46.59 89.82 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.387 1.054 . . . . 74.54 110.944 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -61.25 -43.89 98.14 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.009 0.818 . . . . 72.44 110.248 -174.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.47 ' HB3' HD23 ' A' ' 26' ' ' LEU . 5.1 mptp? -79.28 -36.91 39.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.501 -0.772 . . . . 75.43 111.337 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.1 tp -73.99 -38.22 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 118.751 0.705 . . . . 74.22 110.324 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.46 ' HA ' HG23 ' A' ' 124' ' ' VAL . 23.4 tm0? -72.32 -39.34 68.28 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 176.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.63 -39.21 97.08 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.513 0.508 . . . . 72.13 112.28 174.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -65.13 -51.42 61.33 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.504 0.722 . . . . 73.32 109.616 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.529 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.8 m -68.77 -42.12 82.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-O 118.936 -0.554 . . . . 75.22 111.04 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.1 -29.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 118.85 0.75 . . . . 74.13 110.605 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.3 t -77.81 -39.17 44.69 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.201 0.6 . . . . 71.23 110.882 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.684 HD21 HG23 ' A' ' 155' ' ' ILE . 35.0 tp -72.48 -29.45 63.65 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.521 1.128 . . . . 74.22 111.509 -174.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 38.0 mt -86.75 0.3 54.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.195 0.598 . . . . 75.44 111.123 -177.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.31 81.05 4.69 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.076 -0.713 . . . . 74.0 109.076 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 61.7 pttt -61.56 -6.1 2.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.875 1.27 . . . . 74.15 113.819 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -54.44 -42.72 70.9 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.955 0.902 . . . . 72.32 110.838 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -109.17 -37.98 5.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.285 1.034 . . . . 73.11 109.637 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.445 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 56.7 m-85 -79.26 -1.54 37.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.796 1.238 . . . . 72.14 114.15 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 30.3 ttmt -50.64 -12.74 0.11 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.1 1.148 . . . . 72.34 114.1 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 77.4 m-20 -82.29 22.09 0.86 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.745 0.818 . . . . 71.12 111.467 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 72.8 mt -89.23 136.95 32.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.171 0.588 . . . . 74.53 109.598 172.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.47 122.95 25.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.661 -1.607 . . . . 44.54 106.661 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -99.39 129.44 45.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.937 0.495 . . . . 74.55 109.8 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.429 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 96.6 m-85 -130.33 146.12 51.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.826 0.451 . . . . 74.52 110.525 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.37 170.26 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.933 0.493 . . . . 65.31 109.751 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.54 138.84 22.27 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.658 -0.701 . . . . 55.12 112.353 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -59.86 -47.47 85.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.7 1.2 . . . . 71.51 109.833 171.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -38.35 68.35 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.795 1.238 . . . . 75.32 111.206 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.02 -46.34 68.22 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.923 -1.035 . . . . 74.54 110.292 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.01 -3.25 51.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.352 0.661 . . . . 72.01 112.429 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.94 -41.66 14.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.258 0.623 . . . . 73.32 111.726 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.62 46.37 0.1 OUTLIER Glycine 0 N--CA 1.469 0.867 0 C-N-CA 121.271 -0.49 . . . . 73.25 112.839 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.93 -165.2 1.68 Allowed 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.154 0.982 . . . . 63.4 108.826 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -55.09 122.56 11.23 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.792 -0.818 . . . . 74.42 108.792 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -50.38 -31.04 13.68 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.957 1.411 . . . . 75.23 111.621 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 123.87 -174.39 16.77 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.797 -0.638 . . . . 53.0 112.902 172.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.4 164.79 16.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.926 1.291 . . . . 63.24 108.072 167.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.615 HG22 ' HD1' ' A' ' 88' ' ' PHE . 41.9 t -79.15 116.94 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.585 0.707 . . . . 74.14 111.77 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.35 106.17 5.85 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.071 -1.422 . . . . 62.4 107.908 161.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.684 HG23 HD21 ' A' ' 127' ' ' LEU . 54.8 mt -90.41 106.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.534 0.733 . . . . 74.42 110.236 -165.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 169' ' ' LEU . 44.9 mm -96.05 115.98 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.033 -0.358 . . . . 72.42 110.033 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -100.51 121.4 41.51 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.09 0.556 . . . . 74.53 110.0 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.511 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 32.6 m-85 -83.43 98.34 9.45 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.633 -0.877 . . . . 73.33 108.633 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -90.74 131.88 36.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.686 -0.857 . . . . 74.22 108.686 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.79 108.38 19.95 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.166 -0.679 . . . . 71.31 109.166 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.03 111.47 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 108.978 -0.749 . . . . 74.41 108.978 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.33 21.5 11.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.428 1.091 . . . . 71.43 112.826 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.19 31.17 14.83 Favored Glycine 0 C--N 1.347 1.144 0 C-N-CA 121.908 -0.187 . . . . 64.03 112.909 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -133.71 121.71 22.34 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.881 0.872 . . . . 71.4 109.326 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.92 126.65 30.45 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.545 0.528 . . . . 75.23 109.634 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.01 107.22 37.99 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 108.221 -1.029 . . . . 74.42 108.221 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 57.8 Cg_endo -68.15 127.57 16.14 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.677 2.252 . . . . 75.34 111.178 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 20.8 m -118.06 104.79 11.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.184 0.594 . . . . 71.25 109.845 -171.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 56.2 tp -78.01 106.19 9.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.621 0.769 . . . . 74.31 109.674 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.509 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.3 mtt -103.28 122.81 45.56 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.571 0.748 . . . . 73.41 109.139 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 85.9 mt -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.937 -1.875 . . . . 74.44 105.937 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.0 p -83.09 143.71 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 108.047 -1.094 . . . . 65.41 108.047 173.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -48.56 -37.58 18.24 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.501 1.52 . . . . 74.54 111.707 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.455 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 8.7 tp10 -83.72 -0.52 51.18 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.688 0.795 . . . . 74.13 112.191 -175.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -104.73 -33.29 8.5 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.545 0.738 . . . . 72.43 110.373 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.66 133.48 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.33 0.586 . . . . 74.31 110.285 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.411 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.8 mm -127.9 131.94 69.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 107.385 -1.339 . . . . 73.02 107.385 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' HB2' HD11 ' A' ' 2' ' ' LEU . 10.5 pt-20 -95.06 124.8 39.31 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.245 -0.65 . . . . 70.43 109.245 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.424 ' HB3' HG22 ' A' ' 3' ' ' ILE . 15.9 tp10 -108.4 125.54 51.85 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.841 -0.8 . . . . 65.54 108.841 175.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.457 ' HA ' HD21 ' A' ' 2' ' ' LEU . 13.8 mptt -71.28 154.25 41.78 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.746 0.818 . . . . 72.12 110.621 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 39.8 m -133.3 86.41 2.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.492 -0.559 . . . . 71.01 109.492 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -170.08 0.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.085 0.954 . . . . 71.51 112.149 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 . . . . . 0 CA--C 1.552 1.026 0 C-N-CA 123.573 0.749 . . . . 73.42 109.152 -178.679 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' HA ' ' A' ' 16' ' ' ASP . 25.0 ptp . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.933 -0.395 . . . . 73.42 109.933 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.16 123.32 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.649 -0.871 . . . . 71.11 108.649 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.591 HG22 ' HB3' ' A' ' 179' ' ' GLU . 9.7 tt -96.82 119.95 45.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.6 0.714 . . . . 74.01 110.068 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -102.71 110.83 22.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.717 -1.957 . . . . 63.54 105.717 173.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -131.24 134.95 46.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.068 0.547 . . . . 74.42 111.736 -167.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.409 ' HA ' HD13 ' A' ' 176' ' ' ILE . 27.7 t70 -81.65 131.2 35.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.71 0.804 . . . . 71.32 109.751 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 175' ' ' ALA . 25.9 pt -77.94 -11.55 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 74.53 112.752 -171.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.571 ' HE1' ' HB2' ' A' ' 175' ' ' ALA . 9.0 m-85 -94.15 -64.68 1.05 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.082 0.401 . . . . 73.43 110.619 -172.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.481 HG22 ' HB3' ' A' ' 149' ' ' GLU . 3.2 p -132.08 -37.68 1.12 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.385 1.074 . . . . 72.5 113.702 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.34 23.56 8.26 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.048 0.939 . . . . 71.22 111.854 -162.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -46.35 -26.32 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 126.014 1.726 . . . . 74.11 115.027 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.91 27.58 0.87 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.367 1.067 . . . . 74.41 111.16 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.63 -73.69 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.735 1.614 . . . . 75.5 112.39 -173.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 m -152.15 131.87 13.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.973 0.509 . . . . 61.14 109.85 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 34.5 p -131.34 91.79 3.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.037 0.935 . . . . 75.41 108.942 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.42 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.0 t70 -168.31 177.55 5.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.594 0.757 . . . . 74.45 109.628 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 p -83.39 81.55 8.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.589 0.756 . . . . 74.04 109.344 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 36.9 m-85 -103.19 152.79 38.68 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 115.188 -0.915 . . . . 74.33 109.57 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -46.98 119.12 3.16 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.872 2.381 . . . . 64.34 112.83 173.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.4 ' HE3' ' HB2' ' A' ' 22' ' ' LEU . 17.7 tpt -112.26 120.93 43.44 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.224 -1.028 . . . . 74.22 108.224 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -142.44 116.62 9.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.764 -1.569 . . . . 75.43 106.764 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.4 ' HB2' ' HE3' ' A' ' 20' ' ' MET . 57.9 tp -123.64 113.91 19.28 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.104 0.962 . . . . 73.12 108.606 -172.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.25 137.0 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.08 0.952 . . . . 63.14 109.649 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 56.09 18.98 3.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 125.417 1.487 . . . . 71.34 113.315 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.62 14.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.371 1.068 . . . . 73.23 112.113 -172.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 119' ' ' LYS . 37.2 tp -112.74 -51.28 2.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.62 0.768 . . . . 73.52 110.636 -168.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -116.15 122.09 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.534 -0.757 . . . . 72.13 109.708 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.59 113.06 21.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.851 -1.166 . . . . 71.42 107.851 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -103.99 107.62 18.6 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.016 0.926 . . . . 73.34 109.032 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.581 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 45.9 t80 -90.2 112.62 24.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.595 1.158 . . . . 74.4 109.159 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HE2' HG11 ' A' ' 166' ' ' VAL . 62.5 tttm -69.2 143.5 53.99 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.067 0.547 . . . . 72.33 110.546 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.19 -174.54 33.2 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 110.822 -0.911 . . . . 72.11 110.822 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 20.2 ptmt -134.43 151.56 51.26 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.477 0.639 . . . . 73.52 111.088 -173.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -75.39 125.21 28.53 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.303 -0.629 . . . . 73.52 109.303 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.446 HG22 HD12 ' A' ' 72' ' ' LEU . 4.7 m -150.85 155.99 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.211 1.404 . . . . 74.22 108.962 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.5 m -133.27 161.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.847 -0.798 . . . . 71.12 108.847 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -138.12 110.22 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.631 -0.877 . . . . 75.22 108.631 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -117.29 147.36 42.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.285 -1.005 . . . . 75.53 108.285 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -59.43 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.739 1.216 . . . . 63.43 111.106 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.25 -52.42 0.65 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.085 -1.416 . . . . 70.43 111.722 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -165.31 2.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.526 0.731 . . . . 74.54 112.122 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.453 HD11 HD22 ' A' ' 44' ' ' LEU . 7.4 tt -142.91 119.24 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.054 0.942 . . . . 74.24 110.51 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.36 87.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 107.951 -1.129 . . . . 74.51 107.951 168.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.453 HD22 HD11 ' A' ' 42' ' ' ILE . 2.3 pp -83.67 -21.18 32.49 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.555 0.342 . . . . 74.32 111.323 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.26 149.85 34.67 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.53 0.732 . . . . 55.32 110.882 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.32 40.59 0.07 OUTLIER Glycine 0 C--N 1.335 0.48 0 CA-C-N 114.864 -1.062 . . . . 75.14 111.128 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 t 58.97 49.37 9.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.835 1.254 . . . . 74.34 109.785 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -133.75 137.44 28.67 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 114.69 -1.141 . . . . 74.12 110.027 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.01 -155.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.642 2.228 . . . . 64.05 110.951 168.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 t -78.48 67.67 4.3 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.905 0.482 . . . . 73.01 110.383 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.61 91.83 6.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.408 0.683 . . . . 72.03 109.947 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -71.09 -57.11 4.84 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.114 0.966 . . . . 74.35 110.929 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 60.25 23.01 12.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.025 1.33 . . . . 73.12 113.308 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -131.1 50.38 0.89 Allowed Glycine 0 N--CA 1.468 0.803 0 N-CA-C 111.779 -0.528 . . . . 60.44 111.779 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.7 -22.64 63.4 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.991 0.516 . . . . 73.42 110.274 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -128.6 48.93 2.25 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.791 1.236 . . . . 74.41 107.702 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.04 105.36 0.31 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.107 0.963 . . . . 64.34 112.177 -174.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -114.2 7.59 16.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.759 1.224 . . . . 65.12 110.535 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.82 114.14 6.55 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 123.532 0.52 . . . . 63.04 111.838 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.2 p -74.6 83.13 2.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.582 0.753 . . . . 64.41 110.576 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -130.64 131.31 44.83 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.544 0.738 . . . . 75.01 110.022 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -96.72 -16.0 21.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.374 1.069 . . . . 75.04 110.103 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -139.07 75.63 1.53 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.591 0.756 . . . . 75.25 110.888 -175.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.19 85.27 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.211 -1.403 . . . . 74.41 107.211 159.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HG2' HD21 ' A' ' 72' ' ' LEU . 37.4 tt0 -93.34 75.5 4.54 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 107.795 -1.187 . . . . 64.4 107.795 172.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -89.01 144.76 25.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.553 -1.203 . . . . 72.32 110.589 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.01 -130.54 3.13 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.099 -0.8 . . . . 73.32 111.099 164.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.488 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 20.4 pt -112.73 150.06 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 122.881 0.472 . . . . 74.14 111.212 168.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -41.17 -41.32 1.77 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 127.122 2.169 . . . . 72.35 113.146 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.578 HG21 ' HB2' ' A' ' 169' ' ' LEU . 66.9 mt -57.58 -55.32 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 124.336 1.023 . . . . 75.14 110.352 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 76' ' ' LEU . 40.3 t -60.56 -44.91 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 114.407 -1.269 . . . . 73.31 111.215 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.49 HD21 ' HG2' ' A' ' 65' ' ' GLU . 19.1 mt -72.34 -35.8 68.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.418 -0.81 . . . . 72.1 111.127 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -72.04 -33.88 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.757 0.823 . . . . 75.35 110.83 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -97.7 -5.68 34.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.417 0.687 . . . . 74.11 111.64 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt 55.5 63.13 2.17 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.937 1.295 . . . . 73.24 110.683 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.526 ' HB2' HG11 ' A' ' 71' ' ' VAL . 58.0 mt -100.52 135.35 42.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.713 -1.131 . . . . 72.4 109.367 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.75 130.35 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.519 -0.548 . . . . 75.1 109.519 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.98 134.32 43.08 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.804 -1.089 . . . . 73.03 111.902 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.4 mtp -145.56 103.84 3.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.853 1.661 . . . . 74.5 107.273 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.471 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 95.6 m-20 -86.05 149.98 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.522 -0.736 . . . . 74.52 109.691 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.406 ' HB2' ' HE2' ' A' ' 138' ' ' PHE . 37.0 t -60.72 -20.38 61.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.625 -0.716 . . . . 74.24 111.812 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.471 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 95.1 m-85 -58.28 -57.72 11.65 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.331 1.053 . . . . 74.44 110.925 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -74.24 -35.14 63.83 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.274 -0.876 . . . . 73.2 111.851 -174.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -121.44 19.37 11.31 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 112.208 0.447 . . . . 72.25 112.208 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.39 -39.6 7.11 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.681 0.993 . . . . 51.42 113.681 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.0 m -65.98 -60.18 3.1 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.507 0.723 . . . . 70.31 111.378 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.2 mtt -76.75 -14.54 59.93 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.988 -0.551 . . . . 75.22 111.431 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.672 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 40.5 t80 -70.1 -38.51 75.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.21 0.604 . . . . 73.43 109.862 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -70.07 -26.15 63.88 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 110.216 -0.291 . . . . 75.04 110.216 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.3 72.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.012 -0.54 . . . . 70.12 110.785 170.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.672 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 33.1 m-85 -58.48 -44.86 89.53 Favored 'General case' 0 C--N 1.367 1.346 0 C-N-CA 123.205 0.602 . . . . 72.42 109.784 170.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm -64.15 -38.78 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.843 0.857 . . . . 63.11 111.613 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -60.02 -46.92 87.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.935 0.494 . . . . 73.22 111.713 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -66.49 -44.89 81.38 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 71.02 110.395 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -50.41 -59.31 4.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.204 1.802 . . . . 73.11 110.85 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 64.0 mtt -57.26 -57.45 12.57 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.164 0.915 . . . . 73.54 111.022 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.17 -30.69 71.23 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.285 0.366 . . . . 72.22 111.639 -173.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -78.34 -45.15 23.28 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.74 0.416 . . . . 72.25 110.991 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.472 HG12 ' HB1' ' A' ' 175' ' ' ALA . 32.4 m -68.27 -28.8 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 123.196 0.31 . . . . 74.3 110.583 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.486 ' HA ' ' HE1' ' A' ' 103' ' ' MET . 52.6 mt -75.04 -45.36 42.68 Favored 'Isoleucine or valine' 0 C--N 1.359 0.978 0 C-N-CA 123.431 0.692 . . . . 73.53 110.307 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.63 -31.87 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.444 0.698 . . . . 73.05 111.337 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -69.78 -61.35 1.82 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.984 0.914 . . . . 73.24 109.811 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.486 ' HE1' ' HA ' ' A' ' 100' ' ' ILE . 21.9 ptt? -64.5 -50.31 67.89 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.66 0.6 . . . . 55.23 111.444 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.82 -20.93 66.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.348 0.659 . . . . 71.43 111.991 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -72.64 -25.73 61.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.387 0.675 . . . . 75.22 110.388 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.57 0.09 12.58 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.799 0.84 . . . . 62.43 111.538 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -120.02 -74.11 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.158 0.583 . . . . 65.51 110.206 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 50.08 18.78 0.41 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.548 1.939 . . . . 72.44 115.131 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.86 -22.64 49.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.249 0.62 . . . . 75.51 110.001 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.52 ' HA ' HG21 ' A' ' 113' ' ' VAL . 86.0 tttt 84.15 -38.76 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.148 1.779 . . . . 75.44 111.73 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.89 62.79 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.227 0.467 . . . . 75.3 110.637 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -86.2 -44.55 12.09 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.938 0.895 . . . . 74.3 111.742 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.52 HG21 ' HA ' ' A' ' 110' ' ' LYS . 33.5 m -78.03 -34.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.139 -0.482 . . . . 73.44 111.564 -174.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.72 -25.3 56.49 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.701 -0.481 . . . . 72.12 109.701 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.7 -47.98 57.01 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.351 0.66 . . . . 73.35 109.691 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -61.85 -47.69 83.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.216 1.006 . . . . 74.24 110.828 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.56 -36.18 79.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.195 0.998 . . . . 72.32 110.786 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.72 -46.17 83.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.66 0.784 . . . . 73.43 109.939 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.401 ' HB3' HD21 ' A' ' 26' ' ' LEU . 34.4 mmtp -66.49 -37.75 85.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.465 -0.789 . . . . 72.55 111.107 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.7 mm -73.24 -36.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.82 0.848 . . . . 72.31 110.682 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -61.32 -52.51 64.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.744 -0.835 . . . . 73.1 108.744 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.67 -37.44 94.37 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.66 -0.7 . . . . 65.23 112.325 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -62.51 -55.32 28.57 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.1 0.96 . . . . 74.35 110.743 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -67.23 -41.15 86.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-O 118.402 -0.809 . . . . 75.12 111.151 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.3 -42.52 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.095 0.861 . . . . 74.2 110.787 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -70.24 -31.4 68.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.883 0.473 . . . . 61.15 111.311 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.653 HD22 HG21 ' A' ' 155' ' ' ILE . 31.9 tp -84.03 -21.65 31.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.058 0.943 . . . . 75.24 111.342 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -92.88 -0.37 57.25 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.694 0.797 . . . . 71.23 111.589 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.82 101.32 0.19 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.09 0.556 . . . . 51.45 110.487 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 15.3 ptmm? -61.77 -12.41 16.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.962 1.305 . . . . 71.32 114.432 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.68 -46.46 82.33 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.829 0.452 . . . . 63.15 111.113 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -110.13 -40.36 4.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.242 1.017 . . . . 75.35 109.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -81.58 -3.47 53.39 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.233 1.013 . . . . 73.43 112.608 -167.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 61.1 tttm -46.09 -31.01 2.11 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.423 1.089 . . . . 75.2 111.895 160.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -97.57 26.66 4.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.332 1.053 . . . . 54.13 111.596 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 mt -88.69 140.61 29.28 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.214 -0.662 . . . . 64.54 109.214 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.55 112.34 25.03 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.401 -1.333 . . . . 71.35 107.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.406 ' HE2' ' HB2' ' A' ' 81' ' ' CYS . 76.7 m-85 -99.71 140.35 34.05 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.579 -0.897 . . . . 75.55 108.579 -175.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.521 ' HB2' ' HB1' ' A' ' 154' ' ' ALA . 45.5 m-85 -131.84 150.04 52.27 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.953 -1.128 . . . . 74.24 107.953 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.2 tt -124.13 141.05 45.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 107.948 -1.13 . . . . 75.11 107.948 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.32 138.61 47.69 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.014 0.822 . . . . 71.12 111.904 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 49.0 tt0 -43.31 -54.21 4.77 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.178 0.991 . . . . 74.4 112.18 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -64.24 -38.35 90.74 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.9 0.75 . . . . 74.42 111.29 -172.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.25 97.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.717 0.807 . . . . 74.42 110.924 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 -16.28 56.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.401 1.08 . . . . 64.11 113.215 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 42.3 mt-10 -64.27 -31.41 72.61 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.775 0.43 . . . . 73.32 111.693 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.19 51.86 0.03 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.739 -0.944 . . . . 60.13 110.739 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.72 -170.18 2.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.778 0.831 . . . . 74.54 110.314 -173.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.481 ' HB3' HG22 ' A' ' 9' ' ' THR . 12.7 tp10 -51.18 142.83 11.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.461 1.104 . . . . 74.32 111.53 173.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -50.98 -26.46 6.04 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.779 1.77 . . . . 71.12 115.779 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.66 176.54 21.43 Favored Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.051 0.219 . . . . 73.45 112.902 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.07 127.16 33.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 106.758 -1.571 . . . . 70.03 106.758 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 155' ' ' ILE . 67.9 t -74.63 113.7 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.322 -0.622 . . . . 65.22 109.322 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 139' ' ' PHE . . . -64.81 97.09 0.2 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.62 1.168 . . . . 73.24 109.654 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.653 HG21 HD22 ' A' ' 127' ' ' LEU . 85.2 mt -88.15 102.73 12.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 108.538 -0.912 . . . . 75.13 108.538 -172.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.482 HD11 HD11 ' A' ' 68' ' ' ILE . 41.0 mm -95.56 114.29 31.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 116.255 -0.43 . . . . 75.52 109.967 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.71 130.18 54.89 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.406 -1.27 . . . . 74.2 108.313 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.3 p90 -83.12 124.41 30.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.992 -1.484 . . . . 62.44 106.992 173.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -116.14 135.74 53.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.635 -1.246 . . . . 75.21 107.635 -171.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.11 115.39 28.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.032 -0.729 . . . . 74.04 109.032 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.6 107.64 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.952 -0.759 . . . . 74.43 108.952 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 63.97 30.63 14.1 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.416 1.086 . . . . 64.12 110.734 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.94 25.03 75.71 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.59 -0.732 . . . . 61.02 113.038 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.1 m -108.34 134.85 50.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.612 0.765 . . . . 73.1 109.129 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -73.14 111.43 8.25 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.888 -0.782 . . . . 73.44 108.888 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.436 HG11 ' HE2' ' A' ' 31' ' ' LYS . 27.0 m -128.63 88.07 53.16 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 121.845 0.831 . . . . 74.15 108.98 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 80.6 Cg_exo -55.37 121.4 9.86 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.788 2.325 . . . . 71.4 111.989 168.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.6 t -115.28 140.07 49.42 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.347 1.059 . . . . 71.24 109.098 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.7 tp -91.75 114.54 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.712 1.205 . . . . 73.41 108.967 176.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 81.1 mtp -93.84 123.04 36.93 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 107.568 -1.271 . . . . 74.34 107.568 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.557 HD12 HG23 ' A' ' 176' ' ' ILE . 94.0 mt -132.84 141.26 48.36 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.629 1.572 . . . . 73.13 107.511 -177.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.2 p -80.87 133.7 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.471 -0.937 . . . . 73.12 108.471 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -66.29 -19.62 65.87 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.431 0.692 . . . . 75.41 112.254 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.38 -30.43 47.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.768 0.318 . . . . 73.4 111.48 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.571 ' HB2' ' HE1' ' A' ' 8' ' ' PHE . . . -104.21 -10.16 18.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.092 0.557 . . . . 72.31 111.678 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 171' ' ' LEU . 36.1 mm -126.25 108.34 19.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.787 -1.561 . . . . 64.11 106.787 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.2 mm -95.04 113.18 28.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.288 -0.869 . . . . 74.31 109.596 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.37 135.84 44.31 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.434 -1.321 . . . . 75.23 107.434 166.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.591 ' HB3' HG22 ' A' ' 3' ' ' ILE . 36.9 tt0 -149.19 134.74 18.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.818 0.342 . . . . 73.12 110.235 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.582 ' HE3' HD13 ' A' ' 182' ' ' LEU . 37.8 tttp -81.14 112.42 18.48 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.45 -0.945 . . . . 75.12 108.45 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.75 92.36 3.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.887 -0.783 . . . . 74.41 108.887 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.582 HD13 ' HE3' ' A' ' 180' ' ' LYS . 48.1 mt -98.74 152.96 19.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.094 0.558 . . . . 65.22 110.88 -174.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 CA--C 1.557 1.222 0 C-N-CA 122.892 0.477 . . . . 75.32 110.389 178.577 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.924 -0.769 . . . . 75.24 108.924 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.496 HD11 ' SD ' ' A' ' 20' ' ' MET . 84.0 mt -133.16 153.07 51.86 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.143 -0.688 . . . . 74.04 109.143 175.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' A' ' 179' ' ' GLU . 4.4 tt -114.49 116.74 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.906 -1.516 . . . . 71.42 106.906 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.421 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 5.2 m-85 -100.97 130.93 47.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.26 -1.385 . . . . 73.3 107.26 -174.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.96 161.7 19.76 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.289 1.036 . . . . 71.32 109.638 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 35.3 t70 -116.02 178.06 4.46 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.383 1.073 . . . . 74.13 109.743 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.96 -39.27 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 CA-C-O 121.348 0.594 . . . . 73.31 110.306 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -110.93 -55.25 2.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.679 1.192 . . . . 65.43 110.002 -168.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.446 ' HB ' HD21 ' A' ' 13' ' ' LEU . 3.7 m -90.06 15.74 9.6 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 113.755 -1.566 . . . . 72.44 111.234 -168.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.541 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.7 p-10 -63.2 -7.11 5.21 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 114.603 1.334 . . . . 75.35 114.603 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -48.82 -50.98 31.93 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.403 1.064 . . . . 72.23 111.393 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -123.35 -40.54 2.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.017 0.927 . . . . 74.32 109.144 164.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD21 ' HB ' ' A' ' 9' ' ' THR . 2.0 tm? 42.9 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.294 1.837 . . . . 73.54 111.67 -167.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 4' ' ' TYR . 67.1 p -155.26 154.49 32.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.66 0.784 . . . . 74.41 110.783 175.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.449 ' HG ' HG13 ' A' ' 3' ' ' ILE . 48.1 m -163.16 96.35 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.959 0.904 . . . . 73.21 110.468 -171.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -179.16 172.77 1.21 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.612 1.165 . . . . 70.31 108.912 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -38.8 -55.1 1.55 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.466 1.106 . . . . 73.21 111.355 165.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 43.07 108.29 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 125.924 1.69 . . . . 71.43 114.84 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.92 121.04 9.29 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 121.951 1.767 . . . . 75.11 110.951 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.496 ' SD ' HD11 ' A' ' 2' ' ' LEU . 44.4 mtm -101.28 150.45 22.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.128 0.971 . . . . 72.42 109.718 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -156.76 134.27 10.74 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.113 -0.699 . . . . 74.54 109.113 171.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.73 122.55 47.44 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.18 -1.045 . . . . 73.43 108.18 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.52 135.19 52.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.465 0.706 . . . . 75.31 110.082 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 60.5 14.18 4.66 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.678 1.191 . . . . 71.15 112.536 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 48.58 33.84 4.47 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.547 1.139 . . . . 74.24 111.67 -171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 119' ' ' LYS . 32.8 tp -125.81 -52.47 1.56 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.236 -0.893 . . . . 72.24 109.632 -175.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.1 t -114.13 128.9 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.281 -0.872 . . . . 74.03 109.226 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.88 112.84 21.52 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 106.829 -1.545 . . . . 65.22 106.829 166.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -104.43 145.06 30.81 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.175 -0.676 . . . . 72.42 109.175 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -142.93 105.48 4.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.484 1.114 . . . . 73.11 108.411 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.67 149.22 26.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.348 0.659 . . . . 74.11 110.415 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.97 -161.76 9.53 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.88 -1.055 . . . . 74.14 111.262 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 139.83 51.02 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.76 0.824 . . . . 74.4 109.891 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -73.76 115.81 13.63 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.71 -1.132 . . . . 74.51 109.236 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -147.45 -175.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.721 1.208 . . . . 71.33 109.792 -170.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 44' ' ' LEU . 26.0 m -113.16 161.05 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.448 0.699 . . . . 72.31 110.909 173.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 60.6 ttt180 -136.3 112.18 9.55 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.666 1.186 . . . . 75.44 108.366 174.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HD2' HG21 ' A' ' 64' ' ' VAL . 52.0 tttm -135.66 96.73 3.5 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.521 -0.918 . . . . 75.43 108.521 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 47.7 -81.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 126.326 1.851 . . . . 74.52 112.987 -173.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.15 26.13 0.31 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.856 -0.898 . . . . 71.41 110.856 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.32 98.14 4.02 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.689 1.596 . . . . 63.2 107.182 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.7 pt -131.39 136.86 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.215 0.531 . . . . 71.23 110.99 -176.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.78 49.42 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.578 1.151 . . . . 71.44 108.389 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.478 ' HB3' HG23 ' A' ' 36' ' ' VAL . 1.1 pp -57.0 143.05 39.65 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.331 -1.304 . . . . 74.13 111.684 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.0 -10.42 55.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.726 -0.67 . . . . 74.44 110.486 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.58 -105.42 0.42 Allowed Glycine 0 C--N 1.362 2.026 0 N-CA-C 110.591 -1.004 . . . . 74.41 110.591 -171.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 t -80.35 95.57 6.41 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.96 -1.496 . . . . 74.25 106.96 167.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -65.29 112.14 7.69 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.776 0.831 . . . . 74.31 110.626 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.26 117.51 4.4 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.697 2.265 . . . . 74.12 112.385 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.1 t 58.22 85.18 0.09 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.657 1.183 . . . . 75.24 111.25 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.06 98.33 8.59 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.225 -0.657 . . . . 71.41 109.225 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -14.25 60.62 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.976 -1.011 . . . . 75.53 112.075 -176.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 10.2 tp10 -136.25 -82.88 0.38 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.505 0.322 . . . . 75.4 111.089 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.97 23.27 67.49 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 123.022 0.201 . . . . 72.42 113.515 -175.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.444 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -138.07 37.26 2.34 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.792 0.837 . . . . 72.11 110.794 -173.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.87 -19.56 60.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.758 0.823 . . . . 74.32 112.13 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 63.73 24.92 14.02 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.139 1.376 . . . . 55.14 112.113 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 62.78 90.83 0.07 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.496 1.119 . . . . 74.5 110.398 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.36 14.56 1.44 Allowed Glycine 0 N--CA 1.477 1.419 0 CA-C-O 120.327 -0.152 . . . . 73.31 113.085 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.7 m -150.15 25.88 0.8 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.482 1.113 . . . . 73.14 108.492 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -122.47 39.42 3.92 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.884 1.274 . . . . 74.44 109.979 -168.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -50.54 -46.51 57.48 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.771 1.228 . . . . 74.5 111.74 -177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -133.47 23.54 4.05 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.562 0.745 . . . . 74.23 110.37 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.402 HG21 ' HD2' ' A' ' 38' ' ' LYS . 46.2 t -106.73 97.91 6.25 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 109.157 -0.683 . . . . 74.03 109.157 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.8 mp0 -78.26 82.06 4.59 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.313 -0.995 . . . . 73.34 108.313 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 6.9 tmm_? -76.11 146.37 39.33 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.982 -0.747 . . . . 75.34 108.982 168.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.33 -136.7 5.54 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.644 -0.582 . . . . 61.21 111.644 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.712 HD11 HD13 ' A' ' 70' ' ' ILE . 2.1 tt -104.31 126.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.627 1.171 . . . . 73.02 109.026 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.26 -29.46 33.06 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.188 1.395 . . . . 64.03 113.502 -172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.712 HD13 HD11 ' A' ' 68' ' ' ILE . 56.5 mt -61.53 -44.87 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.428 1.091 . . . . 74.13 110.048 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 76' ' ' LEU . 44.0 t -74.68 -41.79 47.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-N 114.179 -1.373 . . . . 73.14 110.268 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 35.2 mt -67.2 -24.09 65.81 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.668 0.605 . . . . 75.44 110.914 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -62.36 -61.11 2.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.635 1.174 . . . . 71.01 110.513 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -87.01 -20.17 27.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.729 0.812 . . . . 72.32 111.227 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 41.2 ttmt 66.38 69.62 0.42 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.042 1.337 . . . . 75.34 109.124 -168.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HB2' HG13 ' A' ' 71' ' ' VAL . 70.4 mt -80.44 136.34 36.32 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.255 -1.017 . . . . 73.1 108.255 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.91 130.28 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.09 -0.707 . . . . 74.51 109.09 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.47 148.54 37.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.039 . . . . 73.3 112.59 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.54 ' HE1' HG21 ' A' ' 153' ' ' VAL . 56.2 ttp -148.69 134.42 18.85 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.239 -1.346 . . . . 74.43 107.657 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -119.09 142.69 47.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.091 0.556 . . . . 60.03 109.645 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.6 -11.92 48.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.711 0.805 . . . . 73.44 111.753 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -80.25 -34.63 36.95 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.973 0.909 . . . . 70.44 111.424 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -103.06 -37.22 7.86 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.172 0.511 . . . . 70.13 110.635 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.4 20.4 16.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.315 1.046 . . . . 72.55 111.925 -169.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -44.77 -43.48 8.61 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.748 1.219 . . . . 71.12 113.57 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.3 t -65.62 -52.04 55.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.057 0.943 . . . . 73.02 111.353 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.1 mpt? -68.63 -42.29 78.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.967 0.907 . . . . 73.33 110.688 -173.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.465 ' HE1' HG13 ' A' ' 153' ' ' VAL . 51.5 t80 -63.04 -41.87 99.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.766 1.226 . . . . 75.44 111.236 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -65.28 -36.56 84.47 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.212 0.605 . . . . 73.41 110.637 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.79 87.52 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.787 -0.642 . . . . 74.44 110.307 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -65.03 -45.63 84.66 Favored 'General case' 0 C--O 1.193 -1.874 0 CA-C-O 118.571 -0.728 . . . . 75.31 110.808 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.25 -43.08 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.36 0.664 . . . . 64.44 111.67 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.81 -49.07 78.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.702 0.801 . . . . 72.04 111.26 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -79.5 -38.25 34.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.256 0.622 . . . . 74.13 111.173 -173.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -50.99 -53.75 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.632 1.573 . . . . 74.52 110.387 170.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.9 ttp -53.79 -55.87 22.62 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 124.184 0.927 . . . . 74.4 110.14 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.36 -36.67 66.57 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.48 1.112 . . . . 73.53 112.186 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.09 -41.53 18.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.026 0.931 . . . . 71.41 111.936 -169.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -76.88 -27.74 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.673 0.389 . . . . 75.11 111.916 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.459 HD12 ' HG3' ' A' ' 117' ' ' LYS . 84.8 mt -73.05 -36.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.312 0.645 . . . . 72.51 109.303 171.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.59 -44.89 95.19 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.892 0.877 . . . . 65.23 110.562 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -63.2 -44.44 95.36 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.666 -0.697 . . . . 74.33 110.106 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.485 ' SD ' ' CG ' ' A' ' 116' ' ' PHE . 22.9 ttt -66.82 -40.05 87.91 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.258 -0.883 . . . . 73.2 111.329 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.564 ' HA ' HG11 ' A' ' 113' ' ' VAL . 7.6 tp10 -55.27 -40.67 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.563 1.145 . . . . 72.14 111.556 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -37.3 74.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.085 -0.961 . . . . 74.44 111.439 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -115.07 0.74 13.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.16 0.584 . . . . 71.24 111.62 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.481 ' HB2' ' HG2' ' A' ' 103' ' ' MET . 18.3 m120 -148.7 41.99 0.96 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.257 1.023 . . . . 70.24 109.22 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.73 10.68 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.697 1.599 . . . . 71.44 113.632 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.69 -24.37 21.64 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.934 1.294 . . . . 72.45 112.005 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? 89.72 -58.01 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.666 1.986 . . . . 74.4 112.483 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.91 63.18 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.1 0.409 . . . . 55.1 110.933 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.01 -45.89 25.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.09 0.956 . . . . 73.15 111.049 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 104' ' ' GLU . 8.0 m -76.03 -26.92 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.716 0.406 . . . . 74.42 111.571 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.43 -36.37 73.93 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.447 0.699 . . . . 75.13 110.345 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.93 81.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.701 -0.681 . . . . 74.34 110.399 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.485 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 79.3 t80 -63.07 -41.99 99.57 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.444 1.098 . . . . 65.01 110.331 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.459 ' HG3' HD12 ' A' ' 100' ' ' ILE . 35.5 ttpt -63.9 -38.29 90.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.133 0.973 . . . . 75.43 110.478 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -67.19 -41.5 85.75 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.884 0.874 . . . . 74.01 110.005 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.576 ' HB3' HD22 ' A' ' 26' ' ' LEU . 87.9 mttt -67.24 -39.8 86.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.415 -0.811 . . . . 75.24 111.034 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 124' ' ' VAL . 23.3 mm -67.72 -47.05 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.468 0.707 . . . . 73.41 109.731 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -51.9 -51.83 54.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.666 1.186 . . . . 75.4 110.41 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.76 -38.12 89.35 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.776 -1.102 . . . . 75.12 113.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -65.43 -54.83 22.9 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.354 0.662 . . . . 71.42 110.463 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.5 m -66.5 -42.04 89.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 118.35 -0.833 . . . . 70.13 111.208 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.47 -35.98 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 119.505 1.048 . . . . 72.24 110.871 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.1 t -74.3 -38.01 63.49 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 123.481 0.712 . . . . 64.35 110.956 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.39 -19.04 39.9 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.787 0.835 . . . . 75.13 111.128 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.4 mt -93.7 2.22 56.35 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.142 0.577 . . . . 74.41 111.398 174.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 91.58 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.326 0.584 . . . . 65.52 109.843 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -59.12 -8.28 1.47 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.336 1.455 . . . . 75.22 114.685 -168.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.32 -46.59 72.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.928 0.891 . . . . 75.55 110.333 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -109.29 -39.09 5.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.964 0.906 . . . . 75.1 110.435 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -79.23 -1.89 38.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.595 1.158 . . . . 73.54 113.248 -163.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -51.89 -24.75 6.71 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 122.858 0.463 . . . . 74.32 111.615 160.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -93.92 29.63 2.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.753 1.221 . . . . 64.55 110.351 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.3 mt -94.02 153.43 18.18 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.919 -0.771 . . . . 74.52 108.919 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.58 117.42 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.272 -1.381 . . . . 72.12 107.272 172.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.568 ' HD1' HG23 ' A' ' 155' ' ' ILE . 50.1 m-85 -94.12 140.78 29.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.142 -1.058 . . . . 71.1 108.142 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.456 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 83.6 m-85 -136.46 153.81 50.95 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.774 -0.454 . . . . 74.32 109.774 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 tt -143.71 149.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.857 -1.164 . . . . 75.33 107.857 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.08 123.94 34.15 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.293 -0.723 . . . . 73.31 111.293 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -55.22 -34.01 63.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.825 0.85 . . . . 71.54 112.499 -177.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -66.39 -43.13 86.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.963 0.905 . . . . 75.21 110.196 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.717 ' HA ' ' HB2' ' A' ' 148' ' ' ALA . . . -63.24 -35.62 80.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.312 -0.858 . . . . 74.31 110.189 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.46 -12.43 57.84 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 72.11 112.143 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -95.63 -40.74 9.26 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.356 0.662 . . . . 71.54 111.065 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.18 49.62 0.28 Allowed Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.126 -0.488 . . . . 74.32 112.588 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 144' ' ' ALA . . . -158.22 -179.77 8.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.696 0.798 . . . . 71.55 109.91 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.7 155.35 48.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.102 0.561 . . . . 71.35 111.055 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 67.61 20.38 9.65 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.078 1.351 . . . . 65.43 113.315 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.72 144.73 33.87 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.118 0.261 . . . . 72.5 112.868 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -69.93 139.55 52.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.767 0.827 . . . . 65.15 112.302 -168.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.54 HG21 ' HE1' ' A' ' 79' ' ' MET . 31.7 t -88.51 94.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.578 -0.737 . . . . 75.12 109.544 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.406 ' HA ' HD22 ' A' ' 171' ' ' LEU . . . -67.15 104.24 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.158 -0.928 . . . . 75.41 108.588 169.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.568 HG23 ' HD1' ' A' ' 138' ' ' PHE . 1.1 pt -95.12 113.68 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.421 0.629 . . . . 64.0 109.919 -168.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 169' ' ' LEU . 50.8 mm -107.09 133.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.8 -1.091 . . . . 72.34 110.207 -170.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 45.7 mt-10 -94.41 142.26 27.63 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.861 -0.792 . . . . 62.33 108.861 166.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -119.92 87.15 2.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.004 -1.85 . . . . 70.14 106.004 155.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 17.9 ttt180 -95.32 170.2 9.54 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 113.9 -1.5 . . . . 74.42 109.06 -171.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -98.12 124.97 42.93 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.552 1.069 . . . . 75.11 111.956 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.88 105.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.611 1.164 . . . . 75.13 108.466 167.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.4 t70 63.68 5.52 2.25 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.729 1.212 . . . . 75.5 112.695 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.35 -18.16 8.88 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.449 -0.639 . . . . 74.53 114.077 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 t -101.11 167.33 10.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 117.789 0.794 . . . . 71.45 109.609 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 1.2 pm0 -94.72 126.79 40.26 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.99 0.516 . . . . 74.53 112.105 -172.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 t -78.79 107.54 6.18 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 72.35 108.979 166.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.0 Cg_endo -87.97 112.5 0.77 Allowed 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 122.712 2.275 . . . . 65.3 109.988 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.3 m -126.31 118.21 24.61 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.811 0.444 . . . . 74.54 111.037 -174.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 156' ' ' ILE . 53.0 tp -78.92 134.28 36.88 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.109 -0.7 . . . . 71.43 109.109 166.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' MET . . . . . 0.512 ' HB2' HG13 ' A' ' 155' ' ' ILE . 65.7 mtt -124.37 138.44 54.37 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.885 -1.154 . . . . 74.12 107.885 165.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 176' ' ' ILE . 53.5 mt -152.16 150.85 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.098 1.759 . . . . 73.42 106.789 169.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.8 p -78.76 149.1 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.599 -0.889 . . . . 73.54 108.599 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -63.6 -31.58 72.79 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.321 0.649 . . . . 75.11 110.214 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 103' ' ' MET . 67.6 mm-40 -76.97 -3.37 38.54 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.504 0.928 . . . . 73.31 113.504 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.72 -25.13 14.78 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.965 0.506 . . . . 55.04 110.065 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.454 HD12 HD11 ' A' ' 171' ' ' LEU . 48.3 mm -106.52 125.28 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.422 0.689 . . . . 65.43 110.866 -170.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.0 mm -110.22 109.36 28.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.59 -1.263 . . . . 74.33 107.59 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.61 111.5 19.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.068 -0.969 . . . . 70.41 108.657 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.6 ' HB3' HG22 ' A' ' 3' ' ' ILE . 8.8 tp10 -95.11 130.44 41.81 Favored 'General case' 0 C--O 1.248 0.98 0 N-CA-C 109.394 -0.595 . . . . 71.41 109.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -71.87 108.58 5.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.141 -0.936 . . . . 74.22 109.797 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.9 t -94.32 89.82 6.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.465 0.706 . . . . 75.12 110.011 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.86 -61.18 1.46 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.022 0.929 . . . . 54.45 109.267 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 123.846 0.858 . . . . 74.33 109.597 -178.818 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.633 ' SD ' ' HA ' ' A' ' 16' ' ' ASP . 45.2 tpp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.438 -0.579 . . . . 74.44 109.438 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 18' ' ' PHE . 79.3 mt -118.47 152.96 34.93 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.689 -0.856 . . . . 74.11 108.689 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.0 pt -131.99 121.08 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 108.563 -0.903 . . . . 75.54 108.563 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 23.1 p90 -122.15 135.58 54.8 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 121.58 -0.7 . . . . 74.24 109.946 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 46.4 mtpt -137.72 135.09 36.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.839 -1.528 . . . . 71.3 109.448 -159.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.94 144.32 36.92 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.298 -0.631 . . . . 63.54 109.298 173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.23 -26.42 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 113.475 0.917 . . . . 74.12 113.475 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -96.72 -67.85 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 114.238 1.199 . . . . 74.2 114.238 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -130.38 -22.45 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.462 0.912 . . . . 74.52 113.462 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.57 23.15 13.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.458 1.103 . . . . 60.52 109.74 -169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.26 -15.29 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.574 1.55 . . . . 74.44 114.286 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -76.24 -40.45 51.99 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 121.55 -0.718 . . . . 75.34 111.78 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 37.4 mt 21.18 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 126.455 1.902 . . . . 73.05 113.813 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.5 m -152.14 123.03 7.5 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.782 0.289 . . . . 72.42 111.782 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.6 m -113.01 94.66 5.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.595 1.158 . . . . 73.22 110.538 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.633 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 26.7 t70 -168.97 166.17 11.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.95 0.9 . . . . 71.23 109.668 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -70.32 78.43 0.54 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.527 0.731 . . . . 74.34 110.334 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 32.1 m-85 -104.21 146.7 33.06 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 124.784 1.233 . . . . 73.23 110.673 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.38 118.9 5.91 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.52 2.147 . . . . 73.34 112.603 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.7 ptm -113.4 145.68 40.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.342 0.657 . . . . 75.13 109.927 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.557 ' HB2' ' HZ1' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -151.47 137.64 18.35 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.235 -0.654 . . . . 75.23 109.235 174.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.53 148.53 24.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.386 1.074 . . . . 75.44 108.232 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.11 134.25 47.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 C-N-CA 124.074 0.95 . . . . 71.13 109.375 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 59.51 16.47 5.29 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.945 1.298 . . . . 64.42 112.53 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 54.61 32.73 17.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.509 1.523 . . . . 74.34 112.542 -174.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 119' ' ' LYS . 55.2 tp -132.23 -50.97 0.94 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.226 0.61 . . . . 74.02 111.033 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.39 141.92 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.319 0.648 . . . . 71.34 109.819 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.69 113.24 24.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.586 -0.894 . . . . 72.12 108.586 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HG3' ' HB3' ' A' ' 21' ' ' LYS . 6.0 pt-20 -82.88 104.08 12.83 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.007 -1.479 . . . . 61.34 107.007 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.0 t80 -88.88 112.67 23.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.94 -1.504 . . . . 73.42 106.94 177.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.484 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 2.2 mmmp? -67.2 148.88 51.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.912 0.885 . . . . 72.33 110.969 -171.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 157.78 27.51 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.496 0.497 . . . . 72.43 113.575 -174.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -121.26 140.23 52.34 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.311 -0.996 . . . . 73.11 108.311 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -74.33 116.78 15.39 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.001 -1.481 . . . . 74.45 107.001 167.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.48 HG22 HD12 ' A' ' 72' ' ' LEU . 34.4 m -131.08 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 124.545 1.138 . . . . 75.42 108.398 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 m -125.86 153.93 34.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.814 0.846 . . . . 75.33 109.655 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.503 ' HB2' HD11 ' A' ' 72' ' ' LEU . 12.9 ttp180 -141.53 110.26 6.1 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.071 0.462 . . . . 74.55 110.945 170.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -133.94 137.99 45.2 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 107.585 -1.265 . . . . 75.42 107.585 169.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -9.89 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.039 0.755 . . . . 65.3 113.039 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.83 -38.65 2.15 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.303 -0.319 . . . . 60.43 112.303 170.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -121.27 138.3 54.3 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.179 0.592 . . . . 74.13 112.321 -167.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.18 3.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.927 0.891 . . . . 63.54 110.405 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -63.16 114.08 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.301 0.641 . . . . 62.3 110.875 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -66.26 96.45 0.34 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.179 -0.675 . . . . 71.1 109.179 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.6 -48.18 72.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.541 1.137 . . . . 55.41 111.578 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.17 35.75 88.7 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.333 -0.848 . . . . 44.02 112.893 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.6 t -110.95 169.65 8.62 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.808 0.843 . . . . 75.52 110.713 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.38 148.68 89.47 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.641 0.776 . . . . 74.03 112.022 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.29 103.82 0.11 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 123.28 2.653 . . . . 75.01 110.822 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.8 p -79.15 12.76 2.12 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.241 0.83 . . . . 73.33 113.241 -167.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.27 76.38 0.35 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.731 0.813 . . . . 72.43 109.517 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HB2' ' HE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -137.28 23.44 2.98 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.481 -1.236 . . . . 73.01 110.759 -167.019 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.59 28.37 0.77 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.076 -0.966 . . . . 73.42 110.69 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.46 -12.19 69.35 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.234 -0.759 . . . . 74.15 114.497 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 74.07 -71.37 0.13 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.817 1.247 . . . . 74.34 111.614 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -77.74 84.48 4.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.418 0.628 . . . . 64.03 109.439 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -155.91 131.5 9.65 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.233 -1.025 . . . . 73.34 108.233 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 63' ' ' HIS . 18.1 m-20 60.94 28.7 18.47 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.397 1.079 . . . . 74.21 111.862 -175.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.72 -92.78 1.12 Allowed Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.4 -0.818 . . . . 62.33 111.536 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.2 t -94.36 -158.25 0.62 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.791 1.236 . . . . 75.33 109.635 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -74.43 17.81 0.18 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.451 0.7 . . . . 72.42 112.727 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.47 -29.49 58.83 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.99 0.516 . . . . 73.04 109.897 168.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 34.2 t-80 -82.79 70.76 9.84 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.659 -0.7 . . . . 71.42 109.876 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.4 t -80.77 -67.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 107.233 -1.395 . . . . 64.34 107.233 165.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . 0.252 2.1 pt-20 68.7 -45.85 0.54 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.694 2.398 . . . . 74.52 113.528 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -134.15 146.35 50.12 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 108.398 -0.964 . . . . 73.42 108.398 -173.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.57 44.65 Favored Glycine 0 N--CA 1.447 -0.58 0 O-C-N 123.604 0.565 . . . . 72.45 112.259 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 70' ' ' ILE . 1.8 tt -94.82 130.1 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.219 -1.03 . . . . 73.01 108.219 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -47.97 -40.67 23.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.753 1.621 . . . . 71.23 113.416 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.761 HD11 HD11 ' A' ' 68' ' ' ILE . 62.4 mt -55.36 -47.88 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.741 1.216 . . . . 75.24 110.666 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.1 -48.63 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.405 0.682 . . . . 75.11 111.713 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 37' ' ' ARG . 63.0 mt -60.83 -33.91 73.75 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.094 0.871 . . . . 74.51 111.092 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -79.35 -48.65 13.68 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.169 0.987 . . . . 75.43 111.16 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -87.15 1.78 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.91 0.484 . . . . 75.03 111.612 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 70.5 mmtt 64.38 34.86 10.11 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.833 1.253 . . . . 74.35 111.165 173.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.51 132.71 40.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.205 -0.665 . . . . 71.03 109.205 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 p -84.64 133.46 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 N-CA-C 109.883 -0.414 . . . . 72.43 109.883 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.79 140.34 45.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.157 1.383 . . . . 73.01 112.677 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -148.06 131.55 16.72 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.505 -0.924 . . . . 71.43 108.505 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 45.2 m-80 -88.0 137.57 32.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.816 0.446 . . . . 71.2 110.491 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 133' ' ' PHE . 9.1 p -57.74 -30.75 65.83 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.501 1.521 . . . . 74.43 111.204 172.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.433 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 47.1 m-85 -59.51 -34.58 72.8 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.673 -1.603 . . . . 73.24 110.832 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.46 -18.59 14.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.752 0.821 . . . . 75.13 111.829 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.69 14.98 20.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.261 0.624 . . . . 72.24 112.143 -169.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.89 -53.96 50.86 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.563 0.62 . . . . 75.52 112.213 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.7 t -70.5 -36.54 73.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.345 0.658 . . . . 65.31 110.745 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.0 mmm -62.39 -38.39 89.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.273 0.629 . . . . 73.43 110.846 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.412 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 76.4 t80 -78.95 -25.45 43.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.707 0.803 . . . . 72.32 110.627 -176.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -62.94 -41.79 99.6 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.951 -0.759 . . . . 75.03 108.951 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.4 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 74.32 111.05 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 23.2 m-85 -61.37 -37.98 85.34 Favored 'General case' 0 C--N 1.364 1.205 0 CA-C-O 119.506 -0.283 . . . . 74.43 110.48 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.766 HG21 HD12 ' A' ' 128' ' ' LEU . 14.8 mm -66.47 -41.67 89.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 124.061 0.851 . . . . 74.14 111.876 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -61.88 -38.4 88.16 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.89 0.768 . . . . 75.33 110.204 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.82 -45.22 68.35 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.457 -0.792 . . . . 72.23 110.431 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . 84.6 t80 -55.76 -57.31 12.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.738 1.615 . . . . 70.31 111.621 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.2 ptm -63.97 -31.64 72.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.493 0.717 . . . . 70.52 110.693 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -61.5 -58.55 7.72 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.867 -0.42 . . . . 73.13 109.867 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.5 -27.38 62.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.336 -0.847 . . . . 74.04 112.223 -168.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 174' ' ' GLU . 22.5 m -75.2 -38.46 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 117.697 0.226 . . . . 72.21 111.326 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.577 ' HA ' ' HE1' ' A' ' 103' ' ' MET . 55.4 mt -69.31 -38.05 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 110.324 -0.25 . . . . 73.54 110.324 176.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 -46.4 88.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.017 0.527 . . . . 74.44 110.685 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.518 ' HD1' ' HG3' ' A' ' 174' ' ' GLU . 49.3 t-80 -53.23 -56.01 19.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.129 0.971 . . . . 75.2 111.057 -176.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.577 ' HE1' ' HA ' ' A' ' 100' ' ' ILE . 19.4 ptt? -64.63 -45.49 86.61 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.086 0.866 . . . . 74.02 111.346 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.142 0.977 . . . . 75.55 111.529 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -62.8 -27.1 69.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.993 0.917 . . . . 74.05 113.177 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -116.26 -6.91 11.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.139 0.422 . . . . 72.02 112.139 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.83 -64.67 1.04 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.52 -0.919 . . . . 72.42 108.52 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 74.35 -26.99 0.19 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.09 1.356 . . . . 74.21 112.166 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.65 125.8 29.87 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.658 0.783 . . . . 64.23 109.747 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.94 -23.31 66.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.521 1.128 . . . . 74.32 111.248 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.18 73.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.961 0.904 . . . . 64.42 111.483 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.48 -48.69 6.01 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.584 0.754 . . . . 62.34 110.031 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.9 -34.08 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 113.19 0.811 . . . . 72.34 113.19 -169.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.21 -38.98 89.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 118.702 0.683 . . . . 74.22 110.254 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.98 -45.49 73.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.016 -0.993 . . . . 75.55 110.786 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.36 -42.03 96.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.74 0.416 . . . . 73.24 110.291 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.78 -38.58 75.71 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.727 0.811 . . . . 63.33 110.824 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -68.36 -43.07 78.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.411 0.685 . . . . 74.44 110.52 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.413 ' HB3' HD22 ' A' ' 26' ' ' LEU . 70.3 mmtt -60.12 -55.85 28.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.73 0.812 . . . . 75.13 111.134 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.49 HD13 HG22 ' A' ' 172' ' ' VAL . 10.5 tp -66.97 -31.18 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.488 0.715 . . . . 73.42 110.232 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.62 -62.76 1.47 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 123.041 0.536 . . . . 74.41 110.123 168.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.77 -27.45 66.6 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.606 0.567 . . . . 52.02 113.77 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -73.88 -45.17 52.55 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.152 0.581 . . . . 75.24 111.009 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.67 -25.34 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 122.989 0.181 . . . . 73.14 110.892 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.08 -27.58 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.879 -0.513 . . . . 74.41 109.803 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -76.68 -50.97 12.4 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.367 0.667 . . . . 70.43 110.375 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.503 HD23 HG23 ' A' ' 155' ' ' ILE . 36.8 tp -75.15 -33.02 61.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.296 1.039 . . . . 64.51 112.766 -166.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.766 HD12 HG21 ' A' ' 92' ' ' ILE . 95.9 mt -79.07 2.89 19.08 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.86 0.689 . . . . 70.24 112.86 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.55 143.11 48.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.254 -1.017 . . . . 73.32 108.254 170.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 25.8 pttm -57.75 -27.36 62.95 Favored 'General case' 0 C--O 1.212 -0.87 0 O-C-N 124.1 0.875 . . . . 74.31 111.89 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -46.1 87.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.229 1.412 . . . . 72.41 110.59 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.461 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 1.5 mpp_? -67.85 -44.33 77.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.596 -1.183 . . . . 75.45 110.115 175.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.492 ' O ' ' SG ' ' A' ' 81' ' ' CYS . 7.2 m-85 -61.53 -25.76 67.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.831 0.853 . . . . 73.33 113.029 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 25.2 mtpp -64.88 -20.43 66.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.859 0.464 . . . . 74.51 111.382 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -132.57 17.09 4.36 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.375 0.67 . . . . 74.44 112.154 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 44.1 mt -93.07 139.38 30.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.277 0.489 . . . . 73.23 110.272 172.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -122.16 123.38 41.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.69 -1.226 . . . . 62.23 107.69 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -95.38 128.75 42.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.218 0.532 . . . . 75.42 109.684 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -130.65 151.86 50.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.19 -1.041 . . . . 73.2 108.19 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.3 pt -134.0 167.94 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 108.324 -0.991 . . . . 73.55 108.324 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.81 144.65 48.2 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.761 -0.536 . . . . 53.45 111.761 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 36.7 tt0 -52.9 -42.71 65.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.113 0.565 . . . . 74.24 110.735 173.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.678 HH11 ' HB2' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -60.76 -42.62 97.81 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.309 1.444 . . . . 75.3 110.319 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.677 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . . . -56.09 -51.68 67.02 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.951 0.9 . . . . 75.43 111.59 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.86 -29.16 61.96 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.455 -0.793 . . . . 73.04 112.4 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -74.26 -41.74 60.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.553 . . . . 72.13 110.856 -171.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.23 62.63 0.08 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.15 -0.78 . . . . 71.35 111.15 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.678 ' HB2' HH11 ' A' ' 143' ' ' ARG . . . -157.59 175.6 13.72 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.155 0.582 . . . . 73.32 110.865 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.82 170.56 13.38 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.896 0.878 . . . . 73.33 113.16 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -86.09 67.19 9.9 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.722 1.209 . . . . 74.31 108.003 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.09 -112.0 0.01 OUTLIER Glycine 0 CA--C 1.54 1.625 0 CA-C-N 113.229 -1.805 . . . . 75.44 114.39 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.38 155.99 17.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.202 0.601 . . . . 73.52 109.558 169.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 85.4 t -103.01 126.55 57.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.817 -0.808 . . . . 75.44 108.817 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.09 103.84 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.127 0.971 . . . . 73.12 109.113 170.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.503 HG23 HD23 ' A' ' 127' ' ' LEU . 63.2 mt -90.68 110.6 22.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.171 -0.677 . . . . 75.04 109.171 -171.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.4 HD13 HD12 ' A' ' 68' ' ' ILE . 51.2 mm -96.91 98.96 8.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.215 0.531 . . . . 74.42 110.001 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.43 96.51 5.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.894 -1.15 . . . . 74.31 107.894 169.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 45.0 p90 -107.02 129.12 54.85 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.411 -0.588 . . . . 73.4 109.411 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.16 -177.36 6.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.473 1.109 . . . . 72.41 109.09 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.19 137.52 54.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.43 0.292 . . . . 72.11 110.28 171.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.7 p -111.03 111.95 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 N-CA-C 108.22 -1.029 . . . . 72.42 108.22 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 63.49 17.43 10.34 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.828 1.251 . . . . 73.34 112.367 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.18 -19.03 30.22 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.113 -0.271 . . . . 65.23 112.719 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.4 m -82.28 106.94 14.57 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.3 0.55 . . . . 72.01 109.537 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -71.97 101.61 2.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 74.22 109.922 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.7 m -105.6 101.19 30.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 113.627 -1.624 . . . . 74.43 109.348 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.597 ' HB2' HD13 ' A' ' 68' ' ' ILE . 92.0 Cg_endo -92.15 118.36 0.45 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.95 2.433 . . . . 75.23 111.703 172.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 28.1 m -114.43 135.53 54.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.129 0.972 . . . . 74.11 109.565 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 38.6 tp -79.61 146.24 32.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.803 -0.814 . . . . 74.31 108.803 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.0 ptp -141.05 132.5 26.86 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.428 0.632 . . . . 65.21 109.635 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 154' ' ' ALA . 94.8 mt -139.14 149.83 44.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.482 1.913 . . . . 74.34 107.032 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.49 HG22 HD13 ' A' ' 120' ' ' ILE . 6.2 p -83.14 146.54 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.476 -0.935 . . . . 72.31 108.476 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.595 ' HB3' ' HZ2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -52.14 -25.42 8.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.754 1.621 . . . . 75.21 112.585 -177.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . 2.0 tp10 -89.22 -27.07 20.87 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.085 0.954 . . . . 64.4 112.583 -172.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.37 -6.51 37.4 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.949 0.5 . . . . 71.14 110.77 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 172' ' ' VAL . 10.5 tp -118.12 151.4 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.053 0.941 . . . . 73.34 108.72 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 47.3 mm -124.55 107.97 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.1 -1.444 . . . . 74.42 107.1 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 140.59 46.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.675 -0.491 . . . . 75.21 109.675 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.88 124.82 13.49 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.294 -1.002 . . . . 71.45 108.294 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.49 ' HG2' HD23 ' A' ' 182' ' ' LEU . 36.2 ttpt -80.72 103.99 10.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.405 0.682 . . . . 75.44 109.602 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.31 90.0 8.14 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.395 0.678 . . . . 74.32 109.457 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.49 HD23 ' HG2' ' A' ' 180' ' ' LYS . 2.6 pt? -118.9 175.07 5.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.443 0.697 . . . . 73.52 109.855 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.562 1.409 0 C-N-CA 123.546 0.738 . . . . 73.24 110.078 -179.049 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 63.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 110.204 -0.295 . . . . 70.11 110.204 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mt -104.43 137.76 41.82 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.444 0.698 . . . . 72.43 109.882 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.428 HG22 ' HB2' ' A' ' 15' ' ' SER . 21.1 pt -121.43 122.23 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 109.498 -0.556 . . . . 74.42 109.498 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.731 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 18.6 p90 -124.3 114.88 20.15 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.85 0.86 . . . . 73.41 110.061 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 169.14 14.37 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.836 0.854 . . . . 73.31 110.438 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -114.67 175.34 5.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.425 0.69 . . . . 71.33 109.432 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.28 -28.33 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 112.918 0.71 . . . . 70.02 112.918 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.58 -59.88 1.89 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.488 0.715 . . . . 74.21 110.295 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -84.41 19.8 1.83 Allowed 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.147 -0.933 . . . . 75.32 110.8 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -45.35 -35.87 3.84 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.194 2.197 . . . . 61.33 114.012 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.07 -9.76 42.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.338 0.655 . . . . 71.41 112.375 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -121.17 16.5 11.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.668 0.787 . . . . 72.42 111.287 -172.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.403 ' HB3' ' H ' ' A' ' 14' ' ' SER . 4.6 mm? -105.27 -164.54 1.04 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 75.3 108.468 177.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 13' ' ' LEU . 32.5 t -151.64 152.28 32.62 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.212 0.529 . . . . 71.24 111.712 -168.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.428 ' HB2' HG22 ' A' ' 3' ' ' ILE . 59.9 p -137.18 101.39 4.53 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.08 0.952 . . . . 72.14 109.124 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.2 t70 -157.37 -84.11 0.05 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.782 0.433 . . . . 75.21 110.273 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 m 177.69 86.77 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.264 1.826 . . . . 71.32 107.383 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.08 148.19 64.83 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.028 -0.987 . . . . 71.13 108.341 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.86 118.46 5.63 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.87 1.713 . . . . 74.12 112.559 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.731 ' SD ' ' HB3' ' A' ' 4' ' ' TYR . 58.4 mtm -114.34 144.66 42.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.746 0.818 . . . . 72.53 109.353 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -131.32 156.56 45.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.933 . . . . 73.34 108.896 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.541 HD11 ' HD3' ' A' ' 173' ' ' LYS . 28.3 tp -127.97 139.57 52.49 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.472 -0.936 . . . . 72.34 108.472 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.84 145.56 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 C-N-CA 123.213 0.605 . . . . 65.24 109.721 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 67.72 2.51 3.05 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.579 1.152 . . . . 72.2 112.356 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 55.49 29.08 12.67 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.112 0.965 . . . . 73.53 110.827 -167.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 119' ' ' LYS . 49.8 tp -134.45 -51.32 0.81 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.543 0.687 . . . . 74.25 110.483 -175.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.2 t -107.23 127.18 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.728 -1.123 . . . . 72.24 109.834 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -83.02 134.09 35.06 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.405 -0.961 . . . . 75.2 108.405 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.4 tt0 -130.17 104.7 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.076 -0.965 . . . . 74.55 109.056 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.6 t80 -90.59 124.36 34.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.099 -0.704 . . . . 73.32 109.099 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -80.15 138.59 36.92 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.745 -0.465 . . . . 75.41 109.745 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.99 151.5 20.05 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.517 -0.633 . . . . 55.25 111.517 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -93.58 150.25 20.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.191 0.596 . . . . 73.35 110.265 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -83.16 106.04 14.63 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.115 -1.069 . . . . 74.41 108.115 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.417 HG23 HD11 ' A' ' 72' ' ' LEU . 16.8 m -141.83 162.89 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.508 0.723 . . . . 71.43 109.583 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.419 HG21 HD13 ' A' ' 42' ' ' ILE . 11.4 m -127.04 151.31 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.946 -0.39 . . . . 60.34 109.946 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.6 107.59 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.352 -1.351 . . . . 74.44 107.352 160.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -123.64 95.02 4.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.525 -1.287 . . . . 73.51 107.525 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 49.2 -77.33 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 126.392 1.877 . . . . 64.42 113.161 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.8 45.71 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.779 -0.928 . . . . 72.3 110.779 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.74 137.23 16.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.294 1.038 . . . . 71.31 110.15 -173.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 36' ' ' VAL . 5.9 tp -115.56 91.14 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 123.948 0.899 . . . . 74.33 110.062 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.57 90.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.983 -1.117 . . . . 72.23 107.983 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 mp -50.58 -39.27 49.21 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.816 1.246 . . . . 72.04 112.275 -169.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 58.03 66.5 1.1 Allowed 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.069 0.947 . . . . 65.24 110.669 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.16 68.96 0.85 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.311 -0.858 . . . . 70.34 112.1 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 p -148.39 156.67 42.79 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 125.115 1.366 . . . . 75.22 108.77 -172.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -60.1 -52.53 72.7 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 117.796 -1.097 . . . . 74.5 112.685 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.88 101.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.404 3.449 0 C-N-CA 122.618 2.212 . . . . 73.24 114.158 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.2 m -113.43 104.59 12.44 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.438 1.095 . . . . 75.42 108.793 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' O ' ' HD3' ' A' ' 66' ' ' ARG . . . -146.51 177.74 8.82 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.817 0.847 . . . . 70.11 109.857 -173.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 63.2 15.4 8.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.593 0.96 . . . . 75.51 113.593 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -84.69 80.25 9.32 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.842 1.306 . . . . 75.32 109.836 178.182 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.87 84.12 0.1 OUTLIER Glycine 0 C--N 1.344 1.024 0 CA-C-N 113.87 -1.514 . . . . 64.15 110.975 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.68 -58.82 6.57 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.386 1.074 . . . . 75.41 111.691 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.06 116.21 11.77 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.346 0.658 . . . . 72.21 109.692 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -173.51 -163.91 0.2 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.422 -1.325 . . . . 63.03 107.422 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -75.65 98.0 3.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.934 -1.135 . . . . 74.33 107.934 168.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.2 50.21 0.89 Allowed Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.448 -1.061 . . . . 75.25 110.448 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 42.8 m -67.2 152.92 44.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.927 0.891 . . . . 71.53 112.336 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -137.17 -159.79 0.99 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.6 1.16 . . . . 72.45 109.133 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.42 169.52 2.89 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.755 0.822 . . . . 73.15 110.108 164.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -75.92 61.66 1.5 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.787 0.435 . . . . 74.31 110.866 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 12.1 t -97.43 69.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.685 0 N-CA-C 108.266 -1.013 . . . . 74.31 108.266 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.51 67.91 10.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.611 -1.255 . . . . 72.44 107.611 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 51' ' ' ALA . 12.8 ptm180 -91.88 157.01 17.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.853 -1.067 . . . . 74.22 112.089 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.3 -124.48 1.95 Allowed Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.151 -0.477 . . . . 64.41 112.336 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 12.6 pt -112.47 154.68 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.344 0.658 . . . . 75.43 111.153 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -53.83 -42.05 68.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.745 1.218 . . . . 73.33 112.7 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.6 mt -58.27 -45.99 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.711 1.204 . . . . 72.01 110.106 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 76' ' ' LEU . 75.8 t -72.63 -49.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 114.239 -1.346 . . . . 64.53 112.093 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 57.2 mt -67.94 -33.18 74.18 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.661 0.601 . . . . 71.24 112.404 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.56 -29.55 70.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.613 0.571 . . . . 74.32 111.304 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -115.52 -19.74 10.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.696 0.998 . . . . 73.25 113.696 -170.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HB2' ' HZ2' ' A' ' 75' ' ' LYS . 8.0 mtmp? 68.56 59.85 0.39 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.887 0.875 . . . . 71.31 109.195 -170.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.439 ' HB2' HG13 ' A' ' 71' ' ' VAL . 87.2 mt -77.42 125.5 29.43 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 107.506 -1.294 . . . . 74.53 107.506 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.34 124.85 39.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 109.114 -0.698 . . . . 73.04 109.114 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.11 158.9 33.95 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 122.0 0.905 . . . . 55.03 112.48 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.55 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 3.2 tpt -147.38 112.17 5.38 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 105.744 -1.947 . . . . 71.02 105.744 -173.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 15.6 m120 -100.42 128.3 46.52 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.192 0.597 . . . . 55.33 110.139 -171.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.98 -12.85 12.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.804 1.641 . . . . 72.53 113.054 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.427 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 69.1 m-85 -73.88 -38.07 64.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.048 1.339 . . . . 71.23 111.085 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.04 -38.15 6.4 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.414 0.686 . . . . 75.42 112.614 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.55 ' HB3' ' HE2' ' A' ' 79' ' ' MET . 44.0 p30 -66.96 -3.13 6.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.025 1.861 . . . . 64.21 116.025 -159.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -30.12 -63.77 0.13 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.843 1.657 . . . . 63.15 114.815 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.8 m -64.33 -42.76 96.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.903 0.481 . . . . 75.25 111.693 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 85.2 mmm -71.67 -50.93 26.01 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.474 0.484 . . . . 74.31 111.907 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HE2' HD22 ' A' ' 128' ' ' LEU . 58.2 t80 -65.71 -40.0 91.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.599 0.76 . . . . 75.22 111.527 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.28 -35.13 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.78 0.432 . . . . 74.44 110.542 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' O ' ' HG2' ' A' ' 94' ' ' LYS . . . -64.26 -42.7 96.35 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 123.296 0.373 . . . . 64.3 110.184 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -67.92 -33.98 75.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.654 0.782 . . . . 75.44 112.033 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.25 -38.87 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.187 0.595 . . . . 62.51 110.641 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -41.3 98.54 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.112 -0.699 . . . . 72.43 109.112 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mmtt -61.97 -60.75 3.16 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.508 -0.923 . . . . 71.12 108.508 175.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -43.6 -60.85 1.59 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.132 1.773 . . . . 74.2 111.493 -177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 42.5 ttp -56.51 -60.64 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.134 0.974 . . . . 71.24 110.631 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -60.12 -41.62 93.01 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.422 0.451 . . . . 74.13 111.322 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -72.47 -39.8 67.46 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 119.124 -0.465 . . . . 52.02 111.63 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.487 HG11 ' HB1' ' A' ' 175' ' ' ALA . 22.2 m -70.71 -37.27 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 117.823 0.283 . . . . 75.44 111.375 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.89 -43.24 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.074 0.464 . . . . 75.21 109.797 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.05 -30.21 68.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.284 1.034 . . . . 73.34 111.335 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -62.53 -48.77 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.55 0.74 . . . . 75.22 109.463 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.408 ' HG3' ' HG3' ' A' ' 174' ' ' GLU . 16.1 mmt -78.28 -21.02 50.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.741 -0.663 . . . . 73.41 112.064 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.29 -30.29 62.02 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.773 -0.579 . . . . 75.33 109.868 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -75.01 -31.58 61.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.509 0.723 . . . . 73.51 110.71 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -99.12 -29.68 12.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.252 0.621 . . . . 72.54 112.613 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -103.18 -43.68 5.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 74.01 108.686 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 64.68 19.82 11.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.692 1.197 . . . . 75.32 112.433 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m-20 -94.85 103.74 15.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.301 -1.0 . . . . 75.23 108.301 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.25 -37.89 81.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.07 0.948 . . . . 74.54 111.827 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.29 74.61 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.416 0.686 . . . . 74.45 111.52 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 109' ' ' ASP . 3.6 t70 -75.42 -49.84 17.68 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.059 0.943 . . . . 75.42 110.712 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.94 -23.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.468 -0.787 . . . . 74.34 111.659 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.15 -35.45 61.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.873 0.469 . . . . 72.24 110.203 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 118' ' ' LYS . . . -69.64 -39.42 77.15 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.482 -0.562 . . . . 75.13 109.482 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -65.63 -38.54 89.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.181 0.993 . . . . 73.31 110.771 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.35 -33.86 73.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.237 1.015 . . . . 74.45 110.798 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 18.0 tppt? -64.92 -48.96 72.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.509 0.724 . . . . 74.31 110.32 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HB3' HD22 ' A' ' 26' ' ' LEU . 13.5 mptt -63.93 -40.12 95.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.415 0.286 . . . . 74.2 111.63 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 172' ' ' VAL . 17.6 mm -70.27 -48.26 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 118.994 -0.527 . . . . 74.54 111.095 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.24 -46.08 83.32 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.081 -0.711 . . . . 75.0 109.081 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.13 94.54 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.285 0.991 . . . . 71.31 113.292 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.3 -52.09 56.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 122.992 0.517 . . . . 74.45 109.861 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.465 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 25.8 m -70.85 -37.3 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 123.644 0.59 . . . . 75.13 111.727 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.89 -32.83 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.81 0.732 . . . . 73.31 109.784 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -74.98 -40.96 60.43 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.875 -0.602 . . . . 64.2 111.497 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.3 tp -78.87 -19.35 52.15 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.305 1.042 . . . . 73.42 112.307 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 47.4 mt -93.64 2.65 56.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.271 0.628 . . . . 75.31 111.49 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.3 91.15 2.16 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.746 0.418 . . . . 53.31 109.933 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -63.16 -6.72 4.56 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.745 1.218 . . . . 75.2 113.778 -170.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.26 -41.68 76.2 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.14 0.576 . . . . 74.44 110.194 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -108.74 -48.44 3.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.969 1.308 . . . . 74.33 110.558 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -81.37 -1.12 44.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.268 1.427 . . . . 73.24 114.491 -164.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -57.19 -16.89 9.07 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.053 0.541 . . . . 74.52 111.237 165.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.98 15.31 10.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.246 1.018 . . . . 75.33 111.089 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.61 148.65 23.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.56 -0.904 . . . . 71.43 108.56 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.53 111.68 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.599 -1.63 . . . . 75.21 106.599 175.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.448 ' HB3' HG11 ' A' ' 153' ' ' VAL . 46.1 m-85 -90.21 142.11 28.04 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.731 -0.84 . . . . 74.24 108.731 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -137.82 155.79 48.63 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.922 0.889 . . . . 73.41 108.735 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.38 143.2 20.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.011 -1.477 . . . . 72.34 107.011 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.46 134.89 49.97 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 118.992 -0.893 . . . . 63.41 113.073 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -55.25 -38.27 68.3 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.139 0.975 . . . . 73.45 111.355 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -65.63 -44.42 86.53 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.204 -0.907 . . . . 75.3 111.659 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.93 -21.42 51.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.049 0.54 . . . . 74.14 111.647 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.89 0.18 51.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.744 0.817 . . . . 61.23 110.942 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.04 -24.04 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.799 0.84 . . . . 71.44 110.62 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.48 47.77 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.748 -0.205 . . . . 30.31 113.361 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.75 78.32 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.06 0.544 . . . . 74.45 110.586 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.12 -3.43 32.76 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.505 0.722 . . . . 71.31 111.828 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.25 -18.64 55.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.574 0.75 . . . . 75.14 109.667 169.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.86 150.4 50.08 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 124.376 1.047 . . . . 64.44 113.373 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -96.16 155.5 16.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.479 0.711 . . . . 75.41 110.088 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 138' ' ' PHE . 53.3 t -88.13 129.34 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.565 0.746 . . . . 75.53 111.296 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.18 111.5 10.48 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.487 1.115 . . . . 75.41 109.33 170.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.4 mt -93.78 113.02 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.437 0.695 . . . . 74.13 109.398 -170.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 169' ' ' LEU . 45.7 mm -98.7 123.7 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.955 -0.465 . . . . 73.45 109.984 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.29 128.88 49.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.802 1.241 . . . . 74.02 108.889 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -81.21 114.5 20.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.814 -1.18 . . . . 75.12 107.814 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.574 ' HB3' HG12 ' A' ' 166' ' ' VAL . 18.2 tpp85 -88.68 141.25 28.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.459 0.704 . . . . 72.3 109.646 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -100.68 124.43 46.28 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.694 -0.484 . . . . 65.35 109.694 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.562 HG11 ' HB ' ' A' ' 164' ' ' THR . 3.1 p -125.77 90.67 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.056 0.942 . . . . 74.55 109.273 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 62.23 17.5 9.32 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.063 1.345 . . . . 71.35 113.31 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.23 -14.69 9.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 120.027 -0.318 . . . . 71.1 113.382 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.562 ' HB ' HG11 ' A' ' 161' ' ' VAL . 80.5 m -88.2 138.66 31.24 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.263 0.625 . . . . 74.41 110.112 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 112.16 24.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.513 0.725 . . . . 64.13 109.296 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 159' ' ' ARG . 2.6 p -119.75 104.02 45.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.46 1.104 . . . . 75.14 109.293 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.27 130.45 39.44 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.597 2.198 . . . . 71.25 112.574 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.1 p -137.02 131.07 32.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.048 0.539 . . . . 74.5 110.587 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 28.7 tp -76.43 137.96 40.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 64.52 109.477 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.8 ttm -123.95 122.25 37.45 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.67 -1.233 . . . . 75.24 107.67 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 34.5 mt -151.8 167.9 26.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.65 1.58 . . . . 72.43 106.76 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.443 HG21 HD11 ' A' ' 120' ' ' ILE . 12.3 p -88.35 139.92 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 118.593 0.633 . . . . 63.43 109.596 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.541 ' HD3' HD11 ' A' ' 22' ' ' LEU . 58.7 pttt -69.21 -24.1 63.99 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.943 0.497 . . . . 75.44 112.147 -173.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.408 ' HG3' ' HG3' ' A' ' 103' ' ' MET . 11.2 mp0 -64.87 -23.89 67.37 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.797 0.839 . . . . 63.32 112.045 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.487 ' HB1' HG11 ' A' ' 99' ' ' VAL . . . -96.82 -10.38 26.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.487 0.715 . . . . 61.41 111.358 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 42.5 mm -107.02 147.53 12.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.355 0.662 . . . . 71.23 109.555 -175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.71 108.2 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.13 -1.433 . . . . 72.41 107.13 170.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -109.49 117.93 35.27 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.601 -1.259 . . . . 71.32 107.601 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -144.66 135.6 24.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.592 -0.892 . . . . 75.34 108.592 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -124.44 109.01 12.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 74.44 109.164 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -96.64 91.89 5.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.786 0.834 . . . . 71.12 109.724 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.47 -46.92 4.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 74.34 109.828 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.617 -0.883 . . . . 74.01 108.617 -178.638 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.031 0.443 . . . . 71.43 110.087 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.6 mt -105.39 161.67 14.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.054 0.942 . . . . 73.51 108.755 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 62.0 mt -115.97 118.72 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.701 -0.852 . . . . 75.21 108.701 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -104.57 96.26 6.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.829 -0.804 . . . . 65.13 108.829 -174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 68.3 mttm -122.34 152.17 40.42 Favored 'General case' 0 C--O 1.21 -0.992 0 C-N-CA 123.859 0.864 . . . . 73.2 109.213 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.428 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 7.2 t70 -114.02 143.21 45.13 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 106.955 -1.498 . . . . 74.15 106.955 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -52.84 -20.6 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.823 1.045 . . . . 73.31 113.823 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -107.13 -42.49 4.86 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.189 0.996 . . . . 74.53 110.5 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 6' ' ' ASP . 33.2 p -104.93 18.43 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.816 0.847 . . . . 75.44 112.098 -172.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 8.7 p-10 -60.75 -11.92 9.03 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.511 1.524 . . . . 73.33 113.784 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.31 -58.26 4.83 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 125.133 1.521 . . . . 54.52 110.53 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -122.91 -38.17 2.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.416 -0.811 . . . . 64.44 111.473 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.7 tp 5.54 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.885 2.074 . . . . 74.13 114.203 -163.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.49 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 70.6 m -156.95 146.0 20.16 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.95 0.5 . . . . 54.13 110.779 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 p -148.6 103.64 3.42 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 118.833 0.742 . . . . 74.31 110.957 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -168.28 176.34 5.98 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.343 1.457 . . . . 64.5 108.196 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -72.83 75.37 1.15 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.185 0.517 . . . . 72.11 110.116 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 14' ' ' SER . 64.2 m-85 -87.32 147.28 41.84 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.722 0.809 . . . . 74.4 110.769 -177.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.15 117.7 2.71 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.716 2.278 . . . . 75.44 112.737 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.588 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 60.6 ttp -119.35 114.43 22.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.605 1.162 . . . . 74.22 109.399 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.34 136.61 33.36 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.779 -1.193 . . . . 73.44 107.779 171.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.401 HD21 ' HA ' ' A' ' 25' ' ' ASP . 59.9 tp -113.15 142.54 45.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.132 -1.062 . . . . 64.32 108.132 174.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.25 130.76 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.148 -0.686 . . . . 73.33 109.148 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.99 12.74 4.1 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.902 1.281 . . . . 74.12 112.811 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' HA ' HD21 ' A' ' 22' ' ' LEU . 8.6 m-20 53.37 12.11 0.32 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.638 1.175 . . . . 72.03 113.418 -167.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.689 HD23 ' HG3' ' A' ' 119' ' ' LYS . 45.5 tp -107.08 -45.59 4.11 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.774 0.83 . . . . 74.25 110.027 -171.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 t -120.3 131.38 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.473 -0.785 . . . . 74.01 109.446 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.588 ' HE1' ' HG3' ' A' ' 20' ' ' MET . 82.0 t80 -98.07 126.7 43.62 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.897 -1.149 . . . . 73.53 107.897 171.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 154.6 30.8 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.415 0.626 . . . . 73.01 110.811 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.524 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 50.7 t80 -136.42 129.92 31.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.268 1.427 . . . . 74.33 108.655 -171.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -78.98 153.71 30.12 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.154 0.502 . . . . 74.13 110.976 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.37 172.58 39.36 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.312 -0.858 . . . . 73.31 111.004 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 47.4 mtmt -128.28 154.29 46.05 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.569 -0.901 . . . . 74.2 108.569 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 6.4 p-80 -73.98 130.15 39.28 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.5 -1.296 . . . . 75.32 107.5 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.687 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 15.9 m -139.73 149.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.54 0.736 . . . . 75.21 109.305 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.504 ' HB ' ' HG2' ' A' ' 66' ' ' ARG . 7.4 m -123.3 120.32 59.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.299 -1.371 . . . . 73.53 107.299 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 59.3 ttt180 -138.53 117.43 12.41 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.531 -0.759 . . . . 75.43 108.96 -169.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -133.08 118.6 18.94 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.038 -0.727 . . . . 75.43 109.038 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 64.43 24.68 13.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.422 1.089 . . . . 75.24 112.028 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -27.07 18.74 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-O 120.019 -0.323 . . . . 74.45 113.008 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.23 123.17 24.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.231 0.612 . . . . 74.43 110.204 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.591 HD13 ' HB ' ' A' ' 35' ' ' VAL . 5.5 tp -124.94 116.35 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.659 0.783 . . . . 75.11 109.897 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -162.68 92.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.809 0.843 . . . . 72.04 108.773 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.687 ' HB3' ' HA ' ' A' ' 35' ' ' VAL . 1.0 OUTLIER -56.89 166.41 1.0 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.643 1.177 . . . . 75.33 113.8 -175.214 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.16 172.1 13.58 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.972 0.909 . . . . 75.33 109.149 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.35 69.36 1.99 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.709 -0.957 . . . . 63.31 110.709 171.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.4 m -94.72 134.95 36.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.318 1.047 . . . . 74.11 109.807 -172.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.9 165.85 39.11 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.081 0.953 . . . . 74.02 110.716 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.72 122.87 12.48 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.523 2.149 . . . . 75.34 111.982 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 m -78.55 86.03 4.58 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 122.928 0.491 . . . . 60.53 110.062 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.65 127.24 47.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.002 0.921 . . . . 75.13 109.48 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -94.17 15.71 16.56 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.284 1.033 . . . . 72.22 111.3 -173.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 69.41 -63.92 0.36 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.247 1.419 . . . . 74.32 110.129 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -125.63 71.28 0.46 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.581 -0.607 . . . . 34.14 111.581 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.2 96.69 0.16 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.757 0.823 . . . . 75.02 110.602 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.98 -52.13 65.28 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.855 1.262 . . . . 75.44 111.878 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.34 79.8 8.37 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.069 -1.086 . . . . 71.03 108.069 174.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.68 84.48 5.5 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.669 -1.151 . . . . 71.4 110.383 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.426 ' HA2' HG22 ' A' ' 77' ' ' VAL . . . 134.23 45.73 0.11 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.033 -0.985 . . . . 75.21 112.371 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -65.65 113.4 4.21 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.819 0.848 . . . . 73.13 111.311 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -79.72 20.83 0.56 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.144 0.978 . . . . 74.01 111.625 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.73 124.67 23.55 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.082 0.953 . . . . 73.41 109.667 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -74.55 76.72 1.97 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.267 1.032 . . . . 74.33 109.645 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t -137.82 89.96 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 105.647 -1.983 . . . . 73.3 105.647 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.489 ' HA ' HD22 ' A' ' 72' ' ' LEU . 51.8 mt-10 -82.52 62.64 6.27 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.505 0.669 . . . . 75.34 111.324 -174.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.504 ' HG2' ' HB ' ' A' ' 36' ' ' VAL . 49.0 mtt180 -108.69 120.51 42.68 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.153 -1.055 . . . . 74.41 108.153 173.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.28 -136.08 4.6 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 109.703 -1.359 . . . . 70.11 109.703 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 24.2 pt -110.4 143.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 117.354 0.577 . . . . 75.55 110.5 173.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.96 -34.48 59.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.152 1.381 . . . . 72.51 112.223 -176.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.482 HG21 ' HB2' ' A' ' 169' ' ' LEU . 60.1 mt -56.46 -51.04 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.924 0.89 . . . . 75.34 110.637 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 76' ' ' LEU . 63.1 t -70.26 -49.32 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.887 -1.051 . . . . 73.45 111.518 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 65' ' ' GLU . 33.4 mt -63.28 -39.85 95.73 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.814 0.846 . . . . 74.14 111.069 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.96 -32.93 73.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.31 1.044 . . . . 75.02 111.579 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.16 -6.69 21.91 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.247 0.619 . . . . 73.21 112.44 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.98 61.54 3.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.906 1.283 . . . . 75.2 111.383 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.491 ' HB2' HG11 ' A' ' 71' ' ' VAL . 59.1 mt -93.95 132.05 38.79 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.371 -0.831 . . . . 73.21 109.945 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.426 HG22 ' HA2' ' A' ' 59' ' ' GLY . 3.4 p -79.4 136.88 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.445 0.698 . . . . 71.22 109.881 175.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.69 144.46 10.92 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.829 1.652 . . . . 74.35 113.58 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.7 mmm -147.95 104.18 3.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 106.346 -1.724 . . . . 74.42 106.346 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -93.01 136.58 33.14 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.9 -0.778 . . . . 74.32 108.9 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 85' ' ' ALA . 52.1 t -65.56 -14.22 60.62 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.618 0.767 . . . . 72.01 110.842 173.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -75.75 -47.62 25.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.941 . . . . 72.0 110.617 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.17 -33.2 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.137 -0.938 . . . . 73.13 110.703 -175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.49 22.44 12.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.632 1.173 . . . . 70.34 111.704 -166.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 81' ' ' CYS . . . -49.82 -56.41 10.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.453 0.701 . . . . 73.13 112.284 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.8 m -70.39 -33.68 71.67 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.397 -0.82 . . . . 75.13 111.018 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 42.5 tpp -66.08 -36.86 84.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.059 0.944 . . . . 74.34 110.55 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.522 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 64.1 t80 -72.85 -29.21 63.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.82 0.848 . . . . 74.13 110.576 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -40.91 98.92 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.398 -0.593 . . . . 75.54 109.398 170.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.84 93.97 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.922 -0.581 . . . . 61.2 110.695 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.522 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 58.1 m-85 -60.61 -52.64 64.3 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-O 118.777 -0.63 . . . . 74.1 110.797 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mm -58.47 -37.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.641 0.776 . . . . 73.24 111.56 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -65.17 -49.28 70.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.956 0.502 . . . . 74.44 111.42 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -47.12 83.44 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.612 -0.884 . . . . 74.03 108.612 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 152' ' ' GLN . 22.6 t80 -52.55 -56.61 14.03 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.888 2.075 . . . . 70.45 112.195 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.1 ttt -59.17 -50.81 72.6 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.985 0.803 . . . . 72.25 109.773 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -61.68 -36.05 79.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.672 -0.694 . . . . 65.43 111.338 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.11 -52.88 29.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.015 0.926 . . . . 74.0 111.525 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.93 -31.88 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.163 0.585 . . . . 74.05 112.563 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.15 -43.15 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.492 -0.559 . . . . 74.53 109.492 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.93 -38.83 87.17 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.912 0.885 . . . . 74.14 110.622 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -63.22 -50.88 68.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.206 1.002 . . . . 73.31 109.998 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ttt -63.52 -43.13 98.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.118 -0.946 . . . . 74.25 110.725 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -74.21 -23.01 59.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.845 0.858 . . . . 74.1 111.837 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.45 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 29.0 ttmt -70.5 -20.51 62.84 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.708 . . . . 74.43 109.783 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -112.83 1.21 15.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.469 1.108 . . . . 62.14 111.218 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.35 -68.97 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.005 0.522 . . . . 71.54 110.711 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.88 11.88 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.487 1.915 . . . . 74.01 115.079 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -83.51 -8.75 59.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.909 . . . . 73.03 110.581 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 80.01 -45.21 0.29 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.774 1.63 . . . . 75.42 113.974 169.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.01 71.77 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.477 0.58 . . . . 74.23 112.493 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.83 -44.79 22.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.378 0.671 . . . . 65.34 109.791 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.09 -23.53 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.299 -0.864 . . . . 74.24 111.242 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.64 -47.75 74.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.497 1.119 . . . . 73.22 110.172 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.31 95.36 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 124.098 0.874 . . . . 72.11 110.078 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.47 -45.21 80.45 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.259 0.974 . . . . 73.25 111.752 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.43 -45.88 84.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.341 0.656 . . . . 73.34 110.616 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -65.15 -39.55 93.14 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.255 -1.339 . . . . 72.22 110.47 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.689 ' HG3' HD23 ' A' ' 26' ' ' LEU . 14.0 tppt? -69.07 -49.58 56.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.598 0.759 . . . . 71.42 110.43 -173.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.444 ' HA ' HD21 ' A' ' 26' ' ' LEU . 8.5 tp -72.4 -37.75 58.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 123.374 0.669 . . . . 71.4 110.978 -174.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -66.86 -39.96 87.73 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.184 -0.673 . . . . 75.12 109.184 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.3 99.92 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.648 0.592 . . . . 65.21 112.414 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -66.04 -47.36 74.64 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.138 0.575 . . . . 70.43 110.203 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.488 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -69.7 -40.73 79.63 Favored 'Isoleucine or valine' 0 C--N 1.361 1.104 0 CA-C-O 118.476 -0.773 . . . . 71.44 111.565 -174.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.15 -33.22 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 119.495 1.043 . . . . 74.41 110.272 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -72.38 -34.06 67.66 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.9 0.88 . . . . 73.01 110.769 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 155' ' ' ILE . 28.7 tp -81.54 -26.28 35.19 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.361 1.064 . . . . 74.22 111.197 -174.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.0 mt -88.24 4.47 45.67 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.834 0.854 . . . . 74.13 111.461 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.55 85.84 0.3 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 123.632 0.773 . . . . 71.43 110.284 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -62.22 -6.83 3.41 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.194 1.398 . . . . 74.2 114.753 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.97 -47.07 84.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.028 0.931 . . . . 74.44 110.865 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.465 ' H ' ' HD3' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -112.22 -31.77 6.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.625 1.17 . . . . 75.22 110.873 174.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.73 -1.93 36.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.017 0.927 . . . . 71.31 113.218 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -10.88 4.45 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.474 0.579 . . . . 71.01 112.311 171.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.5 21.71 4.43 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.098 0.959 . . . . 73.24 110.788 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.57 137.71 32.09 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.636 -0.505 . . . . 75.2 109.636 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -111.15 145.83 37.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.654 -1.61 . . . . 73.23 106.654 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.424 ' HB3' HG12 ' A' ' 153' ' ' VAL . 59.9 m-85 -125.32 141.11 52.27 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.296 -1.002 . . . . 74.41 108.296 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -149.32 147.98 28.99 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 124.165 0.986 . . . . 75.42 108.394 -175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.522 ' HB ' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -150.97 147.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.065 -1.087 . . . . 73.3 108.065 -177.238 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.78 139.04 42.66 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.385 -1.086 . . . . 72.31 110.385 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.65 -21.16 28.53 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.505 0.653 . . . . 75.21 109.978 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.75 -46.41 75.49 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.422 -0.955 . . . . 73.34 108.422 164.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.58 98.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.173 -1.376 . . . . 71.51 111.668 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.92 -46.38 52.96 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.262 0.625 . . . . 73.11 111.649 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.48 -41.32 93.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.188 0.595 . . . . 75.11 111.148 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -63.76 -58.45 11.04 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.245 -0.742 . . . . 55.43 111.245 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 176.63 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.389 1.076 . . . . 53.21 108.548 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -41.41 118.84 1.11 Allowed 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.917 0.887 . . . . 61.0 113.267 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -38.71 -41.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.258 1.423 . . . . 73.25 112.73 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.72 -34.8 4.59 Favored Glycine 0 CA--C 1.502 -0.773 0 CA-C-N 114.681 -1.145 . . . . 72.05 112.224 -175.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.433 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 20.5 pm0 -98.1 156.59 16.59 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.702 -0.851 . . . . 71.02 108.702 173.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.522 HG13 ' HB ' ' A' ' 140' ' ' ILE . 24.9 t -109.24 143.96 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 107.123 -1.436 . . . . 75.31 107.123 171.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.428 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -63.28 108.79 1.38 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.73 0.812 . . . . 73.33 109.657 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.62 HG21 HD21 ' A' ' 127' ' ' LEU . 58.9 mt -86.5 104.38 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.746 0.818 . . . . 75.11 109.337 -170.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 44.2 mm -89.51 100.11 10.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.451 -0.795 . . . . 74.2 110.048 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.35 95.14 7.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.939 -1.134 . . . . 62.21 107.939 170.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 36.9 p90 -85.56 109.32 18.45 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.627 -0.879 . . . . 73.43 108.627 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -100.43 -179.48 4.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.855 1.262 . . . . 72.51 108.747 -172.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -124.08 120.59 32.81 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.801 0.728 . . . . 75.34 110.408 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -90.08 89.49 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.393 -1.336 . . . . 74.14 107.393 170.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.56 33.78 20.4 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.624 -1.171 . . . . 64.5 111.926 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 111.54 -23.76 17.03 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.753 -0.471 . . . . 73.32 113.28 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.6 m -86.0 125.24 33.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.685 -0.857 . . . . 73.05 108.685 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 20.5 tt0 -72.08 121.96 20.13 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.433 0.56 . . . . 73.1 109.723 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.0 p -117.46 90.25 34.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.892 1.277 . . . . 75.11 109.037 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.574 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 98.4 Cg_exo -50.2 125.92 16.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.226 2.617 . . . . 74.25 112.473 167.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.0 m -123.82 115.06 20.72 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.904 -0.776 . . . . 74.52 108.904 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.524 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp -76.51 130.7 38.3 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.054 0.942 . . . . 72.35 108.909 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.2 ttp -128.14 123.0 33.35 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.06 0.944 . . . . 73.32 109.174 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' A' ' 154' ' ' ALA . 95.2 mt -139.11 157.58 45.72 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.341 1.456 . . . . 73.52 107.614 176.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.6 p -78.25 131.97 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.891 -0.781 . . . . 64.41 108.891 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -52.22 -28.77 19.77 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.637 1.575 . . . . 75.4 111.983 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -67.15 -34.95 78.65 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.243 1.017 . . . . 74.11 111.844 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.18 -13.43 15.43 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.224 0.61 . . . . 74.22 112.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 28' ' ' TYR . 11.0 tp -108.93 161.91 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.084 -1.45 . . . . 72.3 107.084 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 42.3 mm -135.79 132.26 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.092 0.957 . . . . 71.34 108.593 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.3 96.95 5.29 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.129 -1.063 . . . . 63.43 108.129 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 41.4 tt0 -99.19 102.07 13.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.482 -0.933 . . . . 71.42 108.482 -174.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.17 134.08 45.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.549 0.74 . . . . 75.15 110.546 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.7 t -117.76 96.15 5.25 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.239 -1.023 . . . . 65.31 108.239 173.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.07 153.62 42.95 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.312 0.645 . . . . 74.34 109.919 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.253 1.265 0 CA-C-N 115.456 -0.793 . . . . 71.11 108.988 177.258 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.598 0.713 . . . . 74.12 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.47 160.59 29.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.106 0.962 . . . . 73.12 108.431 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 28.1 mt -116.74 118.9 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.573 -1.269 . . . . 73.45 107.573 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -97.92 97.23 8.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.362 -0.977 . . . . 71.1 108.362 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -111.43 110.29 20.67 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.199 0.6 . . . . 75.22 109.679 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 9.8 t70 -83.85 135.93 34.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.643 -1.614 . . . . 73.32 106.643 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.7 pt -64.04 -17.87 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 118.542 0.61 . . . . 71.31 112.232 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -113.98 -52.07 2.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.383 1.073 . . . . 74.22 110.47 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -90.05 17.46 6.89 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.622 -1.172 . . . . 73.02 111.634 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 29.0 t70 -46.91 -43.84 19.24 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.034 1.333 . . . . 74.42 112.671 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.24 -19.3 65.78 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.117 -1.401 . . . . 71.31 111.906 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.571 ' HG3' ' HA3' ' A' ' 141' ' ' GLY . 6.9 mm-40 -120.8 12.5 11.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.808 1.243 . . . . 74.44 111.403 -174.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.96 -148.34 0.34 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.433 0.693 . . . . 73.42 109.794 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -150.07 160.14 43.87 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.435 0.562 . . . . 75.45 111.388 -163.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 60.0 p -124.38 -160.77 0.95 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.026 0.93 . . . . 73.24 109.573 165.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 74.11 -162.86 0.08 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.073 0.949 . . . . 74.25 110.905 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -96.98 58.01 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.549 0.69 . . . . 73.33 110.307 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.9 149.27 62.99 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 115.427 -0.806 . . . . 74.0 109.007 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 16.5 Cg_exo -68.02 117.6 5.03 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 121.684 1.589 . . . . 71.25 112.025 -176.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.457 ' SD ' ' CD1' ' A' ' 28' ' ' TYR . 12.6 tmm? -148.98 139.44 22.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.042 0.937 . . . . 74.31 109.69 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -139.45 158.28 44.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.269 1.028 . . . . 75.53 109.147 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.12 119.76 37.33 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.469 -0.938 . . . . 74.21 108.469 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.23 136.15 43.34 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 123.808 0.843 . . . . 74.21 108.93 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 65.51 8.3 4.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.269 1.028 . . . . 71.22 113.044 171.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 55.42 30.49 15.08 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.265 1.026 . . . . 65.14 111.626 -171.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.457 HD12 ' HB ' ' A' ' 120' ' ' ILE . 21.3 tp -132.93 -44.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.881 -0.6 . . . . 73.03 111.076 -172.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.08 140.6 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.967 0.507 . . . . 75.24 109.988 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.457 ' CD1' ' SD ' ' A' ' 20' ' ' MET . 30.2 m-85 -92.47 115.09 27.78 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 109.179 -0.675 . . . . 75.33 109.179 168.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.13 126.99 31.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.747 -1.205 . . . . 74.41 107.747 166.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.612 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.5 t80 -117.06 104.93 11.74 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.973 -1.491 . . . . 74.54 106.973 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.569 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 41.0 mmtm -79.48 143.38 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.377 0.671 . . . . 75.22 111.374 -175.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -139.77 -168.55 11.35 Favored Glycine 0 C--O 1.241 0.582 0 CA-C-N 114.677 -1.147 . . . . 74.45 110.51 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -118.97 150.85 39.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.36 0.664 . . . . 74.43 110.913 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -80.3 107.73 13.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.639 -1.245 . . . . 65.34 107.639 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.528 HG11 HD23 ' A' ' 44' ' ' LEU . 29.6 m -132.96 155.8 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.773 0.829 . . . . 74.42 109.159 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 44' ' ' LEU . 3.0 m -94.09 141.14 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.446 -0.576 . . . . 64.32 109.446 177.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.707 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -142.13 110.08 5.86 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.604 -1.258 . . . . 73.31 107.604 -178.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 15.6 tptm -89.23 161.66 16.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.942 0.897 . . . . 72.12 108.957 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -45.88 -38.62 7.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.64 0.978 . . . . 73.23 113.64 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.39 42.29 1.37 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.586 -0.279 . . . . 74.15 112.419 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 11.7 tp10 -164.52 142.51 6.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.55 . . . . 73.43 111.057 -176.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 tp -137.83 96.06 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.392 1.077 . . . . 70.03 108.507 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.08 110.76 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.121 0.968 . . . . 72.2 109.363 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.721 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -60.42 144.16 51.61 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.912 0.885 . . . . 63.2 111.248 178.02 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.69 103.93 10.87 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.212 0.605 . . . . 72.34 110.776 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.02 -36.63 21.16 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 111.414 -0.674 . . . . 64.24 111.414 171.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 t -94.81 155.66 16.71 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.338 -0.986 . . . . 74.33 108.338 169.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.8 t30 64.21 99.03 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.513 1.125 . . . . 75.12 111.241 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -66.23 115.74 3.65 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.105 2.537 . . . . 63.0 112.743 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 p -98.02 82.92 3.04 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.579 0.752 . . . . 75.22 109.959 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.93 25.43 9.14 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.747 0.819 . . . . 72.21 109.297 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -113.41 79.17 1.21 Allowed 'General case' 0 C--N 1.354 0.796 0 C-N-CA 124.281 1.032 . . . . 72.13 109.544 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -74.02 -30.35 62.4 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.098 -0.501 . . . . 70.55 110.12 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.71 15.65 35.43 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.86 -0.609 . . . . 72.41 113.365 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.3 87.78 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.151 0.58 . . . . 64.21 110.829 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -103.38 111.91 24.55 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.247 1.019 . . . . 75.03 109.473 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -147.36 -174.16 4.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.322 0.649 . . . . 74.03 110.02 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.23 -39.07 71.95 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.603 1.161 . . . . 72.53 112.183 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.2 107.49 2.33 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.619 -0.719 . . . . 74.1 111.711 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.3 m -66.96 -30.29 70.38 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.495 0.718 . . . . 64.12 112.005 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.11 -163.74 1.41 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.416 1.086 . . . . 73.41 108.703 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -79.85 137.3 36.9 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 107.643 -1.243 . . . . 55.31 107.643 168.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -77.12 84.66 3.61 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.497 1.142 . . . . 71.21 111.583 -171.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.34 -88.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 104.179 -2.526 . . . . 63.44 104.179 162.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 77.0 -51.0 0.56 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 125.198 1.399 . . . . 75.22 113.339 157.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -139.15 158.37 44.29 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.552 0.741 . . . . 65.32 109.613 -164.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.4 -158.06 29.0 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 111.235 -0.746 . . . . 74.45 111.235 160.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 pt -110.14 147.3 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.375 0.67 . . . . 75.13 109.209 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.67 -26.84 68.85 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.885 0.874 . . . . 75.45 111.748 -174.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 169' ' ' LEU . 41.7 mm -54.01 -48.21 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.356 0.662 . . . . 54.4 110.205 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.5 t -80.71 -51.08 16.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.017 -0.992 . . . . 73.12 111.674 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.707 HD13 ' HB2' ' A' ' 37' ' ' ARG . 50.6 mt -64.49 -25.47 68.01 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.809 0.844 . . . . 71.31 112.353 -171.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -91.18 -43.68 9.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.571 0.748 . . . . 75.5 110.526 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 12' ' ' GLU . 65.2 m80 -94.9 9.51 38.96 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.779 0.659 . . . . 73.21 112.779 -170.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? 64.02 33.77 11.93 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.991 0.807 . . . . 73.5 110.85 168.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 72.3 mt -78.5 120.74 23.64 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.543 -0.54 . . . . 71.52 109.543 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.18 136.37 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.697 0.799 . . . . 75.24 109.158 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.17 145.69 55.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.243 1.017 . . . . 75.14 113.194 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.9 mtt -133.06 102.9 5.78 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 105.211 -2.144 . . . . 75.11 105.211 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -68.45 125.4 26.36 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 108.892 -0.781 . . . . 72.23 108.892 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.6 -25.17 59.65 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.924 0.869 . . . . 74.41 111.071 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -70.01 -32.77 71.12 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 113.792 -1.549 . . . . 65.4 110.721 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -103.83 -39.72 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.347 0.659 . . . . 75.43 111.02 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.4 -11.89 39.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.063 0.945 . . . . 74.42 112.779 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -37.63 -51.85 1.21 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.391 1.626 . . . . 70.15 115.391 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.5 m -68.86 -45.14 71.83 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.074 0.464 . . . . 75.33 111.374 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 72.9 mtm -67.07 -27.99 67.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.177 -0.919 . . . . 74.54 110.432 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.461 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 81.0 t80 -70.79 -39.99 72.82 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.73 0.812 . . . . 74.44 110.78 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -66.13 -31.06 71.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.671 0.388 . . . . 75.42 110.657 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.7 82.63 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.945 -0.571 . . . . 74.24 110.257 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.461 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 19.4 m-85 -60.81 -41.69 96.2 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 109.669 -0.493 . . . . 73.32 109.669 173.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.73 -29.94 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.632 0.773 . . . . 73.32 110.625 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -62.79 -53.43 54.39 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.188 0.449 . . . . 74.54 111.381 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.11 -47.33 71.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.252 0.345 . . . . 62.42 110.389 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -45.74 -62.7 1.19 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.61 1.964 . . . . 75.25 112.054 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . 0.5 ' HE2' ' HE2' ' A' ' 97' ' ' LYS . 39.3 ttp -57.23 -47.99 79.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.583 1.153 . . . . 75.31 111.43 -175.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HE2' ' HE2' ' A' ' 96' ' ' MET . 72.8 mmtt -68.4 -35.7 78.05 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.783 -0.644 . . . . 74.12 111.896 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -47.31 63.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.525 0.73 . . . . 74.11 110.251 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 174' ' ' GLU . 19.6 m -71.53 -33.09 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.915 -0.584 . . . . 71.11 112.44 -173.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.26 -39.9 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.536 -0.542 . . . . 73.31 109.536 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.1 -46.62 75.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.023 0.929 . . . . 75.5 111.578 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.53 -43.98 92.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.501 0.72 . . . . 72.31 110.458 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.711 ' SD ' HG11 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -62.81 -50.1 72.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.466 1.106 . . . . 74.21 112.604 -174.081 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.674 ' HA ' HG12 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -70.03 -32.72 71.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.435 0.294 . . . . 71.24 111.68 -172.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -58.47 -21.67 52.25 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.154 0.502 . . . . 72.12 111.596 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -106.55 -26.1 11.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.605 0.762 . . . . 54.24 111.831 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 112' ' ' ASP . 13.3 m120 -146.46 35.12 0.96 Allowed 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 123.11 0.564 . . . . 74.13 112.052 -167.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 31.1 ttp180 -69.83 7.55 0.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.006 0.922 . . . . 74.04 112.748 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.3 -21.88 26.9 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.136 0.974 . . . . 75.12 111.248 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.493 ' HA ' HG21 ' A' ' 113' ' ' VAL . 97.8 mttt 83.26 -8.84 1.1 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.685 1.594 . . . . 73.02 113.029 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.34 88.15 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.59 0.632 . . . . 64.44 110.004 168.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 107' ' ' ASN . 15.5 t0 -95.36 -44.54 7.52 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.072 -0.967 . . . . 73.33 110.69 -170.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.711 HG11 ' SD ' ' A' ' 103' ' ' MET . 35.8 m -76.37 -31.72 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 113.114 0.783 . . . . 73.41 113.114 -176.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.32 -40.12 95.3 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.163 0.438 . . . . 63.01 110.158 172.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.59 67.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.39 -0.823 . . . . 73.1 110.077 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.413 ' HB2' ' HE3' ' A' ' 103' ' ' MET . 90.0 t80 -56.99 -47.13 81.55 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.827 0.851 . . . . 75.11 111.605 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -63.83 -43.9 94.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.114 0.966 . . . . 74.11 110.434 -176.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.69 -45.73 91.22 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 123.753 0.658 . . . . 73.2 110.433 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.17 -39.31 68.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.256 -0.884 . . . . 74.22 111.559 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.457 ' HB ' HD12 ' A' ' 26' ' ' LEU . 10.8 tp -73.49 -38.78 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 117.95 0.341 . . . . 73.14 110.105 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -66.93 -44.0 81.81 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.041 0.536 . . . . 75.22 109.857 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.55 -38.23 95.47 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 124.088 0.867 . . . . 54.33 112.786 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 25.5 t90 -66.36 -52.69 44.4 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 123.874 0.87 . . . . 64.21 110.221 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.4 m -69.69 -36.9 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 119.152 -0.451 . . . . 74.44 111.842 -176.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.58 -33.95 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.606 0.639 . . . . 70.31 110.372 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.2 p -80.52 -34.06 35.92 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.497 0.319 . . . . 62.44 111.004 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.596 HD22 HG23 ' A' ' 155' ' ' ILE . 17.2 tp -69.53 -27.72 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.856 0.862 . . . . 73.32 110.623 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.3 mt -94.49 3.53 55.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.948 0.899 . . . . 75.11 111.438 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.01 95.0 4.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.046 -0.724 . . . . 61.03 109.046 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -58.3 -19.21 32.95 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.69 1.196 . . . . 75.44 113.774 -170.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.11 -45.91 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.315 1.046 . . . . 71.43 111.737 -173.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -108.58 -37.57 5.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 74.44 110.168 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -77.4 -1.84 32.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.664 1.186 . . . . 74.11 113.77 -170.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.05 -15.11 8.12 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 122.884 0.473 . . . . 74.21 111.179 164.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.22 26.09 6.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.019 0.927 . . . . 75.53 110.702 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -89.14 155.18 19.59 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.28 -1.007 . . . . 73.43 108.28 164.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.439 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -130.03 113.7 14.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.977 -1.49 . . . . 75.12 106.977 170.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.16 146.8 26.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.721 -0.844 . . . . 73.02 108.721 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.584 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 74.0 m-85 -143.47 162.49 35.66 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 123.405 0.682 . . . . 73.33 109.584 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.69 154.14 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.065 -1.457 . . . . 73.54 107.065 170.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.571 ' HA3' ' HG3' ' A' ' 12' ' ' GLU . . . -57.09 134.55 52.26 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-O 119.717 -0.49 . . . . 75.43 112.28 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 39.5 tt0 -61.57 -44.55 96.81 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.994 0.517 . . . . 72.34 110.26 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -57.16 -41.5 79.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 74.33 111.417 177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.567 ' HA ' ' HB1' ' A' ' 148' ' ' ALA . . . -65.43 -35.14 80.03 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.431 -0.804 . . . . 74.44 111.15 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.77 4.04 48.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.555 1.142 . . . . 70.02 112.801 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 52.9 mt-10 -110.34 -42.14 4.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.427 0.691 . . . . 73.53 110.219 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.89 67.91 0.18 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.813 -0.631 . . . . 65.21 112.977 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.567 ' HB1' ' HA ' ' A' ' 144' ' ' ALA . . . -155.19 -92.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.405 0.682 . . . . 72.24 109.954 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -155.23 152.14 28.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.221 1.008 . . . . 75.35 109.763 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -70.89 -36.86 72.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.75 -0.659 . . . . 64.52 109.992 169.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 35.33 -119.73 0.4 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 125.516 1.76 . . . . 70.42 116.437 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -94.49 128.53 41.13 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.373 -0.602 . . . . 71.34 109.373 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.9 t -79.85 131.67 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.753 0.821 . . . . 74.54 109.422 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.3 100.19 2.09 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.209 1.004 . . . . 64.12 109.229 170.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.596 HG23 HD22 ' A' ' 127' ' ' LEU . 86.8 mt -92.11 113.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.555 -0.535 . . . . 74.44 109.555 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 137' ' ' ALA . 42.0 mm -101.73 125.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.624 0.37 . . . . 73.22 110.855 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.72 120.28 36.12 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.653 -1.24 . . . . 74.5 107.653 165.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 12.0 p90 -95.21 102.73 14.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.482 -1.303 . . . . 71.21 107.482 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.471 ' O ' HG22 ' A' ' 166' ' ' VAL . 11.3 tpt180 -87.39 102.52 14.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.387 0.675 . . . . 74.42 109.891 -166.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.61 109.11 2.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.385 1.074 . . . . 74.13 111.803 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.83 117.74 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 123.966 0.906 . . . . 73.41 109.624 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.3 t70 70.36 -62.13 0.44 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.346 1.858 . . . . 75.34 111.408 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -171.68 21.02 0.07 OUTLIER Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.013 -0.54 . . . . 73.23 112.513 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.9 m -136.26 127.75 28.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.743 0.817 . . . . 75.2 109.227 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 4.2 mp0 -81.17 137.7 35.89 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.098 0.559 . . . . 71.32 110.03 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 159' ' ' ARG . 34.2 m -109.42 113.19 58.59 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.4 0.68 . . . . 71.14 109.252 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.51 114.84 2.22 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.406 2.737 . . . . 74.5 112.361 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 m -120.68 103.9 9.49 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.127 -1.064 . . . . 74.31 108.127 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.3 tp -77.59 129.75 36.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 108.882 -0.784 . . . . 73.52 108.882 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.4 mtt -112.17 122.76 48.65 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.575 -0.898 . . . . 62.34 108.575 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -133.71 130.24 37.87 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 106.626 -1.62 . . . . 74.33 106.626 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 176' ' ' ILE . 14.8 p -66.25 133.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.617 -0.883 . . . . 74.01 108.617 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -63.29 -4.89 2.86 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.183 1.179 . . . . 71.22 114.183 -168.307 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.53 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . 42.0 mm-40 -95.68 -17.59 21.17 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.361 0.875 . . . . 75.3 113.361 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -108.62 -0.87 19.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.902 0.481 . . . . 64.53 110.49 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.474 HG21 ' O ' ' A' ' 172' ' ' VAL . 5.9 tp -126.88 119.79 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 106.653 -1.61 . . . . 74.01 106.653 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.8 mm -102.96 110.78 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.339 -0.846 . . . . 74.42 109.392 -172.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.52 96.06 1.89 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.061 -1.427 . . . . 73.34 109.518 172.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.599 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 10.5 tp10 -92.31 98.76 11.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.079 -1.452 . . . . 74.52 107.079 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -87.98 95.27 10.06 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.151 -0.932 . . . . 74.13 110.959 -165.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.2 t -92.79 88.88 6.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.261 -1.014 . . . . 74.13 108.261 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.33 54.43 0.73 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.464 1.106 . . . . 73.45 109.691 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.742 -1.117 . . . . 63.34 108.895 177.352 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.448 ' HG3' ' HB3' ' A' ' 181' ' ' CYS . 12.6 tpt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.965 -0.383 . . . . 55.43 109.965 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 180' ' ' LYS . 73.5 mt -132.51 134.08 44.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.969 0.908 . . . . 75.25 109.341 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 68.7 mt -103.0 120.94 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.275 -1.379 . . . . 63.12 107.275 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.745 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 74.6 m-85 -105.08 135.88 45.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.534 -0.543 . . . . 75.13 109.534 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' HG3' ' HB ' ' A' ' 177' ' ' ILE . 0.2 OUTLIER -137.48 146.25 44.02 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.714 0.806 . . . . 74.42 110.12 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.412 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 27.0 t70 -106.35 172.4 6.83 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.903 1.281 . . . . 53.13 107.827 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.81 -35.84 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 O-C-N 121.458 -0.776 . . . . 72.12 111.437 175.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.82 -43.18 3.85 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.333 1.053 . . . . 74.32 110.903 -167.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -98.32 20.25 12.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 75.24 111.003 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.412 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 12.6 t70 -45.45 -43.03 11.09 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.523 1.929 . . . . 63.14 113.443 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -49.51 -61.68 1.97 Allowed 'General case' 0 N--CA 1.476 0.87 0 O-C-N 125.626 1.829 . . . . 64.53 112.626 -166.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.3 21.76 7.9 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.779 0.659 . . . . 60.22 112.779 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 tp -49.12 -65.37 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 112.578 0.584 . . . . 54.31 112.578 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.745 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 22.7 t -158.19 173.46 16.67 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.759 0.424 . . . . 73.13 110.282 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 35.8 p 172.88 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.078 0.951 . . . . 71.31 111.205 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.8 t70 -174.0 167.93 4.22 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.899 1.28 . . . . 73.41 109.026 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 m -68.88 65.11 0.13 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.297 1.039 . . . . 60.51 112.448 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 60.4 m-85 -87.9 134.07 36.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 122.976 0.51 . . . . 64.34 109.672 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HG2' ' HB3' ' A' ' 31' ' ' LYS . 52.6 Cg_endo -67.32 121.09 8.18 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.121 1.881 . . . . 63.22 110.401 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.66 147.02 52.33 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.082 -0.508 . . . . 64.2 110.633 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 26.2 mtpp -131.69 158.71 40.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.168 . . . . 65.44 108.53 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.63 110.88 18.44 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.673 -1.232 . . . . 74.54 107.673 167.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.17 139.13 20.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.907 0.883 . . . . 60.52 109.38 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 62.73 10.45 4.22 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.425 1.09 . . . . 74.2 112.926 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.5 t70 51.27 38.66 22.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.402 1.081 . . . . 64.03 110.622 -167.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.426 HD11 ' HB ' ' A' ' 120' ' ' ILE . 39.2 tp -134.74 -50.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.943 -0.571 . . . . 73.34 111.469 -172.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.9 t -125.11 138.29 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.341 0.657 . . . . 72.43 110.527 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 36.0 m-85 -86.1 119.96 26.96 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.077 0.951 . . . . 73.23 110.186 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 25.5 mm-40 -88.56 103.5 15.96 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 124.52 1.138 . . . . 75.11 108.569 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 25.0 t80 -109.74 103.92 12.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.423 -1.695 . . . . 72.44 106.423 -174.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 42.1 tttm -85.04 145.0 27.91 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.103 0.477 . . . . 73.23 111.048 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -133.78 -163.41 10.37 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 114.989 -1.005 . . . . 52.55 111.878 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -144.21 143.15 30.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.639 0.776 . . . . 73.31 109.224 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -74.25 121.53 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.468 -0.567 . . . . 65.42 109.468 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 72' ' ' LEU . 18.4 m -146.44 166.66 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.635 0.774 . . . . 64.3 109.163 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -128.84 139.69 51.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.225 -1.028 . . . . 75.43 108.225 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.703 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 17.9 tpt180 -100.13 108.41 20.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.364 -1.347 . . . . 74.34 107.364 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.685 ' HG2' HG22 ' A' ' 64' ' ' VAL . 5.6 tmtm? -124.72 106.39 10.04 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.12 -2.178 . . . . 73.24 105.12 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -72.67 79.58 1.1 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 121.742 0.782 . . . . 61.32 110.249 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.67 -35.76 0.34 Allowed Glycine 0 C--O 1.237 0.332 0 CA-C-N 114.693 -1.14 . . . . 73.33 111.92 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -174.9 105.0 0.09 Allowed 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.577 -0.527 . . . . 74.54 109.577 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.7 tt . . . . . 0 CA--C 1.554 1.111 0 CA-C-O 121.5 0.667 . . . . 65.44 110.743 179.789 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.685 HG22 ' HG2' ' A' ' 38' ' ' LYS . 18.3 t . . . . . 0 C--O 1.241 0.607 0 N-CA-C 108.657 -0.868 . . . . 55.22 108.657 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.1 mp0 -69.62 74.52 0.4 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.137 -1.061 . . . . 72.31 108.137 166.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 -75.96 134.43 40.2 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.636 1.175 . . . . 53.24 110.617 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.0 -141.38 6.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 112.089 -0.404 . . . . 44.52 112.089 170.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.441 HD11 HD12 ' A' ' 156' ' ' ILE . 18.4 pt -111.18 158.72 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.799 0.44 . . . . 74.34 110.125 170.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.94 -30.48 71.6 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 75.24 111.915 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 169' ' ' LEU . 69.2 mt -59.75 -52.61 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.375 1.07 . . . . 63.45 109.955 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.24 -48.04 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 114.251 -1.34 . . . . 75.31 111.443 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.479 HD12 HG23 ' A' ' 35' ' ' VAL . 79.3 mt -67.45 -23.25 65.5 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.577 0.751 . . . . 71.22 112.071 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -53.61 -53.84 46.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.181 0.992 . . . . 74.52 110.893 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -114.69 -1.61 13.25 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.436 -0.802 . . . . 75.34 112.427 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 66.71 70.14 0.4 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.448 1.099 . . . . 65.53 109.427 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.7 133.69 33.8 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.397 -0.964 . . . . 75.12 108.397 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.68 129.55 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.678 0.391 . . . . 73.21 110.369 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.42 147.04 46.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.477 0.711 . . . . 71.54 112.483 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.3 mtp -148.03 143.97 27.59 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.515 1.926 . . . . 73.33 106.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.0 m-80 -126.97 124.04 38.54 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.211 -1.033 . . . . 72.43 108.211 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.538 ' SG ' ' HD3' ' A' ' 130' ' ' LYS . 16.9 p -58.96 -15.27 12.13 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.844 0.857 . . . . 73.23 112.624 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.405 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 98.4 m-85 -57.29 -48.7 78.23 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.237 1.015 . . . . 72.35 111.545 174.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.81 -39.16 6.4 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.396 0.678 . . . . 73.23 110.543 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.76 20.11 1.22 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.61 1.164 . . . . 74.52 112.516 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.97 49.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.929 0.891 . . . . 72.45 112.876 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.3 m -68.33 -50.68 51.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.025 0.53 . . . . 74.13 112.105 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.3 mmm -60.26 -47.49 85.78 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.93 0.892 . . . . 72.03 111.44 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -64.04 -36.22 83.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.587 -1.188 . . . . 75.4 111.095 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.7 -37.44 87.36 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.109 0.564 . . . . 60.24 110.697 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 94' ' ' LYS . . . -61.51 -48.99 78.54 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.001 -0.545 . . . . 55.25 109.986 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -65.24 -32.23 73.8 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.958 0.725 . . . . 75.43 112.958 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 mm -66.19 -41.19 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.239 0.616 . . . . 75.54 111.575 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.98 -36.42 82.14 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.622 0.249 . . . . 72.2 110.786 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.677 ' HD3' ' HA ' ' A' ' 150' ' ' ASN . 96.6 mttt -64.43 -47.05 80.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.733 0.813 . . . . 61.3 109.83 174.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -53.76 -62.41 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.964 1.706 . . . . 65.23 111.858 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.3 ptm -62.3 -38.15 88.28 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.411 0.444 . . . . 70.22 111.269 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -66.21 -42.26 89.0 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 110.286 -0.264 . . . . 60.51 110.286 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -65.59 -54.11 32.43 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.808 0.843 . . . . 72.31 111.445 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.552 HG11 HG11 ' A' ' 172' ' ' VAL . 17.8 m -67.4 -40.17 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.114 0.566 . . . . 73.21 112.173 -171.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 86.6 mt -69.4 -45.68 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 109.626 -0.509 . . . . 73.01 109.626 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.81 -35.23 80.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.371 0.668 . . . . 62.11 111.608 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -59.4 -47.35 85.77 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.878 . . . . 73.33 109.065 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.514 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.6 tpt -71.37 -28.32 63.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.631 -1.168 . . . . 65.13 111.178 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HA ' HG11 ' A' ' 113' ' ' VAL . 29.6 mm-40 -67.43 -23.49 65.54 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.035 0.534 . . . . 73.23 111.394 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -86.02 -30.64 22.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.774 -0.648 . . . . 73.41 109.76 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.31 -36.58 58.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.333 0.653 . . . . 73.22 111.622 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -118.46 -66.68 1.05 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.83 0.852 . . . . 64.13 109.438 -170.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 74.86 -30.49 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.053 1.341 . . . . 73.24 112.892 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.89 -16.86 63.87 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.034 1.334 . . . . 44.45 113.671 -166.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 113' ' ' VAL . 40.4 mmtm 79.99 -2.55 2.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.237 1.415 . . . . 72.33 112.299 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.05 -60.36 2.9 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.921 0.488 . . . . 52.4 110.856 171.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -91.11 -34.34 15.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.728 -0.669 . . . . 63.03 111.592 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' HG3' ' A' ' 103' ' ' MET . 26.9 m -68.96 -44.84 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 112.135 0.42 . . . . 50.01 112.135 -175.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 24.0 t70 -72.51 -32.91 66.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.558 0.743 . . . . 72.31 110.203 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -65.47 -53.08 47.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.772 0.67 . . . . 61.41 109.789 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -56.82 -37.63 71.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.618 -1.174 . . . . 72.23 110.603 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.1 -44.34 92.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.403 1.081 . . . . 72.31 111.158 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 46.0 mmtm -63.37 -38.5 91.38 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.566 0.541 . . . . 72.43 110.609 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 13.9 mmmm -71.73 -49.47 38.98 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.774 -0.648 . . . . 71.31 111.084 -176.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.426 ' HB ' HD11 ' A' ' 26' ' ' LEU . 9.3 tp -74.02 -37.58 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 123.285 0.366 . . . . 73.44 110.732 -173.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -68.35 -45.53 72.59 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.678 -0.86 . . . . 35.22 108.678 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.99 97.34 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.007 -0.542 . . . . 72.33 112.271 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -64.25 -50.71 66.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.695 0.798 . . . . 71.53 110.441 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.1 m -67.57 -38.24 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 O-C-N 123.782 0.676 . . . . 71.14 111.198 -175.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.97 -39.93 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.081 0.401 . . . . 60.52 110.538 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.7 t -70.61 -45.35 65.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.476 -0.329 . . . . 70.14 110.179 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.66 -32.03 73.37 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.897 1.279 . . . . 73.13 111.89 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 59.2 mt -88.47 3.12 51.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.052 0.541 . . . . 60.32 111.827 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.19 92.49 6.9 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.004 0.522 . . . . 52.42 109.714 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.538 ' HD3' ' SG ' ' A' ' 81' ' ' CYS . 48.0 mtmt -60.4 -9.2 3.28 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.088 1.355 . . . . 74.15 114.266 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -53.62 -47.65 70.05 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 73.25 110.472 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.531 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -111.9 -34.4 6.01 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.101 -0.954 . . . . 74.1 110.767 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -73.29 -0.31 14.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.633 1.345 . . . . 70.05 114.633 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.1 ptmt -50.56 -9.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.676 1.362 . . . . 51.01 114.676 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -81.92 6.77 14.82 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.735 0.814 . . . . 74.42 111.732 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 157' ' ' GLU . 90.6 mt -89.41 140.99 28.96 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.355 0.662 . . . . 64.22 109.688 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.57 113.35 15.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.87 -1.9 . . . . 75.35 105.87 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.446 ' HE2' ' SG ' ' A' ' 81' ' ' CYS . 65.0 m-85 -87.61 136.51 32.92 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.631 -0.507 . . . . 71.33 109.631 -172.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -135.44 153.28 51.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.012 -1.107 . . . . 72.22 108.012 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.2 tt -139.01 145.35 27.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 108.945 -0.761 . . . . 63.21 108.945 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.68 131.27 51.33 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.267 0.979 . . . . 73.53 112.222 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.98 -33.68 3.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.262 1.425 . . . . 63.44 112.522 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -73.48 -49.34 27.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.23 1.012 . . . . 73.14 110.563 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.7 78.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.566 0.746 . . . . 62.01 111.72 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.72 -8.94 59.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.693 -0.685 . . . . 54.33 112.764 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -89.01 -41.83 12.12 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.058 0.456 . . . . 65.2 109.85 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -100.7 5.09 56.64 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.64 -0.709 . . . . 72.03 113.672 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 60.45 34.74 20.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.833 0.853 . . . . 75.42 110.568 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -63.18 178.37 0.51 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.719 1.208 . . . . 64.33 112.996 -173.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.677 ' HA ' ' HD3' ' A' ' 94' ' ' LYS . 12.8 t-20 -88.11 8.17 28.12 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.716 -1.129 . . . . 74.11 109.614 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.25 144.65 48.71 Favored Glycine 0 C--N 1.359 1.853 0 CA-C-N 115.952 -0.567 . . . . 73.45 113.01 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.456 ' NE2' HD22 ' A' ' 171' ' ' LEU . 8.9 pt20 -85.0 162.74 19.24 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.672 0.789 . . . . 73.34 110.916 -174.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.15 125.36 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.814 -1.085 . . . . 72.32 110.015 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.16 107.95 3.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.383 1.073 . . . . 75.13 109.36 169.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.6 mt -90.94 102.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.422 -0.585 . . . . 74.3 109.422 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.441 HD12 HD11 ' A' ' 68' ' ' ILE . 47.2 mm -93.22 148.03 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.939 -0.763 . . . . 74.3 108.939 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.638 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -139.17 147.41 41.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.735 0.814 . . . . 74.41 108.942 169.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -98.24 134.37 41.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.195 -1.039 . . . . 63.11 108.195 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 23.7 ttm180 -124.83 153.14 42.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.051 0.94 . . . . 61.15 108.849 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.76 93.99 4.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.941 0.337 . . . . 64.25 110.491 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.3 p -119.37 123.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.716 0.806 . . . . 73.22 110.166 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 55.75 32.57 19.72 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.516 1.126 . . . . 74.44 112.612 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.01 68.89 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.181 -0.463 . . . . 43.02 113.422 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 m -128.05 125.8 40.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.254 0.622 . . . . 74.0 110.257 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 9.5 pt-20 -73.48 112.89 9.98 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.461 0.704 . . . . 71.51 109.267 169.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.93 106.89 46.91 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.483 0.713 . . . . 74.35 109.348 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.7 Cg_exo -76.16 117.05 4.52 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 122.675 2.25 . . . . 71.22 111.154 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.2 m -116.1 124.23 49.86 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.153 -0.684 . . . . 75.31 109.153 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 29.3 tp -76.99 137.7 39.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.395 1.078 . . . . 72.41 109.937 171.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 74.2 mtp -117.63 122.72 44.34 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.344 -1.354 . . . . 73.12 107.344 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.456 HD22 ' NE2' ' A' ' 152' ' ' GLN . 80.1 mt -136.33 147.85 47.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.076 -1.083 . . . . 71.24 108.076 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.552 HG11 HG11 ' A' ' 99' ' ' VAL . 10.0 p -75.46 144.65 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 109.464 -0.569 . . . . 74.35 109.464 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.438 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 12.8 ptmm? -57.0 -32.79 66.48 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.642 0.777 . . . . 63.44 112.188 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 172' ' ' VAL . 4.1 tp10 -85.82 1.1 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.809 0.844 . . . . 74.11 113.046 -165.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.46 -1.01 6.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.46 0.304 . . . . 70.52 111.637 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.24 141.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.624 0.77 . . . . 74.21 109.501 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.541 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.1 mm -126.88 114.0 35.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.214 -1.402 . . . . 72.32 107.214 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -84.47 127.0 33.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.235 -0.654 . . . . 63.11 109.235 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -116.3 101.78 8.98 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.075 -0.713 . . . . 72.14 109.075 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.424 ' HA ' HD23 ' A' ' 2' ' ' LEU . 36.0 ttpt -68.51 137.76 54.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.412 0.685 . . . . 71.51 110.539 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 21.8 t -131.87 88.3 2.55 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.623 -0.88 . . . . 63.02 108.623 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.3 mt -131.2 100.8 5.32 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.672 1.189 . . . . 71.53 108.257 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.559 1.298 0 C-N-CA 123.808 0.843 . . . . 73.41 110.718 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 108.772 -0.825 . . . . 72.11 108.772 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.0 mt -94.53 115.41 27.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.117 0.484 . . . . 44.22 110.497 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 49.8 mt -99.04 132.48 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.091 -1.077 . . . . 65.33 108.091 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 64.5 m-85 -121.76 132.39 54.59 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.484 -0.932 . . . . 71.44 108.484 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.565 ' NZ ' ' HB2' ' A' ' 179' ' ' GLU . 3.5 mppt? -120.67 120.18 34.97 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.415 0.686 . . . . 73.42 110.877 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.584 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 21.5 t70 -69.05 177.87 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.195 0.998 . . . . 70.23 108.797 170.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 pt -81.88 -29.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.838 -1.164 . . . . 74.11 111.62 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.05 -38.71 4.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.605 0.762 . . . . 64.35 110.64 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 m -96.28 15.81 20.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.833 -1.076 . . . . 70.21 109.686 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 4.2 p-10 -54.62 -33.85 61.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.214 1.406 . . . . 73.22 113.253 -172.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.61 -57.39 8.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.382 1.676 . . . . 73.2 112.131 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -123.83 24.34 8.39 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.766 0.654 . . . . 74.53 112.766 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 tm? -60.28 -61.14 2.82 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.572 0.349 . . . . 64.35 110.552 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 35.6 t -155.21 161.27 41.23 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 110.048 -0.353 . . . . 62.02 110.048 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 23.0 t 172.3 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.455 1.097 . . . . 74.31 109.838 -168.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.488 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 23.4 t70 -177.8 165.24 2.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.802 1.241 . . . . 63.51 109.145 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 p -67.8 88.35 0.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.414 -0.588 . . . . 72.43 109.414 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 23.4 m-85 -109.83 151.67 42.5 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.915 -1.039 . . . . 61.24 111.514 -175.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.66 120.74 7.11 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.913 1.742 . . . . 51.54 110.982 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.9 135.96 34.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.47 -0.937 . . . . 45.14 108.47 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 8.6 mmmm -141.82 107.32 5.05 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.219 -1.4 . . . . 75.24 107.219 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.6 tp -109.29 133.65 52.78 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.809 -0.812 . . . . 74.24 108.809 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.92 137.13 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.826 0.851 . . . . 72.24 109.083 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.5 t70 66.42 4.32 3.21 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.401 1.08 . . . . 75.42 112.263 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.8 t70 59.47 11.68 2.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.904 1.281 . . . . 74.21 112.57 -167.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.3 tp -113.03 -41.51 3.72 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.686 -0.634 . . . . 73.5 110.158 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.47 130.94 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.089 0.556 . . . . 72.21 109.656 -167.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -93.61 117.77 30.52 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.561 -0.903 . . . . 72.44 108.561 171.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 7.0 pt-20 -97.42 119.56 36.19 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.479 0.712 . . . . 53.33 109.728 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.608 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 23.3 t80 -110.76 106.21 15.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.25 -1.019 . . . . 75.34 108.25 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.05 113.5 4.51 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.21 0.204 . . . . 73.3 111.19 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.13 165.4 22.85 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 110.825 -0.91 . . . . 75.1 110.825 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.663 ' HG2' ' HB2' ' A' ' 69' ' ' ASP . 18.2 ptpt -94.37 125.38 38.97 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.65 0.725 . . . . 74.33 109.673 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.608 ' HB3' ' HG3' ' A' ' 167' ' ' PRO . 0.3 OUTLIER -73.63 106.84 5.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.158 0.583 . . . . 55.32 109.436 177.056 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.46 ' HB ' HD11 ' A' ' 42' ' ' ILE . 9.9 m -139.24 162.24 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.675 0.79 . . . . 53.22 110.786 -170.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 m -109.56 124.01 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.197 -0.94 . . . . 72.15 109.422 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.454 ' HB2' HD13 ' A' ' 72' ' ' LEU . 16.7 tpt180 -132.7 108.09 8.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.013 -0.365 . . . . 74.14 110.013 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -129.65 160.46 33.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.281 1.032 . . . . 63.0 108.526 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 50.73 -76.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.635 1.974 . . . . 71.03 113.497 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.31 32.35 0.11 Allowed Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.676 -0.57 . . . . 63.44 111.676 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -147.39 146.67 29.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.356 0.662 . . . . 73.45 110.322 -175.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.46 HD11 ' HB ' ' A' ' 35' ' ' VAL . 5.9 tp . . . . . 0 CA--C 1.555 1.153 0 C-N-CA 124.796 1.238 . . . . 65.53 109.063 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--O 1.236 0.358 0 N-CA-C 105.012 -2.218 . . . . 65.53 105.012 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.75 ' HG3' ' HG2' ' A' ' 66' ' ' ARG 0.25 10.4 pt-20 65.15 -36.08 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 127.612 2.365 . . . . 70.04 115.632 164.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.75 ' HG2' ' HG3' ' A' ' 65' ' ' GLU . 18.1 mmt180 -132.66 110.92 10.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 104.76 -2.311 . . . . 65.12 104.76 -174.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.6 37.83 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.468 -0.653 . . . . 53.22 111.468 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.56 HD11 HD12 ' A' ' 156' ' ' ILE . 30.9 pt -109.6 160.07 8.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.143 -0.688 . . . . 73.35 109.143 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.663 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . 24.1 t70 -39.15 -40.53 0.73 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.26 1.024 . . . . 75.14 113.038 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.413 HD11 ' HD1' ' A' ' 30' ' ' PHE . 46.0 mm -56.54 -42.36 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.461 -0.791 . . . . 73.3 111.125 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.8 t -85.28 -49.52 15.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 C-N-CA 123.56 0.744 . . . . 74.31 111.717 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' A' ' 37' ' ' ARG . 33.8 mt -72.13 -49.0 39.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.217 0.607 . . . . 64.05 111.919 -169.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -69.79 -26.0 64.06 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 62.14 111.274 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -103.42 -14.95 16.05 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.027 0.381 . . . . 71.04 112.027 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? 60.07 69.97 0.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.516 1.126 . . . . 64.34 110.759 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 mt -96.57 142.13 29.0 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.402 -1.272 . . . . 72.44 109.113 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.04 124.22 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 108.794 -0.817 . . . . 65.54 108.794 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.35 151.08 5.72 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.482 1.113 . . . . 73.35 113.811 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.7 tpt -147.03 103.64 3.62 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 113.839 -1.528 . . . . 64.44 107.271 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -94.24 93.95 8.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.111 -1.441 . . . . 72.52 107.111 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 30.1 p -68.91 -31.02 69.64 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.508 0.67 . . . . 73.35 110.111 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.09 -21.18 61.53 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.42 -1.263 . . . . 73.54 111.711 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -105.18 -16.72 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.509 0.724 . . . . 63.23 112.197 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.39 23.53 6.37 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.301 0.64 . . . . 73.21 110.596 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.18 -28.94 3.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.014 1.725 . . . . 62.33 114.823 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.3 m -62.25 -59.18 5.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 118.109 0.413 . . . . 73.34 111.503 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.2 mmm -64.74 -39.25 93.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.489 0.716 . . . . 73.32 110.233 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -61.1 -46.23 91.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.037 -0.983 . . . . 74.31 112.076 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -61.33 -35.28 76.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.924 0.765 . . . . 74.42 110.106 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.57 82.41 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.746 -0.661 . . . . 63.53 111.323 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -67.37 -43.72 80.74 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.536 0.334 . . . . 72.43 111.498 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -64.08 -33.52 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.604 1.162 . . . . 62.23 111.449 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.87 -47.08 86.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.415 0.686 . . . . 70.35 109.851 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -72.82 -40.46 65.79 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.533 -0.758 . . . . 75.11 110.902 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.08 -54.92 36.94 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.657 1.583 . . . . 75.3 112.069 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttt -59.7 -46.14 89.97 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.738 0.648 . . . . 74.43 110.115 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -58.23 -44.91 88.46 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 115.659 -0.7 . . . . 75.5 109.535 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -62.59 -50.37 71.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.316 1.046 . . . . 72.33 111.144 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 175' ' ' ALA . 26.4 m -67.93 -39.17 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.275 0.63 . . . . 65.42 112.566 -174.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.5 mt -73.39 -38.48 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.495 -0.557 . . . . 60.33 109.495 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.34 -27.19 66.93 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.813 1.245 . . . . 70.35 111.162 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -63.55 -57.92 8.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.952 0.901 . . . . 63.33 109.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.546 ' HG3' HG12 ' A' ' 113' ' ' VAL . 23.2 ptm -73.89 -19.74 60.62 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.86 0.725 . . . . 75.44 111.575 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.482 ' HG2' ' HE ' ' A' ' 108' ' ' ARG . 26.6 tt0 -53.8 -55.77 23.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.014 0.926 . . . . 71.41 110.759 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -24.34 66.14 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.825 0.703 . . . . 63.21 111.317 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -94.35 -16.43 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.2 1.0 . . . . 72.54 110.787 -173.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -129.11 -83.43 0.57 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.83 0.852 . . . . 73.3 110.316 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HE ' ' HG2' ' A' ' 104' ' ' GLU . 94.2 mtt180 53.56 20.9 2.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.751 1.019 . . . . 74.3 113.751 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.19 -21.96 59.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.397 0.679 . . . . 73.53 109.44 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 86.53 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.415 1.886 . . . . 75.14 112.238 174.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.47 -44.39 91.2 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.878 0.325 . . . . 71.22 111.878 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.9 -41.46 36.48 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.46 0.704 . . . . 60.4 110.654 -171.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.546 HG12 ' HG3' ' A' ' 103' ' ' MET . 33.4 m -70.71 -28.6 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 115.818 -0.628 . . . . 70.12 110.858 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 29.9 t70 -68.1 -47.79 67.24 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.124 0.57 . . . . 65.05 110.465 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.09 -38.28 90.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.785 0.678 . . . . 62.11 110.082 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -65.36 -49.57 68.86 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.232 -0.894 . . . . 70.41 111.348 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.572 ' HA ' HG22 ' A' ' 120' ' ' ILE . 21.9 pttp -67.46 -25.84 66.09 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.177 0.298 . . . . 72.15 110.894 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -61.91 -51.19 69.16 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.822 0.701 . . . . 74.45 110.566 169.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.83 -36.5 59.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.848 0.685 . . . . 65.41 112.848 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' A' ' 117' ' ' LYS . 10.6 tp -73.18 -37.18 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 118.538 0.608 . . . . 71.32 109.682 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -48.12 69.38 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.001 0.521 . . . . 74.21 110.091 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.28 94.31 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.63 0.581 . . . . 50.13 112.331 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.41 -55.26 22.18 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 123.513 0.725 . . . . 74.1 110.232 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.1 m -66.05 -41.72 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 118.721 -0.656 . . . . 65.43 111.482 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.79 -40.03 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.686 0.676 . . . . 63.24 110.419 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -73.19 -32.81 65.04 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.067 0.547 . . . . 72.34 111.51 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.683 HD21 HG21 ' A' ' 155' ' ' ILE . 31.0 tp -77.29 -31.2 54.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.567 0.747 . . . . 64.44 110.992 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 56.2 mt -84.0 3.64 33.43 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.855 0.862 . . . . 64.14 111.246 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.04 84.01 0.98 Allowed 'General case' 0 C--N 1.357 0.935 0 N-CA-C 109.263 -0.643 . . . . 61.32 109.263 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -66.09 -14.84 62.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.863 1.431 . . . . 74.41 114.863 -163.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.61 -36.4 80.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.208 0.527 . . . . 71.14 110.489 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.1 mtp-105 -105.76 -39.15 6.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.168 0.987 . . . . 70.13 110.42 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -81.67 -1.43 46.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.383 1.073 . . . . 74.45 113.784 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -47.64 -10.85 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.958 1.466 . . . . 74.34 114.958 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -82.01 6.21 16.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.808 0.843 . . . . 72.04 111.66 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 157' ' ' GLU . 96.3 mt -91.69 154.31 19.08 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.286 0.634 . . . . 64.03 110.002 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.62 125.65 18.42 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.793 -1.558 . . . . 62.33 106.793 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -98.68 153.05 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.284 -1.006 . . . . 72.41 108.284 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -143.58 171.15 14.56 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.642 0.777 . . . . 72.11 109.074 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.99 149.12 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.929 -1.137 . . . . 63.35 107.929 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.81 132.79 44.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.474 -0.626 . . . . 75.2 112.23 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.53 -42.65 99.14 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.761 -0.459 . . . . 73.42 109.761 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.611 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -65.71 -33.71 76.52 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.5 -0.773 . . . . 73.42 111.931 172.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.51 -44.24 75.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.192 0.597 . . . . 74.41 110.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.06 65.75 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.246 0.966 . . . . 60.34 110.875 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -57.36 -36.57 71.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.369 1.067 . . . . 74.02 111.513 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.6 -52.92 23.0 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.361 -0.836 . . . . 60.21 111.137 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -167.72 154.78 8.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.555 0.742 . . . . 75.54 109.944 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.11 10.05 9.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.3 0.24 . . . . 72.53 110.97 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -88.88 -3.89 58.62 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.585 0.754 . . . . 74.3 110.601 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.66 151.54 24.38 Favored Glycine 0 C--N 1.356 1.642 0 O-C-N 123.963 0.79 . . . . 50.13 113.697 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -79.52 135.52 36.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.029 0.532 . . . . 73.51 111.33 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.41 112.07 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.202 -0.908 . . . . 71.51 110.527 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.88 115.48 14.52 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.415 1.086 . . . . 71.1 109.964 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.683 HG21 HD21 ' A' ' 127' ' ' LEU . 54.4 mt -92.8 115.21 31.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 122.922 0.489 . . . . 74.44 109.932 -171.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.56 HD12 HD11 ' A' ' 68' ' ' ILE . 35.1 mm -98.81 116.22 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 118.441 0.564 . . . . 60.24 110.562 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 159' ' ' ARG . 46.0 tt0 -97.22 101.46 13.03 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.259 1.023 . . . . 75.31 109.554 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -75.62 89.7 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.564 -1.273 . . . . 70.41 107.564 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.45 ' HB2' ' HG2' ' A' ' 157' ' ' GLU . 39.0 ttt85 -99.52 149.7 22.96 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.808 -0.812 . . . . 72.42 108.808 -172.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -122.47 130.56 53.19 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.592 -0.892 . . . . 74.32 108.592 167.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.1 109.37 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.362 -0.977 . . . . 73.45 108.362 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 60.1 28.84 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.498 1.119 . . . . 75.32 110.568 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.54 -17.08 59.92 Favored Glycine 0 C--N 1.357 1.743 0 CA-C-N 115.548 -0.751 . . . . 71.43 113.432 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.7 m -81.32 112.24 18.44 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.238 0.519 . . . . 74.4 110.42 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -71.84 103.33 3.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.501 0.72 . . . . 51.24 110.09 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.05 92.67 15.67 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 125.12 1.368 . . . . 75.55 109.224 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.608 ' HG3' ' HB3' ' A' ' 34' ' ' HIS . 72.1 Cg_endo -75.26 116.53 4.56 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.395 2.063 . . . . 73.3 111.645 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 31.1 p -117.22 135.6 53.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.282 1.033 . . . . 64.03 110.605 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.4 tp -77.18 114.05 15.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.131 0.972 . . . . 71.31 108.895 170.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 66.6 mmm -102.67 121.49 42.52 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.259 -1.386 . . . . 64.13 107.259 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.1 mt -136.0 147.12 47.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 106.966 -1.494 . . . . 74.44 106.966 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 99' ' ' VAL . 7.5 p -73.05 131.17 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.55 -0.907 . . . . 64.04 108.55 173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.61 -34.82 59.83 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.38 1.472 . . . . 55.22 111.634 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.17 -18.45 65.31 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 75.15 112.2 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -127.36 15.95 7.15 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.428 0.691 . . . . 71.02 111.74 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.5 tp -131.49 119.01 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 N-CA-C 108.199 -1.038 . . . . 71.34 108.199 165.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.43 113.74 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.644 -0.502 . . . . 53.03 109.644 -168.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -70.61 154.51 41.8 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.192 0.997 . . . . 64.35 111.244 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.582 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.4 tp10 -147.51 101.6 3.37 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.36 -0.607 . . . . 74.1 109.36 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -83.46 94.55 8.03 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.908 -0.404 . . . . 73.34 109.908 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 44.0 t -96.49 89.73 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.93 -1.137 . . . . 63.53 107.93 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.92 172.83 16.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.741 -0.663 . . . . 74.23 111.134 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 CA--C 1.559 1.324 0 C-N-CA 124.556 1.142 . . . . 64.53 110.793 -171.505 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.65 ' HG3' ' HG ' ' A' ' 2' ' ' LEU . 20.9 ptt? . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 112.997 0.74 . . . . 55.12 112.997 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.65 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 87.0 mt -136.03 161.51 35.47 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 123.327 0.651 . . . . 62.21 110.815 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 57.1 mt -96.65 120.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.351 -1.351 . . . . 63.55 107.351 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 22.7 m-85 -112.54 96.95 6.28 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.518 -1.66 . . . . 73.3 106.518 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 14.0 ptmm? -107.41 127.24 53.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.272 -0.876 . . . . 71.35 110.898 -173.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 25.1 t70 -74.2 178.16 5.29 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.59 -1.186 . . . . 65.04 109.807 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 HD21 ' A' ' 98' ' ' ASN . 62.0 mt -76.22 -38.66 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.578 -0.701 . . . . 61.24 110.732 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.7 -50.84 2.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.251 1.02 . . . . 52.21 109.867 -172.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -90.25 17.65 6.89 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.095 -0.957 . . . . 74.01 111.106 -171.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.565 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 9.0 p-10 -55.19 -26.57 39.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.773 1.629 . . . . 74.21 113.657 -170.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -49.46 -62.19 1.68 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 125.178 1.549 . . . . 74.14 112.493 -170.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -123.6 24.08 8.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.273 -0.876 . . . . 63.32 111.901 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 1.8 tm? -59.43 -73.58 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.993 0.517 . . . . 73.1 109.648 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 27.1 m -149.73 151.94 34.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.968 -1.123 . . . . 70.44 107.968 167.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 m -155.76 111.9 3.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.098 0.559 . . . . 72.52 110.359 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.269 4.1 p-10 51.88 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.31 1.844 . . . . 74.02 112.33 172.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.1 p -60.71 5.85 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.435 1.642 . . . . 53.53 115.435 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.41 146.94 32.87 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.777 0.831 . . . . 64.22 109.935 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -91.38 173.09 2.75 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.348 2.699 . . . . 74.12 114.312 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.657 ' HA ' ' HE1' ' A' ' 28' ' ' TYR . 23.8 ptt? -114.09 151.68 32.21 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.898 -1.046 . . . . 73.12 109.799 169.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -149.39 97.53 2.66 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 106.818 -1.549 . . . . 72.15 106.818 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.0 tp -91.72 122.03 33.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.812 -0.81 . . . . 73.01 108.812 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.96 134.32 53.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 C-N-CA 123.693 0.797 . . . . 71.51 108.954 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.31 21.72 8.57 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.848 0.859 . . . . 71.44 111.764 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 68.15 -9.29 0.5 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.824 1.249 . . . . 72.44 113.756 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.6 tp -102.76 -52.56 3.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.516 -0.74 . . . . 73.52 111.448 -167.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -103.71 129.08 56.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.043 -0.981 . . . . 64.42 109.586 -164.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.657 ' HE1' ' HA ' ' A' ' 20' ' ' MET . 17.2 t80 -83.35 112.83 20.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.38 -1.341 . . . . 71.24 107.38 170.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.8 121.64 38.87 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.528 -1.214 . . . . 64.12 108.196 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -113.13 136.58 52.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.459 0.704 . . . . 72.01 109.548 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 136.15 57.88 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.374 1.07 . . . . 44.32 113.314 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.62 146.21 14.07 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 110.58 -1.008 . . . . 73.43 110.58 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.79 151.83 40.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.266 0.533 . . . . 72.34 109.69 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -74.97 124.34 26.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.715 -0.476 . . . . 75.43 109.715 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.53 160.58 16.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 124.407 1.083 . . . . 63.42 109.454 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.533 HG12 ' HG3' ' A' ' 66' ' ' ARG . 16.1 m -120.14 103.55 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.791 -1.559 . . . . 63.44 106.791 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.619 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.5 mtp180 -101.06 155.74 17.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.812 -1.085 . . . . 71.22 108.315 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 20.6 ttpp -135.5 161.83 34.38 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.627 -1.249 . . . . 74.32 107.627 170.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -43.37 -32.41 0.83 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.465 1.506 . . . . 75.23 113.927 -172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.83 54.83 0.53 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.448 -0.661 . . . . 55.2 111.448 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.8 tt0 -163.97 150.67 11.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.34 0.656 . . . . 72.24 110.939 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 124.841 1.256 . . . . 74.25 107.799 168.571 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 107.479 -1.304 . . . . 64.42 107.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.3 mt-10 -85.59 70.5 10.75 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.518 -1.29 . . . . 71.25 107.518 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HG3' HG12 ' A' ' 36' ' ' VAL . 18.7 ttp180 -96.55 139.18 33.02 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.465 0.65 . . . . 73.35 111.025 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.69 -131.99 5.22 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 114.858 -1.065 . . . . 63.34 111.374 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.789 HD12 ' HB2' ' A' ' 167' ' ' PRO . 0.8 OUTLIER -99.87 133.97 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.184 0.594 . . . . 72.23 110.755 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -36.79 -48.32 0.72 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.835 2.054 . . . . 65.32 114.186 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.7 mm -50.31 -53.33 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 124.164 0.915 . . . . 70.32 111.436 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 76' ' ' LEU . 57.7 t -80.84 -23.17 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.615 0.766 . . . . 73.51 111.299 -170.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 60.7 mt -77.47 -38.13 49.89 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.905 0.482 . . . . 51.3 110.578 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -79.52 -49.38 12.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.81 0.844 . . . . 75.31 110.819 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.89 -21.39 34.27 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.555 0.342 . . . . 62.43 111.094 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm 63.11 66.97 0.7 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 124.632 1.173 . . . . 73.34 110.85 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.556 ' HB2' HG13 ' A' ' 71' ' ' VAL . 40.5 mt -93.18 162.72 13.91 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.442 -1.254 . . . . 65.13 109.587 174.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.12 135.65 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.636 0.775 . . . . 73.11 109.912 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.11 152.85 44.87 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.493 0.923 . . . . 62.32 113.493 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 59.8 mtm -146.06 104.93 3.87 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.106 1.762 . . . . 72.2 106.434 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.68 124.58 25.05 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.202 -0.666 . . . . 73.24 109.202 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 3.8 m -56.31 -30.89 63.14 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.848 0.859 . . . . 73.11 111.612 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -69.49 -45.54 68.71 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 113.592 -1.64 . . . . 74.22 112.86 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -97.73 -28.23 13.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.883 0.473 . . . . 74.14 111.914 -173.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.97 19.5 18.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.151 0.98 . . . . 71.1 111.132 -169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.76 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.264 1.025 . . . . 71.04 113.743 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -72.79 -55.51 6.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.037 0.935 . . . . 72.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.6 mtt -64.07 -37.2 86.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.055 0.542 . . . . 72.22 110.403 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.621 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 14.9 t80 -54.04 -49.07 69.78 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.747 1.219 . . . . 74.51 111.03 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -64.61 -34.9 79.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 74.34 110.093 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.46 81.14 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.328 0.392 . . . . 65.11 111.005 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -67.67 -32.7 73.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.504 0.722 . . . . 71.3 112.505 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.9 mm -67.31 -44.71 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.468 0.707 . . . . 74.3 111.245 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.6 -40.61 92.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.914 0.486 . . . . 74.45 109.827 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -63.28 -50.22 70.97 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.262 -0.881 . . . . 71.12 109.435 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -56.51 -51.01 70.13 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.243 1.417 . . . . 74.11 112.12 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.5 -40.27 85.2 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.344 0.402 . . . . 71.21 110.993 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -68.43 -38.68 81.4 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.875 -0.417 . . . . 72.35 109.875 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.494 HD21 HD12 ' A' ' 7' ' ' ILE . 30.2 t30 -58.45 -55.69 31.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 63.43 110.625 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.519 HG11 HG11 ' A' ' 172' ' ' VAL . 22.3 m -71.41 -39.98 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 114.969 -1.014 . . . . 62.1 112.865 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.25 -45.82 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 110.014 -0.365 . . . . 72.33 110.014 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -56.03 -38.47 70.6 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.474 0.71 . . . . 71.14 110.8 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -56.33 -58.11 9.37 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.152 0.907 . . . . 72.24 110.197 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.4 mmm -70.28 -26.74 63.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.535 -0.302 . . . . 72.33 111.138 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.53 ' HA ' HG11 ' A' ' 113' ' ' VAL . 40.5 tt0 -64.35 -45.91 85.72 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.359 1.064 . . . . 62.13 110.681 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -89.29 -9.61 49.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.273 0.471 . . . . 74.15 112.273 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.25 -22.9 21.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.508 0.559 . . . . 52.54 112.508 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -124.86 -43.95 1.96 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.573 0.349 . . . . 72.11 111.16 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.96 25.62 14.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.718 0.807 . . . . 72.33 111.234 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -119.13 126.59 51.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.032 0.933 . . . . 74.54 109.361 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -62.24 -36.0 80.67 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.748 0.819 . . . . 72.14 111.85 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.34 60.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.783 0.433 . . . . 72.51 110.889 -172.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.11 -60.64 2.21 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.445 -0.576 . . . . 72.32 109.445 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 104' ' ' GLU . 30.3 m -67.45 -35.52 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.737 -1.12 . . . . 74.41 112.875 -167.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.54 -33.9 35.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.458 0.703 . . . . 72.4 110.324 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.26 64.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.706 -0.479 . . . . 74.3 109.706 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.424 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 42.0 t80 -71.49 -40.62 70.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.972 -1.013 . . . . 72.23 110.129 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -62.31 -38.62 90.11 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.685 0.794 . . . . 74.13 110.207 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.81 -40.42 88.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.557 -1.201 . . . . 70.11 109.698 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -71.71 -37.18 70.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.627 0.771 . . . . 74.12 109.927 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 172' ' ' VAL . 8.3 mm -65.05 -47.81 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.655 0.782 . . . . 64.12 109.2 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.11 -37.83 81.16 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.784 0.678 . . . . 74.5 110.577 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.52 58.62 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 115.83 -0.623 . . . . 42.25 112.393 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.79 -51.19 61.08 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.053 0.502 . . . . 73.33 110.762 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.591 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.0 m -70.87 -41.71 77.25 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.966 0 CA-C-O 118.546 -0.74 . . . . 73.2 111.071 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.57 -32.28 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 119.727 1.149 . . . . 72.2 110.619 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.6 t -70.63 -32.58 69.95 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.522 0.329 . . . . 62.52 110.597 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.653 ' HA ' ' HD2' ' A' ' 132' ' ' ARG . 37.8 tp -76.03 -40.43 53.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.004 0.922 . . . . 65.04 111.174 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.621 HD22 ' HZ ' ' A' ' 88' ' ' PHE . 47.6 mt -77.65 1.7 18.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.1 0.96 . . . . 75.32 111.142 -170.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.23 130.04 39.36 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.364 -1.347 . . . . 74.13 107.364 168.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 50.3 mtmt -68.06 -6.46 22.84 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.467 0.914 . . . . 64.45 113.467 -173.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 22.7 t70 -68.52 -30.34 69.13 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.763 0.825 . . . . 63.2 109.764 171.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.653 ' HD2' ' HA ' ' A' ' 127' ' ' LEU . 42.6 mtt180 -81.34 -33.2 32.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.992 -0.443 . . . . 65.33 110.515 171.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.625 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.1 m-85 -67.0 -20.23 65.85 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.549 0.739 . . . . 73.41 111.866 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 131' ' ' ASP . 24.3 pttm -61.98 -30.9 71.24 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.582 0.551 . . . . 72.14 110.577 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -127.56 25.5 6.06 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.332 1.053 . . . . 74.11 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.625 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 24.2 mt -100.27 144.28 29.47 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.585 0.707 . . . . 73.32 111.341 168.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.4 121.06 15.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.523 -1.658 . . . . 74.02 106.523 167.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.464 ' HB3' HG11 ' A' ' 153' ' ' VAL . 66.4 m-85 -93.57 134.31 35.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.747 -0.464 . . . . 72.53 109.747 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.06 140.96 50.77 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 75.43 109.452 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.4 tt -120.89 159.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.994 -1.484 . . . . 74.01 106.994 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.23 129.72 49.9 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.177 -0.791 . . . . 51.33 111.53 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.29 -41.49 79.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.526 0.731 . . . . 72.33 110.049 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -69.51 -38.55 77.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.861 -1.063 . . . . 71.5 110.666 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.34 -31.44 72.57 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.448 0.699 . . . . 55.22 110.58 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 5.43 12.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.711 0.804 . . . . 71.34 112.049 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.83 -10.28 45.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 64.14 110.403 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.62 -55.51 0.01 OUTLIER Glycine 0 C--N 1.352 1.42 0 N-CA-C 112.016 -0.433 . . . . 72.21 112.016 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.82 83.31 2.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.452 0.701 . . . . 74.13 110.649 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.92 -2.23 50.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.124 0.97 . . . . 74.52 111.22 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.11 78.75 1.83 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.208 -1.775 . . . . 70.01 106.208 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -123.89 -166.58 12.56 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-N 113.797 -1.547 . . . . 21.21 111.733 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.404 HE21 HD22 ' A' ' 171' ' ' LEU . 53.8 tt0 -101.58 142.1 33.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.002 -0.74 . . . . 61.53 109.002 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 138' ' ' PHE . 75.8 t -109.4 131.92 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.259 0.624 . . . . 74.23 112.058 -171.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.406 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.67 109.53 4.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.265 -1.334 . . . . 75.24 109.558 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 71.5 mt -85.56 105.5 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.966 -0.753 . . . . 73.14 108.966 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 169' ' ' LEU . 40.9 mm -103.58 119.61 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.008 -0.738 . . . . 72.21 109.008 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.405 ' HB3' HD23 ' A' ' 136' ' ' LEU . 12.1 pt-20 -124.94 127.81 47.64 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.827 0.346 . . . . 74.34 110.482 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -75.97 110.63 10.6 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 115.106 -0.952 . . . . 73.21 109.341 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.514 ' HB2' HG13 ' A' ' 166' ' ' VAL . 22.6 mmt85 -101.86 172.8 6.72 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.357 -0.979 . . . . 73.44 108.357 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -122.58 119.06 29.71 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.128 0.571 . . . . 73.33 110.603 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.73 118.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.021 0.528 . . . . 62.42 109.903 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 67.83 -67.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.899 1.68 . . . . 71.12 110.9 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.79 35.68 0.11 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.211 -0.756 . . . . 63.12 111.211 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.6 t -141.86 158.17 44.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.088 0.555 . . . . 52.44 110.863 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -78.75 114.46 17.69 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.748 0.819 . . . . 71.04 111.103 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 159' ' ' ARG . 5.8 p -117.73 89.14 32.33 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 109.11 -0.7 . . . . 74.24 109.11 175.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.789 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.3 Cg_endo -82.61 122.53 3.56 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 122.342 2.028 . . . . 64.31 110.159 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -105.42 140.0 39.2 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.727 0.811 . . . . 71.44 109.73 -168.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 156' ' ' ILE . 30.8 tp -82.36 123.34 29.01 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.917 0.76 . . . . 53.42 109.635 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.99 123.09 48.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.945 0.898 . . . . 63.51 108.882 174.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.472 HD13 HD11 ' A' ' 176' ' ' ILE . 79.7 mt -140.97 145.51 36.09 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.987 -1.486 . . . . 72.51 106.987 172.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.519 HG11 HG11 ' A' ' 99' ' ' VAL . 7.1 p -76.76 134.88 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 109.427 -0.583 . . . . 73.34 109.427 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -56.75 -36.76 70.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.511 1.124 . . . . 71.01 111.871 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -68.48 -25.91 65.21 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.901 0.881 . . . . 52.22 112.5 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.444 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -97.59 -1.91 42.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.816 0.446 . . . . 72.34 110.336 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.472 HD11 HD13 ' A' ' 171' ' ' LEU . 48.9 mm -102.55 132.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.362 -0.977 . . . . 72.21 108.362 174.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 44.3 mm -93.22 111.8 25.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.302 -0.999 . . . . 74.41 108.302 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.35 104.34 6.82 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.402 -0.962 . . . . 75.24 108.402 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.7 tp10 -104.04 111.06 23.47 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.966 -1.124 . . . . 72.04 107.966 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.44 129.66 34.68 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.806 -0.442 . . . . 73.03 109.806 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.4 t -100.81 104.35 15.59 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.734 -0.667 . . . . 65.21 110.417 -171.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.35 161.66 26.51 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.285 1.034 . . . . 64.42 109.399 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 C--O 1.252 1.219 0 CA-C-N 115.104 -0.953 . . . . 73.42 108.553 178.272 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.067 0.46 . . . . 71.43 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.2 mt -84.33 123.82 30.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.849 -0.797 . . . . 61.45 108.849 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.504 HG22 ' HB3' ' A' ' 15' ' ' SER . 33.3 pt -99.39 128.58 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.535 0.734 . . . . 71.2 109.251 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.501 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 12.9 m-85 -122.95 124.22 42.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.947 1.299 . . . . 74.25 107.807 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 23.3 pttm -145.85 147.12 31.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.083 0.856 . . . . 74.24 112.239 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 14.9 t70 -101.25 124.08 46.39 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.899 0.88 . . . . 70.22 109.996 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' A' ' 175' ' ' ALA . 43.4 pt -66.56 -26.85 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.68 0.622 . . . . 63.04 112.68 -164.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.61 -60.97 2.11 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.293 0.568 . . . . 74.52 111.587 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 m -125.53 -46.48 1.75 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.91 -1.041 . . . . 74.4 111.737 -159.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 2.8 t0 -101.4 24.05 10.17 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.99 0.916 . . . . 74.02 110.486 -166.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 5.6 p-10 -50.81 -2.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.016 2.228 . . . . 72.05 117.016 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -99.59 -41.52 7.3 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.645 1.111 . . . . 75.03 109.86 167.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 26.6 tp 36.51 -88.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.79 2.036 . . . . 72.22 113.655 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.401 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 73.5 m -157.3 134.48 10.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.802 0.841 . . . . 74.24 109.477 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.504 ' HB3' HG22 ' A' ' 3' ' ' ILE . 50.4 m -130.73 97.93 4.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.487 0.715 . . . . 74.44 109.149 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HB3' ' HE1' ' A' ' 18' ' ' PHE . 24.3 t70 -166.52 -90.64 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.185 0.594 . . . . 73.24 110.258 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 m -170.2 78.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.463 1.105 . . . . 61.13 108.874 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.452 ' HE1' ' HB3' ' A' ' 16' ' ' ASP . 53.9 m-85 -112.43 139.12 22.26 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.744 0.817 . . . . 73.43 110.213 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HD2' ' HE1' ' A' ' 30' ' ' PHE . 57.9 Cg_exo -53.8 117.57 4.0 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.202 1.935 . . . . 74.12 111.495 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.92 134.26 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.364 -0.835 . . . . 74.42 109.507 -172.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 39.1 ttmt -137.2 140.17 41.57 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.738 -1.208 . . . . 52.34 107.738 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 tp -131.75 108.07 9.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.831 -1.174 . . . . 74.15 107.831 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.35 133.64 42.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.848 0.859 . . . . 71.5 110.017 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.92 14.65 4.41 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.749 1.22 . . . . 42.45 112.763 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.7 t70 58.23 10.36 1.25 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.641 1.177 . . . . 73.35 111.987 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 119' ' ' LYS . 51.8 tp -103.9 -47.1 4.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.01 0.924 . . . . 70.0 111.333 -167.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -126.93 131.54 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 115.835 -0.621 . . . . 63.04 110.077 -172.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.45 ' HB2' HG21 ' A' ' 176' ' ' ILE . 82.1 t80 -85.24 135.11 34.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.41 1.084 . . . . 72.23 108.439 169.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 32.5 tt0 -117.98 144.99 45.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.362 0.665 . . . . 74.23 109.286 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.615 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.5 t80 -131.97 138.45 48.3 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.91 1.284 . . . . 72.24 107.683 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.33 153.94 39.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.647 0.379 . . . . 62.12 110.714 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.1 159.72 30.61 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.977 -0.556 . . . . 63.23 112.124 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -134.83 138.88 44.62 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.01 0.924 . . . . 74.44 109.244 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -70.57 120.46 16.23 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.543 -1.28 . . . . 73.52 107.543 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.84 -178.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.477 0.711 . . . . 72.13 109.941 -168.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.9 156.05 42.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.305 1.042 . . . . 62.23 108.578 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 38.1 ttm180 -140.06 132.64 28.74 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.282 0.563 . . . . 72.31 109.977 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.585 ' HD2' ' HB2' ' A' ' 41' ' ' GLU . 65.0 mttp -133.38 156.17 48.14 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.142 1.377 . . . . 73.03 107.456 164.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.09 -38.62 83.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 75.4 112.019 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.85 -44.04 1.58 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.951 -0.568 . . . . 75.43 113.16 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.585 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 24.6 mm-40 -95.9 163.35 13.19 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.296 0.638 . . . . 71.22 111.836 -171.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 tp . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 124.889 1.276 . . . . 62.32 108.407 178.467 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.511 HG22 ' HE3' ' A' ' 38' ' ' LYS . 37.7 t . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 108.894 -0.78 . . . . 73.04 108.894 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 9.4 mp0 -75.27 73.91 2.38 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.977 -1.49 . . . . 73.04 106.977 171.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -92.22 135.5 33.95 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.846 -1.07 . . . . 74.25 110.693 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.44 -154.43 25.52 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.836 -1.306 . . . . 73.02 109.836 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -94.62 153.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.684 0.742 . . . . 73.43 111.496 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -42.88 -46.66 5.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.888 1.675 . . . . 65.54 113.097 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.583 HD13 ' HB2' ' A' ' 169' ' ' LEU . 45.1 mt -60.42 -47.97 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.919 1.288 . . . . 73.11 110.877 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -72.83 -42.56 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 114.604 -1.18 . . . . 74.43 112.195 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.49 -36.27 80.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.917 0.487 . . . . 60.11 110.768 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -59.58 -61.97 2.23 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.364 0.666 . . . . 45.3 110.634 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.476 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 59.6 t-80 -81.57 -17.7 47.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.264 -0.426 . . . . 71.42 112.1 -170.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 64.37 61.12 0.89 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.736 1.255 . . . . 74.4 108.427 -167.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 95.7 mt -82.07 133.46 35.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.066 -1.424 . . . . 74.43 109.399 174.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.701 HG11 ' HB2' ' A' ' 145' ' ' ALA . 7.3 p -91.93 138.38 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.325 0.65 . . . . 74.12 109.386 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.33 147.41 53.0 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.994 0.902 . . . . 72.45 111.519 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -132.64 103.12 5.97 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 103.081 -2.933 . . . . 72.03 103.081 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 12.2 t-20 -69.14 116.54 9.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.515 1.126 . . . . 72.4 111.104 -172.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 26.5 p -63.99 -28.77 70.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.59 0.756 . . . . 74.51 111.843 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -73.3 -58.89 2.99 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.493 -1.231 . . . . 61.44 112.157 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -103.51 -6.73 21.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.922 0.712 . . . . 71.53 112.922 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 16.1 m-20 -121.2 22.69 10.81 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.647 0.779 . . . . 74.42 111.266 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.56 -35.21 40.17 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.835 0.854 . . . . 74.15 112.399 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.6 m -64.11 -38.27 90.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.442 0.697 . . . . 62.13 111.353 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 mtt -60.18 -45.84 91.74 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.627 -0.508 . . . . 75.34 109.627 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 46.1 t80 -63.09 -35.42 80.19 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.889 0.743 . . . . 73.11 111.245 -176.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.9 -25.34 55.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.196 0.598 . . . . 71.21 111.47 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.29 -45.89 75.23 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 109.576 -0.527 . . . . 70.03 109.576 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 76.4 m-85 -54.15 -54.54 38.27 Favored 'General case' 0 C--O 1.202 -1.444 0 CA-C-N 114.71 -1.132 . . . . 73.12 109.473 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.02 -42.46 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.093 0.957 . . . . 54.13 112.088 -172.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -59.75 -55.64 31.76 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 122.442 0.297 . . . . 64.42 111.167 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -37.78 76.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 123.526 0.516 . . . . 74.3 110.386 -174.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -55.95 -57.01 13.91 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.838 1.655 . . . . 74.45 111.434 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.4 ttm -67.86 -40.09 83.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.847 0.717 . . . . 44.02 111.56 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -61.7 -44.68 96.47 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.376 0.422 . . . . 71.45 110.323 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -70.6 -45.2 65.75 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 124.16 0.913 . . . . 64.14 111.235 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.56 -40.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.202 0.314 . . . . 74.51 111.758 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.8 mt -73.43 -39.47 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 117.983 0.356 . . . . 70.11 110.746 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.19 -38.72 85.86 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.709 0.804 . . . . 74.55 110.974 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.87 -44.78 54.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.562 -0.744 . . . . 73.41 110.129 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.542 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -58.61 -40.37 83.08 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.642 0.777 . . . . 70.23 109.735 177.102 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.482 ' HA ' HG11 ' A' ' 113' ' ' VAL . 40.9 tt0 -65.7 -29.73 70.32 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.302 1.041 . . . . 74.44 111.374 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -75.1 -40.15 60.15 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.335 0.654 . . . . 72.3 110.131 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -73.2 -34.52 66.01 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.22 1.008 . . . . 72.14 111.86 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.59 -45.96 5.35 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.868 0.867 . . . . 53.41 111.639 -171.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 77.82 -17.17 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.241 1.416 . . . . 71.15 112.532 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 113' ' ' VAL . 23.9 t70 -96.6 126.27 41.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.13 109.657 -174.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -77.65 -27.15 50.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.161 0.584 . . . . 75.4 112.118 -174.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.56 89.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.731 0.412 . . . . 72.22 111.804 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -85.6 -33.54 21.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.629 0.772 . . . . 75.35 111.354 -174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.542 HG12 ' SD ' ' A' ' 103' ' ' MET . 16.9 m -78.99 -28.07 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 117.944 0.338 . . . . 42.01 111.833 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.99 -42.13 85.6 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.888 0.475 . . . . 73.54 109.84 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.39 -45.86 78.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.593 -0.73 . . . . 50.21 110.052 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.426 ' HZ ' ' HB2' ' A' ' 174' ' ' GLU . 81.1 t80 -56.31 -45.83 80.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.437 1.095 . . . . 71.24 111.119 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -57.35 -47.86 80.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 72.44 110.667 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -69.04 -26.53 65.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.703 0.801 . . . . 62.32 111.411 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HB3' HD22 ' A' ' 26' ' ' LEU . 32.5 mmtp -78.14 -35.51 48.88 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.344 0.658 . . . . 71.24 110.644 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.2 mm -69.66 -44.22 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.635 0.374 . . . . 50.44 110.046 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -58.42 -46.53 86.29 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.96 0.904 . . . . 74.33 109.614 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.39 99.22 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 124.194 0.934 . . . . 65.33 112.925 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -64.62 -51.51 62.29 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.301 0.64 . . . . 75.14 110.174 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.9 m -70.99 -41.22 76.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 0 CA-C-O 118.309 -0.853 . . . . 73.53 111.096 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.41 -33.04 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 119.486 1.039 . . . . 73.02 110.218 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.2 t -72.3 -42.15 65.81 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.437 0.695 . . . . 64.43 110.616 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' HA ' ' HG3' ' A' ' 132' ' ' ARG . 34.8 tp -79.09 -20.05 49.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.432 1.093 . . . . 51.11 111.952 -173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -83.39 4.07 29.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.005 0.922 . . . . 64.01 112.206 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.32 38.98 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.009 0.524 . . . . 74.31 110.723 172.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 4.3 ttpm? -62.33 -45.03 95.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.027 0.931 . . . . 71.23 112.289 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.53 -24.49 64.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.146 0.578 . . . . 64.44 111.425 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.582 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 30.0 mmt180 -68.72 -54.49 15.82 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.059 -0.719 . . . . 72.22 109.059 170.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.608 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.0 m-85 -59.92 -22.5 62.5 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.416 1.086 . . . . 75.12 113.783 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -66.64 -27.84 68.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 61.33 110.137 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -115.78 0.08 13.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.35 0.66 . . . . 72.32 111.263 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 60.8 mt -89.36 132.38 34.98 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.58 0.627 . . . . 71.24 109.677 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.51 117.03 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.225 -2.139 . . . . 64.42 105.225 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.543 ' HB3' HG11 ' A' ' 153' ' ' VAL . 33.6 m-85 -90.36 143.45 26.75 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.759 -0.83 . . . . 71.13 108.759 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.606 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 82.9 m-85 -140.7 152.93 45.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.138 0.575 . . . . 73.22 110.598 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.0 pt -144.89 172.96 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.05 1.34 . . . . 72.4 107.635 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.86 134.23 51.08 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.708 -1.051 . . . . 74.31 111.103 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -40.65 -48.14 2.88 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.337 1.236 . . . . 74.34 114.337 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -64.02 -28.56 69.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.835 0.854 . . . . 51.35 112.543 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.46 -14.46 62.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.683 0.793 . . . . 74.22 111.999 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.701 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -75.36 -2.92 30.68 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.229 0.611 . . . . 53.2 112.313 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -81.47 -33.12 32.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 74.35 110.137 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.11 -2.06 0.03 OUTLIER Glycine 0 C--N 1.357 1.727 0 N-CA-C 115.834 1.094 . . . . 65.1 115.834 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.12 75.11 9.49 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.717 1.258 . . . . 64.43 110.725 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.401 ' HG3' ' ND2' ' A' ' 150' ' ' ASN . 11.3 pt-20 -88.56 -0.53 57.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.245 1.018 . . . . 74.12 111.479 175.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 149' ' ' GLU . 47.1 m-80 -130.61 79.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.22 -1.03 . . . . 72.41 108.22 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -147.72 -148.55 4.77 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.067 -1.213 . . . . 51.04 110.067 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.96 152.92 22.1 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.328 -0.99 . . . . 63.44 108.328 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 138' ' ' PHE . 93.8 t -113.25 132.16 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.755 0.822 . . . . 51.24 110.445 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.74 101.38 3.67 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.338 -0.986 . . . . 72.41 108.338 166.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 127' ' ' LEU . 67.1 mt -89.54 120.35 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.632 -0.507 . . . . 64.53 109.632 -170.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.4 mm -105.63 119.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.839 0.455 . . . . 71.01 110.488 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -103.88 111.7 24.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.76 1.224 . . . . 64.54 109.48 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -75.61 89.82 2.77 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.443 -0.947 . . . . 71.02 108.443 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -89.61 164.67 14.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.217 1.007 . . . . 74.42 109.332 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -122.51 115.2 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.197 0.599 . . . . 74.32 110.151 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -120.43 97.88 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.821 0.849 . . . . 64.44 109.585 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 65.56 11.59 7.57 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.089 1.356 . . . . 54.41 112.583 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 118.85 -14.33 11.43 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.748 -0.473 . . . . 63.31 113.039 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.7 m -88.7 111.49 22.02 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 117.23 0.515 . . . . 72.24 109.804 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.68 114.39 9.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.289 -0.869 . . . . 64.43 109.167 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.423 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 13.2 m -123.5 98.16 41.23 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.746 1.218 . . . . 75.01 110.004 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 166' ' ' VAL . 38.7 Cg_endo -65.62 112.8 2.28 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.478 2.119 . . . . 71.0 111.163 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 p -113.96 134.19 54.99 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.141 0.976 . . . . 70.35 109.375 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 39.3 tp -77.33 140.91 40.09 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.493 0.717 . . . . 62.21 109.621 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 25.3 ptp -131.85 129.36 40.31 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 108.124 -1.065 . . . . 72.24 108.124 169.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -130.96 137.44 49.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.803 1.641 . . . . 74.42 106.903 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 174' ' ' GLU . 7.6 p -72.12 143.14 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.419 0.287 . . . . 70.34 111.455 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -32.6 -50.35 0.25 Allowed 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 126.951 2.1 . . . . 74.31 113.397 171.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.458 ' H ' HG22 ' A' ' 172' ' ' VAL . 1.4 tm-20 -68.85 -38.94 80.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.57 -1.195 . . . . 53.35 110.455 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.595 ' HA ' HG12 ' A' ' 7' ' ' ILE . . . -98.06 -6.46 31.74 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.99 -0.528 . . . . 31.11 111.123 -172.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.45 HG21 ' HB2' ' A' ' 28' ' ' TYR . 8.6 tp -108.41 136.64 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.767 -1.198 . . . . 73.51 107.767 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.0 mm -125.81 118.37 51.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.401 -1.703 . . . . 74.31 106.401 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.69 123.54 42.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.788 -1.19 . . . . 73.24 107.788 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -141.2 149.49 41.47 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.501 0.72 . . . . 72.14 109.274 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -98.7 96.82 8.18 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.231 -0.655 . . . . 50.24 109.231 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.59 93.92 4.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.294 0.638 . . . . 75.22 110.763 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 117.25 17.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.555 0.742 . . . . 62.3 109.201 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 . . . . . 0 CA--C 1.554 1.109 0 CA-C-O 118.909 -0.567 . . . . 64.01 110.076 175.818 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 17' ' ' SER . 22.4 mmt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 110.031 -0.359 . . . . 73.11 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.11 135.13 51.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.026 0.531 . . . . 62.53 109.656 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 5.1 tt -95.14 120.21 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.23 -0.656 . . . . 72.21 109.23 173.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.541 ' HB3' HD11 ' A' ' 176' ' ' ILE . 27.2 m-85 -105.92 125.99 51.65 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.389 -1.337 . . . . 71.11 107.389 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.586 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 48.5 pttt -151.25 159.52 44.32 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 123.559 0.537 . . . . 64.01 111.909 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 8.3 t70 -87.23 144.87 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.86 -0.793 . . . . 72.24 108.86 173.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 pt -66.63 -11.56 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 113.218 0.822 . . . . 55.3 113.218 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.17 -59.46 1.85 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.77 0.714 . . . . 72.34 112.527 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -125.99 -32.54 2.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.745 1.387 . . . . 63.0 114.745 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.608 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 19.0 m-20 -81.85 21.88 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.798 0.726 . . . . 75.23 111.539 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 7.5 m-20 -48.45 -20.99 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.305 1.224 . . . . 71.41 114.305 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.78 28.11 9.02 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 123.829 0.851 . . . . 61.42 110.212 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 41.3 tp -57.42 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.784 1.234 . . . . 62.11 112.107 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.7 m -155.62 126.74 7.1 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.83 -0.433 . . . . 72.43 109.83 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 29.2 p -133.77 102.03 5.31 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.064 0.546 . . . . 72.33 109.895 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -172.67 -176.35 1.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.038 -1.097 . . . . 74.04 108.038 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.409 ' N ' ' SD ' ' A' ' 1' ' ' MET . 58.9 m -79.71 84.88 5.47 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.425 -0.954 . . . . 64.33 108.425 172.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB2' ' HE2' ' A' ' 4' ' ' TYR . 73.6 m-85 -102.25 129.74 25.6 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.581 -0.896 . . . . 74.11 108.581 175.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 11.9 Cg_endo -56.19 122.07 11.13 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.026 2.484 . . . . 54.44 112.429 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.4 mtm -83.82 144.14 29.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.307 -0.861 . . . . 75.41 109.9 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -143.06 101.74 3.88 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.249 -1.389 . . . . 72.52 107.249 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.5 tp -103.67 126.43 50.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.502 0.721 . . . . 70.33 109.358 -174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.7 129.19 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.264 0.626 . . . . 52.33 109.8 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 64.48 12.0 7.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.659 1.183 . . . . 73.34 113.454 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 55.59 11.17 0.59 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.362 1.065 . . . . 44.55 113.102 -166.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.4 tp -105.66 -44.19 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.08 0.952 . . . . 73.1 110.394 -168.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.56 130.01 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.283 -0.871 . . . . 74.55 109.473 -171.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -90.21 117.59 29.08 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.692 -0.855 . . . . 70.22 108.692 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -92.75 126.34 37.78 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.158 0.983 . . . . 72.21 109.627 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 80.3 t80 -107.52 127.92 54.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.852 1.261 . . . . 73.03 108.024 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' ' HG2' ' A' ' 19' ' ' PRO . 72.4 mmtt -68.23 145.23 54.48 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 75.04 111.916 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.27 162.24 35.14 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.608 0.568 . . . . 64.23 112.021 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.38 142.96 50.68 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.027 0.931 . . . . 72.14 109.138 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -67.91 117.54 9.92 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.115 -0.698 . . . . 73.02 109.115 173.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.41 162.93 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.521 0.728 . . . . 61.13 110.626 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.56 131.89 72.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 108.64 -0.874 . . . . 70.42 108.64 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 73.2 mtp180 -105.31 108.13 19.48 Favored 'General case' 0 C--O 1.255 1.38 0 N-CA-C 108.504 -0.924 . . . . 73.41 108.504 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.501 ' NZ ' HG22 ' A' ' 64' ' ' VAL . 62.9 mmtt -134.3 148.37 50.76 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.099 1.759 . . . . 73.53 108.415 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.06 -7.08 43.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.936 0.894 . . . . 71.41 112.014 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.52 33.44 0.32 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.086 0.394 . . . . 61.42 114.086 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 39.7 tt0 -156.52 141.47 17.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.555 -0.535 . . . . 65.25 109.555 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 CA--C 1.563 1.474 0 CA-C-O 121.893 0.854 . . . . 74.5 110.423 -170.194 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.501 HG22 ' NZ ' ' A' ' 38' ' ' LYS . 12.7 t . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 107.897 -1.149 . . . . 74.42 107.897 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.2 mm-40 -98.72 66.78 1.67 Allowed 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.597 0.713 . . . . 71.52 109.16 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -89.15 143.38 26.88 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.609 -0.723 . . . . 61.03 110.006 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.07 -133.01 3.85 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.508 -1.037 . . . . 63.43 110.508 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.469 HD11 HD12 ' A' ' 156' ' ' ILE . 4.7 pt -111.26 154.08 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 122.508 0.323 . . . . 73.13 110.858 172.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.59 -39.23 73.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.454 1.101 . . . . 73.14 113.099 -173.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.04 -48.88 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.99 0.916 . . . . 71.42 110.527 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 76' ' ' LEU . 55.0 t -67.85 -43.48 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 114.999 -1.0 . . . . 74.44 111.099 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 75.9 mt -72.76 -21.97 60.92 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.183 0.593 . . . . 63.42 111.841 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -70.71 -53.59 15.05 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.362 0.665 . . . . 54.43 109.511 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -86.55 -21.14 27.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.19 0.596 . . . . 75.35 111.101 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? 65.67 71.13 0.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.871 1.268 . . . . 72.3 109.727 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 91.1 mt -91.44 145.68 24.43 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.969 -1.014 . . . . 74.44 110.151 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 129.17 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.564 0.746 . . . . 61.43 109.855 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.77 153.56 32.44 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.615 0.969 . . . . 72.34 113.615 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.408 ' HE3' ' HB2' ' A' ' 79' ' ' MET . 40.6 ttm -150.16 112.11 4.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.799 2.039 . . . . 71.42 106.078 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.66 152.33 29.12 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.979 0.809 . . . . 72.2 111.702 -172.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.546 ' SG ' ' HE2' ' A' ' 138' ' ' PHE . 85.6 m -65.96 -16.63 64.05 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.402 0.89 . . . . 51.11 113.402 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -71.3 -55.23 8.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.973 0.509 . . . . 74.51 110.367 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.36 -40.63 5.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.231 0.612 . . . . 62.33 112.061 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.83 20.55 3.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.628 0.771 . . . . 65.54 112.854 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.77 85.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.293 0.637 . . . . 75.51 112.29 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -77.35 -31.31 54.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.348 0.659 . . . . 63.21 111.711 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.9 mmt -64.42 -50.92 65.71 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.319 -0.622 . . . . 35.51 109.319 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.86 -23.41 62.31 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.141 -0.936 . . . . 73.22 110.725 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -68.97 -37.64 78.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.291 0.636 . . . . 75.03 109.93 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.4 83.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.18 0.592 . . . . 72.11 110.238 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -69.39 -32.9 72.21 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 123.409 0.684 . . . . 73.34 112.499 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mm -65.87 -33.6 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 117.898 0.317 . . . . 55.11 110.644 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -63.11 -45.65 91.03 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 122.314 0.246 . . . . 55.11 110.571 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -61.6 -54.45 42.85 Favored 'General case' 0 C--N 1.36 1.058 0 N-CA-C 109.227 -0.657 . . . . 72.05 109.227 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.507 ' HD2' ' HG2' ' A' ' 152' ' ' GLN . 60.1 t80 -44.4 -68.53 0.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.792 2.037 . . . . 60.32 111.603 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 40.9 ttp -57.35 -50.38 73.13 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 124.127 0.971 . . . . 74.45 111.595 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -56.82 -50.04 73.59 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.111 0.882 . . . . 63.11 110.537 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -71.93 -48.01 48.41 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.74 -0.664 . . . . 75.33 111.604 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.599 HG11 HG11 ' A' ' 172' ' ' VAL . 23.8 m -66.25 -38.9 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 112.396 0.517 . . . . 40.02 112.396 -172.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.0 mt -77.91 -42.14 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 120.439 0.161 . . . . 70.32 110.921 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.05 -45.41 85.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.617 0.767 . . . . 73.34 111.355 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -67.14 -40.26 86.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.15 0.58 . . . . 62.14 109.959 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.36 -51.48 69.76 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 123.842 0.714 . . . . 73.23 110.62 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.81 -23.66 66.74 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.291 0.637 . . . . 75.35 111.257 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 31.8 ttmt -75.07 -24.47 58.21 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.338 0.655 . . . . 64.54 110.87 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -114.5 -13.39 12.2 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.2 0.6 . . . . 72.23 112.18 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -100.74 -46.06 5.28 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.717 0.807 . . . . 74.14 109.399 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 66.29 18.29 10.88 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.068 1.347 . . . . 74.51 113.144 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.18 111.13 19.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.64 -1.245 . . . . 62.03 107.64 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -69.5 -29.69 67.38 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.595 0.559 . . . . 75.44 111.632 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.34 -32.15 66.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 60.45 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.22 -47.55 56.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.686 0.794 . . . . 72.45 109.492 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.7 m -79.28 -17.82 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 115.237 -0.892 . . . . 73.01 111.935 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.08 -35.35 74.13 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.013 -0.736 . . . . 72.31 109.013 170.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.31 73.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.192 -0.913 . . . . 72.24 110.09 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -62.25 -41.61 98.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.0 0.52 . . . . 73.22 110.391 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.404 ' HA ' HG22 ' A' ' 120' ' ' ILE . 37.5 ttpt -62.24 -34.86 77.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.598 0.759 . . . . 74.43 110.589 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -66.4 -43.25 86.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.51 -0.768 . . . . 71.01 110.411 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -46.76 71.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.781 -0.645 . . . . 73.44 111.441 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 117' ' ' LYS . 9.0 tp -78.96 -33.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.606 0.363 . . . . 61.11 110.944 -168.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -41.06 95.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.082 -1.081 . . . . 72.0 108.082 171.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.8 -40.98 97.4 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.832 0.708 . . . . 63.04 113.013 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -67.88 -48.0 67.29 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 122.656 0.382 . . . . 71.34 111.003 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 31.4 m -70.5 -38.37 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 118.997 -0.525 . . . . 55.32 111.796 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.39 -32.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 118.683 0.674 . . . . 73.52 110.194 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -69.43 -42.03 75.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.453 0.701 . . . . 74.31 110.581 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 155' ' ' ILE . 14.4 tp -74.8 -30.89 61.56 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.247 1.019 . . . . 64.24 111.076 -170.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 86.5 mt -86.09 1.93 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.923 0.889 . . . . 65.01 110.78 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.04 67.03 8.94 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 122.08 0.943 . . . . 72.03 108.701 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.74 -6.22 30.48 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 114.191 -1.368 . . . . 55.55 113.593 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.73 -33.76 74.62 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.25 0.62 . . . . 64.22 110.449 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -105.44 -39.18 6.22 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.429 1.092 . . . . 71.33 109.527 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -80.33 0.67 31.98 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.112 1.365 . . . . 72.15 114.203 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -14.6 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 N-CA-C 114.288 1.218 . . . . 75.02 114.288 175.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.426 ' ND2' ' HG3' ' A' ' 157' ' ' GLU . 4.9 p-10 -79.44 13.63 1.9 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.026 0.93 . . . . 74.21 112.024 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.26 146.47 24.2 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.496 0.719 . . . . 73.54 109.425 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -139.06 112.49 8.21 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.72 -1.956 . . . . 74.43 105.72 169.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.641 ' HB3' HG11 ' A' ' 153' ' ' VAL . 37.1 m-85 -85.75 145.24 27.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.445 -0.946 . . . . 73.33 108.445 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 69.5 m-85 -139.41 143.79 37.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.349 0.66 . . . . 73.35 109.461 -176.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.6 pt -131.51 177.01 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.615 -0.883 . . . . 73.33 108.615 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.56 120.94 23.66 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 123.656 0.597 . . . . 74.32 111.621 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.39 -36.17 61.15 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.864 1.266 . . . . 75.43 110.24 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.54 -45.85 71.08 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.878 -1.055 . . . . 71.32 111.298 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.456 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -65.63 -25.74 67.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.519 0.728 . . . . 74.52 111.947 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.24 -7.66 56.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.894 0.877 . . . . 65.31 112.239 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -85.28 -40.39 16.64 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.535 -0.543 . . . . 74.51 109.535 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.09 52.03 0.05 OUTLIER Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.996 -0.547 . . . . 61.22 112.489 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -145.35 -179.49 6.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.828 0.851 . . . . 52.0 109.592 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -119.99 121.63 39.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.878 0.871 . . . . 72.31 108.72 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -91.27 -26.68 18.87 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.756 -0.461 . . . . 61.32 109.756 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.73 -68.16 2.23 Favored Glycine 0 C--N 1.342 0.879 0 O-C-N 124.593 1.183 . . . . 70.23 113.656 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.507 ' HG2' ' HD2' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -100.47 133.16 45.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.247 -1.39 . . . . 75.53 107.247 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' ' 138' ' ' PHE . 71.5 t -94.02 141.63 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.768 0.827 . . . . 70.23 111.572 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.712 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -72.32 97.2 1.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.891 0.876 . . . . 34.0 109.6 169.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 127' ' ' LEU . 85.6 mt -89.84 104.65 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.342 -0.614 . . . . 71.03 109.342 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 68' ' ' ILE . 41.3 mm -93.59 125.63 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.039 -0.726 . . . . 74.12 109.039 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.426 ' HG3' ' ND2' ' A' ' 135' ' ' ASN . 21.7 tt0 -129.2 112.12 13.6 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.703 -0.851 . . . . 73.12 108.703 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.589 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 54.1 p90 -81.22 99.31 8.51 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 106.76 -1.57 . . . . 61.53 106.76 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -83.46 143.18 30.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.047 -0.979 . . . . 64.34 110.769 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.77 120.78 21.61 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.123 0.487 . . . . 64.42 109.718 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.11 95.37 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 125.336 1.454 . . . . 72.24 107.951 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.62 17.66 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.185 0.994 . . . . 72.53 112.11 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.31 6.93 47.18 Favored Glycine 0 C--N 1.353 1.521 0 C-N-CA 123.146 0.403 . . . . 75.11 113.545 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 m -111.94 156.42 22.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.242 1.017 . . . . 71.42 109.516 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 12.8 pt-20 -84.51 138.51 32.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.903 0.481 . . . . 75.41 110.156 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.54 99.37 18.98 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.783 0.833 . . . . 42.31 108.8 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.04 114.11 1.87 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.902 2.401 . . . . 74.2 113.195 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.3 p -115.75 121.23 41.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.875 0.87 . . . . 63.35 108.714 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 30.7 tp -76.76 107.4 9.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.467 -0.938 . . . . 51.41 108.467 172.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 73.7 mtp -94.96 122.69 37.86 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 107.875 -1.157 . . . . 63.12 107.875 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 154' ' ' ALA . 85.3 mt -134.7 145.04 48.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.558 1.543 . . . . 50.53 107.081 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.599 HG11 HG11 ' A' ' 99' ' ' VAL . 7.5 p -73.6 141.66 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.618 -0.882 . . . . 65.11 108.618 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.548 ' HA ' HG22 ' A' ' 176' ' ' ILE . 61.6 tttp -57.86 -30.02 65.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.004 0.922 . . . . 74.42 111.758 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.65 2.16 42.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.822 0.849 . . . . 65.14 112.267 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.98 -9.03 4.88 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.472 0.709 . . . . 73.43 111.375 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' A' ' 173' ' ' LYS . 8.6 tp -97.8 133.85 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 107.141 -1.429 . . . . 74.41 107.141 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.2 mm -104.57 110.53 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 106.864 -1.532 . . . . 61.53 106.864 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.89 90.31 3.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.012 1.325 . . . . 74.31 107.582 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' A' ' 3' ' ' ILE . 12.2 tp10 -106.13 144.02 33.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.817 -0.808 . . . . 61.42 108.817 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.571 ' HE2' HD11 ' A' ' 182' ' ' LEU . 13.8 ptmt -100.27 123.92 45.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.681 0.792 . . . . 72.34 110.134 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.26 87.4 7.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.597 -0.89 . . . . 73.45 108.597 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.571 HD11 ' HE2' ' A' ' 180' ' ' LYS . 82.8 mt -90.31 87.93 7.01 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.741 -0.837 . . . . 54.4 108.741 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 C--O 1.254 1.336 0 N-CA-C 107.263 -1.384 . . . . 71.42 107.263 178.956 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 86.1 mmm . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.701 0.286 . . . . 64.55 110.441 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.6 HD22 ' HA ' ' A' ' 180' ' ' LYS . 62.3 mt -120.52 155.74 32.99 Favored 'General case' 0 C--O 1.25 1.087 0 C-N-CA 123.781 0.832 . . . . 61.43 109.742 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 60.3 mt -96.85 120.25 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.373 -0.973 . . . . 60.33 108.373 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -110.33 99.41 8.44 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.265 -1.383 . . . . 75.52 107.265 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 10' ' ' ASP . 55.2 pttt -129.53 165.3 21.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.314 -0.403 . . . . 73.23 110.054 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 10.3 m-20 -85.89 -177.94 6.46 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.839 0.828 . . . . 74.21 110.207 174.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.6 mt -84.19 -24.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 114.87 -1.059 . . . . 62.31 110.041 157.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -107.11 -59.76 1.77 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.788 0.835 . . . . 73.24 112.267 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -96.82 17.56 16.42 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.013 0.925 . . . . 72.54 110.439 -174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 5.3 p-10 -52.42 -29.21 23.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.111 1.364 . . . . 72.24 113.212 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -48.62 72.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.765 1.291 . . . . 74.43 111.323 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -120.3 17.87 12.25 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.688 -0.687 . . . . 63.22 112.268 -168.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -78.23 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.261 0.937 . . . . 74.1 109.176 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -143.78 122.79 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 120.741 1.61 . . . . 73.51 112.617 -168.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.52 ' HB3' HG23 ' A' ' 3' ' ' ILE . 35.7 p -116.12 104.87 11.98 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.865 0.866 . . . . 63.34 108.995 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 1' ' ' MET . 37.4 t70 -160.64 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 110.141 -0.318 . . . . 63.03 110.141 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.9 p -127.69 71.5 1.36 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.027 -0.731 . . . . 70.12 109.027 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -120.67 93.9 48.68 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.004 -0.739 . . . . 61.44 109.004 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.54 135.74 66.58 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.638 2.225 . . . . 53.54 111.622 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.448 ' SD ' ' HE3' ' A' ' 180' ' ' LYS . 24.2 ptt? -83.48 138.98 33.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.928 -0.767 . . . . 74.22 108.928 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -152.4 122.74 7.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.035 -1.098 . . . . 74.42 108.035 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -130.64 122.89 28.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.64 0.776 . . . . 71.4 109.039 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.13 142.86 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.322 0.649 . . . . 73.55 110.327 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 59.39 8.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.34 1.456 . . . . 61.42 113.515 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 51.72 39.28 25.01 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.243 1.017 . . . . 72.4 110.587 -168.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.0 tp -134.99 -51.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.794 . . . . 71.25 110.532 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.28 125.9 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.58 0.752 . . . . 63.43 110.299 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -83.6 119.96 25.37 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.981 -1.118 . . . . 74.42 107.981 171.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 6.7 pt-20 -111.51 141.65 44.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.176 0.591 . . . . 65.23 109.833 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.43 ' HD1' HD11 ' A' ' 70' ' ' ILE . 33.2 t80 -136.76 140.28 42.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.997 -1.112 . . . . 74.04 107.997 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.8 97.05 8.96 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.088 0.555 . . . . 72.24 110.061 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.98 130.6 11.6 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.942 -0.572 . . . . 63.02 111.706 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -97.62 124.04 41.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.367 0.583 . . . . 70.1 109.454 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -64.72 114.27 4.33 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 108.783 -0.821 . . . . 73.4 108.783 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.515 HG23 HD12 ' A' ' 72' ' ' LEU . 15.4 m -148.47 161.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.208 1.003 . . . . 55.12 108.88 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.42 143.78 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.183 -1.043 . . . . 64.22 108.183 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -91.74 116.08 28.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.404 -1.702 . . . . 73.15 106.404 169.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -119.46 145.48 46.25 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.87 -1.53 . . . . 71.02 106.87 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -62.8 89.02 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.432 0.634 . . . . 72.15 111.548 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.32 52.02 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 114.639 -1.164 . . . . 62.23 113.998 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -159.85 -174.59 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.899 0.48 . . . . 72.14 110.757 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tt . . . . . 0 N--CA 1.469 0.476 0 C-N-CA 123.687 0.795 . . . . 73.33 109.483 176.99 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 31.7 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 107.852 -1.166 . . . . 75.33 107.852 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 39.5 mt-10 -75.32 77.18 2.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.718 -1.216 . . . . 72.23 107.718 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -76.59 135.63 39.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.89 -1.05 . . . . 72.11 110.545 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.44 -136.84 4.53 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.443 -0.663 . . . . 63.34 111.443 173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 pt -110.22 155.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.509 0.324 . . . . 75.02 110.779 172.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.75 -39.27 70.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.382 1.073 . . . . 74.52 112.391 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.43 HD11 ' HD1' ' A' ' 30' ' ' PHE . 41.3 mt -55.29 -44.87 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 124.104 0.962 . . . . 73.42 110.47 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.74 -55.08 19.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 CA-C-N 114.011 -1.449 . . . . 74.42 110.656 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 35' ' ' VAL . 18.2 mt -67.94 -30.37 69.66 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.726 -0.67 . . . . 64.41 111.088 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.65 -52.38 38.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.838 -1.073 . . . . 70.35 110.95 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -89.37 -13.56 37.53 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.106 -0.497 . . . . 64.51 111.798 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt 68.42 66.32 0.32 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.24 1.016 . . . . 75.3 109.437 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 94.9 mt -86.57 131.36 34.19 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.96 -1.018 . . . . 75.2 108.677 173.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.804 HG11 ' HB2' ' A' ' 145' ' ' ALA . 4.4 p -86.42 129.89 37.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.524 0.73 . . . . 55.45 109.424 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.56 151.67 37.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 123.663 0.785 . . . . 74.45 112.247 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 39.5 tpp -149.5 140.28 22.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.347 -1.353 . . . . 70.42 107.347 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.632 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 29.7 m-80 -130.06 123.18 29.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.066 0.546 . . . . 73.43 110.334 -169.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 28.0 p -67.73 -16.26 64.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.014 0.526 . . . . 33.52 111.72 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.632 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 97.5 m-85 -45.88 -60.76 2.06 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.287 1.035 . . . . 65.01 111.319 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -105.23 -33.31 8.27 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.244 1.018 . . . . 72.13 111.255 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -93.02 19.98 7.23 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.002 0.521 . . . . 65.34 111.728 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.97 27.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.85 0.86 . . . . 63.44 113.203 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -77.96 -50.74 11.57 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.515 0.726 . . . . 54.02 112.25 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -72.91 -33.48 66.01 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.1 0.56 . . . . 71.13 110.971 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.516 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 35.0 t80 -64.91 -42.92 94.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.103 0.561 . . . . 65.11 110.568 170.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -63.46 -27.62 69.41 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 120.678 0.275 . . . . 73.55 110.564 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.2 -36.72 74.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.192 0.597 . . . . 54.11 110.571 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.516 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 34.8 m-85 -63.83 -35.85 81.97 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.654 0.382 . . . . 74.14 110.526 170.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mm -65.61 -36.5 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.453 0.701 . . . . 75.43 111.459 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.36 -44.82 96.51 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.579 0.352 . . . . 75.24 110.699 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -68.09 -42.81 79.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.909 -0.587 . . . . 73.24 109.886 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -48.86 -66.63 0.37 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.625 1.57 . . . . 74.23 111.07 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.1 ptm -60.46 -40.61 91.83 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.507 0.504 . . . . 62.13 111.19 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -62.93 -45.59 91.74 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 122.68 0.392 . . . . 71.44 110.379 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -72.9 -48.72 34.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.346 0.658 . . . . 74.34 111.206 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -66.41 -38.06 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 123.541 0.525 . . . . 53.51 112.188 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.418 HD13 ' HE3' ' A' ' 117' ' ' LYS . 63.8 mt -77.89 -40.18 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 122.969 0.508 . . . . 72.51 110.148 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.52 -42.71 99.69 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.134 0.974 . . . . 73.22 111.83 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -66.96 -45.03 78.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.297 -0.865 . . . . 64.51 109.104 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.9 ttt -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 124.349 1.031 . . . . 74.4 110.692 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.23 -41.29 79.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.258 1.023 . . . . 70.45 112.174 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.58 -19.22 62.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.797 0.666 . . . . 72.4 112.797 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -114.37 0.9 14.25 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.386 0.539 . . . . 73.23 111.891 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.56 -48.06 2.88 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.754 -0.832 . . . . 65.53 108.754 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 57.37 8.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 126.848 2.059 . . . . 75.23 113.996 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -113.91 115.13 27.2 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.987 -0.746 . . . . 72.12 108.987 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -64.6 -32.85 74.68 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.026 0.829 . . . . 75.11 111.833 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.58 68.24 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.791 0.329 . . . . 73.01 110.603 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.19 -54.59 6.32 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.976 -0.75 . . . . 61.25 108.976 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.9 -22.22 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 115.932 -0.576 . . . . 54.25 111.677 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.05 -41.73 97.27 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.303 0.641 . . . . 74.54 110.221 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.053 0.845 . . . . 40.44 110.172 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -57.64 -61.12 2.74 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.173 0.92 . . . . 75.25 111.733 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.418 ' HE3' HD13 ' A' ' 100' ' ' ILE . 21.8 ptmt -73.19 -15.38 61.45 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.615 0.572 . . . . 65.43 111.858 -173.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -68.14 -51.49 45.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.55 -0.907 . . . . 74.21 108.55 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.12 -32.86 72.55 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.081 -1.418 . . . . 71.43 111.878 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mm -67.98 -47.62 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.068 0.547 . . . . 63.4 110.262 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.35 -49.53 75.85 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.91 0.756 . . . . 42.11 109.499 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.59 98.76 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 123.819 0.7 . . . . 74.13 112.981 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -62.45 -50.5 71.2 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.696 0.799 . . . . 74.42 109.79 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.5 m -70.79 -42.14 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 118.503 -0.76 . . . . 62.2 111.816 -173.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.55 -32.16 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 119.221 0.919 . . . . 73.4 110.757 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.2 t -73.97 -38.96 64.03 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 120.907 0.384 . . . . 60.1 110.081 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 155' ' ' ILE . 28.4 tp -73.88 -26.94 60.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.929 1.292 . . . . 73.42 111.867 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 64.8 mt -88.42 2.24 53.12 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.852 0.861 . . . . 62.54 111.822 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 93.87 6.77 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.209 0.528 . . . . 72.35 109.586 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 50.9 mtpt -67.07 -5.38 12.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.331 1.234 . . . . 72.42 114.331 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -47.15 83.08 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 118.231 0.469 . . . . 73.25 110.794 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -109.06 -37.64 5.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.768 0.827 . . . . 71.51 110.547 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.37 -1.79 38.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.714 1.206 . . . . 73.32 114.148 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 37.3 ttpt -55.26 -15.54 2.52 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.705 0.631 . . . . 65.54 112.705 172.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -83.68 6.72 19.95 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.598 0.759 . . . . 72.02 111.276 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.63 129.18 34.96 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.415 0.686 . . . . 62.33 109.309 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.85 120.17 39.75 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.658 -1.238 . . . . 53.44 107.658 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.431 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 65.1 m-85 -102.7 141.91 34.73 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.422 -0.585 . . . . 74.24 109.422 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 95.1 m-85 -139.65 149.76 44.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.239 -0.652 . . . . 73.43 109.239 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.4 pt -133.66 168.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.892 -0.781 . . . . 75.21 108.892 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.61 143.93 48.99 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.821 -0.433 . . . . 63.41 112.227 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -44.86 -39.31 5.25 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.698 0.799 . . . . 60.31 111.993 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -62.77 -38.53 90.95 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 72.42 111.898 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -68.59 -29.74 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.267 0.627 . . . . 62.34 111.727 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.804 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -84.53 -25.33 28.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.575 0.35 . . . . 74.53 111.215 173.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -65.81 -29.89 70.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.499 0.72 . . . . 72.11 110.55 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.53 0.01 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.074 -0.81 . . . . 71.41 111.074 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -159.41 -170.69 3.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.165 0.586 . . . . 64.33 111.134 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.95 -173.01 0.9 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 75.32 108.858 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 79.21 -20.82 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.521 1.528 . . . . 75.15 111.963 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.13 146.72 47.78 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.908 -0.477 . . . . 72.35 111.908 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -67.62 134.23 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.397 0.679 . . . . 75.53 111.52 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.439 HG11 ' HE1' ' A' ' 88' ' ' PHE . 59.9 t -83.36 117.96 30.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.699 -0.682 . . . . 70.2 109.679 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -67.01 101.5 0.86 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.828 0.851 . . . . 75.04 109.525 168.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.666 HG21 HD21 ' A' ' 127' ' ' LEU . 67.1 mt -90.78 105.88 16.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.22 -1.03 . . . . 74.25 108.22 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -94.84 96.35 5.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.333 -0.617 . . . . 61.13 109.333 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -81.47 157.23 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.732 -1.122 . . . . 73.44 108.011 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.1 p90 -120.45 139.24 53.14 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.021 -1.103 . . . . 72.31 108.021 175.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.417 ' HB2' HG23 ' A' ' 166' ' ' VAL . 24.1 mmt180 -118.98 161.27 20.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.263 -0.643 . . . . 72.33 109.263 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -115.84 119.84 37.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.489 0.716 . . . . 70.51 110.403 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.88 97.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.296 1.038 . . . . 71.44 108.773 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 61.94 18.06 9.51 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.446 1.098 . . . . 75.14 113.777 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.84 1.37 22.7 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 120.122 -0.266 . . . . 75.52 113.194 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.9 m -110.11 134.37 52.25 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.954 0.901 . . . . 73.32 109.634 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.91 120.66 23.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.878 -1.156 . . . . 75.01 107.878 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 159' ' ' ARG . 2.7 m -117.84 89.33 33.39 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.495 -1.298 . . . . 74.14 107.495 169.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 84.3 Cg_exo -54.19 126.25 21.5 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.006 2.47 . . . . 73.32 113.269 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -103.58 107.22 17.98 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.105 -1.072 . . . . 73.52 108.105 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 16.5 tp -75.17 112.42 11.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.676 -1.231 . . . . 72.53 107.676 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ptp -105.83 136.11 46.05 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 122.07 0.938 . . . . 65.54 108.945 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 154' ' ' ALA . 68.1 mt -141.77 158.33 43.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 112.963 -1.926 . . . . 73.21 106.534 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 174' ' ' GLU . 10.6 p -86.73 140.65 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.363 -0.977 . . . . 62.32 108.363 168.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -57.77 -27.33 62.97 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.537 0.735 . . . . 73.34 111.722 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 172' ' ' VAL . 17.0 mm-40 -90.12 13.58 14.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.594 0.757 . . . . 61.03 112.858 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.92 -1.14 7.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.588 0.755 . . . . 60.32 110.921 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.434 HG13 HD13 ' A' ' 171' ' ' LEU . 36.3 mm -132.0 137.0 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.047 0.939 . . . . 71.04 109.55 -174.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.94 109.81 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.854 -1.165 . . . . 52.34 107.854 171.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.05 106.15 18.35 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.403 -1.332 . . . . 72.12 107.403 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.649 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 43.3 mt-10 -92.78 98.11 11.19 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.425 -1.324 . . . . 70.52 107.425 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.645 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -72.97 96.43 2.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 113.794 -1.548 . . . . 65.15 109.403 179.263 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.91 87.78 2.89 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.272 -1.01 . . . . 72.43 108.272 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 97.5 mt -83.33 110.61 18.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.194 -0.912 . . . . 64.05 110.459 -171.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 108.031 -1.1 . . . . 74.22 108.031 175.43 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.826 -0.435 . . . . 51.34 109.826 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.9 mt -95.35 127.7 41.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.07 -0.715 . . . . 65.54 109.07 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.597 ' HB ' ' HG3' ' A' ' 179' ' ' GLU . 45.9 mt -97.4 127.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.332 0.653 . . . . 73.32 109.482 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.424 ' OH ' ' HB3' ' A' ' 20' ' ' MET . 31.1 m-85 -121.72 114.42 21.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.842 1.257 . . . . 75.23 107.792 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -123.11 150.72 42.86 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.342 0.657 . . . . 74.21 110.02 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.15 134.19 34.74 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.89 -1.152 . . . . 63.2 107.89 166.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.2 pt -68.71 -27.66 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.786 0.661 . . . . 73.51 112.786 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 98' ' ' ASN . 74.8 m-85 -85.61 -63.31 1.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.079 0.399 . . . . 75.34 112.068 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -131.33 -33.82 1.45 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.522 0.564 . . . . 74.15 112.522 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.83 24.03 5.77 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.05 0.94 . . . . 44.05 112.721 -156.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.19 -29.07 1.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.866 1.266 . . . . 73.1 113.605 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -84.42 24.68 0.95 Allowed 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 113.2 0.815 . . . . 73.24 113.2 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.4 mt -45.28 -76.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.534 1.134 . . . . 45.14 112.564 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 p -160.79 134.87 7.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.154 0.581 . . . . 63.11 110.359 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.421 ' HB2' HG12 ' A' ' 3' ' ' ILE . 38.9 p -141.53 99.91 3.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.091 0.86 . . . . 42.3 109.655 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB3' ' HD2' ' A' ' 18' ' ' PHE . 25.9 t70 -163.85 169.66 17.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.711 0.805 . . . . 70.32 109.364 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -80.99 9.49 6.47 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.862 0.865 . . . . 74.22 113.13 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.517 ' HD2' ' HB3' ' A' ' 16' ' ' ASP . 51.4 p90 -54.49 141.82 52.96 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 118.34 0.518 . . . . 73.14 111.787 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.38 119.82 7.22 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 123.008 2.472 . . . . 54.0 113.258 -164.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.424 ' HB3' ' OH ' ' A' ' 4' ' ' TYR . 24.2 ptt? -101.94 151.81 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.977 -0.556 . . . . 72.15 110.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -135.91 145.96 46.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.181 -1.415 . . . . 72.24 107.181 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.0 tp -134.32 118.52 17.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.271 -1.011 . . . . 64.33 108.271 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.51 133.88 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.056 0.942 . . . . 63.32 109.278 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 58.44 10.46 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.131 1.373 . . . . 64.33 114.55 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 50.72 25.08 1.93 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.723 0.809 . . . . 73.4 112.362 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 119' ' ' LYS . 63.3 tp -109.15 -46.14 3.63 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.1 t -124.44 124.4 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 122.673 0.389 . . . . 74.14 110.822 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -84.63 114.42 21.99 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.604 -1.258 . . . . 73.44 107.604 167.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 47.3 mt-10 -106.97 135.01 49.26 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.227 -0.897 . . . . 65.5 110.44 176.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 27.7 t80 -127.11 133.59 50.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.215 1.006 . . . . 74.33 108.984 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.73 139.55 30.41 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.019 0.438 . . . . 71.13 109.828 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -172.59 12.97 Favored Glycine 0 CA--C 1.508 -0.372 0 N-CA-C 110.538 -1.025 . . . . 65.4 110.538 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -144.84 144.55 31.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 53.14 109.992 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -65.03 117.37 7.56 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.121 -1.066 . . . . 74.14 108.121 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.71 163.61 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.854 1.261 . . . . 53.3 109.382 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 2.9 m -119.54 104.86 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.241 -1.022 . . . . 71.12 108.241 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.708 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 13.5 tpt180 -80.73 106.62 12.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.772 -1.195 . . . . 70.32 107.772 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 87.5 tttt -135.04 154.11 51.82 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.818 -1.083 . . . . 73.54 109.579 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -51.63 -26.76 9.57 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.003 1.321 . . . . 73.13 112.836 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.88 27.83 1.29 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.667 -0.518 . . . . 51.21 114.197 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 39.6 mm-40 -146.08 152.45 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.734 0.813 . . . . 75.43 109.352 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 6.4 tp . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 123.599 0.76 . . . . 74.4 110.194 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.238 0.477 0 N-CA-C 106.868 -1.531 . . . . 74.3 106.868 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.708 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 48.1 mt-10 -67.36 80.86 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.849 0.833 . . . . 74.42 109.091 170.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -75.55 132.42 40.7 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.785 -1.098 . . . . 70.1 110.011 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.06 -141.45 7.73 Favored Glycine 0 CA--C 1.498 -0.982 0 N-CA-C 110.048 -1.221 . . . . 61.42 110.048 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 30.1 pt -111.5 147.41 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.426 0.613 . . . . 74.41 110.63 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.7 -24.33 65.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.438 0.695 . . . . 62.0 112.846 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 169' ' ' LEU . 52.9 mt -60.16 -40.39 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.609 0.719 . . . . 74.42 110.165 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.17 -51.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.351 -0.841 . . . . 74.34 111.625 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.703 HD22 ' HB3' ' A' ' 65' ' ' GLU . 24.1 mt -64.88 -45.62 85.23 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.079 0.862 . . . . 64.33 111.492 -169.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -80.62 -18.03 49.45 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.559 -0.746 . . . . 65.13 111.854 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -107.79 -1.45 20.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.791 -0.568 . . . . 72.24 111.357 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 55.95 56.69 5.75 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.226 1.011 . . . . 72.44 111.726 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.638 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 62.8 mt -95.13 138.3 33.03 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.016 -0.993 . . . . 71.13 109.73 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.4 134.48 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.922 -0.77 . . . . 73.21 108.922 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.26 141.45 57.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.143 -0.935 . . . . 64.34 112.928 -174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 ptm -140.81 109.96 6.18 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 107.136 -1.431 . . . . 64.1 107.136 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.45 152.98 20.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.703 -0.681 . . . . 51.31 110.306 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.424 ' SG ' ' HE1' ' A' ' 138' ' ' PHE . 64.8 m -67.34 -3.56 8.47 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.045 1.128 . . . . 74.1 114.045 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -94.13 -60.24 1.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.796 0.439 . . . . 74.4 110.018 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -78.36 -43.62 27.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.862 0.865 . . . . 75.41 110.273 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.13 20.56 8.94 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.842 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.81 -53.82 22.99 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.416 1.086 . . . . 60.14 113.904 -174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.0 m -68.33 -40.59 81.58 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.5 0.667 . . . . 73.24 110.996 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.438 ' HG3' ' CE2' ' A' ' 91' ' ' TYR . 14.2 tpt -68.59 -29.07 67.52 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.179 -0.919 . . . . 72.35 110.245 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -66.46 -42.12 88.04 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.355 1.462 . . . . 74.31 110.063 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.78 -41.65 82.47 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.86 0.725 . . . . 62.42 110.167 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.88 -45.42 86.07 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.394 0.678 . . . . 74.15 112.389 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.56 ' HE1' HD12 ' A' ' 140' ' ' ILE . 30.3 m-85 -55.17 -48.21 74.08 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.456 0.702 . . . . 62.2 112.151 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.13 -41.33 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.802 0.689 . . . . 70.34 112.614 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -52.63 -47.76 66.82 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.361 0.528 . . . . 71.35 111.334 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -70.24 -45.35 66.66 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.162 -0.926 . . . . 72.34 110.996 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -49.83 -51.42 40.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.631 1.172 . . . . 75.42 110.63 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.4 ttt -58.09 -54.64 44.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.764 1.226 . . . . 60.24 111.392 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.3 -24.17 62.98 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.316 -0.402 . . . . 64.02 111.901 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 8' ' ' PHE . 8.8 m120 -88.12 -40.63 13.62 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.542 0.737 . . . . 72.32 112.264 -174.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 120' ' ' ILE . 29.5 m -66.8 -36.96 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 110.14 -0.318 . . . . 73.11 110.14 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.09 -31.23 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 122.438 0.295 . . . . 75.11 110.543 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.24 -52.93 61.81 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.853 0.461 . . . . 73.42 111.028 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -66.32 -38.29 87.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.913 -0.585 . . . . 73.41 111.391 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.636 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -67.26 -58.14 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.671 0.389 . . . . 74.4 110.741 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.13 -42.2 80.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.352 1.061 . . . . 53.13 112.337 -168.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -68.65 -22.09 64.42 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.094 0.558 . . . . 62.33 111.433 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.09 -17.95 16.45 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.278 0.631 . . . . 74.11 111.446 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -105.31 -52.17 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.061 0.545 . . . . 75.32 111.004 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 81.38 -21.45 0.31 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.457 1.503 . . . . 71.01 113.066 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -79.52 127.35 32.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.354 0.525 . . . . 63.3 110.516 -172.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -43.39 81.08 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 124.55 1.156 . . . . 62.4 112.454 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.03 -30.65 39.55 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.143 0.577 . . . . 74.22 112.52 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.06 -36.62 22.91 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.574 0.35 . . . . 55.22 110.542 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.636 HG12 ' SD ' ' A' ' 103' ' ' MET . 23.4 m -69.91 -29.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.729 0.299 . . . . 75.15 110.385 172.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.76 -31.82 68.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.679 0.791 . . . . 75.41 109.921 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 119' ' ' LYS . . . -67.2 -53.81 26.87 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.456 0.702 . . . . 61.05 109.689 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -55.82 -43.27 76.8 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 123.878 0.736 . . . . 73.44 110.465 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.37 -43.94 79.7 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 124.579 1.174 . . . . 74.55 111.181 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 74.54 110.204 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.465 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.5 mptm? -66.92 -45.2 78.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.204 0.602 . . . . 74.24 111.142 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 99' ' ' VAL . 10.8 tp -73.03 -39.15 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 122.794 0.438 . . . . 71.21 110.301 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -67.11 -44.79 79.04 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.217 0.607 . . . . 72.05 109.885 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.24 99.76 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.91 0.756 . . . . 61.44 111.887 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.521 ' HZ2' ' HB3' ' A' ' 170' ' ' MET . 34.1 t90 -63.11 -50.99 68.33 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.826 0.85 . . . . 72.33 110.434 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.8 m -68.62 -47.64 75.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 CA-C-O 118.9 -0.571 . . . . 62.12 111.019 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.8 m -62.1 -31.23 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.09 0.859 . . . . 64.12 111.509 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 m -76.37 -43.68 39.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.032 0.533 . . . . 61.25 111.219 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.8 tp -77.07 -33.86 57.07 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 123.237 0.615 . . . . 73.52 111.704 -170.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.3 mt -80.54 4.04 19.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.596 0.759 . . . . 72.24 112.248 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.67 108.38 0.73 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.916 0.886 . . . . 64.41 111.434 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.61 -5.49 40.69 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.745 1.017 . . . . 63.01 113.745 -170.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -97.45 -45.17 6.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.865 0.466 . . . . 72.23 111.151 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -100.4 -47.88 4.76 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.198 0.999 . . . . 72.32 110.508 -172.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 39.2 m-85 -86.24 -2.66 58.58 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.075 0.95 . . . . 63.24 112.402 -173.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -52.57 2.53 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.158 1.91 . . . . 65.31 116.158 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -83.3 17.31 2.13 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 71.32 110.82 167.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 87.6 mt -89.82 151.01 22.0 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.426 0.632 . . . . 63.11 110.489 175.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.32 119.36 17.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.109 -1.811 . . . . 60.14 106.109 169.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.424 ' HE1' ' SG ' ' A' ' 81' ' ' CYS . 91.1 m-85 -93.59 149.31 21.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.178 -1.045 . . . . 75.42 108.178 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.696 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . 82.3 m-85 -138.78 161.62 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.354 -0.609 . . . . 74.22 109.354 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.56 HD12 ' HE1' ' A' ' 91' ' ' TYR . 4.7 tt -136.4 143.29 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.648 -1.241 . . . . 61.54 107.648 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.72 150.47 49.84 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.525 0.516 . . . . 70.21 112.997 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.91 -47.84 52.0 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.495 1.518 . . . . 65.51 114.367 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -42.17 73.83 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.235 0.614 . . . . 73.12 110.684 -171.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.04 60.57 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.287 1.035 . . . . 73.24 110.872 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.46 -5.37 42.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.993 0.917 . . . . 64.32 112.583 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.83 -5.0 56.71 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.583 0.353 . . . . 75.13 111.028 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.67 42.94 1.28 Allowed Glycine 0 C--N 1.345 1.041 0 C-N-CA 122.876 0.274 . . . . 73.1 112.666 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.95 -67.48 0.85 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.104 -0.702 . . . . 63.03 109.104 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -159.16 173.37 16.5 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 74.05 109.558 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -54.96 -27.59 44.98 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.565 1.146 . . . . 71.15 112.547 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.85 -153.46 41.21 Favored Glycine 0 C--N 1.357 1.726 0 O-C-N 123.793 0.683 . . . . 60.31 111.446 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.578 ' HG3' HD22 ' A' ' 171' ' ' LEU . 50.3 tp60 -87.28 120.16 28.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.616 -0.883 . . . . 73.44 108.616 162.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.77 116.24 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 109.297 -0.631 . . . . 72.13 109.297 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 139' ' ' PHE . . . -76.65 99.97 5.21 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.159 -0.928 . . . . 70.12 110.494 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -91.47 108.58 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.476 -0.784 . . . . 74.51 109.628 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 49.9 mm -99.0 109.63 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.667 0.387 . . . . 74.35 110.71 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.491 ' HA ' HD23 ' A' ' 136' ' ' LEU . 45.7 tt0 -86.94 107.41 18.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.317 -0.623 . . . . 73.2 109.317 171.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -75.0 87.91 2.36 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.378 -1.341 . . . . 72.4 107.378 169.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.532 ' HB3' HG23 ' A' ' 166' ' ' VAL . 8.0 tpt180 -85.92 119.83 26.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.048 -0.978 . . . . 74.24 108.62 -170.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.73 97.62 10.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.758 0.423 . . . . 71.25 109.957 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.402 HG13 ' HB ' ' A' ' 164' ' ' THR . 3.8 p -96.41 97.64 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.606 0.763 . . . . 73.01 109.306 173.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 64.7 17.38 10.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.415 1.086 . . . . 73.2 112.916 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 115.5 -10.13 19.47 Favored Glycine 0 N--CA 1.475 1.245 0 CA-C-O 120.156 -0.247 . . . . 72.01 113.335 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.402 ' HB ' HG13 ' A' ' 161' ' ' VAL . 19.4 m -97.38 128.61 44.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.332 0.653 . . . . 62.31 109.974 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.52 120.85 22.3 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.422 -0.955 . . . . 72.1 108.422 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 159' ' ' ARG . 12.4 m -115.88 95.72 44.89 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.624 -1.25 . . . . 73.24 107.624 171.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 123.91 14.97 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.451 2.767 . . . . 71.43 112.366 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.5 m -117.89 110.45 17.76 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.569 -0.901 . . . . 62.13 108.569 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 62.8 tp -76.24 117.43 17.92 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.633 -0.877 . . . . 71.31 108.633 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.521 ' HB3' ' HZ2' ' A' ' 123' ' ' TRP . 63.5 mtt -112.26 120.92 43.41 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.957 -1.127 . . . . 74.25 107.957 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.578 HD22 ' HG3' ' A' ' 152' ' ' GLN . 78.5 mt -131.73 145.49 51.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.017 -1.475 . . . . 75.31 107.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.433 HG12 ' OE1' ' A' ' 152' ' ' GLN . 14.7 p -82.67 137.91 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.796 -0.816 . . . . 74.44 108.796 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -57.18 -22.19 38.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.858 1.263 . . . . 72.02 111.687 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.427 ' H ' HG22 ' A' ' 172' ' ' VAL . 8.5 tp10 -78.48 -36.91 44.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.4 0.519 . . . . 74.14 112.4 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -97.64 -0.78 45.03 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.738 0.304 . . . . 72.03 110.597 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 41.3 mm -121.96 133.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 C-N-CA 124.131 0.972 . . . . 73.01 109.337 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.3 mm -99.0 109.73 24.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.418 -0.956 . . . . 74.24 108.418 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -95.68 123.45 39.25 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.464 -1.31 . . . . 72.1 107.464 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.597 ' HG3' ' HB ' ' A' ' 3' ' ' ILE . 8.1 pt-20 -146.98 125.04 12.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.218 -0.66 . . . . 63.12 109.218 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -81.49 95.81 7.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.59 -0.732 . . . . 64.43 109.324 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.37 88.8 6.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.38 -0.97 . . . . 74.14 108.38 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 67.1 mt -71.46 143.14 50.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.233 -0.894 . . . . 72.54 109.909 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.773 -0.632 . . . . 75.03 109.468 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.669 -0.493 . . . . 73.54 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.27 161.59 20.15 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.575 -0.898 . . . . 62.11 108.575 173.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.44 HD11 ' HD3' ' A' ' 5' ' ' LYS . 12.7 tt -133.66 118.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 53.13 109.802 172.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 177' ' ' ILE . 21.5 p90 -122.58 124.09 42.7 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.899 -1.148 . . . . 73.13 107.899 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 22.2 pttp -153.29 171.24 18.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.381 0.673 . . . . 63.43 109.995 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -105.09 142.77 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 61.51 108.812 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.406 HG22 HG12 ' A' ' 177' ' ' ILE . 22.1 pt -79.68 -9.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.293 0.637 . . . . 64.45 112.603 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -107.76 -60.21 1.74 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.708 0.29 . . . . 74.44 111.657 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.411 HG23 ' HA3' ' A' ' 151' ' ' GLY . 1.2 p -125.32 -49.49 1.68 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.837 0.68 . . . . 75.14 112.837 -164.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -87.31 21.84 2.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 63.31 111.181 -172.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.549 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 16.7 t70 -48.24 -21.68 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.013 1.325 . . . . 72.25 112.814 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.95 25.33 2.14 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.823 1.249 . . . . 72.5 112.722 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 10' ' ' ASP . 40.9 mt -62.99 -92.3 0.0 OUTLIER 'General case' 0 C--N 1.371 1.542 0 CA-C-N 119.128 0.877 . . . . 75.13 110.378 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 68.1 m -154.65 129.97 9.73 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.994 0.815 . . . . 55.03 112.258 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.7 t -109.67 81.93 1.51 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.224 1.009 . . . . 65.31 108.795 163.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -162.2 166.92 24.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.083 0.953 . . . . 71.15 109.301 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.3 80.91 0.74 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.595 0.712 . . . . 71.03 110.93 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 61.7 m-85 -114.2 139.65 24.02 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.913 1.285 . . . . 75.44 108.98 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 16.5 Cg_exo -68.45 119.86 6.84 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.488 2.125 . . . . 43.52 112.092 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.08 144.13 27.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.637 0.775 . . . . 73.53 109.786 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.19 146.74 47.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.969 -0.752 . . . . 74.05 108.969 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.73 138.67 53.88 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.882 -0.785 . . . . 72.43 108.882 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.35 128.43 63.89 Favored 'Isoleucine or valine' 0 C--O 1.266 1.932 0 N-CA-C 109.001 -0.74 . . . . 61.22 109.001 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 72.78 -85.53 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.933 1.693 . . . . 62.32 108.741 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.5 t70 172.14 28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.575 1.95 . . . . 44.52 106.788 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 tp -135.15 -52.16 0.78 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.485 -0.779 . . . . 63.35 110.712 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.1 t -118.21 131.28 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.088 -0.505 . . . . 55.14 109.783 -168.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -83.62 135.49 34.58 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.122 -1.066 . . . . 64.11 108.122 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.87 155.76 47.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.42 0.629 . . . . 70.45 110.673 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.3 t80 -139.99 147.86 41.05 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.14 -0.936 . . . . 74.32 109.259 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.58 154.02 39.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.712 0.805 . . . . 72.31 111.892 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 156.46 28.42 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.722 -0.275 . . . . 75.02 112.858 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -154.37 159.24 41.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.836 0.854 . . . . 64.22 109.935 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -70.21 120.41 15.86 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.371 -0.603 . . . . 71.12 109.371 169.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.75 168.11 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.896 1.278 . . . . 53.02 108.473 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.97 145.32 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.722 -0.844 . . . . 64.14 108.722 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.758 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 27.2 mmt180 -134.33 109.16 8.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.06 -1.83 . . . . 72.35 106.06 174.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -133.07 97.32 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.761 -0.459 . . . . 73.41 109.761 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 39.95 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 126.616 1.966 . . . . 74.3 115.132 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.75 49.77 0.82 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.787 -0.925 . . . . 50.13 110.787 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -170.78 152.55 3.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.551 1.141 . . . . 73.14 109.0 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tt . . . . . 0 CA--C 1.547 0.835 0 C-N-CA 123.601 0.76 . . . . 64.41 109.694 172.407 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.008 -1.108 . . . . 64.13 108.008 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.758 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 3.3 mp0 -72.58 80.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.81 -0.811 . . . . 75.03 108.81 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.37 146.54 24.32 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.084 0.954 . . . . 70.14 109.416 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.65 -143.93 15.07 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.551 -1.019 . . . . 64.3 110.551 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 167' ' ' PRO . 0.8 OUTLIER -83.7 122.04 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 117.595 0.698 . . . . 64.13 109.413 -175.274 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.44 -47.52 9.91 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.756 2.022 . . . . 61.41 113.824 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' A' ' 169' ' ' LEU . 66.4 mt -51.81 -48.45 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.82 1.248 . . . . 63.31 110.457 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.51 HG13 ' HB2' ' A' ' 76' ' ' LEU . 56.0 t -70.56 -41.55 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.816 -1.084 . . . . 65.44 111.75 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 43.8 mt -64.08 -39.77 94.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.564 0.746 . . . . 61.44 111.341 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.25 -38.14 63.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.966 0.906 . . . . 72.22 111.128 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.49 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 28.5 m170 -92.07 -11.97 34.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.371 0.669 . . . . 72.43 111.555 -172.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 28.0 mtpp 62.44 46.7 5.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.897 1.279 . . . . 70.21 111.137 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.51 ' HB2' HG13 ' A' ' 71' ' ' VAL . 63.1 mt -80.43 130.79 35.39 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.376 -0.602 . . . . 74.24 109.376 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.8 135.42 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.214 -0.661 . . . . 70.45 109.214 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.45 148.01 24.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 63.22 113.325 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -146.64 103.54 3.67 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 106.307 -1.738 . . . . 74.23 106.307 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -92.6 118.12 30.69 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.931 -0.766 . . . . 75.45 108.931 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.4 p -63.64 -27.85 69.51 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.907 0.483 . . . . 74.21 111.188 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -68.03 -41.62 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.619 -1.173 . . . . 74.34 111.582 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.16 -22.88 13.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.628 0.771 . . . . 64.43 111.998 -170.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -116.66 21.0 13.73 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.456 1.102 . . . . 31.13 110.753 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.97 13.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.89 1.276 . . . . 54.1 113.779 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.9 m -61.45 -56.72 17.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.588 0.755 . . . . 61.23 111.26 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.6 mtp -59.92 -36.71 77.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.882 0.473 . . . . 44.13 111.072 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.42 -39.29 91.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.0 0.52 . . . . 63.4 111.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.06 -38.54 89.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.007 0.523 . . . . 74.12 109.974 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.38 94.11 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.072 -0.967 . . . . 61.52 110.739 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' O ' ' HB3' ' A' ' 95' ' ' PHE . 54.2 m-85 -59.28 -50.4 74.15 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 119.0 -0.524 . . . . 73.41 111.107 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mm -55.65 -44.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.453 0.701 . . . . 74.22 111.886 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -64.4 -56.2 15.9 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.099 0.56 . . . . 74.33 109.722 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -65.11 -55.85 16.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.537 0.523 . . . . 64.05 110.069 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 8.4 t80 -45.34 -61.13 1.79 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.325 1.45 . . . . 72.51 112.962 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.6 ttt -64.19 -41.27 97.15 Favored 'General case' 0 C--O 1.248 0.984 0 O-C-N 123.415 0.447 . . . . 74.42 111.449 -171.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -62.66 -41.35 99.01 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.139 -0.482 . . . . 74.11 110.683 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.44 -48.62 74.63 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.044 0.84 . . . . 74.33 111.373 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.57 ' O ' ' HG2' ' A' ' 103' ' ' MET . 29.2 m -62.24 -48.75 86.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.565 0.541 . . . . 75.14 110.433 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.473 HD13 ' HG3' ' A' ' 117' ' ' LYS . 47.0 mt -69.73 -43.01 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 O-C-N 123.308 0.38 . . . . 64.44 110.953 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.06 -37.83 81.04 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.732 0.813 . . . . 71.11 111.877 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -70.84 -41.23 71.76 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.83 0.706 . . . . 64.55 110.608 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.57 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 79.4 mmm -64.81 -36.52 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.079 -0.712 . . . . 75.25 109.079 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.45 -37.54 71.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.129 1.371 . . . . 74.43 110.462 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 -12.82 60.18 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 73.23 111.194 -175.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -104.37 -6.02 21.17 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.211 1.005 . . . . 75.33 109.801 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 47.02 77.29 0.09 Allowed 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.13 1.772 . . . . 71.31 112.225 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -61.12 -36.24 79.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.438 -0.801 . . . . 65.13 108.88 166.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 112' ' ' ASP . 21.5 t70 152.06 147.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 128.503 2.721 . . . . 74.41 106.063 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -58.0 -51.88 67.84 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.684 0.794 . . . . 62.52 110.99 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.28 -22.37 61.96 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.761 -0.654 . . . . 54.33 111.547 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 109' ' ' ASP . 20.9 t70 -80.28 -42.55 22.89 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.107 0.563 . . . . 64.13 111.017 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.21 -27.66 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.965 0.506 . . . . 71.53 110.278 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.29 -36.1 63.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.822 0.849 . . . . 65.43 110.856 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.43 -40.94 76.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.229 0.612 . . . . 64.11 110.147 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -64.62 -40.03 94.76 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.0 0.92 . . . . 72.24 109.588 172.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HG3' HD13 ' A' ' 100' ' ' ILE . 29.1 ttpp -63.56 -33.16 74.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.464 0.705 . . . . 44.02 110.721 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -74.93 -39.22 61.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.566 0.746 . . . . 72.31 110.819 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -66.85 -46.9 73.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 61.01 111.447 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.01 -32.47 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.182 0.593 . . . . 72.4 109.624 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -62.36 -48.09 81.32 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 122.892 0.477 . . . . 44.33 110.008 172.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.67 98.74 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 124.454 1.096 . . . . 44.04 112.403 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -65.39 -48.95 71.12 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.204 0.602 . . . . 75.44 110.191 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -70.2 -41.81 78.91 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.462 0 CA-C-O 118.216 -0.897 . . . . 62.01 111.133 -174.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 m -71.88 -21.5 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 120.061 1.3 . . . . 74.44 111.507 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.2 t -73.72 -43.24 59.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.246 0.546 . . . . 72.01 109.605 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.524 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 34.7 tp -73.04 -36.0 66.84 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.459 1.103 . . . . 71.22 111.405 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.498 ' HA ' ' CE1' ' A' ' 133' ' ' PHE . 77.0 mt -79.83 4.02 17.85 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.587 1.155 . . . . 53.25 112.684 -171.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.13 141.56 49.14 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.486 -0.561 . . . . 62.01 109.486 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 99.8 mttt -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.561 0.745 . . . . 71.24 111.715 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.28 -16.41 63.01 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.816 0.846 . . . . 70.01 110.64 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.524 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 8.9 tpt180 -96.9 -41.59 8.35 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.324 1.049 . . . . 64.03 109.188 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.65 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.7 m-85 -62.82 -12.85 27.27 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.742 1.217 . . . . 64.33 113.146 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -50.21 -30.31 11.25 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.878 0.736 . . . . 75.44 112.618 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 32.2 p30 -131.4 17.87 4.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.704 0.801 . . . . 63.44 112.177 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 26.1 mt -96.12 128.94 43.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.201 0.525 . . . . 74.2 111.381 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.79 139.08 54.18 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 105.362 -2.088 . . . . 64.13 105.362 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.478 ' HB3' HG11 ' A' ' 153' ' ' VAL . 98.1 m-85 -116.0 148.03 40.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.501 -0.926 . . . . 63.25 108.501 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -146.56 136.4 23.3 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 107.716 -1.216 . . . . 71.15 107.716 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -127.57 148.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.044 -1.095 . . . . 74.01 108.044 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -51.85 145.49 15.16 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.343 0.497 . . . . 75.2 114.343 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 10.9 tp10 -52.05 -54.97 23.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.743 0.817 . . . . 60.24 111.107 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -72.15 -15.28 61.97 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.898 0.879 . . . . 72.42 111.567 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.96 -34.88 43.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.586 0.755 . . . . 20.41 110.445 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.45 7.57 4.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.078 0.951 . . . . 73.31 112.032 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -73.48 -20.32 60.71 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.861 0.864 . . . . 52.1 109.813 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.01 30.32 0.81 Allowed Glycine 0 C--N 1.356 1.647 0 C-N-CA 123.739 0.685 . . . . 74.42 112.363 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.85 90.27 5.28 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 63.21 110.367 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.35 163.27 25.52 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.026 0.931 . . . . 73.24 112.391 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 79.97 7.34 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.769 1.628 . . . . 64.35 111.495 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.411 ' HA3' HG23 ' A' ' 9' ' ' THR . . . -95.64 -177.61 36.86 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 116.137 1.215 . . . . 53.32 116.137 -170.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -111.95 152.27 28.25 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.825 1.65 . . . . 70.13 109.866 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 138' ' ' PHE . 92.7 t -108.22 136.04 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.935 0.894 . . . . 65.43 108.632 173.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -64.62 114.44 4.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.098 0.959 . . . . 51.1 110.27 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 61.3 mt -87.03 107.67 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.99 0.916 . . . . 71.45 108.864 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.48 121.56 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 72.3 110.092 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.62 98.2 7.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.264 1.426 . . . . 71.22 108.974 -166.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 135' ' ' ASN . 57.5 m-85 -82.86 118.65 23.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.761 0.424 . . . . 74.53 110.705 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -125.31 -179.32 4.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.101 0.96 . . . . 75.42 109.436 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -123.86 110.83 15.35 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.215 0.606 . . . . 61.25 110.941 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.95 102.12 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.226 1.01 . . . . 64.5 108.31 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.95 31.55 19.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.239 1.016 . . . . 74.45 110.841 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.57 65.63 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.044 -0.525 . . . . 72.43 113.817 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.7 m -90.42 131.39 36.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.202 0.601 . . . . 74.3 109.841 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -71.14 123.11 21.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.509 0.724 . . . . 72.22 109.979 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.96 102.49 31.4 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.492 1.117 . . . . 51.5 110.21 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 68' ' ' ILE . 72.3 Cg_endo -85.83 118.33 1.77 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.79 2.327 . . . . 70.03 112.236 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.1 m -103.78 141.91 35.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.991 0.916 . . . . 54.42 109.991 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.683 ' HB2' HD13 ' A' ' 70' ' ' ILE . 46.4 tp -77.22 130.35 37.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.086 -1.079 . . . . 72.33 108.086 171.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.432 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 33.2 tpp -131.4 122.48 26.39 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.863 -1.532 . . . . 74.44 106.863 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 154' ' ' ALA . 48.8 mt -159.76 145.65 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.696 1.198 . . . . 74.41 108.107 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 176' ' ' ILE . 14.6 p -80.24 134.43 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.355 0.98 . . . . 64.32 109.795 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -55.27 -30.39 60.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.869 1.268 . . . . 62.33 112.975 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -71.13 -25.99 62.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.264 0.625 . . . . 74.22 111.713 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.01 -1.5 42.5 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.997 0.519 . . . . 43.25 111.008 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.438 HD11 HD13 ' A' ' 171' ' ' LEU . 42.7 mm -112.5 138.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.039 0.535 . . . . 73.33 110.703 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 38.0 mm -96.62 109.46 23.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 105.96 -1.867 . . . . 70.4 105.96 167.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.6 99.29 6.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.599 -1.63 . . . . 75.21 106.599 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -126.75 155.72 42.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.011 0.924 . . . . 72.51 110.081 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 180' ' ' LYS . 7.6 ptpt -106.63 113.74 27.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.262 1.025 . . . . 73.23 109.725 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 46.7 m -95.88 91.15 5.89 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.462 -0.79 . . . . 71.41 109.085 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.64 168.81 18.87 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.013 0.525 . . . . 63.45 110.584 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.056 0 N-CA-C 108.853 -0.795 . . . . 74.14 108.853 -178.22 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.854 -0.424 . . . . 75.52 109.854 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.73 130.64 53.17 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.927 0.491 . . . . 64.42 111.538 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 tt -99.15 118.92 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 N-CA-C 107.662 -1.236 . . . . 61.0 107.662 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -125.11 115.1 19.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.426 0.69 . . . . 72.1 110.902 -163.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 1.5 mptp? -121.3 153.14 38.11 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.49 0.716 . . . . 63.22 110.57 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.35 148.63 22.19 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.454 -0.943 . . . . 75.41 108.454 159.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 175' ' ' ALA . 47.2 pt -83.27 -24.58 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 112.563 0.579 . . . . 73.41 112.563 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -86.99 -64.0 1.22 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.796 0.665 . . . . 74.33 112.796 -169.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 144' ' ' ALA . 6.3 m -132.3 -34.73 1.21 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.877 0.695 . . . . 65.25 112.877 -172.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -92.5 21.79 5.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.941 1.296 . . . . 65.5 110.934 -164.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -46.78 -28.27 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.556 1.542 . . . . 53.14 112.891 -172.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.93 26.26 1.87 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.763 0.825 . . . . 72.32 112.596 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 10' ' ' ASP . 18.2 mt -44.93 -93.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.974 1.31 . . . . 74.34 112.557 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.3 m -156.28 152.26 27.48 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.965 -0.46 . . . . 54.3 110.917 -167.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -140.13 98.81 3.52 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.144 -1.058 . . . . 64.12 108.144 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -161.5 -176.2 5.21 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 110.267 -0.271 . . . . 73.33 110.267 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -68.33 92.82 0.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.36 1.064 . . . . 71.21 110.097 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HB3' ' HE2' ' A' ' 30' ' ' PHE . 41.2 m-85 -109.29 139.5 21.11 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 123.486 0.714 . . . . 75.11 111.18 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.36 119.08 6.05 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.197 1.931 . . . . 74.53 110.872 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.0 ttp -126.42 123.2 37.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.469 -0.787 . . . . 73.0 109.184 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.59 131.03 22.32 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.892 -1.521 . . . . 74.25 106.892 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.7 tp -101.77 124.06 46.77 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.81 -0.811 . . . . 72.03 108.81 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.39 140.05 38.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 124.424 1.089 . . . . 70.01 108.551 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 64.29 12.99 7.63 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.006 0.922 . . . . 73.45 112.453 173.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 58.38 21.84 8.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.31 1.044 . . . . 71.2 111.966 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.3 tp -130.74 -52.83 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.758 0.423 . . . . 61.13 110.686 -167.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -117.56 141.61 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.395 0.678 . . . . 45.42 111.239 -167.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 178' ' ' GLU . 46.6 m-85 -88.7 118.15 28.17 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.128 0.971 . . . . 74.45 109.936 168.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -85.69 104.41 15.38 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.462 -1.245 . . . . 73.2 107.885 167.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.7 t80 -100.58 106.81 18.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.419 -1.326 . . . . 74.24 107.419 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.83 154.36 27.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.103 0.477 . . . . 65.3 110.964 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.01 -172.2 23.96 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.094 -0.802 . . . . 72.31 111.094 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -135.21 137.34 42.54 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.468 0.634 . . . . 63.23 110.717 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -74.18 118.67 17.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.796 0.839 . . . . 74.11 109.198 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.567 ' HB ' HD11 ' A' ' 42' ' ' ILE . 12.6 m -141.63 168.67 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.705 1.202 . . . . 65.2 110.69 -165.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.97 114.01 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.765 0.793 . . . . 70.33 109.235 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.803 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 35.8 ttm180 -92.71 111.04 22.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.282 -1.007 . . . . 70.42 108.282 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -120.81 149.31 42.77 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.083 0.953 . . . . 75.34 109.361 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -72.45 81.83 1.07 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.728 -0.841 . . . . 65.23 108.728 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.83 -62.19 0.18 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 114.365 -1.289 . . . . 73.23 110.259 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -172.17 157.95 4.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.634 0.774 . . . . 75.54 110.163 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' A' ' 35' ' ' VAL . 6.5 tp . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 108.092 -1.077 . . . . 73.14 108.092 169.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 C--O 1.24 0.56 0 N-CA-C 106.346 -1.724 . . . . 65.31 106.346 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 13.2 mm-40 -75.74 69.41 2.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.032 -1.099 . . . . 73.23 108.032 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -82.28 122.26 27.72 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.552 -1.204 . . . . 74.51 108.026 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.78 -164.82 37.64 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.057 -1.617 . . . . 74.34 109.057 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 70' ' ' ILE . 37.2 pt -96.65 148.82 5.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 117.471 0.636 . . . . 72.15 110.33 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.69 -30.85 63.87 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.746 1.218 . . . . 71.11 112.312 -174.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 68' ' ' ILE . 61.1 mt -56.52 -51.24 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.022 1.329 . . . . 75.01 110.613 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.674 HG13 ' HB2' ' A' ' 76' ' ' LEU . 47.2 t -78.65 -44.11 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 114.451 -1.25 . . . . 52.03 111.21 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.58 -18.17 65.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.666 0.786 . . . . 72.42 112.089 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -48.52 -58.52 4.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.331 1.052 . . . . 53.22 110.681 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.04 -7.72 16.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.819 -0.628 . . . . 64.43 112.598 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttp 62.21 69.88 0.6 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.558 1.161 . . . . 73.34 109.052 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.674 ' HB2' HG13 ' A' ' 71' ' ' VAL . 64.3 mt -75.16 157.03 35.27 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.54 -0.755 . . . . 64.42 109.57 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.51 127.84 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.276 -0.638 . . . . 75.12 109.276 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.87 152.07 20.19 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.939 0.876 . . . . 73.52 112.887 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 86.0 mmm -143.83 137.22 27.82 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 104.72 -2.326 . . . . 60.15 104.72 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 140.42 35.64 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.327 0.512 . . . . 71.22 109.788 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 134' ' ' LYS . 24.9 p -58.96 -14.81 10.28 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.504 0.722 . . . . 55.34 112.907 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -66.3 -59.09 4.04 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.4 0.68 . . . . 75.54 112.197 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -98.21 -38.24 9.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.846 0.458 . . . . 73.14 110.728 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -92.5 21.59 5.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.622 0.769 . . . . 73.34 112.681 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.2 -53.2 29.67 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.759 0.824 . . . . 50.41 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 m -72.84 -37.72 67.34 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.774 0.83 . . . . 73.14 111.6 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.5 mpt? -66.5 -45.87 78.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.237 1.015 . . . . 60.3 110.3 -176.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 36.2 t80 -63.38 -47.18 83.12 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.376 -1.284 . . . . 75.43 111.236 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 37.1 ttmt -65.39 -28.83 69.54 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.349 0.405 . . . . 62.52 110.701 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.55 93.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.425 0.69 . . . . 65.43 110.7 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 31.2 m-85 -61.09 -40.04 92.24 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 115.961 -0.563 . . . . 73.22 111.115 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.407 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 42.0 mm -65.19 -32.54 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.731 0.812 . . . . 72.32 111.675 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 89' ' ' LYS . 96.4 mttt -61.53 -47.45 85.51 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.066 0.547 . . . . 65.0 111.437 171.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -66.91 -42.28 85.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.098 0.559 . . . . 75.44 110.675 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.465 ' O ' HG13 ' A' ' 99' ' ' VAL . 79.0 t80 -51.86 -60.79 2.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.117 1.767 . . . . 63.01 111.035 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.9 ttp -61.04 -40.92 95.45 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.731 0.645 . . . . 64.34 111.018 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -56.02 -55.73 29.27 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.214 0.606 . . . . 74.42 110.684 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -72.27 -36.68 69.06 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.496 0.498 . . . . 62.35 111.854 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 95' ' ' PHE . 18.1 m -67.77 -38.78 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.432 0.53 . . . . 63.12 112.432 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.05 -35.93 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 121.001 0.429 . . . . 74.11 110.529 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.78 -47.83 84.54 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.074 0.95 . . . . 71.22 110.765 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -66.56 -44.34 82.58 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.617 -1.174 . . . . 50.33 110.061 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.5 ' HG3' HG12 ' A' ' 113' ' ' VAL . 15.4 tpt -55.53 -53.35 57.52 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.118 0.886 . . . . 71.4 111.724 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.435 ' HA ' HG11 ' A' ' 113' ' ' VAL . 41.1 tt0 -65.2 -27.09 68.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.568 0.542 . . . . 73.2 111.579 -172.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.58 -45.28 76.01 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.201 0.524 . . . . 75.12 110.616 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -83.82 -29.54 27.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.081 0.953 . . . . 72.41 111.388 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -99.57 -50.66 4.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.632 0.773 . . . . 72.53 109.938 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 73.29 -13.3 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.146 1.379 . . . . 62.22 113.611 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.22 122.6 33.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.564 -0.902 . . . . 75.32 108.564 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.07 -37.48 85.91 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.189 0.596 . . . . 64.11 112.591 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.8 -30.26 66.68 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.611 0.364 . . . . 74.04 111.834 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.08 -30.92 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.598 0.359 . . . . 70.11 110.317 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.5 HG12 ' HG3' ' A' ' 103' ' ' MET . 27.0 m -80.65 -25.68 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 121.903 0.081 . . . . 52.04 110.974 173.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.25 -39.29 94.19 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.649 0.779 . . . . 72.31 109.64 167.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.31 -40.87 67.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.688 -1.142 . . . . 73.01 110.435 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -63.37 -44.95 93.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.805 0.442 . . . . 74.4 111.188 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -65.58 -35.75 81.74 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.904 -0.406 . . . . 63.45 109.904 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.28 -36.89 85.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.929 0.892 . . . . 72.23 111.045 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.44 -52.84 22.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.236 0.614 . . . . 51.34 110.633 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 99' ' ' VAL . 8.5 tp -73.89 -40.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.164 0.29 . . . . 75.15 110.986 -169.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -68.18 -35.27 77.75 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.283 -0.636 . . . . 74.45 109.283 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.19 94.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.643 -0.708 . . . . 54.53 113.342 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -66.33 -47.89 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.903 -0.776 . . . . 73.11 108.903 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.0 m -74.49 -30.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-N 115.582 -0.736 . . . . 70.44 111.88 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.47 -25.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 119.118 0.872 . . . . 73.15 110.068 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -81.77 -42.2 20.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.022 0.529 . . . . 74.41 111.232 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.499 HD21 HG21 ' A' ' 155' ' ' ILE . 54.7 tp -79.31 -23.95 43.17 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.124 0.969 . . . . 72.43 112.118 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 41.3 mt -93.4 4.4 54.03 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.841 0.456 . . . . 72.14 111.63 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 99.75 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.331 0.652 . . . . 74.22 111.141 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 13.4 ptmm? -51.68 -39.8 58.93 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.863 1.801 . . . . 74.51 115.863 -162.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.31 -29.53 66.28 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.891 0.7 . . . . 74.41 112.891 -163.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -111.51 -29.75 7.64 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.401 0.519 . . . . 51.41 112.401 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.48 -2.22 58.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.495 0.924 . . . . 64.33 113.495 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.444 ' HG3' ' SG ' ' A' ' 81' ' ' CYS . 26.5 ttpp -51.07 -24.63 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 112.546 0.573 . . . . 65.43 112.546 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.15 25.94 3.99 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.152 0.981 . . . . 75.53 111.66 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.08 142.07 28.19 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.424 -0.954 . . . . 74.43 108.424 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.28 110.51 22.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.341 -1.355 . . . . 55.55 107.341 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.36 143.11 26.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.717 -1.216 . . . . 71.35 107.717 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -137.48 137.38 38.63 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.765 -0.828 . . . . 61.54 108.765 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 tt -109.9 148.15 13.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.355 0 N-CA-C 106.73 -1.582 . . . . 72.12 106.73 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.634 ' HA2' HD22 ' A' ' 76' ' ' LEU . . . -48.37 130.48 20.23 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 124.386 1.053 . . . . 71.04 112.766 175.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 11.0 tp10 -56.98 -38.28 72.79 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.21 0.604 . . . . 73.13 110.923 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -71.54 -35.25 70.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.959 0.904 . . . . 73.14 109.259 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 9' ' ' THR . . . -65.12 -42.76 93.62 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.255 -0.884 . . . . 63.3 110.628 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -19.52 65.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.287 0.635 . . . . 73.13 112.593 -176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 49.8 mt-10 -79.75 -23.12 42.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.942 0.497 . . . . 63.23 111.928 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.86 49.06 0.08 OUTLIER Glycine 0 C--N 1.348 1.243 0 C-N-CA 121.288 -0.482 . . . . 71.22 113.867 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.96 98.53 0.29 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.858 0.863 . . . . 72.34 110.731 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.57 14.39 4.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.479 0.711 . . . . 65.11 111.221 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.61 -3.78 29.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.281 1.032 . . . . 75.24 111.006 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.68 163.83 35.74 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.891 0.744 . . . . 73.31 114.871 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -78.77 141.62 37.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.043 0.937 . . . . 71.34 112.479 -172.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.05 111.03 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 123.347 0.659 . . . . 63.31 110.028 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.521 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.54 111.36 5.32 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.849 -1.069 . . . . 34.34 108.78 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.499 HG21 HD21 ' A' ' 127' ' ' LEU . 63.0 mt -92.77 124.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.44 -0.948 . . . . 75.23 108.44 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 68' ' ' ILE . 49.7 mm -109.39 111.29 35.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 109.362 -0.607 . . . . 75.51 109.362 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.26 116.15 26.26 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.726 0.641 . . . . 74.13 109.831 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -69.86 88.54 0.56 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.669 1.187 . . . . 74.35 109.304 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -94.65 134.06 37.63 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.149 -0.97 . . . . 71.02 109.816 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.4 102.71 15.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.909 0.484 . . . . 55.33 110.109 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.8 p -90.19 92.31 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 N-CA-C 108.295 -1.002 . . . . 72.31 108.295 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.68 -66.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.914 1.685 . . . . 54.23 111.514 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -163.89 29.05 0.23 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.764 -0.934 . . . . 75.3 110.764 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 98.5 m -135.73 148.08 48.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.583 1.153 . . . . 54.41 108.032 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.53 136.44 36.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.286 0.494 . . . . 73.33 110.054 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.29 112.75 18.22 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.342 1.057 . . . . 73.02 108.271 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 115.4 3.62 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.183 1.922 . . . . 53.42 111.666 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.4 p -111.35 108.66 18.32 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.095 -1.076 . . . . 51.44 108.095 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 19.5 tp -75.96 120.37 21.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.719 0.807 . . . . 71.33 109.538 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.5 mtt -100.1 122.2 42.6 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 123.783 0.833 . . . . 73.45 109.117 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.534 HD13 HD11 ' A' ' 176' ' ' ILE . 42.6 mt -141.07 140.16 34.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.353 1.461 . . . . 73.45 107.487 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 99' ' ' VAL . 10.5 p -81.77 147.59 6.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.395 -0.594 . . . . 62.44 109.395 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -51.06 -44.93 61.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.813 1.245 . . . . 64.43 112.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -82.29 3.65 26.83 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.419 0.896 . . . . 74.31 113.419 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 7' ' ' ILE . . . -105.93 -5.0 19.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.212 0.605 . . . . 33.11 111.474 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.534 HD11 HD13 ' A' ' 171' ' ' LEU . 48.2 mm -122.79 143.97 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.448 0.699 . . . . 74.1 110.006 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.729 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 41.3 mm -98.62 109.68 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 N-CA-C 106.905 -1.517 . . . . 74.53 106.905 168.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HG2' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -130.19 116.68 18.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.873 0.869 . . . . 74.24 109.575 -171.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -141.28 132.4 26.31 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.191 0.597 . . . . 70.3 109.872 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -76.94 102.8 6.55 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.999 -0.741 . . . . 71.53 108.999 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.7 t -77.73 87.67 3.99 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.403 0.621 . . . . 72.53 110.082 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.9 mt -87.35 92.66 9.15 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.514 -0.921 . . . . 71.34 108.514 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.467 0.707 . . . . 71.12 109.206 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 49.9 ttm . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 108.279 -1.008 . . . . 61.01 108.279 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 mt -91.87 139.77 30.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.442 -0.577 . . . . 42.14 109.442 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 179' ' ' GLU . 4.0 tt -110.09 117.88 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.448 -0.945 . . . . 65.22 108.448 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.509 ' HD1' ' HB2' ' A' ' 14' ' ' SER . 0.9 OUTLIER -103.09 123.0 45.83 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.309 -1.737 . . . . 72.0 106.309 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -124.14 151.86 43.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.572 0.749 . . . . 75.13 109.899 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 38.8 t70 -99.5 174.67 6.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.577 -0.897 . . . . 64.51 108.577 173.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.6 tt -72.99 -34.73 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.356 0.662 . . . . 52.05 110.995 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.4 -48.45 2.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.093 0.957 . . . . 62.51 109.872 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -88.33 16.37 6.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.143 -1.39 . . . . 73.45 111.394 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 5.8 p-10 -52.7 -39.01 61.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.312 1.045 . . . . 74.22 112.841 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.23 -25.86 67.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.177 -0.919 . . . . 74.45 111.502 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -105.8 -1.61 24.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.599 0.759 . . . . 74.33 112.469 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mt -84.96 -154.45 0.18 Allowed 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.453 1.024 . . . . 73.31 110.309 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.509 ' HB2' ' HD1' ' A' ' 4' ' ' TYR . 15.1 m -115.45 124.54 51.4 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.248 0.462 . . . . 62.33 112.248 -158.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -116.5 85.2 2.26 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.206 -0.665 . . . . 64.2 109.206 168.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -166.03 -105.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.529 -0.76 . . . . 72.23 109.388 -172.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 p -177.91 84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.08 0.952 . . . . 55.04 108.642 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -115.75 129.5 25.11 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.315 1.046 . . . . 61.22 109.264 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.87 135.81 43.2 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.078 2.518 . . . . 72.12 112.188 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.28 162.78 37.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.047 -0.524 . . . . 51.33 111.042 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 4.8 ttmp? -144.89 159.56 42.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.784 0.833 . . . . 72.33 109.389 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.23 128.58 50.2 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.325 -0.991 . . . . 75.42 108.325 168.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -120.54 146.15 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.901 0.88 . . . . 73.41 109.817 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 t70 67.52 5.72 4.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.576 1.15 . . . . 73.14 113.153 167.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.56 18.35 6.93 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.597 1.159 . . . . 74.0 111.294 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 119' ' ' LYS . 52.8 tp -129.54 -50.03 1.16 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.004 -0.544 . . . . 64.22 111.131 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.3 t -110.79 124.12 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.4 0.619 . . . . 74.45 110.47 -172.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -85.34 115.8 23.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 114.816 -1.083 . . . . 64.44 108.598 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 21' ' ' LYS . 42.0 mt-10 -89.33 149.34 23.07 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.882 0.873 . . . . 64.34 110.534 173.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.747 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 35.9 t80 -139.84 142.5 36.6 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.875 -1.157 . . . . 75.23 107.875 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.02 120.72 14.13 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.273 0.358 . . . . 74.42 111.672 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.8 157.71 14.78 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.201 -1.16 . . . . 73.42 110.201 166.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -144.9 147.32 32.64 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.598 -0.89 . . . . 71.43 108.598 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -87.59 109.18 19.46 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.624 -0.88 . . . . 65.43 108.624 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 HD12 ' A' ' 72' ' ' LEU . 18.5 m -145.22 174.3 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.612 1.165 . . . . 74.54 109.876 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 66' ' ' ARG . 25.7 m -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.339 -0.615 . . . . 63.34 109.339 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -120.05 107.58 13.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.591 -0.892 . . . . 64.23 108.591 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD2' HG22 ' A' ' 64' ' ' VAL . 63.9 tttp -134.83 96.19 3.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.143 -1.058 . . . . 64.15 108.143 166.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 60.02 -66.36 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.564 1.546 . . . . 75.44 112.2 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.02 43.89 0.19 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.662 -0.975 . . . . 74.33 110.662 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -113.93 100.15 8.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.065 0.946 . . . . 72.13 109.448 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 CA--C 1.554 1.119 0 CA-C-O 122.823 1.297 . . . . 71.01 110.335 -177.121 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.421 HG22 ' HD2' ' A' ' 38' ' ' LYS . 58.0 t . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 108.061 -1.088 . . . . 71.01 108.061 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 72' ' ' LEU . 30.4 mm-40 -88.0 70.76 9.42 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.231 -0.895 . . . . 64.32 108.612 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HA ' HG12 ' A' ' 36' ' ' VAL . 8.1 ptp180 -85.14 139.05 32.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.677 -0.692 . . . . 75.54 110.936 172.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.36 -126.68 2.75 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.289 -0.414 . . . . 33.42 112.152 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 34.6 pt -113.83 142.41 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.383 0.673 . . . . 70.21 112.763 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.6 -46.61 2.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.989 2.116 . . . . 72.33 114.402 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 156' ' ' ILE . 29.5 mm -54.3 -43.19 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.937 0.875 . . . . 75.22 111.023 -176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.6 t -83.2 -40.36 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.388 -1.278 . . . . 73.24 112.402 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 16.5 mt -74.22 -32.33 62.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.063 0.459 . . . . 72.51 110.572 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -78.25 -24.37 46.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.642 0.777 . . . . 75.41 111.535 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -122.47 -6.71 8.69 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.816 0.673 . . . . 55.04 112.816 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 45.0 tptt 54.63 70.32 0.63 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.111 1.364 . . . . 52.41 110.928 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -96.04 139.35 32.34 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.215 -0.902 . . . . 71.3 109.038 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.649 HG13 HG23 ' A' ' 140' ' ' ILE . 4.0 p -89.85 133.61 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.049 -0.723 . . . . 71.23 109.049 174.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.425 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 pt-20 -56.54 152.48 11.71 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.933 0.893 . . . . 71.32 113.274 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.7 tpt -148.44 144.6 27.53 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 125.206 1.402 . . . . 74.12 107.481 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -137.52 151.48 48.47 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.207 0.527 . . . . 74.52 111.327 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 26.0 p -88.86 -2.16 58.45 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.143 -0.935 . . . . 73.43 111.327 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -75.52 -61.81 1.79 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.022 0.749 . . . . 74.42 113.022 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -103.96 -35.04 8.27 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.389 0.676 . . . . 75.14 110.439 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.29 20.6 2.32 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 70.32 112.094 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' CYS . . . -55.01 -35.35 64.31 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.38 1.072 . . . . 75.24 113.252 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.1 m -70.03 -44.68 68.75 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 73.4 111.058 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -70.43 -42.1 72.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.42 109.855 -176.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.423 ' HE2' HD22 ' A' ' 128' ' ' LEU . 53.2 t80 -68.48 -32.44 72.43 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.463 -1.244 . . . . 53.04 111.36 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -64.14 -34.92 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.888 0.475 . . . . 61.33 110.522 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -39.4 88.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.696 -0.683 . . . . 72.24 109.855 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -69.11 -33.54 73.66 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.765 0.654 . . . . 72.2 112.765 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -62.91 -41.24 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.957 0.503 . . . . 53.52 110.788 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -59.21 -44.66 92.25 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.653 0.595 . . . . 75.52 110.15 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -60.25 4.01 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 114.87 -1.059 . . . . 74.13 109.619 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -49.25 -62.5 1.5 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.925 1.69 . . . . 60.4 112.955 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.55 -44.64 90.14 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.559 0.537 . . . . 75.11 111.618 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -66.77 -36.11 81.65 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 118.296 0.498 . . . . 74.22 110.674 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.26 -53.21 59.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.103 0.961 . . . . 52.43 110.47 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.3 m -78.69 -29.66 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.341 -0.845 . . . . 54.43 112.186 -170.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.55 -40.67 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.787 -0.449 . . . . 73.43 109.787 172.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.32 -36.88 79.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.79 0.836 . . . . 71.02 111.227 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -66.09 -42.57 89.13 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.257 0.623 . . . . 73.33 109.563 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.516 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 27.0 ttt -66.32 -37.06 84.49 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 116.009 -0.541 . . . . 64.44 111.154 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.649 0.78 . . . . 73.33 111.458 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -84.17 -37.63 21.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.35 0.26 . . . . 63.41 111.372 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.45 ' OD1' ' HA ' ' A' ' 103' ' ' MET . 1.8 p-10 -96.78 5.25 50.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.173 -0.329 . . . . 74.04 111.823 -175.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.85 -50.3 1.14 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.656 0.782 . . . . 74.14 109.742 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 49.28 21.67 0.57 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.868 1.667 . . . . 74.13 112.994 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.2 131.47 51.47 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.686 1.195 . . . . 75.31 108.354 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -63.65 -45.06 91.9 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.281 0.988 . . . . 73.5 111.843 -173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.55 76.19 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.04 0.536 . . . . 72.41 112.115 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.81 -45.37 51.81 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.846 0.459 . . . . 72.2 111.22 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.67 -30.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 123.655 0.597 . . . . 74.42 111.338 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -41.78 76.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.325 0.65 . . . . 74.31 111.072 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.78 -42.45 86.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.01 0.433 . . . . 74.35 110.2 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.424 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 88.3 t80 -67.0 -42.13 85.54 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.036 -0.984 . . . . 60.5 110.762 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 64.3 tttp -53.87 -47.08 71.4 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.996 0.81 . . . . 73.24 110.102 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -65.88 -39.54 90.76 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.736 1.273 . . . . 75.3 109.789 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HB3' HD13 ' A' ' 26' ' ' LEU . 8.8 tptp -69.22 -49.17 58.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.287 0.635 . . . . 75.33 109.638 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 tp -74.56 -42.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.991 -0.55 . . . . 64.5 110.874 -170.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 12.5 pt20 -66.07 -39.47 90.08 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 109.572 -0.529 . . . . 73.51 109.572 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.73 99.23 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.501 0.5 . . . . 71.21 112.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -67.82 -50.99 53.71 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 118.98 -0.534 . . . . 71.45 109.935 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.529 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.7 m -68.32 -43.3 84.5 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 O-C-N 123.654 0.596 . . . . 73.44 111.299 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 -25.56 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.083 0.553 . . . . 74.41 110.894 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -77.67 -40.52 41.29 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.878 0.471 . . . . 73.02 110.575 167.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 155' ' ' ILE . 41.0 tp -73.71 -28.42 61.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.917 1.287 . . . . 72.52 111.5 -171.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 83.9 mt -84.37 1.55 44.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.722 0.809 . . . . 72.11 111.082 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.83 85.37 2.2 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 123.455 0.702 . . . . 75.31 109.416 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -55.67 -29.49 59.41 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.679 1.592 . . . . 75.2 114.556 -166.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.33 -22.8 61.12 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.349 0.5 . . . . 72.14 112.349 -171.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -103.18 -51.34 3.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.071 0.948 . . . . 72.24 108.806 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -76.96 0.24 21.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.697 1.599 . . . . 73.4 114.9 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -46.25 -7.44 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.435 1.642 . . . . 55.53 115.435 171.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -82.18 9.76 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.955 0.902 . . . . 63.42 111.339 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.02 148.07 23.29 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.736 0.814 . . . . 63.23 109.089 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.444 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . . . -138.92 116.07 11.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.19 -1.781 . . . . 75.24 106.19 170.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -89.15 147.63 24.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.29 -1.004 . . . . 64.34 108.29 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 78' ' ' GLU . 75.7 m-85 -141.27 143.15 33.95 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.389 -0.597 . . . . 63.4 109.389 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.649 HG23 HG13 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -123.61 138.01 54.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 105.174 -2.158 . . . . 73.11 105.174 176.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.92 126.28 39.68 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.125 -0.82 . . . . 62.31 111.336 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -56.75 -38.56 72.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 75.4 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -57.26 -47.09 82.3 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.628 1.171 . . . . 74.05 111.253 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.43 84.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.325 0.65 . . . . 72.42 111.149 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.0 -3.59 16.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.653 -0.703 . . . . 64.43 112.237 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -104.9 -18.02 14.35 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.319 1.048 . . . . 64.41 110.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.71 -74.32 0.01 OUTLIER Glycine 0 C--N 1.355 1.594 0 O-C-N 122.307 -0.246 . . . . 64.14 112.778 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.25 80.24 9.13 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.534 0.734 . . . . 70.43 109.809 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.01 1.56 2.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.29 1.036 . . . . 70.41 113.587 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -97.89 9.06 43.66 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.983 0.913 . . . . 75.14 110.624 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.04 154.62 43.76 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.796 0.685 . . . . 52.43 112.718 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -85.61 143.91 28.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 74.21 111.077 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.14 116.34 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.295 0.638 . . . . 62.04 110.636 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.35 113.95 7.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.745 1.218 . . . . 43.51 109.721 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.548 HG21 HD21 ' A' ' 127' ' ' LEU . 75.1 mt -91.59 109.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.217 -0.66 . . . . 71.14 109.217 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 169' ' ' LEU . 40.0 mm -96.71 144.7 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.431 -0.581 . . . . 64.43 109.431 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.99 109.66 9.71 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.251 -1.018 . . . . 61.32 108.251 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.65 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 6.2 p90 -83.4 91.96 7.46 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.352 -1.351 . . . . 74.42 107.352 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.518 ' HB3' HG13 ' A' ' 166' ' ' VAL . 7.5 tpt180 -74.4 91.61 2.24 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.158 -1.383 . . . . 74.44 108.72 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.35 112.44 5.22 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.21 -0.905 . . . . 74.42 110.904 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.48 92.08 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.526 1.13 . . . . 63.3 108.581 168.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 t70 46.35 61.87 2.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.568 1.547 . . . . 75.1 112.515 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.92 -12.8 68.68 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-N 115.515 -0.766 . . . . 73.34 113.441 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.18 106.97 17.71 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.004 -0.739 . . . . 74.33 109.004 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 14.4 pt-20 -73.31 141.09 47.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.484 -0.561 . . . . 71.11 109.484 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.518 HG13 ' HB3' ' A' ' 159' ' ' ARG . 3.7 p -127.27 91.29 46.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 108.199 -1.037 . . . . 61.1 108.199 166.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 52.1 Cg_exo -56.24 143.51 84.99 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.148 2.565 . . . . 61.33 112.663 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.1 m -145.87 126.47 14.21 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 65.22 108.576 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.7 tp -77.35 130.33 37.0 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.416 -0.957 . . . . 51.1 108.416 170.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.6 mtt -128.85 123.8 33.67 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.188 0.995 . . . . 75.23 108.622 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 154' ' ' ALA . 79.7 mt -141.32 170.89 14.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.878 1.671 . . . . 64.32 106.512 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 174' ' ' GLU . 11.8 p -83.42 147.22 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 108.836 -0.802 . . . . 72.11 108.836 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.91 -27.55 43.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.909 0.884 . . . . 74.22 112.456 175.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 12.8 tp10 -85.56 -2.44 58.15 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.768 0.827 . . . . 73.4 111.574 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.99 -11.99 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.859 0.864 . . . . 74.04 110.159 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.2 mm -108.81 140.88 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.286 0.565 . . . . 72.51 110.879 -174.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.1 mm -124.08 109.19 22.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.444 1.498 . . . . 64.51 107.192 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.68 121.02 31.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.568 -0.901 . . . . 64.55 108.568 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.673 ' HB3' HG23 ' A' ' 3' ' ' ILE . 33.6 tt0 -121.92 116.01 23.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.185 -1.043 . . . . 73.24 108.185 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.04 109.85 22.16 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.166 0.508 . . . . 71.24 111.609 -170.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 1' ' ' MET . 47.7 t -100.88 95.43 6.61 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.729 -0.841 . . . . 64.35 108.729 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.28 -35.35 0.55 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.137 0.975 . . . . 74.13 110.583 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 C--O 1.248 0.992 0 C-N-CA 123.736 0.814 . . . . 75.53 109.368 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttm . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.037 -0.727 . . . . 62.24 109.037 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 99.0 mt -123.21 133.92 54.18 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.365 0.266 . . . . 63.24 110.51 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 61.8 mt -106.55 117.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.668 -1.234 . . . . 54.54 107.668 170.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.625 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 91.5 m-85 -89.71 122.16 32.55 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.507 -0.923 . . . . 75.23 108.507 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.19 131.4 53.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.628 0.771 . . . . 52.13 110.776 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.553 ' HA ' HG12 ' A' ' 176' ' ' ILE . 25.0 t70 -90.34 174.44 7.58 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.334 1.021 . . . . 64.01 108.433 172.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 7' ' ' ILE . 8.3 mt -53.74 -58.97 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.184 0.594 . . . . 63.52 110.967 171.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -112.7 -23.1 10.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 65.12 111.517 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -98.24 14.12 28.91 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.998 0.919 . . . . 72.43 110.563 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.3 p-10 -48.28 -33.08 8.21 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 124.245 1.018 . . . . 54.43 113.422 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.56 -42.93 64.1 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.194 -0.912 . . . . 65.4 110.97 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.65 ' HB2' ' HG2' ' A' ' 143' ' ' ARG . 5.0 tp10 -121.25 24.72 9.89 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.188 0.595 . . . . 71.24 111.581 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 2.6 tm? -77.19 -81.88 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.11 -0.7 . . . . 75.53 109.11 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 53.1 m -157.4 -178.35 7.28 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.154 0.982 . . . . 61.51 110.386 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 73.4 p 177.3 -177.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.276 1.03 . . . . 54.51 111.397 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 85.91 -109.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.188 1.795 . . . . 53.24 111.634 165.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -144.04 42.39 1.42 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.86 -0.793 . . . . 75.13 108.86 -163.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -108.31 98.89 29.47 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.352 -0.84 . . . . 64.2 109.372 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.36 134.81 9.13 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 124.153 3.235 . . . . 53.03 114.978 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.15 146.55 42.18 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.125 -0.943 . . . . 70.42 108.596 174.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 66.6 mttm -110.66 157.45 19.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.198 -1.408 . . . . 54.22 107.198 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -130.73 108.06 9.61 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.629 -0.878 . . . . 74.02 108.629 175.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.48 127.46 50.98 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 109.018 -0.734 . . . . 73.32 109.018 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.2 t70 56.24 25.37 9.17 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.417 1.073 . . . . 74.45 112.485 175.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 53.11 16.02 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.063 1.135 . . . . 71.42 114.063 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 119' ' ' LYS . 34.5 tp -105.07 -51.48 3.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.947 0.499 . . . . 73.33 110.201 -174.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.469 HG11 ' SD ' ' A' ' 170' ' ' MET . 21.6 t -123.49 133.72 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 116.547 -0.297 . . . . 73.35 111.376 -168.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 m-85 -84.76 120.12 26.06 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.576 -0.898 . . . . 53.13 108.576 167.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 40.2 tt0 -99.06 103.18 15.09 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.696 -1.224 . . . . 74.04 107.696 170.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.724 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 30.7 t80 -94.21 141.2 28.83 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.848 1.259 . . . . 75.4 109.307 -169.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -71.49 139.88 49.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.837 0.855 . . . . 71.21 112.718 -169.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.29 149.73 17.13 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 114.768 -1.106 . . . . 23.5 111.257 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 69' ' ' ASP . 16.2 ptpt -126.93 161.41 28.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.961 0.904 . . . . 64.23 108.658 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -75.19 120.67 21.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.603 -0.517 . . . . 70.53 109.603 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 HD12 ' A' ' 72' ' ' LEU . 4.1 m -145.06 164.58 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.442 0.697 . . . . 74.03 110.486 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -94.89 160.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.217 -0.447 . . . . 51.12 110.765 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.4 ' HB3' HD22 ' A' ' 72' ' ' LEU . 60.0 ttt180 -142.74 112.44 6.87 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.912 -0.403 . . . . 72.41 109.912 169.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -125.27 140.21 53.03 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.468 -0.938 . . . . 75.44 108.468 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -26.41 65.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 123.388 0.43 . . . . 65.32 111.699 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.0 -61.7 4.44 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.657 0.598 . . . . 74.14 111.802 172.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.8 152.09 0.94 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.137 0.975 . . . . 73.35 108.719 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 CA--C 1.55 0.962 0 CA-C-O 121.397 0.618 . . . . 54.13 109.682 174.53 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.558 -0.164 . . . . 72.13 110.558 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 73.53 -57.71 0.62 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.327 1.851 . . . . 73.33 111.604 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -116.13 129.28 56.25 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.285 1.034 . . . . 75.1 109.082 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.08 -165.02 29.4 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.234 -0.984 . . . . 73.44 113.287 166.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 156' ' ' ILE . 26.4 pt -104.12 146.89 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 113.914 -1.143 . . . . 71.33 110.988 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 33' ' ' LYS . 10.9 t70 -48.2 -47.16 35.61 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.312 1.445 . . . . 50.55 112.614 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.632 HD13 ' HB2' ' A' ' 169' ' ' LEU . 67.6 mt -52.73 -45.65 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.073 -1.421 . . . . 52.22 111.333 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 76' ' ' LEU . 53.7 t -94.04 -28.56 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.017 0.527 . . . . 74.21 112.063 -173.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.505 HD12 HG23 ' A' ' 35' ' ' VAL . 84.2 mt -75.66 -18.67 59.57 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 122.227 -0.296 . . . . 72.23 110.31 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -95.37 -55.82 2.92 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.388 0.675 . . . . 73.21 110.638 172.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -86.79 3.32 45.65 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.755 0.422 . . . . 62.01 112.1 -171.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.704 ' HE3' ' HG3' ' A' ' 142' ' ' GLU . 34.4 ttpt 58.03 35.36 25.15 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.897 0.856 . . . . 75.35 111.682 165.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' HB2' HG22 ' A' ' 71' ' ' VAL . 59.2 mt -74.52 141.59 44.85 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.021 -0.536 . . . . 75.32 110.438 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.184 0.594 . . . . 74.15 110.36 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.26 145.27 42.05 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.75 1.389 . . . . 74.24 114.75 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.55 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 80.3 mtp -141.91 134.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.616 1.966 . . . . 70.41 105.813 171.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.535 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.2 m-80 -93.77 138.17 32.24 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.915 0.325 . . . . 72.04 110.204 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 29.7 p -67.08 -21.7 65.86 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.528 0.331 . . . . 41.12 111.28 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 64.0 m-85 -58.23 -52.75 64.27 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.978 -1.01 . . . . 71.24 110.567 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -105.28 -36.85 7.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.147 0.979 . . . . 73.55 112.847 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -91.91 18.95 7.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.596 0.759 . . . . 64.51 112.701 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.07 98.87 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.45 0.568 . . . . 44.3 111.194 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -65.63 -45.25 83.76 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.265 1.026 . . . . 73.25 111.467 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.09 -38.8 92.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.562 -0.745 . . . . 64.51 110.797 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -75.99 -28.91 58.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.956 0.902 . . . . 75.42 111.035 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -68.59 -38.38 80.62 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.497 -0.557 . . . . 64.02 109.497 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.4 98.89 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.778 -1.101 . . . . 70.22 110.477 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -59.09 -45.63 90.35 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.547 -0.751 . . . . 65.33 110.616 173.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.47 -40.37 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.699 . . . . 55.15 111.688 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -63.29 -45.42 91.49 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.627 0.371 . . . . 75.25 111.531 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -73.08 -47.06 47.78 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.73 -0.668 . . . . 74.41 110.893 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -53.51 -44.82 69.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.032 1.733 . . . . 75.24 111.201 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.1 ttm -59.04 -53.58 56.8 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.079 0.862 . . . . 70.52 110.521 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.173 -0.921 . . . . 73.11 110.933 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.82 -47.47 46.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.572 0.749 . . . . 62.45 112.254 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 175' ' ' ALA . 31.0 m -69.54 -34.06 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.044 0.538 . . . . 54.45 112.14 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.52 -35.14 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 123.168 0.292 . . . . 63.34 110.585 176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.92 -46.16 88.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.471 0.709 . . . . 72.24 110.077 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -62.51 -48.86 77.71 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.51 -0.768 . . . . 64.31 110.687 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.551 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.7 tpt -61.93 -38.75 89.6 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.717 0.807 . . . . 61.34 111.053 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.588 ' HA ' HG11 ' A' ' 113' ' ' VAL . 43.4 tt0 -71.88 -38.89 69.94 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.274 1.03 . . . . 74.34 110.27 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -80.51 -27.45 37.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.59 0.356 . . . . 53.42 111.609 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -82.28 -36.29 27.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.018 0.527 . . . . 63.12 110.839 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -101.13 -49.26 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.196 0.598 . . . . 73.45 110.945 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 70.24 4.24 4.78 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.37 1.248 . . . . 52.34 114.37 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -99.44 117.89 34.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.984 -0.747 . . . . 74.13 108.984 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -50.76 -45.17 58.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.991 1.316 . . . . 70.04 112.189 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.45 66.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.017 0.527 . . . . 75.22 112.417 -173.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.99 -45.26 18.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.67 0.388 . . . . 73.4 110.137 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.588 HG11 ' HA ' ' A' ' 104' ' ' GLU . 33.7 m -71.65 -23.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 116.368 -0.378 . . . . 74.43 111.248 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.05 -43.89 91.74 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.51 0.724 . . . . 71.32 110.534 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.44 -46.3 76.91 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.902 0.751 . . . . 61.53 110.164 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -57.6 -48.13 80.26 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.34 0.656 . . . . 71.1 111.787 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.67 -30.65 67.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.648 -0.501 . . . . 74.14 109.648 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -61.16 -45.1 96.02 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.735 -0.839 . . . . 55.13 108.735 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HB3' HD22 ' A' ' 26' ' ' LEU . 3.1 mptm? -65.52 -46.46 79.51 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 75.21 110.875 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 172' ' ' VAL . 26.7 mm -66.83 -42.06 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 119.319 -0.372 . . . . 54.0 110.495 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -54.77 -57.29 12.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.776 0.831 . . . . 62.14 109.999 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.7 -38.35 95.76 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.748 0.655 . . . . 45.34 113.259 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -64.69 -53.28 49.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.904 0.882 . . . . 75.41 110.442 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 120' ' ' ILE . 34.0 m -70.57 -30.48 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 119.276 -0.392 . . . . 64.53 111.553 -177.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.53 -41.46 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 118.501 0.591 . . . . 62.43 110.328 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.6 t -65.84 -43.5 88.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 120.96 0.41 . . . . 63.5 109.922 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.528 HD21 HG21 ' A' ' 155' ' ' ILE . 21.1 tp -73.11 -30.08 63.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.662 1.185 . . . . 73.34 112.221 -169.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.55 3.07 45.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.448 0.699 . . . . 65.22 111.951 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -67.62 150.97 48.07 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.458 0.703 . . . . 73.24 111.217 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -93.45 -28.7 15.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.086 1.143 . . . . 74.2 114.086 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.08 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.117 0.872 . . . . 74.35 113.267 -165.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -110.81 -32.87 6.7 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.213 0.605 . . . . 72.41 111.296 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 98.1 m-85 -78.17 -1.23 31.7 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.489 0.716 . . . . 63.03 112.038 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -55.59 -20.99 15.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.167 -0.333 . . . . 75.41 111.133 160.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -82.48 17.28 1.79 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.704 1.201 . . . . 74.15 110.856 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 156' ' ' ILE . 93.3 mt -89.8 148.05 23.44 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.079 -0.711 . . . . 54.01 109.079 170.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.75 126.45 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.739 -1.578 . . . . 42.53 106.739 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 11.1 m-85 -91.37 134.12 34.87 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.617 -0.512 . . . . 63.52 109.617 -171.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.27 151.91 50.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.298 0.639 . . . . 71.11 109.293 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.4 pt -137.16 170.7 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.317 -0.994 . . . . 74.41 108.317 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.64 44.42 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.872 -0.491 . . . . 61.43 111.872 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.704 ' HG3' ' HE3' ' A' ' 75' ' ' LYS . 10.7 mm-40 -53.24 -43.15 67.11 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.32 1.048 . . . . 75.2 112.259 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.65 ' HG2' ' HB2' ' A' ' 12' ' ' GLU . 3.0 mmt180 -65.67 -37.37 86.32 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.332 0.653 . . . . 75.12 110.353 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -59.86 -58.6 7.85 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.044 0.84 . . . . 53.01 109.136 173.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.85 -17.96 63.67 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.997 0.919 . . . . 72.11 113.084 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.49 -41.03 40.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 63.31 110.997 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.67 -26.43 0.03 OUTLIER Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.369 -0.378 . . . . 31.11 113.591 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -72.86 177.11 5.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.062 0.431 . . . . 71.14 111.229 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.09 -172.61 2.31 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 122.153 -0.342 . . . . 74.33 110.68 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.34 -49.95 12.67 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.14 0.793 . . . . 52.41 113.14 -161.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.09 -98.58 0.17 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.235 -0.746 . . . . 71.35 111.235 -156.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -121.93 144.09 49.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.155 0.582 . . . . 74.22 110.104 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 155' ' ' ILE . 89.2 t -75.96 133.09 31.91 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 108.433 -0.951 . . . . 72.43 108.433 166.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.43 97.16 0.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.645 -0.872 . . . . 71.42 108.645 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.528 HG21 HD21 ' A' ' 127' ' ' LEU . 55.3 mt -85.87 101.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 108.515 -0.92 . . . . 72.32 108.515 -171.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 68' ' ' ILE . 36.1 mm -91.85 140.22 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.036 -0.727 . . . . 74.11 109.036 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.41 105.47 7.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.232 -1.025 . . . . 73.14 108.232 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -73.5 88.77 1.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.396 -0.964 . . . . 63.2 108.396 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -92.68 174.14 7.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.425 1.49 . . . . 74.12 108.85 -165.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.75 138.73 54.54 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.258 0.623 . . . . 74.43 110.575 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.32 102.63 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 124.401 1.081 . . . . 72.22 109.302 169.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.5 t70 62.46 24.96 14.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 124.266 1.026 . . . . 72.33 112.474 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.12 -14.02 33.85 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 121.797 -0.564 . . . . 72.13 113.008 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -94.78 122.23 37.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.524 0.729 . . . . 74.11 110.336 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.94 116.18 13.14 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-O 121.151 0.5 . . . . 73.44 110.047 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.21 93.68 46.42 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 115.07 -0.968 . . . . 64.03 110.523 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.474 ' HG3' ' HB ' ' A' ' 68' ' ' ILE . 11.4 Cg_endo -52.48 121.52 9.2 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.623 2.882 . . . . 75.3 112.498 167.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.6 p -107.99 117.13 33.34 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.374 1.07 . . . . 72.21 108.429 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 17.4 tp -80.17 117.57 21.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.416 -0.587 . . . . 75.33 109.416 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.469 ' SD ' HG11 ' A' ' 27' ' ' VAL . 30.7 tpp -100.96 120.82 40.73 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 107.205 -1.406 . . . . 62.42 107.205 -175.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.448 HD22 HD12 ' A' ' 176' ' ' ILE . 84.0 mt -143.77 143.87 31.56 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.656 1.182 . . . . 74.13 109.207 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.498 HG21 HD11 ' A' ' 120' ' ' ILE . 15.0 p -91.07 138.32 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.972 0.805 . . . . 74.53 109.763 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.54 -26.45 67.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.323 1.449 . . . . 53.31 112.011 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 172' ' ' VAL . 10.0 mp0 -86.14 -0.97 56.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.134 0.574 . . . . 60.14 112.343 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -120.0 -18.75 8.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.605 0.762 . . . . 32.51 110.553 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' A' ' 6' ' ' ASP . 3.3 mt -136.64 139.58 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.336 0.654 . . . . 65.41 110.219 -172.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 30.8 mm -142.17 139.59 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.449 1.1 . . . . 71.24 108.114 -171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.02 143.01 34.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.27 0.557 . . . . 74.54 109.992 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.7 tp10 -101.33 109.39 21.23 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.098 -1.075 . . . . 61.42 108.098 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -69.84 98.04 1.18 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.886 0.741 . . . . 73.13 109.951 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.7 t -108.16 91.63 3.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.274 -1.01 . . . . 51.13 108.274 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.36 173.8 14.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.037 0.535 . . . . 75.41 110.634 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.254 1.332 0 CA-C-N 114.923 -1.035 . . . . 72.55 108.552 178.822 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.529 ' HG3' ' SG ' ' A' ' 181' ' ' CYS . 26.2 ptt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.946 0.403 . . . . 70.53 110.212 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 180' ' ' LYS . 95.6 mt -118.72 159.82 22.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.505 0.722 . . . . 72.42 110.067 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 56.3 mt -126.8 118.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 106.996 -1.483 . . . . 65.25 106.996 171.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.768 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 5.6 t80 -101.4 113.94 27.48 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.015 -1.106 . . . . 73.13 108.015 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -125.59 117.13 22.9 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.131 0.972 . . . . 72.53 110.295 -167.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.87 134.83 48.36 Favored 'General case' 0 C--O 1.205 -1.285 0 N-CA-C 108.344 -0.984 . . . . 71.42 108.344 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 pt -66.39 -5.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 113.293 0.849 . . . . 75.43 113.293 -170.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -107.94 -46.72 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.736 -0.838 . . . . 71.41 108.736 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 p -111.82 18.66 18.71 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.827 1.251 . . . . 74.0 112.456 -173.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -46.94 -42.22 17.4 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.183 1.793 . . . . 71.21 113.545 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -55.95 -39.13 71.29 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.89 1.369 . . . . 73.54 112.543 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -120.61 11.32 11.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.176 0.591 . . . . 74.42 111.458 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -95.9 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 112.871 0.693 . . . . 55.03 112.871 -163.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.768 ' HB3' ' HB3' ' A' ' 4' ' ' TYR . 35.5 t -158.21 178.44 10.18 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.93 0.787 . . . . 31.21 111.367 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 33.0 p 163.32 104.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.691 1.597 . . . . 74.51 109.377 -168.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -171.59 161.07 6.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.572 0.749 . . . . 73.43 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -68.87 83.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.391 0.676 . . . . 72.41 111.316 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.61 ' HZ ' ' HB2' ' A' ' 4' ' ' TYR . 3.8 p90 -127.18 159.09 66.93 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.906 0.882 . . . . 62.41 110.275 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.97 120.86 3.08 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.134 1.89 . . . . 65.12 112.883 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.6 ' HB2' ' HE2' ' A' ' 28' ' ' TYR . 17.8 ptm -87.71 157.88 18.95 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.052 0.541 . . . . 73.21 110.527 174.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -152.03 145.63 24.95 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.038 -0.727 . . . . 51.03 109.038 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.55 125.78 52.88 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.502 -0.925 . . . . 70.42 108.502 173.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.19 129.81 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.281 0.632 . . . . 71.32 110.268 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.92 23.74 6.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.151 1.38 . . . . 64.23 113.992 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 t70 54.76 26.83 8.04 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.829 0.852 . . . . 65.33 112.054 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.531 HD13 ' HE2' ' A' ' 119' ' ' LYS . 64.7 tp -135.1 -51.17 0.77 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.991 0.901 . . . . 73.23 110.483 -170.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -120.41 148.7 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.888 -1.506 . . . . 74.5 107.885 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.6 ' HE2' ' HB2' ' A' ' 20' ' ' MET . 44.6 t80 -86.18 139.39 31.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.244 -1.021 . . . . 72.42 108.244 170.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -123.61 129.37 51.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.805 0.842 . . . . 74.42 109.695 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.729 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 48.8 t80 -114.31 124.68 52.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.128 0.571 . . . . 73.22 109.473 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.46 95.74 8.36 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.942 -0.762 . . . . 75.43 108.942 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.3 176.56 46.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.751 -0.659 . . . . 72.32 112.464 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -125.13 158.06 34.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.355 0.662 . . . . 72.43 109.629 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -90.59 117.57 29.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.194 -0.669 . . . . 61.01 109.194 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 72' ' ' LEU . 19.7 m -143.49 153.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.494 0.664 . . . . 71.1 110.098 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.6 127.53 66.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.544 -1.28 . . . . 52.42 107.544 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 10.7 tpt180 -105.3 108.55 20.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 106.677 -1.601 . . . . 73.23 106.677 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -106.26 96.59 6.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.895 -0.78 . . . . 70.4 108.895 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 46.64 58.46 4.63 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.087 1.355 . . . . 72.52 111.962 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.97 -33.09 3.86 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.937 -1.029 . . . . 74.34 113.657 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -93.19 116.16 28.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.45 1.1 . . . . 73.42 110.033 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.1 tt . . . . . 0 CA--C 1.55 0.947 0 N-CA-C 109.048 -0.723 . . . . 75.22 109.048 172.525 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 107.682 -1.229 . . . . 71.14 107.682 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.652 ' HB3' HD22 ' A' ' 72' ' ' LEU . 40.9 mt-10 -94.16 62.07 2.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.51 -0.768 . . . . 73.52 109.538 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -74.93 127.7 33.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.136 -0.938 . . . . 74.15 109.301 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.29 -134.74 3.65 Favored Glycine 0 C--N 1.343 0.919 0 O-C-N 123.512 0.508 . . . . 72.22 112.416 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 27.0 pt -111.9 151.75 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.86 0.864 . . . . 75.45 110.906 177.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.11 -35.1 74.5 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.366 1.066 . . . . 64.23 112.73 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 169' ' ' LEU . 47.7 mt -53.88 -46.53 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.56 1.144 . . . . 65.53 110.497 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 76' ' ' LEU . 55.1 t -75.97 -44.32 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 113.898 -1.501 . . . . 62.23 111.888 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.652 HD22 ' HB3' ' A' ' 65' ' ' GLU . 55.5 mt -66.16 -32.04 73.25 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.642 0.589 . . . . 71.32 111.18 -175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.94 -52.36 66.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.278 1.031 . . . . 75.51 111.846 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -89.42 -22.85 22.33 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 116.18 -0.463 . . . . 75.23 111.663 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 mmmp? 69.28 70.36 0.26 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.225 1.01 . . . . 75.32 109.836 -166.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.67 ' HB2' HG13 ' A' ' 71' ' ' VAL . 76.0 mt -85.66 151.74 23.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.8 -1.091 . . . . 73.31 109.269 173.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.689 HG11 ' HB2' ' A' ' 145' ' ' ALA . 11.3 p -90.54 138.43 19.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 N-CA-C 109.111 -0.7 . . . . 73.05 109.111 170.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.43 138.85 57.93 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.074 0.859 . . . . 74.11 109.922 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 33.7 tpp -132.42 103.03 5.98 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 105.572 -2.01 . . . . 73.03 105.572 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' HB2' ' A' ' 82' ' ' TYR . 20.7 t-20 -63.89 113.59 3.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.183 -1.826 . . . . 73.45 111.18 -170.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.407 ' SG ' ' CD2' ' A' ' 133' ' ' PHE . 41.5 t -59.05 -33.51 70.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.431 1.092 . . . . 65.2 111.345 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.44 ' HB2' ' OD1' ' A' ' 80' ' ' ASN . 60.8 m-85 -68.13 -29.65 68.61 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 113.919 -1.491 . . . . 75.14 110.75 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -104.87 -33.11 8.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.935 0.894 . . . . 51.31 112.445 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.32 19.52 15.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.314 0.646 . . . . 74.43 111.791 -162.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.59 72.52 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 112.205 0.446 . . . . 73.13 112.205 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.2 m -72.49 -43.89 63.03 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.275 0.63 . . . . 63.33 111.292 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 mmt -70.75 -29.72 66.03 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.463 0.305 . . . . 74.45 110.514 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.578 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 81.0 t80 -67.52 -32.67 73.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 45.11 110.172 173.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -64.61 -36.9 85.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.792 0.437 . . . . 73.21 110.002 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.12 82.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.065 0.546 . . . . 50.31 111.153 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.578 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 54.1 m-85 -69.85 -34.59 73.83 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 118.914 -0.565 . . . . 74.23 111.998 173.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.597 HG13 HD21 ' A' ' 128' ' ' LEU . 35.7 mm -66.11 -36.16 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.294 0.638 . . . . 74.2 110.577 174.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -57.52 -46.83 83.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.354 0.662 . . . . 73.0 111.11 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.58 -44.95 73.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.053 0.541 . . . . 71.33 110.704 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -47.78 -65.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.49 1.916 . . . . 73.43 111.078 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 70.9 mtp -63.09 -44.06 96.76 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.728 0.811 . . . . 74.15 111.384 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -57.85 -49.9 75.11 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.656 0.597 . . . . 72.15 110.97 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.08 -43.84 70.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.856 -1.066 . . . . 74.11 111.283 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 172' ' ' VAL . 34.3 m -69.18 -38.93 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 112.862 0.689 . . . . 63.32 112.862 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.45 -43.19 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.421 -0.585 . . . . 72.43 109.421 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 14.7 t70 -56.83 -41.09 77.25 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.231 0.957 . . . . 72.25 109.939 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -58.87 -48.07 82.7 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.386 1.074 . . . . 70.31 109.724 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.624 ' HB3' HG12 ' A' ' 113' ' ' VAL . 96.0 mmm -62.42 -36.18 81.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.338 -0.846 . . . . 74.33 111.263 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.07 -24.84 62.41 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.428 0.691 . . . . 73.21 111.494 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 29.5 mtpp -81.39 -49.89 10.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.923 0.489 . . . . 74.11 110.431 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -84.2 -14.03 51.16 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.302 0.641 . . . . 72.34 112.659 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -140.05 -59.64 0.54 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.108 0.413 . . . . 74.04 111.063 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 69.35 15.64 8.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.756 1.222 . . . . 75.44 112.479 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.16 114.58 19.17 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.473 -0.936 . . . . 63.55 108.473 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -57.24 -42.68 81.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.112 0.965 . . . . 73.32 112.249 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.17 87.87 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.571 0.544 . . . . 65.15 111.234 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.91 -42.44 48.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.32 0.648 . . . . 70.05 110.766 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' A' ' 103' ' ' MET . 33.0 m -72.83 -28.55 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.05 0.54 . . . . 70.22 110.67 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 26.5 t70 -67.95 -43.92 77.95 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 123.6 0.562 . . . . 75.53 109.889 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -42.51 94.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.698 0.624 . . . . 75.13 109.946 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -44.12 97.78 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.849 0.86 . . . . 72.2 110.918 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -39.02 85.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.07 0.948 . . . . 75.0 110.504 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 57.5 mtpt -71.87 -36.9 70.24 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.886 0.741 . . . . 72.44 110.885 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.531 ' HE2' HD13 ' A' ' 26' ' ' LEU . 60.1 mtpt -64.28 -44.45 91.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.045 0.538 . . . . 60.14 109.992 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.0 -44.56 96.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 C-N-CA 123.732 0.813 . . . . 75.21 109.897 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.423 ' O ' HG22 ' A' ' 125' ' ' VAL . 7.2 tp-100 -56.35 -51.11 69.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.022 0.929 . . . . 71.41 110.649 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.58 98.2 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.14 0.9 . . . . 61.21 113.264 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -62.91 -49.92 72.88 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.867 0.467 . . . . 73.43 109.746 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 32.9 m -67.21 -49.03 76.4 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.338 0 CA-C-O 117.531 -1.223 . . . . 74.12 110.488 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 121' ' ' GLN . 33.4 m -64.16 -31.16 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 120.107 1.321 . . . . 63.42 112.002 -176.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.7 m -72.09 -37.54 69.55 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.672 0.389 . . . . 71.12 110.361 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.563 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 40.5 tp -77.32 -26.06 51.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.316 1.046 . . . . 65.32 111.171 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.597 HD21 HG13 ' A' ' 92' ' ' ILE . 95.0 mt -85.45 2.51 44.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.39 1.076 . . . . 74.21 111.447 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.87 147.8 40.73 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.143 -0.688 . . . . 51.11 109.143 170.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 40.7 ttmt -69.29 -13.4 62.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.081 0.552 . . . . 71.21 111.212 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.2 -45.57 87.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.493 0.717 . . . . 61.23 110.068 168.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 5.1 mpt_? -78.38 -47.45 17.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.061 -0.972 . . . . 74.35 110.413 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.643 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.2 m-85 -57.84 -25.97 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.746 0.818 . . . . 54.15 112.673 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.12 -36.06 78.72 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.607 0.763 . . . . 63.44 110.905 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.62 -7.96 19.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.918 1.287 . . . . 71.05 111.281 -177.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 63.1 mt -88.54 139.59 30.33 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.649 0.737 . . . . 72.34 110.939 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.66 124.81 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 105.798 -1.926 . . . . 61.41 105.798 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.568 ' HB3' HG11 ' A' ' 153' ' ' VAL . 21.8 m-85 -95.88 140.5 30.56 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.818 -0.808 . . . . 62.24 108.818 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -138.34 138.44 38.32 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.411 -0.589 . . . . 54.42 109.411 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.21 175.66 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.562 -0.903 . . . . 74.11 108.562 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.1 120.04 20.43 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.222 -0.751 . . . . 30.03 111.222 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.37 -18.31 16.9 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.312 0.856 . . . . 63.11 113.312 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -68.7 -40.42 80.0 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.376 0.671 . . . . 75.24 109.656 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 149' ' ' GLU . . . -80.41 -6.03 57.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.165 0.986 . . . . 63.14 112.491 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.689 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -70.16 2.17 3.97 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.698 0.799 . . . . 63.31 112.484 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -24.59 61.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.026 0.93 . . . . 71.53 110.448 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.01 -64.31 0.01 OUTLIER Glycine 0 C--N 1.354 1.579 0 CA-C-N 116.113 -0.494 . . . . 71.43 112.221 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -163.27 146.02 10.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.949 0.5 . . . . 73.44 110.628 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.454 ' HA ' ' HB1' ' A' ' 144' ' ' ALA . 10.9 tp10 -71.18 -41.29 70.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.115 0.566 . . . . 65.0 110.557 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.566 ' H ' ' HE1' ' A' ' 91' ' ' TYR . 80.0 m-20 59.99 44.12 13.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.016 0.926 . . . . 73.14 110.805 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.34 -150.9 5.77 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.03 -0.986 . . . . 63.33 110.827 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.63 140.36 31.35 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.716 -0.846 . . . . 75.44 108.716 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 138' ' ' PHE . 94.0 t -87.18 142.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.82 0.848 . . . . 53.33 109.897 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.79 97.51 0.16 Allowed 'General case' 0 C--O 1.245 0.821 0 N-CA-C 108.942 -0.762 . . . . 62.14 108.942 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.489 HG21 HD21 ' A' ' 127' ' ' LEU . 75.9 mt -85.31 101.58 9.94 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.916 -1.142 . . . . 73.23 107.916 -173.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.57 114.16 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.237 0.615 . . . . 72.34 109.39 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -112.23 103.77 11.94 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.459 -0.941 . . . . 74.42 108.459 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 6.5 p90 -81.73 94.45 7.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.754 -0.832 . . . . 74.42 108.754 -174.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -90.28 155.06 19.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.257 -0.645 . . . . 74.25 109.257 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -103.95 123.76 47.75 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 110.106 -0.331 . . . . 70.11 110.106 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.71 116.21 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.592 -0.892 . . . . 33.24 108.592 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.18 15.16 7.25 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.213 1.005 . . . . 63.24 112.285 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 94.78 25.33 15.37 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 121.887 -0.508 . . . . 74.53 112.892 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.3 m -121.74 130.61 53.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.497 0.719 . . . . 61.32 110.431 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.76 98.62 7.85 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.808 -0.812 . . . . 73.14 108.808 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.46 95.62 19.71 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.823 0.849 . . . . 74.31 109.796 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 59.9 Cg_endo -68.2 129.54 19.52 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 122.538 2.159 . . . . 44.34 111.389 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.8 p -109.85 110.2 21.09 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.797 -0.816 . . . . 62.55 108.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.729 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -79.1 112.54 16.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.456 -0.793 . . . . 75.33 109.382 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.47 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.0 mtt -100.83 122.32 43.22 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 107.876 -1.157 . . . . 73.14 107.876 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 mt -141.62 130.93 23.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.544 -1.65 . . . . 44.1 106.544 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 99' ' ' VAL . 3.9 p -69.09 137.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.005 0.522 . . . . 65.24 110.431 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tmpt? -60.27 -35.48 75.61 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 74.54 111.827 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -70.32 -6.01 32.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.429 0.9 . . . . 72.13 113.429 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.08 -6.37 6.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.223 0.609 . . . . 71.31 111.933 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.6 tp -124.98 143.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.433 0.635 . . . . 71.34 110.128 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 40.6 mm -130.93 110.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.449 -1.315 . . . . 70.34 107.449 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.87 127.46 42.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.138 -1.06 . . . . 64.42 108.138 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 23.5 mm-40 -115.04 114.75 25.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.382 0.673 . . . . 73.21 111.568 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' A' ' 2' ' ' LEU . 33.2 mtmm -83.4 96.68 8.62 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.465 0.706 . . . . 74.31 109.915 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.529 ' SG ' ' HG3' ' A' ' 1' ' ' MET . 9.3 p -108.84 88.95 2.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.959 -0.756 . . . . 63.24 108.959 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.17 -68.18 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.153 -0.93 . . . . 70.35 109.301 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 CA--C 1.552 1.02 0 C-N-CA 123.47 0.708 . . . . 71.12 110.204 -174.8 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB3' ' HA ' ' A' ' 16' ' ' ASP . 65.5 mtt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 62.22 109.471 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 180' ' ' LYS . 43.1 mt -115.42 146.92 41.16 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.3 0.64 . . . . 70.4 109.988 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 57.3 mt -95.8 119.61 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.242 -0.651 . . . . 71.21 109.242 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.454 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.0 m-85 -118.91 129.09 55.0 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.422 -1.325 . . . . 74.43 107.422 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.38 155.07 43.61 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.557 0.343 . . . . 72.33 111.08 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 10.3 t70 -101.14 144.62 29.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.597 0.759 . . . . 65.44 109.743 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.5 pt -81.33 -6.42 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 112.752 0.649 . . . . 65.12 112.752 -171.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -106.7 -64.02 1.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.172 0.804 . . . . 61.31 113.172 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.0 m -130.06 -25.33 2.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.828 0.677 . . . . 74.31 112.828 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 12.9 t0 -99.9 25.87 6.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.538 0.735 . . . . 51.25 110.759 -170.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.63 -20.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.101 1.519 . . . . 64.34 115.101 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.85 -37.61 19.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.258 -0.901 . . . . 72.52 111.052 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 31.5 tp 28.55 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.001 2.12 . . . . 73.54 114.243 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 67.6 m -157.94 121.88 4.12 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 72.44 109.58 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 45.3 p -113.7 67.46 0.67 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.776 0.798 . . . . 55.11 109.65 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 37.6 t70 -159.49 177.28 11.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.992 -1.004 . . . . 65.12 109.852 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 m -84.54 76.29 10.19 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.056 -0.72 . . . . 72.32 109.056 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 14' ' ' SER . 15.7 m-85 -100.58 139.16 20.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 115.276 -0.874 . . . . 72.44 110.748 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.9 118.7 5.66 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.693 2.262 . . . . 74.11 112.14 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -129.25 162.69 27.31 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.169 -0.923 . . . . 73.12 111.042 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -151.2 115.26 5.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.972 1.309 . . . . 70.14 107.649 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.8 113.28 24.17 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.624 -1.621 . . . . 65.0 106.624 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.87 132.12 51.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 C-N-CA 123.111 0.564 . . . . 65.42 110.056 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.0 t0 55.04 22.96 4.78 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 125.064 1.346 . . . . 70.21 112.719 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 t70 59.81 12.38 2.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.681 1.592 . . . . 71.04 112.65 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' HG3' ' A' ' 119' ' ' LYS . 55.3 tp -109.49 -51.88 2.83 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.523 -0.736 . . . . 62.14 111.214 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.64 126.03 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.571 -0.741 . . . . 73.43 109.987 -167.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -83.31 114.87 21.71 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.408 -1.33 . . . . 74.41 107.408 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 35.2 tt0 -112.68 119.49 38.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 65.15 110.316 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -105.4 107.12 17.93 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.999 -1.112 . . . . 75.12 107.999 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -77.06 153.13 34.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.616 0.366 . . . . 63.44 111.13 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.19 -163.88 12.1 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.285 -0.726 . . . . 74.21 111.285 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.02 136.72 34.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.356 0.663 . . . . 71.42 109.404 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 4.2 t60 -69.07 128.47 36.79 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.762 -0.829 . . . . 72.5 108.762 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 72' ' ' LEU . 13.9 m -147.28 178.57 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.407 0 C-N-CA 124.345 1.058 . . . . 74.14 109.711 -174.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 21.8 m -125.4 141.44 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 116.263 -0.426 . . . . 73.32 111.526 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 72' ' ' LEU . 9.6 mpt_? -105.23 105.54 15.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.368 -1.345 . . . . 62.24 107.368 165.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -127.45 125.23 40.15 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.864 -0.791 . . . . 74.14 108.864 -165.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.45 84.39 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.28 . . . . 63.32 111.406 -174.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -48.96 0.59 Allowed Glycine 0 C--O 1.239 0.46 0 CA-C-N 114.692 -1.14 . . . . 54.33 111.638 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -166.51 129.21 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.289 0.636 . . . . 73.0 110.158 -173.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tt . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 109.265 -0.643 . . . . 72.01 109.265 174.409 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 119.435 -0.317 . . . . 71.42 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 36' ' ' VAL 0.298 8.4 pt-20 51.39 -70.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.336 2.254 . . . . 64.31 113.178 -163.679 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -74.16 111.6 9.49 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.702 0.801 . . . . 63.05 110.974 -161.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.16 -172.28 45.15 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.316 -0.945 . . . . 74.15 111.69 160.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 16.4 pt -96.06 150.65 4.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.004 -0.739 . . . . 63.41 109.004 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -56.06 -34.07 65.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 53.35 112.362 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 68' ' ' ILE . 61.8 mt -55.06 -51.37 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.389 1.076 . . . . 62.34 110.16 176.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 76' ' ' LEU . 30.6 t -75.02 -46.26 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.604 1.161 . . . . 64.12 112.224 -175.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 35' ' ' VAL . 80.5 mt -63.19 -37.17 86.19 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.046 0.841 . . . . 73.21 111.088 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -68.21 -47.0 69.05 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.986 -1.007 . . . . 65.5 109.204 174.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -80.55 -17.66 50.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.045 0.938 . . . . 64.42 111.957 -166.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 62.82 61.66 1.14 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.281 1.433 . . . . 71.43 111.044 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.622 ' HB2' HG13 ' A' ' 71' ' ' VAL . 83.8 mt -101.28 140.15 35.97 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.378 -0.828 . . . . 73.23 110.483 174.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.57 137.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.478 0.711 . . . . 65.53 109.219 171.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.45 157.06 24.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.454 1.121 . . . . 73.1 113.685 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 ttm -147.28 104.21 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.172 -2.159 . . . . 72.25 105.172 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.601 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 80.1 m-20 -101.87 124.94 48.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.331 -0.618 . . . . 52.22 109.331 -171.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.598 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 20.6 p -61.4 -11.14 9.12 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.109 0.964 . . . . 64.01 112.522 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.601 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 90.9 m-85 -53.5 -48.85 68.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.386 1.074 . . . . 72.1 111.461 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.95 -39.22 6.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.604 0.762 . . . . 74.43 110.571 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.16 20.39 3.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.408 1.083 . . . . 75.42 113.336 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.47 69.73 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.154 0.582 . . . . 65.21 111.614 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t -65.93 -38.72 89.39 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.972 0.909 . . . . 71.12 110.725 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.472 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.2 mpt? -69.25 -40.62 77.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.174 -0.921 . . . . 65.14 110.658 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -70.61 -31.9 69.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.571 0.748 . . . . 75.0 110.466 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -67.42 -35.23 78.85 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 61.14 111.113 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.27 95.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.202 0.601 . . . . 64.11 110.154 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.57 -34.37 74.07 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-N 115.567 -0.742 . . . . 64.13 111.79 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.78 -34.05 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.629 0.772 . . . . 72.12 111.281 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.01 -47.6 82.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.731 0.413 . . . . 74.14 110.607 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.63 -46.7 78.27 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.975 0.797 . . . . 53.34 109.681 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.454 ' O ' HG22 ' A' ' 99' ' ' VAL . 72.7 t80 -48.26 -64.84 0.68 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.011 1.724 . . . . 74.44 111.755 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 27.6 ttt -58.08 -48.61 79.61 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.409 1.068 . . . . 75.11 110.765 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -58.35 -51.43 69.85 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.035 0.835 . . . . 73.24 111.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -73.72 -39.32 64.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.659 0.599 . . . . 74.12 111.82 -168.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.0 m -67.2 -37.79 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 111.857 0.317 . . . . 70.24 111.857 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 113' ' ' VAL . 81.7 mt -71.6 -54.24 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.627 -0.509 . . . . 72.02 109.627 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.91 -33.18 70.26 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.533 1.533 . . . . 63.13 112.357 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -81.56 -52.63 7.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.262 0.625 . . . . 74.22 110.65 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.431 ' HG2' ' HG3' ' A' ' 174' ' ' GLU . 11.7 tpt -72.2 -31.47 65.92 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.85 0.315 . . . . 73.24 111.85 -167.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.36 -55.46 21.44 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.626 0.77 . . . . 71.01 112.351 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -82.32 -0.03 43.8 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.087 0.47 . . . . 61.55 110.412 -166.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -101.59 -36.35 8.8 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.174 0.99 . . . . 75.15 110.041 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -92.69 -78.66 0.41 Allowed 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.422 -0.808 . . . . 62.23 111.767 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.453 ' HB3' ' HB2' ' A' ' 112' ' ' ASP . 63.1 ttt180 -153.47 13.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.6 0.714 . . . . 73.53 112.337 -169.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.6 t70 68.94 -74.13 0.08 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.275 1.43 . . . . 75.45 113.059 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.04 -66.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 112.518 0.562 . . . . 74.02 112.518 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.87 87.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.087 1.143 . . . . 33.12 114.087 -162.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -73.53 -46.44 47.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.297 -0.41 . . . . 63.3 111.095 -170.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.622 ' HA ' ' HB3' ' A' ' 116' ' ' PHE . 13.6 m -76.24 -22.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 119.241 -0.409 . . . . 74.33 111.506 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.59 -55.09 34.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.165 0.586 . . . . 64.41 110.507 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.99 88.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.14 0.9 . . . . 73.44 110.244 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.622 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 18.9 t80 -61.96 -41.9 98.52 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.444 -1.253 . . . . 64.35 111.496 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -64.6 -41.47 96.21 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.906 0.482 . . . . 62.53 110.62 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.45 -42.79 95.77 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.088 0.868 . . . . 62.0 110.285 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.75 ' HG3' HD22 ' A' ' 26' ' ' LEU . 17.9 tppt? -72.91 -40.18 65.71 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.473 1.109 . . . . 71.12 111.755 -174.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.4 tp -76.45 -34.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.292 0.637 . . . . 72.43 109.51 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -61.37 -44.46 97.13 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 124.119 0.887 . . . . 62.41 109.138 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.34 -41.39 99.47 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.803 0.689 . . . . 64.32 112.836 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.63 -53.05 57.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.424 0.69 . . . . 75.13 110.703 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 18.7 m -63.61 -44.76 98.68 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.17 0 CA-C-O 118.298 -0.858 . . . . 75.14 111.432 -175.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.6 -38.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 119.205 0.911 . . . . 55.01 111.39 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 m -71.81 -31.09 66.19 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.901 0.48 . . . . 73.14 111.399 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.702 HD21 HG21 ' A' ' 155' ' ' ILE . 28.9 tp -82.96 -18.99 38.02 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 71.33 110.584 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.8 mt -91.95 3.24 55.64 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.895 0.878 . . . . 72.42 111.069 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.12 88.31 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.796 0.838 . . . . 71.3 110.474 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -58.24 -19.81 37.0 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.886 1.439 . . . . 61.2 114.886 -163.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.48 -40.77 95.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.636 0.774 . . . . 72.12 112.133 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -108.19 -37.2 6.09 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.348 0.594 . . . . 71.53 110.872 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.1 -2.36 48.0 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.187 0.995 . . . . 65.45 113.453 -168.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.34 -15.8 18.52 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 112.259 0.466 . . . . 72.45 112.259 163.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -103.31 26.72 8.0 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.785 0.834 . . . . 74.24 110.32 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.5 mt -86.63 133.18 33.72 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.862 -1.162 . . . . 73.12 107.862 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.73 109.3 21.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.723 -1.584 . . . . 72.3 106.723 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 42.5 m-85 -92.24 145.89 24.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.058 -1.09 . . . . 75.25 108.058 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 78.6 m-85 -140.51 146.36 38.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.21 0.529 . . . . 75.23 110.659 -175.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.441 HD13 ' HB3' ' A' ' 144' ' ' ALA . 2.1 pp -146.98 163.18 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.257 -1.757 . . . . 74.31 106.257 167.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.7 147.29 50.89 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.885 -0.886 . . . . 72.25 110.885 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.44 -25.32 50.17 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.92 0.86 . . . . 72.31 112.714 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -36.36 80.48 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.538 1.135 . . . . 51.11 111.129 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 150' ' ' ASN . . . -68.14 -42.69 79.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.985 0.914 . . . . 64.31 110.634 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.57 -0.69 47.98 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.252 -0.886 . . . . 75.01 112.36 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -90.89 -19.0 23.83 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.417 1.087 . . . . 71.44 109.922 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.74 45.89 1.17 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.006 -0.543 . . . . 61.35 111.811 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -156.7 108.44 2.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.462 0.705 . . . . 73.45 109.283 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 49.29 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.566 1.546 . . . . 71.23 113.712 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.55 ' HA ' ' HB1' ' A' ' 144' ' ' ALA . 17.6 m120 -61.25 -43.03 99.54 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.783 0.833 . . . . 71.2 111.282 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 58.53 -148.77 37.51 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 115.421 0.928 . . . . 51.01 115.421 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 138.64 31.31 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.011 0.924 . . . . 64.53 109.266 -174.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.0 t -82.73 123.91 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.134 0.574 . . . . 54.31 110.977 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.68 105.3 6.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.381 1.072 . . . . 70.21 109.294 170.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.702 HG21 HD21 ' A' ' 127' ' ' LEU . 74.9 mt -91.75 121.26 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.297 -0.631 . . . . 71.42 109.297 -173.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 169' ' ' LEU . 47.7 mm -109.08 114.84 47.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 110.048 -0.352 . . . . 73.34 110.048 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.89 118.27 36.59 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 124.244 0.965 . . . . 75.12 108.641 170.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 16.1 p90 -79.96 112.52 17.33 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.669 -1.604 . . . . 72.44 106.669 170.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -103.01 128.49 49.83 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.628 -0.508 . . . . 62.44 109.628 -173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.18 120.23 22.69 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.556 0.342 . . . . 70.01 110.872 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.23 107.17 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.422 1.489 . . . . 62.41 108.824 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 61.92 23.64 13.95 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.811 1.244 . . . . 65.55 112.783 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.22 65.3 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 113.867 0.307 . . . . 73.01 113.867 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.1 m -110.87 137.54 48.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.285 1.034 . . . . 74.15 108.834 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 9.0 pt-20 -72.95 145.61 46.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.167 0.439 . . . . 52.13 110.405 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.4 101.16 21.83 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 107.645 -1.242 . . . . 74.12 107.645 167.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.75 128.52 20.13 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.401 2.067 . . . . 71.43 112.299 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 53.1 p -121.0 118.43 29.82 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.227 -1.027 . . . . 72.42 108.227 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 tp -77.23 111.73 13.17 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.936 -0.764 . . . . 71.25 108.936 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 57.5 mtt -101.63 122.53 44.03 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.657 -0.868 . . . . 73.13 108.657 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.427 HD13 HD11 ' A' ' 176' ' ' ILE . 93.0 mt -136.65 143.43 43.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.752 -1.944 . . . . 72.2 105.752 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.93 138.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.063 0.847 . . . . 64.33 109.976 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.455 ' HB3' ' HZ3' ' A' ' 173' ' ' LYS . 4.3 ttpm? -58.38 -29.16 65.8 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.904 1.282 . . . . 71.04 112.272 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 103' ' ' MET . 11.1 mp0 -70.1 -26.32 63.93 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.606 0.763 . . . . 75.34 111.217 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.47 0.43 50.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 75.03 110.723 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.427 HD11 HD13 ' A' ' 171' ' ' LEU . 46.6 mm -121.16 125.05 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.301 0.64 . . . . 62.13 109.597 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mm -99.2 108.36 22.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.362 -1.347 . . . . 72.35 107.362 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.84 116.18 26.93 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.0 -1.482 . . . . 71.03 107.0 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -126.31 106.09 9.27 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.253 -1.388 . . . . 62.01 107.253 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.56 ' HA ' HD22 ' A' ' 2' ' ' LEU . 56.4 pttt -88.3 119.79 29.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.951 0.5 . . . . 72.02 110.904 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 34.6 t -78.25 89.84 4.32 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.803 0.841 . . . . 74.41 109.834 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.23 129.83 39.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.667 0.787 . . . . 42.24 110.516 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.883 0.873 . . . . 75.53 108.822 -179.476 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtm . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 120.656 0.265 . . . . 65.13 110.324 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 180' ' ' LYS . 32.6 mt -115.63 161.78 18.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.567 0.747 . . . . 72.41 110.969 -166.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.455 HG23 ' HB3' ' A' ' 179' ' ' GLU . 8.3 tt -105.75 130.16 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.962 -1.125 . . . . 74.42 107.962 169.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 9.1 m-30 -97.83 136.7 37.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.452 0.644 . . . . 73.15 111.711 -174.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HG3' ' HB ' ' A' ' 177' ' ' ILE . 15.3 ptmt -138.47 136.42 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.068 -1.424 . . . . 72.12 108.945 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.783 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 29.9 t70 -109.17 177.21 4.82 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.574 1.55 . . . . 62.32 110.54 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 pt -65.73 -43.07 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 123.921 0.888 . . . . 72.33 112.511 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -111.42 -51.67 2.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.368 1.067 . . . . 74.24 109.26 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -84.25 19.05 1.96 Allowed 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.026 -1.443 . . . . 62.22 110.666 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.783 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 13.0 t70 -44.37 -42.8 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.319 1.847 . . . . 64.22 113.608 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.25 -47.3 80.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.805 -1.543 . . . . 63.03 111.774 -173.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -124.41 27.35 7.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.634 0.774 . . . . 71.31 112.033 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.687 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 3.0 tm? -64.63 -79.68 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.079 -0.388 . . . . 72.44 110.327 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 75.1 m -153.32 -176.17 5.67 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.764 0.792 . . . . 74.51 111.348 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 t -151.34 95.12 2.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.943 -1.503 . . . . 70.2 106.943 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.94 95.65 0.06 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.206 1.402 . . . . 73.32 110.633 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 p -120.46 25.1 10.0 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.977 -1.49 . . . . 53.2 106.977 158.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -135.52 155.33 78.49 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.446 -1.252 . . . . 55.44 109.987 -171.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.08 120.11 7.27 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.843 1.695 . . . . 73.31 112.726 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.75 149.93 20.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.551 0.741 . . . . 74.24 110.324 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 66.6 mttm -136.18 144.97 45.25 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.508 0.723 . . . . 75.54 109.417 -173.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.0 tp -130.71 145.05 51.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.591 0.756 . . . . 72.03 109.485 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.98 133.87 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.468 0.707 . . . . 72.03 109.689 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 58.82 16.23 4.36 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.211 1.404 . . . . 72.53 113.681 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 47.25 26.56 0.71 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.536 1.135 . . . . 73.53 112.616 -167.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 119' ' ' LYS . 37.1 tp -119.94 -46.69 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.179 0.992 . . . . 72.34 109.937 -174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.81 126.54 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.115 0.566 . . . . 74.1 110.395 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.15 122.74 29.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.491 -1.3 . . . . 72.22 107.491 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 5.1 pt-20 -112.73 147.03 37.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.197 0.522 . . . . 74.22 110.118 170.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -131.49 105.08 7.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.369 -1.345 . . . . 63.43 107.369 166.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 167' ' ' PRO . 15.2 ptmt -82.01 103.64 11.79 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.11 -0.7 . . . . 74.41 109.11 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.42 ' H ' HD11 ' A' ' 70' ' ' ILE . . . -81.82 -157.4 19.46 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.042 -0.981 . . . . 63.53 112.09 176.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -124.12 161.3 25.92 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.806 0.842 . . . . 75.42 109.913 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -93.13 118.09 30.82 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.156 -1.053 . . . . 73.01 108.156 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 m -146.98 159.8 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.331 0.586 . . . . 62.11 111.42 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 m -133.88 132.57 56.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.181 -1.044 . . . . 63.31 108.181 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.62 149.67 43.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.132 -1.433 . . . . 74.13 107.132 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -133.86 132.06 39.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.628 -0.878 . . . . 74.21 108.628 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 65.17 12.49 8.03 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.097 1.359 . . . . 62.53 113.503 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.8 21.24 26.55 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 123.051 0.358 . . . . 24.2 112.481 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.44 127.27 43.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.271 1.028 . . . . 75.12 109.175 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp . . . . . 0 CA--C 1.556 1.19 0 N-CA-C 109.282 -0.636 . . . . 73.2 109.282 176.627 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 108.132 -1.062 . . . . 72.22 108.132 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.4 73.31 3.16 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.959 -1.126 . . . . 70.24 107.959 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -91.97 137.28 32.49 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.952 -0.567 . . . . 72.13 109.54 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.18 -122.72 2.75 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 112.15 -0.38 . . . . 62.11 112.15 170.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.457 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 42.2 pt -112.5 138.8 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.308 0.643 . . . . 54.43 111.648 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -47.8 -46.87 31.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.209 1.404 . . . . 55.44 113.765 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.446 HD13 ' HB2' ' A' ' 169' ' ' LEU . 57.6 mt -50.41 -46.13 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.382 1.073 . . . . 73.31 111.705 -174.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.25 -47.11 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.289 -0.869 . . . . 44.44 111.216 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 17.2 mt -64.2 -36.12 83.03 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.214 0.946 . . . . 70.01 110.517 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -60.98 -37.06 81.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.879 1.672 . . . . 34.11 110.803 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.549 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 26.3 m170 -106.89 -13.33 15.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.974 -1.012 . . . . 75.3 111.99 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 55.02 57.47 5.57 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.532 1.133 . . . . 72.22 111.488 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 74' ' ' HIS . 79.5 mt -84.64 146.13 27.64 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.651 0.78 . . . . 71.5 110.431 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.84 123.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 109.538 -0.541 . . . . 70.21 109.538 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -70.6 147.36 49.31 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.704 -1.135 . . . . 42.23 112.876 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 70.4 mtp -143.74 122.35 12.52 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.015 -2.217 . . . . 53.1 105.015 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -101.0 152.86 20.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.772 -0.58 . . . . 73.44 112.007 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 20.4 p -66.88 -23.97 66.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.616 0.766 . . . . 65.02 113.058 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -72.14 -43.67 64.32 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.922 0.489 . . . . 45.21 111.575 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.73 -48.19 3.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.333 0.653 . . . . 64.34 111.395 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.41 21.0 3.04 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.122 0.969 . . . . 73.32 112.432 -171.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.4 74.83 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.591 0.757 . . . . 51.23 112.584 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.6 t -74.04 -41.22 62.13 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.812 0.845 . . . . 72.32 110.794 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -61.55 -43.99 97.84 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.06 0.544 . . . . 63.43 110.049 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.631 ' HD1' HG21 ' A' ' 153' ' ' VAL . 46.5 t80 -58.83 -42.91 90.39 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.381 1.472 . . . . 74.23 111.086 176.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -58.93 -41.45 87.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.624 0.77 . . . . 72.22 110.369 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.36 88.84 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.349 0.66 . . . . 75.42 111.277 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 63.8 m-85 -59.6 -45.24 92.49 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.737 0.415 . . . . 61.54 111.371 171.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.43 -38.31 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.814 0.846 . . . . 73.42 111.0 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -58.18 -47.74 82.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.972 0.509 . . . . 60.44 111.476 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -65.71 -51.04 62.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.545 0.738 . . . . 74.34 110.656 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -49.98 -62.29 1.65 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.941 2.097 . . . . 72.31 111.655 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 48.2 mtm -64.6 -33.98 77.19 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.634 0.584 . . . . 71.12 111.04 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -60.58 -47.03 88.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.836 0.454 . . . . 74.32 110.076 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -77.31 -48.9 16.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.486 0.714 . . . . 54.34 110.57 -172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.45 -40.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.363 0.265 . . . . 74.21 111.069 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 77.0 mt -71.19 -45.68 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 119.016 -0.516 . . . . 65.41 109.723 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 26.5 t70 -53.59 -47.69 69.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 123.882 0.873 . . . . 64.33 112.634 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -65.36 -43.18 91.6 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.757 0.423 . . . . 62.23 110.143 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.457 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 7.6 tpt -68.84 -26.07 64.97 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.653 -0.703 . . . . 63.13 110.048 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.642 ' HA ' HG11 ' A' ' 113' ' ' VAL . 1.7 tm-20 -76.4 -38.04 56.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.856 1.263 . . . . 75.14 109.787 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 64.7 mttm -67.15 -25.92 66.4 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.698 0.399 . . . . 71.24 110.61 174.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -86.17 0.68 53.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.087 0.955 . . . . 73.01 111.701 -176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -130.42 -53.43 1.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.439 0.695 . . . . 62.33 110.168 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 56.82 23.06 7.62 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.042 2.137 . . . . 72.03 112.854 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.48 -89.0 0.61 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.81 0.844 . . . . 63.01 109.564 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttp 173.13 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.648 1.179 . . . . 72.13 109.782 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.13 92.14 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.731 0.641 . . . . 52.23 112.731 -164.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.29 -48.54 17.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.765 0.426 . . . . 73.51 109.95 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 104' ' ' GLU . 35.0 m -70.39 -24.09 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.723 -0.671 . . . . 74.32 112.22 -174.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 23.0 t70 -65.43 -37.48 87.03 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.376 0.67 . . . . 73.54 109.865 172.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.425 ' O ' ' HD3' ' A' ' 119' ' ' LYS . . . -72.62 -49.49 31.64 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.876 0.735 . . . . 62.45 109.935 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -55.16 -47.92 74.48 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.885 0.474 . . . . 75.22 110.418 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -60.7 -46.59 89.82 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.387 1.054 . . . . 74.54 110.944 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -61.25 -43.89 98.14 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.009 0.818 . . . . 70.24 110.248 -174.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.474 ' HB3' HD22 ' A' ' 26' ' ' LEU . 5.1 mptp? -79.28 -36.91 39.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.501 -0.772 . . . . 51.42 111.337 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.1 tp -73.99 -38.22 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 118.751 0.705 . . . . 74.22 110.324 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.446 ' HA ' HG22 ' A' ' 124' ' ' VAL . 23.4 tm0? -72.32 -39.34 68.28 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 176.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.63 -39.21 97.08 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.513 0.508 . . . . 72.13 112.28 174.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -65.13 -51.42 61.33 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.504 0.722 . . . . 73.32 109.616 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.8 m -68.77 -42.12 82.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-O 118.936 -0.554 . . . . 75.22 111.04 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.1 -29.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 118.85 0.75 . . . . 74.13 110.605 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.3 t -77.81 -39.17 44.69 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.201 0.6 . . . . 71.23 110.882 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.694 HD21 HG21 ' A' ' 155' ' ' ILE . 35.0 tp -72.48 -29.45 63.65 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.521 1.128 . . . . 63.13 111.509 -174.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 38.0 mt -86.75 0.3 54.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.195 0.598 . . . . 73.52 111.123 -177.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.31 81.05 4.69 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.076 -0.713 . . . . 21.31 109.076 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 61.7 pttt -61.56 -6.1 2.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.875 1.27 . . . . 63.23 113.819 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -54.44 -42.72 70.9 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.955 0.902 . . . . 61.05 110.838 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -109.17 -37.98 5.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.285 1.034 . . . . 73.11 109.637 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.456 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 56.7 m-85 -79.26 -1.54 37.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.796 1.238 . . . . 72.14 114.15 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 30.3 ttmt -50.64 -12.74 0.11 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.1 1.148 . . . . 62.32 114.1 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 77.4 m-20 -82.29 22.09 0.86 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.745 0.818 . . . . 71.12 111.467 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 72.8 mt -89.23 136.95 32.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.171 0.588 . . . . 73.15 109.598 172.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.47 122.95 25.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.661 -1.607 . . . . 43.52 106.661 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -99.39 129.44 45.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.937 0.495 . . . . 54.53 109.8 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 96.6 m-85 -130.33 146.12 51.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.826 0.451 . . . . 74.52 110.525 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.37 170.26 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.933 0.493 . . . . 63.14 109.751 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.54 138.84 22.27 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.658 -0.701 . . . . 55.12 112.353 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -59.86 -47.47 85.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.7 1.2 . . . . 64.4 109.833 171.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -38.35 68.35 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.795 1.238 . . . . 73.23 111.206 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.02 -46.34 68.22 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.923 -1.035 . . . . 73.11 110.292 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.01 -3.25 51.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.352 0.661 . . . . 72.01 112.429 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.94 -41.66 14.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.258 0.623 . . . . 73.32 111.726 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.62 46.37 0.1 OUTLIER Glycine 0 N--CA 1.469 0.867 0 C-N-CA 121.271 -0.49 . . . . 73.25 112.839 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.93 -165.2 1.68 Allowed 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.154 0.982 . . . . 63.2 108.826 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -55.09 122.56 11.23 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.792 -0.818 . . . . 74.25 108.792 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -50.38 -31.04 13.68 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.957 1.411 . . . . 70.3 111.621 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 123.87 -174.39 16.77 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.797 -0.638 . . . . 53.0 112.902 172.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.442 HE22 HD22 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -121.4 164.79 16.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.926 1.291 . . . . 63.24 108.072 167.344 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.631 HG21 ' HD1' ' A' ' 88' ' ' PHE . 41.9 t -79.15 116.94 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.585 0.707 . . . . 71.13 111.77 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.35 106.17 5.85 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.071 -1.422 . . . . 62.4 107.908 161.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.694 HG21 HD21 ' A' ' 127' ' ' LEU . 54.8 mt -90.41 106.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.534 0.733 . . . . 71.02 110.236 -165.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 169' ' ' LEU . 44.9 mm -96.05 115.98 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.033 -0.358 . . . . 71.35 110.033 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -100.51 121.4 41.51 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.09 0.556 . . . . 74.53 110.0 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 32.6 m-85 -83.43 98.34 9.45 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.633 -0.877 . . . . 73.33 108.633 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -90.74 131.88 36.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.686 -0.857 . . . . 74.22 108.686 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.79 108.38 19.95 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.166 -0.679 . . . . 71.31 109.166 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.03 111.47 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 108.978 -0.749 . . . . 64.44 108.978 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.33 21.5 11.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.428 1.091 . . . . 71.43 112.826 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.19 31.17 14.83 Favored Glycine 0 C--N 1.347 1.144 0 C-N-CA 121.908 -0.187 . . . . 64.03 112.909 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -133.71 121.71 22.34 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.881 0.872 . . . . 64.34 109.326 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.92 126.65 30.45 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.545 0.528 . . . . 75.23 109.634 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.01 107.22 37.99 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 108.221 -1.029 . . . . 51.43 108.221 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 57.8 Cg_endo -68.15 127.57 16.14 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.677 2.252 . . . . 75.34 111.178 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 20.8 m -118.06 104.79 11.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.184 0.594 . . . . 71.25 109.845 -171.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 56.2 tp -78.01 106.19 9.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.621 0.769 . . . . 74.31 109.674 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.524 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.3 mtt -103.28 122.81 45.56 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.571 0.748 . . . . 73.41 109.139 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.442 HD22 HE22 ' A' ' 152' ' ' GLN . 85.9 mt -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.937 -1.875 . . . . 74.44 105.937 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 174' ' ' GLU . 14.0 p -83.09 143.71 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 108.047 -1.094 . . . . 62.21 108.047 173.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -48.56 -37.58 18.24 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.501 1.52 . . . . 64.21 111.707 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 8.7 tp10 -83.72 -0.52 51.18 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.688 0.795 . . . . 74.13 112.191 -175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -104.73 -33.29 8.5 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.545 0.738 . . . . 61.45 110.373 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.66 133.48 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.33 0.586 . . . . 74.31 110.285 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.418 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.8 mm -127.9 131.94 69.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 107.385 -1.339 . . . . 61.32 107.385 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.44 ' HB2' HD13 ' A' ' 2' ' ' LEU . 10.5 pt-20 -95.06 124.8 39.31 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.245 -0.65 . . . . 62.54 109.245 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.455 ' HB3' HG23 ' A' ' 3' ' ' ILE . 15.9 tp10 -108.4 125.54 51.85 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.841 -0.8 . . . . 65.54 108.841 175.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.453 ' HA ' HD22 ' A' ' 2' ' ' LEU . 13.8 mptt -71.28 154.25 41.78 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.746 0.818 . . . . 45.55 110.621 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 39.8 m -133.3 86.41 2.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.492 -0.559 . . . . 63.14 109.492 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -170.08 0.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.085 0.954 . . . . 71.0 112.149 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 . . . . . 0 CA--C 1.552 1.026 0 C-N-CA 123.573 0.749 . . . . 71.13 109.152 -178.679 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.933 -0.395 . . . . 72.52 109.933 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.16 123.32 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.649 -0.871 . . . . 51.51 108.649 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 179' ' ' GLU . 9.7 tt -96.82 119.95 45.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.6 0.714 . . . . 74.01 110.068 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -102.71 110.83 22.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.717 -1.957 . . . . 63.42 105.717 173.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -131.24 134.95 46.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.068 0.547 . . . . 74.42 111.736 -167.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.408 ' HA ' HD13 ' A' ' 176' ' ' ILE . 27.7 t70 -81.65 131.2 35.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.71 0.804 . . . . 71.32 109.751 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 175' ' ' ALA . 25.9 pt -77.94 -11.55 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 73.22 112.752 -171.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.569 ' HE1' ' HB1' ' A' ' 175' ' ' ALA . 9.0 m-85 -94.15 -64.68 1.05 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.082 0.401 . . . . 73.05 110.619 -172.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' HB3' ' A' ' 149' ' ' GLU . 3.2 p -132.08 -37.68 1.12 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.385 1.074 . . . . 72.32 113.702 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.34 23.56 8.26 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.048 0.939 . . . . 71.22 111.854 -162.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -46.35 -26.32 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 126.014 1.726 . . . . 73.11 115.027 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.91 27.58 0.87 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.367 1.067 . . . . 74.41 111.16 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.63 -73.69 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.735 1.614 . . . . 75.5 112.39 -173.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 m -152.15 131.87 13.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.973 0.509 . . . . 61.14 109.85 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 34.5 p -131.34 91.79 3.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.037 0.935 . . . . 75.41 108.942 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.426 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.0 t70 -168.31 177.55 5.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.594 0.757 . . . . 74.45 109.628 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 p -83.39 81.55 8.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.589 0.756 . . . . 53.31 109.344 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 36.9 m-85 -103.19 152.79 38.68 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 115.188 -0.915 . . . . 74.33 109.57 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -46.98 119.12 3.16 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.872 2.381 . . . . 61.44 112.83 173.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.7 tpt -112.26 120.93 43.44 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.224 -1.028 . . . . 71.31 108.224 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -142.44 116.62 9.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.764 -1.569 . . . . 74.23 106.764 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.9 tp -123.64 113.91 19.28 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.104 0.962 . . . . 73.12 108.606 -172.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.25 137.0 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.08 0.952 . . . . 52.54 109.649 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 56.09 18.98 3.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 125.417 1.487 . . . . 71.34 113.315 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.62 14.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.371 1.068 . . . . 73.23 112.113 -172.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 119' ' ' LYS . 37.2 tp -112.74 -51.28 2.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.62 0.768 . . . . 73.14 110.636 -168.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -116.15 122.09 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.534 -0.757 . . . . 61.45 109.708 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.59 113.06 21.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.851 -1.166 . . . . 62.1 107.851 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -103.99 107.62 18.6 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.016 0.926 . . . . 73.34 109.032 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 45.9 t80 -90.2 112.62 24.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.595 1.158 . . . . 64.2 109.159 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HE2' HG11 ' A' ' 166' ' ' VAL . 62.5 tttm -69.2 143.5 53.99 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.067 0.547 . . . . 72.33 110.546 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.19 -174.54 33.2 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 110.822 -0.911 . . . . 64.22 110.822 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 20.2 ptmt -134.43 151.56 51.26 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.477 0.639 . . . . 73.52 111.088 -173.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -75.39 125.21 28.53 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.303 -0.629 . . . . 73.52 109.303 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 HD12 ' A' ' 72' ' ' LEU . 4.7 m -150.85 155.99 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.211 1.404 . . . . 64.31 108.962 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.5 m -133.27 161.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.847 -0.798 . . . . 64.32 108.847 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -138.12 110.22 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.631 -0.877 . . . . 73.53 108.631 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -117.29 147.36 42.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.285 -1.005 . . . . 75.53 108.285 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -59.43 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.739 1.216 . . . . 55.0 111.106 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.25 -52.42 0.65 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.085 -1.416 . . . . 70.34 111.722 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -165.31 2.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.526 0.731 . . . . 74.54 112.122 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 tt . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 124.054 0.942 . . . . 72.31 110.51 -179.381 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 107.211 -1.403 . . . . 72.34 107.211 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' HG2' HD22 ' A' ' 72' ' ' LEU . 37.4 tt0 -93.34 75.5 4.54 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 107.795 -1.187 . . . . 64.4 107.795 172.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -89.01 144.76 25.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.553 -1.203 . . . . 72.32 110.589 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.01 -130.54 3.13 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.099 -0.8 . . . . 71.41 111.099 164.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 156' ' ' ILE . 20.4 pt -112.73 150.06 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 122.881 0.472 . . . . 74.14 111.212 168.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -41.17 -41.32 1.77 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 127.122 2.169 . . . . 72.35 113.146 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' A' ' 169' ' ' LEU . 66.9 mt -57.58 -55.32 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 124.336 1.023 . . . . 61.35 110.352 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG13 ' HB2' ' A' ' 76' ' ' LEU . 40.3 t -60.56 -44.91 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 114.407 -1.269 . . . . 63.34 111.215 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' HG2' ' A' ' 65' ' ' GLU . 19.1 mt -72.34 -35.8 68.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.418 -0.81 . . . . 61.05 111.127 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -72.04 -33.88 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.757 0.823 . . . . 72.11 110.83 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -97.7 -5.68 34.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.417 0.687 . . . . 74.11 111.64 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt 55.5 63.13 2.17 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.937 1.295 . . . . 73.24 110.683 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HB2' HG13 ' A' ' 71' ' ' VAL . 58.0 mt -100.52 135.35 42.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.713 -1.131 . . . . 64.52 109.367 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.75 130.35 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.519 -0.548 . . . . 75.1 109.519 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.98 134.32 43.08 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.804 -1.089 . . . . 61.35 111.902 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.4 mtp -145.56 103.84 3.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.853 1.661 . . . . 72.23 107.273 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.485 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 95.6 m-20 -86.05 149.98 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.522 -0.736 . . . . 63.43 109.691 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 138' ' ' PHE . 37.0 t -60.72 -20.38 61.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.625 -0.716 . . . . 74.24 111.812 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.485 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 95.1 m-85 -58.28 -57.72 11.65 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.331 1.053 . . . . 74.44 110.925 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -74.24 -35.14 63.83 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.274 -0.876 . . . . 73.2 111.851 -174.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -121.44 19.37 11.31 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 112.208 0.447 . . . . 64.12 112.208 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.39 -39.6 7.11 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.681 0.993 . . . . 51.42 113.681 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.0 m -65.98 -60.18 3.1 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.507 0.723 . . . . 55.22 111.378 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.2 mtt -76.75 -14.54 59.93 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.988 -0.551 . . . . 75.22 111.431 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.67 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 40.5 t80 -70.1 -38.51 75.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.21 0.604 . . . . 72.1 109.862 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -70.07 -26.15 63.88 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 110.216 -0.291 . . . . 75.04 110.216 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.3 72.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.012 -0.54 . . . . 70.12 110.785 170.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.67 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 33.1 m-85 -58.48 -44.86 89.53 Favored 'General case' 0 C--N 1.367 1.346 0 C-N-CA 123.205 0.602 . . . . 63.21 109.784 170.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm -64.15 -38.78 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.843 0.857 . . . . 54.24 111.613 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -60.02 -46.92 87.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.935 0.494 . . . . 64.44 111.713 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -66.49 -44.89 81.38 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 64.0 110.395 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -50.41 -59.31 4.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.204 1.802 . . . . 73.11 110.85 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 64.0 mtt -57.26 -57.45 12.57 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.164 0.915 . . . . 54.44 111.022 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.17 -30.69 71.23 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.285 0.366 . . . . 72.22 111.639 -173.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -78.34 -45.15 23.28 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.74 0.416 . . . . 72.23 110.991 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 175' ' ' ALA . 32.4 m -68.27 -28.8 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 123.196 0.31 . . . . 74.3 110.583 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' HE2' ' A' ' 103' ' ' MET . 52.6 mt -75.04 -45.36 42.68 Favored 'Isoleucine or valine' 0 C--N 1.359 0.978 0 C-N-CA 123.431 0.692 . . . . 73.53 110.307 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.63 -31.87 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.444 0.698 . . . . 52.33 111.337 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -69.78 -61.35 1.82 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.984 0.914 . . . . 73.24 109.811 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.441 ' HE1' ' O ' ' A' ' 113' ' ' VAL . 21.9 ptt? -64.5 -50.31 67.89 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.66 0.6 . . . . 52.44 111.444 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.82 -20.93 66.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.348 0.659 . . . . 71.43 111.991 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -72.64 -25.73 61.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.387 0.675 . . . . 75.22 110.388 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.57 0.09 12.58 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.799 0.84 . . . . 62.43 111.538 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -120.02 -74.11 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.158 0.583 . . . . 65.51 110.206 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 50.08 18.78 0.41 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.548 1.939 . . . . 72.44 115.131 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.86 -22.64 49.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.249 0.62 . . . . 71.4 110.001 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 113' ' ' VAL . 86.0 tttt 84.15 -38.76 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.148 1.779 . . . . 70.35 111.73 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.89 62.79 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.227 0.467 . . . . 75.3 110.637 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -86.2 -44.55 12.09 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.938 0.895 . . . . 74.25 111.742 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 110' ' ' LYS . 33.5 m -78.03 -34.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.139 -0.482 . . . . 73.44 111.564 -174.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.72 -25.3 56.49 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.701 -0.481 . . . . 72.12 109.701 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.7 -47.98 57.01 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.351 0.66 . . . . 63.12 109.691 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -61.85 -47.69 83.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.216 1.006 . . . . 74.24 110.828 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.56 -36.18 79.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.195 0.998 . . . . 72.32 110.786 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.72 -46.17 83.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.66 0.784 . . . . 73.43 109.939 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HB3' HD22 ' A' ' 26' ' ' LEU . 34.4 mmtp -66.49 -37.75 85.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.465 -0.789 . . . . 72.55 111.107 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 124' ' ' VAL . 22.7 mm -73.24 -36.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.82 0.848 . . . . 63.23 110.682 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.422 ' O ' HG23 ' A' ' 125' ' ' VAL . 22.4 tm0? -61.32 -52.51 64.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.744 -0.835 . . . . 73.1 108.744 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.67 -37.44 94.37 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.66 -0.7 . . . . 65.23 112.325 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -62.51 -55.32 28.57 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.1 0.96 . . . . 74.35 110.743 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.507 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -67.23 -41.15 86.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-O 118.402 -0.809 . . . . 75.12 111.151 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 121' ' ' GLN . 88.2 t -60.3 -42.52 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.095 0.861 . . . . 63.11 110.787 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -70.24 -31.4 68.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.883 0.473 . . . . 61.15 111.311 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 155' ' ' ILE . 31.9 tp -84.03 -21.65 31.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.058 0.943 . . . . 64.02 111.342 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -92.88 -0.37 57.25 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.694 0.797 . . . . 55.1 111.589 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.82 101.32 0.19 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.09 0.556 . . . . 51.45 110.487 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 15.3 ptmm? -61.77 -12.41 16.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.962 1.305 . . . . 64.14 114.432 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.68 -46.46 82.33 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.829 0.452 . . . . 63.15 111.113 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -110.13 -40.36 4.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.242 1.017 . . . . 75.35 109.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -81.58 -3.47 53.39 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.233 1.013 . . . . 65.41 112.608 -167.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 61.1 tttm -46.09 -31.01 2.11 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.423 1.089 . . . . 75.2 111.895 160.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -97.57 26.66 4.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.332 1.053 . . . . 54.13 111.596 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 mt -88.69 140.61 29.28 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.214 -0.662 . . . . 61.52 109.214 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.55 112.34 25.03 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.401 -1.333 . . . . 71.14 107.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.405 ' HE2' ' HB2' ' A' ' 81' ' ' CYS . 76.7 m-85 -99.71 140.35 34.05 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.579 -0.897 . . . . 72.54 108.579 -175.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . 45.5 m-85 -131.84 150.04 52.27 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.953 -1.128 . . . . 74.21 107.953 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.2 tt -124.13 141.05 45.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 107.948 -1.13 . . . . 75.11 107.948 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.32 138.61 47.69 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.014 0.822 . . . . 62.41 111.904 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 49.0 tt0 -43.31 -54.21 4.77 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.178 0.991 . . . . 74.4 112.18 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -64.24 -38.35 90.74 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.9 0.75 . . . . 64.3 111.29 -172.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.25 97.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.717 0.807 . . . . 14.42 110.924 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 -16.28 56.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.401 1.08 . . . . 64.11 113.215 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 42.3 mt-10 -64.27 -31.41 72.61 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.775 0.43 . . . . 73.32 111.693 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.19 51.86 0.03 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.739 -0.944 . . . . 35.04 110.739 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.72 -170.18 2.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.778 0.831 . . . . 74.54 110.314 -173.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.494 ' HB3' HG23 ' A' ' 9' ' ' THR . 12.7 tp10 -51.18 142.83 11.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.461 1.104 . . . . 72.34 111.53 173.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -50.98 -26.46 6.04 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.779 1.77 . . . . 71.12 115.779 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.66 176.54 21.43 Favored Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.051 0.219 . . . . 73.45 112.902 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.07 127.16 33.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 106.758 -1.571 . . . . 63.43 106.758 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 155' ' ' ILE . 67.9 t -74.63 113.7 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.322 -0.622 . . . . 65.22 109.322 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 139' ' ' PHE . . . -64.81 97.09 0.2 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.62 1.168 . . . . 73.22 109.654 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.659 HG21 HD21 ' A' ' 127' ' ' LEU . 85.2 mt -88.15 102.73 12.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 108.538 -0.912 . . . . 75.13 108.538 -172.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.629 HD12 HD11 ' A' ' 68' ' ' ILE . 41.0 mm -95.56 114.29 31.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 116.255 -0.43 . . . . 54.31 109.967 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.71 130.18 54.89 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.406 -1.27 . . . . 74.2 108.313 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.3 p90 -83.12 124.41 30.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.992 -1.484 . . . . 62.44 106.992 173.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -116.14 135.74 53.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.635 -1.246 . . . . 64.14 107.635 -171.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.11 115.39 28.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.032 -0.729 . . . . 44.14 109.032 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.6 107.64 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.952 -0.759 . . . . 73.31 108.952 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 63.97 30.63 14.1 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.416 1.086 . . . . 64.12 110.734 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.94 25.03 75.71 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.59 -0.732 . . . . 54.42 113.038 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.1 m -108.34 134.85 50.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.612 0.765 . . . . 61.23 109.129 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -73.14 111.43 8.25 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.888 -0.782 . . . . 73.44 108.888 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.422 HG11 ' HE2' ' A' ' 31' ' ' LYS . 27.0 m -128.63 88.07 53.16 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 121.845 0.831 . . . . 74.15 108.98 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 80.6 Cg_exo -55.37 121.4 9.86 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.788 2.325 . . . . 71.4 111.989 168.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.6 t -115.28 140.07 49.42 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.347 1.059 . . . . 71.24 109.098 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.7 tp -91.75 114.54 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.712 1.205 . . . . 73.41 108.967 176.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 81.1 mtp -93.84 123.04 36.93 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 107.568 -1.271 . . . . 61.35 107.568 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.578 HD13 HG21 ' A' ' 176' ' ' ILE . 94.0 mt -132.84 141.26 48.36 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.629 1.572 . . . . 64.24 107.511 -177.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.2 p -80.87 133.7 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.471 -0.937 . . . . 71.33 108.471 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -66.29 -19.62 65.87 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.431 0.692 . . . . 75.41 112.254 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.38 -30.43 47.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.768 0.318 . . . . 71.42 111.48 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.569 ' HB1' ' HE1' ' A' ' 8' ' ' PHE . . . -104.21 -10.16 18.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.092 0.557 . . . . 72.31 111.678 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 171' ' ' LEU . 36.1 mm -126.25 108.34 19.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.787 -1.561 . . . . 62.31 106.787 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.2 mm -95.04 113.18 28.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.288 -0.869 . . . . 73.35 109.596 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.37 135.84 44.31 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.434 -1.321 . . . . 75.23 107.434 166.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.616 ' HB3' HG23 ' A' ' 3' ' ' ILE . 36.9 tt0 -149.19 134.74 18.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.818 0.342 . . . . 73.12 110.235 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.588 ' HE3' HD11 ' A' ' 182' ' ' LEU . 37.8 tttp -81.14 112.42 18.48 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.45 -0.945 . . . . 61.31 108.45 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.75 92.36 3.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.887 -0.783 . . . . 65.24 108.887 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.588 HD11 ' HE3' ' A' ' 180' ' ' LYS . 48.1 mt -98.74 152.96 19.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.094 0.558 . . . . 53.22 110.88 -174.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 CA--C 1.557 1.222 0 C-N-CA 122.892 0.477 . . . . 71.24 110.389 178.577 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.924 -0.769 . . . . 75.24 108.924 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.516 HD12 ' SD ' ' A' ' 20' ' ' MET . 84.0 mt -133.16 153.07 51.86 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.143 -0.688 . . . . 61.25 109.143 175.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.626 HG23 ' HB3' ' A' ' 179' ' ' GLU . 4.4 tt -114.49 116.74 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.906 -1.516 . . . . 55.32 106.906 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 5.2 m-85 -100.97 130.93 47.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.26 -1.385 . . . . 73.3 107.26 -174.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.96 161.7 19.76 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.289 1.036 . . . . 71.32 109.638 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 35.3 t70 -116.02 178.06 4.46 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.383 1.073 . . . . 65.13 109.743 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.96 -39.27 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 CA-C-O 121.348 0.594 . . . . 71.54 110.306 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -110.93 -55.25 2.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.679 1.192 . . . . 63.32 110.002 -168.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.495 ' HB ' HD23 ' A' ' 13' ' ' LEU . 3.7 m -90.06 15.74 9.6 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 113.755 -1.566 . . . . 72.44 111.234 -168.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.7 p-10 -63.2 -7.11 5.21 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 114.603 1.334 . . . . 75.35 114.603 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -48.82 -50.98 31.93 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.403 1.064 . . . . 72.23 111.393 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -123.35 -40.54 2.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.017 0.927 . . . . 72.11 109.144 164.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.495 HD23 ' HB ' ' A' ' 9' ' ' THR . 2.0 tm? 42.9 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.294 1.837 . . . . 73.23 111.67 -167.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.406 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 67.1 p -155.26 154.49 32.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.66 0.784 . . . . 51.15 110.783 175.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.1 m -163.16 96.35 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.959 0.904 . . . . 73.21 110.468 -171.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -179.16 172.77 1.21 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.612 1.165 . . . . 63.31 108.912 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -38.8 -55.1 1.55 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.466 1.106 . . . . 73.21 111.355 165.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 14' ' ' SER . 9.7 m-30 43.07 108.29 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 125.924 1.69 . . . . 71.43 114.84 174.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.92 121.04 9.29 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 121.951 1.767 . . . . 75.11 110.951 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.516 ' SD ' HD12 ' A' ' 2' ' ' LEU . 44.4 mtm -101.28 150.45 22.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.128 0.971 . . . . 72.42 109.718 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -156.76 134.27 10.74 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.113 -0.699 . . . . 71.44 109.113 171.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.73 122.55 47.44 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.18 -1.045 . . . . 44.44 108.18 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.52 135.19 52.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.465 0.706 . . . . 71.42 110.082 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 60.5 14.18 4.66 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.678 1.191 . . . . 71.15 112.536 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 48.58 33.84 4.47 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.547 1.139 . . . . 74.24 111.67 -171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 119' ' ' LYS . 32.8 tp -125.81 -52.47 1.56 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.236 -0.893 . . . . 72.13 109.632 -175.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.1 t -114.13 128.9 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.281 -0.872 . . . . 71.23 109.226 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.88 112.84 21.52 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 106.829 -1.545 . . . . 65.22 106.829 166.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -104.43 145.06 30.81 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.175 -0.676 . . . . 62.15 109.175 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -142.93 105.48 4.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.484 1.114 . . . . 72.42 108.411 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.67 149.22 26.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.348 0.659 . . . . 65.4 110.415 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.97 -161.76 9.53 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.88 -1.055 . . . . 74.14 111.262 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 139.83 51.02 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.76 0.824 . . . . 72.14 109.891 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -73.76 115.81 13.63 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.71 -1.132 . . . . 74.51 109.236 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -147.45 -175.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.721 1.208 . . . . 71.21 109.792 -170.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 m -113.16 161.05 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.448 0.699 . . . . 72.31 110.909 173.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 60.6 ttt180 -136.3 112.18 9.55 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.666 1.186 . . . . 72.42 108.366 174.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HD2' HG22 ' A' ' 64' ' ' VAL . 52.0 tttm -135.66 96.73 3.5 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 47.7 -81.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 126.326 1.851 . . . . 74.52 112.987 -173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.15 26.13 0.31 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.856 -0.898 . . . . 71.41 110.856 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.32 98.14 4.02 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.689 1.596 . . . . 45.44 107.182 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.7 pt . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 121.215 0.531 . . . . 71.23 110.99 -176.026 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.41 HG22 ' HD2' ' A' ' 38' ' ' LYS . 46.2 t . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.157 -0.683 . . . . 55.12 109.157 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.8 mp0 -78.26 82.06 4.59 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.313 -0.995 . . . . 73.34 108.313 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -76.11 146.37 39.33 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.982 -0.747 . . . . 75.34 108.982 168.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.33 -136.7 5.54 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.644 -0.582 . . . . 61.21 111.644 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.784 HD11 HD12 ' A' ' 70' ' ' ILE . 2.1 tt -104.31 126.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.627 1.171 . . . . 41.34 109.026 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.26 -29.46 33.06 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.188 1.395 . . . . 64.03 113.502 -172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.784 HD12 HD11 ' A' ' 68' ' ' ILE . 56.5 mt -61.53 -44.87 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.428 1.091 . . . . 53.02 110.048 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 76' ' ' LEU . 44.0 t -74.68 -41.79 47.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-N 114.179 -1.373 . . . . 73.14 110.268 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 35.2 mt -67.2 -24.09 65.81 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.668 0.605 . . . . 72.23 110.914 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -62.36 -61.11 2.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.635 1.174 . . . . 60.31 110.513 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -87.01 -20.17 27.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.729 0.812 . . . . 72.32 111.227 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 41.2 ttmt 66.38 69.62 0.42 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.042 1.337 . . . . 73.45 109.124 -168.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.586 ' HB2' HG13 ' A' ' 71' ' ' VAL . 70.4 mt -80.44 136.34 36.32 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.255 -1.017 . . . . 62.42 108.255 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.91 130.28 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.09 -0.707 . . . . 74.51 109.09 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.47 148.54 37.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.039 . . . . 72.1 112.59 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 56.2 ttp -148.69 134.42 18.85 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.239 -1.346 . . . . 65.42 107.657 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -119.09 142.69 47.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.091 0.556 . . . . 43.02 109.645 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.6 -11.92 48.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.711 0.805 . . . . 52.41 111.753 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -80.25 -34.63 36.95 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.973 0.909 . . . . 65.11 111.424 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -103.06 -37.22 7.86 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.172 0.511 . . . . 54.14 110.635 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.4 20.4 16.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.315 1.046 . . . . 71.11 111.925 -169.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -44.77 -43.48 8.61 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.748 1.219 . . . . 71.12 113.57 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.3 t -65.62 -52.04 55.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.057 0.943 . . . . 63.53 111.353 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.1 mpt? -68.63 -42.29 78.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.967 0.907 . . . . 62.33 110.688 -173.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.465 ' HE1' HG11 ' A' ' 153' ' ' VAL . 51.5 t80 -63.04 -41.87 99.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.766 1.226 . . . . 73.34 111.236 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -65.28 -36.56 84.47 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.212 0.605 . . . . 73.23 110.637 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.79 87.52 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.787 -0.642 . . . . 64.22 110.307 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -65.03 -45.63 84.66 Favored 'General case' 0 C--O 1.193 -1.874 0 CA-C-O 118.571 -0.728 . . . . 75.31 110.808 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.25 -43.08 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.36 0.664 . . . . 64.44 111.67 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.81 -49.07 78.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.702 0.801 . . . . 71.42 111.26 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -79.5 -38.25 34.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.256 0.622 . . . . 71.32 111.173 -173.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -50.99 -53.75 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.632 1.573 . . . . 74.13 110.387 170.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.9 ttp -53.79 -55.87 22.62 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 124.184 0.927 . . . . 74.4 110.14 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.36 -36.67 66.57 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.48 1.112 . . . . 63.14 112.186 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.09 -41.53 18.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.026 0.931 . . . . 71.41 111.936 -169.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -76.88 -27.74 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.673 0.389 . . . . 62.21 111.916 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.467 HD13 ' HG3' ' A' ' 117' ' ' LYS . 84.8 mt -73.05 -36.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.312 0.645 . . . . 64.5 109.303 171.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.59 -44.89 95.19 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.892 0.877 . . . . 65.22 110.562 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -63.2 -44.44 95.36 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.666 -0.697 . . . . 64.12 110.106 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.494 ' HG2' ' HB2' ' A' ' 107' ' ' ASN . 22.9 ttt -66.82 -40.05 87.91 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.258 -0.883 . . . . 64.32 111.329 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.562 ' HA ' HG11 ' A' ' 113' ' ' VAL . 7.6 tp10 -55.27 -40.67 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.563 1.145 . . . . 64.25 111.556 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -37.3 74.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.085 -0.961 . . . . 65.11 111.439 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -115.07 0.74 13.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.16 0.584 . . . . 64.34 111.62 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 103' ' ' MET . 18.3 m120 -148.7 41.99 0.96 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.257 1.023 . . . . 63.52 109.22 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.73 10.68 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.697 1.599 . . . . 61.42 113.632 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.69 -24.37 21.64 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.934 1.294 . . . . 72.45 112.005 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? 89.72 -58.01 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.666 1.986 . . . . 74.4 112.483 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.91 63.18 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.1 0.409 . . . . 55.1 110.933 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.01 -45.89 25.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.09 0.956 . . . . 54.1 111.049 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 104' ' ' GLU . 8.0 m -76.03 -26.92 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.716 0.406 . . . . 74.42 111.571 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.43 -36.37 73.93 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.447 0.699 . . . . 72.45 110.345 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.93 81.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.701 -0.681 . . . . 74.34 110.399 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.485 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 79.3 t80 -63.07 -41.99 99.57 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.444 1.098 . . . . 55.33 110.331 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.467 ' HG3' HD13 ' A' ' 100' ' ' ILE . 35.5 ttpt -63.9 -38.29 90.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.133 0.973 . . . . 72.42 110.478 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -67.19 -41.5 85.75 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.884 0.874 . . . . 70.31 110.005 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.596 ' HB3' HD22 ' A' ' 26' ' ' LEU . 87.9 mttt -67.24 -39.8 86.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.415 -0.811 . . . . 75.24 111.034 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 124' ' ' VAL . 23.3 mm -67.72 -47.05 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.468 0.707 . . . . 72.13 109.731 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -51.9 -51.83 54.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.666 1.186 . . . . 75.4 110.41 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.76 -38.12 89.35 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.776 -1.102 . . . . 64.22 113.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -65.43 -54.83 22.9 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.354 0.662 . . . . 64.34 110.463 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.5 m -66.5 -42.04 89.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 118.35 -0.833 . . . . 64.22 111.208 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.47 -35.98 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 119.505 1.048 . . . . 71.11 110.871 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.1 t -74.3 -38.01 63.49 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 123.481 0.712 . . . . 64.21 110.956 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.39 -19.04 39.9 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.787 0.835 . . . . 71.33 111.128 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.4 mt -93.7 2.22 56.35 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.142 0.577 . . . . 74.41 111.398 174.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 91.58 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.326 0.584 . . . . 64.11 109.843 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -59.12 -8.28 1.47 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.336 1.455 . . . . 75.22 114.685 -168.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.32 -46.59 72.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.928 0.891 . . . . 75.55 110.333 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -109.29 -39.09 5.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.964 0.906 . . . . 75.1 110.435 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -79.23 -1.89 38.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.595 1.158 . . . . 70.42 113.248 -163.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -51.89 -24.75 6.71 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 122.858 0.463 . . . . 64.41 111.615 160.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -93.92 29.63 2.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.753 1.221 . . . . 64.31 110.351 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.3 mt -94.02 153.43 18.18 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.919 -0.771 . . . . 73.11 108.919 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.58 117.42 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.272 -1.381 . . . . 72.12 107.272 172.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.57 ' HD1' HG22 ' A' ' 155' ' ' ILE . 50.1 m-85 -94.12 140.78 29.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.142 -1.058 . . . . 65.24 108.142 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 83.6 m-85 -136.46 153.81 50.95 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.774 -0.454 . . . . 74.32 109.774 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 tt -143.71 149.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.857 -1.164 . . . . 73.52 107.857 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.08 123.94 34.15 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.293 -0.723 . . . . 73.31 111.293 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -55.22 -34.01 63.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.825 0.85 . . . . 70.14 112.499 -177.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -66.39 -43.13 86.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.963 0.905 . . . . 75.21 110.196 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.24 -35.62 80.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.312 -0.858 . . . . 65.31 110.189 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.46 -12.43 57.84 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 64.1 112.143 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -95.63 -40.74 9.26 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.356 0.662 . . . . 55.44 111.065 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.18 49.62 0.28 Allowed Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.126 -0.488 . . . . 74.32 112.588 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.75 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -158.22 -179.77 8.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.696 0.798 . . . . 62.22 109.91 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.7 155.35 48.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.102 0.561 . . . . 71.35 111.055 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 67.61 20.38 9.65 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.078 1.351 . . . . 64.15 113.315 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.72 144.73 33.87 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.118 0.261 . . . . 72.5 112.868 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -69.93 139.55 52.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.767 0.827 . . . . 64.43 112.302 -168.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.465 HG11 ' HE1' ' A' ' 88' ' ' PHE . 31.7 t -88.51 94.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.578 -0.737 . . . . 75.12 109.544 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.15 104.24 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.158 -0.928 . . . . 75.41 108.588 169.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.57 HG22 ' HD1' ' A' ' 138' ' ' PHE . 1.1 pt -95.12 113.68 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.421 0.629 . . . . 61.13 109.919 -168.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 169' ' ' LEU . 50.8 mm -107.09 133.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.8 -1.091 . . . . 61.22 110.207 -170.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 45.7 mt-10 -94.41 142.26 27.63 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.861 -0.792 . . . . 61.54 108.861 166.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -119.92 87.15 2.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.004 -1.85 . . . . 70.14 106.004 155.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 17.9 ttt180 -95.32 170.2 9.54 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 113.9 -1.5 . . . . 74.42 109.06 -171.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -98.12 124.97 42.93 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.552 1.069 . . . . 75.11 111.956 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.88 105.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.611 1.164 . . . . 73.42 108.466 167.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.4 t70 63.68 5.52 2.25 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.729 1.212 . . . . 75.5 112.695 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.35 -18.16 8.88 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.449 -0.639 . . . . 74.53 114.077 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 t -101.11 167.33 10.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 117.789 0.794 . . . . 71.45 109.609 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 1.2 pm0 -94.72 126.79 40.26 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.99 0.516 . . . . 64.11 112.105 -172.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 t -78.79 107.54 6.18 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 72.35 108.979 166.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.0 Cg_endo -87.97 112.5 0.77 Allowed 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 122.712 2.275 . . . . 65.3 109.988 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.3 m -126.31 118.21 24.61 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.811 0.444 . . . . 74.54 111.037 -174.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.473 ' HA ' HD13 ' A' ' 156' ' ' ILE . 53.0 tp -78.92 134.28 36.88 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.109 -0.7 . . . . 71.43 109.109 166.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.524 ' HB2' HG13 ' A' ' 155' ' ' ILE . 65.7 mtt -124.37 138.44 54.37 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.885 -1.154 . . . . 74.12 107.885 165.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.509 HD13 HD11 ' A' ' 176' ' ' ILE . 53.5 mt -152.16 150.85 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.098 1.759 . . . . 73.42 106.789 169.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.8 p -78.76 149.1 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.599 -0.889 . . . . 72.32 108.599 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -63.6 -31.58 72.79 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.321 0.649 . . . . 71.45 110.214 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 103' ' ' MET . 67.6 mm-40 -76.97 -3.37 38.54 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.504 0.928 . . . . 73.31 113.504 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.72 -25.13 14.78 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.965 0.506 . . . . 50.33 110.065 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.509 HD11 HD13 ' A' ' 171' ' ' LEU . 48.3 mm -106.52 125.28 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.422 0.689 . . . . 51.41 110.866 -170.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.0 mm -110.22 109.36 28.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.59 -1.263 . . . . 52.42 107.59 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.61 111.5 19.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.068 -0.969 . . . . 70.41 108.657 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.626 ' HB3' HG23 ' A' ' 3' ' ' ILE . 8.8 tp10 -95.11 130.44 41.81 Favored 'General case' 0 C--O 1.248 0.98 0 N-CA-C 109.394 -0.595 . . . . 71.41 109.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -71.87 108.58 5.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.141 -0.936 . . . . 74.22 109.797 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.9 t -94.32 89.82 6.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.465 0.706 . . . . 71.0 110.011 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.86 -61.18 1.46 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.022 0.929 . . . . 44.34 109.267 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 123.846 0.858 . . . . 74.33 109.597 -178.818 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.609 ' SD ' ' HA ' ' A' ' 16' ' ' ASP . 45.2 tpp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.438 -0.579 . . . . 73.13 109.438 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 18' ' ' PHE . 79.3 mt -118.47 152.96 34.93 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.689 -0.856 . . . . 74.11 108.689 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.0 pt -131.99 121.08 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 108.563 -0.903 . . . . 70.12 108.563 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 23.1 p90 -122.15 135.58 54.8 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 121.58 -0.7 . . . . 45.34 109.946 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 46.4 mtpt -137.72 135.09 36.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.839 -1.528 . . . . 70.41 109.448 -159.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.94 144.32 36.92 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.298 -0.631 . . . . 54.33 109.298 173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.23 -26.42 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 113.475 0.917 . . . . 74.12 113.475 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -96.72 -67.85 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 114.238 1.199 . . . . 74.2 114.238 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -130.38 -22.45 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.462 0.912 . . . . 74.52 113.462 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.57 23.15 13.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.458 1.103 . . . . 60.52 109.74 -169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.26 -15.29 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.574 1.55 . . . . 71.2 114.286 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -76.24 -40.45 51.99 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 121.55 -0.718 . . . . 75.34 111.78 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 37.4 mt 21.18 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 126.455 1.902 . . . . 73.05 113.813 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.5 m -152.14 123.03 7.5 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.782 0.289 . . . . 72.32 111.782 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.6 m -113.01 94.66 5.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.595 1.158 . . . . 73.22 110.538 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.609 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 26.7 t70 -168.97 166.17 11.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.95 0.9 . . . . 64.34 109.668 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -70.32 78.43 0.54 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.527 0.731 . . . . 65.21 110.334 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 32.1 m-85 -104.21 146.7 33.06 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 124.784 1.233 . . . . 45.3 110.673 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.38 118.9 5.91 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.52 2.147 . . . . 73.34 112.603 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.7 ptm -113.4 145.68 40.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.342 0.657 . . . . 64.13 109.927 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -151.47 137.64 18.35 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.235 -0.654 . . . . 63.45 109.235 174.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.53 148.53 24.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.386 1.074 . . . . 75.44 108.232 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.11 134.25 47.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 C-N-CA 124.074 0.95 . . . . 71.13 109.375 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 59.51 16.47 5.29 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.945 1.298 . . . . 62.01 112.53 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 54.61 32.73 17.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.509 1.523 . . . . 60.25 112.542 -174.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 119' ' ' LYS . 55.2 tp -132.23 -50.97 0.94 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.226 0.61 . . . . 74.02 111.033 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.39 141.92 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.319 0.648 . . . . 71.34 109.819 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.69 113.24 24.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.586 -0.894 . . . . 72.12 108.586 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG3' ' HB3' ' A' ' 21' ' ' LYS . 6.0 pt-20 -82.88 104.08 12.83 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.007 -1.479 . . . . 61.34 107.007 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.581 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.0 t80 -88.88 112.67 23.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.94 -1.504 . . . . 71.42 106.94 177.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -67.2 148.88 51.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.912 0.885 . . . . 71.11 110.969 -171.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 157.78 27.51 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.496 0.497 . . . . 63.31 113.575 -174.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -121.26 140.23 52.34 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.311 -0.996 . . . . 73.11 108.311 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -74.33 116.78 15.39 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.001 -1.481 . . . . 74.45 107.001 167.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 72' ' ' LEU . 34.4 m -131.08 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 124.545 1.138 . . . . 75.12 108.398 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 m -125.86 153.93 34.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.814 0.846 . . . . 75.3 109.655 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.536 ' HB2' HD13 ' A' ' 72' ' ' LEU . 12.9 ttp180 -141.53 110.26 6.1 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.071 0.462 . . . . 74.55 110.945 170.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HG3' ' H ' ' A' ' 40' ' ' GLY . 51.9 tptt -133.94 137.99 45.2 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 107.585 -1.265 . . . . 72.54 107.585 169.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -9.89 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.039 0.755 . . . . 65.3 113.039 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' A' ' 38' ' ' LYS . . . -106.83 -38.65 2.15 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.303 -0.319 . . . . 60.43 112.303 170.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -121.27 138.3 54.3 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.179 0.592 . . . . 74.11 112.321 -167.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.488 1.474 0 C-N-CA 123.927 0.891 . . . . 61.02 110.405 177.036 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 107.233 -1.395 . . . . 64.34 107.233 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . 0.252 2.1 pt-20 68.7 -45.85 0.54 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.694 2.398 . . . . 74.52 113.528 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -134.15 146.35 50.12 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 108.398 -0.964 . . . . 60.34 108.398 -173.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.57 44.65 Favored Glycine 0 N--CA 1.447 -0.58 0 O-C-N 123.604 0.565 . . . . 55.03 112.259 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.802 HD11 HD12 ' A' ' 70' ' ' ILE . 1.8 tt -94.82 130.1 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.219 -1.03 . . . . 70.01 108.219 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -47.97 -40.67 23.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.753 1.621 . . . . 71.23 113.416 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.802 HD12 HD11 ' A' ' 68' ' ' ILE . 62.4 mt -55.36 -47.88 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.741 1.216 . . . . 71.32 110.666 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.1 -48.63 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.405 0.682 . . . . 74.53 111.713 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 37' ' ' ARG . 63.0 mt -60.83 -33.91 73.75 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.094 0.871 . . . . 74.51 111.092 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -79.35 -48.65 13.68 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.169 0.987 . . . . 75.43 111.16 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -87.15 1.78 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.91 0.484 . . . . 75.03 111.612 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 70.5 mmtt 64.38 34.86 10.11 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.833 1.253 . . . . 73.43 111.165 173.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.51 132.71 40.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.205 -0.665 . . . . 53.24 109.205 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 p -84.64 133.46 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 N-CA-C 109.883 -0.414 . . . . 72.43 109.883 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.79 140.34 45.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.157 1.383 . . . . 70.23 112.677 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -148.06 131.55 16.72 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.505 -0.924 . . . . 71.43 108.505 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 45.2 m-80 -88.0 137.57 32.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.816 0.446 . . . . 63.15 110.491 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.1 p -57.74 -30.75 65.83 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.501 1.521 . . . . 74.43 111.204 172.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.427 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 47.1 m-85 -59.51 -34.58 72.8 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.673 -1.603 . . . . 73.24 110.832 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.46 -18.59 14.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.752 0.821 . . . . 75.13 111.829 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.69 14.98 20.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.261 0.624 . . . . 72.24 112.143 -169.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.89 -53.96 50.86 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.563 0.62 . . . . 75.52 112.213 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.7 t -70.5 -36.54 73.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.345 0.658 . . . . 65.31 110.745 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.0 mmm -62.39 -38.39 89.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.273 0.629 . . . . 73.43 110.846 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.409 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 76.4 t80 -78.95 -25.45 43.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.707 0.803 . . . . 72.32 110.627 -176.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -62.94 -41.79 99.6 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.951 -0.759 . . . . 75.03 108.951 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.4 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 74.32 111.05 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 23.2 m-85 -61.37 -37.98 85.34 Favored 'General case' 0 C--N 1.364 1.205 0 CA-C-O 119.506 -0.283 . . . . 72.21 110.48 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.785 HG21 HD11 ' A' ' 128' ' ' LEU . 14.8 mm -66.47 -41.67 89.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 124.061 0.851 . . . . 74.14 111.876 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -61.88 -38.4 88.16 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.89 0.768 . . . . 75.33 110.204 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.82 -45.22 68.35 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.457 -0.792 . . . . 72.11 110.431 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . 84.6 t80 -55.76 -57.31 12.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.738 1.615 . . . . 63.43 111.621 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.2 ptm -63.97 -31.64 72.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.493 0.717 . . . . 70.52 110.693 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -61.5 -58.55 7.72 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.867 -0.42 . . . . 73.13 109.867 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.5 -27.38 62.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.336 -0.847 . . . . 71.01 112.223 -168.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 174' ' ' GLU . 22.5 m -75.2 -38.46 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 117.697 0.226 . . . . 72.02 111.326 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' HE2' ' A' ' 103' ' ' MET . 55.4 mt -69.31 -38.05 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 110.324 -0.25 . . . . 73.53 110.324 176.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 -46.4 88.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.017 0.527 . . . . 70.12 110.685 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -53.23 -56.01 19.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.129 0.971 . . . . 64.05 111.057 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.439 ' HE1' ' O ' ' A' ' 113' ' ' VAL . 19.4 ptt? -64.63 -45.49 86.61 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.086 0.866 . . . . 64.2 111.346 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.142 0.977 . . . . 75.55 111.529 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -62.8 -27.1 69.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.993 0.917 . . . . 65.3 113.177 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -116.26 -6.91 11.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.139 0.422 . . . . 72.02 112.139 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.83 -64.67 1.04 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.52 -0.919 . . . . 71.51 108.52 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 74.35 -26.99 0.19 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.09 1.356 . . . . 70.51 112.166 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.65 125.8 29.87 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.658 0.783 . . . . 64.23 109.747 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.94 -23.31 66.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.521 1.128 . . . . 74.11 111.248 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.18 73.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.961 0.904 . . . . 62.31 111.483 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.48 -48.69 6.01 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.584 0.754 . . . . 54.32 110.031 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.439 ' O ' ' HE1' ' A' ' 103' ' ' MET . 27.6 m -75.9 -34.08 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 113.19 0.811 . . . . 70.15 113.19 -169.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.21 -38.98 89.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 118.702 0.683 . . . . 74.22 110.254 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.98 -45.49 73.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.016 -0.993 . . . . 74.23 110.786 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.36 -42.03 96.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.74 0.416 . . . . 65.35 110.291 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.78 -38.58 75.71 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.727 0.811 . . . . 63.15 110.824 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -68.36 -43.07 78.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.411 0.685 . . . . 71.44 110.52 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HB3' HD22 ' A' ' 26' ' ' LEU . 70.3 mmtt -60.12 -55.85 28.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.73 0.812 . . . . 75.13 111.134 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.491 HD13 HG21 ' A' ' 172' ' ' VAL . 10.5 tp -66.97 -31.18 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.488 0.715 . . . . 73.34 110.232 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.62 -62.76 1.47 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 123.041 0.536 . . . . 74.41 110.123 168.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.77 -27.45 66.6 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.606 0.567 . . . . 12.13 113.77 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -73.88 -45.17 52.55 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.152 0.581 . . . . 71.55 111.009 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.67 -25.34 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 122.989 0.181 . . . . 61.41 110.892 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.08 -27.58 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.879 -0.513 . . . . 61.12 109.803 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -76.68 -50.97 12.4 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.367 0.667 . . . . 64.14 110.375 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 155' ' ' ILE . 36.8 tp -75.15 -33.02 61.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.296 1.039 . . . . 61.32 112.766 -166.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.785 HD11 HG21 ' A' ' 92' ' ' ILE . 95.9 mt -79.07 2.89 19.08 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.86 0.689 . . . . 70.24 112.86 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.55 143.11 48.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.254 -1.017 . . . . 73.32 108.254 170.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 25.8 pttm -57.75 -27.36 62.95 Favored 'General case' 0 C--O 1.212 -0.87 0 O-C-N 124.1 0.875 . . . . 63.22 111.89 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -46.1 87.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.229 1.412 . . . . 72.41 110.59 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.477 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 1.5 mpp_? -67.85 -44.33 77.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.596 -1.183 . . . . 65.55 110.115 175.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.492 ' HE1' ' HA ' ' A' ' 128' ' ' LEU . 7.2 m-85 -61.53 -25.76 67.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.831 0.853 . . . . 53.24 113.029 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 25.2 mtpp -64.88 -20.43 66.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.859 0.464 . . . . 74.51 111.382 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -132.57 17.09 4.36 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.375 0.67 . . . . 71.33 112.154 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 44.1 mt -93.07 139.38 30.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.277 0.489 . . . . 72.1 110.272 172.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -122.16 123.38 41.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.69 -1.226 . . . . 62.23 107.69 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -95.38 128.75 42.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.218 0.532 . . . . 71.42 109.684 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -130.65 151.86 50.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.19 -1.041 . . . . 64.42 108.19 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.3 pt -134.0 167.94 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 108.324 -0.991 . . . . 72.53 108.324 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.81 144.65 48.2 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.761 -0.536 . . . . 24.11 111.761 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 36.7 tt0 -52.9 -42.71 65.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.113 0.565 . . . . 74.24 110.735 173.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.694 HH11 ' HB2' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -60.76 -42.62 97.81 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.309 1.444 . . . . 71.55 110.319 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.699 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -56.09 -51.68 67.02 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.951 0.9 . . . . 74.33 111.59 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.86 -29.16 61.96 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.455 -0.793 . . . . 72.25 112.4 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -74.26 -41.74 60.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.553 . . . . 72.13 110.856 -171.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.23 62.63 0.08 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.15 -0.78 . . . . 71.35 111.15 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -157.59 175.6 13.72 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.155 0.582 . . . . 73.32 110.865 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.82 170.56 13.38 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.896 0.878 . . . . 64.0 113.16 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -86.09 67.19 9.9 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.722 1.209 . . . . 74.2 108.003 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.09 -112.0 0.01 OUTLIER Glycine 0 CA--C 1.54 1.625 0 CA-C-N 113.229 -1.805 . . . . 75.44 114.39 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.38 155.99 17.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.202 0.601 . . . . 73.52 109.558 169.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 85.4 t -103.01 126.55 57.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.817 -0.808 . . . . 73.41 108.817 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.626 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.09 103.84 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.127 0.971 . . . . 64.13 109.113 170.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 127' ' ' LEU . 63.2 mt -90.68 110.6 22.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.171 -0.677 . . . . 75.04 109.171 -171.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 68' ' ' ILE . 51.2 mm -96.91 98.96 8.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.215 0.531 . . . . 74.02 110.001 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.43 96.51 5.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.894 -1.15 . . . . 74.31 107.894 169.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 45.0 p90 -107.02 129.12 54.85 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.411 -0.588 . . . . 72.33 109.411 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.16 -177.36 6.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.473 1.109 . . . . 72.41 109.09 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.19 137.52 54.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.43 0.292 . . . . 72.11 110.28 171.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.7 p -111.03 111.95 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 N-CA-C 108.22 -1.029 . . . . 72.42 108.22 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 63.49 17.43 10.34 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.828 1.251 . . . . 54.45 112.367 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.18 -19.03 30.22 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.113 -0.271 . . . . 62.43 112.719 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.4 m -82.28 106.94 14.57 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.3 0.55 . . . . 72.01 109.537 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -71.97 101.61 2.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 71.1 109.922 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.7 m -105.6 101.19 30.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 113.627 -1.624 . . . . 71.34 109.348 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.629 ' HB2' HD12 ' A' ' 68' ' ' ILE . 92.0 Cg_endo -92.15 118.36 0.45 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.95 2.433 . . . . 61.34 111.703 172.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 28.1 m -114.43 135.53 54.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.129 0.972 . . . . 71.3 109.565 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 38.6 tp -79.61 146.24 32.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.803 -0.814 . . . . 50.53 108.803 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.0 ptp -141.05 132.5 26.86 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.428 0.632 . . . . 65.21 109.635 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.626 HD21 ' HA ' ' A' ' 154' ' ' ALA . 94.8 mt -139.14 149.83 44.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.482 1.913 . . . . 74.34 107.032 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.491 HG21 HD13 ' A' ' 120' ' ' ILE . 6.2 p -83.14 146.54 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.476 -0.935 . . . . 72.31 108.476 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -25.42 8.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.754 1.621 . . . . 72.1 112.585 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . 2.0 tp10 -89.22 -27.07 20.87 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.085 0.954 . . . . 63.32 112.583 -172.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.37 -6.51 37.4 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.949 0.5 . . . . 71.14 110.77 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 172' ' ' VAL . 10.5 tp -118.12 151.4 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.053 0.941 . . . . 73.34 108.72 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 47.3 mm -124.55 107.97 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.1 -1.444 . . . . 74.42 107.1 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 140.59 46.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.675 -0.491 . . . . 75.21 109.675 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.88 124.82 13.49 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.294 -1.002 . . . . 63.55 108.294 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.497 ' HG2' HD22 ' A' ' 182' ' ' LEU . 36.2 ttpt -80.72 103.99 10.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.405 0.682 . . . . 75.44 109.602 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.31 90.0 8.14 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.395 0.678 . . . . 74.32 109.457 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 182' ' ' LEU . 2.6 pt? -118.9 175.07 5.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.443 0.697 . . . . 73.25 109.855 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.562 1.409 0 C-N-CA 123.546 0.738 . . . . 65.42 110.078 -179.049 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 63.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 110.204 -0.295 . . . . 70.11 110.204 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mt -104.43 137.76 41.82 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.444 0.698 . . . . 72.43 109.882 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.517 HG22 ' HB2' ' A' ' 15' ' ' SER . 21.1 pt -121.43 122.23 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 109.498 -0.556 . . . . 74.42 109.498 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.741 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 18.6 p90 -124.3 114.88 20.15 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.85 0.86 . . . . 73.41 110.061 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 169.14 14.37 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.836 0.854 . . . . 73.31 110.438 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -114.67 175.34 5.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.425 0.69 . . . . 71.33 109.432 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.28 -28.33 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 112.918 0.71 . . . . 60.4 112.918 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.58 -59.88 1.89 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.488 0.715 . . . . 74.21 110.295 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -84.41 19.8 1.83 Allowed 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.147 -0.933 . . . . 72.14 110.8 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -45.35 -35.87 3.84 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.194 2.197 . . . . 61.33 114.012 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.07 -9.76 42.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.338 0.655 . . . . 71.41 112.375 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -121.17 16.5 11.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.668 0.787 . . . . 72.42 111.287 -172.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -105.27 -164.54 1.04 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 72.32 108.468 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -151.64 152.28 32.62 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.212 0.529 . . . . 71.24 111.712 -168.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.517 ' HB2' HG22 ' A' ' 3' ' ' ILE . 59.9 p -137.18 101.39 4.53 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.08 0.952 . . . . 65.43 109.124 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.2 t70 -157.37 -84.11 0.05 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.782 0.433 . . . . 75.21 110.273 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 m 177.69 86.77 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.264 1.826 . . . . 63.25 107.383 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.08 148.19 64.83 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.028 -0.987 . . . . 64.13 108.341 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.86 118.46 5.63 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.87 1.713 . . . . 74.12 112.559 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.741 ' SD ' ' HB3' ' A' ' 4' ' ' TYR . 58.4 mtm -114.34 144.66 42.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.746 0.818 . . . . 72.12 109.353 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -131.32 156.56 45.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.933 . . . . 61.14 108.896 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.591 HD11 ' HD3' ' A' ' 173' ' ' LYS . 28.3 tp -127.97 139.57 52.49 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.472 -0.936 . . . . 64.25 108.472 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.84 145.56 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 C-N-CA 123.213 0.605 . . . . 65.24 109.721 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 67.72 2.51 3.05 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.579 1.152 . . . . 54.33 112.356 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 55.49 29.08 12.67 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.112 0.965 . . . . 73.53 110.827 -167.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 119' ' ' LYS . 49.8 tp -134.45 -51.32 0.81 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.543 0.687 . . . . 73.42 110.483 -175.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.2 t -107.23 127.18 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.728 -1.123 . . . . 61.02 109.834 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -83.02 134.09 35.06 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.405 -0.961 . . . . 74.34 108.405 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.4 tt0 -130.17 104.7 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.076 -0.965 . . . . 74.55 109.056 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.589 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.6 t80 -90.59 124.36 34.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.099 -0.704 . . . . 73.32 109.099 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -80.15 138.59 36.92 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.745 -0.465 . . . . 72.42 109.745 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.99 151.5 20.05 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.517 -0.633 . . . . 42.52 111.517 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -93.58 150.25 20.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.191 0.596 . . . . 72.13 110.265 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -83.16 106.04 14.63 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.115 -1.069 . . . . 61.45 108.115 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG23 HD12 ' A' ' 72' ' ' LEU . 16.8 m -141.83 162.89 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.508 0.723 . . . . 61.03 109.583 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.43 HG22 HD12 ' A' ' 42' ' ' ILE . 11.4 m -127.04 151.31 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.946 -0.39 . . . . 60.24 109.946 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.6 107.59 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.352 -1.351 . . . . 74.44 107.352 160.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -123.64 95.02 4.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.525 -1.287 . . . . 73.51 107.525 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 49.2 -77.33 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 126.392 1.877 . . . . 64.42 113.161 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.8 45.71 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.779 -0.928 . . . . 71.32 110.779 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.74 137.23 16.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.294 1.038 . . . . 63.22 110.15 -173.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 36' ' ' VAL . 5.9 tp . . . . . 0 CA--C 1.56 1.354 0 C-N-CA 123.948 0.899 . . . . 74.01 110.062 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 108.266 -1.013 . . . . 70.52 108.266 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.51 67.91 10.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.611 -1.255 . . . . 61.43 107.611 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -91.88 157.01 17.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.853 -1.067 . . . . 73.41 112.089 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.3 -124.48 1.95 Allowed Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.151 -0.477 . . . . 43.31 112.336 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 12.6 pt -112.47 154.68 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.344 0.658 . . . . 75.43 111.153 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -53.83 -42.05 68.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.745 1.218 . . . . 45.31 112.7 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.6 mt -58.27 -45.99 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.711 1.204 . . . . 64.21 110.106 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 76' ' ' LEU . 75.8 t -72.63 -49.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 114.239 -1.346 . . . . 63.21 112.093 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 57.2 mt -67.94 -33.18 74.18 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.661 0.601 . . . . 71.24 112.404 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.56 -29.55 70.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.613 0.571 . . . . 71.55 111.304 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -115.52 -19.74 10.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.696 0.998 . . . . 73.25 113.696 -170.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? 68.56 59.85 0.39 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.887 0.875 . . . . 71.31 109.195 -170.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 71' ' ' VAL . 87.2 mt -77.42 125.5 29.43 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 107.506 -1.294 . . . . 74.23 107.506 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.34 124.85 39.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 109.114 -0.698 . . . . 41.22 109.114 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.11 158.9 33.95 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 122.0 0.905 . . . . 55.03 112.48 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.2 tpt -147.38 112.17 5.38 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 105.744 -1.947 . . . . 71.02 105.744 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 89.3 m-20 -100.42 128.3 46.52 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.192 0.597 . . . . 54.3 110.139 -171.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.98 -12.85 12.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.804 1.641 . . . . 71.54 113.054 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.432 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 69.1 m-85 -73.88 -38.07 64.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.048 1.339 . . . . 71.23 111.085 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.04 -38.15 6.4 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.414 0.686 . . . . 74.24 112.614 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -66.96 -3.13 6.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.025 1.861 . . . . 64.21 116.025 -159.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -30.12 -63.77 0.13 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.843 1.657 . . . . 63.15 114.815 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.8 m -64.33 -42.76 96.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.903 0.481 . . . . 75.25 111.693 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 85.2 mmm -71.67 -50.93 26.01 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.474 0.484 . . . . 74.31 111.907 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.41 ' HE2' HD22 ' A' ' 128' ' ' LEU . 58.2 t80 -65.71 -40.0 91.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.599 0.76 . . . . 75.11 111.527 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.28 -35.13 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.78 0.432 . . . . 65.31 110.542 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 94' ' ' LYS . . . -64.26 -42.7 96.35 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 123.296 0.373 . . . . 42.24 110.184 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -67.92 -33.98 75.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.654 0.782 . . . . 75.44 112.033 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.25 -38.87 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.187 0.595 . . . . 51.44 110.641 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -41.3 98.54 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.112 -0.699 . . . . 72.34 109.112 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mmtt -61.97 -60.75 3.16 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.508 -0.923 . . . . 71.12 108.508 175.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.4 ' O ' HG13 ' A' ' 99' ' ' VAL . 60.8 t80 -43.6 -60.85 1.59 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.132 1.773 . . . . 71.34 111.493 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 42.5 ttp -56.51 -60.64 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.134 0.974 . . . . 54.1 110.631 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -60.12 -41.62 93.01 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.422 0.451 . . . . 72.35 111.322 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -72.47 -39.8 67.46 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 119.124 -0.465 . . . . 33.3 111.63 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 175' ' ' ALA . 22.2 m -70.71 -37.27 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 117.823 0.283 . . . . 75.44 111.375 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.89 -43.24 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.074 0.464 . . . . 75.21 109.797 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.05 -30.21 68.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.284 1.034 . . . . 72.03 111.335 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -62.53 -48.77 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.55 0.74 . . . . 60.1 109.463 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.432 ' HG3' ' HG3' ' A' ' 174' ' ' GLU . 16.1 mmt -78.28 -21.02 50.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.741 -0.663 . . . . 73.41 112.064 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.29 -30.29 62.02 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.773 -0.579 . . . . 75.33 109.868 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -75.01 -31.58 61.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.509 0.723 . . . . 73.51 110.71 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -99.12 -29.68 12.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.252 0.621 . . . . 72.54 112.613 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -103.18 -43.68 5.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 73.11 108.686 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 64.68 19.82 11.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.692 1.197 . . . . 73.33 112.433 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m-20 -94.85 103.74 15.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.301 -1.0 . . . . 75.23 108.301 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.25 -37.89 81.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.07 0.948 . . . . 62.02 111.827 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.29 74.61 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.416 0.686 . . . . 74.45 111.52 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 109' ' ' ASP . 3.6 t70 -75.42 -49.84 17.68 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.059 0.943 . . . . 63.2 110.712 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.94 -23.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.468 -0.787 . . . . 73.03 111.659 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.15 -35.45 61.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.873 0.469 . . . . 72.24 110.203 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 118' ' ' LYS . . . -69.64 -39.42 77.15 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.482 -0.562 . . . . 63.03 109.482 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -65.63 -38.54 89.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.181 0.993 . . . . 73.31 110.771 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.35 -33.86 73.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.237 1.015 . . . . 73.1 110.798 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 18.0 tppt? -64.92 -48.96 72.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.509 0.724 . . . . 73.12 110.32 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HB3' HD22 ' A' ' 26' ' ' LEU . 13.5 mptt -63.93 -40.12 95.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.415 0.286 . . . . 74.2 111.63 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 172' ' ' VAL . 17.6 mm -70.27 -48.26 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 118.994 -0.527 . . . . 73.05 111.095 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.24 -46.08 83.32 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.081 -0.711 . . . . 54.14 109.081 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.13 94.54 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.285 0.991 . . . . 43.01 113.292 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.3 -52.09 56.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 122.992 0.517 . . . . 74.45 109.861 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 25.8 m -70.85 -37.3 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 123.644 0.59 . . . . 73.12 111.727 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.89 -32.83 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.81 0.732 . . . . 73.31 109.784 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -74.98 -40.96 60.43 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.875 -0.602 . . . . 64.2 111.497 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.3 tp -78.87 -19.35 52.15 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.305 1.042 . . . . 73.11 112.307 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 47.4 mt -93.64 2.65 56.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.271 0.628 . . . . 72.25 111.49 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.3 91.15 2.16 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.746 0.418 . . . . 52.03 109.933 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 44.5 mtmt -63.16 -6.72 4.56 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.745 1.218 . . . . 73.12 113.778 -170.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.26 -41.68 76.2 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.14 0.576 . . . . 74.44 110.194 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -108.74 -48.44 3.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.969 1.308 . . . . 74.33 110.558 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -81.37 -1.12 44.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.268 1.427 . . . . 73.24 114.491 -164.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 34.9 ttmt -57.19 -16.89 9.07 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.053 0.541 . . . . 52.12 111.237 165.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -89.98 15.31 10.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.246 1.018 . . . . 74.24 111.089 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.61 148.65 23.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.56 -0.904 . . . . 64.32 108.56 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.53 111.68 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.599 -1.63 . . . . 73.14 106.599 175.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.437 ' HB3' HG11 ' A' ' 153' ' ' VAL . 46.1 m-85 -90.21 142.11 28.04 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.731 -0.84 . . . . 72.14 108.731 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -137.82 155.79 48.63 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.922 0.889 . . . . 73.41 108.735 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.38 143.2 20.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.011 -1.477 . . . . 72.34 107.011 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.46 134.89 49.97 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 118.992 -0.893 . . . . 63.41 113.073 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -55.25 -38.27 68.3 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.139 0.975 . . . . 72.44 111.355 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -65.63 -44.42 86.53 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.204 -0.907 . . . . 75.02 111.659 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.93 -21.42 51.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.049 0.54 . . . . 65.3 111.647 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.89 0.18 51.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.744 0.817 . . . . 61.23 110.942 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.04 -24.04 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.799 0.84 . . . . 71.43 110.62 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.48 47.77 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.748 -0.205 . . . . 21.52 113.361 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.75 78.32 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.06 0.544 . . . . 74.45 110.586 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.12 -3.43 32.76 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.505 0.722 . . . . 64.11 111.828 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.25 -18.64 55.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.574 0.75 . . . . 32.24 109.667 169.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.86 150.4 50.08 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 124.376 1.047 . . . . 50.24 113.373 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -96.16 155.5 16.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.479 0.711 . . . . 75.41 110.088 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.437 HG11 ' HB3' ' A' ' 138' ' ' PHE . 53.3 t -88.13 129.34 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.565 0.746 . . . . 75.53 111.296 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.18 111.5 10.48 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.487 1.115 . . . . 75.41 109.33 170.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.4 mt -93.78 113.02 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.437 0.695 . . . . 71.41 109.398 -170.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 169' ' ' LEU . 45.7 mm -98.7 123.7 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.955 -0.465 . . . . 73.45 109.984 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.29 128.88 49.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.802 1.241 . . . . 74.02 108.889 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -81.21 114.5 20.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.814 -1.18 . . . . 63.02 107.814 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.591 ' HB3' HG13 ' A' ' 166' ' ' VAL . 18.2 tpp85 -88.68 141.25 28.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.459 0.704 . . . . 64.25 109.646 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -100.68 124.43 46.28 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.694 -0.484 . . . . 65.35 109.694 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.595 HG13 ' HB ' ' A' ' 164' ' ' THR . 3.1 p -125.77 90.67 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.056 0.942 . . . . 73.35 109.273 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 62.23 17.5 9.32 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.063 1.345 . . . . 71.35 113.31 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.23 -14.69 9.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 120.027 -0.318 . . . . 71.1 113.382 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.595 ' HB ' HG13 ' A' ' 161' ' ' VAL . 80.5 m -88.2 138.66 31.24 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.263 0.625 . . . . 74.41 110.112 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 112.16 24.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.513 0.725 . . . . 64.13 109.296 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 159' ' ' ARG . 2.6 p -119.75 104.02 45.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.46 1.104 . . . . 75.14 109.293 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.27 130.45 39.44 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.597 2.198 . . . . 71.25 112.574 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.1 p -137.02 131.07 32.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.048 0.539 . . . . 63.1 110.587 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 28.7 tp -76.43 137.96 40.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 54.44 109.477 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.8 ttm -123.95 122.25 37.45 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.67 -1.233 . . . . 72.41 107.67 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 34.5 mt -151.8 167.9 26.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.65 1.58 . . . . 63.35 106.76 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.438 HG21 HD11 ' A' ' 120' ' ' ILE . 12.3 p -88.35 139.92 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 118.593 0.633 . . . . 63.43 109.596 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.591 ' HD3' HD11 ' A' ' 22' ' ' LEU . 58.7 pttt -69.21 -24.1 63.99 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.943 0.497 . . . . 74.42 112.147 -173.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.432 ' HG3' ' HG3' ' A' ' 103' ' ' MET . 11.2 mp0 -64.87 -23.89 67.37 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.797 0.839 . . . . 62.33 112.045 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -96.82 -10.38 26.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.487 0.715 . . . . 61.21 111.358 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.415 HG22 ' HG3' ' A' ' 178' ' ' GLU . 42.5 mm -107.02 147.53 12.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.355 0.662 . . . . 62.4 109.555 -175.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.71 108.2 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.13 -1.433 . . . . 72.41 107.13 170.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.415 ' HG3' HG22 ' A' ' 176' ' ' ILE . 16.0 mt-10 -109.49 117.93 35.27 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.601 -1.259 . . . . 71.32 107.601 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -144.66 135.6 24.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.592 -0.892 . . . . 75.34 108.592 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -124.44 109.01 12.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 52.13 109.164 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -96.64 91.89 5.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.786 0.834 . . . . 61.44 109.724 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.47 -46.92 4.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 74.34 109.828 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.617 -0.883 . . . . 74.01 108.617 -178.638 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.031 0.443 . . . . 71.43 110.087 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.6 mt -105.39 161.67 14.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.054 0.942 . . . . 64.2 108.755 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 62.0 mt -115.97 118.72 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.701 -0.852 . . . . 75.21 108.701 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -104.57 96.26 6.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.829 -0.804 . . . . 63.11 108.829 -174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 68.3 mttm -122.34 152.17 40.42 Favored 'General case' 0 C--O 1.21 -0.992 0 C-N-CA 123.859 0.864 . . . . 63.24 109.213 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 7.2 t70 -114.02 143.21 45.13 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 106.955 -1.498 . . . . 74.15 106.955 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -52.84 -20.6 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.823 1.045 . . . . 65.44 113.823 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -107.13 -42.49 4.86 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.189 0.996 . . . . 74.53 110.5 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 6' ' ' ASP . 33.2 p -104.93 18.43 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.816 0.847 . . . . 62.13 112.098 -172.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 8.7 p-10 -60.75 -11.92 9.03 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.511 1.524 . . . . 73.33 113.784 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.31 -58.26 4.83 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 125.133 1.521 . . . . 54.52 110.53 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -122.91 -38.17 2.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.416 -0.811 . . . . 62.23 111.473 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.7 tp 5.54 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.885 2.074 . . . . 72.35 114.203 -163.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.513 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 70.6 m -156.95 146.0 20.16 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.95 0.5 . . . . 33.45 110.779 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 p -148.6 103.64 3.42 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 118.833 0.742 . . . . 72.14 110.957 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -168.28 176.34 5.98 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.343 1.457 . . . . 64.5 108.196 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -72.83 75.37 1.15 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.185 0.517 . . . . 62.03 110.116 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 14' ' ' SER . 64.2 m-85 -87.32 147.28 41.84 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.722 0.809 . . . . 72.43 110.769 -177.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.15 117.7 2.71 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.716 2.278 . . . . 71.44 112.737 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.619 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 60.6 ttp -119.35 114.43 22.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.605 1.162 . . . . 74.22 109.399 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -140.34 136.61 33.36 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.779 -1.193 . . . . 73.44 107.779 171.146 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 25' ' ' ASP . 59.9 tp -113.15 142.54 45.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.132 -1.062 . . . . 64.32 108.132 174.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.25 130.76 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.148 -0.686 . . . . 64.23 109.148 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.99 12.74 4.1 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.902 1.281 . . . . 65.34 112.811 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' HA ' HD21 ' A' ' 22' ' ' LEU . 8.6 m-20 53.37 12.11 0.32 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.638 1.175 . . . . 62.11 113.418 -167.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.712 HD22 ' HG3' ' A' ' 119' ' ' LYS . 45.5 tp -107.08 -45.59 4.11 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.774 0.83 . . . . 54.41 110.027 -171.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 t -120.3 131.38 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.473 -0.785 . . . . 74.01 109.446 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.619 ' HE1' ' HG3' ' A' ' 20' ' ' MET . 82.0 t80 -98.07 126.7 43.62 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.897 -1.149 . . . . 73.53 107.897 171.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 154.6 30.8 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.415 0.626 . . . . 73.01 110.811 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 50.7 t80 -136.42 129.92 31.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.268 1.427 . . . . 63.34 108.655 -171.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -78.98 153.71 30.12 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.154 0.502 . . . . 74.13 110.976 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.37 172.58 39.36 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.312 -0.858 . . . . 73.31 111.004 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 47.4 mtmt -128.28 154.29 46.05 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.569 -0.901 . . . . 73.43 108.569 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 6.4 p-80 -73.98 130.15 39.28 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.5 -1.296 . . . . 75.32 107.5 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 42' ' ' ILE . 15.9 m -139.73 149.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.54 0.736 . . . . 71.2 109.305 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.493 ' HB ' ' HG2' ' A' ' 66' ' ' ARG . 7.4 m -123.3 120.32 59.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.299 -1.371 . . . . 73.53 107.299 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 59.3 ttt180 -138.53 117.43 12.41 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.531 -0.759 . . . . 72.22 108.96 -169.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -133.08 118.6 18.94 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.038 -0.727 . . . . 75.43 109.038 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 64.43 24.68 13.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.422 1.089 . . . . 75.24 112.028 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -27.07 18.74 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-O 120.019 -0.323 . . . . 62.13 113.008 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.23 123.17 24.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.231 0.612 . . . . 74.43 110.204 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 35' ' ' VAL . 5.5 tp . . . . . 0 CA--C 1.547 0.851 0 C-N-CA 123.659 0.783 . . . . 75.11 109.897 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.241 0.622 0 N-CA-C 105.647 -1.983 . . . . 73.3 105.647 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HA ' HD22 ' A' ' 72' ' ' LEU . 51.8 mt-10 -82.52 62.64 6.27 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.505 0.669 . . . . 73.04 111.324 -174.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.493 ' HG2' ' HB ' ' A' ' 36' ' ' VAL . 49.0 mtt180 -108.69 120.51 42.68 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.153 -1.055 . . . . 74.41 108.153 173.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.28 -136.08 4.6 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 109.703 -1.359 . . . . 60.34 109.703 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 24.2 pt -110.4 143.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 117.354 0.577 . . . . 73.32 110.5 173.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.96 -34.48 59.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.152 1.381 . . . . 72.51 112.223 -176.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 169' ' ' LEU . 60.1 mt -56.46 -51.04 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.924 0.89 . . . . 75.34 110.637 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 76' ' ' LEU . 63.1 t -70.26 -49.32 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.887 -1.051 . . . . 72.1 111.518 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 65' ' ' GLU . 33.4 mt -63.28 -39.85 95.73 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.814 0.846 . . . . 42.42 111.069 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.96 -32.93 73.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.31 1.044 . . . . 72.41 111.579 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.16 -6.69 21.91 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.247 0.619 . . . . 63.51 112.44 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.98 61.54 3.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.906 1.283 . . . . 75.2 111.383 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.495 ' HB2' HG13 ' A' ' 71' ' ' VAL . 59.1 mt -93.95 132.05 38.79 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.371 -0.831 . . . . 73.21 109.945 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 p -79.4 136.88 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.445 0.698 . . . . 71.22 109.881 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.69 144.46 10.92 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.829 1.652 . . . . 71.32 113.58 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.7 mmm -147.95 104.18 3.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 106.346 -1.724 . . . . 74.42 106.346 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -93.01 136.58 33.14 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.9 -0.778 . . . . 74.32 108.9 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 52.1 t -65.56 -14.22 60.62 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.618 0.767 . . . . 72.01 110.842 173.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -75.75 -47.62 25.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.941 . . . . 64.43 110.617 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.17 -33.2 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.137 -0.938 . . . . 73.13 110.703 -175.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.49 22.44 12.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.632 1.173 . . . . 70.34 111.704 -166.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 81' ' ' CYS . . . -49.82 -56.41 10.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.453 0.701 . . . . 71.33 112.284 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.8 m -70.39 -33.68 71.67 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.397 -0.82 . . . . 54.32 111.018 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 42.5 tpp -66.08 -36.86 84.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.059 0.944 . . . . 73.21 110.55 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.507 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 64.1 t80 -72.85 -29.21 63.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.82 0.848 . . . . 74.13 110.576 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -40.91 98.92 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.398 -0.593 . . . . 75.54 109.398 170.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.84 93.97 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.922 -0.581 . . . . 52.32 110.695 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.507 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 58.1 m-85 -60.61 -52.64 64.3 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-O 118.777 -0.63 . . . . 73.53 110.797 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mm -58.47 -37.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.641 0.776 . . . . 64.44 111.56 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -65.17 -49.28 70.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.956 0.502 . . . . 74.44 111.42 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -47.12 83.44 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.612 -0.884 . . . . 71.11 108.612 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 152' ' ' GLN . 22.6 t80 -52.55 -56.61 14.03 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.888 2.075 . . . . 52.21 112.195 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.1 ttt -59.17 -50.81 72.6 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.985 0.803 . . . . 71.23 109.773 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -61.68 -36.05 79.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.672 -0.694 . . . . 53.21 111.338 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.11 -52.88 29.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.015 0.926 . . . . 65.12 111.525 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.93 -31.88 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.163 0.585 . . . . 73.3 112.563 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.15 -43.15 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.492 -0.559 . . . . 71.25 109.492 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.93 -38.83 87.17 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.912 0.885 . . . . 74.14 110.622 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -63.22 -50.88 68.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.206 1.002 . . . . 63.33 109.998 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ttt -63.52 -43.13 98.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.118 -0.946 . . . . 74.25 110.725 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -74.21 -23.01 59.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.845 0.858 . . . . 62.43 111.837 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.464 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 29.0 ttmt -70.5 -20.51 62.84 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.708 . . . . 62.25 109.783 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -112.83 1.21 15.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.469 1.108 . . . . 62.14 111.218 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.35 -68.97 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.005 0.522 . . . . 71.54 110.711 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.88 11.88 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.487 1.915 . . . . 73.23 115.079 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -83.51 -8.75 59.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.909 . . . . 73.03 110.581 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 80.01 -45.21 0.29 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.774 1.63 . . . . 75.42 113.974 169.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.01 71.77 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.477 0.58 . . . . 73.24 112.493 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.83 -44.79 22.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.378 0.671 . . . . 63.21 109.791 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.09 -23.53 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.299 -0.864 . . . . 74.24 111.242 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.64 -47.75 74.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.497 1.119 . . . . 72.05 110.172 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.31 95.36 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 124.098 0.874 . . . . 63.44 110.078 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.47 -45.21 80.45 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.259 0.974 . . . . 65.41 111.752 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.43 -45.88 84.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.341 0.656 . . . . 73.34 110.616 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -65.15 -39.55 93.14 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.255 -1.339 . . . . 64.43 110.47 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.712 ' HG3' HD22 ' A' ' 26' ' ' LEU . 14.0 tppt? -69.07 -49.58 56.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.598 0.759 . . . . 71.42 110.43 -173.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.458 ' HA ' HD21 ' A' ' 26' ' ' LEU . 8.5 tp -72.4 -37.75 58.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 123.374 0.669 . . . . 61.41 110.978 -174.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -66.86 -39.96 87.73 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.184 -0.673 . . . . 75.12 109.184 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.3 99.92 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.648 0.592 . . . . 51.33 112.414 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -66.04 -47.36 74.64 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.138 0.575 . . . . 65.44 110.203 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -69.7 -40.73 79.63 Favored 'Isoleucine or valine' 0 C--N 1.361 1.104 0 CA-C-O 118.476 -0.773 . . . . 71.44 111.565 -174.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.15 -33.22 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 119.495 1.043 . . . . 72.23 110.272 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -72.38 -34.06 67.66 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.9 0.88 . . . . 44.15 110.769 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.623 HD21 HG21 ' A' ' 155' ' ' ILE . 28.7 tp -81.54 -26.28 35.19 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.361 1.064 . . . . 74.22 111.197 -174.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.0 mt -88.24 4.47 45.67 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.834 0.854 . . . . 62.0 111.461 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.55 85.84 0.3 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 123.632 0.773 . . . . 65.42 110.284 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -62.22 -6.83 3.41 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.194 1.398 . . . . 73.23 114.753 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.97 -47.07 84.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.028 0.931 . . . . 74.44 110.865 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.549 ' H ' ' HD3' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -112.22 -31.77 6.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.625 1.17 . . . . 61.41 110.873 174.099 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.73 -1.93 36.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.017 0.927 . . . . 71.31 113.218 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -10.88 4.45 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.474 0.579 . . . . 71.01 112.311 171.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.5 21.71 4.43 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.098 0.959 . . . . 70.11 110.788 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.57 137.71 32.09 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.636 -0.505 . . . . 75.2 109.636 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -111.15 145.83 37.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.654 -1.61 . . . . 73.22 106.654 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.429 ' HB3' HG11 ' A' ' 153' ' ' VAL . 59.9 m-85 -125.32 141.11 52.27 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.296 -1.002 . . . . 73.54 108.296 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 68.2 m-85 -149.32 147.98 28.99 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 124.165 0.986 . . . . 75.42 108.394 -175.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.534 ' HB ' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -150.97 147.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.065 -1.087 . . . . 65.01 108.065 -177.238 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.78 139.04 42.66 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.385 -1.086 . . . . 72.31 110.385 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.65 -21.16 28.53 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.505 0.653 . . . . 75.21 109.978 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.75 -46.41 75.49 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.422 -0.955 . . . . 73.31 108.422 164.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.58 98.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.173 -1.376 . . . . 71.51 111.668 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.92 -46.38 52.96 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.262 0.625 . . . . 73.11 111.649 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.48 -41.32 93.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.188 0.595 . . . . 73.34 111.148 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -63.76 -58.45 11.04 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.245 -0.742 . . . . 55.43 111.245 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 176.63 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.389 1.076 . . . . 52.34 108.548 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -41.41 118.84 1.11 Allowed 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.917 0.887 . . . . 61.0 113.267 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -38.71 -41.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.258 1.423 . . . . 73.25 112.73 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.72 -34.8 4.59 Favored Glycine 0 CA--C 1.502 -0.773 0 CA-C-N 114.681 -1.145 . . . . 70.13 112.224 -175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 20.5 pm0 -98.1 156.59 16.59 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.702 -0.851 . . . . 71.02 108.702 173.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.534 HG13 ' HB ' ' A' ' 140' ' ' ILE . 24.9 t -109.24 143.96 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 107.123 -1.436 . . . . 71.42 107.123 171.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.427 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -63.28 108.79 1.38 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.73 0.812 . . . . 62.15 109.657 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.623 HG21 HD21 ' A' ' 127' ' ' LEU . 58.9 mt -86.5 104.38 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.746 0.818 . . . . 74.43 109.337 -170.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 44.2 mm -89.51 100.11 10.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.451 -0.795 . . . . 73.53 110.048 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.35 95.14 7.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.939 -1.134 . . . . 54.34 107.939 170.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 36.9 p90 -85.56 109.32 18.45 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.627 -0.879 . . . . 71.32 108.627 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -100.43 -179.48 4.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.855 1.262 . . . . 63.15 108.747 -172.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -124.08 120.59 32.81 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.801 0.728 . . . . 75.34 110.408 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -90.08 89.49 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.393 -1.336 . . . . 72.43 107.393 170.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.56 33.78 20.4 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.624 -1.171 . . . . 64.5 111.926 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 111.54 -23.76 17.03 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.753 -0.471 . . . . 73.32 113.28 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.6 m -86.0 125.24 33.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.685 -0.857 . . . . 73.05 108.685 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 20.5 tt0 -72.08 121.96 20.13 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.433 0.56 . . . . 72.3 109.723 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.0 p -117.46 90.25 34.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.892 1.277 . . . . 75.11 109.037 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 98.4 Cg_exo -50.2 125.92 16.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.226 2.617 . . . . 71.55 112.473 167.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.0 m -123.82 115.06 20.72 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.904 -0.776 . . . . 74.52 108.904 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp -76.51 130.7 38.3 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.054 0.942 . . . . 72.35 108.909 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.2 ttp -128.14 123.0 33.35 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.06 0.944 . . . . 70.42 109.174 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 154' ' ' ALA . 95.2 mt -139.11 157.58 45.72 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.341 1.456 . . . . 64.22 107.614 176.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 174' ' ' GLU . 13.6 p -78.25 131.97 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.891 -0.781 . . . . 41.43 108.891 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -52.22 -28.77 19.77 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.637 1.575 . . . . 75.4 111.983 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.419 ' H ' HG22 ' A' ' 172' ' ' VAL . 15.4 tp10 -67.15 -34.95 78.65 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.243 1.017 . . . . 74.11 111.844 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.18 -13.43 15.43 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.224 0.61 . . . . 74.22 112.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.513 HG21 ' HB3' ' A' ' 28' ' ' TYR . 11.0 tp -108.93 161.91 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.084 -1.45 . . . . 71.35 107.084 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 42.3 mm -135.79 132.26 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.092 0.957 . . . . 63.33 108.593 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.3 96.95 5.29 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.129 -1.063 . . . . 63.13 108.129 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 41.4 tt0 -99.19 102.07 13.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.482 -0.933 . . . . 71.42 108.482 -174.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.17 134.08 45.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.549 0.74 . . . . 75.15 110.546 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.7 t -117.76 96.15 5.25 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.239 -1.023 . . . . 65.31 108.239 173.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.07 153.62 42.95 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.312 0.645 . . . . 74.34 109.919 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.253 1.265 0 CA-C-N 115.456 -0.793 . . . . 71.11 108.988 177.258 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.598 0.713 . . . . 73.35 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.47 160.59 29.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.106 0.962 . . . . 65.25 108.431 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 28.1 mt -116.74 118.9 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.573 -1.269 . . . . 72.32 107.573 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -97.92 97.23 8.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.362 -0.977 . . . . 70.22 108.362 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -111.43 110.29 20.67 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.199 0.6 . . . . 75.22 109.679 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 9.8 t70 -83.85 135.93 34.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.643 -1.614 . . . . 73.32 106.643 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.7 pt -64.04 -17.87 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 118.542 0.61 . . . . 71.31 112.232 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -113.98 -52.07 2.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.383 1.073 . . . . 74.22 110.47 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -90.05 17.46 6.89 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.622 -1.172 . . . . 73.02 111.634 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 29.0 t70 -46.91 -43.84 19.24 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.034 1.333 . . . . 74.42 112.671 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.24 -19.3 65.78 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.117 -1.401 . . . . 71.31 111.906 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.591 ' HG3' ' HA3' ' A' ' 141' ' ' GLY . 6.9 mm-40 -120.8 12.5 11.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.808 1.243 . . . . 74.44 111.403 -174.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.96 -148.34 0.34 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.433 0.693 . . . . 73.42 109.794 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -150.07 160.14 43.87 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.435 0.562 . . . . 75.45 111.388 -163.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 60.0 p -124.38 -160.77 0.95 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.026 0.93 . . . . 73.24 109.573 165.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 74.11 -162.86 0.08 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.073 0.949 . . . . 73.24 110.905 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -96.98 58.01 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.549 0.69 . . . . 73.33 110.307 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.9 149.27 62.99 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 115.427 -0.806 . . . . 74.0 109.007 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 16.5 Cg_exo -68.02 117.6 5.03 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 121.684 1.589 . . . . 71.25 112.025 -176.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.457 ' SD ' ' CD1' ' A' ' 28' ' ' TYR . 12.6 tmm? -148.98 139.44 22.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.042 0.937 . . . . 64.12 109.69 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -139.45 158.28 44.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.269 1.028 . . . . 75.53 109.147 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.12 119.76 37.33 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.469 -0.938 . . . . 74.21 108.469 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.23 136.15 43.34 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 123.808 0.843 . . . . 74.21 108.93 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 65.51 8.3 4.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.269 1.028 . . . . 71.22 113.044 171.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 55.42 30.49 15.08 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.265 1.026 . . . . 60.32 111.626 -171.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.498 HD11 ' HB ' ' A' ' 120' ' ' ILE . 21.3 tp -132.93 -44.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.881 -0.6 . . . . 73.03 111.076 -172.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.08 140.6 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.967 0.507 . . . . 72.23 109.988 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.457 ' CD1' ' SD ' ' A' ' 20' ' ' MET . 30.2 m-85 -92.47 115.09 27.78 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 109.179 -0.675 . . . . 64.41 109.179 168.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.13 126.99 31.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.747 -1.205 . . . . 74.41 107.747 166.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.5 t80 -117.06 104.93 11.74 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.973 -1.491 . . . . 74.54 106.973 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 41.0 mmtm -79.48 143.38 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.377 0.671 . . . . 71.05 111.374 -175.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -139.77 -168.55 11.35 Favored Glycine 0 C--O 1.241 0.582 0 CA-C-N 114.677 -1.147 . . . . 74.45 110.51 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -118.97 150.85 39.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.36 0.664 . . . . 74.02 110.913 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -80.3 107.73 13.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.639 -1.245 . . . . 65.34 107.639 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.96 155.8 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.773 0.829 . . . . 74.42 109.159 -173.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.09 141.14 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.446 -0.576 . . . . 62.22 109.446 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.757 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -142.13 110.08 5.86 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.604 -1.258 . . . . 73.31 107.604 -178.099 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 15.6 tptm -89.23 161.66 16.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.942 0.897 . . . . 72.12 108.957 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -45.88 -38.62 7.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.64 0.978 . . . . 73.23 113.64 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.39 42.29 1.37 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.586 -0.279 . . . . 60.13 112.419 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 11.7 tp10 -164.52 142.51 6.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.55 . . . . 73.43 111.057 -176.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 tp . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.392 1.077 . . . . 70.02 108.507 172.659 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.516 -0.343 0 N-CA-C 104.179 -2.526 . . . . 63.23 104.179 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 77.0 -51.0 0.56 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 125.198 1.399 . . . . 51.22 113.339 157.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -139.15 158.37 44.29 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.552 0.741 . . . . 65.32 109.613 -164.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.4 -158.06 29.0 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 111.235 -0.746 . . . . 74.45 111.235 160.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 pt -110.14 147.3 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.375 0.67 . . . . 75.13 109.209 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.67 -26.84 68.85 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.885 0.874 . . . . 75.45 111.748 -174.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 169' ' ' LEU . 41.7 mm -54.01 -48.21 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.356 0.662 . . . . 53.21 110.205 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.5 t -80.71 -51.08 16.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.017 -0.992 . . . . 73.12 111.674 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.757 HD13 ' HB2' ' A' ' 37' ' ' ARG . 50.6 mt -64.49 -25.47 68.01 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.809 0.844 . . . . 61.22 112.353 -171.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -91.18 -43.68 9.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.571 0.748 . . . . 64.52 110.526 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -94.9 9.51 38.96 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.779 0.659 . . . . 51.12 112.779 -170.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? 64.02 33.77 11.93 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.991 0.807 . . . . 64.33 110.85 168.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 72.3 mt -78.5 120.74 23.64 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.543 -0.54 . . . . 55.32 109.543 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.18 136.37 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.697 0.799 . . . . 75.24 109.158 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.17 145.69 55.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.243 1.017 . . . . 75.14 113.194 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.9 mtt -133.06 102.9 5.78 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 105.211 -2.144 . . . . 75.11 105.211 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -68.45 125.4 26.36 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 108.892 -0.781 . . . . 72.23 108.892 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.6 -25.17 59.65 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.924 0.869 . . . . 74.41 111.071 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -70.01 -32.77 71.12 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 113.792 -1.549 . . . . 64.11 110.721 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -103.83 -39.72 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.347 0.659 . . . . 75.43 111.02 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.4 -11.89 39.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.063 0.945 . . . . 74.42 112.779 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -37.63 -51.85 1.21 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.391 1.626 . . . . 52.11 115.391 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.5 m -68.86 -45.14 71.83 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.074 0.464 . . . . 72.14 111.374 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 72.9 mtm -67.07 -27.99 67.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.177 -0.919 . . . . 70.31 110.432 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.463 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 81.0 t80 -70.79 -39.99 72.82 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.73 0.812 . . . . 73.22 110.78 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -66.13 -31.06 71.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.671 0.388 . . . . 73.2 110.657 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.7 82.63 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.945 -0.571 . . . . 74.24 110.257 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 19.4 m-85 -60.81 -41.69 96.2 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 109.669 -0.493 . . . . 71.33 109.669 173.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.73 -29.94 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.632 0.773 . . . . 73.32 110.625 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -62.79 -53.43 54.39 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.188 0.449 . . . . 73.12 111.381 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.11 -47.33 71.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.252 0.345 . . . . 61.24 110.389 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -45.74 -62.7 1.19 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.61 1.964 . . . . 75.22 112.054 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 39.3 ttp -57.23 -47.99 79.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.583 1.153 . . . . 75.31 111.43 -175.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -68.4 -35.7 78.05 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.783 -0.644 . . . . 74.12 111.896 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -69.81 -47.31 63.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.525 0.73 . . . . 74.11 110.251 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 174' ' ' GLU . 19.6 m -71.53 -33.09 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.915 -0.584 . . . . 71.11 112.44 -173.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.26 -39.9 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.536 -0.542 . . . . 73.31 109.536 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.1 -46.62 75.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.023 0.929 . . . . 75.5 111.578 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.53 -43.98 92.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.501 0.72 . . . . 72.31 110.458 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -62.81 -50.1 72.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.466 1.106 . . . . 73.44 112.604 -174.081 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.689 ' HA ' HG11 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -70.03 -32.72 71.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.435 0.294 . . . . 71.24 111.68 -172.573 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -58.47 -21.67 52.25 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.154 0.502 . . . . 70.11 111.596 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -106.55 -26.1 11.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.605 0.762 . . . . 51.21 111.831 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 112' ' ' ASP . 13.3 m120 -146.46 35.12 0.96 Allowed 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 123.11 0.564 . . . . 64.43 112.052 -167.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.538 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 31.1 ttp180 -69.83 7.55 0.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.006 0.922 . . . . 73.3 112.748 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.3 -21.88 26.9 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.136 0.974 . . . . 72.51 111.248 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 113' ' ' VAL . 97.8 mttt 83.26 -8.84 1.1 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.685 1.594 . . . . 63.25 113.029 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.34 88.15 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.59 0.632 . . . . 64.44 110.004 168.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 107' ' ' ASN . 15.5 t0 -95.36 -44.54 7.52 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.072 -0.967 . . . . 64.11 110.69 -170.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.756 HG12 ' SD ' ' A' ' 103' ' ' MET . 35.8 m -76.37 -31.72 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 113.114 0.783 . . . . 71.04 113.114 -176.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.32 -40.12 95.3 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.163 0.438 . . . . 63.01 110.158 172.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.59 67.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.39 -0.823 . . . . 72.52 110.077 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.99 -47.13 81.55 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.827 0.851 . . . . 73.02 111.605 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -63.83 -43.9 94.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.114 0.966 . . . . 74.11 110.434 -176.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.69 -45.73 91.22 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 123.753 0.658 . . . . 70.42 110.433 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.17 -39.31 68.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.256 -0.884 . . . . 74.22 111.559 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.498 ' HB ' HD11 ' A' ' 26' ' ' LEU . 10.8 tp -73.49 -38.78 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 117.95 0.341 . . . . 63.23 110.105 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -66.93 -44.0 81.81 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.041 0.536 . . . . 75.22 109.857 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.55 -38.23 95.47 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 124.088 0.867 . . . . 54.33 112.786 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 25.5 t90 -66.36 -52.69 44.4 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 123.874 0.87 . . . . 64.11 110.221 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.4 m -69.69 -36.9 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 119.152 -0.451 . . . . 74.44 111.842 -176.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.58 -33.95 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.606 0.639 . . . . 63.43 110.372 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.2 p -80.52 -34.06 35.92 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.497 0.319 . . . . 62.44 111.004 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 155' ' ' ILE . 17.2 tp -69.53 -27.72 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.856 0.862 . . . . 73.3 110.623 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.3 mt -94.49 3.53 55.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.948 0.899 . . . . 73.25 111.438 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.01 95.0 4.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.046 -0.724 . . . . 31.44 109.046 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -58.3 -19.21 32.95 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.69 1.196 . . . . 72.53 113.774 -170.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.11 -45.91 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.315 1.046 . . . . 62.33 111.737 -173.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -108.58 -37.57 5.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 64.14 110.168 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -77.4 -1.84 32.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.664 1.186 . . . . 74.11 113.77 -170.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.05 -15.11 8.12 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 122.884 0.473 . . . . 74.11 111.179 164.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.22 26.09 6.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.019 0.927 . . . . 54.24 110.702 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -89.14 155.18 19.59 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.28 -1.007 . . . . 64.52 108.28 164.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -130.03 113.7 14.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.977 -1.49 . . . . 71.21 106.977 170.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.16 146.8 26.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.721 -0.844 . . . . 72.42 108.721 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 74.0 m-85 -143.47 162.49 35.66 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 123.405 0.682 . . . . 72.25 109.584 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.69 154.14 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.065 -1.457 . . . . 70.44 107.065 170.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.591 ' HA3' ' HG3' ' A' ' 12' ' ' GLU . . . -57.09 134.55 52.26 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-O 119.717 -0.49 . . . . 50.13 112.28 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 39.5 tt0 -61.57 -44.55 96.81 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.994 0.517 . . . . 72.34 110.26 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -57.16 -41.5 79.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 74.33 111.417 177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.629 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -65.43 -35.14 80.03 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.431 -0.804 . . . . 74.44 111.15 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.77 4.04 48.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.555 1.142 . . . . 64.52 112.801 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 52.9 mt-10 -110.34 -42.14 4.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.427 0.691 . . . . 63.31 110.219 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.89 67.91 0.18 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.813 -0.631 . . . . 65.21 112.977 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -155.19 -92.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.405 0.682 . . . . 72.24 109.954 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -155.23 152.14 28.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.221 1.008 . . . . 74.25 109.763 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -70.89 -36.86 72.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.75 -0.659 . . . . 64.52 109.992 169.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 35.33 -119.73 0.4 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 125.516 1.76 . . . . 43.42 116.437 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -94.49 128.53 41.13 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.373 -0.602 . . . . 64.12 109.373 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.9 t -79.85 131.67 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.753 0.821 . . . . 74.12 109.422 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.3 100.19 2.09 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.209 1.004 . . . . 53.02 109.229 170.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.62 HG21 HD21 ' A' ' 127' ' ' LEU . 86.8 mt -92.11 113.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.555 -0.535 . . . . 74.44 109.555 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 137' ' ' ALA . 42.0 mm -101.73 125.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.624 0.37 . . . . 54.25 110.855 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.72 120.28 36.12 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.653 -1.24 . . . . 74.5 107.653 165.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.612 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 12.0 p90 -95.21 102.73 14.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.482 -1.303 . . . . 71.21 107.482 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.462 ' O ' HG22 ' A' ' 166' ' ' VAL . 11.3 tpt180 -87.39 102.52 14.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.387 0.675 . . . . 63.0 109.891 -166.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.61 109.11 2.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.385 1.074 . . . . 71.23 111.803 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.83 117.74 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 123.966 0.906 . . . . 73.41 109.624 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.3 t70 70.36 -62.13 0.44 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.346 1.858 . . . . 75.34 111.408 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -171.68 21.02 0.07 OUTLIER Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.013 -0.54 . . . . 73.23 112.513 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.9 m -136.26 127.75 28.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.743 0.817 . . . . 71.43 109.227 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 4.2 mp0 -81.17 137.7 35.89 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.098 0.559 . . . . 71.32 110.03 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 159' ' ' ARG . 34.2 m -109.42 113.19 58.59 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.4 0.68 . . . . 62.53 109.252 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.51 114.84 2.22 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.406 2.737 . . . . 73.35 112.361 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 m -120.68 103.9 9.49 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.127 -1.064 . . . . 74.31 108.127 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.3 tp -77.59 129.75 36.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 108.882 -0.784 . . . . 64.41 108.882 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.4 mtt -112.17 122.76 48.65 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.575 -0.898 . . . . 62.34 108.575 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -133.71 130.24 37.87 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 106.626 -1.62 . . . . 42.1 106.626 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 176' ' ' ILE . 14.8 p -66.25 133.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.617 -0.883 . . . . 64.33 108.617 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -63.29 -4.89 2.86 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.183 1.179 . . . . 51.24 114.183 -168.307 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . 42.0 mm-40 -95.68 -17.59 21.17 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.361 0.875 . . . . 75.3 113.361 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -108.62 -0.87 19.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.902 0.481 . . . . 64.53 110.49 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 172' ' ' VAL . 5.9 tp -126.88 119.79 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 106.653 -1.61 . . . . 72.22 106.653 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.8 mm -102.96 110.78 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.339 -0.846 . . . . 72.13 109.392 -172.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.52 96.06 1.89 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.061 -1.427 . . . . 50.11 109.518 172.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.597 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 10.5 tp10 -92.31 98.76 11.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.079 -1.452 . . . . 74.52 107.079 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -87.98 95.27 10.06 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.151 -0.932 . . . . 63.31 110.959 -165.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.2 t -92.79 88.88 6.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.261 -1.014 . . . . 74.13 108.261 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.33 54.43 0.73 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.464 1.106 . . . . 73.45 109.691 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.742 -1.117 . . . . 63.34 108.895 177.352 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' HG3' ' HB3' ' A' ' 181' ' ' CYS . 12.6 tpt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.965 -0.383 . . . . 55.43 109.965 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 180' ' ' LYS . 73.5 mt -132.51 134.08 44.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.969 0.908 . . . . 75.25 109.341 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 68.7 mt -103.0 120.94 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.275 -1.379 . . . . 63.12 107.275 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.745 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 74.6 m-85 -105.08 135.88 45.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.534 -0.543 . . . . 75.13 109.534 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' HG3' ' HB ' ' A' ' 177' ' ' ILE . 0.2 OUTLIER -137.48 146.25 44.02 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.714 0.806 . . . . 74.42 110.12 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.412 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 27.0 t70 -106.35 172.4 6.83 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.903 1.281 . . . . 53.13 107.827 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.81 -35.84 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 O-C-N 121.458 -0.776 . . . . 72.12 111.437 175.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.82 -43.18 3.85 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.333 1.053 . . . . 74.32 110.903 -167.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -98.32 20.25 12.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 75.24 111.003 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.412 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 12.6 t70 -45.45 -43.03 11.09 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.523 1.929 . . . . 63.14 113.443 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -49.51 -61.68 1.97 Allowed 'General case' 0 N--CA 1.476 0.87 0 O-C-N 125.626 1.829 . . . . 64.53 112.626 -166.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.3 21.76 7.9 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.779 0.659 . . . . 60.22 112.779 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 tp -49.12 -65.37 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 112.578 0.584 . . . . 54.31 112.578 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.745 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 22.7 t -158.19 173.46 16.67 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.759 0.424 . . . . 73.13 110.282 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 35.8 p 172.88 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.078 0.951 . . . . 71.31 111.205 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.8 t70 -174.0 167.93 4.22 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.899 1.28 . . . . 73.41 109.026 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 m -68.88 65.11 0.13 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.297 1.039 . . . . 60.51 112.448 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 60.4 m-85 -87.9 134.07 36.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 122.976 0.51 . . . . 64.34 109.672 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HG2' ' HB3' ' A' ' 31' ' ' LYS . 52.6 Cg_endo -67.32 121.09 8.18 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.121 1.881 . . . . 63.22 110.401 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.66 147.02 52.33 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.082 -0.508 . . . . 64.2 110.633 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 26.2 mtpp -131.69 158.71 40.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.168 . . . . 65.44 108.53 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.63 110.88 18.44 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.673 -1.232 . . . . 74.54 107.673 167.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.17 139.13 20.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.907 0.883 . . . . 60.52 109.38 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 62.73 10.45 4.22 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.425 1.09 . . . . 74.2 112.926 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.5 t70 51.27 38.66 22.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.402 1.081 . . . . 64.03 110.622 -167.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.426 HD11 ' HB ' ' A' ' 120' ' ' ILE . 39.2 tp -134.74 -50.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.943 -0.571 . . . . 73.34 111.469 -172.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.9 t -125.11 138.29 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.341 0.657 . . . . 72.43 110.527 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 36.0 m-85 -86.1 119.96 26.96 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.077 0.951 . . . . 73.23 110.186 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 25.5 mm-40 -88.56 103.5 15.96 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 124.52 1.138 . . . . 75.11 108.569 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 25.0 t80 -109.74 103.92 12.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.423 -1.695 . . . . 72.44 106.423 -174.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 42.1 tttm -85.04 145.0 27.91 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.103 0.477 . . . . 73.23 111.048 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -133.78 -163.41 10.37 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 114.989 -1.005 . . . . 52.55 111.878 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -144.21 143.15 30.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.639 0.776 . . . . 73.31 109.224 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -74.25 121.53 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.468 -0.567 . . . . 65.42 109.468 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 72' ' ' LEU . 18.4 m -146.44 166.66 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.635 0.774 . . . . 64.3 109.163 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG11 ' OG ' ' A' ' 47' ' ' SER . 11.4 m -128.84 139.69 51.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.225 -1.028 . . . . 75.43 108.225 174.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.703 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 17.9 tpt180 -100.13 108.41 20.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.364 -1.347 . . . . 74.34 107.364 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.685 ' HG2' HG22 ' A' ' 64' ' ' VAL . 5.6 tmtm? -124.72 106.39 10.04 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.12 -2.178 . . . . 73.24 105.12 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -72.67 79.58 1.1 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 121.742 0.782 . . . . 61.32 110.249 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.67 -35.76 0.34 Allowed Glycine 0 C--O 1.237 0.332 0 CA-C-N 114.693 -1.14 . . . . 73.33 111.92 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HG2' HG23 ' A' ' 43' ' ' VAL . 42.6 tt0 -174.9 105.0 0.09 Allowed 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.577 -0.527 . . . . 74.54 109.577 -174.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.7 tt -73.36 98.77 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-O 121.5 0.667 . . . . 65.44 110.743 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG23 ' HG2' ' A' ' 41' ' ' GLU . 61.4 t -128.37 116.74 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 108.255 -1.017 . . . . 75.44 108.255 172.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.69 -39.97 94.58 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.497 1.119 . . . . 74.42 111.305 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.88 -11.01 59.84 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.672 0.789 . . . . 55.32 111.43 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.95 66.21 2.53 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.095 -0.802 . . . . 74.24 111.095 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.426 ' OG ' HG11 ' A' ' 36' ' ' VAL . 46.4 m -136.84 158.41 44.53 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.098 0.959 . . . . 75.04 109.319 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -67.99 113.28 13.93 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.612 0.765 . . . . 74.11 110.338 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.57 92.49 0.36 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.782 2.321 . . . . 64.03 110.624 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.3 t -73.39 94.94 2.12 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.788 -0.642 . . . . 71.21 109.374 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.06 -59.45 3.46 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.725 0.81 . . . . 74.11 111.062 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -99.2 -70.32 0.73 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.302 -0.863 . . . . 73.32 109.929 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -127.31 -47.22 1.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.589 0.756 . . . . 63.34 110.961 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.36 28.02 68.68 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.114 -0.794 . . . . 73.41 111.114 -170.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.89 39.18 0.98 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.513 1.125 . . . . 34.44 111.047 -172.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 60' ' ' SER . 5.7 mm-40 -61.58 106.62 0.68 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.049 0.939 . . . . 73.25 108.531 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -53.36 -43.97 68.2 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 124.166 0.916 . . . . 73.11 112.361 -169.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -97.68 91.45 5.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.588 -0.893 . . . . 53.54 108.588 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.96 85.97 0.25 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.57 -0.741 . . . . 74.33 112.569 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 20.0 m -56.01 -34.98 66.31 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.906 0.882 . . . . 61.45 112.586 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -140.64 -169.02 2.7 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.719 1.208 . . . . 51.43 109.109 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -106.27 54.1 0.69 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.665 0.786 . . . . 71.42 109.225 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 60.66 32.95 20.38 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.591 1.156 . . . . 65.54 109.684 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.685 HG22 ' HG2' ' A' ' 38' ' ' LYS . 18.3 t -100.81 92.29 2.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.657 -0.868 . . . . 55.22 108.657 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.1 mp0 -69.62 74.52 0.4 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.137 -1.061 . . . . 72.31 108.137 166.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 -75.96 134.43 40.2 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.636 1.175 . . . . 53.24 110.617 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.0 -141.38 6.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 112.089 -0.404 . . . . 44.52 112.089 170.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.441 HD11 HD12 ' A' ' 156' ' ' ILE . 18.4 pt -111.18 158.72 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.799 0.44 . . . . 74.34 110.125 170.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.94 -30.48 71.6 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 75.24 111.915 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 169' ' ' LEU . 69.2 mt -59.75 -52.61 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.375 1.07 . . . . 63.45 109.955 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.24 -48.04 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 114.251 -1.34 . . . . 75.31 111.443 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.479 HD12 HG23 ' A' ' 35' ' ' VAL . 79.3 mt -67.45 -23.25 65.5 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.577 0.751 . . . . 71.22 112.071 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -53.61 -53.84 46.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.181 0.992 . . . . 74.52 110.893 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -114.69 -1.61 13.25 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.436 -0.802 . . . . 75.34 112.427 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 66.71 70.14 0.4 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.448 1.099 . . . . 65.53 109.427 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.7 133.69 33.8 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.397 -0.964 . . . . 75.12 108.397 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.68 129.55 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.678 0.391 . . . . 73.21 110.369 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.42 147.04 46.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.477 0.711 . . . . 71.54 112.483 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.3 mtp -148.03 143.97 27.59 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.515 1.926 . . . . 73.33 106.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.0 m-80 -126.97 124.04 38.54 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.211 -1.033 . . . . 72.43 108.211 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.538 ' SG ' ' HD3' ' A' ' 130' ' ' LYS . 16.9 p -58.96 -15.27 12.13 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.844 0.857 . . . . 73.23 112.624 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.405 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 98.4 m-85 -57.29 -48.7 78.23 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.237 1.015 . . . . 72.35 111.545 174.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.81 -39.16 6.4 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.396 0.678 . . . . 73.23 110.543 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.76 20.11 1.22 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.61 1.164 . . . . 74.52 112.516 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.97 49.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.929 0.891 . . . . 72.45 112.876 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.3 m -68.33 -50.68 51.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.025 0.53 . . . . 74.13 112.105 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.3 mmm -60.26 -47.49 85.78 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.93 0.892 . . . . 72.03 111.44 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -64.04 -36.22 83.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.587 -1.188 . . . . 75.4 111.095 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.7 -37.44 87.36 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.109 0.564 . . . . 60.24 110.697 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 94' ' ' LYS . . . -61.51 -48.99 78.54 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.001 -0.545 . . . . 55.25 109.986 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -65.24 -32.23 73.8 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.958 0.725 . . . . 75.43 112.958 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 mm -66.19 -41.19 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.239 0.616 . . . . 75.54 111.575 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.98 -36.42 82.14 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.622 0.249 . . . . 72.2 110.786 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.677 ' HD3' ' HA ' ' A' ' 150' ' ' ASN . 96.6 mttt -64.43 -47.05 80.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.733 0.813 . . . . 61.3 109.83 174.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -53.76 -62.41 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.964 1.706 . . . . 65.23 111.858 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.3 ptm -62.3 -38.15 88.28 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.411 0.444 . . . . 70.22 111.269 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -66.21 -42.26 89.0 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 110.286 -0.264 . . . . 60.51 110.286 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -65.59 -54.11 32.43 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.808 0.843 . . . . 72.31 111.445 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.552 HG11 HG11 ' A' ' 172' ' ' VAL . 17.8 m -67.4 -40.17 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.114 0.566 . . . . 73.21 112.173 -171.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 86.6 mt -69.4 -45.68 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 109.626 -0.509 . . . . 73.01 109.626 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.81 -35.23 80.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.371 0.668 . . . . 62.11 111.608 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -59.4 -47.35 85.77 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.878 . . . . 73.33 109.065 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.514 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.6 tpt -71.37 -28.32 63.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.631 -1.168 . . . . 65.13 111.178 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HA ' HG11 ' A' ' 113' ' ' VAL . 29.6 mm-40 -67.43 -23.49 65.54 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.035 0.534 . . . . 73.23 111.394 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -86.02 -30.64 22.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.774 -0.648 . . . . 73.41 109.76 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.31 -36.58 58.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.333 0.653 . . . . 73.22 111.622 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -118.46 -66.68 1.05 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.83 0.852 . . . . 64.13 109.438 -170.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 74.86 -30.49 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.053 1.341 . . . . 73.24 112.892 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.89 -16.86 63.87 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.034 1.334 . . . . 44.45 113.671 -166.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 113' ' ' VAL . 40.4 mmtm 79.99 -2.55 2.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.237 1.415 . . . . 72.33 112.299 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.05 -60.36 2.9 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.921 0.488 . . . . 52.4 110.856 171.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -91.11 -34.34 15.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.728 -0.669 . . . . 63.03 111.592 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' HG3' ' A' ' 103' ' ' MET . 26.9 m -68.96 -44.84 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 112.135 0.42 . . . . 50.01 112.135 -175.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 24.0 t70 -72.51 -32.91 66.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.558 0.743 . . . . 72.31 110.203 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -65.47 -53.08 47.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.772 0.67 . . . . 61.41 109.789 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -56.82 -37.63 71.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.618 -1.174 . . . . 72.23 110.603 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.1 -44.34 92.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.403 1.081 . . . . 72.31 111.158 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 46.0 mmtm -63.37 -38.5 91.38 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.566 0.541 . . . . 72.43 110.609 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 13.9 mmmm -71.73 -49.47 38.98 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.774 -0.648 . . . . 71.31 111.084 -176.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.426 ' HB ' HD11 ' A' ' 26' ' ' LEU . 9.3 tp -74.02 -37.58 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 123.285 0.366 . . . . 73.44 110.732 -173.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -68.35 -45.53 72.59 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.678 -0.86 . . . . 35.22 108.678 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.99 97.34 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.007 -0.542 . . . . 72.33 112.271 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -64.25 -50.71 66.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.695 0.798 . . . . 71.53 110.441 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.1 m -67.57 -38.24 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 O-C-N 123.782 0.676 . . . . 71.14 111.198 -175.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.97 -39.93 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.081 0.401 . . . . 60.52 110.538 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.7 t -70.61 -45.35 65.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.476 -0.329 . . . . 70.14 110.179 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.66 -32.03 73.37 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.897 1.279 . . . . 73.13 111.89 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 59.2 mt -88.47 3.12 51.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.052 0.541 . . . . 60.32 111.827 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.19 92.49 6.9 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.004 0.522 . . . . 52.42 109.714 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.538 ' HD3' ' SG ' ' A' ' 81' ' ' CYS . 48.0 mtmt -60.4 -9.2 3.28 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.088 1.355 . . . . 74.15 114.266 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -53.62 -47.65 70.05 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 73.25 110.472 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.531 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -111.9 -34.4 6.01 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.101 -0.954 . . . . 74.1 110.767 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -73.29 -0.31 14.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.633 1.345 . . . . 70.05 114.633 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.1 ptmt -50.56 -9.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.676 1.362 . . . . 51.01 114.676 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -81.92 6.77 14.82 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.735 0.814 . . . . 74.42 111.732 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 157' ' ' GLU . 90.6 mt -89.41 140.99 28.96 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.355 0.662 . . . . 64.22 109.688 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.57 113.35 15.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.87 -1.9 . . . . 75.35 105.87 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.446 ' HE2' ' SG ' ' A' ' 81' ' ' CYS . 65.0 m-85 -87.61 136.51 32.92 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.631 -0.507 . . . . 71.33 109.631 -172.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -135.44 153.28 51.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.012 -1.107 . . . . 72.22 108.012 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.2 tt -139.01 145.35 27.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 108.945 -0.761 . . . . 63.21 108.945 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.68 131.27 51.33 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.267 0.979 . . . . 73.53 112.222 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.98 -33.68 3.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.262 1.425 . . . . 63.44 112.522 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -73.48 -49.34 27.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.23 1.012 . . . . 73.14 110.563 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.7 78.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.566 0.746 . . . . 62.01 111.72 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.72 -8.94 59.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.693 -0.685 . . . . 54.33 112.764 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -89.01 -41.83 12.12 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.058 0.456 . . . . 65.2 109.85 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -100.7 5.09 56.64 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.64 -0.709 . . . . 72.03 113.672 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 60.45 34.74 20.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.833 0.853 . . . . 75.42 110.568 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -63.18 178.37 0.51 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.719 1.208 . . . . 64.33 112.996 -173.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.677 ' HA ' ' HD3' ' A' ' 94' ' ' LYS . 12.8 t-20 -88.11 8.17 28.12 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.716 -1.129 . . . . 74.11 109.614 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.25 144.65 48.71 Favored Glycine 0 C--N 1.359 1.853 0 CA-C-N 115.952 -0.567 . . . . 73.45 113.01 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.456 ' NE2' HD22 ' A' ' 171' ' ' LEU . 8.9 pt20 -85.0 162.74 19.24 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.672 0.789 . . . . 73.34 110.916 -174.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.15 125.36 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.814 -1.085 . . . . 72.32 110.015 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.16 107.95 3.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.383 1.073 . . . . 75.13 109.36 169.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.6 mt -90.94 102.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.422 -0.585 . . . . 74.3 109.422 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.441 HD12 HD11 ' A' ' 68' ' ' ILE . 47.2 mm -93.22 148.03 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.939 -0.763 . . . . 74.3 108.939 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.638 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -139.17 147.41 41.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.735 0.814 . . . . 74.41 108.942 169.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -98.24 134.37 41.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.195 -1.039 . . . . 63.11 108.195 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 23.7 ttm180 -124.83 153.14 42.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.051 0.94 . . . . 61.15 108.849 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.76 93.99 4.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.941 0.337 . . . . 64.25 110.491 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.3 p -119.37 123.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.716 0.806 . . . . 73.22 110.166 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 55.75 32.57 19.72 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.516 1.126 . . . . 74.44 112.612 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.01 68.89 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.181 -0.463 . . . . 43.02 113.422 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 m -128.05 125.8 40.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.254 0.622 . . . . 74.0 110.257 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 9.5 pt-20 -73.48 112.89 9.98 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.461 0.704 . . . . 71.51 109.267 169.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.93 106.89 46.91 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.483 0.713 . . . . 74.35 109.348 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.7 Cg_exo -76.16 117.05 4.52 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 122.675 2.25 . . . . 71.22 111.154 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.2 m -116.1 124.23 49.86 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.153 -0.684 . . . . 75.31 109.153 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 29.3 tp -76.99 137.7 39.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.395 1.078 . . . . 72.41 109.937 171.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 74.2 mtp -117.63 122.72 44.34 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.344 -1.354 . . . . 73.12 107.344 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.456 HD22 ' NE2' ' A' ' 152' ' ' GLN . 80.1 mt -136.33 147.85 47.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.076 -1.083 . . . . 71.24 108.076 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.552 HG11 HG11 ' A' ' 99' ' ' VAL . 10.0 p -75.46 144.65 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 109.464 -0.569 . . . . 74.35 109.464 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.438 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 12.8 ptmm? -57.0 -32.79 66.48 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.642 0.777 . . . . 63.44 112.188 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 172' ' ' VAL . 4.1 tp10 -85.82 1.1 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.809 0.844 . . . . 74.11 113.046 -165.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.46 -1.01 6.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.46 0.304 . . . . 70.52 111.637 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.24 141.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.624 0.77 . . . . 74.21 109.501 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.541 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.1 mm -126.88 114.0 35.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.214 -1.402 . . . . 72.32 107.214 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -84.47 127.0 33.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.235 -0.654 . . . . 63.11 109.235 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -116.3 101.78 8.98 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.075 -0.713 . . . . 72.14 109.075 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.424 ' HA ' HD23 ' A' ' 2' ' ' LEU . 36.0 ttpt -68.51 137.76 54.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.412 0.685 . . . . 71.51 110.539 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 21.8 t -131.87 88.3 2.55 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.623 -0.88 . . . . 63.02 108.623 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.3 mt -131.2 100.8 5.32 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.672 1.189 . . . . 71.53 108.257 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.559 1.298 0 C-N-CA 123.808 0.843 . . . . 73.41 110.718 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 108.772 -0.825 . . . . 72.11 108.772 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.0 mt -94.53 115.41 27.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.117 0.484 . . . . 44.22 110.497 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 49.8 mt -99.04 132.48 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.091 -1.077 . . . . 65.33 108.091 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 64.5 m-85 -121.76 132.39 54.59 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.484 -0.932 . . . . 71.44 108.484 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.565 ' NZ ' ' HB2' ' A' ' 179' ' ' GLU . 3.5 mppt? -120.67 120.18 34.97 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.415 0.686 . . . . 73.42 110.877 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.584 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 21.5 t70 -69.05 177.87 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.195 0.998 . . . . 70.23 108.797 170.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 pt -81.88 -29.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.838 -1.164 . . . . 74.11 111.62 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.05 -38.71 4.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.605 0.762 . . . . 64.35 110.64 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 m -96.28 15.81 20.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.833 -1.076 . . . . 70.21 109.686 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 4.2 p-10 -54.62 -33.85 61.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.214 1.406 . . . . 73.22 113.253 -172.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.61 -57.39 8.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.382 1.676 . . . . 73.2 112.131 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -123.83 24.34 8.39 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.766 0.654 . . . . 74.53 112.766 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 tm? -60.28 -61.14 2.82 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.572 0.349 . . . . 64.35 110.552 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 35.6 t -155.21 161.27 41.23 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 110.048 -0.353 . . . . 62.02 110.048 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 23.0 t 172.3 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.455 1.097 . . . . 74.31 109.838 -168.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.488 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 23.4 t70 -177.8 165.24 2.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.802 1.241 . . . . 63.51 109.145 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 p -67.8 88.35 0.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.414 -0.588 . . . . 72.43 109.414 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 23.4 m-85 -109.83 151.67 42.5 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.915 -1.039 . . . . 61.24 111.514 -175.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.66 120.74 7.11 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.913 1.742 . . . . 51.54 110.982 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.9 135.96 34.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.47 -0.937 . . . . 45.14 108.47 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 8.6 mmmm -141.82 107.32 5.05 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.219 -1.4 . . . . 75.24 107.219 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.6 tp -109.29 133.65 52.78 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.809 -0.812 . . . . 74.24 108.809 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.92 137.13 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.826 0.851 . . . . 72.24 109.083 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.5 t70 66.42 4.32 3.21 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.401 1.08 . . . . 75.42 112.263 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.8 t70 59.47 11.68 2.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.904 1.281 . . . . 74.21 112.57 -167.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.3 tp -113.03 -41.51 3.72 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.686 -0.634 . . . . 73.5 110.158 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.47 130.94 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.089 0.556 . . . . 72.21 109.656 -167.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -93.61 117.77 30.52 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.561 -0.903 . . . . 72.44 108.561 171.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 7.0 pt-20 -97.42 119.56 36.19 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.479 0.712 . . . . 53.33 109.728 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.608 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 23.3 t80 -110.76 106.21 15.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.25 -1.019 . . . . 75.34 108.25 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.05 113.5 4.51 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.21 0.204 . . . . 73.3 111.19 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.13 165.4 22.85 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 110.825 -0.91 . . . . 75.1 110.825 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.663 ' HG2' ' HB2' ' A' ' 69' ' ' ASP . 18.2 ptpt -94.37 125.38 38.97 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.65 0.725 . . . . 74.33 109.673 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.608 ' HB3' ' HG3' ' A' ' 167' ' ' PRO . 0.3 OUTLIER -73.63 106.84 5.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.158 0.583 . . . . 55.32 109.436 177.056 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.46 ' HB ' HD11 ' A' ' 42' ' ' ILE . 9.9 m -139.24 162.24 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.675 0.79 . . . . 53.22 110.786 -170.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 44' ' ' LEU . 14.8 m -109.56 124.01 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.197 -0.94 . . . . 72.15 109.422 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.454 ' HB2' HD13 ' A' ' 72' ' ' LEU . 16.7 tpt180 -132.7 108.09 8.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.013 -0.365 . . . . 74.14 110.013 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -129.65 160.46 33.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.281 1.032 . . . . 63.0 108.526 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 50.73 -76.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.635 1.974 . . . . 71.03 113.497 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.31 32.35 0.11 Allowed Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.676 -0.57 . . . . 63.44 111.676 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -147.39 146.67 29.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.356 0.662 . . . . 73.45 110.322 -175.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.46 HD11 ' HB ' ' A' ' 35' ' ' VAL . 5.9 tp -106.16 104.07 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 124.796 1.238 . . . . 65.53 109.063 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.11 103.39 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.354 0.662 . . . . 73.33 109.29 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.533 ' HA ' HG22 ' A' ' 36' ' ' VAL . 2.8 mm? -56.54 86.3 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.125 1.37 . . . . 71.12 112.545 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.27 86.62 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 124.268 1.027 . . . . 73.44 110.39 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.57 -145.69 44.86 Favored Glycine 0 C--N 1.353 1.509 0 O-C-N 124.48 1.112 . . . . 64.33 114.687 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.8 m -88.36 86.02 6.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.742 0.817 . . . . 74.53 109.21 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -155.07 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 114.485 -1.234 . . . . 71.35 109.233 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -88.76 -171.06 0.54 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 121.844 1.696 . . . . 54.34 111.277 165.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.5 p -66.5 97.37 0.43 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.738 -0.664 . . . . 72.33 110.331 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.42 -30.77 71.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.547 1.139 . . . . 74.42 112.057 -172.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -91.48 22.57 3.9 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.593 0.757 . . . . 75.1 111.881 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -135.01 149.75 50.22 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 106.747 -1.575 . . . . 74.5 106.747 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.69 0.21 84.55 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 116.14 1.216 . . . . 63.04 116.14 -168.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 77.19 -52.9 0.56 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.32 1.448 . . . . 52.43 110.832 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.22 130.79 14.89 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.074 -1.084 . . . . 65.23 108.074 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -87.74 -34.75 18.24 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.575 0.75 . . . . 73.23 111.098 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.23 91.51 1.68 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.94 -1.133 . . . . 44.35 107.94 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.68 -25.61 5.57 Favored Glycine 0 N--CA 1.474 1.176 0 N-CA-C 111.147 -0.781 . . . . 73.14 111.147 -173.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.7 t -117.4 51.94 1.0 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.105 -1.442 . . . . 75.51 107.105 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.55 -51.03 25.61 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.183 -1.371 . . . . 54.05 109.886 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.63 -23.88 63.56 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.402 -0.817 . . . . 71.21 109.947 171.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 60.59 83.98 0.13 Allowed 'General case' 0 C--N 1.35 0.612 0 C-N-CA 124.727 1.211 . . . . 72.51 110.388 -170.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -74.14 -96.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 105.012 -2.218 . . . . 65.53 105.012 161.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.75 ' HG3' ' HG2' ' A' ' 66' ' ' ARG 0.25 10.4 pt-20 65.15 -36.08 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 127.612 2.365 . . . . 70.04 115.632 164.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.75 ' HG2' ' HG3' ' A' ' 65' ' ' GLU . 18.1 mmt180 -132.66 110.92 10.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 104.76 -2.311 . . . . 65.12 104.76 -174.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.6 37.83 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.468 -0.653 . . . . 53.22 111.468 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.56 HD11 HD12 ' A' ' 156' ' ' ILE . 30.9 pt -109.6 160.07 8.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.143 -0.688 . . . . 73.35 109.143 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.663 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . 24.1 t70 -39.15 -40.53 0.73 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.26 1.024 . . . . 75.14 113.038 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.413 HD11 ' HD1' ' A' ' 30' ' ' PHE . 46.0 mm -56.54 -42.36 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.461 -0.791 . . . . 73.3 111.125 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.8 t -85.28 -49.52 15.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 C-N-CA 123.56 0.744 . . . . 74.31 111.717 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' A' ' 37' ' ' ARG . 33.8 mt -72.13 -49.0 39.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.217 0.607 . . . . 64.05 111.919 -169.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -69.79 -26.0 64.06 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 62.14 111.274 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -103.42 -14.95 16.05 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.027 0.381 . . . . 71.04 112.027 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? 60.07 69.97 0.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.516 1.126 . . . . 64.34 110.759 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 mt -96.57 142.13 29.0 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.402 -1.272 . . . . 72.44 109.113 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.04 124.22 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 108.794 -0.817 . . . . 65.54 108.794 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.35 151.08 5.72 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.482 1.113 . . . . 73.35 113.811 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.7 tpt -147.03 103.64 3.62 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 113.839 -1.528 . . . . 64.44 107.271 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -94.24 93.95 8.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.111 -1.441 . . . . 72.52 107.111 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 30.1 p -68.91 -31.02 69.64 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.508 0.67 . . . . 73.35 110.111 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.09 -21.18 61.53 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.42 -1.263 . . . . 73.54 111.711 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -105.18 -16.72 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.509 0.724 . . . . 63.23 112.197 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.39 23.53 6.37 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.301 0.64 . . . . 73.21 110.596 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.18 -28.94 3.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.014 1.725 . . . . 62.33 114.823 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.3 m -62.25 -59.18 5.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 118.109 0.413 . . . . 73.34 111.503 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.2 mmm -64.74 -39.25 93.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.489 0.716 . . . . 73.32 110.233 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -61.1 -46.23 91.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.037 -0.983 . . . . 74.31 112.076 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -61.33 -35.28 76.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.924 0.765 . . . . 74.42 110.106 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.57 82.41 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.746 -0.661 . . . . 63.53 111.323 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -67.37 -43.72 80.74 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.536 0.334 . . . . 72.43 111.498 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -64.08 -33.52 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.604 1.162 . . . . 62.23 111.449 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.87 -47.08 86.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.415 0.686 . . . . 70.35 109.851 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -72.82 -40.46 65.79 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.533 -0.758 . . . . 75.11 110.902 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.08 -54.92 36.94 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.657 1.583 . . . . 75.3 112.069 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttt -59.7 -46.14 89.97 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.738 0.648 . . . . 74.43 110.115 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -58.23 -44.91 88.46 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 115.659 -0.7 . . . . 75.5 109.535 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -62.59 -50.37 71.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.316 1.046 . . . . 72.33 111.144 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 175' ' ' ALA . 26.4 m -67.93 -39.17 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.275 0.63 . . . . 65.42 112.566 -174.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.5 mt -73.39 -38.48 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.495 -0.557 . . . . 60.33 109.495 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.34 -27.19 66.93 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.813 1.245 . . . . 70.35 111.162 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -63.55 -57.92 8.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.952 0.901 . . . . 63.33 109.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.546 ' HG3' HG12 ' A' ' 113' ' ' VAL . 23.2 ptm -73.89 -19.74 60.62 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.86 0.725 . . . . 75.44 111.575 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.482 ' HG2' ' HE ' ' A' ' 108' ' ' ARG . 26.6 tt0 -53.8 -55.77 23.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.014 0.926 . . . . 71.41 110.759 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -24.34 66.14 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.825 0.703 . . . . 63.21 111.317 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -94.35 -16.43 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.2 1.0 . . . . 72.54 110.787 -173.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -129.11 -83.43 0.57 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.83 0.852 . . . . 73.3 110.316 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HE ' ' HG2' ' A' ' 104' ' ' GLU . 94.2 mtt180 53.56 20.9 2.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.751 1.019 . . . . 74.3 113.751 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.19 -21.96 59.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.397 0.679 . . . . 73.53 109.44 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 86.53 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.415 1.886 . . . . 75.14 112.238 174.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.47 -44.39 91.2 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.878 0.325 . . . . 71.22 111.878 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.9 -41.46 36.48 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.46 0.704 . . . . 60.4 110.654 -171.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.546 HG12 ' HG3' ' A' ' 103' ' ' MET . 33.4 m -70.71 -28.6 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 115.818 -0.628 . . . . 70.12 110.858 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 29.9 t70 -68.1 -47.79 67.24 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.124 0.57 . . . . 65.05 110.465 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.09 -38.28 90.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.785 0.678 . . . . 62.11 110.082 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -65.36 -49.57 68.86 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.232 -0.894 . . . . 70.41 111.348 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.572 ' HA ' HG22 ' A' ' 120' ' ' ILE . 21.9 pttp -67.46 -25.84 66.09 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.177 0.298 . . . . 72.15 110.894 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -61.91 -51.19 69.16 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.822 0.701 . . . . 74.45 110.566 169.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.83 -36.5 59.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.848 0.685 . . . . 65.41 112.848 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' A' ' 117' ' ' LYS . 10.6 tp -73.18 -37.18 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 118.538 0.608 . . . . 71.32 109.682 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -48.12 69.38 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.001 0.521 . . . . 74.21 110.091 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.28 94.31 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.63 0.581 . . . . 50.13 112.331 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.41 -55.26 22.18 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 123.513 0.725 . . . . 74.1 110.232 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.1 m -66.05 -41.72 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 118.721 -0.656 . . . . 65.43 111.482 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.79 -40.03 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.686 0.676 . . . . 63.24 110.419 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -73.19 -32.81 65.04 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.067 0.547 . . . . 72.34 111.51 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.683 HD21 HG21 ' A' ' 155' ' ' ILE . 31.0 tp -77.29 -31.2 54.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.567 0.747 . . . . 64.44 110.992 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 56.2 mt -84.0 3.64 33.43 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.855 0.862 . . . . 64.14 111.246 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.04 84.01 0.98 Allowed 'General case' 0 C--N 1.357 0.935 0 N-CA-C 109.263 -0.643 . . . . 61.32 109.263 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -66.09 -14.84 62.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.863 1.431 . . . . 74.41 114.863 -163.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.61 -36.4 80.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.208 0.527 . . . . 71.14 110.489 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.1 mtp-105 -105.76 -39.15 6.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.168 0.987 . . . . 70.13 110.42 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -81.67 -1.43 46.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.383 1.073 . . . . 74.45 113.784 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -47.64 -10.85 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.958 1.466 . . . . 74.34 114.958 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -82.01 6.21 16.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.808 0.843 . . . . 72.04 111.66 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 157' ' ' GLU . 96.3 mt -91.69 154.31 19.08 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.286 0.634 . . . . 64.03 110.002 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.62 125.65 18.42 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.793 -1.558 . . . . 62.33 106.793 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -98.68 153.05 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.284 -1.006 . . . . 72.41 108.284 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -143.58 171.15 14.56 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.642 0.777 . . . . 72.11 109.074 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.99 149.12 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.929 -1.137 . . . . 63.35 107.929 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.81 132.79 44.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.474 -0.626 . . . . 75.2 112.23 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.53 -42.65 99.14 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.761 -0.459 . . . . 73.42 109.761 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.611 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -65.71 -33.71 76.52 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.5 -0.773 . . . . 73.42 111.931 172.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.51 -44.24 75.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.192 0.597 . . . . 74.41 110.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.06 65.75 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.246 0.966 . . . . 60.34 110.875 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -57.36 -36.57 71.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.369 1.067 . . . . 74.02 111.513 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.6 -52.92 23.0 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.361 -0.836 . . . . 60.21 111.137 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -167.72 154.78 8.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.555 0.742 . . . . 75.54 109.944 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.11 10.05 9.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.3 0.24 . . . . 72.53 110.97 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -88.88 -3.89 58.62 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.585 0.754 . . . . 74.3 110.601 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.66 151.54 24.38 Favored Glycine 0 C--N 1.356 1.642 0 O-C-N 123.963 0.79 . . . . 50.13 113.697 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -79.52 135.52 36.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.029 0.532 . . . . 73.51 111.33 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.41 112.07 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.202 -0.908 . . . . 71.51 110.527 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.88 115.48 14.52 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.415 1.086 . . . . 71.1 109.964 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.683 HG21 HD21 ' A' ' 127' ' ' LEU . 54.4 mt -92.8 115.21 31.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 122.922 0.489 . . . . 74.44 109.932 -171.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.56 HD12 HD11 ' A' ' 68' ' ' ILE . 35.1 mm -98.81 116.22 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 118.441 0.564 . . . . 60.24 110.562 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 159' ' ' ARG . 46.0 tt0 -97.22 101.46 13.03 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.259 1.023 . . . . 75.31 109.554 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -75.62 89.7 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.564 -1.273 . . . . 70.41 107.564 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.45 ' HB2' ' HG2' ' A' ' 157' ' ' GLU . 39.0 ttt85 -99.52 149.7 22.96 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.808 -0.812 . . . . 72.42 108.808 -172.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -122.47 130.56 53.19 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.592 -0.892 . . . . 74.32 108.592 167.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.1 109.37 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.362 -0.977 . . . . 73.45 108.362 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 60.1 28.84 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.498 1.119 . . . . 75.32 110.568 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.54 -17.08 59.92 Favored Glycine 0 C--N 1.357 1.743 0 CA-C-N 115.548 -0.751 . . . . 71.43 113.432 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.7 m -81.32 112.24 18.44 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.238 0.519 . . . . 74.4 110.42 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -71.84 103.33 3.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.501 0.72 . . . . 51.24 110.09 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.05 92.67 15.67 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 125.12 1.368 . . . . 75.55 109.224 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.608 ' HG3' ' HB3' ' A' ' 34' ' ' HIS . 72.1 Cg_endo -75.26 116.53 4.56 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.395 2.063 . . . . 73.3 111.645 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 31.1 p -117.22 135.6 53.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.282 1.033 . . . . 64.03 110.605 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.4 tp -77.18 114.05 15.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.131 0.972 . . . . 71.31 108.895 170.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 66.6 mmm -102.67 121.49 42.52 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.259 -1.386 . . . . 64.13 107.259 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.1 mt -136.0 147.12 47.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 106.966 -1.494 . . . . 74.44 106.966 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 99' ' ' VAL . 7.5 p -73.05 131.17 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.55 -0.907 . . . . 64.04 108.55 173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.61 -34.82 59.83 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.38 1.472 . . . . 55.22 111.634 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.17 -18.45 65.31 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 75.15 112.2 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -127.36 15.95 7.15 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.428 0.691 . . . . 71.02 111.74 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.5 tp -131.49 119.01 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 N-CA-C 108.199 -1.038 . . . . 71.34 108.199 165.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.43 113.74 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.644 -0.502 . . . . 53.03 109.644 -168.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -70.61 154.51 41.8 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.192 0.997 . . . . 64.35 111.244 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.582 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.4 tp10 -147.51 101.6 3.37 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.36 -0.607 . . . . 74.1 109.36 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -83.46 94.55 8.03 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.908 -0.404 . . . . 73.34 109.908 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 44.0 t -96.49 89.73 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.93 -1.137 . . . . 63.53 107.93 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.92 172.83 16.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.741 -0.663 . . . . 74.23 111.134 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 CA--C 1.559 1.324 0 C-N-CA 124.556 1.142 . . . . 64.53 110.793 -171.505 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.65 ' HG3' ' HG ' ' A' ' 2' ' ' LEU . 20.9 ptt? . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 112.997 0.74 . . . . 55.12 112.997 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.65 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 87.0 mt -136.03 161.51 35.47 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 123.327 0.651 . . . . 62.21 110.815 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 57.1 mt -96.65 120.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.351 -1.351 . . . . 63.55 107.351 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 22.7 m-85 -112.54 96.95 6.28 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.518 -1.66 . . . . 73.3 106.518 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 14.0 ptmm? -107.41 127.24 53.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.272 -0.876 . . . . 71.35 110.898 -173.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 25.1 t70 -74.2 178.16 5.29 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.59 -1.186 . . . . 65.04 109.807 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 HD21 ' A' ' 98' ' ' ASN . 62.0 mt -76.22 -38.66 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.578 -0.701 . . . . 61.24 110.732 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.7 -50.84 2.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.251 1.02 . . . . 52.21 109.867 -172.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -90.25 17.65 6.89 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.095 -0.957 . . . . 74.01 111.106 -171.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.565 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 9.0 p-10 -55.19 -26.57 39.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.773 1.629 . . . . 74.21 113.657 -170.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -49.46 -62.19 1.68 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 125.178 1.549 . . . . 74.14 112.493 -170.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -123.6 24.08 8.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.273 -0.876 . . . . 63.32 111.901 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 1.8 tm? -59.43 -73.58 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.993 0.517 . . . . 73.1 109.648 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 27.1 m -149.73 151.94 34.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.968 -1.123 . . . . 70.44 107.968 167.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 m -155.76 111.9 3.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.098 0.559 . . . . 72.52 110.359 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.269 4.1 p-10 51.88 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.31 1.844 . . . . 74.02 112.33 172.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.1 p -60.71 5.85 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.435 1.642 . . . . 53.53 115.435 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.41 146.94 32.87 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.777 0.831 . . . . 64.22 109.935 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -91.38 173.09 2.75 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.348 2.699 . . . . 74.12 114.312 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.657 ' HA ' ' HE1' ' A' ' 28' ' ' TYR . 23.8 ptt? -114.09 151.68 32.21 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.898 -1.046 . . . . 73.12 109.799 169.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -149.39 97.53 2.66 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 106.818 -1.549 . . . . 72.15 106.818 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.0 tp -91.72 122.03 33.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.812 -0.81 . . . . 73.01 108.812 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.96 134.32 53.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 C-N-CA 123.693 0.797 . . . . 71.51 108.954 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.31 21.72 8.57 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.848 0.859 . . . . 71.44 111.764 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 68.15 -9.29 0.5 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.824 1.249 . . . . 72.44 113.756 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.6 tp -102.76 -52.56 3.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.516 -0.74 . . . . 73.52 111.448 -167.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -103.71 129.08 56.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.043 -0.981 . . . . 64.42 109.586 -164.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.657 ' HE1' ' HA ' ' A' ' 20' ' ' MET . 17.2 t80 -83.35 112.83 20.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.38 -1.341 . . . . 71.24 107.38 170.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.8 121.64 38.87 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.528 -1.214 . . . . 64.12 108.196 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -113.13 136.58 52.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.459 0.704 . . . . 72.01 109.548 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 136.15 57.88 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.374 1.07 . . . . 44.32 113.314 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.62 146.21 14.07 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 110.58 -1.008 . . . . 73.43 110.58 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.79 151.83 40.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.266 0.533 . . . . 72.34 109.69 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -74.97 124.34 26.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.715 -0.476 . . . . 75.43 109.715 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.53 160.58 16.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 124.407 1.083 . . . . 63.42 109.454 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG12 ' HG3' ' A' ' 66' ' ' ARG . 16.1 m -120.14 103.55 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.791 -1.559 . . . . 63.44 106.791 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.619 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.5 mtp180 -101.06 155.74 17.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.812 -1.085 . . . . 71.22 108.315 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 20.6 ttpp -135.5 161.83 34.38 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.627 -1.249 . . . . 74.32 107.627 170.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -43.37 -32.41 0.83 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.465 1.506 . . . . 75.23 113.927 -172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.83 54.83 0.53 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.448 -0.661 . . . . 55.2 111.448 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.8 tt0 -163.97 150.67 11.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.34 0.656 . . . . 72.24 110.939 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp -163.56 87.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 124.841 1.256 . . . . 74.25 107.799 168.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.11 -7.83 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.856 0.862 . . . . 63.11 111.903 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.501 ' HA ' HG22 ' A' ' 36' ' ' VAL . 3.4 mm? 58.03 75.51 0.38 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 124.194 0.997 . . . . 74.13 111.372 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.62 -13.52 17.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.705 0.802 . . . . 63.15 111.21 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.36 87.81 0.51 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.315 -0.714 . . . . 75.42 111.315 -174.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.458 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 31.2 t -76.89 84.51 3.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.646 0.778 . . . . 75.52 110.547 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -161.35 111.54 1.24 Allowed Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 109.332 -0.618 . . . . 73.41 109.332 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.79 -36.97 7.24 Favored 'Trans proline' 0 CA--C 1.555 1.563 0 C-N-CA 122.765 2.31 . . . . 62.21 112.775 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 p -167.06 -179.83 4.82 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.829 0.851 . . . . 62.25 110.069 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.27 92.68 0.58 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.466 0.707 . . . . 43.44 110.422 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -169.07 -167.94 0.79 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.924 1.29 . . . . 74.41 109.66 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.66 -39.26 88.13 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.338 0.655 . . . . 70.31 110.977 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.23 18.08 65.47 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 123.778 0.674 . . . . 73.35 112.346 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.69 87.04 6.76 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.895 -0.78 . . . . 42.32 108.895 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HB3' ' OG ' ' A' ' 60' ' ' SER . 8.5 tp10 -58.79 115.84 3.35 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.154 0.981 . . . . 73.44 110.426 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t70 62.6 45.78 5.9 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.773 1.295 . . . . 74.3 110.133 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 66.13 14.37 9.6 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.213 1.405 . . . . 74.34 112.856 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.74 -130.39 1.23 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 111.059 -0.816 . . . . 75.42 111.059 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 56' ' ' GLU . 24.4 p 71.41 -23.36 0.18 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 126.401 1.88 . . . . 74.04 113.184 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -74.04 80.69 1.72 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.059 -1.089 . . . . 73.42 108.059 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -175.07 -52.79 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 104.552 -2.388 . . . . 72.33 104.552 -166.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -76.45 -47.28 23.55 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 107.196 -1.409 . . . . 74.32 107.196 166.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.24 97.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 107.479 -1.304 . . . . 64.42 107.479 162.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.3 mt-10 -85.59 70.5 10.75 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.518 -1.29 . . . . 71.25 107.518 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HG3' HG12 ' A' ' 36' ' ' VAL . 18.7 ttp180 -96.55 139.18 33.02 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.465 0.65 . . . . 73.35 111.025 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.69 -131.99 5.22 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 114.858 -1.065 . . . . 63.34 111.374 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.789 HD12 ' HB2' ' A' ' 167' ' ' PRO . 0.8 OUTLIER -99.87 133.97 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.184 0.594 . . . . 72.23 110.755 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -36.79 -48.32 0.72 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.835 2.054 . . . . 65.32 114.186 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.7 mm -50.31 -53.33 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 124.164 0.915 . . . . 70.32 111.436 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 76' ' ' LEU . 57.7 t -80.84 -23.17 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.615 0.766 . . . . 73.51 111.299 -170.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 60.7 mt -77.47 -38.13 49.89 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.905 0.482 . . . . 51.3 110.578 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -79.52 -49.38 12.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.81 0.844 . . . . 75.31 110.819 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.89 -21.39 34.27 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.555 0.342 . . . . 62.43 111.094 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm 63.11 66.97 0.7 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 124.632 1.173 . . . . 73.34 110.85 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.556 ' HB2' HG13 ' A' ' 71' ' ' VAL . 40.5 mt -93.18 162.72 13.91 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.442 -1.254 . . . . 65.13 109.587 174.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.12 135.65 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.636 0.775 . . . . 73.11 109.912 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.11 152.85 44.87 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.493 0.923 . . . . 62.32 113.493 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 59.8 mtm -146.06 104.93 3.87 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.106 1.762 . . . . 72.2 106.434 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.68 124.58 25.05 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.202 -0.666 . . . . 73.24 109.202 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 3.8 m -56.31 -30.89 63.14 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.848 0.859 . . . . 73.11 111.612 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -69.49 -45.54 68.71 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 113.592 -1.64 . . . . 74.22 112.86 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -97.73 -28.23 13.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.883 0.473 . . . . 74.14 111.914 -173.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.97 19.5 18.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.151 0.98 . . . . 71.1 111.132 -169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.76 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.264 1.025 . . . . 71.04 113.743 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -72.79 -55.51 6.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.037 0.935 . . . . 72.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.6 mtt -64.07 -37.2 86.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.055 0.542 . . . . 72.22 110.403 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.621 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 14.9 t80 -54.04 -49.07 69.78 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.747 1.219 . . . . 74.51 111.03 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -64.61 -34.9 79.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 74.34 110.093 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.46 81.14 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.328 0.392 . . . . 65.11 111.005 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -67.67 -32.7 73.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.504 0.722 . . . . 71.3 112.505 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.9 mm -67.31 -44.71 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.468 0.707 . . . . 74.3 111.245 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.6 -40.61 92.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.914 0.486 . . . . 74.45 109.827 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -63.28 -50.22 70.97 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.262 -0.881 . . . . 71.12 109.435 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -56.51 -51.01 70.13 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.243 1.417 . . . . 74.11 112.12 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.5 -40.27 85.2 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.344 0.402 . . . . 71.21 110.993 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -68.43 -38.68 81.4 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.875 -0.417 . . . . 72.35 109.875 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.494 HD21 HD12 ' A' ' 7' ' ' ILE . 30.2 t30 -58.45 -55.69 31.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 63.43 110.625 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.519 HG11 HG11 ' A' ' 172' ' ' VAL . 22.3 m -71.41 -39.98 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 114.969 -1.014 . . . . 62.1 112.865 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.25 -45.82 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 110.014 -0.365 . . . . 72.33 110.014 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -56.03 -38.47 70.6 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.474 0.71 . . . . 71.14 110.8 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -56.33 -58.11 9.37 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.152 0.907 . . . . 72.24 110.197 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.4 mmm -70.28 -26.74 63.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.535 -0.302 . . . . 72.33 111.138 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.53 ' HA ' HG11 ' A' ' 113' ' ' VAL . 40.5 tt0 -64.35 -45.91 85.72 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.359 1.064 . . . . 62.13 110.681 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -89.29 -9.61 49.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.273 0.471 . . . . 74.15 112.273 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -90.25 -22.9 21.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.508 0.559 . . . . 52.54 112.508 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -124.86 -43.95 1.96 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.573 0.349 . . . . 72.11 111.16 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.96 25.62 14.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.718 0.807 . . . . 72.33 111.234 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -119.13 126.59 51.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.032 0.933 . . . . 74.54 109.361 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -62.24 -36.0 80.67 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.748 0.819 . . . . 72.14 111.85 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.34 60.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.783 0.433 . . . . 72.51 110.889 -172.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.11 -60.64 2.21 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.445 -0.576 . . . . 72.32 109.445 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 104' ' ' GLU . 30.3 m -67.45 -35.52 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.737 -1.12 . . . . 74.41 112.875 -167.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.54 -33.9 35.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.458 0.703 . . . . 72.4 110.324 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.26 64.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.706 -0.479 . . . . 74.3 109.706 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.424 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 42.0 t80 -71.49 -40.62 70.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.972 -1.013 . . . . 72.23 110.129 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -62.31 -38.62 90.11 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.685 0.794 . . . . 74.13 110.207 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.81 -40.42 88.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.557 -1.201 . . . . 70.11 109.698 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -71.71 -37.18 70.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.627 0.771 . . . . 74.12 109.927 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 172' ' ' VAL . 8.3 mm -65.05 -47.81 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.655 0.782 . . . . 64.12 109.2 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.11 -37.83 81.16 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.784 0.678 . . . . 74.5 110.577 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.52 58.62 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 115.83 -0.623 . . . . 42.25 112.393 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.79 -51.19 61.08 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.053 0.502 . . . . 73.33 110.762 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.591 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.0 m -70.87 -41.71 77.25 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.966 0 CA-C-O 118.546 -0.74 . . . . 73.2 111.071 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.57 -32.28 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 119.727 1.149 . . . . 72.2 110.619 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.6 t -70.63 -32.58 69.95 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.522 0.329 . . . . 62.52 110.597 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.653 ' HA ' ' HD2' ' A' ' 132' ' ' ARG . 37.8 tp -76.03 -40.43 53.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.004 0.922 . . . . 65.04 111.174 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.621 HD22 ' HZ ' ' A' ' 88' ' ' PHE . 47.6 mt -77.65 1.7 18.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.1 0.96 . . . . 75.32 111.142 -170.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.23 130.04 39.36 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.364 -1.347 . . . . 74.13 107.364 168.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 50.3 mtmt -68.06 -6.46 22.84 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.467 0.914 . . . . 64.45 113.467 -173.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 22.7 t70 -68.52 -30.34 69.13 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.763 0.825 . . . . 63.2 109.764 171.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.653 ' HD2' ' HA ' ' A' ' 127' ' ' LEU . 42.6 mtt180 -81.34 -33.2 32.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.992 -0.443 . . . . 65.33 110.515 171.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.625 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.1 m-85 -67.0 -20.23 65.85 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.549 0.739 . . . . 73.41 111.866 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 131' ' ' ASP . 24.3 pttm -61.98 -30.9 71.24 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.582 0.551 . . . . 72.14 110.577 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -127.56 25.5 6.06 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.332 1.053 . . . . 74.11 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.625 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 24.2 mt -100.27 144.28 29.47 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.585 0.707 . . . . 73.32 111.341 168.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.4 121.06 15.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.523 -1.658 . . . . 74.02 106.523 167.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.464 ' HB3' HG11 ' A' ' 153' ' ' VAL . 66.4 m-85 -93.57 134.31 35.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.747 -0.464 . . . . 72.53 109.747 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.06 140.96 50.77 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 75.43 109.452 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.4 tt -120.89 159.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.994 -1.484 . . . . 74.01 106.994 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.23 129.72 49.9 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.177 -0.791 . . . . 51.33 111.53 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.29 -41.49 79.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.526 0.731 . . . . 72.33 110.049 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -69.51 -38.55 77.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.861 -1.063 . . . . 71.5 110.666 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.34 -31.44 72.57 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.448 0.699 . . . . 55.22 110.58 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 5.43 12.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.711 0.804 . . . . 71.34 112.049 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.83 -10.28 45.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 64.14 110.403 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.62 -55.51 0.01 OUTLIER Glycine 0 C--N 1.352 1.42 0 N-CA-C 112.016 -0.433 . . . . 72.21 112.016 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.82 83.31 2.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.452 0.701 . . . . 74.13 110.649 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.92 -2.23 50.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.124 0.97 . . . . 74.52 111.22 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.11 78.75 1.83 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.208 -1.775 . . . . 70.01 106.208 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -123.89 -166.58 12.56 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-N 113.797 -1.547 . . . . 21.21 111.733 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.404 HE21 HD22 ' A' ' 171' ' ' LEU . 53.8 tt0 -101.58 142.1 33.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.002 -0.74 . . . . 61.53 109.002 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 138' ' ' PHE . 75.8 t -109.4 131.92 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.259 0.624 . . . . 74.23 112.058 -171.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.406 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.67 109.53 4.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.265 -1.334 . . . . 75.24 109.558 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 71.5 mt -85.56 105.5 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.966 -0.753 . . . . 73.14 108.966 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 169' ' ' LEU . 40.9 mm -103.58 119.61 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.008 -0.738 . . . . 72.21 109.008 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.405 ' HB3' HD23 ' A' ' 136' ' ' LEU . 12.1 pt-20 -124.94 127.81 47.64 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.827 0.346 . . . . 74.34 110.482 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -75.97 110.63 10.6 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 115.106 -0.952 . . . . 73.21 109.341 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.514 ' HB2' HG13 ' A' ' 166' ' ' VAL . 22.6 mmt85 -101.86 172.8 6.72 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.357 -0.979 . . . . 73.44 108.357 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -122.58 119.06 29.71 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.128 0.571 . . . . 73.33 110.603 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.73 118.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.021 0.528 . . . . 62.42 109.903 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 67.83 -67.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.899 1.68 . . . . 71.12 110.9 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.79 35.68 0.11 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.211 -0.756 . . . . 63.12 111.211 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.6 t -141.86 158.17 44.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.088 0.555 . . . . 52.44 110.863 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -78.75 114.46 17.69 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.748 0.819 . . . . 71.04 111.103 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 159' ' ' ARG . 5.8 p -117.73 89.14 32.33 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 109.11 -0.7 . . . . 74.24 109.11 175.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.789 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.3 Cg_endo -82.61 122.53 3.56 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 122.342 2.028 . . . . 64.31 110.159 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -105.42 140.0 39.2 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.727 0.811 . . . . 71.44 109.73 -168.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 156' ' ' ILE . 30.8 tp -82.36 123.34 29.01 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.917 0.76 . . . . 53.42 109.635 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.99 123.09 48.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.945 0.898 . . . . 63.51 108.882 174.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.472 HD13 HD11 ' A' ' 176' ' ' ILE . 79.7 mt -140.97 145.51 36.09 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.987 -1.486 . . . . 72.51 106.987 172.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.519 HG11 HG11 ' A' ' 99' ' ' VAL . 7.1 p -76.76 134.88 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 109.427 -0.583 . . . . 73.34 109.427 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -56.75 -36.76 70.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.511 1.124 . . . . 71.01 111.871 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -68.48 -25.91 65.21 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.901 0.881 . . . . 52.22 112.5 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.444 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -97.59 -1.91 42.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.816 0.446 . . . . 72.34 110.336 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.472 HD11 HD13 ' A' ' 171' ' ' LEU . 48.9 mm -102.55 132.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.362 -0.977 . . . . 72.21 108.362 174.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 44.3 mm -93.22 111.8 25.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.302 -0.999 . . . . 74.41 108.302 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.35 104.34 6.82 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.402 -0.962 . . . . 75.24 108.402 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.7 tp10 -104.04 111.06 23.47 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.966 -1.124 . . . . 72.04 107.966 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.44 129.66 34.68 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.806 -0.442 . . . . 73.03 109.806 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.4 t -100.81 104.35 15.59 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.734 -0.667 . . . . 65.21 110.417 -171.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.35 161.66 26.51 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.285 1.034 . . . . 64.42 109.399 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 C--O 1.252 1.219 0 CA-C-N 115.104 -0.953 . . . . 73.42 108.553 178.272 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.067 0.46 . . . . 71.43 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.2 mt -84.33 123.82 30.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.849 -0.797 . . . . 61.45 108.849 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.504 HG22 ' HB3' ' A' ' 15' ' ' SER . 33.3 pt -99.39 128.58 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.535 0.734 . . . . 71.2 109.251 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.501 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 12.9 m-85 -122.95 124.22 42.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.947 1.299 . . . . 74.25 107.807 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 23.3 pttm -145.85 147.12 31.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.083 0.856 . . . . 74.24 112.239 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 14.9 t70 -101.25 124.08 46.39 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.899 0.88 . . . . 70.22 109.996 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' A' ' 175' ' ' ALA . 43.4 pt -66.56 -26.85 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.68 0.622 . . . . 63.04 112.68 -164.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.61 -60.97 2.11 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.293 0.568 . . . . 74.52 111.587 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 m -125.53 -46.48 1.75 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.91 -1.041 . . . . 74.4 111.737 -159.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 2.8 t0 -101.4 24.05 10.17 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.99 0.916 . . . . 74.02 110.486 -166.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 5.6 p-10 -50.81 -2.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.016 2.228 . . . . 72.05 117.016 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -99.59 -41.52 7.3 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.645 1.111 . . . . 75.03 109.86 167.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 26.6 tp 36.51 -88.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.79 2.036 . . . . 72.22 113.655 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.401 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 73.5 m -157.3 134.48 10.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.802 0.841 . . . . 74.24 109.477 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.504 ' HB3' HG22 ' A' ' 3' ' ' ILE . 50.4 m -130.73 97.93 4.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.487 0.715 . . . . 74.44 109.149 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HB3' ' HE1' ' A' ' 18' ' ' PHE . 24.3 t70 -166.52 -90.64 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.185 0.594 . . . . 73.24 110.258 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 m -170.2 78.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.463 1.105 . . . . 61.13 108.874 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.452 ' HE1' ' HB3' ' A' ' 16' ' ' ASP . 53.9 m-85 -112.43 139.12 22.26 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.744 0.817 . . . . 73.43 110.213 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HD2' ' HE1' ' A' ' 30' ' ' PHE . 57.9 Cg_exo -53.8 117.57 4.0 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.202 1.935 . . . . 74.12 111.495 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.92 134.26 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.364 -0.835 . . . . 74.42 109.507 -172.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 39.1 ttmt -137.2 140.17 41.57 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.738 -1.208 . . . . 52.34 107.738 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 tp -131.75 108.07 9.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.831 -1.174 . . . . 74.15 107.831 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.35 133.64 42.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.848 0.859 . . . . 71.5 110.017 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.92 14.65 4.41 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.749 1.22 . . . . 42.45 112.763 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.7 t70 58.23 10.36 1.25 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.641 1.177 . . . . 73.35 111.987 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 119' ' ' LYS . 51.8 tp -103.9 -47.1 4.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.01 0.924 . . . . 70.0 111.333 -167.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -126.93 131.54 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 115.835 -0.621 . . . . 63.04 110.077 -172.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.45 ' HB2' HG21 ' A' ' 176' ' ' ILE . 82.1 t80 -85.24 135.11 34.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.41 1.084 . . . . 72.23 108.439 169.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 32.5 tt0 -117.98 144.99 45.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.362 0.665 . . . . 74.23 109.286 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.615 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.5 t80 -131.97 138.45 48.3 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.91 1.284 . . . . 72.24 107.683 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.33 153.94 39.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.647 0.379 . . . . 62.12 110.714 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.1 159.72 30.61 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.977 -0.556 . . . . 63.23 112.124 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -134.83 138.88 44.62 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.01 0.924 . . . . 74.44 109.244 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -70.57 120.46 16.23 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.543 -1.28 . . . . 73.52 107.543 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.84 -178.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.477 0.711 . . . . 72.13 109.941 -168.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.9 156.05 42.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.305 1.042 . . . . 62.23 108.578 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 38.1 ttm180 -140.06 132.64 28.74 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.282 0.563 . . . . 72.31 109.977 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.585 ' HD2' ' HB2' ' A' ' 41' ' ' GLU . 65.0 mttp -133.38 156.17 48.14 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.142 1.377 . . . . 73.03 107.456 164.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.09 -38.62 83.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 75.4 112.019 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.85 -44.04 1.58 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.951 -0.568 . . . . 75.43 113.16 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.585 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 24.6 mm-40 -95.9 163.35 13.19 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.296 0.638 . . . . 71.22 111.836 -171.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 tp -161.25 104.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.889 1.276 . . . . 62.32 108.407 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -157.11 101.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 121.634 0.731 . . . . 45.11 110.715 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -93.74 -3.35 52.36 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.046 0.939 . . . . 71.31 111.017 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 94.18 0.36 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.992 0.917 . . . . 62.22 110.418 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.42 -86.16 0.05 OUTLIER Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.153 -1.179 . . . . 62.32 110.153 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -145.83 147.31 31.69 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.672 0.789 . . . . 73.32 109.941 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -62.63 -46.33 88.84 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.592 0.757 . . . . 64.23 109.76 170.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.07 94.4 0.89 Allowed 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 121.353 1.368 . . . . 73.51 110.248 165.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.4 m -77.03 1.32 18.26 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.422 0.689 . . . . 53.51 111.823 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 55' ' ' ALA . . . 65.8 14.44 9.55 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 124.713 1.205 . . . . 61.43 111.941 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.46 -11.12 60.71 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.571 1.148 . . . . 73.34 112.11 -169.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -94.26 106.65 18.63 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.786 0.834 . . . . 70.22 108.933 169.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.61 4.58 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 114.46 0.544 . . . . 54.21 114.46 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.503 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . . . -68.06 -29.01 67.87 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.9 0.88 . . . . 41.14 112.869 -170.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -85.82 114.33 22.67 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.16 -1.422 . . . . 75.32 107.16 165.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.89 137.57 57.76 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 124.09 0.869 . . . . 71.14 110.21 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.16 101.25 0.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.349 1.06 . . . . 62.13 110.248 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.04 6.7 55.8 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.498 -0.774 . . . . 62.54 113.515 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.8 t -101.23 92.32 4.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.663 0.785 . . . . 54.43 109.332 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 64' ' ' VAL . 6.3 p-10 -134.17 -3.77 2.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.29 1.036 . . . . 72.03 110.7 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 68.54 -72.02 0.11 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.883 1.673 . . . . 71.15 110.825 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -161.99 36.89 0.12 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.238 1.018 . . . . 72.0 108.521 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.511 HG22 ' HE3' ' A' ' 38' ' ' LYS . 37.7 t -100.28 114.53 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.894 -0.78 . . . . 73.04 108.894 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 9.4 mp0 -75.27 73.91 2.38 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.977 -1.49 . . . . 73.04 106.977 171.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -92.22 135.5 33.95 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.846 -1.07 . . . . 74.25 110.693 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.44 -154.43 25.52 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.836 -1.306 . . . . 73.02 109.836 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -94.62 153.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.684 0.742 . . . . 73.43 111.496 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -42.88 -46.66 5.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.888 1.675 . . . . 65.54 113.097 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.583 HD13 ' HB2' ' A' ' 169' ' ' LEU . 45.1 mt -60.42 -47.97 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.919 1.288 . . . . 73.11 110.877 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -72.83 -42.56 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 114.604 -1.18 . . . . 74.43 112.195 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.49 -36.27 80.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.917 0.487 . . . . 60.11 110.768 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -59.58 -61.97 2.23 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.364 0.666 . . . . 45.3 110.634 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.476 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 59.6 t-80 -81.57 -17.7 47.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.264 -0.426 . . . . 71.42 112.1 -170.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 64.37 61.12 0.89 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.736 1.255 . . . . 74.4 108.427 -167.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 95.7 mt -82.07 133.46 35.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.066 -1.424 . . . . 74.43 109.399 174.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.701 HG11 ' HB2' ' A' ' 145' ' ' ALA . 7.3 p -91.93 138.38 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.325 0.65 . . . . 74.12 109.386 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.33 147.41 53.0 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.994 0.902 . . . . 72.45 111.519 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -132.64 103.12 5.97 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 103.081 -2.933 . . . . 72.03 103.081 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 12.2 t-20 -69.14 116.54 9.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.515 1.126 . . . . 72.4 111.104 -172.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 26.5 p -63.99 -28.77 70.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.59 0.756 . . . . 74.51 111.843 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -73.3 -58.89 2.99 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.493 -1.231 . . . . 61.44 112.157 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -103.51 -6.73 21.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.922 0.712 . . . . 71.53 112.922 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 16.1 m-20 -121.2 22.69 10.81 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.647 0.779 . . . . 74.42 111.266 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.56 -35.21 40.17 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.835 0.854 . . . . 74.15 112.399 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.6 m -64.11 -38.27 90.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.442 0.697 . . . . 62.13 111.353 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 mtt -60.18 -45.84 91.74 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.627 -0.508 . . . . 75.34 109.627 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 46.1 t80 -63.09 -35.42 80.19 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.889 0.743 . . . . 73.11 111.245 -176.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.9 -25.34 55.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.196 0.598 . . . . 71.21 111.47 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.29 -45.89 75.23 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 109.576 -0.527 . . . . 70.03 109.576 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 76.4 m-85 -54.15 -54.54 38.27 Favored 'General case' 0 C--O 1.202 -1.444 0 CA-C-N 114.71 -1.132 . . . . 73.12 109.473 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.02 -42.46 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.093 0.957 . . . . 54.13 112.088 -172.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -59.75 -55.64 31.76 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 122.442 0.297 . . . . 64.42 111.167 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -37.78 76.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 123.526 0.516 . . . . 74.3 110.386 -174.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -55.95 -57.01 13.91 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.838 1.655 . . . . 74.45 111.434 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.4 ttm -67.86 -40.09 83.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.847 0.717 . . . . 44.02 111.56 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -61.7 -44.68 96.47 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.376 0.422 . . . . 71.45 110.323 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -70.6 -45.2 65.75 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 124.16 0.913 . . . . 64.14 111.235 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.56 -40.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.202 0.314 . . . . 74.51 111.758 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.8 mt -73.43 -39.47 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 117.983 0.356 . . . . 70.11 110.746 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.19 -38.72 85.86 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.709 0.804 . . . . 74.55 110.974 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.87 -44.78 54.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.562 -0.744 . . . . 73.41 110.129 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.542 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -58.61 -40.37 83.08 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.642 0.777 . . . . 70.23 109.735 177.102 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.482 ' HA ' HG11 ' A' ' 113' ' ' VAL . 40.9 tt0 -65.7 -29.73 70.32 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.302 1.041 . . . . 74.44 111.374 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -75.1 -40.15 60.15 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.335 0.654 . . . . 72.3 110.131 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -73.2 -34.52 66.01 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.22 1.008 . . . . 72.14 111.86 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -100.59 -45.96 5.35 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.868 0.867 . . . . 53.41 111.639 -171.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 77.82 -17.17 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.241 1.416 . . . . 71.15 112.532 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 113' ' ' VAL . 23.9 t70 -96.6 126.27 41.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.13 109.657 -174.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -77.65 -27.15 50.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.161 0.584 . . . . 75.4 112.118 -174.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.56 89.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.731 0.412 . . . . 72.22 111.804 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -85.6 -33.54 21.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.629 0.772 . . . . 75.35 111.354 -174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.542 HG12 ' SD ' ' A' ' 103' ' ' MET . 16.9 m -78.99 -28.07 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 117.944 0.338 . . . . 42.01 111.833 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.99 -42.13 85.6 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.888 0.475 . . . . 73.54 109.84 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.39 -45.86 78.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.593 -0.73 . . . . 50.21 110.052 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.426 ' HZ ' ' HB2' ' A' ' 174' ' ' GLU . 81.1 t80 -56.31 -45.83 80.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.437 1.095 . . . . 71.24 111.119 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -57.35 -47.86 80.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 72.44 110.667 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -69.04 -26.53 65.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.703 0.801 . . . . 62.32 111.411 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HB3' HD22 ' A' ' 26' ' ' LEU . 32.5 mmtp -78.14 -35.51 48.88 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.344 0.658 . . . . 71.24 110.644 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.2 mm -69.66 -44.22 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.635 0.374 . . . . 50.44 110.046 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -58.42 -46.53 86.29 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.96 0.904 . . . . 74.33 109.614 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.39 99.22 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 124.194 0.934 . . . . 65.33 112.925 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -64.62 -51.51 62.29 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.301 0.64 . . . . 75.14 110.174 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.9 m -70.99 -41.22 76.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 0 CA-C-O 118.309 -0.853 . . . . 73.53 111.096 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.41 -33.04 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 119.486 1.039 . . . . 73.02 110.218 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.2 t -72.3 -42.15 65.81 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.437 0.695 . . . . 64.43 110.616 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' HA ' ' HG3' ' A' ' 132' ' ' ARG . 34.8 tp -79.09 -20.05 49.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.432 1.093 . . . . 51.11 111.952 -173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -83.39 4.07 29.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.005 0.922 . . . . 64.01 112.206 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.32 38.98 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.009 0.524 . . . . 74.31 110.723 172.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 4.3 ttpm? -62.33 -45.03 95.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.027 0.931 . . . . 71.23 112.289 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.53 -24.49 64.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.146 0.578 . . . . 64.44 111.425 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.582 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 30.0 mmt180 -68.72 -54.49 15.82 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.059 -0.719 . . . . 72.22 109.059 170.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.608 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.0 m-85 -59.92 -22.5 62.5 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.416 1.086 . . . . 75.12 113.783 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -66.64 -27.84 68.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 61.33 110.137 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -115.78 0.08 13.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.35 0.66 . . . . 72.32 111.263 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 60.8 mt -89.36 132.38 34.98 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.58 0.627 . . . . 71.24 109.677 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.51 117.03 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.225 -2.139 . . . . 64.42 105.225 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.543 ' HB3' HG11 ' A' ' 153' ' ' VAL . 33.6 m-85 -90.36 143.45 26.75 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.759 -0.83 . . . . 71.13 108.759 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.606 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 82.9 m-85 -140.7 152.93 45.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.138 0.575 . . . . 73.22 110.598 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.0 pt -144.89 172.96 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.05 1.34 . . . . 72.4 107.635 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.86 134.23 51.08 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.708 -1.051 . . . . 74.31 111.103 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -40.65 -48.14 2.88 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.337 1.236 . . . . 74.34 114.337 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -64.02 -28.56 69.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.835 0.854 . . . . 51.35 112.543 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.46 -14.46 62.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.683 0.793 . . . . 74.22 111.999 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.701 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -75.36 -2.92 30.68 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.229 0.611 . . . . 53.2 112.313 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -81.47 -33.12 32.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 74.35 110.137 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.11 -2.06 0.03 OUTLIER Glycine 0 C--N 1.357 1.727 0 N-CA-C 115.834 1.094 . . . . 65.1 115.834 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.12 75.11 9.49 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.717 1.258 . . . . 64.43 110.725 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.401 ' HG3' ' ND2' ' A' ' 150' ' ' ASN . 11.3 pt-20 -88.56 -0.53 57.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.245 1.018 . . . . 74.12 111.479 175.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 149' ' ' GLU . 47.1 m-80 -130.61 79.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.22 -1.03 . . . . 72.41 108.22 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -147.72 -148.55 4.77 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.067 -1.213 . . . . 51.04 110.067 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.96 152.92 22.1 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.328 -0.99 . . . . 63.44 108.328 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 138' ' ' PHE . 93.8 t -113.25 132.16 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.755 0.822 . . . . 51.24 110.445 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.74 101.38 3.67 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.338 -0.986 . . . . 72.41 108.338 166.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 127' ' ' LEU . 67.1 mt -89.54 120.35 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.632 -0.507 . . . . 64.53 109.632 -170.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.4 mm -105.63 119.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.839 0.455 . . . . 71.01 110.488 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -103.88 111.7 24.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.76 1.224 . . . . 64.54 109.48 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -75.61 89.82 2.77 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.443 -0.947 . . . . 71.02 108.443 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -89.61 164.67 14.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.217 1.007 . . . . 74.42 109.332 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -122.51 115.2 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.197 0.599 . . . . 74.32 110.151 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -120.43 97.88 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.821 0.849 . . . . 64.44 109.585 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 65.56 11.59 7.57 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.089 1.356 . . . . 54.41 112.583 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 118.85 -14.33 11.43 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.748 -0.473 . . . . 63.31 113.039 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.7 m -88.7 111.49 22.02 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 117.23 0.515 . . . . 72.24 109.804 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.68 114.39 9.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.289 -0.869 . . . . 64.43 109.167 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.423 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 13.2 m -123.5 98.16 41.23 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.746 1.218 . . . . 75.01 110.004 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 166' ' ' VAL . 38.7 Cg_endo -65.62 112.8 2.28 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.478 2.119 . . . . 71.0 111.163 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 p -113.96 134.19 54.99 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.141 0.976 . . . . 70.35 109.375 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 39.3 tp -77.33 140.91 40.09 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.493 0.717 . . . . 62.21 109.621 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 25.3 ptp -131.85 129.36 40.31 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 108.124 -1.065 . . . . 72.24 108.124 169.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -130.96 137.44 49.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.803 1.641 . . . . 74.42 106.903 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 174' ' ' GLU . 7.6 p -72.12 143.14 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.419 0.287 . . . . 70.34 111.455 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -32.6 -50.35 0.25 Allowed 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 126.951 2.1 . . . . 74.31 113.397 171.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.458 ' H ' HG22 ' A' ' 172' ' ' VAL . 1.4 tm-20 -68.85 -38.94 80.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.57 -1.195 . . . . 53.35 110.455 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.595 ' HA ' HG12 ' A' ' 7' ' ' ILE . . . -98.06 -6.46 31.74 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.99 -0.528 . . . . 31.11 111.123 -172.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.45 HG21 ' HB2' ' A' ' 28' ' ' TYR . 8.6 tp -108.41 136.64 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.767 -1.198 . . . . 73.51 107.767 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.0 mm -125.81 118.37 51.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.401 -1.703 . . . . 74.31 106.401 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.69 123.54 42.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.788 -1.19 . . . . 73.24 107.788 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -141.2 149.49 41.47 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.501 0.72 . . . . 72.14 109.274 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -98.7 96.82 8.18 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.231 -0.655 . . . . 50.24 109.231 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.59 93.92 4.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.294 0.638 . . . . 75.22 110.763 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 117.25 17.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.555 0.742 . . . . 62.3 109.201 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 . . . . . 0 CA--C 1.554 1.109 0 CA-C-O 118.909 -0.567 . . . . 64.01 110.076 175.818 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 17' ' ' SER . 22.4 mmt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 110.031 -0.359 . . . . 73.11 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.11 135.13 51.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.026 0.531 . . . . 62.53 109.656 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 5.1 tt -95.14 120.21 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.23 -0.656 . . . . 72.21 109.23 173.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.541 ' HB3' HD11 ' A' ' 176' ' ' ILE . 27.2 m-85 -105.92 125.99 51.65 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.389 -1.337 . . . . 71.11 107.389 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.586 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 48.5 pttt -151.25 159.52 44.32 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 123.559 0.537 . . . . 64.01 111.909 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 8.3 t70 -87.23 144.87 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.86 -0.793 . . . . 72.24 108.86 173.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 pt -66.63 -11.56 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 113.218 0.822 . . . . 55.3 113.218 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.17 -59.46 1.85 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.77 0.714 . . . . 72.34 112.527 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -125.99 -32.54 2.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.745 1.387 . . . . 63.0 114.745 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.608 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 19.0 m-20 -81.85 21.88 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.798 0.726 . . . . 75.23 111.539 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 7.5 m-20 -48.45 -20.99 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.305 1.224 . . . . 71.41 114.305 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.78 28.11 9.02 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 123.829 0.851 . . . . 61.42 110.212 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 41.3 tp -57.42 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.784 1.234 . . . . 62.11 112.107 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.7 m -155.62 126.74 7.1 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.83 -0.433 . . . . 72.43 109.83 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 29.2 p -133.77 102.03 5.31 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.064 0.546 . . . . 72.33 109.895 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -172.67 -176.35 1.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.038 -1.097 . . . . 74.04 108.038 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.409 ' N ' ' SD ' ' A' ' 1' ' ' MET . 58.9 m -79.71 84.88 5.47 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.425 -0.954 . . . . 64.33 108.425 172.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB2' ' HE2' ' A' ' 4' ' ' TYR . 73.6 m-85 -102.25 129.74 25.6 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.581 -0.896 . . . . 74.11 108.581 175.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 11.9 Cg_endo -56.19 122.07 11.13 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.026 2.484 . . . . 54.44 112.429 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.4 mtm -83.82 144.14 29.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.307 -0.861 . . . . 75.41 109.9 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -143.06 101.74 3.88 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.249 -1.389 . . . . 72.52 107.249 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.5 tp -103.67 126.43 50.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.502 0.721 . . . . 70.33 109.358 -174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.7 129.19 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.264 0.626 . . . . 52.33 109.8 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 64.48 12.0 7.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.659 1.183 . . . . 73.34 113.454 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 55.59 11.17 0.59 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.362 1.065 . . . . 44.55 113.102 -166.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.4 tp -105.66 -44.19 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.08 0.952 . . . . 73.1 110.394 -168.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.56 130.01 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.283 -0.871 . . . . 74.55 109.473 -171.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -90.21 117.59 29.08 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.692 -0.855 . . . . 70.22 108.692 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -92.75 126.34 37.78 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.158 0.983 . . . . 72.21 109.627 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 80.3 t80 -107.52 127.92 54.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.852 1.261 . . . . 73.03 108.024 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' ' HG2' ' A' ' 19' ' ' PRO . 72.4 mmtt -68.23 145.23 54.48 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 75.04 111.916 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.27 162.24 35.14 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.608 0.568 . . . . 64.23 112.021 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.38 142.96 50.68 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.027 0.931 . . . . 72.14 109.138 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -67.91 117.54 9.92 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.115 -0.698 . . . . 73.02 109.115 173.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.41 162.93 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.521 0.728 . . . . 61.13 110.626 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.56 131.89 72.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 108.64 -0.874 . . . . 70.42 108.64 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 73.2 mtp180 -105.31 108.13 19.48 Favored 'General case' 0 C--O 1.255 1.38 0 N-CA-C 108.504 -0.924 . . . . 73.41 108.504 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.501 ' NZ ' HG22 ' A' ' 64' ' ' VAL . 62.9 mmtt -134.3 148.37 50.76 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.099 1.759 . . . . 73.53 108.415 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.06 -7.08 43.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.936 0.894 . . . . 71.41 112.014 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.52 33.44 0.32 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.086 0.394 . . . . 61.42 114.086 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 39.7 tt0 -156.52 141.47 17.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.555 -0.535 . . . . 65.25 109.555 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp -140.32 35.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 CA-C-O 121.893 0.854 . . . . 74.5 110.423 -170.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.36 74.35 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 CA-C-O 122.267 1.032 . . . . 71.15 111.488 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pp -106.6 -4.8 19.22 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.428 0.899 . . . . 64.31 113.428 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.34 -19.63 46.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.026 0.531 . . . . 64.04 111.407 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.92 75.83 1.31 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 112.574 -0.211 . . . . 75.42 112.574 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.6 m -76.27 -29.05 57.29 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.287 0.635 . . . . 72.02 111.609 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -154.43 155.1 30.43 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.624 0.77 . . . . 75.14 110.39 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.72 94.78 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.586 2.191 . . . . 73.15 111.647 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -87.55 81.24 7.81 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.518 -0.765 . . . . 63.44 110.347 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.58 144.28 29.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.932 0.893 . . . . 74.12 109.193 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 143.74 41.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.423 1.089 . . . . 74.13 108.544 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -87.98 77.51 8.43 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.009 -0.737 . . . . 61.15 109.009 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.81 69.37 1.35 Allowed Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.657 -0.701 . . . . 71.45 112.186 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.61 98.78 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.522 1.529 . . . . 60.31 113.023 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.54 94.21 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.117 0.967 . . . . 74.42 111.091 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -143.75 -160.98 1.18 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.428 1.491 . . . . 63.53 108.078 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.8 -37.64 84.94 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.743 -0.836 . . . . 61.44 108.743 166.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.77 41.76 95.55 Favored Glycine 0 C--N 1.354 1.576 0 CA-C-N 115.35 -0.841 . . . . 63.32 111.2 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -144.88 -40.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.094 0.558 . . . . 71.33 111.503 -170.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -162.58 74.14 0.39 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.865 0.84 . . . . 73.34 110.364 -175.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -97.53 -16.76 19.95 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.15 -0.932 . . . . 71.13 110.314 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 64.61 17.17 10.76 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.613 1.165 . . . . 74.11 111.301 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.501 HG22 ' NZ ' ' A' ' 38' ' ' LYS . 12.7 t -106.8 84.17 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.575 0 N-CA-C 107.897 -1.149 . . . . 74.42 107.897 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.2 mm-40 -98.72 66.78 1.67 Allowed 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.597 0.713 . . . . 71.52 109.16 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -89.15 143.38 26.88 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.609 -0.723 . . . . 61.03 110.006 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.07 -133.01 3.85 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.508 -1.037 . . . . 63.43 110.508 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.469 HD11 HD12 ' A' ' 156' ' ' ILE . 4.7 pt -111.26 154.08 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 122.508 0.323 . . . . 73.13 110.858 172.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.59 -39.23 73.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.454 1.101 . . . . 73.14 113.099 -173.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.04 -48.88 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.99 0.916 . . . . 71.42 110.527 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 76' ' ' LEU . 55.0 t -67.85 -43.48 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 114.999 -1.0 . . . . 74.44 111.099 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 75.9 mt -72.76 -21.97 60.92 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.183 0.593 . . . . 63.42 111.841 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -70.71 -53.59 15.05 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.362 0.665 . . . . 54.43 109.511 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -86.55 -21.14 27.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.19 0.596 . . . . 75.35 111.101 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? 65.67 71.13 0.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.871 1.268 . . . . 72.3 109.727 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 91.1 mt -91.44 145.68 24.43 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.969 -1.014 . . . . 74.44 110.151 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 129.17 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.564 0.746 . . . . 61.43 109.855 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.77 153.56 32.44 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.615 0.969 . . . . 72.34 113.615 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.408 ' HE3' ' HB2' ' A' ' 79' ' ' MET . 40.6 ttm -150.16 112.11 4.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.799 2.039 . . . . 71.42 106.078 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.66 152.33 29.12 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.979 0.809 . . . . 72.2 111.702 -172.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.546 ' SG ' ' HE2' ' A' ' 138' ' ' PHE . 85.6 m -65.96 -16.63 64.05 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.402 0.89 . . . . 51.11 113.402 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -71.3 -55.23 8.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.973 0.509 . . . . 74.51 110.367 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.36 -40.63 5.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.231 0.612 . . . . 62.33 112.061 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.83 20.55 3.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.628 0.771 . . . . 65.54 112.854 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.77 85.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.293 0.637 . . . . 75.51 112.29 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -77.35 -31.31 54.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.348 0.659 . . . . 63.21 111.711 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.9 mmt -64.42 -50.92 65.71 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.319 -0.622 . . . . 35.51 109.319 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.86 -23.41 62.31 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.141 -0.936 . . . . 73.22 110.725 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -68.97 -37.64 78.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.291 0.636 . . . . 75.03 109.93 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.4 83.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.18 0.592 . . . . 72.11 110.238 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -69.39 -32.9 72.21 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 123.409 0.684 . . . . 73.34 112.499 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mm -65.87 -33.6 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 117.898 0.317 . . . . 55.11 110.644 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -63.11 -45.65 91.03 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 122.314 0.246 . . . . 55.11 110.571 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -61.6 -54.45 42.85 Favored 'General case' 0 C--N 1.36 1.058 0 N-CA-C 109.227 -0.657 . . . . 72.05 109.227 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.507 ' HD2' ' HG2' ' A' ' 152' ' ' GLN . 60.1 t80 -44.4 -68.53 0.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.792 2.037 . . . . 60.32 111.603 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 40.9 ttp -57.35 -50.38 73.13 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 124.127 0.971 . . . . 74.45 111.595 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -56.82 -50.04 73.59 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.111 0.882 . . . . 63.11 110.537 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -71.93 -48.01 48.41 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.74 -0.664 . . . . 75.33 111.604 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.599 HG11 HG11 ' A' ' 172' ' ' VAL . 23.8 m -66.25 -38.9 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 112.396 0.517 . . . . 40.02 112.396 -172.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.0 mt -77.91 -42.14 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 120.439 0.161 . . . . 70.32 110.921 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.05 -45.41 85.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.617 0.767 . . . . 73.34 111.355 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -67.14 -40.26 86.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.15 0.58 . . . . 62.14 109.959 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.36 -51.48 69.76 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 123.842 0.714 . . . . 73.23 110.62 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.81 -23.66 66.74 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.291 0.637 . . . . 75.35 111.257 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 31.8 ttmt -75.07 -24.47 58.21 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.338 0.655 . . . . 64.54 110.87 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -114.5 -13.39 12.2 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.2 0.6 . . . . 72.23 112.18 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -100.74 -46.06 5.28 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.717 0.807 . . . . 74.14 109.399 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 66.29 18.29 10.88 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.068 1.347 . . . . 74.51 113.144 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.18 111.13 19.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.64 -1.245 . . . . 62.03 107.64 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -69.5 -29.69 67.38 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.595 0.559 . . . . 75.44 111.632 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.34 -32.15 66.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 60.45 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.22 -47.55 56.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.686 0.794 . . . . 72.45 109.492 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.7 m -79.28 -17.82 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 115.237 -0.892 . . . . 73.01 111.935 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.08 -35.35 74.13 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.013 -0.736 . . . . 72.31 109.013 170.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.31 73.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.192 -0.913 . . . . 72.24 110.09 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -62.25 -41.61 98.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.0 0.52 . . . . 73.22 110.391 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.404 ' HA ' HG22 ' A' ' 120' ' ' ILE . 37.5 ttpt -62.24 -34.86 77.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.598 0.759 . . . . 74.43 110.589 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -66.4 -43.25 86.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.51 -0.768 . . . . 71.01 110.411 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -46.76 71.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.781 -0.645 . . . . 73.44 111.441 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 117' ' ' LYS . 9.0 tp -78.96 -33.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.606 0.363 . . . . 61.11 110.944 -168.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -41.06 95.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.082 -1.081 . . . . 72.0 108.082 171.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.8 -40.98 97.4 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.832 0.708 . . . . 63.04 113.013 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -67.88 -48.0 67.29 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 122.656 0.382 . . . . 71.34 111.003 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 31.4 m -70.5 -38.37 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 118.997 -0.525 . . . . 55.32 111.796 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.39 -32.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 118.683 0.674 . . . . 73.52 110.194 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -69.43 -42.03 75.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.453 0.701 . . . . 74.31 110.581 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 155' ' ' ILE . 14.4 tp -74.8 -30.89 61.56 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.247 1.019 . . . . 64.24 111.076 -170.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 86.5 mt -86.09 1.93 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.923 0.889 . . . . 65.01 110.78 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.04 67.03 8.94 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 122.08 0.943 . . . . 72.03 108.701 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.74 -6.22 30.48 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 114.191 -1.368 . . . . 55.55 113.593 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.73 -33.76 74.62 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.25 0.62 . . . . 64.22 110.449 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -105.44 -39.18 6.22 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.429 1.092 . . . . 71.33 109.527 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -80.33 0.67 31.98 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.112 1.365 . . . . 72.15 114.203 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -14.6 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 N-CA-C 114.288 1.218 . . . . 75.02 114.288 175.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.426 ' ND2' ' HG3' ' A' ' 157' ' ' GLU . 4.9 p-10 -79.44 13.63 1.9 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.026 0.93 . . . . 74.21 112.024 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.26 146.47 24.2 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.496 0.719 . . . . 73.54 109.425 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -139.06 112.49 8.21 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.72 -1.956 . . . . 74.43 105.72 169.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.641 ' HB3' HG11 ' A' ' 153' ' ' VAL . 37.1 m-85 -85.75 145.24 27.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.445 -0.946 . . . . 73.33 108.445 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 69.5 m-85 -139.41 143.79 37.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.349 0.66 . . . . 73.35 109.461 -176.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.6 pt -131.51 177.01 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.615 -0.883 . . . . 73.33 108.615 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.56 120.94 23.66 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 123.656 0.597 . . . . 74.32 111.621 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.39 -36.17 61.15 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.864 1.266 . . . . 75.43 110.24 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.54 -45.85 71.08 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.878 -1.055 . . . . 71.32 111.298 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.456 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -65.63 -25.74 67.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.519 0.728 . . . . 74.52 111.947 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.24 -7.66 56.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.894 0.877 . . . . 65.31 112.239 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -85.28 -40.39 16.64 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.535 -0.543 . . . . 74.51 109.535 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.09 52.03 0.05 OUTLIER Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.996 -0.547 . . . . 61.22 112.489 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -145.35 -179.49 6.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.828 0.851 . . . . 52.0 109.592 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -119.99 121.63 39.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.878 0.871 . . . . 72.31 108.72 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -91.27 -26.68 18.87 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.756 -0.461 . . . . 61.32 109.756 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.73 -68.16 2.23 Favored Glycine 0 C--N 1.342 0.879 0 O-C-N 124.593 1.183 . . . . 70.23 113.656 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.507 ' HG2' ' HD2' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -100.47 133.16 45.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.247 -1.39 . . . . 75.53 107.247 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' ' 138' ' ' PHE . 71.5 t -94.02 141.63 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.768 0.827 . . . . 70.23 111.572 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.712 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -72.32 97.2 1.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.891 0.876 . . . . 34.0 109.6 169.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 127' ' ' LEU . 85.6 mt -89.84 104.65 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.342 -0.614 . . . . 71.03 109.342 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 68' ' ' ILE . 41.3 mm -93.59 125.63 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.039 -0.726 . . . . 74.12 109.039 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.426 ' HG3' ' ND2' ' A' ' 135' ' ' ASN . 21.7 tt0 -129.2 112.12 13.6 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.703 -0.851 . . . . 73.12 108.703 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.589 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 54.1 p90 -81.22 99.31 8.51 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 106.76 -1.57 . . . . 61.53 106.76 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -83.46 143.18 30.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.047 -0.979 . . . . 64.34 110.769 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.77 120.78 21.61 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.123 0.487 . . . . 64.42 109.718 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.11 95.37 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 125.336 1.454 . . . . 72.24 107.951 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.62 17.66 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.185 0.994 . . . . 72.53 112.11 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.31 6.93 47.18 Favored Glycine 0 C--N 1.353 1.521 0 C-N-CA 123.146 0.403 . . . . 75.11 113.545 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 m -111.94 156.42 22.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.242 1.017 . . . . 71.42 109.516 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 12.8 pt-20 -84.51 138.51 32.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.903 0.481 . . . . 75.41 110.156 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.54 99.37 18.98 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.783 0.833 . . . . 42.31 108.8 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.04 114.11 1.87 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.902 2.401 . . . . 74.2 113.195 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.3 p -115.75 121.23 41.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.875 0.87 . . . . 63.35 108.714 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 30.7 tp -76.76 107.4 9.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.467 -0.938 . . . . 51.41 108.467 172.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 73.7 mtp -94.96 122.69 37.86 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 107.875 -1.157 . . . . 63.12 107.875 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 154' ' ' ALA . 85.3 mt -134.7 145.04 48.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.558 1.543 . . . . 50.53 107.081 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.599 HG11 HG11 ' A' ' 99' ' ' VAL . 7.5 p -73.6 141.66 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.618 -0.882 . . . . 65.11 108.618 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.548 ' HA ' HG22 ' A' ' 176' ' ' ILE . 61.6 tttp -57.86 -30.02 65.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.004 0.922 . . . . 74.42 111.758 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.65 2.16 42.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.822 0.849 . . . . 65.14 112.267 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.98 -9.03 4.88 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.472 0.709 . . . . 73.43 111.375 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' A' ' 173' ' ' LYS . 8.6 tp -97.8 133.85 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 107.141 -1.429 . . . . 74.41 107.141 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.2 mm -104.57 110.53 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 106.864 -1.532 . . . . 61.53 106.864 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.89 90.31 3.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.012 1.325 . . . . 74.31 107.582 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' A' ' 3' ' ' ILE . 12.2 tp10 -106.13 144.02 33.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.817 -0.808 . . . . 61.42 108.817 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.571 ' HE2' HD11 ' A' ' 182' ' ' LEU . 13.8 ptmt -100.27 123.92 45.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.681 0.792 . . . . 72.34 110.134 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.26 87.4 7.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.597 -0.89 . . . . 73.45 108.597 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.571 HD11 ' HE2' ' A' ' 180' ' ' LYS . 82.8 mt -90.31 87.93 7.01 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.741 -0.837 . . . . 54.4 108.741 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 C--O 1.254 1.336 0 N-CA-C 107.263 -1.384 . . . . 71.42 107.263 178.956 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 86.1 mmm . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.701 0.286 . . . . 64.55 110.441 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.6 HD22 ' HA ' ' A' ' 180' ' ' LYS . 62.3 mt -120.52 155.74 32.99 Favored 'General case' 0 C--O 1.25 1.087 0 C-N-CA 123.781 0.832 . . . . 61.43 109.742 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 60.3 mt -96.85 120.25 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.373 -0.973 . . . . 60.33 108.373 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -110.33 99.41 8.44 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.265 -1.383 . . . . 75.52 107.265 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 10' ' ' ASP . 55.2 pttt -129.53 165.3 21.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.314 -0.403 . . . . 73.23 110.054 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 10.3 m-20 -85.89 -177.94 6.46 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.839 0.828 . . . . 74.21 110.207 174.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.6 mt -84.19 -24.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 114.87 -1.059 . . . . 62.31 110.041 157.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -107.11 -59.76 1.77 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.788 0.835 . . . . 73.24 112.267 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -96.82 17.56 16.42 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.013 0.925 . . . . 72.54 110.439 -174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 5.3 p-10 -52.42 -29.21 23.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.111 1.364 . . . . 72.24 113.212 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -48.62 72.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.765 1.291 . . . . 74.43 111.323 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -120.3 17.87 12.25 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.688 -0.687 . . . . 63.22 112.268 -168.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -78.23 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.261 0.937 . . . . 74.1 109.176 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -143.78 122.79 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 120.741 1.61 . . . . 73.51 112.617 -168.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.52 ' HB3' HG23 ' A' ' 3' ' ' ILE . 35.7 p -116.12 104.87 11.98 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.865 0.866 . . . . 63.34 108.995 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 1' ' ' MET . 37.4 t70 -160.64 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 110.141 -0.318 . . . . 63.03 110.141 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.9 p -127.69 71.5 1.36 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.027 -0.731 . . . . 70.12 109.027 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -120.67 93.9 48.68 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.004 -0.739 . . . . 61.44 109.004 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.54 135.74 66.58 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.638 2.225 . . . . 53.54 111.622 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.448 ' SD ' ' HE3' ' A' ' 180' ' ' LYS . 24.2 ptt? -83.48 138.98 33.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.928 -0.767 . . . . 74.22 108.928 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -152.4 122.74 7.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.035 -1.098 . . . . 74.42 108.035 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -130.64 122.89 28.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.64 0.776 . . . . 71.4 109.039 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.13 142.86 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.322 0.649 . . . . 73.55 110.327 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 59.39 8.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.34 1.456 . . . . 61.42 113.515 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 51.72 39.28 25.01 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.243 1.017 . . . . 72.4 110.587 -168.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.0 tp -134.99 -51.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.794 . . . . 71.25 110.532 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.28 125.9 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.58 0.752 . . . . 63.43 110.299 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -83.6 119.96 25.37 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.981 -1.118 . . . . 74.42 107.981 171.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 6.7 pt-20 -111.51 141.65 44.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.176 0.591 . . . . 65.23 109.833 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.43 ' HD1' HD11 ' A' ' 70' ' ' ILE . 33.2 t80 -136.76 140.28 42.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.997 -1.112 . . . . 74.04 107.997 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.8 97.05 8.96 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.088 0.555 . . . . 72.24 110.061 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.98 130.6 11.6 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.942 -0.572 . . . . 63.02 111.706 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -97.62 124.04 41.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.367 0.583 . . . . 70.1 109.454 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -64.72 114.27 4.33 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 108.783 -0.821 . . . . 73.4 108.783 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.562 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 15.4 m -148.47 161.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.208 1.003 . . . . 55.12 108.88 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.528 HG13 ' HA ' ' A' ' 44' ' ' LEU . 3.3 m -128.42 143.78 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.183 -1.043 . . . . 64.22 108.183 173.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -91.74 116.08 28.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.404 -1.702 . . . . 73.15 106.404 169.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -119.46 145.48 46.25 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.87 -1.53 . . . . 71.02 106.87 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -62.8 89.02 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.432 0.634 . . . . 72.15 111.548 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.32 52.02 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 114.639 -1.164 . . . . 62.23 113.998 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -159.85 -174.59 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.899 0.48 . . . . 72.14 110.757 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tt -148.44 130.21 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.687 0.795 . . . . 73.33 109.483 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.18 79.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 107.95 -1.13 . . . . 71.11 107.95 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.562 ' HB3' ' HA ' ' A' ' 35' ' ' VAL . 1.1 pp -69.99 -23.23 63.12 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.689 0.796 . . . . 71.32 112.36 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.59 160.88 22.43 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.588 0.755 . . . . 62.03 110.145 176.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.72 68.35 2.51 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.015 -0.834 . . . . 75.21 111.015 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.5 m -129.31 1.77 5.13 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.279 1.032 . . . . 72.5 110.507 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -76.11 108.32 5.93 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.513 -1.292 . . . . 71.44 107.513 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -82.61 42.89 1.38 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.96 2.44 . . . . 72.42 112.836 -173.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.2 t -158.23 177.79 10.89 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.15 0.98 . . . . 74.1 109.426 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . 68.34 81.93 0.18 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.597 1.159 . . . . 60.52 112.193 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.46 -40.95 0.12 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.482 0.713 . . . . 72.35 111.397 173.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -172.65 -70.31 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.753 0.821 . . . . 73.4 109.666 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.78 -29.59 67.18 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 116.052 -0.522 . . . . 70.34 112.82 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.25 105.92 16.24 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.357 -1.349 . . . . 61.52 107.357 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -118.0 -48.33 2.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.415 0.686 . . . . 75.41 110.844 -171.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.53 -17.08 62.34 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 116.183 -0.462 . . . . 74.14 112.045 -172.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -109.52 130.7 55.49 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.302 -1.37 . . . . 74.1 107.302 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . 85.46 26.78 34.8 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.216 -0.902 . . . . 73.52 112.026 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -74.17 122.23 22.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.556 0.742 . . . . 74.1 110.392 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HB3' ' NH1' ' A' ' 66' ' ' ARG . 5.1 p-10 -67.77 -1.26 5.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.235 0.828 . . . . 74.0 113.235 -171.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -59.07 -57.16 14.27 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 123.877 0.871 . . . . 71.03 110.3 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -98.55 -25.36 14.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.763 0.425 . . . . 71.45 111.134 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 31.7 t -77.62 77.44 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.043 0 N-CA-C 107.852 -1.166 . . . . 75.33 107.852 168.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 39.5 mt-10 -75.32 77.18 2.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.718 -1.216 . . . . 72.23 107.718 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 61' ' ' ASP . 6.1 ptp180 -76.59 135.63 39.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.89 -1.05 . . . . 72.11 110.545 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.44 -136.84 4.53 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.443 -0.663 . . . . 63.34 111.443 173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 pt -110.22 155.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.509 0.324 . . . . 75.02 110.779 172.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.75 -39.27 70.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.382 1.073 . . . . 74.52 112.391 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.43 HD11 ' HD1' ' A' ' 30' ' ' PHE . 41.3 mt -55.29 -44.87 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 124.104 0.962 . . . . 73.42 110.47 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.74 -55.08 19.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 CA-C-N 114.011 -1.449 . . . . 74.42 110.656 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 35' ' ' VAL . 18.2 mt -67.94 -30.37 69.66 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.726 -0.67 . . . . 64.41 111.088 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.65 -52.38 38.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.838 -1.073 . . . . 70.35 110.95 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -89.37 -13.56 37.53 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.106 -0.497 . . . . 64.51 111.798 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt 68.42 66.32 0.32 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.24 1.016 . . . . 75.3 109.437 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 94.9 mt -86.57 131.36 34.19 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.96 -1.018 . . . . 75.2 108.677 173.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.804 HG11 ' HB2' ' A' ' 145' ' ' ALA . 4.4 p -86.42 129.89 37.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.524 0.73 . . . . 55.45 109.424 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.56 151.67 37.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 123.663 0.785 . . . . 74.45 112.247 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 39.5 tpp -149.5 140.28 22.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.347 -1.353 . . . . 70.42 107.347 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.632 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 29.7 m-80 -130.06 123.18 29.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.066 0.546 . . . . 73.43 110.334 -169.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 28.0 p -67.73 -16.26 64.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.014 0.526 . . . . 33.52 111.72 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.632 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 97.5 m-85 -45.88 -60.76 2.06 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.287 1.035 . . . . 65.01 111.319 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -105.23 -33.31 8.27 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.244 1.018 . . . . 72.13 111.255 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -93.02 19.98 7.23 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.002 0.521 . . . . 65.34 111.728 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.97 27.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.85 0.86 . . . . 63.44 113.203 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -77.96 -50.74 11.57 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.515 0.726 . . . . 54.02 112.25 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -72.91 -33.48 66.01 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.1 0.56 . . . . 71.13 110.971 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.516 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 35.0 t80 -64.91 -42.92 94.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.103 0.561 . . . . 65.11 110.568 170.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -63.46 -27.62 69.41 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 120.678 0.275 . . . . 73.55 110.564 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.2 -36.72 74.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.192 0.597 . . . . 54.11 110.571 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.516 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 34.8 m-85 -63.83 -35.85 81.97 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.654 0.382 . . . . 74.14 110.526 170.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mm -65.61 -36.5 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.453 0.701 . . . . 75.43 111.459 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.36 -44.82 96.51 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.579 0.352 . . . . 75.24 110.699 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -68.09 -42.81 79.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.909 -0.587 . . . . 73.24 109.886 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -48.86 -66.63 0.37 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.625 1.57 . . . . 74.23 111.07 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.1 ptm -60.46 -40.61 91.83 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.507 0.504 . . . . 62.13 111.19 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -62.93 -45.59 91.74 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 122.68 0.392 . . . . 71.44 110.379 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -72.9 -48.72 34.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.346 0.658 . . . . 74.34 111.206 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -66.41 -38.06 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 123.541 0.525 . . . . 53.51 112.188 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.418 HD13 ' HE3' ' A' ' 117' ' ' LYS . 63.8 mt -77.89 -40.18 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 122.969 0.508 . . . . 72.51 110.148 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.52 -42.71 99.69 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.134 0.974 . . . . 73.22 111.83 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -66.96 -45.03 78.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.297 -0.865 . . . . 64.51 109.104 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.9 ttt -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 124.349 1.031 . . . . 74.4 110.692 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.23 -41.29 79.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.258 1.023 . . . . 70.45 112.174 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.58 -19.22 62.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.797 0.666 . . . . 72.4 112.797 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -114.37 0.9 14.25 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.386 0.539 . . . . 73.23 111.891 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.56 -48.06 2.88 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.754 -0.832 . . . . 65.53 108.754 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 57.37 8.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 126.848 2.059 . . . . 75.23 113.996 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -113.91 115.13 27.2 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.987 -0.746 . . . . 72.12 108.987 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -64.6 -32.85 74.68 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.026 0.829 . . . . 75.11 111.833 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.58 68.24 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.791 0.329 . . . . 73.01 110.603 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.19 -54.59 6.32 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.976 -0.75 . . . . 61.25 108.976 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.9 -22.22 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 115.932 -0.576 . . . . 54.25 111.677 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.05 -41.73 97.27 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.303 0.641 . . . . 74.54 110.221 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.053 0.845 . . . . 40.44 110.172 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -57.64 -61.12 2.74 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.173 0.92 . . . . 75.25 111.733 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.418 ' HE3' HD13 ' A' ' 100' ' ' ILE . 21.8 ptmt -73.19 -15.38 61.45 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.615 0.572 . . . . 65.43 111.858 -173.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -68.14 -51.49 45.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.55 -0.907 . . . . 74.21 108.55 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.12 -32.86 72.55 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.081 -1.418 . . . . 71.43 111.878 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mm -67.98 -47.62 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.068 0.547 . . . . 63.4 110.262 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.35 -49.53 75.85 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.91 0.756 . . . . 42.11 109.499 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.59 98.76 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 123.819 0.7 . . . . 74.13 112.981 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -62.45 -50.5 71.2 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.696 0.799 . . . . 74.42 109.79 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.5 m -70.79 -42.14 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 118.503 -0.76 . . . . 62.2 111.816 -173.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.55 -32.16 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 119.221 0.919 . . . . 73.4 110.757 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.2 t -73.97 -38.96 64.03 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 120.907 0.384 . . . . 60.1 110.081 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 155' ' ' ILE . 28.4 tp -73.88 -26.94 60.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.929 1.292 . . . . 73.42 111.867 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 64.8 mt -88.42 2.24 53.12 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.852 0.861 . . . . 62.54 111.822 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 93.87 6.77 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.209 0.528 . . . . 72.35 109.586 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 50.9 mtpt -67.07 -5.38 12.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.331 1.234 . . . . 72.42 114.331 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -47.15 83.08 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 118.231 0.469 . . . . 73.25 110.794 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -109.06 -37.64 5.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.768 0.827 . . . . 71.51 110.547 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.37 -1.79 38.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.714 1.206 . . . . 73.32 114.148 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 37.3 ttpt -55.26 -15.54 2.52 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.705 0.631 . . . . 65.54 112.705 172.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -83.68 6.72 19.95 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.598 0.759 . . . . 72.02 111.276 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.63 129.18 34.96 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.415 0.686 . . . . 62.33 109.309 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.85 120.17 39.75 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.658 -1.238 . . . . 53.44 107.658 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.431 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 65.1 m-85 -102.7 141.91 34.73 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.422 -0.585 . . . . 74.24 109.422 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 95.1 m-85 -139.65 149.76 44.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.239 -0.652 . . . . 73.43 109.239 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.4 pt -133.66 168.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.892 -0.781 . . . . 75.21 108.892 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.61 143.93 48.99 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.821 -0.433 . . . . 63.41 112.227 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -44.86 -39.31 5.25 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.698 0.799 . . . . 60.31 111.993 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -62.77 -38.53 90.95 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 72.42 111.898 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -68.59 -29.74 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.267 0.627 . . . . 62.34 111.727 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.804 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -84.53 -25.33 28.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.575 0.35 . . . . 74.53 111.215 173.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -65.81 -29.89 70.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.499 0.72 . . . . 72.11 110.55 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.53 0.01 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.074 -0.81 . . . . 71.41 111.074 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -159.41 -170.69 3.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.165 0.586 . . . . 64.33 111.134 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.95 -173.01 0.9 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 75.32 108.858 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 79.21 -20.82 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.521 1.528 . . . . 75.15 111.963 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.13 146.72 47.78 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.908 -0.477 . . . . 72.35 111.908 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -67.62 134.23 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.397 0.679 . . . . 75.53 111.52 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.439 HG11 ' HE1' ' A' ' 88' ' ' PHE . 59.9 t -83.36 117.96 30.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.699 -0.682 . . . . 70.2 109.679 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -67.01 101.5 0.86 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.828 0.851 . . . . 75.04 109.525 168.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.666 HG21 HD21 ' A' ' 127' ' ' LEU . 67.1 mt -90.78 105.88 16.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.22 -1.03 . . . . 74.25 108.22 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -94.84 96.35 5.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.333 -0.617 . . . . 61.13 109.333 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -81.47 157.23 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.732 -1.122 . . . . 73.44 108.011 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.1 p90 -120.45 139.24 53.14 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.021 -1.103 . . . . 72.31 108.021 175.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.417 ' HB2' HG23 ' A' ' 166' ' ' VAL . 24.1 mmt180 -118.98 161.27 20.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.263 -0.643 . . . . 72.33 109.263 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -115.84 119.84 37.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.489 0.716 . . . . 70.51 110.403 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.88 97.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.296 1.038 . . . . 71.44 108.773 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 61.94 18.06 9.51 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.446 1.098 . . . . 75.14 113.777 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.84 1.37 22.7 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 120.122 -0.266 . . . . 75.52 113.194 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.9 m -110.11 134.37 52.25 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.954 0.901 . . . . 73.32 109.634 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.91 120.66 23.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.878 -1.156 . . . . 75.01 107.878 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 159' ' ' ARG . 2.7 m -117.84 89.33 33.39 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.495 -1.298 . . . . 74.14 107.495 169.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 84.3 Cg_exo -54.19 126.25 21.5 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.006 2.47 . . . . 73.32 113.269 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -103.58 107.22 17.98 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.105 -1.072 . . . . 73.52 108.105 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 16.5 tp -75.17 112.42 11.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.676 -1.231 . . . . 72.53 107.676 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ptp -105.83 136.11 46.05 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 122.07 0.938 . . . . 65.54 108.945 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 154' ' ' ALA . 68.1 mt -141.77 158.33 43.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 112.963 -1.926 . . . . 73.21 106.534 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 174' ' ' GLU . 10.6 p -86.73 140.65 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.363 -0.977 . . . . 62.32 108.363 168.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -57.77 -27.33 62.97 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.537 0.735 . . . . 73.34 111.722 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 172' ' ' VAL . 17.0 mm-40 -90.12 13.58 14.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.594 0.757 . . . . 61.03 112.858 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.92 -1.14 7.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.588 0.755 . . . . 60.32 110.921 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.434 HG13 HD13 ' A' ' 171' ' ' LEU . 36.3 mm -132.0 137.0 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.047 0.939 . . . . 71.04 109.55 -174.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.94 109.81 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.854 -1.165 . . . . 52.34 107.854 171.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.05 106.15 18.35 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.403 -1.332 . . . . 72.12 107.403 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.649 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 43.3 mt-10 -92.78 98.11 11.19 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.425 -1.324 . . . . 70.52 107.425 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.645 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -72.97 96.43 2.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 113.794 -1.548 . . . . 65.15 109.403 179.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.91 87.78 2.89 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.272 -1.01 . . . . 72.43 108.272 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 97.5 mt -83.33 110.61 18.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.194 -0.912 . . . . 64.05 110.459 -171.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 108.031 -1.1 . . . . 74.22 108.031 175.43 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.826 -0.435 . . . . 51.34 109.826 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.9 mt -95.35 127.7 41.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.07 -0.715 . . . . 65.54 109.07 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.597 ' HB ' ' HG3' ' A' ' 179' ' ' GLU . 45.9 mt -97.4 127.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.332 0.653 . . . . 73.32 109.482 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.424 ' OH ' ' HB3' ' A' ' 20' ' ' MET . 31.1 m-85 -121.72 114.42 21.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.842 1.257 . . . . 75.23 107.792 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -123.11 150.72 42.86 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.342 0.657 . . . . 74.21 110.02 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.15 134.19 34.74 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.89 -1.152 . . . . 63.2 107.89 166.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.2 pt -68.71 -27.66 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.786 0.661 . . . . 73.51 112.786 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 98' ' ' ASN . 74.8 m-85 -85.61 -63.31 1.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.079 0.399 . . . . 75.34 112.068 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -131.33 -33.82 1.45 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.522 0.564 . . . . 74.15 112.522 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.83 24.03 5.77 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.05 0.94 . . . . 44.05 112.721 -156.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.19 -29.07 1.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.866 1.266 . . . . 73.1 113.605 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -84.42 24.68 0.95 Allowed 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 113.2 0.815 . . . . 73.24 113.2 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.4 mt -45.28 -76.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.534 1.134 . . . . 45.14 112.564 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 p -160.79 134.87 7.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.154 0.581 . . . . 63.11 110.359 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.421 ' HB2' HG12 ' A' ' 3' ' ' ILE . 38.9 p -141.53 99.91 3.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.091 0.86 . . . . 42.3 109.655 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB3' ' HD2' ' A' ' 18' ' ' PHE . 25.9 t70 -163.85 169.66 17.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.711 0.805 . . . . 70.32 109.364 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -80.99 9.49 6.47 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.862 0.865 . . . . 74.22 113.13 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.517 ' HD2' ' HB3' ' A' ' 16' ' ' ASP . 51.4 p90 -54.49 141.82 52.96 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 118.34 0.518 . . . . 73.14 111.787 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.38 119.82 7.22 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 123.008 2.472 . . . . 54.0 113.258 -164.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.424 ' HB3' ' OH ' ' A' ' 4' ' ' TYR . 24.2 ptt? -101.94 151.81 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.977 -0.556 . . . . 72.15 110.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -135.91 145.96 46.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.181 -1.415 . . . . 72.24 107.181 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.0 tp -134.32 118.52 17.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.271 -1.011 . . . . 64.33 108.271 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.51 133.88 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.056 0.942 . . . . 63.32 109.278 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 58.44 10.46 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.131 1.373 . . . . 64.33 114.55 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 50.72 25.08 1.93 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.723 0.809 . . . . 73.4 112.362 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 119' ' ' LYS . 63.3 tp -109.15 -46.14 3.63 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.1 t -124.44 124.4 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 122.673 0.389 . . . . 74.14 110.822 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -84.63 114.42 21.99 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.604 -1.258 . . . . 73.44 107.604 167.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 47.3 mt-10 -106.97 135.01 49.26 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.227 -0.897 . . . . 65.5 110.44 176.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 27.7 t80 -127.11 133.59 50.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.215 1.006 . . . . 74.33 108.984 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.73 139.55 30.41 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.019 0.438 . . . . 71.13 109.828 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -172.59 12.97 Favored Glycine 0 CA--C 1.508 -0.372 0 N-CA-C 110.538 -1.025 . . . . 65.4 110.538 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -144.84 144.55 31.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 53.14 109.992 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' O ' HD11 ' A' ' 44' ' ' LEU . 3.5 t-160 -65.03 117.37 7.56 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.121 -1.066 . . . . 74.14 108.121 169.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.71 163.61 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.854 1.261 . . . . 53.3 109.382 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG13 HD23 ' A' ' 44' ' ' LEU . 2.9 m -119.54 104.86 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.241 -1.022 . . . . 71.12 108.241 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.708 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 13.5 tpt180 -80.73 106.62 12.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.772 -1.195 . . . . 70.32 107.772 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 87.5 tttt -135.04 154.11 51.82 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.818 -1.083 . . . . 73.54 109.579 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -51.63 -26.76 9.57 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.003 1.321 . . . . 73.13 112.836 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.88 27.83 1.29 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.667 -0.518 . . . . 51.21 114.197 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 39.6 mm-40 -146.08 152.45 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.734 0.813 . . . . 75.43 109.352 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 6.4 tp -155.04 -43.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.599 0.76 . . . . 74.4 110.194 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.1 t -76.28 106.96 6.66 Favored 'Isoleucine or valine' 0 C--N 1.349 0.576 0 C-N-CA 123.735 0.814 . . . . 50.25 109.662 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.574 HD23 HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -103.18 -162.89 0.94 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.783 0.833 . . . . 74.23 110.072 174.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.84 -172.78 3.01 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.394 1.078 . . . . 34.03 108.163 171.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.35 65.16 3.4 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.075 -0.81 . . . . 50.13 111.075 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.9 m -150.04 157.71 43.42 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.364 1.066 . . . . 43.15 109.77 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 m120 63.37 74.13 0.46 Allowed Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.681 1.192 . . . . 75.04 111.647 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.66 177.87 7.12 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.841 2.361 . . . . 53.41 111.413 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 p -72.04 102.15 2.91 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 109.77 -0.456 . . . . 75.25 109.77 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.45 155.76 34.49 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.58 0.752 . . . . 74.4 111.95 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.19 120.81 9.9 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.233 1.013 . . . . 72.23 109.524 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 69.34 77.42 0.22 Allowed 'General case' 0 CA--C 1.547 0.828 0 O-C-N 124.913 1.383 . . . . 75.31 109.464 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.47 43.69 2.19 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.825 -0.625 . . . . 73.03 112.423 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.06 -65.6 0.98 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.199 0.6 . . . . 74.1 109.79 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 51.97 49.59 20.38 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.161 1.384 . . . . 73.13 112.314 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 4.6 p-10 -65.26 -23.96 67.19 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.875 -0.602 . . . . 74.1 111.13 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -62.13 -37.27 84.5 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.552 0.741 . . . . 74.34 110.649 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.01 42.61 1.71 Allowed Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.907 -0.588 . . . . 71.51 111.683 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' A' ' 57' ' ' ASP . 44.4 p -73.51 93.65 2.02 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-O 121.331 0.586 . . . . 75.32 109.459 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -136.79 -63.53 0.61 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.484 -0.78 . . . . 71.21 109.555 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 64.13 33.77 11.66 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.225 1.01 . . . . 74.34 112.538 169.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -62.81 -25.1 68.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.497 0.665 . . . . 61.0 109.859 167.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t -92.86 90.38 3.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.868 -1.531 . . . . 74.3 106.868 164.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.708 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 48.1 mt-10 -67.36 80.86 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.849 0.833 . . . . 74.42 109.091 170.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -75.55 132.42 40.7 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.785 -1.098 . . . . 70.1 110.011 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.06 -141.45 7.73 Favored Glycine 0 CA--C 1.498 -0.982 0 N-CA-C 110.048 -1.221 . . . . 61.42 110.048 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 30.1 pt -111.5 147.41 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.426 0.613 . . . . 74.41 110.63 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.7 -24.33 65.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.438 0.695 . . . . 62.0 112.846 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 169' ' ' LEU . 52.9 mt -60.16 -40.39 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.609 0.719 . . . . 74.42 110.165 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.17 -51.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.351 -0.841 . . . . 74.34 111.625 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.703 HD22 ' HB3' ' A' ' 65' ' ' GLU . 24.1 mt -64.88 -45.62 85.23 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.079 0.862 . . . . 64.33 111.492 -169.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -80.62 -18.03 49.45 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.559 -0.746 . . . . 65.13 111.854 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -107.79 -1.45 20.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.791 -0.568 . . . . 72.24 111.357 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 55.95 56.69 5.75 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.226 1.011 . . . . 72.44 111.726 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.638 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 62.8 mt -95.13 138.3 33.03 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.016 -0.993 . . . . 71.13 109.73 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.4 134.48 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.922 -0.77 . . . . 73.21 108.922 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.26 141.45 57.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.143 -0.935 . . . . 64.34 112.928 -174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 ptm -140.81 109.96 6.18 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 107.136 -1.431 . . . . 64.1 107.136 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.45 152.98 20.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.703 -0.681 . . . . 51.31 110.306 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.424 ' SG ' ' HE1' ' A' ' 138' ' ' PHE . 64.8 m -67.34 -3.56 8.47 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.045 1.128 . . . . 74.1 114.045 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -94.13 -60.24 1.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.796 0.439 . . . . 74.4 110.018 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -78.36 -43.62 27.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.862 0.865 . . . . 75.41 110.273 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.13 20.56 8.94 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.842 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.81 -53.82 22.99 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.416 1.086 . . . . 60.14 113.904 -174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.0 m -68.33 -40.59 81.58 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.5 0.667 . . . . 73.24 110.996 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.438 ' HG3' ' CE2' ' A' ' 91' ' ' TYR . 14.2 tpt -68.59 -29.07 67.52 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.179 -0.919 . . . . 72.35 110.245 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -66.46 -42.12 88.04 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.355 1.462 . . . . 74.31 110.063 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.78 -41.65 82.47 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.86 0.725 . . . . 62.42 110.167 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.88 -45.42 86.07 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.394 0.678 . . . . 74.15 112.389 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.56 ' HE1' HD12 ' A' ' 140' ' ' ILE . 30.3 m-85 -55.17 -48.21 74.08 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.456 0.702 . . . . 62.2 112.151 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.13 -41.33 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.802 0.689 . . . . 70.34 112.614 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -52.63 -47.76 66.82 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.361 0.528 . . . . 71.35 111.334 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -70.24 -45.35 66.66 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.162 -0.926 . . . . 72.34 110.996 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -49.83 -51.42 40.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.631 1.172 . . . . 75.42 110.63 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.4 ttt -58.09 -54.64 44.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.764 1.226 . . . . 60.24 111.392 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.3 -24.17 62.98 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.316 -0.402 . . . . 64.02 111.901 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 8' ' ' PHE . 8.8 m120 -88.12 -40.63 13.62 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.542 0.737 . . . . 72.32 112.264 -174.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 120' ' ' ILE . 29.5 m -66.8 -36.96 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 110.14 -0.318 . . . . 73.11 110.14 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.09 -31.23 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 122.438 0.295 . . . . 75.11 110.543 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.24 -52.93 61.81 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.853 0.461 . . . . 73.42 111.028 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -66.32 -38.29 87.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.913 -0.585 . . . . 73.41 111.391 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.636 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -67.26 -58.14 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.671 0.389 . . . . 74.4 110.741 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.13 -42.2 80.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.352 1.061 . . . . 53.13 112.337 -168.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -68.65 -22.09 64.42 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.094 0.558 . . . . 62.33 111.433 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -101.09 -17.95 16.45 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.278 0.631 . . . . 74.11 111.446 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -105.31 -52.17 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.061 0.545 . . . . 75.32 111.004 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 81.38 -21.45 0.31 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.457 1.503 . . . . 71.01 113.066 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -79.52 127.35 32.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.354 0.525 . . . . 63.3 110.516 -172.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -43.39 81.08 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 124.55 1.156 . . . . 62.4 112.454 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.03 -30.65 39.55 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.143 0.577 . . . . 74.22 112.52 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.06 -36.62 22.91 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.574 0.35 . . . . 55.22 110.542 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.636 HG12 ' SD ' ' A' ' 103' ' ' MET . 23.4 m -69.91 -29.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.729 0.299 . . . . 75.15 110.385 172.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.76 -31.82 68.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.679 0.791 . . . . 75.41 109.921 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 119' ' ' LYS . . . -67.2 -53.81 26.87 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.456 0.702 . . . . 61.05 109.689 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -55.82 -43.27 76.8 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 123.878 0.736 . . . . 73.44 110.465 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.37 -43.94 79.7 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 124.579 1.174 . . . . 74.55 111.181 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 74.54 110.204 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.465 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.5 mptm? -66.92 -45.2 78.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.204 0.602 . . . . 74.24 111.142 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 99' ' ' VAL . 10.8 tp -73.03 -39.15 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 122.794 0.438 . . . . 71.21 110.301 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -67.11 -44.79 79.04 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.217 0.607 . . . . 72.05 109.885 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.24 99.76 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.91 0.756 . . . . 61.44 111.887 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.521 ' HZ2' ' HB3' ' A' ' 170' ' ' MET . 34.1 t90 -63.11 -50.99 68.33 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.826 0.85 . . . . 72.33 110.434 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.8 m -68.62 -47.64 75.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 CA-C-O 118.9 -0.571 . . . . 62.12 111.019 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.8 m -62.1 -31.23 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.09 0.859 . . . . 64.12 111.509 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 m -76.37 -43.68 39.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.032 0.533 . . . . 61.25 111.219 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.8 tp -77.07 -33.86 57.07 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 123.237 0.615 . . . . 73.52 111.704 -170.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.3 mt -80.54 4.04 19.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.596 0.759 . . . . 72.24 112.248 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.67 108.38 0.73 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.916 0.886 . . . . 64.41 111.434 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.61 -5.49 40.69 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.745 1.017 . . . . 63.01 113.745 -170.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -97.45 -45.17 6.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.865 0.466 . . . . 72.23 111.151 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -100.4 -47.88 4.76 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.198 0.999 . . . . 72.32 110.508 -172.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 39.2 m-85 -86.24 -2.66 58.58 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.075 0.95 . . . . 63.24 112.402 -173.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -52.57 2.53 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.158 1.91 . . . . 65.31 116.158 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -83.3 17.31 2.13 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 71.32 110.82 167.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 87.6 mt -89.82 151.01 22.0 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.426 0.632 . . . . 63.11 110.489 175.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.32 119.36 17.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.109 -1.811 . . . . 60.14 106.109 169.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.424 ' HE1' ' SG ' ' A' ' 81' ' ' CYS . 91.1 m-85 -93.59 149.31 21.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.178 -1.045 . . . . 75.42 108.178 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.696 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . 82.3 m-85 -138.78 161.62 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.354 -0.609 . . . . 74.22 109.354 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.56 HD12 ' HE1' ' A' ' 91' ' ' TYR . 4.7 tt -136.4 143.29 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.648 -1.241 . . . . 61.54 107.648 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.72 150.47 49.84 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.525 0.516 . . . . 70.21 112.997 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.91 -47.84 52.0 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.495 1.518 . . . . 65.51 114.367 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -42.17 73.83 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.235 0.614 . . . . 73.12 110.684 -171.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.04 60.57 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.287 1.035 . . . . 73.24 110.872 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.46 -5.37 42.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.993 0.917 . . . . 64.32 112.583 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.83 -5.0 56.71 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.583 0.353 . . . . 75.13 111.028 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.67 42.94 1.28 Allowed Glycine 0 C--N 1.345 1.041 0 C-N-CA 122.876 0.274 . . . . 73.1 112.666 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.95 -67.48 0.85 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.104 -0.702 . . . . 63.03 109.104 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -159.16 173.37 16.5 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 74.05 109.558 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -54.96 -27.59 44.98 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.565 1.146 . . . . 71.15 112.547 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.85 -153.46 41.21 Favored Glycine 0 C--N 1.357 1.726 0 O-C-N 123.793 0.683 . . . . 60.31 111.446 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.578 ' HG3' HD22 ' A' ' 171' ' ' LEU . 50.3 tp60 -87.28 120.16 28.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.616 -0.883 . . . . 73.44 108.616 162.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.77 116.24 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 109.297 -0.631 . . . . 72.13 109.297 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 139' ' ' PHE . . . -76.65 99.97 5.21 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.159 -0.928 . . . . 70.12 110.494 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -91.47 108.58 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.476 -0.784 . . . . 74.51 109.628 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 49.9 mm -99.0 109.63 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.667 0.387 . . . . 74.35 110.71 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.491 ' HA ' HD23 ' A' ' 136' ' ' LEU . 45.7 tt0 -86.94 107.41 18.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.317 -0.623 . . . . 73.2 109.317 171.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -75.0 87.91 2.36 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.378 -1.341 . . . . 72.4 107.378 169.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.532 ' HB3' HG23 ' A' ' 166' ' ' VAL . 8.0 tpt180 -85.92 119.83 26.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.048 -0.978 . . . . 74.24 108.62 -170.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.73 97.62 10.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.758 0.423 . . . . 71.25 109.957 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.402 HG13 ' HB ' ' A' ' 164' ' ' THR . 3.8 p -96.41 97.64 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.606 0.763 . . . . 73.01 109.306 173.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 64.7 17.38 10.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.415 1.086 . . . . 73.2 112.916 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 115.5 -10.13 19.47 Favored Glycine 0 N--CA 1.475 1.245 0 CA-C-O 120.156 -0.247 . . . . 72.01 113.335 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.402 ' HB ' HG13 ' A' ' 161' ' ' VAL . 19.4 m -97.38 128.61 44.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.332 0.653 . . . . 62.31 109.974 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.52 120.85 22.3 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.422 -0.955 . . . . 72.1 108.422 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 159' ' ' ARG . 12.4 m -115.88 95.72 44.89 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.624 -1.25 . . . . 73.24 107.624 171.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 123.91 14.97 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.451 2.767 . . . . 71.43 112.366 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.5 m -117.89 110.45 17.76 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.569 -0.901 . . . . 62.13 108.569 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 62.8 tp -76.24 117.43 17.92 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.633 -0.877 . . . . 71.31 108.633 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.521 ' HB3' ' HZ2' ' A' ' 123' ' ' TRP . 63.5 mtt -112.26 120.92 43.41 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.957 -1.127 . . . . 74.25 107.957 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.578 HD22 ' HG3' ' A' ' 152' ' ' GLN . 78.5 mt -131.73 145.49 51.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.017 -1.475 . . . . 75.31 107.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.433 HG12 ' OE1' ' A' ' 152' ' ' GLN . 14.7 p -82.67 137.91 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.796 -0.816 . . . . 74.44 108.796 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -57.18 -22.19 38.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.858 1.263 . . . . 72.02 111.687 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.427 ' H ' HG22 ' A' ' 172' ' ' VAL . 8.5 tp10 -78.48 -36.91 44.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.4 0.519 . . . . 74.14 112.4 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -97.64 -0.78 45.03 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.738 0.304 . . . . 72.03 110.597 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 41.3 mm -121.96 133.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 C-N-CA 124.131 0.972 . . . . 73.01 109.337 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.3 mm -99.0 109.73 24.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.418 -0.956 . . . . 74.24 108.418 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -95.68 123.45 39.25 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.464 -1.31 . . . . 72.1 107.464 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.597 ' HG3' ' HB ' ' A' ' 3' ' ' ILE . 8.1 pt-20 -146.98 125.04 12.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.218 -0.66 . . . . 63.12 109.218 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -81.49 95.81 7.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.59 -0.732 . . . . 64.43 109.324 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.37 88.8 6.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.38 -0.97 . . . . 74.14 108.38 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 67.1 mt -71.46 143.14 50.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.233 -0.894 . . . . 72.54 109.909 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.773 -0.632 . . . . 75.03 109.468 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.669 -0.493 . . . . 73.54 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.27 161.59 20.15 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.575 -0.898 . . . . 62.11 108.575 173.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.44 HD11 ' HD3' ' A' ' 5' ' ' LYS . 12.7 tt -133.66 118.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 53.13 109.802 172.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 177' ' ' ILE . 21.5 p90 -122.58 124.09 42.7 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.899 -1.148 . . . . 73.13 107.899 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 22.2 pttp -153.29 171.24 18.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.381 0.673 . . . . 63.43 109.995 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -105.09 142.77 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 61.51 108.812 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.406 HG22 HG12 ' A' ' 177' ' ' ILE . 22.1 pt -79.68 -9.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.293 0.637 . . . . 64.45 112.603 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -107.76 -60.21 1.74 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.708 0.29 . . . . 74.44 111.657 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.411 HG23 ' HA3' ' A' ' 151' ' ' GLY . 1.2 p -125.32 -49.49 1.68 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.837 0.68 . . . . 75.14 112.837 -164.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -87.31 21.84 2.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 63.31 111.181 -172.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.549 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 16.7 t70 -48.24 -21.68 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.013 1.325 . . . . 72.25 112.814 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.95 25.33 2.14 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.823 1.249 . . . . 72.5 112.722 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 10' ' ' ASP . 40.9 mt -62.99 -92.3 0.0 OUTLIER 'General case' 0 C--N 1.371 1.542 0 CA-C-N 119.128 0.877 . . . . 75.13 110.378 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 68.1 m -154.65 129.97 9.73 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.994 0.815 . . . . 55.03 112.258 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.7 t -109.67 81.93 1.51 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.224 1.009 . . . . 65.31 108.795 163.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -162.2 166.92 24.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.083 0.953 . . . . 71.15 109.301 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.3 80.91 0.74 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.595 0.712 . . . . 71.03 110.93 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 61.7 m-85 -114.2 139.65 24.02 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.913 1.285 . . . . 75.44 108.98 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 16.5 Cg_exo -68.45 119.86 6.84 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.488 2.125 . . . . 43.52 112.092 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.08 144.13 27.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.637 0.775 . . . . 73.53 109.786 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.19 146.74 47.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.969 -0.752 . . . . 74.05 108.969 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.73 138.67 53.88 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.882 -0.785 . . . . 72.43 108.882 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.35 128.43 63.89 Favored 'Isoleucine or valine' 0 C--O 1.266 1.932 0 N-CA-C 109.001 -0.74 . . . . 61.22 109.001 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 72.78 -85.53 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.933 1.693 . . . . 62.32 108.741 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.5 t70 172.14 28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.575 1.95 . . . . 44.52 106.788 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 tp -135.15 -52.16 0.78 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.485 -0.779 . . . . 63.35 110.712 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.1 t -118.21 131.28 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.088 -0.505 . . . . 55.14 109.783 -168.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -83.62 135.49 34.58 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.122 -1.066 . . . . 64.11 108.122 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.87 155.76 47.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.42 0.629 . . . . 70.45 110.673 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.3 t80 -139.99 147.86 41.05 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.14 -0.936 . . . . 74.32 109.259 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.58 154.02 39.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.712 0.805 . . . . 72.31 111.892 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 156.46 28.42 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.722 -0.275 . . . . 75.02 112.858 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -154.37 159.24 41.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.836 0.854 . . . . 64.22 109.935 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -70.21 120.41 15.86 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.371 -0.603 . . . . 71.12 109.371 169.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.75 168.11 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.896 1.278 . . . . 53.02 108.473 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.97 145.32 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.722 -0.844 . . . . 64.14 108.722 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.758 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 27.2 mmt180 -134.33 109.16 8.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.06 -1.83 . . . . 72.35 106.06 174.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -133.07 97.32 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.761 -0.459 . . . . 73.41 109.761 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 39.95 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 126.616 1.966 . . . . 74.3 115.132 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.75 49.77 0.82 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.787 -0.925 . . . . 50.13 110.787 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -170.78 152.55 3.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.551 1.141 . . . . 73.14 109.0 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tt -156.65 105.73 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.601 0.76 . . . . 64.41 109.694 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -138.59 110.46 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.931 0.892 . . . . 64.23 109.258 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.18 7.05 16.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.918 0.887 . . . . 74.0 110.935 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.09 87.1 0.76 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.253 0.621 . . . . 44.21 109.815 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.36 5.56 4.13 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.78 -0.645 . . . . 52.55 112.839 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.3 p -71.37 90.19 0.94 Allowed 'General case' 0 C--O 1.245 0.851 0 N-CA-C 109.313 -0.625 . . . . 74.4 109.313 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -55.7 125.38 61.07 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.287 1.435 . . . . 71.3 111.048 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.15 104.88 0.12 Allowed 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 122.968 2.445 . . . . 74.52 111.392 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.4 m -81.38 28.02 0.4 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.183 0.993 . . . . 75.22 113.105 -166.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.34 -44.85 72.47 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.298 1.039 . . . . 72.23 110.948 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -137.41 92.5 2.71 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.155 -1.054 . . . . 60.41 108.155 168.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -104.04 -19.45 14.19 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.282 -0.872 . . . . 64.23 109.698 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.54 141.06 6.54 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 109.398 -1.481 . . . . 64.55 109.398 -169.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.45 72.57 4.98 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.702 0.801 . . . . 74.13 110.096 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -164.26 56.66 0.15 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 121.689 0.757 . . . . 63.24 109.901 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.98 139.64 50.63 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.7 -0.682 . . . . 74.13 109.692 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -146.47 93.74 2.34 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.084 -1.08 . . . . 73.42 108.084 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.31 50.23 3.58 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.781 -0.528 . . . . 54.43 111.781 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 27.6 t -86.12 45.14 1.19 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.245 1.018 . . . . 74.35 109.576 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -152.85 66.85 0.8 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.986 1.314 . . . . 62.02 108.462 -173.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.72 -24.03 63.5 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.689 -1.141 . . . . 71.02 111.409 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -88.74 5.86 41.39 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.745 0.818 . . . . 65.15 111.727 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.6 t -123.39 93.89 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.008 -1.108 . . . . 64.13 108.008 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.758 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 3.3 mp0 -72.58 80.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.81 -0.811 . . . . 75.03 108.81 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.37 146.54 24.32 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.084 0.954 . . . . 70.14 109.416 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.65 -143.93 15.07 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.551 -1.019 . . . . 64.3 110.551 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 167' ' ' PRO . 0.8 OUTLIER -83.7 122.04 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 117.595 0.698 . . . . 64.13 109.413 -175.274 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.44 -47.52 9.91 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.756 2.022 . . . . 61.41 113.824 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' A' ' 169' ' ' LEU . 66.4 mt -51.81 -48.45 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.82 1.248 . . . . 63.31 110.457 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.51 HG13 ' HB2' ' A' ' 76' ' ' LEU . 56.0 t -70.56 -41.55 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.816 -1.084 . . . . 65.44 111.75 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 43.8 mt -64.08 -39.77 94.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.564 0.746 . . . . 61.44 111.341 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.25 -38.14 63.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.966 0.906 . . . . 72.22 111.128 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.49 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 28.5 m170 -92.07 -11.97 34.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.371 0.669 . . . . 72.43 111.555 -172.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 28.0 mtpp 62.44 46.7 5.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.897 1.279 . . . . 70.21 111.137 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.51 ' HB2' HG13 ' A' ' 71' ' ' VAL . 63.1 mt -80.43 130.79 35.39 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.376 -0.602 . . . . 74.24 109.376 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.8 135.42 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.214 -0.661 . . . . 70.45 109.214 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.45 148.01 24.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 63.22 113.325 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -146.64 103.54 3.67 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 106.307 -1.738 . . . . 74.23 106.307 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -92.6 118.12 30.69 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.931 -0.766 . . . . 75.45 108.931 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.4 p -63.64 -27.85 69.51 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.907 0.483 . . . . 74.21 111.188 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -68.03 -41.62 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.619 -1.173 . . . . 74.34 111.582 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.16 -22.88 13.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.628 0.771 . . . . 64.43 111.998 -170.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -116.66 21.0 13.73 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.456 1.102 . . . . 31.13 110.753 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.97 13.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.89 1.276 . . . . 54.1 113.779 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.9 m -61.45 -56.72 17.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.588 0.755 . . . . 61.23 111.26 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.6 mtp -59.92 -36.71 77.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.882 0.473 . . . . 44.13 111.072 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.42 -39.29 91.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.0 0.52 . . . . 63.4 111.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.06 -38.54 89.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.007 0.523 . . . . 74.12 109.974 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.38 94.11 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.072 -0.967 . . . . 61.52 110.739 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' O ' ' HB3' ' A' ' 95' ' ' PHE . 54.2 m-85 -59.28 -50.4 74.15 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 119.0 -0.524 . . . . 73.41 111.107 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mm -55.65 -44.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.453 0.701 . . . . 74.22 111.886 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -64.4 -56.2 15.9 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.099 0.56 . . . . 74.33 109.722 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -65.11 -55.85 16.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.537 0.523 . . . . 64.05 110.069 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 8.4 t80 -45.34 -61.13 1.79 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.325 1.45 . . . . 72.51 112.962 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.6 ttt -64.19 -41.27 97.15 Favored 'General case' 0 C--O 1.248 0.984 0 O-C-N 123.415 0.447 . . . . 74.42 111.449 -171.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -62.66 -41.35 99.01 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.139 -0.482 . . . . 74.11 110.683 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.44 -48.62 74.63 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.044 0.84 . . . . 74.33 111.373 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.57 ' O ' ' HG2' ' A' ' 103' ' ' MET . 29.2 m -62.24 -48.75 86.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.565 0.541 . . . . 75.14 110.433 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.473 HD13 ' HG3' ' A' ' 117' ' ' LYS . 47.0 mt -69.73 -43.01 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 O-C-N 123.308 0.38 . . . . 64.44 110.953 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.06 -37.83 81.04 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.732 0.813 . . . . 71.11 111.877 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -70.84 -41.23 71.76 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.83 0.706 . . . . 64.55 110.608 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.57 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 79.4 mmm -64.81 -36.52 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.079 -0.712 . . . . 75.25 109.079 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.45 -37.54 71.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.129 1.371 . . . . 74.43 110.462 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 -12.82 60.18 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 73.23 111.194 -175.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -104.37 -6.02 21.17 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.211 1.005 . . . . 75.33 109.801 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 47.02 77.29 0.09 Allowed 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.13 1.772 . . . . 71.31 112.225 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -61.12 -36.24 79.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.438 -0.801 . . . . 65.13 108.88 166.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 112' ' ' ASP . 21.5 t70 152.06 147.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 128.503 2.721 . . . . 74.41 106.063 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -58.0 -51.88 67.84 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.684 0.794 . . . . 62.52 110.99 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.28 -22.37 61.96 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.761 -0.654 . . . . 54.33 111.547 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 109' ' ' ASP . 20.9 t70 -80.28 -42.55 22.89 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.107 0.563 . . . . 64.13 111.017 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.21 -27.66 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.965 0.506 . . . . 71.53 110.278 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.29 -36.1 63.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.822 0.849 . . . . 65.43 110.856 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.43 -40.94 76.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.229 0.612 . . . . 64.11 110.147 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -64.62 -40.03 94.76 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.0 0.92 . . . . 72.24 109.588 172.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HG3' HD13 ' A' ' 100' ' ' ILE . 29.1 ttpp -63.56 -33.16 74.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.464 0.705 . . . . 44.02 110.721 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -74.93 -39.22 61.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.566 0.746 . . . . 72.31 110.819 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -66.85 -46.9 73.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 61.01 111.447 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.01 -32.47 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.182 0.593 . . . . 72.4 109.624 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -62.36 -48.09 81.32 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 122.892 0.477 . . . . 44.33 110.008 172.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.67 98.74 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 124.454 1.096 . . . . 44.04 112.403 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -65.39 -48.95 71.12 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.204 0.602 . . . . 75.44 110.191 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -70.2 -41.81 78.91 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.462 0 CA-C-O 118.216 -0.897 . . . . 62.01 111.133 -174.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 m -71.88 -21.5 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 120.061 1.3 . . . . 74.44 111.507 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.2 t -73.72 -43.24 59.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.246 0.546 . . . . 72.01 109.605 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.524 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 34.7 tp -73.04 -36.0 66.84 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.459 1.103 . . . . 71.22 111.405 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.498 ' HA ' ' CE1' ' A' ' 133' ' ' PHE . 77.0 mt -79.83 4.02 17.85 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.587 1.155 . . . . 53.25 112.684 -171.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.13 141.56 49.14 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.486 -0.561 . . . . 62.01 109.486 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 99.8 mttt -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.561 0.745 . . . . 71.24 111.715 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.28 -16.41 63.01 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.816 0.846 . . . . 70.01 110.64 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.524 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 8.9 tpt180 -96.9 -41.59 8.35 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.324 1.049 . . . . 64.03 109.188 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.65 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.7 m-85 -62.82 -12.85 27.27 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.742 1.217 . . . . 64.33 113.146 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -50.21 -30.31 11.25 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.878 0.736 . . . . 75.44 112.618 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 32.2 p30 -131.4 17.87 4.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.704 0.801 . . . . 63.44 112.177 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 26.1 mt -96.12 128.94 43.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.201 0.525 . . . . 74.2 111.381 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.79 139.08 54.18 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 105.362 -2.088 . . . . 64.13 105.362 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.478 ' HB3' HG11 ' A' ' 153' ' ' VAL . 98.1 m-85 -116.0 148.03 40.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.501 -0.926 . . . . 63.25 108.501 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -146.56 136.4 23.3 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 107.716 -1.216 . . . . 71.15 107.716 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -127.57 148.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.044 -1.095 . . . . 74.01 108.044 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -51.85 145.49 15.16 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.343 0.497 . . . . 75.2 114.343 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 10.9 tp10 -52.05 -54.97 23.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.743 0.817 . . . . 60.24 111.107 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -72.15 -15.28 61.97 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.898 0.879 . . . . 72.42 111.567 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.96 -34.88 43.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.586 0.755 . . . . 20.41 110.445 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.45 7.57 4.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.078 0.951 . . . . 73.31 112.032 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -73.48 -20.32 60.71 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.861 0.864 . . . . 52.1 109.813 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.01 30.32 0.81 Allowed Glycine 0 C--N 1.356 1.647 0 C-N-CA 123.739 0.685 . . . . 74.42 112.363 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.85 90.27 5.28 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 63.21 110.367 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.35 163.27 25.52 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.026 0.931 . . . . 73.24 112.391 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 79.97 7.34 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.769 1.628 . . . . 64.35 111.495 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.411 ' HA3' HG23 ' A' ' 9' ' ' THR . . . -95.64 -177.61 36.86 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 116.137 1.215 . . . . 53.32 116.137 -170.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -111.95 152.27 28.25 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.825 1.65 . . . . 70.13 109.866 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 138' ' ' PHE . 92.7 t -108.22 136.04 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.935 0.894 . . . . 65.43 108.632 173.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -64.62 114.44 4.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.098 0.959 . . . . 51.1 110.27 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 61.3 mt -87.03 107.67 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.99 0.916 . . . . 71.45 108.864 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.48 121.56 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 72.3 110.092 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.62 98.2 7.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.264 1.426 . . . . 71.22 108.974 -166.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 135' ' ' ASN . 57.5 m-85 -82.86 118.65 23.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.761 0.424 . . . . 74.53 110.705 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -125.31 -179.32 4.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.101 0.96 . . . . 75.42 109.436 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -123.86 110.83 15.35 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.215 0.606 . . . . 61.25 110.941 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.95 102.12 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.226 1.01 . . . . 64.5 108.31 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.95 31.55 19.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.239 1.016 . . . . 74.45 110.841 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.57 65.63 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.044 -0.525 . . . . 72.43 113.817 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.7 m -90.42 131.39 36.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.202 0.601 . . . . 74.3 109.841 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -71.14 123.11 21.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.509 0.724 . . . . 72.22 109.979 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.96 102.49 31.4 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.492 1.117 . . . . 51.5 110.21 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 68' ' ' ILE . 72.3 Cg_endo -85.83 118.33 1.77 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.79 2.327 . . . . 70.03 112.236 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.1 m -103.78 141.91 35.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.991 0.916 . . . . 54.42 109.991 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.683 ' HB2' HD13 ' A' ' 70' ' ' ILE . 46.4 tp -77.22 130.35 37.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.086 -1.079 . . . . 72.33 108.086 171.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.432 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 33.2 tpp -131.4 122.48 26.39 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.863 -1.532 . . . . 74.44 106.863 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 154' ' ' ALA . 48.8 mt -159.76 145.65 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.696 1.198 . . . . 74.41 108.107 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 176' ' ' ILE . 14.6 p -80.24 134.43 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.355 0.98 . . . . 64.32 109.795 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -55.27 -30.39 60.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.869 1.268 . . . . 62.33 112.975 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -71.13 -25.99 62.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.264 0.625 . . . . 74.22 111.713 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.01 -1.5 42.5 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.997 0.519 . . . . 43.25 111.008 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.438 HD11 HD13 ' A' ' 171' ' ' LEU . 42.7 mm -112.5 138.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.039 0.535 . . . . 73.33 110.703 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 38.0 mm -96.62 109.46 23.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 105.96 -1.867 . . . . 70.4 105.96 167.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.6 99.29 6.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.599 -1.63 . . . . 75.21 106.599 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -126.75 155.72 42.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.011 0.924 . . . . 72.51 110.081 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 180' ' ' LYS . 7.6 ptpt -106.63 113.74 27.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.262 1.025 . . . . 73.23 109.725 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 46.7 m -95.88 91.15 5.89 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.462 -0.79 . . . . 71.41 109.085 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.64 168.81 18.87 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.013 0.525 . . . . 63.45 110.584 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.056 0 N-CA-C 108.853 -0.795 . . . . 74.14 108.853 -178.22 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.854 -0.424 . . . . 75.52 109.854 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.73 130.64 53.17 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.927 0.491 . . . . 64.42 111.538 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 tt -99.15 118.92 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 N-CA-C 107.662 -1.236 . . . . 61.0 107.662 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -125.11 115.1 19.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.426 0.69 . . . . 72.1 110.902 -163.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 1.5 mptp? -121.3 153.14 38.11 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.49 0.716 . . . . 63.22 110.57 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.35 148.63 22.19 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.454 -0.943 . . . . 75.41 108.454 159.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 175' ' ' ALA . 47.2 pt -83.27 -24.58 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 112.563 0.579 . . . . 73.41 112.563 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -86.99 -64.0 1.22 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.796 0.665 . . . . 74.33 112.796 -169.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 144' ' ' ALA . 6.3 m -132.3 -34.73 1.21 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.877 0.695 . . . . 65.25 112.877 -172.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -92.5 21.79 5.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.941 1.296 . . . . 65.5 110.934 -164.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -46.78 -28.27 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.556 1.542 . . . . 53.14 112.891 -172.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.93 26.26 1.87 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.763 0.825 . . . . 72.32 112.596 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 10' ' ' ASP . 18.2 mt -44.93 -93.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.974 1.31 . . . . 74.34 112.557 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.3 m -156.28 152.26 27.48 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.965 -0.46 . . . . 54.3 110.917 -167.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -140.13 98.81 3.52 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.144 -1.058 . . . . 64.12 108.144 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -161.5 -176.2 5.21 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 110.267 -0.271 . . . . 73.33 110.267 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -68.33 92.82 0.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.36 1.064 . . . . 71.21 110.097 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HB3' ' HE2' ' A' ' 30' ' ' PHE . 41.2 m-85 -109.29 139.5 21.11 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 123.486 0.714 . . . . 75.11 111.18 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.36 119.08 6.05 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.197 1.931 . . . . 74.53 110.872 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.0 ttp -126.42 123.2 37.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.469 -0.787 . . . . 73.0 109.184 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.59 131.03 22.32 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.892 -1.521 . . . . 74.25 106.892 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.7 tp -101.77 124.06 46.77 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.81 -0.811 . . . . 72.03 108.81 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.39 140.05 38.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 124.424 1.089 . . . . 70.01 108.551 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 64.29 12.99 7.63 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.006 0.922 . . . . 73.45 112.453 173.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 58.38 21.84 8.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.31 1.044 . . . . 71.2 111.966 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.3 tp -130.74 -52.83 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.758 0.423 . . . . 61.13 110.686 -167.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -117.56 141.61 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.395 0.678 . . . . 45.42 111.239 -167.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 178' ' ' GLU . 46.6 m-85 -88.7 118.15 28.17 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.128 0.971 . . . . 74.45 109.936 168.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -85.69 104.41 15.38 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.462 -1.245 . . . . 73.2 107.885 167.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.7 t80 -100.58 106.81 18.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.419 -1.326 . . . . 74.24 107.419 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.83 154.36 27.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.103 0.477 . . . . 65.3 110.964 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.01 -172.2 23.96 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.094 -0.802 . . . . 72.31 111.094 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -135.21 137.34 42.54 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.468 0.634 . . . . 63.23 110.717 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -74.18 118.67 17.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.796 0.839 . . . . 74.11 109.198 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.567 ' HB ' HD11 ' A' ' 42' ' ' ILE . 12.6 m -141.63 168.67 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.705 1.202 . . . . 65.2 110.69 -165.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.97 114.01 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.765 0.793 . . . . 70.33 109.235 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.803 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 35.8 ttm180 -92.71 111.04 22.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.282 -1.007 . . . . 70.42 108.282 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -120.81 149.31 42.77 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.083 0.953 . . . . 75.34 109.361 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -72.45 81.83 1.07 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.728 -0.841 . . . . 65.23 108.728 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.83 -62.19 0.18 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 114.365 -1.289 . . . . 73.23 110.259 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -172.17 157.95 4.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.634 0.774 . . . . 75.54 110.163 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' A' ' 35' ' ' VAL . 6.5 tp -75.33 84.76 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 108.092 -1.077 . . . . 73.14 108.092 169.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.6 -25.53 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.245 -0.888 . . . . 72.41 112.787 -168.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 60.67 88.36 0.08 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.825 0.85 . . . . 64.11 110.112 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.47 4.23 11.19 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.301 1.04 . . . . 71.11 111.081 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.71 -107.57 1.92 Allowed Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.589 0.614 . . . . 62.33 113.373 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.8 m -133.15 96.9 3.85 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.168 0.987 . . . . 73.42 109.638 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -67.83 157.55 86.19 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.173 0.989 . . . . 72.13 110.932 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.6 84.9 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.326 2.018 . . . . 70.21 111.981 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -151.57 107.94 3.46 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.2 1.4 . . . . 71.53 108.116 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.04 -174.21 3.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.623 0.769 . . . . 62.01 110.968 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -77.25 85.17 3.7 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.301 0.572 . . . . 73.11 110.477 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.01 22.91 0.66 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.824 -1.08 . . . . 74.33 110.315 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 174.8 153.83 10.46 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.735 -0.546 . . . . 51.41 111.735 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.55 -1.15 44.59 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.04 0.936 . . . . 53.43 111.591 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.11 103.46 15.95 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.929 0.892 . . . . 71.11 111.191 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -91.09 133.78 35.05 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.223 -0.658 . . . . 73.32 109.223 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -111.51 22.3 15.23 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.583 0.753 . . . . 70.25 110.795 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.06 36.25 18.85 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 110.926 -0.87 . . . . 64.44 110.926 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.5 p -145.53 -57.12 0.32 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.834 0.854 . . . . 55.14 110.393 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.32 -33.4 74.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.238 1.015 . . . . 60.21 111.965 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -129.96 7.37 5.12 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.45 1.1 . . . . 74.15 110.927 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -128.71 -2.6 5.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.083 0.553 . . . . 74.13 112.461 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.99 100.36 2.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 106.346 -1.724 . . . . 65.31 106.346 161.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 13.2 mm-40 -75.74 69.41 2.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.032 -1.099 . . . . 73.23 108.032 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -82.28 122.26 27.72 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.552 -1.204 . . . . 74.51 108.026 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.78 -164.82 37.64 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.057 -1.617 . . . . 74.34 109.057 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 70' ' ' ILE . 37.2 pt -96.65 148.82 5.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 117.471 0.636 . . . . 72.15 110.33 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.69 -30.85 63.87 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.746 1.218 . . . . 71.11 112.312 -174.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 68' ' ' ILE . 61.1 mt -56.52 -51.24 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.022 1.329 . . . . 75.01 110.613 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.674 HG13 ' HB2' ' A' ' 76' ' ' LEU . 47.2 t -78.65 -44.11 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 114.451 -1.25 . . . . 52.03 111.21 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.58 -18.17 65.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.666 0.786 . . . . 72.42 112.089 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -48.52 -58.52 4.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.331 1.052 . . . . 53.22 110.681 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.04 -7.72 16.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.819 -0.628 . . . . 64.43 112.598 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttp 62.21 69.88 0.6 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.558 1.161 . . . . 73.34 109.052 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.674 ' HB2' HG13 ' A' ' 71' ' ' VAL . 64.3 mt -75.16 157.03 35.27 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.54 -0.755 . . . . 64.42 109.57 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.51 127.84 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.276 -0.638 . . . . 75.12 109.276 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.87 152.07 20.19 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.939 0.876 . . . . 73.52 112.887 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 86.0 mmm -143.83 137.22 27.82 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 104.72 -2.326 . . . . 60.15 104.72 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 140.42 35.64 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.327 0.512 . . . . 71.22 109.788 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 134' ' ' LYS . 24.9 p -58.96 -14.81 10.28 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.504 0.722 . . . . 55.34 112.907 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -66.3 -59.09 4.04 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.4 0.68 . . . . 75.54 112.197 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -98.21 -38.24 9.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.846 0.458 . . . . 73.14 110.728 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -92.5 21.59 5.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.622 0.769 . . . . 73.34 112.681 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.2 -53.2 29.67 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.759 0.824 . . . . 50.41 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 m -72.84 -37.72 67.34 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.774 0.83 . . . . 73.14 111.6 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.5 mpt? -66.5 -45.87 78.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.237 1.015 . . . . 60.3 110.3 -176.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 36.2 t80 -63.38 -47.18 83.12 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.376 -1.284 . . . . 75.43 111.236 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 37.1 ttmt -65.39 -28.83 69.54 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.349 0.405 . . . . 62.52 110.701 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.55 93.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.425 0.69 . . . . 65.43 110.7 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 31.2 m-85 -61.09 -40.04 92.24 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 115.961 -0.563 . . . . 73.22 111.115 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.407 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 42.0 mm -65.19 -32.54 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.731 0.812 . . . . 72.32 111.675 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 89' ' ' LYS . 96.4 mttt -61.53 -47.45 85.51 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.066 0.547 . . . . 65.0 111.437 171.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -66.91 -42.28 85.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.098 0.559 . . . . 75.44 110.675 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.465 ' O ' HG13 ' A' ' 99' ' ' VAL . 79.0 t80 -51.86 -60.79 2.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.117 1.767 . . . . 63.01 111.035 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.9 ttp -61.04 -40.92 95.45 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.731 0.645 . . . . 64.34 111.018 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -56.02 -55.73 29.27 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.214 0.606 . . . . 74.42 110.684 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -72.27 -36.68 69.06 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.496 0.498 . . . . 62.35 111.854 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 95' ' ' PHE . 18.1 m -67.77 -38.78 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.432 0.53 . . . . 63.12 112.432 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.05 -35.93 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 121.001 0.429 . . . . 74.11 110.529 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.78 -47.83 84.54 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.074 0.95 . . . . 71.22 110.765 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -66.56 -44.34 82.58 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.617 -1.174 . . . . 50.33 110.061 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.5 ' HG3' HG12 ' A' ' 113' ' ' VAL . 15.4 tpt -55.53 -53.35 57.52 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.118 0.886 . . . . 71.4 111.724 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.435 ' HA ' HG11 ' A' ' 113' ' ' VAL . 41.1 tt0 -65.2 -27.09 68.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.568 0.542 . . . . 73.2 111.579 -172.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.58 -45.28 76.01 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.201 0.524 . . . . 75.12 110.616 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -83.82 -29.54 27.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.081 0.953 . . . . 72.41 111.388 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -99.57 -50.66 4.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.632 0.773 . . . . 72.53 109.938 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 73.29 -13.3 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.146 1.379 . . . . 62.22 113.611 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.22 122.6 33.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.564 -0.902 . . . . 75.32 108.564 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.07 -37.48 85.91 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.189 0.596 . . . . 64.11 112.591 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.8 -30.26 66.68 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.611 0.364 . . . . 74.04 111.834 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.08 -30.92 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.598 0.359 . . . . 70.11 110.317 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.5 HG12 ' HG3' ' A' ' 103' ' ' MET . 27.0 m -80.65 -25.68 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 121.903 0.081 . . . . 52.04 110.974 173.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.25 -39.29 94.19 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.649 0.779 . . . . 72.31 109.64 167.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.31 -40.87 67.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.688 -1.142 . . . . 73.01 110.435 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -63.37 -44.95 93.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.805 0.442 . . . . 74.4 111.188 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -65.58 -35.75 81.74 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.904 -0.406 . . . . 63.45 109.904 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.28 -36.89 85.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.929 0.892 . . . . 72.23 111.045 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.44 -52.84 22.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.236 0.614 . . . . 51.34 110.633 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 99' ' ' VAL . 8.5 tp -73.89 -40.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.164 0.29 . . . . 75.15 110.986 -169.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -68.18 -35.27 77.75 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.283 -0.636 . . . . 74.45 109.283 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.19 94.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.643 -0.708 . . . . 54.53 113.342 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -66.33 -47.89 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.903 -0.776 . . . . 73.11 108.903 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.0 m -74.49 -30.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-N 115.582 -0.736 . . . . 70.44 111.88 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.47 -25.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 119.118 0.872 . . . . 73.15 110.068 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -81.77 -42.2 20.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.022 0.529 . . . . 74.41 111.232 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.499 HD21 HG21 ' A' ' 155' ' ' ILE . 54.7 tp -79.31 -23.95 43.17 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.124 0.969 . . . . 72.43 112.118 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 41.3 mt -93.4 4.4 54.03 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.841 0.456 . . . . 72.14 111.63 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 99.75 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.331 0.652 . . . . 74.22 111.141 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 13.4 ptmm? -51.68 -39.8 58.93 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.863 1.801 . . . . 74.51 115.863 -162.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.31 -29.53 66.28 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.891 0.7 . . . . 74.41 112.891 -163.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -111.51 -29.75 7.64 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.401 0.519 . . . . 51.41 112.401 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.48 -2.22 58.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.495 0.924 . . . . 64.33 113.495 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.444 ' HG3' ' SG ' ' A' ' 81' ' ' CYS . 26.5 ttpp -51.07 -24.63 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 112.546 0.573 . . . . 65.43 112.546 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.15 25.94 3.99 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.152 0.981 . . . . 75.53 111.66 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.08 142.07 28.19 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.424 -0.954 . . . . 74.43 108.424 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.28 110.51 22.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.341 -1.355 . . . . 55.55 107.341 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.36 143.11 26.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.717 -1.216 . . . . 71.35 107.717 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -137.48 137.38 38.63 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.765 -0.828 . . . . 61.54 108.765 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 tt -109.9 148.15 13.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.355 0 N-CA-C 106.73 -1.582 . . . . 72.12 106.73 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.634 ' HA2' HD22 ' A' ' 76' ' ' LEU . . . -48.37 130.48 20.23 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 124.386 1.053 . . . . 71.04 112.766 175.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 11.0 tp10 -56.98 -38.28 72.79 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.21 0.604 . . . . 73.13 110.923 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -71.54 -35.25 70.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.959 0.904 . . . . 73.14 109.259 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 9' ' ' THR . . . -65.12 -42.76 93.62 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.255 -0.884 . . . . 63.3 110.628 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -19.52 65.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.287 0.635 . . . . 73.13 112.593 -176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 49.8 mt-10 -79.75 -23.12 42.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.942 0.497 . . . . 63.23 111.928 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.86 49.06 0.08 OUTLIER Glycine 0 C--N 1.348 1.243 0 C-N-CA 121.288 -0.482 . . . . 71.22 113.867 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.96 98.53 0.29 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.858 0.863 . . . . 72.34 110.731 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.57 14.39 4.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.479 0.711 . . . . 65.11 111.221 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.61 -3.78 29.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.281 1.032 . . . . 75.24 111.006 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.68 163.83 35.74 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.891 0.744 . . . . 73.31 114.871 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -78.77 141.62 37.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.043 0.937 . . . . 71.34 112.479 -172.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.05 111.03 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 123.347 0.659 . . . . 63.31 110.028 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.521 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.54 111.36 5.32 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.849 -1.069 . . . . 34.34 108.78 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.499 HG21 HD21 ' A' ' 127' ' ' LEU . 63.0 mt -92.77 124.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.44 -0.948 . . . . 75.23 108.44 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 68' ' ' ILE . 49.7 mm -109.39 111.29 35.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 109.362 -0.607 . . . . 75.51 109.362 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.26 116.15 26.26 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.726 0.641 . . . . 74.13 109.831 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -69.86 88.54 0.56 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.669 1.187 . . . . 74.35 109.304 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -94.65 134.06 37.63 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.149 -0.97 . . . . 71.02 109.816 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.4 102.71 15.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.909 0.484 . . . . 55.33 110.109 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.8 p -90.19 92.31 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 N-CA-C 108.295 -1.002 . . . . 72.31 108.295 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.68 -66.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.914 1.685 . . . . 54.23 111.514 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -163.89 29.05 0.23 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.764 -0.934 . . . . 75.3 110.764 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 98.5 m -135.73 148.08 48.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.583 1.153 . . . . 54.41 108.032 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.53 136.44 36.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.286 0.494 . . . . 73.33 110.054 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.29 112.75 18.22 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.342 1.057 . . . . 73.02 108.271 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 115.4 3.62 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.183 1.922 . . . . 53.42 111.666 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.4 p -111.35 108.66 18.32 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.095 -1.076 . . . . 51.44 108.095 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 19.5 tp -75.96 120.37 21.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.719 0.807 . . . . 71.33 109.538 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.5 mtt -100.1 122.2 42.6 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 123.783 0.833 . . . . 73.45 109.117 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.534 HD13 HD11 ' A' ' 176' ' ' ILE . 42.6 mt -141.07 140.16 34.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.353 1.461 . . . . 73.45 107.487 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 99' ' ' VAL . 10.5 p -81.77 147.59 6.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.395 -0.594 . . . . 62.44 109.395 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -51.06 -44.93 61.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.813 1.245 . . . . 64.43 112.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -82.29 3.65 26.83 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.419 0.896 . . . . 74.31 113.419 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 7' ' ' ILE . . . -105.93 -5.0 19.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.212 0.605 . . . . 33.11 111.474 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.534 HD11 HD13 ' A' ' 171' ' ' LEU . 48.2 mm -122.79 143.97 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.448 0.699 . . . . 74.1 110.006 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.729 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 41.3 mm -98.62 109.68 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 N-CA-C 106.905 -1.517 . . . . 74.53 106.905 168.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HG2' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -130.19 116.68 18.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.873 0.869 . . . . 74.24 109.575 -171.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -141.28 132.4 26.31 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.191 0.597 . . . . 70.3 109.872 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -76.94 102.8 6.55 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.999 -0.741 . . . . 71.53 108.999 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.7 t -77.73 87.67 3.99 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.403 0.621 . . . . 72.53 110.082 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.9 mt -87.35 92.66 9.15 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.514 -0.921 . . . . 71.34 108.514 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.467 0.707 . . . . 71.12 109.206 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 49.9 ttm . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 108.279 -1.008 . . . . 61.01 108.279 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 mt -91.87 139.77 30.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.442 -0.577 . . . . 42.14 109.442 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 179' ' ' GLU . 4.0 tt -110.09 117.88 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.448 -0.945 . . . . 65.22 108.448 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.509 ' HD1' ' HB2' ' A' ' 14' ' ' SER . 0.9 OUTLIER -103.09 123.0 45.83 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.309 -1.737 . . . . 72.0 106.309 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -124.14 151.86 43.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.572 0.749 . . . . 75.13 109.899 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 38.8 t70 -99.5 174.67 6.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.577 -0.897 . . . . 64.51 108.577 173.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.6 tt -72.99 -34.73 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.356 0.662 . . . . 52.05 110.995 178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.4 -48.45 2.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.093 0.957 . . . . 62.51 109.872 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -88.33 16.37 6.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.143 -1.39 . . . . 73.45 111.394 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 5.8 p-10 -52.7 -39.01 61.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.312 1.045 . . . . 74.22 112.841 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.23 -25.86 67.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.177 -0.919 . . . . 74.45 111.502 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -105.8 -1.61 24.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.599 0.759 . . . . 74.33 112.469 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mt -84.96 -154.45 0.18 Allowed 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.453 1.024 . . . . 73.31 110.309 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.509 ' HB2' ' HD1' ' A' ' 4' ' ' TYR . 15.1 m -115.45 124.54 51.4 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.248 0.462 . . . . 62.33 112.248 -158.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -116.5 85.2 2.26 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.206 -0.665 . . . . 64.2 109.206 168.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -166.03 -105.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.529 -0.76 . . . . 72.23 109.388 -172.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 p -177.91 84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.08 0.952 . . . . 55.04 108.642 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -115.75 129.5 25.11 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.315 1.046 . . . . 61.22 109.264 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.87 135.81 43.2 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.078 2.518 . . . . 72.12 112.188 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.28 162.78 37.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.047 -0.524 . . . . 51.33 111.042 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 4.8 ttmp? -144.89 159.56 42.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.784 0.833 . . . . 72.33 109.389 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.23 128.58 50.2 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.325 -0.991 . . . . 75.42 108.325 168.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -120.54 146.15 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.901 0.88 . . . . 73.41 109.817 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 t70 67.52 5.72 4.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.576 1.15 . . . . 73.14 113.153 167.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.56 18.35 6.93 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.597 1.159 . . . . 74.0 111.294 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 119' ' ' LYS . 52.8 tp -129.54 -50.03 1.16 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.004 -0.544 . . . . 64.22 111.131 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.3 t -110.79 124.12 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.4 0.619 . . . . 74.45 110.47 -172.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -85.34 115.8 23.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 114.816 -1.083 . . . . 64.44 108.598 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 21' ' ' LYS . 42.0 mt-10 -89.33 149.34 23.07 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.882 0.873 . . . . 64.34 110.534 173.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.747 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 35.9 t80 -139.84 142.5 36.6 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.875 -1.157 . . . . 75.23 107.875 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.02 120.72 14.13 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.273 0.358 . . . . 74.42 111.672 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.8 157.71 14.78 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.201 -1.16 . . . . 73.42 110.201 166.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -144.9 147.32 32.64 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.598 -0.89 . . . . 71.43 108.598 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -87.59 109.18 19.46 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.624 -0.88 . . . . 65.43 108.624 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 HD12 ' A' ' 72' ' ' LEU . 18.5 m -145.22 174.3 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.612 1.165 . . . . 74.54 109.876 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 66' ' ' ARG . 25.7 m -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.339 -0.615 . . . . 63.34 109.339 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -120.05 107.58 13.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.591 -0.892 . . . . 64.23 108.591 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD2' HG22 ' A' ' 64' ' ' VAL . 63.9 tttp -134.83 96.19 3.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.143 -1.058 . . . . 64.15 108.143 166.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 60.02 -66.36 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.564 1.546 . . . . 75.44 112.2 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.02 43.89 0.19 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.662 -0.975 . . . . 74.33 110.662 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -113.93 100.15 8.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.065 0.946 . . . . 72.13 109.448 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.567 HD11 HD23 ' A' ' 44' ' ' LEU . 7.5 tp -92.15 77.24 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 CA-C-O 122.823 1.297 . . . . 71.01 110.335 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 m -120.14 85.78 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.476 -1.238 . . . . 74.42 109.317 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.567 HD23 HD11 ' A' ' 42' ' ' ILE . 2.4 pp -103.87 156.8 17.55 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.434 -0.803 . . . . 72.22 112.223 -171.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.46 176.14 5.15 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.576 -1.193 . . . . 34.42 108.102 164.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.63 -141.51 9.28 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 121.771 -0.252 . . . . 34.2 113.177 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.0 m -62.02 135.52 57.57 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.513 0.725 . . . . 72.34 109.851 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 64.16 65.74 1.1 Allowed Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.4 1.08 . . . . 74.32 110.119 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -94.76 14.14 1.33 Allowed 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.471 2.781 . . . . 75.4 113.725 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.5 t 58.5 59.91 2.78 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.564 1.146 . . . . 72.22 110.36 -172.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.26 21.2 15.49 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.161 -0.927 . . . . 51.3 111.266 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.01 103.35 1.14 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.025 0.93 . . . . 63.11 109.856 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -89.59 -136.9 0.12 Allowed 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 123.665 0.786 . . . . 75.15 109.187 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.19 38.82 28.63 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 110.245 -1.142 . . . . 72.45 110.245 -169.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.98 70.51 0.5 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.758 1.223 . . . . 50.42 108.062 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -90.48 34.56 0.88 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.809 0.843 . . . . 75.42 111.365 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -91.02 153.04 20.43 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.835 -0.802 . . . . 63.05 108.835 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.2 -22.14 63.91 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.534 0.333 . . . . 71.41 111.532 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.02 -34.67 89.08 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.466 0.479 . . . . 62.55 112.843 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.2 m -89.36 -1.44 58.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.561 0.744 . . . . 73.11 111.001 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -101.48 115.2 29.98 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.853 0.461 . . . . 74.02 110.827 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -133.87 27.48 3.93 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.926 1.29 . . . . 64.14 108.085 166.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.7 m80 66.04 22.72 11.17 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.136 1.374 . . . . 72.53 113.011 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.552 HG23 ' HG2' ' A' ' 62' ' ' GLU . 58.0 t -78.81 80.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 108.061 -1.088 . . . . 71.01 108.061 168.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 72' ' ' LEU . 30.4 mm-40 -88.0 70.76 9.42 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.231 -0.895 . . . . 64.32 108.612 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HA ' HG12 ' A' ' 36' ' ' VAL . 8.1 ptp180 -85.14 139.05 32.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.677 -0.692 . . . . 75.54 110.936 172.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.36 -126.68 2.75 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.289 -0.414 . . . . 33.42 112.152 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 34.6 pt -113.83 142.41 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.383 0.673 . . . . 70.21 112.763 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.6 -46.61 2.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.989 2.116 . . . . 72.33 114.402 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 156' ' ' ILE . 29.5 mm -54.3 -43.19 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.937 0.875 . . . . 75.22 111.023 -176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.6 t -83.2 -40.36 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.388 -1.278 . . . . 73.24 112.402 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 16.5 mt -74.22 -32.33 62.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.063 0.459 . . . . 72.51 110.572 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -78.25 -24.37 46.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.642 0.777 . . . . 75.41 111.535 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -122.47 -6.71 8.69 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.816 0.673 . . . . 55.04 112.816 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 45.0 tptt 54.63 70.32 0.63 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.111 1.364 . . . . 52.41 110.928 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -96.04 139.35 32.34 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.215 -0.902 . . . . 71.3 109.038 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.649 HG13 HG23 ' A' ' 140' ' ' ILE . 4.0 p -89.85 133.61 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.049 -0.723 . . . . 71.23 109.049 174.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.425 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 pt-20 -56.54 152.48 11.71 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.933 0.893 . . . . 71.32 113.274 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.7 tpt -148.44 144.6 27.53 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 125.206 1.402 . . . . 74.12 107.481 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -137.52 151.48 48.47 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.207 0.527 . . . . 74.52 111.327 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 26.0 p -88.86 -2.16 58.45 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.143 -0.935 . . . . 73.43 111.327 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -75.52 -61.81 1.79 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.022 0.749 . . . . 74.42 113.022 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -103.96 -35.04 8.27 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.389 0.676 . . . . 75.14 110.439 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.29 20.6 2.32 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 70.32 112.094 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' CYS . . . -55.01 -35.35 64.31 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.38 1.072 . . . . 75.24 113.252 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.1 m -70.03 -44.68 68.75 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 73.4 111.058 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -70.43 -42.1 72.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.42 109.855 -176.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.423 ' HE2' HD22 ' A' ' 128' ' ' LEU . 53.2 t80 -68.48 -32.44 72.43 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.463 -1.244 . . . . 53.04 111.36 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -64.14 -34.92 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.888 0.475 . . . . 61.33 110.522 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -39.4 88.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.696 -0.683 . . . . 72.24 109.855 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -69.11 -33.54 73.66 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.765 0.654 . . . . 72.2 112.765 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -62.91 -41.24 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.957 0.503 . . . . 53.52 110.788 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -59.21 -44.66 92.25 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.653 0.595 . . . . 75.52 110.15 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -60.25 4.01 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 114.87 -1.059 . . . . 74.13 109.619 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -49.25 -62.5 1.5 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.925 1.69 . . . . 60.4 112.955 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.55 -44.64 90.14 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.559 0.537 . . . . 75.11 111.618 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -66.77 -36.11 81.65 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 118.296 0.498 . . . . 74.22 110.674 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.26 -53.21 59.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.103 0.961 . . . . 52.43 110.47 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.3 m -78.69 -29.66 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.341 -0.845 . . . . 54.43 112.186 -170.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.55 -40.67 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.787 -0.449 . . . . 73.43 109.787 172.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.32 -36.88 79.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.79 0.836 . . . . 71.02 111.227 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -66.09 -42.57 89.13 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.257 0.623 . . . . 73.33 109.563 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.516 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 27.0 ttt -66.32 -37.06 84.49 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 116.009 -0.541 . . . . 64.44 111.154 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.649 0.78 . . . . 73.33 111.458 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -84.17 -37.63 21.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.35 0.26 . . . . 63.41 111.372 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.45 ' OD1' ' HA ' ' A' ' 103' ' ' MET . 1.8 p-10 -96.78 5.25 50.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.173 -0.329 . . . . 74.04 111.823 -175.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.85 -50.3 1.14 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.656 0.782 . . . . 74.14 109.742 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 49.28 21.67 0.57 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.868 1.667 . . . . 74.13 112.994 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.2 131.47 51.47 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.686 1.195 . . . . 75.31 108.354 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -63.65 -45.06 91.9 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.281 0.988 . . . . 73.5 111.843 -173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.55 76.19 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.04 0.536 . . . . 72.41 112.115 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.81 -45.37 51.81 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.846 0.459 . . . . 72.2 111.22 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.67 -30.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 123.655 0.597 . . . . 74.42 111.338 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -41.78 76.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.325 0.65 . . . . 74.31 111.072 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.78 -42.45 86.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.01 0.433 . . . . 74.35 110.2 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.424 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 88.3 t80 -67.0 -42.13 85.54 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.036 -0.984 . . . . 60.5 110.762 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 64.3 tttp -53.87 -47.08 71.4 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.996 0.81 . . . . 73.24 110.102 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -65.88 -39.54 90.76 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.736 1.273 . . . . 75.3 109.789 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HB3' HD13 ' A' ' 26' ' ' LEU . 8.8 tptp -69.22 -49.17 58.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.287 0.635 . . . . 75.33 109.638 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 tp -74.56 -42.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.991 -0.55 . . . . 64.5 110.874 -170.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 12.5 pt20 -66.07 -39.47 90.08 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 109.572 -0.529 . . . . 73.51 109.572 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.73 99.23 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.501 0.5 . . . . 71.21 112.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -67.82 -50.99 53.71 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 118.98 -0.534 . . . . 71.45 109.935 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.529 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.7 m -68.32 -43.3 84.5 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 O-C-N 123.654 0.596 . . . . 73.44 111.299 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 -25.56 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.083 0.553 . . . . 74.41 110.894 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -77.67 -40.52 41.29 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.878 0.471 . . . . 73.02 110.575 167.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 155' ' ' ILE . 41.0 tp -73.71 -28.42 61.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.917 1.287 . . . . 72.52 111.5 -171.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 83.9 mt -84.37 1.55 44.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.722 0.809 . . . . 72.11 111.082 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.83 85.37 2.2 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 123.455 0.702 . . . . 75.31 109.416 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -55.67 -29.49 59.41 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.679 1.592 . . . . 75.2 114.556 -166.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.33 -22.8 61.12 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.349 0.5 . . . . 72.14 112.349 -171.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -103.18 -51.34 3.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.071 0.948 . . . . 72.24 108.806 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -76.96 0.24 21.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.697 1.599 . . . . 73.4 114.9 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -46.25 -7.44 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.435 1.642 . . . . 55.53 115.435 171.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -82.18 9.76 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.955 0.902 . . . . 63.42 111.339 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.02 148.07 23.29 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.736 0.814 . . . . 63.23 109.089 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.444 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . . . -138.92 116.07 11.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.19 -1.781 . . . . 75.24 106.19 170.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -89.15 147.63 24.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.29 -1.004 . . . . 64.34 108.29 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 78' ' ' GLU . 75.7 m-85 -141.27 143.15 33.95 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.389 -0.597 . . . . 63.4 109.389 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.649 HG23 HG13 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -123.61 138.01 54.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 105.174 -2.158 . . . . 73.11 105.174 176.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.92 126.28 39.68 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.125 -0.82 . . . . 62.31 111.336 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -56.75 -38.56 72.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 75.4 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -57.26 -47.09 82.3 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.628 1.171 . . . . 74.05 111.253 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.43 84.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.325 0.65 . . . . 72.42 111.149 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.0 -3.59 16.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.653 -0.703 . . . . 64.43 112.237 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -104.9 -18.02 14.35 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.319 1.048 . . . . 64.41 110.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.71 -74.32 0.01 OUTLIER Glycine 0 C--N 1.355 1.594 0 O-C-N 122.307 -0.246 . . . . 64.14 112.778 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.25 80.24 9.13 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.534 0.734 . . . . 70.43 109.809 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.01 1.56 2.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.29 1.036 . . . . 70.41 113.587 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -97.89 9.06 43.66 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.983 0.913 . . . . 75.14 110.624 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.04 154.62 43.76 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.796 0.685 . . . . 52.43 112.718 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -85.61 143.91 28.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 74.21 111.077 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.14 116.34 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.295 0.638 . . . . 62.04 110.636 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.35 113.95 7.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.745 1.218 . . . . 43.51 109.721 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.548 HG21 HD21 ' A' ' 127' ' ' LEU . 75.1 mt -91.59 109.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.217 -0.66 . . . . 71.14 109.217 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 169' ' ' LEU . 40.0 mm -96.71 144.7 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.431 -0.581 . . . . 64.43 109.431 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.99 109.66 9.71 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.251 -1.018 . . . . 61.32 108.251 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.65 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 6.2 p90 -83.4 91.96 7.46 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.352 -1.351 . . . . 74.42 107.352 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.518 ' HB3' HG13 ' A' ' 166' ' ' VAL . 7.5 tpt180 -74.4 91.61 2.24 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.158 -1.383 . . . . 74.44 108.72 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.35 112.44 5.22 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.21 -0.905 . . . . 74.42 110.904 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.48 92.08 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.526 1.13 . . . . 63.3 108.581 168.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 t70 46.35 61.87 2.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.568 1.547 . . . . 75.1 112.515 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.92 -12.8 68.68 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-N 115.515 -0.766 . . . . 73.34 113.441 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.18 106.97 17.71 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.004 -0.739 . . . . 74.33 109.004 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 14.4 pt-20 -73.31 141.09 47.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.484 -0.561 . . . . 71.11 109.484 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.518 HG13 ' HB3' ' A' ' 159' ' ' ARG . 3.7 p -127.27 91.29 46.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 108.199 -1.037 . . . . 61.1 108.199 166.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 52.1 Cg_exo -56.24 143.51 84.99 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.148 2.565 . . . . 61.33 112.663 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.1 m -145.87 126.47 14.21 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 65.22 108.576 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.7 tp -77.35 130.33 37.0 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.416 -0.957 . . . . 51.1 108.416 170.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.6 mtt -128.85 123.8 33.67 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.188 0.995 . . . . 75.23 108.622 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 154' ' ' ALA . 79.7 mt -141.32 170.89 14.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.878 1.671 . . . . 64.32 106.512 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 174' ' ' GLU . 11.8 p -83.42 147.22 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 108.836 -0.802 . . . . 72.11 108.836 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.91 -27.55 43.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.909 0.884 . . . . 74.22 112.456 175.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 12.8 tp10 -85.56 -2.44 58.15 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.768 0.827 . . . . 73.4 111.574 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.99 -11.99 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.859 0.864 . . . . 74.04 110.159 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.2 mm -108.81 140.88 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.286 0.565 . . . . 72.51 110.879 -174.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.1 mm -124.08 109.19 22.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.444 1.498 . . . . 64.51 107.192 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.68 121.02 31.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.568 -0.901 . . . . 64.55 108.568 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.673 ' HB3' HG23 ' A' ' 3' ' ' ILE . 33.6 tt0 -121.92 116.01 23.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.185 -1.043 . . . . 73.24 108.185 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.04 109.85 22.16 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.166 0.508 . . . . 71.24 111.609 -170.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 1' ' ' MET . 47.7 t -100.88 95.43 6.61 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.729 -0.841 . . . . 64.35 108.729 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.28 -35.35 0.55 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.137 0.975 . . . . 74.13 110.583 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 C--O 1.248 0.992 0 C-N-CA 123.736 0.814 . . . . 75.53 109.368 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttm . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.037 -0.727 . . . . 62.24 109.037 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 99.0 mt -123.21 133.92 54.18 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.365 0.266 . . . . 63.24 110.51 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 61.8 mt -106.55 117.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.668 -1.234 . . . . 54.54 107.668 170.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.625 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 91.5 m-85 -89.71 122.16 32.55 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.507 -0.923 . . . . 75.23 108.507 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.19 131.4 53.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.628 0.771 . . . . 52.13 110.776 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.553 ' HA ' HG12 ' A' ' 176' ' ' ILE . 25.0 t70 -90.34 174.44 7.58 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.334 1.021 . . . . 64.01 108.433 172.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 7' ' ' ILE . 8.3 mt -53.74 -58.97 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.184 0.594 . . . . 63.52 110.967 171.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -112.7 -23.1 10.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 65.12 111.517 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -98.24 14.12 28.91 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.998 0.919 . . . . 72.43 110.563 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.3 p-10 -48.28 -33.08 8.21 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 124.245 1.018 . . . . 54.43 113.422 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.56 -42.93 64.1 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.194 -0.912 . . . . 65.4 110.97 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.65 ' HB2' ' HG2' ' A' ' 143' ' ' ARG . 5.0 tp10 -121.25 24.72 9.89 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.188 0.595 . . . . 71.24 111.581 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 2.6 tm? -77.19 -81.88 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.11 -0.7 . . . . 75.53 109.11 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 53.1 m -157.4 -178.35 7.28 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.154 0.982 . . . . 61.51 110.386 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 73.4 p 177.3 -177.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.276 1.03 . . . . 54.51 111.397 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 85.91 -109.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.188 1.795 . . . . 53.24 111.634 165.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -144.04 42.39 1.42 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.86 -0.793 . . . . 75.13 108.86 -163.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -108.31 98.89 29.47 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.352 -0.84 . . . . 64.2 109.372 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.36 134.81 9.13 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 124.153 3.235 . . . . 53.03 114.978 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.15 146.55 42.18 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.125 -0.943 . . . . 70.42 108.596 174.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 66.6 mttm -110.66 157.45 19.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.198 -1.408 . . . . 54.22 107.198 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -130.73 108.06 9.61 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.629 -0.878 . . . . 74.02 108.629 175.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.48 127.46 50.98 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 109.018 -0.734 . . . . 73.32 109.018 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.2 t70 56.24 25.37 9.17 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.417 1.073 . . . . 74.45 112.485 175.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 53.11 16.02 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.063 1.135 . . . . 71.42 114.063 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 119' ' ' LYS . 34.5 tp -105.07 -51.48 3.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.947 0.499 . . . . 73.33 110.201 -174.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.469 HG11 ' SD ' ' A' ' 170' ' ' MET . 21.6 t -123.49 133.72 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 116.547 -0.297 . . . . 73.35 111.376 -168.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 m-85 -84.76 120.12 26.06 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.576 -0.898 . . . . 53.13 108.576 167.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 40.2 tt0 -99.06 103.18 15.09 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.696 -1.224 . . . . 74.04 107.696 170.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.724 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 30.7 t80 -94.21 141.2 28.83 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.848 1.259 . . . . 75.4 109.307 -169.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -71.49 139.88 49.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.837 0.855 . . . . 71.21 112.718 -169.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.29 149.73 17.13 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 114.768 -1.106 . . . . 23.5 111.257 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 69' ' ' ASP . 16.2 ptpt -126.93 161.41 28.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.961 0.904 . . . . 64.23 108.658 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -75.19 120.67 21.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.603 -0.517 . . . . 70.53 109.603 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 HD12 ' A' ' 72' ' ' LEU . 4.1 m -145.06 164.58 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.442 0.697 . . . . 74.03 110.486 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -94.89 160.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.217 -0.447 . . . . 51.12 110.765 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.4 ' HB3' HD22 ' A' ' 72' ' ' LEU . 60.0 ttt180 -142.74 112.44 6.87 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.912 -0.403 . . . . 72.41 109.912 169.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -125.27 140.21 53.03 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.468 -0.938 . . . . 75.44 108.468 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.795 ' HG3' ' HB3' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -59.73 -26.41 65.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 123.388 0.43 . . . . 65.32 111.699 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.0 -61.7 4.44 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.657 0.598 . . . . 74.14 111.802 172.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.8 152.09 0.94 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.137 0.975 . . . . 73.35 108.719 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tt -72.53 102.83 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 121.397 0.618 . . . . 54.13 109.682 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.4 t -109.32 81.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.277 1.031 . . . . 71.15 108.526 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -85.27 -18.85 32.7 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.964 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.16 127.06 55.46 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.183 0.993 . . . . 34.33 108.86 175.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.65 68.19 1.23 Allowed Glycine 0 C--N 1.346 1.107 0 O-C-N 123.403 0.439 . . . . 71.31 112.177 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.1 p -84.92 123.23 30.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.104 0.562 . . . . 34.42 109.892 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -67.01 151.65 96.89 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.295 0.638 . . . . 75.41 110.377 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.88 97.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.379 2.053 . . . . 75.31 111.218 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.7 t -58.64 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.345 1.058 . . . . 73.41 111.415 -174.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.11 94.24 7.03 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.934 -1.03 . . . . 52.45 109.814 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -77.38 88.06 3.77 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.621 0.724 . . . . 73.41 109.071 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -134.3 91.31 2.78 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.777 -1.101 . . . . 74.13 109.154 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.08 122.75 0.7 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.924 -1.034 . . . . 22.21 111.21 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.16 89.68 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.424 0.69 . . . . 75.02 111.258 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -73.38 100.67 3.26 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.775 -0.648 . . . . 73.55 109.274 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -76.78 145.69 38.36 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.182 0.993 . . . . 50.11 110.857 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -114.15 -4.0 13.17 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.633 0.773 . . . . 63.13 111.869 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.03 84.04 0.06 OUTLIER Glycine 0 CA--C 1.534 1.273 0 O-C-N 123.976 0.798 . . . . 45.13 114.169 -172.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.6 p -100.32 167.8 10.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.36 1.064 . . . . 43.43 110.394 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -73.54 -12.21 60.69 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.669 0.787 . . . . 71.14 111.893 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -53.13 -44.18 67.51 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.456 1.102 . . . . 71.34 109.935 167.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.795 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 34.0 p-80 -129.84 84.81 2.24 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.503 -1.226 . . . . 74.31 107.923 174.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.64 -31.36 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 122.628 0.371 . . . . 72.13 110.558 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 73.53 -57.71 0.62 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.327 1.851 . . . . 73.33 111.604 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -116.13 129.28 56.25 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.285 1.034 . . . . 75.1 109.082 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.08 -165.02 29.4 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.234 -0.984 . . . . 73.44 113.287 166.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 156' ' ' ILE . 26.4 pt -104.12 146.89 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 113.914 -1.143 . . . . 71.33 110.988 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 33' ' ' LYS . 10.9 t70 -48.2 -47.16 35.61 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.312 1.445 . . . . 50.55 112.614 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.632 HD13 ' HB2' ' A' ' 169' ' ' LEU . 67.6 mt -52.73 -45.65 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.073 -1.421 . . . . 52.22 111.333 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 76' ' ' LEU . 53.7 t -94.04 -28.56 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.017 0.527 . . . . 74.21 112.063 -173.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.505 HD12 HG23 ' A' ' 35' ' ' VAL . 84.2 mt -75.66 -18.67 59.57 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 122.227 -0.296 . . . . 72.23 110.31 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -95.37 -55.82 2.92 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.388 0.675 . . . . 73.21 110.638 172.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -86.79 3.32 45.65 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.755 0.422 . . . . 62.01 112.1 -171.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.704 ' HE3' ' HG3' ' A' ' 142' ' ' GLU . 34.4 ttpt 58.03 35.36 25.15 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.897 0.856 . . . . 75.35 111.682 165.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' HB2' HG22 ' A' ' 71' ' ' VAL . 59.2 mt -74.52 141.59 44.85 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.021 -0.536 . . . . 75.32 110.438 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.184 0.594 . . . . 74.15 110.36 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.26 145.27 42.05 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.75 1.389 . . . . 74.24 114.75 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.55 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 80.3 mtp -141.91 134.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.616 1.966 . . . . 70.41 105.813 171.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.535 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.2 m-80 -93.77 138.17 32.24 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.915 0.325 . . . . 72.04 110.204 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 29.7 p -67.08 -21.7 65.86 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.528 0.331 . . . . 41.12 111.28 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 64.0 m-85 -58.23 -52.75 64.27 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.978 -1.01 . . . . 71.24 110.567 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -105.28 -36.85 7.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.147 0.979 . . . . 73.55 112.847 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -91.91 18.95 7.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.596 0.759 . . . . 64.51 112.701 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.07 98.87 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.45 0.568 . . . . 44.3 111.194 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -65.63 -45.25 83.76 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.265 1.026 . . . . 73.25 111.467 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.09 -38.8 92.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.562 -0.745 . . . . 64.51 110.797 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -75.99 -28.91 58.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.956 0.902 . . . . 75.42 111.035 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -68.59 -38.38 80.62 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.497 -0.557 . . . . 64.02 109.497 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.4 98.89 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.778 -1.101 . . . . 70.22 110.477 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -59.09 -45.63 90.35 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.547 -0.751 . . . . 65.33 110.616 173.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.47 -40.37 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.699 . . . . 55.15 111.688 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -63.29 -45.42 91.49 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.627 0.371 . . . . 75.25 111.531 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -73.08 -47.06 47.78 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.73 -0.668 . . . . 74.41 110.893 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -53.51 -44.82 69.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.032 1.733 . . . . 75.24 111.201 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.1 ttm -59.04 -53.58 56.8 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.079 0.862 . . . . 70.52 110.521 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.173 -0.921 . . . . 73.11 110.933 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.82 -47.47 46.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.572 0.749 . . . . 62.45 112.254 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 175' ' ' ALA . 31.0 m -69.54 -34.06 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.044 0.538 . . . . 54.45 112.14 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.52 -35.14 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 123.168 0.292 . . . . 63.34 110.585 176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.92 -46.16 88.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.471 0.709 . . . . 72.24 110.077 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -62.51 -48.86 77.71 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.51 -0.768 . . . . 64.31 110.687 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.551 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.7 tpt -61.93 -38.75 89.6 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.717 0.807 . . . . 61.34 111.053 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.588 ' HA ' HG11 ' A' ' 113' ' ' VAL . 43.4 tt0 -71.88 -38.89 69.94 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.274 1.03 . . . . 74.34 110.27 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -80.51 -27.45 37.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.59 0.356 . . . . 53.42 111.609 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -82.28 -36.29 27.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.018 0.527 . . . . 63.12 110.839 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -101.13 -49.26 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.196 0.598 . . . . 73.45 110.945 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 70.24 4.24 4.78 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.37 1.248 . . . . 52.34 114.37 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -99.44 117.89 34.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.984 -0.747 . . . . 74.13 108.984 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -50.76 -45.17 58.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.991 1.316 . . . . 70.04 112.189 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.45 66.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.017 0.527 . . . . 75.22 112.417 -173.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.99 -45.26 18.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.67 0.388 . . . . 73.4 110.137 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.588 HG11 ' HA ' ' A' ' 104' ' ' GLU . 33.7 m -71.65 -23.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 116.368 -0.378 . . . . 74.43 111.248 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.05 -43.89 91.74 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.51 0.724 . . . . 71.32 110.534 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.44 -46.3 76.91 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.902 0.751 . . . . 61.53 110.164 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -57.6 -48.13 80.26 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.34 0.656 . . . . 71.1 111.787 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.67 -30.65 67.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.648 -0.501 . . . . 74.14 109.648 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -61.16 -45.1 96.02 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.735 -0.839 . . . . 55.13 108.735 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HB3' HD22 ' A' ' 26' ' ' LEU . 3.1 mptm? -65.52 -46.46 79.51 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 75.21 110.875 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 172' ' ' VAL . 26.7 mm -66.83 -42.06 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 119.319 -0.372 . . . . 54.0 110.495 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -54.77 -57.29 12.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.776 0.831 . . . . 62.14 109.999 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.7 -38.35 95.76 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.748 0.655 . . . . 45.34 113.259 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -64.69 -53.28 49.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.904 0.882 . . . . 75.41 110.442 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 120' ' ' ILE . 34.0 m -70.57 -30.48 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 119.276 -0.392 . . . . 64.53 111.553 -177.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.53 -41.46 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 118.501 0.591 . . . . 62.43 110.328 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.6 t -65.84 -43.5 88.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 120.96 0.41 . . . . 63.5 109.922 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.528 HD21 HG21 ' A' ' 155' ' ' ILE . 21.1 tp -73.11 -30.08 63.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.662 1.185 . . . . 73.34 112.221 -169.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.55 3.07 45.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.448 0.699 . . . . 65.22 111.951 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -67.62 150.97 48.07 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.458 0.703 . . . . 73.24 111.217 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -93.45 -28.7 15.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.086 1.143 . . . . 74.2 114.086 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.08 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.117 0.872 . . . . 74.35 113.267 -165.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -110.81 -32.87 6.7 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.213 0.605 . . . . 72.41 111.296 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 98.1 m-85 -78.17 -1.23 31.7 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.489 0.716 . . . . 63.03 112.038 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -55.59 -20.99 15.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.167 -0.333 . . . . 75.41 111.133 160.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -82.48 17.28 1.79 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.704 1.201 . . . . 74.15 110.856 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 156' ' ' ILE . 93.3 mt -89.8 148.05 23.44 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.079 -0.711 . . . . 54.01 109.079 170.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.75 126.45 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.739 -1.578 . . . . 42.53 106.739 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 11.1 m-85 -91.37 134.12 34.87 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.617 -0.512 . . . . 63.52 109.617 -171.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.27 151.91 50.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.298 0.639 . . . . 71.11 109.293 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.4 pt -137.16 170.7 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.317 -0.994 . . . . 74.41 108.317 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.64 44.42 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.872 -0.491 . . . . 61.43 111.872 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.704 ' HG3' ' HE3' ' A' ' 75' ' ' LYS . 10.7 mm-40 -53.24 -43.15 67.11 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.32 1.048 . . . . 75.2 112.259 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.65 ' HG2' ' HB2' ' A' ' 12' ' ' GLU . 3.0 mmt180 -65.67 -37.37 86.32 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.332 0.653 . . . . 75.12 110.353 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -59.86 -58.6 7.85 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.044 0.84 . . . . 53.01 109.136 173.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.85 -17.96 63.67 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.997 0.919 . . . . 72.11 113.084 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.49 -41.03 40.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 63.31 110.997 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.67 -26.43 0.03 OUTLIER Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.369 -0.378 . . . . 31.11 113.591 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -72.86 177.11 5.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.062 0.431 . . . . 71.14 111.229 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.09 -172.61 2.31 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 122.153 -0.342 . . . . 74.33 110.68 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.34 -49.95 12.67 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.14 0.793 . . . . 52.41 113.14 -161.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.09 -98.58 0.17 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.235 -0.746 . . . . 71.35 111.235 -156.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -121.93 144.09 49.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.155 0.582 . . . . 74.22 110.104 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 155' ' ' ILE . 89.2 t -75.96 133.09 31.91 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 108.433 -0.951 . . . . 72.43 108.433 166.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.43 97.16 0.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.645 -0.872 . . . . 71.42 108.645 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.528 HG21 HD21 ' A' ' 127' ' ' LEU . 55.3 mt -85.87 101.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 108.515 -0.92 . . . . 72.32 108.515 -171.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 68' ' ' ILE . 36.1 mm -91.85 140.22 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.036 -0.727 . . . . 74.11 109.036 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.41 105.47 7.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.232 -1.025 . . . . 73.14 108.232 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -73.5 88.77 1.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.396 -0.964 . . . . 63.2 108.396 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -92.68 174.14 7.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.425 1.49 . . . . 74.12 108.85 -165.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.75 138.73 54.54 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.258 0.623 . . . . 74.43 110.575 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.32 102.63 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 124.401 1.081 . . . . 72.22 109.302 169.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.5 t70 62.46 24.96 14.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 124.266 1.026 . . . . 72.33 112.474 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.12 -14.02 33.85 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 121.797 -0.564 . . . . 72.13 113.008 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -94.78 122.23 37.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.524 0.729 . . . . 74.11 110.336 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.94 116.18 13.14 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-O 121.151 0.5 . . . . 73.44 110.047 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.21 93.68 46.42 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 115.07 -0.968 . . . . 64.03 110.523 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.474 ' HG3' ' HB ' ' A' ' 68' ' ' ILE . 11.4 Cg_endo -52.48 121.52 9.2 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.623 2.882 . . . . 75.3 112.498 167.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.6 p -107.99 117.13 33.34 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.374 1.07 . . . . 72.21 108.429 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 17.4 tp -80.17 117.57 21.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.416 -0.587 . . . . 75.33 109.416 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.469 ' SD ' HG11 ' A' ' 27' ' ' VAL . 30.7 tpp -100.96 120.82 40.73 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 107.205 -1.406 . . . . 62.42 107.205 -175.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.448 HD22 HD12 ' A' ' 176' ' ' ILE . 84.0 mt -143.77 143.87 31.56 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.656 1.182 . . . . 74.13 109.207 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.498 HG21 HD11 ' A' ' 120' ' ' ILE . 15.0 p -91.07 138.32 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.972 0.805 . . . . 74.53 109.763 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.54 -26.45 67.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.323 1.449 . . . . 53.31 112.011 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 172' ' ' VAL . 10.0 mp0 -86.14 -0.97 56.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.134 0.574 . . . . 60.14 112.343 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -120.0 -18.75 8.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.605 0.762 . . . . 32.51 110.553 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' A' ' 6' ' ' ASP . 3.3 mt -136.64 139.58 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.336 0.654 . . . . 65.41 110.219 -172.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 30.8 mm -142.17 139.59 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.449 1.1 . . . . 71.24 108.114 -171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.02 143.01 34.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.27 0.557 . . . . 74.54 109.992 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.7 tp10 -101.33 109.39 21.23 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.098 -1.075 . . . . 61.42 108.098 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -69.84 98.04 1.18 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.886 0.741 . . . . 73.13 109.951 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.7 t -108.16 91.63 3.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.274 -1.01 . . . . 51.13 108.274 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.36 173.8 14.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.037 0.535 . . . . 75.41 110.634 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.254 1.332 0 CA-C-N 114.923 -1.035 . . . . 72.55 108.552 178.822 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.529 ' HG3' ' SG ' ' A' ' 181' ' ' CYS . 26.2 ptt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.946 0.403 . . . . 70.53 110.212 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 180' ' ' LYS . 95.6 mt -118.72 159.82 22.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.505 0.722 . . . . 72.42 110.067 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 56.3 mt -126.8 118.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 106.996 -1.483 . . . . 65.25 106.996 171.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.768 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 5.6 t80 -101.4 113.94 27.48 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.015 -1.106 . . . . 73.13 108.015 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -125.59 117.13 22.9 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.131 0.972 . . . . 72.53 110.295 -167.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.87 134.83 48.36 Favored 'General case' 0 C--O 1.205 -1.285 0 N-CA-C 108.344 -0.984 . . . . 71.42 108.344 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 pt -66.39 -5.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 113.293 0.849 . . . . 75.43 113.293 -170.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -107.94 -46.72 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.736 -0.838 . . . . 71.41 108.736 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 p -111.82 18.66 18.71 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.827 1.251 . . . . 74.0 112.456 -173.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -46.94 -42.22 17.4 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.183 1.793 . . . . 71.21 113.545 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -55.95 -39.13 71.29 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.89 1.369 . . . . 73.54 112.543 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -120.61 11.32 11.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.176 0.591 . . . . 74.42 111.458 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -95.9 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 112.871 0.693 . . . . 55.03 112.871 -163.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.768 ' HB3' ' HB3' ' A' ' 4' ' ' TYR . 35.5 t -158.21 178.44 10.18 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.93 0.787 . . . . 31.21 111.367 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 33.0 p 163.32 104.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.691 1.597 . . . . 74.51 109.377 -168.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -171.59 161.07 6.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.572 0.749 . . . . 73.43 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -68.87 83.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.391 0.676 . . . . 72.41 111.316 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.61 ' HZ ' ' HB2' ' A' ' 4' ' ' TYR . 3.8 p90 -127.18 159.09 66.93 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.906 0.882 . . . . 62.41 110.275 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.97 120.86 3.08 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.134 1.89 . . . . 65.12 112.883 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.6 ' HB2' ' HE2' ' A' ' 28' ' ' TYR . 17.8 ptm -87.71 157.88 18.95 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.052 0.541 . . . . 73.21 110.527 174.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -152.03 145.63 24.95 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.038 -0.727 . . . . 51.03 109.038 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.55 125.78 52.88 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.502 -0.925 . . . . 70.42 108.502 173.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.19 129.81 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.281 0.632 . . . . 71.32 110.268 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.92 23.74 6.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.151 1.38 . . . . 64.23 113.992 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 t70 54.76 26.83 8.04 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.829 0.852 . . . . 65.33 112.054 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.531 HD13 ' HE2' ' A' ' 119' ' ' LYS . 64.7 tp -135.1 -51.17 0.77 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.991 0.901 . . . . 73.23 110.483 -170.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -120.41 148.7 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.888 -1.506 . . . . 74.5 107.885 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.6 ' HE2' ' HB2' ' A' ' 20' ' ' MET . 44.6 t80 -86.18 139.39 31.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.244 -1.021 . . . . 72.42 108.244 170.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -123.61 129.37 51.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.805 0.842 . . . . 74.42 109.695 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.729 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 48.8 t80 -114.31 124.68 52.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.128 0.571 . . . . 73.22 109.473 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.46 95.74 8.36 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.942 -0.762 . . . . 75.43 108.942 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.3 176.56 46.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.751 -0.659 . . . . 72.32 112.464 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -125.13 158.06 34.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.355 0.662 . . . . 72.43 109.629 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -90.59 117.57 29.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.194 -0.669 . . . . 61.01 109.194 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 72' ' ' LEU . 19.7 m -143.49 153.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.494 0.664 . . . . 71.1 110.098 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.6 127.53 66.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.544 -1.28 . . . . 52.42 107.544 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 10.7 tpt180 -105.3 108.55 20.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 106.677 -1.601 . . . . 73.23 106.677 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -106.26 96.59 6.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.895 -0.78 . . . . 70.4 108.895 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 46.64 58.46 4.63 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.087 1.355 . . . . 72.52 111.962 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.97 -33.09 3.86 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.937 -1.029 . . . . 74.34 113.657 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -93.19 116.16 28.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.45 1.1 . . . . 73.42 110.033 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.1 tt -80.83 115.88 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 109.048 -0.723 . . . . 75.22 109.048 172.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.03 90.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.462 1.105 . . . . 71.21 108.591 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 pp -101.89 173.09 6.56 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.954 0.901 . . . . 74.43 111.265 -177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.12 -43.01 0.06 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.875 -1.057 . . . . 75.25 108.698 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.24 135.1 2.04 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.546 -0.752 . . . . 64.01 111.556 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m -81.91 82.69 7.46 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 117.379 0.589 . . . . 73.34 109.923 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -55.73 -48.62 96.15 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.949 0.899 . . . . 74.4 111.558 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.14 149.03 45.43 Favored 'Trans proline' 0 C--N 1.391 2.795 0 CA-C-N 120.53 1.225 . . . . 70.02 111.307 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.0 m -77.01 171.33 14.98 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.529 -0.545 . . . . 64.53 109.529 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.72 86.0 0.92 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.192 0.52 . . . . 65.1 110.103 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.99 86.16 4.19 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.325 1.05 . . . . 72.44 109.589 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 15.8 mm-40 -94.47 70.73 3.67 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.62 0.768 . . . . 51.14 109.628 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.57 11.05 6.06 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.058 -0.973 . . . . 73.12 112.802 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.93 94.05 9.49 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.162 -0.681 . . . . 74.44 109.162 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -79.33 -36.86 38.85 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.681 0.793 . . . . 75.52 111.269 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -79.61 -23.39 42.67 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.3 -0.863 . . . . 64.43 110.954 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -137.09 126.66 25.22 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.724 0.81 . . . . 53.1 109.504 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.77 37.77 0.76 Allowed Glycine 0 N--CA 1.466 0.661 0 N-CA-C 111.375 -0.69 . . . . 72.1 111.375 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.5 p -80.02 138.17 36.96 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.177 0.591 . . . . 54.32 109.565 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -94.66 96.63 9.54 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.219 0.608 . . . . 75.51 109.529 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -76.16 -178.82 4.65 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.296 -0.631 . . . . 54.41 109.296 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -79.75 16.02 1.23 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.416 0.286 . . . . 73.45 111.281 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t -78.63 80.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.841 0 N-CA-C 107.682 -1.229 . . . . 71.14 107.682 166.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.652 ' HB3' HD22 ' A' ' 72' ' ' LEU . 40.9 mt-10 -94.16 62.07 2.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.51 -0.768 . . . . 73.52 109.538 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -74.93 127.7 33.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.136 -0.938 . . . . 74.15 109.301 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.29 -134.74 3.65 Favored Glycine 0 C--N 1.343 0.919 0 O-C-N 123.512 0.508 . . . . 72.22 112.416 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 27.0 pt -111.9 151.75 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.86 0.864 . . . . 75.45 110.906 177.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.11 -35.1 74.5 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.366 1.066 . . . . 64.23 112.73 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 169' ' ' LEU . 47.7 mt -53.88 -46.53 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.56 1.144 . . . . 65.53 110.497 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 76' ' ' LEU . 55.1 t -75.97 -44.32 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 113.898 -1.501 . . . . 62.23 111.888 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.652 HD22 ' HB3' ' A' ' 65' ' ' GLU . 55.5 mt -66.16 -32.04 73.25 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.642 0.589 . . . . 71.32 111.18 -175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -58.94 -52.36 66.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.278 1.031 . . . . 75.51 111.846 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -89.42 -22.85 22.33 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 116.18 -0.463 . . . . 75.23 111.663 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 mmmp? 69.28 70.36 0.26 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.225 1.01 . . . . 75.32 109.836 -166.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.67 ' HB2' HG13 ' A' ' 71' ' ' VAL . 76.0 mt -85.66 151.74 23.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.8 -1.091 . . . . 73.31 109.269 173.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.689 HG11 ' HB2' ' A' ' 145' ' ' ALA . 11.3 p -90.54 138.43 19.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 N-CA-C 109.111 -0.7 . . . . 73.05 109.111 170.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' HG2' ' HG3' ' A' ' 53' ' ' GLU . 9.2 tp10 -60.43 138.85 57.93 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.074 0.859 . . . . 74.11 109.922 166.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 33.7 tpp -132.42 103.03 5.98 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 105.572 -2.01 . . . . 73.03 105.572 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' HB2' ' A' ' 82' ' ' TYR . 20.7 t-20 -63.89 113.59 3.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.183 -1.826 . . . . 73.45 111.18 -170.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.407 ' SG ' ' CD2' ' A' ' 133' ' ' PHE . 41.5 t -59.05 -33.51 70.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.431 1.092 . . . . 65.2 111.345 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.44 ' HB2' ' OD1' ' A' ' 80' ' ' ASN . 60.8 m-85 -68.13 -29.65 68.61 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 113.919 -1.491 . . . . 75.14 110.75 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -104.87 -33.11 8.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.935 0.894 . . . . 51.31 112.445 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.32 19.52 15.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.314 0.646 . . . . 74.43 111.791 -162.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.59 72.52 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 112.205 0.446 . . . . 73.13 112.205 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.2 m -72.49 -43.89 63.03 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.275 0.63 . . . . 63.33 111.292 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 mmt -70.75 -29.72 66.03 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.463 0.305 . . . . 74.45 110.514 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.578 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 81.0 t80 -67.52 -32.67 73.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 45.11 110.172 173.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -64.61 -36.9 85.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.792 0.437 . . . . 73.21 110.002 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.12 82.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.065 0.546 . . . . 50.31 111.153 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.578 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 54.1 m-85 -69.85 -34.59 73.83 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 118.914 -0.565 . . . . 74.23 111.998 173.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.597 HG13 HD21 ' A' ' 128' ' ' LEU . 35.7 mm -66.11 -36.16 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.294 0.638 . . . . 74.2 110.577 174.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -57.52 -46.83 83.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.354 0.662 . . . . 73.0 111.11 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.58 -44.95 73.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.053 0.541 . . . . 71.33 110.704 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -47.78 -65.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.49 1.916 . . . . 73.43 111.078 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 70.9 mtp -63.09 -44.06 96.76 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.728 0.811 . . . . 74.15 111.384 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -57.85 -49.9 75.11 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.656 0.597 . . . . 72.15 110.97 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.08 -43.84 70.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.856 -1.066 . . . . 74.11 111.283 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 172' ' ' VAL . 34.3 m -69.18 -38.93 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 112.862 0.689 . . . . 63.32 112.862 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.45 -43.19 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.421 -0.585 . . . . 72.43 109.421 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 14.7 t70 -56.83 -41.09 77.25 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.231 0.957 . . . . 72.25 109.939 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -58.87 -48.07 82.7 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.386 1.074 . . . . 70.31 109.724 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.624 ' HB3' HG12 ' A' ' 113' ' ' VAL . 96.0 mmm -62.42 -36.18 81.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.338 -0.846 . . . . 74.33 111.263 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.07 -24.84 62.41 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.428 0.691 . . . . 73.21 111.494 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 29.5 mtpp -81.39 -49.89 10.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.923 0.489 . . . . 74.11 110.431 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -84.2 -14.03 51.16 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.302 0.641 . . . . 72.34 112.659 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -140.05 -59.64 0.54 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.108 0.413 . . . . 74.04 111.063 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 69.35 15.64 8.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.756 1.222 . . . . 75.44 112.479 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.16 114.58 19.17 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.473 -0.936 . . . . 63.55 108.473 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -57.24 -42.68 81.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.112 0.965 . . . . 73.32 112.249 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.17 87.87 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.571 0.544 . . . . 65.15 111.234 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.91 -42.44 48.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.32 0.648 . . . . 70.05 110.766 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' A' ' 103' ' ' MET . 33.0 m -72.83 -28.55 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.05 0.54 . . . . 70.22 110.67 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 26.5 t70 -67.95 -43.92 77.95 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 123.6 0.562 . . . . 75.53 109.889 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -42.51 94.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.698 0.624 . . . . 75.13 109.946 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -44.12 97.78 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.849 0.86 . . . . 72.2 110.918 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -39.02 85.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.07 0.948 . . . . 75.0 110.504 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 57.5 mtpt -71.87 -36.9 70.24 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.886 0.741 . . . . 72.44 110.885 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.531 ' HE2' HD13 ' A' ' 26' ' ' LEU . 60.1 mtpt -64.28 -44.45 91.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.045 0.538 . . . . 60.14 109.992 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.0 -44.56 96.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 C-N-CA 123.732 0.813 . . . . 75.21 109.897 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.423 ' O ' HG22 ' A' ' 125' ' ' VAL . 7.2 tp-100 -56.35 -51.11 69.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.022 0.929 . . . . 71.41 110.649 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.58 98.2 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.14 0.9 . . . . 61.21 113.264 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -62.91 -49.92 72.88 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.867 0.467 . . . . 73.43 109.746 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 32.9 m -67.21 -49.03 76.4 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.338 0 CA-C-O 117.531 -1.223 . . . . 74.12 110.488 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 121' ' ' GLN . 33.4 m -64.16 -31.16 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 120.107 1.321 . . . . 63.42 112.002 -176.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.7 m -72.09 -37.54 69.55 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.672 0.389 . . . . 71.12 110.361 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.563 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 40.5 tp -77.32 -26.06 51.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.316 1.046 . . . . 65.32 111.171 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.597 HD21 HG13 ' A' ' 92' ' ' ILE . 95.0 mt -85.45 2.51 44.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.39 1.076 . . . . 74.21 111.447 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.87 147.8 40.73 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.143 -0.688 . . . . 51.11 109.143 170.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 40.7 ttmt -69.29 -13.4 62.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.081 0.552 . . . . 71.21 111.212 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.2 -45.57 87.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.493 0.717 . . . . 61.23 110.068 168.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 5.1 mpt_? -78.38 -47.45 17.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.061 -0.972 . . . . 74.35 110.413 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.643 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.2 m-85 -57.84 -25.97 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.746 0.818 . . . . 54.15 112.673 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.12 -36.06 78.72 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.607 0.763 . . . . 63.44 110.905 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.62 -7.96 19.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.918 1.287 . . . . 71.05 111.281 -177.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 63.1 mt -88.54 139.59 30.33 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.649 0.737 . . . . 72.34 110.939 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.66 124.81 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 105.798 -1.926 . . . . 61.41 105.798 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.568 ' HB3' HG11 ' A' ' 153' ' ' VAL . 21.8 m-85 -95.88 140.5 30.56 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.818 -0.808 . . . . 62.24 108.818 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -138.34 138.44 38.32 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.411 -0.589 . . . . 54.42 109.411 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.21 175.66 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.562 -0.903 . . . . 74.11 108.562 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.1 120.04 20.43 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.222 -0.751 . . . . 30.03 111.222 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.37 -18.31 16.9 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.312 0.856 . . . . 63.11 113.312 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -68.7 -40.42 80.0 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.376 0.671 . . . . 75.24 109.656 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 149' ' ' GLU . . . -80.41 -6.03 57.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.165 0.986 . . . . 63.14 112.491 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.689 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -70.16 2.17 3.97 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.698 0.799 . . . . 63.31 112.484 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -24.59 61.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.026 0.93 . . . . 71.53 110.448 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.01 -64.31 0.01 OUTLIER Glycine 0 C--N 1.354 1.579 0 CA-C-N 116.113 -0.494 . . . . 71.43 112.221 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -163.27 146.02 10.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.949 0.5 . . . . 73.44 110.628 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.454 ' HA ' ' HB1' ' A' ' 144' ' ' ALA . 10.9 tp10 -71.18 -41.29 70.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.115 0.566 . . . . 65.0 110.557 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.566 ' H ' ' HE1' ' A' ' 91' ' ' TYR . 80.0 m-20 59.99 44.12 13.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.016 0.926 . . . . 73.14 110.805 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.34 -150.9 5.77 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.03 -0.986 . . . . 63.33 110.827 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.63 140.36 31.35 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.716 -0.846 . . . . 75.44 108.716 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 138' ' ' PHE . 94.0 t -87.18 142.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.82 0.848 . . . . 53.33 109.897 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.79 97.51 0.16 Allowed 'General case' 0 C--O 1.245 0.821 0 N-CA-C 108.942 -0.762 . . . . 62.14 108.942 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.489 HG21 HD21 ' A' ' 127' ' ' LEU . 75.9 mt -85.31 101.58 9.94 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.916 -1.142 . . . . 73.23 107.916 -173.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.57 114.16 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.237 0.615 . . . . 72.34 109.39 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -112.23 103.77 11.94 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.459 -0.941 . . . . 74.42 108.459 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 6.5 p90 -81.73 94.45 7.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.754 -0.832 . . . . 74.42 108.754 -174.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -90.28 155.06 19.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.257 -0.645 . . . . 74.25 109.257 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -103.95 123.76 47.75 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 110.106 -0.331 . . . . 70.11 110.106 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.71 116.21 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.592 -0.892 . . . . 33.24 108.592 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.18 15.16 7.25 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.213 1.005 . . . . 63.24 112.285 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 94.78 25.33 15.37 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 121.887 -0.508 . . . . 74.53 112.892 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.3 m -121.74 130.61 53.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.497 0.719 . . . . 61.32 110.431 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.76 98.62 7.85 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.808 -0.812 . . . . 73.14 108.808 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.46 95.62 19.71 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.823 0.849 . . . . 74.31 109.796 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 59.9 Cg_endo -68.2 129.54 19.52 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 122.538 2.159 . . . . 44.34 111.389 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.8 p -109.85 110.2 21.09 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.797 -0.816 . . . . 62.55 108.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.729 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -79.1 112.54 16.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.456 -0.793 . . . . 75.33 109.382 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.47 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.0 mtt -100.83 122.32 43.22 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 107.876 -1.157 . . . . 73.14 107.876 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 mt -141.62 130.93 23.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.544 -1.65 . . . . 44.1 106.544 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 99' ' ' VAL . 3.9 p -69.09 137.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.005 0.522 . . . . 65.24 110.431 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tmpt? -60.27 -35.48 75.61 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 74.54 111.827 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -70.32 -6.01 32.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.429 0.9 . . . . 72.13 113.429 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.08 -6.37 6.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.223 0.609 . . . . 71.31 111.933 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.6 tp -124.98 143.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.433 0.635 . . . . 71.34 110.128 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 40.6 mm -130.93 110.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.449 -1.315 . . . . 70.34 107.449 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.87 127.46 42.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.138 -1.06 . . . . 64.42 108.138 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 23.5 mm-40 -115.04 114.75 25.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.382 0.673 . . . . 73.21 111.568 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' A' ' 2' ' ' LEU . 33.2 mtmm -83.4 96.68 8.62 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.465 0.706 . . . . 74.31 109.915 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.529 ' SG ' ' HG3' ' A' ' 1' ' ' MET . 9.3 p -108.84 88.95 2.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.959 -0.756 . . . . 63.24 108.959 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.17 -68.18 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.153 -0.93 . . . . 70.35 109.301 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 CA--C 1.552 1.02 0 C-N-CA 123.47 0.708 . . . . 71.12 110.204 -174.8 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB3' ' HA ' ' A' ' 16' ' ' ASP . 65.5 mtt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 62.22 109.471 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 180' ' ' LYS . 43.1 mt -115.42 146.92 41.16 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.3 0.64 . . . . 70.4 109.988 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 57.3 mt -95.8 119.61 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.242 -0.651 . . . . 71.21 109.242 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.454 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.0 m-85 -118.91 129.09 55.0 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.422 -1.325 . . . . 74.43 107.422 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.38 155.07 43.61 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.557 0.343 . . . . 72.33 111.08 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 10.3 t70 -101.14 144.62 29.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.597 0.759 . . . . 65.44 109.743 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.5 pt -81.33 -6.42 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 112.752 0.649 . . . . 65.12 112.752 -171.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -106.7 -64.02 1.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.172 0.804 . . . . 61.31 113.172 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.0 m -130.06 -25.33 2.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.828 0.677 . . . . 74.31 112.828 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 12.9 t0 -99.9 25.87 6.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.538 0.735 . . . . 51.25 110.759 -170.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.63 -20.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.101 1.519 . . . . 64.34 115.101 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.85 -37.61 19.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.258 -0.901 . . . . 72.52 111.052 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 31.5 tp 28.55 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.001 2.12 . . . . 73.54 114.243 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 67.6 m -157.94 121.88 4.12 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 72.44 109.58 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 45.3 p -113.7 67.46 0.67 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.776 0.798 . . . . 55.11 109.65 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 37.6 t70 -159.49 177.28 11.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.992 -1.004 . . . . 65.12 109.852 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 m -84.54 76.29 10.19 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.056 -0.72 . . . . 72.32 109.056 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 14' ' ' SER . 15.7 m-85 -100.58 139.16 20.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 115.276 -0.874 . . . . 72.44 110.748 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.9 118.7 5.66 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.693 2.262 . . . . 74.11 112.14 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -129.25 162.69 27.31 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.169 -0.923 . . . . 73.12 111.042 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -151.2 115.26 5.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.972 1.309 . . . . 70.14 107.649 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.8 113.28 24.17 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.624 -1.621 . . . . 65.0 106.624 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.87 132.12 51.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 C-N-CA 123.111 0.564 . . . . 65.42 110.056 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.0 t0 55.04 22.96 4.78 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 125.064 1.346 . . . . 70.21 112.719 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 t70 59.81 12.38 2.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.681 1.592 . . . . 71.04 112.65 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' HG3' ' A' ' 119' ' ' LYS . 55.3 tp -109.49 -51.88 2.83 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.523 -0.736 . . . . 62.14 111.214 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.64 126.03 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.571 -0.741 . . . . 73.43 109.987 -167.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -83.31 114.87 21.71 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.408 -1.33 . . . . 74.41 107.408 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 35.2 tt0 -112.68 119.49 38.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 65.15 110.316 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -105.4 107.12 17.93 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.999 -1.112 . . . . 75.12 107.999 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -77.06 153.13 34.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.616 0.366 . . . . 63.44 111.13 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.19 -163.88 12.1 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.285 -0.726 . . . . 74.21 111.285 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.02 136.72 34.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.356 0.663 . . . . 71.42 109.404 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 4.2 t60 -69.07 128.47 36.79 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.762 -0.829 . . . . 72.5 108.762 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 72' ' ' LEU . 13.9 m -147.28 178.57 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.407 0 C-N-CA 124.345 1.058 . . . . 74.14 109.711 -174.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 21.8 m -125.4 141.44 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 116.263 -0.426 . . . . 73.32 111.526 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 72' ' ' LEU . 9.6 mpt_? -105.23 105.54 15.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.368 -1.345 . . . . 62.24 107.368 165.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -127.45 125.23 40.15 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.864 -0.791 . . . . 74.14 108.864 -165.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.45 84.39 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.28 . . . . 63.32 111.406 -174.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -48.96 0.59 Allowed Glycine 0 C--O 1.239 0.46 0 CA-C-N 114.692 -1.14 . . . . 54.33 111.638 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -166.51 129.21 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.289 0.636 . . . . 73.0 110.158 -173.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tt -72.2 106.52 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 109.265 -0.643 . . . . 72.01 109.265 174.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.63 88.28 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-O 121.824 0.821 . . . . 63.23 109.452 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -73.69 -19.35 60.84 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 115.415 -0.811 . . . . 74.33 111.398 -177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.42 -20.93 25.96 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.869 0.868 . . . . 72.44 110.621 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.48 70.1 2.89 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.349 0.406 . . . . 64.24 112.401 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.9 m -87.91 90.37 8.36 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.06 0.944 . . . . 64.5 109.097 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -61.87 -53.1 63.36 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 124.63 1.172 . . . . 72.41 113.28 -167.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.15 -2.16 11.86 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 121.976 1.784 . . . . 52.25 114.051 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m 59.99 21.08 10.17 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.226 1.011 . . . . 71.34 112.06 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -164.05 78.71 0.39 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.13 -1.433 . . . . 53.15 107.13 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HG2' ' HD3' ' A' ' 66' ' ' ARG . 29.9 tt0 -68.96 -29.31 67.51 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.717 -1.129 . . . . 74.32 110.968 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -59.98 78.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.791 1.237 . . . . 74.32 111.683 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.09 -60.33 1.19 Allowed Glycine 0 C--N 1.342 0.882 0 N-CA-C 110.353 -1.099 . . . . 74.02 110.353 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.45 32.01 21.12 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.955 0.902 . . . . 54.22 111.956 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -166.17 100.24 0.63 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.142 0.977 . . . . 53.13 108.769 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.6 t70 77.72 -30.28 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.217 1.407 . . . . 64.01 113.27 170.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.94 -13.02 60.04 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.333 1.053 . . . . 74.42 112.26 -174.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.96 24.53 15.16 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 123.062 0.363 . . . . 70.53 112.787 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.7 t -66.37 153.28 43.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.404 1.081 . . . . 60.31 111.218 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.48 -21.48 66.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.042 0.937 . . . . 61.11 111.286 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.22 111.34 9.3 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.778 -1.193 . . . . 75.52 107.778 170.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.2 m80 76.41 -57.34 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.166 1.787 . . . . 75.02 111.953 -171.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t 72.26 -78.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.021 1.329 . . . . 71.42 111.202 -172.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 36' ' ' VAL 0.298 8.4 pt-20 51.39 -70.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.336 2.254 . . . . 64.31 113.178 -163.679 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HD3' ' HG2' ' A' ' 52' ' ' GLU . 60.4 ttp85 -74.16 111.6 9.49 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.702 0.801 . . . . 63.05 110.974 -161.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.16 -172.28 45.15 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.316 -0.945 . . . . 74.15 111.69 160.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 16.4 pt -96.06 150.65 4.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.004 -0.739 . . . . 63.41 109.004 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -56.06 -34.07 65.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 53.35 112.362 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 68' ' ' ILE . 61.8 mt -55.06 -51.37 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.389 1.076 . . . . 62.34 110.16 176.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 76' ' ' LEU . 30.6 t -75.02 -46.26 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.604 1.161 . . . . 64.12 112.224 -175.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 35' ' ' VAL . 80.5 mt -63.19 -37.17 86.19 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.046 0.841 . . . . 73.21 111.088 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -68.21 -47.0 69.05 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.986 -1.007 . . . . 65.5 109.204 174.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -80.55 -17.66 50.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.045 0.938 . . . . 64.42 111.957 -166.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 62.82 61.66 1.14 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.281 1.433 . . . . 71.43 111.044 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.622 ' HB2' HG13 ' A' ' 71' ' ' VAL . 83.8 mt -101.28 140.15 35.97 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.378 -0.828 . . . . 73.23 110.483 174.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.57 137.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.478 0.711 . . . . 65.53 109.219 171.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.45 157.06 24.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.454 1.121 . . . . 73.1 113.685 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 ttm -147.28 104.21 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.172 -2.159 . . . . 72.25 105.172 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.601 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 80.1 m-20 -101.87 124.94 48.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.331 -0.618 . . . . 52.22 109.331 -171.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.598 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 20.6 p -61.4 -11.14 9.12 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.109 0.964 . . . . 64.01 112.522 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.601 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 90.9 m-85 -53.5 -48.85 68.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.386 1.074 . . . . 72.1 111.461 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.95 -39.22 6.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.604 0.762 . . . . 74.43 110.571 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.16 20.39 3.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.408 1.083 . . . . 75.42 113.336 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.47 69.73 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.154 0.582 . . . . 65.21 111.614 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t -65.93 -38.72 89.39 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.972 0.909 . . . . 71.12 110.725 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.472 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.2 mpt? -69.25 -40.62 77.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.174 -0.921 . . . . 65.14 110.658 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -70.61 -31.9 69.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.571 0.748 . . . . 75.0 110.466 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -67.42 -35.23 78.85 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 61.14 111.113 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.27 95.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.202 0.601 . . . . 64.11 110.154 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.57 -34.37 74.07 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-N 115.567 -0.742 . . . . 64.13 111.79 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.78 -34.05 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.629 0.772 . . . . 72.12 111.281 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.01 -47.6 82.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.731 0.413 . . . . 74.14 110.607 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.63 -46.7 78.27 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.975 0.797 . . . . 53.34 109.681 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.454 ' O ' HG22 ' A' ' 99' ' ' VAL . 72.7 t80 -48.26 -64.84 0.68 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.011 1.724 . . . . 74.44 111.755 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 27.6 ttt -58.08 -48.61 79.61 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.409 1.068 . . . . 75.11 110.765 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -58.35 -51.43 69.85 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.035 0.835 . . . . 73.24 111.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -73.72 -39.32 64.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.659 0.599 . . . . 74.12 111.82 -168.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.0 m -67.2 -37.79 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 111.857 0.317 . . . . 70.24 111.857 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 113' ' ' VAL . 81.7 mt -71.6 -54.24 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.627 -0.509 . . . . 72.02 109.627 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.91 -33.18 70.26 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.533 1.533 . . . . 63.13 112.357 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -81.56 -52.63 7.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.262 0.625 . . . . 74.22 110.65 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.431 ' HG2' ' HG3' ' A' ' 174' ' ' GLU . 11.7 tpt -72.2 -31.47 65.92 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.85 0.315 . . . . 73.24 111.85 -167.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.36 -55.46 21.44 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.626 0.77 . . . . 71.01 112.351 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -82.32 -0.03 43.8 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.087 0.47 . . . . 61.55 110.412 -166.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -101.59 -36.35 8.8 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.174 0.99 . . . . 75.15 110.041 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -92.69 -78.66 0.41 Allowed 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.422 -0.808 . . . . 62.23 111.767 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.453 ' HB3' ' HB2' ' A' ' 112' ' ' ASP . 63.1 ttt180 -153.47 13.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.6 0.714 . . . . 73.53 112.337 -169.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.6 t70 68.94 -74.13 0.08 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.275 1.43 . . . . 75.45 113.059 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.04 -66.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 112.518 0.562 . . . . 74.02 112.518 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.87 87.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.087 1.143 . . . . 33.12 114.087 -162.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -73.53 -46.44 47.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.297 -0.41 . . . . 63.3 111.095 -170.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.622 ' HA ' ' HB3' ' A' ' 116' ' ' PHE . 13.6 m -76.24 -22.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 119.241 -0.409 . . . . 74.33 111.506 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.59 -55.09 34.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.165 0.586 . . . . 64.41 110.507 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.99 88.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.14 0.9 . . . . 73.44 110.244 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.622 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 18.9 t80 -61.96 -41.9 98.52 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.444 -1.253 . . . . 64.35 111.496 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -64.6 -41.47 96.21 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.906 0.482 . . . . 62.53 110.62 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.45 -42.79 95.77 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.088 0.868 . . . . 62.0 110.285 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.75 ' HG3' HD22 ' A' ' 26' ' ' LEU . 17.9 tppt? -72.91 -40.18 65.71 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.473 1.109 . . . . 71.12 111.755 -174.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.4 tp -76.45 -34.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.292 0.637 . . . . 72.43 109.51 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -61.37 -44.46 97.13 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 124.119 0.887 . . . . 62.41 109.138 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.34 -41.39 99.47 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.803 0.689 . . . . 64.32 112.836 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.63 -53.05 57.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.424 0.69 . . . . 75.13 110.703 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 18.7 m -63.61 -44.76 98.68 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.17 0 CA-C-O 118.298 -0.858 . . . . 75.14 111.432 -175.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.6 -38.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 119.205 0.911 . . . . 55.01 111.39 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 m -71.81 -31.09 66.19 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.901 0.48 . . . . 73.14 111.399 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.702 HD21 HG21 ' A' ' 155' ' ' ILE . 28.9 tp -82.96 -18.99 38.02 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 71.33 110.584 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.8 mt -91.95 3.24 55.64 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.895 0.878 . . . . 72.42 111.069 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.12 88.31 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.796 0.838 . . . . 71.3 110.474 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -58.24 -19.81 37.0 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.886 1.439 . . . . 61.2 114.886 -163.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.48 -40.77 95.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.636 0.774 . . . . 72.12 112.133 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -108.19 -37.2 6.09 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.348 0.594 . . . . 71.53 110.872 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.1 -2.36 48.0 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.187 0.995 . . . . 65.45 113.453 -168.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.34 -15.8 18.52 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 112.259 0.466 . . . . 72.45 112.259 163.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -103.31 26.72 8.0 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.785 0.834 . . . . 74.24 110.32 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.5 mt -86.63 133.18 33.72 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.862 -1.162 . . . . 73.12 107.862 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.73 109.3 21.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.723 -1.584 . . . . 72.3 106.723 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 42.5 m-85 -92.24 145.89 24.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.058 -1.09 . . . . 75.25 108.058 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 78.6 m-85 -140.51 146.36 38.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.21 0.529 . . . . 75.23 110.659 -175.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.441 HD13 ' HB3' ' A' ' 144' ' ' ALA . 2.1 pp -146.98 163.18 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.257 -1.757 . . . . 74.31 106.257 167.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.7 147.29 50.89 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.885 -0.886 . . . . 72.25 110.885 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.44 -25.32 50.17 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.92 0.86 . . . . 72.31 112.714 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -36.36 80.48 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.538 1.135 . . . . 51.11 111.129 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 150' ' ' ASN . . . -68.14 -42.69 79.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.985 0.914 . . . . 64.31 110.634 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.57 -0.69 47.98 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.252 -0.886 . . . . 75.01 112.36 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -90.89 -19.0 23.83 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.417 1.087 . . . . 71.44 109.922 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.74 45.89 1.17 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.006 -0.543 . . . . 61.35 111.811 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -156.7 108.44 2.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.462 0.705 . . . . 73.45 109.283 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 49.29 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.566 1.546 . . . . 71.23 113.712 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.55 ' HA ' ' HB1' ' A' ' 144' ' ' ALA . 17.6 m120 -61.25 -43.03 99.54 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.783 0.833 . . . . 71.2 111.282 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 58.53 -148.77 37.51 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 115.421 0.928 . . . . 51.01 115.421 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 138.64 31.31 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.011 0.924 . . . . 64.53 109.266 -174.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.0 t -82.73 123.91 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.134 0.574 . . . . 54.31 110.977 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.68 105.3 6.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.381 1.072 . . . . 70.21 109.294 170.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.702 HG21 HD21 ' A' ' 127' ' ' LEU . 74.9 mt -91.75 121.26 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.297 -0.631 . . . . 71.42 109.297 -173.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 169' ' ' LEU . 47.7 mm -109.08 114.84 47.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 110.048 -0.352 . . . . 73.34 110.048 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.89 118.27 36.59 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 124.244 0.965 . . . . 75.12 108.641 170.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 16.1 p90 -79.96 112.52 17.33 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.669 -1.604 . . . . 72.44 106.669 170.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -103.01 128.49 49.83 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.628 -0.508 . . . . 62.44 109.628 -173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.18 120.23 22.69 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.556 0.342 . . . . 70.01 110.872 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.23 107.17 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.422 1.489 . . . . 62.41 108.824 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 61.92 23.64 13.95 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.811 1.244 . . . . 65.55 112.783 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.22 65.3 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 113.867 0.307 . . . . 73.01 113.867 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.1 m -110.87 137.54 48.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.285 1.034 . . . . 74.15 108.834 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 9.0 pt-20 -72.95 145.61 46.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.167 0.439 . . . . 52.13 110.405 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.4 101.16 21.83 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 107.645 -1.242 . . . . 74.12 107.645 167.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.75 128.52 20.13 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.401 2.067 . . . . 71.43 112.299 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 53.1 p -121.0 118.43 29.82 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.227 -1.027 . . . . 72.42 108.227 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 tp -77.23 111.73 13.17 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.936 -0.764 . . . . 71.25 108.936 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 57.5 mtt -101.63 122.53 44.03 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.657 -0.868 . . . . 73.13 108.657 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.427 HD13 HD11 ' A' ' 176' ' ' ILE . 93.0 mt -136.65 143.43 43.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.752 -1.944 . . . . 72.2 105.752 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.93 138.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.063 0.847 . . . . 64.33 109.976 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.455 ' HB3' ' HZ3' ' A' ' 173' ' ' LYS . 4.3 ttpm? -58.38 -29.16 65.8 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.904 1.282 . . . . 71.04 112.272 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 103' ' ' MET . 11.1 mp0 -70.1 -26.32 63.93 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.606 0.763 . . . . 75.34 111.217 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.47 0.43 50.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 75.03 110.723 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.427 HD11 HD13 ' A' ' 171' ' ' LEU . 46.6 mm -121.16 125.05 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.301 0.64 . . . . 62.13 109.597 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mm -99.2 108.36 22.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.362 -1.347 . . . . 72.35 107.362 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.84 116.18 26.93 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.0 -1.482 . . . . 71.03 107.0 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -126.31 106.09 9.27 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.253 -1.388 . . . . 62.01 107.253 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.56 ' HA ' HD22 ' A' ' 2' ' ' LEU . 56.4 pttt -88.3 119.79 29.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.951 0.5 . . . . 72.02 110.904 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 34.6 t -78.25 89.84 4.32 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.803 0.841 . . . . 74.41 109.834 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.23 129.83 39.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.667 0.787 . . . . 42.24 110.516 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.883 0.873 . . . . 75.53 108.822 -179.476 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtm . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 120.656 0.265 . . . . 65.13 110.324 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 180' ' ' LYS . 32.6 mt -115.63 161.78 18.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.567 0.747 . . . . 72.41 110.969 -166.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.455 HG23 ' HB3' ' A' ' 179' ' ' GLU . 8.3 tt -105.75 130.16 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.962 -1.125 . . . . 74.42 107.962 169.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 9.1 m-30 -97.83 136.7 37.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.452 0.644 . . . . 73.15 111.711 -174.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HG3' ' HB ' ' A' ' 177' ' ' ILE . 15.3 ptmt -138.47 136.42 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.068 -1.424 . . . . 72.12 108.945 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.783 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 29.9 t70 -109.17 177.21 4.82 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.574 1.55 . . . . 62.32 110.54 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 pt -65.73 -43.07 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 123.921 0.888 . . . . 72.33 112.511 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -111.42 -51.67 2.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.368 1.067 . . . . 74.24 109.26 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -84.25 19.05 1.96 Allowed 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.026 -1.443 . . . . 62.22 110.666 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.783 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 13.0 t70 -44.37 -42.8 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.319 1.847 . . . . 64.22 113.608 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.25 -47.3 80.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.805 -1.543 . . . . 63.03 111.774 -173.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -124.41 27.35 7.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.634 0.774 . . . . 71.31 112.033 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.687 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 3.0 tm? -64.63 -79.68 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.079 -0.388 . . . . 72.44 110.327 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 75.1 m -153.32 -176.17 5.67 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.764 0.792 . . . . 74.51 111.348 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 t -151.34 95.12 2.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.943 -1.503 . . . . 70.2 106.943 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.94 95.65 0.06 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.206 1.402 . . . . 73.32 110.633 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 p -120.46 25.1 10.0 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.977 -1.49 . . . . 53.2 106.977 158.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -135.52 155.33 78.49 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.446 -1.252 . . . . 55.44 109.987 -171.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.08 120.11 7.27 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.843 1.695 . . . . 73.31 112.726 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.75 149.93 20.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.551 0.741 . . . . 74.24 110.324 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 66.6 mttm -136.18 144.97 45.25 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.508 0.723 . . . . 75.54 109.417 -173.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.0 tp -130.71 145.05 51.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.591 0.756 . . . . 72.03 109.485 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.98 133.87 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.468 0.707 . . . . 72.03 109.689 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 58.82 16.23 4.36 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.211 1.404 . . . . 72.53 113.681 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 47.25 26.56 0.71 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.536 1.135 . . . . 73.53 112.616 -167.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 119' ' ' LYS . 37.1 tp -119.94 -46.69 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.179 0.992 . . . . 72.34 109.937 -174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.81 126.54 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.115 0.566 . . . . 74.1 110.395 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.15 122.74 29.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.491 -1.3 . . . . 72.22 107.491 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 5.1 pt-20 -112.73 147.03 37.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.197 0.522 . . . . 74.22 110.118 170.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -131.49 105.08 7.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.369 -1.345 . . . . 63.43 107.369 166.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 167' ' ' PRO . 15.2 ptmt -82.01 103.64 11.79 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.11 -0.7 . . . . 74.41 109.11 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.42 ' H ' HD11 ' A' ' 70' ' ' ILE . . . -81.82 -157.4 19.46 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.042 -0.981 . . . . 63.53 112.09 176.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -124.12 161.3 25.92 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.806 0.842 . . . . 75.42 109.913 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -93.13 118.09 30.82 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.156 -1.053 . . . . 73.01 108.156 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 m -146.98 159.8 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.331 0.586 . . . . 62.11 111.42 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 44' ' ' LEU . 12.7 m -133.88 132.57 56.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.181 -1.044 . . . . 63.31 108.181 174.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.62 149.67 43.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.132 -1.433 . . . . 74.13 107.132 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -133.86 132.06 39.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.628 -0.878 . . . . 74.21 108.628 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 65.17 12.49 8.03 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.097 1.359 . . . . 62.53 113.503 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.8 21.24 26.55 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 123.051 0.358 . . . . 24.2 112.481 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.44 127.27 43.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.271 1.028 . . . . 75.12 109.175 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -72.04 118.86 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 N-CA-C 109.282 -0.636 . . . . 73.2 109.282 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.0 -46.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 112.775 0.657 . . . . 75.04 112.775 -169.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HA ' HG22 ' A' ' 36' ' ' VAL . 3.2 mm? 51.38 81.44 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.269 1.028 . . . . 74.12 110.741 -168.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.56 20.18 5.65 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.895 0.878 . . . . 71.24 110.224 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.03 -135.67 28.16 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.538 -0.625 . . . . 34.31 111.538 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.439 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 38.6 m 61.1 29.53 18.93 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.511 1.124 . . . . 74.51 112.607 173.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -128.7 52.41 9.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 113.375 0.88 . . . . 72.05 113.375 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.14 -34.99 55.32 Favored 'Trans proline' 0 C--N 1.387 2.575 0 CA-C-N 120.631 1.261 . . . . 74.44 111.06 171.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.5 m -131.66 152.48 50.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.675 1.19 . . . . 74.53 109.377 175.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.22 82.09 1.54 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.011 0.924 . . . . 43.53 109.019 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.53 -29.88 30.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.877 0.871 . . . . 63.34 111.005 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 mp0 -80.91 75.04 7.87 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.334 0.654 . . . . 73.14 109.368 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.64 -63.06 2.84 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.739 -1.345 . . . . 72.11 109.739 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 179.32 -76.23 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.433 1.493 . . . . 74.32 108.899 167.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 59.44 -82.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 126.032 1.733 . . . . 64.21 113.441 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -168.94 -90.72 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.344 0.658 . . . . 74.14 109.685 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.808 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 1.4 m-20 -139.6 21.38 2.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 52.13 112.087 -169.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.83 -43.14 84.71 Favored Glycine 0 N--CA 1.473 1.139 0 N-CA-C 112.066 -0.414 . . . . 64.02 112.066 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.4 m -138.92 63.41 1.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.867 -1.161 . . . . 73.21 107.867 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.808 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 16.1 t70 -76.21 87.72 3.06 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.863 -1.062 . . . . 72.24 110.867 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 64' ' ' VAL . 26.9 tt0 -157.62 151.22 23.88 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.346 -0.983 . . . . 53.4 108.346 170.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -80.44 23.55 0.5 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.275 0.63 . . . . 60.15 112.286 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.462 HG23 ' HG2' ' A' ' 62' ' ' GLU . 5.3 t -77.32 83.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.624 0 N-CA-C 108.132 -1.062 . . . . 72.22 108.132 170.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.4 73.31 3.16 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.959 -1.126 . . . . 70.24 107.959 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 47' ' ' SER . 15.3 ptp180 -91.97 137.28 32.49 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.952 -0.567 . . . . 72.13 109.54 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.18 -122.72 2.75 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 112.15 -0.38 . . . . 62.11 112.15 170.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.457 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 42.2 pt -112.5 138.8 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.308 0.643 . . . . 54.43 111.648 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -47.8 -46.87 31.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.209 1.404 . . . . 55.44 113.765 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.446 HD13 ' HB2' ' A' ' 169' ' ' LEU . 57.6 mt -50.41 -46.13 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.382 1.073 . . . . 73.31 111.705 -174.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.25 -47.11 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.289 -0.869 . . . . 44.44 111.216 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 17.2 mt -64.2 -36.12 83.03 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.214 0.946 . . . . 70.01 110.517 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -60.98 -37.06 81.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.879 1.672 . . . . 34.11 110.803 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.549 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 26.3 m170 -106.89 -13.33 15.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.974 -1.012 . . . . 75.3 111.99 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 55.02 57.47 5.57 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.532 1.133 . . . . 72.22 111.488 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 74' ' ' HIS . 79.5 mt -84.64 146.13 27.64 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.651 0.78 . . . . 71.5 110.431 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.84 123.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 109.538 -0.541 . . . . 70.21 109.538 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -70.6 147.36 49.31 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.704 -1.135 . . . . 42.23 112.876 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 70.4 mtp -143.74 122.35 12.52 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.015 -2.217 . . . . 53.1 105.015 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -101.0 152.86 20.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.772 -0.58 . . . . 73.44 112.007 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 20.4 p -66.88 -23.97 66.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.616 0.766 . . . . 65.02 113.058 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -72.14 -43.67 64.32 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.922 0.489 . . . . 45.21 111.575 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.73 -48.19 3.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.333 0.653 . . . . 64.34 111.395 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.41 21.0 3.04 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.122 0.969 . . . . 73.32 112.432 -171.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.4 74.83 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.591 0.757 . . . . 51.23 112.584 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.6 t -74.04 -41.22 62.13 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.812 0.845 . . . . 72.32 110.794 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -61.55 -43.99 97.84 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.06 0.544 . . . . 63.43 110.049 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.631 ' HD1' HG21 ' A' ' 153' ' ' VAL . 46.5 t80 -58.83 -42.91 90.39 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.381 1.472 . . . . 74.23 111.086 176.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -58.93 -41.45 87.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.624 0.77 . . . . 72.22 110.369 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.36 88.84 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.349 0.66 . . . . 75.42 111.277 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 63.8 m-85 -59.6 -45.24 92.49 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.737 0.415 . . . . 61.54 111.371 171.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.43 -38.31 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.814 0.846 . . . . 73.42 111.0 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -58.18 -47.74 82.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.972 0.509 . . . . 60.44 111.476 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -65.71 -51.04 62.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.545 0.738 . . . . 74.34 110.656 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -49.98 -62.29 1.65 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.941 2.097 . . . . 72.31 111.655 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 48.2 mtm -64.6 -33.98 77.19 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.634 0.584 . . . . 71.12 111.04 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -60.58 -47.03 88.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.836 0.454 . . . . 74.32 110.076 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -77.31 -48.9 16.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.486 0.714 . . . . 54.34 110.57 -172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.45 -40.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.363 0.265 . . . . 74.21 111.069 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 77.0 mt -71.19 -45.68 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 119.016 -0.516 . . . . 65.41 109.723 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 26.5 t70 -53.59 -47.69 69.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 123.882 0.873 . . . . 64.33 112.634 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -65.36 -43.18 91.6 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.757 0.423 . . . . 62.23 110.143 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.457 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 7.6 tpt -68.84 -26.07 64.97 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.653 -0.703 . . . . 63.13 110.048 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.642 ' HA ' HG11 ' A' ' 113' ' ' VAL . 1.7 tm-20 -76.4 -38.04 56.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.856 1.263 . . . . 75.14 109.787 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 64.7 mttm -67.15 -25.92 66.4 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.698 0.399 . . . . 71.24 110.61 174.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -86.17 0.68 53.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.087 0.955 . . . . 73.01 111.701 -176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -130.42 -53.43 1.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.439 0.695 . . . . 62.33 110.168 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 56.82 23.06 7.62 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.042 2.137 . . . . 72.03 112.854 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.48 -89.0 0.61 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.81 0.844 . . . . 63.01 109.564 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttp 173.13 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.648 1.179 . . . . 72.13 109.782 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.13 92.14 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.731 0.641 . . . . 52.23 112.731 -164.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.29 -48.54 17.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.765 0.426 . . . . 73.51 109.95 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 104' ' ' GLU . 35.0 m -70.39 -24.09 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.723 -0.671 . . . . 74.32 112.22 -174.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 23.0 t70 -65.43 -37.48 87.03 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.376 0.67 . . . . 73.54 109.865 172.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.425 ' O ' ' HD3' ' A' ' 119' ' ' LYS . . . -72.62 -49.49 31.64 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.876 0.735 . . . . 62.45 109.935 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -55.16 -47.92 74.48 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.885 0.474 . . . . 75.22 110.418 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -60.7 -46.59 89.82 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.387 1.054 . . . . 74.54 110.944 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -61.25 -43.89 98.14 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.009 0.818 . . . . 70.24 110.248 -174.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.474 ' HB3' HD22 ' A' ' 26' ' ' LEU . 5.1 mptp? -79.28 -36.91 39.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.501 -0.772 . . . . 51.42 111.337 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.1 tp -73.99 -38.22 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 118.751 0.705 . . . . 74.22 110.324 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.446 ' HA ' HG22 ' A' ' 124' ' ' VAL . 23.4 tm0? -72.32 -39.34 68.28 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 176.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.63 -39.21 97.08 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.513 0.508 . . . . 72.13 112.28 174.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -65.13 -51.42 61.33 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.504 0.722 . . . . 73.32 109.616 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.8 m -68.77 -42.12 82.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-O 118.936 -0.554 . . . . 75.22 111.04 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.1 -29.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 118.85 0.75 . . . . 74.13 110.605 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.3 t -77.81 -39.17 44.69 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.201 0.6 . . . . 71.23 110.882 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.694 HD21 HG21 ' A' ' 155' ' ' ILE . 35.0 tp -72.48 -29.45 63.65 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.521 1.128 . . . . 63.13 111.509 -174.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 38.0 mt -86.75 0.3 54.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.195 0.598 . . . . 73.52 111.123 -177.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.31 81.05 4.69 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.076 -0.713 . . . . 21.31 109.076 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 61.7 pttt -61.56 -6.1 2.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.875 1.27 . . . . 63.23 113.819 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -54.44 -42.72 70.9 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.955 0.902 . . . . 61.05 110.838 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -109.17 -37.98 5.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.285 1.034 . . . . 73.11 109.637 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.456 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 56.7 m-85 -79.26 -1.54 37.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.796 1.238 . . . . 72.14 114.15 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 30.3 ttmt -50.64 -12.74 0.11 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.1 1.148 . . . . 62.32 114.1 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 77.4 m-20 -82.29 22.09 0.86 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.745 0.818 . . . . 71.12 111.467 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 72.8 mt -89.23 136.95 32.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.171 0.588 . . . . 73.15 109.598 172.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.47 122.95 25.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.661 -1.607 . . . . 43.52 106.661 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -99.39 129.44 45.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.937 0.495 . . . . 54.53 109.8 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 96.6 m-85 -130.33 146.12 51.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.826 0.451 . . . . 74.52 110.525 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.37 170.26 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.933 0.493 . . . . 63.14 109.751 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.54 138.84 22.27 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.658 -0.701 . . . . 55.12 112.353 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -59.86 -47.47 85.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.7 1.2 . . . . 64.4 109.833 171.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -38.35 68.35 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.795 1.238 . . . . 73.23 111.206 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.02 -46.34 68.22 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.923 -1.035 . . . . 73.11 110.292 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.01 -3.25 51.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.352 0.661 . . . . 72.01 112.429 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.94 -41.66 14.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.258 0.623 . . . . 73.32 111.726 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.62 46.37 0.1 OUTLIER Glycine 0 N--CA 1.469 0.867 0 C-N-CA 121.271 -0.49 . . . . 73.25 112.839 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.93 -165.2 1.68 Allowed 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.154 0.982 . . . . 63.2 108.826 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -55.09 122.56 11.23 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.792 -0.818 . . . . 74.25 108.792 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -50.38 -31.04 13.68 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.957 1.411 . . . . 70.3 111.621 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 123.87 -174.39 16.77 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.797 -0.638 . . . . 53.0 112.902 172.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.442 HE22 HD22 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -121.4 164.79 16.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.926 1.291 . . . . 63.24 108.072 167.344 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.631 HG21 ' HD1' ' A' ' 88' ' ' PHE . 41.9 t -79.15 116.94 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.585 0.707 . . . . 71.13 111.77 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.35 106.17 5.85 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.071 -1.422 . . . . 62.4 107.908 161.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.694 HG21 HD21 ' A' ' 127' ' ' LEU . 54.8 mt -90.41 106.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.534 0.733 . . . . 71.02 110.236 -165.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 169' ' ' LEU . 44.9 mm -96.05 115.98 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.033 -0.358 . . . . 71.35 110.033 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -100.51 121.4 41.51 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.09 0.556 . . . . 74.53 110.0 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 32.6 m-85 -83.43 98.34 9.45 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.633 -0.877 . . . . 73.33 108.633 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -90.74 131.88 36.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.686 -0.857 . . . . 74.22 108.686 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.79 108.38 19.95 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.166 -0.679 . . . . 71.31 109.166 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.03 111.47 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 108.978 -0.749 . . . . 64.44 108.978 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.33 21.5 11.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.428 1.091 . . . . 71.43 112.826 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.19 31.17 14.83 Favored Glycine 0 C--N 1.347 1.144 0 C-N-CA 121.908 -0.187 . . . . 64.03 112.909 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -133.71 121.71 22.34 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.881 0.872 . . . . 64.34 109.326 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.92 126.65 30.45 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.545 0.528 . . . . 75.23 109.634 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.01 107.22 37.99 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 108.221 -1.029 . . . . 51.43 108.221 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 57.8 Cg_endo -68.15 127.57 16.14 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.677 2.252 . . . . 75.34 111.178 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 20.8 m -118.06 104.79 11.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.184 0.594 . . . . 71.25 109.845 -171.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 56.2 tp -78.01 106.19 9.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.621 0.769 . . . . 74.31 109.674 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.524 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.3 mtt -103.28 122.81 45.56 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.571 0.748 . . . . 73.41 109.139 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.442 HD22 HE22 ' A' ' 152' ' ' GLN . 85.9 mt -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.937 -1.875 . . . . 74.44 105.937 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 174' ' ' GLU . 14.0 p -83.09 143.71 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 108.047 -1.094 . . . . 62.21 108.047 173.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -48.56 -37.58 18.24 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.501 1.52 . . . . 64.21 111.707 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 8.7 tp10 -83.72 -0.52 51.18 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.688 0.795 . . . . 74.13 112.191 -175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -104.73 -33.29 8.5 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.545 0.738 . . . . 61.45 110.373 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.66 133.48 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.33 0.586 . . . . 74.31 110.285 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.418 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.8 mm -127.9 131.94 69.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 107.385 -1.339 . . . . 61.32 107.385 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' HB2' HD13 ' A' ' 2' ' ' LEU . 10.5 pt-20 -95.06 124.8 39.31 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.245 -0.65 . . . . 62.54 109.245 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.455 ' HB3' HG23 ' A' ' 3' ' ' ILE . 15.9 tp10 -108.4 125.54 51.85 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.841 -0.8 . . . . 65.54 108.841 175.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.453 ' HA ' HD22 ' A' ' 2' ' ' LEU . 13.8 mptt -71.28 154.25 41.78 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.746 0.818 . . . . 45.55 110.621 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 39.8 m -133.3 86.41 2.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.492 -0.559 . . . . 63.14 109.492 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -170.08 0.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.085 0.954 . . . . 71.0 112.149 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 . . . . . 0 CA--C 1.552 1.026 0 C-N-CA 123.573 0.749 . . . . 71.13 109.152 -178.679 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.933 -0.395 . . . . 72.52 109.933 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.16 123.32 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.649 -0.871 . . . . 51.51 108.649 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 179' ' ' GLU . 9.7 tt -96.82 119.95 45.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.6 0.714 . . . . 74.01 110.068 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -102.71 110.83 22.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.717 -1.957 . . . . 63.42 105.717 173.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -131.24 134.95 46.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.068 0.547 . . . . 74.42 111.736 -167.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.408 ' HA ' HD13 ' A' ' 176' ' ' ILE . 27.7 t70 -81.65 131.2 35.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.71 0.804 . . . . 71.32 109.751 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 175' ' ' ALA . 25.9 pt -77.94 -11.55 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 73.22 112.752 -171.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.569 ' HE1' ' HB1' ' A' ' 175' ' ' ALA . 9.0 m-85 -94.15 -64.68 1.05 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.082 0.401 . . . . 73.05 110.619 -172.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' HB3' ' A' ' 149' ' ' GLU . 3.2 p -132.08 -37.68 1.12 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.385 1.074 . . . . 72.32 113.702 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.34 23.56 8.26 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.048 0.939 . . . . 71.22 111.854 -162.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -46.35 -26.32 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 126.014 1.726 . . . . 73.11 115.027 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.91 27.58 0.87 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.367 1.067 . . . . 74.41 111.16 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.63 -73.69 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.735 1.614 . . . . 75.5 112.39 -173.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 m -152.15 131.87 13.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.973 0.509 . . . . 61.14 109.85 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 34.5 p -131.34 91.79 3.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.037 0.935 . . . . 75.41 108.942 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.426 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.0 t70 -168.31 177.55 5.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.594 0.757 . . . . 74.45 109.628 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 p -83.39 81.55 8.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.589 0.756 . . . . 53.31 109.344 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 36.9 m-85 -103.19 152.79 38.68 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 115.188 -0.915 . . . . 74.33 109.57 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -46.98 119.12 3.16 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.872 2.381 . . . . 61.44 112.83 173.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.7 tpt -112.26 120.93 43.44 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.224 -1.028 . . . . 71.31 108.224 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -142.44 116.62 9.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.764 -1.569 . . . . 74.23 106.764 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.9 tp -123.64 113.91 19.28 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.104 0.962 . . . . 73.12 108.606 -172.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.25 137.0 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.08 0.952 . . . . 52.54 109.649 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 56.09 18.98 3.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 125.417 1.487 . . . . 71.34 113.315 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.62 14.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.371 1.068 . . . . 73.23 112.113 -172.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 119' ' ' LYS . 37.2 tp -112.74 -51.28 2.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.62 0.768 . . . . 73.14 110.636 -168.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -116.15 122.09 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.534 -0.757 . . . . 61.45 109.708 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.59 113.06 21.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.851 -1.166 . . . . 62.1 107.851 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -103.99 107.62 18.6 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.016 0.926 . . . . 73.34 109.032 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 45.9 t80 -90.2 112.62 24.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.595 1.158 . . . . 64.2 109.159 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HE2' HG11 ' A' ' 166' ' ' VAL . 62.5 tttm -69.2 143.5 53.99 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.067 0.547 . . . . 72.33 110.546 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.19 -174.54 33.2 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 110.822 -0.911 . . . . 64.22 110.822 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 20.2 ptmt -134.43 151.56 51.26 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.477 0.639 . . . . 73.52 111.088 -173.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -75.39 125.21 28.53 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.303 -0.629 . . . . 73.52 109.303 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 HD12 ' A' ' 72' ' ' LEU . 4.7 m -150.85 155.99 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.211 1.404 . . . . 64.31 108.962 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.5 m -133.27 161.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.847 -0.798 . . . . 64.32 108.847 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -138.12 110.22 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.631 -0.877 . . . . 73.53 108.631 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -117.29 147.36 42.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.285 -1.005 . . . . 75.53 108.285 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -59.43 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.739 1.216 . . . . 55.0 111.106 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.25 -52.42 0.65 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.085 -1.416 . . . . 70.34 111.722 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -165.31 2.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.526 0.731 . . . . 74.54 112.122 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.519 HD11 HD23 ' A' ' 44' ' ' LEU . 7.4 tt -142.91 119.24 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.054 0.942 . . . . 72.31 110.51 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.36 87.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 107.951 -1.129 . . . . 74.51 107.951 168.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.519 HD23 HD11 ' A' ' 42' ' ' ILE . 2.3 pp -83.67 -21.18 32.49 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.555 0.342 . . . . 74.32 111.323 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.26 149.85 34.67 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.53 0.732 . . . . 45.53 110.882 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.32 40.59 0.07 OUTLIER Glycine 0 C--N 1.335 0.48 0 CA-C-N 114.864 -1.062 . . . . 54.31 111.128 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 t 58.97 49.37 9.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.835 1.254 . . . . 74.34 109.785 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -133.75 137.44 28.67 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 114.69 -1.141 . . . . 72.42 110.027 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.01 -155.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.642 2.228 . . . . 54.3 110.951 168.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 t -78.48 67.67 4.3 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.905 0.482 . . . . 63.21 110.383 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.61 91.83 6.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.408 0.683 . . . . 64.33 109.947 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -71.09 -57.11 4.84 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.114 0.966 . . . . 74.35 110.929 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 60.25 23.01 12.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.025 1.33 . . . . 73.12 113.308 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -131.1 50.38 0.89 Allowed Glycine 0 N--CA 1.468 0.803 0 N-CA-C 111.779 -0.528 . . . . 60.44 111.779 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.7 -22.64 63.4 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.991 0.516 . . . . 73.42 110.274 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -128.6 48.93 2.25 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.791 1.236 . . . . 71.3 107.702 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.04 105.36 0.31 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.107 0.963 . . . . 64.34 112.177 -174.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -114.2 7.59 16.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.759 1.224 . . . . 62.4 110.535 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.82 114.14 6.55 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 123.532 0.52 . . . . 55.33 111.838 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.2 p -74.6 83.13 2.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.582 0.753 . . . . 64.41 110.576 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -130.64 131.31 44.83 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.544 0.738 . . . . 63.54 110.022 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -96.72 -16.0 21.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.374 1.069 . . . . 61.53 110.103 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -139.07 75.63 1.53 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.591 0.756 . . . . 73.02 110.888 -175.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.19 85.27 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.211 -1.403 . . . . 72.34 107.211 159.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' HG2' HD22 ' A' ' 72' ' ' LEU . 37.4 tt0 -93.34 75.5 4.54 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 107.795 -1.187 . . . . 64.4 107.795 172.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -89.01 144.76 25.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.553 -1.203 . . . . 72.32 110.589 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.01 -130.54 3.13 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.099 -0.8 . . . . 71.41 111.099 164.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 156' ' ' ILE . 20.4 pt -112.73 150.06 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 122.881 0.472 . . . . 74.14 111.212 168.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -41.17 -41.32 1.77 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 127.122 2.169 . . . . 72.35 113.146 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' A' ' 169' ' ' LEU . 66.9 mt -57.58 -55.32 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 124.336 1.023 . . . . 61.35 110.352 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG13 ' HB2' ' A' ' 76' ' ' LEU . 40.3 t -60.56 -44.91 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 114.407 -1.269 . . . . 63.34 111.215 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' HG2' ' A' ' 65' ' ' GLU . 19.1 mt -72.34 -35.8 68.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.418 -0.81 . . . . 61.05 111.127 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -72.04 -33.88 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.757 0.823 . . . . 72.11 110.83 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -97.7 -5.68 34.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.417 0.687 . . . . 74.11 111.64 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt 55.5 63.13 2.17 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.937 1.295 . . . . 73.24 110.683 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HB2' HG13 ' A' ' 71' ' ' VAL . 58.0 mt -100.52 135.35 42.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.713 -1.131 . . . . 64.52 109.367 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.75 130.35 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.519 -0.548 . . . . 75.1 109.519 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.98 134.32 43.08 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.804 -1.089 . . . . 61.35 111.902 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.4 mtp -145.56 103.84 3.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.853 1.661 . . . . 72.23 107.273 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.485 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 95.6 m-20 -86.05 149.98 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.522 -0.736 . . . . 63.43 109.691 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 138' ' ' PHE . 37.0 t -60.72 -20.38 61.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.625 -0.716 . . . . 74.24 111.812 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.485 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 95.1 m-85 -58.28 -57.72 11.65 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.331 1.053 . . . . 74.44 110.925 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -74.24 -35.14 63.83 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.274 -0.876 . . . . 73.2 111.851 -174.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -121.44 19.37 11.31 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 112.208 0.447 . . . . 64.12 112.208 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.39 -39.6 7.11 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.681 0.993 . . . . 51.42 113.681 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.0 m -65.98 -60.18 3.1 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.507 0.723 . . . . 55.22 111.378 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.2 mtt -76.75 -14.54 59.93 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.988 -0.551 . . . . 75.22 111.431 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.67 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 40.5 t80 -70.1 -38.51 75.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.21 0.604 . . . . 72.1 109.862 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -70.07 -26.15 63.88 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 110.216 -0.291 . . . . 75.04 110.216 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.3 72.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.012 -0.54 . . . . 70.12 110.785 170.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.67 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 33.1 m-85 -58.48 -44.86 89.53 Favored 'General case' 0 C--N 1.367 1.346 0 C-N-CA 123.205 0.602 . . . . 63.21 109.784 170.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm -64.15 -38.78 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.843 0.857 . . . . 54.24 111.613 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -60.02 -46.92 87.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.935 0.494 . . . . 64.44 111.713 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -66.49 -44.89 81.38 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 64.0 110.395 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -50.41 -59.31 4.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.204 1.802 . . . . 73.11 110.85 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 64.0 mtt -57.26 -57.45 12.57 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.164 0.915 . . . . 54.44 111.022 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.17 -30.69 71.23 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.285 0.366 . . . . 72.22 111.639 -173.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -78.34 -45.15 23.28 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.74 0.416 . . . . 72.23 110.991 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 175' ' ' ALA . 32.4 m -68.27 -28.8 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 123.196 0.31 . . . . 74.3 110.583 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' HE2' ' A' ' 103' ' ' MET . 52.6 mt -75.04 -45.36 42.68 Favored 'Isoleucine or valine' 0 C--N 1.359 0.978 0 C-N-CA 123.431 0.692 . . . . 73.53 110.307 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.63 -31.87 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.444 0.698 . . . . 52.33 111.337 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -69.78 -61.35 1.82 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.984 0.914 . . . . 73.24 109.811 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.441 ' HE1' ' O ' ' A' ' 113' ' ' VAL . 21.9 ptt? -64.5 -50.31 67.89 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.66 0.6 . . . . 52.44 111.444 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.82 -20.93 66.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.348 0.659 . . . . 71.43 111.991 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -72.64 -25.73 61.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.387 0.675 . . . . 75.22 110.388 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.57 0.09 12.58 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.799 0.84 . . . . 62.43 111.538 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -120.02 -74.11 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.158 0.583 . . . . 65.51 110.206 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 50.08 18.78 0.41 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.548 1.939 . . . . 72.44 115.131 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.86 -22.64 49.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.249 0.62 . . . . 71.4 110.001 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 113' ' ' VAL . 86.0 tttt 84.15 -38.76 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.148 1.779 . . . . 70.35 111.73 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.89 62.79 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.227 0.467 . . . . 75.3 110.637 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -86.2 -44.55 12.09 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.938 0.895 . . . . 74.25 111.742 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 110' ' ' LYS . 33.5 m -78.03 -34.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.139 -0.482 . . . . 73.44 111.564 -174.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.72 -25.3 56.49 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.701 -0.481 . . . . 72.12 109.701 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.7 -47.98 57.01 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.351 0.66 . . . . 63.12 109.691 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -61.85 -47.69 83.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.216 1.006 . . . . 74.24 110.828 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.56 -36.18 79.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.195 0.998 . . . . 72.32 110.786 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.72 -46.17 83.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.66 0.784 . . . . 73.43 109.939 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HB3' HD22 ' A' ' 26' ' ' LEU . 34.4 mmtp -66.49 -37.75 85.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.465 -0.789 . . . . 72.55 111.107 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 124' ' ' VAL . 22.7 mm -73.24 -36.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.82 0.848 . . . . 63.23 110.682 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.422 ' O ' HG23 ' A' ' 125' ' ' VAL . 22.4 tm0? -61.32 -52.51 64.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.744 -0.835 . . . . 73.1 108.744 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.67 -37.44 94.37 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.66 -0.7 . . . . 65.23 112.325 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -62.51 -55.32 28.57 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.1 0.96 . . . . 74.35 110.743 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.507 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -67.23 -41.15 86.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-O 118.402 -0.809 . . . . 75.12 111.151 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 121' ' ' GLN . 88.2 t -60.3 -42.52 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.095 0.861 . . . . 63.11 110.787 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -70.24 -31.4 68.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.883 0.473 . . . . 61.15 111.311 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 155' ' ' ILE . 31.9 tp -84.03 -21.65 31.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.058 0.943 . . . . 64.02 111.342 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -92.88 -0.37 57.25 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.694 0.797 . . . . 55.1 111.589 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.82 101.32 0.19 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.09 0.556 . . . . 51.45 110.487 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 15.3 ptmm? -61.77 -12.41 16.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.962 1.305 . . . . 64.14 114.432 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.68 -46.46 82.33 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.829 0.452 . . . . 63.15 111.113 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -110.13 -40.36 4.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.242 1.017 . . . . 75.35 109.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -81.58 -3.47 53.39 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.233 1.013 . . . . 65.41 112.608 -167.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 61.1 tttm -46.09 -31.01 2.11 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.423 1.089 . . . . 75.2 111.895 160.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -97.57 26.66 4.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.332 1.053 . . . . 54.13 111.596 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 mt -88.69 140.61 29.28 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.214 -0.662 . . . . 61.52 109.214 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.55 112.34 25.03 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.401 -1.333 . . . . 71.14 107.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.405 ' HE2' ' HB2' ' A' ' 81' ' ' CYS . 76.7 m-85 -99.71 140.35 34.05 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.579 -0.897 . . . . 72.54 108.579 -175.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . 45.5 m-85 -131.84 150.04 52.27 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.953 -1.128 . . . . 74.21 107.953 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.2 tt -124.13 141.05 45.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 107.948 -1.13 . . . . 75.11 107.948 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.32 138.61 47.69 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.014 0.822 . . . . 62.41 111.904 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 49.0 tt0 -43.31 -54.21 4.77 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.178 0.991 . . . . 74.4 112.18 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -64.24 -38.35 90.74 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.9 0.75 . . . . 64.3 111.29 -172.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.25 97.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.717 0.807 . . . . 14.42 110.924 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 -16.28 56.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.401 1.08 . . . . 64.11 113.215 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 42.3 mt-10 -64.27 -31.41 72.61 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.775 0.43 . . . . 73.32 111.693 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.19 51.86 0.03 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.739 -0.944 . . . . 35.04 110.739 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.72 -170.18 2.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.778 0.831 . . . . 74.54 110.314 -173.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.494 ' HB3' HG23 ' A' ' 9' ' ' THR . 12.7 tp10 -51.18 142.83 11.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.461 1.104 . . . . 72.34 111.53 173.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -50.98 -26.46 6.04 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.779 1.77 . . . . 71.12 115.779 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.66 176.54 21.43 Favored Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.051 0.219 . . . . 73.45 112.902 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.07 127.16 33.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 106.758 -1.571 . . . . 63.43 106.758 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 155' ' ' ILE . 67.9 t -74.63 113.7 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.322 -0.622 . . . . 65.22 109.322 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 139' ' ' PHE . . . -64.81 97.09 0.2 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.62 1.168 . . . . 73.22 109.654 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.659 HG21 HD21 ' A' ' 127' ' ' LEU . 85.2 mt -88.15 102.73 12.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 108.538 -0.912 . . . . 75.13 108.538 -172.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.629 HD12 HD11 ' A' ' 68' ' ' ILE . 41.0 mm -95.56 114.29 31.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 116.255 -0.43 . . . . 54.31 109.967 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.71 130.18 54.89 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.406 -1.27 . . . . 74.2 108.313 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.3 p90 -83.12 124.41 30.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.992 -1.484 . . . . 62.44 106.992 173.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -116.14 135.74 53.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.635 -1.246 . . . . 64.14 107.635 -171.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.11 115.39 28.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.032 -0.729 . . . . 44.14 109.032 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.6 107.64 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.952 -0.759 . . . . 73.31 108.952 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 63.97 30.63 14.1 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.416 1.086 . . . . 64.12 110.734 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.94 25.03 75.71 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.59 -0.732 . . . . 54.42 113.038 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.1 m -108.34 134.85 50.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.612 0.765 . . . . 61.23 109.129 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -73.14 111.43 8.25 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.888 -0.782 . . . . 73.44 108.888 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.422 HG11 ' HE2' ' A' ' 31' ' ' LYS . 27.0 m -128.63 88.07 53.16 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 121.845 0.831 . . . . 74.15 108.98 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 80.6 Cg_exo -55.37 121.4 9.86 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.788 2.325 . . . . 71.4 111.989 168.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.6 t -115.28 140.07 49.42 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.347 1.059 . . . . 71.24 109.098 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.7 tp -91.75 114.54 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.712 1.205 . . . . 73.41 108.967 176.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 81.1 mtp -93.84 123.04 36.93 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 107.568 -1.271 . . . . 61.35 107.568 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.578 HD13 HG21 ' A' ' 176' ' ' ILE . 94.0 mt -132.84 141.26 48.36 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.629 1.572 . . . . 64.24 107.511 -177.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.2 p -80.87 133.7 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.471 -0.937 . . . . 71.33 108.471 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -66.29 -19.62 65.87 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.431 0.692 . . . . 75.41 112.254 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.38 -30.43 47.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.768 0.318 . . . . 71.42 111.48 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.569 ' HB1' ' HE1' ' A' ' 8' ' ' PHE . . . -104.21 -10.16 18.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.092 0.557 . . . . 72.31 111.678 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 171' ' ' LEU . 36.1 mm -126.25 108.34 19.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.787 -1.561 . . . . 62.31 106.787 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.2 mm -95.04 113.18 28.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.288 -0.869 . . . . 73.35 109.596 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.37 135.84 44.31 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.434 -1.321 . . . . 75.23 107.434 166.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.616 ' HB3' HG23 ' A' ' 3' ' ' ILE . 36.9 tt0 -149.19 134.74 18.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.818 0.342 . . . . 73.12 110.235 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.588 ' HE3' HD11 ' A' ' 182' ' ' LEU . 37.8 tttp -81.14 112.42 18.48 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.45 -0.945 . . . . 61.31 108.45 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.75 92.36 3.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.887 -0.783 . . . . 65.24 108.887 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.588 HD11 ' HE3' ' A' ' 180' ' ' LYS . 48.1 mt -98.74 152.96 19.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.094 0.558 . . . . 53.22 110.88 -174.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 CA--C 1.557 1.222 0 C-N-CA 122.892 0.477 . . . . 71.24 110.389 178.577 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.924 -0.769 . . . . 75.24 108.924 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.516 HD12 ' SD ' ' A' ' 20' ' ' MET . 84.0 mt -133.16 153.07 51.86 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.143 -0.688 . . . . 61.25 109.143 175.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.626 HG23 ' HB3' ' A' ' 179' ' ' GLU . 4.4 tt -114.49 116.74 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.906 -1.516 . . . . 55.32 106.906 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 5.2 m-85 -100.97 130.93 47.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.26 -1.385 . . . . 73.3 107.26 -174.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.96 161.7 19.76 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.289 1.036 . . . . 71.32 109.638 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 35.3 t70 -116.02 178.06 4.46 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.383 1.073 . . . . 65.13 109.743 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.96 -39.27 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 CA-C-O 121.348 0.594 . . . . 71.54 110.306 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -110.93 -55.25 2.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.679 1.192 . . . . 63.32 110.002 -168.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.495 ' HB ' HD23 ' A' ' 13' ' ' LEU . 3.7 m -90.06 15.74 9.6 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 113.755 -1.566 . . . . 72.44 111.234 -168.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.7 p-10 -63.2 -7.11 5.21 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 114.603 1.334 . . . . 75.35 114.603 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -48.82 -50.98 31.93 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.403 1.064 . . . . 72.23 111.393 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -123.35 -40.54 2.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.017 0.927 . . . . 72.11 109.144 164.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.495 HD23 ' HB ' ' A' ' 9' ' ' THR . 2.0 tm? 42.9 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.294 1.837 . . . . 73.23 111.67 -167.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.406 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 67.1 p -155.26 154.49 32.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.66 0.784 . . . . 51.15 110.783 175.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.1 m -163.16 96.35 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.959 0.904 . . . . 73.21 110.468 -171.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -179.16 172.77 1.21 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.612 1.165 . . . . 63.31 108.912 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -38.8 -55.1 1.55 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.466 1.106 . . . . 73.21 111.355 165.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 14' ' ' SER . 9.7 m-30 43.07 108.29 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 125.924 1.69 . . . . 71.43 114.84 174.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.92 121.04 9.29 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 121.951 1.767 . . . . 75.11 110.951 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.516 ' SD ' HD12 ' A' ' 2' ' ' LEU . 44.4 mtm -101.28 150.45 22.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.128 0.971 . . . . 72.42 109.718 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -156.76 134.27 10.74 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.113 -0.699 . . . . 71.44 109.113 171.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.73 122.55 47.44 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.18 -1.045 . . . . 44.44 108.18 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.52 135.19 52.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.465 0.706 . . . . 71.42 110.082 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 60.5 14.18 4.66 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.678 1.191 . . . . 71.15 112.536 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 48.58 33.84 4.47 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.547 1.139 . . . . 74.24 111.67 -171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 119' ' ' LYS . 32.8 tp -125.81 -52.47 1.56 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.236 -0.893 . . . . 72.13 109.632 -175.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.1 t -114.13 128.9 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.281 -0.872 . . . . 71.23 109.226 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.88 112.84 21.52 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 106.829 -1.545 . . . . 65.22 106.829 166.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -104.43 145.06 30.81 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.175 -0.676 . . . . 62.15 109.175 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -142.93 105.48 4.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.484 1.114 . . . . 72.42 108.411 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.67 149.22 26.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.348 0.659 . . . . 65.4 110.415 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.97 -161.76 9.53 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.88 -1.055 . . . . 74.14 111.262 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 139.83 51.02 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.76 0.824 . . . . 72.14 109.891 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -73.76 115.81 13.63 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.71 -1.132 . . . . 74.51 109.236 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -147.45 -175.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.721 1.208 . . . . 71.21 109.792 -170.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.482 HG22 ' HB3' ' A' ' 44' ' ' LEU . 26.0 m -113.16 161.05 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.448 0.699 . . . . 72.31 110.909 173.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 60.6 ttt180 -136.3 112.18 9.55 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.666 1.186 . . . . 72.42 108.366 174.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HD2' HG22 ' A' ' 64' ' ' VAL . 52.0 tttm -135.66 96.73 3.5 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 47.7 -81.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 126.326 1.851 . . . . 74.52 112.987 -173.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.15 26.13 0.31 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.856 -0.898 . . . . 71.41 110.856 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.32 98.14 4.02 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.689 1.596 . . . . 45.44 107.182 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.476 HD12 HD23 ' A' ' 44' ' ' LEU . 7.7 pt -131.39 136.86 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.215 0.531 . . . . 71.23 110.99 -176.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.78 49.42 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.578 1.151 . . . . 62.33 108.389 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.482 ' HB3' HG22 ' A' ' 36' ' ' VAL . 1.1 pp -57.0 143.05 39.65 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.331 -1.304 . . . . 61.24 111.684 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.0 -10.42 55.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.726 -0.67 . . . . 73.4 110.486 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.58 -105.42 0.42 Allowed Glycine 0 C--N 1.362 2.026 0 N-CA-C 110.591 -1.004 . . . . 74.41 110.591 -171.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 t -80.35 95.57 6.41 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.96 -1.496 . . . . 73.5 106.96 167.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -65.29 112.14 7.69 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.776 0.831 . . . . 74.31 110.626 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.26 117.51 4.4 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.697 2.265 . . . . 62.15 112.385 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.1 t 58.22 85.18 0.09 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.657 1.183 . . . . 72.53 111.25 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.06 98.33 8.59 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.225 -0.657 . . . . 61.54 109.225 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -14.25 60.62 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.976 -1.011 . . . . 74.44 112.075 -176.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 10.2 tp10 -136.25 -82.88 0.38 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.505 0.322 . . . . 75.13 111.089 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.97 23.27 67.49 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 123.022 0.201 . . . . 72.42 113.515 -175.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -138.07 37.26 2.34 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.792 0.837 . . . . 64.23 110.794 -173.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.87 -19.56 60.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.758 0.823 . . . . 74.32 112.13 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 63.73 24.92 14.02 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.139 1.376 . . . . 55.14 112.113 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 62.78 90.83 0.07 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.496 1.119 . . . . 74.5 110.398 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.36 14.56 1.44 Allowed Glycine 0 N--CA 1.477 1.419 0 CA-C-O 120.327 -0.152 . . . . 31.23 113.085 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.7 m -150.15 25.88 0.8 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.482 1.113 . . . . 61.43 108.492 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -122.47 39.42 3.92 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.884 1.274 . . . . 74.44 109.979 -168.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -50.54 -46.51 57.48 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.771 1.228 . . . . 74.5 111.74 -177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -133.47 23.54 4.05 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.562 0.745 . . . . 74.23 110.37 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.41 HG22 ' HD2' ' A' ' 38' ' ' LYS . 46.2 t -106.73 97.91 6.25 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 109.157 -0.683 . . . . 55.12 109.157 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.8 mp0 -78.26 82.06 4.59 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.313 -0.995 . . . . 73.34 108.313 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -76.11 146.37 39.33 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.982 -0.747 . . . . 75.34 108.982 168.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.33 -136.7 5.54 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.644 -0.582 . . . . 61.21 111.644 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.784 HD11 HD12 ' A' ' 70' ' ' ILE . 2.1 tt -104.31 126.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.627 1.171 . . . . 41.34 109.026 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.26 -29.46 33.06 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.188 1.395 . . . . 64.03 113.502 -172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.784 HD12 HD11 ' A' ' 68' ' ' ILE . 56.5 mt -61.53 -44.87 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.428 1.091 . . . . 53.02 110.048 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 76' ' ' LEU . 44.0 t -74.68 -41.79 47.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-N 114.179 -1.373 . . . . 73.14 110.268 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 35.2 mt -67.2 -24.09 65.81 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.668 0.605 . . . . 72.23 110.914 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -62.36 -61.11 2.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.635 1.174 . . . . 60.31 110.513 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -87.01 -20.17 27.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.729 0.812 . . . . 72.32 111.227 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 41.2 ttmt 66.38 69.62 0.42 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.042 1.337 . . . . 73.45 109.124 -168.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.586 ' HB2' HG13 ' A' ' 71' ' ' VAL . 70.4 mt -80.44 136.34 36.32 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.255 -1.017 . . . . 62.42 108.255 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.91 130.28 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.09 -0.707 . . . . 74.51 109.09 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.47 148.54 37.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.039 . . . . 72.1 112.59 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 56.2 ttp -148.69 134.42 18.85 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.239 -1.346 . . . . 65.42 107.657 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -119.09 142.69 47.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.091 0.556 . . . . 43.02 109.645 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.6 -11.92 48.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.711 0.805 . . . . 52.41 111.753 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -80.25 -34.63 36.95 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.973 0.909 . . . . 65.11 111.424 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -103.06 -37.22 7.86 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.172 0.511 . . . . 54.14 110.635 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.4 20.4 16.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.315 1.046 . . . . 71.11 111.925 -169.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -44.77 -43.48 8.61 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.748 1.219 . . . . 71.12 113.57 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.3 t -65.62 -52.04 55.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.057 0.943 . . . . 63.53 111.353 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.1 mpt? -68.63 -42.29 78.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.967 0.907 . . . . 62.33 110.688 -173.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.465 ' HE1' HG11 ' A' ' 153' ' ' VAL . 51.5 t80 -63.04 -41.87 99.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.766 1.226 . . . . 73.34 111.236 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -65.28 -36.56 84.47 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.212 0.605 . . . . 73.23 110.637 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.79 87.52 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.787 -0.642 . . . . 64.22 110.307 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -65.03 -45.63 84.66 Favored 'General case' 0 C--O 1.193 -1.874 0 CA-C-O 118.571 -0.728 . . . . 75.31 110.808 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.25 -43.08 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.36 0.664 . . . . 64.44 111.67 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.81 -49.07 78.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.702 0.801 . . . . 71.42 111.26 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -79.5 -38.25 34.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.256 0.622 . . . . 71.32 111.173 -173.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -50.99 -53.75 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.632 1.573 . . . . 74.13 110.387 170.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.9 ttp -53.79 -55.87 22.62 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 124.184 0.927 . . . . 74.4 110.14 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.36 -36.67 66.57 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.48 1.112 . . . . 63.14 112.186 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.09 -41.53 18.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.026 0.931 . . . . 71.41 111.936 -169.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -76.88 -27.74 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.673 0.389 . . . . 62.21 111.916 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.467 HD13 ' HG3' ' A' ' 117' ' ' LYS . 84.8 mt -73.05 -36.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.312 0.645 . . . . 64.5 109.303 171.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.59 -44.89 95.19 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.892 0.877 . . . . 65.22 110.562 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -63.2 -44.44 95.36 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.666 -0.697 . . . . 64.12 110.106 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.494 ' HG2' ' HB2' ' A' ' 107' ' ' ASN . 22.9 ttt -66.82 -40.05 87.91 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.258 -0.883 . . . . 64.32 111.329 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.562 ' HA ' HG11 ' A' ' 113' ' ' VAL . 7.6 tp10 -55.27 -40.67 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.563 1.145 . . . . 64.25 111.556 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -37.3 74.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.085 -0.961 . . . . 65.11 111.439 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -115.07 0.74 13.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.16 0.584 . . . . 64.34 111.62 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 103' ' ' MET . 18.3 m120 -148.7 41.99 0.96 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.257 1.023 . . . . 63.52 109.22 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.73 10.68 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.697 1.599 . . . . 61.42 113.632 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.69 -24.37 21.64 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.934 1.294 . . . . 72.45 112.005 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? 89.72 -58.01 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.666 1.986 . . . . 74.4 112.483 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.91 63.18 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.1 0.409 . . . . 55.1 110.933 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.01 -45.89 25.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.09 0.956 . . . . 54.1 111.049 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 104' ' ' GLU . 8.0 m -76.03 -26.92 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.716 0.406 . . . . 74.42 111.571 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.43 -36.37 73.93 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.447 0.699 . . . . 72.45 110.345 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.93 81.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.701 -0.681 . . . . 74.34 110.399 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.485 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 79.3 t80 -63.07 -41.99 99.57 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.444 1.098 . . . . 55.33 110.331 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.467 ' HG3' HD13 ' A' ' 100' ' ' ILE . 35.5 ttpt -63.9 -38.29 90.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.133 0.973 . . . . 72.42 110.478 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -67.19 -41.5 85.75 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.884 0.874 . . . . 70.31 110.005 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.596 ' HB3' HD22 ' A' ' 26' ' ' LEU . 87.9 mttt -67.24 -39.8 86.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.415 -0.811 . . . . 75.24 111.034 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 124' ' ' VAL . 23.3 mm -67.72 -47.05 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.468 0.707 . . . . 72.13 109.731 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -51.9 -51.83 54.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.666 1.186 . . . . 75.4 110.41 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.76 -38.12 89.35 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.776 -1.102 . . . . 64.22 113.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -65.43 -54.83 22.9 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.354 0.662 . . . . 64.34 110.463 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.5 m -66.5 -42.04 89.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 118.35 -0.833 . . . . 64.22 111.208 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.47 -35.98 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 119.505 1.048 . . . . 71.11 110.871 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.1 t -74.3 -38.01 63.49 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 123.481 0.712 . . . . 64.21 110.956 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.39 -19.04 39.9 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.787 0.835 . . . . 71.33 111.128 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.4 mt -93.7 2.22 56.35 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.142 0.577 . . . . 74.41 111.398 174.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 91.58 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.326 0.584 . . . . 64.11 109.843 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -59.12 -8.28 1.47 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.336 1.455 . . . . 75.22 114.685 -168.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.32 -46.59 72.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.928 0.891 . . . . 75.55 110.333 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -109.29 -39.09 5.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.964 0.906 . . . . 75.1 110.435 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -79.23 -1.89 38.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.595 1.158 . . . . 70.42 113.248 -163.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -51.89 -24.75 6.71 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 122.858 0.463 . . . . 64.41 111.615 160.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -93.92 29.63 2.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.753 1.221 . . . . 64.31 110.351 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.3 mt -94.02 153.43 18.18 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.919 -0.771 . . . . 73.11 108.919 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.58 117.42 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.272 -1.381 . . . . 72.12 107.272 172.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.57 ' HD1' HG22 ' A' ' 155' ' ' ILE . 50.1 m-85 -94.12 140.78 29.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.142 -1.058 . . . . 65.24 108.142 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 83.6 m-85 -136.46 153.81 50.95 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.774 -0.454 . . . . 74.32 109.774 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 tt -143.71 149.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.857 -1.164 . . . . 73.52 107.857 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.08 123.94 34.15 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.293 -0.723 . . . . 73.31 111.293 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -55.22 -34.01 63.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.825 0.85 . . . . 70.14 112.499 -177.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -66.39 -43.13 86.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.963 0.905 . . . . 75.21 110.196 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.24 -35.62 80.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.312 -0.858 . . . . 65.31 110.189 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.46 -12.43 57.84 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 64.1 112.143 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -95.63 -40.74 9.26 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.356 0.662 . . . . 55.44 111.065 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.18 49.62 0.28 Allowed Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.126 -0.488 . . . . 74.32 112.588 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.75 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -158.22 -179.77 8.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.696 0.798 . . . . 62.22 109.91 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.7 155.35 48.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.102 0.561 . . . . 71.35 111.055 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 67.61 20.38 9.65 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.078 1.351 . . . . 64.15 113.315 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.72 144.73 33.87 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.118 0.261 . . . . 72.5 112.868 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -69.93 139.55 52.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.767 0.827 . . . . 64.43 112.302 -168.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.465 HG11 ' HE1' ' A' ' 88' ' ' PHE . 31.7 t -88.51 94.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.578 -0.737 . . . . 75.12 109.544 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.15 104.24 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.158 -0.928 . . . . 75.41 108.588 169.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.57 HG22 ' HD1' ' A' ' 138' ' ' PHE . 1.1 pt -95.12 113.68 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.421 0.629 . . . . 61.13 109.919 -168.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 169' ' ' LEU . 50.8 mm -107.09 133.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.8 -1.091 . . . . 61.22 110.207 -170.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 45.7 mt-10 -94.41 142.26 27.63 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.861 -0.792 . . . . 61.54 108.861 166.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -119.92 87.15 2.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.004 -1.85 . . . . 70.14 106.004 155.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 17.9 ttt180 -95.32 170.2 9.54 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 113.9 -1.5 . . . . 74.42 109.06 -171.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -98.12 124.97 42.93 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.552 1.069 . . . . 75.11 111.956 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.88 105.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.611 1.164 . . . . 73.42 108.466 167.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.4 t70 63.68 5.52 2.25 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.729 1.212 . . . . 75.5 112.695 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.35 -18.16 8.88 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.449 -0.639 . . . . 74.53 114.077 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 t -101.11 167.33 10.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 117.789 0.794 . . . . 71.45 109.609 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 1.2 pm0 -94.72 126.79 40.26 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.99 0.516 . . . . 64.11 112.105 -172.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 t -78.79 107.54 6.18 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 72.35 108.979 166.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.0 Cg_endo -87.97 112.5 0.77 Allowed 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 122.712 2.275 . . . . 65.3 109.988 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.3 m -126.31 118.21 24.61 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.811 0.444 . . . . 74.54 111.037 -174.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.473 ' HA ' HD13 ' A' ' 156' ' ' ILE . 53.0 tp -78.92 134.28 36.88 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.109 -0.7 . . . . 71.43 109.109 166.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.524 ' HB2' HG13 ' A' ' 155' ' ' ILE . 65.7 mtt -124.37 138.44 54.37 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.885 -1.154 . . . . 74.12 107.885 165.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.509 HD13 HD11 ' A' ' 176' ' ' ILE . 53.5 mt -152.16 150.85 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.098 1.759 . . . . 73.42 106.789 169.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.8 p -78.76 149.1 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.599 -0.889 . . . . 72.32 108.599 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -63.6 -31.58 72.79 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.321 0.649 . . . . 71.45 110.214 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 103' ' ' MET . 67.6 mm-40 -76.97 -3.37 38.54 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.504 0.928 . . . . 73.31 113.504 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.72 -25.13 14.78 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.965 0.506 . . . . 50.33 110.065 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.509 HD11 HD13 ' A' ' 171' ' ' LEU . 48.3 mm -106.52 125.28 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.422 0.689 . . . . 51.41 110.866 -170.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.0 mm -110.22 109.36 28.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.59 -1.263 . . . . 52.42 107.59 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.61 111.5 19.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.068 -0.969 . . . . 70.41 108.657 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.626 ' HB3' HG23 ' A' ' 3' ' ' ILE . 8.8 tp10 -95.11 130.44 41.81 Favored 'General case' 0 C--O 1.248 0.98 0 N-CA-C 109.394 -0.595 . . . . 71.41 109.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -71.87 108.58 5.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.141 -0.936 . . . . 74.22 109.797 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.9 t -94.32 89.82 6.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.465 0.706 . . . . 71.0 110.011 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.86 -61.18 1.46 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.022 0.929 . . . . 44.34 109.267 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 123.846 0.858 . . . . 74.33 109.597 -178.818 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.609 ' SD ' ' HA ' ' A' ' 16' ' ' ASP . 45.2 tpp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.438 -0.579 . . . . 73.13 109.438 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 18' ' ' PHE . 79.3 mt -118.47 152.96 34.93 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.689 -0.856 . . . . 74.11 108.689 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.0 pt -131.99 121.08 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 108.563 -0.903 . . . . 70.12 108.563 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 23.1 p90 -122.15 135.58 54.8 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 121.58 -0.7 . . . . 45.34 109.946 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 46.4 mtpt -137.72 135.09 36.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.839 -1.528 . . . . 70.41 109.448 -159.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.94 144.32 36.92 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.298 -0.631 . . . . 54.33 109.298 173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.23 -26.42 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 113.475 0.917 . . . . 74.12 113.475 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -96.72 -67.85 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 114.238 1.199 . . . . 74.2 114.238 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -130.38 -22.45 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.462 0.912 . . . . 74.52 113.462 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.57 23.15 13.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.458 1.103 . . . . 60.52 109.74 -169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.26 -15.29 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.574 1.55 . . . . 71.2 114.286 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -76.24 -40.45 51.99 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 121.55 -0.718 . . . . 75.34 111.78 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 37.4 mt 21.18 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 126.455 1.902 . . . . 73.05 113.813 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.5 m -152.14 123.03 7.5 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.782 0.289 . . . . 72.32 111.782 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.6 m -113.01 94.66 5.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.595 1.158 . . . . 73.22 110.538 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.609 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 26.7 t70 -168.97 166.17 11.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.95 0.9 . . . . 64.34 109.668 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -70.32 78.43 0.54 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.527 0.731 . . . . 65.21 110.334 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 32.1 m-85 -104.21 146.7 33.06 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 124.784 1.233 . . . . 45.3 110.673 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.38 118.9 5.91 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.52 2.147 . . . . 73.34 112.603 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.7 ptm -113.4 145.68 40.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.342 0.657 . . . . 64.13 109.927 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -151.47 137.64 18.35 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.235 -0.654 . . . . 63.45 109.235 174.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.53 148.53 24.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.386 1.074 . . . . 75.44 108.232 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.11 134.25 47.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 C-N-CA 124.074 0.95 . . . . 71.13 109.375 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 59.51 16.47 5.29 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.945 1.298 . . . . 62.01 112.53 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 54.61 32.73 17.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.509 1.523 . . . . 60.25 112.542 -174.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 119' ' ' LYS . 55.2 tp -132.23 -50.97 0.94 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.226 0.61 . . . . 74.02 111.033 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.39 141.92 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.319 0.648 . . . . 71.34 109.819 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.69 113.24 24.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.586 -0.894 . . . . 72.12 108.586 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG3' ' HB3' ' A' ' 21' ' ' LYS . 6.0 pt-20 -82.88 104.08 12.83 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.007 -1.479 . . . . 61.34 107.007 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.581 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.0 t80 -88.88 112.67 23.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.94 -1.504 . . . . 71.42 106.94 177.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -67.2 148.88 51.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.912 0.885 . . . . 71.11 110.969 -171.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 157.78 27.51 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.496 0.497 . . . . 63.31 113.575 -174.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -121.26 140.23 52.34 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.311 -0.996 . . . . 73.11 108.311 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -74.33 116.78 15.39 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.001 -1.481 . . . . 74.45 107.001 167.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 72' ' ' LEU . 34.4 m -131.08 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 124.545 1.138 . . . . 75.12 108.398 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG22 HD13 ' A' ' 44' ' ' LEU . 32.0 m -125.86 153.93 34.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.814 0.846 . . . . 75.3 109.655 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.536 ' HB2' HD13 ' A' ' 72' ' ' LEU . 12.9 ttp180 -141.53 110.26 6.1 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.071 0.462 . . . . 74.55 110.945 170.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HG3' ' H ' ' A' ' 40' ' ' GLY . 51.9 tptt -133.94 137.99 45.2 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 107.585 -1.265 . . . . 72.54 107.585 169.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -9.89 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.039 0.755 . . . . 65.3 113.039 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' A' ' 38' ' ' LYS . . . -106.83 -38.65 2.15 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.303 -0.319 . . . . 60.43 112.303 170.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -121.27 138.3 54.3 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.179 0.592 . . . . 74.11 112.321 -167.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.18 3.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.927 0.891 . . . . 61.02 110.405 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -63.16 114.08 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.301 0.641 . . . . 62.3 110.875 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.426 HD22 ' H ' ' A' ' 44' ' ' LEU . 1.4 mm? -66.26 96.45 0.34 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.179 -0.675 . . . . 71.1 109.179 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.6 -48.18 72.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.541 1.137 . . . . 55.41 111.578 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.17 35.75 88.7 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.333 -0.848 . . . . 44.02 112.893 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.6 t -110.95 169.65 8.62 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.808 0.843 . . . . 75.52 110.713 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.38 148.68 89.47 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.641 0.776 . . . . 71.52 112.022 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.29 103.82 0.11 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 123.28 2.653 . . . . 75.01 110.822 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.8 p -79.15 12.76 2.12 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.241 0.83 . . . . 72.14 113.241 -167.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.27 76.38 0.35 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.731 0.813 . . . . 72.43 109.517 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.28 23.44 2.98 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.481 -1.236 . . . . 73.01 110.759 -167.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.59 28.37 0.77 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.076 -0.966 . . . . 73.42 110.69 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.46 -12.19 69.35 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.234 -0.759 . . . . 74.15 114.497 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 74.07 -71.37 0.13 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.817 1.247 . . . . 74.34 111.614 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -77.74 84.48 4.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.418 0.628 . . . . 62.34 109.439 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -155.91 131.5 9.65 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.233 -1.025 . . . . 73.34 108.233 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 63' ' ' HIS . 18.1 m-20 60.94 28.7 18.47 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.397 1.079 . . . . 64.55 111.862 -175.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.72 -92.78 1.12 Allowed Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.4 -0.818 . . . . 62.33 111.536 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.2 t -94.36 -158.25 0.62 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.791 1.236 . . . . 65.05 109.635 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -74.43 17.81 0.18 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.451 0.7 . . . . 72.42 112.727 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.47 -29.49 58.83 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.99 0.516 . . . . 62.3 109.897 168.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 83.1 t60 -82.79 70.76 9.84 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.659 -0.7 . . . . 71.42 109.876 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.4 t -80.77 -67.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 107.233 -1.395 . . . . 64.34 107.233 165.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . 0.252 2.1 pt-20 68.7 -45.85 0.54 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.694 2.398 . . . . 74.52 113.528 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -134.15 146.35 50.12 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 108.398 -0.964 . . . . 60.34 108.398 -173.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.57 44.65 Favored Glycine 0 N--CA 1.447 -0.58 0 O-C-N 123.604 0.565 . . . . 55.03 112.259 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.802 HD11 HD12 ' A' ' 70' ' ' ILE . 1.8 tt -94.82 130.1 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.219 -1.03 . . . . 70.01 108.219 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -47.97 -40.67 23.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.753 1.621 . . . . 71.23 113.416 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.802 HD12 HD11 ' A' ' 68' ' ' ILE . 62.4 mt -55.36 -47.88 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.741 1.216 . . . . 71.32 110.666 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.1 -48.63 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.405 0.682 . . . . 74.53 111.713 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 37' ' ' ARG . 63.0 mt -60.83 -33.91 73.75 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.094 0.871 . . . . 74.51 111.092 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -79.35 -48.65 13.68 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.169 0.987 . . . . 75.43 111.16 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -87.15 1.78 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.91 0.484 . . . . 75.03 111.612 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 70.5 mmtt 64.38 34.86 10.11 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.833 1.253 . . . . 73.43 111.165 173.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.51 132.71 40.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.205 -0.665 . . . . 53.24 109.205 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 p -84.64 133.46 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 N-CA-C 109.883 -0.414 . . . . 72.43 109.883 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.79 140.34 45.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.157 1.383 . . . . 70.23 112.677 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -148.06 131.55 16.72 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.505 -0.924 . . . . 71.43 108.505 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 45.2 m-80 -88.0 137.57 32.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.816 0.446 . . . . 63.15 110.491 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.1 p -57.74 -30.75 65.83 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.501 1.521 . . . . 74.43 111.204 172.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.427 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 47.1 m-85 -59.51 -34.58 72.8 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.673 -1.603 . . . . 73.24 110.832 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.46 -18.59 14.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.752 0.821 . . . . 75.13 111.829 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.69 14.98 20.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.261 0.624 . . . . 72.24 112.143 -169.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.89 -53.96 50.86 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.563 0.62 . . . . 75.52 112.213 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.7 t -70.5 -36.54 73.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.345 0.658 . . . . 65.31 110.745 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.0 mmm -62.39 -38.39 89.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.273 0.629 . . . . 73.43 110.846 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 76.4 t80 -78.95 -25.45 43.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.707 0.803 . . . . 72.32 110.627 -176.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -62.94 -41.79 99.6 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.951 -0.759 . . . . 75.03 108.951 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.4 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 74.32 111.05 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 23.2 m-85 -61.37 -37.98 85.34 Favored 'General case' 0 C--N 1.364 1.205 0 CA-C-O 119.506 -0.283 . . . . 72.21 110.48 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.785 HG21 HD11 ' A' ' 128' ' ' LEU . 14.8 mm -66.47 -41.67 89.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 124.061 0.851 . . . . 74.14 111.876 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -61.88 -38.4 88.16 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.89 0.768 . . . . 75.33 110.204 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.82 -45.22 68.35 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.457 -0.792 . . . . 72.11 110.431 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . 84.6 t80 -55.76 -57.31 12.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.738 1.615 . . . . 63.43 111.621 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.2 ptm -63.97 -31.64 72.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.493 0.717 . . . . 70.52 110.693 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -61.5 -58.55 7.72 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.867 -0.42 . . . . 73.13 109.867 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.5 -27.38 62.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.336 -0.847 . . . . 71.01 112.223 -168.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 174' ' ' GLU . 22.5 m -75.2 -38.46 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 117.697 0.226 . . . . 72.02 111.326 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' HE2' ' A' ' 103' ' ' MET . 55.4 mt -69.31 -38.05 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 110.324 -0.25 . . . . 73.53 110.324 176.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 -46.4 88.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.017 0.527 . . . . 70.12 110.685 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -53.23 -56.01 19.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.129 0.971 . . . . 64.05 111.057 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.439 ' HE1' ' O ' ' A' ' 113' ' ' VAL . 19.4 ptt? -64.63 -45.49 86.61 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.086 0.866 . . . . 64.2 111.346 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.142 0.977 . . . . 75.55 111.529 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -62.8 -27.1 69.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.993 0.917 . . . . 65.3 113.177 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -116.26 -6.91 11.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.139 0.422 . . . . 72.02 112.139 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.83 -64.67 1.04 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.52 -0.919 . . . . 71.51 108.52 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 74.35 -26.99 0.19 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.09 1.356 . . . . 70.51 112.166 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.65 125.8 29.87 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.658 0.783 . . . . 64.23 109.747 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.94 -23.31 66.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.521 1.128 . . . . 74.11 111.248 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.18 73.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.961 0.904 . . . . 62.31 111.483 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.48 -48.69 6.01 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.584 0.754 . . . . 54.32 110.031 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.439 ' O ' ' HE1' ' A' ' 103' ' ' MET . 27.6 m -75.9 -34.08 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 113.19 0.811 . . . . 70.15 113.19 -169.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.21 -38.98 89.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 118.702 0.683 . . . . 74.22 110.254 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.98 -45.49 73.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.016 -0.993 . . . . 74.23 110.786 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.36 -42.03 96.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.74 0.416 . . . . 65.35 110.291 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.78 -38.58 75.71 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.727 0.811 . . . . 63.15 110.824 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -68.36 -43.07 78.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.411 0.685 . . . . 71.44 110.52 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HB3' HD22 ' A' ' 26' ' ' LEU . 70.3 mmtt -60.12 -55.85 28.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.73 0.812 . . . . 75.13 111.134 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.491 HD13 HG21 ' A' ' 172' ' ' VAL . 10.5 tp -66.97 -31.18 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.488 0.715 . . . . 73.34 110.232 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.62 -62.76 1.47 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 123.041 0.536 . . . . 74.41 110.123 168.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.77 -27.45 66.6 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.606 0.567 . . . . 12.13 113.77 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -73.88 -45.17 52.55 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.152 0.581 . . . . 71.55 111.009 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.67 -25.34 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 122.989 0.181 . . . . 61.41 110.892 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.08 -27.58 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.879 -0.513 . . . . 61.12 109.803 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -76.68 -50.97 12.4 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.367 0.667 . . . . 64.14 110.375 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 155' ' ' ILE . 36.8 tp -75.15 -33.02 61.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.296 1.039 . . . . 61.32 112.766 -166.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.785 HD11 HG21 ' A' ' 92' ' ' ILE . 95.9 mt -79.07 2.89 19.08 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.86 0.689 . . . . 70.24 112.86 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.55 143.11 48.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.254 -1.017 . . . . 73.32 108.254 170.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 25.8 pttm -57.75 -27.36 62.95 Favored 'General case' 0 C--O 1.212 -0.87 0 O-C-N 124.1 0.875 . . . . 63.22 111.89 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -46.1 87.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.229 1.412 . . . . 72.41 110.59 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.477 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 1.5 mpp_? -67.85 -44.33 77.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.596 -1.183 . . . . 65.55 110.115 175.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.492 ' HE1' ' HA ' ' A' ' 128' ' ' LEU . 7.2 m-85 -61.53 -25.76 67.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.831 0.853 . . . . 53.24 113.029 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 25.2 mtpp -64.88 -20.43 66.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.859 0.464 . . . . 74.51 111.382 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -132.57 17.09 4.36 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.375 0.67 . . . . 71.33 112.154 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 44.1 mt -93.07 139.38 30.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.277 0.489 . . . . 72.1 110.272 172.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -122.16 123.38 41.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.69 -1.226 . . . . 62.23 107.69 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -95.38 128.75 42.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.218 0.532 . . . . 71.42 109.684 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -130.65 151.86 50.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.19 -1.041 . . . . 64.42 108.19 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.3 pt -134.0 167.94 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 108.324 -0.991 . . . . 72.53 108.324 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.81 144.65 48.2 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.761 -0.536 . . . . 24.11 111.761 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 36.7 tt0 -52.9 -42.71 65.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.113 0.565 . . . . 74.24 110.735 173.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.694 HH11 ' HB2' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -60.76 -42.62 97.81 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.309 1.444 . . . . 71.55 110.319 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.699 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -56.09 -51.68 67.02 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.951 0.9 . . . . 74.33 111.59 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.86 -29.16 61.96 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.455 -0.793 . . . . 72.25 112.4 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -74.26 -41.74 60.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.553 . . . . 72.13 110.856 -171.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.23 62.63 0.08 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.15 -0.78 . . . . 71.35 111.15 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -157.59 175.6 13.72 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.155 0.582 . . . . 73.32 110.865 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.82 170.56 13.38 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.896 0.878 . . . . 64.0 113.16 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -86.09 67.19 9.9 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.722 1.209 . . . . 74.2 108.003 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.09 -112.0 0.01 OUTLIER Glycine 0 CA--C 1.54 1.625 0 CA-C-N 113.229 -1.805 . . . . 75.44 114.39 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.38 155.99 17.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.202 0.601 . . . . 73.52 109.558 169.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 85.4 t -103.01 126.55 57.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.817 -0.808 . . . . 73.41 108.817 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.626 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.09 103.84 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.127 0.971 . . . . 64.13 109.113 170.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 127' ' ' LEU . 63.2 mt -90.68 110.6 22.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.171 -0.677 . . . . 75.04 109.171 -171.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 68' ' ' ILE . 51.2 mm -96.91 98.96 8.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.215 0.531 . . . . 74.02 110.001 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.43 96.51 5.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.894 -1.15 . . . . 74.31 107.894 169.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 45.0 p90 -107.02 129.12 54.85 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.411 -0.588 . . . . 72.33 109.411 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.16 -177.36 6.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.473 1.109 . . . . 72.41 109.09 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.19 137.52 54.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.43 0.292 . . . . 72.11 110.28 171.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.7 p -111.03 111.95 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 N-CA-C 108.22 -1.029 . . . . 72.42 108.22 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 63.49 17.43 10.34 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.828 1.251 . . . . 54.45 112.367 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.18 -19.03 30.22 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.113 -0.271 . . . . 62.43 112.719 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.4 m -82.28 106.94 14.57 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.3 0.55 . . . . 72.01 109.537 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -71.97 101.61 2.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 71.1 109.922 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.7 m -105.6 101.19 30.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 113.627 -1.624 . . . . 71.34 109.348 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.629 ' HB2' HD12 ' A' ' 68' ' ' ILE . 92.0 Cg_endo -92.15 118.36 0.45 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.95 2.433 . . . . 61.34 111.703 172.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 28.1 m -114.43 135.53 54.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.129 0.972 . . . . 71.3 109.565 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 38.6 tp -79.61 146.24 32.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.803 -0.814 . . . . 50.53 108.803 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.0 ptp -141.05 132.5 26.86 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.428 0.632 . . . . 65.21 109.635 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.626 HD21 ' HA ' ' A' ' 154' ' ' ALA . 94.8 mt -139.14 149.83 44.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.482 1.913 . . . . 74.34 107.032 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.491 HG21 HD13 ' A' ' 120' ' ' ILE . 6.2 p -83.14 146.54 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.476 -0.935 . . . . 72.31 108.476 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -25.42 8.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.754 1.621 . . . . 72.1 112.585 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . 2.0 tp10 -89.22 -27.07 20.87 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.085 0.954 . . . . 63.32 112.583 -172.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.37 -6.51 37.4 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.949 0.5 . . . . 71.14 110.77 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 172' ' ' VAL . 10.5 tp -118.12 151.4 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.053 0.941 . . . . 73.34 108.72 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 47.3 mm -124.55 107.97 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.1 -1.444 . . . . 74.42 107.1 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 140.59 46.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.675 -0.491 . . . . 75.21 109.675 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.88 124.82 13.49 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.294 -1.002 . . . . 63.55 108.294 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.497 ' HG2' HD22 ' A' ' 182' ' ' LEU . 36.2 ttpt -80.72 103.99 10.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.405 0.682 . . . . 75.44 109.602 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.31 90.0 8.14 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.395 0.678 . . . . 74.32 109.457 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 182' ' ' LEU . 2.6 pt? -118.9 175.07 5.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.443 0.697 . . . . 73.25 109.855 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.562 1.409 0 C-N-CA 123.546 0.738 . . . . 65.42 110.078 -179.049 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 63.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 110.204 -0.295 . . . . 70.11 110.204 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mt -104.43 137.76 41.82 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.444 0.698 . . . . 72.43 109.882 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.517 HG22 ' HB2' ' A' ' 15' ' ' SER . 21.1 pt -121.43 122.23 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 109.498 -0.556 . . . . 74.42 109.498 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.741 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 18.6 p90 -124.3 114.88 20.15 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.85 0.86 . . . . 73.41 110.061 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 169.14 14.37 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.836 0.854 . . . . 73.31 110.438 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -114.67 175.34 5.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.425 0.69 . . . . 71.33 109.432 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.28 -28.33 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 112.918 0.71 . . . . 60.4 112.918 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.58 -59.88 1.89 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.488 0.715 . . . . 74.21 110.295 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -84.41 19.8 1.83 Allowed 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.147 -0.933 . . . . 72.14 110.8 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -45.35 -35.87 3.84 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.194 2.197 . . . . 61.33 114.012 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.07 -9.76 42.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.338 0.655 . . . . 71.41 112.375 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -121.17 16.5 11.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.668 0.787 . . . . 72.42 111.287 -172.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -105.27 -164.54 1.04 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 72.32 108.468 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -151.64 152.28 32.62 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.212 0.529 . . . . 71.24 111.712 -168.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.517 ' HB2' HG22 ' A' ' 3' ' ' ILE . 59.9 p -137.18 101.39 4.53 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.08 0.952 . . . . 65.43 109.124 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.2 t70 -157.37 -84.11 0.05 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.782 0.433 . . . . 75.21 110.273 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 m 177.69 86.77 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.264 1.826 . . . . 63.25 107.383 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.08 148.19 64.83 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.028 -0.987 . . . . 64.13 108.341 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.86 118.46 5.63 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.87 1.713 . . . . 74.12 112.559 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.741 ' SD ' ' HB3' ' A' ' 4' ' ' TYR . 58.4 mtm -114.34 144.66 42.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.746 0.818 . . . . 72.12 109.353 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -131.32 156.56 45.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.933 . . . . 61.14 108.896 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.591 HD11 ' HD3' ' A' ' 173' ' ' LYS . 28.3 tp -127.97 139.57 52.49 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.472 -0.936 . . . . 64.25 108.472 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.84 145.56 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 C-N-CA 123.213 0.605 . . . . 65.24 109.721 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 67.72 2.51 3.05 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.579 1.152 . . . . 54.33 112.356 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 55.49 29.08 12.67 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.112 0.965 . . . . 73.53 110.827 -167.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 119' ' ' LYS . 49.8 tp -134.45 -51.32 0.81 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.543 0.687 . . . . 73.42 110.483 -175.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.2 t -107.23 127.18 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.728 -1.123 . . . . 61.02 109.834 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -83.02 134.09 35.06 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.405 -0.961 . . . . 74.34 108.405 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.4 tt0 -130.17 104.7 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.076 -0.965 . . . . 74.55 109.056 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.589 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.6 t80 -90.59 124.36 34.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.099 -0.704 . . . . 73.32 109.099 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -80.15 138.59 36.92 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.745 -0.465 . . . . 72.42 109.745 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.99 151.5 20.05 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.517 -0.633 . . . . 42.52 111.517 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -93.58 150.25 20.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.191 0.596 . . . . 72.13 110.265 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -83.16 106.04 14.63 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.115 -1.069 . . . . 61.45 108.115 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG23 HD12 ' A' ' 72' ' ' LEU . 16.8 m -141.83 162.89 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.508 0.723 . . . . 61.03 109.583 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.43 HG22 HD12 ' A' ' 42' ' ' ILE . 11.4 m -127.04 151.31 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.946 -0.39 . . . . 60.24 109.946 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.6 107.59 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.352 -1.351 . . . . 74.44 107.352 160.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -123.64 95.02 4.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.525 -1.287 . . . . 73.51 107.525 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 49.2 -77.33 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 126.392 1.877 . . . . 64.42 113.161 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.8 45.71 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.779 -0.928 . . . . 71.32 110.779 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.74 137.23 16.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.294 1.038 . . . . 63.22 110.15 -173.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 36' ' ' VAL . 5.9 tp -115.56 91.14 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 123.948 0.899 . . . . 74.01 110.062 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.57 90.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.983 -1.117 . . . . 72.23 107.983 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 44' ' ' LEU . 6.5 mp -50.58 -39.27 49.21 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.816 1.246 . . . . 72.04 112.275 -169.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 58.03 66.5 1.1 Allowed 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.069 0.947 . . . . 65.02 110.669 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.16 68.96 0.85 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.311 -0.858 . . . . 70.34 112.1 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 p -148.39 156.67 42.79 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 125.115 1.366 . . . . 75.22 108.77 -172.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.41 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 2.5 m-20 -60.1 -52.53 72.7 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 117.796 -1.097 . . . . 74.5 112.685 -176.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 48' ' ' ASN . 71.1 Cg_exo -52.88 101.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.404 3.449 0 C-N-CA 122.618 2.212 . . . . 72.44 114.158 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.2 m -113.43 104.59 12.44 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.438 1.095 . . . . 72.33 108.793 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' A' ' 66' ' ' ARG . . . -146.51 177.74 8.82 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.817 0.847 . . . . 60.02 109.857 -173.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 63.2 15.4 8.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.593 0.96 . . . . 75.51 113.593 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -84.69 80.25 9.32 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.842 1.306 . . . . 75.32 109.836 178.182 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.87 84.12 0.1 OUTLIER Glycine 0 C--N 1.344 1.024 0 CA-C-N 113.87 -1.514 . . . . 44.5 110.975 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.68 -58.82 6.57 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.386 1.074 . . . . 63.04 111.691 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.06 116.21 11.77 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.346 0.658 . . . . 72.21 109.692 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -173.51 -163.91 0.2 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.422 -1.325 . . . . 63.03 107.422 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -75.65 98.0 3.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.934 -1.135 . . . . 74.33 107.934 168.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.2 50.21 0.89 Allowed Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.448 -1.061 . . . . 75.25 110.448 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 42.8 m -67.2 152.92 44.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.927 0.891 . . . . 71.53 112.336 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -137.17 -159.79 0.99 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.6 1.16 . . . . 72.45 109.133 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.42 169.52 2.89 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.755 0.822 . . . . 73.15 110.108 164.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -75.92 61.66 1.5 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.787 0.435 . . . . 74.31 110.866 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 12.1 t -97.43 69.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.685 0 N-CA-C 108.266 -1.013 . . . . 70.52 108.266 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.51 67.91 10.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.611 -1.255 . . . . 61.43 107.611 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 51' ' ' ALA . 12.8 ptm180 -91.88 157.01 17.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.853 -1.067 . . . . 73.41 112.089 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.3 -124.48 1.95 Allowed Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.151 -0.477 . . . . 43.31 112.336 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 12.6 pt -112.47 154.68 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.344 0.658 . . . . 75.43 111.153 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -53.83 -42.05 68.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.745 1.218 . . . . 45.31 112.7 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.6 mt -58.27 -45.99 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.711 1.204 . . . . 64.21 110.106 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 76' ' ' LEU . 75.8 t -72.63 -49.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 114.239 -1.346 . . . . 63.21 112.093 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 57.2 mt -67.94 -33.18 74.18 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.661 0.601 . . . . 71.24 112.404 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.56 -29.55 70.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.613 0.571 . . . . 71.55 111.304 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -115.52 -19.74 10.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.696 0.998 . . . . 73.25 113.696 -170.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? 68.56 59.85 0.39 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.887 0.875 . . . . 71.31 109.195 -170.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 71' ' ' VAL . 87.2 mt -77.42 125.5 29.43 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 107.506 -1.294 . . . . 74.23 107.506 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.34 124.85 39.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 109.114 -0.698 . . . . 41.22 109.114 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.11 158.9 33.95 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 122.0 0.905 . . . . 55.03 112.48 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.2 tpt -147.38 112.17 5.38 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 105.744 -1.947 . . . . 71.02 105.744 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 89.3 m-20 -100.42 128.3 46.52 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.192 0.597 . . . . 54.3 110.139 -171.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.98 -12.85 12.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.804 1.641 . . . . 71.54 113.054 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.432 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 69.1 m-85 -73.88 -38.07 64.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.048 1.339 . . . . 71.23 111.085 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.04 -38.15 6.4 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.414 0.686 . . . . 74.24 112.614 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -66.96 -3.13 6.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.025 1.861 . . . . 64.21 116.025 -159.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -30.12 -63.77 0.13 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.843 1.657 . . . . 63.15 114.815 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.8 m -64.33 -42.76 96.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.903 0.481 . . . . 75.25 111.693 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 85.2 mmm -71.67 -50.93 26.01 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.474 0.484 . . . . 74.31 111.907 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.41 ' HE2' HD22 ' A' ' 128' ' ' LEU . 58.2 t80 -65.71 -40.0 91.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.599 0.76 . . . . 75.11 111.527 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.28 -35.13 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.78 0.432 . . . . 65.31 110.542 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 94' ' ' LYS . . . -64.26 -42.7 96.35 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 123.296 0.373 . . . . 42.24 110.184 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -67.92 -33.98 75.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.654 0.782 . . . . 75.44 112.033 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.25 -38.87 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.187 0.595 . . . . 51.44 110.641 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -41.3 98.54 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.112 -0.699 . . . . 72.34 109.112 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mmtt -61.97 -60.75 3.16 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.508 -0.923 . . . . 71.12 108.508 175.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.4 ' O ' HG13 ' A' ' 99' ' ' VAL . 60.8 t80 -43.6 -60.85 1.59 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.132 1.773 . . . . 71.34 111.493 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 42.5 ttp -56.51 -60.64 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.134 0.974 . . . . 54.1 110.631 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -60.12 -41.62 93.01 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.422 0.451 . . . . 72.35 111.322 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -72.47 -39.8 67.46 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 119.124 -0.465 . . . . 33.3 111.63 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 175' ' ' ALA . 22.2 m -70.71 -37.27 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 117.823 0.283 . . . . 75.44 111.375 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.89 -43.24 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.074 0.464 . . . . 75.21 109.797 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.05 -30.21 68.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.284 1.034 . . . . 72.03 111.335 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -62.53 -48.77 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.55 0.74 . . . . 60.1 109.463 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.432 ' HG3' ' HG3' ' A' ' 174' ' ' GLU . 16.1 mmt -78.28 -21.02 50.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.741 -0.663 . . . . 73.41 112.064 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.29 -30.29 62.02 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.773 -0.579 . . . . 75.33 109.868 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -75.01 -31.58 61.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.509 0.723 . . . . 73.51 110.71 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -99.12 -29.68 12.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.252 0.621 . . . . 72.54 112.613 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -103.18 -43.68 5.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 73.11 108.686 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 64.68 19.82 11.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.692 1.197 . . . . 73.33 112.433 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m-20 -94.85 103.74 15.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.301 -1.0 . . . . 75.23 108.301 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.25 -37.89 81.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.07 0.948 . . . . 62.02 111.827 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.29 74.61 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.416 0.686 . . . . 74.45 111.52 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 109' ' ' ASP . 3.6 t70 -75.42 -49.84 17.68 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.059 0.943 . . . . 63.2 110.712 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.94 -23.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.468 -0.787 . . . . 73.03 111.659 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.15 -35.45 61.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.873 0.469 . . . . 72.24 110.203 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 118' ' ' LYS . . . -69.64 -39.42 77.15 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.482 -0.562 . . . . 63.03 109.482 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -65.63 -38.54 89.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.181 0.993 . . . . 73.31 110.771 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.35 -33.86 73.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.237 1.015 . . . . 73.1 110.798 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 18.0 tppt? -64.92 -48.96 72.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.509 0.724 . . . . 73.12 110.32 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HB3' HD22 ' A' ' 26' ' ' LEU . 13.5 mptt -63.93 -40.12 95.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.415 0.286 . . . . 74.2 111.63 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 172' ' ' VAL . 17.6 mm -70.27 -48.26 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 118.994 -0.527 . . . . 73.05 111.095 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.24 -46.08 83.32 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.081 -0.711 . . . . 54.14 109.081 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.13 94.54 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.285 0.991 . . . . 43.01 113.292 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.3 -52.09 56.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 122.992 0.517 . . . . 74.45 109.861 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 25.8 m -70.85 -37.3 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 123.644 0.59 . . . . 73.12 111.727 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.89 -32.83 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.81 0.732 . . . . 73.31 109.784 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -74.98 -40.96 60.43 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.875 -0.602 . . . . 64.2 111.497 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.3 tp -78.87 -19.35 52.15 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.305 1.042 . . . . 73.11 112.307 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 47.4 mt -93.64 2.65 56.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.271 0.628 . . . . 72.25 111.49 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.3 91.15 2.16 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.746 0.418 . . . . 52.03 109.933 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 44.5 mtmt -63.16 -6.72 4.56 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.745 1.218 . . . . 73.12 113.778 -170.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.26 -41.68 76.2 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.14 0.576 . . . . 74.44 110.194 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -108.74 -48.44 3.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.969 1.308 . . . . 74.33 110.558 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -81.37 -1.12 44.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.268 1.427 . . . . 73.24 114.491 -164.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 34.9 ttmt -57.19 -16.89 9.07 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.053 0.541 . . . . 52.12 111.237 165.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -89.98 15.31 10.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.246 1.018 . . . . 74.24 111.089 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.61 148.65 23.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.56 -0.904 . . . . 64.32 108.56 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.53 111.68 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.599 -1.63 . . . . 73.14 106.599 175.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' HB3' HG11 ' A' ' 153' ' ' VAL . 46.1 m-85 -90.21 142.11 28.04 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.731 -0.84 . . . . 72.14 108.731 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -137.82 155.79 48.63 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.922 0.889 . . . . 73.41 108.735 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.38 143.2 20.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.011 -1.477 . . . . 72.34 107.011 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.46 134.89 49.97 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 118.992 -0.893 . . . . 63.41 113.073 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -55.25 -38.27 68.3 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.139 0.975 . . . . 72.44 111.355 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -65.63 -44.42 86.53 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.204 -0.907 . . . . 75.02 111.659 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.93 -21.42 51.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.049 0.54 . . . . 65.3 111.647 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.89 0.18 51.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.744 0.817 . . . . 61.23 110.942 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.04 -24.04 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.799 0.84 . . . . 71.43 110.62 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.48 47.77 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.748 -0.205 . . . . 21.52 113.361 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.75 78.32 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.06 0.544 . . . . 74.45 110.586 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.12 -3.43 32.76 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.505 0.722 . . . . 64.11 111.828 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.25 -18.64 55.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.574 0.75 . . . . 32.24 109.667 169.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.86 150.4 50.08 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 124.376 1.047 . . . . 50.24 113.373 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -96.16 155.5 16.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.479 0.711 . . . . 75.41 110.088 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.437 HG11 ' HB3' ' A' ' 138' ' ' PHE . 53.3 t -88.13 129.34 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.565 0.746 . . . . 75.53 111.296 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.18 111.5 10.48 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.487 1.115 . . . . 75.41 109.33 170.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.4 mt -93.78 113.02 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.437 0.695 . . . . 71.41 109.398 -170.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 169' ' ' LEU . 45.7 mm -98.7 123.7 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.955 -0.465 . . . . 73.45 109.984 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.29 128.88 49.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.802 1.241 . . . . 74.02 108.889 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -81.21 114.5 20.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.814 -1.18 . . . . 63.02 107.814 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.591 ' HB3' HG13 ' A' ' 166' ' ' VAL . 18.2 tpp85 -88.68 141.25 28.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.459 0.704 . . . . 64.25 109.646 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -100.68 124.43 46.28 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.694 -0.484 . . . . 65.35 109.694 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.595 HG13 ' HB ' ' A' ' 164' ' ' THR . 3.1 p -125.77 90.67 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.056 0.942 . . . . 73.35 109.273 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 62.23 17.5 9.32 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.063 1.345 . . . . 71.35 113.31 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.23 -14.69 9.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 120.027 -0.318 . . . . 71.1 113.382 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.595 ' HB ' HG13 ' A' ' 161' ' ' VAL . 80.5 m -88.2 138.66 31.24 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.263 0.625 . . . . 74.41 110.112 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 112.16 24.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.513 0.725 . . . . 64.13 109.296 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 159' ' ' ARG . 2.6 p -119.75 104.02 45.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.46 1.104 . . . . 75.14 109.293 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.27 130.45 39.44 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.597 2.198 . . . . 71.25 112.574 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.1 p -137.02 131.07 32.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.048 0.539 . . . . 63.1 110.587 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 28.7 tp -76.43 137.96 40.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 54.44 109.477 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.8 ttm -123.95 122.25 37.45 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.67 -1.233 . . . . 72.41 107.67 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 34.5 mt -151.8 167.9 26.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.65 1.58 . . . . 63.35 106.76 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.438 HG21 HD11 ' A' ' 120' ' ' ILE . 12.3 p -88.35 139.92 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 118.593 0.633 . . . . 63.43 109.596 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.591 ' HD3' HD11 ' A' ' 22' ' ' LEU . 58.7 pttt -69.21 -24.1 63.99 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.943 0.497 . . . . 74.42 112.147 -173.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.432 ' HG3' ' HG3' ' A' ' 103' ' ' MET . 11.2 mp0 -64.87 -23.89 67.37 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.797 0.839 . . . . 62.33 112.045 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -96.82 -10.38 26.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.487 0.715 . . . . 61.21 111.358 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.415 HG22 ' HG3' ' A' ' 178' ' ' GLU . 42.5 mm -107.02 147.53 12.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.355 0.662 . . . . 62.4 109.555 -175.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.71 108.2 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.13 -1.433 . . . . 72.41 107.13 170.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.415 ' HG3' HG22 ' A' ' 176' ' ' ILE . 16.0 mt-10 -109.49 117.93 35.27 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.601 -1.259 . . . . 71.32 107.601 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -144.66 135.6 24.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.592 -0.892 . . . . 75.34 108.592 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -124.44 109.01 12.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 52.13 109.164 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -96.64 91.89 5.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.786 0.834 . . . . 61.44 109.724 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.47 -46.92 4.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 74.34 109.828 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.617 -0.883 . . . . 74.01 108.617 -178.638 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.031 0.443 . . . . 71.43 110.087 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.6 mt -105.39 161.67 14.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.054 0.942 . . . . 64.2 108.755 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 62.0 mt -115.97 118.72 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.701 -0.852 . . . . 75.21 108.701 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -104.57 96.26 6.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.829 -0.804 . . . . 63.11 108.829 -174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 68.3 mttm -122.34 152.17 40.42 Favored 'General case' 0 C--O 1.21 -0.992 0 C-N-CA 123.859 0.864 . . . . 63.24 109.213 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 7.2 t70 -114.02 143.21 45.13 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 106.955 -1.498 . . . . 74.15 106.955 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -52.84 -20.6 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.823 1.045 . . . . 65.44 113.823 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -107.13 -42.49 4.86 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.189 0.996 . . . . 74.53 110.5 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 6' ' ' ASP . 33.2 p -104.93 18.43 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.816 0.847 . . . . 62.13 112.098 -172.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 8.7 p-10 -60.75 -11.92 9.03 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.511 1.524 . . . . 73.33 113.784 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.31 -58.26 4.83 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 125.133 1.521 . . . . 54.52 110.53 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -122.91 -38.17 2.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.416 -0.811 . . . . 62.23 111.473 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.7 tp 5.54 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.885 2.074 . . . . 72.35 114.203 -163.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.513 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 70.6 m -156.95 146.0 20.16 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.95 0.5 . . . . 33.45 110.779 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 p -148.6 103.64 3.42 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 118.833 0.742 . . . . 72.14 110.957 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -168.28 176.34 5.98 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.343 1.457 . . . . 64.5 108.196 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -72.83 75.37 1.15 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.185 0.517 . . . . 62.03 110.116 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 14' ' ' SER . 64.2 m-85 -87.32 147.28 41.84 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.722 0.809 . . . . 72.43 110.769 -177.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.15 117.7 2.71 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.716 2.278 . . . . 71.44 112.737 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.619 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 60.6 ttp -119.35 114.43 22.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.605 1.162 . . . . 74.22 109.399 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -140.34 136.61 33.36 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.779 -1.193 . . . . 73.44 107.779 171.146 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 25' ' ' ASP . 59.9 tp -113.15 142.54 45.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.132 -1.062 . . . . 64.32 108.132 174.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.25 130.76 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.148 -0.686 . . . . 64.23 109.148 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.99 12.74 4.1 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.902 1.281 . . . . 65.34 112.811 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' HA ' HD21 ' A' ' 22' ' ' LEU . 8.6 m-20 53.37 12.11 0.32 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.638 1.175 . . . . 62.11 113.418 -167.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.712 HD22 ' HG3' ' A' ' 119' ' ' LYS . 45.5 tp -107.08 -45.59 4.11 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.774 0.83 . . . . 54.41 110.027 -171.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 t -120.3 131.38 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.473 -0.785 . . . . 74.01 109.446 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.619 ' HE1' ' HG3' ' A' ' 20' ' ' MET . 82.0 t80 -98.07 126.7 43.62 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.897 -1.149 . . . . 73.53 107.897 171.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 154.6 30.8 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.415 0.626 . . . . 73.01 110.811 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 50.7 t80 -136.42 129.92 31.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.268 1.427 . . . . 63.34 108.655 -171.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -78.98 153.71 30.12 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.154 0.502 . . . . 74.13 110.976 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.37 172.58 39.36 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.312 -0.858 . . . . 73.31 111.004 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 47.4 mtmt -128.28 154.29 46.05 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.569 -0.901 . . . . 73.43 108.569 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 6.4 p-80 -73.98 130.15 39.28 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.5 -1.296 . . . . 75.32 107.5 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.696 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 15.9 m -139.73 149.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.54 0.736 . . . . 71.2 109.305 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 44' ' ' LEU . 7.4 m -123.3 120.32 59.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.299 -1.371 . . . . 73.53 107.299 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 59.3 ttt180 -138.53 117.43 12.41 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.531 -0.759 . . . . 72.22 108.96 -169.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -133.08 118.6 18.94 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.038 -0.727 . . . . 75.43 109.038 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 64.43 24.68 13.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.422 1.089 . . . . 75.24 112.028 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -27.07 18.74 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-O 120.019 -0.323 . . . . 62.13 113.008 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.23 123.17 24.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.231 0.612 . . . . 74.43 110.204 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 35' ' ' VAL . 5.5 tp -124.94 116.35 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.659 0.783 . . . . 75.11 109.897 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -162.68 92.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.809 0.843 . . . . 72.04 108.773 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.696 ' HB3' ' HA ' ' A' ' 35' ' ' VAL . 1.0 OUTLIER -56.89 166.41 1.0 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.643 1.177 . . . . 64.34 113.8 -175.214 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.16 172.1 13.58 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.972 0.909 . . . . 42.34 109.149 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.35 69.36 1.99 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.709 -0.957 . . . . 61.44 110.709 171.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.4 m -94.72 134.95 36.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.318 1.047 . . . . 63.13 109.807 -172.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.9 165.85 39.11 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.081 0.953 . . . . 74.02 110.716 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.72 122.87 12.48 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.523 2.149 . . . . 74.11 111.982 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 m -78.55 86.03 4.58 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 122.928 0.491 . . . . 51.2 110.062 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.65 127.24 47.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.002 0.921 . . . . 75.13 109.48 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -94.17 15.71 16.56 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.284 1.033 . . . . 72.22 111.3 -173.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 69.41 -63.92 0.36 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.247 1.419 . . . . 71.23 110.129 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -125.63 71.28 0.46 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.581 -0.607 . . . . 23.21 111.581 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.2 96.69 0.16 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.757 0.823 . . . . 75.02 110.602 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.98 -52.13 65.28 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.855 1.262 . . . . 71.41 111.878 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.34 79.8 8.37 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.069 -1.086 . . . . 61.02 108.069 174.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.68 84.48 5.5 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.669 -1.151 . . . . 55.54 110.383 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.467 ' HA2' HG23 ' A' ' 77' ' ' VAL . . . 134.23 45.73 0.11 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.033 -0.985 . . . . 75.21 112.371 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -65.65 113.4 4.21 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.819 0.848 . . . . 63.51 111.311 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -79.72 20.83 0.56 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.144 0.978 . . . . 55.24 111.625 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.73 124.67 23.55 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.082 0.953 . . . . 72.22 109.667 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -74.55 76.72 1.97 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.267 1.032 . . . . 74.23 109.645 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t -137.82 89.96 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 105.647 -1.983 . . . . 73.3 105.647 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HA ' HD22 ' A' ' 72' ' ' LEU . 51.8 mt-10 -82.52 62.64 6.27 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.505 0.669 . . . . 73.04 111.324 -174.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.493 ' HG2' ' HB ' ' A' ' 36' ' ' VAL . 49.0 mtt180 -108.69 120.51 42.68 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.153 -1.055 . . . . 74.41 108.153 173.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.28 -136.08 4.6 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 109.703 -1.359 . . . . 60.34 109.703 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 24.2 pt -110.4 143.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 117.354 0.577 . . . . 73.32 110.5 173.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.96 -34.48 59.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.152 1.381 . . . . 72.51 112.223 -176.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 169' ' ' LEU . 60.1 mt -56.46 -51.04 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.924 0.89 . . . . 75.34 110.637 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 76' ' ' LEU . 63.1 t -70.26 -49.32 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.887 -1.051 . . . . 72.1 111.518 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 65' ' ' GLU . 33.4 mt -63.28 -39.85 95.73 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.814 0.846 . . . . 42.42 111.069 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.96 -32.93 73.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.31 1.044 . . . . 72.41 111.579 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.16 -6.69 21.91 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.247 0.619 . . . . 63.51 112.44 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.98 61.54 3.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.906 1.283 . . . . 75.2 111.383 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.495 ' HB2' HG13 ' A' ' 71' ' ' VAL . 59.1 mt -93.95 132.05 38.79 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.371 -0.831 . . . . 73.21 109.945 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.467 HG23 ' HA2' ' A' ' 59' ' ' GLY . 3.4 p -79.4 136.88 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.445 0.698 . . . . 71.22 109.881 175.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.69 144.46 10.92 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.829 1.652 . . . . 71.32 113.58 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.7 mmm -147.95 104.18 3.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 106.346 -1.724 . . . . 74.42 106.346 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -93.01 136.58 33.14 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.9 -0.778 . . . . 74.32 108.9 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 52.1 t -65.56 -14.22 60.62 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.618 0.767 . . . . 72.01 110.842 173.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -75.75 -47.62 25.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.941 . . . . 64.43 110.617 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.17 -33.2 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.137 -0.938 . . . . 73.13 110.703 -175.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.49 22.44 12.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.632 1.173 . . . . 70.34 111.704 -166.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 81' ' ' CYS . . . -49.82 -56.41 10.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.453 0.701 . . . . 71.33 112.284 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.8 m -70.39 -33.68 71.67 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.397 -0.82 . . . . 54.32 111.018 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 42.5 tpp -66.08 -36.86 84.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.059 0.944 . . . . 73.21 110.55 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.507 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 64.1 t80 -72.85 -29.21 63.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.82 0.848 . . . . 74.13 110.576 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -40.91 98.92 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.398 -0.593 . . . . 75.54 109.398 170.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.84 93.97 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.922 -0.581 . . . . 52.32 110.695 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.507 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 58.1 m-85 -60.61 -52.64 64.3 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-O 118.777 -0.63 . . . . 73.53 110.797 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mm -58.47 -37.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.641 0.776 . . . . 64.44 111.56 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -65.17 -49.28 70.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.956 0.502 . . . . 74.44 111.42 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -47.12 83.44 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.612 -0.884 . . . . 71.11 108.612 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 152' ' ' GLN . 22.6 t80 -52.55 -56.61 14.03 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.888 2.075 . . . . 52.21 112.195 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.1 ttt -59.17 -50.81 72.6 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.985 0.803 . . . . 71.23 109.773 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -61.68 -36.05 79.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.672 -0.694 . . . . 53.21 111.338 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.11 -52.88 29.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.015 0.926 . . . . 65.12 111.525 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.93 -31.88 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.163 0.585 . . . . 73.3 112.563 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.15 -43.15 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.492 -0.559 . . . . 71.25 109.492 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.93 -38.83 87.17 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.912 0.885 . . . . 74.14 110.622 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -63.22 -50.88 68.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.206 1.002 . . . . 63.33 109.998 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ttt -63.52 -43.13 98.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.118 -0.946 . . . . 74.25 110.725 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -74.21 -23.01 59.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.845 0.858 . . . . 62.43 111.837 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.464 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 29.0 ttmt -70.5 -20.51 62.84 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.708 . . . . 62.25 109.783 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -112.83 1.21 15.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.469 1.108 . . . . 62.14 111.218 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.35 -68.97 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.005 0.522 . . . . 71.54 110.711 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.88 11.88 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.487 1.915 . . . . 73.23 115.079 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -83.51 -8.75 59.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.909 . . . . 73.03 110.581 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 80.01 -45.21 0.29 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.774 1.63 . . . . 75.42 113.974 169.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.01 71.77 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.477 0.58 . . . . 73.24 112.493 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.83 -44.79 22.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.378 0.671 . . . . 63.21 109.791 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.09 -23.53 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.299 -0.864 . . . . 74.24 111.242 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.64 -47.75 74.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.497 1.119 . . . . 72.05 110.172 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.31 95.36 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 124.098 0.874 . . . . 63.44 110.078 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.47 -45.21 80.45 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.259 0.974 . . . . 65.41 111.752 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.43 -45.88 84.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.341 0.656 . . . . 73.34 110.616 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -65.15 -39.55 93.14 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.255 -1.339 . . . . 64.43 110.47 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.712 ' HG3' HD22 ' A' ' 26' ' ' LEU . 14.0 tppt? -69.07 -49.58 56.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.598 0.759 . . . . 71.42 110.43 -173.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.458 ' HA ' HD21 ' A' ' 26' ' ' LEU . 8.5 tp -72.4 -37.75 58.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 123.374 0.669 . . . . 61.41 110.978 -174.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -66.86 -39.96 87.73 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.184 -0.673 . . . . 75.12 109.184 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.3 99.92 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.648 0.592 . . . . 51.33 112.414 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -66.04 -47.36 74.64 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.138 0.575 . . . . 65.44 110.203 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -69.7 -40.73 79.63 Favored 'Isoleucine or valine' 0 C--N 1.361 1.104 0 CA-C-O 118.476 -0.773 . . . . 71.44 111.565 -174.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.15 -33.22 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 119.495 1.043 . . . . 72.23 110.272 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -72.38 -34.06 67.66 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.9 0.88 . . . . 44.15 110.769 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.623 HD21 HG21 ' A' ' 155' ' ' ILE . 28.7 tp -81.54 -26.28 35.19 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.361 1.064 . . . . 74.22 111.197 -174.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.0 mt -88.24 4.47 45.67 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.834 0.854 . . . . 62.0 111.461 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.55 85.84 0.3 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 123.632 0.773 . . . . 65.42 110.284 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -62.22 -6.83 3.41 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.194 1.398 . . . . 73.23 114.753 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.97 -47.07 84.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.028 0.931 . . . . 74.44 110.865 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.549 ' H ' ' HD3' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -112.22 -31.77 6.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.625 1.17 . . . . 61.41 110.873 174.099 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.73 -1.93 36.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.017 0.927 . . . . 71.31 113.218 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -10.88 4.45 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.474 0.579 . . . . 71.01 112.311 171.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.5 21.71 4.43 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.098 0.959 . . . . 70.11 110.788 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.57 137.71 32.09 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.636 -0.505 . . . . 75.2 109.636 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -111.15 145.83 37.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.654 -1.61 . . . . 73.22 106.654 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.429 ' HB3' HG11 ' A' ' 153' ' ' VAL . 59.9 m-85 -125.32 141.11 52.27 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.296 -1.002 . . . . 73.54 108.296 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 68.2 m-85 -149.32 147.98 28.99 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 124.165 0.986 . . . . 75.42 108.394 -175.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.534 ' HB ' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -150.97 147.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.065 -1.087 . . . . 65.01 108.065 -177.238 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.78 139.04 42.66 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.385 -1.086 . . . . 72.31 110.385 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.65 -21.16 28.53 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.505 0.653 . . . . 75.21 109.978 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.75 -46.41 75.49 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.422 -0.955 . . . . 73.31 108.422 164.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.58 98.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.173 -1.376 . . . . 71.51 111.668 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.92 -46.38 52.96 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.262 0.625 . . . . 73.11 111.649 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.48 -41.32 93.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.188 0.595 . . . . 73.34 111.148 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -63.76 -58.45 11.04 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.245 -0.742 . . . . 55.43 111.245 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 176.63 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.389 1.076 . . . . 52.34 108.548 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -41.41 118.84 1.11 Allowed 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.917 0.887 . . . . 61.0 113.267 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -38.71 -41.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.258 1.423 . . . . 73.25 112.73 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.72 -34.8 4.59 Favored Glycine 0 CA--C 1.502 -0.773 0 CA-C-N 114.681 -1.145 . . . . 70.13 112.224 -175.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 20.5 pm0 -98.1 156.59 16.59 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.702 -0.851 . . . . 71.02 108.702 173.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.534 HG13 ' HB ' ' A' ' 140' ' ' ILE . 24.9 t -109.24 143.96 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 107.123 -1.436 . . . . 71.42 107.123 171.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.427 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -63.28 108.79 1.38 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.73 0.812 . . . . 62.15 109.657 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.623 HG21 HD21 ' A' ' 127' ' ' LEU . 58.9 mt -86.5 104.38 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.746 0.818 . . . . 74.43 109.337 -170.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 44.2 mm -89.51 100.11 10.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.451 -0.795 . . . . 73.53 110.048 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.35 95.14 7.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.939 -1.134 . . . . 54.34 107.939 170.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 36.9 p90 -85.56 109.32 18.45 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.627 -0.879 . . . . 71.32 108.627 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -100.43 -179.48 4.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.855 1.262 . . . . 63.15 108.747 -172.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -124.08 120.59 32.81 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.801 0.728 . . . . 75.34 110.408 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -90.08 89.49 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.393 -1.336 . . . . 72.43 107.393 170.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.56 33.78 20.4 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.624 -1.171 . . . . 64.5 111.926 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 111.54 -23.76 17.03 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.753 -0.471 . . . . 73.32 113.28 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.6 m -86.0 125.24 33.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.685 -0.857 . . . . 73.05 108.685 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 20.5 tt0 -72.08 121.96 20.13 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.433 0.56 . . . . 72.3 109.723 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.0 p -117.46 90.25 34.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.892 1.277 . . . . 75.11 109.037 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 98.4 Cg_exo -50.2 125.92 16.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.226 2.617 . . . . 71.55 112.473 167.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.0 m -123.82 115.06 20.72 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.904 -0.776 . . . . 74.52 108.904 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp -76.51 130.7 38.3 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.054 0.942 . . . . 72.35 108.909 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.2 ttp -128.14 123.0 33.35 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.06 0.944 . . . . 70.42 109.174 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 154' ' ' ALA . 95.2 mt -139.11 157.58 45.72 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.341 1.456 . . . . 64.22 107.614 176.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 174' ' ' GLU . 13.6 p -78.25 131.97 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.891 -0.781 . . . . 41.43 108.891 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -52.22 -28.77 19.77 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.637 1.575 . . . . 75.4 111.983 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.419 ' H ' HG22 ' A' ' 172' ' ' VAL . 15.4 tp10 -67.15 -34.95 78.65 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.243 1.017 . . . . 74.11 111.844 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.18 -13.43 15.43 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.224 0.61 . . . . 74.22 112.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.513 HG21 ' HB3' ' A' ' 28' ' ' TYR . 11.0 tp -108.93 161.91 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.084 -1.45 . . . . 71.35 107.084 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 42.3 mm -135.79 132.26 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.092 0.957 . . . . 63.33 108.593 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.3 96.95 5.29 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.129 -1.063 . . . . 63.13 108.129 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 41.4 tt0 -99.19 102.07 13.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.482 -0.933 . . . . 71.42 108.482 -174.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.17 134.08 45.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.549 0.74 . . . . 75.15 110.546 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.7 t -117.76 96.15 5.25 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.239 -1.023 . . . . 65.31 108.239 173.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.07 153.62 42.95 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.312 0.645 . . . . 74.34 109.919 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.253 1.265 0 CA-C-N 115.456 -0.793 . . . . 71.11 108.988 177.258 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.598 0.713 . . . . 73.35 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.47 160.59 29.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.106 0.962 . . . . 65.25 108.431 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 28.1 mt -116.74 118.9 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.573 -1.269 . . . . 72.32 107.573 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -97.92 97.23 8.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.362 -0.977 . . . . 70.22 108.362 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -111.43 110.29 20.67 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.199 0.6 . . . . 75.22 109.679 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 9.8 t70 -83.85 135.93 34.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.643 -1.614 . . . . 73.32 106.643 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.7 pt -64.04 -17.87 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 118.542 0.61 . . . . 71.31 112.232 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -113.98 -52.07 2.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.383 1.073 . . . . 74.22 110.47 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -90.05 17.46 6.89 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.622 -1.172 . . . . 73.02 111.634 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 29.0 t70 -46.91 -43.84 19.24 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.034 1.333 . . . . 74.42 112.671 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.24 -19.3 65.78 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.117 -1.401 . . . . 71.31 111.906 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.591 ' HG3' ' HA3' ' A' ' 141' ' ' GLY . 6.9 mm-40 -120.8 12.5 11.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.808 1.243 . . . . 74.44 111.403 -174.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.96 -148.34 0.34 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.433 0.693 . . . . 73.42 109.794 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -150.07 160.14 43.87 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.435 0.562 . . . . 75.45 111.388 -163.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 60.0 p -124.38 -160.77 0.95 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.026 0.93 . . . . 73.24 109.573 165.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 74.11 -162.86 0.08 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.073 0.949 . . . . 73.24 110.905 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -96.98 58.01 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.549 0.69 . . . . 73.33 110.307 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.9 149.27 62.99 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 115.427 -0.806 . . . . 74.0 109.007 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 16.5 Cg_exo -68.02 117.6 5.03 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 121.684 1.589 . . . . 71.25 112.025 -176.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.457 ' SD ' ' CD1' ' A' ' 28' ' ' TYR . 12.6 tmm? -148.98 139.44 22.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.042 0.937 . . . . 64.12 109.69 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -139.45 158.28 44.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.269 1.028 . . . . 75.53 109.147 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.12 119.76 37.33 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.469 -0.938 . . . . 74.21 108.469 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.23 136.15 43.34 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 123.808 0.843 . . . . 74.21 108.93 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 65.51 8.3 4.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.269 1.028 . . . . 71.22 113.044 171.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 55.42 30.49 15.08 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.265 1.026 . . . . 60.32 111.626 -171.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.498 HD11 ' HB ' ' A' ' 120' ' ' ILE . 21.3 tp -132.93 -44.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.881 -0.6 . . . . 73.03 111.076 -172.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.08 140.6 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.967 0.507 . . . . 72.23 109.988 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.457 ' CD1' ' SD ' ' A' ' 20' ' ' MET . 30.2 m-85 -92.47 115.09 27.78 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 109.179 -0.675 . . . . 64.41 109.179 168.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.13 126.99 31.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.747 -1.205 . . . . 74.41 107.747 166.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.5 t80 -117.06 104.93 11.74 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.973 -1.491 . . . . 74.54 106.973 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 41.0 mmtm -79.48 143.38 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.377 0.671 . . . . 71.05 111.374 -175.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -139.77 -168.55 11.35 Favored Glycine 0 C--O 1.241 0.582 0 CA-C-N 114.677 -1.147 . . . . 74.45 110.51 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -118.97 150.85 39.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.36 0.664 . . . . 74.02 110.913 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -80.3 107.73 13.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.639 -1.245 . . . . 65.34 107.639 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.588 HG12 HD23 ' A' ' 44' ' ' LEU . 29.6 m -132.96 155.8 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.773 0.829 . . . . 74.42 109.159 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 44' ' ' LEU . 3.0 m -94.09 141.14 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.446 -0.576 . . . . 62.22 109.446 177.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.757 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -142.13 110.08 5.86 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.604 -1.258 . . . . 73.31 107.604 -178.099 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 15.6 tptm -89.23 161.66 16.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.942 0.897 . . . . 72.12 108.957 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -45.88 -38.62 7.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.64 0.978 . . . . 73.23 113.64 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.39 42.29 1.37 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.586 -0.279 . . . . 60.13 112.419 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 11.7 tp10 -164.52 142.51 6.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.55 . . . . 73.43 111.057 -176.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 tp -137.83 96.06 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.392 1.077 . . . . 70.02 108.507 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.08 110.76 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.121 0.968 . . . . 72.2 109.363 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.705 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -60.42 144.16 51.61 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.912 0.885 . . . . 63.2 111.248 178.02 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.69 103.93 10.87 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.212 0.605 . . . . 65.52 110.776 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.02 -36.63 21.16 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 111.414 -0.674 . . . . 62.55 111.414 171.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 t -94.81 155.66 16.71 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.338 -0.986 . . . . 71.02 108.338 169.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.8 t30 64.21 99.03 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.513 1.125 . . . . 75.12 111.241 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -66.23 115.74 3.65 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.105 2.537 . . . . 61.31 112.743 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 p -98.02 82.92 3.04 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.579 0.752 . . . . 73.34 109.959 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.93 25.43 9.14 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.747 0.819 . . . . 65.44 109.297 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -113.41 79.17 1.21 Allowed 'General case' 0 C--N 1.354 0.796 0 C-N-CA 124.281 1.032 . . . . 71.12 109.544 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -74.02 -30.35 62.4 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.098 -0.501 . . . . 55.42 110.12 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.71 15.65 35.43 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.86 -0.609 . . . . 34.32 113.365 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.3 87.78 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.151 0.58 . . . . 64.21 110.829 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -103.38 111.91 24.55 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.247 1.019 . . . . 75.03 109.473 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -147.36 -174.16 4.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.322 0.649 . . . . 74.03 110.02 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.23 -39.07 71.95 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.603 1.161 . . . . 64.22 112.183 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.2 107.49 2.33 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.619 -0.719 . . . . 74.1 111.711 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.3 m -66.96 -30.29 70.38 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.495 0.718 . . . . 64.12 112.005 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.11 -163.74 1.41 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.416 1.086 . . . . 65.51 108.703 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -79.85 137.3 36.9 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 107.643 -1.243 . . . . 55.31 107.643 168.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -77.12 84.66 3.61 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.497 1.142 . . . . 64.15 111.583 -171.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.34 -88.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 104.179 -2.526 . . . . 63.23 104.179 162.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 77.0 -51.0 0.56 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 125.198 1.399 . . . . 51.22 113.339 157.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -139.15 158.37 44.29 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.552 0.741 . . . . 65.32 109.613 -164.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.4 -158.06 29.0 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 111.235 -0.746 . . . . 74.45 111.235 160.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 pt -110.14 147.3 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.375 0.67 . . . . 75.13 109.209 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.67 -26.84 68.85 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.885 0.874 . . . . 75.45 111.748 -174.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 169' ' ' LEU . 41.7 mm -54.01 -48.21 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.356 0.662 . . . . 53.21 110.205 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.5 t -80.71 -51.08 16.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.017 -0.992 . . . . 73.12 111.674 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.757 HD13 ' HB2' ' A' ' 37' ' ' ARG . 50.6 mt -64.49 -25.47 68.01 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.809 0.844 . . . . 61.22 112.353 -171.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -91.18 -43.68 9.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.571 0.748 . . . . 64.52 110.526 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -94.9 9.51 38.96 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.779 0.659 . . . . 51.12 112.779 -170.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? 64.02 33.77 11.93 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.991 0.807 . . . . 64.33 110.85 168.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 72.3 mt -78.5 120.74 23.64 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.543 -0.54 . . . . 55.32 109.543 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.18 136.37 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.697 0.799 . . . . 75.24 109.158 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.17 145.69 55.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.243 1.017 . . . . 75.14 113.194 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.9 mtt -133.06 102.9 5.78 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 105.211 -2.144 . . . . 75.11 105.211 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -68.45 125.4 26.36 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 108.892 -0.781 . . . . 72.23 108.892 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.6 -25.17 59.65 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.924 0.869 . . . . 74.41 111.071 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -70.01 -32.77 71.12 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 113.792 -1.549 . . . . 64.11 110.721 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -103.83 -39.72 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.347 0.659 . . . . 75.43 111.02 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.4 -11.89 39.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.063 0.945 . . . . 74.42 112.779 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -37.63 -51.85 1.21 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.391 1.626 . . . . 52.11 115.391 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.5 m -68.86 -45.14 71.83 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.074 0.464 . . . . 72.14 111.374 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 72.9 mtm -67.07 -27.99 67.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.177 -0.919 . . . . 70.31 110.432 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.463 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 81.0 t80 -70.79 -39.99 72.82 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.73 0.812 . . . . 73.22 110.78 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -66.13 -31.06 71.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.671 0.388 . . . . 73.2 110.657 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.7 82.63 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.945 -0.571 . . . . 74.24 110.257 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 19.4 m-85 -60.81 -41.69 96.2 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 109.669 -0.493 . . . . 71.33 109.669 173.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.73 -29.94 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.632 0.773 . . . . 73.32 110.625 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -62.79 -53.43 54.39 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.188 0.449 . . . . 73.12 111.381 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.11 -47.33 71.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.252 0.345 . . . . 61.24 110.389 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -45.74 -62.7 1.19 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.61 1.964 . . . . 75.22 112.054 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 39.3 ttp -57.23 -47.99 79.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.583 1.153 . . . . 75.31 111.43 -175.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -68.4 -35.7 78.05 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.783 -0.644 . . . . 74.12 111.896 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -69.81 -47.31 63.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.525 0.73 . . . . 74.11 110.251 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 174' ' ' GLU . 19.6 m -71.53 -33.09 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.915 -0.584 . . . . 71.11 112.44 -173.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.26 -39.9 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.536 -0.542 . . . . 73.31 109.536 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.1 -46.62 75.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.023 0.929 . . . . 75.5 111.578 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.53 -43.98 92.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.501 0.72 . . . . 72.31 110.458 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -62.81 -50.1 72.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.466 1.106 . . . . 73.44 112.604 -174.081 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.689 ' HA ' HG11 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -70.03 -32.72 71.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.435 0.294 . . . . 71.24 111.68 -172.573 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -58.47 -21.67 52.25 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.154 0.502 . . . . 70.11 111.596 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -106.55 -26.1 11.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.605 0.762 . . . . 51.21 111.831 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 112' ' ' ASP . 13.3 m120 -146.46 35.12 0.96 Allowed 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 123.11 0.564 . . . . 64.43 112.052 -167.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.538 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 31.1 ttp180 -69.83 7.55 0.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.006 0.922 . . . . 73.3 112.748 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.3 -21.88 26.9 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.136 0.974 . . . . 72.51 111.248 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 113' ' ' VAL . 97.8 mttt 83.26 -8.84 1.1 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.685 1.594 . . . . 63.25 113.029 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.34 88.15 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.59 0.632 . . . . 64.44 110.004 168.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 107' ' ' ASN . 15.5 t0 -95.36 -44.54 7.52 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.072 -0.967 . . . . 64.11 110.69 -170.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.756 HG12 ' SD ' ' A' ' 103' ' ' MET . 35.8 m -76.37 -31.72 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 113.114 0.783 . . . . 71.04 113.114 -176.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.32 -40.12 95.3 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.163 0.438 . . . . 63.01 110.158 172.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.59 67.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.39 -0.823 . . . . 72.52 110.077 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.99 -47.13 81.55 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.827 0.851 . . . . 73.02 111.605 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -63.83 -43.9 94.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.114 0.966 . . . . 74.11 110.434 -176.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.69 -45.73 91.22 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 123.753 0.658 . . . . 70.42 110.433 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.17 -39.31 68.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.256 -0.884 . . . . 74.22 111.559 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.498 ' HB ' HD11 ' A' ' 26' ' ' LEU . 10.8 tp -73.49 -38.78 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 117.95 0.341 . . . . 63.23 110.105 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -66.93 -44.0 81.81 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.041 0.536 . . . . 75.22 109.857 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.55 -38.23 95.47 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 124.088 0.867 . . . . 54.33 112.786 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 25.5 t90 -66.36 -52.69 44.4 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 123.874 0.87 . . . . 64.11 110.221 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.4 m -69.69 -36.9 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 119.152 -0.451 . . . . 74.44 111.842 -176.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.58 -33.95 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.606 0.639 . . . . 63.43 110.372 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.2 p -80.52 -34.06 35.92 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.497 0.319 . . . . 62.44 111.004 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 155' ' ' ILE . 17.2 tp -69.53 -27.72 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.856 0.862 . . . . 73.3 110.623 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.3 mt -94.49 3.53 55.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.948 0.899 . . . . 73.25 111.438 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.01 95.0 4.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.046 -0.724 . . . . 31.44 109.046 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -58.3 -19.21 32.95 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.69 1.196 . . . . 72.53 113.774 -170.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.11 -45.91 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.315 1.046 . . . . 62.33 111.737 -173.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -108.58 -37.57 5.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 64.14 110.168 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -77.4 -1.84 32.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.664 1.186 . . . . 74.11 113.77 -170.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.05 -15.11 8.12 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 122.884 0.473 . . . . 74.11 111.179 164.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.22 26.09 6.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.019 0.927 . . . . 54.24 110.702 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -89.14 155.18 19.59 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.28 -1.007 . . . . 64.52 108.28 164.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -130.03 113.7 14.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.977 -1.49 . . . . 71.21 106.977 170.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.16 146.8 26.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.721 -0.844 . . . . 72.42 108.721 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 74.0 m-85 -143.47 162.49 35.66 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 123.405 0.682 . . . . 72.25 109.584 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.69 154.14 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.065 -1.457 . . . . 70.44 107.065 170.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.591 ' HA3' ' HG3' ' A' ' 12' ' ' GLU . . . -57.09 134.55 52.26 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-O 119.717 -0.49 . . . . 50.13 112.28 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 39.5 tt0 -61.57 -44.55 96.81 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.994 0.517 . . . . 72.34 110.26 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -57.16 -41.5 79.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 74.33 111.417 177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.629 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -65.43 -35.14 80.03 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.431 -0.804 . . . . 74.44 111.15 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.77 4.04 48.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.555 1.142 . . . . 64.52 112.801 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 52.9 mt-10 -110.34 -42.14 4.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.427 0.691 . . . . 63.31 110.219 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.89 67.91 0.18 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.813 -0.631 . . . . 65.21 112.977 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -155.19 -92.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.405 0.682 . . . . 72.24 109.954 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -155.23 152.14 28.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.221 1.008 . . . . 74.25 109.763 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -70.89 -36.86 72.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.75 -0.659 . . . . 64.52 109.992 169.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 35.33 -119.73 0.4 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 125.516 1.76 . . . . 43.42 116.437 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -94.49 128.53 41.13 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.373 -0.602 . . . . 64.12 109.373 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.9 t -79.85 131.67 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.753 0.821 . . . . 74.12 109.422 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.3 100.19 2.09 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.209 1.004 . . . . 53.02 109.229 170.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.62 HG21 HD21 ' A' ' 127' ' ' LEU . 86.8 mt -92.11 113.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.555 -0.535 . . . . 74.44 109.555 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 137' ' ' ALA . 42.0 mm -101.73 125.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.624 0.37 . . . . 54.25 110.855 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.72 120.28 36.12 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.653 -1.24 . . . . 74.5 107.653 165.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.612 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 12.0 p90 -95.21 102.73 14.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.482 -1.303 . . . . 71.21 107.482 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.462 ' O ' HG22 ' A' ' 166' ' ' VAL . 11.3 tpt180 -87.39 102.52 14.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.387 0.675 . . . . 63.0 109.891 -166.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.61 109.11 2.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.385 1.074 . . . . 71.23 111.803 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.83 117.74 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 123.966 0.906 . . . . 73.41 109.624 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.3 t70 70.36 -62.13 0.44 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.346 1.858 . . . . 75.34 111.408 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -171.68 21.02 0.07 OUTLIER Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.013 -0.54 . . . . 73.23 112.513 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.9 m -136.26 127.75 28.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.743 0.817 . . . . 71.43 109.227 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 4.2 mp0 -81.17 137.7 35.89 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.098 0.559 . . . . 71.32 110.03 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 159' ' ' ARG . 34.2 m -109.42 113.19 58.59 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.4 0.68 . . . . 62.53 109.252 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.51 114.84 2.22 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.406 2.737 . . . . 73.35 112.361 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 m -120.68 103.9 9.49 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.127 -1.064 . . . . 74.31 108.127 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.3 tp -77.59 129.75 36.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 108.882 -0.784 . . . . 64.41 108.882 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.4 mtt -112.17 122.76 48.65 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.575 -0.898 . . . . 62.34 108.575 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -133.71 130.24 37.87 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 106.626 -1.62 . . . . 42.1 106.626 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 176' ' ' ILE . 14.8 p -66.25 133.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.617 -0.883 . . . . 64.33 108.617 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -63.29 -4.89 2.86 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.183 1.179 . . . . 51.24 114.183 -168.307 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . 42.0 mm-40 -95.68 -17.59 21.17 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.361 0.875 . . . . 75.3 113.361 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -108.62 -0.87 19.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.902 0.481 . . . . 64.53 110.49 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 172' ' ' VAL . 5.9 tp -126.88 119.79 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 106.653 -1.61 . . . . 72.22 106.653 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.8 mm -102.96 110.78 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.339 -0.846 . . . . 72.13 109.392 -172.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.52 96.06 1.89 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.061 -1.427 . . . . 50.11 109.518 172.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.597 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 10.5 tp10 -92.31 98.76 11.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.079 -1.452 . . . . 74.52 107.079 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -87.98 95.27 10.06 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.151 -0.932 . . . . 63.31 110.959 -165.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.2 t -92.79 88.88 6.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.261 -1.014 . . . . 74.13 108.261 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.33 54.43 0.73 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.464 1.106 . . . . 73.45 109.691 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.742 -1.117 . . . . 63.34 108.895 177.352 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.448 ' HG3' ' HB3' ' A' ' 181' ' ' CYS . 12.6 tpt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.965 -0.383 . . . . 55.43 109.965 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 180' ' ' LYS . 73.5 mt -132.51 134.08 44.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.969 0.908 . . . . 75.25 109.341 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 68.7 mt -103.0 120.94 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.275 -1.379 . . . . 63.12 107.275 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.745 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 74.6 m-85 -105.08 135.88 45.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.534 -0.543 . . . . 75.13 109.534 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' HG3' ' HB ' ' A' ' 177' ' ' ILE . 0.2 OUTLIER -137.48 146.25 44.02 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.714 0.806 . . . . 74.42 110.12 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.412 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 27.0 t70 -106.35 172.4 6.83 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.903 1.281 . . . . 53.13 107.827 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 98' ' ' ASN . 72.5 mt -64.81 -35.84 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 O-C-N 121.458 -0.776 . . . . 72.12 111.437 175.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.82 -43.18 3.85 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.333 1.053 . . . . 74.32 110.903 -167.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -98.32 20.25 12.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 75.24 111.003 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.412 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 12.6 t70 -45.45 -43.03 11.09 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.523 1.929 . . . . 63.14 113.443 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -49.51 -61.68 1.97 Allowed 'General case' 0 N--CA 1.476 0.87 0 O-C-N 125.626 1.829 . . . . 64.53 112.626 -166.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.3 21.76 7.9 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.779 0.659 . . . . 60.22 112.779 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 tp -49.12 -65.37 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 112.578 0.584 . . . . 54.31 112.578 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.745 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 22.7 t -158.19 173.46 16.67 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.759 0.424 . . . . 73.13 110.282 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 35.8 p 172.88 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.078 0.951 . . . . 71.31 111.205 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.8 t70 -174.0 167.93 4.22 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.899 1.28 . . . . 73.41 109.026 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 m -68.88 65.11 0.13 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.297 1.039 . . . . 60.51 112.448 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 60.4 m-85 -87.9 134.07 36.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 122.976 0.51 . . . . 64.34 109.672 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HG2' ' HB3' ' A' ' 31' ' ' LYS . 52.6 Cg_endo -67.32 121.09 8.18 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.121 1.881 . . . . 63.22 110.401 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.66 147.02 52.33 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.082 -0.508 . . . . 64.2 110.633 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 26.2 mtpp -131.69 158.71 40.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.168 . . . . 65.44 108.53 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.63 110.88 18.44 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.673 -1.232 . . . . 74.54 107.673 167.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.17 139.13 20.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.907 0.883 . . . . 60.52 109.38 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 62.73 10.45 4.22 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.425 1.09 . . . . 74.2 112.926 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.5 t70 51.27 38.66 22.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.402 1.081 . . . . 64.03 110.622 -167.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.426 HD11 ' HB ' ' A' ' 120' ' ' ILE . 39.2 tp -134.74 -50.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.943 -0.571 . . . . 73.34 111.469 -172.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.9 t -125.11 138.29 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.341 0.657 . . . . 72.43 110.527 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 36.0 m-85 -86.1 119.96 26.96 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.077 0.951 . . . . 73.23 110.186 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 25.5 mm-40 -88.56 103.5 15.96 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 124.52 1.138 . . . . 75.11 108.569 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 25.0 t80 -109.74 103.92 12.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.423 -1.695 . . . . 72.44 106.423 -174.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 42.1 tttm -85.04 145.0 27.91 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.103 0.477 . . . . 73.23 111.048 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -133.78 -163.41 10.37 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 114.989 -1.005 . . . . 52.55 111.878 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -144.21 143.15 30.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.639 0.776 . . . . 73.31 109.224 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -74.25 121.53 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.468 -0.567 . . . . 65.42 109.468 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 72' ' ' LEU . 18.4 m -146.44 166.66 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.635 0.774 . . . . 64.3 109.163 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 m -128.84 139.69 51.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.225 -1.028 . . . . 75.43 108.225 174.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.703 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 17.9 tpt180 -100.13 108.41 20.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.364 -1.347 . . . . 74.34 107.364 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.685 ' HG2' HG22 ' A' ' 64' ' ' VAL . 5.6 tmtm? -124.72 106.39 10.04 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.12 -2.178 . . . . 73.24 105.12 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -72.67 79.58 1.1 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 121.742 0.782 . . . . 61.32 110.249 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.67 -35.76 0.34 Allowed Glycine 0 C--O 1.237 0.332 0 CA-C-N 114.693 -1.14 . . . . 73.33 111.92 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -174.9 105.0 0.09 Allowed 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.577 -0.527 . . . . 74.54 109.577 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.7 tt . . . . . 0 CA--C 1.554 1.111 0 CA-C-O 121.5 0.667 . . . . 65.44 110.743 179.789 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.685 HG22 ' HG2' ' A' ' 38' ' ' LYS . 18.3 t . . . . . 0 C--O 1.241 0.607 0 N-CA-C 108.657 -0.868 . . . . 55.22 108.657 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.1 mp0 -69.62 74.52 0.4 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.137 -1.061 . . . . 72.31 108.137 166.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 -75.96 134.43 40.2 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.636 1.175 . . . . 53.24 110.617 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.0 -141.38 6.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 112.089 -0.404 . . . . 44.52 112.089 170.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.441 HD11 HD12 ' A' ' 156' ' ' ILE . 18.4 pt -111.18 158.72 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.799 0.44 . . . . 74.34 110.125 170.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.94 -30.48 71.6 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 75.24 111.915 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 169' ' ' LEU . 69.2 mt -59.75 -52.61 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.375 1.07 . . . . 63.45 109.955 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.24 -48.04 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 114.251 -1.34 . . . . 75.31 111.443 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.479 HD12 HG23 ' A' ' 35' ' ' VAL . 79.3 mt -67.45 -23.25 65.5 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.577 0.751 . . . . 71.22 112.071 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -53.61 -53.84 46.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.181 0.992 . . . . 74.52 110.893 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -114.69 -1.61 13.25 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.436 -0.802 . . . . 75.34 112.427 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 66.71 70.14 0.4 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.448 1.099 . . . . 65.53 109.427 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.7 133.69 33.8 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.397 -0.964 . . . . 75.12 108.397 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.68 129.55 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.678 0.391 . . . . 73.21 110.369 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.42 147.04 46.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.477 0.711 . . . . 71.54 112.483 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.3 mtp -148.03 143.97 27.59 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.515 1.926 . . . . 73.33 106.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.0 m-80 -126.97 124.04 38.54 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.211 -1.033 . . . . 72.43 108.211 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.538 ' SG ' ' HD3' ' A' ' 130' ' ' LYS . 16.9 p -58.96 -15.27 12.13 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.844 0.857 . . . . 73.23 112.624 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.405 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 98.4 m-85 -57.29 -48.7 78.23 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.237 1.015 . . . . 72.35 111.545 174.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.81 -39.16 6.4 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.396 0.678 . . . . 73.23 110.543 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.76 20.11 1.22 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.61 1.164 . . . . 74.52 112.516 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.97 49.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.929 0.891 . . . . 72.45 112.876 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.3 m -68.33 -50.68 51.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.025 0.53 . . . . 74.13 112.105 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.3 mmm -60.26 -47.49 85.78 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.93 0.892 . . . . 72.03 111.44 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -64.04 -36.22 83.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.587 -1.188 . . . . 75.4 111.095 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.7 -37.44 87.36 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.109 0.564 . . . . 60.24 110.697 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 94' ' ' LYS . . . -61.51 -48.99 78.54 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.001 -0.545 . . . . 55.25 109.986 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -65.24 -32.23 73.8 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.958 0.725 . . . . 75.43 112.958 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 mm -66.19 -41.19 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.239 0.616 . . . . 75.54 111.575 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.98 -36.42 82.14 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.622 0.249 . . . . 72.2 110.786 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.677 ' HD3' ' HA ' ' A' ' 150' ' ' ASN . 96.6 mttt -64.43 -47.05 80.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.733 0.813 . . . . 61.3 109.83 174.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -53.76 -62.41 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.964 1.706 . . . . 65.23 111.858 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.3 ptm -62.3 -38.15 88.28 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.411 0.444 . . . . 70.22 111.269 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -66.21 -42.26 89.0 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 110.286 -0.264 . . . . 60.51 110.286 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.566 HD21 HD12 ' A' ' 7' ' ' ILE . 7.9 t30 -65.59 -54.11 32.43 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.808 0.843 . . . . 72.31 111.445 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.552 HG11 HG11 ' A' ' 172' ' ' VAL . 17.8 m -67.4 -40.17 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.114 0.566 . . . . 73.21 112.173 -171.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 86.6 mt -69.4 -45.68 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 109.626 -0.509 . . . . 73.01 109.626 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.81 -35.23 80.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.371 0.668 . . . . 62.11 111.608 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -59.4 -47.35 85.77 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.878 . . . . 73.33 109.065 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.514 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.6 tpt -71.37 -28.32 63.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.631 -1.168 . . . . 65.13 111.178 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HA ' HG11 ' A' ' 113' ' ' VAL . 29.6 mm-40 -67.43 -23.49 65.54 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.035 0.534 . . . . 73.23 111.394 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -86.02 -30.64 22.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.774 -0.648 . . . . 73.41 109.76 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.31 -36.58 58.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.333 0.653 . . . . 73.22 111.622 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -118.46 -66.68 1.05 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.83 0.852 . . . . 64.13 109.438 -170.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 74.86 -30.49 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.053 1.341 . . . . 73.24 112.892 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.89 -16.86 63.87 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.034 1.334 . . . . 44.45 113.671 -166.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 113' ' ' VAL . 40.4 mmtm 79.99 -2.55 2.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.237 1.415 . . . . 72.33 112.299 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.05 -60.36 2.9 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.921 0.488 . . . . 52.4 110.856 171.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -91.11 -34.34 15.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.728 -0.669 . . . . 63.03 111.592 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' HG3' ' A' ' 103' ' ' MET . 26.9 m -68.96 -44.84 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 112.135 0.42 . . . . 50.01 112.135 -175.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 24.0 t70 -72.51 -32.91 66.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.558 0.743 . . . . 72.31 110.203 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -65.47 -53.08 47.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.772 0.67 . . . . 61.41 109.789 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -56.82 -37.63 71.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.618 -1.174 . . . . 72.23 110.603 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.1 -44.34 92.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.403 1.081 . . . . 72.31 111.158 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 46.0 mmtm -63.37 -38.5 91.38 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.566 0.541 . . . . 72.43 110.609 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 13.9 mmmm -71.73 -49.47 38.98 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.774 -0.648 . . . . 71.31 111.084 -176.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.426 ' HB ' HD11 ' A' ' 26' ' ' LEU . 9.3 tp -74.02 -37.58 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 123.285 0.366 . . . . 73.44 110.732 -173.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.35 -45.53 72.59 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.678 -0.86 . . . . 35.22 108.678 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.99 97.34 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.007 -0.542 . . . . 72.33 112.271 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -64.25 -50.71 66.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.695 0.798 . . . . 71.53 110.441 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.1 m -67.57 -38.24 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 O-C-N 123.782 0.676 . . . . 71.14 111.198 -175.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.97 -39.93 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.081 0.401 . . . . 60.52 110.538 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.7 t -70.61 -45.35 65.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.476 -0.329 . . . . 70.14 110.179 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.66 -32.03 73.37 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.897 1.279 . . . . 73.13 111.89 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 59.2 mt -88.47 3.12 51.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.052 0.541 . . . . 60.32 111.827 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.19 92.49 6.9 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.004 0.522 . . . . 52.42 109.714 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.538 ' HD3' ' SG ' ' A' ' 81' ' ' CYS . 48.0 mtmt -60.4 -9.2 3.28 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.088 1.355 . . . . 74.15 114.266 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -53.62 -47.65 70.05 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 73.25 110.472 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.531 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -111.9 -34.4 6.01 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.101 -0.954 . . . . 74.1 110.767 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -73.29 -0.31 14.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.633 1.345 . . . . 70.05 114.633 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.1 ptmt -50.56 -9.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.676 1.362 . . . . 51.01 114.676 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -81.92 6.77 14.82 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.735 0.814 . . . . 74.42 111.732 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 157' ' ' GLU . 90.6 mt -89.41 140.99 28.96 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.355 0.662 . . . . 64.22 109.688 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.57 113.35 15.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.87 -1.9 . . . . 75.35 105.87 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.446 ' HE2' ' SG ' ' A' ' 81' ' ' CYS . 65.0 m-85 -87.61 136.51 32.92 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.631 -0.507 . . . . 71.33 109.631 -172.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -135.44 153.28 51.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.012 -1.107 . . . . 72.22 108.012 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.2 tt -139.01 145.35 27.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 108.945 -0.761 . . . . 63.21 108.945 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.68 131.27 51.33 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.267 0.979 . . . . 73.53 112.222 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.98 -33.68 3.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.262 1.425 . . . . 63.44 112.522 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -73.48 -49.34 27.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.23 1.012 . . . . 73.14 110.563 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.7 78.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.566 0.746 . . . . 62.01 111.72 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.72 -8.94 59.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.693 -0.685 . . . . 54.33 112.764 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -89.01 -41.83 12.12 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.058 0.456 . . . . 65.2 109.85 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -100.7 5.09 56.64 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.64 -0.709 . . . . 72.03 113.672 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 60.45 34.74 20.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.833 0.853 . . . . 75.42 110.568 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -63.18 178.37 0.51 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.719 1.208 . . . . 64.33 112.996 -173.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.677 ' HA ' ' HD3' ' A' ' 94' ' ' LYS . 4.2 t30 -88.11 8.17 28.12 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.716 -1.129 . . . . 74.11 109.614 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.25 144.65 48.71 Favored Glycine 0 C--N 1.359 1.853 0 CA-C-N 115.952 -0.567 . . . . 73.45 113.01 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.456 ' NE2' HD22 ' A' ' 171' ' ' LEU . 8.9 pt20 -85.0 162.74 19.24 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.672 0.789 . . . . 73.34 110.916 -174.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.15 125.36 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.814 -1.085 . . . . 72.32 110.015 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.16 107.95 3.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.383 1.073 . . . . 75.13 109.36 169.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.6 mt -90.94 102.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.422 -0.585 . . . . 74.3 109.422 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.441 HD12 HD11 ' A' ' 68' ' ' ILE . 47.2 mm -93.22 148.03 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.939 -0.763 . . . . 74.3 108.939 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.638 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -139.17 147.41 41.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.735 0.814 . . . . 74.41 108.942 169.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -98.24 134.37 41.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.195 -1.039 . . . . 63.11 108.195 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 23.7 ttm180 -124.83 153.14 42.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.051 0.94 . . . . 61.15 108.849 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.76 93.99 4.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.941 0.337 . . . . 64.25 110.491 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.3 p -119.37 123.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.716 0.806 . . . . 73.22 110.166 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 55.75 32.57 19.72 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.516 1.126 . . . . 74.44 112.612 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.01 68.89 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.181 -0.463 . . . . 43.02 113.422 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 m -128.05 125.8 40.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.254 0.622 . . . . 74.0 110.257 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 9.5 pt-20 -73.48 112.89 9.98 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.461 0.704 . . . . 71.51 109.267 169.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.93 106.89 46.91 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.483 0.713 . . . . 74.35 109.348 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.7 Cg_exo -76.16 117.05 4.52 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 122.675 2.25 . . . . 71.22 111.154 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.2 m -116.1 124.23 49.86 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.153 -0.684 . . . . 75.31 109.153 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 29.3 tp -76.99 137.7 39.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.395 1.078 . . . . 72.41 109.937 171.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 74.2 mtp -117.63 122.72 44.34 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.344 -1.354 . . . . 73.12 107.344 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.456 HD22 ' NE2' ' A' ' 152' ' ' GLN . 80.1 mt -136.33 147.85 47.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.076 -1.083 . . . . 71.24 108.076 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.552 HG11 HG11 ' A' ' 99' ' ' VAL . 10.0 p -75.46 144.65 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 109.464 -0.569 . . . . 74.35 109.464 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.438 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 12.8 ptmm? -57.0 -32.79 66.48 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.642 0.777 . . . . 63.44 112.188 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 172' ' ' VAL . 4.1 tp10 -85.82 1.1 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.809 0.844 . . . . 74.11 113.046 -165.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.46 -1.01 6.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.46 0.304 . . . . 70.52 111.637 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.24 141.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.624 0.77 . . . . 74.21 109.501 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.541 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.1 mm -126.88 114.0 35.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.214 -1.402 . . . . 72.32 107.214 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -84.47 127.0 33.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.235 -0.654 . . . . 63.11 109.235 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -116.3 101.78 8.98 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.075 -0.713 . . . . 72.14 109.075 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.424 ' HA ' HD23 ' A' ' 2' ' ' LEU . 36.0 ttpt -68.51 137.76 54.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.412 0.685 . . . . 71.51 110.539 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 21.8 t -131.87 88.3 2.55 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.623 -0.88 . . . . 63.02 108.623 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.3 mt -131.2 100.8 5.32 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.672 1.189 . . . . 71.53 108.257 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.559 1.298 0 C-N-CA 123.808 0.843 . . . . 73.41 110.718 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 108.772 -0.825 . . . . 72.11 108.772 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.0 mt -94.53 115.41 27.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.117 0.484 . . . . 44.22 110.497 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 49.8 mt -99.04 132.48 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.091 -1.077 . . . . 65.33 108.091 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 64.5 m-85 -121.76 132.39 54.59 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.484 -0.932 . . . . 71.44 108.484 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.565 ' NZ ' ' HB2' ' A' ' 179' ' ' GLU . 3.5 mppt? -120.67 120.18 34.97 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.415 0.686 . . . . 73.42 110.877 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.584 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 21.5 t70 -69.05 177.87 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.195 0.998 . . . . 70.23 108.797 170.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 pt -81.88 -29.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.838 -1.164 . . . . 74.11 111.62 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.05 -38.71 4.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.605 0.762 . . . . 64.35 110.64 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 m -96.28 15.81 20.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.833 -1.076 . . . . 70.21 109.686 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 4.2 p-10 -54.62 -33.85 61.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.214 1.406 . . . . 73.22 113.253 -172.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.61 -57.39 8.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.382 1.676 . . . . 73.2 112.131 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -123.83 24.34 8.39 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.766 0.654 . . . . 74.53 112.766 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 tm? -60.28 -61.14 2.82 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.572 0.349 . . . . 64.35 110.552 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 35.6 t -155.21 161.27 41.23 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 110.048 -0.353 . . . . 62.02 110.048 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 23.0 t 172.3 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.455 1.097 . . . . 74.31 109.838 -168.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.488 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 23.4 t70 -177.8 165.24 2.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.802 1.241 . . . . 63.51 109.145 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 p -67.8 88.35 0.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.414 -0.588 . . . . 72.43 109.414 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 23.4 m-85 -109.83 151.67 42.5 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.915 -1.039 . . . . 61.24 111.514 -175.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.66 120.74 7.11 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.913 1.742 . . . . 51.54 110.982 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.9 135.96 34.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.47 -0.937 . . . . 45.14 108.47 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 8.6 mmmm -141.82 107.32 5.05 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.219 -1.4 . . . . 75.24 107.219 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.6 tp -109.29 133.65 52.78 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.809 -0.812 . . . . 74.24 108.809 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.92 137.13 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.826 0.851 . . . . 72.24 109.083 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.5 t70 66.42 4.32 3.21 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.401 1.08 . . . . 75.42 112.263 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.8 t70 59.47 11.68 2.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.904 1.281 . . . . 74.21 112.57 -167.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.3 tp -113.03 -41.51 3.72 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.686 -0.634 . . . . 73.5 110.158 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.47 130.94 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.089 0.556 . . . . 72.21 109.656 -167.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -93.61 117.77 30.52 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.561 -0.903 . . . . 72.44 108.561 171.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 7.0 pt-20 -97.42 119.56 36.19 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.479 0.712 . . . . 53.33 109.728 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.608 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 23.3 t80 -110.76 106.21 15.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.25 -1.019 . . . . 75.34 108.25 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.05 113.5 4.51 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.21 0.204 . . . . 73.3 111.19 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.13 165.4 22.85 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 110.825 -0.91 . . . . 75.1 110.825 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.663 ' HG2' ' HB2' ' A' ' 69' ' ' ASP . 18.2 ptpt -94.37 125.38 38.97 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.65 0.725 . . . . 74.33 109.673 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.608 ' HB3' ' HG3' ' A' ' 167' ' ' PRO . 0.3 OUTLIER -73.63 106.84 5.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.158 0.583 . . . . 55.32 109.436 177.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.46 ' HB ' HD11 ' A' ' 42' ' ' ILE . 9.9 m -139.24 162.24 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.675 0.79 . . . . 53.22 110.786 -170.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.8 m -109.56 124.01 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.197 -0.94 . . . . 72.15 109.422 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.454 ' HB2' HD13 ' A' ' 72' ' ' LEU . 16.7 tpt180 -132.7 108.09 8.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.013 -0.365 . . . . 74.14 110.013 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -129.65 160.46 33.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.281 1.032 . . . . 63.0 108.526 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 50.73 -76.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.635 1.974 . . . . 71.03 113.497 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.31 32.35 0.11 Allowed Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.676 -0.57 . . . . 63.44 111.676 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -147.39 146.67 29.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.356 0.662 . . . . 73.45 110.322 -175.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.46 HD11 ' HB ' ' A' ' 35' ' ' VAL . 5.9 tp . . . . . 0 CA--C 1.555 1.153 0 C-N-CA 124.796 1.238 . . . . 65.53 109.063 176.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 C--O 1.236 0.358 0 N-CA-C 105.012 -2.218 . . . . 65.53 105.012 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.75 ' HG3' ' HG2' ' A' ' 66' ' ' ARG 0.25 10.4 pt-20 65.15 -36.08 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 127.612 2.365 . . . . 70.04 115.632 164.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.75 ' HG2' ' HG3' ' A' ' 65' ' ' GLU . 18.1 mmt180 -132.66 110.92 10.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 104.76 -2.311 . . . . 65.12 104.76 -174.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.6 37.83 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.468 -0.653 . . . . 53.22 111.468 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.56 HD11 HD12 ' A' ' 156' ' ' ILE . 30.9 pt -109.6 160.07 8.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.143 -0.688 . . . . 73.35 109.143 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.663 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . 24.1 t70 -39.15 -40.53 0.73 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.26 1.024 . . . . 75.14 113.038 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.413 HD11 ' HD1' ' A' ' 30' ' ' PHE . 46.0 mm -56.54 -42.36 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.461 -0.791 . . . . 73.3 111.125 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.8 t -85.28 -49.52 15.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 C-N-CA 123.56 0.744 . . . . 74.31 111.717 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' A' ' 37' ' ' ARG . 33.8 mt -72.13 -49.0 39.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.217 0.607 . . . . 64.05 111.919 -169.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -69.79 -26.0 64.06 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 62.14 111.274 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -103.42 -14.95 16.05 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.027 0.381 . . . . 71.04 112.027 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? 60.07 69.97 0.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.516 1.126 . . . . 64.34 110.759 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 mt -96.57 142.13 29.0 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.402 -1.272 . . . . 72.44 109.113 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.04 124.22 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 108.794 -0.817 . . . . 65.54 108.794 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.35 151.08 5.72 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.482 1.113 . . . . 73.35 113.811 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.7 tpt -147.03 103.64 3.62 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 113.839 -1.528 . . . . 64.44 107.271 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -94.24 93.95 8.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.111 -1.441 . . . . 72.52 107.111 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 30.1 p -68.91 -31.02 69.64 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.508 0.67 . . . . 73.35 110.111 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.09 -21.18 61.53 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.42 -1.263 . . . . 73.54 111.711 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -105.18 -16.72 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.509 0.724 . . . . 63.23 112.197 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.39 23.53 6.37 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.301 0.64 . . . . 73.21 110.596 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.18 -28.94 3.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.014 1.725 . . . . 62.33 114.823 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.3 m -62.25 -59.18 5.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 118.109 0.413 . . . . 73.34 111.503 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.2 mmm -64.74 -39.25 93.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.489 0.716 . . . . 73.32 110.233 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -61.1 -46.23 91.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.037 -0.983 . . . . 74.31 112.076 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -61.33 -35.28 76.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.924 0.765 . . . . 74.42 110.106 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.57 82.41 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.746 -0.661 . . . . 63.53 111.323 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -67.37 -43.72 80.74 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.536 0.334 . . . . 72.43 111.498 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -64.08 -33.52 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.604 1.162 . . . . 62.23 111.449 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.87 -47.08 86.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.415 0.686 . . . . 70.35 109.851 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -72.82 -40.46 65.79 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.533 -0.758 . . . . 75.11 110.902 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.08 -54.92 36.94 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.657 1.583 . . . . 75.3 112.069 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttt -59.7 -46.14 89.97 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.738 0.648 . . . . 74.43 110.115 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -58.23 -44.91 88.46 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 115.659 -0.7 . . . . 75.5 109.535 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -62.59 -50.37 71.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.316 1.046 . . . . 72.33 111.144 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 175' ' ' ALA . 26.4 m -67.93 -39.17 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.275 0.63 . . . . 65.42 112.566 -174.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.5 mt -73.39 -38.48 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.495 -0.557 . . . . 60.33 109.495 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.34 -27.19 66.93 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.813 1.245 . . . . 70.35 111.162 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -63.55 -57.92 8.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.952 0.901 . . . . 63.33 109.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.546 ' HG3' HG12 ' A' ' 113' ' ' VAL . 23.2 ptm -73.89 -19.74 60.62 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.86 0.725 . . . . 75.44 111.575 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.482 ' HG2' ' HE ' ' A' ' 108' ' ' ARG . 26.6 tt0 -53.8 -55.77 23.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.014 0.926 . . . . 71.41 110.759 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -24.34 66.14 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.825 0.703 . . . . 63.21 111.317 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -94.35 -16.43 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.2 1.0 . . . . 72.54 110.787 -173.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -129.11 -83.43 0.57 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.83 0.852 . . . . 73.3 110.316 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HE ' ' HG2' ' A' ' 104' ' ' GLU . 94.2 mtt180 53.56 20.9 2.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.751 1.019 . . . . 74.3 113.751 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.19 -21.96 59.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.397 0.679 . . . . 73.53 109.44 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 86.53 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.415 1.886 . . . . 75.14 112.238 174.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.47 -44.39 91.2 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.878 0.325 . . . . 71.22 111.878 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.9 -41.46 36.48 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.46 0.704 . . . . 60.4 110.654 -171.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.546 HG12 ' HG3' ' A' ' 103' ' ' MET . 33.4 m -70.71 -28.6 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 115.818 -0.628 . . . . 70.12 110.858 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 29.9 t70 -68.1 -47.79 67.24 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.124 0.57 . . . . 65.05 110.465 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.09 -38.28 90.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.785 0.678 . . . . 62.11 110.082 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -65.36 -49.57 68.86 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.232 -0.894 . . . . 70.41 111.348 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.572 ' HA ' HG22 ' A' ' 120' ' ' ILE . 21.9 pttp -67.46 -25.84 66.09 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.177 0.298 . . . . 72.15 110.894 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -61.91 -51.19 69.16 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.822 0.701 . . . . 74.45 110.566 169.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.83 -36.5 59.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.848 0.685 . . . . 65.41 112.848 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' A' ' 117' ' ' LYS . 10.6 tp -73.18 -37.18 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 118.538 0.608 . . . . 71.32 109.682 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -48.12 69.38 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.001 0.521 . . . . 74.21 110.091 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.28 94.31 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.63 0.581 . . . . 50.13 112.331 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.41 -55.26 22.18 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 123.513 0.725 . . . . 74.1 110.232 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.1 m -66.05 -41.72 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 118.721 -0.656 . . . . 65.43 111.482 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.79 -40.03 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.686 0.676 . . . . 63.24 110.419 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -73.19 -32.81 65.04 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.067 0.547 . . . . 72.34 111.51 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.683 HD21 HG21 ' A' ' 155' ' ' ILE . 31.0 tp -77.29 -31.2 54.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.567 0.747 . . . . 64.44 110.992 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 56.2 mt -84.0 3.64 33.43 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.855 0.862 . . . . 64.14 111.246 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.04 84.01 0.98 Allowed 'General case' 0 C--N 1.357 0.935 0 N-CA-C 109.263 -0.643 . . . . 61.32 109.263 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -66.09 -14.84 62.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.863 1.431 . . . . 74.41 114.863 -163.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.61 -36.4 80.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.208 0.527 . . . . 71.14 110.489 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.1 mtp-105 -105.76 -39.15 6.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.168 0.987 . . . . 70.13 110.42 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -81.67 -1.43 46.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.383 1.073 . . . . 74.45 113.784 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -47.64 -10.85 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.958 1.466 . . . . 74.34 114.958 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -82.01 6.21 16.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.808 0.843 . . . . 72.04 111.66 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 157' ' ' GLU . 96.3 mt -91.69 154.31 19.08 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.286 0.634 . . . . 64.03 110.002 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.62 125.65 18.42 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.793 -1.558 . . . . 62.33 106.793 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -98.68 153.05 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.284 -1.006 . . . . 72.41 108.284 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -143.58 171.15 14.56 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.642 0.777 . . . . 72.11 109.074 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.99 149.12 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.929 -1.137 . . . . 63.35 107.929 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.81 132.79 44.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.474 -0.626 . . . . 75.2 112.23 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.53 -42.65 99.14 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.761 -0.459 . . . . 73.42 109.761 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.611 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -65.71 -33.71 76.52 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.5 -0.773 . . . . 73.42 111.931 172.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.51 -44.24 75.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.192 0.597 . . . . 74.41 110.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.06 65.75 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.246 0.966 . . . . 60.34 110.875 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -57.36 -36.57 71.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.369 1.067 . . . . 74.02 111.513 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.6 -52.92 23.0 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.361 -0.836 . . . . 60.21 111.137 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -167.72 154.78 8.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.555 0.742 . . . . 75.54 109.944 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.11 10.05 9.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.3 0.24 . . . . 72.53 110.97 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -88.88 -3.89 58.62 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.585 0.754 . . . . 74.3 110.601 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.66 151.54 24.38 Favored Glycine 0 C--N 1.356 1.642 0 O-C-N 123.963 0.79 . . . . 50.13 113.697 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -79.52 135.52 36.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.029 0.532 . . . . 73.51 111.33 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.41 112.07 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.202 -0.908 . . . . 71.51 110.527 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.88 115.48 14.52 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.415 1.086 . . . . 71.1 109.964 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.683 HG21 HD21 ' A' ' 127' ' ' LEU . 54.4 mt -92.8 115.21 31.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 122.922 0.489 . . . . 74.44 109.932 -171.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.56 HD12 HD11 ' A' ' 68' ' ' ILE . 35.1 mm -98.81 116.22 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 118.441 0.564 . . . . 60.24 110.562 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 159' ' ' ARG . 46.0 tt0 -97.22 101.46 13.03 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.259 1.023 . . . . 75.31 109.554 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -75.62 89.7 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.564 -1.273 . . . . 70.41 107.564 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.45 ' HB2' ' HG2' ' A' ' 157' ' ' GLU . 39.0 ttt85 -99.52 149.7 22.96 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.808 -0.812 . . . . 72.42 108.808 -172.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -122.47 130.56 53.19 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.592 -0.892 . . . . 74.32 108.592 167.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.1 109.37 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.362 -0.977 . . . . 73.45 108.362 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 60.1 28.84 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.498 1.119 . . . . 75.32 110.568 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.54 -17.08 59.92 Favored Glycine 0 C--N 1.357 1.743 0 CA-C-N 115.548 -0.751 . . . . 71.43 113.432 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.7 m -81.32 112.24 18.44 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.238 0.519 . . . . 74.4 110.42 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -71.84 103.33 3.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.501 0.72 . . . . 51.24 110.09 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.05 92.67 15.67 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 125.12 1.368 . . . . 75.55 109.224 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.608 ' HG3' ' HB3' ' A' ' 34' ' ' HIS . 72.1 Cg_endo -75.26 116.53 4.56 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.395 2.063 . . . . 73.3 111.645 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 31.1 p -117.22 135.6 53.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.282 1.033 . . . . 64.03 110.605 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.4 tp -77.18 114.05 15.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.131 0.972 . . . . 71.31 108.895 170.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 66.6 mmm -102.67 121.49 42.52 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.259 -1.386 . . . . 64.13 107.259 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.1 mt -136.0 147.12 47.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 106.966 -1.494 . . . . 74.44 106.966 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 99' ' ' VAL . 7.5 p -73.05 131.17 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.55 -0.907 . . . . 64.04 108.55 173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.61 -34.82 59.83 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.38 1.472 . . . . 55.22 111.634 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.17 -18.45 65.31 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 75.15 112.2 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -127.36 15.95 7.15 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.428 0.691 . . . . 71.02 111.74 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.5 tp -131.49 119.01 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 N-CA-C 108.199 -1.038 . . . . 71.34 108.199 165.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.43 113.74 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.644 -0.502 . . . . 53.03 109.644 -168.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -70.61 154.51 41.8 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.192 0.997 . . . . 64.35 111.244 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.582 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.4 tp10 -147.51 101.6 3.37 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.36 -0.607 . . . . 74.1 109.36 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -83.46 94.55 8.03 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.908 -0.404 . . . . 73.34 109.908 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 44.0 t -96.49 89.73 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.93 -1.137 . . . . 63.53 107.93 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.92 172.83 16.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.741 -0.663 . . . . 74.23 111.134 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 CA--C 1.559 1.324 0 C-N-CA 124.556 1.142 . . . . 64.53 110.793 -171.505 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.65 ' HG3' ' HG ' ' A' ' 2' ' ' LEU . 20.9 ptt? . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 112.997 0.74 . . . . 55.12 112.997 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.65 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 87.0 mt -136.03 161.51 35.47 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 123.327 0.651 . . . . 62.21 110.815 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 57.1 mt -96.65 120.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.351 -1.351 . . . . 63.55 107.351 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 22.7 m-85 -112.54 96.95 6.28 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.518 -1.66 . . . . 73.3 106.518 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 14.0 ptmm? -107.41 127.24 53.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.272 -0.876 . . . . 71.35 110.898 -173.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 25.1 t70 -74.2 178.16 5.29 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.59 -1.186 . . . . 65.04 109.807 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 HD21 ' A' ' 98' ' ' ASN . 62.0 mt -76.22 -38.66 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.578 -0.701 . . . . 61.24 110.732 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.7 -50.84 2.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.251 1.02 . . . . 52.21 109.867 -172.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -90.25 17.65 6.89 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.095 -0.957 . . . . 74.01 111.106 -171.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.565 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 9.0 p-10 -55.19 -26.57 39.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.773 1.629 . . . . 74.21 113.657 -170.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -49.46 -62.19 1.68 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 125.178 1.549 . . . . 74.14 112.493 -170.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -123.6 24.08 8.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.273 -0.876 . . . . 63.32 111.901 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 1.8 tm? -59.43 -73.58 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.993 0.517 . . . . 73.1 109.648 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 27.1 m -149.73 151.94 34.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.968 -1.123 . . . . 70.44 107.968 167.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 m -155.76 111.9 3.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.098 0.559 . . . . 72.52 110.359 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.269 4.1 p-10 51.88 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.31 1.844 . . . . 74.02 112.33 172.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.1 p -60.71 5.85 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.435 1.642 . . . . 53.53 115.435 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.41 146.94 32.87 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.777 0.831 . . . . 64.22 109.935 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -91.38 173.09 2.75 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.348 2.699 . . . . 74.12 114.312 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.657 ' HA ' ' HE1' ' A' ' 28' ' ' TYR . 23.8 ptt? -114.09 151.68 32.21 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.898 -1.046 . . . . 73.12 109.799 169.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -149.39 97.53 2.66 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 106.818 -1.549 . . . . 72.15 106.818 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.0 tp -91.72 122.03 33.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.812 -0.81 . . . . 73.01 108.812 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.96 134.32 53.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 C-N-CA 123.693 0.797 . . . . 71.51 108.954 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.31 21.72 8.57 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.848 0.859 . . . . 71.44 111.764 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 68.15 -9.29 0.5 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.824 1.249 . . . . 72.44 113.756 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.6 tp -102.76 -52.56 3.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.516 -0.74 . . . . 73.52 111.448 -167.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -103.71 129.08 56.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.043 -0.981 . . . . 64.42 109.586 -164.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.657 ' HE1' ' HA ' ' A' ' 20' ' ' MET . 17.2 t80 -83.35 112.83 20.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.38 -1.341 . . . . 71.24 107.38 170.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.8 121.64 38.87 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.528 -1.214 . . . . 64.12 108.196 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -113.13 136.58 52.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.459 0.704 . . . . 72.01 109.548 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 136.15 57.88 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.374 1.07 . . . . 44.32 113.314 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.62 146.21 14.07 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 110.58 -1.008 . . . . 73.43 110.58 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.79 151.83 40.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.266 0.533 . . . . 72.34 109.69 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -74.97 124.34 26.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.715 -0.476 . . . . 75.43 109.715 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.53 160.58 16.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 124.407 1.083 . . . . 63.42 109.454 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.533 HG12 ' HG3' ' A' ' 66' ' ' ARG . 16.1 m -120.14 103.55 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.791 -1.559 . . . . 63.44 106.791 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.619 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.5 mtp180 -101.06 155.74 17.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.812 -1.085 . . . . 71.22 108.315 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 20.6 ttpp -135.5 161.83 34.38 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.627 -1.249 . . . . 74.32 107.627 170.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -43.37 -32.41 0.83 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.465 1.506 . . . . 75.23 113.927 -172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.83 54.83 0.53 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.448 -0.661 . . . . 55.2 111.448 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.8 tt0 -163.97 150.67 11.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.34 0.656 . . . . 72.24 110.939 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 124.841 1.256 . . . . 74.25 107.799 168.571 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 107.479 -1.304 . . . . 64.42 107.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.3 mt-10 -85.59 70.5 10.75 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.518 -1.29 . . . . 71.25 107.518 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HG3' HG12 ' A' ' 36' ' ' VAL . 18.7 ttp180 -96.55 139.18 33.02 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.465 0.65 . . . . 73.35 111.025 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.69 -131.99 5.22 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 114.858 -1.065 . . . . 63.34 111.374 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.789 HD12 ' HB2' ' A' ' 167' ' ' PRO . 0.8 OUTLIER -99.87 133.97 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.184 0.594 . . . . 72.23 110.755 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -36.79 -48.32 0.72 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.835 2.054 . . . . 65.32 114.186 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.7 mm -50.31 -53.33 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 124.164 0.915 . . . . 70.32 111.436 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 76' ' ' LEU . 57.7 t -80.84 -23.17 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.615 0.766 . . . . 73.51 111.299 -170.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 60.7 mt -77.47 -38.13 49.89 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.905 0.482 . . . . 51.3 110.578 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.52 -49.38 12.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.81 0.844 . . . . 75.31 110.819 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.89 -21.39 34.27 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.555 0.342 . . . . 62.43 111.094 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm 63.11 66.97 0.7 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 124.632 1.173 . . . . 73.34 110.85 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.556 ' HB2' HG13 ' A' ' 71' ' ' VAL . 40.5 mt -93.18 162.72 13.91 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.442 -1.254 . . . . 65.13 109.587 174.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.12 135.65 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.636 0.775 . . . . 73.11 109.912 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.11 152.85 44.87 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.493 0.923 . . . . 62.32 113.493 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 59.8 mtm -146.06 104.93 3.87 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.106 1.762 . . . . 72.2 106.434 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.68 124.58 25.05 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.202 -0.666 . . . . 73.24 109.202 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 3.8 m -56.31 -30.89 63.14 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.848 0.859 . . . . 73.11 111.612 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -69.49 -45.54 68.71 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 113.592 -1.64 . . . . 74.22 112.86 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -97.73 -28.23 13.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.883 0.473 . . . . 74.14 111.914 -173.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.97 19.5 18.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.151 0.98 . . . . 71.1 111.132 -169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.76 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.264 1.025 . . . . 71.04 113.743 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -72.79 -55.51 6.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.037 0.935 . . . . 72.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.6 mtt -64.07 -37.2 86.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.055 0.542 . . . . 72.22 110.403 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.621 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 14.9 t80 -54.04 -49.07 69.78 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.747 1.219 . . . . 74.51 111.03 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -64.61 -34.9 79.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 74.34 110.093 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.46 81.14 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.328 0.392 . . . . 65.11 111.005 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -67.67 -32.7 73.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.504 0.722 . . . . 71.3 112.505 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.9 mm -67.31 -44.71 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.468 0.707 . . . . 74.3 111.245 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.6 -40.61 92.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.914 0.486 . . . . 74.45 109.827 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -63.28 -50.22 70.97 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.262 -0.881 . . . . 71.12 109.435 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -56.51 -51.01 70.13 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.243 1.417 . . . . 74.11 112.12 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.5 -40.27 85.2 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.344 0.402 . . . . 71.21 110.993 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -68.43 -38.68 81.4 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.875 -0.417 . . . . 72.35 109.875 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.494 HD21 HD12 ' A' ' 7' ' ' ILE . 30.2 t30 -58.45 -55.69 31.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 63.43 110.625 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.519 HG11 HG11 ' A' ' 172' ' ' VAL . 22.3 m -71.41 -39.98 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 114.969 -1.014 . . . . 62.1 112.865 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.25 -45.82 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 110.014 -0.365 . . . . 72.33 110.014 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -56.03 -38.47 70.6 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.474 0.71 . . . . 71.14 110.8 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -56.33 -58.11 9.37 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.152 0.907 . . . . 72.24 110.197 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.4 mmm -70.28 -26.74 63.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.535 -0.302 . . . . 72.33 111.138 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.53 ' HA ' HG11 ' A' ' 113' ' ' VAL . 40.5 tt0 -64.35 -45.91 85.72 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.359 1.064 . . . . 62.13 110.681 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -89.29 -9.61 49.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.273 0.471 . . . . 74.15 112.273 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.25 -22.9 21.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.508 0.559 . . . . 52.54 112.508 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -124.86 -43.95 1.96 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.573 0.349 . . . . 72.11 111.16 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.96 25.62 14.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.718 0.807 . . . . 72.33 111.234 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -119.13 126.59 51.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.032 0.933 . . . . 74.54 109.361 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -62.24 -36.0 80.67 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.748 0.819 . . . . 72.14 111.85 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.34 60.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.783 0.433 . . . . 72.51 110.889 -172.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.11 -60.64 2.21 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.445 -0.576 . . . . 72.32 109.445 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 104' ' ' GLU . 30.3 m -67.45 -35.52 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.737 -1.12 . . . . 74.41 112.875 -167.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.54 -33.9 35.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.458 0.703 . . . . 72.4 110.324 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.26 64.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.706 -0.479 . . . . 74.3 109.706 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.424 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 42.0 t80 -71.49 -40.62 70.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.972 -1.013 . . . . 72.23 110.129 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -62.31 -38.62 90.11 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.685 0.794 . . . . 74.13 110.207 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.81 -40.42 88.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.557 -1.201 . . . . 70.11 109.698 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -71.71 -37.18 70.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.627 0.771 . . . . 74.12 109.927 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 172' ' ' VAL . 8.3 mm -65.05 -47.81 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.655 0.782 . . . . 64.12 109.2 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.11 -37.83 81.16 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.784 0.678 . . . . 74.5 110.577 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.52 58.62 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 115.83 -0.623 . . . . 42.25 112.393 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.79 -51.19 61.08 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.053 0.502 . . . . 73.33 110.762 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.591 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.0 m -70.87 -41.71 77.25 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.966 0 CA-C-O 118.546 -0.74 . . . . 73.2 111.071 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.57 -32.28 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 119.727 1.149 . . . . 72.2 110.619 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.6 t -70.63 -32.58 69.95 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.522 0.329 . . . . 62.52 110.597 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.653 ' HA ' ' HD2' ' A' ' 132' ' ' ARG . 37.8 tp -76.03 -40.43 53.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.004 0.922 . . . . 65.04 111.174 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.621 HD22 ' HZ ' ' A' ' 88' ' ' PHE . 47.6 mt -77.65 1.7 18.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.1 0.96 . . . . 75.32 111.142 -170.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.23 130.04 39.36 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.364 -1.347 . . . . 74.13 107.364 168.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 50.3 mtmt -68.06 -6.46 22.84 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.467 0.914 . . . . 64.45 113.467 -173.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 22.7 t70 -68.52 -30.34 69.13 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.763 0.825 . . . . 63.2 109.764 171.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.653 ' HD2' ' HA ' ' A' ' 127' ' ' LEU . 42.6 mtt180 -81.34 -33.2 32.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.992 -0.443 . . . . 65.33 110.515 171.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.625 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.1 m-85 -67.0 -20.23 65.85 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.549 0.739 . . . . 73.41 111.866 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 131' ' ' ASP . 24.3 pttm -61.98 -30.9 71.24 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.582 0.551 . . . . 72.14 110.577 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -127.56 25.5 6.06 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.332 1.053 . . . . 74.11 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.625 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 24.2 mt -100.27 144.28 29.47 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.585 0.707 . . . . 73.32 111.341 168.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.4 121.06 15.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.523 -1.658 . . . . 74.02 106.523 167.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.464 ' HB3' HG11 ' A' ' 153' ' ' VAL . 66.4 m-85 -93.57 134.31 35.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.747 -0.464 . . . . 72.53 109.747 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.06 140.96 50.77 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 75.43 109.452 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.4 tt -120.89 159.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.994 -1.484 . . . . 74.01 106.994 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.23 129.72 49.9 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.177 -0.791 . . . . 51.33 111.53 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.29 -41.49 79.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.526 0.731 . . . . 72.33 110.049 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -69.51 -38.55 77.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.861 -1.063 . . . . 71.5 110.666 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.34 -31.44 72.57 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.448 0.699 . . . . 55.22 110.58 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 5.43 12.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.711 0.804 . . . . 71.34 112.049 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.83 -10.28 45.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 64.14 110.403 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.62 -55.51 0.01 OUTLIER Glycine 0 C--N 1.352 1.42 0 N-CA-C 112.016 -0.433 . . . . 72.21 112.016 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.82 83.31 2.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.452 0.701 . . . . 74.13 110.649 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.92 -2.23 50.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.124 0.97 . . . . 74.52 111.22 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.11 78.75 1.83 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.208 -1.775 . . . . 70.01 106.208 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -123.89 -166.58 12.56 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-N 113.797 -1.547 . . . . 21.21 111.733 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.404 HE21 HD22 ' A' ' 171' ' ' LEU . 53.8 tt0 -101.58 142.1 33.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.002 -0.74 . . . . 61.53 109.002 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 138' ' ' PHE . 75.8 t -109.4 131.92 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.259 0.624 . . . . 74.23 112.058 -171.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.406 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.67 109.53 4.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.265 -1.334 . . . . 75.24 109.558 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 71.5 mt -85.56 105.5 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.966 -0.753 . . . . 73.14 108.966 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 169' ' ' LEU . 40.9 mm -103.58 119.61 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.008 -0.738 . . . . 72.21 109.008 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.405 ' HB3' HD23 ' A' ' 136' ' ' LEU . 12.1 pt-20 -124.94 127.81 47.64 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.827 0.346 . . . . 74.34 110.482 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -75.97 110.63 10.6 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 115.106 -0.952 . . . . 73.21 109.341 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.514 ' HB2' HG13 ' A' ' 166' ' ' VAL . 22.6 mmt85 -101.86 172.8 6.72 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.357 -0.979 . . . . 73.44 108.357 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -122.58 119.06 29.71 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.128 0.571 . . . . 73.33 110.603 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.73 118.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.021 0.528 . . . . 62.42 109.903 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 67.83 -67.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.899 1.68 . . . . 71.12 110.9 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.79 35.68 0.11 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.211 -0.756 . . . . 63.12 111.211 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.6 t -141.86 158.17 44.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.088 0.555 . . . . 52.44 110.863 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -78.75 114.46 17.69 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.748 0.819 . . . . 71.04 111.103 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 159' ' ' ARG . 5.8 p -117.73 89.14 32.33 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 109.11 -0.7 . . . . 74.24 109.11 175.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.789 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.3 Cg_endo -82.61 122.53 3.56 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 122.342 2.028 . . . . 64.31 110.159 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -105.42 140.0 39.2 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.727 0.811 . . . . 71.44 109.73 -168.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 156' ' ' ILE . 30.8 tp -82.36 123.34 29.01 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.917 0.76 . . . . 53.42 109.635 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.99 123.09 48.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.945 0.898 . . . . 63.51 108.882 174.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.472 HD13 HD11 ' A' ' 176' ' ' ILE . 79.7 mt -140.97 145.51 36.09 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.987 -1.486 . . . . 72.51 106.987 172.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.519 HG11 HG11 ' A' ' 99' ' ' VAL . 7.1 p -76.76 134.88 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 109.427 -0.583 . . . . 73.34 109.427 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -56.75 -36.76 70.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.511 1.124 . . . . 71.01 111.871 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -68.48 -25.91 65.21 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.901 0.881 . . . . 52.22 112.5 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.444 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -97.59 -1.91 42.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.816 0.446 . . . . 72.34 110.336 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.472 HD11 HD13 ' A' ' 171' ' ' LEU . 48.9 mm -102.55 132.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.362 -0.977 . . . . 72.21 108.362 174.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 44.3 mm -93.22 111.8 25.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.302 -0.999 . . . . 74.41 108.302 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.35 104.34 6.82 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.402 -0.962 . . . . 75.24 108.402 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.7 tp10 -104.04 111.06 23.47 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.966 -1.124 . . . . 72.04 107.966 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.44 129.66 34.68 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.806 -0.442 . . . . 73.03 109.806 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.4 t -100.81 104.35 15.59 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.734 -0.667 . . . . 65.21 110.417 -171.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.35 161.66 26.51 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.285 1.034 . . . . 64.42 109.399 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 C--O 1.252 1.219 0 CA-C-N 115.104 -0.953 . . . . 73.42 108.553 178.272 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.067 0.46 . . . . 71.43 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.2 mt -84.33 123.82 30.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.849 -0.797 . . . . 61.45 108.849 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.504 HG22 ' HB3' ' A' ' 15' ' ' SER . 33.3 pt -99.39 128.58 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.535 0.734 . . . . 71.2 109.251 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.501 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 12.9 m-85 -122.95 124.22 42.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.947 1.299 . . . . 74.25 107.807 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 23.3 pttm -145.85 147.12 31.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.083 0.856 . . . . 74.24 112.239 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 14.9 t70 -101.25 124.08 46.39 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.899 0.88 . . . . 70.22 109.996 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' A' ' 175' ' ' ALA . 43.4 pt -66.56 -26.85 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.68 0.622 . . . . 63.04 112.68 -164.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.61 -60.97 2.11 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.293 0.568 . . . . 74.52 111.587 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 m -125.53 -46.48 1.75 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.91 -1.041 . . . . 74.4 111.737 -159.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 2.8 t0 -101.4 24.05 10.17 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.99 0.916 . . . . 74.02 110.486 -166.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 5.6 p-10 -50.81 -2.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.016 2.228 . . . . 72.05 117.016 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -99.59 -41.52 7.3 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.645 1.111 . . . . 75.03 109.86 167.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 26.6 tp 36.51 -88.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.79 2.036 . . . . 72.22 113.655 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.401 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 73.5 m -157.3 134.48 10.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.802 0.841 . . . . 74.24 109.477 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.504 ' HB3' HG22 ' A' ' 3' ' ' ILE . 50.4 m -130.73 97.93 4.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.487 0.715 . . . . 74.44 109.149 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HB3' ' HE1' ' A' ' 18' ' ' PHE . 24.3 t70 -166.52 -90.64 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.185 0.594 . . . . 73.24 110.258 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 m -170.2 78.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.463 1.105 . . . . 61.13 108.874 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.452 ' HE1' ' HB3' ' A' ' 16' ' ' ASP . 53.9 m-85 -112.43 139.12 22.26 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.744 0.817 . . . . 73.43 110.213 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HD2' ' HE1' ' A' ' 30' ' ' PHE . 57.9 Cg_exo -53.8 117.57 4.0 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.202 1.935 . . . . 74.12 111.495 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.92 134.26 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.364 -0.835 . . . . 74.42 109.507 -172.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 39.1 ttmt -137.2 140.17 41.57 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.738 -1.208 . . . . 52.34 107.738 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 tp -131.75 108.07 9.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.831 -1.174 . . . . 74.15 107.831 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.35 133.64 42.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.848 0.859 . . . . 71.5 110.017 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.92 14.65 4.41 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.749 1.22 . . . . 42.45 112.763 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.7 t70 58.23 10.36 1.25 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.641 1.177 . . . . 73.35 111.987 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 119' ' ' LYS . 51.8 tp -103.9 -47.1 4.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.01 0.924 . . . . 70.0 111.333 -167.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -126.93 131.54 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 115.835 -0.621 . . . . 63.04 110.077 -172.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.45 ' HB2' HG21 ' A' ' 176' ' ' ILE . 82.1 t80 -85.24 135.11 34.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.41 1.084 . . . . 72.23 108.439 169.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 32.5 tt0 -117.98 144.99 45.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.362 0.665 . . . . 74.23 109.286 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.615 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.5 t80 -131.97 138.45 48.3 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.91 1.284 . . . . 72.24 107.683 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.33 153.94 39.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.647 0.379 . . . . 62.12 110.714 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.1 159.72 30.61 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.977 -0.556 . . . . 63.23 112.124 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -134.83 138.88 44.62 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.01 0.924 . . . . 74.44 109.244 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -70.57 120.46 16.23 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.543 -1.28 . . . . 73.52 107.543 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.84 -178.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.477 0.711 . . . . 72.13 109.941 -168.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.9 156.05 42.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.305 1.042 . . . . 62.23 108.578 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 38.1 ttm180 -140.06 132.64 28.74 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.282 0.563 . . . . 72.31 109.977 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.585 ' HD2' ' HB2' ' A' ' 41' ' ' GLU . 65.0 mttp -133.38 156.17 48.14 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.142 1.377 . . . . 73.03 107.456 164.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.09 -38.62 83.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 75.4 112.019 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.85 -44.04 1.58 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.951 -0.568 . . . . 75.43 113.16 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.585 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 24.6 mm-40 -95.9 163.35 13.19 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.296 0.638 . . . . 71.22 111.836 -171.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 tp . . . . . 0 CA--C 1.553 1.086 0 C-N-CA 124.889 1.276 . . . . 62.32 108.407 178.467 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.511 HG22 ' HE3' ' A' ' 38' ' ' LYS . 37.7 t . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 108.894 -0.78 . . . . 73.04 108.894 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 9.4 mp0 -75.27 73.91 2.38 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.977 -1.49 . . . . 73.04 106.977 171.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -92.22 135.5 33.95 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.846 -1.07 . . . . 74.25 110.693 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.44 -154.43 25.52 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.836 -1.306 . . . . 73.02 109.836 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -94.62 153.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.684 0.742 . . . . 73.43 111.496 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -42.88 -46.66 5.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.888 1.675 . . . . 65.54 113.097 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.583 HD13 ' HB2' ' A' ' 169' ' ' LEU . 45.1 mt -60.42 -47.97 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.919 1.288 . . . . 73.11 110.877 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -72.83 -42.56 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 114.604 -1.18 . . . . 74.43 112.195 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.49 -36.27 80.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.917 0.487 . . . . 60.11 110.768 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -59.58 -61.97 2.23 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.364 0.666 . . . . 45.3 110.634 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.476 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 59.6 t-80 -81.57 -17.7 47.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.264 -0.426 . . . . 71.42 112.1 -170.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 64.37 61.12 0.89 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.736 1.255 . . . . 74.4 108.427 -167.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 95.7 mt -82.07 133.46 35.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.066 -1.424 . . . . 74.43 109.399 174.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.701 HG11 ' HB2' ' A' ' 145' ' ' ALA . 7.3 p -91.93 138.38 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.325 0.65 . . . . 74.12 109.386 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.33 147.41 53.0 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.994 0.902 . . . . 72.45 111.519 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -132.64 103.12 5.97 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 103.081 -2.933 . . . . 72.03 103.081 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 12.2 t-20 -69.14 116.54 9.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.515 1.126 . . . . 72.4 111.104 -172.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 26.5 p -63.99 -28.77 70.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.59 0.756 . . . . 74.51 111.843 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -73.3 -58.89 2.99 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.493 -1.231 . . . . 61.44 112.157 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -103.51 -6.73 21.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.922 0.712 . . . . 71.53 112.922 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 16.1 m-20 -121.2 22.69 10.81 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.647 0.779 . . . . 74.42 111.266 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.56 -35.21 40.17 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.835 0.854 . . . . 74.15 112.399 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.6 m -64.11 -38.27 90.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.442 0.697 . . . . 62.13 111.353 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 mtt -60.18 -45.84 91.74 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.627 -0.508 . . . . 75.34 109.627 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 46.1 t80 -63.09 -35.42 80.19 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.889 0.743 . . . . 73.11 111.245 -176.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.9 -25.34 55.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.196 0.598 . . . . 71.21 111.47 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.29 -45.89 75.23 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 109.576 -0.527 . . . . 70.03 109.576 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 76.4 m-85 -54.15 -54.54 38.27 Favored 'General case' 0 C--O 1.202 -1.444 0 CA-C-N 114.71 -1.132 . . . . 73.12 109.473 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.02 -42.46 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.093 0.957 . . . . 54.13 112.088 -172.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -59.75 -55.64 31.76 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 122.442 0.297 . . . . 64.42 111.167 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -37.78 76.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 123.526 0.516 . . . . 74.3 110.386 -174.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -55.95 -57.01 13.91 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.838 1.655 . . . . 74.45 111.434 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.4 ttm -67.86 -40.09 83.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.847 0.717 . . . . 44.02 111.56 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -61.7 -44.68 96.47 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.376 0.422 . . . . 71.45 110.323 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -70.6 -45.2 65.75 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 124.16 0.913 . . . . 64.14 111.235 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.56 -40.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.202 0.314 . . . . 74.51 111.758 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.8 mt -73.43 -39.47 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 117.983 0.356 . . . . 70.11 110.746 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.19 -38.72 85.86 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.709 0.804 . . . . 74.55 110.974 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.87 -44.78 54.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.562 -0.744 . . . . 73.41 110.129 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.542 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -58.61 -40.37 83.08 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.642 0.777 . . . . 70.23 109.735 177.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.482 ' HA ' HG11 ' A' ' 113' ' ' VAL . 40.9 tt0 -65.7 -29.73 70.32 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.302 1.041 . . . . 74.44 111.374 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -75.1 -40.15 60.15 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.335 0.654 . . . . 72.3 110.131 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -73.2 -34.52 66.01 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.22 1.008 . . . . 72.14 111.86 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.741 HD21 ' HB3' ' A' ' 112' ' ' ASP . 42.5 t30 -100.59 -45.96 5.35 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.868 0.867 . . . . 53.41 111.639 -171.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 77.82 -17.17 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.241 1.416 . . . . 71.15 112.532 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 113' ' ' VAL . 23.9 t70 -96.6 126.27 41.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.13 109.657 -174.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -77.65 -27.15 50.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.161 0.584 . . . . 75.4 112.118 -174.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.56 89.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.731 0.412 . . . . 72.22 111.804 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.741 ' HB3' HD21 ' A' ' 107' ' ' ASN . 30.0 t70 -85.6 -33.54 21.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.629 0.772 . . . . 75.35 111.354 -174.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.627 HG13 HD22 ' A' ' 107' ' ' ASN . 16.9 m -78.99 -28.07 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 117.944 0.338 . . . . 42.01 111.833 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.99 -42.13 85.6 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.888 0.475 . . . . 73.54 109.84 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.39 -45.86 78.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.593 -0.73 . . . . 50.21 110.052 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.426 ' HZ ' ' HB2' ' A' ' 174' ' ' GLU . 81.1 t80 -56.31 -45.83 80.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.437 1.095 . . . . 71.24 111.119 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -57.35 -47.86 80.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 72.44 110.667 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -69.04 -26.53 65.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.703 0.801 . . . . 62.32 111.411 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HB3' HD22 ' A' ' 26' ' ' LEU . 32.5 mmtp -78.14 -35.51 48.88 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.344 0.658 . . . . 71.24 110.644 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.2 mm -69.66 -44.22 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.635 0.374 . . . . 50.44 110.046 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -58.42 -46.53 86.29 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.96 0.904 . . . . 74.33 109.614 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.39 99.22 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 124.194 0.934 . . . . 65.33 112.925 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -64.62 -51.51 62.29 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.301 0.64 . . . . 75.14 110.174 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.9 m -70.99 -41.22 76.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 0 CA-C-O 118.309 -0.853 . . . . 73.53 111.096 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.41 -33.04 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 119.486 1.039 . . . . 73.02 110.218 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.2 t -72.3 -42.15 65.81 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.437 0.695 . . . . 64.43 110.616 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' HA ' ' HG3' ' A' ' 132' ' ' ARG . 34.8 tp -79.09 -20.05 49.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.432 1.093 . . . . 51.11 111.952 -173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -83.39 4.07 29.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.005 0.922 . . . . 64.01 112.206 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.32 38.98 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.009 0.524 . . . . 74.31 110.723 172.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 4.3 ttpm? -62.33 -45.03 95.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.027 0.931 . . . . 71.23 112.289 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.53 -24.49 64.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.146 0.578 . . . . 64.44 111.425 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.582 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 30.0 mmt180 -68.72 -54.49 15.82 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.059 -0.719 . . . . 72.22 109.059 170.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.608 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.0 m-85 -59.92 -22.5 62.5 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.416 1.086 . . . . 75.12 113.783 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -66.64 -27.84 68.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 61.33 110.137 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -115.78 0.08 13.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.35 0.66 . . . . 72.32 111.263 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 60.8 mt -89.36 132.38 34.98 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.58 0.627 . . . . 71.24 109.677 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.51 117.03 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.225 -2.139 . . . . 64.42 105.225 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.543 ' HB3' HG11 ' A' ' 153' ' ' VAL . 33.6 m-85 -90.36 143.45 26.75 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.759 -0.83 . . . . 71.13 108.759 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.606 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 82.9 m-85 -140.7 152.93 45.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.138 0.575 . . . . 73.22 110.598 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.0 pt -144.89 172.96 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.05 1.34 . . . . 72.4 107.635 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.86 134.23 51.08 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.708 -1.051 . . . . 74.31 111.103 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -40.65 -48.14 2.88 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.337 1.236 . . . . 74.34 114.337 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -64.02 -28.56 69.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.835 0.854 . . . . 51.35 112.543 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.46 -14.46 62.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.683 0.793 . . . . 74.22 111.999 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.701 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -75.36 -2.92 30.68 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.229 0.611 . . . . 53.2 112.313 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -81.47 -33.12 32.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 74.35 110.137 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.11 -2.06 0.03 OUTLIER Glycine 0 C--N 1.357 1.727 0 N-CA-C 115.834 1.094 . . . . 65.1 115.834 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.12 75.11 9.49 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.717 1.258 . . . . 64.43 110.725 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.401 ' HG3' ' ND2' ' A' ' 150' ' ' ASN . 11.3 pt-20 -88.56 -0.53 57.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.245 1.018 . . . . 74.12 111.479 175.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 149' ' ' GLU . 47.1 m-80 -130.61 79.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.22 -1.03 . . . . 72.41 108.22 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -147.72 -148.55 4.77 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.067 -1.213 . . . . 51.04 110.067 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.96 152.92 22.1 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.328 -0.99 . . . . 63.44 108.328 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 138' ' ' PHE . 93.8 t -113.25 132.16 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.755 0.822 . . . . 51.24 110.445 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.74 101.38 3.67 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.338 -0.986 . . . . 72.41 108.338 166.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 127' ' ' LEU . 67.1 mt -89.54 120.35 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.632 -0.507 . . . . 64.53 109.632 -170.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.4 mm -105.63 119.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.839 0.455 . . . . 71.01 110.488 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -103.88 111.7 24.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.76 1.224 . . . . 64.54 109.48 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -75.61 89.82 2.77 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.443 -0.947 . . . . 71.02 108.443 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -89.61 164.67 14.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.217 1.007 . . . . 74.42 109.332 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -122.51 115.2 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.197 0.599 . . . . 74.32 110.151 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -120.43 97.88 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.821 0.849 . . . . 64.44 109.585 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 65.56 11.59 7.57 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.089 1.356 . . . . 54.41 112.583 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 118.85 -14.33 11.43 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.748 -0.473 . . . . 63.31 113.039 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.7 m -88.7 111.49 22.02 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 117.23 0.515 . . . . 72.24 109.804 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.68 114.39 9.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.289 -0.869 . . . . 64.43 109.167 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.423 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 13.2 m -123.5 98.16 41.23 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.746 1.218 . . . . 75.01 110.004 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 166' ' ' VAL . 38.7 Cg_endo -65.62 112.8 2.28 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.478 2.119 . . . . 71.0 111.163 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 p -113.96 134.19 54.99 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.141 0.976 . . . . 70.35 109.375 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 39.3 tp -77.33 140.91 40.09 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.493 0.717 . . . . 62.21 109.621 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 25.3 ptp -131.85 129.36 40.31 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 108.124 -1.065 . . . . 72.24 108.124 169.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -130.96 137.44 49.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.803 1.641 . . . . 74.42 106.903 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 174' ' ' GLU . 7.6 p -72.12 143.14 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.419 0.287 . . . . 70.34 111.455 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -32.6 -50.35 0.25 Allowed 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 126.951 2.1 . . . . 74.31 113.397 171.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.458 ' H ' HG22 ' A' ' 172' ' ' VAL . 1.4 tm-20 -68.85 -38.94 80.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.57 -1.195 . . . . 53.35 110.455 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.595 ' HA ' HG12 ' A' ' 7' ' ' ILE . . . -98.06 -6.46 31.74 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.99 -0.528 . . . . 31.11 111.123 -172.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.45 HG21 ' HB2' ' A' ' 28' ' ' TYR . 8.6 tp -108.41 136.64 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.767 -1.198 . . . . 73.51 107.767 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.0 mm -125.81 118.37 51.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.401 -1.703 . . . . 74.31 106.401 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.69 123.54 42.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.788 -1.19 . . . . 73.24 107.788 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -141.2 149.49 41.47 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.501 0.72 . . . . 72.14 109.274 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -98.7 96.82 8.18 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.231 -0.655 . . . . 50.24 109.231 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.59 93.92 4.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.294 0.638 . . . . 75.22 110.763 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 117.25 17.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.555 0.742 . . . . 62.3 109.201 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 . . . . . 0 CA--C 1.554 1.109 0 CA-C-O 118.909 -0.567 . . . . 64.01 110.076 175.818 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 17' ' ' SER . 22.4 mmt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 110.031 -0.359 . . . . 73.11 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.11 135.13 51.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.026 0.531 . . . . 62.53 109.656 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 5.1 tt -95.14 120.21 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.23 -0.656 . . . . 72.21 109.23 173.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.541 ' HB3' HD11 ' A' ' 176' ' ' ILE . 27.2 m-85 -105.92 125.99 51.65 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.389 -1.337 . . . . 71.11 107.389 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.586 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 48.5 pttt -151.25 159.52 44.32 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 123.559 0.537 . . . . 64.01 111.909 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 8.3 t70 -87.23 144.87 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.86 -0.793 . . . . 72.24 108.86 173.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 pt -66.63 -11.56 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 113.218 0.822 . . . . 55.3 113.218 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.17 -59.46 1.85 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.77 0.714 . . . . 72.34 112.527 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -125.99 -32.54 2.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.745 1.387 . . . . 63.0 114.745 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.608 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 19.0 m-20 -81.85 21.88 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.798 0.726 . . . . 75.23 111.539 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 7.5 m-20 -48.45 -20.99 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.305 1.224 . . . . 71.41 114.305 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.78 28.11 9.02 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 123.829 0.851 . . . . 61.42 110.212 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.601 ' HA ' ' HD2' ' A' ' 74' ' ' HIS . 41.3 tp -57.42 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.784 1.234 . . . . 62.11 112.107 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.7 m -155.62 126.74 7.1 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.83 -0.433 . . . . 72.43 109.83 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 29.2 p -133.77 102.03 5.31 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.064 0.546 . . . . 72.33 109.895 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -172.67 -176.35 1.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.038 -1.097 . . . . 74.04 108.038 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.409 ' N ' ' SD ' ' A' ' 1' ' ' MET . 58.9 m -79.71 84.88 5.47 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.425 -0.954 . . . . 64.33 108.425 172.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB2' ' HE2' ' A' ' 4' ' ' TYR . 73.6 m-85 -102.25 129.74 25.6 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.581 -0.896 . . . . 74.11 108.581 175.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 11.9 Cg_endo -56.19 122.07 11.13 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.026 2.484 . . . . 54.44 112.429 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.4 mtm -83.82 144.14 29.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.307 -0.861 . . . . 75.41 109.9 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -143.06 101.74 3.88 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.249 -1.389 . . . . 72.52 107.249 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.5 tp -103.67 126.43 50.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.502 0.721 . . . . 70.33 109.358 -174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.7 129.19 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.264 0.626 . . . . 52.33 109.8 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 64.48 12.0 7.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.659 1.183 . . . . 73.34 113.454 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 55.59 11.17 0.59 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.362 1.065 . . . . 44.55 113.102 -166.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.4 tp -105.66 -44.19 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.08 0.952 . . . . 73.1 110.394 -168.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.56 130.01 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.283 -0.871 . . . . 74.55 109.473 -171.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -90.21 117.59 29.08 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.692 -0.855 . . . . 70.22 108.692 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -92.75 126.34 37.78 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.158 0.983 . . . . 72.21 109.627 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 80.3 t80 -107.52 127.92 54.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.852 1.261 . . . . 73.03 108.024 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' ' HG2' ' A' ' 19' ' ' PRO . 72.4 mmtt -68.23 145.23 54.48 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 75.04 111.916 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.27 162.24 35.14 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.608 0.568 . . . . 64.23 112.021 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.38 142.96 50.68 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.027 0.931 . . . . 72.14 109.138 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -67.91 117.54 9.92 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.115 -0.698 . . . . 73.02 109.115 173.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.41 162.93 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.521 0.728 . . . . 61.13 110.626 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.56 131.89 72.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 108.64 -0.874 . . . . 70.42 108.64 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 73.2 mtp180 -105.31 108.13 19.48 Favored 'General case' 0 C--O 1.255 1.38 0 N-CA-C 108.504 -0.924 . . . . 73.41 108.504 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.501 ' NZ ' HG22 ' A' ' 64' ' ' VAL . 62.9 mmtt -134.3 148.37 50.76 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.099 1.759 . . . . 73.53 108.415 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.06 -7.08 43.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.936 0.894 . . . . 71.41 112.014 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.52 33.44 0.32 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.086 0.394 . . . . 61.42 114.086 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 39.7 tt0 -156.52 141.47 17.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.555 -0.535 . . . . 65.25 109.555 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 CA--C 1.563 1.474 0 CA-C-O 121.893 0.854 . . . . 74.5 110.423 -170.194 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.501 HG22 ' NZ ' ' A' ' 38' ' ' LYS . 12.7 t . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 107.897 -1.149 . . . . 74.42 107.897 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.2 mm-40 -98.72 66.78 1.67 Allowed 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.597 0.713 . . . . 71.52 109.16 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -89.15 143.38 26.88 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.609 -0.723 . . . . 61.03 110.006 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.07 -133.01 3.85 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.508 -1.037 . . . . 63.43 110.508 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.469 HD11 HD12 ' A' ' 156' ' ' ILE . 4.7 pt -111.26 154.08 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 122.508 0.323 . . . . 73.13 110.858 172.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.59 -39.23 73.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.454 1.101 . . . . 73.14 113.099 -173.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.04 -48.88 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.99 0.916 . . . . 71.42 110.527 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 76' ' ' LEU . 55.0 t -67.85 -43.48 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 114.999 -1.0 . . . . 74.44 111.099 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 75.9 mt -72.76 -21.97 60.92 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.183 0.593 . . . . 63.42 111.841 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -70.71 -53.59 15.05 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.362 0.665 . . . . 54.43 109.511 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.601 ' HD2' ' HA ' ' A' ' 13' ' ' LEU . 48.9 t-80 -86.55 -21.14 27.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.19 0.596 . . . . 75.35 111.101 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? 65.67 71.13 0.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.871 1.268 . . . . 72.3 109.727 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 91.1 mt -91.44 145.68 24.43 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.969 -1.014 . . . . 74.44 110.151 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 129.17 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.564 0.746 . . . . 61.43 109.855 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.77 153.56 32.44 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.615 0.969 . . . . 72.34 113.615 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.408 ' HE3' ' HB2' ' A' ' 79' ' ' MET . 40.6 ttm -150.16 112.11 4.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.799 2.039 . . . . 71.42 106.078 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.66 152.33 29.12 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.979 0.809 . . . . 72.2 111.702 -172.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.546 ' SG ' ' HE2' ' A' ' 138' ' ' PHE . 85.6 m -65.96 -16.63 64.05 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.402 0.89 . . . . 51.11 113.402 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -71.3 -55.23 8.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.973 0.509 . . . . 74.51 110.367 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.36 -40.63 5.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.231 0.612 . . . . 62.33 112.061 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.83 20.55 3.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.628 0.771 . . . . 65.54 112.854 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.77 85.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.293 0.637 . . . . 75.51 112.29 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -77.35 -31.31 54.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.348 0.659 . . . . 63.21 111.711 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.9 mmt -64.42 -50.92 65.71 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.319 -0.622 . . . . 35.51 109.319 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.86 -23.41 62.31 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.141 -0.936 . . . . 73.22 110.725 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -68.97 -37.64 78.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.291 0.636 . . . . 75.03 109.93 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.4 83.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.18 0.592 . . . . 72.11 110.238 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -69.39 -32.9 72.21 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 123.409 0.684 . . . . 73.34 112.499 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mm -65.87 -33.6 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 117.898 0.317 . . . . 55.11 110.644 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -63.11 -45.65 91.03 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 122.314 0.246 . . . . 55.11 110.571 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -61.6 -54.45 42.85 Favored 'General case' 0 C--N 1.36 1.058 0 N-CA-C 109.227 -0.657 . . . . 72.05 109.227 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.507 ' HD2' ' HG2' ' A' ' 152' ' ' GLN . 60.1 t80 -44.4 -68.53 0.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.792 2.037 . . . . 60.32 111.603 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 40.9 ttp -57.35 -50.38 73.13 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 124.127 0.971 . . . . 74.45 111.595 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -56.82 -50.04 73.59 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.111 0.882 . . . . 63.11 110.537 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -71.93 -48.01 48.41 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.74 -0.664 . . . . 75.33 111.604 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.599 HG11 HG11 ' A' ' 172' ' ' VAL . 23.8 m -66.25 -38.9 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 112.396 0.517 . . . . 40.02 112.396 -172.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.0 mt -77.91 -42.14 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 120.439 0.161 . . . . 70.32 110.921 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.05 -45.41 85.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.617 0.767 . . . . 73.34 111.355 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -67.14 -40.26 86.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.15 0.58 . . . . 62.14 109.959 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.36 -51.48 69.76 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 123.842 0.714 . . . . 73.23 110.62 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.81 -23.66 66.74 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.291 0.637 . . . . 75.35 111.257 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 31.8 ttmt -75.07 -24.47 58.21 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.338 0.655 . . . . 64.54 110.87 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -114.5 -13.39 12.2 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.2 0.6 . . . . 72.23 112.18 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -100.74 -46.06 5.28 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.717 0.807 . . . . 74.14 109.399 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 66.29 18.29 10.88 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.068 1.347 . . . . 74.51 113.144 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.18 111.13 19.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.64 -1.245 . . . . 62.03 107.64 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -69.5 -29.69 67.38 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.595 0.559 . . . . 75.44 111.632 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.34 -32.15 66.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 60.45 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.22 -47.55 56.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.686 0.794 . . . . 72.45 109.492 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.7 m -79.28 -17.82 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 115.237 -0.892 . . . . 73.01 111.935 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.08 -35.35 74.13 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.013 -0.736 . . . . 72.31 109.013 170.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.31 73.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.192 -0.913 . . . . 72.24 110.09 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -62.25 -41.61 98.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.0 0.52 . . . . 73.22 110.391 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.404 ' HA ' HG22 ' A' ' 120' ' ' ILE . 37.5 ttpt -62.24 -34.86 77.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.598 0.759 . . . . 74.43 110.589 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -66.4 -43.25 86.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.51 -0.768 . . . . 71.01 110.411 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -46.76 71.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.781 -0.645 . . . . 73.44 111.441 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 117' ' ' LYS . 9.0 tp -78.96 -33.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.606 0.363 . . . . 61.11 110.944 -168.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -41.06 95.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.082 -1.081 . . . . 72.0 108.082 171.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.8 -40.98 97.4 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.832 0.708 . . . . 63.04 113.013 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -67.88 -48.0 67.29 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 122.656 0.382 . . . . 71.34 111.003 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 31.4 m -70.5 -38.37 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 118.997 -0.525 . . . . 55.32 111.796 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.39 -32.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 118.683 0.674 . . . . 73.52 110.194 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -69.43 -42.03 75.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.453 0.701 . . . . 74.31 110.581 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 155' ' ' ILE . 14.4 tp -74.8 -30.89 61.56 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.247 1.019 . . . . 64.24 111.076 -170.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 86.5 mt -86.09 1.93 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.923 0.889 . . . . 65.01 110.78 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.04 67.03 8.94 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 122.08 0.943 . . . . 72.03 108.701 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.74 -6.22 30.48 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 114.191 -1.368 . . . . 55.55 113.593 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.73 -33.76 74.62 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.25 0.62 . . . . 64.22 110.449 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -105.44 -39.18 6.22 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.429 1.092 . . . . 71.33 109.527 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -80.33 0.67 31.98 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.112 1.365 . . . . 72.15 114.203 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -14.6 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 N-CA-C 114.288 1.218 . . . . 75.02 114.288 175.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.426 ' ND2' ' HG3' ' A' ' 157' ' ' GLU . 4.9 p-10 -79.44 13.63 1.9 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.026 0.93 . . . . 74.21 112.024 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.26 146.47 24.2 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.496 0.719 . . . . 73.54 109.425 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -139.06 112.49 8.21 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.72 -1.956 . . . . 74.43 105.72 169.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.641 ' HB3' HG11 ' A' ' 153' ' ' VAL . 37.1 m-85 -85.75 145.24 27.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.445 -0.946 . . . . 73.33 108.445 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 69.5 m-85 -139.41 143.79 37.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.349 0.66 . . . . 73.35 109.461 -176.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.6 pt -131.51 177.01 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.615 -0.883 . . . . 73.33 108.615 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.56 120.94 23.66 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 123.656 0.597 . . . . 74.32 111.621 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.39 -36.17 61.15 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.864 1.266 . . . . 75.43 110.24 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.54 -45.85 71.08 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.878 -1.055 . . . . 71.32 111.298 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.456 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -65.63 -25.74 67.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.519 0.728 . . . . 74.52 111.947 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.24 -7.66 56.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.894 0.877 . . . . 65.31 112.239 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -85.28 -40.39 16.64 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.535 -0.543 . . . . 74.51 109.535 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.09 52.03 0.05 OUTLIER Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.996 -0.547 . . . . 61.22 112.489 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -145.35 -179.49 6.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.828 0.851 . . . . 52.0 109.592 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -119.99 121.63 39.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.878 0.871 . . . . 72.31 108.72 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -91.27 -26.68 18.87 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.756 -0.461 . . . . 61.32 109.756 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.73 -68.16 2.23 Favored Glycine 0 C--N 1.342 0.879 0 O-C-N 124.593 1.183 . . . . 70.23 113.656 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.507 ' HG2' ' HD2' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -100.47 133.16 45.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.247 -1.39 . . . . 75.53 107.247 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' ' 138' ' ' PHE . 71.5 t -94.02 141.63 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.768 0.827 . . . . 70.23 111.572 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.712 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -72.32 97.2 1.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.891 0.876 . . . . 34.0 109.6 169.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 127' ' ' LEU . 85.6 mt -89.84 104.65 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.342 -0.614 . . . . 71.03 109.342 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 68' ' ' ILE . 41.3 mm -93.59 125.63 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.039 -0.726 . . . . 74.12 109.039 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.426 ' HG3' ' ND2' ' A' ' 135' ' ' ASN . 21.7 tt0 -129.2 112.12 13.6 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.703 -0.851 . . . . 73.12 108.703 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.589 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 54.1 p90 -81.22 99.31 8.51 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 106.76 -1.57 . . . . 61.53 106.76 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -83.46 143.18 30.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.047 -0.979 . . . . 64.34 110.769 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.77 120.78 21.61 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.123 0.487 . . . . 64.42 109.718 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.11 95.37 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 125.336 1.454 . . . . 72.24 107.951 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.62 17.66 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.185 0.994 . . . . 72.53 112.11 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.31 6.93 47.18 Favored Glycine 0 C--N 1.353 1.521 0 C-N-CA 123.146 0.403 . . . . 75.11 113.545 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 m -111.94 156.42 22.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.242 1.017 . . . . 71.42 109.516 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 12.8 pt-20 -84.51 138.51 32.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.903 0.481 . . . . 75.41 110.156 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.54 99.37 18.98 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.783 0.833 . . . . 42.31 108.8 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.04 114.11 1.87 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.902 2.401 . . . . 74.2 113.195 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.3 p -115.75 121.23 41.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.875 0.87 . . . . 63.35 108.714 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 30.7 tp -76.76 107.4 9.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.467 -0.938 . . . . 51.41 108.467 172.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 73.7 mtp -94.96 122.69 37.86 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 107.875 -1.157 . . . . 63.12 107.875 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 154' ' ' ALA . 85.3 mt -134.7 145.04 48.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.558 1.543 . . . . 50.53 107.081 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.599 HG11 HG11 ' A' ' 99' ' ' VAL . 7.5 p -73.6 141.66 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.618 -0.882 . . . . 65.11 108.618 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.548 ' HA ' HG22 ' A' ' 176' ' ' ILE . 61.6 tttp -57.86 -30.02 65.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.004 0.922 . . . . 74.42 111.758 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.65 2.16 42.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.822 0.849 . . . . 65.14 112.267 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.98 -9.03 4.88 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.472 0.709 . . . . 73.43 111.375 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' A' ' 173' ' ' LYS . 8.6 tp -97.8 133.85 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 107.141 -1.429 . . . . 74.41 107.141 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.2 mm -104.57 110.53 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 106.864 -1.532 . . . . 61.53 106.864 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.89 90.31 3.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.012 1.325 . . . . 74.31 107.582 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' A' ' 3' ' ' ILE . 12.2 tp10 -106.13 144.02 33.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.817 -0.808 . . . . 61.42 108.817 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.571 ' HE2' HD11 ' A' ' 182' ' ' LEU . 13.8 ptmt -100.27 123.92 45.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.681 0.792 . . . . 72.34 110.134 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.26 87.4 7.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.597 -0.89 . . . . 73.45 108.597 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.571 HD11 ' HE2' ' A' ' 180' ' ' LYS . 82.8 mt -90.31 87.93 7.01 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.741 -0.837 . . . . 54.4 108.741 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 C--O 1.254 1.336 0 N-CA-C 107.263 -1.384 . . . . 71.42 107.263 178.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 86.1 mmm . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.701 0.286 . . . . 64.55 110.441 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.6 HD22 ' HA ' ' A' ' 180' ' ' LYS . 62.3 mt -120.52 155.74 32.99 Favored 'General case' 0 C--O 1.25 1.087 0 C-N-CA 123.781 0.832 . . . . 61.43 109.742 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 60.3 mt -96.85 120.25 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.373 -0.973 . . . . 60.33 108.373 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -110.33 99.41 8.44 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.265 -1.383 . . . . 75.52 107.265 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 10' ' ' ASP . 55.2 pttt -129.53 165.3 21.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.314 -0.403 . . . . 73.23 110.054 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 10.3 m-20 -85.89 -177.94 6.46 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.839 0.828 . . . . 74.21 110.207 174.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.6 mt -84.19 -24.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 114.87 -1.059 . . . . 62.31 110.041 157.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -107.11 -59.76 1.77 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.788 0.835 . . . . 73.24 112.267 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -96.82 17.56 16.42 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.013 0.925 . . . . 72.54 110.439 -174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 5.3 p-10 -52.42 -29.21 23.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.111 1.364 . . . . 72.24 113.212 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -48.62 72.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.765 1.291 . . . . 74.43 111.323 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -120.3 17.87 12.25 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.688 -0.687 . . . . 63.22 112.268 -168.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -78.23 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.261 0.937 . . . . 74.1 109.176 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -143.78 122.79 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 120.741 1.61 . . . . 73.51 112.617 -168.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.52 ' HB3' HG23 ' A' ' 3' ' ' ILE . 35.7 p -116.12 104.87 11.98 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.865 0.866 . . . . 63.34 108.995 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 1' ' ' MET . 37.4 t70 -160.64 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 110.141 -0.318 . . . . 63.03 110.141 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.9 p -127.69 71.5 1.36 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.027 -0.731 . . . . 70.12 109.027 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -120.67 93.9 48.68 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.004 -0.739 . . . . 61.44 109.004 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.54 135.74 66.58 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.638 2.225 . . . . 53.54 111.622 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.448 ' SD ' ' HE3' ' A' ' 180' ' ' LYS . 24.2 ptt? -83.48 138.98 33.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.928 -0.767 . . . . 74.22 108.928 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -152.4 122.74 7.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.035 -1.098 . . . . 74.42 108.035 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -130.64 122.89 28.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.64 0.776 . . . . 71.4 109.039 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.13 142.86 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.322 0.649 . . . . 73.55 110.327 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 59.39 8.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.34 1.456 . . . . 61.42 113.515 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 51.72 39.28 25.01 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.243 1.017 . . . . 72.4 110.587 -168.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.0 tp -134.99 -51.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.794 . . . . 71.25 110.532 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.28 125.9 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.58 0.752 . . . . 63.43 110.299 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -83.6 119.96 25.37 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.981 -1.118 . . . . 74.42 107.981 171.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 6.7 pt-20 -111.51 141.65 44.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.176 0.591 . . . . 65.23 109.833 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.43 ' HD1' HD11 ' A' ' 70' ' ' ILE . 33.2 t80 -136.76 140.28 42.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.997 -1.112 . . . . 74.04 107.997 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.8 97.05 8.96 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.088 0.555 . . . . 72.24 110.061 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.98 130.6 11.6 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.942 -0.572 . . . . 63.02 111.706 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -97.62 124.04 41.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.367 0.583 . . . . 70.1 109.454 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -64.72 114.27 4.33 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 108.783 -0.821 . . . . 73.4 108.783 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.515 HG23 HD12 ' A' ' 72' ' ' LEU . 15.4 m -148.47 161.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.208 1.003 . . . . 55.12 108.88 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.42 143.78 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.183 -1.043 . . . . 64.22 108.183 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -91.74 116.08 28.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.404 -1.702 . . . . 73.15 106.404 169.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -119.46 145.48 46.25 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.87 -1.53 . . . . 71.02 106.87 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -62.8 89.02 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.432 0.634 . . . . 72.15 111.548 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.32 52.02 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 114.639 -1.164 . . . . 62.23 113.998 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -159.85 -174.59 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.899 0.48 . . . . 72.14 110.757 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tt . . . . . 0 N--CA 1.469 0.476 0 C-N-CA 123.687 0.795 . . . . 73.33 109.483 176.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 31.7 t . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 107.852 -1.166 . . . . 75.33 107.852 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 39.5 mt-10 -75.32 77.18 2.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.718 -1.216 . . . . 72.23 107.718 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -76.59 135.63 39.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.89 -1.05 . . . . 72.11 110.545 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.44 -136.84 4.53 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.443 -0.663 . . . . 63.34 111.443 173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 pt -110.22 155.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.509 0.324 . . . . 75.02 110.779 172.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.75 -39.27 70.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.382 1.073 . . . . 74.52 112.391 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.43 HD11 ' HD1' ' A' ' 30' ' ' PHE . 41.3 mt -55.29 -44.87 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 124.104 0.962 . . . . 73.42 110.47 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.74 -55.08 19.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 CA-C-N 114.011 -1.449 . . . . 74.42 110.656 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 35' ' ' VAL . 18.2 mt -67.94 -30.37 69.66 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.726 -0.67 . . . . 64.41 111.088 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.65 -52.38 38.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.838 -1.073 . . . . 70.35 110.95 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -89.37 -13.56 37.53 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.106 -0.497 . . . . 64.51 111.798 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt 68.42 66.32 0.32 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.24 1.016 . . . . 75.3 109.437 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 94.9 mt -86.57 131.36 34.19 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.96 -1.018 . . . . 75.2 108.677 173.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.804 HG11 ' HB2' ' A' ' 145' ' ' ALA . 4.4 p -86.42 129.89 37.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.524 0.73 . . . . 55.45 109.424 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.56 151.67 37.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 123.663 0.785 . . . . 74.45 112.247 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 39.5 tpp -149.5 140.28 22.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.347 -1.353 . . . . 70.42 107.347 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.632 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 29.7 m-80 -130.06 123.18 29.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.066 0.546 . . . . 73.43 110.334 -169.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 28.0 p -67.73 -16.26 64.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.014 0.526 . . . . 33.52 111.72 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.632 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 97.5 m-85 -45.88 -60.76 2.06 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.287 1.035 . . . . 65.01 111.319 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -105.23 -33.31 8.27 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.244 1.018 . . . . 72.13 111.255 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -93.02 19.98 7.23 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.002 0.521 . . . . 65.34 111.728 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.97 27.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.85 0.86 . . . . 63.44 113.203 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -77.96 -50.74 11.57 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.515 0.726 . . . . 54.02 112.25 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -72.91 -33.48 66.01 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.1 0.56 . . . . 71.13 110.971 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.516 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 35.0 t80 -64.91 -42.92 94.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.103 0.561 . . . . 65.11 110.568 170.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -63.46 -27.62 69.41 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 120.678 0.275 . . . . 73.55 110.564 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.2 -36.72 74.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.192 0.597 . . . . 54.11 110.571 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.516 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 34.8 m-85 -63.83 -35.85 81.97 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.654 0.382 . . . . 74.14 110.526 170.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mm -65.61 -36.5 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.453 0.701 . . . . 75.43 111.459 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.36 -44.82 96.51 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.579 0.352 . . . . 75.24 110.699 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -68.09 -42.81 79.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.909 -0.587 . . . . 73.24 109.886 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -48.86 -66.63 0.37 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.625 1.57 . . . . 74.23 111.07 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.1 ptm -60.46 -40.61 91.83 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.507 0.504 . . . . 62.13 111.19 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -62.93 -45.59 91.74 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 122.68 0.392 . . . . 71.44 110.379 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -72.9 -48.72 34.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.346 0.658 . . . . 74.34 111.206 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -66.41 -38.06 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 123.541 0.525 . . . . 53.51 112.188 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.418 HD13 ' HE3' ' A' ' 117' ' ' LYS . 63.8 mt -77.89 -40.18 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 122.969 0.508 . . . . 72.51 110.148 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.52 -42.71 99.69 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.134 0.974 . . . . 73.22 111.83 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -66.96 -45.03 78.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.297 -0.865 . . . . 64.51 109.104 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.471 ' HA ' HD21 ' A' ' 106' ' ' ASN . 26.9 ttt -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 124.349 1.031 . . . . 74.4 110.692 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.23 -41.29 79.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.258 1.023 . . . . 70.45 112.174 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.58 -19.22 62.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.797 0.666 . . . . 72.4 112.797 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.471 HD21 ' HA ' ' A' ' 103' ' ' MET . 9.5 p30 -114.37 0.9 14.25 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.386 0.539 . . . . 73.23 111.891 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.56 -48.06 2.88 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.754 -0.832 . . . . 65.53 108.754 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 57.37 8.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 126.848 2.059 . . . . 75.23 113.996 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -113.91 115.13 27.2 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.987 -0.746 . . . . 72.12 108.987 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -64.6 -32.85 74.68 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.026 0.829 . . . . 75.11 111.833 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.58 68.24 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.791 0.329 . . . . 73.01 110.603 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.19 -54.59 6.32 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.976 -0.75 . . . . 61.25 108.976 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.9 -22.22 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 115.932 -0.576 . . . . 54.25 111.677 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.05 -41.73 97.27 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.303 0.641 . . . . 74.54 110.221 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.053 0.845 . . . . 40.44 110.172 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -57.64 -61.12 2.74 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.173 0.92 . . . . 75.25 111.733 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.418 ' HE3' HD13 ' A' ' 100' ' ' ILE . 21.8 ptmt -73.19 -15.38 61.45 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.615 0.572 . . . . 65.43 111.858 -173.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -68.14 -51.49 45.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.55 -0.907 . . . . 74.21 108.55 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.12 -32.86 72.55 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.081 -1.418 . . . . 71.43 111.878 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mm -67.98 -47.62 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.068 0.547 . . . . 63.4 110.262 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.35 -49.53 75.85 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.91 0.756 . . . . 42.11 109.499 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.59 98.76 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 123.819 0.7 . . . . 74.13 112.981 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -62.45 -50.5 71.2 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.696 0.799 . . . . 74.42 109.79 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.5 m -70.79 -42.14 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 118.503 -0.76 . . . . 62.2 111.816 -173.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.55 -32.16 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 119.221 0.919 . . . . 73.4 110.757 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.2 t -73.97 -38.96 64.03 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 120.907 0.384 . . . . 60.1 110.081 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 155' ' ' ILE . 28.4 tp -73.88 -26.94 60.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.929 1.292 . . . . 73.42 111.867 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 64.8 mt -88.42 2.24 53.12 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.852 0.861 . . . . 62.54 111.822 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 93.87 6.77 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.209 0.528 . . . . 72.35 109.586 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 50.9 mtpt -67.07 -5.38 12.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.331 1.234 . . . . 72.42 114.331 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -47.15 83.08 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 118.231 0.469 . . . . 73.25 110.794 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -109.06 -37.64 5.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.768 0.827 . . . . 71.51 110.547 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.37 -1.79 38.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.714 1.206 . . . . 73.32 114.148 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 37.3 ttpt -55.26 -15.54 2.52 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.705 0.631 . . . . 65.54 112.705 172.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -83.68 6.72 19.95 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.598 0.759 . . . . 72.02 111.276 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.63 129.18 34.96 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.415 0.686 . . . . 62.33 109.309 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.85 120.17 39.75 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.658 -1.238 . . . . 53.44 107.658 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.431 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 65.1 m-85 -102.7 141.91 34.73 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.422 -0.585 . . . . 74.24 109.422 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 95.1 m-85 -139.65 149.76 44.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.239 -0.652 . . . . 73.43 109.239 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.4 pt -133.66 168.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.892 -0.781 . . . . 75.21 108.892 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.61 143.93 48.99 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.821 -0.433 . . . . 63.41 112.227 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -44.86 -39.31 5.25 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.698 0.799 . . . . 60.31 111.993 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -62.77 -38.53 90.95 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 72.42 111.898 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -68.59 -29.74 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.267 0.627 . . . . 62.34 111.727 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.804 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -84.53 -25.33 28.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.575 0.35 . . . . 74.53 111.215 173.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -65.81 -29.89 70.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.499 0.72 . . . . 72.11 110.55 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.53 0.01 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.074 -0.81 . . . . 71.41 111.074 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -159.41 -170.69 3.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.165 0.586 . . . . 64.33 111.134 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.95 -173.01 0.9 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 75.32 108.858 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 79.21 -20.82 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.521 1.528 . . . . 75.15 111.963 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.13 146.72 47.78 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.908 -0.477 . . . . 72.35 111.908 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -67.62 134.23 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.397 0.679 . . . . 75.53 111.52 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.439 HG11 ' HE1' ' A' ' 88' ' ' PHE . 59.9 t -83.36 117.96 30.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.699 -0.682 . . . . 70.2 109.679 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -67.01 101.5 0.86 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.828 0.851 . . . . 75.04 109.525 168.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.666 HG21 HD21 ' A' ' 127' ' ' LEU . 67.1 mt -90.78 105.88 16.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.22 -1.03 . . . . 74.25 108.22 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -94.84 96.35 5.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.333 -0.617 . . . . 61.13 109.333 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -81.47 157.23 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.732 -1.122 . . . . 73.44 108.011 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.1 p90 -120.45 139.24 53.14 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.021 -1.103 . . . . 72.31 108.021 175.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.417 ' HB2' HG23 ' A' ' 166' ' ' VAL . 24.1 mmt180 -118.98 161.27 20.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.263 -0.643 . . . . 72.33 109.263 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -115.84 119.84 37.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.489 0.716 . . . . 70.51 110.403 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.88 97.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.296 1.038 . . . . 71.44 108.773 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 61.94 18.06 9.51 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.446 1.098 . . . . 75.14 113.777 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.84 1.37 22.7 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 120.122 -0.266 . . . . 75.52 113.194 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.9 m -110.11 134.37 52.25 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.954 0.901 . . . . 73.32 109.634 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.91 120.66 23.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.878 -1.156 . . . . 75.01 107.878 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 159' ' ' ARG . 2.7 m -117.84 89.33 33.39 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.495 -1.298 . . . . 74.14 107.495 169.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 84.3 Cg_exo -54.19 126.25 21.5 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.006 2.47 . . . . 73.32 113.269 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -103.58 107.22 17.98 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.105 -1.072 . . . . 73.52 108.105 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 16.5 tp -75.17 112.42 11.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.676 -1.231 . . . . 72.53 107.676 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ptp -105.83 136.11 46.05 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 122.07 0.938 . . . . 65.54 108.945 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 154' ' ' ALA . 68.1 mt -141.77 158.33 43.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 112.963 -1.926 . . . . 73.21 106.534 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 174' ' ' GLU . 10.6 p -86.73 140.65 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.363 -0.977 . . . . 62.32 108.363 168.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -57.77 -27.33 62.97 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.537 0.735 . . . . 73.34 111.722 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 172' ' ' VAL . 17.0 mm-40 -90.12 13.58 14.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.594 0.757 . . . . 61.03 112.858 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.92 -1.14 7.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.588 0.755 . . . . 60.32 110.921 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.434 HG13 HD13 ' A' ' 171' ' ' LEU . 36.3 mm -132.0 137.0 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.047 0.939 . . . . 71.04 109.55 -174.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.94 109.81 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.854 -1.165 . . . . 52.34 107.854 171.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.05 106.15 18.35 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.403 -1.332 . . . . 72.12 107.403 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.649 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 43.3 mt-10 -92.78 98.11 11.19 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.425 -1.324 . . . . 70.52 107.425 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.645 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -72.97 96.43 2.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 113.794 -1.548 . . . . 65.15 109.403 179.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.91 87.78 2.89 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.272 -1.01 . . . . 72.43 108.272 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 97.5 mt -83.33 110.61 18.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.194 -0.912 . . . . 64.05 110.459 -171.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 108.031 -1.1 . . . . 74.22 108.031 175.43 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.826 -0.435 . . . . 51.34 109.826 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.9 mt -95.35 127.7 41.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.07 -0.715 . . . . 65.54 109.07 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.597 ' HB ' ' HG3' ' A' ' 179' ' ' GLU . 45.9 mt -97.4 127.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.332 0.653 . . . . 73.32 109.482 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.424 ' OH ' ' HB3' ' A' ' 20' ' ' MET . 31.1 m-85 -121.72 114.42 21.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.842 1.257 . . . . 75.23 107.792 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -123.11 150.72 42.86 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.342 0.657 . . . . 74.21 110.02 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.15 134.19 34.74 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.89 -1.152 . . . . 63.2 107.89 166.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.2 pt -68.71 -27.66 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.786 0.661 . . . . 73.51 112.786 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 98' ' ' ASN . 74.8 m-85 -85.61 -63.31 1.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.079 0.399 . . . . 75.34 112.068 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -131.33 -33.82 1.45 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.522 0.564 . . . . 74.15 112.522 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.83 24.03 5.77 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.05 0.94 . . . . 44.05 112.721 -156.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.19 -29.07 1.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.866 1.266 . . . . 73.1 113.605 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -84.42 24.68 0.95 Allowed 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 113.2 0.815 . . . . 73.24 113.2 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.4 mt -45.28 -76.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.534 1.134 . . . . 45.14 112.564 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 p -160.79 134.87 7.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.154 0.581 . . . . 63.11 110.359 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.421 ' HB2' HG12 ' A' ' 3' ' ' ILE . 38.9 p -141.53 99.91 3.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.091 0.86 . . . . 42.3 109.655 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB3' ' HD2' ' A' ' 18' ' ' PHE . 25.9 t70 -163.85 169.66 17.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.711 0.805 . . . . 70.32 109.364 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -80.99 9.49 6.47 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.862 0.865 . . . . 74.22 113.13 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.517 ' HD2' ' HB3' ' A' ' 16' ' ' ASP . 51.4 p90 -54.49 141.82 52.96 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 118.34 0.518 . . . . 73.14 111.787 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.38 119.82 7.22 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 123.008 2.472 . . . . 54.0 113.258 -164.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.424 ' HB3' ' OH ' ' A' ' 4' ' ' TYR . 24.2 ptt? -101.94 151.81 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.977 -0.556 . . . . 72.15 110.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -135.91 145.96 46.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.181 -1.415 . . . . 72.24 107.181 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.0 tp -134.32 118.52 17.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.271 -1.011 . . . . 64.33 108.271 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.51 133.88 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.056 0.942 . . . . 63.32 109.278 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 58.44 10.46 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.131 1.373 . . . . 64.33 114.55 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 50.72 25.08 1.93 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.723 0.809 . . . . 73.4 112.362 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 119' ' ' LYS . 63.3 tp -109.15 -46.14 3.63 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.1 t -124.44 124.4 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 122.673 0.389 . . . . 74.14 110.822 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -84.63 114.42 21.99 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.604 -1.258 . . . . 73.44 107.604 167.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 47.3 mt-10 -106.97 135.01 49.26 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.227 -0.897 . . . . 65.5 110.44 176.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 27.7 t80 -127.11 133.59 50.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.215 1.006 . . . . 74.33 108.984 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.73 139.55 30.41 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.019 0.438 . . . . 71.13 109.828 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -172.59 12.97 Favored Glycine 0 CA--C 1.508 -0.372 0 N-CA-C 110.538 -1.025 . . . . 65.4 110.538 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -144.84 144.55 31.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 53.14 109.992 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -65.03 117.37 7.56 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.121 -1.066 . . . . 74.14 108.121 169.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.71 163.61 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.854 1.261 . . . . 53.3 109.382 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 2.9 m -119.54 104.86 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.241 -1.022 . . . . 71.12 108.241 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.708 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 13.5 tpt180 -80.73 106.62 12.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.772 -1.195 . . . . 70.32 107.772 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 87.5 tttt -135.04 154.11 51.82 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.818 -1.083 . . . . 73.54 109.579 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -51.63 -26.76 9.57 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.003 1.321 . . . . 73.13 112.836 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.88 27.83 1.29 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.667 -0.518 . . . . 51.21 114.197 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 39.6 mm-40 -146.08 152.45 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.734 0.813 . . . . 75.43 109.352 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 6.4 tp . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 123.599 0.76 . . . . 74.4 110.194 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.238 0.477 0 N-CA-C 106.868 -1.531 . . . . 74.3 106.868 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.708 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 48.1 mt-10 -67.36 80.86 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.849 0.833 . . . . 74.42 109.091 170.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -75.55 132.42 40.7 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.785 -1.098 . . . . 70.1 110.011 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.06 -141.45 7.73 Favored Glycine 0 CA--C 1.498 -0.982 0 N-CA-C 110.048 -1.221 . . . . 61.42 110.048 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 30.1 pt -111.5 147.41 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.426 0.613 . . . . 74.41 110.63 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.7 -24.33 65.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.438 0.695 . . . . 62.0 112.846 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 169' ' ' LEU . 52.9 mt -60.16 -40.39 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.609 0.719 . . . . 74.42 110.165 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.17 -51.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.351 -0.841 . . . . 74.34 111.625 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.703 HD22 ' HB3' ' A' ' 65' ' ' GLU . 24.1 mt -64.88 -45.62 85.23 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.079 0.862 . . . . 64.33 111.492 -169.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -80.62 -18.03 49.45 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.559 -0.746 . . . . 65.13 111.854 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -107.79 -1.45 20.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.791 -0.568 . . . . 72.24 111.357 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 55.95 56.69 5.75 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.226 1.011 . . . . 72.44 111.726 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.638 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 62.8 mt -95.13 138.3 33.03 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.016 -0.993 . . . . 71.13 109.73 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.4 134.48 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.922 -0.77 . . . . 73.21 108.922 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.26 141.45 57.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.143 -0.935 . . . . 64.34 112.928 -174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 ptm -140.81 109.96 6.18 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 107.136 -1.431 . . . . 64.1 107.136 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.45 152.98 20.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.703 -0.681 . . . . 51.31 110.306 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.424 ' SG ' ' HE1' ' A' ' 138' ' ' PHE . 64.8 m -67.34 -3.56 8.47 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.045 1.128 . . . . 74.1 114.045 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -94.13 -60.24 1.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.796 0.439 . . . . 74.4 110.018 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -78.36 -43.62 27.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.862 0.865 . . . . 75.41 110.273 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.13 20.56 8.94 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.842 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.81 -53.82 22.99 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.416 1.086 . . . . 60.14 113.904 -174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.0 m -68.33 -40.59 81.58 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.5 0.667 . . . . 73.24 110.996 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.438 ' HG3' ' CE2' ' A' ' 91' ' ' TYR . 14.2 tpt -68.59 -29.07 67.52 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.179 -0.919 . . . . 72.35 110.245 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -66.46 -42.12 88.04 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.355 1.462 . . . . 74.31 110.063 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.78 -41.65 82.47 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.86 0.725 . . . . 62.42 110.167 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.88 -45.42 86.07 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.394 0.678 . . . . 74.15 112.389 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.56 ' HE1' HD12 ' A' ' 140' ' ' ILE . 30.3 m-85 -55.17 -48.21 74.08 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.456 0.702 . . . . 62.2 112.151 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.13 -41.33 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.802 0.689 . . . . 70.34 112.614 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -52.63 -47.76 66.82 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.361 0.528 . . . . 71.35 111.334 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -70.24 -45.35 66.66 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.162 -0.926 . . . . 72.34 110.996 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -49.83 -51.42 40.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.631 1.172 . . . . 75.42 110.63 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.4 ttt -58.09 -54.64 44.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.764 1.226 . . . . 60.24 111.392 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.3 -24.17 62.98 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.316 -0.402 . . . . 64.02 111.901 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 8' ' ' PHE . 99.5 m-20 -88.12 -40.63 13.62 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.542 0.737 . . . . 72.32 112.264 -174.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 120' ' ' ILE . 29.5 m -66.8 -36.96 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 110.14 -0.318 . . . . 73.11 110.14 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.09 -31.23 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 122.438 0.295 . . . . 75.11 110.543 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.24 -52.93 61.81 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.853 0.461 . . . . 73.42 111.028 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -66.32 -38.29 87.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.913 -0.585 . . . . 73.41 111.391 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.636 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -67.26 -58.14 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.671 0.389 . . . . 74.4 110.741 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.13 -42.2 80.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.352 1.061 . . . . 53.13 112.337 -168.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -68.65 -22.09 64.42 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.094 0.558 . . . . 62.33 111.433 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.436 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -101.09 -17.95 16.45 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.278 0.631 . . . . 74.11 111.446 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -105.31 -52.17 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.061 0.545 . . . . 75.32 111.004 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 81.38 -21.45 0.31 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.457 1.503 . . . . 71.01 113.066 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -79.52 127.35 32.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.354 0.525 . . . . 63.3 110.516 -172.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -43.39 81.08 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 124.55 1.156 . . . . 62.4 112.454 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.03 -30.65 39.55 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.143 0.577 . . . . 74.22 112.52 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.06 -36.62 22.91 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.574 0.35 . . . . 55.22 110.542 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.636 HG12 ' SD ' ' A' ' 103' ' ' MET . 23.4 m -69.91 -29.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.729 0.299 . . . . 75.15 110.385 172.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.76 -31.82 68.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.679 0.791 . . . . 75.41 109.921 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 119' ' ' LYS . . . -67.2 -53.81 26.87 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.456 0.702 . . . . 61.05 109.689 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -55.82 -43.27 76.8 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 123.878 0.736 . . . . 73.44 110.465 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.37 -43.94 79.7 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 124.579 1.174 . . . . 74.55 111.181 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 74.54 110.204 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.465 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.5 mptm? -66.92 -45.2 78.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.204 0.602 . . . . 74.24 111.142 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 99' ' ' VAL . 10.8 tp -73.03 -39.15 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 122.794 0.438 . . . . 71.21 110.301 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -67.11 -44.79 79.04 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.217 0.607 . . . . 72.05 109.885 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.24 99.76 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.91 0.756 . . . . 61.44 111.887 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.521 ' HZ2' ' HB3' ' A' ' 170' ' ' MET . 34.1 t90 -63.11 -50.99 68.33 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.826 0.85 . . . . 72.33 110.434 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.8 m -68.62 -47.64 75.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 CA-C-O 118.9 -0.571 . . . . 62.12 111.019 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.8 m -62.1 -31.23 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.09 0.859 . . . . 64.12 111.509 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 m -76.37 -43.68 39.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.032 0.533 . . . . 61.25 111.219 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.8 tp -77.07 -33.86 57.07 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 123.237 0.615 . . . . 73.52 111.704 -170.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.3 mt -80.54 4.04 19.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.596 0.759 . . . . 72.24 112.248 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.67 108.38 0.73 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.916 0.886 . . . . 64.41 111.434 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.61 -5.49 40.69 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.745 1.017 . . . . 63.01 113.745 -170.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -97.45 -45.17 6.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.865 0.466 . . . . 72.23 111.151 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -100.4 -47.88 4.76 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.198 0.999 . . . . 72.32 110.508 -172.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 39.2 m-85 -86.24 -2.66 58.58 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.075 0.95 . . . . 63.24 112.402 -173.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -52.57 2.53 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.158 1.91 . . . . 65.31 116.158 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -83.3 17.31 2.13 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 71.32 110.82 167.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 87.6 mt -89.82 151.01 22.0 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.426 0.632 . . . . 63.11 110.489 175.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.32 119.36 17.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.109 -1.811 . . . . 60.14 106.109 169.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.424 ' HE1' ' SG ' ' A' ' 81' ' ' CYS . 91.1 m-85 -93.59 149.31 21.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.178 -1.045 . . . . 75.42 108.178 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.696 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . 82.3 m-85 -138.78 161.62 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.354 -0.609 . . . . 74.22 109.354 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.56 HD12 ' HE1' ' A' ' 91' ' ' TYR . 4.7 tt -136.4 143.29 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.648 -1.241 . . . . 61.54 107.648 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.72 150.47 49.84 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.525 0.516 . . . . 70.21 112.997 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.91 -47.84 52.0 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.495 1.518 . . . . 65.51 114.367 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -42.17 73.83 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.235 0.614 . . . . 73.12 110.684 -171.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.04 60.57 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.287 1.035 . . . . 73.24 110.872 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.46 -5.37 42.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.993 0.917 . . . . 64.32 112.583 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.83 -5.0 56.71 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.583 0.353 . . . . 75.13 111.028 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.67 42.94 1.28 Allowed Glycine 0 C--N 1.345 1.041 0 C-N-CA 122.876 0.274 . . . . 73.1 112.666 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.95 -67.48 0.85 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.104 -0.702 . . . . 63.03 109.104 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -159.16 173.37 16.5 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 74.05 109.558 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -54.96 -27.59 44.98 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.565 1.146 . . . . 71.15 112.547 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.85 -153.46 41.21 Favored Glycine 0 C--N 1.357 1.726 0 O-C-N 123.793 0.683 . . . . 60.31 111.446 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.578 ' HG3' HD22 ' A' ' 171' ' ' LEU . 50.3 tp60 -87.28 120.16 28.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.616 -0.883 . . . . 73.44 108.616 162.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.77 116.24 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 109.297 -0.631 . . . . 72.13 109.297 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 139' ' ' PHE . . . -76.65 99.97 5.21 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.159 -0.928 . . . . 70.12 110.494 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -91.47 108.58 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.476 -0.784 . . . . 74.51 109.628 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 49.9 mm -99.0 109.63 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.667 0.387 . . . . 74.35 110.71 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.491 ' HA ' HD23 ' A' ' 136' ' ' LEU . 45.7 tt0 -86.94 107.41 18.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.317 -0.623 . . . . 73.2 109.317 171.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -75.0 87.91 2.36 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.378 -1.341 . . . . 72.4 107.378 169.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.532 ' HB3' HG23 ' A' ' 166' ' ' VAL . 8.0 tpt180 -85.92 119.83 26.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.048 -0.978 . . . . 74.24 108.62 -170.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.73 97.62 10.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.758 0.423 . . . . 71.25 109.957 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.402 HG13 ' HB ' ' A' ' 164' ' ' THR . 3.8 p -96.41 97.64 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.606 0.763 . . . . 73.01 109.306 173.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 64.7 17.38 10.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.415 1.086 . . . . 73.2 112.916 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 115.5 -10.13 19.47 Favored Glycine 0 N--CA 1.475 1.245 0 CA-C-O 120.156 -0.247 . . . . 72.01 113.335 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.402 ' HB ' HG13 ' A' ' 161' ' ' VAL . 19.4 m -97.38 128.61 44.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.332 0.653 . . . . 62.31 109.974 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.52 120.85 22.3 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.422 -0.955 . . . . 72.1 108.422 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 159' ' ' ARG . 12.4 m -115.88 95.72 44.89 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.624 -1.25 . . . . 73.24 107.624 171.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 123.91 14.97 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.451 2.767 . . . . 71.43 112.366 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.5 m -117.89 110.45 17.76 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.569 -0.901 . . . . 62.13 108.569 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 62.8 tp -76.24 117.43 17.92 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.633 -0.877 . . . . 71.31 108.633 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.521 ' HB3' ' HZ2' ' A' ' 123' ' ' TRP . 63.5 mtt -112.26 120.92 43.41 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.957 -1.127 . . . . 74.25 107.957 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.578 HD22 ' HG3' ' A' ' 152' ' ' GLN . 78.5 mt -131.73 145.49 51.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.017 -1.475 . . . . 75.31 107.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.433 HG12 ' OE1' ' A' ' 152' ' ' GLN . 14.7 p -82.67 137.91 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.796 -0.816 . . . . 74.44 108.796 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -57.18 -22.19 38.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.858 1.263 . . . . 72.02 111.687 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.427 ' H ' HG22 ' A' ' 172' ' ' VAL . 8.5 tp10 -78.48 -36.91 44.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.4 0.519 . . . . 74.14 112.4 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -97.64 -0.78 45.03 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.738 0.304 . . . . 72.03 110.597 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 41.3 mm -121.96 133.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 C-N-CA 124.131 0.972 . . . . 73.01 109.337 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.3 mm -99.0 109.73 24.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.418 -0.956 . . . . 74.24 108.418 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -95.68 123.45 39.25 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.464 -1.31 . . . . 72.1 107.464 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.597 ' HG3' ' HB ' ' A' ' 3' ' ' ILE . 8.1 pt-20 -146.98 125.04 12.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.218 -0.66 . . . . 63.12 109.218 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -81.49 95.81 7.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.59 -0.732 . . . . 64.43 109.324 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.37 88.8 6.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.38 -0.97 . . . . 74.14 108.38 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 67.1 mt -71.46 143.14 50.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.233 -0.894 . . . . 72.54 109.909 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.773 -0.632 . . . . 75.03 109.468 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.669 -0.493 . . . . 73.54 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.27 161.59 20.15 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.575 -0.898 . . . . 62.11 108.575 173.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.44 HD11 ' HD3' ' A' ' 5' ' ' LYS . 12.7 tt -133.66 118.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 53.13 109.802 172.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 177' ' ' ILE . 21.5 p90 -122.58 124.09 42.7 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.899 -1.148 . . . . 73.13 107.899 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 22.2 pttp -153.29 171.24 18.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.381 0.673 . . . . 63.43 109.995 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -105.09 142.77 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 61.51 108.812 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.406 HG22 HG12 ' A' ' 177' ' ' ILE . 22.1 pt -79.68 -9.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.293 0.637 . . . . 64.45 112.603 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -107.76 -60.21 1.74 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.708 0.29 . . . . 74.44 111.657 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.411 HG23 ' HA3' ' A' ' 151' ' ' GLY . 1.2 p -125.32 -49.49 1.68 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.837 0.68 . . . . 75.14 112.837 -164.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -87.31 21.84 2.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 63.31 111.181 -172.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.549 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 16.7 t70 -48.24 -21.68 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.013 1.325 . . . . 72.25 112.814 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.95 25.33 2.14 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.823 1.249 . . . . 72.5 112.722 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 10' ' ' ASP . 40.9 mt -62.99 -92.3 0.0 OUTLIER 'General case' 0 C--N 1.371 1.542 0 CA-C-N 119.128 0.877 . . . . 75.13 110.378 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 68.1 m -154.65 129.97 9.73 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.994 0.815 . . . . 55.03 112.258 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.7 t -109.67 81.93 1.51 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.224 1.009 . . . . 65.31 108.795 163.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -162.2 166.92 24.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.083 0.953 . . . . 71.15 109.301 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.3 80.91 0.74 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.595 0.712 . . . . 71.03 110.93 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 61.7 m-85 -114.2 139.65 24.02 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.913 1.285 . . . . 75.44 108.98 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 16.5 Cg_exo -68.45 119.86 6.84 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.488 2.125 . . . . 43.52 112.092 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.08 144.13 27.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.637 0.775 . . . . 73.53 109.786 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.19 146.74 47.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.969 -0.752 . . . . 74.05 108.969 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.73 138.67 53.88 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.882 -0.785 . . . . 72.43 108.882 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.35 128.43 63.89 Favored 'Isoleucine or valine' 0 C--O 1.266 1.932 0 N-CA-C 109.001 -0.74 . . . . 61.22 109.001 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 72.78 -85.53 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.933 1.693 . . . . 62.32 108.741 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.5 t70 172.14 28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.575 1.95 . . . . 44.52 106.788 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 tp -135.15 -52.16 0.78 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.485 -0.779 . . . . 63.35 110.712 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.1 t -118.21 131.28 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.088 -0.505 . . . . 55.14 109.783 -168.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -83.62 135.49 34.58 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.122 -1.066 . . . . 64.11 108.122 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.87 155.76 47.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.42 0.629 . . . . 70.45 110.673 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.3 t80 -139.99 147.86 41.05 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.14 -0.936 . . . . 74.32 109.259 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.58 154.02 39.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.712 0.805 . . . . 72.31 111.892 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 156.46 28.42 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.722 -0.275 . . . . 75.02 112.858 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -154.37 159.24 41.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.836 0.854 . . . . 64.22 109.935 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -70.21 120.41 15.86 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.371 -0.603 . . . . 71.12 109.371 169.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.75 168.11 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.896 1.278 . . . . 53.02 108.473 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.97 145.32 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.722 -0.844 . . . . 64.14 108.722 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.758 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 27.2 mmt180 -134.33 109.16 8.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.06 -1.83 . . . . 72.35 106.06 174.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -133.07 97.32 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.761 -0.459 . . . . 73.41 109.761 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 39.95 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 126.616 1.966 . . . . 74.3 115.132 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.75 49.77 0.82 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.787 -0.925 . . . . 50.13 110.787 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -170.78 152.55 3.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.551 1.141 . . . . 73.14 109.0 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tt . . . . . 0 CA--C 1.547 0.835 0 C-N-CA 123.601 0.76 . . . . 64.41 109.694 172.407 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.008 -1.108 . . . . 64.13 108.008 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.758 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 3.3 mp0 -72.58 80.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.81 -0.811 . . . . 75.03 108.81 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.37 146.54 24.32 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.084 0.954 . . . . 70.14 109.416 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.65 -143.93 15.07 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.551 -1.019 . . . . 64.3 110.551 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 167' ' ' PRO . 0.8 OUTLIER -83.7 122.04 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 117.595 0.698 . . . . 64.13 109.413 -175.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.44 -47.52 9.91 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.756 2.022 . . . . 61.41 113.824 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' A' ' 169' ' ' LEU . 66.4 mt -51.81 -48.45 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.82 1.248 . . . . 63.31 110.457 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.51 HG13 ' HB2' ' A' ' 76' ' ' LEU . 56.0 t -70.56 -41.55 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.816 -1.084 . . . . 65.44 111.75 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 43.8 mt -64.08 -39.77 94.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.564 0.746 . . . . 61.44 111.341 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.25 -38.14 63.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.966 0.906 . . . . 72.22 111.128 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.49 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 28.5 m170 -92.07 -11.97 34.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.371 0.669 . . . . 72.43 111.555 -172.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 28.0 mtpp 62.44 46.7 5.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.897 1.279 . . . . 70.21 111.137 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.51 ' HB2' HG13 ' A' ' 71' ' ' VAL . 63.1 mt -80.43 130.79 35.39 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.376 -0.602 . . . . 74.24 109.376 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.8 135.42 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.214 -0.661 . . . . 70.45 109.214 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.45 148.01 24.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 63.22 113.325 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -146.64 103.54 3.67 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 106.307 -1.738 . . . . 74.23 106.307 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -92.6 118.12 30.69 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.931 -0.766 . . . . 75.45 108.931 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.4 p -63.64 -27.85 69.51 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.907 0.483 . . . . 74.21 111.188 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -68.03 -41.62 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.619 -1.173 . . . . 74.34 111.582 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.16 -22.88 13.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.628 0.771 . . . . 64.43 111.998 -170.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -116.66 21.0 13.73 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.456 1.102 . . . . 31.13 110.753 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.97 13.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.89 1.276 . . . . 54.1 113.779 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.9 m -61.45 -56.72 17.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.588 0.755 . . . . 61.23 111.26 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.6 mtp -59.92 -36.71 77.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.882 0.473 . . . . 44.13 111.072 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.42 -39.29 91.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.0 0.52 . . . . 63.4 111.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.06 -38.54 89.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.007 0.523 . . . . 74.12 109.974 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.38 94.11 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.072 -0.967 . . . . 61.52 110.739 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.416 ' O ' ' HB3' ' A' ' 95' ' ' PHE . 54.2 m-85 -59.28 -50.4 74.15 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 119.0 -0.524 . . . . 73.41 111.107 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mm -55.65 -44.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.453 0.701 . . . . 74.22 111.886 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -64.4 -56.2 15.9 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.099 0.56 . . . . 74.33 109.722 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -65.11 -55.85 16.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.537 0.523 . . . . 64.05 110.069 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 8.4 t80 -45.34 -61.13 1.79 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.325 1.45 . . . . 72.51 112.962 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.6 ttt -64.19 -41.27 97.15 Favored 'General case' 0 C--O 1.248 0.984 0 O-C-N 123.415 0.447 . . . . 74.42 111.449 -171.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -62.66 -41.35 99.01 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.139 -0.482 . . . . 74.11 110.683 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.44 -48.62 74.63 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.044 0.84 . . . . 74.33 111.373 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.57 ' O ' ' HG2' ' A' ' 103' ' ' MET . 29.2 m -62.24 -48.75 86.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.565 0.541 . . . . 75.14 110.433 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.473 HD13 ' HG3' ' A' ' 117' ' ' LYS . 47.0 mt -69.73 -43.01 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 O-C-N 123.308 0.38 . . . . 64.44 110.953 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.06 -37.83 81.04 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.732 0.813 . . . . 71.11 111.877 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -70.84 -41.23 71.76 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.83 0.706 . . . . 64.55 110.608 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.57 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 79.4 mmm -64.81 -36.52 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.079 -0.712 . . . . 75.25 109.079 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.45 -37.54 71.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.129 1.371 . . . . 74.43 110.462 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 -12.82 60.18 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 73.23 111.194 -175.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -104.37 -6.02 21.17 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.211 1.005 . . . . 75.33 109.801 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 47.02 77.29 0.09 Allowed 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.13 1.772 . . . . 71.31 112.225 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -61.12 -36.24 79.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.438 -0.801 . . . . 65.13 108.88 166.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 112' ' ' ASP . 21.5 t70 152.06 147.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 128.503 2.721 . . . . 74.41 106.063 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -58.0 -51.88 67.84 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.684 0.794 . . . . 62.52 110.99 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.28 -22.37 61.96 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.761 -0.654 . . . . 54.33 111.547 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 109' ' ' ASP . 20.9 t70 -80.28 -42.55 22.89 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.107 0.563 . . . . 64.13 111.017 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.21 -27.66 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.965 0.506 . . . . 71.53 110.278 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.29 -36.1 63.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.822 0.849 . . . . 65.43 110.856 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.43 -40.94 76.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.229 0.612 . . . . 64.11 110.147 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -64.62 -40.03 94.76 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.0 0.92 . . . . 72.24 109.588 172.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HG3' HD13 ' A' ' 100' ' ' ILE . 29.1 ttpp -63.56 -33.16 74.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.464 0.705 . . . . 44.02 110.721 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -74.93 -39.22 61.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.566 0.746 . . . . 72.31 110.819 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -66.85 -46.9 73.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 61.01 111.447 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.01 -32.47 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.182 0.593 . . . . 72.4 109.624 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.4 HE21 HG13 ' A' ' 125' ' ' VAL . 21.9 tp60 -62.36 -48.09 81.32 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 122.892 0.477 . . . . 44.33 110.008 172.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.67 98.74 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 124.454 1.096 . . . . 44.04 112.403 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -65.39 -48.95 71.12 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.204 0.602 . . . . 75.44 110.191 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -70.2 -41.81 78.91 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.462 0 CA-C-O 118.216 -0.897 . . . . 62.01 111.133 -174.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.4 HG13 HE21 ' A' ' 121' ' ' GLN . 25.0 m -71.88 -21.5 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 120.061 1.3 . . . . 74.44 111.507 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.2 t -73.72 -43.24 59.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.246 0.546 . . . . 72.01 109.605 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.524 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 34.7 tp -73.04 -36.0 66.84 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.459 1.103 . . . . 71.22 111.405 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.498 ' HA ' ' CE1' ' A' ' 133' ' ' PHE . 77.0 mt -79.83 4.02 17.85 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.587 1.155 . . . . 53.25 112.684 -171.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.13 141.56 49.14 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.486 -0.561 . . . . 62.01 109.486 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 99.8 mttt -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.561 0.745 . . . . 71.24 111.715 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.28 -16.41 63.01 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.816 0.846 . . . . 70.01 110.64 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.524 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 8.9 tpt180 -96.9 -41.59 8.35 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.324 1.049 . . . . 64.03 109.188 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.65 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.7 m-85 -62.82 -12.85 27.27 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.742 1.217 . . . . 64.33 113.146 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -50.21 -30.31 11.25 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.878 0.736 . . . . 75.44 112.618 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 32.2 p30 -131.4 17.87 4.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.704 0.801 . . . . 63.44 112.177 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 26.1 mt -96.12 128.94 43.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.201 0.525 . . . . 74.2 111.381 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.79 139.08 54.18 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 105.362 -2.088 . . . . 64.13 105.362 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.478 ' HB3' HG11 ' A' ' 153' ' ' VAL . 98.1 m-85 -116.0 148.03 40.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.501 -0.926 . . . . 63.25 108.501 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -146.56 136.4 23.3 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 107.716 -1.216 . . . . 71.15 107.716 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -127.57 148.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.044 -1.095 . . . . 74.01 108.044 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -51.85 145.49 15.16 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.343 0.497 . . . . 75.2 114.343 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 10.9 tp10 -52.05 -54.97 23.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.743 0.817 . . . . 60.24 111.107 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -72.15 -15.28 61.97 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.898 0.879 . . . . 72.42 111.567 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.96 -34.88 43.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.586 0.755 . . . . 20.41 110.445 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.45 7.57 4.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.078 0.951 . . . . 73.31 112.032 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -73.48 -20.32 60.71 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.861 0.864 . . . . 52.1 109.813 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.01 30.32 0.81 Allowed Glycine 0 C--N 1.356 1.647 0 C-N-CA 123.739 0.685 . . . . 74.42 112.363 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.85 90.27 5.28 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 63.21 110.367 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.35 163.27 25.52 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.026 0.931 . . . . 73.24 112.391 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 79.97 7.34 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.769 1.628 . . . . 64.35 111.495 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.411 ' HA3' HG23 ' A' ' 9' ' ' THR . . . -95.64 -177.61 36.86 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 116.137 1.215 . . . . 53.32 116.137 -170.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -111.95 152.27 28.25 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.825 1.65 . . . . 70.13 109.866 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 138' ' ' PHE . 92.7 t -108.22 136.04 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.935 0.894 . . . . 65.43 108.632 173.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -64.62 114.44 4.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.098 0.959 . . . . 51.1 110.27 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 61.3 mt -87.03 107.67 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.99 0.916 . . . . 71.45 108.864 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.48 121.56 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 72.3 110.092 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.62 98.2 7.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.264 1.426 . . . . 71.22 108.974 -166.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 135' ' ' ASN . 57.5 m-85 -82.86 118.65 23.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.761 0.424 . . . . 74.53 110.705 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -125.31 -179.32 4.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.101 0.96 . . . . 75.42 109.436 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -123.86 110.83 15.35 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.215 0.606 . . . . 61.25 110.941 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.95 102.12 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.226 1.01 . . . . 64.5 108.31 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.95 31.55 19.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.239 1.016 . . . . 74.45 110.841 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.57 65.63 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.044 -0.525 . . . . 72.43 113.817 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.7 m -90.42 131.39 36.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.202 0.601 . . . . 74.3 109.841 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -71.14 123.11 21.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.509 0.724 . . . . 72.22 109.979 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.96 102.49 31.4 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.492 1.117 . . . . 51.5 110.21 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 68' ' ' ILE . 72.3 Cg_endo -85.83 118.33 1.77 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.79 2.327 . . . . 70.03 112.236 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.1 m -103.78 141.91 35.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.991 0.916 . . . . 54.42 109.991 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.683 ' HB2' HD13 ' A' ' 70' ' ' ILE . 46.4 tp -77.22 130.35 37.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.086 -1.079 . . . . 72.33 108.086 171.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.432 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 33.2 tpp -131.4 122.48 26.39 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.863 -1.532 . . . . 74.44 106.863 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 154' ' ' ALA . 48.8 mt -159.76 145.65 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.696 1.198 . . . . 74.41 108.107 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 176' ' ' ILE . 14.6 p -80.24 134.43 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.355 0.98 . . . . 64.32 109.795 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -55.27 -30.39 60.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.869 1.268 . . . . 62.33 112.975 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -71.13 -25.99 62.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.264 0.625 . . . . 74.22 111.713 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.01 -1.5 42.5 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.997 0.519 . . . . 43.25 111.008 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.438 HD11 HD13 ' A' ' 171' ' ' LEU . 42.7 mm -112.5 138.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.039 0.535 . . . . 73.33 110.703 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 38.0 mm -96.62 109.46 23.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 105.96 -1.867 . . . . 70.4 105.96 167.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.6 99.29 6.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.599 -1.63 . . . . 75.21 106.599 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -126.75 155.72 42.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.011 0.924 . . . . 72.51 110.081 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 180' ' ' LYS . 7.6 ptpt -106.63 113.74 27.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.262 1.025 . . . . 73.23 109.725 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 46.7 m -95.88 91.15 5.89 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.462 -0.79 . . . . 71.41 109.085 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.64 168.81 18.87 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.013 0.525 . . . . 63.45 110.584 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.056 0 N-CA-C 108.853 -0.795 . . . . 74.14 108.853 -178.22 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.854 -0.424 . . . . 75.52 109.854 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.73 130.64 53.17 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.927 0.491 . . . . 64.42 111.538 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 tt -99.15 118.92 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 N-CA-C 107.662 -1.236 . . . . 61.0 107.662 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -125.11 115.1 19.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.426 0.69 . . . . 72.1 110.902 -163.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 1.5 mptp? -121.3 153.14 38.11 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.49 0.716 . . . . 63.22 110.57 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.35 148.63 22.19 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.454 -0.943 . . . . 75.41 108.454 159.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 175' ' ' ALA . 47.2 pt -83.27 -24.58 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 112.563 0.579 . . . . 73.41 112.563 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -86.99 -64.0 1.22 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.796 0.665 . . . . 74.33 112.796 -169.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 144' ' ' ALA . 6.3 m -132.3 -34.73 1.21 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.877 0.695 . . . . 65.25 112.877 -172.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -92.5 21.79 5.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.941 1.296 . . . . 65.5 110.934 -164.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -46.78 -28.27 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.556 1.542 . . . . 53.14 112.891 -172.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.93 26.26 1.87 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.763 0.825 . . . . 72.32 112.596 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 10' ' ' ASP . 18.2 mt -44.93 -93.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.974 1.31 . . . . 74.34 112.557 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.3 m -156.28 152.26 27.48 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.965 -0.46 . . . . 54.3 110.917 -167.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -140.13 98.81 3.52 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.144 -1.058 . . . . 64.12 108.144 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -161.5 -176.2 5.21 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 110.267 -0.271 . . . . 73.33 110.267 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -68.33 92.82 0.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.36 1.064 . . . . 71.21 110.097 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HB3' ' HE2' ' A' ' 30' ' ' PHE . 41.2 m-85 -109.29 139.5 21.11 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 123.486 0.714 . . . . 75.11 111.18 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.36 119.08 6.05 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.197 1.931 . . . . 74.53 110.872 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.0 ttp -126.42 123.2 37.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.469 -0.787 . . . . 73.0 109.184 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.59 131.03 22.32 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.892 -1.521 . . . . 74.25 106.892 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.7 tp -101.77 124.06 46.77 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.81 -0.811 . . . . 72.03 108.81 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.39 140.05 38.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 124.424 1.089 . . . . 70.01 108.551 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 64.29 12.99 7.63 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.006 0.922 . . . . 73.45 112.453 173.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 58.38 21.84 8.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.31 1.044 . . . . 71.2 111.966 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.3 tp -130.74 -52.83 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.758 0.423 . . . . 61.13 110.686 -167.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -117.56 141.61 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.395 0.678 . . . . 45.42 111.239 -167.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 178' ' ' GLU . 46.6 m-85 -88.7 118.15 28.17 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.128 0.971 . . . . 74.45 109.936 168.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -85.69 104.41 15.38 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.462 -1.245 . . . . 73.2 107.885 167.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.7 t80 -100.58 106.81 18.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.419 -1.326 . . . . 74.24 107.419 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.83 154.36 27.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.103 0.477 . . . . 65.3 110.964 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.01 -172.2 23.96 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.094 -0.802 . . . . 72.31 111.094 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -135.21 137.34 42.54 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.468 0.634 . . . . 63.23 110.717 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -74.18 118.67 17.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.796 0.839 . . . . 74.11 109.198 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.567 ' HB ' HD11 ' A' ' 42' ' ' ILE . 12.6 m -141.63 168.67 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.705 1.202 . . . . 65.2 110.69 -165.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.97 114.01 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.765 0.793 . . . . 70.33 109.235 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.803 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 35.8 ttm180 -92.71 111.04 22.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.282 -1.007 . . . . 70.42 108.282 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -120.81 149.31 42.77 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.083 0.953 . . . . 75.34 109.361 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -72.45 81.83 1.07 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.728 -0.841 . . . . 65.23 108.728 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.83 -62.19 0.18 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 114.365 -1.289 . . . . 73.23 110.259 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -172.17 157.95 4.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.634 0.774 . . . . 75.54 110.163 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' A' ' 35' ' ' VAL . 6.5 tp . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 108.092 -1.077 . . . . 73.14 108.092 169.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 C--O 1.24 0.56 0 N-CA-C 106.346 -1.724 . . . . 65.31 106.346 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 13.2 mm-40 -75.74 69.41 2.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.032 -1.099 . . . . 73.23 108.032 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -82.28 122.26 27.72 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.552 -1.204 . . . . 74.51 108.026 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.78 -164.82 37.64 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.057 -1.617 . . . . 74.34 109.057 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 70' ' ' ILE . 37.2 pt -96.65 148.82 5.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 117.471 0.636 . . . . 72.15 110.33 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.69 -30.85 63.87 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.746 1.218 . . . . 71.11 112.312 -174.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 68' ' ' ILE . 61.1 mt -56.52 -51.24 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.022 1.329 . . . . 75.01 110.613 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.674 HG13 ' HB2' ' A' ' 76' ' ' LEU . 47.2 t -78.65 -44.11 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 114.451 -1.25 . . . . 52.03 111.21 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.58 -18.17 65.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.666 0.786 . . . . 72.42 112.089 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -48.52 -58.52 4.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.331 1.052 . . . . 53.22 110.681 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.04 -7.72 16.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.819 -0.628 . . . . 64.43 112.598 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttp 62.21 69.88 0.6 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.558 1.161 . . . . 73.34 109.052 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.674 ' HB2' HG13 ' A' ' 71' ' ' VAL . 64.3 mt -75.16 157.03 35.27 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.54 -0.755 . . . . 64.42 109.57 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.51 127.84 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.276 -0.638 . . . . 75.12 109.276 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.87 152.07 20.19 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.939 0.876 . . . . 73.52 112.887 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 86.0 mmm -143.83 137.22 27.82 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 104.72 -2.326 . . . . 60.15 104.72 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 140.42 35.64 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.327 0.512 . . . . 71.22 109.788 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 134' ' ' LYS . 24.9 p -58.96 -14.81 10.28 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.504 0.722 . . . . 55.34 112.907 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -66.3 -59.09 4.04 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.4 0.68 . . . . 75.54 112.197 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -98.21 -38.24 9.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.846 0.458 . . . . 73.14 110.728 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -92.5 21.59 5.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.622 0.769 . . . . 73.34 112.681 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.2 -53.2 29.67 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.759 0.824 . . . . 50.41 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 m -72.84 -37.72 67.34 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.774 0.83 . . . . 73.14 111.6 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.5 mpt? -66.5 -45.87 78.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.237 1.015 . . . . 60.3 110.3 -176.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 36.2 t80 -63.38 -47.18 83.12 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.376 -1.284 . . . . 75.43 111.236 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 37.1 ttmt -65.39 -28.83 69.54 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.349 0.405 . . . . 62.52 110.701 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.55 93.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.425 0.69 . . . . 65.43 110.7 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 31.2 m-85 -61.09 -40.04 92.24 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 115.961 -0.563 . . . . 73.22 111.115 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.407 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 42.0 mm -65.19 -32.54 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.731 0.812 . . . . 72.32 111.675 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 89' ' ' LYS . 96.4 mttt -61.53 -47.45 85.51 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.066 0.547 . . . . 65.0 111.437 171.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -66.91 -42.28 85.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.098 0.559 . . . . 75.44 110.675 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.465 ' O ' HG13 ' A' ' 99' ' ' VAL . 79.0 t80 -51.86 -60.79 2.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.117 1.767 . . . . 63.01 111.035 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.9 ttp -61.04 -40.92 95.45 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.731 0.645 . . . . 64.34 111.018 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -56.02 -55.73 29.27 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.214 0.606 . . . . 74.42 110.684 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -72.27 -36.68 69.06 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.496 0.498 . . . . 62.35 111.854 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 95' ' ' PHE . 18.1 m -67.77 -38.78 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.432 0.53 . . . . 63.12 112.432 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.05 -35.93 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 121.001 0.429 . . . . 74.11 110.529 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.78 -47.83 84.54 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.074 0.95 . . . . 71.22 110.765 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -66.56 -44.34 82.58 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.617 -1.174 . . . . 50.33 110.061 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.5 ' HG3' HG12 ' A' ' 113' ' ' VAL . 15.4 tpt -55.53 -53.35 57.52 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.118 0.886 . . . . 71.4 111.724 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.435 ' HA ' HG11 ' A' ' 113' ' ' VAL . 41.1 tt0 -65.2 -27.09 68.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.568 0.542 . . . . 73.2 111.579 -172.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.58 -45.28 76.01 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.201 0.524 . . . . 75.12 110.616 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -83.82 -29.54 27.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.081 0.953 . . . . 72.41 111.388 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -99.57 -50.66 4.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.632 0.773 . . . . 72.53 109.938 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 73.29 -13.3 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.146 1.379 . . . . 62.22 113.611 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.22 122.6 33.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.564 -0.902 . . . . 75.32 108.564 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.07 -37.48 85.91 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.189 0.596 . . . . 64.11 112.591 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.8 -30.26 66.68 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.611 0.364 . . . . 74.04 111.834 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.08 -30.92 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.598 0.359 . . . . 70.11 110.317 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.5 HG12 ' HG3' ' A' ' 103' ' ' MET . 27.0 m -80.65 -25.68 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 121.903 0.081 . . . . 52.04 110.974 173.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.25 -39.29 94.19 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.649 0.779 . . . . 72.31 109.64 167.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.31 -40.87 67.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.688 -1.142 . . . . 73.01 110.435 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -63.37 -44.95 93.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.805 0.442 . . . . 74.4 111.188 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -65.58 -35.75 81.74 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.904 -0.406 . . . . 63.45 109.904 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.28 -36.89 85.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.929 0.892 . . . . 72.23 111.045 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.44 -52.84 22.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.236 0.614 . . . . 51.34 110.633 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 99' ' ' VAL . 8.5 tp -73.89 -40.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.164 0.29 . . . . 75.15 110.986 -169.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -68.18 -35.27 77.75 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.283 -0.636 . . . . 74.45 109.283 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.19 94.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.643 -0.708 . . . . 54.53 113.342 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -66.33 -47.89 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.903 -0.776 . . . . 73.11 108.903 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.0 m -74.49 -30.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-N 115.582 -0.736 . . . . 70.44 111.88 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.47 -25.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 119.118 0.872 . . . . 73.15 110.068 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -81.77 -42.2 20.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.022 0.529 . . . . 74.41 111.232 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.499 HD21 HG21 ' A' ' 155' ' ' ILE . 54.7 tp -79.31 -23.95 43.17 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.124 0.969 . . . . 72.43 112.118 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 41.3 mt -93.4 4.4 54.03 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.841 0.456 . . . . 72.14 111.63 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 99.75 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.331 0.652 . . . . 74.22 111.141 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 13.4 ptmm? -51.68 -39.8 58.93 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.863 1.801 . . . . 74.51 115.863 -162.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.31 -29.53 66.28 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.891 0.7 . . . . 74.41 112.891 -163.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -111.51 -29.75 7.64 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.401 0.519 . . . . 51.41 112.401 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.48 -2.22 58.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.495 0.924 . . . . 64.33 113.495 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.444 ' HG3' ' SG ' ' A' ' 81' ' ' CYS . 26.5 ttpp -51.07 -24.63 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 112.546 0.573 . . . . 65.43 112.546 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.15 25.94 3.99 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.152 0.981 . . . . 75.53 111.66 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.08 142.07 28.19 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.424 -0.954 . . . . 74.43 108.424 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.28 110.51 22.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.341 -1.355 . . . . 55.55 107.341 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.36 143.11 26.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.717 -1.216 . . . . 71.35 107.717 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -137.48 137.38 38.63 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.765 -0.828 . . . . 61.54 108.765 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 tt -109.9 148.15 13.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.355 0 N-CA-C 106.73 -1.582 . . . . 72.12 106.73 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.634 ' HA2' HD22 ' A' ' 76' ' ' LEU . . . -48.37 130.48 20.23 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 124.386 1.053 . . . . 71.04 112.766 175.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 11.0 tp10 -56.98 -38.28 72.79 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.21 0.604 . . . . 73.13 110.923 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -71.54 -35.25 70.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.959 0.904 . . . . 73.14 109.259 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 9' ' ' THR . . . -65.12 -42.76 93.62 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.255 -0.884 . . . . 63.3 110.628 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -19.52 65.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.287 0.635 . . . . 73.13 112.593 -176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 49.8 mt-10 -79.75 -23.12 42.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.942 0.497 . . . . 63.23 111.928 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.86 49.06 0.08 OUTLIER Glycine 0 C--N 1.348 1.243 0 C-N-CA 121.288 -0.482 . . . . 71.22 113.867 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.96 98.53 0.29 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.858 0.863 . . . . 72.34 110.731 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.57 14.39 4.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.479 0.711 . . . . 65.11 111.221 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.61 -3.78 29.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.281 1.032 . . . . 75.24 111.006 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.68 163.83 35.74 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.891 0.744 . . . . 73.31 114.871 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -78.77 141.62 37.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.043 0.937 . . . . 71.34 112.479 -172.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.05 111.03 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 123.347 0.659 . . . . 63.31 110.028 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.521 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.54 111.36 5.32 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.849 -1.069 . . . . 34.34 108.78 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.499 HG21 HD21 ' A' ' 127' ' ' LEU . 63.0 mt -92.77 124.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.44 -0.948 . . . . 75.23 108.44 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 68' ' ' ILE . 49.7 mm -109.39 111.29 35.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 109.362 -0.607 . . . . 75.51 109.362 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.26 116.15 26.26 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.726 0.641 . . . . 74.13 109.831 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -69.86 88.54 0.56 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.669 1.187 . . . . 74.35 109.304 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -94.65 134.06 37.63 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.149 -0.97 . . . . 71.02 109.816 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.4 102.71 15.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.909 0.484 . . . . 55.33 110.109 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.8 p -90.19 92.31 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 N-CA-C 108.295 -1.002 . . . . 72.31 108.295 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.68 -66.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.914 1.685 . . . . 54.23 111.514 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -163.89 29.05 0.23 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.764 -0.934 . . . . 75.3 110.764 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 98.5 m -135.73 148.08 48.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.583 1.153 . . . . 54.41 108.032 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.53 136.44 36.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.286 0.494 . . . . 73.33 110.054 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.29 112.75 18.22 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.342 1.057 . . . . 73.02 108.271 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 115.4 3.62 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.183 1.922 . . . . 53.42 111.666 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.4 p -111.35 108.66 18.32 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.095 -1.076 . . . . 51.44 108.095 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 19.5 tp -75.96 120.37 21.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.719 0.807 . . . . 71.33 109.538 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.5 mtt -100.1 122.2 42.6 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 123.783 0.833 . . . . 73.45 109.117 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.534 HD13 HD11 ' A' ' 176' ' ' ILE . 42.6 mt -141.07 140.16 34.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.353 1.461 . . . . 73.45 107.487 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 99' ' ' VAL . 10.5 p -81.77 147.59 6.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.395 -0.594 . . . . 62.44 109.395 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -51.06 -44.93 61.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.813 1.245 . . . . 64.43 112.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -82.29 3.65 26.83 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.419 0.896 . . . . 74.31 113.419 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 7' ' ' ILE . . . -105.93 -5.0 19.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.212 0.605 . . . . 33.11 111.474 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.534 HD11 HD13 ' A' ' 171' ' ' LEU . 48.2 mm -122.79 143.97 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.448 0.699 . . . . 74.1 110.006 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.729 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 41.3 mm -98.62 109.68 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 N-CA-C 106.905 -1.517 . . . . 74.53 106.905 168.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HG2' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -130.19 116.68 18.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.873 0.869 . . . . 74.24 109.575 -171.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -141.28 132.4 26.31 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.191 0.597 . . . . 70.3 109.872 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -76.94 102.8 6.55 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.999 -0.741 . . . . 71.53 108.999 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.7 t -77.73 87.67 3.99 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.403 0.621 . . . . 72.53 110.082 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.9 mt -87.35 92.66 9.15 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.514 -0.921 . . . . 71.34 108.514 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.467 0.707 . . . . 71.12 109.206 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 49.9 ttm . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 108.279 -1.008 . . . . 61.01 108.279 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 mt -91.87 139.77 30.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.442 -0.577 . . . . 42.14 109.442 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 179' ' ' GLU . 4.0 tt -110.09 117.88 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.448 -0.945 . . . . 65.22 108.448 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.509 ' HD1' ' HB2' ' A' ' 14' ' ' SER . 0.9 OUTLIER -103.09 123.0 45.83 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.309 -1.737 . . . . 72.0 106.309 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -124.14 151.86 43.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.572 0.749 . . . . 75.13 109.899 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 38.8 t70 -99.5 174.67 6.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.577 -0.897 . . . . 64.51 108.577 173.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.521 HD13 HD21 ' A' ' 98' ' ' ASN . 20.6 tt -72.99 -34.73 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.356 0.662 . . . . 52.05 110.995 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.4 -48.45 2.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.093 0.957 . . . . 62.51 109.872 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -88.33 16.37 6.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.143 -1.39 . . . . 73.45 111.394 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 5.8 p-10 -52.7 -39.01 61.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.312 1.045 . . . . 74.22 112.841 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.23 -25.86 67.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.177 -0.919 . . . . 74.45 111.502 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -105.8 -1.61 24.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.599 0.759 . . . . 74.33 112.469 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mt -84.96 -154.45 0.18 Allowed 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.453 1.024 . . . . 73.31 110.309 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.509 ' HB2' ' HD1' ' A' ' 4' ' ' TYR . 15.1 m -115.45 124.54 51.4 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.248 0.462 . . . . 62.33 112.248 -158.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -116.5 85.2 2.26 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.206 -0.665 . . . . 64.2 109.206 168.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -166.03 -105.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.529 -0.76 . . . . 72.23 109.388 -172.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 p -177.91 84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.08 0.952 . . . . 55.04 108.642 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -115.75 129.5 25.11 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.315 1.046 . . . . 61.22 109.264 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.87 135.81 43.2 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.078 2.518 . . . . 72.12 112.188 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.28 162.78 37.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.047 -0.524 . . . . 51.33 111.042 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 4.8 ttmp? -144.89 159.56 42.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.784 0.833 . . . . 72.33 109.389 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.23 128.58 50.2 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.325 -0.991 . . . . 75.42 108.325 168.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -120.54 146.15 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.901 0.88 . . . . 73.41 109.817 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 t70 67.52 5.72 4.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.576 1.15 . . . . 73.14 113.153 167.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.56 18.35 6.93 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.597 1.159 . . . . 74.0 111.294 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 119' ' ' LYS . 52.8 tp -129.54 -50.03 1.16 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.004 -0.544 . . . . 64.22 111.131 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.3 t -110.79 124.12 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.4 0.619 . . . . 74.45 110.47 -172.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -85.34 115.8 23.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 114.816 -1.083 . . . . 64.44 108.598 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 21' ' ' LYS . 42.0 mt-10 -89.33 149.34 23.07 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.882 0.873 . . . . 64.34 110.534 173.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.747 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 35.9 t80 -139.84 142.5 36.6 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.875 -1.157 . . . . 75.23 107.875 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.02 120.72 14.13 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.273 0.358 . . . . 74.42 111.672 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.8 157.71 14.78 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.201 -1.16 . . . . 73.42 110.201 166.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -144.9 147.32 32.64 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.598 -0.89 . . . . 71.43 108.598 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -87.59 109.18 19.46 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.624 -0.88 . . . . 65.43 108.624 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 HD12 ' A' ' 72' ' ' LEU . 18.5 m -145.22 174.3 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.612 1.165 . . . . 74.54 109.876 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 66' ' ' ARG . 25.7 m -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.339 -0.615 . . . . 63.34 109.339 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -120.05 107.58 13.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.591 -0.892 . . . . 64.23 108.591 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD2' HG22 ' A' ' 64' ' ' VAL . 63.9 tttp -134.83 96.19 3.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.143 -1.058 . . . . 64.15 108.143 166.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 60.02 -66.36 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.564 1.546 . . . . 75.44 112.2 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.02 43.89 0.19 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.662 -0.975 . . . . 74.33 110.662 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -113.93 100.15 8.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.065 0.946 . . . . 72.13 109.448 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 0 CA--C 1.554 1.119 0 CA-C-O 122.823 1.297 . . . . 71.01 110.335 -177.121 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.421 HG22 ' HD2' ' A' ' 38' ' ' LYS . 58.0 t . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 108.061 -1.088 . . . . 71.01 108.061 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 72' ' ' LEU . 30.4 mm-40 -88.0 70.76 9.42 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.231 -0.895 . . . . 64.32 108.612 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HA ' HG12 ' A' ' 36' ' ' VAL . 8.1 ptp180 -85.14 139.05 32.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.677 -0.692 . . . . 75.54 110.936 172.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.36 -126.68 2.75 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.289 -0.414 . . . . 33.42 112.152 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 34.6 pt -113.83 142.41 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.383 0.673 . . . . 70.21 112.763 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.6 -46.61 2.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.989 2.116 . . . . 72.33 114.402 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 156' ' ' ILE . 29.5 mm -54.3 -43.19 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.937 0.875 . . . . 75.22 111.023 -176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.6 t -83.2 -40.36 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.388 -1.278 . . . . 73.24 112.402 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 16.5 mt -74.22 -32.33 62.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.063 0.459 . . . . 72.51 110.572 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -78.25 -24.37 46.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.642 0.777 . . . . 75.41 111.535 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -122.47 -6.71 8.69 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.816 0.673 . . . . 55.04 112.816 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 45.0 tptt 54.63 70.32 0.63 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.111 1.364 . . . . 52.41 110.928 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -96.04 139.35 32.34 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.215 -0.902 . . . . 71.3 109.038 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.649 HG13 HG23 ' A' ' 140' ' ' ILE . 4.0 p -89.85 133.61 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.049 -0.723 . . . . 71.23 109.049 174.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.425 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 pt-20 -56.54 152.48 11.71 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.933 0.893 . . . . 71.32 113.274 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.7 tpt -148.44 144.6 27.53 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 125.206 1.402 . . . . 74.12 107.481 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -137.52 151.48 48.47 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.207 0.527 . . . . 74.52 111.327 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 26.0 p -88.86 -2.16 58.45 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.143 -0.935 . . . . 73.43 111.327 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -75.52 -61.81 1.79 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.022 0.749 . . . . 74.42 113.022 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -103.96 -35.04 8.27 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.389 0.676 . . . . 75.14 110.439 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.29 20.6 2.32 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 70.32 112.094 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' CYS . . . -55.01 -35.35 64.31 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.38 1.072 . . . . 75.24 113.252 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.1 m -70.03 -44.68 68.75 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 73.4 111.058 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -70.43 -42.1 72.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.42 109.855 -176.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.423 ' HE2' HD22 ' A' ' 128' ' ' LEU . 53.2 t80 -68.48 -32.44 72.43 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.463 -1.244 . . . . 53.04 111.36 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -64.14 -34.92 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.888 0.475 . . . . 61.33 110.522 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -39.4 88.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.696 -0.683 . . . . 72.24 109.855 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -69.11 -33.54 73.66 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.765 0.654 . . . . 72.2 112.765 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -62.91 -41.24 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.957 0.503 . . . . 53.52 110.788 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -59.21 -44.66 92.25 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.653 0.595 . . . . 75.52 110.15 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -60.25 4.01 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 114.87 -1.059 . . . . 74.13 109.619 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -49.25 -62.5 1.5 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.925 1.69 . . . . 60.4 112.955 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.55 -44.64 90.14 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.559 0.537 . . . . 75.11 111.618 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -66.77 -36.11 81.65 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 118.296 0.498 . . . . 74.22 110.674 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.521 HD21 HD13 ' A' ' 7' ' ' ILE . 25.2 t30 -61.26 -53.21 59.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.103 0.961 . . . . 52.43 110.47 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.3 m -78.69 -29.66 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.341 -0.845 . . . . 54.43 112.186 -170.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.55 -40.67 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.787 -0.449 . . . . 73.43 109.787 172.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.32 -36.88 79.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.79 0.836 . . . . 71.02 111.227 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -66.09 -42.57 89.13 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.257 0.623 . . . . 73.33 109.563 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.578 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 27.0 ttt -66.32 -37.06 84.49 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 116.009 -0.541 . . . . 64.44 111.154 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.649 0.78 . . . . 73.33 111.458 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -84.17 -37.63 21.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.35 0.26 . . . . 63.41 111.372 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.578 ' ND2' ' HA ' ' A' ' 103' ' ' MET . 6.0 p30 -96.78 5.25 50.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.173 -0.329 . . . . 74.04 111.823 -175.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -129.85 -50.3 1.14 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.656 0.782 . . . . 74.14 109.742 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 49.28 21.67 0.57 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.868 1.667 . . . . 74.13 112.994 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.2 131.47 51.47 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.686 1.195 . . . . 75.31 108.354 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -63.65 -45.06 91.9 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.281 0.988 . . . . 73.5 111.843 -173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.55 76.19 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.04 0.536 . . . . 72.41 112.115 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.81 -45.37 51.81 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.846 0.459 . . . . 72.2 111.22 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.67 -30.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 123.655 0.597 . . . . 74.42 111.338 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -41.78 76.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.325 0.65 . . . . 74.31 111.072 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.78 -42.45 86.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.01 0.433 . . . . 74.35 110.2 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.424 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 88.3 t80 -67.0 -42.13 85.54 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.036 -0.984 . . . . 60.5 110.762 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 64.3 tttp -53.87 -47.08 71.4 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.996 0.81 . . . . 73.24 110.102 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -65.88 -39.54 90.76 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.736 1.273 . . . . 75.3 109.789 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HB3' HD13 ' A' ' 26' ' ' LEU . 8.8 tptp -69.22 -49.17 58.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.287 0.635 . . . . 75.33 109.638 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 tp -74.56 -42.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.991 -0.55 . . . . 64.5 110.874 -170.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 12.5 pt20 -66.07 -39.47 90.08 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 109.572 -0.529 . . . . 73.51 109.572 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.73 99.23 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.501 0.5 . . . . 71.21 112.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -67.82 -50.99 53.71 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 118.98 -0.534 . . . . 71.45 109.935 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.529 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.7 m -68.32 -43.3 84.5 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 O-C-N 123.654 0.596 . . . . 73.44 111.299 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 -25.56 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.083 0.553 . . . . 74.41 110.894 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -77.67 -40.52 41.29 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.878 0.471 . . . . 73.02 110.575 167.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 155' ' ' ILE . 41.0 tp -73.71 -28.42 61.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.917 1.287 . . . . 72.52 111.5 -171.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 83.9 mt -84.37 1.55 44.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.722 0.809 . . . . 72.11 111.082 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.83 85.37 2.2 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 123.455 0.702 . . . . 75.31 109.416 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -55.67 -29.49 59.41 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.679 1.592 . . . . 75.2 114.556 -166.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.33 -22.8 61.12 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.349 0.5 . . . . 72.14 112.349 -171.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -103.18 -51.34 3.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.071 0.948 . . . . 72.24 108.806 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -76.96 0.24 21.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.697 1.599 . . . . 73.4 114.9 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -46.25 -7.44 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.435 1.642 . . . . 55.53 115.435 171.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -82.18 9.76 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.955 0.902 . . . . 63.42 111.339 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.02 148.07 23.29 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.736 0.814 . . . . 63.23 109.089 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.444 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . . . -138.92 116.07 11.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.19 -1.781 . . . . 75.24 106.19 170.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -89.15 147.63 24.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.29 -1.004 . . . . 64.34 108.29 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 78' ' ' GLU . 75.7 m-85 -141.27 143.15 33.95 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.389 -0.597 . . . . 63.4 109.389 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.649 HG23 HG13 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -123.61 138.01 54.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 105.174 -2.158 . . . . 73.11 105.174 176.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.92 126.28 39.68 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.125 -0.82 . . . . 62.31 111.336 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -56.75 -38.56 72.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 75.4 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -57.26 -47.09 82.3 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.628 1.171 . . . . 74.05 111.253 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.43 84.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.325 0.65 . . . . 72.42 111.149 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.0 -3.59 16.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.653 -0.703 . . . . 64.43 112.237 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -104.9 -18.02 14.35 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.319 1.048 . . . . 64.41 110.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.71 -74.32 0.01 OUTLIER Glycine 0 C--N 1.355 1.594 0 O-C-N 122.307 -0.246 . . . . 64.14 112.778 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.25 80.24 9.13 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.534 0.734 . . . . 70.43 109.809 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.01 1.56 2.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.29 1.036 . . . . 70.41 113.587 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -97.89 9.06 43.66 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.983 0.913 . . . . 75.14 110.624 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.04 154.62 43.76 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.796 0.685 . . . . 52.43 112.718 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.61 143.91 28.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 74.21 111.077 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.14 116.34 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.295 0.638 . . . . 62.04 110.636 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.35 113.95 7.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.745 1.218 . . . . 43.51 109.721 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.548 HG21 HD21 ' A' ' 127' ' ' LEU . 75.1 mt -91.59 109.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.217 -0.66 . . . . 71.14 109.217 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 169' ' ' LEU . 40.0 mm -96.71 144.7 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.431 -0.581 . . . . 64.43 109.431 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.99 109.66 9.71 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.251 -1.018 . . . . 61.32 108.251 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.65 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 6.2 p90 -83.4 91.96 7.46 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.352 -1.351 . . . . 74.42 107.352 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.518 ' HB3' HG13 ' A' ' 166' ' ' VAL . 7.5 tpt180 -74.4 91.61 2.24 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.158 -1.383 . . . . 74.44 108.72 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.35 112.44 5.22 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.21 -0.905 . . . . 74.42 110.904 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.48 92.08 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.526 1.13 . . . . 63.3 108.581 168.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 t70 46.35 61.87 2.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.568 1.547 . . . . 75.1 112.515 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.92 -12.8 68.68 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-N 115.515 -0.766 . . . . 73.34 113.441 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.18 106.97 17.71 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.004 -0.739 . . . . 74.33 109.004 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 14.4 pt-20 -73.31 141.09 47.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.484 -0.561 . . . . 71.11 109.484 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.518 HG13 ' HB3' ' A' ' 159' ' ' ARG . 3.7 p -127.27 91.29 46.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 108.199 -1.037 . . . . 61.1 108.199 166.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 52.1 Cg_exo -56.24 143.51 84.99 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.148 2.565 . . . . 61.33 112.663 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.1 m -145.87 126.47 14.21 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 65.22 108.576 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.7 tp -77.35 130.33 37.0 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.416 -0.957 . . . . 51.1 108.416 170.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.6 mtt -128.85 123.8 33.67 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.188 0.995 . . . . 75.23 108.622 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 154' ' ' ALA . 79.7 mt -141.32 170.89 14.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.878 1.671 . . . . 64.32 106.512 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 174' ' ' GLU . 11.8 p -83.42 147.22 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 108.836 -0.802 . . . . 72.11 108.836 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.91 -27.55 43.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.909 0.884 . . . . 74.22 112.456 175.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 12.8 tp10 -85.56 -2.44 58.15 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.768 0.827 . . . . 73.4 111.574 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.99 -11.99 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.859 0.864 . . . . 74.04 110.159 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.2 mm -108.81 140.88 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.286 0.565 . . . . 72.51 110.879 -174.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.1 mm -124.08 109.19 22.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.444 1.498 . . . . 64.51 107.192 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.68 121.02 31.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.568 -0.901 . . . . 64.55 108.568 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.673 ' HB3' HG23 ' A' ' 3' ' ' ILE . 33.6 tt0 -121.92 116.01 23.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.185 -1.043 . . . . 73.24 108.185 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.04 109.85 22.16 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.166 0.508 . . . . 71.24 111.609 -170.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 1' ' ' MET . 47.7 t -100.88 95.43 6.61 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.729 -0.841 . . . . 64.35 108.729 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.28 -35.35 0.55 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.137 0.975 . . . . 74.13 110.583 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 C--O 1.248 0.992 0 C-N-CA 123.736 0.814 . . . . 75.53 109.368 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttm . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.037 -0.727 . . . . 62.24 109.037 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 99.0 mt -123.21 133.92 54.18 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.365 0.266 . . . . 63.24 110.51 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 61.8 mt -106.55 117.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.668 -1.234 . . . . 54.54 107.668 170.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.625 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 91.5 m-85 -89.71 122.16 32.55 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.507 -0.923 . . . . 75.23 108.507 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.19 131.4 53.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.628 0.771 . . . . 52.13 110.776 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.553 ' HA ' HG12 ' A' ' 176' ' ' ILE . 25.0 t70 -90.34 174.44 7.58 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.334 1.021 . . . . 64.01 108.433 172.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 7' ' ' ILE . 8.3 mt -53.74 -58.97 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.184 0.594 . . . . 63.52 110.967 171.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -112.7 -23.1 10.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 65.12 111.517 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -98.24 14.12 28.91 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.998 0.919 . . . . 72.43 110.563 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.3 p-10 -48.28 -33.08 8.21 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 124.245 1.018 . . . . 54.43 113.422 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.56 -42.93 64.1 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.194 -0.912 . . . . 65.4 110.97 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.65 ' HB2' ' HG2' ' A' ' 143' ' ' ARG . 5.0 tp10 -121.25 24.72 9.89 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.188 0.595 . . . . 71.24 111.581 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 2.6 tm? -77.19 -81.88 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.11 -0.7 . . . . 75.53 109.11 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 53.1 m -157.4 -178.35 7.28 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.154 0.982 . . . . 61.51 110.386 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 73.4 p 177.3 -177.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.276 1.03 . . . . 54.51 111.397 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 85.91 -109.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.188 1.795 . . . . 53.24 111.634 165.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -144.04 42.39 1.42 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.86 -0.793 . . . . 75.13 108.86 -163.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -108.31 98.89 29.47 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.352 -0.84 . . . . 64.2 109.372 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.36 134.81 9.13 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 124.153 3.235 . . . . 53.03 114.978 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.15 146.55 42.18 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.125 -0.943 . . . . 70.42 108.596 174.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 66.6 mttm -110.66 157.45 19.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.198 -1.408 . . . . 54.22 107.198 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -130.73 108.06 9.61 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.629 -0.878 . . . . 74.02 108.629 175.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.48 127.46 50.98 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 109.018 -0.734 . . . . 73.32 109.018 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.2 t70 56.24 25.37 9.17 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.417 1.073 . . . . 74.45 112.485 175.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 53.11 16.02 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.063 1.135 . . . . 71.42 114.063 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 119' ' ' LYS . 34.5 tp -105.07 -51.48 3.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.947 0.499 . . . . 73.33 110.201 -174.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.469 HG11 ' SD ' ' A' ' 170' ' ' MET . 21.6 t -123.49 133.72 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 116.547 -0.297 . . . . 73.35 111.376 -168.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 m-85 -84.76 120.12 26.06 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.576 -0.898 . . . . 53.13 108.576 167.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 40.2 tt0 -99.06 103.18 15.09 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.696 -1.224 . . . . 74.04 107.696 170.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.724 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 30.7 t80 -94.21 141.2 28.83 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.848 1.259 . . . . 75.4 109.307 -169.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -71.49 139.88 49.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.837 0.855 . . . . 71.21 112.718 -169.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.29 149.73 17.13 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 114.768 -1.106 . . . . 23.5 111.257 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 69' ' ' ASP . 16.2 ptpt -126.93 161.41 28.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.961 0.904 . . . . 64.23 108.658 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -75.19 120.67 21.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.603 -0.517 . . . . 70.53 109.603 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 HD12 ' A' ' 72' ' ' LEU . 4.1 m -145.06 164.58 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.442 0.697 . . . . 74.03 110.486 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -94.89 160.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.217 -0.447 . . . . 51.12 110.765 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.4 ' HB3' HD22 ' A' ' 72' ' ' LEU . 60.0 ttt180 -142.74 112.44 6.87 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.912 -0.403 . . . . 72.41 109.912 169.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -125.27 140.21 53.03 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.468 -0.938 . . . . 75.44 108.468 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -26.41 65.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 123.388 0.43 . . . . 65.32 111.699 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.0 -61.7 4.44 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.657 0.598 . . . . 74.14 111.802 172.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.8 152.09 0.94 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.137 0.975 . . . . 73.35 108.719 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tt . . . . . 0 CA--C 1.55 0.962 0 CA-C-O 121.397 0.618 . . . . 54.13 109.682 174.53 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.558 -0.164 . . . . 72.13 110.558 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 73.53 -57.71 0.62 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.327 1.851 . . . . 73.33 111.604 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -116.13 129.28 56.25 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.285 1.034 . . . . 75.1 109.082 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.08 -165.02 29.4 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.234 -0.984 . . . . 73.44 113.287 166.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 156' ' ' ILE . 26.4 pt -104.12 146.89 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 113.914 -1.143 . . . . 71.33 110.988 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 33' ' ' LYS . 10.9 t70 -48.2 -47.16 35.61 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.312 1.445 . . . . 50.55 112.614 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.632 HD13 ' HB2' ' A' ' 169' ' ' LEU . 67.6 mt -52.73 -45.65 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.073 -1.421 . . . . 52.22 111.333 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 76' ' ' LEU . 53.7 t -94.04 -28.56 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.017 0.527 . . . . 74.21 112.063 -173.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.505 HD12 HG23 ' A' ' 35' ' ' VAL . 84.2 mt -75.66 -18.67 59.57 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 122.227 -0.296 . . . . 72.23 110.31 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -95.37 -55.82 2.92 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.388 0.675 . . . . 73.21 110.638 172.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -86.79 3.32 45.65 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.755 0.422 . . . . 62.01 112.1 -171.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.704 ' HE3' ' HG3' ' A' ' 142' ' ' GLU . 34.4 ttpt 58.03 35.36 25.15 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.897 0.856 . . . . 75.35 111.682 165.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' HB2' HG22 ' A' ' 71' ' ' VAL . 59.2 mt -74.52 141.59 44.85 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.021 -0.536 . . . . 75.32 110.438 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.184 0.594 . . . . 74.15 110.36 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.26 145.27 42.05 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.75 1.389 . . . . 74.24 114.75 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.55 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 80.3 mtp -141.91 134.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.616 1.966 . . . . 70.41 105.813 171.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.535 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.2 m-80 -93.77 138.17 32.24 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.915 0.325 . . . . 72.04 110.204 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 29.7 p -67.08 -21.7 65.86 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.528 0.331 . . . . 41.12 111.28 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 64.0 m-85 -58.23 -52.75 64.27 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.978 -1.01 . . . . 71.24 110.567 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -105.28 -36.85 7.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.147 0.979 . . . . 73.55 112.847 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -91.91 18.95 7.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.596 0.759 . . . . 64.51 112.701 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.07 98.87 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.45 0.568 . . . . 44.3 111.194 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -65.63 -45.25 83.76 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.265 1.026 . . . . 73.25 111.467 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.09 -38.8 92.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.562 -0.745 . . . . 64.51 110.797 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -75.99 -28.91 58.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.956 0.902 . . . . 75.42 111.035 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -68.59 -38.38 80.62 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.497 -0.557 . . . . 64.02 109.497 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.4 98.89 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.778 -1.101 . . . . 70.22 110.477 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -59.09 -45.63 90.35 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.547 -0.751 . . . . 65.33 110.616 173.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.47 -40.37 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.699 . . . . 55.15 111.688 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -63.29 -45.42 91.49 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.627 0.371 . . . . 75.25 111.531 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -73.08 -47.06 47.78 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.73 -0.668 . . . . 74.41 110.893 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -53.51 -44.82 69.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.032 1.733 . . . . 75.24 111.201 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.1 ttm -59.04 -53.58 56.8 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.079 0.862 . . . . 70.52 110.521 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.173 -0.921 . . . . 73.11 110.933 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.82 -47.47 46.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.572 0.749 . . . . 62.45 112.254 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 175' ' ' ALA . 31.0 m -69.54 -34.06 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.044 0.538 . . . . 54.45 112.14 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.52 -35.14 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 123.168 0.292 . . . . 63.34 110.585 176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.92 -46.16 88.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.471 0.709 . . . . 72.24 110.077 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -62.51 -48.86 77.71 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.51 -0.768 . . . . 64.31 110.687 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.551 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.7 tpt -61.93 -38.75 89.6 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.717 0.807 . . . . 61.34 111.053 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.588 ' HA ' HG11 ' A' ' 113' ' ' VAL . 43.4 tt0 -71.88 -38.89 69.94 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.274 1.03 . . . . 74.34 110.27 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -80.51 -27.45 37.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.59 0.356 . . . . 53.42 111.609 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.28 -36.29 27.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.018 0.527 . . . . 63.12 110.839 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -101.13 -49.26 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.196 0.598 . . . . 73.45 110.945 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 70.24 4.24 4.78 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.37 1.248 . . . . 52.34 114.37 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -99.44 117.89 34.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.984 -0.747 . . . . 74.13 108.984 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -50.76 -45.17 58.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.991 1.316 . . . . 70.04 112.189 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.45 66.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.017 0.527 . . . . 75.22 112.417 -173.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.99 -45.26 18.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.67 0.388 . . . . 73.4 110.137 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.588 HG11 ' HA ' ' A' ' 104' ' ' GLU . 33.7 m -71.65 -23.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 116.368 -0.378 . . . . 74.43 111.248 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.05 -43.89 91.74 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.51 0.724 . . . . 71.32 110.534 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.44 -46.3 76.91 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.902 0.751 . . . . 61.53 110.164 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -57.6 -48.13 80.26 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.34 0.656 . . . . 71.1 111.787 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.67 -30.65 67.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.648 -0.501 . . . . 74.14 109.648 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -61.16 -45.1 96.02 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.735 -0.839 . . . . 55.13 108.735 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HB3' HD22 ' A' ' 26' ' ' LEU . 3.1 mptm? -65.52 -46.46 79.51 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 75.21 110.875 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 172' ' ' VAL . 26.7 mm -66.83 -42.06 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 119.319 -0.372 . . . . 54.0 110.495 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -54.77 -57.29 12.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.776 0.831 . . . . 62.14 109.999 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.7 -38.35 95.76 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.748 0.655 . . . . 45.34 113.259 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -64.69 -53.28 49.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.904 0.882 . . . . 75.41 110.442 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 120' ' ' ILE . 34.0 m -70.57 -30.48 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 119.276 -0.392 . . . . 64.53 111.553 -177.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.53 -41.46 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 118.501 0.591 . . . . 62.43 110.328 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.6 t -65.84 -43.5 88.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 120.96 0.41 . . . . 63.5 109.922 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.528 HD21 HG21 ' A' ' 155' ' ' ILE . 21.1 tp -73.11 -30.08 63.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.662 1.185 . . . . 73.34 112.221 -169.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.55 3.07 45.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.448 0.699 . . . . 65.22 111.951 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -67.62 150.97 48.07 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.458 0.703 . . . . 73.24 111.217 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -93.45 -28.7 15.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.086 1.143 . . . . 74.2 114.086 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.08 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.117 0.872 . . . . 74.35 113.267 -165.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -110.81 -32.87 6.7 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.213 0.605 . . . . 72.41 111.296 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 98.1 m-85 -78.17 -1.23 31.7 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.489 0.716 . . . . 63.03 112.038 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -55.59 -20.99 15.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.167 -0.333 . . . . 75.41 111.133 160.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -82.48 17.28 1.79 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.704 1.201 . . . . 74.15 110.856 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 156' ' ' ILE . 93.3 mt -89.8 148.05 23.44 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.079 -0.711 . . . . 54.01 109.079 170.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.75 126.45 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.739 -1.578 . . . . 42.53 106.739 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 11.1 m-85 -91.37 134.12 34.87 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.617 -0.512 . . . . 63.52 109.617 -171.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.27 151.91 50.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.298 0.639 . . . . 71.11 109.293 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.4 pt -137.16 170.7 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.317 -0.994 . . . . 74.41 108.317 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.64 44.42 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.872 -0.491 . . . . 61.43 111.872 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.704 ' HG3' ' HE3' ' A' ' 75' ' ' LYS . 10.7 mm-40 -53.24 -43.15 67.11 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.32 1.048 . . . . 75.2 112.259 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.65 ' HG2' ' HB2' ' A' ' 12' ' ' GLU . 3.0 mmt180 -65.67 -37.37 86.32 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.332 0.653 . . . . 75.12 110.353 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -59.86 -58.6 7.85 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.044 0.84 . . . . 53.01 109.136 173.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.85 -17.96 63.67 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.997 0.919 . . . . 72.11 113.084 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.49 -41.03 40.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 63.31 110.997 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.67 -26.43 0.03 OUTLIER Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.369 -0.378 . . . . 31.11 113.591 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -72.86 177.11 5.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.062 0.431 . . . . 71.14 111.229 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.09 -172.61 2.31 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 122.153 -0.342 . . . . 74.33 110.68 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.34 -49.95 12.67 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.14 0.793 . . . . 52.41 113.14 -161.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.09 -98.58 0.17 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.235 -0.746 . . . . 71.35 111.235 -156.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -121.93 144.09 49.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.155 0.582 . . . . 74.22 110.104 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 155' ' ' ILE . 89.2 t -75.96 133.09 31.91 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 108.433 -0.951 . . . . 72.43 108.433 166.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.43 97.16 0.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.645 -0.872 . . . . 71.42 108.645 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.528 HG21 HD21 ' A' ' 127' ' ' LEU . 55.3 mt -85.87 101.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 108.515 -0.92 . . . . 72.32 108.515 -171.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 68' ' ' ILE . 36.1 mm -91.85 140.22 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.036 -0.727 . . . . 74.11 109.036 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.41 105.47 7.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.232 -1.025 . . . . 73.14 108.232 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -73.5 88.77 1.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.396 -0.964 . . . . 63.2 108.396 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -92.68 174.14 7.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.425 1.49 . . . . 74.12 108.85 -165.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.75 138.73 54.54 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.258 0.623 . . . . 74.43 110.575 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.32 102.63 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 124.401 1.081 . . . . 72.22 109.302 169.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.5 t70 62.46 24.96 14.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 124.266 1.026 . . . . 72.33 112.474 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.12 -14.02 33.85 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 121.797 -0.564 . . . . 72.13 113.008 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -94.78 122.23 37.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.524 0.729 . . . . 74.11 110.336 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.94 116.18 13.14 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-O 121.151 0.5 . . . . 73.44 110.047 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.21 93.68 46.42 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 115.07 -0.968 . . . . 64.03 110.523 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.474 ' HG3' ' HB ' ' A' ' 68' ' ' ILE . 11.4 Cg_endo -52.48 121.52 9.2 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.623 2.882 . . . . 75.3 112.498 167.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.6 p -107.99 117.13 33.34 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.374 1.07 . . . . 72.21 108.429 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 17.4 tp -80.17 117.57 21.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.416 -0.587 . . . . 75.33 109.416 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.469 ' SD ' HG11 ' A' ' 27' ' ' VAL . 30.7 tpp -100.96 120.82 40.73 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 107.205 -1.406 . . . . 62.42 107.205 -175.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.448 HD22 HD12 ' A' ' 176' ' ' ILE . 84.0 mt -143.77 143.87 31.56 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.656 1.182 . . . . 74.13 109.207 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.498 HG21 HD11 ' A' ' 120' ' ' ILE . 15.0 p -91.07 138.32 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.972 0.805 . . . . 74.53 109.763 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.54 -26.45 67.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.323 1.449 . . . . 53.31 112.011 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 172' ' ' VAL . 10.0 mp0 -86.14 -0.97 56.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.134 0.574 . . . . 60.14 112.343 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -120.0 -18.75 8.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.605 0.762 . . . . 32.51 110.553 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' A' ' 6' ' ' ASP . 3.3 mt -136.64 139.58 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.336 0.654 . . . . 65.41 110.219 -172.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 30.8 mm -142.17 139.59 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.449 1.1 . . . . 71.24 108.114 -171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.02 143.01 34.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.27 0.557 . . . . 74.54 109.992 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.7 tp10 -101.33 109.39 21.23 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.098 -1.075 . . . . 61.42 108.098 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -69.84 98.04 1.18 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.886 0.741 . . . . 73.13 109.951 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.7 t -108.16 91.63 3.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.274 -1.01 . . . . 51.13 108.274 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.36 173.8 14.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.037 0.535 . . . . 75.41 110.634 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.254 1.332 0 CA-C-N 114.923 -1.035 . . . . 72.55 108.552 178.822 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.529 ' HG3' ' SG ' ' A' ' 181' ' ' CYS . 26.2 ptt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.946 0.403 . . . . 70.53 110.212 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 180' ' ' LYS . 95.6 mt -118.72 159.82 22.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.505 0.722 . . . . 72.42 110.067 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 56.3 mt -126.8 118.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 106.996 -1.483 . . . . 65.25 106.996 171.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.768 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 5.6 t80 -101.4 113.94 27.48 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.015 -1.106 . . . . 73.13 108.015 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -125.59 117.13 22.9 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.131 0.972 . . . . 72.53 110.295 -167.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.87 134.83 48.36 Favored 'General case' 0 C--O 1.205 -1.285 0 N-CA-C 108.344 -0.984 . . . . 71.42 108.344 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 pt -66.39 -5.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 113.293 0.849 . . . . 75.43 113.293 -170.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -107.94 -46.72 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.736 -0.838 . . . . 71.41 108.736 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 p -111.82 18.66 18.71 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.827 1.251 . . . . 74.0 112.456 -173.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -46.94 -42.22 17.4 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.183 1.793 . . . . 71.21 113.545 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -55.95 -39.13 71.29 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.89 1.369 . . . . 73.54 112.543 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -120.61 11.32 11.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.176 0.591 . . . . 74.42 111.458 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -95.9 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 112.871 0.693 . . . . 55.03 112.871 -163.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.768 ' HB3' ' HB3' ' A' ' 4' ' ' TYR . 35.5 t -158.21 178.44 10.18 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.93 0.787 . . . . 31.21 111.367 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 33.0 p 163.32 104.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.691 1.597 . . . . 74.51 109.377 -168.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -171.59 161.07 6.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.572 0.749 . . . . 73.43 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -68.87 83.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.391 0.676 . . . . 72.41 111.316 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.61 ' HZ ' ' HB2' ' A' ' 4' ' ' TYR . 3.8 p90 -127.18 159.09 66.93 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.906 0.882 . . . . 62.41 110.275 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.97 120.86 3.08 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.134 1.89 . . . . 65.12 112.883 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.6 ' HB2' ' HE2' ' A' ' 28' ' ' TYR . 17.8 ptm -87.71 157.88 18.95 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.052 0.541 . . . . 73.21 110.527 174.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -152.03 145.63 24.95 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.038 -0.727 . . . . 51.03 109.038 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.55 125.78 52.88 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.502 -0.925 . . . . 70.42 108.502 173.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.19 129.81 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.281 0.632 . . . . 71.32 110.268 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.92 23.74 6.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.151 1.38 . . . . 64.23 113.992 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 t70 54.76 26.83 8.04 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.829 0.852 . . . . 65.33 112.054 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.531 HD13 ' HE2' ' A' ' 119' ' ' LYS . 64.7 tp -135.1 -51.17 0.77 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.991 0.901 . . . . 73.23 110.483 -170.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -120.41 148.7 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.888 -1.506 . . . . 74.5 107.885 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.6 ' HE2' ' HB2' ' A' ' 20' ' ' MET . 44.6 t80 -86.18 139.39 31.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.244 -1.021 . . . . 72.42 108.244 170.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -123.61 129.37 51.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.805 0.842 . . . . 74.42 109.695 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.729 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 48.8 t80 -114.31 124.68 52.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.128 0.571 . . . . 73.22 109.473 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.46 95.74 8.36 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.942 -0.762 . . . . 75.43 108.942 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.3 176.56 46.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.751 -0.659 . . . . 72.32 112.464 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -125.13 158.06 34.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.355 0.662 . . . . 72.43 109.629 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -90.59 117.57 29.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.194 -0.669 . . . . 61.01 109.194 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 72' ' ' LEU . 19.7 m -143.49 153.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.494 0.664 . . . . 71.1 110.098 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.6 127.53 66.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.544 -1.28 . . . . 52.42 107.544 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 10.7 tpt180 -105.3 108.55 20.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 106.677 -1.601 . . . . 73.23 106.677 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -106.26 96.59 6.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.895 -0.78 . . . . 70.4 108.895 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 46.64 58.46 4.63 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.087 1.355 . . . . 72.52 111.962 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.97 -33.09 3.86 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.937 -1.029 . . . . 74.34 113.657 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -93.19 116.16 28.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.45 1.1 . . . . 73.42 110.033 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.1 tt . . . . . 0 CA--C 1.55 0.947 0 N-CA-C 109.048 -0.723 . . . . 75.22 109.048 172.525 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 107.682 -1.229 . . . . 71.14 107.682 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.652 ' HB3' HD22 ' A' ' 72' ' ' LEU . 40.9 mt-10 -94.16 62.07 2.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.51 -0.768 . . . . 73.52 109.538 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -74.93 127.7 33.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.136 -0.938 . . . . 74.15 109.301 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.29 -134.74 3.65 Favored Glycine 0 C--N 1.343 0.919 0 O-C-N 123.512 0.508 . . . . 72.22 112.416 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 27.0 pt -111.9 151.75 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.86 0.864 . . . . 75.45 110.906 177.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.11 -35.1 74.5 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.366 1.066 . . . . 64.23 112.73 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 169' ' ' LEU . 47.7 mt -53.88 -46.53 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.56 1.144 . . . . 65.53 110.497 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 76' ' ' LEU . 55.1 t -75.97 -44.32 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 113.898 -1.501 . . . . 62.23 111.888 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.652 HD22 ' HB3' ' A' ' 65' ' ' GLU . 55.5 mt -66.16 -32.04 73.25 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.642 0.589 . . . . 71.32 111.18 -175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -58.94 -52.36 66.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.278 1.031 . . . . 75.51 111.846 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -89.42 -22.85 22.33 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 116.18 -0.463 . . . . 75.23 111.663 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 mmmp? 69.28 70.36 0.26 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.225 1.01 . . . . 75.32 109.836 -166.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.67 ' HB2' HG13 ' A' ' 71' ' ' VAL . 76.0 mt -85.66 151.74 23.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.8 -1.091 . . . . 73.31 109.269 173.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.689 HG11 ' HB2' ' A' ' 145' ' ' ALA . 11.3 p -90.54 138.43 19.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 N-CA-C 109.111 -0.7 . . . . 73.05 109.111 170.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.43 138.85 57.93 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.074 0.859 . . . . 74.11 109.922 166.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 33.7 tpp -132.42 103.03 5.98 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 105.572 -2.01 . . . . 73.03 105.572 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' HB2' ' A' ' 82' ' ' TYR . 20.7 t-20 -63.89 113.59 3.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.183 -1.826 . . . . 73.45 111.18 -170.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.407 ' SG ' ' CD2' ' A' ' 133' ' ' PHE . 41.5 t -59.05 -33.51 70.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.431 1.092 . . . . 65.2 111.345 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.44 ' HB2' ' OD1' ' A' ' 80' ' ' ASN . 60.8 m-85 -68.13 -29.65 68.61 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 113.919 -1.491 . . . . 75.14 110.75 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -104.87 -33.11 8.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.935 0.894 . . . . 51.31 112.445 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.32 19.52 15.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.314 0.646 . . . . 74.43 111.791 -162.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.59 72.52 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 112.205 0.446 . . . . 73.13 112.205 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.2 m -72.49 -43.89 63.03 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.275 0.63 . . . . 63.33 111.292 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 mmt -70.75 -29.72 66.03 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.463 0.305 . . . . 74.45 110.514 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.578 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 81.0 t80 -67.52 -32.67 73.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 45.11 110.172 173.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -64.61 -36.9 85.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.792 0.437 . . . . 73.21 110.002 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.12 82.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.065 0.546 . . . . 50.31 111.153 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.578 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 54.1 m-85 -69.85 -34.59 73.83 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 118.914 -0.565 . . . . 74.23 111.998 173.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.597 HG13 HD21 ' A' ' 128' ' ' LEU . 35.7 mm -66.11 -36.16 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.294 0.638 . . . . 74.2 110.577 174.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -57.52 -46.83 83.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.354 0.662 . . . . 73.0 111.11 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.58 -44.95 73.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.053 0.541 . . . . 71.33 110.704 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -47.78 -65.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.49 1.916 . . . . 73.43 111.078 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 70.9 mtp -63.09 -44.06 96.76 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.728 0.811 . . . . 74.15 111.384 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -57.85 -49.9 75.11 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.656 0.597 . . . . 72.15 110.97 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.08 -43.84 70.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.856 -1.066 . . . . 74.11 111.283 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 172' ' ' VAL . 34.3 m -69.18 -38.93 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 112.862 0.689 . . . . 63.32 112.862 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.45 -43.19 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.421 -0.585 . . . . 72.43 109.421 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 14.7 t70 -56.83 -41.09 77.25 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.231 0.957 . . . . 72.25 109.939 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -58.87 -48.07 82.7 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.386 1.074 . . . . 70.31 109.724 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.624 ' HB3' HG12 ' A' ' 113' ' ' VAL . 96.0 mmm -62.42 -36.18 81.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.338 -0.846 . . . . 74.33 111.263 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.07 -24.84 62.41 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.428 0.691 . . . . 73.21 111.494 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 29.5 mtpp -81.39 -49.89 10.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.923 0.489 . . . . 74.11 110.431 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -84.2 -14.03 51.16 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.302 0.641 . . . . 72.34 112.659 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -140.05 -59.64 0.54 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.108 0.413 . . . . 74.04 111.063 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 69.35 15.64 8.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.756 1.222 . . . . 75.44 112.479 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.16 114.58 19.17 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.473 -0.936 . . . . 63.55 108.473 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -57.24 -42.68 81.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.112 0.965 . . . . 73.32 112.249 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.17 87.87 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.571 0.544 . . . . 65.15 111.234 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.91 -42.44 48.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.32 0.648 . . . . 70.05 110.766 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' A' ' 103' ' ' MET . 33.0 m -72.83 -28.55 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.05 0.54 . . . . 70.22 110.67 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 26.5 t70 -67.95 -43.92 77.95 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 123.6 0.562 . . . . 75.53 109.889 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -42.51 94.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.698 0.624 . . . . 75.13 109.946 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -44.12 97.78 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.849 0.86 . . . . 72.2 110.918 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -39.02 85.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.07 0.948 . . . . 75.0 110.504 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 57.5 mtpt -71.87 -36.9 70.24 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.886 0.741 . . . . 72.44 110.885 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.531 ' HE2' HD13 ' A' ' 26' ' ' LEU . 60.1 mtpt -64.28 -44.45 91.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.045 0.538 . . . . 60.14 109.992 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.0 -44.56 96.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 C-N-CA 123.732 0.813 . . . . 75.21 109.897 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.423 ' O ' HG22 ' A' ' 125' ' ' VAL . 7.2 tp-100 -56.35 -51.11 69.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.022 0.929 . . . . 71.41 110.649 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.58 98.2 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.14 0.9 . . . . 61.21 113.264 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -62.91 -49.92 72.88 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.867 0.467 . . . . 73.43 109.746 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 32.9 m -67.21 -49.03 76.4 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.338 0 CA-C-O 117.531 -1.223 . . . . 74.12 110.488 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 121' ' ' GLN . 33.4 m -64.16 -31.16 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 120.107 1.321 . . . . 63.42 112.002 -176.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.7 m -72.09 -37.54 69.55 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.672 0.389 . . . . 71.12 110.361 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.563 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 40.5 tp -77.32 -26.06 51.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.316 1.046 . . . . 65.32 111.171 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.597 HD21 HG13 ' A' ' 92' ' ' ILE . 95.0 mt -85.45 2.51 44.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.39 1.076 . . . . 74.21 111.447 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.87 147.8 40.73 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.143 -0.688 . . . . 51.11 109.143 170.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 40.7 ttmt -69.29 -13.4 62.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.081 0.552 . . . . 71.21 111.212 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.2 -45.57 87.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.493 0.717 . . . . 61.23 110.068 168.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 5.1 mpt_? -78.38 -47.45 17.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.061 -0.972 . . . . 74.35 110.413 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.643 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.2 m-85 -57.84 -25.97 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.746 0.818 . . . . 54.15 112.673 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.12 -36.06 78.72 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.607 0.763 . . . . 63.44 110.905 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -104.62 -7.96 19.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.918 1.287 . . . . 71.05 111.281 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 63.1 mt -88.54 139.59 30.33 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.649 0.737 . . . . 72.34 110.939 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.66 124.81 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 105.798 -1.926 . . . . 61.41 105.798 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.568 ' HB3' HG11 ' A' ' 153' ' ' VAL . 21.8 m-85 -95.88 140.5 30.56 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.818 -0.808 . . . . 62.24 108.818 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -138.34 138.44 38.32 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.411 -0.589 . . . . 54.42 109.411 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.21 175.66 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.562 -0.903 . . . . 74.11 108.562 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.1 120.04 20.43 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.222 -0.751 . . . . 30.03 111.222 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.37 -18.31 16.9 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.312 0.856 . . . . 63.11 113.312 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -68.7 -40.42 80.0 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.376 0.671 . . . . 75.24 109.656 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 149' ' ' GLU . . . -80.41 -6.03 57.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.165 0.986 . . . . 63.14 112.491 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.689 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -70.16 2.17 3.97 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.698 0.799 . . . . 63.31 112.484 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -24.59 61.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.026 0.93 . . . . 71.53 110.448 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.01 -64.31 0.01 OUTLIER Glycine 0 C--N 1.354 1.579 0 CA-C-N 116.113 -0.494 . . . . 71.43 112.221 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -163.27 146.02 10.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.949 0.5 . . . . 73.44 110.628 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.454 ' HA ' ' HB1' ' A' ' 144' ' ' ALA . 10.9 tp10 -71.18 -41.29 70.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.115 0.566 . . . . 65.0 110.557 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.566 ' H ' ' HE1' ' A' ' 91' ' ' TYR . 80.0 m-20 59.99 44.12 13.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.016 0.926 . . . . 73.14 110.805 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.34 -150.9 5.77 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.03 -0.986 . . . . 63.33 110.827 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.63 140.36 31.35 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.716 -0.846 . . . . 75.44 108.716 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 138' ' ' PHE . 94.0 t -87.18 142.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.82 0.848 . . . . 53.33 109.897 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.79 97.51 0.16 Allowed 'General case' 0 C--O 1.245 0.821 0 N-CA-C 108.942 -0.762 . . . . 62.14 108.942 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.489 HG21 HD21 ' A' ' 127' ' ' LEU . 75.9 mt -85.31 101.58 9.94 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.916 -1.142 . . . . 73.23 107.916 -173.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.57 114.16 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.237 0.615 . . . . 72.34 109.39 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -112.23 103.77 11.94 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.459 -0.941 . . . . 74.42 108.459 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 6.5 p90 -81.73 94.45 7.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.754 -0.832 . . . . 74.42 108.754 -174.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -90.28 155.06 19.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.257 -0.645 . . . . 74.25 109.257 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -103.95 123.76 47.75 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 110.106 -0.331 . . . . 70.11 110.106 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.71 116.21 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.592 -0.892 . . . . 33.24 108.592 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.18 15.16 7.25 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.213 1.005 . . . . 63.24 112.285 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 94.78 25.33 15.37 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 121.887 -0.508 . . . . 74.53 112.892 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.3 m -121.74 130.61 53.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.497 0.719 . . . . 61.32 110.431 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.76 98.62 7.85 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.808 -0.812 . . . . 73.14 108.808 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.46 95.62 19.71 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.823 0.849 . . . . 74.31 109.796 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 59.9 Cg_endo -68.2 129.54 19.52 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 122.538 2.159 . . . . 44.34 111.389 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.8 p -109.85 110.2 21.09 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.797 -0.816 . . . . 62.55 108.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.729 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -79.1 112.54 16.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.456 -0.793 . . . . 75.33 109.382 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.47 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.0 mtt -100.83 122.32 43.22 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 107.876 -1.157 . . . . 73.14 107.876 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 mt -141.62 130.93 23.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.544 -1.65 . . . . 44.1 106.544 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 99' ' ' VAL . 3.9 p -69.09 137.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.005 0.522 . . . . 65.24 110.431 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tmpt? -60.27 -35.48 75.61 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 74.54 111.827 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -70.32 -6.01 32.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.429 0.9 . . . . 72.13 113.429 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.08 -6.37 6.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.223 0.609 . . . . 71.31 111.933 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.6 tp -124.98 143.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.433 0.635 . . . . 71.34 110.128 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 40.6 mm -130.93 110.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.449 -1.315 . . . . 70.34 107.449 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.87 127.46 42.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.138 -1.06 . . . . 64.42 108.138 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 23.5 mm-40 -115.04 114.75 25.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.382 0.673 . . . . 73.21 111.568 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' A' ' 2' ' ' LEU . 33.2 mtmm -83.4 96.68 8.62 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.465 0.706 . . . . 74.31 109.915 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.529 ' SG ' ' HG3' ' A' ' 1' ' ' MET . 9.3 p -108.84 88.95 2.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.959 -0.756 . . . . 63.24 108.959 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.17 -68.18 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.153 -0.93 . . . . 70.35 109.301 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 CA--C 1.552 1.02 0 C-N-CA 123.47 0.708 . . . . 71.12 110.204 -174.8 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB3' ' HA ' ' A' ' 16' ' ' ASP . 65.5 mtt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 62.22 109.471 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 180' ' ' LYS . 43.1 mt -115.42 146.92 41.16 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.3 0.64 . . . . 70.4 109.988 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 57.3 mt -95.8 119.61 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.242 -0.651 . . . . 71.21 109.242 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.454 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.0 m-85 -118.91 129.09 55.0 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.422 -1.325 . . . . 74.43 107.422 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.38 155.07 43.61 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.557 0.343 . . . . 72.33 111.08 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 10.3 t70 -101.14 144.62 29.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.597 0.759 . . . . 65.44 109.743 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.5 pt -81.33 -6.42 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 112.752 0.649 . . . . 65.12 112.752 -171.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -106.7 -64.02 1.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.172 0.804 . . . . 61.31 113.172 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.0 m -130.06 -25.33 2.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.828 0.677 . . . . 74.31 112.828 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 12.9 t0 -99.9 25.87 6.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.538 0.735 . . . . 51.25 110.759 -170.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.63 -20.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.101 1.519 . . . . 64.34 115.101 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.85 -37.61 19.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.258 -0.901 . . . . 72.52 111.052 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 31.5 tp 28.55 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.001 2.12 . . . . 73.54 114.243 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 67.6 m -157.94 121.88 4.12 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 72.44 109.58 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 45.3 p -113.7 67.46 0.67 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.776 0.798 . . . . 55.11 109.65 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 37.6 t70 -159.49 177.28 11.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.992 -1.004 . . . . 65.12 109.852 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 m -84.54 76.29 10.19 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.056 -0.72 . . . . 72.32 109.056 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 14' ' ' SER . 15.7 m-85 -100.58 139.16 20.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 115.276 -0.874 . . . . 72.44 110.748 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.9 118.7 5.66 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.693 2.262 . . . . 74.11 112.14 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -129.25 162.69 27.31 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.169 -0.923 . . . . 73.12 111.042 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -151.2 115.26 5.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.972 1.309 . . . . 70.14 107.649 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.8 113.28 24.17 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.624 -1.621 . . . . 65.0 106.624 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.87 132.12 51.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 C-N-CA 123.111 0.564 . . . . 65.42 110.056 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.0 t0 55.04 22.96 4.78 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 125.064 1.346 . . . . 70.21 112.719 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 t70 59.81 12.38 2.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.681 1.592 . . . . 71.04 112.65 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' HG3' ' A' ' 119' ' ' LYS . 55.3 tp -109.49 -51.88 2.83 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.523 -0.736 . . . . 62.14 111.214 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.64 126.03 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.571 -0.741 . . . . 73.43 109.987 -167.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -83.31 114.87 21.71 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.408 -1.33 . . . . 74.41 107.408 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 35.2 tt0 -112.68 119.49 38.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 65.15 110.316 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -105.4 107.12 17.93 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.999 -1.112 . . . . 75.12 107.999 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -77.06 153.13 34.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.616 0.366 . . . . 63.44 111.13 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.19 -163.88 12.1 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.285 -0.726 . . . . 74.21 111.285 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.02 136.72 34.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.356 0.663 . . . . 71.42 109.404 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 4.2 t60 -69.07 128.47 36.79 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.762 -0.829 . . . . 72.5 108.762 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 72' ' ' LEU . 13.9 m -147.28 178.57 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.407 0 C-N-CA 124.345 1.058 . . . . 74.14 109.711 -174.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 21.8 m -125.4 141.44 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 116.263 -0.426 . . . . 73.32 111.526 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 72' ' ' LEU . 9.6 mpt_? -105.23 105.54 15.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.368 -1.345 . . . . 62.24 107.368 165.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -127.45 125.23 40.15 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.864 -0.791 . . . . 74.14 108.864 -165.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.45 84.39 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.28 . . . . 63.32 111.406 -174.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -48.96 0.59 Allowed Glycine 0 C--O 1.239 0.46 0 CA-C-N 114.692 -1.14 . . . . 54.33 111.638 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -166.51 129.21 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.289 0.636 . . . . 73.0 110.158 -173.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tt . . . . . 0 CA--C 1.548 0.884 0 N-CA-C 109.265 -0.643 . . . . 72.01 109.265 174.409 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 119.435 -0.317 . . . . 71.42 111.202 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 36' ' ' VAL 0.298 8.4 pt-20 51.39 -70.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.336 2.254 . . . . 64.31 113.178 -163.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -74.16 111.6 9.49 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.702 0.801 . . . . 63.05 110.974 -161.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.16 -172.28 45.15 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.316 -0.945 . . . . 74.15 111.69 160.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 16.4 pt -96.06 150.65 4.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.004 -0.739 . . . . 63.41 109.004 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -56.06 -34.07 65.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 53.35 112.362 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 68' ' ' ILE . 61.8 mt -55.06 -51.37 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.389 1.076 . . . . 62.34 110.16 176.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 76' ' ' LEU . 30.6 t -75.02 -46.26 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.604 1.161 . . . . 64.12 112.224 -175.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 35' ' ' VAL . 80.5 mt -63.19 -37.17 86.19 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.046 0.841 . . . . 73.21 111.088 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -68.21 -47.0 69.05 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.986 -1.007 . . . . 65.5 109.204 174.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -80.55 -17.66 50.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.045 0.938 . . . . 64.42 111.957 -166.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 62.82 61.66 1.14 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.281 1.433 . . . . 71.43 111.044 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.622 ' HB2' HG13 ' A' ' 71' ' ' VAL . 83.8 mt -101.28 140.15 35.97 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.378 -0.828 . . . . 73.23 110.483 174.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.57 137.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.478 0.711 . . . . 65.53 109.219 171.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.45 157.06 24.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.454 1.121 . . . . 73.1 113.685 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 ttm -147.28 104.21 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.172 -2.159 . . . . 72.25 105.172 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.601 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 80.1 m-20 -101.87 124.94 48.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.331 -0.618 . . . . 52.22 109.331 -171.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.598 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 20.6 p -61.4 -11.14 9.12 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.109 0.964 . . . . 64.01 112.522 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.601 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 90.9 m-85 -53.5 -48.85 68.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.386 1.074 . . . . 72.1 111.461 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.95 -39.22 6.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.604 0.762 . . . . 74.43 110.571 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.16 20.39 3.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.408 1.083 . . . . 75.42 113.336 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.47 69.73 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.154 0.582 . . . . 65.21 111.614 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t -65.93 -38.72 89.39 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.972 0.909 . . . . 71.12 110.725 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.472 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.2 mpt? -69.25 -40.62 77.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.174 -0.921 . . . . 65.14 110.658 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -70.61 -31.9 69.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.571 0.748 . . . . 75.0 110.466 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -67.42 -35.23 78.85 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 61.14 111.113 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.27 95.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.202 0.601 . . . . 64.11 110.154 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.57 -34.37 74.07 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-N 115.567 -0.742 . . . . 64.13 111.79 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.78 -34.05 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.629 0.772 . . . . 72.12 111.281 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.01 -47.6 82.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.731 0.413 . . . . 74.14 110.607 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.63 -46.7 78.27 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.975 0.797 . . . . 53.34 109.681 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.454 ' O ' HG22 ' A' ' 99' ' ' VAL . 72.7 t80 -48.26 -64.84 0.68 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.011 1.724 . . . . 74.44 111.755 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 27.6 ttt -58.08 -48.61 79.61 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.409 1.068 . . . . 75.11 110.765 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -58.35 -51.43 69.85 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.035 0.835 . . . . 73.24 111.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -73.72 -39.32 64.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.659 0.599 . . . . 74.12 111.82 -168.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.0 m -67.2 -37.79 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 111.857 0.317 . . . . 70.24 111.857 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 113' ' ' VAL . 81.7 mt -71.6 -54.24 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.627 -0.509 . . . . 72.02 109.627 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.91 -33.18 70.26 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.533 1.533 . . . . 63.13 112.357 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -81.56 -52.63 7.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.262 0.625 . . . . 74.22 110.65 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.431 ' HG2' ' HG3' ' A' ' 174' ' ' GLU . 11.7 tpt -72.2 -31.47 65.92 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.85 0.315 . . . . 73.24 111.85 -167.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.36 -55.46 21.44 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.626 0.77 . . . . 71.01 112.351 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -82.32 -0.03 43.8 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.087 0.47 . . . . 61.55 110.412 -166.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -101.59 -36.35 8.8 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.174 0.99 . . . . 75.15 110.041 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -92.69 -78.66 0.41 Allowed 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.422 -0.808 . . . . 62.23 111.767 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.453 ' HB3' ' HB2' ' A' ' 112' ' ' ASP . 63.1 ttt180 -153.47 13.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.6 0.714 . . . . 73.53 112.337 -169.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.6 t70 68.94 -74.13 0.08 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.275 1.43 . . . . 75.45 113.059 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.04 -66.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 112.518 0.562 . . . . 74.02 112.518 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.87 87.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.087 1.143 . . . . 33.12 114.087 -162.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -73.53 -46.44 47.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.297 -0.41 . . . . 63.3 111.095 -170.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.622 ' HA ' ' HB3' ' A' ' 116' ' ' PHE . 13.6 m -76.24 -22.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 119.241 -0.409 . . . . 74.33 111.506 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.59 -55.09 34.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.165 0.586 . . . . 64.41 110.507 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.99 88.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.14 0.9 . . . . 73.44 110.244 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.622 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 18.9 t80 -61.96 -41.9 98.52 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.444 -1.253 . . . . 64.35 111.496 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -64.6 -41.47 96.21 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.906 0.482 . . . . 62.53 110.62 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.45 -42.79 95.77 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.088 0.868 . . . . 62.0 110.285 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.75 ' HG3' HD22 ' A' ' 26' ' ' LEU . 17.9 tppt? -72.91 -40.18 65.71 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.473 1.109 . . . . 71.12 111.755 -174.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.4 tp -76.45 -34.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.292 0.637 . . . . 72.43 109.51 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -61.37 -44.46 97.13 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 124.119 0.887 . . . . 62.41 109.138 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.34 -41.39 99.47 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.803 0.689 . . . . 64.32 112.836 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.63 -53.05 57.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.424 0.69 . . . . 75.13 110.703 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 18.7 m -63.61 -44.76 98.68 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.17 0 CA-C-O 118.298 -0.858 . . . . 75.14 111.432 -175.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.6 -38.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 119.205 0.911 . . . . 55.01 111.39 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 m -71.81 -31.09 66.19 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.901 0.48 . . . . 73.14 111.399 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.702 HD21 HG21 ' A' ' 155' ' ' ILE . 28.9 tp -82.96 -18.99 38.02 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 71.33 110.584 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.8 mt -91.95 3.24 55.64 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.895 0.878 . . . . 72.42 111.069 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.12 88.31 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.796 0.838 . . . . 71.3 110.474 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -58.24 -19.81 37.0 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.886 1.439 . . . . 61.2 114.886 -163.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.48 -40.77 95.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.636 0.774 . . . . 72.12 112.133 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -108.19 -37.2 6.09 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.348 0.594 . . . . 71.53 110.872 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.1 -2.36 48.0 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.187 0.995 . . . . 65.45 113.453 -168.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.34 -15.8 18.52 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 112.259 0.466 . . . . 72.45 112.259 163.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -103.31 26.72 8.0 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.785 0.834 . . . . 74.24 110.32 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.5 mt -86.63 133.18 33.72 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.862 -1.162 . . . . 73.12 107.862 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.73 109.3 21.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.723 -1.584 . . . . 72.3 106.723 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 42.5 m-85 -92.24 145.89 24.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.058 -1.09 . . . . 75.25 108.058 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 78.6 m-85 -140.51 146.36 38.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.21 0.529 . . . . 75.23 110.659 -175.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.441 HD13 ' HB3' ' A' ' 144' ' ' ALA . 2.1 pp -146.98 163.18 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.257 -1.757 . . . . 74.31 106.257 167.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.7 147.29 50.89 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.885 -0.886 . . . . 72.25 110.885 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.44 -25.32 50.17 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.92 0.86 . . . . 72.31 112.714 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -36.36 80.48 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.538 1.135 . . . . 51.11 111.129 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 150' ' ' ASN . . . -68.14 -42.69 79.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.985 0.914 . . . . 64.31 110.634 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.57 -0.69 47.98 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.252 -0.886 . . . . 75.01 112.36 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -90.89 -19.0 23.83 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.417 1.087 . . . . 71.44 109.922 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.74 45.89 1.17 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.006 -0.543 . . . . 61.35 111.811 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -156.7 108.44 2.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.462 0.705 . . . . 73.45 109.283 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 49.29 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.566 1.546 . . . . 71.23 113.712 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.55 ' HA ' ' HB1' ' A' ' 144' ' ' ALA . 17.6 m120 -61.25 -43.03 99.54 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.783 0.833 . . . . 71.2 111.282 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 58.53 -148.77 37.51 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 115.421 0.928 . . . . 51.01 115.421 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 138.64 31.31 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.011 0.924 . . . . 64.53 109.266 -174.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.0 t -82.73 123.91 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.134 0.574 . . . . 54.31 110.977 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.68 105.3 6.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.381 1.072 . . . . 70.21 109.294 170.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.702 HG21 HD21 ' A' ' 127' ' ' LEU . 74.9 mt -91.75 121.26 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.297 -0.631 . . . . 71.42 109.297 -173.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 169' ' ' LEU . 47.7 mm -109.08 114.84 47.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 110.048 -0.352 . . . . 73.34 110.048 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.89 118.27 36.59 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 124.244 0.965 . . . . 75.12 108.641 170.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 16.1 p90 -79.96 112.52 17.33 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.669 -1.604 . . . . 72.44 106.669 170.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -103.01 128.49 49.83 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.628 -0.508 . . . . 62.44 109.628 -173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.18 120.23 22.69 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.556 0.342 . . . . 70.01 110.872 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.23 107.17 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.422 1.489 . . . . 62.41 108.824 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 61.92 23.64 13.95 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.811 1.244 . . . . 65.55 112.783 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.22 65.3 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 113.867 0.307 . . . . 73.01 113.867 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.1 m -110.87 137.54 48.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.285 1.034 . . . . 74.15 108.834 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 9.0 pt-20 -72.95 145.61 46.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.167 0.439 . . . . 52.13 110.405 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.4 101.16 21.83 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 107.645 -1.242 . . . . 74.12 107.645 167.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.75 128.52 20.13 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.401 2.067 . . . . 71.43 112.299 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 53.1 p -121.0 118.43 29.82 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.227 -1.027 . . . . 72.42 108.227 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 tp -77.23 111.73 13.17 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.936 -0.764 . . . . 71.25 108.936 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 57.5 mtt -101.63 122.53 44.03 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.657 -0.868 . . . . 73.13 108.657 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.427 HD13 HD11 ' A' ' 176' ' ' ILE . 93.0 mt -136.65 143.43 43.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.752 -1.944 . . . . 72.2 105.752 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.93 138.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.063 0.847 . . . . 64.33 109.976 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.455 ' HB3' ' HZ3' ' A' ' 173' ' ' LYS . 4.3 ttpm? -58.38 -29.16 65.8 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.904 1.282 . . . . 71.04 112.272 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 103' ' ' MET . 11.1 mp0 -70.1 -26.32 63.93 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.606 0.763 . . . . 75.34 111.217 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.47 0.43 50.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 75.03 110.723 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.427 HD11 HD13 ' A' ' 171' ' ' LEU . 46.6 mm -121.16 125.05 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.301 0.64 . . . . 62.13 109.597 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mm -99.2 108.36 22.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.362 -1.347 . . . . 72.35 107.362 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.84 116.18 26.93 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.0 -1.482 . . . . 71.03 107.0 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -126.31 106.09 9.27 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.253 -1.388 . . . . 62.01 107.253 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.56 ' HA ' HD22 ' A' ' 2' ' ' LEU . 56.4 pttt -88.3 119.79 29.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.951 0.5 . . . . 72.02 110.904 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 34.6 t -78.25 89.84 4.32 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.803 0.841 . . . . 74.41 109.834 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.23 129.83 39.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.667 0.787 . . . . 42.24 110.516 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.883 0.873 . . . . 75.53 108.822 -179.476 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtm . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 120.656 0.265 . . . . 65.13 110.324 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 180' ' ' LYS . 32.6 mt -115.63 161.78 18.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.567 0.747 . . . . 72.41 110.969 -166.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.455 HG23 ' HB3' ' A' ' 179' ' ' GLU . 8.3 tt -105.75 130.16 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.962 -1.125 . . . . 74.42 107.962 169.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 9.1 m-30 -97.83 136.7 37.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.452 0.644 . . . . 73.15 111.711 -174.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HG3' ' HB ' ' A' ' 177' ' ' ILE . 15.3 ptmt -138.47 136.42 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.068 -1.424 . . . . 72.12 108.945 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.783 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 29.9 t70 -109.17 177.21 4.82 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.574 1.55 . . . . 62.32 110.54 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 pt -65.73 -43.07 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 123.921 0.888 . . . . 72.33 112.511 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -111.42 -51.67 2.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.368 1.067 . . . . 74.24 109.26 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -84.25 19.05 1.96 Allowed 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.026 -1.443 . . . . 62.22 110.666 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.783 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 13.0 t70 -44.37 -42.8 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.319 1.847 . . . . 64.22 113.608 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.25 -47.3 80.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.805 -1.543 . . . . 63.03 111.774 -173.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -124.41 27.35 7.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.634 0.774 . . . . 71.31 112.033 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.687 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 3.0 tm? -64.63 -79.68 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.079 -0.388 . . . . 72.44 110.327 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 75.1 m -153.32 -176.17 5.67 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.764 0.792 . . . . 74.51 111.348 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 t -151.34 95.12 2.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.943 -1.503 . . . . 70.2 106.943 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.94 95.65 0.06 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.206 1.402 . . . . 73.32 110.633 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 p -120.46 25.1 10.0 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.977 -1.49 . . . . 53.2 106.977 158.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -135.52 155.33 78.49 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.446 -1.252 . . . . 55.44 109.987 -171.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.08 120.11 7.27 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.843 1.695 . . . . 73.31 112.726 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.75 149.93 20.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.551 0.741 . . . . 74.24 110.324 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 66.6 mttm -136.18 144.97 45.25 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.508 0.723 . . . . 75.54 109.417 -173.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.0 tp -130.71 145.05 51.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.591 0.756 . . . . 72.03 109.485 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.98 133.87 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.468 0.707 . . . . 72.03 109.689 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 58.82 16.23 4.36 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.211 1.404 . . . . 72.53 113.681 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 47.25 26.56 0.71 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.536 1.135 . . . . 73.53 112.616 -167.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 119' ' ' LYS . 37.1 tp -119.94 -46.69 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.179 0.992 . . . . 72.34 109.937 -174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.81 126.54 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.115 0.566 . . . . 74.1 110.395 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.15 122.74 29.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.491 -1.3 . . . . 72.22 107.491 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 5.1 pt-20 -112.73 147.03 37.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.197 0.522 . . . . 74.22 110.118 170.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -131.49 105.08 7.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.369 -1.345 . . . . 63.43 107.369 166.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 167' ' ' PRO . 15.2 ptmt -82.01 103.64 11.79 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.11 -0.7 . . . . 74.41 109.11 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.42 ' H ' HD11 ' A' ' 70' ' ' ILE . . . -81.82 -157.4 19.46 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.042 -0.981 . . . . 63.53 112.09 176.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -124.12 161.3 25.92 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.806 0.842 . . . . 75.42 109.913 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -93.13 118.09 30.82 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.156 -1.053 . . . . 73.01 108.156 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 m -146.98 159.8 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.331 0.586 . . . . 62.11 111.42 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.7 m -133.88 132.57 56.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.181 -1.044 . . . . 63.31 108.181 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.62 149.67 43.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.132 -1.433 . . . . 74.13 107.132 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -133.86 132.06 39.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.628 -0.878 . . . . 74.21 108.628 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 65.17 12.49 8.03 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.097 1.359 . . . . 62.53 113.503 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.8 21.24 26.55 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 123.051 0.358 . . . . 24.2 112.481 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.44 127.27 43.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.271 1.028 . . . . 75.12 109.175 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp . . . . . 0 CA--C 1.556 1.19 0 N-CA-C 109.282 -0.636 . . . . 73.2 109.282 176.627 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 108.132 -1.062 . . . . 72.22 108.132 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.4 73.31 3.16 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.959 -1.126 . . . . 70.24 107.959 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -91.97 137.28 32.49 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.952 -0.567 . . . . 72.13 109.54 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.18 -122.72 2.75 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 112.15 -0.38 . . . . 62.11 112.15 170.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.457 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 42.2 pt -112.5 138.8 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.308 0.643 . . . . 54.43 111.648 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -47.8 -46.87 31.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.209 1.404 . . . . 55.44 113.765 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.446 HD13 ' HB2' ' A' ' 169' ' ' LEU . 57.6 mt -50.41 -46.13 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.382 1.073 . . . . 73.31 111.705 -174.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.25 -47.11 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.289 -0.869 . . . . 44.44 111.216 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 17.2 mt -64.2 -36.12 83.03 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.214 0.946 . . . . 70.01 110.517 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -60.98 -37.06 81.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.879 1.672 . . . . 34.11 110.803 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.549 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 26.3 m170 -106.89 -13.33 15.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.974 -1.012 . . . . 75.3 111.99 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 55.02 57.47 5.57 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.532 1.133 . . . . 72.22 111.488 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 74' ' ' HIS . 79.5 mt -84.64 146.13 27.64 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.651 0.78 . . . . 71.5 110.431 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.84 123.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 109.538 -0.541 . . . . 70.21 109.538 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -70.6 147.36 49.31 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.704 -1.135 . . . . 42.23 112.876 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 70.4 mtp -143.74 122.35 12.52 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.015 -2.217 . . . . 53.1 105.015 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -101.0 152.86 20.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.772 -0.58 . . . . 73.44 112.007 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 20.4 p -66.88 -23.97 66.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.616 0.766 . . . . 65.02 113.058 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -72.14 -43.67 64.32 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.922 0.489 . . . . 45.21 111.575 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.73 -48.19 3.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.333 0.653 . . . . 64.34 111.395 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.41 21.0 3.04 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.122 0.969 . . . . 73.32 112.432 -171.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.4 74.83 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.591 0.757 . . . . 51.23 112.584 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.6 t -74.04 -41.22 62.13 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.812 0.845 . . . . 72.32 110.794 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -61.55 -43.99 97.84 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.06 0.544 . . . . 63.43 110.049 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.631 ' HD1' HG21 ' A' ' 153' ' ' VAL . 46.5 t80 -58.83 -42.91 90.39 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.381 1.472 . . . . 74.23 111.086 176.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -58.93 -41.45 87.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.624 0.77 . . . . 72.22 110.369 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.36 88.84 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.349 0.66 . . . . 75.42 111.277 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.503 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 63.8 m-85 -59.6 -45.24 92.49 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.737 0.415 . . . . 61.54 111.371 171.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.43 -38.31 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.814 0.846 . . . . 73.42 111.0 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -58.18 -47.74 82.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.972 0.509 . . . . 60.44 111.476 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -65.71 -51.04 62.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.545 0.738 . . . . 74.34 110.656 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -49.98 -62.29 1.65 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.941 2.097 . . . . 72.31 111.655 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 48.2 mtm -64.6 -33.98 77.19 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.634 0.584 . . . . 71.12 111.04 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -60.58 -47.03 88.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.836 0.454 . . . . 74.32 110.076 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.31 -48.9 16.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.486 0.714 . . . . 54.34 110.57 -172.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.45 -40.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.363 0.265 . . . . 74.21 111.069 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 77.0 mt -71.19 -45.68 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 119.016 -0.516 . . . . 65.41 109.723 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 26.5 t70 -53.59 -47.69 69.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 123.882 0.873 . . . . 64.33 112.634 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -65.36 -43.18 91.6 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.757 0.423 . . . . 62.23 110.143 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.457 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 7.6 tpt -68.84 -26.07 64.97 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.653 -0.703 . . . . 63.13 110.048 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.642 ' HA ' HG11 ' A' ' 113' ' ' VAL . 1.7 tm-20 -76.4 -38.04 56.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.856 1.263 . . . . 75.14 109.787 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 64.7 mttm -67.15 -25.92 66.4 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.698 0.399 . . . . 71.24 110.61 174.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.17 0.68 53.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.087 0.955 . . . . 73.01 111.701 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -130.42 -53.43 1.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.439 0.695 . . . . 62.33 110.168 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 56.82 23.06 7.62 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.042 2.137 . . . . 72.03 112.854 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.48 -89.0 0.61 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.81 0.844 . . . . 63.01 109.564 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttp 173.13 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.648 1.179 . . . . 72.13 109.782 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.13 92.14 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.731 0.641 . . . . 52.23 112.731 -164.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.29 -48.54 17.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.765 0.426 . . . . 73.51 109.95 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 104' ' ' GLU . 35.0 m -70.39 -24.09 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.723 -0.671 . . . . 74.32 112.22 -174.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 23.0 t70 -65.43 -37.48 87.03 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.376 0.67 . . . . 73.54 109.865 172.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.425 ' O ' ' HD3' ' A' ' 119' ' ' LYS . . . -72.62 -49.49 31.64 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.876 0.735 . . . . 62.45 109.935 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -55.16 -47.92 74.48 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.885 0.474 . . . . 75.22 110.418 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -60.7 -46.59 89.82 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.387 1.054 . . . . 74.54 110.944 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -61.25 -43.89 98.14 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.009 0.818 . . . . 70.24 110.248 -174.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.474 ' HB3' HD22 ' A' ' 26' ' ' LEU . 5.1 mptp? -79.28 -36.91 39.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.501 -0.772 . . . . 51.42 111.337 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.1 tp -73.99 -38.22 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 118.751 0.705 . . . . 74.22 110.324 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.446 ' HA ' HG22 ' A' ' 124' ' ' VAL . 23.4 tm0? -72.32 -39.34 68.28 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 176.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.63 -39.21 97.08 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.513 0.508 . . . . 72.13 112.28 174.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -65.13 -51.42 61.33 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.504 0.722 . . . . 73.32 109.616 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.8 m -68.77 -42.12 82.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-O 118.936 -0.554 . . . . 75.22 111.04 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.1 -29.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 118.85 0.75 . . . . 74.13 110.605 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.3 t -77.81 -39.17 44.69 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.201 0.6 . . . . 71.23 110.882 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.694 HD21 HG21 ' A' ' 155' ' ' ILE . 35.0 tp -72.48 -29.45 63.65 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.521 1.128 . . . . 63.13 111.509 -174.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 38.0 mt -86.75 0.3 54.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.195 0.598 . . . . 73.52 111.123 -177.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.31 81.05 4.69 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.076 -0.713 . . . . 21.31 109.076 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 61.7 pttt -61.56 -6.1 2.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.875 1.27 . . . . 63.23 113.819 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -54.44 -42.72 70.9 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.955 0.902 . . . . 61.05 110.838 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -109.17 -37.98 5.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.285 1.034 . . . . 73.11 109.637 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.456 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 56.7 m-85 -79.26 -1.54 37.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.796 1.238 . . . . 72.14 114.15 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 30.3 ttmt -50.64 -12.74 0.11 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.1 1.148 . . . . 62.32 114.1 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 77.4 m-20 -82.29 22.09 0.86 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.745 0.818 . . . . 71.12 111.467 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 72.8 mt -89.23 136.95 32.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.171 0.588 . . . . 73.15 109.598 172.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.47 122.95 25.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.661 -1.607 . . . . 43.52 106.661 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -99.39 129.44 45.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.937 0.495 . . . . 54.53 109.8 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 96.6 m-85 -130.33 146.12 51.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.826 0.451 . . . . 74.52 110.525 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.37 170.26 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.933 0.493 . . . . 63.14 109.751 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.54 138.84 22.27 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.658 -0.701 . . . . 55.12 112.353 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -59.86 -47.47 85.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.7 1.2 . . . . 64.4 109.833 171.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -38.35 68.35 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.795 1.238 . . . . 73.23 111.206 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.02 -46.34 68.22 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.923 -1.035 . . . . 73.11 110.292 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.01 -3.25 51.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.352 0.661 . . . . 72.01 112.429 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.94 -41.66 14.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.258 0.623 . . . . 73.32 111.726 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.62 46.37 0.1 OUTLIER Glycine 0 N--CA 1.469 0.867 0 C-N-CA 121.271 -0.49 . . . . 73.25 112.839 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.93 -165.2 1.68 Allowed 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.154 0.982 . . . . 63.2 108.826 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -55.09 122.56 11.23 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.792 -0.818 . . . . 74.25 108.792 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -50.38 -31.04 13.68 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.957 1.411 . . . . 70.3 111.621 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 123.87 -174.39 16.77 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.797 -0.638 . . . . 53.0 112.902 172.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.442 HE22 HD22 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -121.4 164.79 16.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.926 1.291 . . . . 63.24 108.072 167.344 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.631 HG21 ' HD1' ' A' ' 88' ' ' PHE . 41.9 t -79.15 116.94 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.585 0.707 . . . . 71.13 111.77 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.35 106.17 5.85 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.071 -1.422 . . . . 62.4 107.908 161.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.694 HG21 HD21 ' A' ' 127' ' ' LEU . 54.8 mt -90.41 106.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.534 0.733 . . . . 71.02 110.236 -165.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 169' ' ' LEU . 44.9 mm -96.05 115.98 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.033 -0.358 . . . . 71.35 110.033 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -100.51 121.4 41.51 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.09 0.556 . . . . 74.53 110.0 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 32.6 m-85 -83.43 98.34 9.45 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.633 -0.877 . . . . 73.33 108.633 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -90.74 131.88 36.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.686 -0.857 . . . . 74.22 108.686 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.79 108.38 19.95 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.166 -0.679 . . . . 71.31 109.166 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.03 111.47 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 108.978 -0.749 . . . . 64.44 108.978 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.33 21.5 11.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.428 1.091 . . . . 71.43 112.826 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.19 31.17 14.83 Favored Glycine 0 C--N 1.347 1.144 0 C-N-CA 121.908 -0.187 . . . . 64.03 112.909 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -133.71 121.71 22.34 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.881 0.872 . . . . 64.34 109.326 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.92 126.65 30.45 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.545 0.528 . . . . 75.23 109.634 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.01 107.22 37.99 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 108.221 -1.029 . . . . 51.43 108.221 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 57.8 Cg_endo -68.15 127.57 16.14 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.677 2.252 . . . . 75.34 111.178 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 20.8 m -118.06 104.79 11.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.184 0.594 . . . . 71.25 109.845 -171.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 56.2 tp -78.01 106.19 9.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.621 0.769 . . . . 74.31 109.674 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.524 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.3 mtt -103.28 122.81 45.56 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.571 0.748 . . . . 73.41 109.139 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.442 HD22 HE22 ' A' ' 152' ' ' GLN . 85.9 mt -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.937 -1.875 . . . . 74.44 105.937 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 174' ' ' GLU . 14.0 p -83.09 143.71 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 108.047 -1.094 . . . . 62.21 108.047 173.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -48.56 -37.58 18.24 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.501 1.52 . . . . 64.21 111.707 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 8.7 tp10 -83.72 -0.52 51.18 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.688 0.795 . . . . 74.13 112.191 -175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -104.73 -33.29 8.5 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.545 0.738 . . . . 61.45 110.373 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.66 133.48 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.33 0.586 . . . . 74.31 110.285 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.418 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.8 mm -127.9 131.94 69.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 107.385 -1.339 . . . . 61.32 107.385 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.44 ' HB2' HD13 ' A' ' 2' ' ' LEU . 10.5 pt-20 -95.06 124.8 39.31 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.245 -0.65 . . . . 62.54 109.245 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.455 ' HB3' HG23 ' A' ' 3' ' ' ILE . 15.9 tp10 -108.4 125.54 51.85 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.841 -0.8 . . . . 65.54 108.841 175.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.453 ' HA ' HD22 ' A' ' 2' ' ' LEU . 13.8 mptt -71.28 154.25 41.78 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.746 0.818 . . . . 45.55 110.621 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 39.8 m -133.3 86.41 2.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.492 -0.559 . . . . 63.14 109.492 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -170.08 0.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.085 0.954 . . . . 71.0 112.149 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 . . . . . 0 CA--C 1.552 1.026 0 C-N-CA 123.573 0.749 . . . . 71.13 109.152 -178.679 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.933 -0.395 . . . . 72.52 109.933 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.16 123.32 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.649 -0.871 . . . . 51.51 108.649 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 179' ' ' GLU . 9.7 tt -96.82 119.95 45.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.6 0.714 . . . . 74.01 110.068 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -102.71 110.83 22.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.717 -1.957 . . . . 63.42 105.717 173.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -131.24 134.95 46.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.068 0.547 . . . . 74.42 111.736 -167.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.408 ' HA ' HD13 ' A' ' 176' ' ' ILE . 27.7 t70 -81.65 131.2 35.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.71 0.804 . . . . 71.32 109.751 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 175' ' ' ALA . 25.9 pt -77.94 -11.55 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 73.22 112.752 -171.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.569 ' HE1' ' HB1' ' A' ' 175' ' ' ALA . 9.0 m-85 -94.15 -64.68 1.05 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.082 0.401 . . . . 73.05 110.619 -172.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' HB3' ' A' ' 149' ' ' GLU . 3.2 p -132.08 -37.68 1.12 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.385 1.074 . . . . 72.32 113.702 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.34 23.56 8.26 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.048 0.939 . . . . 71.22 111.854 -162.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -46.35 -26.32 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 126.014 1.726 . . . . 73.11 115.027 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.91 27.58 0.87 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.367 1.067 . . . . 74.41 111.16 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.63 -73.69 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.735 1.614 . . . . 75.5 112.39 -173.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 m -152.15 131.87 13.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.973 0.509 . . . . 61.14 109.85 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 34.5 p -131.34 91.79 3.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.037 0.935 . . . . 75.41 108.942 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.426 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.0 t70 -168.31 177.55 5.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.594 0.757 . . . . 74.45 109.628 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 p -83.39 81.55 8.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.589 0.756 . . . . 53.31 109.344 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 36.9 m-85 -103.19 152.79 38.68 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 115.188 -0.915 . . . . 74.33 109.57 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -46.98 119.12 3.16 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.872 2.381 . . . . 61.44 112.83 173.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.7 tpt -112.26 120.93 43.44 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.224 -1.028 . . . . 71.31 108.224 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -142.44 116.62 9.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.764 -1.569 . . . . 74.23 106.764 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.9 tp -123.64 113.91 19.28 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.104 0.962 . . . . 73.12 108.606 -172.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.25 137.0 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.08 0.952 . . . . 52.54 109.649 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 56.09 18.98 3.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 125.417 1.487 . . . . 71.34 113.315 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.62 14.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.371 1.068 . . . . 73.23 112.113 -172.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 119' ' ' LYS . 37.2 tp -112.74 -51.28 2.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.62 0.768 . . . . 73.14 110.636 -168.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -116.15 122.09 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.534 -0.757 . . . . 61.45 109.708 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.59 113.06 21.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.851 -1.166 . . . . 62.1 107.851 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -103.99 107.62 18.6 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.016 0.926 . . . . 73.34 109.032 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 45.9 t80 -90.2 112.62 24.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.595 1.158 . . . . 64.2 109.159 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HE2' HG11 ' A' ' 166' ' ' VAL . 62.5 tttm -69.2 143.5 53.99 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.067 0.547 . . . . 72.33 110.546 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.19 -174.54 33.2 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 110.822 -0.911 . . . . 64.22 110.822 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 20.2 ptmt -134.43 151.56 51.26 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.477 0.639 . . . . 73.52 111.088 -173.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -75.39 125.21 28.53 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.303 -0.629 . . . . 73.52 109.303 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 HD12 ' A' ' 72' ' ' LEU . 4.7 m -150.85 155.99 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.211 1.404 . . . . 64.31 108.962 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.5 m -133.27 161.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.847 -0.798 . . . . 64.32 108.847 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -138.12 110.22 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.631 -0.877 . . . . 73.53 108.631 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -117.29 147.36 42.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.285 -1.005 . . . . 75.53 108.285 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -59.43 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.739 1.216 . . . . 55.0 111.106 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.25 -52.42 0.65 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.085 -1.416 . . . . 70.34 111.722 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -165.31 2.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.526 0.731 . . . . 74.54 112.122 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.4 tt . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 124.054 0.942 . . . . 72.31 110.51 -179.381 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 107.211 -1.403 . . . . 72.34 107.211 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' HG2' HD22 ' A' ' 72' ' ' LEU . 37.4 tt0 -93.34 75.5 4.54 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 107.795 -1.187 . . . . 64.4 107.795 172.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -89.01 144.76 25.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.553 -1.203 . . . . 72.32 110.589 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.01 -130.54 3.13 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.099 -0.8 . . . . 71.41 111.099 164.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 156' ' ' ILE . 20.4 pt -112.73 150.06 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 122.881 0.472 . . . . 74.14 111.212 168.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -41.17 -41.32 1.77 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 127.122 2.169 . . . . 72.35 113.146 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' A' ' 169' ' ' LEU . 66.9 mt -57.58 -55.32 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 124.336 1.023 . . . . 61.35 110.352 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG13 ' HB2' ' A' ' 76' ' ' LEU . 40.3 t -60.56 -44.91 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 114.407 -1.269 . . . . 63.34 111.215 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' HG2' ' A' ' 65' ' ' GLU . 19.1 mt -72.34 -35.8 68.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.418 -0.81 . . . . 61.05 111.127 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -72.04 -33.88 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.757 0.823 . . . . 72.11 110.83 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -97.7 -5.68 34.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.417 0.687 . . . . 74.11 111.64 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt 55.5 63.13 2.17 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.937 1.295 . . . . 73.24 110.683 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HB2' HG13 ' A' ' 71' ' ' VAL . 58.0 mt -100.52 135.35 42.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.713 -1.131 . . . . 64.52 109.367 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.75 130.35 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.519 -0.548 . . . . 75.1 109.519 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.98 134.32 43.08 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.804 -1.089 . . . . 61.35 111.902 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.4 mtp -145.56 103.84 3.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.853 1.661 . . . . 72.23 107.273 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.485 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 95.6 m-20 -86.05 149.98 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.522 -0.736 . . . . 63.43 109.691 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 138' ' ' PHE . 37.0 t -60.72 -20.38 61.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.625 -0.716 . . . . 74.24 111.812 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.485 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 95.1 m-85 -58.28 -57.72 11.65 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.331 1.053 . . . . 74.44 110.925 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -74.24 -35.14 63.83 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.274 -0.876 . . . . 73.2 111.851 -174.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -121.44 19.37 11.31 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 112.208 0.447 . . . . 64.12 112.208 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.39 -39.6 7.11 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.681 0.993 . . . . 51.42 113.681 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.0 m -65.98 -60.18 3.1 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.507 0.723 . . . . 55.22 111.378 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.2 mtt -76.75 -14.54 59.93 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.988 -0.551 . . . . 75.22 111.431 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.67 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 40.5 t80 -70.1 -38.51 75.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.21 0.604 . . . . 72.1 109.862 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -70.07 -26.15 63.88 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 110.216 -0.291 . . . . 75.04 110.216 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.3 72.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.012 -0.54 . . . . 70.12 110.785 170.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.67 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 33.1 m-85 -58.48 -44.86 89.53 Favored 'General case' 0 C--N 1.367 1.346 0 C-N-CA 123.205 0.602 . . . . 63.21 109.784 170.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm -64.15 -38.78 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.843 0.857 . . . . 54.24 111.613 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -60.02 -46.92 87.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.935 0.494 . . . . 64.44 111.713 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -66.49 -44.89 81.38 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 64.0 110.395 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -50.41 -59.31 4.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.204 1.802 . . . . 73.11 110.85 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 64.0 mtt -57.26 -57.45 12.57 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.164 0.915 . . . . 54.44 111.022 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.17 -30.69 71.23 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.285 0.366 . . . . 72.22 111.639 -173.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -78.34 -45.15 23.28 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.74 0.416 . . . . 72.23 110.991 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 175' ' ' ALA . 32.4 m -68.27 -28.8 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 123.196 0.31 . . . . 74.3 110.583 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' HE2' ' A' ' 103' ' ' MET . 52.6 mt -75.04 -45.36 42.68 Favored 'Isoleucine or valine' 0 C--N 1.359 0.978 0 C-N-CA 123.431 0.692 . . . . 73.53 110.307 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.63 -31.87 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.444 0.698 . . . . 52.33 111.337 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -69.78 -61.35 1.82 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.984 0.914 . . . . 73.24 109.811 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.441 ' HE1' ' O ' ' A' ' 113' ' ' VAL . 21.9 ptt? -64.5 -50.31 67.89 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.66 0.6 . . . . 52.44 111.444 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.82 -20.93 66.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.348 0.659 . . . . 71.43 111.991 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -72.64 -25.73 61.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.387 0.675 . . . . 75.22 110.388 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.57 0.09 12.58 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.799 0.84 . . . . 62.43 111.538 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -120.02 -74.11 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.158 0.583 . . . . 65.51 110.206 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 50.08 18.78 0.41 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.548 1.939 . . . . 72.44 115.131 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.86 -22.64 49.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.249 0.62 . . . . 71.4 110.001 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 113' ' ' VAL . 86.0 tttt 84.15 -38.76 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.148 1.779 . . . . 70.35 111.73 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.89 62.79 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.227 0.467 . . . . 75.3 110.637 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -86.2 -44.55 12.09 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.938 0.895 . . . . 74.25 111.742 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 110' ' ' LYS . 33.5 m -78.03 -34.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.139 -0.482 . . . . 73.44 111.564 -174.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.72 -25.3 56.49 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.701 -0.481 . . . . 72.12 109.701 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.7 -47.98 57.01 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.351 0.66 . . . . 63.12 109.691 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -61.85 -47.69 83.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.216 1.006 . . . . 74.24 110.828 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.56 -36.18 79.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.195 0.998 . . . . 72.32 110.786 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.72 -46.17 83.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.66 0.784 . . . . 73.43 109.939 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HB3' HD22 ' A' ' 26' ' ' LEU . 34.4 mmtp -66.49 -37.75 85.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.465 -0.789 . . . . 72.55 111.107 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 124' ' ' VAL . 22.7 mm -73.24 -36.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.82 0.848 . . . . 63.23 110.682 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.422 ' O ' HG23 ' A' ' 125' ' ' VAL . 22.4 tm0? -61.32 -52.51 64.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.744 -0.835 . . . . 73.1 108.744 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.67 -37.44 94.37 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.66 -0.7 . . . . 65.23 112.325 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -62.51 -55.32 28.57 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.1 0.96 . . . . 74.35 110.743 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.507 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -67.23 -41.15 86.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-O 118.402 -0.809 . . . . 75.12 111.151 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 121' ' ' GLN . 88.2 t -60.3 -42.52 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.095 0.861 . . . . 63.11 110.787 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -70.24 -31.4 68.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.883 0.473 . . . . 61.15 111.311 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 155' ' ' ILE . 31.9 tp -84.03 -21.65 31.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.058 0.943 . . . . 64.02 111.342 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -92.88 -0.37 57.25 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.694 0.797 . . . . 55.1 111.589 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.82 101.32 0.19 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.09 0.556 . . . . 51.45 110.487 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 15.3 ptmm? -61.77 -12.41 16.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.962 1.305 . . . . 64.14 114.432 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.68 -46.46 82.33 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.829 0.452 . . . . 63.15 111.113 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -110.13 -40.36 4.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.242 1.017 . . . . 75.35 109.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -81.58 -3.47 53.39 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.233 1.013 . . . . 65.41 112.608 -167.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 61.1 tttm -46.09 -31.01 2.11 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.423 1.089 . . . . 75.2 111.895 160.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -97.57 26.66 4.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.332 1.053 . . . . 54.13 111.596 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 mt -88.69 140.61 29.28 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.214 -0.662 . . . . 61.52 109.214 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.55 112.34 25.03 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.401 -1.333 . . . . 71.14 107.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.405 ' HE2' ' HB2' ' A' ' 81' ' ' CYS . 76.7 m-85 -99.71 140.35 34.05 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.579 -0.897 . . . . 72.54 108.579 -175.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . 45.5 m-85 -131.84 150.04 52.27 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.953 -1.128 . . . . 74.21 107.953 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.2 tt -124.13 141.05 45.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 107.948 -1.13 . . . . 75.11 107.948 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.32 138.61 47.69 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.014 0.822 . . . . 62.41 111.904 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 49.0 tt0 -43.31 -54.21 4.77 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.178 0.991 . . . . 74.4 112.18 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -64.24 -38.35 90.74 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.9 0.75 . . . . 64.3 111.29 -172.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.25 97.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.717 0.807 . . . . 14.42 110.924 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 -16.28 56.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.401 1.08 . . . . 64.11 113.215 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 42.3 mt-10 -64.27 -31.41 72.61 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.775 0.43 . . . . 73.32 111.693 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.19 51.86 0.03 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.739 -0.944 . . . . 35.04 110.739 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.72 -170.18 2.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.778 0.831 . . . . 74.54 110.314 -173.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.494 ' HB3' HG23 ' A' ' 9' ' ' THR . 12.7 tp10 -51.18 142.83 11.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.461 1.104 . . . . 72.34 111.53 173.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -50.98 -26.46 6.04 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.779 1.77 . . . . 71.12 115.779 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.66 176.54 21.43 Favored Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.051 0.219 . . . . 73.45 112.902 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.07 127.16 33.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 106.758 -1.571 . . . . 63.43 106.758 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 155' ' ' ILE . 67.9 t -74.63 113.7 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.322 -0.622 . . . . 65.22 109.322 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 139' ' ' PHE . . . -64.81 97.09 0.2 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.62 1.168 . . . . 73.22 109.654 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.659 HG21 HD21 ' A' ' 127' ' ' LEU . 85.2 mt -88.15 102.73 12.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 108.538 -0.912 . . . . 75.13 108.538 -172.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.629 HD12 HD11 ' A' ' 68' ' ' ILE . 41.0 mm -95.56 114.29 31.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 116.255 -0.43 . . . . 54.31 109.967 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.71 130.18 54.89 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.406 -1.27 . . . . 74.2 108.313 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.3 p90 -83.12 124.41 30.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.992 -1.484 . . . . 62.44 106.992 173.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -116.14 135.74 53.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.635 -1.246 . . . . 64.14 107.635 -171.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.11 115.39 28.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.032 -0.729 . . . . 44.14 109.032 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.6 107.64 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.952 -0.759 . . . . 73.31 108.952 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 63.97 30.63 14.1 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.416 1.086 . . . . 64.12 110.734 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.94 25.03 75.71 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.59 -0.732 . . . . 54.42 113.038 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.1 m -108.34 134.85 50.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.612 0.765 . . . . 61.23 109.129 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -73.14 111.43 8.25 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.888 -0.782 . . . . 73.44 108.888 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.422 HG11 ' HE2' ' A' ' 31' ' ' LYS . 27.0 m -128.63 88.07 53.16 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 121.845 0.831 . . . . 74.15 108.98 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 80.6 Cg_exo -55.37 121.4 9.86 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.788 2.325 . . . . 71.4 111.989 168.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.6 t -115.28 140.07 49.42 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.347 1.059 . . . . 71.24 109.098 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.7 tp -91.75 114.54 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.712 1.205 . . . . 73.41 108.967 176.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 81.1 mtp -93.84 123.04 36.93 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 107.568 -1.271 . . . . 61.35 107.568 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.578 HD13 HG21 ' A' ' 176' ' ' ILE . 94.0 mt -132.84 141.26 48.36 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.629 1.572 . . . . 64.24 107.511 -177.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.2 p -80.87 133.7 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.471 -0.937 . . . . 71.33 108.471 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -66.29 -19.62 65.87 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.431 0.692 . . . . 75.41 112.254 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.38 -30.43 47.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.768 0.318 . . . . 71.42 111.48 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.569 ' HB1' ' HE1' ' A' ' 8' ' ' PHE . . . -104.21 -10.16 18.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.092 0.557 . . . . 72.31 111.678 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 171' ' ' LEU . 36.1 mm -126.25 108.34 19.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.787 -1.561 . . . . 62.31 106.787 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.2 mm -95.04 113.18 28.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.288 -0.869 . . . . 73.35 109.596 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.37 135.84 44.31 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.434 -1.321 . . . . 75.23 107.434 166.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.616 ' HB3' HG23 ' A' ' 3' ' ' ILE . 36.9 tt0 -149.19 134.74 18.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.818 0.342 . . . . 73.12 110.235 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.588 ' HE3' HD11 ' A' ' 182' ' ' LEU . 37.8 tttp -81.14 112.42 18.48 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.45 -0.945 . . . . 61.31 108.45 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.75 92.36 3.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.887 -0.783 . . . . 65.24 108.887 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.588 HD11 ' HE3' ' A' ' 180' ' ' LYS . 48.1 mt -98.74 152.96 19.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.094 0.558 . . . . 53.22 110.88 -174.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 CA--C 1.557 1.222 0 C-N-CA 122.892 0.477 . . . . 71.24 110.389 178.577 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.924 -0.769 . . . . 75.24 108.924 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.516 HD12 ' SD ' ' A' ' 20' ' ' MET . 84.0 mt -133.16 153.07 51.86 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.143 -0.688 . . . . 61.25 109.143 175.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.626 HG23 ' HB3' ' A' ' 179' ' ' GLU . 4.4 tt -114.49 116.74 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.906 -1.516 . . . . 55.32 106.906 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 5.2 m-85 -100.97 130.93 47.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.26 -1.385 . . . . 73.3 107.26 -174.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.96 161.7 19.76 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.289 1.036 . . . . 71.32 109.638 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 35.3 t70 -116.02 178.06 4.46 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.383 1.073 . . . . 65.13 109.743 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.96 -39.27 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 CA-C-O 121.348 0.594 . . . . 71.54 110.306 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -110.93 -55.25 2.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.679 1.192 . . . . 63.32 110.002 -168.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.495 ' HB ' HD23 ' A' ' 13' ' ' LEU . 3.7 m -90.06 15.74 9.6 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 113.755 -1.566 . . . . 72.44 111.234 -168.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.7 p-10 -63.2 -7.11 5.21 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 114.603 1.334 . . . . 75.35 114.603 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -48.82 -50.98 31.93 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.403 1.064 . . . . 72.23 111.393 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -123.35 -40.54 2.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.017 0.927 . . . . 72.11 109.144 164.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.495 HD23 ' HB ' ' A' ' 9' ' ' THR . 2.0 tm? 42.9 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.294 1.837 . . . . 73.23 111.67 -167.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.406 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 67.1 p -155.26 154.49 32.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.66 0.784 . . . . 51.15 110.783 175.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.1 m -163.16 96.35 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.959 0.904 . . . . 73.21 110.468 -171.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -179.16 172.77 1.21 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.612 1.165 . . . . 63.31 108.912 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -38.8 -55.1 1.55 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.466 1.106 . . . . 73.21 111.355 165.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 14' ' ' SER . 9.7 m-30 43.07 108.29 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 125.924 1.69 . . . . 71.43 114.84 174.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.92 121.04 9.29 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 121.951 1.767 . . . . 75.11 110.951 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.516 ' SD ' HD12 ' A' ' 2' ' ' LEU . 44.4 mtm -101.28 150.45 22.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.128 0.971 . . . . 72.42 109.718 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -156.76 134.27 10.74 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.113 -0.699 . . . . 71.44 109.113 171.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.73 122.55 47.44 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.18 -1.045 . . . . 44.44 108.18 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.52 135.19 52.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.465 0.706 . . . . 71.42 110.082 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 60.5 14.18 4.66 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.678 1.191 . . . . 71.15 112.536 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 48.58 33.84 4.47 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.547 1.139 . . . . 74.24 111.67 -171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 119' ' ' LYS . 32.8 tp -125.81 -52.47 1.56 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.236 -0.893 . . . . 72.13 109.632 -175.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.1 t -114.13 128.9 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.281 -0.872 . . . . 71.23 109.226 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.88 112.84 21.52 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 106.829 -1.545 . . . . 65.22 106.829 166.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -104.43 145.06 30.81 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.175 -0.676 . . . . 62.15 109.175 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -142.93 105.48 4.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.484 1.114 . . . . 72.42 108.411 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.67 149.22 26.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.348 0.659 . . . . 65.4 110.415 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.97 -161.76 9.53 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.88 -1.055 . . . . 74.14 111.262 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 139.83 51.02 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.76 0.824 . . . . 72.14 109.891 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -73.76 115.81 13.63 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.71 -1.132 . . . . 74.51 109.236 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -147.45 -175.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.721 1.208 . . . . 71.21 109.792 -170.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 m -113.16 161.05 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.448 0.699 . . . . 72.31 110.909 173.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 60.6 ttt180 -136.3 112.18 9.55 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.666 1.186 . . . . 72.42 108.366 174.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HD2' HG22 ' A' ' 64' ' ' VAL . 52.0 tttm -135.66 96.73 3.5 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 47.7 -81.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 126.326 1.851 . . . . 74.52 112.987 -173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.15 26.13 0.31 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.856 -0.898 . . . . 71.41 110.856 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.32 98.14 4.02 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.689 1.596 . . . . 45.44 107.182 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.7 pt . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 121.215 0.531 . . . . 71.23 110.99 -176.026 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.41 HG22 ' HD2' ' A' ' 38' ' ' LYS . 46.2 t . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 109.157 -0.683 . . . . 55.12 109.157 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.8 mp0 -78.26 82.06 4.59 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.313 -0.995 . . . . 73.34 108.313 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -76.11 146.37 39.33 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.982 -0.747 . . . . 75.34 108.982 168.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.33 -136.7 5.54 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.644 -0.582 . . . . 61.21 111.644 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.784 HD11 HD12 ' A' ' 70' ' ' ILE . 2.1 tt -104.31 126.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.627 1.171 . . . . 41.34 109.026 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.26 -29.46 33.06 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.188 1.395 . . . . 64.03 113.502 -172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.784 HD12 HD11 ' A' ' 68' ' ' ILE . 56.5 mt -61.53 -44.87 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.428 1.091 . . . . 53.02 110.048 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 76' ' ' LEU . 44.0 t -74.68 -41.79 47.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-N 114.179 -1.373 . . . . 73.14 110.268 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 35.2 mt -67.2 -24.09 65.81 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.668 0.605 . . . . 72.23 110.914 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -62.36 -61.11 2.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.635 1.174 . . . . 60.31 110.513 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -87.01 -20.17 27.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.729 0.812 . . . . 72.32 111.227 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 41.2 ttmt 66.38 69.62 0.42 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.042 1.337 . . . . 73.45 109.124 -168.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.586 ' HB2' HG13 ' A' ' 71' ' ' VAL . 70.4 mt -80.44 136.34 36.32 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.255 -1.017 . . . . 62.42 108.255 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.91 130.28 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.09 -0.707 . . . . 74.51 109.09 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.47 148.54 37.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.039 . . . . 72.1 112.59 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 56.2 ttp -148.69 134.42 18.85 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.239 -1.346 . . . . 65.42 107.657 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -119.09 142.69 47.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.091 0.556 . . . . 43.02 109.645 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.6 -11.92 48.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.711 0.805 . . . . 52.41 111.753 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -80.25 -34.63 36.95 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.973 0.909 . . . . 65.11 111.424 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -103.06 -37.22 7.86 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.172 0.511 . . . . 54.14 110.635 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.4 20.4 16.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.315 1.046 . . . . 71.11 111.925 -169.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -44.77 -43.48 8.61 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.748 1.219 . . . . 71.12 113.57 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.3 t -65.62 -52.04 55.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.057 0.943 . . . . 63.53 111.353 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.1 mpt? -68.63 -42.29 78.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.967 0.907 . . . . 62.33 110.688 -173.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.465 ' HE1' HG11 ' A' ' 153' ' ' VAL . 51.5 t80 -63.04 -41.87 99.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.766 1.226 . . . . 73.34 111.236 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -65.28 -36.56 84.47 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.212 0.605 . . . . 73.23 110.637 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.79 87.52 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.787 -0.642 . . . . 64.22 110.307 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -65.03 -45.63 84.66 Favored 'General case' 0 C--O 1.193 -1.874 0 CA-C-O 118.571 -0.728 . . . . 75.31 110.808 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.25 -43.08 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.36 0.664 . . . . 64.44 111.67 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.81 -49.07 78.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.702 0.801 . . . . 71.42 111.26 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -79.5 -38.25 34.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.256 0.622 . . . . 71.32 111.173 -173.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -50.99 -53.75 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.632 1.573 . . . . 74.13 110.387 170.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.9 ttp -53.79 -55.87 22.62 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 124.184 0.927 . . . . 74.4 110.14 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.36 -36.67 66.57 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.48 1.112 . . . . 63.14 112.186 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.09 -41.53 18.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.026 0.931 . . . . 71.41 111.936 -169.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -76.88 -27.74 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.673 0.389 . . . . 62.21 111.916 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.467 HD13 ' HG3' ' A' ' 117' ' ' LYS . 84.8 mt -73.05 -36.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.312 0.645 . . . . 64.5 109.303 171.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.59 -44.89 95.19 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.892 0.877 . . . . 65.22 110.562 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -63.2 -44.44 95.36 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.666 -0.697 . . . . 64.12 110.106 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.494 ' HG2' ' HB2' ' A' ' 107' ' ' ASN . 22.9 ttt -66.82 -40.05 87.91 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.258 -0.883 . . . . 64.32 111.329 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.562 ' HA ' HG11 ' A' ' 113' ' ' VAL . 7.6 tp10 -55.27 -40.67 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.563 1.145 . . . . 64.25 111.556 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -37.3 74.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.085 -0.961 . . . . 65.11 111.439 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -115.07 0.74 13.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.16 0.584 . . . . 64.34 111.62 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 103' ' ' MET . 18.3 m120 -148.7 41.99 0.96 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.257 1.023 . . . . 63.52 109.22 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.73 10.68 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.697 1.599 . . . . 61.42 113.632 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.69 -24.37 21.64 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.934 1.294 . . . . 72.45 112.005 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? 89.72 -58.01 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.666 1.986 . . . . 74.4 112.483 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.91 63.18 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.1 0.409 . . . . 55.1 110.933 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.01 -45.89 25.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.09 0.956 . . . . 54.1 111.049 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 104' ' ' GLU . 8.0 m -76.03 -26.92 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.716 0.406 . . . . 74.42 111.571 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.43 -36.37 73.93 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.447 0.699 . . . . 72.45 110.345 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.93 81.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.701 -0.681 . . . . 74.34 110.399 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.485 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 79.3 t80 -63.07 -41.99 99.57 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.444 1.098 . . . . 55.33 110.331 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.467 ' HG3' HD13 ' A' ' 100' ' ' ILE . 35.5 ttpt -63.9 -38.29 90.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.133 0.973 . . . . 72.42 110.478 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -67.19 -41.5 85.75 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.884 0.874 . . . . 70.31 110.005 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.596 ' HB3' HD22 ' A' ' 26' ' ' LEU . 87.9 mttt -67.24 -39.8 86.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.415 -0.811 . . . . 75.24 111.034 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 124' ' ' VAL . 23.3 mm -67.72 -47.05 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.468 0.707 . . . . 72.13 109.731 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -51.9 -51.83 54.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.666 1.186 . . . . 75.4 110.41 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.76 -38.12 89.35 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.776 -1.102 . . . . 64.22 113.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -65.43 -54.83 22.9 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.354 0.662 . . . . 64.34 110.463 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.5 m -66.5 -42.04 89.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 118.35 -0.833 . . . . 64.22 111.208 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.47 -35.98 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 119.505 1.048 . . . . 71.11 110.871 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.1 t -74.3 -38.01 63.49 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 123.481 0.712 . . . . 64.21 110.956 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.39 -19.04 39.9 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.787 0.835 . . . . 71.33 111.128 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.4 mt -93.7 2.22 56.35 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.142 0.577 . . . . 74.41 111.398 174.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 91.58 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.326 0.584 . . . . 64.11 109.843 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -59.12 -8.28 1.47 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.336 1.455 . . . . 75.22 114.685 -168.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.32 -46.59 72.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.928 0.891 . . . . 75.55 110.333 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -109.29 -39.09 5.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.964 0.906 . . . . 75.1 110.435 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -79.23 -1.89 38.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.595 1.158 . . . . 70.42 113.248 -163.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -51.89 -24.75 6.71 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 122.858 0.463 . . . . 64.41 111.615 160.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -93.92 29.63 2.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.753 1.221 . . . . 64.31 110.351 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.3 mt -94.02 153.43 18.18 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.919 -0.771 . . . . 73.11 108.919 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.58 117.42 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.272 -1.381 . . . . 72.12 107.272 172.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.57 ' HD1' HG22 ' A' ' 155' ' ' ILE . 50.1 m-85 -94.12 140.78 29.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.142 -1.058 . . . . 65.24 108.142 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 83.6 m-85 -136.46 153.81 50.95 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.774 -0.454 . . . . 74.32 109.774 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 tt -143.71 149.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.857 -1.164 . . . . 73.52 107.857 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.08 123.94 34.15 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.293 -0.723 . . . . 73.31 111.293 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -55.22 -34.01 63.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.825 0.85 . . . . 70.14 112.499 -177.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -66.39 -43.13 86.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.963 0.905 . . . . 75.21 110.196 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.24 -35.62 80.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.312 -0.858 . . . . 65.31 110.189 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.46 -12.43 57.84 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 64.1 112.143 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -95.63 -40.74 9.26 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.356 0.662 . . . . 55.44 111.065 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.18 49.62 0.28 Allowed Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.126 -0.488 . . . . 74.32 112.588 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.75 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -158.22 -179.77 8.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.696 0.798 . . . . 62.22 109.91 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.7 155.35 48.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.102 0.561 . . . . 71.35 111.055 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 67.61 20.38 9.65 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.078 1.351 . . . . 64.15 113.315 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.72 144.73 33.87 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.118 0.261 . . . . 72.5 112.868 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -69.93 139.55 52.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.767 0.827 . . . . 64.43 112.302 -168.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.465 HG11 ' HE1' ' A' ' 88' ' ' PHE . 31.7 t -88.51 94.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.578 -0.737 . . . . 75.12 109.544 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.15 104.24 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.158 -0.928 . . . . 75.41 108.588 169.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.57 HG22 ' HD1' ' A' ' 138' ' ' PHE . 1.1 pt -95.12 113.68 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.421 0.629 . . . . 61.13 109.919 -168.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 169' ' ' LEU . 50.8 mm -107.09 133.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.8 -1.091 . . . . 61.22 110.207 -170.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 45.7 mt-10 -94.41 142.26 27.63 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.861 -0.792 . . . . 61.54 108.861 166.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -119.92 87.15 2.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.004 -1.85 . . . . 70.14 106.004 155.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 17.9 ttt180 -95.32 170.2 9.54 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 113.9 -1.5 . . . . 74.42 109.06 -171.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -98.12 124.97 42.93 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.552 1.069 . . . . 75.11 111.956 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.88 105.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.611 1.164 . . . . 73.42 108.466 167.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.4 t70 63.68 5.52 2.25 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.729 1.212 . . . . 75.5 112.695 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.35 -18.16 8.88 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.449 -0.639 . . . . 74.53 114.077 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 t -101.11 167.33 10.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 117.789 0.794 . . . . 71.45 109.609 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 1.2 pm0 -94.72 126.79 40.26 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.99 0.516 . . . . 64.11 112.105 -172.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 t -78.79 107.54 6.18 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 72.35 108.979 166.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.0 Cg_endo -87.97 112.5 0.77 Allowed 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 122.712 2.275 . . . . 65.3 109.988 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.3 m -126.31 118.21 24.61 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.811 0.444 . . . . 74.54 111.037 -174.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.473 ' HA ' HD13 ' A' ' 156' ' ' ILE . 53.0 tp -78.92 134.28 36.88 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.109 -0.7 . . . . 71.43 109.109 166.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.524 ' HB2' HG13 ' A' ' 155' ' ' ILE . 65.7 mtt -124.37 138.44 54.37 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.885 -1.154 . . . . 74.12 107.885 165.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.509 HD13 HD11 ' A' ' 176' ' ' ILE . 53.5 mt -152.16 150.85 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.098 1.759 . . . . 73.42 106.789 169.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.8 p -78.76 149.1 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.599 -0.889 . . . . 72.32 108.599 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -63.6 -31.58 72.79 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.321 0.649 . . . . 71.45 110.214 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 103' ' ' MET . 67.6 mm-40 -76.97 -3.37 38.54 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.504 0.928 . . . . 73.31 113.504 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.72 -25.13 14.78 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.965 0.506 . . . . 50.33 110.065 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.509 HD11 HD13 ' A' ' 171' ' ' LEU . 48.3 mm -106.52 125.28 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.422 0.689 . . . . 51.41 110.866 -170.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.0 mm -110.22 109.36 28.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.59 -1.263 . . . . 52.42 107.59 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.61 111.5 19.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.068 -0.969 . . . . 70.41 108.657 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.626 ' HB3' HG23 ' A' ' 3' ' ' ILE . 8.8 tp10 -95.11 130.44 41.81 Favored 'General case' 0 C--O 1.248 0.98 0 N-CA-C 109.394 -0.595 . . . . 71.41 109.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -71.87 108.58 5.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.141 -0.936 . . . . 74.22 109.797 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.9 t -94.32 89.82 6.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.465 0.706 . . . . 71.0 110.011 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.86 -61.18 1.46 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.022 0.929 . . . . 44.34 109.267 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 123.846 0.858 . . . . 74.33 109.597 -178.818 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.609 ' SD ' ' HA ' ' A' ' 16' ' ' ASP . 45.2 tpp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.438 -0.579 . . . . 73.13 109.438 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 18' ' ' PHE . 79.3 mt -118.47 152.96 34.93 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.689 -0.856 . . . . 74.11 108.689 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.0 pt -131.99 121.08 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 108.563 -0.903 . . . . 70.12 108.563 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 23.1 p90 -122.15 135.58 54.8 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 121.58 -0.7 . . . . 45.34 109.946 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 46.4 mtpt -137.72 135.09 36.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.839 -1.528 . . . . 70.41 109.448 -159.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.94 144.32 36.92 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.298 -0.631 . . . . 54.33 109.298 173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.23 -26.42 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 113.475 0.917 . . . . 74.12 113.475 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -96.72 -67.85 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 114.238 1.199 . . . . 74.2 114.238 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -130.38 -22.45 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.462 0.912 . . . . 74.52 113.462 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.57 23.15 13.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.458 1.103 . . . . 60.52 109.74 -169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.26 -15.29 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.574 1.55 . . . . 71.2 114.286 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -76.24 -40.45 51.99 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 121.55 -0.718 . . . . 75.34 111.78 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 37.4 mt 21.18 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 126.455 1.902 . . . . 73.05 113.813 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.5 m -152.14 123.03 7.5 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.782 0.289 . . . . 72.32 111.782 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.6 m -113.01 94.66 5.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.595 1.158 . . . . 73.22 110.538 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.609 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 26.7 t70 -168.97 166.17 11.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.95 0.9 . . . . 64.34 109.668 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -70.32 78.43 0.54 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.527 0.731 . . . . 65.21 110.334 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 32.1 m-85 -104.21 146.7 33.06 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 124.784 1.233 . . . . 45.3 110.673 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.38 118.9 5.91 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.52 2.147 . . . . 73.34 112.603 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.7 ptm -113.4 145.68 40.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.342 0.657 . . . . 64.13 109.927 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -151.47 137.64 18.35 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.235 -0.654 . . . . 63.45 109.235 174.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.53 148.53 24.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.386 1.074 . . . . 75.44 108.232 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.11 134.25 47.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 C-N-CA 124.074 0.95 . . . . 71.13 109.375 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 59.51 16.47 5.29 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.945 1.298 . . . . 62.01 112.53 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 54.61 32.73 17.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.509 1.523 . . . . 60.25 112.542 -174.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 119' ' ' LYS . 55.2 tp -132.23 -50.97 0.94 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.226 0.61 . . . . 74.02 111.033 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.39 141.92 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.319 0.648 . . . . 71.34 109.819 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.69 113.24 24.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.586 -0.894 . . . . 72.12 108.586 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG3' ' HB3' ' A' ' 21' ' ' LYS . 6.0 pt-20 -82.88 104.08 12.83 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.007 -1.479 . . . . 61.34 107.007 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.581 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.0 t80 -88.88 112.67 23.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.94 -1.504 . . . . 71.42 106.94 177.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -67.2 148.88 51.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.912 0.885 . . . . 71.11 110.969 -171.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 157.78 27.51 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.496 0.497 . . . . 63.31 113.575 -174.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -121.26 140.23 52.34 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.311 -0.996 . . . . 73.11 108.311 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -74.33 116.78 15.39 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.001 -1.481 . . . . 74.45 107.001 167.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 72' ' ' LEU . 34.4 m -131.08 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 124.545 1.138 . . . . 75.12 108.398 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 m -125.86 153.93 34.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.814 0.846 . . . . 75.3 109.655 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.536 ' HB2' HD13 ' A' ' 72' ' ' LEU . 12.9 ttp180 -141.53 110.26 6.1 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.071 0.462 . . . . 74.55 110.945 170.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HG3' ' H ' ' A' ' 40' ' ' GLY . 51.9 tptt -133.94 137.99 45.2 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 107.585 -1.265 . . . . 72.54 107.585 169.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -9.89 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.039 0.755 . . . . 65.3 113.039 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' A' ' 38' ' ' LYS . . . -106.83 -38.65 2.15 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.303 -0.319 . . . . 60.43 112.303 170.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -121.27 138.3 54.3 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.179 0.592 . . . . 74.11 112.321 -167.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.488 1.474 0 C-N-CA 123.927 0.891 . . . . 61.02 110.405 177.036 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 107.233 -1.395 . . . . 64.34 107.233 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . 0.252 2.1 pt-20 68.7 -45.85 0.54 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.694 2.398 . . . . 74.52 113.528 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -134.15 146.35 50.12 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 108.398 -0.964 . . . . 60.34 108.398 -173.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.57 44.65 Favored Glycine 0 N--CA 1.447 -0.58 0 O-C-N 123.604 0.565 . . . . 55.03 112.259 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.802 HD11 HD12 ' A' ' 70' ' ' ILE . 1.8 tt -94.82 130.1 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.219 -1.03 . . . . 70.01 108.219 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -47.97 -40.67 23.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.753 1.621 . . . . 71.23 113.416 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.802 HD12 HD11 ' A' ' 68' ' ' ILE . 62.4 mt -55.36 -47.88 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.741 1.216 . . . . 71.32 110.666 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.1 -48.63 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.405 0.682 . . . . 74.53 111.713 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 37' ' ' ARG . 63.0 mt -60.83 -33.91 73.75 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.094 0.871 . . . . 74.51 111.092 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -79.35 -48.65 13.68 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.169 0.987 . . . . 75.43 111.16 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -87.15 1.78 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.91 0.484 . . . . 75.03 111.612 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 70.5 mmtt 64.38 34.86 10.11 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.833 1.253 . . . . 73.43 111.165 173.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.51 132.71 40.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.205 -0.665 . . . . 53.24 109.205 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 p -84.64 133.46 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 N-CA-C 109.883 -0.414 . . . . 72.43 109.883 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.79 140.34 45.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.157 1.383 . . . . 70.23 112.677 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -148.06 131.55 16.72 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.505 -0.924 . . . . 71.43 108.505 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 45.2 m-80 -88.0 137.57 32.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.816 0.446 . . . . 63.15 110.491 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.1 p -57.74 -30.75 65.83 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.501 1.521 . . . . 74.43 111.204 172.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.427 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 47.1 m-85 -59.51 -34.58 72.8 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.673 -1.603 . . . . 73.24 110.832 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.46 -18.59 14.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.752 0.821 . . . . 75.13 111.829 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.69 14.98 20.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.261 0.624 . . . . 72.24 112.143 -169.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.89 -53.96 50.86 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.563 0.62 . . . . 75.52 112.213 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.7 t -70.5 -36.54 73.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.345 0.658 . . . . 65.31 110.745 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.0 mmm -62.39 -38.39 89.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.273 0.629 . . . . 73.43 110.846 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.409 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 76.4 t80 -78.95 -25.45 43.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.707 0.803 . . . . 72.32 110.627 -176.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -62.94 -41.79 99.6 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.951 -0.759 . . . . 75.03 108.951 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.4 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 74.32 111.05 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 23.2 m-85 -61.37 -37.98 85.34 Favored 'General case' 0 C--N 1.364 1.205 0 CA-C-O 119.506 -0.283 . . . . 72.21 110.48 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.785 HG21 HD11 ' A' ' 128' ' ' LEU . 14.8 mm -66.47 -41.67 89.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 124.061 0.851 . . . . 74.14 111.876 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -61.88 -38.4 88.16 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.89 0.768 . . . . 75.33 110.204 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.82 -45.22 68.35 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.457 -0.792 . . . . 72.11 110.431 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . 84.6 t80 -55.76 -57.31 12.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.738 1.615 . . . . 63.43 111.621 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.2 ptm -63.97 -31.64 72.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.493 0.717 . . . . 70.52 110.693 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -61.5 -58.55 7.72 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.867 -0.42 . . . . 73.13 109.867 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.5 -27.38 62.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.336 -0.847 . . . . 71.01 112.223 -168.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 174' ' ' GLU . 22.5 m -75.2 -38.46 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 117.697 0.226 . . . . 72.02 111.326 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' HE2' ' A' ' 103' ' ' MET . 55.4 mt -69.31 -38.05 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 110.324 -0.25 . . . . 73.53 110.324 176.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 -46.4 88.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.017 0.527 . . . . 70.12 110.685 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -53.23 -56.01 19.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.129 0.971 . . . . 64.05 111.057 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.439 ' HE1' ' O ' ' A' ' 113' ' ' VAL . 19.4 ptt? -64.63 -45.49 86.61 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.086 0.866 . . . . 64.2 111.346 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.142 0.977 . . . . 75.55 111.529 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -62.8 -27.1 69.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.993 0.917 . . . . 65.3 113.177 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -116.26 -6.91 11.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.139 0.422 . . . . 72.02 112.139 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.83 -64.67 1.04 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.52 -0.919 . . . . 71.51 108.52 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 74.35 -26.99 0.19 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.09 1.356 . . . . 70.51 112.166 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.65 125.8 29.87 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.658 0.783 . . . . 64.23 109.747 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.94 -23.31 66.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.521 1.128 . . . . 74.11 111.248 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.18 73.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.961 0.904 . . . . 62.31 111.483 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.48 -48.69 6.01 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.584 0.754 . . . . 54.32 110.031 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.439 ' O ' ' HE1' ' A' ' 103' ' ' MET . 27.6 m -75.9 -34.08 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 113.19 0.811 . . . . 70.15 113.19 -169.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.21 -38.98 89.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 118.702 0.683 . . . . 74.22 110.254 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.98 -45.49 73.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.016 -0.993 . . . . 74.23 110.786 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.36 -42.03 96.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.74 0.416 . . . . 65.35 110.291 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.78 -38.58 75.71 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.727 0.811 . . . . 63.15 110.824 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -68.36 -43.07 78.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.411 0.685 . . . . 71.44 110.52 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HB3' HD22 ' A' ' 26' ' ' LEU . 70.3 mmtt -60.12 -55.85 28.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.73 0.812 . . . . 75.13 111.134 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.491 HD13 HG21 ' A' ' 172' ' ' VAL . 10.5 tp -66.97 -31.18 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.488 0.715 . . . . 73.34 110.232 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.62 -62.76 1.47 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 123.041 0.536 . . . . 74.41 110.123 168.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.77 -27.45 66.6 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.606 0.567 . . . . 12.13 113.77 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -73.88 -45.17 52.55 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.152 0.581 . . . . 71.55 111.009 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.67 -25.34 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 122.989 0.181 . . . . 61.41 110.892 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.08 -27.58 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.879 -0.513 . . . . 61.12 109.803 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -76.68 -50.97 12.4 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.367 0.667 . . . . 64.14 110.375 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 155' ' ' ILE . 36.8 tp -75.15 -33.02 61.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.296 1.039 . . . . 61.32 112.766 -166.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.785 HD11 HG21 ' A' ' 92' ' ' ILE . 95.9 mt -79.07 2.89 19.08 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.86 0.689 . . . . 70.24 112.86 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.55 143.11 48.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.254 -1.017 . . . . 73.32 108.254 170.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 25.8 pttm -57.75 -27.36 62.95 Favored 'General case' 0 C--O 1.212 -0.87 0 O-C-N 124.1 0.875 . . . . 63.22 111.89 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -46.1 87.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.229 1.412 . . . . 72.41 110.59 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.477 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 1.5 mpp_? -67.85 -44.33 77.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.596 -1.183 . . . . 65.55 110.115 175.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.492 ' HE1' ' HA ' ' A' ' 128' ' ' LEU . 7.2 m-85 -61.53 -25.76 67.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.831 0.853 . . . . 53.24 113.029 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 25.2 mtpp -64.88 -20.43 66.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.859 0.464 . . . . 74.51 111.382 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -132.57 17.09 4.36 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.375 0.67 . . . . 71.33 112.154 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 44.1 mt -93.07 139.38 30.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.277 0.489 . . . . 72.1 110.272 172.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -122.16 123.38 41.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.69 -1.226 . . . . 62.23 107.69 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -95.38 128.75 42.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.218 0.532 . . . . 71.42 109.684 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -130.65 151.86 50.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.19 -1.041 . . . . 64.42 108.19 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.3 pt -134.0 167.94 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 108.324 -0.991 . . . . 72.53 108.324 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.81 144.65 48.2 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.761 -0.536 . . . . 24.11 111.761 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 36.7 tt0 -52.9 -42.71 65.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.113 0.565 . . . . 74.24 110.735 173.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.694 HH11 ' HB2' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -60.76 -42.62 97.81 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.309 1.444 . . . . 71.55 110.319 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.699 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -56.09 -51.68 67.02 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.951 0.9 . . . . 74.33 111.59 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.86 -29.16 61.96 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.455 -0.793 . . . . 72.25 112.4 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -74.26 -41.74 60.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.553 . . . . 72.13 110.856 -171.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.23 62.63 0.08 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.15 -0.78 . . . . 71.35 111.15 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -157.59 175.6 13.72 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.155 0.582 . . . . 73.32 110.865 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.82 170.56 13.38 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.896 0.878 . . . . 64.0 113.16 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -86.09 67.19 9.9 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.722 1.209 . . . . 74.2 108.003 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.09 -112.0 0.01 OUTLIER Glycine 0 CA--C 1.54 1.625 0 CA-C-N 113.229 -1.805 . . . . 75.44 114.39 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.38 155.99 17.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.202 0.601 . . . . 73.52 109.558 169.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 85.4 t -103.01 126.55 57.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.817 -0.808 . . . . 73.41 108.817 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.626 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.09 103.84 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.127 0.971 . . . . 64.13 109.113 170.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 127' ' ' LEU . 63.2 mt -90.68 110.6 22.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.171 -0.677 . . . . 75.04 109.171 -171.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 68' ' ' ILE . 51.2 mm -96.91 98.96 8.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.215 0.531 . . . . 74.02 110.001 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.43 96.51 5.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.894 -1.15 . . . . 74.31 107.894 169.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 45.0 p90 -107.02 129.12 54.85 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.411 -0.588 . . . . 72.33 109.411 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.16 -177.36 6.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.473 1.109 . . . . 72.41 109.09 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.19 137.52 54.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.43 0.292 . . . . 72.11 110.28 171.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.7 p -111.03 111.95 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 N-CA-C 108.22 -1.029 . . . . 72.42 108.22 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 63.49 17.43 10.34 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.828 1.251 . . . . 54.45 112.367 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.18 -19.03 30.22 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.113 -0.271 . . . . 62.43 112.719 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.4 m -82.28 106.94 14.57 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.3 0.55 . . . . 72.01 109.537 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -71.97 101.61 2.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 71.1 109.922 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.7 m -105.6 101.19 30.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 113.627 -1.624 . . . . 71.34 109.348 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.629 ' HB2' HD12 ' A' ' 68' ' ' ILE . 92.0 Cg_endo -92.15 118.36 0.45 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.95 2.433 . . . . 61.34 111.703 172.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 28.1 m -114.43 135.53 54.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.129 0.972 . . . . 71.3 109.565 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 38.6 tp -79.61 146.24 32.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.803 -0.814 . . . . 50.53 108.803 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.0 ptp -141.05 132.5 26.86 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.428 0.632 . . . . 65.21 109.635 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.626 HD21 ' HA ' ' A' ' 154' ' ' ALA . 94.8 mt -139.14 149.83 44.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.482 1.913 . . . . 74.34 107.032 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.491 HG21 HD13 ' A' ' 120' ' ' ILE . 6.2 p -83.14 146.54 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.476 -0.935 . . . . 72.31 108.476 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -25.42 8.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.754 1.621 . . . . 72.1 112.585 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . 2.0 tp10 -89.22 -27.07 20.87 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.085 0.954 . . . . 63.32 112.583 -172.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.37 -6.51 37.4 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.949 0.5 . . . . 71.14 110.77 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 172' ' ' VAL . 10.5 tp -118.12 151.4 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.053 0.941 . . . . 73.34 108.72 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 47.3 mm -124.55 107.97 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.1 -1.444 . . . . 74.42 107.1 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 140.59 46.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.675 -0.491 . . . . 75.21 109.675 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.88 124.82 13.49 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.294 -1.002 . . . . 63.55 108.294 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.497 ' HG2' HD22 ' A' ' 182' ' ' LEU . 36.2 ttpt -80.72 103.99 10.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.405 0.682 . . . . 75.44 109.602 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.31 90.0 8.14 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.395 0.678 . . . . 74.32 109.457 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 182' ' ' LEU . 2.6 pt? -118.9 175.07 5.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.443 0.697 . . . . 73.25 109.855 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.562 1.409 0 C-N-CA 123.546 0.738 . . . . 65.42 110.078 -179.049 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 63.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 110.204 -0.295 . . . . 70.11 110.204 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mt -104.43 137.76 41.82 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.444 0.698 . . . . 72.43 109.882 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.517 HG22 ' HB2' ' A' ' 15' ' ' SER . 21.1 pt -121.43 122.23 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 109.498 -0.556 . . . . 74.42 109.498 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.741 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 18.6 p90 -124.3 114.88 20.15 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.85 0.86 . . . . 73.41 110.061 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 169.14 14.37 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.836 0.854 . . . . 73.31 110.438 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -114.67 175.34 5.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.425 0.69 . . . . 71.33 109.432 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.28 -28.33 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 112.918 0.71 . . . . 60.4 112.918 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.58 -59.88 1.89 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.488 0.715 . . . . 74.21 110.295 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -84.41 19.8 1.83 Allowed 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.147 -0.933 . . . . 72.14 110.8 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -45.35 -35.87 3.84 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.194 2.197 . . . . 61.33 114.012 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.07 -9.76 42.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.338 0.655 . . . . 71.41 112.375 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -121.17 16.5 11.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.668 0.787 . . . . 72.42 111.287 -172.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -105.27 -164.54 1.04 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 72.32 108.468 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -151.64 152.28 32.62 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.212 0.529 . . . . 71.24 111.712 -168.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.517 ' HB2' HG22 ' A' ' 3' ' ' ILE . 59.9 p -137.18 101.39 4.53 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.08 0.952 . . . . 65.43 109.124 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.2 t70 -157.37 -84.11 0.05 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.782 0.433 . . . . 75.21 110.273 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 m 177.69 86.77 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.264 1.826 . . . . 63.25 107.383 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.08 148.19 64.83 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.028 -0.987 . . . . 64.13 108.341 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.86 118.46 5.63 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.87 1.713 . . . . 74.12 112.559 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.741 ' SD ' ' HB3' ' A' ' 4' ' ' TYR . 58.4 mtm -114.34 144.66 42.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.746 0.818 . . . . 72.12 109.353 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -131.32 156.56 45.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.933 . . . . 61.14 108.896 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.591 HD11 ' HD3' ' A' ' 173' ' ' LYS . 28.3 tp -127.97 139.57 52.49 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.472 -0.936 . . . . 64.25 108.472 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.84 145.56 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 C-N-CA 123.213 0.605 . . . . 65.24 109.721 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 67.72 2.51 3.05 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.579 1.152 . . . . 54.33 112.356 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 55.49 29.08 12.67 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.112 0.965 . . . . 73.53 110.827 -167.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 119' ' ' LYS . 49.8 tp -134.45 -51.32 0.81 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.543 0.687 . . . . 73.42 110.483 -175.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.2 t -107.23 127.18 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.728 -1.123 . . . . 61.02 109.834 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -83.02 134.09 35.06 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.405 -0.961 . . . . 74.34 108.405 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.4 tt0 -130.17 104.7 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.076 -0.965 . . . . 74.55 109.056 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.589 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.6 t80 -90.59 124.36 34.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.099 -0.704 . . . . 73.32 109.099 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -80.15 138.59 36.92 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.745 -0.465 . . . . 72.42 109.745 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.99 151.5 20.05 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.517 -0.633 . . . . 42.52 111.517 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -93.58 150.25 20.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.191 0.596 . . . . 72.13 110.265 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -83.16 106.04 14.63 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.115 -1.069 . . . . 61.45 108.115 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.431 HG23 HD12 ' A' ' 72' ' ' LEU . 16.8 m -141.83 162.89 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.508 0.723 . . . . 61.03 109.583 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.43 HG22 HD12 ' A' ' 42' ' ' ILE . 11.4 m -127.04 151.31 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.946 -0.39 . . . . 60.24 109.946 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.6 107.59 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.352 -1.351 . . . . 74.44 107.352 160.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -123.64 95.02 4.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.525 -1.287 . . . . 73.51 107.525 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 49.2 -77.33 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 126.392 1.877 . . . . 64.42 113.161 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.8 45.71 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.779 -0.928 . . . . 71.32 110.779 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.74 137.23 16.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.294 1.038 . . . . 63.22 110.15 -173.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 36' ' ' VAL . 5.9 tp . . . . . 0 CA--C 1.56 1.354 0 C-N-CA 123.948 0.899 . . . . 74.01 110.062 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 108.266 -1.013 . . . . 70.52 108.266 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.51 67.91 10.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.611 -1.255 . . . . 61.43 107.611 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -91.88 157.01 17.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.853 -1.067 . . . . 73.41 112.089 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.3 -124.48 1.95 Allowed Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.151 -0.477 . . . . 43.31 112.336 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 12.6 pt -112.47 154.68 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.344 0.658 . . . . 75.43 111.153 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -53.83 -42.05 68.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.745 1.218 . . . . 45.31 112.7 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.6 mt -58.27 -45.99 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.711 1.204 . . . . 64.21 110.106 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 76' ' ' LEU . 75.8 t -72.63 -49.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 114.239 -1.346 . . . . 63.21 112.093 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 57.2 mt -67.94 -33.18 74.18 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.661 0.601 . . . . 71.24 112.404 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.56 -29.55 70.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.613 0.571 . . . . 71.55 111.304 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -115.52 -19.74 10.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.696 0.998 . . . . 73.25 113.696 -170.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? 68.56 59.85 0.39 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.887 0.875 . . . . 71.31 109.195 -170.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 71' ' ' VAL . 87.2 mt -77.42 125.5 29.43 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 107.506 -1.294 . . . . 74.23 107.506 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.34 124.85 39.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 109.114 -0.698 . . . . 41.22 109.114 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.11 158.9 33.95 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 122.0 0.905 . . . . 55.03 112.48 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.2 tpt -147.38 112.17 5.38 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 105.744 -1.947 . . . . 71.02 105.744 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 15.6 m120 -100.42 128.3 46.52 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.192 0.597 . . . . 54.3 110.139 -171.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.98 -12.85 12.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.804 1.641 . . . . 71.54 113.054 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.432 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 69.1 m-85 -73.88 -38.07 64.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.048 1.339 . . . . 71.23 111.085 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.04 -38.15 6.4 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.414 0.686 . . . . 74.24 112.614 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -66.96 -3.13 6.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.025 1.861 . . . . 64.21 116.025 -159.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -30.12 -63.77 0.13 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.843 1.657 . . . . 63.15 114.815 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.8 m -64.33 -42.76 96.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.903 0.481 . . . . 75.25 111.693 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 85.2 mmm -71.67 -50.93 26.01 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.474 0.484 . . . . 74.31 111.907 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.41 ' HE2' HD22 ' A' ' 128' ' ' LEU . 58.2 t80 -65.71 -40.0 91.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.599 0.76 . . . . 75.11 111.527 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.28 -35.13 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.78 0.432 . . . . 65.31 110.542 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 94' ' ' LYS . . . -64.26 -42.7 96.35 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 123.296 0.373 . . . . 42.24 110.184 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -67.92 -33.98 75.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.654 0.782 . . . . 75.44 112.033 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.25 -38.87 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.187 0.595 . . . . 51.44 110.641 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -41.3 98.54 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.112 -0.699 . . . . 72.34 109.112 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mmtt -61.97 -60.75 3.16 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.508 -0.923 . . . . 71.12 108.508 175.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.4 ' O ' HG13 ' A' ' 99' ' ' VAL . 60.8 t80 -43.6 -60.85 1.59 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.132 1.773 . . . . 71.34 111.493 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 42.5 ttp -56.51 -60.64 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.134 0.974 . . . . 54.1 110.631 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -60.12 -41.62 93.01 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.422 0.451 . . . . 72.35 111.322 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -72.47 -39.8 67.46 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 119.124 -0.465 . . . . 33.3 111.63 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 175' ' ' ALA . 22.2 m -70.71 -37.27 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 117.823 0.283 . . . . 75.44 111.375 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.89 -43.24 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.074 0.464 . . . . 75.21 109.797 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.05 -30.21 68.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.284 1.034 . . . . 72.03 111.335 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -62.53 -48.77 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.55 0.74 . . . . 60.1 109.463 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.432 ' HG3' ' HG3' ' A' ' 174' ' ' GLU . 16.1 mmt -78.28 -21.02 50.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.741 -0.663 . . . . 73.41 112.064 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.29 -30.29 62.02 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.773 -0.579 . . . . 75.33 109.868 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -75.01 -31.58 61.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.509 0.723 . . . . 73.51 110.71 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -99.12 -29.68 12.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.252 0.621 . . . . 72.54 112.613 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -103.18 -43.68 5.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 73.11 108.686 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 64.68 19.82 11.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.692 1.197 . . . . 73.33 112.433 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m-20 -94.85 103.74 15.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.301 -1.0 . . . . 75.23 108.301 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.25 -37.89 81.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.07 0.948 . . . . 62.02 111.827 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.29 74.61 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.416 0.686 . . . . 74.45 111.52 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 109' ' ' ASP . 3.6 t70 -75.42 -49.84 17.68 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.059 0.943 . . . . 63.2 110.712 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.94 -23.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.468 -0.787 . . . . 73.03 111.659 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.15 -35.45 61.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.873 0.469 . . . . 72.24 110.203 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 118' ' ' LYS . . . -69.64 -39.42 77.15 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.482 -0.562 . . . . 63.03 109.482 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -65.63 -38.54 89.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.181 0.993 . . . . 73.31 110.771 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.35 -33.86 73.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.237 1.015 . . . . 73.1 110.798 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 18.0 tppt? -64.92 -48.96 72.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.509 0.724 . . . . 73.12 110.32 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HB3' HD22 ' A' ' 26' ' ' LEU . 13.5 mptt -63.93 -40.12 95.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.415 0.286 . . . . 74.2 111.63 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 172' ' ' VAL . 17.6 mm -70.27 -48.26 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 118.994 -0.527 . . . . 73.05 111.095 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.24 -46.08 83.32 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.081 -0.711 . . . . 54.14 109.081 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.13 94.54 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.285 0.991 . . . . 43.01 113.292 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.3 -52.09 56.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 122.992 0.517 . . . . 74.45 109.861 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 25.8 m -70.85 -37.3 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 123.644 0.59 . . . . 73.12 111.727 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.89 -32.83 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.81 0.732 . . . . 73.31 109.784 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -74.98 -40.96 60.43 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.875 -0.602 . . . . 64.2 111.497 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.3 tp -78.87 -19.35 52.15 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.305 1.042 . . . . 73.11 112.307 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 47.4 mt -93.64 2.65 56.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.271 0.628 . . . . 72.25 111.49 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.3 91.15 2.16 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.746 0.418 . . . . 52.03 109.933 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 44.5 mtmt -63.16 -6.72 4.56 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.745 1.218 . . . . 73.12 113.778 -170.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.26 -41.68 76.2 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.14 0.576 . . . . 74.44 110.194 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -108.74 -48.44 3.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.969 1.308 . . . . 74.33 110.558 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -81.37 -1.12 44.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.268 1.427 . . . . 73.24 114.491 -164.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 34.9 ttmt -57.19 -16.89 9.07 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.053 0.541 . . . . 52.12 111.237 165.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.98 15.31 10.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.246 1.018 . . . . 74.24 111.089 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.61 148.65 23.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.56 -0.904 . . . . 64.32 108.56 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.53 111.68 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.599 -1.63 . . . . 73.14 106.599 175.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.437 ' HB3' HG11 ' A' ' 153' ' ' VAL . 46.1 m-85 -90.21 142.11 28.04 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.731 -0.84 . . . . 72.14 108.731 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -137.82 155.79 48.63 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.922 0.889 . . . . 73.41 108.735 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.38 143.2 20.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.011 -1.477 . . . . 72.34 107.011 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.46 134.89 49.97 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 118.992 -0.893 . . . . 63.41 113.073 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -55.25 -38.27 68.3 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.139 0.975 . . . . 72.44 111.355 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -65.63 -44.42 86.53 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.204 -0.907 . . . . 75.02 111.659 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.93 -21.42 51.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.049 0.54 . . . . 65.3 111.647 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.89 0.18 51.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.744 0.817 . . . . 61.23 110.942 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.04 -24.04 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.799 0.84 . . . . 71.43 110.62 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.48 47.77 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.748 -0.205 . . . . 21.52 113.361 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.75 78.32 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.06 0.544 . . . . 74.45 110.586 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.12 -3.43 32.76 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.505 0.722 . . . . 64.11 111.828 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.25 -18.64 55.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.574 0.75 . . . . 32.24 109.667 169.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.86 150.4 50.08 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 124.376 1.047 . . . . 50.24 113.373 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -96.16 155.5 16.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.479 0.711 . . . . 75.41 110.088 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.437 HG11 ' HB3' ' A' ' 138' ' ' PHE . 53.3 t -88.13 129.34 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.565 0.746 . . . . 75.53 111.296 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.18 111.5 10.48 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.487 1.115 . . . . 75.41 109.33 170.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.4 mt -93.78 113.02 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.437 0.695 . . . . 71.41 109.398 -170.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 169' ' ' LEU . 45.7 mm -98.7 123.7 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.955 -0.465 . . . . 73.45 109.984 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.29 128.88 49.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.802 1.241 . . . . 74.02 108.889 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -81.21 114.5 20.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.814 -1.18 . . . . 63.02 107.814 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.591 ' HB3' HG13 ' A' ' 166' ' ' VAL . 18.2 tpp85 -88.68 141.25 28.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.459 0.704 . . . . 64.25 109.646 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -100.68 124.43 46.28 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.694 -0.484 . . . . 65.35 109.694 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.595 HG13 ' HB ' ' A' ' 164' ' ' THR . 3.1 p -125.77 90.67 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.056 0.942 . . . . 73.35 109.273 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 62.23 17.5 9.32 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.063 1.345 . . . . 71.35 113.31 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.23 -14.69 9.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 120.027 -0.318 . . . . 71.1 113.382 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.595 ' HB ' HG13 ' A' ' 161' ' ' VAL . 80.5 m -88.2 138.66 31.24 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.263 0.625 . . . . 74.41 110.112 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 112.16 24.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.513 0.725 . . . . 64.13 109.296 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 159' ' ' ARG . 2.6 p -119.75 104.02 45.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.46 1.104 . . . . 75.14 109.293 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.27 130.45 39.44 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.597 2.198 . . . . 71.25 112.574 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.1 p -137.02 131.07 32.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.048 0.539 . . . . 63.1 110.587 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 28.7 tp -76.43 137.96 40.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 54.44 109.477 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.8 ttm -123.95 122.25 37.45 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.67 -1.233 . . . . 72.41 107.67 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 34.5 mt -151.8 167.9 26.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.65 1.58 . . . . 63.35 106.76 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.438 HG21 HD11 ' A' ' 120' ' ' ILE . 12.3 p -88.35 139.92 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 118.593 0.633 . . . . 63.43 109.596 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.591 ' HD3' HD11 ' A' ' 22' ' ' LEU . 58.7 pttt -69.21 -24.1 63.99 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.943 0.497 . . . . 74.42 112.147 -173.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.432 ' HG3' ' HG3' ' A' ' 103' ' ' MET . 11.2 mp0 -64.87 -23.89 67.37 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.797 0.839 . . . . 62.33 112.045 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -96.82 -10.38 26.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.487 0.715 . . . . 61.21 111.358 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.415 HG22 ' HG3' ' A' ' 178' ' ' GLU . 42.5 mm -107.02 147.53 12.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.355 0.662 . . . . 62.4 109.555 -175.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.71 108.2 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.13 -1.433 . . . . 72.41 107.13 170.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.415 ' HG3' HG22 ' A' ' 176' ' ' ILE . 16.0 mt-10 -109.49 117.93 35.27 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.601 -1.259 . . . . 71.32 107.601 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -144.66 135.6 24.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.592 -0.892 . . . . 75.34 108.592 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -124.44 109.01 12.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 52.13 109.164 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -96.64 91.89 5.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.786 0.834 . . . . 61.44 109.724 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.47 -46.92 4.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 74.34 109.828 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.617 -0.883 . . . . 74.01 108.617 -178.638 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.031 0.443 . . . . 71.43 110.087 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.6 mt -105.39 161.67 14.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.054 0.942 . . . . 64.2 108.755 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 62.0 mt -115.97 118.72 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.701 -0.852 . . . . 75.21 108.701 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -104.57 96.26 6.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.829 -0.804 . . . . 63.11 108.829 -174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 68.3 mttm -122.34 152.17 40.42 Favored 'General case' 0 C--O 1.21 -0.992 0 C-N-CA 123.859 0.864 . . . . 63.24 109.213 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 7.2 t70 -114.02 143.21 45.13 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 106.955 -1.498 . . . . 74.15 106.955 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -52.84 -20.6 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.823 1.045 . . . . 65.44 113.823 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -107.13 -42.49 4.86 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.189 0.996 . . . . 74.53 110.5 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 6' ' ' ASP . 33.2 p -104.93 18.43 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.816 0.847 . . . . 62.13 112.098 -172.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 8.7 p-10 -60.75 -11.92 9.03 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.511 1.524 . . . . 73.33 113.784 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.31 -58.26 4.83 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 125.133 1.521 . . . . 54.52 110.53 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -122.91 -38.17 2.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.416 -0.811 . . . . 62.23 111.473 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.7 tp 5.54 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.885 2.074 . . . . 72.35 114.203 -163.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.513 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 70.6 m -156.95 146.0 20.16 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.95 0.5 . . . . 33.45 110.779 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 p -148.6 103.64 3.42 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 118.833 0.742 . . . . 72.14 110.957 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -168.28 176.34 5.98 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.343 1.457 . . . . 64.5 108.196 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -72.83 75.37 1.15 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.185 0.517 . . . . 62.03 110.116 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 14' ' ' SER . 64.2 m-85 -87.32 147.28 41.84 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.722 0.809 . . . . 72.43 110.769 -177.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.15 117.7 2.71 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.716 2.278 . . . . 71.44 112.737 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.619 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 60.6 ttp -119.35 114.43 22.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.605 1.162 . . . . 74.22 109.399 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -140.34 136.61 33.36 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.779 -1.193 . . . . 73.44 107.779 171.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 25' ' ' ASP . 59.9 tp -113.15 142.54 45.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.132 -1.062 . . . . 64.32 108.132 174.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.25 130.76 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.148 -0.686 . . . . 64.23 109.148 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.99 12.74 4.1 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.902 1.281 . . . . 65.34 112.811 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' HA ' HD21 ' A' ' 22' ' ' LEU . 8.6 m-20 53.37 12.11 0.32 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.638 1.175 . . . . 62.11 113.418 -167.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.712 HD22 ' HG3' ' A' ' 119' ' ' LYS . 45.5 tp -107.08 -45.59 4.11 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.774 0.83 . . . . 54.41 110.027 -171.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 t -120.3 131.38 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.473 -0.785 . . . . 74.01 109.446 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.619 ' HE1' ' HG3' ' A' ' 20' ' ' MET . 82.0 t80 -98.07 126.7 43.62 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.897 -1.149 . . . . 73.53 107.897 171.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 154.6 30.8 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.415 0.626 . . . . 73.01 110.811 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 50.7 t80 -136.42 129.92 31.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.268 1.427 . . . . 63.34 108.655 -171.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -78.98 153.71 30.12 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.154 0.502 . . . . 74.13 110.976 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.37 172.58 39.36 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.312 -0.858 . . . . 73.31 111.004 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 47.4 mtmt -128.28 154.29 46.05 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.569 -0.901 . . . . 73.43 108.569 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 6.4 p-80 -73.98 130.15 39.28 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.5 -1.296 . . . . 75.32 107.5 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 42' ' ' ILE . 15.9 m -139.73 149.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.54 0.736 . . . . 71.2 109.305 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.493 ' HB ' ' HG2' ' A' ' 66' ' ' ARG . 7.4 m -123.3 120.32 59.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.299 -1.371 . . . . 73.53 107.299 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 59.3 ttt180 -138.53 117.43 12.41 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.531 -0.759 . . . . 72.22 108.96 -169.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -133.08 118.6 18.94 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.038 -0.727 . . . . 75.43 109.038 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 64.43 24.68 13.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.422 1.089 . . . . 75.24 112.028 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -27.07 18.74 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-O 120.019 -0.323 . . . . 62.13 113.008 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.23 123.17 24.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.231 0.612 . . . . 74.43 110.204 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 35' ' ' VAL . 5.5 tp . . . . . 0 CA--C 1.547 0.851 0 C-N-CA 123.659 0.783 . . . . 75.11 109.897 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t . . . . . 0 C--O 1.241 0.622 0 N-CA-C 105.647 -1.983 . . . . 73.3 105.647 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HA ' HD22 ' A' ' 72' ' ' LEU . 51.8 mt-10 -82.52 62.64 6.27 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.505 0.669 . . . . 73.04 111.324 -174.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.493 ' HG2' ' HB ' ' A' ' 36' ' ' VAL . 49.0 mtt180 -108.69 120.51 42.68 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.153 -1.055 . . . . 74.41 108.153 173.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.28 -136.08 4.6 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 109.703 -1.359 . . . . 60.34 109.703 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 24.2 pt -110.4 143.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 117.354 0.577 . . . . 73.32 110.5 173.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.96 -34.48 59.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.152 1.381 . . . . 72.51 112.223 -176.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 169' ' ' LEU . 60.1 mt -56.46 -51.04 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.924 0.89 . . . . 75.34 110.637 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 76' ' ' LEU . 63.1 t -70.26 -49.32 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.887 -1.051 . . . . 72.1 111.518 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 65' ' ' GLU . 33.4 mt -63.28 -39.85 95.73 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.814 0.846 . . . . 42.42 111.069 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.96 -32.93 73.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.31 1.044 . . . . 72.41 111.579 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.16 -6.69 21.91 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.247 0.619 . . . . 63.51 112.44 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.98 61.54 3.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.906 1.283 . . . . 75.2 111.383 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.495 ' HB2' HG13 ' A' ' 71' ' ' VAL . 59.1 mt -93.95 132.05 38.79 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.371 -0.831 . . . . 73.21 109.945 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 p -79.4 136.88 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.445 0.698 . . . . 71.22 109.881 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.69 144.46 10.92 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.829 1.652 . . . . 71.32 113.58 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.7 mmm -147.95 104.18 3.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 106.346 -1.724 . . . . 74.42 106.346 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -93.01 136.58 33.14 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.9 -0.778 . . . . 74.32 108.9 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 52.1 t -65.56 -14.22 60.62 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.618 0.767 . . . . 72.01 110.842 173.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -75.75 -47.62 25.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.941 . . . . 64.43 110.617 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.17 -33.2 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.137 -0.938 . . . . 73.13 110.703 -175.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.49 22.44 12.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.632 1.173 . . . . 70.34 111.704 -166.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 81' ' ' CYS . . . -49.82 -56.41 10.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.453 0.701 . . . . 71.33 112.284 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.8 m -70.39 -33.68 71.67 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.397 -0.82 . . . . 54.32 111.018 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 42.5 tpp -66.08 -36.86 84.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.059 0.944 . . . . 73.21 110.55 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.507 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 64.1 t80 -72.85 -29.21 63.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.82 0.848 . . . . 74.13 110.576 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -40.91 98.92 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.398 -0.593 . . . . 75.54 109.398 170.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.84 93.97 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.922 -0.581 . . . . 52.32 110.695 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.507 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 58.1 m-85 -60.61 -52.64 64.3 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-O 118.777 -0.63 . . . . 73.53 110.797 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mm -58.47 -37.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.641 0.776 . . . . 64.44 111.56 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -65.17 -49.28 70.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.956 0.502 . . . . 74.44 111.42 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -47.12 83.44 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.612 -0.884 . . . . 71.11 108.612 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 152' ' ' GLN . 22.6 t80 -52.55 -56.61 14.03 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.888 2.075 . . . . 52.21 112.195 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.1 ttt -59.17 -50.81 72.6 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.985 0.803 . . . . 71.23 109.773 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -61.68 -36.05 79.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.672 -0.694 . . . . 53.21 111.338 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.11 -52.88 29.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.015 0.926 . . . . 65.12 111.525 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.93 -31.88 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.163 0.585 . . . . 73.3 112.563 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.15 -43.15 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.492 -0.559 . . . . 71.25 109.492 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.93 -38.83 87.17 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.912 0.885 . . . . 74.14 110.622 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -63.22 -50.88 68.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.206 1.002 . . . . 63.33 109.998 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ttt -63.52 -43.13 98.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.118 -0.946 . . . . 74.25 110.725 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -74.21 -23.01 59.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.845 0.858 . . . . 62.43 111.837 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.464 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 29.0 ttmt -70.5 -20.51 62.84 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.708 . . . . 62.25 109.783 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -112.83 1.21 15.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.469 1.108 . . . . 62.14 111.218 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.35 -68.97 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.005 0.522 . . . . 71.54 110.711 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.88 11.88 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.487 1.915 . . . . 73.23 115.079 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -83.51 -8.75 59.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.909 . . . . 73.03 110.581 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 80.01 -45.21 0.29 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.774 1.63 . . . . 75.42 113.974 169.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.01 71.77 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.477 0.58 . . . . 73.24 112.493 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.83 -44.79 22.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.378 0.671 . . . . 63.21 109.791 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.09 -23.53 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.299 -0.864 . . . . 74.24 111.242 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.64 -47.75 74.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.497 1.119 . . . . 72.05 110.172 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.31 95.36 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 124.098 0.874 . . . . 63.44 110.078 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.47 -45.21 80.45 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.259 0.974 . . . . 65.41 111.752 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.43 -45.88 84.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.341 0.656 . . . . 73.34 110.616 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -65.15 -39.55 93.14 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.255 -1.339 . . . . 64.43 110.47 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.712 ' HG3' HD22 ' A' ' 26' ' ' LEU . 14.0 tppt? -69.07 -49.58 56.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.598 0.759 . . . . 71.42 110.43 -173.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.458 ' HA ' HD21 ' A' ' 26' ' ' LEU . 8.5 tp -72.4 -37.75 58.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 123.374 0.669 . . . . 61.41 110.978 -174.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -66.86 -39.96 87.73 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.184 -0.673 . . . . 75.12 109.184 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.3 99.92 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.648 0.592 . . . . 51.33 112.414 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -66.04 -47.36 74.64 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.138 0.575 . . . . 65.44 110.203 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -69.7 -40.73 79.63 Favored 'Isoleucine or valine' 0 C--N 1.361 1.104 0 CA-C-O 118.476 -0.773 . . . . 71.44 111.565 -174.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.15 -33.22 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 119.495 1.043 . . . . 72.23 110.272 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -72.38 -34.06 67.66 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.9 0.88 . . . . 44.15 110.769 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.623 HD21 HG21 ' A' ' 155' ' ' ILE . 28.7 tp -81.54 -26.28 35.19 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.361 1.064 . . . . 74.22 111.197 -174.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.0 mt -88.24 4.47 45.67 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.834 0.854 . . . . 62.0 111.461 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.55 85.84 0.3 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 123.632 0.773 . . . . 65.42 110.284 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -62.22 -6.83 3.41 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.194 1.398 . . . . 73.23 114.753 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.97 -47.07 84.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.028 0.931 . . . . 74.44 110.865 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.549 ' H ' ' HD3' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -112.22 -31.77 6.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.625 1.17 . . . . 61.41 110.873 174.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.73 -1.93 36.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.017 0.927 . . . . 71.31 113.218 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -10.88 4.45 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.474 0.579 . . . . 71.01 112.311 171.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.5 21.71 4.43 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.098 0.959 . . . . 70.11 110.788 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.57 137.71 32.09 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.636 -0.505 . . . . 75.2 109.636 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -111.15 145.83 37.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.654 -1.61 . . . . 73.22 106.654 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.429 ' HB3' HG11 ' A' ' 153' ' ' VAL . 59.9 m-85 -125.32 141.11 52.27 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.296 -1.002 . . . . 73.54 108.296 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 68.2 m-85 -149.32 147.98 28.99 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 124.165 0.986 . . . . 75.42 108.394 -175.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.534 ' HB ' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -150.97 147.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.065 -1.087 . . . . 65.01 108.065 -177.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.78 139.04 42.66 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.385 -1.086 . . . . 72.31 110.385 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.65 -21.16 28.53 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.505 0.653 . . . . 75.21 109.978 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.75 -46.41 75.49 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.422 -0.955 . . . . 73.31 108.422 164.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.58 98.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.173 -1.376 . . . . 71.51 111.668 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.92 -46.38 52.96 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.262 0.625 . . . . 73.11 111.649 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.48 -41.32 93.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.188 0.595 . . . . 73.34 111.148 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -63.76 -58.45 11.04 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.245 -0.742 . . . . 55.43 111.245 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 176.63 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.389 1.076 . . . . 52.34 108.548 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -41.41 118.84 1.11 Allowed 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.917 0.887 . . . . 61.0 113.267 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -38.71 -41.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.258 1.423 . . . . 73.25 112.73 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.72 -34.8 4.59 Favored Glycine 0 CA--C 1.502 -0.773 0 CA-C-N 114.681 -1.145 . . . . 70.13 112.224 -175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 20.5 pm0 -98.1 156.59 16.59 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.702 -0.851 . . . . 71.02 108.702 173.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.534 HG13 ' HB ' ' A' ' 140' ' ' ILE . 24.9 t -109.24 143.96 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 107.123 -1.436 . . . . 71.42 107.123 171.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.427 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -63.28 108.79 1.38 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.73 0.812 . . . . 62.15 109.657 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.623 HG21 HD21 ' A' ' 127' ' ' LEU . 58.9 mt -86.5 104.38 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.746 0.818 . . . . 74.43 109.337 -170.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 44.2 mm -89.51 100.11 10.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.451 -0.795 . . . . 73.53 110.048 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.35 95.14 7.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.939 -1.134 . . . . 54.34 107.939 170.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 36.9 p90 -85.56 109.32 18.45 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.627 -0.879 . . . . 71.32 108.627 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -100.43 -179.48 4.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.855 1.262 . . . . 63.15 108.747 -172.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -124.08 120.59 32.81 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.801 0.728 . . . . 75.34 110.408 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -90.08 89.49 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.393 -1.336 . . . . 72.43 107.393 170.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.56 33.78 20.4 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.624 -1.171 . . . . 64.5 111.926 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 111.54 -23.76 17.03 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.753 -0.471 . . . . 73.32 113.28 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.6 m -86.0 125.24 33.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.685 -0.857 . . . . 73.05 108.685 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 20.5 tt0 -72.08 121.96 20.13 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.433 0.56 . . . . 72.3 109.723 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.0 p -117.46 90.25 34.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.892 1.277 . . . . 75.11 109.037 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 98.4 Cg_exo -50.2 125.92 16.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.226 2.617 . . . . 71.55 112.473 167.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.0 m -123.82 115.06 20.72 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.904 -0.776 . . . . 74.52 108.904 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp -76.51 130.7 38.3 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.054 0.942 . . . . 72.35 108.909 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.2 ttp -128.14 123.0 33.35 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.06 0.944 . . . . 70.42 109.174 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 154' ' ' ALA . 95.2 mt -139.11 157.58 45.72 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.341 1.456 . . . . 64.22 107.614 176.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 174' ' ' GLU . 13.6 p -78.25 131.97 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.891 -0.781 . . . . 41.43 108.891 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -52.22 -28.77 19.77 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.637 1.575 . . . . 75.4 111.983 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.419 ' H ' HG22 ' A' ' 172' ' ' VAL . 15.4 tp10 -67.15 -34.95 78.65 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.243 1.017 . . . . 74.11 111.844 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.18 -13.43 15.43 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.224 0.61 . . . . 74.22 112.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.513 HG21 ' HB3' ' A' ' 28' ' ' TYR . 11.0 tp -108.93 161.91 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.084 -1.45 . . . . 71.35 107.084 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 42.3 mm -135.79 132.26 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.092 0.957 . . . . 63.33 108.593 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.3 96.95 5.29 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.129 -1.063 . . . . 63.13 108.129 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 41.4 tt0 -99.19 102.07 13.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.482 -0.933 . . . . 71.42 108.482 -174.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.17 134.08 45.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.549 0.74 . . . . 75.15 110.546 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.7 t -117.76 96.15 5.25 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.239 -1.023 . . . . 65.31 108.239 173.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.07 153.62 42.95 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.312 0.645 . . . . 74.34 109.919 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.253 1.265 0 CA-C-N 115.456 -0.793 . . . . 71.11 108.988 177.258 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.598 0.713 . . . . 73.35 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.47 160.59 29.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.106 0.962 . . . . 65.25 108.431 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 28.1 mt -116.74 118.9 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.573 -1.269 . . . . 72.32 107.573 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -97.92 97.23 8.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.362 -0.977 . . . . 70.22 108.362 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -111.43 110.29 20.67 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.199 0.6 . . . . 75.22 109.679 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 9.8 t70 -83.85 135.93 34.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.643 -1.614 . . . . 73.32 106.643 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.7 pt -64.04 -17.87 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 118.542 0.61 . . . . 71.31 112.232 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -113.98 -52.07 2.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.383 1.073 . . . . 74.22 110.47 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -90.05 17.46 6.89 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.622 -1.172 . . . . 73.02 111.634 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 29.0 t70 -46.91 -43.84 19.24 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.034 1.333 . . . . 74.42 112.671 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.24 -19.3 65.78 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.117 -1.401 . . . . 71.31 111.906 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.591 ' HG3' ' HA3' ' A' ' 141' ' ' GLY . 6.9 mm-40 -120.8 12.5 11.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.808 1.243 . . . . 74.44 111.403 -174.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.96 -148.34 0.34 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.433 0.693 . . . . 73.42 109.794 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -150.07 160.14 43.87 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.435 0.562 . . . . 75.45 111.388 -163.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 60.0 p -124.38 -160.77 0.95 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.026 0.93 . . . . 73.24 109.573 165.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 74.11 -162.86 0.08 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.073 0.949 . . . . 73.24 110.905 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -96.98 58.01 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.549 0.69 . . . . 73.33 110.307 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.9 149.27 62.99 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 115.427 -0.806 . . . . 74.0 109.007 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 16.5 Cg_exo -68.02 117.6 5.03 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 121.684 1.589 . . . . 71.25 112.025 -176.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.457 ' SD ' ' CD1' ' A' ' 28' ' ' TYR . 12.6 tmm? -148.98 139.44 22.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.042 0.937 . . . . 64.12 109.69 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -139.45 158.28 44.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.269 1.028 . . . . 75.53 109.147 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.12 119.76 37.33 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.469 -0.938 . . . . 74.21 108.469 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.23 136.15 43.34 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 123.808 0.843 . . . . 74.21 108.93 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 65.51 8.3 4.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.269 1.028 . . . . 71.22 113.044 171.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 55.42 30.49 15.08 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.265 1.026 . . . . 60.32 111.626 -171.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.498 HD11 ' HB ' ' A' ' 120' ' ' ILE . 21.3 tp -132.93 -44.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.881 -0.6 . . . . 73.03 111.076 -172.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.08 140.6 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.967 0.507 . . . . 72.23 109.988 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.457 ' CD1' ' SD ' ' A' ' 20' ' ' MET . 30.2 m-85 -92.47 115.09 27.78 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 109.179 -0.675 . . . . 64.41 109.179 168.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.13 126.99 31.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.747 -1.205 . . . . 74.41 107.747 166.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.5 t80 -117.06 104.93 11.74 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.973 -1.491 . . . . 74.54 106.973 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 41.0 mmtm -79.48 143.38 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.377 0.671 . . . . 71.05 111.374 -175.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -139.77 -168.55 11.35 Favored Glycine 0 C--O 1.241 0.582 0 CA-C-N 114.677 -1.147 . . . . 74.45 110.51 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -118.97 150.85 39.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.36 0.664 . . . . 74.02 110.913 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -80.3 107.73 13.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.639 -1.245 . . . . 65.34 107.639 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.6 m -132.96 155.8 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.773 0.829 . . . . 74.42 109.159 -173.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 m -94.09 141.14 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.446 -0.576 . . . . 62.22 109.446 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.757 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -142.13 110.08 5.86 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.604 -1.258 . . . . 73.31 107.604 -178.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 15.6 tptm -89.23 161.66 16.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.942 0.897 . . . . 72.12 108.957 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -45.88 -38.62 7.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.64 0.978 . . . . 73.23 113.64 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.39 42.29 1.37 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.586 -0.279 . . . . 60.13 112.419 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 11.7 tp10 -164.52 142.51 6.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.55 . . . . 73.43 111.057 -176.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 tp . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 124.392 1.077 . . . . 70.02 108.507 172.659 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.516 -0.343 0 N-CA-C 104.179 -2.526 . . . . 63.23 104.179 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 77.0 -51.0 0.56 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 125.198 1.399 . . . . 51.22 113.339 157.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -139.15 158.37 44.29 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.552 0.741 . . . . 65.32 109.613 -164.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.4 -158.06 29.0 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 111.235 -0.746 . . . . 74.45 111.235 160.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 pt -110.14 147.3 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.375 0.67 . . . . 75.13 109.209 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.67 -26.84 68.85 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.885 0.874 . . . . 75.45 111.748 -174.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 169' ' ' LEU . 41.7 mm -54.01 -48.21 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.356 0.662 . . . . 53.21 110.205 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.5 t -80.71 -51.08 16.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.017 -0.992 . . . . 73.12 111.674 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.757 HD13 ' HB2' ' A' ' 37' ' ' ARG . 50.6 mt -64.49 -25.47 68.01 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.809 0.844 . . . . 61.22 112.353 -171.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -91.18 -43.68 9.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.571 0.748 . . . . 64.52 110.526 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -94.9 9.51 38.96 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.779 0.659 . . . . 51.12 112.779 -170.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? 64.02 33.77 11.93 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.991 0.807 . . . . 64.33 110.85 168.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 72.3 mt -78.5 120.74 23.64 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.543 -0.54 . . . . 55.32 109.543 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.18 136.37 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.697 0.799 . . . . 75.24 109.158 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.17 145.69 55.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.243 1.017 . . . . 75.14 113.194 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.9 mtt -133.06 102.9 5.78 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 105.211 -2.144 . . . . 75.11 105.211 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -68.45 125.4 26.36 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 108.892 -0.781 . . . . 72.23 108.892 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.6 -25.17 59.65 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.924 0.869 . . . . 74.41 111.071 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -70.01 -32.77 71.12 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 113.792 -1.549 . . . . 64.11 110.721 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -103.83 -39.72 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.347 0.659 . . . . 75.43 111.02 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.4 -11.89 39.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.063 0.945 . . . . 74.42 112.779 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -37.63 -51.85 1.21 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.391 1.626 . . . . 52.11 115.391 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.5 m -68.86 -45.14 71.83 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.074 0.464 . . . . 72.14 111.374 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 72.9 mtm -67.07 -27.99 67.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.177 -0.919 . . . . 70.31 110.432 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.463 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 81.0 t80 -70.79 -39.99 72.82 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.73 0.812 . . . . 73.22 110.78 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -66.13 -31.06 71.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.671 0.388 . . . . 73.2 110.657 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.7 82.63 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.945 -0.571 . . . . 74.24 110.257 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 19.4 m-85 -60.81 -41.69 96.2 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 109.669 -0.493 . . . . 71.33 109.669 173.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.73 -29.94 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.632 0.773 . . . . 73.32 110.625 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -62.79 -53.43 54.39 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.188 0.449 . . . . 73.12 111.381 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.11 -47.33 71.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.252 0.345 . . . . 61.24 110.389 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -45.74 -62.7 1.19 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.61 1.964 . . . . 75.22 112.054 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 39.3 ttp -57.23 -47.99 79.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.583 1.153 . . . . 75.31 111.43 -175.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -68.4 -35.7 78.05 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.783 -0.644 . . . . 74.12 111.896 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -47.31 63.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.525 0.73 . . . . 74.11 110.251 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 174' ' ' GLU . 19.6 m -71.53 -33.09 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.915 -0.584 . . . . 71.11 112.44 -173.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.26 -39.9 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.536 -0.542 . . . . 73.31 109.536 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.1 -46.62 75.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.023 0.929 . . . . 75.5 111.578 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.53 -43.98 92.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.501 0.72 . . . . 72.31 110.458 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -62.81 -50.1 72.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.466 1.106 . . . . 73.44 112.604 -174.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.689 ' HA ' HG11 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -70.03 -32.72 71.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.435 0.294 . . . . 71.24 111.68 -172.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -58.47 -21.67 52.25 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.154 0.502 . . . . 70.11 111.596 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -106.55 -26.1 11.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.605 0.762 . . . . 51.21 111.831 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 112' ' ' ASP . 13.3 m120 -146.46 35.12 0.96 Allowed 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 123.11 0.564 . . . . 64.43 112.052 -167.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.538 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 31.1 ttp180 -69.83 7.55 0.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.006 0.922 . . . . 73.3 112.748 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.3 -21.88 26.9 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.136 0.974 . . . . 72.51 111.248 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 113' ' ' VAL . 97.8 mttt 83.26 -8.84 1.1 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.685 1.594 . . . . 63.25 113.029 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.34 88.15 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.59 0.632 . . . . 64.44 110.004 168.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 107' ' ' ASN . 15.5 t0 -95.36 -44.54 7.52 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.072 -0.967 . . . . 64.11 110.69 -170.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.756 HG12 ' SD ' ' A' ' 103' ' ' MET . 35.8 m -76.37 -31.72 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 113.114 0.783 . . . . 71.04 113.114 -176.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.32 -40.12 95.3 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.163 0.438 . . . . 63.01 110.158 172.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.59 67.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.39 -0.823 . . . . 72.52 110.077 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.99 -47.13 81.55 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.827 0.851 . . . . 73.02 111.605 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -63.83 -43.9 94.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.114 0.966 . . . . 74.11 110.434 -176.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.69 -45.73 91.22 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 123.753 0.658 . . . . 70.42 110.433 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.17 -39.31 68.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.256 -0.884 . . . . 74.22 111.559 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.498 ' HB ' HD11 ' A' ' 26' ' ' LEU . 10.8 tp -73.49 -38.78 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 117.95 0.341 . . . . 63.23 110.105 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -66.93 -44.0 81.81 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.041 0.536 . . . . 75.22 109.857 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.55 -38.23 95.47 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 124.088 0.867 . . . . 54.33 112.786 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 25.5 t90 -66.36 -52.69 44.4 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 123.874 0.87 . . . . 64.11 110.221 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.4 m -69.69 -36.9 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 119.152 -0.451 . . . . 74.44 111.842 -176.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.58 -33.95 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.606 0.639 . . . . 63.43 110.372 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.2 p -80.52 -34.06 35.92 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.497 0.319 . . . . 62.44 111.004 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 155' ' ' ILE . 17.2 tp -69.53 -27.72 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.856 0.862 . . . . 73.3 110.623 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.3 mt -94.49 3.53 55.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.948 0.899 . . . . 73.25 111.438 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.01 95.0 4.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.046 -0.724 . . . . 31.44 109.046 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -58.3 -19.21 32.95 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.69 1.196 . . . . 72.53 113.774 -170.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.11 -45.91 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.315 1.046 . . . . 62.33 111.737 -173.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -108.58 -37.57 5.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 64.14 110.168 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -77.4 -1.84 32.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.664 1.186 . . . . 74.11 113.77 -170.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.05 -15.11 8.12 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 122.884 0.473 . . . . 74.11 111.179 164.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.22 26.09 6.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.019 0.927 . . . . 54.24 110.702 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -89.14 155.18 19.59 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.28 -1.007 . . . . 64.52 108.28 164.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -130.03 113.7 14.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.977 -1.49 . . . . 71.21 106.977 170.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.16 146.8 26.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.721 -0.844 . . . . 72.42 108.721 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 74.0 m-85 -143.47 162.49 35.66 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 123.405 0.682 . . . . 72.25 109.584 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.69 154.14 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.065 -1.457 . . . . 70.44 107.065 170.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.591 ' HA3' ' HG3' ' A' ' 12' ' ' GLU . . . -57.09 134.55 52.26 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-O 119.717 -0.49 . . . . 50.13 112.28 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 39.5 tt0 -61.57 -44.55 96.81 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.994 0.517 . . . . 72.34 110.26 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -57.16 -41.5 79.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 74.33 111.417 177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.629 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -65.43 -35.14 80.03 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.431 -0.804 . . . . 74.44 111.15 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.77 4.04 48.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.555 1.142 . . . . 64.52 112.801 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 52.9 mt-10 -110.34 -42.14 4.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.427 0.691 . . . . 63.31 110.219 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.89 67.91 0.18 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.813 -0.631 . . . . 65.21 112.977 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -155.19 -92.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.405 0.682 . . . . 72.24 109.954 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -155.23 152.14 28.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.221 1.008 . . . . 74.25 109.763 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -70.89 -36.86 72.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.75 -0.659 . . . . 64.52 109.992 169.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 35.33 -119.73 0.4 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 125.516 1.76 . . . . 43.42 116.437 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -94.49 128.53 41.13 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.373 -0.602 . . . . 64.12 109.373 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.9 t -79.85 131.67 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.753 0.821 . . . . 74.12 109.422 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.3 100.19 2.09 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.209 1.004 . . . . 53.02 109.229 170.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.62 HG21 HD21 ' A' ' 127' ' ' LEU . 86.8 mt -92.11 113.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.555 -0.535 . . . . 74.44 109.555 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 137' ' ' ALA . 42.0 mm -101.73 125.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.624 0.37 . . . . 54.25 110.855 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.72 120.28 36.12 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.653 -1.24 . . . . 74.5 107.653 165.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.612 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 12.0 p90 -95.21 102.73 14.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.482 -1.303 . . . . 71.21 107.482 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.462 ' O ' HG22 ' A' ' 166' ' ' VAL . 11.3 tpt180 -87.39 102.52 14.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.387 0.675 . . . . 63.0 109.891 -166.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.61 109.11 2.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.385 1.074 . . . . 71.23 111.803 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.83 117.74 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 123.966 0.906 . . . . 73.41 109.624 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.3 t70 70.36 -62.13 0.44 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.346 1.858 . . . . 75.34 111.408 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -171.68 21.02 0.07 OUTLIER Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.013 -0.54 . . . . 73.23 112.513 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.9 m -136.26 127.75 28.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.743 0.817 . . . . 71.43 109.227 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 4.2 mp0 -81.17 137.7 35.89 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.098 0.559 . . . . 71.32 110.03 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 159' ' ' ARG . 34.2 m -109.42 113.19 58.59 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.4 0.68 . . . . 62.53 109.252 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.51 114.84 2.22 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.406 2.737 . . . . 73.35 112.361 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 m -120.68 103.9 9.49 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.127 -1.064 . . . . 74.31 108.127 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.3 tp -77.59 129.75 36.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 108.882 -0.784 . . . . 64.41 108.882 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.4 mtt -112.17 122.76 48.65 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.575 -0.898 . . . . 62.34 108.575 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -133.71 130.24 37.87 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 106.626 -1.62 . . . . 42.1 106.626 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 176' ' ' ILE . 14.8 p -66.25 133.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.617 -0.883 . . . . 64.33 108.617 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -63.29 -4.89 2.86 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.183 1.179 . . . . 51.24 114.183 -168.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . 42.0 mm-40 -95.68 -17.59 21.17 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.361 0.875 . . . . 75.3 113.361 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -108.62 -0.87 19.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.902 0.481 . . . . 64.53 110.49 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 172' ' ' VAL . 5.9 tp -126.88 119.79 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 106.653 -1.61 . . . . 72.22 106.653 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.8 mm -102.96 110.78 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.339 -0.846 . . . . 72.13 109.392 -172.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.52 96.06 1.89 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.061 -1.427 . . . . 50.11 109.518 172.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.597 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 10.5 tp10 -92.31 98.76 11.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.079 -1.452 . . . . 74.52 107.079 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -87.98 95.27 10.06 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.151 -0.932 . . . . 63.31 110.959 -165.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.2 t -92.79 88.88 6.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.261 -1.014 . . . . 74.13 108.261 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.33 54.43 0.73 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.464 1.106 . . . . 73.45 109.691 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.742 -1.117 . . . . 63.34 108.895 177.352 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' HG3' ' HB3' ' A' ' 181' ' ' CYS . 12.6 tpt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 109.965 -0.383 . . . . 55.43 109.965 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 180' ' ' LYS . 73.5 mt -132.51 134.08 44.57 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.969 0.908 . . . . 75.25 109.341 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 68.7 mt -103.0 120.94 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.275 -1.379 . . . . 63.12 107.275 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.745 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 74.6 m-85 -105.08 135.88 45.61 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.534 -0.543 . . . . 75.13 109.534 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' HG3' ' HB ' ' A' ' 177' ' ' ILE . 0.2 OUTLIER -137.48 146.25 44.02 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.714 0.806 . . . . 74.42 110.12 179.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.412 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 27.0 t70 -106.35 172.4 6.83 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.903 1.281 . . . . 53.13 107.827 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.566 HD12 HD21 ' A' ' 98' ' ' ASN . 72.5 mt -64.81 -35.84 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 O-C-N 121.458 -0.776 . . . . 72.12 111.437 175.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -110.82 -43.18 3.85 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.333 1.053 . . . . 74.32 110.903 -167.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.2 p -98.32 20.25 12.9 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.361 1.065 . . . . 75.24 111.003 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.412 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 12.6 t70 -45.45 -43.03 11.09 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.523 1.929 . . . . 63.14 113.443 -175.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -49.51 -61.68 1.97 Allowed 'General case' 0 N--CA 1.476 0.87 0 O-C-N 125.626 1.829 . . . . 64.53 112.626 -166.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -125.3 21.76 7.9 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.779 0.659 . . . . 60.22 112.779 -173.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 tp -49.12 -65.37 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 112.578 0.584 . . . . 54.31 112.578 -170.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.745 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 22.7 t -158.19 173.46 16.67 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 122.759 0.424 . . . . 73.13 110.282 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 35.8 p 172.88 89.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.078 0.951 . . . . 71.31 111.205 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.8 t70 -174.0 167.93 4.22 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.899 1.28 . . . . 73.41 109.026 173.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 m -68.88 65.11 0.13 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.297 1.039 . . . . 60.51 112.448 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 60.4 m-85 -87.9 134.07 36.1 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 122.976 0.51 . . . . 64.34 109.672 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HG2' ' HB3' ' A' ' 31' ' ' LYS . 52.6 Cg_endo -67.32 121.09 8.18 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 122.121 1.881 . . . . 63.22 110.401 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.2 ptm -132.66 147.02 52.33 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.082 -0.508 . . . . 64.2 110.633 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.657 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 26.2 mtpp -131.69 158.71 40.39 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.621 1.168 . . . . 65.44 108.53 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.8 tp -117.63 110.88 18.44 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.673 -1.232 . . . . 74.54 107.673 167.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 p -98.17 139.13 20.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.907 0.883 . . . . 60.52 109.38 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t70 62.73 10.45 4.22 Favored 'General case' 0 CA--C 1.566 1.559 0 C-N-CA 124.425 1.09 . . . . 74.2 112.926 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.5 t70 51.27 38.66 22.0 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.402 1.081 . . . . 64.03 110.622 -167.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.426 HD11 ' HB ' ' A' ' 120' ' ' ILE . 39.2 tp -134.74 -50.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.943 -0.571 . . . . 73.34 111.469 -172.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.9 t -125.11 138.29 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.341 0.657 . . . . 72.43 110.527 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.438 ' CE2' ' HA ' ' A' ' 173' ' ' LYS . 36.0 m-85 -86.1 119.96 26.96 Favored 'General case' 0 C--O 1.247 0.973 0 C-N-CA 124.077 0.951 . . . . 73.23 110.186 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.657 ' HB2' ' HB2' ' A' ' 21' ' ' LYS . 25.5 mm-40 -88.56 103.5 15.96 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 124.52 1.138 . . . . 75.11 108.569 170.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 25.0 t80 -109.74 103.92 12.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.423 -1.695 . . . . 72.44 106.423 -174.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 42.1 tttm -85.04 145.0 27.91 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.103 0.477 . . . . 73.23 111.048 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -133.78 -163.41 10.37 Favored Glycine 0 C--N 1.339 0.703 0 CA-C-N 114.989 -1.005 . . . . 52.55 111.878 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -144.21 143.15 30.92 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.639 0.776 . . . . 73.31 109.224 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -74.25 121.53 21.42 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.468 -0.567 . . . . 65.42 109.468 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 72' ' ' LEU . 18.4 m -146.44 166.66 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.635 0.774 . . . . 64.3 109.163 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG11 ' OG ' ' A' ' 47' ' ' SER . 11.4 m -128.84 139.69 51.23 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.225 -1.028 . . . . 75.43 108.225 174.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.703 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 17.9 tpt180 -100.13 108.41 20.54 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.364 -1.347 . . . . 74.34 107.364 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.685 ' HG2' HG22 ' A' ' 64' ' ' VAL . 5.6 tmtm? -124.72 106.39 10.04 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.12 -2.178 . . . . 73.24 105.12 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -72.67 79.58 1.1 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 121.742 0.782 . . . . 61.32 110.249 -176.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.67 -35.76 0.34 Allowed Glycine 0 C--O 1.237 0.332 0 CA-C-N 114.693 -1.14 . . . . 73.33 111.92 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HG2' HG23 ' A' ' 43' ' ' VAL . 42.6 tt0 -174.9 105.0 0.09 Allowed 'General case' 0 C--N 1.357 0.897 0 N-CA-C 109.577 -0.527 . . . . 74.54 109.577 -174.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.7 tt -73.36 98.77 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 CA-C-O 121.5 0.667 . . . . 65.44 110.743 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.48 HG23 ' HG2' ' A' ' 41' ' ' GLU . 61.4 t -128.37 116.74 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 108.255 -1.017 . . . . 75.44 108.255 172.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.69 -39.97 94.58 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.497 1.119 . . . . 74.42 111.305 -173.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.88 -11.01 59.84 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.672 0.789 . . . . 55.32 111.43 174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.95 66.21 2.53 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.095 -0.802 . . . . 74.24 111.095 176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.426 ' OG ' HG11 ' A' ' 36' ' ' VAL . 46.4 m -136.84 158.41 44.53 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.098 0.959 . . . . 75.04 109.319 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -67.99 113.28 13.93 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.612 0.765 . . . . 74.11 110.338 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.57 92.49 0.36 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.782 2.321 . . . . 64.03 110.624 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.3 t -73.39 94.94 2.12 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.788 -0.642 . . . . 71.21 109.374 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.06 -59.45 3.46 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.725 0.81 . . . . 74.11 111.062 -175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -99.2 -70.32 0.73 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.302 -0.863 . . . . 73.32 109.929 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -127.31 -47.22 1.46 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.589 0.756 . . . . 63.34 110.961 -172.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.36 28.02 68.68 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.114 -0.794 . . . . 73.41 111.114 -170.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.89 39.18 0.98 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.513 1.125 . . . . 34.44 111.047 -172.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 60' ' ' SER . 5.7 mm-40 -61.58 106.62 0.68 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.049 0.939 . . . . 73.25 108.531 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -53.36 -43.97 68.2 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 124.166 0.916 . . . . 73.11 112.361 -169.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -97.68 91.45 5.41 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.588 -0.893 . . . . 53.54 108.588 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.96 85.97 0.25 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.57 -0.741 . . . . 74.33 112.569 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 20.0 m -56.01 -34.98 66.31 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.906 0.882 . . . . 61.45 112.586 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -140.64 -169.02 2.7 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.719 1.208 . . . . 51.43 109.109 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -106.27 54.1 0.69 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.665 0.786 . . . . 71.42 109.225 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 60.66 32.95 20.38 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.591 1.156 . . . . 65.54 109.684 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.685 HG22 ' HG2' ' A' ' 38' ' ' LYS . 18.3 t -100.81 92.29 2.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.657 -0.868 . . . . 55.22 108.657 177.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.1 mp0 -69.62 74.52 0.4 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.137 -1.061 . . . . 72.31 108.137 166.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 39.4 ttp85 -75.96 134.43 40.2 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.636 1.175 . . . . 53.24 110.617 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.0 -141.38 6.78 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 112.089 -0.404 . . . . 44.52 112.089 170.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.441 HD11 HD12 ' A' ' 156' ' ' ILE . 18.4 pt -111.18 158.72 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 122.799 0.44 . . . . 74.34 110.125 170.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -62.94 -30.48 71.6 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 75.24 111.915 -171.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' A' ' 169' ' ' LEU . 69.2 mt -59.75 -52.61 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.375 1.07 . . . . 63.45 109.955 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.5 t -68.24 -48.04 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 114.251 -1.34 . . . . 75.31 111.443 -177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.479 HD12 HG23 ' A' ' 35' ' ' VAL . 79.3 mt -67.45 -23.25 65.5 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.577 0.751 . . . . 71.22 112.071 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -53.61 -53.84 46.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.181 0.992 . . . . 74.52 110.893 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -114.69 -1.61 13.25 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.436 -0.802 . . . . 75.34 112.427 -175.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.3 mtmm 66.71 70.14 0.4 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.448 1.099 . . . . 65.53 109.427 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.7 mt -87.7 133.69 33.8 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.397 -0.964 . . . . 75.12 108.397 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.68 129.55 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.678 0.391 . . . . 73.21 110.369 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -72.42 147.04 46.54 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.477 0.711 . . . . 71.54 112.483 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.3 mtp -148.03 143.97 27.59 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 126.515 1.926 . . . . 73.33 106.322 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.0 m-80 -126.97 124.04 38.54 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.211 -1.033 . . . . 72.43 108.211 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.538 ' SG ' ' HD3' ' A' ' 130' ' ' LYS . 16.9 p -58.96 -15.27 12.13 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.844 0.857 . . . . 73.23 112.624 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.405 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 98.4 m-85 -57.29 -48.7 78.23 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.237 1.015 . . . . 72.35 111.545 174.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.81 -39.16 6.4 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.396 0.678 . . . . 73.23 110.543 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -82.76 20.11 1.22 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.61 1.164 . . . . 74.52 112.516 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.97 49.75 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.929 0.891 . . . . 72.45 112.876 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.3 m -68.33 -50.68 51.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.025 0.53 . . . . 74.13 112.105 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 71.3 mmm -60.26 -47.49 85.78 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.93 0.892 . . . . 72.03 111.44 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -64.04 -36.22 83.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.587 -1.188 . . . . 75.4 111.095 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.7 -37.44 87.36 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.109 0.564 . . . . 60.24 110.697 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 94' ' ' LYS . . . -61.51 -48.99 78.54 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 116.001 -0.545 . . . . 55.25 109.986 176.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -65.24 -32.23 73.8 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.958 0.725 . . . . 75.43 112.958 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.9 mm -66.19 -41.19 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.239 0.616 . . . . 75.54 111.575 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.98 -36.42 82.14 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.622 0.249 . . . . 72.2 110.786 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.677 ' HD3' ' HA ' ' A' ' 150' ' ' ASN . 96.6 mttt -64.43 -47.05 80.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.733 0.813 . . . . 61.3 109.83 174.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -53.76 -62.41 1.68 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.964 1.706 . . . . 65.23 111.858 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.3 ptm -62.3 -38.15 88.28 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.411 0.444 . . . . 70.22 111.269 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -66.21 -42.26 89.0 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 110.286 -0.264 . . . . 60.51 110.286 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.566 HD21 HD12 ' A' ' 7' ' ' ILE . 7.9 t30 -65.59 -54.11 32.43 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.808 0.843 . . . . 72.31 111.445 -178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.552 HG11 HG11 ' A' ' 172' ' ' VAL . 17.8 m -67.4 -40.17 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 123.114 0.566 . . . . 73.21 112.173 -171.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 86.6 mt -69.4 -45.68 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 109.626 -0.509 . . . . 73.01 109.626 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -64.81 -35.23 80.42 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.371 0.668 . . . . 62.11 111.608 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -59.4 -47.35 85.77 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.878 . . . . 73.33 109.065 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.514 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.6 tpt -71.37 -28.32 63.96 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.631 -1.168 . . . . 65.13 111.178 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.489 ' HA ' HG11 ' A' ' 113' ' ' VAL . 29.6 mm-40 -67.43 -23.49 65.54 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.035 0.534 . . . . 73.23 111.394 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -86.02 -30.64 22.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.774 -0.648 . . . . 73.41 109.76 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.31 -36.58 58.23 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.333 0.653 . . . . 73.22 111.622 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -118.46 -66.68 1.05 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.83 0.852 . . . . 64.13 109.438 -170.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 74.86 -30.49 0.2 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.053 1.341 . . . . 73.24 112.892 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.89 -16.86 63.87 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.034 1.334 . . . . 44.45 113.671 -166.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 113' ' ' VAL . 40.4 mmtm 79.99 -2.55 2.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.237 1.415 . . . . 72.33 112.299 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.05 -60.36 2.9 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 122.921 0.488 . . . . 52.4 110.856 171.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -91.11 -34.34 15.1 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.728 -0.669 . . . . 63.03 111.592 -171.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' HG3' ' A' ' 103' ' ' MET . 26.9 m -68.96 -44.84 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 112.135 0.42 . . . . 50.01 112.135 -175.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 24.0 t70 -72.51 -32.91 66.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.558 0.743 . . . . 72.31 110.203 -176.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 119' ' ' LYS . . . -65.47 -53.08 47.82 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 123.772 0.67 . . . . 61.41 109.789 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -56.82 -37.63 71.48 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 114.618 -1.174 . . . . 72.23 110.603 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.1 -44.34 92.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.403 1.081 . . . . 72.31 111.158 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 46.0 mmtm -63.37 -38.5 91.38 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.566 0.541 . . . . 72.43 110.609 176.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 115' ' ' ALA . 13.9 mmmm -71.73 -49.47 38.98 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.774 -0.648 . . . . 71.31 111.084 -176.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.426 ' HB ' HD11 ' A' ' 26' ' ' LEU . 9.3 tp -74.02 -37.58 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 123.285 0.366 . . . . 73.44 110.732 -173.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.35 -45.53 72.59 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.678 -0.86 . . . . 35.22 108.678 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.99 97.34 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 116.007 -0.542 . . . . 72.33 112.271 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -64.25 -50.71 66.88 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.695 0.798 . . . . 71.53 110.441 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.497 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.1 m -67.57 -38.24 80.17 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 O-C-N 123.782 0.676 . . . . 71.14 111.198 -175.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.97 -39.93 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 CA-C-N 118.081 0.401 . . . . 60.52 110.538 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.7 t -70.61 -45.35 65.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.476 -0.329 . . . . 70.14 110.179 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.66 -32.03 73.37 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.897 1.279 . . . . 73.13 111.89 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 59.2 mt -88.47 3.12 51.29 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.052 0.541 . . . . 60.32 111.827 -176.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.19 92.49 6.9 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.004 0.522 . . . . 52.42 109.714 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.538 ' HD3' ' SG ' ' A' ' 81' ' ' CYS . 48.0 mtmt -60.4 -9.2 3.28 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.088 1.355 . . . . 74.15 114.266 -171.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -53.62 -47.65 70.05 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.517 0.727 . . . . 73.25 110.472 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.531 ' HD2' ' H ' ' A' ' 132' ' ' ARG . 0.2 OUTLIER -111.9 -34.4 6.01 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.101 -0.954 . . . . 74.1 110.767 172.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -73.29 -0.31 14.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.633 1.345 . . . . 70.05 114.633 -176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 130' ' ' LYS . 21.1 ptmt -50.56 -9.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.676 1.362 . . . . 51.01 114.676 173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -81.92 6.77 14.82 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.735 0.814 . . . . 74.42 111.732 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 157' ' ' GLU . 90.6 mt -89.41 140.99 28.96 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.355 0.662 . . . . 64.22 109.688 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -127.57 113.35 15.99 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.87 -1.9 . . . . 75.35 105.87 175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.446 ' HE2' ' SG ' ' A' ' 81' ' ' CYS . 65.0 m-85 -87.61 136.51 32.92 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 109.631 -0.507 . . . . 71.33 109.631 -172.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -135.44 153.28 51.83 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.012 -1.107 . . . . 72.22 108.012 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 8.2 tt -139.01 145.35 27.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 108.945 -0.761 . . . . 63.21 108.945 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.68 131.27 51.33 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.267 0.979 . . . . 73.53 112.222 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.98 -33.68 3.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.262 1.425 . . . . 63.44 112.522 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -73.48 -49.34 27.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.23 1.012 . . . . 73.14 110.563 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.82 -34.7 78.76 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.566 0.746 . . . . 62.01 111.72 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.72 -8.94 59.81 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.693 -0.685 . . . . 54.33 112.764 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -89.01 -41.83 12.12 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.058 0.456 . . . . 65.2 109.85 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -100.7 5.09 56.64 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.64 -0.709 . . . . 72.03 113.672 -175.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 60.45 34.74 20.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.833 0.853 . . . . 75.42 110.568 -177.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -63.18 178.37 0.51 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.719 1.208 . . . . 64.33 112.996 -173.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.677 ' HA ' ' HD3' ' A' ' 94' ' ' LYS . 4.2 t30 -88.11 8.17 28.12 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.716 -1.129 . . . . 74.11 109.614 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.25 144.65 48.71 Favored Glycine 0 C--N 1.359 1.853 0 CA-C-N 115.952 -0.567 . . . . 73.45 113.01 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.456 ' NE2' HD22 ' A' ' 171' ' ' LEU . 8.9 pt20 -85.0 162.74 19.24 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.672 0.789 . . . . 73.34 110.916 -174.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.15 125.36 40.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 114.814 -1.085 . . . . 72.32 110.015 177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.16 107.95 3.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.383 1.073 . . . . 75.13 109.36 169.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 66.6 mt -90.94 102.99 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 109.422 -0.585 . . . . 74.3 109.422 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.441 HD12 HD11 ' A' ' 68' ' ' ILE . 47.2 mm -93.22 148.03 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 108.939 -0.763 . . . . 74.3 108.939 -178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.638 ' HB3' HD23 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -139.17 147.41 41.81 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.735 0.814 . . . . 74.41 108.942 169.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -98.24 134.37 41.37 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.195 -1.039 . . . . 63.11 108.195 165.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 23.7 ttm180 -124.83 153.14 42.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.051 0.94 . . . . 61.15 108.849 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.76 93.99 4.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.941 0.337 . . . . 64.25 110.491 -176.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.3 p -119.37 123.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.716 0.806 . . . . 73.22 110.166 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 55.75 32.57 19.72 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.516 1.126 . . . . 74.44 112.612 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 77.45 23.01 68.89 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.181 -0.463 . . . . 43.02 113.422 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 m -128.05 125.8 40.04 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.254 0.622 . . . . 74.0 110.257 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 9.5 pt-20 -73.48 112.89 9.98 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.461 0.704 . . . . 71.51 109.267 169.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.93 106.89 46.91 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.483 0.713 . . . . 74.35 109.348 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.7 Cg_exo -76.16 117.05 4.52 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 122.675 2.25 . . . . 71.22 111.154 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.2 m -116.1 124.23 49.86 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.153 -0.684 . . . . 75.31 109.153 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 29.3 tp -76.99 137.7 39.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 124.395 1.078 . . . . 72.41 109.937 171.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 74.2 mtp -117.63 122.72 44.34 Favored 'General case' 0 C--O 1.247 0.944 0 N-CA-C 107.344 -1.354 . . . . 73.12 107.344 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.456 HD22 ' NE2' ' A' ' 152' ' ' GLN . 80.1 mt -136.33 147.85 47.62 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.076 -1.083 . . . . 71.24 108.076 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.552 HG11 HG11 ' A' ' 99' ' ' VAL . 10.0 p -75.46 144.65 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 109.464 -0.569 . . . . 74.35 109.464 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.438 ' HA ' ' CE2' ' A' ' 28' ' ' TYR . 12.8 ptmm? -57.0 -32.79 66.48 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.642 0.777 . . . . 63.44 112.188 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.432 ' H ' HG22 ' A' ' 172' ' ' VAL . 4.1 tp10 -85.82 1.1 51.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.809 0.844 . . . . 74.11 113.046 -165.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.46 -1.01 6.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.46 0.304 . . . . 70.52 111.637 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.24 141.19 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.624 0.77 . . . . 74.21 109.501 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.541 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.1 mm -126.88 114.0 35.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.214 -1.402 . . . . 72.32 107.214 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -84.47 127.0 33.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 109.235 -0.654 . . . . 63.11 109.235 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -116.3 101.78 8.98 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.075 -0.713 . . . . 72.14 109.075 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.424 ' HA ' HD23 ' A' ' 2' ' ' LEU . 36.0 ttpt -68.51 137.76 54.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.412 0.685 . . . . 71.51 110.539 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 21.8 t -131.87 88.3 2.55 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.623 -0.88 . . . . 63.02 108.623 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 95.3 mt -131.2 100.8 5.32 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.672 1.189 . . . . 71.53 108.257 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.559 1.298 0 C-N-CA 123.808 0.843 . . . . 73.41 110.718 -176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 108.772 -0.825 . . . . 72.11 108.772 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.0 mt -94.53 115.41 27.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.117 0.484 . . . . 44.22 110.497 -176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 49.8 mt -99.04 132.48 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.091 -1.077 . . . . 65.33 108.091 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.633 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 64.5 m-85 -121.76 132.39 54.59 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.484 -0.932 . . . . 71.44 108.484 178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.565 ' NZ ' ' HB2' ' A' ' 179' ' ' GLU . 3.5 mppt? -120.67 120.18 34.97 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.415 0.686 . . . . 73.42 110.877 -173.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.584 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 21.5 t70 -69.05 177.87 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.195 0.998 . . . . 70.23 108.797 170.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 pt -81.88 -29.57 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.838 -1.164 . . . . 74.11 111.62 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -114.05 -38.71 4.1 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.605 0.762 . . . . 64.35 110.64 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 m -96.28 15.81 20.06 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.833 -1.076 . . . . 70.21 109.686 -170.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 4.2 p-10 -54.62 -33.85 61.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.214 1.406 . . . . 73.22 113.253 -172.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -50.61 -57.39 8.32 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 125.382 1.676 . . . . 73.2 112.131 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -123.83 24.34 8.39 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 112.766 0.654 . . . . 74.53 112.766 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 2.7 tm? -60.28 -61.14 2.82 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.572 0.349 . . . . 64.35 110.552 -176.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 4' ' ' TYR . 35.6 t -155.21 161.27 41.23 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 110.048 -0.353 . . . . 62.02 110.048 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 23.0 t 172.3 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.455 1.097 . . . . 74.31 109.838 -168.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.488 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 23.4 t70 -177.8 165.24 2.02 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.802 1.241 . . . . 63.51 109.145 174.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 p -67.8 88.35 0.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.414 -0.588 . . . . 72.43 109.414 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 23.4 m-85 -109.83 151.67 42.5 Favored Pre-proline 0 N--CA 1.478 0.975 0 CA-C-N 114.915 -1.039 . . . . 61.24 111.514 -175.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.66 120.74 7.11 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 121.913 1.742 . . . . 51.54 110.982 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.9 135.96 34.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.47 -0.937 . . . . 45.14 108.47 176.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 29' ' ' GLU . 8.6 mmmm -141.82 107.32 5.05 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.219 -1.4 . . . . 75.24 107.219 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.6 tp -109.29 133.65 52.78 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.809 -0.812 . . . . 74.24 108.809 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.92 137.13 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.826 0.851 . . . . 72.24 109.083 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.5 t70 66.42 4.32 3.21 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.401 1.08 . . . . 75.42 112.263 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.8 t70 59.47 11.68 2.39 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.904 1.281 . . . . 74.21 112.57 -167.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.3 tp -113.03 -41.51 3.72 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.686 -0.634 . . . . 73.5 110.158 -174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.8 t -119.47 130.94 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.089 0.556 . . . . 72.21 109.656 -167.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -93.61 117.77 30.52 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 108.561 -0.903 . . . . 72.44 108.561 171.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 7.0 pt-20 -97.42 119.56 36.19 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.479 0.712 . . . . 53.33 109.728 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.608 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 23.3 t80 -110.76 106.21 15.32 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.25 -1.019 . . . . 75.34 108.25 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.05 113.5 4.51 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.21 0.204 . . . . 73.3 111.19 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.13 165.4 22.85 Favored Glycine 0 C--N 1.353 1.521 0 N-CA-C 110.825 -0.91 . . . . 75.1 110.825 171.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.663 ' HG2' ' HB2' ' A' ' 69' ' ' ASP . 18.2 ptpt -94.37 125.38 38.97 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 117.65 0.725 . . . . 74.33 109.673 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.608 ' HB3' ' HG3' ' A' ' 167' ' ' PRO . 0.3 OUTLIER -73.63 106.84 5.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.158 0.583 . . . . 55.32 109.436 177.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.46 ' HB ' HD11 ' A' ' 42' ' ' ILE . 9.9 m -139.24 162.24 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.675 0.79 . . . . 53.22 110.786 -170.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 44' ' ' LEU . 14.8 m -109.56 124.01 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 121.197 -0.94 . . . . 72.15 109.422 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.454 ' HB2' HD13 ' A' ' 72' ' ' LEU . 16.7 tpt180 -132.7 108.09 8.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.013 -0.365 . . . . 74.14 110.013 -175.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -129.65 160.46 33.26 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.281 1.032 . . . . 63.0 108.526 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 50.73 -76.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 126.635 1.974 . . . . 71.03 113.497 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.31 32.35 0.11 Allowed Glycine 0 N--CA 1.465 0.574 0 N-CA-C 111.676 -0.57 . . . . 63.44 111.676 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -147.39 146.67 29.71 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.356 0.662 . . . . 73.45 110.322 -175.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.46 HD11 ' HB ' ' A' ' 35' ' ' VAL . 5.9 tp -106.16 104.07 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 124.796 1.238 . . . . 65.53 109.063 176.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.4 p -146.11 103.39 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.354 0.662 . . . . 73.33 109.29 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.533 ' HA ' HG22 ' A' ' 36' ' ' VAL . 2.8 mm? -56.54 86.3 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.125 1.37 . . . . 71.12 112.545 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.27 86.62 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 124.268 1.027 . . . . 73.44 110.39 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.57 -145.69 44.86 Favored Glycine 0 C--N 1.353 1.509 0 O-C-N 124.48 1.112 . . . . 64.33 114.687 170.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.8 m -88.36 86.02 6.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.742 0.817 . . . . 74.53 109.21 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -155.07 -50.77 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 114.485 -1.234 . . . . 71.35 109.233 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -88.76 -171.06 0.54 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 121.844 1.696 . . . . 54.34 111.277 165.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.5 p -66.5 97.37 0.43 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.738 -0.664 . . . . 72.33 110.331 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.42 -30.77 71.2 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.547 1.139 . . . . 74.42 112.057 -172.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -91.48 22.57 3.9 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.593 0.757 . . . . 75.1 111.881 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -135.01 149.75 50.22 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 106.747 -1.575 . . . . 74.5 106.747 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.69 0.21 84.55 Favored Glycine 0 C--N 1.345 1.048 0 N-CA-C 116.14 1.216 . . . . 63.04 116.14 -168.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 77.19 -52.9 0.56 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.32 1.448 . . . . 52.43 110.832 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -149.22 130.79 14.89 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.074 -1.084 . . . . 65.23 108.074 173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -87.74 -34.75 18.24 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.575 0.75 . . . . 73.23 111.098 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.23 91.51 1.68 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.94 -1.133 . . . . 44.35 107.94 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.68 -25.61 5.57 Favored Glycine 0 N--CA 1.474 1.176 0 N-CA-C 111.147 -0.781 . . . . 73.14 111.147 -173.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.7 t -117.4 51.94 1.0 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.105 -1.442 . . . . 75.51 107.105 171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.55 -51.03 25.61 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.183 -1.371 . . . . 54.05 109.886 -174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.63 -23.88 63.56 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.402 -0.817 . . . . 71.21 109.947 171.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 60.59 83.98 0.13 Allowed 'General case' 0 C--N 1.35 0.612 0 C-N-CA 124.727 1.211 . . . . 72.51 110.388 -170.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -74.14 -96.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.383 0 N-CA-C 105.012 -2.218 . . . . 65.53 105.012 161.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.75 ' HG3' ' HG2' ' A' ' 66' ' ' ARG 0.25 10.4 pt-20 65.15 -36.08 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 127.612 2.365 . . . . 70.04 115.632 164.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.75 ' HG2' ' HG3' ' A' ' 65' ' ' GLU . 18.1 mmt180 -132.66 110.92 10.75 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 104.76 -2.311 . . . . 65.12 104.76 -174.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.96 168.6 37.83 Favored Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 111.468 -0.653 . . . . 53.22 111.468 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.56 HD11 HD12 ' A' ' 156' ' ' ILE . 30.9 pt -109.6 160.07 8.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 109.143 -0.688 . . . . 73.35 109.143 174.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.663 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . 24.1 t70 -39.15 -40.53 0.73 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.26 1.024 . . . . 75.14 113.038 177.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.413 HD11 ' HD1' ' A' ' 30' ' ' PHE . 46.0 mm -56.54 -42.36 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.461 -0.791 . . . . 73.3 111.125 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.8 t -85.28 -49.52 15.49 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 C-N-CA 123.56 0.744 . . . . 74.31 111.717 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' A' ' 37' ' ' ARG . 33.8 mt -72.13 -49.0 39.51 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.217 0.607 . . . . 64.05 111.919 -169.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -69.79 -26.0 64.06 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 62.14 111.274 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -103.42 -14.95 16.05 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 112.027 0.381 . . . . 71.04 112.027 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? 60.07 69.97 0.66 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.516 1.126 . . . . 64.34 110.759 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.1 mt -96.57 142.13 29.0 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.402 -1.272 . . . . 72.44 109.113 173.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.04 124.22 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 108.794 -0.817 . . . . 65.54 108.794 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.35 151.08 5.72 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.482 1.113 . . . . 73.35 113.811 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 16.7 tpt -147.03 103.64 3.62 Favored 'General case' 0 C--O 1.248 1.016 0 CA-C-N 113.839 -1.528 . . . . 64.44 107.271 -174.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -94.24 93.95 8.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.111 -1.441 . . . . 72.52 107.111 -176.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 30.1 p -68.91 -31.02 69.64 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 121.508 0.67 . . . . 73.35 110.111 -170.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.09 -21.18 61.53 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.42 -1.263 . . . . 73.54 111.711 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -105.18 -16.72 14.7 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.509 0.724 . . . . 63.23 112.197 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -127.39 23.53 6.37 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.301 0.64 . . . . 73.21 110.596 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.18 -28.94 3.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.014 1.725 . . . . 62.33 114.823 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.3 m -62.25 -59.18 5.4 Favored 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 118.109 0.413 . . . . 73.34 111.503 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.2 mmm -64.74 -39.25 93.31 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.489 0.716 . . . . 73.32 110.233 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -61.1 -46.23 91.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.037 -0.983 . . . . 74.31 112.076 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -61.33 -35.28 76.96 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.924 0.765 . . . . 74.42 110.106 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.14 -40.57 82.41 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.746 -0.661 . . . . 63.53 111.323 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -67.37 -43.72 80.74 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.536 0.334 . . . . 72.43 111.498 177.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -64.08 -33.52 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.604 1.162 . . . . 62.23 111.449 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -61.87 -47.08 86.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.415 0.686 . . . . 70.35 109.851 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -72.82 -40.46 65.79 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.533 -0.758 . . . . 75.11 110.902 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -55.08 -54.92 36.94 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.657 1.583 . . . . 75.3 112.069 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 26.9 ttt -59.7 -46.14 89.97 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.738 0.648 . . . . 74.43 110.115 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -58.23 -44.91 88.46 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 115.659 -0.7 . . . . 75.5 109.535 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -62.59 -50.37 71.57 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.316 1.046 . . . . 72.33 111.144 -172.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' A' ' 175' ' ' ALA . 26.4 m -67.93 -39.17 81.23 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.275 0.63 . . . . 65.42 112.566 -174.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 36.5 mt -73.39 -38.48 53.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 109.495 -0.557 . . . . 60.33 109.495 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.34 -27.19 66.93 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.813 1.245 . . . . 70.35 111.162 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -63.55 -57.92 8.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.952 0.901 . . . . 63.33 109.316 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.546 ' HG3' HG12 ' A' ' 113' ' ' VAL . 23.2 ptm -73.89 -19.74 60.62 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 123.86 0.725 . . . . 75.44 111.575 -177.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.482 ' HG2' ' HE ' ' A' ' 108' ' ' ARG . 26.6 tt0 -53.8 -55.77 23.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.014 0.926 . . . . 71.41 110.759 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.07 -24.34 66.14 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.825 0.703 . . . . 63.21 111.317 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -94.35 -16.43 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.2 1.0 . . . . 72.54 110.787 -173.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -129.11 -83.43 0.57 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.83 0.852 . . . . 73.3 110.316 -172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HE ' ' HG2' ' A' ' 104' ' ' GLU . 94.2 mtt180 53.56 20.9 2.28 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.751 1.019 . . . . 74.3 113.751 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.19 -21.96 59.6 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.397 0.679 . . . . 73.53 109.44 172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 86.53 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.415 1.886 . . . . 75.14 112.238 174.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.47 -44.39 91.2 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.878 0.325 . . . . 71.22 111.878 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.9 -41.46 36.48 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.46 0.704 . . . . 60.4 110.654 -171.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.546 HG12 ' HG3' ' A' ' 103' ' ' MET . 33.4 m -70.71 -28.6 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-N 115.818 -0.628 . . . . 70.12 110.858 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.417 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 29.9 t70 -68.1 -47.79 67.24 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.124 0.57 . . . . 65.05 110.465 173.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.09 -38.28 90.49 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 123.785 0.678 . . . . 62.11 110.082 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -65.36 -49.57 68.86 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.232 -0.894 . . . . 70.41 111.348 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.572 ' HA ' HG22 ' A' ' 120' ' ' ILE . 21.9 pttp -67.46 -25.84 66.09 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.177 0.298 . . . . 72.15 110.894 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -61.91 -51.19 69.16 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.822 0.701 . . . . 74.45 110.566 169.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -75.83 -36.5 59.63 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.848 0.685 . . . . 65.41 112.848 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.572 HG22 ' HA ' ' A' ' 117' ' ' LYS . 10.6 tp -73.18 -37.18 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 118.538 0.608 . . . . 71.32 109.682 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.01 -48.12 69.38 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.001 0.521 . . . . 74.21 110.091 174.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.3 -37.28 94.31 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.63 0.581 . . . . 50.13 112.331 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.2 t90 -64.41 -55.26 22.18 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 123.513 0.725 . . . . 74.1 110.232 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.1 m -66.05 -41.72 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 118.721 -0.656 . . . . 65.43 111.482 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.5 m -62.79 -40.03 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 118.686 0.676 . . . . 63.24 110.419 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.2 t -73.19 -32.81 65.04 Favored 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.067 0.547 . . . . 72.34 111.51 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.683 HD21 HG21 ' A' ' 155' ' ' ILE . 31.0 tp -77.29 -31.2 54.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.567 0.747 . . . . 64.44 110.992 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 56.2 mt -84.0 3.64 33.43 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.855 0.862 . . . . 64.14 111.246 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.04 84.01 0.98 Allowed 'General case' 0 C--N 1.357 0.935 0 N-CA-C 109.263 -0.643 . . . . 61.32 109.263 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -66.09 -14.84 62.44 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 114.863 1.431 . . . . 74.41 114.863 -163.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -67.61 -36.4 80.76 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.208 0.527 . . . . 71.14 110.489 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 40.1 mtp-105 -105.76 -39.15 6.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.168 0.987 . . . . 70.13 110.42 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -81.67 -1.43 46.74 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.383 1.073 . . . . 74.45 113.784 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -47.64 -10.85 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.958 1.466 . . . . 74.34 114.958 174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -82.01 6.21 16.84 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.808 0.843 . . . . 72.04 111.66 176.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 157' ' ' GLU . 96.3 mt -91.69 154.31 19.08 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.286 0.634 . . . . 64.03 110.002 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -140.62 125.65 18.42 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 106.793 -1.558 . . . . 62.33 106.793 171.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -98.68 153.05 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.284 -1.006 . . . . 72.41 108.284 -174.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -143.58 171.15 14.56 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.642 0.777 . . . . 72.11 109.074 -176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.99 149.12 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.929 -1.137 . . . . 63.35 107.929 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -53.81 132.79 44.35 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.474 -0.626 . . . . 75.2 112.23 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.53 -42.65 99.14 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.761 -0.459 . . . . 73.42 109.761 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.611 ' H ' ' HD2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -65.71 -33.71 76.52 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.5 -0.773 . . . . 73.42 111.931 172.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.51 -44.24 75.1 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.192 0.597 . . . . 74.41 110.55 -177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.98 -43.06 65.75 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.246 0.966 . . . . 60.34 110.875 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -57.36 -36.57 71.37 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.369 1.067 . . . . 74.02 111.513 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -68.6 -52.92 23.0 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.361 -0.836 . . . . 60.21 111.137 176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -167.72 154.78 8.27 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.555 0.742 . . . . 75.54 109.944 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.11 10.05 9.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.3 0.24 . . . . 72.53 110.97 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -88.88 -3.89 58.62 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.585 0.754 . . . . 74.3 110.601 173.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -56.66 151.54 24.38 Favored Glycine 0 C--N 1.356 1.642 0 O-C-N 123.963 0.79 . . . . 50.13 113.697 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -79.52 135.52 36.65 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.029 0.532 . . . . 73.51 111.33 -174.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.41 112.07 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.202 -0.908 . . . . 71.51 110.527 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.88 115.48 14.52 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.415 1.086 . . . . 71.1 109.964 174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.683 HG21 HD21 ' A' ' 127' ' ' LEU . 54.4 mt -92.8 115.21 31.13 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 122.922 0.489 . . . . 74.44 109.932 -171.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.56 HD12 HD11 ' A' ' 68' ' ' ILE . 35.1 mm -98.81 116.22 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 118.441 0.564 . . . . 60.24 110.562 -178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 159' ' ' ARG . 46.0 tt0 -97.22 101.46 13.03 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.259 1.023 . . . . 75.31 109.554 176.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -75.62 89.7 2.77 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.564 -1.273 . . . . 70.41 107.564 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.45 ' HB2' ' HG2' ' A' ' 157' ' ' GLU . 39.0 ttt85 -99.52 149.7 22.96 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.808 -0.812 . . . . 72.42 108.808 -172.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -122.47 130.56 53.19 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.592 -0.892 . . . . 74.32 108.592 167.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.1 109.37 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 108.362 -0.977 . . . . 73.45 108.362 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 60.1 28.84 18.44 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.498 1.119 . . . . 75.32 110.568 -170.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.54 -17.08 59.92 Favored Glycine 0 C--N 1.357 1.743 0 CA-C-N 115.548 -0.751 . . . . 71.43 113.432 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.7 m -81.32 112.24 18.44 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 117.238 0.519 . . . . 74.4 110.42 -173.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -71.84 103.33 3.11 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.501 0.72 . . . . 51.24 110.09 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.05 92.67 15.67 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 125.12 1.368 . . . . 75.55 109.224 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.608 ' HG3' ' HB3' ' A' ' 34' ' ' HIS . 72.1 Cg_endo -75.26 116.53 4.56 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.395 2.063 . . . . 73.3 111.645 172.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 31.1 p -117.22 135.6 53.67 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.282 1.033 . . . . 64.03 110.605 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.4 tp -77.18 114.05 15.58 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.131 0.972 . . . . 71.31 108.895 170.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 66.6 mmm -102.67 121.49 42.52 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 107.259 -1.386 . . . . 64.13 107.259 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 79.1 mt -136.0 147.12 47.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 106.966 -1.494 . . . . 74.44 106.966 175.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.454 HG11 HG11 ' A' ' 99' ' ' VAL . 7.5 p -73.05 131.17 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.55 -0.907 . . . . 64.04 108.55 173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -53.61 -34.82 59.83 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.38 1.472 . . . . 55.22 111.634 -177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.17 -18.45 65.31 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.645 0.778 . . . . 75.15 112.2 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.552 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -127.36 15.95 7.15 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.428 0.691 . . . . 71.02 111.74 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 9.5 tp -131.49 119.01 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 N-CA-C 108.199 -1.038 . . . . 71.34 108.199 165.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.43 113.74 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 109.644 -0.502 . . . . 53.03 109.644 -168.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -70.61 154.51 41.8 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.192 0.997 . . . . 64.35 111.244 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.582 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.4 tp10 -147.51 101.6 3.37 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.36 -0.607 . . . . 74.1 109.36 175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -83.46 94.55 8.03 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.908 -0.404 . . . . 73.34 109.908 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 44.0 t -96.49 89.73 5.12 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.93 -1.137 . . . . 63.53 107.93 172.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 pp -153.92 172.83 16.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.741 -0.663 . . . . 74.23 111.134 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 CA--C 1.559 1.324 0 C-N-CA 124.556 1.142 . . . . 64.53 110.793 -171.505 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.65 ' HG3' ' HG ' ' A' ' 2' ' ' LEU . 20.9 ptt? . . . . . 0 N--CA 1.486 1.342 0 N-CA-C 112.997 0.74 . . . . 55.12 112.997 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.65 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 87.0 mt -136.03 161.51 35.47 Favored 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 123.327 0.651 . . . . 62.21 110.815 -170.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 57.1 mt -96.65 120.41 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.351 -1.351 . . . . 63.55 107.351 174.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 22.7 m-85 -112.54 96.95 6.28 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.518 -1.66 . . . . 73.3 106.518 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 14.0 ptmm? -107.41 127.24 53.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.272 -0.876 . . . . 71.35 110.898 -173.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 25.1 t70 -74.2 178.16 5.29 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.59 -1.186 . . . . 65.04 109.807 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 HD21 ' A' ' 98' ' ' ASN . 62.0 mt -76.22 -38.66 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 121.578 -0.701 . . . . 61.24 110.732 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -111.7 -50.84 2.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.251 1.02 . . . . 52.21 109.867 -172.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.0 p -90.25 17.65 6.89 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.095 -0.957 . . . . 74.01 111.106 -171.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.565 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 9.0 p-10 -55.19 -26.57 39.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.773 1.629 . . . . 74.21 113.657 -170.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -49.46 -62.19 1.68 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 125.178 1.549 . . . . 74.14 112.493 -170.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -123.6 24.08 8.64 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.273 -0.876 . . . . 63.32 111.901 -175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 1.8 tm? -59.43 -73.58 0.08 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.993 0.517 . . . . 73.1 109.648 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 27.1 m -149.73 151.94 34.46 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 107.968 -1.123 . . . . 70.44 107.968 167.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 70.6 m -155.76 111.9 3.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.098 0.559 . . . . 72.52 110.359 -169.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.269 4.1 p-10 51.88 -90.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.31 1.844 . . . . 74.02 112.33 172.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.1 p -60.71 5.85 0.05 OUTLIER 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 115.435 1.642 . . . . 53.53 115.435 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -100.41 146.94 32.87 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.777 0.831 . . . . 64.22 109.935 175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -91.38 173.09 2.75 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.348 2.699 . . . . 74.12 114.312 -173.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.657 ' HA ' ' HE1' ' A' ' 28' ' ' TYR . 23.8 ptt? -114.09 151.68 32.21 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.898 -1.046 . . . . 73.12 109.799 169.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -149.39 97.53 2.66 Favored 'General case' 0 C--N 1.334 -0.067 0 N-CA-C 106.818 -1.549 . . . . 72.15 106.818 170.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.0 tp -91.72 122.03 33.9 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.812 -0.81 . . . . 73.01 108.812 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -110.96 134.32 53.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.109 0 C-N-CA 123.693 0.797 . . . . 71.51 108.954 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.2 t70 58.31 21.72 8.57 Favored 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.848 0.859 . . . . 71.44 111.764 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 68.15 -9.29 0.5 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.824 1.249 . . . . 72.44 113.756 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.6 tp -102.76 -52.56 3.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.516 -0.74 . . . . 73.52 111.448 -167.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 t -103.71 129.08 56.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 115.043 -0.981 . . . . 64.42 109.586 -164.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.657 ' HE1' ' HA ' ' A' ' 20' ' ' MET . 17.2 t80 -83.35 112.83 20.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.38 -1.341 . . . . 71.24 107.38 170.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -96.8 121.64 38.87 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.528 -1.214 . . . . 64.12 108.196 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -113.13 136.58 52.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.459 0.704 . . . . 72.01 109.548 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 136.15 57.88 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.374 1.07 . . . . 44.32 113.314 -172.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -154.62 146.21 14.07 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 110.58 -1.008 . . . . 73.43 110.58 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -143.79 151.83 40.44 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.266 0.533 . . . . 72.34 109.69 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -74.97 124.34 26.78 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.715 -0.476 . . . . 75.43 109.715 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 m -143.53 160.58 16.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 C-N-CA 124.407 1.083 . . . . 63.42 109.454 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG12 ' HG3' ' A' ' 66' ' ' ARG . 16.1 m -120.14 103.55 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 106.791 -1.559 . . . . 63.44 106.791 173.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.619 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 17.5 mtp180 -101.06 155.74 17.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.812 -1.085 . . . . 71.22 108.315 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.688 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 20.6 ttpp -135.5 161.83 34.38 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.627 -1.249 . . . . 74.32 107.627 170.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -43.37 -32.41 0.83 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.465 1.506 . . . . 75.23 113.927 -172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.83 54.83 0.53 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.448 -0.661 . . . . 55.2 111.448 172.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.688 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 28.8 tt0 -163.97 150.67 11.66 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.34 0.656 . . . . 72.24 110.939 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 tp -163.56 87.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 C-N-CA 124.841 1.256 . . . . 74.25 107.799 168.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.11 -7.83 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.856 0.862 . . . . 63.11 111.903 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.501 ' HA ' HG22 ' A' ' 36' ' ' VAL . 3.4 mm? 58.03 75.51 0.38 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 124.194 0.997 . . . . 74.13 111.372 -177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.62 -13.52 17.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.705 0.802 . . . . 63.15 111.21 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.36 87.81 0.51 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.315 -0.714 . . . . 75.42 111.315 -174.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.458 ' HB3' ' HD3' ' A' ' 66' ' ' ARG . 31.2 t -76.89 84.51 3.45 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.646 0.778 . . . . 75.52 110.547 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -161.35 111.54 1.24 Allowed Pre-proline 0 N--CA 1.472 0.669 0 N-CA-C 109.332 -0.618 . . . . 73.41 109.332 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.79 -36.97 7.24 Favored 'Trans proline' 0 CA--C 1.555 1.563 0 C-N-CA 122.765 2.31 . . . . 62.21 112.775 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 p -167.06 -179.83 4.82 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.829 0.851 . . . . 62.25 110.069 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.27 92.68 0.58 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.466 0.707 . . . . 43.44 110.422 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -169.07 -167.94 0.79 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.924 1.29 . . . . 74.41 109.66 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.66 -39.26 88.13 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.338 0.655 . . . . 70.31 110.977 174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.23 18.08 65.47 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 123.778 0.674 . . . . 73.35 112.346 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.69 87.04 6.76 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.895 -0.78 . . . . 42.32 108.895 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HB3' ' OG ' ' A' ' 60' ' ' SER . 8.5 tp10 -58.79 115.84 3.35 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.154 0.981 . . . . 73.44 110.426 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.7 t70 62.6 45.78 5.9 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.773 1.295 . . . . 74.3 110.133 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 66.13 14.37 9.6 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.213 1.405 . . . . 74.34 112.856 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -171.74 -130.39 1.23 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 111.059 -0.816 . . . . 75.42 111.059 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 56' ' ' GLU . 24.4 p 71.41 -23.36 0.18 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 126.401 1.88 . . . . 74.04 113.184 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -74.04 80.69 1.72 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 108.059 -1.089 . . . . 73.42 108.059 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -175.07 -52.79 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 104.552 -2.388 . . . . 72.33 104.552 -166.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -76.45 -47.28 23.55 Favored 'General case' 0 C--N 1.348 0.538 0 N-CA-C 107.196 -1.409 . . . . 74.32 107.196 166.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 97.4 t -79.24 97.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 107.479 -1.304 . . . . 64.42 107.479 162.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.3 mt-10 -85.59 70.5 10.75 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.518 -1.29 . . . . 71.25 107.518 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.533 ' HG3' HG12 ' A' ' 36' ' ' VAL . 18.7 ttp180 -96.55 139.18 33.02 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.465 0.65 . . . . 73.35 111.025 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 140.69 -131.99 5.22 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 114.858 -1.065 . . . . 63.34 111.374 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.789 HD12 ' HB2' ' A' ' 167' ' ' PRO . 0.8 OUTLIER -99.87 133.97 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.184 0.594 . . . . 72.23 110.755 178.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -36.79 -48.32 0.72 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.835 2.054 . . . . 65.32 114.186 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.7 mm -50.31 -53.33 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 124.164 0.915 . . . . 70.32 111.436 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 76' ' ' LEU . 57.7 t -80.84 -23.17 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 123.615 0.766 . . . . 73.51 111.299 -170.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 60.7 mt -77.47 -38.13 49.89 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.905 0.482 . . . . 51.3 110.578 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.52 -49.38 12.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.81 0.844 . . . . 75.31 110.819 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.89 -21.39 34.27 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.555 0.342 . . . . 62.43 111.094 -173.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm 63.11 66.97 0.7 Allowed 'General case' 0 C--N 1.36 1.049 0 C-N-CA 124.632 1.173 . . . . 73.34 110.85 -176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.556 ' HB2' HG13 ' A' ' 71' ' ' VAL . 40.5 mt -93.18 162.72 13.91 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 114.442 -1.254 . . . . 65.13 109.587 174.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -113.12 135.65 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.636 0.775 . . . . 73.11 109.912 176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -68.11 152.85 44.87 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.493 0.923 . . . . 62.32 113.493 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 59.8 mtm -146.06 104.93 3.87 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 126.106 1.762 . . . . 72.2 106.434 170.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -71.68 124.58 25.05 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.202 -0.666 . . . . 73.24 109.202 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 3.8 m -56.31 -30.89 63.14 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.848 0.859 . . . . 73.11 111.612 -177.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -69.49 -45.54 68.71 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 113.592 -1.64 . . . . 74.22 112.86 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -97.73 -28.23 13.99 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 122.883 0.473 . . . . 74.14 111.914 -173.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -101.97 19.5 18.29 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.151 0.98 . . . . 71.1 111.132 -169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.53 -27.76 17.86 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 124.264 1.025 . . . . 71.04 113.743 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -72.79 -55.51 6.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.037 0.935 . . . . 72.0 111.189 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 62.6 mtt -64.07 -37.2 86.57 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.055 0.542 . . . . 72.22 110.403 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.621 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 14.9 t80 -54.04 -49.07 69.78 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.747 1.219 . . . . 74.51 111.03 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -64.61 -34.9 79.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.148 0.579 . . . . 74.34 110.093 179.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -47.46 81.14 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.328 0.392 . . . . 65.11 111.005 175.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -67.67 -32.7 73.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.504 0.722 . . . . 71.3 112.505 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.9 mm -67.31 -44.71 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.468 0.707 . . . . 74.3 111.245 173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -60.6 -40.61 92.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.914 0.486 . . . . 74.45 109.827 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -63.28 -50.22 70.97 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 115.262 -0.881 . . . . 71.12 109.435 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -56.51 -51.01 70.13 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.243 1.417 . . . . 74.11 112.12 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 22.3 ptp -67.5 -40.27 85.2 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.344 0.402 . . . . 71.21 110.993 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -68.43 -38.68 81.4 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.875 -0.417 . . . . 72.35 109.875 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.494 HD21 HD12 ' A' ' 7' ' ' ILE . 30.2 t30 -58.45 -55.69 31.81 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.82 1.248 . . . . 63.43 110.625 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.519 HG11 HG11 ' A' ' 172' ' ' VAL . 22.3 m -71.41 -39.98 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 CA-C-N 114.969 -1.014 . . . . 62.1 112.865 -172.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -73.25 -45.82 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 110.014 -0.365 . . . . 72.33 110.014 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -56.03 -38.47 70.6 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.474 0.71 . . . . 71.14 110.8 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -56.33 -58.11 9.37 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.152 0.907 . . . . 72.24 110.197 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 75.4 mmm -70.28 -26.74 63.95 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.535 -0.302 . . . . 72.33 111.138 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.53 ' HA ' HG11 ' A' ' 113' ' ' VAL . 40.5 tt0 -64.35 -45.91 85.72 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.359 1.064 . . . . 62.13 110.681 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -89.29 -9.61 49.91 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.273 0.471 . . . . 74.15 112.273 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.25 -22.9 21.4 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.508 0.559 . . . . 52.54 112.508 175.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -124.86 -43.95 1.96 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.573 0.349 . . . . 72.11 111.16 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.96 25.62 14.82 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.718 0.807 . . . . 72.33 111.234 -174.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -119.13 126.59 51.98 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.032 0.933 . . . . 74.54 109.361 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -62.24 -36.0 80.67 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.748 0.819 . . . . 72.14 111.85 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.34 60.22 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.783 0.433 . . . . 72.51 110.889 -172.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.11 -60.64 2.21 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.445 -0.576 . . . . 72.32 109.445 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 104' ' ' GLU . 30.3 m -67.45 -35.52 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 114.737 -1.12 . . . . 74.41 112.875 -167.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.54 -33.9 35.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.458 0.703 . . . . 72.4 110.324 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.68 -33.26 64.36 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.706 -0.479 . . . . 74.3 109.706 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.424 ' HZ ' ' HB ' ' A' ' 99' ' ' VAL . 42.0 t80 -71.49 -40.62 70.08 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.972 -1.013 . . . . 72.23 110.129 175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -62.31 -38.62 90.11 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.685 0.794 . . . . 74.13 110.207 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.81 -40.42 88.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.557 -1.201 . . . . 70.11 109.698 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -71.71 -37.18 70.69 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.627 0.771 . . . . 74.12 109.927 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 172' ' ' VAL . 8.3 mm -65.05 -47.81 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.655 0.782 . . . . 64.12 109.2 173.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -60.11 -37.83 81.16 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.784 0.678 . . . . 74.5 110.577 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.52 58.62 Favored Glycine 0 C--N 1.342 0.87 0 CA-C-N 115.83 -0.623 . . . . 42.25 112.393 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.79 -51.19 61.08 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 124.053 0.502 . . . . 73.33 110.762 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.591 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.0 m -70.87 -41.71 77.25 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.966 0 CA-C-O 118.546 -0.74 . . . . 73.2 111.071 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.6 t -66.57 -32.28 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-N 119.727 1.149 . . . . 72.2 110.619 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.6 t -70.63 -32.58 69.95 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.522 0.329 . . . . 62.52 110.597 171.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.653 ' HA ' ' HD2' ' A' ' 132' ' ' ARG . 37.8 tp -76.03 -40.43 53.5 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.004 0.922 . . . . 65.04 111.174 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.621 HD22 ' HZ ' ' A' ' 88' ' ' PHE . 47.6 mt -77.65 1.7 18.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.1 0.96 . . . . 75.32 111.142 -170.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.23 130.04 39.36 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.364 -1.347 . . . . 74.13 107.364 168.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 50.3 mtmt -68.06 -6.46 22.84 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.467 0.914 . . . . 64.45 113.467 -173.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 134' ' ' LYS . 22.7 t70 -68.52 -30.34 69.13 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.763 0.825 . . . . 63.2 109.764 171.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.653 ' HD2' ' HA ' ' A' ' 127' ' ' LEU . 42.6 mtt180 -81.34 -33.2 32.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.992 -0.443 . . . . 65.33 110.515 171.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.625 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.1 m-85 -67.0 -20.23 65.85 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.549 0.739 . . . . 73.41 111.866 -177.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 131' ' ' ASP . 24.3 pttm -61.98 -30.9 71.24 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.582 0.551 . . . . 72.14 110.577 172.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -127.56 25.5 6.06 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.332 1.053 . . . . 74.11 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.625 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 24.2 mt -100.27 144.28 29.47 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.585 0.707 . . . . 73.32 111.341 168.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -139.4 121.06 15.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.523 -1.658 . . . . 74.02 106.523 167.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.464 ' HB3' HG11 ' A' ' 153' ' ' VAL . 66.4 m-85 -93.57 134.31 35.98 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.747 -0.464 . . . . 72.53 109.747 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -130.06 140.96 50.77 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 75.43 109.452 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.4 tt -120.89 159.15 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 106.994 -1.484 . . . . 74.01 106.994 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.23 129.72 49.9 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-O 119.177 -0.791 . . . . 51.33 111.53 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -57.29 -41.49 79.88 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.526 0.731 . . . . 72.33 110.049 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -69.51 -38.55 77.64 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.861 -1.063 . . . . 71.5 110.666 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.34 -31.44 72.57 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.448 0.699 . . . . 55.22 110.58 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 5.43 12.19 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.711 0.804 . . . . 71.34 112.049 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -89.83 -10.28 45.96 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 64.14 110.403 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.62 -55.51 0.01 OUTLIER Glycine 0 C--N 1.352 1.42 0 N-CA-C 112.016 -0.433 . . . . 72.21 112.016 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.82 83.31 2.15 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.452 0.701 . . . . 74.13 110.649 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.92 -2.23 50.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.124 0.97 . . . . 74.52 111.22 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -132.11 78.75 1.83 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 106.208 -1.775 . . . . 70.01 106.208 172.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -123.89 -166.58 12.56 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-N 113.797 -1.547 . . . . 21.21 111.733 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.404 HE21 HD22 ' A' ' 171' ' ' LEU . 53.8 tt0 -101.58 142.1 33.45 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.002 -0.74 . . . . 61.53 109.002 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 138' ' ' PHE . 75.8 t -109.4 131.92 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.259 0.624 . . . . 74.23 112.058 -171.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.406 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.67 109.53 4.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.265 -1.334 . . . . 75.24 109.558 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 71.5 mt -85.56 105.5 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 108.966 -0.753 . . . . 73.14 108.966 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 169' ' ' LEU . 40.9 mm -103.58 119.61 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 109.008 -0.738 . . . . 72.21 109.008 -177.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.405 ' HB3' HD23 ' A' ' 136' ' ' LEU . 12.1 pt-20 -124.94 127.81 47.64 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 120.827 0.346 . . . . 74.34 110.482 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -75.97 110.63 10.6 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 115.106 -0.952 . . . . 73.21 109.341 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.514 ' HB2' HG13 ' A' ' 166' ' ' VAL . 22.6 mmt85 -101.86 172.8 6.72 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.357 -0.979 . . . . 73.44 108.357 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -122.58 119.06 29.71 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.128 0.571 . . . . 73.33 110.603 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.6 p -122.73 118.51 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.021 0.528 . . . . 62.42 109.903 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 67.83 -67.64 0.18 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.899 1.68 . . . . 71.12 110.9 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -174.79 35.68 0.11 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 111.211 -0.756 . . . . 63.12 111.211 173.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.6 t -141.86 158.17 44.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.088 0.555 . . . . 52.44 110.863 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -78.75 114.46 17.69 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.748 0.819 . . . . 71.04 111.103 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 159' ' ' ARG . 5.8 p -117.73 89.14 32.33 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 109.11 -0.7 . . . . 74.24 109.11 175.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.789 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.3 Cg_endo -82.61 122.53 3.56 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 122.342 2.028 . . . . 64.31 110.159 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -105.42 140.0 39.2 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.727 0.811 . . . . 71.44 109.73 -168.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 156' ' ' ILE . 30.8 tp -82.36 123.34 29.01 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.917 0.76 . . . . 53.42 109.635 177.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.99 123.09 48.87 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.945 0.898 . . . . 63.51 108.882 174.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.472 HD13 HD11 ' A' ' 176' ' ' ILE . 79.7 mt -140.97 145.51 36.09 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 106.987 -1.486 . . . . 72.51 106.987 172.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.519 HG11 HG11 ' A' ' 99' ' ' VAL . 7.1 p -76.76 134.88 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 109.427 -0.583 . . . . 73.34 109.427 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -56.75 -36.76 70.15 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.511 1.124 . . . . 71.01 111.871 -175.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -68.48 -25.91 65.21 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.901 0.881 . . . . 52.22 112.5 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.444 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -97.59 -1.91 42.82 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.816 0.446 . . . . 72.34 110.336 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.472 HD11 HD13 ' A' ' 171' ' ' LEU . 48.9 mm -102.55 132.14 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.362 -0.977 . . . . 72.21 108.362 174.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 44.3 mm -93.22 111.8 25.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.302 -0.999 . . . . 74.41 108.302 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -76.35 104.34 6.82 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.402 -0.962 . . . . 75.24 108.402 175.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 7.7 tp10 -104.04 111.06 23.47 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.966 -1.124 . . . . 72.04 107.966 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.44 129.66 34.68 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.806 -0.442 . . . . 73.03 109.806 -178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 42.4 t -100.81 104.35 15.59 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.734 -0.667 . . . . 65.21 110.417 -171.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -125.35 161.66 26.51 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.285 1.034 . . . . 64.42 109.399 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 C--O 1.252 1.219 0 CA-C-N 115.104 -0.953 . . . . 73.42 108.553 178.272 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.6 mmm . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.067 0.46 . . . . 71.43 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.2 mt -84.33 123.82 30.6 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.849 -0.797 . . . . 61.45 108.849 169.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.504 HG22 ' HB3' ' A' ' 15' ' ' SER . 33.3 pt -99.39 128.58 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 123.535 0.734 . . . . 71.2 109.251 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.501 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 12.9 m-85 -122.95 124.22 42.7 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.947 1.299 . . . . 74.25 107.807 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 23.3 pttm -145.85 147.12 31.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.083 0.856 . . . . 74.24 112.239 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 175' ' ' ALA . 14.9 t70 -101.25 124.08 46.39 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.899 0.88 . . . . 70.22 109.996 177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.595 HG12 ' HA ' ' A' ' 175' ' ' ALA . 43.4 pt -66.56 -26.85 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 112.68 0.622 . . . . 63.04 112.68 -164.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -80.61 -60.97 2.11 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.293 0.568 . . . . 74.52 111.587 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.4 m -125.53 -46.48 1.75 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.91 -1.041 . . . . 74.4 111.737 -159.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 2.8 t0 -101.4 24.05 10.17 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.99 0.916 . . . . 74.02 110.486 -166.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 5.6 p-10 -50.81 -2.29 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.016 2.228 . . . . 72.05 117.016 -177.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -99.59 -41.52 7.3 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 119.645 1.111 . . . . 75.03 109.86 167.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 26.6 tp 36.51 -88.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.79 2.036 . . . . 72.22 113.655 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.401 ' HB3' ' CE1' ' A' ' 18' ' ' PHE . 73.5 m -157.3 134.48 10.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.802 0.841 . . . . 74.24 109.477 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.504 ' HB3' HG22 ' A' ' 3' ' ' ILE . 50.4 m -130.73 97.93 4.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.487 0.715 . . . . 74.44 109.149 172.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.452 ' HB3' ' HE1' ' A' ' 18' ' ' PHE . 24.3 t70 -166.52 -90.64 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.185 0.594 . . . . 73.24 110.258 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.8 m -170.2 78.72 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.463 1.105 . . . . 61.13 108.874 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.452 ' HE1' ' HB3' ' A' ' 16' ' ' ASP . 53.9 m-85 -112.43 139.12 22.26 Favored Pre-proline 0 N--CA 1.486 1.357 0 C-N-CA 123.744 0.817 . . . . 73.43 110.213 -175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.491 ' HD2' ' HE1' ' A' ' 30' ' ' PHE . 57.9 Cg_exo -53.8 117.57 4.0 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.202 1.935 . . . . 74.12 111.495 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.92 134.26 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.364 -0.835 . . . . 74.42 109.507 -172.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' GLU . 39.1 ttmt -137.2 140.17 41.57 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.738 -1.208 . . . . 52.34 107.738 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.5 tp -131.75 108.07 9.21 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.831 -1.174 . . . . 74.15 107.831 175.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.35 133.64 42.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.848 0.859 . . . . 71.5 110.017 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.92 14.65 4.41 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.749 1.22 . . . . 42.45 112.763 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 37.7 t70 58.23 10.36 1.25 Allowed 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.641 1.177 . . . . 73.35 111.987 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 119' ' ' LYS . 51.8 tp -103.9 -47.1 4.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.01 0.924 . . . . 70.0 111.333 -167.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -126.93 131.54 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 115.835 -0.621 . . . . 63.04 110.077 -172.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.45 ' HB2' HG21 ' A' ' 176' ' ' ILE . 82.1 t80 -85.24 135.11 34.07 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.41 1.084 . . . . 72.23 108.439 169.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 32.5 tt0 -117.98 144.99 45.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.362 0.665 . . . . 74.23 109.286 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.615 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.5 t80 -131.97 138.45 48.3 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.91 1.284 . . . . 72.24 107.683 173.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.33 153.94 39.1 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.647 0.379 . . . . 62.12 110.714 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.1 159.72 30.61 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.977 -0.556 . . . . 63.23 112.124 173.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -134.83 138.88 44.62 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.01 0.924 . . . . 74.44 109.244 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -70.57 120.46 16.23 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 107.543 -1.28 . . . . 73.52 107.543 169.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.6 m -148.84 -178.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.477 0.711 . . . . 72.13 109.941 -168.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.9 156.05 42.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.305 1.042 . . . . 62.23 108.578 174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 38.1 ttm180 -140.06 132.64 28.74 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.282 0.563 . . . . 72.31 109.977 175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.585 ' HD2' ' HB2' ' A' ' 41' ' ' GLU . 65.0 mttp -133.38 156.17 48.14 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.142 1.377 . . . . 73.03 107.456 164.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -60.09 -38.62 83.48 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.287 0.635 . . . . 75.4 112.019 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -104.85 -44.04 1.58 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.951 -0.568 . . . . 75.43 113.16 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.585 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . 24.6 mm-40 -95.9 163.35 13.19 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.296 0.638 . . . . 71.22 111.836 -171.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 tp -161.25 104.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 C-N-CA 124.889 1.276 . . . . 62.32 108.407 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -157.11 101.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 121.634 0.731 . . . . 45.11 110.715 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -93.74 -3.35 52.36 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.046 0.939 . . . . 71.31 111.017 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 94.18 0.36 Allowed 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.992 0.917 . . . . 62.22 110.418 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.42 -86.16 0.05 OUTLIER Glycine 0 C--N 1.335 0.493 0 N-CA-C 110.153 -1.179 . . . . 62.32 110.153 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.9 m -145.83 147.31 31.69 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.672 0.789 . . . . 73.32 109.941 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -62.63 -46.33 88.84 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 123.592 0.757 . . . . 64.23 109.76 170.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.07 94.4 0.89 Allowed 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 121.353 1.368 . . . . 73.51 110.248 165.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.4 m -77.03 1.32 18.26 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.422 0.689 . . . . 53.51 111.823 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 55' ' ' ALA . . . 65.8 14.44 9.55 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 124.713 1.205 . . . . 61.43 111.941 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -71.46 -11.12 60.71 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.571 1.148 . . . . 73.34 112.11 -169.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -94.26 106.65 18.63 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.786 0.834 . . . . 70.22 108.933 169.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.61 4.58 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 114.46 0.544 . . . . 54.21 114.46 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.503 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . . . -68.06 -29.01 67.87 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.9 0.88 . . . . 41.14 112.869 -170.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -85.82 114.33 22.67 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.16 -1.422 . . . . 75.32 107.16 165.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.89 137.57 57.76 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 124.09 0.869 . . . . 71.14 110.21 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.16 101.25 0.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.349 1.06 . . . . 62.13 110.248 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.04 6.7 55.8 Favored Glycine 0 N--CA 1.473 1.115 0 CA-C-N 115.498 -0.774 . . . . 62.54 113.515 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.8 t -101.23 92.32 4.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.663 0.785 . . . . 54.43 109.332 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 64' ' ' VAL . 6.3 p-10 -134.17 -3.77 2.76 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.29 1.036 . . . . 72.03 110.7 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 68.54 -72.02 0.11 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.883 1.673 . . . . 71.15 110.825 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -161.99 36.89 0.12 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.238 1.018 . . . . 72.0 108.521 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.511 HG22 ' HE3' ' A' ' 38' ' ' LYS . 37.7 t -100.28 114.53 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.894 -0.78 . . . . 73.04 108.894 178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 9.4 mp0 -75.27 73.91 2.38 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 106.977 -1.49 . . . . 73.04 106.977 171.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -92.22 135.5 33.95 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.846 -1.07 . . . . 74.25 110.693 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.44 -154.43 25.52 Favored Glycine 0 CA--C 1.506 -0.505 0 N-CA-C 109.836 -1.306 . . . . 73.02 109.836 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 9.4 pt -94.62 153.28 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.684 0.742 . . . . 73.43 111.496 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -42.88 -46.66 5.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.888 1.675 . . . . 65.54 113.097 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.583 HD13 ' HB2' ' A' ' 169' ' ' LEU . 45.1 mt -60.42 -47.97 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 124.919 1.288 . . . . 73.11 110.877 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.1 t -72.83 -42.56 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 114.604 -1.18 . . . . 74.43 112.195 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -67.49 -36.27 80.77 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.917 0.487 . . . . 60.11 110.768 -177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 34.6 t-20 -59.58 -61.97 2.23 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.364 0.666 . . . . 45.3 110.634 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.476 ' HB3' ' HG ' ' A' ' 76' ' ' LEU . 59.6 t-80 -81.57 -17.7 47.41 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.264 -0.426 . . . . 71.42 112.1 -170.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 64.37 61.12 0.89 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.736 1.255 . . . . 74.4 108.427 -167.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 95.7 mt -82.07 133.46 35.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.066 -1.424 . . . . 74.43 109.399 174.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.701 HG11 ' HB2' ' A' ' 145' ' ' ALA . 7.3 p -91.93 138.38 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.325 0.65 . . . . 74.12 109.386 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -67.33 147.41 53.0 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.994 0.902 . . . . 72.45 111.519 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -132.64 103.12 5.97 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 103.081 -2.933 . . . . 72.03 103.081 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 12.2 t-20 -69.14 116.54 9.71 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.515 1.126 . . . . 72.4 111.104 -172.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 133' ' ' PHE . 26.5 p -63.99 -28.77 70.04 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.59 0.756 . . . . 74.51 111.843 -178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -73.3 -58.89 2.99 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.493 -1.231 . . . . 61.44 112.157 -172.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -103.51 -6.73 21.49 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.922 0.712 . . . . 71.53 112.922 -174.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.431 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 16.1 m-20 -121.2 22.69 10.81 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 123.647 0.779 . . . . 74.42 111.266 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.56 -35.21 40.17 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.835 0.854 . . . . 74.15 112.399 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.6 m -64.11 -38.27 90.44 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.442 0.697 . . . . 62.13 111.353 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 mtt -60.18 -45.84 91.74 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 109.627 -0.508 . . . . 75.34 109.627 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 46.1 t80 -63.09 -35.42 80.19 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.889 0.743 . . . . 73.11 111.245 -176.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.9 -25.34 55.98 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.196 0.598 . . . . 71.21 111.47 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.29 -45.89 75.23 Favored 'General case' 0 C--O 1.257 1.452 0 N-CA-C 109.576 -0.527 . . . . 70.03 109.576 171.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 76.4 m-85 -54.15 -54.54 38.27 Favored 'General case' 0 C--O 1.202 -1.444 0 CA-C-N 114.71 -1.132 . . . . 73.12 109.473 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.6 mm -58.02 -42.46 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.093 0.957 . . . . 54.13 112.088 -172.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -59.75 -55.64 31.76 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 122.442 0.297 . . . . 64.42 111.167 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -37.78 76.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 123.526 0.516 . . . . 74.3 110.386 -174.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -55.95 -57.01 13.91 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.838 1.655 . . . . 74.45 111.434 174.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 50.4 ttm -67.86 -40.09 83.7 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.847 0.717 . . . . 44.02 111.56 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -61.7 -44.68 96.47 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.376 0.422 . . . . 71.45 110.323 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -70.6 -45.2 65.75 Favored 'General case' 0 C--O 1.216 -0.667 0 O-C-N 124.16 0.913 . . . . 64.14 111.235 -174.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.56 -40.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 123.202 0.314 . . . . 74.51 111.758 -175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 59.8 mt -73.43 -39.47 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 117.983 0.356 . . . . 70.11 110.746 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -67.19 -38.72 85.86 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.709 0.804 . . . . 74.55 110.974 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.87 -44.78 54.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.562 -0.744 . . . . 73.41 110.129 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.542 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -58.61 -40.37 83.08 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.642 0.777 . . . . 70.23 109.735 177.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.482 ' HA ' HG11 ' A' ' 113' ' ' VAL . 40.9 tt0 -65.7 -29.73 70.32 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.302 1.041 . . . . 74.44 111.374 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -75.1 -40.15 60.15 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.335 0.654 . . . . 72.3 110.131 174.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -73.2 -34.52 66.01 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.22 1.008 . . . . 72.14 111.86 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.741 HD21 ' HB3' ' A' ' 112' ' ' ASP . 42.5 t30 -100.59 -45.96 5.35 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.868 0.867 . . . . 53.41 111.639 -171.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 77.82 -17.17 0.59 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.241 1.416 . . . . 71.15 112.532 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 113' ' ' VAL . 23.9 t70 -96.6 126.27 41.66 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.923 0.889 . . . . 74.13 109.657 -174.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -77.65 -27.15 50.88 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.161 0.584 . . . . 75.4 112.118 -174.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.67 -38.56 89.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.731 0.412 . . . . 72.22 111.804 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.741 ' HB3' HD21 ' A' ' 107' ' ' ASN . 30.0 t70 -85.6 -33.54 21.64 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.629 0.772 . . . . 75.35 111.354 -174.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.627 HG13 HD22 ' A' ' 107' ' ' ASN . 16.9 m -78.99 -28.07 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 CA-C-N 117.944 0.338 . . . . 42.01 111.833 177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.99 -42.13 85.6 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.888 0.475 . . . . 73.54 109.84 171.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.39 -45.86 78.6 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.593 -0.73 . . . . 50.21 110.052 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.426 ' HZ ' ' HB2' ' A' ' 174' ' ' GLU . 81.1 t80 -56.31 -45.83 80.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.437 1.095 . . . . 71.24 111.119 174.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -57.35 -47.86 80.52 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 72.44 110.667 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -69.04 -26.53 65.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.703 0.801 . . . . 62.32 111.411 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HB3' HD22 ' A' ' 26' ' ' LEU . 32.5 mmtp -78.14 -35.51 48.88 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.344 0.658 . . . . 71.24 110.644 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.2 mm -69.66 -44.22 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.635 0.374 . . . . 50.44 110.046 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -58.42 -46.53 86.29 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.96 0.904 . . . . 74.33 109.614 176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.04 -43.39 99.22 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 124.194 0.934 . . . . 65.33 112.925 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -64.62 -51.51 62.29 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.301 0.64 . . . . 75.14 110.174 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 33.9 m -70.99 -41.22 76.92 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.501 0 CA-C-O 118.309 -0.853 . . . . 73.53 111.096 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -62.41 -33.04 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-N 119.486 1.039 . . . . 73.02 110.218 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.2 t -72.3 -42.15 65.81 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.437 0.695 . . . . 64.43 110.616 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' HA ' ' HG3' ' A' ' 132' ' ' ARG . 34.8 tp -79.09 -20.05 49.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.432 1.093 . . . . 51.11 111.952 -173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -83.39 4.07 29.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.005 0.922 . . . . 64.01 112.206 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.3 156.32 38.98 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.009 0.524 . . . . 74.31 110.723 172.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.42 ' NZ ' ' HB3' ' A' ' 130' ' ' LYS . 4.3 ttpm? -62.33 -45.03 95.02 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.027 0.931 . . . . 71.23 112.289 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -68.53 -24.49 64.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.146 0.578 . . . . 64.44 111.425 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.582 ' HG3' ' HA ' ' A' ' 127' ' ' LEU . 30.0 mmt180 -68.72 -54.49 15.82 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.059 -0.719 . . . . 72.22 109.059 170.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.608 ' HA ' ' HB2' ' A' ' 136' ' ' LEU . 7.0 m-85 -59.92 -22.5 62.5 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.416 1.086 . . . . 75.12 113.783 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -66.64 -27.84 68.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.922 0.489 . . . . 61.33 110.137 173.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -115.78 0.08 13.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.35 0.66 . . . . 72.32 111.263 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.608 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 60.8 mt -89.36 132.38 34.98 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 118.58 0.627 . . . . 71.24 109.677 176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.51 117.03 19.82 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.225 -2.139 . . . . 64.42 105.225 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.543 ' HB3' HG11 ' A' ' 153' ' ' VAL . 33.6 m-85 -90.36 143.45 26.75 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 108.759 -0.83 . . . . 71.13 108.759 -174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.606 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 82.9 m-85 -140.7 152.93 45.71 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.138 0.575 . . . . 73.22 110.598 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.0 pt -144.89 172.96 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.05 1.34 . . . . 72.4 107.635 173.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.86 134.23 51.08 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-O 118.708 -1.051 . . . . 74.31 111.103 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -40.65 -48.14 2.88 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 114.337 1.236 . . . . 74.34 114.337 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -64.02 -28.56 69.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.835 0.854 . . . . 51.35 112.543 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.46 -14.46 62.55 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.683 0.793 . . . . 74.22 111.999 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.701 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -75.36 -2.92 30.68 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.229 0.611 . . . . 53.2 112.313 174.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -81.47 -33.12 32.21 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 74.35 110.137 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.11 -2.06 0.03 OUTLIER Glycine 0 C--N 1.357 1.727 0 N-CA-C 115.834 1.094 . . . . 65.1 115.834 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -87.12 75.11 9.49 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 118.717 1.258 . . . . 64.43 110.725 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.401 ' HG3' ' ND2' ' A' ' 150' ' ' ASN . 11.3 pt-20 -88.56 -0.53 57.34 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.245 1.018 . . . . 74.12 111.479 175.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 149' ' ' GLU . 47.1 m-80 -130.61 79.4 1.9 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.22 -1.03 . . . . 72.41 108.22 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -147.72 -148.55 4.77 Favored Glycine 0 N--CA 1.469 0.858 0 N-CA-C 110.067 -1.213 . . . . 51.04 110.067 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.96 152.92 22.1 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 108.328 -0.99 . . . . 63.44 108.328 173.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 138' ' ' PHE . 93.8 t -113.25 132.16 62.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.755 0.822 . . . . 51.24 110.445 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -73.74 101.38 3.67 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 108.338 -0.986 . . . . 72.41 108.338 166.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 127' ' ' LEU . 67.1 mt -89.54 120.35 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 109.632 -0.507 . . . . 64.53 109.632 -170.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 48.4 mm -105.63 119.38 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.839 0.455 . . . . 71.01 110.488 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -103.88 111.7 24.34 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.76 1.224 . . . . 64.54 109.48 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -75.61 89.82 2.77 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.443 -0.947 . . . . 71.02 108.443 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -89.61 164.67 14.65 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.217 1.007 . . . . 74.42 109.332 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -122.51 115.2 21.78 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.197 0.599 . . . . 74.32 110.151 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -120.43 97.88 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.821 0.849 . . . . 64.44 109.585 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 65.56 11.59 7.57 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.089 1.356 . . . . 54.41 112.583 177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 118.85 -14.33 11.43 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.748 -0.473 . . . . 63.31 113.039 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.7 m -88.7 111.49 22.02 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 117.23 0.515 . . . . 72.24 109.804 177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.68 114.39 9.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 115.289 -0.869 . . . . 64.43 109.167 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.423 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 13.2 m -123.5 98.16 41.23 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.746 1.218 . . . . 75.01 110.004 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 166' ' ' VAL . 38.7 Cg_endo -65.62 112.8 2.28 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.478 2.119 . . . . 71.0 111.163 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 p -113.96 134.19 54.99 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.141 0.976 . . . . 70.35 109.375 -174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.615 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 39.3 tp -77.33 140.91 40.09 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.493 0.717 . . . . 62.21 109.621 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 25.3 ptp -131.85 129.36 40.31 Favored 'General case' 0 C--O 1.259 1.583 0 N-CA-C 108.124 -1.065 . . . . 72.24 108.124 169.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 94.9 mt -130.96 137.44 49.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.803 1.641 . . . . 74.42 106.903 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 174' ' ' GLU . 7.6 p -72.12 143.14 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 122.419 0.287 . . . . 70.34 111.455 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -32.6 -50.35 0.25 Allowed 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 126.951 2.1 . . . . 74.31 113.397 171.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.458 ' H ' HG22 ' A' ' 172' ' ' VAL . 1.4 tm-20 -68.85 -38.94 80.11 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.57 -1.195 . . . . 53.35 110.455 -171.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.595 ' HA ' HG12 ' A' ' 7' ' ' ILE . . . -98.06 -6.46 31.74 Favored 'General case' 0 C--O 1.209 -1.058 0 CA-C-O 118.99 -0.528 . . . . 31.11 111.123 -172.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.45 HG21 ' HB2' ' A' ' 28' ' ' TYR . 8.6 tp -108.41 136.64 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 107.767 -1.198 . . . . 73.51 107.767 177.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 38.0 mm -125.81 118.37 51.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.401 -1.703 . . . . 74.31 106.401 176.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -120.69 123.54 42.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.788 -1.19 . . . . 73.24 107.788 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -141.2 149.49 41.47 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.501 0.72 . . . . 72.14 109.274 -175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -98.7 96.82 8.18 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.231 -0.655 . . . . 50.24 109.231 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 45.3 t -112.59 93.92 4.66 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.294 0.638 . . . . 75.22 110.763 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.35 117.25 17.83 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.555 0.742 . . . . 62.3 109.201 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 . . . . . 0 CA--C 1.554 1.109 0 CA-C-O 118.909 -0.567 . . . . 64.01 110.076 175.818 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' A' ' 17' ' ' SER . 22.4 mmt . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 110.031 -0.359 . . . . 73.11 110.031 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.8 mt -110.11 135.13 51.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.026 0.531 . . . . 62.53 109.656 173.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 5.1 tt -95.14 120.21 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.23 -0.656 . . . . 72.21 109.23 173.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.541 ' HB3' HD11 ' A' ' 176' ' ' ILE . 27.2 m-85 -105.92 125.99 51.65 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 107.389 -1.337 . . . . 71.11 107.389 175.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.586 ' HD2' ' HA ' ' A' ' 11' ' ' ASP . 48.5 pttt -151.25 159.52 44.32 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 123.559 0.537 . . . . 64.01 111.909 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 8.3 t70 -87.23 144.87 26.62 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.86 -0.793 . . . . 72.24 108.86 173.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 pt -66.63 -11.56 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 113.218 0.822 . . . . 55.3 113.218 -174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -108.17 -59.46 1.85 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.77 0.714 . . . . 72.34 112.527 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -125.99 -32.54 2.77 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 114.745 1.387 . . . . 63.0 114.745 -167.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.608 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 19.0 m-20 -81.85 21.88 0.81 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 118.798 0.726 . . . . 75.23 111.539 -173.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HA ' ' HD2' ' A' ' 5' ' ' LYS . 7.5 m-20 -48.45 -20.99 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.305 1.224 . . . . 71.41 114.305 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -113.78 28.11 9.02 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 123.829 0.851 . . . . 61.42 110.212 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.601 ' HA ' ' HD2' ' A' ' 74' ' ' HIS . 41.3 tp -57.42 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.784 1.234 . . . . 62.11 112.107 -175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.7 m -155.62 126.74 7.1 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.83 -0.433 . . . . 72.43 109.83 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 29.2 p -133.77 102.03 5.31 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.064 0.546 . . . . 72.33 109.895 -176.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -172.67 -176.35 1.48 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.038 -1.097 . . . . 74.04 108.038 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.409 ' N ' ' SD ' ' A' ' 1' ' ' MET . 58.9 m -79.71 84.88 5.47 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.425 -0.954 . . . . 64.33 108.425 172.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB2' ' HE2' ' A' ' 4' ' ' TYR . 73.6 m-85 -102.25 129.74 25.6 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.581 -0.896 . . . . 74.11 108.581 175.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HG2' ' HG3' ' A' ' 31' ' ' LYS . 11.9 Cg_endo -56.19 122.07 11.13 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.026 2.484 . . . . 54.44 112.429 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.4 mtm -83.82 144.14 29.48 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.307 -0.861 . . . . 75.41 109.9 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -143.06 101.74 3.88 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.249 -1.389 . . . . 72.52 107.249 175.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 64.5 tp -103.67 126.43 50.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.502 0.721 . . . . 70.33 109.358 -174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.7 p -116.7 129.19 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.264 0.626 . . . . 52.33 109.8 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 64.48 12.0 7.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.659 1.183 . . . . 73.34 113.454 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 55.59 11.17 0.59 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.362 1.065 . . . . 44.55 113.102 -166.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.4 tp -105.66 -44.19 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.08 0.952 . . . . 73.1 110.394 -168.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -124.56 130.01 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.283 -0.871 . . . . 74.55 109.473 -171.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -90.21 117.59 29.08 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.692 -0.855 . . . . 70.22 108.692 171.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -92.75 126.34 37.78 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.158 0.983 . . . . 72.21 109.627 170.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 80.3 t80 -107.52 127.92 54.04 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.852 1.261 . . . . 73.03 108.024 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' HG3' ' HG2' ' A' ' 19' ' ' PRO . 72.4 mmtt -68.23 145.23 54.48 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.399 0.68 . . . . 75.04 111.916 -173.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.27 162.24 35.14 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.608 0.568 . . . . 64.23 112.021 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.38 142.96 50.68 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.027 0.931 . . . . 72.14 109.138 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -67.91 117.54 9.92 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.115 -0.698 . . . . 73.02 109.115 173.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.41 162.93 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.521 0.728 . . . . 61.13 110.626 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.56 131.89 72.3 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 N-CA-C 108.64 -0.874 . . . . 70.42 108.64 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.718 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 73.2 mtp180 -105.31 108.13 19.48 Favored 'General case' 0 C--O 1.255 1.38 0 N-CA-C 108.504 -0.924 . . . . 73.41 108.504 174.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.501 ' NZ ' HG22 ' A' ' 64' ' ' VAL . 62.9 mmtt -134.3 148.37 50.76 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.099 1.759 . . . . 73.53 108.415 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -71.06 -7.08 43.98 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.936 0.894 . . . . 71.41 112.014 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.52 33.44 0.32 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.086 0.394 . . . . 61.42 114.086 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 38' ' ' LYS . 39.7 tt0 -156.52 141.47 17.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 109.555 -0.535 . . . . 65.25 109.555 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp -140.32 35.84 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 CA-C-O 121.893 0.854 . . . . 74.5 110.423 -170.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.36 74.35 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 CA-C-O 122.267 1.032 . . . . 71.15 111.488 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pp -106.6 -4.8 19.22 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.428 0.899 . . . . 64.31 113.428 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.34 -19.63 46.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.026 0.531 . . . . 64.04 111.407 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.92 75.83 1.31 Allowed Glycine 0 C--N 1.347 1.155 0 N-CA-C 112.574 -0.211 . . . . 75.42 112.574 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.6 m -76.27 -29.05 57.29 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.287 0.635 . . . . 72.02 111.609 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -154.43 155.1 30.43 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.624 0.77 . . . . 75.14 110.39 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.72 94.78 0.15 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.586 2.191 . . . . 73.15 111.647 174.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -87.55 81.24 7.81 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.518 -0.765 . . . . 63.44 110.347 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.58 144.28 29.45 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.932 0.893 . . . . 74.12 109.193 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 143.74 41.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.423 1.089 . . . . 74.13 108.544 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -87.98 77.51 8.43 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.009 -0.737 . . . . 61.15 109.009 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.81 69.37 1.35 Allowed Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.657 -0.701 . . . . 71.45 112.186 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.61 98.78 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.522 1.529 . . . . 60.31 113.023 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -60.54 94.21 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.117 0.967 . . . . 74.42 111.091 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -143.75 -160.98 1.18 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.428 1.491 . . . . 63.53 108.078 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.8 -37.64 84.94 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.743 -0.836 . . . . 61.44 108.743 166.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.77 41.76 95.55 Favored Glycine 0 C--N 1.354 1.576 0 CA-C-N 115.35 -0.841 . . . . 63.32 111.2 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -144.88 -40.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.094 0.558 . . . . 71.33 111.503 -170.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -162.58 74.14 0.39 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 121.865 0.84 . . . . 73.34 110.364 -175.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -97.53 -16.76 19.95 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.15 -0.932 . . . . 71.13 110.314 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 64.61 17.17 10.76 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.613 1.165 . . . . 74.11 111.301 -175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.501 HG22 ' NZ ' ' A' ' 38' ' ' LYS . 12.7 t -106.8 84.17 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.575 0 N-CA-C 107.897 -1.149 . . . . 74.42 107.897 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.718 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 26.2 mm-40 -98.72 66.78 1.67 Allowed 'General case' 0 C--O 1.224 -0.263 0 CA-C-O 121.597 0.713 . . . . 71.52 109.16 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -89.15 143.38 26.88 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.609 -0.723 . . . . 61.03 110.006 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.07 -133.01 3.85 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.508 -1.037 . . . . 63.43 110.508 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.469 HD11 HD12 ' A' ' 156' ' ' ILE . 4.7 pt -111.26 154.08 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 122.508 0.323 . . . . 73.13 110.858 172.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -56.59 -39.23 73.16 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.454 1.101 . . . . 73.14 113.099 -173.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.04 -48.88 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.99 0.916 . . . . 71.42 110.527 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 76' ' ' LEU . 55.0 t -67.85 -43.48 86.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 114.999 -1.0 . . . . 74.44 111.099 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 75.9 mt -72.76 -21.97 60.92 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.183 0.593 . . . . 63.42 111.841 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -70.71 -53.59 15.05 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.362 0.665 . . . . 54.43 109.511 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.601 ' HD2' ' HA ' ' A' ' 13' ' ' LEU . 48.9 t-80 -86.55 -21.14 27.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.19 0.596 . . . . 75.35 111.101 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? 65.67 71.13 0.43 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.871 1.268 . . . . 72.3 109.727 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 91.1 mt -91.44 145.68 24.43 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.969 -1.014 . . . . 74.44 110.151 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.4 p -98.11 129.17 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.564 0.746 . . . . 61.43 109.855 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -62.77 153.56 32.44 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.615 0.969 . . . . 72.34 113.615 -177.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.408 ' HE3' ' HB2' ' A' ' 79' ' ' MET . 40.6 ttm -150.16 112.11 4.57 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.799 2.039 . . . . 71.42 106.078 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -112.66 152.33 29.12 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 118.979 0.809 . . . . 72.2 111.702 -172.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.546 ' SG ' ' HE2' ' A' ' 138' ' ' PHE . 85.6 m -65.96 -16.63 64.05 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.402 0.89 . . . . 51.11 113.402 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -71.3 -55.23 8.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 122.973 0.509 . . . . 74.51 110.367 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -105.36 -40.63 5.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.231 0.612 . . . . 62.33 112.061 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -87.83 20.55 3.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.628 0.771 . . . . 65.54 112.854 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.62 -43.77 85.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.293 0.637 . . . . 75.51 112.29 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -77.35 -31.31 54.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.348 0.659 . . . . 63.21 111.711 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 24.9 mmt -64.42 -50.92 65.71 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.319 -0.622 . . . . 35.51 109.319 174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -70.86 -23.41 62.31 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.141 -0.936 . . . . 73.22 110.725 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -68.97 -37.64 78.9 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.291 0.636 . . . . 75.03 109.93 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.4 83.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.18 0.592 . . . . 72.11 110.238 174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -69.39 -32.9 72.21 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 123.409 0.684 . . . . 73.34 112.499 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mm -65.87 -33.6 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 117.898 0.317 . . . . 55.11 110.644 174.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -63.11 -45.65 91.03 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 122.314 0.246 . . . . 55.11 110.571 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -61.6 -54.45 42.85 Favored 'General case' 0 C--N 1.36 1.058 0 N-CA-C 109.227 -0.657 . . . . 72.05 109.227 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.507 ' HD2' ' HG2' ' A' ' 152' ' ' GLN . 60.1 t80 -44.4 -68.53 0.19 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.792 2.037 . . . . 60.32 111.603 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 40.9 ttp -57.35 -50.38 73.13 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 124.127 0.971 . . . . 74.45 111.595 -174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -56.82 -50.04 73.59 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.111 0.882 . . . . 63.11 110.537 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -71.93 -48.01 48.41 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 115.74 -0.664 . . . . 75.33 111.604 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.599 HG11 HG11 ' A' ' 172' ' ' VAL . 23.8 m -66.25 -38.9 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 N-CA-C 112.396 0.517 . . . . 40.02 112.396 -172.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 44.0 mt -77.91 -42.14 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 120.439 0.161 . . . . 70.32 110.921 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -65.05 -45.41 85.52 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.617 0.767 . . . . 73.34 111.355 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -67.14 -40.26 86.7 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.15 0.58 . . . . 62.14 109.959 -177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.6 ttt -59.36 -51.48 69.76 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 123.842 0.714 . . . . 73.23 110.62 175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.81 -23.66 66.74 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.291 0.637 . . . . 75.35 111.257 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 31.8 ttmt -75.07 -24.47 58.21 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.338 0.655 . . . . 64.54 110.87 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -114.5 -13.39 12.2 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.2 0.6 . . . . 72.23 112.18 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -100.74 -46.06 5.28 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.717 0.807 . . . . 74.14 109.399 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 66.29 18.29 10.88 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.068 1.347 . . . . 74.51 113.144 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -116.18 111.13 19.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.64 -1.245 . . . . 62.03 107.64 172.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -69.5 -29.69 67.38 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.595 0.559 . . . . 75.44 111.632 -173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.34 -32.15 66.25 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 60.45 110.927 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.22 -47.55 56.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.686 0.794 . . . . 72.45 109.492 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.7 m -79.28 -17.82 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 115.237 -0.892 . . . . 73.01 111.935 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.08 -35.35 74.13 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.013 -0.736 . . . . 72.31 109.013 170.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.84 -39.31 73.05 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.192 -0.913 . . . . 72.24 110.09 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -62.25 -41.61 98.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.0 0.52 . . . . 73.22 110.391 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.404 ' HA ' HG22 ' A' ' 120' ' ' ILE . 37.5 ttpt -62.24 -34.86 77.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.598 0.759 . . . . 74.43 110.589 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -66.4 -43.25 86.34 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.51 -0.768 . . . . 71.01 110.411 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -46.76 71.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.781 -0.645 . . . . 73.44 111.441 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.404 HG22 ' HA ' ' A' ' 117' ' ' LYS . 9.0 tp -78.96 -33.32 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 122.606 0.363 . . . . 61.11 110.944 -168.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.92 -41.06 95.87 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.082 -1.081 . . . . 72.0 108.082 171.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -59.8 -40.98 97.4 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 123.832 0.708 . . . . 63.04 113.013 175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -67.88 -48.0 67.29 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 122.656 0.382 . . . . 71.34 111.003 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.429 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 31.4 m -70.5 -38.37 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-O 118.997 -0.525 . . . . 55.32 111.796 -175.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.39 -32.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 118.683 0.674 . . . . 73.52 110.194 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.7 t -69.43 -42.03 75.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.453 0.701 . . . . 74.31 110.581 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 155' ' ' ILE . 14.4 tp -74.8 -30.89 61.56 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.247 1.019 . . . . 64.24 111.076 -170.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 86.5 mt -86.09 1.93 48.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.923 0.889 . . . . 65.01 110.78 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.04 67.03 8.94 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-O 122.08 0.943 . . . . 72.03 108.701 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.74 -6.22 30.48 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 114.191 -1.368 . . . . 55.55 113.593 -167.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -61.73 -33.76 74.62 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.25 0.62 . . . . 64.22 110.449 172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -105.44 -39.18 6.22 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.429 1.092 . . . . 71.33 109.527 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -80.33 0.67 31.98 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.112 1.365 . . . . 72.15 114.203 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.95 -14.6 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 N-CA-C 114.288 1.218 . . . . 75.02 114.288 175.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.426 ' ND2' ' HG3' ' A' ' 157' ' ' GLU . 4.9 p-10 -79.44 13.63 1.9 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.026 0.93 . . . . 74.21 112.024 175.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.26 146.47 24.2 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.496 0.719 . . . . 73.54 109.425 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -139.06 112.49 8.21 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 105.72 -1.956 . . . . 74.43 105.72 169.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.641 ' HB3' HG11 ' A' ' 153' ' ' VAL . 37.1 m-85 -85.75 145.24 27.35 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.445 -0.946 . . . . 73.33 108.445 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 69.5 m-85 -139.41 143.79 37.82 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.349 0.66 . . . . 73.35 109.461 -176.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 37.6 pt -131.51 177.01 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.615 -0.883 . . . . 73.33 108.615 174.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.56 120.94 23.66 Favored Glycine 0 CA--C 1.522 0.472 0 O-C-N 123.656 0.597 . . . . 74.32 111.621 174.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -53.39 -36.17 61.15 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.864 1.266 . . . . 75.43 110.24 172.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.54 -45.85 71.08 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.878 -1.055 . . . . 71.32 111.298 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.456 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -65.63 -25.74 67.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.519 0.728 . . . . 74.52 111.947 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.24 -7.66 56.3 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.894 0.877 . . . . 65.31 112.239 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -85.28 -40.39 16.64 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 109.535 -0.543 . . . . 74.51 109.535 -175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.09 52.03 0.05 OUTLIER Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.996 -0.547 . . . . 61.22 112.489 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -145.35 -179.49 6.69 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.828 0.851 . . . . 52.0 109.592 176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -119.99 121.63 39.37 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.878 0.871 . . . . 72.31 108.72 175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -91.27 -26.68 18.87 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.756 -0.461 . . . . 61.32 109.756 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.73 -68.16 2.23 Favored Glycine 0 C--N 1.342 0.879 0 O-C-N 124.593 1.183 . . . . 70.23 113.656 174.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.507 ' HG2' ' HD2' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -100.47 133.16 45.31 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 107.247 -1.39 . . . . 75.53 107.247 -179.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.641 HG11 ' HB3' ' A' ' 138' ' ' PHE . 71.5 t -94.02 141.63 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.768 0.827 . . . . 70.23 111.572 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.712 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -72.32 97.2 1.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.891 0.876 . . . . 34.0 109.6 169.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.529 HG21 HD21 ' A' ' 127' ' ' LEU . 85.6 mt -89.84 104.65 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.342 -0.614 . . . . 71.03 109.342 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.469 HD12 HD11 ' A' ' 68' ' ' ILE . 41.3 mm -93.59 125.63 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 109.039 -0.726 . . . . 74.12 109.039 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.426 ' HG3' ' ND2' ' A' ' 135' ' ' ASN . 21.7 tt0 -129.2 112.12 13.6 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.703 -0.851 . . . . 73.12 108.703 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.589 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 54.1 p90 -81.22 99.31 8.51 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 106.76 -1.57 . . . . 61.53 106.76 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.6 ttm-85 -83.46 143.18 30.41 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.047 -0.979 . . . . 64.34 110.769 -168.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -75.77 120.78 21.61 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.123 0.487 . . . . 64.42 109.718 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.11 95.37 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 125.336 1.454 . . . . 72.24 107.951 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.62 17.66 10.98 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.185 0.994 . . . . 72.53 112.11 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 102.31 6.93 47.18 Favored Glycine 0 C--N 1.353 1.521 0 C-N-CA 123.146 0.403 . . . . 75.11 113.545 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 m -111.94 156.42 22.13 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.242 1.017 . . . . 71.42 109.516 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 12.8 pt-20 -84.51 138.51 32.73 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.903 0.481 . . . . 75.41 110.156 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.54 99.37 18.98 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.783 0.833 . . . . 42.31 108.8 168.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.04 114.11 1.87 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 122.902 2.401 . . . . 74.2 113.195 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.3 p -115.75 121.23 41.86 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.875 0.87 . . . . 63.35 108.714 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 30.7 tp -76.76 107.4 9.05 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.467 -0.938 . . . . 51.41 108.467 172.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 73.7 mtp -94.96 122.69 37.86 Favored 'General case' 0 C--O 1.248 0.999 0 N-CA-C 107.875 -1.157 . . . . 63.12 107.875 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.712 HD21 ' HA ' ' A' ' 154' ' ' ALA . 85.3 mt -134.7 145.04 48.13 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.558 1.543 . . . . 50.53 107.081 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.599 HG11 HG11 ' A' ' 99' ' ' VAL . 7.5 p -73.6 141.66 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.618 -0.882 . . . . 65.11 108.618 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.548 ' HA ' HG22 ' A' ' 176' ' ' ILE . 61.6 tttp -57.86 -30.02 65.48 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.004 0.922 . . . . 74.42 111.758 -175.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -84.65 2.16 42.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.822 0.849 . . . . 65.14 112.267 -175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.98 -9.03 4.88 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.472 0.709 . . . . 73.43 111.375 173.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.548 HG22 ' HA ' ' A' ' 173' ' ' LYS . 8.6 tp -97.8 133.85 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 107.141 -1.429 . . . . 74.41 107.141 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 48.2 mm -104.57 110.53 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 106.864 -1.532 . . . . 61.53 106.864 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -101.89 90.31 3.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.012 1.325 . . . . 74.31 107.582 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.451 ' HB3' HG23 ' A' ' 3' ' ' ILE . 12.2 tp10 -106.13 144.02 33.43 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.817 -0.808 . . . . 61.42 108.817 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.571 ' HE2' HD11 ' A' ' 182' ' ' LEU . 13.8 ptmt -100.27 123.92 45.08 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.681 0.792 . . . . 72.34 110.134 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.26 87.4 7.12 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.597 -0.89 . . . . 73.45 108.597 178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.571 HD11 ' HE2' ' A' ' 180' ' ' LYS . 82.8 mt -90.31 87.93 7.01 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.741 -0.837 . . . . 54.4 108.741 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 C--O 1.254 1.336 0 N-CA-C 107.263 -1.384 . . . . 71.42 107.263 178.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 86.1 mmm . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.701 0.286 . . . . 64.55 110.441 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.6 HD22 ' HA ' ' A' ' 180' ' ' LYS . 62.3 mt -120.52 155.74 32.99 Favored 'General case' 0 C--O 1.25 1.087 0 C-N-CA 123.781 0.832 . . . . 61.43 109.742 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 179' ' ' GLU . 60.3 mt -96.85 120.25 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.373 -0.973 . . . . 60.33 108.373 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -110.33 99.41 8.44 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.265 -1.383 . . . . 75.52 107.265 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 10' ' ' ASP . 55.2 pttt -129.53 165.3 21.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.314 -0.403 . . . . 73.23 110.054 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 10.3 m-20 -85.89 -177.94 6.46 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 121.839 0.828 . . . . 74.21 110.207 174.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.6 mt -84.19 -24.4 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 CA-C-N 114.87 -1.059 . . . . 62.31 110.041 157.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -107.11 -59.76 1.77 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.788 0.835 . . . . 73.24 112.267 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -96.82 17.56 16.42 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.013 0.925 . . . . 72.54 110.439 -174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 5' ' ' LYS . 5.3 p-10 -52.42 -29.21 23.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.111 1.364 . . . . 72.24 113.212 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -48.62 72.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.765 1.291 . . . . 74.43 111.323 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -120.3 17.87 12.25 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.688 -0.687 . . . . 63.22 112.268 -168.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 tp -78.23 -135.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 119.261 0.937 . . . . 74.1 109.176 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -143.78 122.79 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 120.741 1.61 . . . . 73.51 112.617 -168.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.52 ' HB3' HG23 ' A' ' 3' ' ' ILE . 35.7 p -116.12 104.87 11.98 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.865 0.866 . . . . 63.34 108.995 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 1' ' ' MET . 37.4 t70 -160.64 -100.89 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 110.141 -0.318 . . . . 63.03 110.141 -175.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 56.9 p -127.69 71.5 1.36 Allowed 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.027 -0.731 . . . . 70.12 109.027 -175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -120.67 93.9 48.68 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.004 -0.739 . . . . 61.44 109.004 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.54 135.74 66.58 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.638 2.225 . . . . 53.54 111.622 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.448 ' SD ' ' HE3' ' A' ' 180' ' ' LYS . 24.2 ptt? -83.48 138.98 33.21 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.928 -0.767 . . . . 74.22 108.928 -177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -152.4 122.74 7.21 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.035 -1.098 . . . . 74.42 108.035 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.7 tp -130.64 122.89 28.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.64 0.776 . . . . 71.4 109.039 -172.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.13 142.86 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.322 0.649 . . . . 73.55 110.327 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.7 t70 59.39 8.23 1.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 125.34 1.456 . . . . 61.42 113.515 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.5 t70 51.72 39.28 25.01 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.243 1.017 . . . . 72.4 110.587 -168.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.0 tp -134.99 -51.74 0.78 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.684 0.794 . . . . 71.25 110.532 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.3 t -115.28 125.9 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.58 0.752 . . . . 63.43 110.299 -170.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -83.6 119.96 25.37 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.981 -1.118 . . . . 74.42 107.981 171.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 6.7 pt-20 -111.51 141.65 44.8 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.176 0.591 . . . . 65.23 109.833 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.43 ' HD1' HD11 ' A' ' 70' ' ' ILE . 33.2 t80 -136.76 140.28 42.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.997 -1.112 . . . . 74.04 107.997 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -83.8 97.05 8.96 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.088 0.555 . . . . 72.24 110.061 -176.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.98 130.6 11.6 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.942 -0.572 . . . . 63.02 111.706 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -97.62 124.04 41.75 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.367 0.583 . . . . 70.1 109.454 -177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -64.72 114.27 4.33 Favored 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 108.783 -0.821 . . . . 73.4 108.783 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.562 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 15.4 m -148.47 161.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.208 1.003 . . . . 55.12 108.88 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.528 HG13 ' HA ' ' A' ' 44' ' ' LEU . 3.3 m -128.42 143.78 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.183 -1.043 . . . . 64.22 108.183 173.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -91.74 116.08 28.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.404 -1.702 . . . . 73.15 106.404 169.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -119.46 145.48 46.25 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.87 -1.53 . . . . 71.02 106.87 170.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -62.8 89.02 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.432 0.634 . . . . 72.15 111.548 -174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.49 5.32 52.02 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 114.639 -1.164 . . . . 62.23 113.998 173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -159.85 -174.59 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.899 0.48 . . . . 72.14 110.757 -176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tt -148.44 130.21 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.687 0.795 . . . . 73.33 109.483 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.5 t -129.18 79.92 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 107.95 -1.13 . . . . 71.11 107.95 168.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.562 ' HB3' ' HA ' ' A' ' 35' ' ' VAL . 1.1 pp -69.99 -23.23 63.12 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.689 0.796 . . . . 71.32 112.36 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.59 160.88 22.43 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.588 0.755 . . . . 62.03 110.145 176.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.72 68.35 2.51 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.015 -0.834 . . . . 75.21 111.015 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.5 m -129.31 1.77 5.13 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.279 1.032 . . . . 72.5 110.507 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -76.11 108.32 5.93 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.513 -1.292 . . . . 71.44 107.513 173.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -82.61 42.89 1.38 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.96 2.44 . . . . 72.42 112.836 -173.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.2 t -158.23 177.79 10.89 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.15 0.98 . . . . 74.1 109.426 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . 68.34 81.93 0.18 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.597 1.159 . . . . 60.52 112.193 175.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.46 -40.95 0.12 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.482 0.713 . . . . 72.35 111.397 173.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -172.65 -70.31 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.753 0.821 . . . . 73.4 109.666 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.78 -29.59 67.18 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 116.052 -0.522 . . . . 70.34 112.82 -176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.25 105.92 16.24 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.357 -1.349 . . . . 61.52 107.357 168.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -118.0 -48.33 2.55 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.415 0.686 . . . . 75.41 110.844 -171.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.53 -17.08 62.34 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 116.183 -0.462 . . . . 74.14 112.045 -172.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -109.52 130.7 55.49 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.302 -1.37 . . . . 74.1 107.302 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . 85.46 26.78 34.8 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.216 -0.902 . . . . 73.52 112.026 -176.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -74.17 122.23 22.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.556 0.742 . . . . 74.1 110.392 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HB3' ' NH1' ' A' ' 66' ' ' ARG . 5.1 p-10 -67.77 -1.26 5.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.235 0.828 . . . . 74.0 113.235 -171.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -59.07 -57.16 14.27 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 123.877 0.871 . . . . 71.03 110.3 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -98.55 -25.36 14.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.763 0.425 . . . . 71.45 111.134 175.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 37' ' ' ARG . 31.7 t -77.62 77.44 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.043 0 N-CA-C 107.852 -1.166 . . . . 75.33 107.852 168.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 39.5 mt-10 -75.32 77.18 2.41 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.718 -1.216 . . . . 72.23 107.718 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 61' ' ' ASP . 6.1 ptp180 -76.59 135.63 39.22 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.89 -1.05 . . . . 72.11 110.545 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.44 -136.84 4.53 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.443 -0.663 . . . . 63.34 111.443 173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 19.1 pt -110.22 155.38 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.509 0.324 . . . . 75.02 110.779 172.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -55.75 -39.27 70.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.382 1.073 . . . . 74.52 112.391 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.43 HD11 ' HD1' ' A' ' 30' ' ' PHE . 41.3 mt -55.29 -44.87 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 124.104 0.962 . . . . 73.42 110.47 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.74 -55.08 19.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 CA-C-N 114.011 -1.449 . . . . 74.42 110.656 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.515 HD12 HG23 ' A' ' 35' ' ' VAL . 18.2 mt -67.94 -30.37 69.66 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.726 -0.67 . . . . 64.41 111.088 -171.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.65 -52.38 38.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.838 -1.073 . . . . 70.35 110.95 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -89.37 -13.56 37.53 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.106 -0.497 . . . . 64.51 111.798 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt 68.42 66.32 0.32 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.24 1.016 . . . . 75.3 109.437 -173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 94.9 mt -86.57 131.36 34.19 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.96 -1.018 . . . . 75.2 108.677 173.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.804 HG11 ' HB2' ' A' ' 145' ' ' ALA . 4.4 p -86.42 129.89 37.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.524 0.73 . . . . 55.45 109.424 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -62.56 151.67 37.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 123.663 0.785 . . . . 74.45 112.247 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 39.5 tpp -149.5 140.28 22.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.347 -1.353 . . . . 70.42 107.347 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.632 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 29.7 m-80 -130.06 123.18 29.86 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.066 0.546 . . . . 73.43 110.334 -169.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 28.0 p -67.73 -16.26 64.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.014 0.526 . . . . 33.52 111.72 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.632 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 97.5 m-85 -45.88 -60.76 2.06 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 124.287 1.035 . . . . 65.01 111.319 176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -105.23 -33.31 8.27 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.244 1.018 . . . . 72.13 111.255 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -93.02 19.98 7.23 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.002 0.521 . . . . 65.34 111.728 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.97 27.81 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.85 0.86 . . . . 63.44 113.203 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.3 m -77.96 -50.74 11.57 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.515 0.726 . . . . 54.02 112.25 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -72.91 -33.48 66.01 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.1 0.56 . . . . 71.13 110.971 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.516 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 35.0 t80 -64.91 -42.92 94.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.103 0.561 . . . . 65.11 110.568 170.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -63.46 -27.62 69.41 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 120.678 0.275 . . . . 73.55 110.564 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.2 -36.72 74.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.192 0.597 . . . . 54.11 110.571 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.516 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 34.8 m-85 -63.83 -35.85 81.97 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.654 0.382 . . . . 74.14 110.526 170.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mm -65.61 -36.5 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.453 0.701 . . . . 75.43 111.459 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.36 -44.82 96.51 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.579 0.352 . . . . 75.24 110.699 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -68.09 -42.81 79.76 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.909 -0.587 . . . . 73.24 109.886 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -48.86 -66.63 0.37 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.625 1.57 . . . . 74.23 111.07 175.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 24.1 ptm -60.46 -40.61 91.83 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.507 0.504 . . . . 62.13 111.19 -175.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -62.93 -45.59 91.74 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 122.68 0.392 . . . . 71.44 110.379 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -72.9 -48.72 34.79 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.346 0.658 . . . . 74.34 111.206 -174.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -66.41 -38.06 80.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 123.541 0.525 . . . . 53.51 112.188 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.418 HD13 ' HE3' ' A' ' 117' ' ' LYS . 63.8 mt -77.89 -40.18 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 C-N-CA 122.969 0.508 . . . . 72.51 110.148 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -62.52 -42.71 99.69 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.134 0.974 . . . . 73.22 111.83 176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -66.96 -45.03 78.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.297 -0.865 . . . . 64.51 109.104 -177.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.471 ' HA ' HD21 ' A' ' 106' ' ' ASN . 26.9 ttt -62.59 -40.49 97.07 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 124.349 1.031 . . . . 74.4 110.692 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -57.23 -41.29 79.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.258 1.023 . . . . 70.45 112.174 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -71.58 -19.22 62.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.797 0.666 . . . . 72.4 112.797 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.471 HD21 ' HA ' ' A' ' 103' ' ' MET . 9.5 p30 -114.37 0.9 14.25 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 118.386 0.539 . . . . 73.23 111.891 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.56 -48.06 2.88 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.754 -0.832 . . . . 65.53 108.754 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 57.37 8.37 0.59 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 126.848 2.059 . . . . 75.23 113.996 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -113.91 115.13 27.2 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.987 -0.746 . . . . 72.12 108.987 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -64.6 -32.85 74.68 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 124.026 0.829 . . . . 75.11 111.833 -177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.92 -31.58 68.24 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.791 0.329 . . . . 73.01 110.603 -176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.19 -54.59 6.32 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.976 -0.75 . . . . 61.25 108.976 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.9 -22.22 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 115.932 -0.576 . . . . 54.25 111.677 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.05 -41.73 97.27 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.303 0.641 . . . . 74.54 110.221 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.68 -38.78 84.19 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.053 0.845 . . . . 40.44 110.172 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -57.64 -61.12 2.74 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.173 0.92 . . . . 75.25 111.733 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.418 ' HE3' HD13 ' A' ' 100' ' ' ILE . 21.8 ptmt -73.19 -15.38 61.45 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 123.615 0.572 . . . . 65.43 111.858 -173.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -68.14 -51.49 45.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.55 -0.907 . . . . 74.21 108.55 171.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -69.12 -32.86 72.55 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.081 -1.418 . . . . 71.43 111.878 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.5 mm -67.98 -47.62 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.068 0.547 . . . . 63.4 110.262 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.35 -49.53 75.85 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.91 0.756 . . . . 42.11 109.499 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.69 -43.59 98.76 Favored Glycine 0 CA--C 1.534 1.259 0 O-C-N 123.819 0.7 . . . . 74.13 112.981 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -62.45 -50.5 71.2 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.696 0.799 . . . . 74.42 109.79 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.485 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.5 m -70.79 -42.14 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 118.503 -0.76 . . . . 62.2 111.816 -173.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.55 -32.16 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-N 119.221 0.919 . . . . 73.4 110.757 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.2 t -73.97 -38.96 64.03 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 120.907 0.384 . . . . 60.1 110.081 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.666 HD21 HG21 ' A' ' 155' ' ' ILE . 28.4 tp -73.88 -26.94 60.81 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.929 1.292 . . . . 73.42 111.867 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 64.8 mt -88.42 2.24 53.12 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.852 0.861 . . . . 62.54 111.822 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 93.87 6.77 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.209 0.528 . . . . 72.35 109.586 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 50.9 mtpt -67.07 -5.38 12.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.331 1.234 . . . . 72.42 114.331 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -47.15 83.08 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 118.231 0.469 . . . . 73.25 110.794 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -109.06 -37.64 5.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.768 0.827 . . . . 71.51 110.547 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -79.37 -1.79 38.66 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.714 1.206 . . . . 73.32 114.148 -172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 37.3 ttpt -55.26 -15.54 2.52 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.705 0.631 . . . . 65.54 112.705 172.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -83.68 6.72 19.95 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.598 0.759 . . . . 72.02 111.276 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.63 129.18 34.96 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.415 0.686 . . . . 62.33 109.309 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.85 120.17 39.75 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.658 -1.238 . . . . 53.44 107.658 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.431 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 65.1 m-85 -102.7 141.91 34.73 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.422 -0.585 . . . . 74.24 109.422 -177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 95.1 m-85 -139.65 149.76 44.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.239 -0.652 . . . . 73.43 109.239 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 23.4 pt -133.66 168.95 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 108.892 -0.781 . . . . 75.21 108.892 173.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.61 143.93 48.99 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-O 119.821 -0.433 . . . . 63.41 112.227 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -44.86 -39.31 5.25 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.698 0.799 . . . . 60.31 111.993 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -62.77 -38.53 90.95 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 72.42 111.898 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -68.59 -29.74 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.267 0.627 . . . . 62.34 111.727 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.804 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -84.53 -25.33 28.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.575 0.35 . . . . 74.53 111.215 173.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -65.81 -29.89 70.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.499 0.72 . . . . 72.11 110.55 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 149.88 59.53 0.01 OUTLIER Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.074 -0.81 . . . . 71.41 111.074 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -159.41 -170.69 3.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.165 0.586 . . . . 64.33 111.134 -175.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.95 -173.01 0.9 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 75.32 108.858 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 79.21 -20.82 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 125.521 1.528 . . . . 75.15 111.963 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.13 146.72 47.78 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 111.908 -0.477 . . . . 72.35 111.908 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -67.62 134.23 50.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.397 0.679 . . . . 75.53 111.52 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.439 HG11 ' HE1' ' A' ' 88' ' ' PHE . 59.9 t -83.36 117.96 30.08 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 CA-C-N 115.699 -0.682 . . . . 70.2 109.679 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.611 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -67.01 101.5 0.86 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.828 0.851 . . . . 75.04 109.525 168.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.666 HG21 HD21 ' A' ' 127' ' ' LEU . 67.1 mt -90.78 105.88 16.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.22 -1.03 . . . . 74.25 108.22 -176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -94.84 96.35 5.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.333 -0.617 . . . . 61.13 109.333 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -81.47 157.23 24.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.732 -1.122 . . . . 73.44 108.011 168.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.1 p90 -120.45 139.24 53.14 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.021 -1.103 . . . . 72.31 108.021 175.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.417 ' HB2' HG23 ' A' ' 166' ' ' VAL . 24.1 mmt180 -118.98 161.27 20.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.263 -0.643 . . . . 72.33 109.263 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -115.84 119.84 37.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.489 0.716 . . . . 70.51 110.403 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.2 p -117.88 97.97 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 124.296 1.038 . . . . 71.44 108.773 173.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 61.94 18.06 9.51 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 124.446 1.098 . . . . 75.14 113.777 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 114.84 1.37 22.7 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 120.122 -0.266 . . . . 75.52 113.194 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.9 m -110.11 134.37 52.25 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.954 0.901 . . . . 73.32 109.634 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -78.91 120.66 23.83 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.878 -1.156 . . . . 75.01 107.878 172.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.417 HG23 ' HB2' ' A' ' 159' ' ' ARG . 2.7 m -117.84 89.33 33.39 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 107.495 -1.298 . . . . 74.14 107.495 169.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 84.3 Cg_exo -54.19 126.25 21.5 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.006 2.47 . . . . 73.32 113.269 174.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -103.58 107.22 17.98 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.105 -1.072 . . . . 73.52 108.105 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 16.5 tp -75.17 112.42 11.42 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.676 -1.231 . . . . 72.53 107.676 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 17.9 ptp -105.83 136.11 46.05 Favored 'General case' 0 C--O 1.257 1.483 0 CA-C-O 122.07 0.938 . . . . 65.54 108.945 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 154' ' ' ALA . 68.1 mt -141.77 158.33 43.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 112.963 -1.926 . . . . 73.21 106.534 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 174' ' ' GLU . 10.6 p -86.73 140.65 15.49 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 N-CA-C 108.363 -0.977 . . . . 62.32 108.363 168.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -57.77 -27.33 62.97 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.537 0.735 . . . . 73.34 111.722 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 172' ' ' VAL . 17.0 mm-40 -90.12 13.58 14.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.594 0.757 . . . . 61.03 112.858 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.92 -1.14 7.23 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.588 0.755 . . . . 60.32 110.921 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.434 HG13 HD13 ' A' ' 171' ' ' LEU . 36.3 mm -132.0 137.0 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.047 0.939 . . . . 71.04 109.55 -174.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 43.4 mm -114.94 109.81 29.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.854 -1.165 . . . . 52.34 107.854 171.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.05 106.15 18.35 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.403 -1.332 . . . . 72.12 107.403 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.649 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 43.3 mt-10 -92.78 98.11 11.19 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.425 -1.324 . . . . 70.52 107.425 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.645 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -72.97 96.43 2.13 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 113.794 -1.548 . . . . 65.15 109.403 179.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.7 m -75.91 87.78 2.89 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.272 -1.01 . . . . 72.43 108.272 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 97.5 mt -83.33 110.61 18.27 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.194 -0.912 . . . . 64.05 110.459 -171.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 108.031 -1.1 . . . . 74.22 108.031 175.43 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 109.826 -0.435 . . . . 51.34 109.826 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.9 mt -95.35 127.7 41.61 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.07 -0.715 . . . . 65.54 109.07 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.597 ' HB ' ' HG3' ' A' ' 179' ' ' GLU . 45.9 mt -97.4 127.93 49.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.332 0.653 . . . . 73.32 109.482 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.424 ' OH ' ' HB3' ' A' ' 20' ' ' MET . 31.1 m-85 -121.72 114.42 21.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.842 1.257 . . . . 75.23 107.792 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -123.11 150.72 42.86 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.342 0.657 . . . . 74.21 110.02 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.15 134.19 34.74 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.89 -1.152 . . . . 63.2 107.89 166.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.2 pt -68.71 -27.66 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 112.786 0.661 . . . . 73.51 112.786 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 98' ' ' ASN . 74.8 m-85 -85.61 -63.31 1.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.079 0.399 . . . . 75.34 112.068 -168.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -131.33 -33.82 1.45 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.522 0.564 . . . . 74.15 112.522 -173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.83 24.03 5.77 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.05 0.94 . . . . 44.05 112.721 -156.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -46.19 -29.07 1.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.866 1.266 . . . . 73.1 113.605 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -84.42 24.68 0.95 Allowed 'General case' 0 CA--C 1.561 1.371 0 N-CA-C 113.2 0.815 . . . . 73.24 113.2 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.4 mt -45.28 -76.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.534 1.134 . . . . 45.14 112.564 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.6 p -160.79 134.87 7.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.154 0.581 . . . . 63.11 110.359 -173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.421 ' HB2' HG12 ' A' ' 3' ' ' ILE . 38.9 p -141.53 99.91 3.66 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.091 0.86 . . . . 42.3 109.655 176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.517 ' HB3' ' HD2' ' A' ' 18' ' ' PHE . 25.9 t70 -163.85 169.66 17.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.711 0.805 . . . . 70.32 109.364 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.3 m -80.99 9.49 6.47 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.862 0.865 . . . . 74.22 113.13 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.517 ' HD2' ' HB3' ' A' ' 16' ' ' ASP . 51.4 p90 -54.49 141.82 52.96 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 118.34 0.518 . . . . 73.14 111.787 176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.38 119.82 7.22 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 123.008 2.472 . . . . 54.0 113.258 -164.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.424 ' HB3' ' OH ' ' A' ' 4' ' ' TYR . 24.2 ptt? -101.94 151.81 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.977 -0.556 . . . . 72.15 110.058 172.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -135.91 145.96 46.84 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.181 -1.415 . . . . 72.24 107.181 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.0 tp -134.32 118.52 17.59 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.271 -1.011 . . . . 64.33 108.271 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -108.51 133.88 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 124.056 0.942 . . . . 63.32 109.278 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 58.44 10.46 1.36 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 125.131 1.373 . . . . 64.33 114.55 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 50.72 25.08 1.93 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 123.723 0.809 . . . . 73.4 112.362 -164.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 119' ' ' LYS . 63.3 tp -109.15 -46.14 3.63 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.977 -0.749 . . . . 74.34 108.977 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.1 t -124.44 124.4 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 122.673 0.389 . . . . 74.14 110.822 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -84.63 114.42 21.99 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.604 -1.258 . . . . 73.44 107.604 167.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 47.3 mt-10 -106.97 135.01 49.26 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.227 -0.897 . . . . 65.5 110.44 176.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 27.7 t80 -127.11 133.59 50.37 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.215 1.006 . . . . 74.33 108.984 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.73 139.55 30.41 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.019 0.438 . . . . 71.13 109.828 175.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.43 -172.59 12.97 Favored Glycine 0 CA--C 1.508 -0.372 0 N-CA-C 110.538 -1.025 . . . . 65.4 110.538 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -144.84 144.55 31.19 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.405 0.682 . . . . 53.14 109.992 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' O ' HD11 ' A' ' 44' ' ' LEU . 3.5 t-160 -65.03 117.37 7.56 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.121 -1.066 . . . . 74.14 108.121 169.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.71 163.61 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 124.854 1.261 . . . . 53.3 109.382 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG13 HD23 ' A' ' 44' ' ' LEU . 2.9 m -119.54 104.86 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.241 -1.022 . . . . 71.12 108.241 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.708 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 13.5 tpt180 -80.73 106.62 12.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.772 -1.195 . . . . 70.32 107.772 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' HD3' ' HB2' ' A' ' 41' ' ' GLU . 87.5 tttt -135.04 154.11 51.82 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.818 -1.083 . . . . 73.54 109.579 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -51.63 -26.76 9.57 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.003 1.321 . . . . 73.13 112.836 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.88 27.83 1.29 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.667 -0.518 . . . . 51.21 114.197 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HB2' ' HD3' ' A' ' 38' ' ' LYS . 39.6 mm-40 -146.08 152.45 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.734 0.813 . . . . 75.43 109.352 175.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 6.4 tp -155.04 -43.61 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.599 0.76 . . . . 74.4 110.194 175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.1 t -76.28 106.96 6.66 Favored 'Isoleucine or valine' 0 C--N 1.349 0.576 0 C-N-CA 123.735 0.814 . . . . 50.25 109.662 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.574 HD23 HG13 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -103.18 -162.89 0.94 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.783 0.833 . . . . 74.23 110.072 174.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.84 -172.78 3.01 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.394 1.078 . . . . 34.03 108.163 171.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -78.35 65.16 3.4 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.075 -0.81 . . . . 50.13 111.075 171.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.9 m -150.04 157.71 43.42 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.364 1.066 . . . . 43.15 109.77 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 m120 63.37 74.13 0.46 Allowed Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.681 1.192 . . . . 75.04 111.647 -178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -81.66 177.87 7.12 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.841 2.361 . . . . 53.41 111.413 173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 p -72.04 102.15 2.91 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 109.77 -0.456 . . . . 75.25 109.77 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.45 155.76 34.49 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.58 0.752 . . . . 74.4 111.95 -176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -59.19 120.81 9.9 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.233 1.013 . . . . 72.23 109.524 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 69.34 77.42 0.22 Allowed 'General case' 0 CA--C 1.547 0.828 0 O-C-N 124.913 1.383 . . . . 75.31 109.464 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.47 43.69 2.19 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.825 -0.625 . . . . 73.03 112.423 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.06 -65.6 0.98 Allowed 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.199 0.6 . . . . 74.1 109.79 175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 51.97 49.59 20.38 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.161 1.384 . . . . 73.13 112.314 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 4.6 p-10 -65.26 -23.96 67.19 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 115.875 -0.602 . . . . 74.1 111.13 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -62.13 -37.27 84.5 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.552 0.741 . . . . 74.34 110.649 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.01 42.61 1.71 Allowed Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.907 -0.588 . . . . 71.51 111.683 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' A' ' 57' ' ' ASP . 44.4 p -73.51 93.65 2.02 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-O 121.331 0.586 . . . . 75.32 109.459 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -136.79 -63.53 0.61 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.484 -0.78 . . . . 71.21 109.555 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 64.13 33.77 11.66 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.225 1.01 . . . . 74.34 112.538 169.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -62.81 -25.1 68.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.497 0.665 . . . . 61.0 109.859 167.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.2 t -92.86 90.38 3.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.868 -1.531 . . . . 74.3 106.868 164.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.708 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 48.1 mt-10 -67.36 80.86 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.849 0.833 . . . . 74.42 109.091 170.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -75.55 132.42 40.7 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.785 -1.098 . . . . 70.1 110.011 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.06 -141.45 7.73 Favored Glycine 0 CA--C 1.498 -0.982 0 N-CA-C 110.048 -1.221 . . . . 61.42 110.048 176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.526 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 30.1 pt -111.5 147.41 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.426 0.613 . . . . 74.41 110.63 171.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -60.7 -24.33 65.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.438 0.695 . . . . 62.0 112.846 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.51 HG21 ' HB2' ' A' ' 169' ' ' LEU . 52.9 mt -60.16 -40.39 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.609 0.719 . . . . 74.42 110.165 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -77.17 -51.71 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.351 -0.841 . . . . 74.34 111.625 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.703 HD22 ' HB3' ' A' ' 65' ' ' GLU . 24.1 mt -64.88 -45.62 85.23 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.079 0.862 . . . . 64.33 111.492 -169.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -80.62 -18.03 49.45 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.559 -0.746 . . . . 65.13 111.854 -176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -107.79 -1.45 20.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.791 -0.568 . . . . 72.24 111.357 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? 55.95 56.69 5.75 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.226 1.011 . . . . 72.44 111.726 178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.638 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 62.8 mt -95.13 138.3 33.03 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.016 -0.993 . . . . 71.13 109.73 176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -102.4 134.48 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.922 -0.77 . . . . 73.21 108.922 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -67.26 141.45 57.23 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.143 -0.935 . . . . 64.34 112.928 -174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 6.7 ptm -140.81 109.96 6.18 Favored 'General case' 0 C--O 1.248 0.994 0 N-CA-C 107.136 -1.431 . . . . 64.1 107.136 165.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -101.45 152.98 20.1 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.703 -0.681 . . . . 51.31 110.306 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.424 ' SG ' ' HE1' ' A' ' 138' ' ' PHE . 64.8 m -67.34 -3.56 8.47 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 114.045 1.128 . . . . 74.1 114.045 -175.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -94.13 -60.24 1.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.796 0.439 . . . . 74.4 110.018 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -78.36 -43.62 27.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.862 0.865 . . . . 75.41 110.273 -177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.13 20.56 8.94 Favored 'General case' 0 C--O 1.201 -1.487 0 CA-C-N 115.245 -0.889 . . . . 75.0 110.842 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.81 -53.82 22.99 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.416 1.086 . . . . 60.14 113.904 -174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.0 m -68.33 -40.59 81.58 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.5 0.667 . . . . 73.24 110.996 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.438 ' HG3' ' CE2' ' A' ' 91' ' ' TYR . 14.2 tpt -68.59 -29.07 67.52 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.179 -0.919 . . . . 72.35 110.245 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -66.46 -42.12 88.04 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.355 1.462 . . . . 74.31 110.063 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -57.78 -41.65 82.47 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.86 0.725 . . . . 62.42 110.167 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.88 -45.42 86.07 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.394 0.678 . . . . 74.15 112.389 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.56 ' HE1' HD12 ' A' ' 140' ' ' ILE . 30.3 m-85 -55.17 -48.21 74.08 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 123.456 0.702 . . . . 62.2 112.151 175.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.13 -41.33 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 123.802 0.689 . . . . 70.34 112.614 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -52.63 -47.76 66.82 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 118.361 0.528 . . . . 71.35 111.334 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -70.24 -45.35 66.66 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 115.162 -0.926 . . . . 72.34 110.996 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -49.83 -51.42 40.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.631 1.172 . . . . 75.42 110.63 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 23.4 ttt -58.09 -54.64 44.69 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.764 1.226 . . . . 60.24 111.392 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.3 -24.17 62.98 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.316 -0.402 . . . . 64.02 111.901 -175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 8' ' ' PHE . 99.5 m-20 -88.12 -40.63 13.62 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.542 0.737 . . . . 72.32 112.264 -174.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 120' ' ' ILE . 29.5 m -66.8 -36.96 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 110.14 -0.318 . . . . 73.11 110.14 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 32.9 mt -75.09 -31.23 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 122.438 0.295 . . . . 75.11 110.543 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -55.24 -52.93 61.81 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.853 0.461 . . . . 73.42 111.028 171.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -66.32 -38.29 87.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.913 -0.585 . . . . 73.41 111.391 -177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.636 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -67.26 -58.14 5.37 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.671 0.389 . . . . 74.4 110.741 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -68.13 -42.2 80.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.352 1.061 . . . . 53.13 112.337 -168.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -68.65 -22.09 64.42 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.094 0.558 . . . . 62.33 111.433 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.436 HD22 ' N ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -101.09 -17.95 16.45 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.278 0.631 . . . . 74.11 111.446 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -105.31 -52.17 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.061 0.545 . . . . 75.32 111.004 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 81.38 -21.45 0.31 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.457 1.503 . . . . 71.01 113.066 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -79.52 127.35 32.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 118.354 0.525 . . . . 63.3 110.516 -172.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -43.39 81.08 Favored 'General case' 0 CA--C 1.551 0.988 0 O-C-N 124.55 1.156 . . . . 62.4 112.454 -173.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.03 -30.65 39.55 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.143 0.577 . . . . 74.22 112.52 -173.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -84.06 -36.62 22.91 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.574 0.35 . . . . 55.22 110.542 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.636 HG12 ' SD ' ' A' ' 103' ' ' MET . 23.4 m -69.91 -29.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-O 120.729 0.299 . . . . 75.15 110.385 172.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -70.76 -31.82 68.76 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.679 0.791 . . . . 75.41 109.921 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.411 ' O ' ' HD3' ' A' ' 119' ' ' LYS . . . -67.2 -53.81 26.87 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.456 0.702 . . . . 61.05 109.689 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -55.82 -43.27 76.8 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 123.878 0.736 . . . . 73.44 110.465 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -56.37 -43.94 79.7 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 124.579 1.174 . . . . 74.55 111.181 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -62.81 -46.6 87.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.451 0.7 . . . . 74.54 110.204 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.465 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.5 mptm? -66.92 -45.2 78.61 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.204 0.602 . . . . 74.24 111.142 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 99' ' ' VAL . 10.8 tp -73.03 -39.15 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 122.794 0.438 . . . . 71.21 110.301 -175.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -67.11 -44.79 79.04 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 123.217 0.607 . . . . 72.05 109.885 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.36 -41.24 99.76 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.91 0.756 . . . . 61.44 111.887 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.521 ' HZ2' ' HB3' ' A' ' 170' ' ' MET . 34.1 t90 -63.11 -50.99 68.33 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.826 0.85 . . . . 72.33 110.434 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.493 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.8 m -68.62 -47.64 75.81 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.769 0 CA-C-O 118.9 -0.571 . . . . 62.12 111.019 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.8 m -62.1 -31.23 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 119.09 0.859 . . . . 64.12 111.509 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.2 m -76.37 -43.68 39.66 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.032 0.533 . . . . 61.25 111.219 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.8 tp -77.07 -33.86 57.07 Favored 'General case' 0 C--O 1.212 -0.88 0 C-N-CA 123.237 0.615 . . . . 73.52 111.704 -170.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 71.3 mt -80.54 4.04 19.73 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.596 0.759 . . . . 72.24 112.248 -174.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.67 108.38 0.73 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.916 0.886 . . . . 64.41 111.434 -175.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.61 -5.49 40.69 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 113.745 1.017 . . . . 63.01 113.745 -170.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -97.45 -45.17 6.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.865 0.466 . . . . 72.23 111.151 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -100.4 -47.88 4.76 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.198 0.999 . . . . 72.32 110.508 -172.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 39.2 m-85 -86.24 -2.66 58.58 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.075 0.95 . . . . 63.24 112.402 -173.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -52.57 2.53 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.158 1.91 . . . . 65.31 116.158 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -83.3 17.31 2.13 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.777 0.831 . . . . 71.32 110.82 167.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 87.6 mt -89.82 151.01 22.0 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.426 0.632 . . . . 63.11 110.489 175.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -135.32 119.36 17.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.109 -1.811 . . . . 60.14 106.109 169.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.424 ' HE1' ' SG ' ' A' ' 81' ' ' CYS . 91.1 m-85 -93.59 149.31 21.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.178 -1.045 . . . . 75.42 108.178 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.696 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . 82.3 m-85 -138.78 161.62 36.78 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.354 -0.609 . . . . 74.22 109.354 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.56 HD12 ' HE1' ' A' ' 91' ' ' TYR . 4.7 tt -136.4 143.29 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.648 -1.241 . . . . 61.54 107.648 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.72 150.47 49.84 Favored Glycine 0 C--N 1.342 0.91 0 O-C-N 123.525 0.516 . . . . 70.21 112.997 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -49.91 -47.84 52.0 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.495 1.518 . . . . 65.51 114.367 -176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -42.17 73.83 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.235 0.614 . . . . 73.12 110.684 -171.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.26 -27.04 60.57 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.287 1.035 . . . . 73.24 110.872 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.46 -5.37 42.17 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.993 0.917 . . . . 64.32 112.583 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.83 -5.0 56.71 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.583 0.353 . . . . 75.13 111.028 172.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 108.67 42.94 1.28 Allowed Glycine 0 C--N 1.345 1.041 0 C-N-CA 122.876 0.274 . . . . 73.1 112.666 174.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -90.95 -67.48 0.85 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.104 -0.702 . . . . 63.03 109.104 172.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -159.16 173.37 16.5 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.829 1.252 . . . . 74.05 109.558 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -54.96 -27.59 44.98 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.565 1.146 . . . . 71.15 112.547 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.85 -153.46 41.21 Favored Glycine 0 C--N 1.357 1.726 0 O-C-N 123.793 0.683 . . . . 60.31 111.446 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.578 ' HG3' HD22 ' A' ' 171' ' ' LEU . 50.3 tp60 -87.28 120.16 28.29 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.616 -0.883 . . . . 73.44 108.616 162.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 93.6 t -76.77 116.24 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 109.297 -0.631 . . . . 72.13 109.297 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 139' ' ' PHE . . . -76.65 99.97 5.21 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.159 -0.928 . . . . 70.12 110.494 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 43.9 mt -91.47 108.58 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.476 -0.784 . . . . 74.51 109.628 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 136' ' ' LEU . 49.9 mm -99.0 109.63 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 122.667 0.387 . . . . 74.35 110.71 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.491 ' HA ' HD23 ' A' ' 136' ' ' LEU . 45.7 tt0 -86.94 107.41 18.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.317 -0.623 . . . . 73.2 109.317 171.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -75.0 87.91 2.36 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.378 -1.341 . . . . 72.4 107.378 169.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.532 ' HB3' HG23 ' A' ' 166' ' ' VAL . 8.0 tpt180 -85.92 119.83 26.66 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.048 -0.978 . . . . 74.24 108.62 -170.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.73 97.62 10.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.758 0.423 . . . . 71.25 109.957 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.402 HG13 ' HB ' ' A' ' 164' ' ' THR . 3.8 p -96.41 97.64 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.606 0.763 . . . . 73.01 109.306 173.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 64.7 17.38 10.91 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.415 1.086 . . . . 73.2 112.916 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 115.5 -10.13 19.47 Favored Glycine 0 N--CA 1.475 1.245 0 CA-C-O 120.156 -0.247 . . . . 72.01 113.335 -176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.402 ' HB ' HG13 ' A' ' 161' ' ' VAL . 19.4 m -97.38 128.61 44.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.332 0.653 . . . . 62.31 109.974 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.52 120.85 22.3 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.422 -0.955 . . . . 72.1 108.422 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.532 HG23 ' HB3' ' A' ' 159' ' ' ARG . 12.4 m -115.88 95.72 44.89 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.624 -1.25 . . . . 73.24 107.624 171.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 123.91 14.97 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.451 2.767 . . . . 71.43 112.366 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 26.5 m -117.89 110.45 17.76 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.569 -0.901 . . . . 62.13 108.569 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.574 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 62.8 tp -76.24 117.43 17.92 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.633 -0.877 . . . . 71.31 108.633 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.521 ' HB3' ' HZ2' ' A' ' 123' ' ' TRP . 63.5 mtt -112.26 120.92 43.41 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.957 -1.127 . . . . 74.25 107.957 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.578 HD22 ' HG3' ' A' ' 152' ' ' GLN . 78.5 mt -131.73 145.49 51.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 107.017 -1.475 . . . . 75.31 107.017 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.433 HG12 ' OE1' ' A' ' 152' ' ' GLN . 14.7 p -82.67 137.91 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 108.796 -0.816 . . . . 74.44 108.796 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -57.18 -22.19 38.62 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.858 1.263 . . . . 72.02 111.687 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.427 ' H ' HG22 ' A' ' 172' ' ' VAL . 8.5 tp10 -78.48 -36.91 44.51 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.4 0.519 . . . . 74.14 112.4 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.428 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -97.64 -0.78 45.03 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 120.738 0.304 . . . . 72.03 110.597 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 41.3 mm -121.96 133.63 67.73 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 C-N-CA 124.131 0.972 . . . . 73.01 109.337 176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.3 mm -99.0 109.73 24.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.418 -0.956 . . . . 74.24 108.418 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -95.68 123.45 39.25 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.464 -1.31 . . . . 72.1 107.464 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.597 ' HG3' ' HB ' ' A' ' 3' ' ' ILE . 8.1 pt-20 -146.98 125.04 12.06 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.218 -0.66 . . . . 63.12 109.218 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -81.49 95.81 7.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.59 -0.732 . . . . 64.43 109.324 -178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 53.6 t -83.37 88.8 6.97 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.38 -0.97 . . . . 74.14 108.38 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 67.1 mt -71.46 143.14 50.16 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.233 -0.894 . . . . 72.54 109.909 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 118.773 -0.632 . . . . 75.03 109.468 179.772 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.669 -0.493 . . . . 73.54 109.669 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.27 161.59 20.15 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.575 -0.898 . . . . 62.11 108.575 173.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.44 HD11 ' HD3' ' A' ' 5' ' ' LYS . 12.7 tt -133.66 118.6 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.115 0.483 . . . . 53.13 109.802 172.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 177' ' ' ILE . 21.5 p90 -122.58 124.09 42.7 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.899 -1.148 . . . . 73.13 107.899 173.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 11' ' ' ASP . 22.2 pttp -153.29 171.24 18.86 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.381 0.673 . . . . 63.43 109.995 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -105.09 142.77 34.29 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.812 -0.81 . . . . 61.51 108.812 177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.406 HG22 HG12 ' A' ' 177' ' ' ILE . 22.1 pt -79.68 -9.08 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 123.293 0.637 . . . . 64.45 112.603 -169.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -107.76 -60.21 1.74 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.708 0.29 . . . . 74.44 111.657 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.411 HG23 ' HA3' ' A' ' 151' ' ' GLY . 1.2 p -125.32 -49.49 1.68 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.837 0.68 . . . . 75.14 112.837 -164.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -87.31 21.84 2.31 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.553 0.741 . . . . 63.31 111.181 -172.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.549 ' HA ' ' HB2' ' A' ' 5' ' ' LYS . 16.7 t70 -48.24 -21.68 0.54 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.013 1.325 . . . . 72.25 112.814 174.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -89.95 25.33 2.14 Favored 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 124.823 1.249 . . . . 72.5 112.722 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 10' ' ' ASP . 40.9 mt -62.99 -92.3 0.0 OUTLIER 'General case' 0 C--N 1.371 1.542 0 CA-C-N 119.128 0.877 . . . . 75.13 110.378 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 4' ' ' TYR . 68.1 m -154.65 129.97 9.73 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 118.994 0.815 . . . . 55.03 112.258 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.7 t -109.67 81.93 1.51 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.224 1.009 . . . . 65.31 108.795 163.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -162.2 166.92 24.89 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.083 0.953 . . . . 71.15 109.301 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.3 80.91 0.74 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.595 0.712 . . . . 71.03 110.93 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 61.7 m-85 -114.2 139.65 24.02 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.913 1.285 . . . . 75.44 108.98 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 18' ' ' PHE . 16.5 Cg_exo -68.45 119.86 6.84 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.488 2.125 . . . . 43.52 112.092 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.08 144.13 27.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.637 0.775 . . . . 73.53 109.786 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.19 146.74 47.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.969 -0.752 . . . . 74.05 108.969 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.9 tp -125.73 138.67 53.88 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.882 -0.785 . . . . 72.43 108.882 174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.35 128.43 63.89 Favored 'Isoleucine or valine' 0 C--O 1.266 1.932 0 N-CA-C 109.001 -0.74 . . . . 61.22 109.001 172.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 72.78 -85.53 0.03 OUTLIER 'General case' 0 C--N 1.359 1.019 0 C-N-CA 125.933 1.693 . . . . 62.32 108.741 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.5 t70 172.14 28.48 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.575 1.95 . . . . 44.52 106.788 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 tp -135.15 -52.16 0.78 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.485 -0.779 . . . . 63.35 110.712 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.1 t -118.21 131.28 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.088 -0.505 . . . . 55.14 109.783 -168.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -83.62 135.49 34.58 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.122 -1.066 . . . . 64.11 108.122 172.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.87 155.76 47.29 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.42 0.629 . . . . 70.45 110.673 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.3 t80 -139.99 147.86 41.05 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.14 -0.936 . . . . 74.32 109.259 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.58 154.02 39.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.712 0.805 . . . . 72.31 111.892 -176.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.74 156.46 28.42 Favored Glycine 0 C--N 1.345 1.076 0 C-N-CA 121.722 -0.275 . . . . 75.02 112.858 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -154.37 159.24 41.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.836 0.854 . . . . 64.22 109.935 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -70.21 120.41 15.86 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 109.371 -0.603 . . . . 71.12 109.371 169.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 m -139.75 168.11 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.896 1.278 . . . . 53.02 108.473 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.97 145.32 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.722 -0.844 . . . . 64.14 108.722 172.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.758 ' HB2' ' HB2' ' A' ' 65' ' ' GLU . 27.2 mmt180 -134.33 109.16 8.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.06 -1.83 . . . . 72.35 106.06 174.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -133.07 97.32 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.761 -0.459 . . . . 73.41 109.761 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 39.95 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 126.616 1.966 . . . . 74.3 115.132 169.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.75 49.77 0.82 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 110.787 -0.925 . . . . 50.13 110.787 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -170.78 152.55 3.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.551 1.141 . . . . 73.14 109.0 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tt -156.65 105.73 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.601 0.76 . . . . 64.41 109.694 172.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.0 p -138.59 110.46 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.931 0.892 . . . . 64.23 109.258 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.18 7.05 16.48 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.918 0.887 . . . . 74.0 110.935 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.09 87.1 0.76 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.253 0.621 . . . . 44.21 109.815 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.36 5.56 4.13 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.78 -0.645 . . . . 52.55 112.839 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.3 p -71.37 90.19 0.94 Allowed 'General case' 0 C--O 1.245 0.851 0 N-CA-C 109.313 -0.625 . . . . 74.4 109.313 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -55.7 125.38 61.07 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 125.287 1.435 . . . . 71.3 111.048 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.15 104.88 0.12 Allowed 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 122.968 2.445 . . . . 74.52 111.392 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.4 m -81.38 28.02 0.4 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.183 0.993 . . . . 75.22 113.105 -166.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.34 -44.85 72.47 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.298 1.039 . . . . 72.23 110.948 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -137.41 92.5 2.71 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.155 -1.054 . . . . 60.41 108.155 168.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -104.04 -19.45 14.19 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.282 -0.872 . . . . 64.23 109.698 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.54 141.06 6.54 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 109.398 -1.481 . . . . 64.55 109.398 -169.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.45 72.57 4.98 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.702 0.801 . . . . 74.13 110.096 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -164.26 56.66 0.15 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 121.689 0.757 . . . . 63.24 109.901 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.98 139.64 50.63 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.7 -0.682 . . . . 74.13 109.692 175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -146.47 93.74 2.34 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.084 -1.08 . . . . 73.42 108.084 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.31 50.23 3.58 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.781 -0.528 . . . . 54.43 111.781 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 27.6 t -86.12 45.14 1.19 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.245 1.018 . . . . 74.35 109.576 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -152.85 66.85 0.8 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.986 1.314 . . . . 62.02 108.462 -173.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.72 -24.03 63.5 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 114.689 -1.141 . . . . 71.02 111.409 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -88.74 5.86 41.39 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.745 0.818 . . . . 65.15 111.727 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.6 t -123.39 93.89 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.008 -1.108 . . . . 64.13 108.008 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.758 ' HB2' ' HB2' ' A' ' 37' ' ' ARG . 3.3 mp0 -72.58 80.0 1.08 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.81 -0.811 . . . . 75.03 108.81 174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -95.37 146.54 24.32 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.084 0.954 . . . . 70.14 109.416 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.65 -143.93 15.07 Favored Glycine 0 N--CA 1.466 0.657 0 N-CA-C 110.551 -1.019 . . . . 64.3 110.551 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 167' ' ' PRO . 0.8 OUTLIER -83.7 122.04 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 117.595 0.698 . . . . 64.13 109.413 -175.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.44 -47.52 9.91 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.756 2.022 . . . . 61.41 113.824 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' A' ' 169' ' ' LEU . 66.4 mt -51.81 -48.45 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 124.82 1.248 . . . . 63.31 110.457 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.51 HG13 ' HB2' ' A' ' 76' ' ' LEU . 56.0 t -70.56 -41.55 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.816 -1.084 . . . . 65.44 111.75 -177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 43.8 mt -64.08 -39.77 94.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.564 0.746 . . . . 61.44 111.341 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -74.25 -38.14 63.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.966 0.906 . . . . 72.22 111.128 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.49 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 28.5 m170 -92.07 -11.97 34.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.371 0.669 . . . . 72.43 111.555 -172.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 28.0 mtpp 62.44 46.7 5.59 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.897 1.279 . . . . 70.21 111.137 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.51 ' HB2' HG13 ' A' ' 71' ' ' VAL . 63.1 mt -80.43 130.79 35.39 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.376 -0.602 . . . . 74.24 109.376 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.8 135.42 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.214 -0.661 . . . . 70.45 109.214 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.45 148.01 24.75 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 63.22 113.325 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -146.64 103.54 3.67 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 106.307 -1.738 . . . . 74.23 106.307 -177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -92.6 118.12 30.69 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 108.931 -0.766 . . . . 75.45 108.931 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 28.4 p -63.64 -27.85 69.51 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.907 0.483 . . . . 74.21 111.188 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -68.03 -41.62 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.619 -1.173 . . . . 74.34 111.582 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.16 -22.88 13.34 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.628 0.771 . . . . 64.43 111.998 -170.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -116.66 21.0 13.73 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.456 1.102 . . . . 31.13 110.753 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.35 -38.97 13.99 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.89 1.276 . . . . 54.1 113.779 -174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.9 m -61.45 -56.72 17.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.588 0.755 . . . . 61.23 111.26 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 81.6 mtp -59.92 -36.71 77.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.882 0.473 . . . . 44.13 111.072 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -65.42 -39.29 91.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.0 0.52 . . . . 63.4 111.179 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.06 -38.54 89.18 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.007 0.523 . . . . 74.12 109.974 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.8 -45.38 94.11 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 115.072 -0.967 . . . . 61.52 110.739 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.416 ' O ' ' HB3' ' A' ' 95' ' ' PHE . 54.2 m-85 -59.28 -50.4 74.15 Favored 'General case' 0 C--N 1.357 0.935 0 CA-C-O 119.0 -0.524 . . . . 73.41 111.107 176.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 28.3 mm -55.65 -44.17 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 123.453 0.701 . . . . 74.22 111.886 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -64.4 -56.2 15.9 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 123.099 0.56 . . . . 74.33 109.722 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -65.11 -55.85 16.35 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.537 0.523 . . . . 64.05 110.069 -171.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 91' ' ' TYR . 8.4 t80 -45.34 -61.13 1.79 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 125.325 1.45 . . . . 72.51 112.962 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.6 ttt -64.19 -41.27 97.15 Favored 'General case' 0 C--O 1.248 0.984 0 O-C-N 123.415 0.447 . . . . 74.42 111.449 -171.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -62.66 -41.35 99.01 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.139 -0.482 . . . . 74.11 110.683 176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -64.44 -48.62 74.63 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 124.044 0.84 . . . . 74.33 111.373 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.57 ' O ' ' HG2' ' A' ' 103' ' ' MET . 29.2 m -62.24 -48.75 86.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 123.565 0.541 . . . . 75.14 110.433 -173.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.473 HD13 ' HG3' ' A' ' 117' ' ' LYS . 47.0 mt -69.73 -43.01 80.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 O-C-N 123.308 0.38 . . . . 64.44 110.953 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.06 -37.83 81.04 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.732 0.813 . . . . 71.11 111.877 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -70.84 -41.23 71.76 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.83 0.706 . . . . 64.55 110.608 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.57 ' HG2' ' O ' ' A' ' 99' ' ' VAL . 79.4 mmm -64.81 -36.52 84.59 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.079 -0.712 . . . . 75.25 109.079 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.45 -37.54 71.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.129 1.371 . . . . 74.43 110.462 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.12 -12.82 60.18 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.227 0.611 . . . . 73.23 111.194 -175.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -104.37 -6.02 21.17 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.211 1.005 . . . . 75.33 109.801 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 47.02 77.29 0.09 Allowed 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.13 1.772 . . . . 71.31 112.225 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -61.12 -36.24 79.2 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.438 -0.801 . . . . 65.13 108.88 166.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 112' ' ' ASP . 21.5 t70 152.06 147.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 128.503 2.721 . . . . 74.41 106.063 172.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -58.0 -51.88 67.84 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.684 0.794 . . . . 62.52 110.99 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.28 -22.37 61.96 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.761 -0.654 . . . . 54.33 111.547 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 109' ' ' ASP . 20.9 t70 -80.28 -42.55 22.89 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.107 0.563 . . . . 64.13 111.017 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.21 -27.66 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 122.965 0.506 . . . . 71.53 110.278 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.29 -36.1 63.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.822 0.849 . . . . 65.43 110.856 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.43 -40.94 76.94 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.229 0.612 . . . . 64.11 110.147 176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -64.62 -40.03 94.76 Favored 'General case' 0 C--N 1.347 0.493 0 C-N-CA 124.0 0.92 . . . . 72.24 109.588 172.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HG3' HD13 ' A' ' 100' ' ' ILE . 29.1 ttpp -63.56 -33.16 74.98 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.464 0.705 . . . . 44.02 110.721 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 47.1 tptt -74.93 -39.22 61.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.566 0.746 . . . . 72.31 110.819 175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -66.85 -46.9 73.61 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.974 0.51 . . . . 61.01 111.447 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.01 -32.47 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 123.182 0.593 . . . . 72.4 109.624 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.4 HE21 HG13 ' A' ' 125' ' ' VAL . 21.9 tp60 -62.36 -48.09 81.32 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 122.892 0.477 . . . . 44.33 110.008 172.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.2 -42.67 98.74 Favored Glycine 0 C--N 1.345 1.028 0 O-C-N 124.454 1.096 . . . . 44.04 112.403 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -65.39 -48.95 71.12 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.204 0.602 . . . . 75.44 110.191 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.445 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.5 m -70.2 -41.81 78.91 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.462 0 CA-C-O 118.216 -0.897 . . . . 62.01 111.133 -174.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.4 HG13 HE21 ' A' ' 121' ' ' GLN . 25.0 m -71.88 -21.5 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-N 120.061 1.3 . . . . 74.44 111.507 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.2 t -73.72 -43.24 59.77 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.246 0.546 . . . . 72.01 109.605 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.524 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 34.7 tp -73.04 -36.0 66.84 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.459 1.103 . . . . 71.22 111.405 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.498 ' HA ' ' CE1' ' A' ' 133' ' ' PHE . 77.0 mt -79.83 4.02 17.85 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.587 1.155 . . . . 53.25 112.684 -171.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.13 141.56 49.14 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.486 -0.561 . . . . 62.01 109.486 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.65 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 99.8 mttt -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.561 0.745 . . . . 71.24 111.715 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -70.28 -16.41 63.01 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.816 0.846 . . . . 70.01 110.64 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.524 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 8.9 tpt180 -96.9 -41.59 8.35 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.324 1.049 . . . . 64.03 109.188 173.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.65 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.7 m-85 -62.82 -12.85 27.27 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.742 1.217 . . . . 64.33 113.146 175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -50.21 -30.31 11.25 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 123.878 0.736 . . . . 75.44 112.618 173.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 32.2 p30 -131.4 17.87 4.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.704 0.801 . . . . 63.44 112.177 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.627 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 26.1 mt -96.12 128.94 43.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.201 0.525 . . . . 74.2 111.381 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.79 139.08 54.18 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 105.362 -2.088 . . . . 64.13 105.362 172.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.478 ' HB3' HG11 ' A' ' 153' ' ' VAL . 98.1 m-85 -116.0 148.03 40.57 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.501 -0.926 . . . . 63.25 108.501 -177.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -146.56 136.4 23.3 Favored 'General case' 0 C--O 1.208 -1.116 0 N-CA-C 107.716 -1.216 . . . . 71.15 107.716 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.0 tt -127.57 148.89 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.044 -1.095 . . . . 74.01 108.044 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -51.85 145.49 15.16 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.343 0.497 . . . . 75.2 114.343 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 10.9 tp10 -52.05 -54.97 23.77 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.743 0.817 . . . . 60.24 111.107 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -72.15 -15.28 61.97 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.898 0.879 . . . . 72.42 111.567 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -78.96 -34.88 43.95 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.586 0.755 . . . . 20.41 110.445 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.45 7.57 4.31 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.078 0.951 . . . . 73.31 112.032 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -73.48 -20.32 60.71 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 123.861 0.864 . . . . 52.1 109.813 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.01 30.32 0.81 Allowed Glycine 0 C--N 1.356 1.647 0 C-N-CA 123.739 0.685 . . . . 74.42 112.363 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.85 90.27 5.28 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.552 0.741 . . . . 63.21 110.367 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -69.35 163.27 25.52 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.026 0.931 . . . . 73.24 112.391 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 79.97 7.34 1.67 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.769 1.628 . . . . 64.35 111.495 174.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.411 ' HA3' HG23 ' A' ' 9' ' ' THR . . . -95.64 -177.61 36.86 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 116.137 1.215 . . . . 53.32 116.137 -170.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -111.95 152.27 28.25 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.825 1.65 . . . . 70.13 109.866 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 138' ' ' PHE . 92.7 t -108.22 136.04 45.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.935 0.894 . . . . 65.43 108.632 173.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -64.62 114.44 4.4 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.098 0.959 . . . . 51.1 110.27 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 170' ' ' MET . 61.3 mt -87.03 107.67 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 123.99 0.916 . . . . 71.45 108.864 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.48 121.56 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 72.3 110.092 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.62 98.2 7.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.264 1.426 . . . . 71.22 108.974 -166.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 135' ' ' ASN . 57.5 m-85 -82.86 118.65 23.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.761 0.424 . . . . 74.53 110.705 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -125.31 -179.32 4.54 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.101 0.96 . . . . 75.42 109.436 173.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -123.86 110.83 15.35 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.215 0.606 . . . . 61.25 110.941 172.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.95 102.12 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.226 1.01 . . . . 64.5 108.31 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 60.95 31.55 19.96 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.239 1.016 . . . . 74.45 110.841 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.22 -13.57 65.63 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 116.044 -0.525 . . . . 72.43 113.817 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 94.7 m -90.42 131.39 36.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.202 0.601 . . . . 74.3 109.841 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -71.14 123.11 21.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.509 0.724 . . . . 72.22 109.979 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.7 p -124.96 102.49 31.4 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.492 1.117 . . . . 51.5 110.21 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.626 ' HB2' HD12 ' A' ' 68' ' ' ILE . 72.3 Cg_endo -85.83 118.33 1.77 Allowed 'Trans proline' 0 CA--C 1.552 1.402 0 C-N-CA 122.79 2.327 . . . . 70.03 112.236 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.1 m -103.78 141.91 35.29 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.991 0.916 . . . . 54.42 109.991 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.683 ' HB2' HD13 ' A' ' 70' ' ' ILE . 46.4 tp -77.22 130.35 37.13 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.086 -1.079 . . . . 72.33 108.086 171.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.432 ' HB3' ' HB ' ' A' ' 155' ' ' ILE . 33.2 tpp -131.4 122.48 26.39 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.863 -1.532 . . . . 74.44 106.863 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 154' ' ' ALA . 48.8 mt -159.76 145.65 15.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.696 1.198 . . . . 74.41 108.107 -173.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 176' ' ' ILE . 14.6 p -80.24 134.43 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 119.355 0.98 . . . . 64.32 109.795 -174.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -55.27 -30.39 60.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.869 1.268 . . . . 62.33 112.975 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -71.13 -25.99 62.81 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.264 0.625 . . . . 74.22 111.713 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.01 -1.5 42.5 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.997 0.519 . . . . 43.25 111.008 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.438 HD11 HD13 ' A' ' 171' ' ' LEU . 42.7 mm -112.5 138.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.039 0.535 . . . . 73.33 110.703 -176.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 4' ' ' TYR . 38.0 mm -96.62 109.46 23.02 Favored 'Isoleucine or valine' 0 C--N 1.346 0.428 0 N-CA-C 105.96 -1.867 . . . . 70.4 105.96 167.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.6 99.29 6.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 106.599 -1.63 . . . . 75.21 106.599 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -126.75 155.72 42.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.011 0.924 . . . . 72.51 110.081 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 180' ' ' LYS . 7.6 ptpt -106.63 113.74 27.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.262 1.025 . . . . 73.23 109.725 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 46.7 m -95.88 91.15 5.89 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.462 -0.79 . . . . 71.41 109.085 177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.64 168.81 18.87 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.013 0.525 . . . . 63.45 110.584 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 . . . . . 0 C--O 1.249 1.056 0 N-CA-C 108.853 -0.795 . . . . 74.14 108.853 -178.22 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 109.854 -0.424 . . . . 75.52 109.854 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.2 mt -122.73 130.64 53.17 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.927 0.491 . . . . 64.42 111.538 -175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.2 tt -99.15 118.92 46.45 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 N-CA-C 107.662 -1.236 . . . . 61.0 107.662 171.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -125.11 115.1 19.95 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.426 0.69 . . . . 72.1 110.902 -163.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 1.5 mptp? -121.3 153.14 38.11 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.49 0.716 . . . . 63.22 110.57 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -91.35 148.63 22.19 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.454 -0.943 . . . . 75.41 108.454 159.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 175' ' ' ALA . 47.2 pt -83.27 -24.58 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 N-CA-C 112.563 0.579 . . . . 73.41 112.563 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -86.99 -64.0 1.22 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.796 0.665 . . . . 74.33 112.796 -169.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 144' ' ' ALA . 6.3 m -132.3 -34.73 1.21 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.877 0.695 . . . . 65.25 112.877 -172.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.495 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -92.5 21.79 5.11 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.941 1.296 . . . . 65.5 110.934 -164.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -46.78 -28.27 1.48 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.556 1.542 . . . . 53.14 112.891 -172.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -89.93 26.26 1.87 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 123.763 0.825 . . . . 72.32 112.596 178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 10' ' ' ASP . 18.2 mt -44.93 -93.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 124.974 1.31 . . . . 74.34 112.557 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.3 m -156.28 152.26 27.48 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.965 -0.46 . . . . 54.3 110.917 -167.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.8 m -140.13 98.81 3.52 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.144 -1.058 . . . . 64.12 108.144 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -161.5 -176.2 5.21 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 110.267 -0.271 . . . . 73.33 110.267 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 m -68.33 92.82 0.44 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.36 1.064 . . . . 71.21 110.097 170.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.414 ' HB3' ' HE2' ' A' ' 30' ' ' PHE . 41.2 m-85 -109.29 139.5 21.11 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 123.486 0.714 . . . . 75.11 111.18 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.36 119.08 6.05 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.197 1.931 . . . . 74.53 110.872 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 51.0 ttp -126.42 123.2 37.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.469 -0.787 . . . . 73.0 109.184 -176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -142.59 131.03 22.32 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.892 -1.521 . . . . 74.25 106.892 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.7 tp -101.77 124.06 46.77 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.81 -0.811 . . . . 72.03 108.81 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -115.39 140.05 38.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 124.424 1.089 . . . . 70.01 108.551 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.8 t70 64.29 12.99 7.63 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.006 0.922 . . . . 73.45 112.453 173.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 58.38 21.84 8.79 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.31 1.044 . . . . 71.2 111.966 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.3 tp -130.74 -52.83 1.07 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.758 0.423 . . . . 61.13 110.686 -167.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.1 t -117.56 141.61 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.395 0.678 . . . . 45.42 111.239 -167.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 178' ' ' GLU . 46.6 m-85 -88.7 118.15 28.17 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.128 0.971 . . . . 74.45 109.936 168.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -85.69 104.41 15.38 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.462 -1.245 . . . . 73.2 107.885 167.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 34.7 t80 -100.58 106.81 18.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.419 -1.326 . . . . 74.24 107.419 175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.83 154.36 27.17 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.103 0.477 . . . . 65.3 110.964 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.01 -172.2 23.96 Favored Glycine 0 N--CA 1.464 0.564 0 N-CA-C 111.094 -0.802 . . . . 72.31 111.094 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -135.21 137.34 42.54 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 117.468 0.634 . . . . 63.23 110.717 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -74.18 118.67 17.41 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.796 0.839 . . . . 74.11 109.198 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.567 ' HB ' HD11 ' A' ' 42' ' ' ILE . 12.6 m -141.63 168.67 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.705 1.202 . . . . 65.2 110.69 -165.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 m -127.97 114.01 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.765 0.793 . . . . 70.33 109.235 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.803 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 35.8 ttm180 -92.71 111.04 22.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.282 -1.007 . . . . 70.42 108.282 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -120.81 149.31 42.77 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.083 0.953 . . . . 75.34 109.361 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -72.45 81.83 1.07 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.728 -0.841 . . . . 65.23 108.728 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.83 -62.19 0.18 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 114.365 -1.289 . . . . 73.23 110.259 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -172.17 157.95 4.4 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.634 0.774 . . . . 75.54 110.163 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.567 HD11 ' HB ' ' A' ' 35' ' ' VAL . 6.5 tp -75.33 84.76 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 108.092 -1.077 . . . . 73.14 108.092 169.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.6 -25.53 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-N 115.245 -0.888 . . . . 72.41 112.787 -168.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 60.67 88.36 0.08 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.825 0.85 . . . . 64.11 110.112 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.47 4.23 11.19 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.301 1.04 . . . . 71.11 111.081 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.71 -107.57 1.92 Allowed Glycine 0 C--N 1.352 1.432 0 C-N-CA 123.589 0.614 . . . . 62.33 113.373 178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 70.8 m -133.15 96.9 3.85 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.168 0.987 . . . . 73.42 109.638 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -67.83 157.55 86.19 Favored Pre-proline 0 N--CA 1.479 0.978 0 C-N-CA 124.173 0.989 . . . . 72.13 110.932 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -63.6 84.9 0.13 Allowed 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.326 2.018 . . . . 70.21 111.981 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -151.57 107.94 3.46 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.2 1.4 . . . . 71.53 108.116 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -140.04 -174.21 3.86 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.623 0.769 . . . . 62.01 110.968 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -77.25 85.17 3.7 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.301 0.572 . . . . 73.11 110.477 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -152.01 22.91 0.66 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.824 -1.08 . . . . 74.33 110.315 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 174.8 153.83 10.46 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.735 -0.546 . . . . 51.41 111.735 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.55 -1.15 44.59 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.04 0.936 . . . . 53.43 111.591 173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.11 103.46 15.95 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.929 0.892 . . . . 71.11 111.191 -175.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -91.09 133.78 35.05 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.223 -0.658 . . . . 73.32 109.223 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -111.51 22.3 15.23 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.583 0.753 . . . . 70.25 110.795 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.06 36.25 18.85 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 110.926 -0.87 . . . . 64.44 110.926 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.5 p -145.53 -57.12 0.32 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.834 0.854 . . . . 55.14 110.393 -173.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.32 -33.4 74.61 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.238 1.015 . . . . 60.21 111.965 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -129.96 7.37 5.12 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.45 1.1 . . . . 74.15 110.927 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -128.71 -2.6 5.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.083 0.553 . . . . 74.13 112.461 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.99 100.36 2.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 106.346 -1.724 . . . . 65.31 106.346 161.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.803 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 13.2 mm-40 -75.74 69.41 2.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.032 -1.099 . . . . 73.23 108.032 173.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -82.28 122.26 27.72 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 114.552 -1.204 . . . . 74.51 108.026 175.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.78 -164.82 37.64 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.057 -1.617 . . . . 74.34 109.057 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 70' ' ' ILE . 37.2 pt -96.65 148.82 5.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 117.471 0.636 . . . . 72.15 110.33 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.69 -30.85 63.87 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.746 1.218 . . . . 71.11 112.312 -174.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 68' ' ' ILE . 61.1 mt -56.52 -51.24 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.022 1.329 . . . . 75.01 110.613 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.674 HG13 ' HB2' ' A' ' 76' ' ' LEU . 47.2 t -78.65 -44.11 25.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-N 114.451 -1.25 . . . . 52.03 111.21 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.58 -18.17 65.13 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.666 0.786 . . . . 72.42 112.089 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -48.52 -58.52 4.55 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.331 1.052 . . . . 53.22 110.681 169.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.04 -7.72 16.81 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.819 -0.628 . . . . 64.43 112.598 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 64.5 tttp 62.21 69.88 0.6 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.558 1.161 . . . . 73.34 109.052 -174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.674 ' HB2' HG13 ' A' ' 71' ' ' VAL . 64.3 mt -75.16 157.03 35.27 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.54 -0.755 . . . . 64.42 109.57 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.51 127.84 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.276 -0.638 . . . . 75.12 109.276 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.87 152.07 20.19 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.939 0.876 . . . . 73.52 112.887 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 86.0 mmm -143.83 137.22 27.82 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 104.72 -2.326 . . . . 60.15 104.72 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 140.42 35.64 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.327 0.512 . . . . 71.22 109.788 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.444 ' SG ' ' HG3' ' A' ' 134' ' ' LYS . 24.9 p -58.96 -14.81 10.28 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 123.504 0.722 . . . . 55.34 112.907 -177.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -66.3 -59.09 4.04 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.4 0.68 . . . . 75.54 112.197 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -98.21 -38.24 9.37 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.846 0.458 . . . . 73.14 110.728 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -92.5 21.59 5.25 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.622 0.769 . . . . 73.34 112.681 -171.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.2 -53.2 29.67 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 123.759 0.824 . . . . 50.41 112.871 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.4 m -72.84 -37.72 67.34 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.774 0.83 . . . . 73.14 111.6 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.407 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.5 mpt? -66.5 -45.87 78.15 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.237 1.015 . . . . 60.3 110.3 -176.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 36.2 t80 -63.38 -47.18 83.12 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.376 -1.284 . . . . 75.43 111.236 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 37.1 ttmt -65.39 -28.83 69.54 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.349 0.405 . . . . 62.52 110.701 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.55 93.79 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.425 0.69 . . . . 65.43 110.7 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.44 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 31.2 m-85 -61.09 -40.04 92.24 Favored 'General case' 0 C--O 1.21 -0.982 0 CA-C-N 115.961 -0.563 . . . . 73.22 111.115 174.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.407 ' HA ' ' HB3' ' A' ' 95' ' ' PHE . 42.0 mm -65.19 -32.54 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.731 0.812 . . . . 72.32 111.675 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 89' ' ' LYS . 96.4 mttt -61.53 -47.45 85.51 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.066 0.547 . . . . 65.0 111.437 171.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -66.91 -42.28 85.7 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.098 0.559 . . . . 75.44 110.675 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.465 ' O ' HG13 ' A' ' 99' ' ' VAL . 79.0 t80 -51.86 -60.79 2.78 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.117 1.767 . . . . 63.01 111.035 176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 56.9 ttp -61.04 -40.92 95.45 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 123.731 0.645 . . . . 64.34 111.018 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -56.02 -55.73 29.27 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.214 0.606 . . . . 74.42 110.684 175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -72.27 -36.68 69.06 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.496 0.498 . . . . 62.35 111.854 -170.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 95' ' ' PHE . 18.1 m -67.77 -38.78 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 112.432 0.53 . . . . 63.12 112.432 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.2 mt -77.05 -35.93 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 121.001 0.429 . . . . 74.11 110.529 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.78 -47.83 84.54 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.074 0.95 . . . . 71.22 110.765 173.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -66.56 -44.34 82.58 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.617 -1.174 . . . . 50.33 110.061 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.5 ' HG3' HG12 ' A' ' 113' ' ' VAL . 15.4 tpt -55.53 -53.35 57.52 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.118 0.886 . . . . 71.4 111.724 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.435 ' HA ' HG11 ' A' ' 113' ' ' VAL . 41.1 tt0 -65.2 -27.09 68.45 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.568 0.542 . . . . 73.2 111.579 -172.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -67.58 -45.28 76.01 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.201 0.524 . . . . 75.12 110.616 176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 -83.82 -29.54 27.23 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.081 0.953 . . . . 72.41 111.388 -173.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -99.57 -50.66 4.0 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.632 0.773 . . . . 72.53 109.938 -169.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 73.29 -13.3 0.72 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.146 1.379 . . . . 62.22 113.611 172.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -91.22 122.6 33.99 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.564 -0.902 . . . . 75.32 108.564 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -66.07 -37.48 85.91 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.189 0.596 . . . . 64.11 112.591 -173.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.8 -30.26 66.68 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.611 0.364 . . . . 74.04 111.834 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -85.08 -30.92 23.68 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.598 0.359 . . . . 70.11 110.317 -175.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.5 HG12 ' HG3' ' A' ' 103' ' ' MET . 27.0 m -80.65 -25.68 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 121.903 0.081 . . . . 52.04 110.974 173.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.25 -39.29 94.19 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.649 0.779 . . . . 72.31 109.64 167.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.31 -40.87 67.16 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.688 -1.142 . . . . 73.01 110.435 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -63.37 -44.95 93.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.805 0.442 . . . . 74.4 111.188 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -65.58 -35.75 81.74 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.904 -0.406 . . . . 63.45 109.904 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -63.28 -36.89 85.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.929 0.892 . . . . 72.23 111.045 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -69.44 -52.84 22.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.236 0.614 . . . . 51.34 110.633 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 99' ' ' VAL . 8.5 tp -73.89 -40.68 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 123.164 0.29 . . . . 75.15 110.986 -169.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -68.18 -35.27 77.75 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.283 -0.636 . . . . 74.45 109.283 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -66.28 -40.19 94.63 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.643 -0.708 . . . . 54.53 113.342 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -66.33 -47.89 72.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.903 -0.776 . . . . 73.11 108.903 -178.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 34.0 m -74.49 -30.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 CA-C-N 115.582 -0.736 . . . . 70.44 111.88 -176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.47 -25.98 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-N 119.118 0.872 . . . . 73.15 110.068 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.0 m -81.77 -42.2 20.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.022 0.529 . . . . 74.41 111.232 172.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.499 HD21 HG21 ' A' ' 155' ' ' ILE . 54.7 tp -79.31 -23.95 43.17 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.124 0.969 . . . . 72.43 112.118 -170.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 41.3 mt -93.4 4.4 54.03 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.841 0.456 . . . . 72.14 111.63 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.97 99.75 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.331 0.652 . . . . 74.22 111.141 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 13.4 ptmm? -51.68 -39.8 58.93 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 115.863 1.801 . . . . 74.51 115.863 -162.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -70.31 -29.53 66.28 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.891 0.7 . . . . 74.41 112.891 -163.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -111.51 -29.75 7.64 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 112.401 0.519 . . . . 51.41 112.401 172.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -87.48 -2.22 58.47 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.495 0.924 . . . . 64.33 113.495 -176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.444 ' HG3' ' SG ' ' A' ' 81' ' ' CYS . 26.5 ttpp -51.07 -24.63 4.07 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 112.546 0.573 . . . . 65.43 112.546 171.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -95.15 25.94 3.99 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.152 0.981 . . . . 75.53 111.66 -175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.08 142.07 28.19 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.424 -0.954 . . . . 74.43 108.424 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -100.28 110.51 22.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.341 -1.355 . . . . 55.55 107.341 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -95.36 143.11 26.99 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.717 -1.216 . . . . 71.35 107.717 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -137.48 137.38 38.63 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 108.765 -0.828 . . . . 61.54 108.765 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.2 tt -109.9 148.15 13.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.355 0 N-CA-C 106.73 -1.582 . . . . 72.12 106.73 172.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.634 ' HA2' HD22 ' A' ' 76' ' ' LEU . . . -48.37 130.48 20.23 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 124.386 1.053 . . . . 71.04 112.766 175.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 11.0 tp10 -56.98 -38.28 72.79 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.21 0.604 . . . . 73.13 110.923 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -71.54 -35.25 70.6 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.959 0.904 . . . . 73.14 109.259 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HA ' HG21 ' A' ' 9' ' ' THR . . . -65.12 -42.76 93.62 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.255 -0.884 . . . . 63.3 110.628 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -19.52 65.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.287 0.635 . . . . 73.13 112.593 -176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 49.8 mt-10 -79.75 -23.12 42.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.942 0.497 . . . . 63.23 111.928 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.86 49.06 0.08 OUTLIER Glycine 0 C--N 1.348 1.243 0 C-N-CA 121.288 -0.482 . . . . 71.22 113.867 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.96 98.53 0.29 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.858 0.863 . . . . 72.34 110.731 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.57 14.39 4.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.479 0.711 . . . . 65.11 111.221 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -100.61 -3.78 29.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.281 1.032 . . . . 75.24 111.006 173.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -64.68 163.83 35.74 Favored Glycine 0 C--N 1.355 1.62 0 O-C-N 123.891 0.744 . . . . 73.31 114.871 -170.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -78.77 141.62 37.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.043 0.937 . . . . 71.34 112.479 -172.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.3 t -98.05 111.03 26.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 123.347 0.659 . . . . 63.31 110.028 170.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.521 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.54 111.36 5.32 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.849 -1.069 . . . . 34.34 108.78 162.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.499 HG21 HD21 ' A' ' 127' ' ' LEU . 63.0 mt -92.77 124.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 108.44 -0.948 . . . . 75.23 108.44 -176.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 68' ' ' ILE . 49.7 mm -109.39 111.29 35.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.898 0 N-CA-C 109.362 -0.607 . . . . 75.51 109.362 -177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.26 116.15 26.26 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.726 0.641 . . . . 74.13 109.831 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -69.86 88.54 0.56 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.669 1.187 . . . . 74.35 109.304 172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -94.65 134.06 37.63 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.149 -0.97 . . . . 71.02 109.816 -172.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -88.4 102.71 15.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.909 0.484 . . . . 55.33 110.109 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.8 p -90.19 92.31 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.214 0 N-CA-C 108.295 -1.002 . . . . 72.31 108.295 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.68 -66.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.914 1.685 . . . . 54.23 111.514 -175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -163.89 29.05 0.23 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.764 -0.934 . . . . 75.3 110.764 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 98.5 m -135.73 148.08 48.7 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.583 1.153 . . . . 54.41 108.032 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -79.53 136.44 36.88 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.286 0.494 . . . . 73.33 110.054 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.6 p -129.29 112.75 18.22 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 124.342 1.057 . . . . 73.02 108.271 168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.09 115.4 3.62 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.183 1.922 . . . . 53.42 111.666 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 29.4 p -111.35 108.66 18.32 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.095 -1.076 . . . . 51.44 108.095 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 19.5 tp -75.96 120.37 21.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.719 0.807 . . . . 71.33 109.538 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.5 mtt -100.1 122.2 42.6 Favored 'General case' 0 C--O 1.254 1.307 0 C-N-CA 123.783 0.833 . . . . 73.45 109.117 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.534 HD13 HD11 ' A' ' 176' ' ' ILE . 42.6 mt -141.07 140.16 34.17 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.353 1.461 . . . . 73.45 107.487 170.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.456 HG11 HG11 ' A' ' 99' ' ' VAL . 10.5 p -81.77 147.59 6.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 N-CA-C 109.395 -0.594 . . . . 62.44 109.395 -178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -51.06 -44.93 61.23 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.813 1.245 . . . . 64.43 112.354 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -82.29 3.65 26.83 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 113.419 0.896 . . . . 74.31 113.419 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 7' ' ' ILE . . . -105.93 -5.0 19.98 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.212 0.605 . . . . 33.11 111.474 170.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.534 HD11 HD13 ' A' ' 171' ' ' LEU . 48.2 mm -122.79 143.97 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.448 0.699 . . . . 74.1 110.006 -177.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.729 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 41.3 mm -98.62 109.68 24.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.459 0 N-CA-C 106.905 -1.517 . . . . 74.53 106.905 168.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.459 ' HG2' ' CE2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -130.19 116.68 18.77 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.873 0.869 . . . . 74.24 109.575 -171.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -141.28 132.4 26.31 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.191 0.597 . . . . 70.3 109.872 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -76.94 102.8 6.55 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.999 -0.741 . . . . 71.53 108.999 174.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.7 t -77.73 87.67 3.99 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.403 0.621 . . . . 72.53 110.082 -175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 56.9 mt -87.35 92.66 9.15 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.514 -0.921 . . . . 71.34 108.514 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.467 0.707 . . . . 71.12 109.206 -179.382 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' O ' ' HB3' ' A' ' 181' ' ' CYS . 49.9 ttm . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 108.279 -1.008 . . . . 61.01 108.279 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 mt -91.87 139.77 30.33 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.442 -0.577 . . . . 42.14 109.442 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 179' ' ' GLU . 4.0 tt -110.09 117.88 55.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 108.448 -0.945 . . . . 65.22 108.448 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.509 ' HD1' ' HB2' ' A' ' 14' ' ' SER . 0.9 OUTLIER -103.09 123.0 45.83 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.309 -1.737 . . . . 72.0 106.309 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -124.14 151.86 43.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.572 0.749 . . . . 75.13 109.899 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.53 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 38.8 t70 -99.5 174.67 6.15 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.577 -0.897 . . . . 64.51 108.577 173.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.521 HD13 HD21 ' A' ' 98' ' ' ASN . 20.6 tt -72.99 -34.73 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.356 0.662 . . . . 52.05 110.995 178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -113.4 -48.45 2.95 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.093 0.957 . . . . 62.51 109.872 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 m -88.33 16.37 6.43 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 114.143 -1.39 . . . . 73.45 111.394 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 5.8 p-10 -52.7 -39.01 61.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.312 1.045 . . . . 74.22 112.841 177.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.23 -25.86 67.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.177 -0.919 . . . . 74.45 111.502 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -105.8 -1.61 24.11 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.599 0.759 . . . . 74.33 112.469 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mt -84.96 -154.45 0.18 Allowed 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.453 1.024 . . . . 73.31 110.309 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.509 ' HB2' ' HD1' ' A' ' 4' ' ' TYR . 15.1 m -115.45 124.54 51.4 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.248 0.462 . . . . 62.33 112.248 -158.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 78.7 p -116.5 85.2 2.26 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.206 -0.665 . . . . 64.2 109.206 168.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -166.03 -105.73 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 115.529 -0.76 . . . . 72.23 109.388 -172.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 p -177.91 84.67 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.08 0.952 . . . . 55.04 108.642 -172.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -115.75 129.5 25.11 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.315 1.046 . . . . 61.22 109.264 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -50.87 135.81 43.2 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 123.078 2.518 . . . . 72.12 112.188 172.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.28 162.78 37.36 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.047 -0.524 . . . . 51.33 111.042 -176.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . 4.8 ttmp? -144.89 159.56 42.72 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.784 0.833 . . . . 72.33 109.389 -175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.8 tp -123.23 128.58 50.2 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.325 -0.991 . . . . 75.42 108.325 168.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -120.54 146.15 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.901 0.88 . . . . 73.41 109.817 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 t70 67.52 5.72 4.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.576 1.15 . . . . 73.14 113.153 167.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t70 59.56 18.35 6.93 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.597 1.159 . . . . 74.0 111.294 -169.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 119' ' ' LYS . 52.8 tp -129.54 -50.03 1.16 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 116.004 -0.544 . . . . 64.22 111.131 -169.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.3 t -110.79 124.12 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.4 0.619 . . . . 74.45 110.47 -172.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -85.34 115.8 23.31 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 114.816 -1.083 . . . . 64.44 108.598 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 21' ' ' LYS . 42.0 mt-10 -89.33 149.34 23.07 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.882 0.873 . . . . 64.34 110.534 173.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.747 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 35.9 t80 -139.84 142.5 36.6 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.875 -1.157 . . . . 75.23 107.875 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.02 120.72 14.13 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.273 0.358 . . . . 74.42 111.672 -173.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.8 157.71 14.78 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.201 -1.16 . . . . 73.42 110.201 166.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -144.9 147.32 32.64 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.598 -0.89 . . . . 71.43 108.598 174.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -87.59 109.18 19.46 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.624 -0.88 . . . . 65.43 108.624 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG23 HD12 ' A' ' 72' ' ' LEU . 18.5 m -145.22 174.3 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.612 1.165 . . . . 74.54 109.876 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 66' ' ' ARG . 25.7 m -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.339 -0.615 . . . . 63.34 109.339 170.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -120.05 107.58 13.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.591 -0.892 . . . . 64.23 108.591 174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD2' HG22 ' A' ' 64' ' ' VAL . 63.9 tttp -134.83 96.19 3.49 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.143 -1.058 . . . . 64.15 108.143 166.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 60.02 -66.36 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.564 1.546 . . . . 75.44 112.2 -176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.02 43.89 0.19 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.662 -0.975 . . . . 74.33 110.662 169.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -113.93 100.15 8.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.065 0.946 . . . . 72.13 109.448 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.567 HD11 HD23 ' A' ' 44' ' ' LEU . 7.5 tp -92.15 77.24 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 CA-C-O 122.823 1.297 . . . . 71.01 110.335 -177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 m -120.14 85.78 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 114.476 -1.238 . . . . 74.42 109.317 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.567 HD23 HD11 ' A' ' 42' ' ' ILE . 2.4 pp -103.87 156.8 17.55 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.434 -0.803 . . . . 72.22 112.223 -171.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.46 176.14 5.15 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 114.576 -1.193 . . . . 34.42 108.102 164.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -90.63 -141.51 9.28 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 121.771 -0.252 . . . . 34.2 113.177 -174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 69.0 m -62.02 135.52 57.57 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.513 0.725 . . . . 72.34 109.851 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 64.16 65.74 1.1 Allowed Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 124.4 1.08 . . . . 74.32 110.119 -171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -94.76 14.14 1.33 Allowed 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.471 2.781 . . . . 75.4 113.725 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.5 t 58.5 59.91 2.78 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.564 1.146 . . . . 72.22 110.36 -172.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -113.26 21.2 15.49 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.161 -0.927 . . . . 51.3 111.266 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.01 103.35 1.14 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.025 0.93 . . . . 63.11 109.856 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -89.59 -136.9 0.12 Allowed 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 123.665 0.786 . . . . 75.15 109.187 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.19 38.82 28.63 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 110.245 -1.142 . . . . 72.45 110.245 -169.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.98 70.51 0.5 Allowed 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.758 1.223 . . . . 50.42 108.062 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -90.48 34.56 0.88 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.809 0.843 . . . . 75.42 111.365 -174.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -91.02 153.04 20.43 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.835 -0.802 . . . . 63.05 108.835 169.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.2 -22.14 63.91 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.534 0.333 . . . . 71.41 111.532 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.02 -34.67 89.08 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.466 0.479 . . . . 62.55 112.843 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.2 m -89.36 -1.44 58.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.561 0.744 . . . . 73.11 111.001 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -101.48 115.2 29.98 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.853 0.461 . . . . 74.02 110.827 177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.552 ' HG2' HG23 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -133.87 27.48 3.93 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.926 1.29 . . . . 64.14 108.085 166.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.7 m80 66.04 22.72 11.17 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 125.136 1.374 . . . . 72.53 113.011 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.552 HG23 ' HG2' ' A' ' 62' ' ' GLU . 58.0 t -78.81 80.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 108.061 -1.088 . . . . 71.01 108.061 168.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.406 ' O ' HD13 ' A' ' 72' ' ' LEU . 30.4 mm-40 -88.0 70.76 9.42 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.231 -0.895 . . . . 64.32 108.612 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.495 ' HA ' HG12 ' A' ' 36' ' ' VAL . 8.1 ptp180 -85.14 139.05 32.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.677 -0.692 . . . . 75.54 110.936 172.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 144.36 -126.68 2.75 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-N 116.289 -0.414 . . . . 33.42 112.152 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 34.6 pt -113.83 142.41 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.383 0.673 . . . . 70.21 112.763 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -40.6 -46.61 2.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.989 2.116 . . . . 72.33 114.402 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 156' ' ' ILE . 29.5 mm -54.3 -43.19 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.937 0.875 . . . . 75.22 111.023 -176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.6 t -83.2 -40.36 16.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.388 -1.278 . . . . 73.24 112.402 -173.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 16.5 mt -74.22 -32.33 62.97 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.063 0.459 . . . . 72.51 110.572 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -78.25 -24.37 46.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.642 0.777 . . . . 75.41 111.535 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -122.47 -6.71 8.69 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 112.816 0.673 . . . . 55.04 112.816 -170.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 75' ' ' LYS . 45.0 tptt 54.63 70.32 0.63 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.111 1.364 . . . . 52.41 110.928 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 44.5 mt -96.04 139.35 32.34 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.215 -0.902 . . . . 71.3 109.038 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.649 HG13 HG23 ' A' ' 140' ' ' ILE . 4.0 p -89.85 133.61 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.049 -0.723 . . . . 71.23 109.049 174.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.425 ' HA ' ' CD1' ' A' ' 139' ' ' PHE . 4.2 pt-20 -56.54 152.48 11.71 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.933 0.893 . . . . 71.32 113.274 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 12.7 tpt -148.44 144.6 27.53 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 125.206 1.402 . . . . 74.12 107.481 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -137.52 151.48 48.47 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.207 0.527 . . . . 74.52 111.327 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 26.0 p -88.86 -2.16 58.45 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.143 -0.935 . . . . 73.43 111.327 170.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -75.52 -61.81 1.79 Allowed 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.022 0.749 . . . . 74.42 113.022 -175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -103.96 -35.04 8.27 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.389 0.676 . . . . 75.14 110.439 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -86.29 20.6 2.32 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.74 0.816 . . . . 70.32 112.094 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' CYS . . . -55.01 -35.35 64.31 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.38 1.072 . . . . 75.24 113.252 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 41.1 m -70.03 -44.68 68.75 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.514 0.726 . . . . 73.4 111.058 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.6 OUTLIER -70.43 -42.1 72.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.42 109.855 -176.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.423 ' HE2' HD22 ' A' ' 128' ' ' LEU . 53.2 t80 -68.48 -32.44 72.43 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 114.463 -1.244 . . . . 53.04 111.36 176.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -64.14 -34.92 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 122.888 0.475 . . . . 61.33 110.522 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -39.4 88.27 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.696 -0.683 . . . . 72.24 109.855 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -69.11 -33.54 73.66 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.765 0.654 . . . . 72.2 112.765 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.4 mm -62.91 -41.24 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.957 0.503 . . . . 53.52 110.788 170.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -59.21 -44.66 92.25 Favored 'General case' 0 C--O 1.247 0.934 0 O-C-N 123.653 0.595 . . . . 75.52 110.15 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -60.25 4.01 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 114.87 -1.059 . . . . 74.13 109.619 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -49.25 -62.5 1.5 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.925 1.69 . . . . 60.4 112.955 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 25.7 ptm -64.55 -44.64 90.14 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.559 0.537 . . . . 75.11 111.618 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -66.77 -36.11 81.65 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 118.296 0.498 . . . . 74.22 110.674 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.521 HD21 HD13 ' A' ' 7' ' ' ILE . 25.2 t30 -61.26 -53.21 59.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.103 0.961 . . . . 52.43 110.47 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 23.3 m -78.69 -29.66 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.341 -0.845 . . . . 54.43 112.186 -170.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.55 -40.67 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.787 -0.449 . . . . 73.43 109.787 172.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -68.32 -36.88 79.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.79 0.836 . . . . 71.02 111.227 176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -66.09 -42.57 89.13 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.257 0.623 . . . . 73.33 109.563 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.578 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 27.0 ttt -66.32 -37.06 84.49 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 116.009 -0.541 . . . . 64.44 111.154 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.69 -25.1 66.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.649 0.78 . . . . 73.33 111.458 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -84.17 -37.63 21.65 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.35 0.26 . . . . 63.41 111.372 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.578 ' ND2' ' HA ' ' A' ' 103' ' ' MET . 6.0 p30 -96.78 5.25 50.96 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.173 -0.329 . . . . 74.04 111.823 -175.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -129.85 -50.3 1.14 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.656 0.782 . . . . 74.14 109.742 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 49.28 21.67 0.57 Allowed 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.868 1.667 . . . . 74.13 112.994 -174.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -104.2 131.47 51.47 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.686 1.195 . . . . 75.31 108.354 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -63.65 -45.06 91.9 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 124.281 0.988 . . . . 73.5 111.843 -173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -34.55 76.19 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.04 0.536 . . . . 72.41 112.115 -177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.81 -45.37 51.81 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.846 0.459 . . . . 72.2 111.22 -177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.4 m -71.67 -30.98 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 123.655 0.597 . . . . 74.42 111.338 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -41.78 76.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.325 0.65 . . . . 74.31 111.072 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.78 -42.45 86.04 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.01 0.433 . . . . 74.35 110.2 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.424 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 88.3 t80 -67.0 -42.13 85.54 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.036 -0.984 . . . . 60.5 110.762 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 64.3 tttp -53.87 -47.08 71.4 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.996 0.81 . . . . 73.24 110.102 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -65.88 -39.54 90.76 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.736 1.273 . . . . 75.3 109.789 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HB3' HD13 ' A' ' 26' ' ' LEU . 8.8 tptp -69.22 -49.17 58.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.287 0.635 . . . . 75.33 109.638 -175.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.5 tp -74.56 -42.04 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 115.991 -0.55 . . . . 64.5 110.874 -170.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 117' ' ' LYS . 12.5 pt20 -66.07 -39.47 90.08 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 109.572 -0.529 . . . . 73.51 109.572 175.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.38 -40.73 99.23 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.501 0.5 . . . . 71.21 112.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -67.82 -50.99 53.71 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 118.98 -0.534 . . . . 71.45 109.935 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.529 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.7 m -68.32 -43.3 84.5 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.294 0 O-C-N 123.654 0.596 . . . . 73.44 111.299 -175.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.18 -25.56 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 123.083 0.553 . . . . 74.41 110.894 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.8 t -77.67 -40.52 41.29 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.878 0.471 . . . . 73.02 110.575 167.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 155' ' ' ILE . 41.0 tp -73.71 -28.42 61.71 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.917 1.287 . . . . 72.52 111.5 -171.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 83.9 mt -84.37 1.55 44.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.722 0.809 . . . . 72.11 111.082 -177.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.83 85.37 2.2 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 123.455 0.702 . . . . 75.31 109.416 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -55.67 -29.49 59.41 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.679 1.592 . . . . 75.2 114.556 -166.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -72.33 -22.8 61.12 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.349 0.5 . . . . 72.14 112.349 -171.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -103.18 -51.34 3.27 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.071 0.948 . . . . 72.24 108.806 171.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -76.96 0.24 21.84 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.697 1.599 . . . . 73.4 114.9 -170.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -46.25 -7.44 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 115.435 1.642 . . . . 55.53 115.435 171.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -82.18 9.76 8.09 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.955 0.902 . . . . 63.42 111.339 170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.02 148.07 23.29 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.736 0.814 . . . . 63.23 109.089 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.444 ' HB2' ' HE1' ' A' ' 158' ' ' TYR . . . -138.92 116.07 11.03 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.19 -1.781 . . . . 75.24 106.19 170.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -89.15 147.63 24.09 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.29 -1.004 . . . . 64.34 108.29 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 78' ' ' GLU . 75.7 m-85 -141.27 143.15 33.95 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.389 -0.597 . . . . 63.4 109.389 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.649 HG23 HG13 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -123.61 138.01 54.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 105.174 -2.158 . . . . 73.11 105.174 176.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.92 126.28 39.68 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.125 -0.82 . . . . 62.31 111.336 176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -56.75 -38.56 72.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.002 0.921 . . . . 75.4 109.649 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -57.26 -47.09 82.3 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.628 1.171 . . . . 74.05 111.253 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.43 84.71 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.325 0.65 . . . . 72.42 111.149 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.0 -3.59 16.94 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 115.653 -0.703 . . . . 64.43 112.237 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -104.9 -18.02 14.35 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.319 1.048 . . . . 64.41 110.198 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.71 -74.32 0.01 OUTLIER Glycine 0 C--N 1.355 1.594 0 O-C-N 122.307 -0.246 . . . . 64.14 112.778 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -83.25 80.24 9.13 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.534 0.734 . . . . 70.43 109.809 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -68.01 1.56 2.63 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.29 1.036 . . . . 70.41 113.587 -173.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -97.89 9.06 43.66 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.983 0.913 . . . . 75.14 110.624 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.04 154.62 43.76 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.796 0.685 . . . . 52.43 112.718 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.61 143.91 28.17 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.378 0.671 . . . . 74.21 111.077 -169.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.14 116.34 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.295 0.638 . . . . 62.04 110.636 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.415 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.35 113.95 7.14 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.745 1.218 . . . . 43.51 109.721 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.548 HG21 HD21 ' A' ' 127' ' ' LEU . 75.1 mt -91.59 109.91 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.217 -0.66 . . . . 71.14 109.217 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 169' ' ' LEU . 40.0 mm -96.71 144.7 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.431 -0.581 . . . . 64.43 109.431 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -132.99 109.66 9.71 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.251 -1.018 . . . . 61.32 108.251 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.65 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 6.2 p90 -83.4 91.96 7.46 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.352 -1.351 . . . . 74.42 107.352 172.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.518 ' HB3' HG13 ' A' ' 166' ' ' VAL . 7.5 tpt180 -74.4 91.61 2.24 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.158 -1.383 . . . . 74.44 108.72 -168.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -68.35 112.44 5.22 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.21 -0.905 . . . . 74.42 110.904 -176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -106.48 92.08 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.526 1.13 . . . . 63.3 108.581 168.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 t70 46.35 61.87 2.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.568 1.547 . . . . 75.1 112.515 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.92 -12.8 68.68 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-N 115.515 -0.766 . . . . 73.34 113.441 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 93.3 m -107.18 106.97 17.71 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.004 -0.739 . . . . 74.33 109.004 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 14.4 pt-20 -73.31 141.09 47.15 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.484 -0.561 . . . . 71.11 109.484 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.518 HG13 ' HB3' ' A' ' 159' ' ' ARG . 3.7 p -127.27 91.29 46.72 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 108.199 -1.037 . . . . 61.1 108.199 166.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 52.1 Cg_exo -56.24 143.51 84.99 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 123.148 2.565 . . . . 61.33 112.663 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.1 m -145.87 126.47 14.21 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 65.22 108.576 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.747 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.7 tp -77.35 130.33 37.0 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 108.416 -0.957 . . . . 51.1 108.416 170.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.6 mtt -128.85 123.8 33.67 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 124.188 0.995 . . . . 75.23 108.622 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 154' ' ' ALA . 79.7 mt -141.32 170.89 14.87 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.878 1.671 . . . . 64.32 106.512 169.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 174' ' ' GLU . 11.8 p -83.42 147.22 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 N-CA-C 108.836 -0.802 . . . . 72.11 108.836 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -54.91 -27.55 43.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.909 0.884 . . . . 74.22 112.456 175.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 12.8 tp10 -85.56 -2.44 58.15 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.768 0.827 . . . . 73.4 111.574 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -105.99 -11.99 15.96 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.859 0.864 . . . . 74.04 110.159 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 47.2 mm -108.81 140.88 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-O 121.286 0.565 . . . . 72.51 110.879 -174.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.1 mm -124.08 109.19 22.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.444 1.498 . . . . 64.51 107.192 175.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.68 121.02 31.46 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.568 -0.901 . . . . 64.55 108.568 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.673 ' HB3' HG23 ' A' ' 3' ' ' ILE . 33.6 tt0 -121.92 116.01 23.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.185 -1.043 . . . . 73.24 108.185 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.04 109.85 22.16 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.166 0.508 . . . . 71.24 111.609 -170.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 1' ' ' MET . 47.7 t -100.88 95.43 6.61 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.729 -0.841 . . . . 64.35 108.729 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.28 -35.35 0.55 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.137 0.975 . . . . 74.13 110.583 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 . . . . . 0 C--O 1.248 0.992 0 C-N-CA 123.736 0.814 . . . . 75.53 109.368 178.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttm . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.037 -0.727 . . . . 62.24 109.037 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 99.0 mt -123.21 133.92 54.18 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.365 0.266 . . . . 63.24 110.51 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.665 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 61.8 mt -106.55 117.08 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 107.668 -1.234 . . . . 54.54 107.668 170.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.625 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 91.5 m-85 -89.71 122.16 32.55 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.507 -0.923 . . . . 75.23 108.507 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.19 131.4 53.67 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.628 0.771 . . . . 52.13 110.776 -169.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.553 ' HA ' HG12 ' A' ' 176' ' ' ILE . 25.0 t70 -90.34 174.44 7.58 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.334 1.021 . . . . 64.01 108.433 172.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 7' ' ' ILE . 8.3 mt -53.74 -58.97 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.184 0.594 . . . . 63.52 110.967 171.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -112.7 -23.1 10.38 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 65.12 111.517 -170.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.5 m -98.24 14.12 28.91 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.998 0.919 . . . . 72.43 110.563 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.3 p-10 -48.28 -33.08 8.21 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 124.245 1.018 . . . . 54.43 113.422 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.56 -42.93 64.1 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.194 -0.912 . . . . 65.4 110.97 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.65 ' HB2' ' HG2' ' A' ' 143' ' ' ARG . 5.0 tp10 -121.25 24.72 9.89 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.188 0.595 . . . . 71.24 111.581 -169.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 2.6 tm? -77.19 -81.88 0.09 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 109.11 -0.7 . . . . 75.53 109.11 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 53.1 m -157.4 -178.35 7.28 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.154 0.982 . . . . 61.51 110.386 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.665 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 73.4 p 177.3 -177.22 0.17 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.276 1.03 . . . . 54.51 111.397 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 85.91 -109.86 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.188 1.795 . . . . 53.24 111.634 165.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.9 m -144.04 42.39 1.42 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.86 -0.793 . . . . 75.13 108.86 -163.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -108.31 98.89 29.47 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.352 -0.84 . . . . 64.2 109.372 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -44.36 134.81 9.13 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 124.153 3.235 . . . . 53.03 114.978 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.15 146.55 42.18 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.125 -0.943 . . . . 70.42 108.596 174.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 66.6 mttm -110.66 157.45 19.7 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.198 -1.408 . . . . 54.22 107.198 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -130.73 108.06 9.61 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.629 -0.878 . . . . 74.02 108.629 175.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.48 127.46 50.98 Favored 'Isoleucine or valine' 0 C--O 1.248 0.989 0 N-CA-C 109.018 -0.734 . . . . 73.32 109.018 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.2 t70 56.24 25.37 9.17 Favored 'General case' 0 CA--C 1.567 1.598 0 O-C-N 124.417 1.073 . . . . 74.45 112.485 175.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 53.11 16.02 0.7 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.063 1.135 . . . . 71.42 114.063 -174.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 119' ' ' LYS . 34.5 tp -105.07 -51.48 3.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.947 0.499 . . . . 73.33 110.201 -174.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.469 HG11 ' SD ' ' A' ' 170' ' ' MET . 21.6 t -123.49 133.72 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 116.547 -0.297 . . . . 73.35 111.376 -168.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 42.2 m-85 -84.76 120.12 26.06 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.576 -0.898 . . . . 53.13 108.576 167.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 40.2 tt0 -99.06 103.18 15.09 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 107.696 -1.224 . . . . 74.04 107.696 170.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.724 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 30.7 t80 -94.21 141.2 28.83 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.848 1.259 . . . . 75.4 109.307 -169.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttpp -71.49 139.88 49.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.837 0.855 . . . . 71.21 112.718 -169.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.29 149.73 17.13 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 114.768 -1.106 . . . . 23.5 111.257 170.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' H ' ' HB3' ' A' ' 69' ' ' ASP . 16.2 ptpt -126.93 161.41 28.37 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.961 0.904 . . . . 64.23 108.658 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -75.19 120.67 21.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.603 -0.517 . . . . 70.53 109.603 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG23 HD12 ' A' ' 72' ' ' LEU . 4.1 m -145.06 164.58 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.442 0.697 . . . . 74.03 110.486 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -94.89 160.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.217 -0.447 . . . . 51.12 110.765 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.4 ' HB3' HD22 ' A' ' 72' ' ' LEU . 60.0 ttt180 -142.74 112.44 6.87 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.912 -0.403 . . . . 72.41 109.912 169.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -125.27 140.21 53.03 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.468 -0.938 . . . . 75.44 108.468 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.795 ' HG3' ' HB3' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -59.73 -26.41 65.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 123.388 0.43 . . . . 65.32 111.699 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.0 -61.7 4.44 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 123.657 0.598 . . . . 74.14 111.802 172.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.8 152.09 0.94 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.137 0.975 . . . . 73.35 108.719 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 tt -72.53 102.83 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 CA-C-O 121.397 0.618 . . . . 54.13 109.682 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.4 t -109.32 81.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.277 1.031 . . . . 71.15 108.526 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pp -85.27 -18.85 32.7 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 116.182 -0.463 . . . . 73.35 110.964 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -111.16 127.06 55.46 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.183 0.993 . . . . 34.33 108.86 175.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.65 68.19 1.23 Allowed Glycine 0 C--N 1.346 1.107 0 O-C-N 123.403 0.439 . . . . 71.31 112.177 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.1 p -84.92 123.23 30.27 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.104 0.562 . . . . 34.42 109.892 175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -67.01 151.65 96.89 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.295 0.638 . . . . 75.41 110.377 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.88 97.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.379 2.053 . . . . 75.31 111.218 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.7 t -58.64 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.345 1.058 . . . . 73.41 111.415 -174.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.11 94.24 7.03 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 114.934 -1.03 . . . . 52.45 109.814 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -77.38 88.06 3.77 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.621 0.724 . . . . 73.41 109.071 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -134.3 91.31 2.78 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.777 -1.101 . . . . 74.13 109.154 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 158.08 122.75 0.7 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.924 -1.034 . . . . 22.21 111.21 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.11 -44.16 89.68 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.424 0.69 . . . . 75.02 111.258 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -73.38 100.67 3.26 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.775 -0.648 . . . . 73.55 109.274 174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -76.78 145.69 38.36 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.182 0.993 . . . . 50.11 110.857 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -114.15 -4.0 13.17 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.633 0.773 . . . . 63.13 111.869 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.03 84.04 0.06 OUTLIER Glycine 0 CA--C 1.534 1.273 0 O-C-N 123.976 0.798 . . . . 45.13 114.169 -172.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.6 p -100.32 167.8 10.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.36 1.064 . . . . 43.43 110.394 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -73.54 -12.21 60.69 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.669 0.787 . . . . 71.14 111.893 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -53.13 -44.18 67.51 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.456 1.102 . . . . 71.34 109.935 167.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.795 ' HB3' ' HG3' ' A' ' 39' ' ' GLU . 34.0 p-80 -129.84 84.81 2.24 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.503 -1.226 . . . . 74.31 107.923 174.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.2 t -57.64 -31.36 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 122.628 0.371 . . . . 72.13 110.558 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 73.53 -57.71 0.62 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.327 1.851 . . . . 73.33 111.604 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.9 ttt-85 -116.13 129.28 56.25 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.285 1.034 . . . . 75.1 109.082 -174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -173.08 -165.02 29.4 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 120.234 -0.984 . . . . 73.44 113.287 166.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 156' ' ' ILE . 26.4 pt -104.12 146.89 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 113.914 -1.143 . . . . 71.33 110.988 175.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 33' ' ' LYS . 10.9 t70 -48.2 -47.16 35.61 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.312 1.445 . . . . 50.55 112.614 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.632 HD13 ' HB2' ' A' ' 169' ' ' LEU . 67.6 mt -52.73 -45.65 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.073 -1.421 . . . . 52.22 111.333 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 76' ' ' LEU . 53.7 t -94.04 -28.56 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.017 0.527 . . . . 74.21 112.063 -173.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.505 HD12 HG23 ' A' ' 35' ' ' VAL . 84.2 mt -75.66 -18.67 59.57 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 122.227 -0.296 . . . . 72.23 110.31 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -95.37 -55.82 2.92 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.388 0.675 . . . . 73.21 110.638 172.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -86.79 3.32 45.65 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.755 0.422 . . . . 62.01 112.1 -171.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.704 ' HE3' ' HG3' ' A' ' 142' ' ' GLU . 34.4 ttpt 58.03 35.36 25.15 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.897 0.856 . . . . 75.35 111.682 165.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' HB2' HG22 ' A' ' 71' ' ' VAL . 59.2 mt -74.52 141.59 44.85 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.021 -0.536 . . . . 75.32 110.438 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.59 129.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.184 0.594 . . . . 74.15 110.36 -176.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -75.26 145.27 42.05 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.75 1.389 . . . . 74.24 114.75 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.55 ' HB2' ' HB2' ' A' ' 138' ' ' PHE . 80.3 mtp -141.91 134.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.616 1.966 . . . . 70.41 105.813 171.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.535 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 40.2 m-80 -93.77 138.17 32.24 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.915 0.325 . . . . 72.04 110.204 -176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 29.7 p -67.08 -21.7 65.86 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.528 0.331 . . . . 41.12 111.28 174.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 64.0 m-85 -58.23 -52.75 64.27 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.978 -1.01 . . . . 71.24 110.567 177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -105.28 -36.85 7.08 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.147 0.979 . . . . 73.55 112.847 -171.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -91.91 18.95 7.11 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.596 0.759 . . . . 64.51 112.701 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.07 98.87 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 118.45 0.568 . . . . 44.3 111.194 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -65.63 -45.25 83.76 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.265 1.026 . . . . 73.25 111.467 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.09 -38.8 92.61 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.562 -0.745 . . . . 64.51 110.797 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -75.99 -28.91 58.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.956 0.902 . . . . 75.42 111.035 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -68.59 -38.38 80.62 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.497 -0.557 . . . . 64.02 109.497 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -62.97 -43.4 98.89 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.778 -1.101 . . . . 70.22 110.477 173.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -59.09 -45.63 90.35 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 115.547 -0.751 . . . . 65.33 110.616 173.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 20.2 mm -60.47 -40.37 84.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.699 . . . . 55.15 111.688 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -63.29 -45.42 91.49 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 122.627 0.371 . . . . 75.25 111.531 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -73.08 -47.06 47.78 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.73 -0.668 . . . . 74.41 110.893 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -53.51 -44.82 69.42 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.032 1.733 . . . . 75.24 111.201 173.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.1 ttm -59.04 -53.58 56.8 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.079 0.862 . . . . 70.52 110.521 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -59.04 -38.4 79.24 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.173 -0.921 . . . . 73.11 110.933 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.82 -47.47 46.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.572 0.749 . . . . 62.45 112.254 -172.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 175' ' ' ALA . 31.0 m -69.54 -34.06 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 123.044 0.538 . . . . 54.45 112.14 -178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 65.7 mt -76.52 -35.14 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 O-C-N 123.168 0.292 . . . . 63.34 110.585 176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.92 -46.16 88.6 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.471 0.709 . . . . 72.24 110.077 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -62.51 -48.86 77.71 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.51 -0.768 . . . . 64.31 110.687 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.551 ' HG3' HG12 ' A' ' 113' ' ' VAL . 9.7 tpt -61.93 -38.75 89.6 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.717 0.807 . . . . 61.34 111.053 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.588 ' HA ' HG11 ' A' ' 113' ' ' VAL . 43.4 tt0 -71.88 -38.89 69.94 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 124.274 1.03 . . . . 74.34 110.27 -175.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -80.51 -27.45 37.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.59 0.356 . . . . 53.42 111.609 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.28 -36.29 27.19 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.018 0.527 . . . . 63.12 110.839 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -101.13 -49.26 4.15 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.196 0.598 . . . . 73.45 110.945 -172.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 70.24 4.24 4.78 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 114.37 1.248 . . . . 52.34 114.37 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -99.44 117.89 34.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.984 -0.747 . . . . 74.13 108.984 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -50.76 -45.17 58.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.991 1.316 . . . . 70.04 112.189 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.96 -31.45 66.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.017 0.527 . . . . 75.22 112.417 -173.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -79.99 -45.26 18.74 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.67 0.388 . . . . 73.4 110.137 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.588 HG11 ' HA ' ' A' ' 104' ' ' GLU . 33.7 m -71.65 -23.51 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 116.368 -0.378 . . . . 74.43 111.248 177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -59.05 -43.89 91.74 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.51 0.724 . . . . 71.32 110.534 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.44 -46.3 76.91 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.902 0.751 . . . . 61.53 110.164 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -57.6 -48.13 80.26 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.34 0.656 . . . . 71.1 111.787 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -70.67 -30.65 67.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.648 -0.501 . . . . 74.14 109.648 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -61.16 -45.1 96.02 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.735 -0.839 . . . . 55.13 108.735 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HB3' HD22 ' A' ' 26' ' ' LEU . 3.1 mptm? -65.52 -46.46 79.51 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.03 -0.986 . . . . 75.21 110.875 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 172' ' ' VAL . 26.7 mm -66.83 -42.06 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 119.319 -0.372 . . . . 54.0 110.495 -178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -54.77 -57.29 12.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.776 0.831 . . . . 62.14 109.999 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.7 -38.35 95.76 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.748 0.655 . . . . 45.34 113.259 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.8 t90 -64.69 -53.28 49.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.904 0.882 . . . . 75.41 110.442 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 120' ' ' ILE . 34.0 m -70.57 -30.48 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 119.276 -0.392 . . . . 64.53 111.553 -177.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.53 -41.46 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 118.501 0.591 . . . . 62.43 110.328 176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.6 t -65.84 -43.5 88.32 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 120.96 0.41 . . . . 63.5 109.922 173.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.528 HD21 HG21 ' A' ' 155' ' ' ILE . 21.1 tp -73.11 -30.08 63.38 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.662 1.185 . . . . 73.34 112.221 -169.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.55 3.07 45.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.448 0.699 . . . . 65.22 111.951 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 133' ' ' PHE . . . -67.62 150.97 48.07 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.458 0.703 . . . . 73.24 111.217 175.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -93.45 -28.7 15.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.086 1.143 . . . . 74.2 114.086 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.08 -48.21 71.73 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.117 0.872 . . . . 74.35 113.267 -165.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -110.81 -32.87 6.7 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.213 0.605 . . . . 72.41 111.296 177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.527 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 98.1 m-85 -78.17 -1.23 31.7 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.489 0.716 . . . . 63.03 112.038 -177.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -55.59 -20.99 15.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 122.167 -0.333 . . . . 75.41 111.133 160.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -82.48 17.28 1.79 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.704 1.201 . . . . 74.15 110.856 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 156' ' ' ILE . 93.3 mt -89.8 148.05 23.44 Favored 'General case' 0 C--N 1.349 0.556 0 N-CA-C 109.079 -0.711 . . . . 54.01 109.079 170.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -138.75 126.45 22.1 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.739 -1.578 . . . . 42.53 106.739 174.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 79' ' ' MET . 11.1 m-85 -91.37 134.12 34.87 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.617 -0.512 . . . . 63.52 109.617 -171.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -136.27 151.91 50.16 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.298 0.639 . . . . 71.11 109.293 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.4 pt -137.16 170.7 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 108.317 -0.994 . . . . 74.41 108.317 168.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.42 154.64 44.42 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.872 -0.491 . . . . 61.43 111.872 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.704 ' HG3' ' HE3' ' A' ' 75' ' ' LYS . 10.7 mm-40 -53.24 -43.15 67.11 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.32 1.048 . . . . 75.2 112.259 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.65 ' HG2' ' HB2' ' A' ' 12' ' ' GLU . 3.0 mmt180 -65.67 -37.37 86.32 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.332 0.653 . . . . 75.12 110.353 -175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -59.86 -58.6 7.85 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.044 0.84 . . . . 53.01 109.136 173.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.85 -17.96 63.67 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.997 0.919 . . . . 72.11 113.084 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -77.49 -41.03 40.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.554 0.742 . . . . 63.31 110.997 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.67 -26.43 0.03 OUTLIER Glycine 0 N--CA 1.471 0.988 0 CA-C-N 116.369 -0.378 . . . . 31.11 113.591 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -72.86 177.11 5.08 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-N 117.062 0.431 . . . . 71.14 111.229 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.09 -172.61 2.31 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 122.153 -0.342 . . . . 74.33 110.68 176.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -78.34 -49.95 12.67 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.14 0.793 . . . . 52.41 113.14 -161.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 61.09 -98.58 0.17 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 111.235 -0.746 . . . . 71.35 111.235 -156.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -121.93 144.09 49.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.155 0.582 . . . . 74.22 110.104 169.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 155' ' ' ILE . 89.2 t -75.96 133.09 31.91 Favored 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 108.433 -0.951 . . . . 72.43 108.433 166.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.43 97.16 0.4 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.645 -0.872 . . . . 71.42 108.645 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.528 HG21 HD21 ' A' ' 127' ' ' LEU . 55.3 mt -85.87 101.57 10.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 N-CA-C 108.515 -0.92 . . . . 72.32 108.515 -171.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 68' ' ' ILE . 36.1 mm -91.85 140.22 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 109.036 -0.727 . . . . 74.11 109.036 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -130.41 105.47 7.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.232 -1.025 . . . . 73.14 108.232 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -73.5 88.77 1.64 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.396 -0.964 . . . . 63.2 108.396 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -92.68 174.14 7.41 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.425 1.49 . . . . 74.12 108.85 -165.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -122.75 138.73 54.54 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.258 0.623 . . . . 74.43 110.575 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.32 102.63 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.244 0 C-N-CA 124.401 1.081 . . . . 72.22 109.302 169.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 30.5 t70 62.46 24.96 14.88 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 124.266 1.026 . . . . 72.33 112.474 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.12 -14.02 33.85 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 121.797 -0.564 . . . . 72.13 113.008 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.2 m -94.78 122.23 37.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.524 0.729 . . . . 74.11 110.336 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -72.94 116.18 13.14 Favored 'General case' 0 C--N 1.355 0.817 0 CA-C-O 121.151 0.5 . . . . 73.44 110.047 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.0 m -124.21 93.68 46.42 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 115.07 -0.968 . . . . 64.03 110.523 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.474 ' HG3' ' HB ' ' A' ' 68' ' ' ILE . 11.4 Cg_endo -52.48 121.52 9.2 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.623 2.882 . . . . 75.3 112.498 167.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.6 p -107.99 117.13 33.34 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.374 1.07 . . . . 72.21 108.429 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.724 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 17.4 tp -80.17 117.57 21.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.416 -0.587 . . . . 75.33 109.416 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.469 ' SD ' HG11 ' A' ' 27' ' ' VAL . 30.7 tpp -100.96 120.82 40.73 Favored 'General case' 0 C--O 1.256 1.434 0 N-CA-C 107.205 -1.406 . . . . 62.42 107.205 -175.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.448 HD22 HD12 ' A' ' 176' ' ' ILE . 84.0 mt -143.77 143.87 31.56 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.656 1.182 . . . . 74.13 109.207 -176.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.498 HG21 HD11 ' A' ' 120' ' ' ILE . 15.0 p -91.07 138.32 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.972 0.805 . . . . 74.53 109.763 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -65.54 -26.45 67.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.323 1.449 . . . . 53.31 112.011 -176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 172' ' ' VAL . 10.0 mp0 -86.14 -0.97 56.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.134 0.574 . . . . 60.14 112.343 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -120.0 -18.75 8.07 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.605 0.762 . . . . 32.51 110.553 171.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' A' ' 6' ' ' ASP . 3.3 mt -136.64 139.58 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.336 0.654 . . . . 65.41 110.219 -172.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 30.8 mm -142.17 139.59 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.449 1.1 . . . . 71.24 108.114 -171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.02 143.01 34.43 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.27 0.557 . . . . 74.54 109.992 171.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.531 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 9.7 tp10 -101.33 109.39 21.23 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.098 -1.075 . . . . 61.42 108.098 177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -69.84 98.04 1.18 Allowed 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.886 0.741 . . . . 73.13 109.951 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.7 t -108.16 91.63 3.73 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.274 -1.01 . . . . 51.13 108.274 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -151.36 173.8 14.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.037 0.535 . . . . 75.41 110.634 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.254 1.332 0 CA-C-N 114.923 -1.035 . . . . 72.55 108.552 178.822 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.529 ' HG3' ' SG ' ' A' ' 181' ' ' CYS . 26.2 ptt? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.946 0.403 . . . . 70.53 110.212 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 180' ' ' LYS . 95.6 mt -118.72 159.82 22.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.505 0.722 . . . . 72.42 110.067 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 56.3 mt -126.8 118.11 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 106.996 -1.483 . . . . 65.25 106.996 171.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.768 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 5.6 t80 -101.4 113.94 27.48 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.015 -1.106 . . . . 73.13 108.015 -172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -125.59 117.13 22.9 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.131 0.972 . . . . 72.53 110.295 -167.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -105.87 134.83 48.36 Favored 'General case' 0 C--O 1.205 -1.285 0 N-CA-C 108.344 -0.984 . . . . 71.42 108.344 177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.7 pt -66.39 -5.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 113.293 0.849 . . . . 75.43 113.293 -170.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -107.94 -46.72 3.71 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.736 -0.838 . . . . 71.41 108.736 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 p -111.82 18.66 18.71 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 124.827 1.251 . . . . 74.0 112.456 -173.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -46.94 -42.22 17.4 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 126.183 1.793 . . . . 71.21 113.545 -175.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -55.95 -39.13 71.29 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.89 1.369 . . . . 73.54 112.543 -172.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -120.61 11.32 11.26 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.176 0.591 . . . . 74.42 111.458 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -95.9 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 112.871 0.693 . . . . 55.03 112.871 -163.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.768 ' HB3' ' HB3' ' A' ' 4' ' ' TYR . 35.5 t -158.21 178.44 10.18 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.93 0.787 . . . . 31.21 111.367 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 33.0 p 163.32 104.43 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.691 1.597 . . . . 74.51 109.377 -168.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -171.59 161.07 6.06 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.572 0.749 . . . . 73.43 110.396 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -68.87 83.77 0.31 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.391 0.676 . . . . 72.41 111.316 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.61 ' HZ ' ' HB2' ' A' ' 4' ' ' TYR . 3.8 p90 -127.18 159.09 66.93 Favored Pre-proline 0 CA--C 1.554 1.118 0 C-N-CA 123.906 0.882 . . . . 62.41 110.275 176.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.97 120.86 3.08 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.134 1.89 . . . . 65.12 112.883 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.6 ' HB2' ' HE2' ' A' ' 28' ' ' TYR . 17.8 ptm -87.71 157.88 18.95 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.052 0.541 . . . . 73.21 110.527 174.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -152.03 145.63 24.95 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.038 -0.727 . . . . 51.03 109.038 171.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.55 125.78 52.88 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.502 -0.925 . . . . 70.42 108.502 173.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.19 129.81 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.281 0.632 . . . . 71.32 110.268 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.92 23.74 6.89 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 125.151 1.38 . . . . 64.23 113.992 175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 t70 54.76 26.83 8.04 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.829 0.852 . . . . 65.33 112.054 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.531 HD13 ' HE2' ' A' ' 119' ' ' LYS . 64.7 tp -135.1 -51.17 0.77 Allowed 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.991 0.901 . . . . 73.23 110.483 -170.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 96.6 t -120.41 148.7 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 113.888 -1.506 . . . . 74.5 107.885 -173.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.6 ' HE2' ' HB2' ' A' ' 20' ' ' MET . 44.6 t80 -86.18 139.39 31.11 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.244 -1.021 . . . . 72.42 108.244 170.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -123.61 129.37 51.06 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.805 0.842 . . . . 74.42 109.695 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.729 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 48.8 t80 -114.31 124.68 52.59 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.128 0.571 . . . . 73.22 109.473 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -83.46 95.74 8.36 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.942 -0.762 . . . . 75.43 108.942 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.3 176.56 46.89 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 115.751 -0.659 . . . . 72.32 112.464 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -125.13 158.06 34.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.355 0.662 . . . . 72.43 109.629 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -90.59 117.57 29.36 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.194 -0.669 . . . . 61.01 109.194 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 72' ' ' LEU . 19.7 m -143.49 153.59 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.494 0.664 . . . . 71.1 110.098 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.6 127.53 66.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.544 -1.28 . . . . 52.42 107.544 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 10.7 tpt180 -105.3 108.55 20.13 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 106.677 -1.601 . . . . 73.23 106.677 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -106.26 96.59 6.58 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.895 -0.78 . . . . 70.4 108.895 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 46.64 58.46 4.63 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.087 1.355 . . . . 72.52 111.962 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.97 -33.09 3.86 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 114.937 -1.029 . . . . 74.34 113.657 178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -93.19 116.16 28.75 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.45 1.1 . . . . 73.42 110.033 -177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.1 tt -80.83 115.88 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 109.048 -0.723 . . . . 75.22 109.048 172.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.03 90.45 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.462 1.105 . . . . 71.21 108.591 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 pp -101.89 173.09 6.56 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.954 0.901 . . . . 74.43 111.265 -177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -159.12 -43.01 0.06 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.875 -1.057 . . . . 75.25 108.698 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.24 135.1 2.04 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 115.546 -0.752 . . . . 64.01 111.556 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m -81.91 82.69 7.46 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 117.379 0.589 . . . . 73.34 109.923 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -55.73 -48.62 96.15 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.949 0.899 . . . . 74.4 111.558 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.14 149.03 45.43 Favored 'Trans proline' 0 C--N 1.391 2.795 0 CA-C-N 120.53 1.225 . . . . 70.02 111.307 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.0 m -77.01 171.33 14.98 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.529 -0.545 . . . . 64.53 109.529 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.72 86.0 0.92 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.192 0.52 . . . . 65.1 110.103 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.99 86.16 4.19 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.325 1.05 . . . . 72.44 109.589 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.52 ' HG3' ' HG2' ' A' ' 78' ' ' GLU . 15.8 mm-40 -94.47 70.73 3.67 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.62 0.768 . . . . 51.14 109.628 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.57 11.05 6.06 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.058 -0.973 . . . . 73.12 112.802 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.93 94.05 9.49 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.162 -0.681 . . . . 74.44 109.162 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -79.33 -36.86 38.85 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.681 0.793 . . . . 75.52 111.269 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -79.61 -23.39 42.67 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.3 -0.863 . . . . 64.43 110.954 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -137.09 126.66 25.22 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.724 0.81 . . . . 53.1 109.504 -178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.77 37.77 0.76 Allowed Glycine 0 N--CA 1.466 0.661 0 N-CA-C 111.375 -0.69 . . . . 72.1 111.375 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.5 p -80.02 138.17 36.96 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.177 0.591 . . . . 54.32 109.565 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -94.66 96.63 9.54 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.219 0.608 . . . . 75.51 109.529 -177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -76.16 -178.82 4.65 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.296 -0.631 . . . . 54.41 109.296 168.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -79.75 16.02 1.23 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.416 0.286 . . . . 73.45 111.281 173.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t -78.63 80.35 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.841 0 N-CA-C 107.682 -1.229 . . . . 71.14 107.682 166.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.652 ' HB3' HD22 ' A' ' 72' ' ' LEU . 40.9 mt-10 -94.16 62.07 2.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.51 -0.768 . . . . 73.52 109.538 -177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -74.93 127.7 33.84 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.136 -0.938 . . . . 74.15 109.301 172.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 161.29 -134.74 3.65 Favored Glycine 0 C--N 1.343 0.919 0 O-C-N 123.512 0.508 . . . . 72.22 112.416 171.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 27.0 pt -111.9 151.75 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 123.86 0.864 . . . . 75.45 110.906 177.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.11 -35.1 74.5 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.366 1.066 . . . . 64.23 112.73 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 169' ' ' LEU . 47.7 mt -53.88 -46.53 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.56 1.144 . . . . 65.53 110.497 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 76' ' ' LEU . 55.1 t -75.97 -44.32 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 113.898 -1.501 . . . . 62.23 111.888 -177.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.652 HD22 ' HB3' ' A' ' 65' ' ' GLU . 55.5 mt -66.16 -32.04 73.25 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.642 0.589 . . . . 71.32 111.18 -175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -58.94 -52.36 66.09 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.278 1.031 . . . . 75.51 111.846 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -89.42 -22.85 22.33 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 116.18 -0.463 . . . . 75.23 111.663 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 mmmp? 69.28 70.36 0.26 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.225 1.01 . . . . 75.32 109.836 -166.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.67 ' HB2' HG13 ' A' ' 71' ' ' VAL . 76.0 mt -85.66 151.74 23.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.8 -1.091 . . . . 73.31 109.269 173.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.689 HG11 ' HB2' ' A' ' 145' ' ' ALA . 11.3 p -90.54 138.43 19.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.085 0 N-CA-C 109.111 -0.7 . . . . 73.05 109.111 170.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' HG2' ' HG3' ' A' ' 53' ' ' GLU . 9.2 tp10 -60.43 138.85 57.93 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 124.074 0.859 . . . . 74.11 109.922 166.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 33.7 tpp -132.42 103.03 5.98 Favored 'General case' 0 C--O 1.249 1.041 0 N-CA-C 105.572 -2.01 . . . . 73.03 105.572 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.44 ' OD1' ' HB2' ' A' ' 82' ' ' TYR . 20.7 t-20 -63.89 113.59 3.54 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 113.183 -1.826 . . . . 73.45 111.18 -170.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.407 ' SG ' ' CD2' ' A' ' 133' ' ' PHE . 41.5 t -59.05 -33.51 70.86 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.431 1.092 . . . . 65.2 111.345 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.44 ' HB2' ' OD1' ' A' ' 80' ' ' ASN . 60.8 m-85 -68.13 -29.65 68.61 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 113.919 -1.491 . . . . 75.14 110.75 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -104.87 -33.11 8.5 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.935 0.894 . . . . 51.31 112.445 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -115.32 19.52 15.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.314 0.646 . . . . 74.43 111.791 -162.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.52 -35.59 72.52 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 112.205 0.446 . . . . 73.13 112.205 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.2 m -72.49 -43.89 63.03 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.275 0.63 . . . . 63.33 111.292 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 mmt -70.75 -29.72 66.03 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.463 0.305 . . . . 74.45 110.514 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.578 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 81.0 t80 -67.52 -32.67 73.63 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 45.11 110.172 173.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -64.61 -36.9 85.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.792 0.437 . . . . 73.21 110.002 172.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.76 -36.12 82.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.065 0.546 . . . . 50.31 111.153 174.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.578 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 54.1 m-85 -69.85 -34.59 73.83 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 118.914 -0.565 . . . . 74.23 111.998 173.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.597 HG13 HD21 ' A' ' 128' ' ' LEU . 35.7 mm -66.11 -36.16 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.294 0.638 . . . . 74.2 110.577 174.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -57.52 -46.83 83.35 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.354 0.662 . . . . 73.0 111.11 171.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -68.58 -44.95 73.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.053 0.541 . . . . 71.33 110.704 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -47.78 -65.62 0.54 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.49 1.916 . . . . 73.43 111.078 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 70.9 mtp -63.09 -44.06 96.76 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.728 0.811 . . . . 74.15 111.384 -174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -57.85 -49.9 75.11 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.656 0.597 . . . . 72.15 110.97 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -70.08 -43.84 70.29 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.856 -1.066 . . . . 74.11 111.283 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 172' ' ' VAL . 34.3 m -69.18 -38.93 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 112.862 0.689 . . . . 63.32 112.862 -175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.45 -43.19 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.421 -0.585 . . . . 72.43 109.421 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.521 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 14.7 t70 -56.83 -41.09 77.25 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.231 0.957 . . . . 72.25 109.939 174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -58.87 -48.07 82.7 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.386 1.074 . . . . 70.31 109.724 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.624 ' HB3' HG12 ' A' ' 113' ' ' VAL . 96.0 mmm -62.42 -36.18 81.55 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.338 -0.846 . . . . 74.33 111.263 177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.07 -24.84 62.41 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.428 0.691 . . . . 73.21 111.494 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 29.5 mtpp -81.39 -49.89 10.13 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.923 0.489 . . . . 74.11 110.431 177.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -84.2 -14.03 51.16 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.302 0.641 . . . . 72.34 112.659 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -140.05 -59.64 0.54 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.108 0.413 . . . . 74.04 111.063 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 69.35 15.64 8.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.756 1.222 . . . . 75.44 112.479 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -80.16 114.58 19.17 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.473 -0.936 . . . . 63.55 108.473 175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -57.24 -42.68 81.94 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.112 0.965 . . . . 73.32 112.249 -171.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.73 -39.17 87.87 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.571 0.544 . . . . 65.15 111.234 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -75.91 -42.44 48.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.32 0.648 . . . . 70.05 110.766 -173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' A' ' 103' ' ' MET . 33.0 m -72.83 -28.55 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.05 0.54 . . . . 70.22 110.67 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 26.5 t70 -67.95 -43.92 77.95 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 123.6 0.562 . . . . 75.53 109.889 172.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.08 -42.51 94.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.698 0.624 . . . . 75.13 109.946 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -44.12 97.78 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.849 0.86 . . . . 72.2 110.918 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.22 -39.02 85.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.07 0.948 . . . . 75.0 110.504 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 114' ' ' ASP . 57.5 mtpt -71.87 -36.9 70.24 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.886 0.741 . . . . 72.44 110.885 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.531 ' HE2' HD13 ' A' ' 26' ' ' LEU . 60.1 mtpt -64.28 -44.45 91.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.045 0.538 . . . . 60.14 109.992 177.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.0 -44.56 96.0 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 C-N-CA 123.732 0.813 . . . . 75.21 109.897 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.423 ' O ' HG22 ' A' ' 125' ' ' VAL . 7.2 tp-100 -56.35 -51.11 69.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.022 0.929 . . . . 71.41 110.649 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.98 -42.58 98.2 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.14 0.9 . . . . 61.21 113.264 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -62.91 -49.92 72.88 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.867 0.467 . . . . 73.43 109.746 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 32.9 m -67.21 -49.03 76.4 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.338 0 CA-C-O 117.531 -1.223 . . . . 74.12 110.488 -174.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 121' ' ' GLN . 33.4 m -64.16 -31.16 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 120.107 1.321 . . . . 63.42 112.002 -176.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.7 m -72.09 -37.54 69.55 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.672 0.389 . . . . 71.12 110.361 172.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.563 ' HA ' ' HG2' ' A' ' 132' ' ' ARG . 40.5 tp -77.32 -26.06 51.82 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.316 1.046 . . . . 65.32 111.171 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.597 HD21 HG13 ' A' ' 92' ' ' ILE . 95.0 mt -85.45 2.51 44.23 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.39 1.076 . . . . 74.21 111.447 -177.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.87 147.8 40.73 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.143 -0.688 . . . . 51.11 109.143 170.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 133' ' ' PHE . 40.7 ttmt -69.29 -13.4 62.37 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.081 0.552 . . . . 71.21 111.212 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -58.2 -45.57 87.35 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.493 0.717 . . . . 61.23 110.068 168.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 127' ' ' LEU . 5.1 mpt_? -78.38 -47.45 17.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.061 -0.972 . . . . 74.35 110.413 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.643 ' HB2' ' HA ' ' A' ' 130' ' ' LYS . 6.2 m-85 -57.84 -25.97 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.746 0.818 . . . . 54.15 112.673 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -61.12 -36.06 78.72 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.607 0.763 . . . . 63.44 110.905 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -104.62 -7.96 19.28 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.918 1.287 . . . . 71.05 111.281 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 133' ' ' PHE . 63.1 mt -88.54 139.59 30.33 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.649 0.737 . . . . 72.34 110.939 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -129.66 124.81 34.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 105.798 -1.926 . . . . 61.41 105.798 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.568 ' HB3' HG11 ' A' ' 153' ' ' VAL . 21.8 m-85 -95.88 140.5 30.56 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 108.818 -0.808 . . . . 62.24 108.818 -173.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -138.34 138.44 38.32 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.411 -0.589 . . . . 54.42 109.411 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.21 175.66 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.562 -0.903 . . . . 74.11 108.562 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -62.1 120.04 20.43 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.222 -0.751 . . . . 30.03 111.222 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -57.37 -18.31 16.9 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 113.312 0.856 . . . . 63.11 113.312 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -68.7 -40.42 80.0 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.376 0.671 . . . . 75.24 109.656 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 149' ' ' GLU . . . -80.41 -6.03 57.43 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.165 0.986 . . . . 63.14 112.491 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.689 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -70.16 2.17 3.97 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.698 0.799 . . . . 63.31 112.484 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -71.91 -24.59 61.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.026 0.93 . . . . 71.53 110.448 173.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.01 -64.31 0.01 OUTLIER Glycine 0 C--N 1.354 1.579 0 CA-C-N 116.113 -0.494 . . . . 71.43 112.221 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -163.27 146.02 10.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.949 0.5 . . . . 73.44 110.628 -173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.454 ' HA ' ' HB1' ' A' ' 144' ' ' ALA . 10.9 tp10 -71.18 -41.29 70.53 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.115 0.566 . . . . 65.0 110.557 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.566 ' H ' ' HE1' ' A' ' 91' ' ' TYR . 80.0 m-20 59.99 44.12 13.77 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.016 0.926 . . . . 73.14 110.805 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -156.34 -150.9 5.77 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 115.03 -0.986 . . . . 63.33 110.827 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.63 140.36 31.35 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.716 -0.846 . . . . 75.44 108.716 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 138' ' ' PHE . 94.0 t -87.18 142.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.82 0.848 . . . . 53.33 109.897 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.79 97.51 0.16 Allowed 'General case' 0 C--O 1.245 0.821 0 N-CA-C 108.942 -0.762 . . . . 62.14 108.942 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.489 HG21 HD21 ' A' ' 127' ' ' LEU . 75.9 mt -85.31 101.58 9.94 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.916 -1.142 . . . . 73.23 107.916 -173.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -101.57 114.16 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.237 0.615 . . . . 72.34 109.39 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -112.23 103.77 11.94 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.459 -0.941 . . . . 74.42 108.459 173.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 6.5 p90 -81.73 94.45 7.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.754 -0.832 . . . . 74.42 108.754 -174.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -90.28 155.06 19.25 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.257 -0.645 . . . . 74.25 109.257 -170.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -103.95 123.76 47.75 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 110.106 -0.331 . . . . 70.11 110.106 175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.71 116.21 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.592 -0.892 . . . . 33.24 108.592 172.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.7 t70 62.18 15.16 7.25 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 124.213 1.005 . . . . 63.24 112.285 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 94.78 25.33 15.37 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 121.887 -0.508 . . . . 74.53 112.892 -175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.3 m -121.74 130.61 53.56 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.497 0.719 . . . . 61.32 110.431 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.76 98.62 7.85 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.808 -0.812 . . . . 73.14 108.808 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.1 p -109.46 95.62 19.71 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.823 0.849 . . . . 74.31 109.796 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 59.9 Cg_endo -68.2 129.54 19.52 Favored 'Trans proline' 0 C--N 1.365 1.445 0 C-N-CA 122.538 2.159 . . . . 44.34 111.389 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 48.8 p -109.85 110.2 21.09 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.797 -0.816 . . . . 62.55 108.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.729 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 33.1 tp -79.1 112.54 16.41 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.456 -0.793 . . . . 75.33 109.382 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.47 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 61.0 mtt -100.83 122.32 43.22 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 107.876 -1.157 . . . . 73.14 107.876 175.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 mt -141.62 130.93 23.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.544 -1.65 . . . . 44.1 106.544 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.634 HG11 HG11 ' A' ' 99' ' ' VAL . 3.9 p -69.09 137.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.005 0.522 . . . . 65.24 110.431 -174.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.5 tmpt? -60.27 -35.48 75.61 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.029 0.932 . . . . 74.54 111.827 -172.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -70.32 -6.01 32.07 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.429 0.9 . . . . 72.13 113.429 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.08 -6.37 6.64 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.223 0.609 . . . . 71.31 111.933 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 10.6 tp -124.98 143.14 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-O 121.433 0.635 . . . . 71.34 110.128 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 40.6 mm -130.93 110.32 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.449 -1.315 . . . . 70.34 107.449 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.87 127.46 42.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.138 -1.06 . . . . 64.42 108.138 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 3' ' ' ILE . 23.5 mm-40 -115.04 114.75 25.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.382 0.673 . . . . 73.21 111.568 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.485 ' HA ' HD23 ' A' ' 2' ' ' LEU . 33.2 mtmm -83.4 96.68 8.62 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.465 0.706 . . . . 74.31 109.915 179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.529 ' SG ' ' HG3' ' A' ' 1' ' ' MET . 9.3 p -108.84 88.95 2.85 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.959 -0.756 . . . . 63.24 108.959 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.17 -68.18 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.153 -0.93 . . . . 70.35 109.301 -177.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 . . . . . 0 CA--C 1.552 1.02 0 C-N-CA 123.47 0.708 . . . . 71.12 110.204 -174.8 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB3' ' HA ' ' A' ' 16' ' ' ASP . 65.5 mtt . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.471 -0.566 . . . . 62.22 109.471 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 180' ' ' LYS . 43.1 mt -115.42 146.92 41.16 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.3 0.64 . . . . 70.4 109.988 -174.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 57.3 mt -95.8 119.61 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.242 -0.651 . . . . 71.21 109.242 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.454 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.0 m-85 -118.91 129.09 55.0 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.422 -1.325 . . . . 74.43 107.422 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.38 155.07 43.61 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 122.557 0.343 . . . . 72.33 111.08 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 10.3 t70 -101.14 144.62 29.81 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.597 0.759 . . . . 65.44 109.743 169.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.5 pt -81.33 -6.42 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 112.752 0.649 . . . . 65.12 112.752 -171.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -106.7 -64.02 1.22 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 113.172 0.804 . . . . 61.31 113.172 -174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 88.0 m -130.06 -25.33 2.52 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.828 0.677 . . . . 74.31 112.828 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.672 ' HB3' ' HB3' ' A' ' 6' ' ' ASP . 12.9 t0 -99.9 25.87 6.89 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.538 0.735 . . . . 51.25 110.759 -170.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -48.63 -20.34 0.44 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 115.101 1.519 . . . . 64.34 115.101 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -85.85 -37.61 19.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.258 -0.901 . . . . 72.52 111.052 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 4' ' ' TYR . 31.5 tp 28.55 -87.89 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 127.001 2.12 . . . . 73.54 114.243 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 18' ' ' PHE . 67.6 m -157.94 121.88 4.12 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.25 1.02 . . . . 72.44 109.58 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 45.3 p -113.7 67.46 0.67 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 121.776 0.798 . . . . 55.11 109.65 174.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 37.6 t70 -159.49 177.28 11.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 114.992 -1.004 . . . . 65.12 109.852 -169.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 m -84.54 76.29 10.19 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 109.056 -0.72 . . . . 72.32 109.056 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 14' ' ' SER . 15.7 m-85 -100.58 139.16 20.39 Favored Pre-proline 0 N--CA 1.476 0.85 0 CA-C-N 115.276 -0.874 . . . . 72.44 110.748 -177.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.9 118.7 5.66 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.693 2.262 . . . . 74.11 112.14 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 ppp? -129.25 162.69 27.31 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.169 -0.923 . . . . 73.12 111.042 -177.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -151.2 115.26 5.0 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.972 1.309 . . . . 70.14 107.649 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.0 tp -88.8 113.28 24.17 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.624 -1.621 . . . . 65.0 106.624 171.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.87 132.12 51.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 C-N-CA 123.111 0.564 . . . . 65.42 110.056 -176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.0 t0 55.04 22.96 4.78 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 125.064 1.346 . . . . 70.21 112.719 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.6 t70 59.81 12.38 2.97 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.681 1.592 . . . . 71.04 112.65 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.75 HD22 ' HG3' ' A' ' 119' ' ' LYS . 55.3 tp -109.49 -51.88 2.83 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 121.523 -0.736 . . . . 62.14 111.214 -174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.64 126.03 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.571 -0.741 . . . . 73.43 109.987 -167.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -83.31 114.87 21.71 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.408 -1.33 . . . . 74.41 107.408 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 35.2 tt0 -112.68 119.49 38.27 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.446 0.698 . . . . 65.15 110.316 -175.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -105.4 107.12 17.93 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 107.999 -1.112 . . . . 75.12 107.999 172.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -77.06 153.13 34.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.616 0.366 . . . . 63.44 111.13 -178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.19 -163.88 12.1 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 111.285 -0.726 . . . . 74.21 111.285 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -140.02 136.72 34.0 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.356 0.663 . . . . 71.42 109.404 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 4.2 t60 -69.07 128.47 36.79 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.762 -0.829 . . . . 72.5 108.762 177.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG23 HD12 ' A' ' 72' ' ' LEU . 13.9 m -147.28 178.57 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.256 1.407 0 C-N-CA 124.345 1.058 . . . . 74.14 109.711 -174.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 21.8 m -125.4 141.44 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 116.263 -0.426 . . . . 73.32 111.526 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.483 ' HD3' HD13 ' A' ' 72' ' ' LEU . 9.6 mpt_? -105.23 105.54 15.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.368 -1.345 . . . . 62.24 107.368 165.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -127.45 125.23 40.15 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.864 -0.791 . . . . 74.14 108.864 -165.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.45 84.39 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.899 1.28 . . . . 63.32 111.406 -174.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 149.07 -48.96 0.59 Allowed Glycine 0 C--O 1.239 0.46 0 CA-C-N 114.692 -1.14 . . . . 54.33 111.638 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -166.51 129.21 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.289 0.636 . . . . 73.0 110.158 -173.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tt -72.2 106.52 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 109.265 -0.643 . . . . 72.01 109.265 174.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.63 88.28 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 CA-C-O 121.824 0.821 . . . . 63.23 109.452 176.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -73.69 -19.35 60.84 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 115.415 -0.811 . . . . 74.33 111.398 -177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.42 -20.93 25.96 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.869 0.868 . . . . 72.44 110.621 171.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -79.48 70.1 2.89 Favored Glycine 0 C--N 1.35 1.354 0 O-C-N 123.349 0.406 . . . . 64.24 112.401 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.9 m -87.91 90.37 8.36 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.06 0.944 . . . . 64.5 109.097 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -61.87 -53.1 63.36 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 124.63 1.172 . . . . 72.41 113.28 -167.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -80.15 -2.16 11.86 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 121.976 1.784 . . . . 52.25 114.051 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m 59.99 21.08 10.17 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.226 1.011 . . . . 71.34 112.06 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -164.05 78.71 0.39 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.13 -1.433 . . . . 53.15 107.13 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.451 ' HG2' ' HD3' ' A' ' 66' ' ' ARG . 29.9 tt0 -68.96 -29.31 67.51 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.717 -1.129 . . . . 74.32 110.968 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -59.98 78.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.791 1.237 . . . . 74.32 111.683 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.09 -60.33 1.19 Allowed Glycine 0 C--N 1.342 0.882 0 N-CA-C 110.353 -1.099 . . . . 74.02 110.353 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 57.45 32.01 21.12 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.955 0.902 . . . . 54.22 111.956 173.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -166.17 100.24 0.63 Allowed 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.142 0.977 . . . . 53.13 108.769 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.6 t70 77.72 -30.28 0.16 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.217 1.407 . . . . 64.01 113.27 170.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.94 -13.02 60.04 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.333 1.053 . . . . 74.42 112.26 -174.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.96 24.53 15.16 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 123.062 0.363 . . . . 70.53 112.787 174.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.7 t -66.37 153.28 43.14 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.404 1.081 . . . . 60.31 111.218 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.48 -21.48 66.64 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.042 0.937 . . . . 61.11 111.286 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.22 111.34 9.3 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 107.778 -1.193 . . . . 75.52 107.778 170.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.2 m80 76.41 -57.34 0.55 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.166 1.787 . . . . 75.02 111.953 -171.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 88.3 t 72.26 -78.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.021 1.329 . . . . 71.42 111.202 -172.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 36' ' ' VAL 0.298 8.4 pt-20 51.39 -70.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.336 2.254 . . . . 64.31 113.178 -163.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.451 ' HD3' ' HG2' ' A' ' 52' ' ' GLU . 60.4 ttp85 -74.16 111.6 9.49 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 123.702 0.801 . . . . 63.05 110.974 -161.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.16 -172.28 45.15 Favored Glycine 0 CA--C 1.501 -0.838 0 C-N-CA 120.316 -0.945 . . . . 74.15 111.69 160.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.519 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 16.4 pt -96.06 150.65 4.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 109.004 -0.739 . . . . 63.41 109.004 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -56.06 -34.07 65.59 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.764 0.826 . . . . 53.35 112.362 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 68' ' ' ILE . 61.8 mt -55.06 -51.37 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.389 1.076 . . . . 62.34 110.16 176.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.622 HG13 ' HB2' ' A' ' 76' ' ' LEU . 30.6 t -75.02 -46.26 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.604 1.161 . . . . 64.12 112.224 -175.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.539 HD12 HG23 ' A' ' 35' ' ' VAL . 80.5 mt -63.19 -37.17 86.19 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.046 0.841 . . . . 73.21 111.088 -174.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -68.21 -47.0 69.05 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.986 -1.007 . . . . 65.5 109.204 174.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -80.55 -17.66 50.79 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.045 0.938 . . . . 64.42 111.957 -166.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm 62.82 61.66 1.14 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.281 1.433 . . . . 71.43 111.044 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.622 ' HB2' HG13 ' A' ' 71' ' ' VAL . 83.8 mt -101.28 140.15 35.97 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 115.378 -0.828 . . . . 73.23 110.483 174.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.57 137.38 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.478 0.711 . . . . 65.53 109.219 171.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.45 157.06 24.31 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.454 1.121 . . . . 73.1 113.685 177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 ttm -147.28 104.21 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 105.172 -2.159 . . . . 72.25 105.172 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.601 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 80.1 m-20 -101.87 124.94 48.35 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.331 -0.618 . . . . 52.22 109.331 -171.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.598 ' HB3' ' HE2' ' A' ' 138' ' ' PHE . 20.6 p -61.4 -11.14 9.12 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.109 0.964 . . . . 64.01 112.522 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.601 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 90.9 m-85 -53.5 -48.85 68.61 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.386 1.074 . . . . 72.1 111.461 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.95 -39.22 6.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.604 0.762 . . . . 74.43 110.571 175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.16 20.39 3.23 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.408 1.083 . . . . 75.42 113.336 -168.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.47 -51.47 69.73 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.154 0.582 . . . . 65.21 111.614 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.8 t -65.93 -38.72 89.39 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.972 0.909 . . . . 71.12 110.725 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.472 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.2 mpt? -69.25 -40.62 77.74 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.174 -0.921 . . . . 65.14 110.658 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -70.61 -31.9 69.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.571 0.748 . . . . 75.0 110.466 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.8 mmmt -67.42 -35.23 78.85 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 61.14 111.113 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.27 95.16 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.202 0.601 . . . . 64.11 110.154 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.57 -34.37 74.07 Favored 'General case' 0 C--O 1.206 -1.227 0 CA-C-N 115.567 -0.742 . . . . 64.13 111.79 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.8 mm -67.78 -34.05 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 123.629 0.772 . . . . 72.12 111.281 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.01 -47.6 82.4 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.731 0.413 . . . . 74.14 110.607 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -65.63 -46.7 78.27 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 123.975 0.797 . . . . 53.34 109.681 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.454 ' O ' HG22 ' A' ' 99' ' ' VAL . 72.7 t80 -48.26 -64.84 0.68 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.011 1.724 . . . . 74.44 111.755 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 27.6 ttt -58.08 -48.61 79.61 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 124.409 1.068 . . . . 75.11 110.765 -174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -58.35 -51.43 69.85 Favored 'General case' 0 C--N 1.348 0.54 0 O-C-N 124.035 0.835 . . . . 73.24 111.59 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -73.72 -39.32 64.4 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.659 0.599 . . . . 74.12 111.82 -168.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 95' ' ' PHE . 35.0 m -67.2 -37.79 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 111.857 0.317 . . . . 70.24 111.857 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.513 HG23 ' HB ' ' A' ' 113' ' ' VAL . 81.7 mt -71.6 -54.24 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.627 -0.509 . . . . 72.02 109.627 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -58.91 -33.18 70.26 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.533 1.533 . . . . 63.13 112.357 -174.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -81.56 -52.63 7.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.262 0.625 . . . . 74.22 110.65 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.431 ' HG2' ' HG3' ' A' ' 174' ' ' GLU . 11.7 tpt -72.2 -31.47 65.92 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.85 0.315 . . . . 73.24 111.85 -167.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.36 -55.46 21.44 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.626 0.77 . . . . 71.01 112.351 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -82.32 -0.03 43.8 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.087 0.47 . . . . 61.55 110.412 -166.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -101.59 -36.35 8.8 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.174 0.99 . . . . 75.15 110.041 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -92.69 -78.66 0.41 Allowed 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.422 -0.808 . . . . 62.23 111.767 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.453 ' HB3' ' HB2' ' A' ' 112' ' ' ASP . 63.1 ttt180 -153.47 13.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.6 0.714 . . . . 73.53 112.337 -169.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.6 t70 68.94 -74.13 0.08 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.275 1.43 . . . . 75.45 113.059 169.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -99.04 -66.42 0.9 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 112.518 0.562 . . . . 74.02 112.518 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.14 -43.87 87.54 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 114.087 1.143 . . . . 33.12 114.087 -162.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -73.53 -46.44 47.62 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.297 -0.41 . . . . 63.3 111.095 -170.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.622 ' HA ' ' HB3' ' A' ' 116' ' ' PHE . 13.6 m -76.24 -22.71 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 119.241 -0.409 . . . . 74.33 111.506 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -61.59 -55.09 34.5 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.165 0.586 . . . . 64.41 110.507 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.98 -41.99 88.9 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.14 0.9 . . . . 73.44 110.244 177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.622 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 18.9 t80 -61.96 -41.9 98.52 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 114.444 -1.253 . . . . 64.35 111.496 177.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -64.6 -41.47 96.21 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.906 0.482 . . . . 62.53 110.62 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.45 -42.79 95.77 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.088 0.868 . . . . 62.0 110.285 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.75 ' HG3' HD22 ' A' ' 26' ' ' LEU . 17.9 tppt? -72.91 -40.18 65.71 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.473 1.109 . . . . 71.12 111.755 -174.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 11.4 tp -76.45 -34.55 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.292 0.637 . . . . 72.43 109.51 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -61.37 -44.46 97.13 Favored 'General case' 0 C--N 1.353 0.735 0 O-C-N 124.119 0.887 . . . . 62.41 109.138 172.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.34 -41.39 99.47 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.803 0.689 . . . . 64.32 112.836 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.63 -53.05 57.56 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.424 0.69 . . . . 75.13 110.703 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 18.7 m -63.61 -44.76 98.68 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.17 0 CA-C-O 118.298 -0.858 . . . . 75.14 111.432 -175.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.7 m -62.6 -38.02 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 119.205 0.911 . . . . 55.01 111.39 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.8 m -71.81 -31.09 66.19 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.901 0.48 . . . . 73.14 111.399 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.702 HD21 HG21 ' A' ' 155' ' ' ILE . 28.9 tp -82.96 -18.99 38.02 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.2 1.0 . . . . 71.33 110.584 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.8 mt -91.95 3.24 55.64 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.895 0.878 . . . . 72.42 111.069 176.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.12 88.31 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.796 0.838 . . . . 71.3 110.474 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -58.24 -19.81 37.0 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 114.886 1.439 . . . . 61.2 114.886 -163.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.48 -40.77 95.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.636 0.774 . . . . 72.12 112.133 -176.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -108.19 -37.2 6.09 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.348 0.594 . . . . 71.53 110.872 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.1 -2.36 48.0 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.187 0.995 . . . . 65.45 113.453 -168.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -59.34 -15.8 18.52 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 112.259 0.466 . . . . 72.45 112.259 163.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -103.31 26.72 8.0 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.785 0.834 . . . . 74.24 110.32 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.5 mt -86.63 133.18 33.72 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.862 -1.162 . . . . 73.12 107.862 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -101.73 109.3 21.05 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.723 -1.584 . . . . 72.3 106.723 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HE2' ' HB3' ' A' ' 81' ' ' CYS . 42.5 m-85 -92.24 145.89 24.14 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.058 -1.09 . . . . 75.25 108.058 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 78.6 m-85 -140.51 146.36 38.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.21 0.529 . . . . 75.23 110.659 -175.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.441 HD13 ' HB3' ' A' ' 144' ' ' ALA . 2.1 pp -146.98 163.18 8.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 106.257 -1.757 . . . . 74.31 106.257 167.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.7 147.29 50.89 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.885 -0.886 . . . . 72.25 110.885 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -56.44 -25.32 50.17 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.92 0.86 . . . . 72.31 112.714 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -36.36 80.48 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.538 1.135 . . . . 51.11 111.129 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' A' ' 150' ' ' ASN . . . -68.14 -42.69 79.77 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.985 0.914 . . . . 64.31 110.634 176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.57 -0.69 47.98 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.252 -0.886 . . . . 75.01 112.36 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -90.89 -19.0 23.83 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.417 1.087 . . . . 71.44 109.922 176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 106.74 45.89 1.17 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.006 -0.543 . . . . 61.35 111.811 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -156.7 108.44 2.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.462 0.705 . . . . 73.45 109.283 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 49.29 89.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.566 1.546 . . . . 71.23 113.712 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.55 ' HA ' ' HB1' ' A' ' 144' ' ' ALA . 17.6 m120 -61.25 -43.03 99.54 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.783 0.833 . . . . 71.2 111.282 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 58.53 -148.77 37.51 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 115.421 0.928 . . . . 51.01 115.421 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 138.64 31.31 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.011 0.924 . . . . 64.53 109.266 -174.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 90.0 t -82.73 123.91 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.134 0.574 . . . . 54.31 110.977 177.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.68 105.3 6.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.381 1.072 . . . . 70.21 109.294 170.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.702 HG21 HD21 ' A' ' 127' ' ' LEU . 74.9 mt -91.75 121.26 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 109.297 -0.631 . . . . 71.42 109.297 -173.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 169' ' ' LEU . 47.7 mm -109.08 114.84 47.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 N-CA-C 110.048 -0.352 . . . . 73.34 110.048 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -100.89 118.27 36.59 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 124.244 0.965 . . . . 75.12 108.641 170.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 165' ' ' GLU . 16.1 p90 -79.96 112.52 17.33 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 106.669 -1.604 . . . . 72.44 106.669 170.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -103.01 128.49 49.83 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.628 -0.508 . . . . 62.44 109.628 -173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.18 120.23 22.69 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.556 0.342 . . . . 70.01 110.872 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.23 107.17 15.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 125.422 1.489 . . . . 62.41 108.824 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 61.92 23.64 13.95 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.811 1.244 . . . . 65.55 112.783 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 95.28 -2.22 65.3 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 113.867 0.307 . . . . 73.01 113.867 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.1 m -110.87 137.54 48.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.285 1.034 . . . . 74.15 108.834 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 158' ' ' TYR . 9.0 pt-20 -72.95 145.61 46.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.167 0.439 . . . . 52.13 110.405 177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.4 101.16 21.83 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 107.645 -1.242 . . . . 74.12 107.645 167.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.75 128.52 20.13 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.401 2.067 . . . . 71.43 112.299 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 53.1 p -121.0 118.43 29.82 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.227 -1.027 . . . . 72.42 108.227 -176.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 35.3 tp -77.23 111.73 13.17 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 108.936 -0.764 . . . . 71.25 108.936 177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 57.5 mtt -101.63 122.53 44.03 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.657 -0.868 . . . . 73.13 108.657 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.427 HD13 HD11 ' A' ' 176' ' ' ILE . 93.0 mt -136.65 143.43 43.47 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.752 -1.944 . . . . 72.2 105.752 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.93 138.59 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 119.063 0.847 . . . . 64.33 109.976 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.455 ' HB3' ' HZ3' ' A' ' 173' ' ' LYS . 4.3 ttpm? -58.38 -29.16 65.8 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.904 1.282 . . . . 71.04 112.272 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 103' ' ' MET . 11.1 mp0 -70.1 -26.32 63.93 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.606 0.763 . . . . 75.34 111.217 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.47 0.43 50.31 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.403 0.681 . . . . 75.03 110.723 175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.427 HD11 HD13 ' A' ' 171' ' ' LEU . 46.6 mm -121.16 125.05 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.301 0.64 . . . . 62.13 109.597 -177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 47.8 mm -99.2 108.36 22.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.362 -1.347 . . . . 72.35 107.362 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.84 116.18 26.93 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.0 -1.482 . . . . 71.03 107.0 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -126.31 106.09 9.27 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.253 -1.388 . . . . 62.01 107.253 -175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.56 ' HA ' HD22 ' A' ' 2' ' ' LEU . 56.4 pttt -88.3 119.79 29.05 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.951 0.5 . . . . 72.02 110.904 -177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 34.6 t -78.25 89.84 4.32 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.803 0.841 . . . . 74.41 109.834 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 54.6 mt -71.23 129.83 39.9 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.667 0.787 . . . . 42.24 110.516 -177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.883 0.873 . . . . 75.53 108.822 -179.476 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.5 mtm . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 120.656 0.265 . . . . 65.13 110.324 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 180' ' ' LYS . 32.6 mt -115.63 161.78 18.17 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.567 0.747 . . . . 72.41 110.969 -166.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.455 HG23 ' HB3' ' A' ' 179' ' ' GLU . 8.3 tt -105.75 130.16 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 107.962 -1.125 . . . . 74.42 107.962 169.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 9.1 m-30 -97.83 136.7 37.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.452 0.644 . . . . 73.15 111.711 -174.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HG3' ' HB ' ' A' ' 177' ' ' ILE . 15.3 ptmt -138.47 136.42 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.068 -1.424 . . . . 72.12 108.945 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.783 ' H ' ' HA ' ' A' ' 10' ' ' ASP . 29.9 t70 -109.17 177.21 4.82 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.574 1.55 . . . . 62.32 110.54 -174.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.3 pt -65.73 -43.07 93.7 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 123.921 0.888 . . . . 72.33 112.511 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -111.42 -51.67 2.84 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.368 1.067 . . . . 74.24 109.26 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 m -84.25 19.05 1.96 Allowed 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.026 -1.443 . . . . 62.22 110.666 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.783 ' HA ' ' H ' ' A' ' 6' ' ' ASP . 13.0 t70 -44.37 -42.8 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 126.319 1.847 . . . . 64.22 113.608 -173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.25 -47.3 80.13 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.805 -1.543 . . . . 63.03 111.774 -173.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -124.41 27.35 7.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.634 0.774 . . . . 71.31 112.033 -169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.687 ' HG ' ' HB2' ' A' ' 6' ' ' ASP . 3.0 tm? -64.63 -79.68 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.079 -0.388 . . . . 72.44 110.327 -177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 4' ' ' TYR . 75.1 m -153.32 -176.17 5.67 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-O 121.764 0.792 . . . . 74.51 111.348 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.1 t -151.34 95.12 2.11 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.943 -1.503 . . . . 70.2 106.943 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -61.94 95.65 0.06 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 125.206 1.402 . . . . 73.32 110.633 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 p -120.46 25.1 10.0 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 106.977 -1.49 . . . . 53.2 106.977 158.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -135.52 155.33 78.49 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.446 -1.252 . . . . 55.44 109.987 -171.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.08 120.11 7.27 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.843 1.695 . . . . 73.31 112.726 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.75 149.93 20.73 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.551 0.741 . . . . 74.24 110.324 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 66.6 mttm -136.18 144.97 45.25 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.508 0.723 . . . . 75.54 109.417 -173.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.0 tp -130.71 145.05 51.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.591 0.756 . . . . 72.03 109.485 -176.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.98 133.87 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.468 0.707 . . . . 72.03 109.689 -178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 58.82 16.23 4.36 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.211 1.404 . . . . 72.53 113.681 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 47.25 26.56 0.71 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.536 1.135 . . . . 73.53 112.616 -167.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.474 HD22 ' HB3' ' A' ' 119' ' ' LYS . 37.1 tp -119.94 -46.69 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.179 0.992 . . . . 72.34 109.937 -174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.81 126.54 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.115 0.566 . . . . 74.1 110.395 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -85.15 122.74 29.78 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.491 -1.3 . . . . 72.22 107.491 167.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 5.1 pt-20 -112.73 147.03 37.69 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.197 0.522 . . . . 74.22 110.118 170.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -131.49 105.08 7.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.369 -1.345 . . . . 63.43 107.369 166.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 167' ' ' PRO . 15.2 ptmt -82.01 103.64 11.79 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.11 -0.7 . . . . 74.41 109.11 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.42 ' H ' HD11 ' A' ' 70' ' ' ILE . . . -81.82 -157.4 19.46 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.042 -0.981 . . . . 63.53 112.09 176.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -124.12 161.3 25.92 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.806 0.842 . . . . 75.42 109.913 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -93.13 118.09 30.82 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.156 -1.053 . . . . 73.01 108.156 172.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 m -146.98 159.8 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-O 121.331 0.586 . . . . 62.11 111.42 -173.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 44' ' ' LEU . 12.7 m -133.88 132.57 56.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.181 -1.044 . . . . 63.31 108.181 174.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.62 149.67 43.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.132 -1.433 . . . . 74.13 107.132 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -133.86 132.06 39.91 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.628 -0.878 . . . . 74.21 108.628 169.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 65.17 12.49 8.03 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.097 1.359 . . . . 62.53 113.503 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.8 21.24 26.55 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 123.051 0.358 . . . . 24.2 112.481 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -127.44 127.27 43.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.271 1.028 . . . . 75.12 109.175 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -72.04 118.86 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 N-CA-C 109.282 -0.636 . . . . 73.2 109.282 176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.0 -46.46 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 112.775 0.657 . . . . 75.04 112.775 -169.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HA ' HG22 ' A' ' 36' ' ' VAL . 3.2 mm? 51.38 81.44 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.269 1.028 . . . . 74.12 110.741 -168.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.56 20.18 5.65 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.895 0.878 . . . . 71.24 110.224 -176.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.03 -135.67 28.16 Favored Glycine 0 C--N 1.352 1.454 0 N-CA-C 111.538 -0.625 . . . . 34.31 111.538 -173.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.439 ' O ' ' HD3' ' A' ' 66' ' ' ARG . 38.6 m 61.1 29.53 18.93 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.511 1.124 . . . . 74.51 112.607 173.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -128.7 52.41 9.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 113.375 0.88 . . . . 72.05 113.375 -177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.14 -34.99 55.32 Favored 'Trans proline' 0 C--N 1.387 2.575 0 CA-C-N 120.631 1.261 . . . . 74.44 111.06 171.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.5 m -131.66 152.48 50.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.675 1.19 . . . . 74.53 109.377 175.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -109.22 82.09 1.54 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.011 0.924 . . . . 43.53 109.019 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -82.53 -29.88 30.12 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.877 0.871 . . . . 63.34 111.005 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.2 mp0 -80.91 75.04 7.87 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.334 0.654 . . . . 73.14 109.368 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.64 -63.06 2.84 Favored Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.739 -1.345 . . . . 72.11 109.739 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 179.32 -76.23 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.433 1.493 . . . . 74.32 108.899 167.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 59.44 -82.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 126.032 1.733 . . . . 64.21 113.441 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -168.94 -90.72 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.344 0.658 . . . . 74.14 109.685 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.808 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 1.4 m-20 -139.6 21.38 2.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.897 0.479 . . . . 52.13 112.087 -169.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -67.83 -43.14 84.71 Favored Glycine 0 N--CA 1.473 1.139 0 N-CA-C 112.066 -0.414 . . . . 64.02 112.066 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.4 m -138.92 63.41 1.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.867 -1.161 . . . . 73.21 107.867 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.808 ' HB2' ' HA ' ' A' ' 58' ' ' ASP . 16.1 t70 -76.21 87.72 3.06 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.863 -1.062 . . . . 72.24 110.867 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 64' ' ' VAL . 26.9 tt0 -157.62 151.22 23.88 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.346 -0.983 . . . . 53.4 108.346 170.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -80.44 23.55 0.5 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.275 0.63 . . . . 60.15 112.286 -173.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.462 HG23 ' HG2' ' A' ' 62' ' ' GLU . 5.3 t -77.32 83.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.624 0 N-CA-C 108.132 -1.062 . . . . 72.22 108.132 170.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.4 73.31 3.16 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.959 -1.126 . . . . 70.24 107.959 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 47' ' ' SER . 15.3 ptp180 -91.97 137.28 32.49 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.952 -0.567 . . . . 72.13 109.54 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.18 -122.72 2.75 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 112.15 -0.38 . . . . 62.11 112.15 170.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.457 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 42.2 pt -112.5 138.8 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.308 0.643 . . . . 54.43 111.648 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -47.8 -46.87 31.0 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.209 1.404 . . . . 55.44 113.765 -176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.446 HD13 ' HB2' ' A' ' 169' ' ' LEU . 57.6 mt -50.41 -46.13 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.382 1.073 . . . . 73.31 111.705 -174.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 94.5 t -75.25 -47.11 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 115.289 -0.869 . . . . 44.44 111.216 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 17.2 mt -64.2 -36.12 83.03 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.214 0.946 . . . . 70.01 110.517 -175.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -60.98 -37.06 81.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.879 1.672 . . . . 34.11 110.803 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.549 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 26.3 m170 -106.89 -13.33 15.25 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.974 -1.012 . . . . 75.3 111.99 -175.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp 55.02 57.47 5.57 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.532 1.133 . . . . 72.22 111.488 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 74' ' ' HIS . 79.5 mt -84.64 146.13 27.64 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.651 0.78 . . . . 71.5 110.431 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -92.84 123.74 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 109.538 -0.541 . . . . 70.21 109.538 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -70.6 147.36 49.31 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.704 -1.135 . . . . 42.23 112.876 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 70.4 mtp -143.74 122.35 12.52 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 105.015 -2.217 . . . . 53.1 105.015 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -101.0 152.86 20.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.772 -0.58 . . . . 73.44 112.007 -168.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 20.4 p -66.88 -23.97 66.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.616 0.766 . . . . 65.02 113.058 -177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -72.14 -43.67 64.32 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.922 0.489 . . . . 45.21 111.575 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.73 -48.19 3.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.333 0.653 . . . . 64.34 111.395 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.41 21.0 3.04 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.122 0.969 . . . . 73.32 112.432 -171.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.4 74.83 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.591 0.757 . . . . 51.23 112.584 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.6 t -74.04 -41.22 62.13 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.812 0.845 . . . . 72.32 110.794 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mmt -61.55 -43.99 97.84 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.06 0.544 . . . . 63.43 110.049 176.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.631 ' HD1' HG21 ' A' ' 153' ' ' VAL . 46.5 t80 -58.83 -42.91 90.39 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.381 1.472 . . . . 74.23 111.086 176.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -58.93 -41.45 87.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.624 0.77 . . . . 72.22 110.369 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.36 88.84 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.349 0.66 . . . . 75.42 111.277 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.503 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 63.8 m-85 -59.6 -45.24 92.49 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.737 0.415 . . . . 61.54 111.371 171.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.43 -38.31 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.814 0.846 . . . . 73.42 111.0 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -58.18 -47.74 82.48 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.972 0.509 . . . . 60.44 111.476 172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -65.71 -51.04 62.53 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.545 0.738 . . . . 74.34 110.656 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -49.98 -62.29 1.65 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.941 2.097 . . . . 72.31 111.655 178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 48.2 mtm -64.6 -33.98 77.19 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.634 0.584 . . . . 71.12 111.04 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -60.58 -47.03 88.02 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.836 0.454 . . . . 74.32 110.076 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.31 -48.9 16.2 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.486 0.714 . . . . 54.34 110.57 -172.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 m -67.45 -40.85 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.363 0.265 . . . . 74.21 111.069 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 104' ' ' GLU . 77.0 mt -71.19 -45.68 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 119.016 -0.516 . . . . 65.41 109.723 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 105' ' ' LYS . 26.5 t70 -53.59 -47.69 69.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 123.882 0.873 . . . . 64.33 112.634 177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -65.36 -43.18 91.6 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.757 0.423 . . . . 62.23 110.143 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.457 ' HB2' ' HG2' ' A' ' 174' ' ' GLU . 7.6 tpt -68.84 -26.07 64.97 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.653 -0.703 . . . . 63.13 110.048 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.642 ' HA ' HG11 ' A' ' 113' ' ' VAL . 1.7 tm-20 -76.4 -38.04 56.22 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.856 1.263 . . . . 75.14 109.787 -176.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 101' ' ' ASP . 64.7 mttm -67.15 -25.92 66.4 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.698 0.399 . . . . 71.24 110.61 174.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.17 0.68 53.06 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.087 0.955 . . . . 73.01 111.701 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -130.42 -53.43 1.09 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.439 0.695 . . . . 62.33 110.168 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 56.82 23.06 7.62 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 127.042 2.137 . . . . 72.03 112.854 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -120.48 -89.0 0.61 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.81 0.844 . . . . 63.01 109.564 -176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttp 173.13 -42.21 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.648 1.179 . . . . 72.13 109.782 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.13 92.14 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.731 0.641 . . . . 52.23 112.731 -164.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.29 -48.54 17.16 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.765 0.426 . . . . 73.51 109.95 -178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 104' ' ' GLU . 35.0 m -70.39 -24.09 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 115.723 -0.671 . . . . 74.32 112.22 -174.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 118' ' ' LYS . 23.0 t70 -65.43 -37.48 87.03 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.376 0.67 . . . . 73.54 109.865 172.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.425 ' O ' ' HD3' ' A' ' 119' ' ' LYS . . . -72.62 -49.49 31.64 Favored 'General case' 0 C--N 1.348 0.506 0 O-C-N 123.876 0.735 . . . . 62.45 109.935 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -55.16 -47.92 74.48 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.885 0.474 . . . . 75.22 110.418 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -60.7 -46.59 89.82 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 124.387 1.054 . . . . 74.54 110.944 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -61.25 -43.89 98.14 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.009 0.818 . . . . 70.24 110.248 -174.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.474 ' HB3' HD22 ' A' ' 26' ' ' LEU . 5.1 mptp? -79.28 -36.91 39.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.501 -0.772 . . . . 51.42 111.337 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.1 tp -73.99 -38.22 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 118.751 0.705 . . . . 74.22 110.324 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.446 ' HA ' HG22 ' A' ' 124' ' ' VAL . 23.4 tm0? -72.32 -39.34 68.28 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 176.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.63 -39.21 97.08 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.513 0.508 . . . . 72.13 112.28 174.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 35.5 t90 -65.13 -51.42 61.33 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 123.504 0.722 . . . . 73.32 109.616 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 35.8 m -68.77 -42.12 82.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.157 0 CA-C-O 118.936 -0.554 . . . . 75.22 111.04 -175.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.1 -29.82 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 118.85 0.75 . . . . 74.13 110.605 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.3 t -77.81 -39.17 44.69 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.201 0.6 . . . . 71.23 110.882 172.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.694 HD21 HG21 ' A' ' 155' ' ' ILE . 35.0 tp -72.48 -29.45 63.65 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.521 1.128 . . . . 63.13 111.509 -174.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 38.0 mt -86.75 0.3 54.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.195 0.598 . . . . 73.52 111.123 -177.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.31 81.05 4.69 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.076 -0.713 . . . . 21.31 109.076 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 61.7 pttt -61.56 -6.1 2.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.875 1.27 . . . . 63.23 113.819 -172.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -54.44 -42.72 70.9 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.955 0.902 . . . . 61.05 110.838 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -109.17 -37.98 5.65 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.285 1.034 . . . . 73.11 109.637 171.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.456 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 56.7 m-85 -79.26 -1.54 37.03 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.796 1.238 . . . . 72.14 114.15 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 30.3 ttmt -50.64 -12.74 0.11 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.1 1.148 . . . . 62.32 114.1 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 77.4 m-20 -82.29 22.09 0.86 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.745 0.818 . . . . 71.12 111.467 175.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 133' ' ' PHE . 72.8 mt -89.23 136.95 32.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.171 0.588 . . . . 73.15 109.598 172.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -132.47 122.95 25.7 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.661 -1.607 . . . . 43.52 106.661 177.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -99.39 129.44 45.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.937 0.495 . . . . 54.53 109.8 -167.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 96.6 m-85 -130.33 146.12 51.88 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.826 0.451 . . . . 74.52 110.525 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.37 170.26 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 122.933 0.493 . . . . 63.14 109.751 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.54 138.84 22.27 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.658 -0.701 . . . . 55.12 112.353 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -59.86 -47.47 85.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.7 1.2 . . . . 64.4 109.833 171.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.23 -38.35 68.35 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.795 1.238 . . . . 73.23 111.206 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.02 -46.34 68.22 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.923 -1.035 . . . . 73.11 110.292 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.01 -3.25 51.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.352 0.661 . . . . 72.01 112.429 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.94 -41.66 14.72 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.258 0.623 . . . . 73.32 111.726 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.62 46.37 0.1 OUTLIER Glycine 0 N--CA 1.469 0.867 0 C-N-CA 121.271 -0.49 . . . . 73.25 112.839 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.93 -165.2 1.68 Allowed 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.154 0.982 . . . . 63.2 108.826 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -55.09 122.56 11.23 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.792 -0.818 . . . . 74.25 108.792 166.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -50.38 -31.04 13.68 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 124.957 1.411 . . . . 70.3 111.621 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 123.87 -174.39 16.77 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.797 -0.638 . . . . 53.0 112.902 172.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.442 HE22 HD22 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -121.4 164.79 16.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.926 1.291 . . . . 63.24 108.072 167.344 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.631 HG21 ' HD1' ' A' ' 88' ' ' PHE . 41.9 t -79.15 116.94 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.585 0.707 . . . . 71.13 111.77 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.35 106.17 5.85 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.071 -1.422 . . . . 62.4 107.908 161.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.694 HG21 HD21 ' A' ' 127' ' ' LEU . 54.8 mt -90.41 106.63 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.534 0.733 . . . . 71.02 110.236 -165.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 169' ' ' LEU . 44.9 mm -96.05 115.98 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 110.033 -0.358 . . . . 71.35 110.033 -178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -100.51 121.4 41.51 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.09 0.556 . . . . 74.53 110.0 171.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 135' ' ' ASN . 32.6 m-85 -83.43 98.34 9.45 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.633 -0.877 . . . . 73.33 108.633 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -90.74 131.88 36.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.686 -0.857 . . . . 74.22 108.686 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -92.79 108.38 19.95 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.166 -0.679 . . . . 71.31 109.166 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.03 111.47 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 N-CA-C 108.978 -0.749 . . . . 64.44 108.978 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 60.33 21.5 11.01 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 124.428 1.091 . . . . 71.43 112.826 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.19 31.17 14.83 Favored Glycine 0 C--N 1.347 1.144 0 C-N-CA 121.908 -0.187 . . . . 64.03 112.909 -177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 97.6 m -133.71 121.71 22.34 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.881 0.872 . . . . 64.34 109.326 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.92 126.65 30.45 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 123.545 0.528 . . . . 75.23 109.634 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.5 m -121.01 107.22 37.99 Favored Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 108.221 -1.029 . . . . 51.43 108.221 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 57.8 Cg_endo -68.15 127.57 16.14 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.677 2.252 . . . . 75.34 111.178 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 20.8 m -118.06 104.79 11.2 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.184 0.594 . . . . 71.25 109.845 -171.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' GLU . 56.2 tp -78.01 106.19 9.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.621 0.769 . . . . 74.31 109.674 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.524 ' HB2' ' HB ' ' A' ' 155' ' ' ILE . 64.3 mtt -103.28 122.81 45.56 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.571 0.748 . . . . 73.41 109.139 -176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.442 HD22 HE22 ' A' ' 152' ' ' GLN . 85.9 mt -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.937 -1.875 . . . . 74.44 105.937 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 174' ' ' GLU . 14.0 p -83.09 143.71 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 108.047 -1.094 . . . . 62.21 108.047 173.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -48.56 -37.58 18.24 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.501 1.52 . . . . 64.21 111.707 175.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 103' ' ' MET . 8.7 tp10 -83.72 -0.52 51.18 Favored 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 123.688 0.795 . . . . 74.13 112.191 -175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -104.73 -33.29 8.5 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.545 0.738 . . . . 61.45 110.373 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.66 133.48 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-O 121.33 0.586 . . . . 74.31 110.285 -171.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.418 ' HB ' ' HG3' ' A' ' 5' ' ' LYS . 46.8 mm -127.9 131.94 69.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 107.385 -1.339 . . . . 61.32 107.385 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.44 ' HB2' HD13 ' A' ' 2' ' ' LEU . 10.5 pt-20 -95.06 124.8 39.31 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.245 -0.65 . . . . 62.54 109.245 175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.455 ' HB3' HG23 ' A' ' 3' ' ' ILE . 15.9 tp10 -108.4 125.54 51.85 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.841 -0.8 . . . . 65.54 108.841 175.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.453 ' HA ' HD22 ' A' ' 2' ' ' LEU . 13.8 mptt -71.28 154.25 41.78 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.746 0.818 . . . . 45.55 110.621 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 39.8 m -133.3 86.41 2.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.492 -0.559 . . . . 63.14 109.492 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -170.08 0.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.085 0.954 . . . . 71.0 112.149 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 . . . . . 0 CA--C 1.552 1.026 0 C-N-CA 123.573 0.749 . . . . 71.13 109.152 -178.679 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 109.933 -0.395 . . . . 72.52 109.933 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 59.1 mt -116.16 123.32 47.53 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.649 -0.871 . . . . 51.51 108.649 169.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.616 HG23 ' HB3' ' A' ' 179' ' ' GLU . 9.7 tt -96.82 119.95 45.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.6 0.714 . . . . 74.01 110.068 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -102.71 110.83 22.89 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 105.717 -1.957 . . . . 63.42 105.717 173.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 51.0 pttt -131.24 134.95 46.93 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.068 0.547 . . . . 74.42 111.736 -167.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.408 ' HA ' HD13 ' A' ' 176' ' ' ILE . 27.7 t70 -81.65 131.2 35.26 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.71 0.804 . . . . 71.32 109.751 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 175' ' ' ALA . 25.9 pt -77.94 -11.55 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 112.752 0.649 . . . . 73.22 112.752 -171.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.569 ' HE1' ' HB1' ' A' ' 175' ' ' ALA . 9.0 m-85 -94.15 -64.68 1.05 Allowed 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.082 0.401 . . . . 73.05 110.619 -172.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.494 HG23 ' HB3' ' A' ' 149' ' ' GLU . 3.2 p -132.08 -37.68 1.12 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.385 1.074 . . . . 72.32 113.702 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -98.34 23.56 8.26 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.048 0.939 . . . . 71.22 111.854 -162.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -46.35 -26.32 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 126.014 1.726 . . . . 73.11 115.027 -176.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.91 27.58 0.87 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.367 1.067 . . . . 74.41 111.16 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.63 -73.69 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.735 1.614 . . . . 75.5 112.39 -173.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 64.3 m -152.15 131.87 13.19 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.973 0.509 . . . . 61.14 109.85 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 34.5 p -131.34 91.79 3.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.037 0.935 . . . . 75.41 108.942 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.426 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 25.0 t70 -168.31 177.55 5.34 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.594 0.757 . . . . 74.45 109.628 -176.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.4 p -83.39 81.55 8.67 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.589 0.756 . . . . 53.31 109.344 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 36.9 m-85 -103.19 152.79 38.68 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 115.188 -0.915 . . . . 74.33 109.57 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -46.98 119.12 3.16 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.872 2.381 . . . . 61.44 112.83 173.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 17.7 tpt -112.26 120.93 43.44 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.224 -1.028 . . . . 71.31 108.224 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -142.44 116.62 9.48 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.764 -1.569 . . . . 74.23 106.764 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.9 tp -123.64 113.91 19.28 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.104 0.962 . . . . 73.12 108.606 -172.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -103.25 137.0 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 124.08 0.952 . . . . 52.54 109.649 -177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 56.09 18.98 3.46 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 125.417 1.487 . . . . 71.34 113.315 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.4 t70 55.62 14.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.371 1.068 . . . . 73.23 112.113 -172.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 119' ' ' LYS . 37.2 tp -112.74 -51.28 2.84 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.62 0.768 . . . . 73.14 110.636 -168.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -116.15 122.09 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 115.534 -0.757 . . . . 61.45 109.708 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -85.59 113.06 21.53 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 107.851 -1.166 . . . . 62.1 107.851 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -103.99 107.62 18.6 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.016 0.926 . . . . 73.34 109.032 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 45.9 t80 -90.2 112.62 24.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.595 1.158 . . . . 64.2 109.159 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HE2' HG11 ' A' ' 166' ' ' VAL . 62.5 tttm -69.2 143.5 53.99 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.067 0.547 . . . . 72.33 110.546 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.19 -174.54 33.2 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 110.822 -0.911 . . . . 64.22 110.822 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 20.2 ptmt -134.43 151.56 51.26 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.477 0.639 . . . . 73.52 111.088 -173.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -75.39 125.21 28.53 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 109.303 -0.629 . . . . 73.52 109.303 175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.485 HG23 HD12 ' A' ' 72' ' ' LEU . 4.7 m -150.85 155.99 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.211 1.404 . . . . 64.31 108.962 -177.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.5 m -133.27 161.82 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 108.847 -0.798 . . . . 64.32 108.847 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -138.12 110.22 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.631 -0.877 . . . . 73.53 108.631 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -117.29 147.36 42.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.285 -1.005 . . . . 75.53 108.285 178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -59.43 88.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.739 1.216 . . . . 55.0 111.106 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.25 -52.42 0.65 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 114.085 -1.416 . . . . 70.34 111.722 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -165.31 2.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.526 0.731 . . . . 74.54 112.122 -169.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.519 HD11 HD23 ' A' ' 44' ' ' LEU . 7.4 tt -142.91 119.24 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.054 0.942 . . . . 72.31 110.51 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.36 87.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 107.951 -1.129 . . . . 74.51 107.951 168.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.519 HD23 HD11 ' A' ' 42' ' ' ILE . 2.3 pp -83.67 -21.18 32.49 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.555 0.342 . . . . 74.32 111.323 -178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.26 149.85 34.67 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.53 0.732 . . . . 45.53 110.882 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 178.32 40.59 0.07 OUTLIER Glycine 0 C--N 1.335 0.48 0 CA-C-N 114.864 -1.062 . . . . 54.31 111.128 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 t 58.97 49.37 9.7 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.835 1.254 . . . . 74.34 109.785 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -133.75 137.44 28.67 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 114.69 -1.141 . . . . 72.42 110.027 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.01 -155.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.642 2.228 . . . . 54.3 110.951 168.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 t -78.48 67.67 4.3 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.905 0.482 . . . . 63.21 110.383 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.61 91.83 6.46 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.408 0.683 . . . . 64.33 109.947 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -71.09 -57.11 4.84 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.114 0.966 . . . . 74.35 110.929 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 60.25 23.01 12.4 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.025 1.33 . . . . 73.12 113.308 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -131.1 50.38 0.89 Allowed Glycine 0 N--CA 1.468 0.803 0 N-CA-C 111.779 -0.528 . . . . 60.44 111.779 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -69.7 -22.64 63.4 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.991 0.516 . . . . 73.42 110.274 173.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -128.6 48.93 2.25 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.791 1.236 . . . . 71.3 107.702 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.04 105.36 0.31 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.107 0.963 . . . . 64.34 112.177 -174.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -114.2 7.59 16.61 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.759 1.224 . . . . 62.4 110.535 173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.82 114.14 6.55 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 123.532 0.52 . . . . 55.33 111.838 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.2 p -74.6 83.13 2.04 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.582 0.753 . . . . 64.41 110.576 -176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -130.64 131.31 44.83 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.544 0.738 . . . . 63.54 110.022 -177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -96.72 -16.0 21.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.374 1.069 . . . . 61.53 110.103 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -139.07 75.63 1.53 Allowed 'General case' 0 C--N 1.352 0.69 0 C-N-CA 123.591 0.756 . . . . 73.02 110.888 -175.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.1 t -127.19 85.27 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.211 -1.403 . . . . 72.34 107.211 159.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' HG2' HD22 ' A' ' 72' ' ' LEU . 37.4 tt0 -93.34 75.5 4.54 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 107.795 -1.187 . . . . 64.4 107.795 172.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -89.01 144.76 25.93 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.553 -1.203 . . . . 72.32 110.589 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.01 -130.54 3.13 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.099 -0.8 . . . . 71.41 111.099 164.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 156' ' ' ILE . 20.4 pt -112.73 150.06 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 122.881 0.472 . . . . 74.14 111.212 168.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -41.17 -41.32 1.77 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 127.122 2.169 . . . . 72.35 113.146 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.59 HG21 ' HB2' ' A' ' 169' ' ' LEU . 66.9 mt -57.58 -55.32 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 124.336 1.023 . . . . 61.35 110.352 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG13 ' HB2' ' A' ' 76' ' ' LEU . 40.3 t -60.56 -44.91 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 114.407 -1.269 . . . . 63.34 111.215 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' HG2' ' A' ' 65' ' ' GLU . 19.1 mt -72.34 -35.8 68.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.418 -0.81 . . . . 61.05 111.127 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -72.04 -33.88 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.757 0.823 . . . . 72.11 110.83 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -97.7 -5.68 34.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.417 0.687 . . . . 74.11 111.64 -175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt 55.5 63.13 2.17 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.937 1.295 . . . . 73.24 110.683 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HB2' HG13 ' A' ' 71' ' ' VAL . 58.0 mt -100.52 135.35 42.1 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.713 -1.131 . . . . 64.52 109.367 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.75 130.35 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 N-CA-C 109.519 -0.548 . . . . 75.1 109.519 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.98 134.32 43.08 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.804 -1.089 . . . . 61.35 111.902 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 80.4 mtp -145.56 103.84 3.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.853 1.661 . . . . 72.23 107.273 177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.485 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 95.6 m-20 -86.05 149.98 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.522 -0.736 . . . . 63.43 109.691 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 138' ' ' PHE . 37.0 t -60.72 -20.38 61.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.625 -0.716 . . . . 74.24 111.812 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.485 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 95.1 m-85 -58.28 -57.72 11.65 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.331 1.053 . . . . 74.44 110.925 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -74.24 -35.14 63.83 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.274 -0.876 . . . . 73.2 111.851 -174.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -121.44 19.37 11.31 Favored 'General case' 0 C--O 1.208 -1.131 0 N-CA-C 112.208 0.447 . . . . 64.12 112.208 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -45.39 -39.6 7.11 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.681 0.993 . . . . 51.42 113.681 -175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.0 m -65.98 -60.18 3.1 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 123.507 0.723 . . . . 55.22 111.378 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 63.2 mtt -76.75 -14.54 59.93 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.988 -0.551 . . . . 75.22 111.431 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.67 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 40.5 t80 -70.1 -38.51 75.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.21 0.604 . . . . 72.1 109.862 169.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -70.07 -26.15 63.88 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 110.216 -0.291 . . . . 75.04 110.216 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.85 -36.3 72.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.012 -0.54 . . . . 70.12 110.785 170.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.67 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 33.1 m-85 -58.48 -44.86 89.53 Favored 'General case' 0 C--N 1.367 1.346 0 C-N-CA 123.205 0.602 . . . . 63.21 109.784 170.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 43.0 mm -64.15 -38.78 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.843 0.857 . . . . 54.24 111.613 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -60.02 -46.92 87.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 122.935 0.494 . . . . 64.44 111.713 174.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -66.49 -44.89 81.38 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 64.0 110.395 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -50.41 -59.31 4.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.204 1.802 . . . . 73.11 110.85 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 64.0 mtt -57.26 -57.45 12.57 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.164 0.915 . . . . 54.44 111.022 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -62.17 -30.69 71.23 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 123.285 0.366 . . . . 72.22 111.639 -173.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -78.34 -45.15 23.28 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.74 0.416 . . . . 72.23 110.991 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 175' ' ' ALA . 32.4 m -68.27 -28.8 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 123.196 0.31 . . . . 74.3 110.583 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.418 HG12 ' HE2' ' A' ' 103' ' ' MET . 52.6 mt -75.04 -45.36 42.68 Favored 'Isoleucine or valine' 0 C--N 1.359 0.978 0 C-N-CA 123.431 0.692 . . . . 73.53 110.307 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.63 -31.87 71.05 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.444 0.698 . . . . 52.33 111.337 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -69.78 -61.35 1.82 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.984 0.914 . . . . 73.24 109.811 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.441 ' HE1' ' O ' ' A' ' 113' ' ' VAL . 21.9 ptt? -64.5 -50.31 67.89 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.66 0.6 . . . . 52.44 111.444 -171.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.82 -20.93 66.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.348 0.659 . . . . 71.43 111.991 -172.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -72.64 -25.73 61.39 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.387 0.675 . . . . 75.22 110.388 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.57 0.09 12.58 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.799 0.84 . . . . 62.43 111.538 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -120.02 -74.11 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.158 0.583 . . . . 65.51 110.206 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 50.08 18.78 0.41 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 126.548 1.939 . . . . 72.44 115.131 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.86 -22.64 49.55 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.249 0.62 . . . . 71.4 110.001 176.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 113' ' ' VAL . 86.0 tttt 84.15 -38.76 0.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.148 1.779 . . . . 70.35 111.73 175.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.89 62.79 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.227 0.467 . . . . 75.3 110.637 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -86.2 -44.55 12.09 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.938 0.895 . . . . 74.25 111.742 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 110' ' ' LYS . 33.5 m -78.03 -34.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.139 -0.482 . . . . 73.44 111.564 -174.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.72 -25.3 56.49 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.701 -0.481 . . . . 72.12 109.701 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.7 -47.98 57.01 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.351 0.66 . . . . 63.12 109.691 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -61.85 -47.69 83.9 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.216 1.006 . . . . 74.24 110.828 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.56 -36.18 79.88 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.195 0.998 . . . . 72.32 110.786 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -64.72 -46.17 83.43 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.66 0.784 . . . . 73.43 109.939 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' HB3' HD22 ' A' ' 26' ' ' LEU . 34.4 mmtp -66.49 -37.75 85.77 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.465 -0.789 . . . . 72.55 111.107 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 124' ' ' VAL . 22.7 mm -73.24 -36.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.82 0.848 . . . . 63.23 110.682 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.422 ' O ' HG23 ' A' ' 125' ' ' VAL . 22.4 tm0? -61.32 -52.51 64.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.744 -0.835 . . . . 73.1 108.744 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.67 -37.44 94.37 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.66 -0.7 . . . . 65.23 112.325 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 30.7 t90 -62.51 -55.32 28.57 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.1 0.96 . . . . 74.35 110.743 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.507 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 27.0 m -67.23 -41.15 86.36 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-O 118.402 -0.809 . . . . 75.12 111.151 -174.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 121' ' ' GLN . 88.2 t -60.3 -42.52 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.095 0.861 . . . . 63.11 110.787 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.9 m -70.24 -31.4 68.79 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.883 0.473 . . . . 61.15 111.311 176.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 155' ' ' ILE . 31.9 tp -84.03 -21.65 31.56 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.058 0.943 . . . . 64.02 111.342 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 91.5 mt -92.88 -0.37 57.25 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.694 0.797 . . . . 55.1 111.589 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.82 101.32 0.19 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.09 0.556 . . . . 51.45 110.487 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 15.3 ptmm? -61.77 -12.41 16.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.962 1.305 . . . . 64.14 114.432 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.68 -46.46 82.33 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.829 0.452 . . . . 63.15 111.113 -177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -110.13 -40.36 4.74 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.242 1.017 . . . . 75.35 109.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -81.58 -3.47 53.39 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.233 1.013 . . . . 65.41 112.608 -167.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 61.1 tttm -46.09 -31.01 2.11 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.423 1.089 . . . . 75.2 111.895 160.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -97.57 26.66 4.82 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.332 1.053 . . . . 54.13 111.596 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.1 mt -88.69 140.61 29.28 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.214 -0.662 . . . . 61.52 109.214 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -107.55 112.34 25.03 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.401 -1.333 . . . . 71.14 107.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.405 ' HE2' ' HB2' ' A' ' 81' ' ' CYS . 76.7 m-85 -99.71 140.35 34.05 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.579 -0.897 . . . . 72.54 108.579 -175.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.553 ' HB2' ' HB3' ' A' ' 154' ' ' ALA . 45.5 m-85 -131.84 150.04 52.27 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 107.953 -1.128 . . . . 74.21 107.953 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.2 tt -124.13 141.05 45.65 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 107.948 -1.13 . . . . 75.11 107.948 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.32 138.61 47.69 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 124.014 0.822 . . . . 62.41 111.904 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 49.0 tt0 -43.31 -54.21 4.77 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.178 0.991 . . . . 74.4 112.18 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -64.24 -38.35 90.74 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.9 0.75 . . . . 64.3 111.29 -172.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.03 -44.25 97.11 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.717 0.807 . . . . 14.42 110.924 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.19 -16.28 56.8 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.401 1.08 . . . . 64.11 113.215 -172.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 42.3 mt-10 -64.27 -31.41 72.61 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.775 0.43 . . . . 73.32 111.693 179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 146.19 51.86 0.03 OUTLIER Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.739 -0.944 . . . . 35.04 110.739 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.72 -170.18 2.96 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.778 0.831 . . . . 74.54 110.314 -173.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.494 ' HB3' HG23 ' A' ' 9' ' ' THR . 12.7 tp10 -51.18 142.83 11.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.461 1.104 . . . . 72.34 111.53 173.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -50.98 -26.46 6.04 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 115.779 1.77 . . . . 71.12 115.779 -172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 70.66 176.54 21.43 Favored Glycine 0 N--CA 1.47 0.963 0 O-C-N 123.051 0.219 . . . . 73.45 112.902 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.07 127.16 33.33 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 106.758 -1.571 . . . . 63.43 106.758 170.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 155' ' ' ILE . 67.9 t -74.63 113.7 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 109.322 -0.622 . . . . 65.22 109.322 -178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 139' ' ' PHE . . . -64.81 97.09 0.2 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.62 1.168 . . . . 73.22 109.654 174.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.659 HG21 HD21 ' A' ' 127' ' ' LEU . 85.2 mt -88.15 102.73 12.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 108.538 -0.912 . . . . 75.13 108.538 -172.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.629 HD12 HD11 ' A' ' 68' ' ' ILE . 41.0 mm -95.56 114.29 31.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 CA-C-N 116.255 -0.43 . . . . 54.31 109.967 -172.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.71 130.18 54.89 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 114.406 -1.27 . . . . 74.2 108.313 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 1.3 p90 -83.12 124.41 30.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.992 -1.484 . . . . 62.44 106.992 173.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -116.14 135.74 53.65 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 107.635 -1.246 . . . . 64.14 107.635 -171.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -98.11 115.39 28.18 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.032 -0.729 . . . . 44.14 109.032 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.6 107.64 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 108.952 -0.759 . . . . 73.31 108.952 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 63.97 30.63 14.1 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.416 1.086 . . . . 64.12 110.734 -175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.94 25.03 75.71 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 115.59 -0.732 . . . . 54.42 113.038 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.1 m -108.34 134.85 50.58 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.612 0.765 . . . . 61.23 109.129 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -73.14 111.43 8.25 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.888 -0.782 . . . . 73.44 108.888 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.422 HG11 ' HE2' ' A' ' 31' ' ' LYS . 27.0 m -128.63 88.07 53.16 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-O 121.845 0.831 . . . . 74.15 108.98 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 80.6 Cg_exo -55.37 121.4 9.86 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.788 2.325 . . . . 71.4 111.989 168.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.6 t -115.28 140.07 49.42 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.347 1.059 . . . . 71.24 109.098 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.7 tp -91.75 114.54 27.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 124.712 1.205 . . . . 73.41 108.967 176.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 81.1 mtp -93.84 123.04 36.93 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 107.568 -1.271 . . . . 61.35 107.568 178.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.578 HD13 HG21 ' A' ' 176' ' ' ILE . 94.0 mt -132.84 141.26 48.36 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.629 1.572 . . . . 64.24 107.511 -177.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.2 p -80.87 133.7 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 108.471 -0.937 . . . . 71.33 108.471 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -66.29 -19.62 65.87 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.431 0.692 . . . . 75.41 112.254 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -78.38 -30.43 47.9 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.768 0.318 . . . . 71.42 111.48 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.569 ' HB1' ' HE1' ' A' ' 8' ' ' PHE . . . -104.21 -10.16 18.11 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.092 0.557 . . . . 72.31 111.678 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.578 HG21 HD13 ' A' ' 171' ' ' LEU . 36.1 mm -126.25 108.34 19.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.787 -1.561 . . . . 62.31 106.787 171.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.2 mm -95.04 113.18 28.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.288 -0.869 . . . . 73.35 109.596 -169.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.37 135.84 44.31 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.434 -1.321 . . . . 75.23 107.434 166.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.616 ' HB3' HG23 ' A' ' 3' ' ' ILE . 36.9 tt0 -149.19 134.74 18.59 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.818 0.342 . . . . 73.12 110.235 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.588 ' HE3' HD11 ' A' ' 182' ' ' LEU . 37.8 tttp -81.14 112.42 18.48 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.45 -0.945 . . . . 61.31 108.45 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.75 92.36 3.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.887 -0.783 . . . . 65.24 108.887 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.588 HD11 ' HE3' ' A' ' 180' ' ' LYS . 48.1 mt -98.74 152.96 19.11 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.094 0.558 . . . . 53.22 110.88 -174.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 CA--C 1.557 1.222 0 C-N-CA 122.892 0.477 . . . . 71.24 110.389 178.577 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 108.924 -0.769 . . . . 75.24 108.924 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.516 HD12 ' SD ' ' A' ' 20' ' ' MET . 84.0 mt -133.16 153.07 51.86 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.143 -0.688 . . . . 61.25 109.143 175.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.626 HG23 ' HB3' ' A' ' 179' ' ' GLU . 4.4 tt -114.49 116.74 53.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 106.906 -1.516 . . . . 55.32 106.906 173.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 5.2 m-85 -100.97 130.93 47.04 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.26 -1.385 . . . . 73.3 107.26 -174.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -118.96 161.7 19.76 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.289 1.036 . . . . 71.32 109.638 -174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 10' ' ' ASP . 35.3 t70 -116.02 178.06 4.46 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.383 1.073 . . . . 65.13 109.743 178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.96 -39.27 79.59 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 CA-C-O 121.348 0.594 . . . . 71.54 110.306 169.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -110.93 -55.25 2.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.679 1.192 . . . . 63.32 110.002 -168.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.495 ' HB ' HD23 ' A' ' 13' ' ' LEU . 3.7 m -90.06 15.74 9.6 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 113.755 -1.566 . . . . 72.44 111.234 -168.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.549 ' HB3' ' O ' ' A' ' 6' ' ' ASP . 6.7 p-10 -63.2 -7.11 5.21 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 114.603 1.334 . . . . 75.35 114.603 -177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -48.82 -50.98 31.93 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.403 1.064 . . . . 72.23 111.393 -176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -123.35 -40.54 2.36 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.017 0.927 . . . . 72.11 109.144 164.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.495 HD23 ' HB ' ' A' ' 9' ' ' THR . 2.0 tm? 42.9 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.294 1.837 . . . . 73.23 111.67 -167.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.406 ' HB2' ' CE2' ' A' ' 18' ' ' PHE . 67.1 p -155.26 154.49 32.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.66 0.784 . . . . 51.15 110.783 175.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 48.1 m -163.16 96.35 0.88 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.959 0.904 . . . . 73.21 110.468 -171.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -179.16 172.77 1.21 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.612 1.165 . . . . 63.31 108.912 175.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -38.8 -55.1 1.55 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.466 1.106 . . . . 73.21 111.355 165.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 14' ' ' SER . 9.7 m-30 43.07 108.29 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 125.924 1.69 . . . . 71.43 114.84 174.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -58.92 121.04 9.29 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 121.951 1.767 . . . . 75.11 110.951 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.516 ' SD ' HD12 ' A' ' 2' ' ' LEU . 44.4 mtm -101.28 150.45 22.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.128 0.971 . . . . 72.42 109.718 -173.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -156.76 134.27 10.74 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.113 -0.699 . . . . 71.44 109.113 171.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.0 tp -113.73 122.55 47.44 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.18 -1.045 . . . . 44.44 108.18 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -112.52 135.19 52.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.465 0.706 . . . . 71.42 110.082 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t70 60.5 14.18 4.66 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.678 1.191 . . . . 71.15 112.536 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 48.58 33.84 4.47 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.547 1.139 . . . . 74.24 111.67 -171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 119' ' ' LYS . 32.8 tp -125.81 -52.47 1.56 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.236 -0.893 . . . . 72.13 109.632 -175.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.1 t -114.13 128.9 70.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.281 -0.872 . . . . 71.23 109.226 -168.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -85.88 112.84 21.52 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 106.829 -1.545 . . . . 65.22 106.829 166.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -104.43 145.06 30.81 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.175 -0.676 . . . . 62.15 109.175 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -142.93 105.48 4.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.484 1.114 . . . . 72.42 108.411 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -83.67 149.22 26.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.348 0.659 . . . . 65.4 110.415 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.97 -161.76 9.53 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 114.88 -1.055 . . . . 74.14 111.262 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 139.83 51.02 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.76 0.824 . . . . 72.14 109.891 -179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -73.76 115.81 13.63 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 114.71 -1.132 . . . . 74.51 109.236 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.5 m -147.45 -175.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.721 1.208 . . . . 71.21 109.792 -170.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.482 HG22 ' HB3' ' A' ' 44' ' ' LEU . 26.0 m -113.16 161.05 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 123.448 0.699 . . . . 72.31 110.909 173.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 60.6 ttt180 -136.3 112.18 9.55 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.666 1.186 . . . . 72.42 108.366 174.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HD2' HG22 ' A' ' 64' ' ' VAL . 52.0 tttm -135.66 96.73 3.5 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 47.7 -81.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 126.326 1.851 . . . . 74.52 112.987 -173.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.15 26.13 0.31 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.856 -0.898 . . . . 71.41 110.856 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -134.32 98.14 4.02 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 125.689 1.596 . . . . 45.44 107.182 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.476 HD12 HD23 ' A' ' 44' ' ' LEU . 7.7 pt -131.39 136.86 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.215 0.531 . . . . 71.23 110.99 -176.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.78 49.42 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.578 1.151 . . . . 62.33 108.389 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.482 ' HB3' HG22 ' A' ' 36' ' ' VAL . 1.1 pp -57.0 143.05 39.65 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.331 -1.304 . . . . 61.24 111.684 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.0 -10.42 55.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.726 -0.67 . . . . 73.4 110.486 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.58 -105.42 0.42 Allowed Glycine 0 C--N 1.362 2.026 0 N-CA-C 110.591 -1.004 . . . . 74.41 110.591 -171.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.3 t -80.35 95.57 6.41 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 106.96 -1.496 . . . . 73.5 106.96 167.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -65.29 112.14 7.69 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 123.776 0.831 . . . . 74.31 110.626 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.26 117.51 4.4 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.697 2.265 . . . . 62.15 112.385 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.1 t 58.22 85.18 0.09 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.657 1.183 . . . . 72.53 111.25 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.06 98.33 8.59 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.225 -0.657 . . . . 61.54 109.225 177.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.93 -14.25 60.62 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.976 -1.011 . . . . 74.44 112.075 -176.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 55' ' ' ALA . 10.2 tp10 -136.25 -82.88 0.38 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.505 0.322 . . . . 75.13 111.089 -178.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.97 23.27 67.49 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 123.022 0.201 . . . . 72.42 113.515 -175.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.513 ' H ' ' HG3' ' A' ' 53' ' ' GLU . . . -138.07 37.26 2.34 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.792 0.837 . . . . 64.23 110.794 -173.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.87 -19.56 60.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.758 0.823 . . . . 74.32 112.13 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 63.73 24.92 14.02 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.139 1.376 . . . . 55.14 112.113 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.1 t70 62.78 90.83 0.07 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.496 1.119 . . . . 74.5 110.398 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.36 14.56 1.44 Allowed Glycine 0 N--CA 1.477 1.419 0 CA-C-O 120.327 -0.152 . . . . 31.23 113.085 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.7 m -150.15 25.88 0.8 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.482 1.113 . . . . 61.43 108.492 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -122.47 39.42 3.92 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.884 1.274 . . . . 74.44 109.979 -168.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -50.54 -46.51 57.48 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.771 1.228 . . . . 74.5 111.74 -177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -133.47 23.54 4.05 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.562 0.745 . . . . 74.23 110.37 173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.41 HG22 ' HD2' ' A' ' 38' ' ' LYS . 46.2 t -106.73 97.91 6.25 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 109.157 -0.683 . . . . 55.12 109.157 173.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 6.8 mp0 -78.26 82.06 4.59 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.313 -0.995 . . . . 73.34 108.313 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -76.11 146.37 39.33 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.982 -0.747 . . . . 75.34 108.982 168.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.33 -136.7 5.54 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.644 -0.582 . . . . 61.21 111.644 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.784 HD11 HD12 ' A' ' 70' ' ' ILE . 2.1 tt -104.31 126.17 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.627 1.171 . . . . 41.34 109.026 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -53.26 -29.46 33.06 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.188 1.395 . . . . 64.03 113.502 -172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.784 HD12 HD11 ' A' ' 68' ' ' ILE . 56.5 mt -61.53 -44.87 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.428 1.091 . . . . 53.02 110.048 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 76' ' ' LEU . 44.0 t -74.68 -41.79 47.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.646 0 CA-C-N 114.179 -1.373 . . . . 73.14 110.268 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 35.2 mt -67.2 -24.09 65.81 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 123.668 0.605 . . . . 72.23 110.914 -178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -62.36 -61.11 2.68 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.635 1.174 . . . . 60.31 110.513 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -87.01 -20.17 27.61 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.729 0.812 . . . . 72.32 111.227 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 41.2 ttmt 66.38 69.62 0.42 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.042 1.337 . . . . 73.45 109.124 -168.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.586 ' HB2' HG13 ' A' ' 71' ' ' VAL . 70.4 mt -80.44 136.34 36.32 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.255 -1.017 . . . . 62.42 108.255 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -84.91 130.28 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.09 -0.707 . . . . 74.51 109.09 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.47 148.54 37.28 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.039 . . . . 72.1 112.59 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 56.2 ttp -148.69 134.42 18.85 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.239 -1.346 . . . . 65.42 107.657 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 -119.09 142.69 47.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.091 0.556 . . . . 43.02 109.645 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.6 -11.92 48.59 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.711 0.805 . . . . 52.41 111.753 170.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -80.25 -34.63 36.95 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.973 0.909 . . . . 65.11 111.424 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -103.06 -37.22 7.86 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.172 0.511 . . . . 54.14 110.635 -173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.4 20.4 16.73 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.315 1.046 . . . . 71.11 111.925 -169.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -44.77 -43.48 8.61 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.748 1.219 . . . . 71.12 113.57 -173.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.3 t -65.62 -52.04 55.0 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.057 0.943 . . . . 63.53 111.353 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.457 ' N ' ' SD ' ' A' ' 87' ' ' MET . 1.1 mpt? -68.63 -42.29 78.25 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.967 0.907 . . . . 62.33 110.688 -173.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.465 ' HE1' HG11 ' A' ' 153' ' ' VAL . 51.5 t80 -63.04 -41.87 99.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.766 1.226 . . . . 73.34 111.236 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -65.28 -36.56 84.47 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.212 0.605 . . . . 73.23 110.637 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.68 -38.79 87.52 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.787 -0.642 . . . . 64.22 110.307 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -65.03 -45.63 84.66 Favored 'General case' 0 C--O 1.193 -1.874 0 CA-C-O 118.571 -0.728 . . . . 75.31 110.808 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.5 mm -58.25 -43.08 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 123.36 0.664 . . . . 64.44 111.67 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -60.81 -49.07 78.96 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.702 0.801 . . . . 71.42 111.26 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -79.5 -38.25 34.85 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.256 0.622 . . . . 71.32 111.173 -173.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -50.99 -53.75 30.51 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 125.632 1.573 . . . . 74.13 110.387 170.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 54.9 ttp -53.79 -55.87 22.62 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 124.184 0.927 . . . . 74.4 110.14 175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.36 -36.67 66.57 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.48 1.112 . . . . 63.14 112.186 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -83.09 -41.53 18.47 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.026 0.931 . . . . 71.41 111.936 -169.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -76.88 -27.74 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.673 0.389 . . . . 62.21 111.916 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.467 HD13 ' HG3' ' A' ' 117' ' ' LYS . 84.8 mt -73.05 -36.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.312 0.645 . . . . 64.5 109.303 171.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -62.59 -44.89 95.19 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.892 0.877 . . . . 65.22 110.562 172.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -63.2 -44.44 95.36 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.666 -0.697 . . . . 64.12 110.106 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.494 ' HG2' ' HB2' ' A' ' 107' ' ' ASN . 22.9 ttt -66.82 -40.05 87.91 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.258 -0.883 . . . . 64.32 111.329 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.562 ' HA ' HG11 ' A' ' 113' ' ' VAL . 7.6 tp10 -55.27 -40.67 71.27 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.563 1.145 . . . . 64.25 111.556 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -37.3 74.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.085 -0.961 . . . . 65.11 111.439 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -115.07 0.74 13.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.16 0.584 . . . . 64.34 111.62 -172.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 103' ' ' MET . 18.3 m120 -148.7 41.99 0.96 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.257 1.023 . . . . 63.52 109.22 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.73 10.68 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.697 1.599 . . . . 61.42 113.632 175.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.69 -24.37 21.64 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.934 1.294 . . . . 72.45 112.005 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? 89.72 -58.01 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.666 1.986 . . . . 74.4 112.483 169.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.09 -20.91 63.18 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 118.1 0.409 . . . . 55.1 110.933 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -77.01 -45.89 25.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.09 0.956 . . . . 54.1 111.049 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 104' ' ' GLU . 8.0 m -76.03 -26.92 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.716 0.406 . . . . 74.42 111.571 177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -70.43 -36.37 73.93 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.447 0.699 . . . . 72.45 110.345 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.96 -41.93 81.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.701 -0.681 . . . . 74.34 110.399 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.485 ' CG ' ' SD ' ' A' ' 103' ' ' MET . 79.3 t80 -63.07 -41.99 99.57 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.444 1.098 . . . . 55.33 110.331 175.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.467 ' HG3' HD13 ' A' ' 100' ' ' ILE . 35.5 ttpt -63.9 -38.29 90.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.133 0.973 . . . . 72.42 110.478 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -67.19 -41.5 85.75 Favored 'General case' 0 C--N 1.351 0.671 0 C-N-CA 123.884 0.874 . . . . 70.31 110.005 177.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.596 ' HB3' HD22 ' A' ' 26' ' ' LEU . 87.9 mttt -67.24 -39.8 86.21 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.415 -0.811 . . . . 75.24 111.034 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.424 ' O ' HG22 ' A' ' 124' ' ' VAL . 23.3 mm -67.72 -47.05 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.468 0.707 . . . . 72.13 109.731 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -51.9 -51.83 54.13 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.666 1.186 . . . . 75.4 110.41 176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.76 -38.12 89.35 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 114.776 -1.102 . . . . 64.22 113.567 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -65.43 -54.83 22.9 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.354 0.662 . . . . 64.34 110.463 -177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.5 m -66.5 -42.04 89.51 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 118.35 -0.833 . . . . 64.22 111.208 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.5 p -63.47 -35.98 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 119.505 1.048 . . . . 71.11 110.871 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.1 t -74.3 -38.01 63.49 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 123.481 0.712 . . . . 64.21 110.956 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.7 tp -82.39 -19.04 39.9 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.787 0.835 . . . . 71.33 111.128 -175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 81.4 mt -93.7 2.22 56.35 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.142 0.577 . . . . 74.41 111.398 174.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.31 91.58 0.25 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-O 121.326 0.584 . . . . 64.11 109.843 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -59.12 -8.28 1.47 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.336 1.455 . . . . 75.22 114.685 -168.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.32 -46.59 72.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.928 0.891 . . . . 75.55 110.333 176.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -109.29 -39.09 5.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.964 0.906 . . . . 75.1 110.435 172.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -79.23 -1.89 38.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.595 1.158 . . . . 70.42 113.248 -163.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -51.89 -24.75 6.71 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 122.858 0.463 . . . . 64.41 111.615 160.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -93.92 29.63 2.05 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.753 1.221 . . . . 64.31 110.351 -177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.3 mt -94.02 153.43 18.18 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.919 -0.771 . . . . 73.11 108.919 166.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -121.58 117.42 26.72 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.272 -1.381 . . . . 72.12 107.272 172.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.57 ' HD1' HG22 ' A' ' 155' ' ' ILE . 50.1 m-85 -94.12 140.78 29.32 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.142 -1.058 . . . . 65.24 108.142 -176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 83.6 m-85 -136.46 153.81 50.95 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.774 -0.454 . . . . 74.32 109.774 -176.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.5 tt -143.71 149.63 17.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.857 -1.164 . . . . 73.52 107.857 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -57.08 123.94 34.15 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.293 -0.723 . . . . 73.31 111.293 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -55.22 -34.01 63.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.825 0.85 . . . . 70.14 112.499 -177.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -66.39 -43.13 86.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.963 0.905 . . . . 75.21 110.196 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.75 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -63.24 -35.62 80.94 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 115.312 -0.858 . . . . 65.31 110.189 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.46 -12.43 57.84 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 64.1 112.143 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -95.63 -40.74 9.26 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.356 0.662 . . . . 55.44 111.065 -173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.18 49.62 0.28 Allowed Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.126 -0.488 . . . . 74.32 112.588 -176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.75 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -158.22 -179.77 8.42 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.696 0.798 . . . . 62.22 109.91 175.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -132.7 155.35 48.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.102 0.561 . . . . 71.35 111.055 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 67.61 20.38 9.65 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.078 1.351 . . . . 64.15 113.315 171.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -55.72 144.73 33.87 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.118 0.261 . . . . 72.5 112.868 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -69.93 139.55 52.93 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.767 0.827 . . . . 64.43 112.302 -168.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.465 HG11 ' HE1' ' A' ' 88' ' ' PHE . 31.7 t -88.51 94.19 4.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 CA-C-N 115.578 -0.737 . . . . 75.12 109.544 174.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.15 104.24 1.39 Allowed 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.158 -0.928 . . . . 75.41 108.588 169.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.57 HG22 ' HD1' ' A' ' 138' ' ' PHE . 1.1 pt -95.12 113.68 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 121.421 0.629 . . . . 61.13 109.919 -168.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.473 HD13 ' HA ' ' A' ' 169' ' ' LEU . 50.8 mm -107.09 133.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.8 -1.091 . . . . 61.22 110.207 -170.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 167' ' ' PRO . 45.7 mt-10 -94.41 142.26 27.63 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.861 -0.792 . . . . 61.54 108.861 166.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -119.92 87.15 2.69 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 106.004 -1.85 . . . . 70.14 106.004 155.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 165' ' ' GLU . 17.9 ttt180 -95.32 170.2 9.54 Favored 'General case' 0 C--O 1.209 -1.065 0 CA-C-N 113.9 -1.5 . . . . 74.42 109.06 -171.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -98.12 124.97 42.93 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.552 1.069 . . . . 75.11 111.956 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.4 p -129.88 105.76 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.611 1.164 . . . . 73.42 108.466 167.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.4 t70 63.68 5.52 2.25 Favored 'General case' 0 CA--C 1.567 1.615 0 C-N-CA 124.729 1.212 . . . . 75.5 112.695 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.35 -18.16 8.88 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.449 -0.639 . . . . 74.53 114.077 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 10.0 t -101.11 167.33 10.29 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 117.789 0.794 . . . . 71.45 109.609 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 159' ' ' ARG . 1.2 pm0 -94.72 126.79 40.26 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.99 0.516 . . . . 64.11 112.105 -172.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 t -78.79 107.54 6.18 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.305 1.042 . . . . 72.35 108.979 166.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 157' ' ' GLU . 3.0 Cg_endo -87.97 112.5 0.77 Allowed 'Trans proline' 0 CA--C 1.548 1.213 0 C-N-CA 122.712 2.275 . . . . 65.3 109.988 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 52.3 m -126.31 118.21 24.61 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.811 0.444 . . . . 74.54 111.037 -174.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.473 ' HA ' HD13 ' A' ' 156' ' ' ILE . 53.0 tp -78.92 134.28 36.88 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.109 -0.7 . . . . 71.43 109.109 166.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.524 ' HB2' HG13 ' A' ' 155' ' ' ILE . 65.7 mtt -124.37 138.44 54.37 Favored 'General case' 0 C--O 1.251 1.161 0 N-CA-C 107.885 -1.154 . . . . 74.12 107.885 165.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.509 HD13 HD11 ' A' ' 176' ' ' ILE . 53.5 mt -152.16 150.85 30.31 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.098 1.759 . . . . 73.42 106.789 169.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.8 p -78.76 149.1 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.599 -0.889 . . . . 72.32 108.599 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -63.6 -31.58 72.79 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.321 0.649 . . . . 71.45 110.214 -177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 103' ' ' MET . 67.6 mm-40 -76.97 -3.37 38.54 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.504 0.928 . . . . 73.31 113.504 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -98.72 -25.13 14.78 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.965 0.506 . . . . 50.33 110.065 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.509 HD11 HD13 ' A' ' 171' ' ' LEU . 48.3 mm -106.52 125.28 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.422 0.689 . . . . 51.41 110.866 -170.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.0 mm -110.22 109.36 28.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.59 -1.263 . . . . 52.42 107.59 174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -83.61 111.5 19.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.068 -0.969 . . . . 70.41 108.657 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.626 ' HB3' HG23 ' A' ' 3' ' ' ILE . 8.8 tp10 -95.11 130.44 41.81 Favored 'General case' 0 C--O 1.248 0.98 0 N-CA-C 109.394 -0.595 . . . . 71.41 109.394 -177.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -71.87 108.58 5.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.141 -0.936 . . . . 74.22 109.797 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.9 t -94.32 89.82 6.05 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.465 0.706 . . . . 71.0 110.011 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -122.86 -61.18 1.46 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.022 0.929 . . . . 44.34 109.267 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 123.846 0.858 . . . . 74.33 109.597 -178.818 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.609 ' SD ' ' HA ' ' A' ' 16' ' ' ASP . 45.2 tpp . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.438 -0.579 . . . . 73.13 109.438 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 18' ' ' PHE . 79.3 mt -118.47 152.96 34.93 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.689 -0.856 . . . . 74.11 108.689 174.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.0 pt -131.99 121.08 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 108.563 -0.903 . . . . 70.12 108.563 176.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 23.1 p90 -122.15 135.58 54.8 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 121.58 -0.7 . . . . 45.34 109.946 175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 177' ' ' ILE . 46.4 mtpt -137.72 135.09 36.09 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.839 -1.528 . . . . 70.41 109.448 -159.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.94 144.32 36.92 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.298 -0.631 . . . . 54.33 109.298 173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.3 pt -69.23 -26.42 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 113.475 0.917 . . . . 74.12 113.475 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -96.72 -67.85 0.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 114.238 1.199 . . . . 74.2 114.238 -170.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -130.38 -22.45 2.76 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.462 0.912 . . . . 74.52 113.462 -170.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.57 23.15 13.1 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.458 1.103 . . . . 60.52 109.74 -169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.26 -15.29 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 125.574 1.55 . . . . 71.2 114.286 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -76.24 -40.45 51.99 Favored 'General case' 0 CA--C 1.555 1.171 0 O-C-N 121.55 -0.718 . . . . 75.34 111.78 174.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' TYR . 37.4 mt 21.18 -89.21 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 126.455 1.902 . . . . 73.05 113.813 -169.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.5 m -152.14 123.03 7.5 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 111.782 0.289 . . . . 72.32 111.782 -177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 21.6 m -113.01 94.66 5.0 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.595 1.158 . . . . 73.22 110.538 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.609 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 26.7 t70 -168.97 166.17 11.21 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.95 0.9 . . . . 64.34 109.668 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 m -70.32 78.43 0.54 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.527 0.731 . . . . 65.21 110.334 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 16' ' ' ASP . 32.1 m-85 -104.21 146.7 33.06 Favored Pre-proline 0 N--CA 1.482 1.158 0 C-N-CA 124.784 1.233 . . . . 45.3 110.673 -174.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -71.38 118.9 5.91 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.52 2.147 . . . . 73.34 112.603 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.7 ptm -113.4 145.68 40.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.342 0.657 . . . . 64.13 109.927 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' HG3' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -151.47 137.64 18.35 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.235 -0.654 . . . . 63.45 109.235 174.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.1 tp -99.53 148.53 24.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.386 1.074 . . . . 75.44 108.232 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.11 134.25 47.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 C-N-CA 124.074 0.95 . . . . 71.13 109.375 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t70 59.51 16.47 5.29 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.945 1.298 . . . . 62.01 112.53 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 54.61 32.73 17.69 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.509 1.523 . . . . 60.25 112.542 -174.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 119' ' ' LYS . 55.2 tp -132.23 -50.97 0.94 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.226 0.61 . . . . 74.02 111.033 -173.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.4 t -119.39 141.92 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.319 0.648 . . . . 71.34 109.819 -169.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.69 113.24 24.7 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.586 -0.894 . . . . 72.12 108.586 167.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HG3' ' HB3' ' A' ' 21' ' ' LYS . 6.0 pt-20 -82.88 104.08 12.83 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.007 -1.479 . . . . 61.34 107.007 166.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.581 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.0 t80 -88.88 112.67 23.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.94 -1.504 . . . . 71.42 106.94 177.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -67.2 148.88 51.21 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.912 0.885 . . . . 71.11 110.969 -171.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.95 157.78 27.51 Favored Glycine 0 C--N 1.342 0.864 0 O-C-N 123.496 0.497 . . . . 63.31 113.575 -174.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -121.26 140.23 52.34 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.311 -0.996 . . . . 73.11 108.311 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -74.33 116.78 15.39 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 107.001 -1.481 . . . . 74.45 107.001 167.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG23 HD12 ' A' ' 72' ' ' LEU . 34.4 m -131.08 -166.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.851 0 C-N-CA 124.545 1.138 . . . . 75.12 108.398 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG22 HD13 ' A' ' 44' ' ' LEU . 32.0 m -125.86 153.93 34.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.814 0.846 . . . . 75.3 109.655 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.536 ' HB2' HD13 ' A' ' 72' ' ' LEU . 12.9 ttp180 -141.53 110.26 6.1 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.071 0.462 . . . . 74.55 110.945 170.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HG3' ' H ' ' A' ' 40' ' ' GLY . 51.9 tptt -133.94 137.99 45.2 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 107.585 -1.265 . . . . 72.54 107.585 169.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -9.89 15.07 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.039 0.755 . . . . 65.3 113.039 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' A' ' 38' ' ' LYS . . . -106.83 -38.65 2.15 Favored Glycine 0 C--N 1.346 1.108 0 N-CA-C 112.303 -0.319 . . . . 60.43 112.303 170.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -121.27 138.3 54.3 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.179 0.592 . . . . 74.11 112.321 -167.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp -125.18 3.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 123.927 0.891 . . . . 61.02 110.405 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -63.16 114.08 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.301 0.641 . . . . 62.3 110.875 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.426 HD22 ' H ' ' A' ' 44' ' ' LEU . 1.4 mm? -66.26 96.45 0.34 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.179 -0.675 . . . . 71.1 109.179 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.6 -48.18 72.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.541 1.137 . . . . 55.41 111.578 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.17 35.75 88.7 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.333 -0.848 . . . . 44.02 112.893 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.6 t -110.95 169.65 8.62 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.808 0.843 . . . . 75.52 110.713 -174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -62.38 148.68 89.47 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.641 0.776 . . . . 71.52 112.022 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.29 103.82 0.11 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 123.28 2.653 . . . . 75.01 110.822 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.8 p -79.15 12.76 2.12 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.241 0.83 . . . . 72.14 113.241 -167.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 64.27 76.38 0.35 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 123.731 0.813 . . . . 72.43 109.517 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.459 ' HB2' ' HE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -137.28 23.44 2.98 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.481 -1.236 . . . . 73.01 110.759 -167.019 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.59 28.37 0.77 Allowed 'General case' 0 CA--C 1.555 1.156 0 CA-C-N 115.076 -0.966 . . . . 73.42 110.69 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.46 -12.19 69.35 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.234 -0.759 . . . . 74.15 114.497 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . 74.07 -71.37 0.13 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.817 1.247 . . . . 74.34 111.614 175.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -77.74 84.48 4.07 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.418 0.628 . . . . 62.34 109.439 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -155.91 131.5 9.65 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.233 -1.025 . . . . 73.34 108.233 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 63' ' ' HIS . 18.1 m-20 60.94 28.7 18.47 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.397 1.079 . . . . 64.55 111.862 -175.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.72 -92.78 1.12 Allowed Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.4 -0.818 . . . . 62.33 111.536 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.2 t -94.36 -158.25 0.62 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.791 1.236 . . . . 65.05 109.635 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -74.43 17.81 0.18 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.451 0.7 . . . . 72.42 112.727 178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.47 -29.49 58.83 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.99 0.516 . . . . 62.3 109.897 168.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 58' ' ' ASP . 34.2 t-80 -82.79 70.76 9.84 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.659 -0.7 . . . . 71.42 109.876 171.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.4 t -80.77 -67.89 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 N-CA-C 107.233 -1.395 . . . . 64.34 107.233 165.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . 0.252 2.1 pt-20 68.7 -45.85 0.54 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 127.694 2.398 . . . . 74.52 113.528 178.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -134.15 146.35 50.12 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 108.398 -0.964 . . . . 60.34 108.398 -173.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.25 -171.57 44.65 Favored Glycine 0 N--CA 1.447 -0.58 0 O-C-N 123.604 0.565 . . . . 55.03 112.259 169.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.802 HD11 HD12 ' A' ' 70' ' ' ILE . 1.8 tt -94.82 130.1 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 108.219 -1.03 . . . . 70.01 108.219 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -47.97 -40.67 23.03 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.753 1.621 . . . . 71.23 113.416 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.802 HD12 HD11 ' A' ' 68' ' ' ILE . 62.4 mt -55.36 -47.88 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.741 1.216 . . . . 71.32 110.666 178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.1 -48.63 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.405 0.682 . . . . 74.53 111.713 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' A' ' 37' ' ' ARG . 63.0 mt -60.83 -33.91 73.75 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.094 0.871 . . . . 74.51 111.092 -175.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -79.35 -48.65 13.68 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.169 0.987 . . . . 75.43 111.16 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -87.15 1.78 51.97 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 122.91 0.484 . . . . 75.03 111.612 -172.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 142' ' ' GLU . 70.5 mmtt 64.38 34.86 10.11 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.833 1.253 . . . . 73.43 111.165 173.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.2 mt -75.51 132.71 40.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.205 -0.665 . . . . 53.24 109.205 -175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 p -84.64 133.46 29.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.269 0 N-CA-C 109.883 -0.414 . . . . 72.43 109.883 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.79 140.34 45.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.157 1.383 . . . . 70.23 112.677 -175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.1 tpt -148.06 131.55 16.72 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 108.505 -0.924 . . . . 71.43 108.505 170.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 45.2 m-80 -88.0 137.57 32.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.816 0.446 . . . . 63.15 110.491 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 9.1 p -57.74 -30.75 65.83 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.501 1.521 . . . . 74.43 111.204 172.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.427 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 47.1 m-85 -59.51 -34.58 72.8 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 113.673 -1.603 . . . . 73.24 110.832 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -104.46 -18.59 14.33 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.752 0.821 . . . . 75.13 111.829 177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -112.69 14.98 20.09 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.261 0.624 . . . . 72.24 112.143 -169.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.89 -53.96 50.86 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 118.563 0.62 . . . . 75.52 112.213 -174.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.7 t -70.5 -36.54 73.86 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.345 0.658 . . . . 65.31 110.745 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 94.0 mmm -62.39 -38.39 89.41 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.273 0.629 . . . . 73.43 110.846 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 76.4 t80 -78.95 -25.45 43.54 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.707 0.803 . . . . 72.32 110.627 -176.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -62.94 -41.79 99.6 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.951 -0.759 . . . . 75.03 108.951 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.77 -41.4 75.22 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 74.32 111.05 175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 23.2 m-85 -61.37 -37.98 85.34 Favored 'General case' 0 C--N 1.364 1.205 0 CA-C-O 119.506 -0.283 . . . . 72.21 110.48 177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.785 HG21 HD11 ' A' ' 128' ' ' LEU . 14.8 mm -66.47 -41.67 89.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 124.061 0.851 . . . . 74.14 111.876 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -61.88 -38.4 88.16 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 118.89 0.768 . . . . 75.33 110.204 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.82 -45.22 68.35 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.457 -0.792 . . . . 72.11 110.431 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.407 ' HB3' ' HA ' ' A' ' 92' ' ' ILE . 84.6 t80 -55.76 -57.31 12.53 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.738 1.615 . . . . 63.43 111.621 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.2 ptm -63.97 -31.64 72.9 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.493 0.717 . . . . 70.52 110.693 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -61.5 -58.55 7.72 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.867 -0.42 . . . . 73.13 109.867 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.5 -27.38 62.22 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.336 -0.847 . . . . 71.01 112.223 -168.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 174' ' ' GLU . 22.5 m -75.2 -38.46 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 117.697 0.226 . . . . 72.02 111.326 175.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' HE2' ' A' ' 103' ' ' MET . 55.4 mt -69.31 -38.05 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 110.324 -0.25 . . . . 73.53 110.324 176.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 -46.4 88.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.017 0.527 . . . . 70.12 110.685 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -53.23 -56.01 19.9 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.129 0.971 . . . . 64.05 111.057 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.439 ' HE1' ' O ' ' A' ' 113' ' ' VAL . 19.4 ptt? -64.63 -45.49 86.61 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.086 0.866 . . . . 64.2 111.346 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -62.1 -40.05 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.142 0.977 . . . . 75.55 111.529 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -62.8 -27.1 69.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.993 0.917 . . . . 65.3 113.177 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -116.26 -6.91 11.83 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 112.139 0.422 . . . . 72.02 112.139 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.83 -64.67 1.04 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.52 -0.919 . . . . 71.51 108.52 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 74.35 -26.99 0.19 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.09 1.356 . . . . 70.51 112.166 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.65 125.8 29.87 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 123.658 0.783 . . . . 64.23 109.747 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.94 -23.31 66.59 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.521 1.128 . . . . 74.11 111.248 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.29 -32.18 73.53 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.961 0.904 . . . . 62.31 111.483 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.48 -48.69 6.01 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.584 0.754 . . . . 54.32 110.031 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.439 ' O ' ' HE1' ' A' ' 103' ' ' MET . 27.6 m -75.9 -34.08 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 113.19 0.811 . . . . 70.15 113.19 -169.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.21 -38.98 89.26 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 118.702 0.683 . . . . 74.22 110.254 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.98 -45.49 73.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.016 -0.993 . . . . 74.23 110.786 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.36 -42.03 96.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.74 0.416 . . . . 65.35 110.291 176.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.78 -38.58 75.71 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.727 0.811 . . . . 63.15 110.824 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -68.36 -43.07 78.2 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.411 0.685 . . . . 71.44 110.52 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HB3' HD22 ' A' ' 26' ' ' LEU . 70.3 mmtt -60.12 -55.85 28.88 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.73 0.812 . . . . 75.13 111.134 178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.491 HD13 HG21 ' A' ' 172' ' ' VAL . 10.5 tp -66.97 -31.18 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.488 0.715 . . . . 73.34 110.232 -174.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -55.62 -62.76 1.47 Allowed 'General case' 0 C--N 1.364 1.231 0 C-N-CA 123.041 0.536 . . . . 74.41 110.123 168.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -60.77 -27.45 66.6 Favored Glycine 0 C--N 1.351 1.411 0 O-C-N 123.606 0.567 . . . . 12.13 113.77 -173.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -73.88 -45.17 52.55 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.152 0.581 . . . . 71.55 111.009 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.2 m -77.67 -25.34 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 O-C-N 122.989 0.181 . . . . 61.41 110.892 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.08 -27.58 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.879 -0.513 . . . . 61.12 109.803 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.4 t -76.68 -50.97 12.4 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.367 0.667 . . . . 64.14 110.375 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.523 HD21 HG21 ' A' ' 155' ' ' ILE . 36.8 tp -75.15 -33.02 61.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.296 1.039 . . . . 61.32 112.766 -166.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.785 HD11 HG21 ' A' ' 92' ' ' ILE . 95.9 mt -79.07 2.89 19.08 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.86 0.689 . . . . 70.24 112.86 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.55 143.11 48.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.254 -1.017 . . . . 73.32 108.254 170.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 134' ' ' LYS . 25.8 pttm -57.75 -27.36 62.95 Favored 'General case' 0 C--O 1.212 -0.87 0 O-C-N 124.1 0.875 . . . . 63.22 111.89 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -46.1 87.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.229 1.412 . . . . 72.41 110.59 -178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.477 ' O ' ' HG ' ' A' ' 136' ' ' LEU . 1.5 mpp_? -67.85 -44.33 77.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.596 -1.183 . . . . 65.55 110.115 175.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.492 ' HE1' ' HA ' ' A' ' 128' ' ' LEU . 7.2 m-85 -61.53 -25.76 67.49 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.831 0.853 . . . . 53.24 113.029 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 25.2 mtpp -64.88 -20.43 66.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.859 0.464 . . . . 74.51 111.382 176.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -132.57 17.09 4.36 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.375 0.67 . . . . 71.33 112.154 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 132' ' ' ARG . 44.1 mt -93.07 139.38 30.61 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 118.277 0.489 . . . . 72.1 110.272 172.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -122.16 123.38 41.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.69 -1.226 . . . . 62.23 107.69 168.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -95.38 128.75 42.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.218 0.532 . . . . 71.42 109.684 -176.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -130.65 151.86 50.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.19 -1.041 . . . . 64.42 108.19 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.3 pt -134.0 167.94 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 108.324 -0.991 . . . . 72.53 108.324 168.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.81 144.65 48.2 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.761 -0.536 . . . . 24.11 111.761 176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 75' ' ' LYS . 36.7 tt0 -52.9 -42.71 65.59 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.113 0.565 . . . . 74.24 110.735 173.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.694 HH11 ' HB2' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -60.76 -42.62 97.81 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.309 1.444 . . . . 71.55 110.319 179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.699 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -56.09 -51.68 67.02 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.951 0.9 . . . . 74.33 111.59 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.86 -29.16 61.96 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.455 -0.793 . . . . 72.25 112.4 -176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -74.26 -41.74 60.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.084 0.553 . . . . 72.13 110.856 -171.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.23 62.63 0.08 OUTLIER Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.15 -0.78 . . . . 71.35 111.15 -177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -157.59 175.6 13.72 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.155 0.582 . . . . 73.32 110.865 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.82 170.56 13.38 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.896 0.878 . . . . 64.0 113.16 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -86.09 67.19 9.9 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 124.722 1.209 . . . . 74.2 108.003 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.09 -112.0 0.01 OUTLIER Glycine 0 CA--C 1.54 1.625 0 CA-C-N 113.229 -1.805 . . . . 75.44 114.39 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.38 155.99 17.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.202 0.601 . . . . 73.52 109.558 169.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 85.4 t -103.01 126.55 57.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 108.817 -0.808 . . . . 73.41 108.817 171.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.626 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -69.09 103.84 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 124.127 0.971 . . . . 64.13 109.113 170.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.523 HG21 HD21 ' A' ' 127' ' ' LEU . 63.2 mt -90.68 110.6 22.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.171 -0.677 . . . . 75.04 109.171 -171.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.417 HD12 HD13 ' A' ' 68' ' ' ILE . 51.2 mm -96.91 98.96 8.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-O 121.215 0.531 . . . . 74.02 110.001 -176.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -78.43 96.51 5.38 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.894 -1.15 . . . . 74.31 107.894 169.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 45.0 p90 -107.02 129.12 54.85 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.411 -0.588 . . . . 72.33 109.411 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -154.16 -177.36 6.38 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.473 1.109 . . . . 72.41 109.09 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -122.19 137.52 54.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.43 0.292 . . . . 72.11 110.28 171.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 8.7 p -111.03 111.95 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 N-CA-C 108.22 -1.029 . . . . 72.42 108.22 173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 63.49 17.43 10.34 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.828 1.251 . . . . 54.45 112.367 -175.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 109.18 -19.03 30.22 Favored Glycine 0 C--N 1.352 1.42 0 CA-C-O 120.113 -0.271 . . . . 62.43 112.719 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 59.4 m -82.28 106.94 14.57 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.3 0.55 . . . . 72.01 109.537 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -71.97 101.61 2.74 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.391 1.091 . . . . 71.1 109.922 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 14.7 m -105.6 101.19 30.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 113.627 -1.624 . . . . 71.34 109.348 -177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.629 ' HB2' HD12 ' A' ' 68' ' ' ILE . 92.0 Cg_endo -92.15 118.36 0.45 Allowed 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 122.95 2.433 . . . . 61.34 111.703 172.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 28.1 m -114.43 135.53 54.0 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.129 0.972 . . . . 71.3 109.565 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 38.6 tp -79.61 146.24 32.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.803 -0.814 . . . . 50.53 108.803 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 15.0 ptp -141.05 132.5 26.86 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.428 0.632 . . . . 65.21 109.635 170.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.626 HD21 ' HA ' ' A' ' 154' ' ' ALA . 94.8 mt -139.14 149.83 44.94 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.482 1.913 . . . . 74.34 107.032 178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.491 HG21 HD13 ' A' ' 120' ' ' ILE . 6.2 p -83.14 146.54 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.476 -0.935 . . . . 72.31 108.476 -179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.14 -25.42 8.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.754 1.621 . . . . 72.1 112.585 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . 2.0 tp10 -89.22 -27.07 20.87 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.085 0.954 . . . . 63.32 112.583 -172.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -96.37 -6.51 37.4 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.949 0.5 . . . . 71.14 110.77 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 172' ' ' VAL . 10.5 tp -118.12 151.4 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.053 0.941 . . . . 73.34 108.72 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 5' ' ' LYS . 47.3 mm -124.55 107.97 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.1 -1.444 . . . . 74.42 107.1 173.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 140.59 46.56 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.675 -0.491 . . . . 75.21 109.675 176.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -144.88 124.82 13.49 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.294 -1.002 . . . . 63.55 108.294 -173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.497 ' HG2' HD22 ' A' ' 182' ' ' LEU . 36.2 ttpt -80.72 103.99 10.94 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.405 0.682 . . . . 75.44 109.602 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 52.7 t -89.31 90.0 8.14 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.395 0.678 . . . . 74.32 109.457 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 182' ' ' LEU . 2.6 pt? -118.9 175.07 5.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.443 0.697 . . . . 73.25 109.855 -178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 CA--C 1.562 1.409 0 C-N-CA 123.546 0.738 . . . . 65.42 110.078 -179.049 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 16' ' ' ASP . 63.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 110.204 -0.295 . . . . 70.11 110.204 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.8 mt -104.43 137.76 41.82 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.444 0.698 . . . . 72.43 109.882 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.517 HG22 ' HB2' ' A' ' 15' ' ' SER . 21.1 pt -121.43 122.23 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 N-CA-C 109.498 -0.556 . . . . 74.42 109.498 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.741 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 18.6 p90 -124.3 114.88 20.15 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.85 0.86 . . . . 73.41 110.061 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 169.14 14.37 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.836 0.854 . . . . 73.31 110.438 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -114.67 175.34 5.53 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.425 0.69 . . . . 71.33 109.432 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -89.28 -28.33 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 112.918 0.71 . . . . 60.4 112.918 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.58 -59.88 1.89 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.488 0.715 . . . . 74.21 110.295 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -84.41 19.8 1.83 Allowed 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.147 -0.933 . . . . 72.14 110.8 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -45.35 -35.87 3.84 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.194 2.197 . . . . 61.33 114.012 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -67.07 -9.76 42.81 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.338 0.655 . . . . 71.41 112.375 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -121.17 16.5 11.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.668 0.787 . . . . 72.42 111.287 -172.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -105.27 -164.54 1.04 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 72.32 108.468 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.5 t -151.64 152.28 32.62 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.212 0.529 . . . . 71.24 111.712 -168.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.517 ' HB2' HG22 ' A' ' 3' ' ' ILE . 59.9 p -137.18 101.39 4.53 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.08 0.952 . . . . 65.43 109.124 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.2 t70 -157.37 -84.11 0.05 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.782 0.433 . . . . 75.21 110.273 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 m 177.69 86.77 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.264 1.826 . . . . 63.25 107.383 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.08 148.19 64.83 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 115.028 -0.987 . . . . 64.13 108.341 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.86 118.46 5.63 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.87 1.713 . . . . 74.12 112.559 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.741 ' SD ' ' HB3' ' A' ' 4' ' ' TYR . 58.4 mtm -114.34 144.66 42.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.746 0.818 . . . . 72.12 109.353 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -131.32 156.56 45.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.933 . . . . 61.14 108.896 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.591 HD11 ' HD3' ' A' ' 173' ' ' LYS . 28.3 tp -127.97 139.57 52.49 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.472 -0.936 . . . . 64.25 108.472 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.84 145.56 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 C-N-CA 123.213 0.605 . . . . 65.24 109.721 -178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 67.72 2.51 3.05 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.579 1.152 . . . . 54.33 112.356 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 23.1 t70 55.49 29.08 12.67 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.112 0.965 . . . . 73.53 110.827 -167.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 119' ' ' LYS . 49.8 tp -134.45 -51.32 0.81 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.543 0.687 . . . . 73.42 110.483 -175.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.2 t -107.23 127.18 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.728 -1.123 . . . . 61.02 109.834 -166.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -83.02 134.09 35.06 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.405 -0.961 . . . . 74.34 108.405 170.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 169' ' ' LEU . 34.4 tt0 -130.17 104.7 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.076 -0.965 . . . . 74.55 109.056 -174.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.589 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 72.6 t80 -90.59 124.36 34.98 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.099 -0.704 . . . . 73.32 109.099 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -80.15 138.59 36.92 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 109.745 -0.465 . . . . 72.42 109.745 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.99 151.5 20.05 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.517 -0.633 . . . . 42.52 111.517 177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -93.58 150.25 20.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.191 0.596 . . . . 72.13 110.265 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -83.16 106.04 14.63 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.115 -1.069 . . . . 61.45 108.115 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.431 HG23 HD12 ' A' ' 72' ' ' LEU . 16.8 m -141.83 162.89 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.508 0.723 . . . . 61.03 109.583 -172.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.43 HG22 HD12 ' A' ' 42' ' ' ILE . 11.4 m -127.04 151.31 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 109.946 -0.39 . . . . 60.24 109.946 173.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.6 107.59 15.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.352 -1.351 . . . . 74.44 107.352 160.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -123.64 95.02 4.42 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.525 -1.287 . . . . 73.51 107.525 177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 49.2 -77.33 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 126.392 1.877 . . . . 64.42 113.161 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.8 45.71 0.73 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.779 -0.928 . . . . 71.32 110.779 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -152.74 137.23 16.77 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.294 1.038 . . . . 63.22 110.15 -173.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 36' ' ' VAL . 5.9 tp -115.56 91.14 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 C-N-CA 123.948 0.899 . . . . 74.01 110.062 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.0 t -112.57 90.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.983 -1.117 . . . . 72.23 107.983 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 44' ' ' LEU . 6.5 mp -50.58 -39.27 49.21 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.816 1.246 . . . . 72.04 112.275 -169.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 58.03 66.5 1.1 Allowed 'General case' 0 C--O 1.242 0.692 0 C-N-CA 124.069 0.947 . . . . 65.02 110.669 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.16 68.96 0.85 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 115.311 -0.858 . . . . 70.34 112.1 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.3 p -148.39 156.67 42.79 Favored 'General case' 0 C--O 1.246 0.882 0 C-N-CA 125.115 1.366 . . . . 75.22 108.77 -172.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.41 ' HB2' ' HD3' ' A' ' 49' ' ' PRO . 2.5 m-20 -60.1 -52.53 72.7 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 117.796 -1.097 . . . . 74.5 112.685 -176.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 48' ' ' ASN . 71.1 Cg_exo -52.88 101.47 0.06 OUTLIER 'Trans proline' 0 C--N 1.404 3.449 0 C-N-CA 122.618 2.212 . . . . 72.44 114.158 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 47.2 m -113.43 104.59 12.44 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.438 1.095 . . . . 72.33 108.793 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' A' ' 66' ' ' ARG . . . -146.51 177.74 8.82 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.817 0.847 . . . . 60.02 109.857 -173.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 63.2 15.4 8.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 113.593 0.96 . . . . 75.51 113.593 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -84.69 80.25 9.32 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.842 1.306 . . . . 75.32 109.836 178.182 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.87 84.12 0.1 OUTLIER Glycine 0 C--N 1.344 1.024 0 CA-C-N 113.87 -1.514 . . . . 44.5 110.975 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.68 -58.82 6.57 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.386 1.074 . . . . 63.04 111.691 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.06 116.21 11.77 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.346 0.658 . . . . 72.21 109.692 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -173.51 -163.91 0.2 Allowed 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.422 -1.325 . . . . 63.03 107.422 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -75.65 98.0 3.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.934 -1.135 . . . . 74.33 107.934 168.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.2 50.21 0.89 Allowed Glycine 0 N--CA 1.466 0.667 0 N-CA-C 110.448 -1.061 . . . . 75.25 110.448 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 42.8 m -67.2 152.92 44.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.927 0.891 . . . . 71.53 112.336 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -137.17 -159.79 0.99 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.6 1.16 . . . . 72.45 109.133 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -62.42 169.52 2.89 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.755 0.822 . . . . 73.15 110.108 164.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -75.92 61.66 1.5 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.787 0.435 . . . . 74.31 110.866 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 53' ' ' GLU . 12.1 t -97.43 69.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.685 0 N-CA-C 108.266 -1.013 . . . . 70.52 108.266 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -86.51 67.91 10.03 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.611 -1.255 . . . . 61.43 107.611 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.436 ' HD3' ' O ' ' A' ' 51' ' ' ALA . 12.8 ptm180 -91.88 157.01 17.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 114.853 -1.067 . . . . 73.41 112.089 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.3 -124.48 1.95 Allowed Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.151 -0.477 . . . . 43.31 112.336 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.538 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 12.6 pt -112.47 154.68 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.344 0.658 . . . . 75.43 111.153 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -53.83 -42.05 68.03 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.745 1.218 . . . . 45.31 112.7 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 33.6 mt -58.27 -45.99 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 124.711 1.204 . . . . 64.21 110.106 -173.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 76' ' ' LEU . 75.8 t -72.63 -49.0 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 114.239 -1.346 . . . . 63.21 112.093 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 57.2 mt -67.94 -33.18 74.18 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.661 0.601 . . . . 71.24 112.404 -168.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.56 -29.55 70.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.613 0.571 . . . . 71.55 111.304 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -115.52 -19.74 10.5 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.696 0.998 . . . . 73.25 113.696 -170.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? 68.56 59.85 0.39 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.887 0.875 . . . . 71.31 109.195 -170.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 71' ' ' VAL . 87.2 mt -77.42 125.5 29.43 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 107.506 -1.294 . . . . 74.23 107.506 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.34 124.85 39.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 109.114 -0.698 . . . . 41.22 109.114 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.11 158.9 33.95 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 122.0 0.905 . . . . 55.03 112.48 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 3.2 tpt -147.38 112.17 5.38 Favored 'General case' 0 C--O 1.247 0.926 0 N-CA-C 105.744 -1.947 . . . . 71.02 105.744 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 82' ' ' TYR . 15.6 m120 -100.42 128.3 46.52 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.192 0.597 . . . . 54.3 110.139 -171.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 34.3 t -60.98 -12.85 12.72 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.804 1.641 . . . . 71.54 113.054 -174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.432 ' HD2' ' HB3' ' A' ' 80' ' ' ASN . 69.1 m-85 -73.88 -38.07 64.51 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.048 1.339 . . . . 71.23 111.085 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -106.04 -38.15 6.4 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.414 0.686 . . . . 74.24 112.614 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -66.96 -3.13 6.32 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 116.025 1.861 . . . . 64.21 116.025 -159.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -30.12 -63.77 0.13 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.843 1.657 . . . . 63.15 114.815 -169.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.8 m -64.33 -42.76 96.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.903 0.481 . . . . 75.25 111.693 -175.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 85.2 mmm -71.67 -50.93 26.01 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.474 0.484 . . . . 74.31 111.907 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.41 ' HE2' HD22 ' A' ' 128' ' ' LEU . 58.2 t80 -65.71 -40.0 91.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.599 0.76 . . . . 75.11 111.527 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.28 -35.13 79.85 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.78 0.432 . . . . 65.31 110.542 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.488 ' O ' ' HG2' ' A' ' 94' ' ' LYS . . . -64.26 -42.7 96.35 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 123.296 0.373 . . . . 42.24 110.184 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -67.92 -33.98 75.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.654 0.782 . . . . 75.44 112.033 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.25 -38.87 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.187 0.595 . . . . 51.44 110.641 173.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -41.3 98.54 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.112 -0.699 . . . . 72.34 109.112 176.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 90' ' ' ALA . 74.6 mmtt -61.97 -60.75 3.16 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.508 -0.923 . . . . 71.12 108.508 175.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.4 ' O ' HG13 ' A' ' 99' ' ' VAL . 60.8 t80 -43.6 -60.85 1.59 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.132 1.773 . . . . 71.34 111.493 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 42.5 ttp -56.51 -60.64 3.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.134 0.974 . . . . 54.1 110.631 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -60.12 -41.62 93.01 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 123.422 0.451 . . . . 72.35 111.322 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -72.47 -39.8 67.46 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 119.124 -0.465 . . . . 33.3 111.63 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.482 HG12 ' HB2' ' A' ' 175' ' ' ALA . 22.2 m -70.71 -37.27 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 117.823 0.283 . . . . 75.44 111.375 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 50.3 mt -68.89 -43.24 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.074 0.464 . . . . 75.21 109.797 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.05 -30.21 68.52 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.284 1.034 . . . . 72.03 111.335 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -62.53 -48.77 78.05 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.55 0.74 . . . . 60.1 109.463 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.432 ' HG3' ' HG3' ' A' ' 174' ' ' GLU . 16.1 mmt -78.28 -21.02 50.37 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.741 -0.663 . . . . 73.41 112.064 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -74.29 -30.29 62.02 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.773 -0.579 . . . . 75.33 109.868 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -75.01 -31.58 61.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.509 0.723 . . . . 73.51 110.71 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -99.12 -29.68 12.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.252 0.621 . . . . 72.54 112.613 -173.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -103.18 -43.68 5.4 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.686 -0.857 . . . . 73.11 108.686 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 64.68 19.82 11.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.692 1.197 . . . . 73.33 112.433 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 112' ' ' ASP . 27.5 m-20 -94.85 103.74 15.63 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.301 -1.0 . . . . 75.23 108.301 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.25 -37.89 81.8 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.07 0.948 . . . . 62.02 111.827 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.7 -33.29 74.61 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.416 0.686 . . . . 74.45 111.52 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 109' ' ' ASP . 3.6 t70 -75.42 -49.84 17.68 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.059 0.943 . . . . 63.2 110.712 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.0 m -77.94 -23.09 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 115.468 -0.787 . . . . 73.03 111.659 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -75.15 -35.45 61.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.873 0.469 . . . . 72.24 110.203 171.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 118' ' ' LYS . . . -69.64 -39.42 77.15 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.482 -0.562 . . . . 63.03 109.482 175.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -65.63 -38.54 89.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.181 0.993 . . . . 73.31 110.771 174.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -60.35 -33.86 73.03 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.237 1.015 . . . . 73.1 110.798 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 115' ' ' ALA . 18.0 tppt? -64.92 -48.96 72.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.509 0.724 . . . . 73.12 110.32 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.461 ' HB3' HD22 ' A' ' 26' ' ' LEU . 13.5 mptt -63.93 -40.12 95.72 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.415 0.286 . . . . 74.2 111.63 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 172' ' ' VAL . 17.6 mm -70.27 -48.26 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 118.994 -0.527 . . . . 73.05 111.095 -177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -57.24 -46.08 83.32 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.081 -0.711 . . . . 54.14 109.081 177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -62.31 -46.13 94.54 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.285 0.991 . . . . 43.01 113.292 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 57.4 t-105 -65.3 -52.09 56.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 122.992 0.517 . . . . 74.45 109.861 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.477 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 25.8 m -70.85 -37.3 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 123.644 0.59 . . . . 73.12 111.727 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.89 -32.83 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.81 0.732 . . . . 73.31 109.784 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.6 m -74.98 -40.96 60.43 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.875 -0.602 . . . . 64.2 111.497 172.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.3 tp -78.87 -19.35 52.15 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.305 1.042 . . . . 73.11 112.307 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 47.4 mt -93.64 2.65 56.27 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.271 0.628 . . . . 72.25 111.49 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.3 91.15 2.16 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.746 0.418 . . . . 52.03 109.933 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 134' ' ' LYS . 44.5 mtmt -63.16 -6.72 4.56 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.745 1.218 . . . . 73.12 113.778 -170.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -56.26 -41.68 76.2 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.14 0.576 . . . . 74.44 110.194 171.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -108.74 -48.44 3.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.969 1.308 . . . . 74.33 110.558 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -81.37 -1.12 44.31 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.268 1.427 . . . . 73.24 114.491 -164.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 130' ' ' LYS . 34.9 ttmt -57.19 -16.89 9.07 Favored 'General case' 0 CA--C 1.56 1.35 0 C-N-CA 123.053 0.541 . . . . 52.12 111.237 165.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -89.98 15.31 10.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.246 1.018 . . . . 74.24 111.089 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.5 mt -88.61 148.65 23.96 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.56 -0.904 . . . . 64.32 108.56 170.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -113.53 111.68 22.31 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.599 -1.63 . . . . 73.14 106.599 175.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.437 ' HB3' HG11 ' A' ' 153' ' ' VAL . 46.1 m-85 -90.21 142.11 28.04 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 108.731 -0.84 . . . . 72.14 108.731 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -137.82 155.79 48.63 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.922 0.889 . . . . 73.41 108.735 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.38 143.2 20.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 107.011 -1.477 . . . . 72.34 107.011 175.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -60.46 134.89 49.97 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 118.992 -0.893 . . . . 63.41 113.073 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -55.25 -38.27 68.3 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.139 0.975 . . . . 72.44 111.355 -178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -65.63 -44.42 86.53 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.204 -0.907 . . . . 75.02 111.659 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.93 -21.42 51.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.049 0.54 . . . . 65.3 111.647 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.89 0.18 51.97 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.744 0.817 . . . . 61.23 110.942 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -93.04 -24.04 18.46 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.799 0.84 . . . . 71.43 110.62 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 176.48 47.77 0.06 OUTLIER Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.748 -0.205 . . . . 21.52 113.361 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.75 78.32 1.4 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.06 0.544 . . . . 74.45 110.586 173.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.12 -3.43 32.76 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.505 0.722 . . . . 64.11 111.828 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.25 -18.64 55.07 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.574 0.75 . . . . 32.24 109.667 169.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -63.86 150.4 50.08 Favored Glycine 0 C--N 1.356 1.674 0 O-C-N 124.376 1.047 . . . . 50.24 113.373 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -96.16 155.5 16.73 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.479 0.711 . . . . 75.41 110.088 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.437 HG11 ' HB3' ' A' ' 138' ' ' PHE . 53.3 t -88.13 129.34 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.565 0.746 . . . . 75.53 111.296 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.18 111.5 10.48 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.487 1.115 . . . . 75.41 109.33 170.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.4 mt -93.78 113.02 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.437 0.695 . . . . 71.41 109.398 -170.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 169' ' ' LEU . 45.7 mm -98.7 123.7 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.955 -0.465 . . . . 73.45 109.984 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -124.29 128.88 49.8 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.802 1.241 . . . . 74.02 108.889 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -81.21 114.5 20.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 107.814 -1.18 . . . . 63.02 107.814 171.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.591 ' HB3' HG13 ' A' ' 166' ' ' VAL . 18.2 tpp85 -88.68 141.25 28.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.459 0.704 . . . . 64.25 109.646 -175.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -100.68 124.43 46.28 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.694 -0.484 . . . . 65.35 109.694 176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.595 HG13 ' HB ' ' A' ' 164' ' ' THR . 3.1 p -125.77 90.67 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.056 0.942 . . . . 73.35 109.273 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 62.23 17.5 9.32 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.063 1.345 . . . . 71.35 113.31 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 121.23 -14.69 9.44 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 120.027 -0.318 . . . . 71.1 113.382 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.595 ' HB ' HG13 ' A' ' 161' ' ' VAL . 80.5 m -88.2 138.66 31.24 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.263 0.625 . . . . 74.41 110.112 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.25 112.16 24.24 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.513 0.725 . . . . 64.13 109.296 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.591 HG13 ' HB3' ' A' ' 159' ' ' ARG . 2.6 p -119.75 104.02 45.22 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.46 1.104 . . . . 75.14 109.293 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.27 130.45 39.44 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.597 2.198 . . . . 71.25 112.574 176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.1 p -137.02 131.07 32.35 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.048 0.539 . . . . 63.1 110.587 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 28.7 tp -76.43 137.96 40.05 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.096 0.958 . . . . 54.44 109.477 171.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 48.8 ttm -123.95 122.25 37.45 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.67 -1.233 . . . . 72.41 107.67 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 34.5 mt -151.8 167.9 26.79 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.65 1.58 . . . . 63.35 106.76 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.438 HG21 HD11 ' A' ' 120' ' ' ILE . 12.3 p -88.35 139.92 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 118.593 0.633 . . . . 63.43 109.596 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.591 ' HD3' HD11 ' A' ' 22' ' ' LEU . 58.7 pttt -69.21 -24.1 63.99 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.943 0.497 . . . . 74.42 112.147 -173.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.432 ' HG3' ' HG3' ' A' ' 103' ' ' MET . 11.2 mp0 -64.87 -23.89 67.37 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.797 0.839 . . . . 62.33 112.045 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 99' ' ' VAL . . . -96.82 -10.38 26.74 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.487 0.715 . . . . 61.21 111.358 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.415 HG22 ' HG3' ' A' ' 178' ' ' GLU . 42.5 mm -107.02 147.53 12.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 123.355 0.662 . . . . 62.4 109.555 -175.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.71 108.2 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 107.13 -1.433 . . . . 72.41 107.13 170.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.415 ' HG3' HG22 ' A' ' 176' ' ' ILE . 16.0 mt-10 -109.49 117.93 35.27 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.601 -1.259 . . . . 71.32 107.601 176.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -144.66 135.6 24.94 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.592 -0.892 . . . . 75.34 108.592 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -124.44 109.01 12.75 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.675 1.19 . . . . 52.13 109.164 -171.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 38.8 t -96.64 91.89 5.95 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.786 0.834 . . . . 61.44 109.724 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -101.47 -46.92 4.84 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.336 0.654 . . . . 74.34 109.828 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.25 1.086 0 N-CA-C 108.617 -0.883 . . . . 74.01 108.617 -178.638 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.031 0.443 . . . . 71.43 110.087 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.6 mt -105.39 161.67 14.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.054 0.942 . . . . 64.2 108.755 174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 179' ' ' GLU . 62.0 mt -115.97 118.72 59.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.701 -0.852 . . . . 75.21 108.701 175.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -104.57 96.26 6.47 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.829 -0.804 . . . . 63.11 108.829 -174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.468 ' HD3' ' HB2' ' A' ' 10' ' ' ASP . 68.3 mttm -122.34 152.17 40.42 Favored 'General case' 0 C--O 1.21 -0.992 0 C-N-CA 123.859 0.864 . . . . 63.24 109.213 -177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.435 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 7.2 t70 -114.02 143.21 45.13 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 106.955 -1.498 . . . . 74.15 106.955 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.9 pt -52.84 -20.6 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.823 1.045 . . . . 65.44 113.823 -171.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -107.13 -42.49 4.86 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.189 0.996 . . . . 74.53 110.5 -177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 6' ' ' ASP . 33.2 p -104.93 18.43 22.36 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.816 0.847 . . . . 62.13 112.098 -172.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 8.7 p-10 -60.75 -11.92 9.03 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.511 1.524 . . . . 73.33 113.784 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.31 -58.26 4.83 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 125.133 1.521 . . . . 54.52 110.53 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -122.91 -38.17 2.65 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.416 -0.811 . . . . 62.23 111.473 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.7 tp 5.54 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.885 2.074 . . . . 72.35 114.203 -163.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.513 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 70.6 m -156.95 146.0 20.16 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 122.95 0.5 . . . . 33.45 110.779 178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.6 p -148.6 103.64 3.42 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 118.833 0.742 . . . . 72.14 110.957 169.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -168.28 176.34 5.98 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.343 1.457 . . . . 64.5 108.196 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -72.83 75.37 1.15 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-O 121.185 0.517 . . . . 62.03 110.116 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.513 ' CE2' ' HB3' ' A' ' 14' ' ' SER . 64.2 m-85 -87.32 147.28 41.84 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.722 0.809 . . . . 72.43 110.769 -177.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -48.15 117.7 2.71 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.716 2.278 . . . . 71.44 112.737 169.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.619 ' HG3' ' HE1' ' A' ' 28' ' ' TYR . 60.6 ttp -119.35 114.43 22.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.605 1.162 . . . . 74.22 109.399 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -140.34 136.61 33.36 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.779 -1.193 . . . . 73.44 107.779 171.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 25' ' ' ASP . 59.9 tp -113.15 142.54 45.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.132 -1.062 . . . . 64.32 108.132 174.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -135.25 130.76 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.148 -0.686 . . . . 64.23 109.148 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.99 12.74 4.1 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.902 1.281 . . . . 65.34 112.811 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' HA ' HD21 ' A' ' 22' ' ' LEU . 8.6 m-20 53.37 12.11 0.32 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 124.638 1.175 . . . . 62.11 113.418 -167.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.712 HD22 ' HG3' ' A' ' 119' ' ' LYS . 45.5 tp -107.08 -45.59 4.11 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.774 0.83 . . . . 54.41 110.027 -171.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.4 t -120.3 131.38 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.473 -0.785 . . . . 74.01 109.446 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.619 ' HE1' ' HG3' ' A' ' 20' ' ' MET . 82.0 t80 -98.07 126.7 43.62 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.897 -1.149 . . . . 73.53 107.897 171.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 154.6 30.8 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.415 0.626 . . . . 73.01 110.811 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 50.7 t80 -136.42 129.92 31.9 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.268 1.427 . . . . 63.34 108.655 -171.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -78.98 153.71 30.12 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.154 0.502 . . . . 74.13 110.976 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.37 172.58 39.36 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.312 -0.858 . . . . 73.31 111.004 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 167' ' ' PRO . 47.4 mtmt -128.28 154.29 46.05 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.569 -0.901 . . . . 73.43 108.569 178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 6.4 p-80 -73.98 130.15 39.28 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.5 -1.296 . . . . 75.32 107.5 165.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.696 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 15.9 m -139.73 149.06 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.54 0.736 . . . . 71.2 109.305 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 44' ' ' LEU . 7.4 m -123.3 120.32 59.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.299 -1.371 . . . . 73.53 107.299 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 65' ' ' GLU . 59.3 ttt180 -138.53 117.43 12.41 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.531 -0.759 . . . . 72.22 108.96 -169.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -133.08 118.6 18.94 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 109.038 -0.727 . . . . 75.43 109.038 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 64.43 24.68 13.22 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.422 1.089 . . . . 75.24 112.028 172.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.99 -27.07 18.74 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-O 120.019 -0.323 . . . . 62.13 113.008 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -75.23 123.17 24.82 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.231 0.612 . . . . 74.43 110.204 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 35' ' ' VAL . 5.5 tp -124.94 116.35 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.659 0.783 . . . . 75.11 109.897 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.9 p -162.68 92.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.809 0.843 . . . . 72.04 108.773 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.696 ' HB3' ' HA ' ' A' ' 35' ' ' VAL . 1.0 OUTLIER -56.89 166.41 1.0 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.643 1.177 . . . . 64.34 113.8 -175.214 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -145.16 172.1 13.58 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.972 0.909 . . . . 42.34 109.149 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.35 69.36 1.99 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.709 -0.957 . . . . 61.44 110.709 171.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.4 m -94.72 134.95 36.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.318 1.047 . . . . 63.13 109.807 -172.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -82.9 165.85 39.11 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.081 0.953 . . . . 74.02 110.716 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.72 122.87 12.48 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.523 2.149 . . . . 74.11 111.982 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.7 m -78.55 86.03 4.58 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 122.928 0.491 . . . . 51.2 110.062 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -124.65 127.24 47.03 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.002 0.921 . . . . 75.13 109.48 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -94.17 15.71 16.56 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.284 1.033 . . . . 72.22 111.3 -173.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 69.41 -63.92 0.36 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.247 1.419 . . . . 71.23 110.129 -172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -125.63 71.28 0.46 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.581 -0.607 . . . . 23.21 111.581 175.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.2 96.69 0.16 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.757 0.823 . . . . 75.02 110.602 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -55.98 -52.13 65.28 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.855 1.262 . . . . 71.41 111.878 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.34 79.8 8.37 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 108.069 -1.086 . . . . 61.02 108.069 174.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.68 84.48 5.5 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.669 -1.151 . . . . 55.54 110.383 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.467 ' HA2' HG23 ' A' ' 77' ' ' VAL . . . 134.23 45.73 0.11 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.033 -0.985 . . . . 75.21 112.371 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -65.65 113.4 4.21 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.819 0.848 . . . . 63.51 111.311 -176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -79.72 20.83 0.56 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.144 0.978 . . . . 55.24 111.625 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.73 124.67 23.55 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.082 0.953 . . . . 72.22 109.667 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -74.55 76.72 1.97 Allowed 'General case' 0 C--O 1.242 0.663 0 CA-C-O 122.267 1.032 . . . . 74.23 109.645 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.9 t -137.82 89.96 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 105.647 -1.983 . . . . 73.3 105.647 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HA ' HD22 ' A' ' 72' ' ' LEU . 51.8 mt-10 -82.52 62.64 6.27 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.505 0.669 . . . . 73.04 111.324 -174.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.493 ' HG2' ' HB ' ' A' ' 36' ' ' VAL . 49.0 mtt180 -108.69 120.51 42.68 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.153 -1.055 . . . . 74.41 108.153 173.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 158.28 -136.08 4.6 Favored Glycine 0 CA--C 1.506 -0.522 0 N-CA-C 109.703 -1.359 . . . . 60.34 109.703 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 24.2 pt -110.4 143.96 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 117.354 0.577 . . . . 73.32 110.5 173.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -53.96 -34.48 59.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.152 1.381 . . . . 72.51 112.223 -176.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 169' ' ' LEU . 60.1 mt -56.46 -51.04 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.924 0.89 . . . . 75.34 110.637 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 76' ' ' LEU . 63.1 t -70.26 -49.32 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 114.887 -1.051 . . . . 72.1 111.518 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 65' ' ' GLU . 33.4 mt -63.28 -39.85 95.73 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.814 0.846 . . . . 42.42 111.069 -173.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -67.96 -32.93 73.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.31 1.044 . . . . 72.41 111.579 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -103.16 -6.69 21.91 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.247 0.619 . . . . 63.51 112.44 -175.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 53.98 61.54 3.02 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.906 1.283 . . . . 75.2 111.383 -175.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.495 ' HB2' HG13 ' A' ' 71' ' ' VAL . 59.1 mt -93.95 132.05 38.79 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.371 -0.831 . . . . 73.21 109.945 179.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.467 HG23 ' HA2' ' A' ' 59' ' ' GLY . 3.4 p -79.4 136.88 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.445 0.698 . . . . 71.22 109.881 175.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.69 144.46 10.92 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.829 1.652 . . . . 71.32 113.58 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.7 mmm -147.95 104.18 3.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 106.346 -1.724 . . . . 74.42 106.346 173.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -93.01 136.58 33.14 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.9 -0.778 . . . . 74.32 108.9 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 52.1 t -65.56 -14.22 60.62 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.618 0.767 . . . . 72.01 110.842 173.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -75.75 -47.62 25.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.941 . . . . 64.43 110.617 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -90.17 -33.2 16.3 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.137 -0.938 . . . . 73.13 110.703 -175.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -117.49 22.44 12.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.632 1.173 . . . . 70.34 111.704 -166.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 81' ' ' CYS . . . -49.82 -56.41 10.49 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.453 0.701 . . . . 71.33 112.284 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.8 m -70.39 -33.68 71.67 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 115.397 -0.82 . . . . 54.32 111.018 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 42.5 tpp -66.08 -36.86 84.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.059 0.944 . . . . 73.21 110.55 176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.507 ' HA ' ' HD2' ' A' ' 91' ' ' TYR . 64.1 t80 -72.85 -29.21 63.02 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.82 0.848 . . . . 74.13 110.576 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -40.91 98.92 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.398 -0.593 . . . . 75.54 109.398 170.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.76 -40.84 93.97 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.922 -0.581 . . . . 52.32 110.695 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.507 ' HD2' ' HA ' ' A' ' 88' ' ' PHE . 58.1 m-85 -60.61 -52.64 64.3 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-O 118.777 -0.63 . . . . 73.53 110.797 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.0 mm -58.47 -37.62 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.641 0.776 . . . . 64.44 111.56 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -65.17 -49.28 70.42 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 122.956 0.502 . . . . 74.44 111.42 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -47.12 83.44 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.612 -0.884 . . . . 71.11 108.612 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CD1' ' HB3' ' A' ' 152' ' ' GLN . 22.6 t80 -52.55 -56.61 14.03 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.888 2.075 . . . . 52.21 112.195 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 28.1 ttt -59.17 -50.81 72.6 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.985 0.803 . . . . 71.23 109.773 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -61.68 -36.05 79.75 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.672 -0.694 . . . . 53.21 111.338 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -68.11 -52.88 29.94 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.015 0.926 . . . . 65.12 111.525 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.93 -31.88 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.163 0.585 . . . . 73.3 112.563 -172.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.15 -43.15 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 N-CA-C 109.492 -0.559 . . . . 71.25 109.492 176.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.93 -38.83 87.17 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.912 0.885 . . . . 74.14 110.622 175.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -63.22 -50.88 68.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.206 1.002 . . . . 63.33 109.998 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 24.1 ttt -63.52 -43.13 98.06 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.118 -0.946 . . . . 74.25 110.725 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -74.21 -23.01 59.13 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.845 0.858 . . . . 62.43 111.837 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.464 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 29.0 ttmt -70.5 -20.51 62.84 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.471 0.708 . . . . 62.25 109.783 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -112.83 1.21 15.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.469 1.108 . . . . 62.14 111.218 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.35 -68.97 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.005 0.522 . . . . 71.54 110.711 -174.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.88 11.88 0.1 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.487 1.915 . . . . 73.23 115.079 -175.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -83.51 -8.75 59.29 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.971 0.909 . . . . 73.03 110.581 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt 80.01 -45.21 0.29 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.774 1.63 . . . . 75.42 113.974 169.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.01 71.77 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 118.477 0.58 . . . . 73.24 112.493 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.83 -44.79 22.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.378 0.671 . . . . 63.21 109.791 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.09 -23.53 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.299 -0.864 . . . . 74.24 111.242 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.64 -47.75 74.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.497 1.119 . . . . 72.05 110.172 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.71 -42.31 95.36 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 124.098 0.874 . . . . 63.44 110.078 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.47 -45.21 80.45 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 124.259 0.974 . . . . 65.41 111.752 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -57.43 -45.88 84.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.341 0.656 . . . . 73.34 110.616 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -65.15 -39.55 93.14 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.255 -1.339 . . . . 64.43 110.47 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.712 ' HG3' HD22 ' A' ' 26' ' ' LEU . 14.0 tppt? -69.07 -49.58 56.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.598 0.759 . . . . 71.42 110.43 -173.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.458 ' HA ' HD21 ' A' ' 26' ' ' LEU . 8.5 tp -72.4 -37.75 58.7 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 123.374 0.669 . . . . 61.41 110.978 -174.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -66.86 -39.96 87.73 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.184 -0.673 . . . . 75.12 109.184 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.01 -41.3 99.92 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.648 0.592 . . . . 51.33 112.414 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 46.3 t-105 -66.04 -47.36 74.64 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.138 0.575 . . . . 65.44 110.203 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 28.2 m -69.7 -40.73 79.63 Favored 'Isoleucine or valine' 0 C--N 1.361 1.104 0 CA-C-O 118.476 -0.773 . . . . 71.44 111.565 -174.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -64.15 -33.22 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 119.495 1.043 . . . . 72.23 110.272 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.0 t -72.38 -34.06 67.66 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.9 0.88 . . . . 44.15 110.769 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.623 HD21 HG21 ' A' ' 155' ' ' ILE . 28.7 tp -81.54 -26.28 35.19 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.361 1.064 . . . . 74.22 111.197 -174.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 85.0 mt -88.24 4.47 45.67 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.834 0.854 . . . . 62.0 111.461 178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.55 85.84 0.3 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 123.632 0.773 . . . . 65.42 110.284 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -62.22 -6.83 3.41 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.194 1.398 . . . . 73.23 114.753 -165.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.97 -47.07 84.06 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.028 0.931 . . . . 74.44 110.865 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.549 ' H ' ' HD3' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -112.22 -31.77 6.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.625 1.17 . . . . 61.41 110.873 174.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -78.73 -1.93 36.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.017 0.927 . . . . 71.31 113.218 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.89 -10.88 4.45 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 118.474 0.579 . . . . 71.01 112.311 171.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -91.5 21.71 4.43 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.098 0.959 . . . . 70.11 110.788 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.57 137.71 32.09 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.636 -0.505 . . . . 75.2 109.636 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' A' ' 156' ' ' ILE . . . -111.15 145.83 37.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.654 -1.61 . . . . 73.22 106.654 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.429 ' HB3' HG11 ' A' ' 153' ' ' VAL . 59.9 m-85 -125.32 141.11 52.27 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.296 -1.002 . . . . 73.54 108.296 177.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 154' ' ' ALA . 68.2 m-85 -149.32 147.98 28.99 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 124.165 0.986 . . . . 75.42 108.394 -175.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.534 ' HB ' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -150.97 147.8 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.065 -1.087 . . . . 65.01 108.065 -177.238 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.78 139.04 42.66 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.385 -1.086 . . . . 72.31 110.385 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.65 -21.16 28.53 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 117.505 0.653 . . . . 75.21 109.978 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.75 -46.41 75.49 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.422 -0.955 . . . . 73.31 108.422 164.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.58 98.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.173 -1.376 . . . . 71.51 111.668 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.92 -46.38 52.96 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.262 0.625 . . . . 73.11 111.649 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.48 -41.32 93.43 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.188 0.595 . . . . 73.34 111.148 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -63.76 -58.45 11.04 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.245 -0.742 . . . . 55.43 111.245 177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 176.63 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.389 1.076 . . . . 52.34 108.548 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -41.41 118.84 1.11 Allowed 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 123.917 0.887 . . . . 61.0 113.267 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -38.71 -41.41 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.258 1.423 . . . . 73.25 112.73 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.72 -34.8 4.59 Favored Glycine 0 CA--C 1.502 -0.773 0 CA-C-N 114.681 -1.145 . . . . 70.13 112.224 -175.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 95' ' ' PHE . 20.5 pm0 -98.1 156.59 16.59 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.702 -0.851 . . . . 71.02 108.702 173.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.534 HG13 ' HB ' ' A' ' 140' ' ' ILE . 24.9 t -109.24 143.96 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 107.123 -1.436 . . . . 71.42 107.123 171.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.427 ' HA ' HD21 ' A' ' 171' ' ' LEU . . . -63.28 108.79 1.38 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.73 0.812 . . . . 62.15 109.657 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.623 HG21 HD21 ' A' ' 127' ' ' LEU . 58.9 mt -86.5 104.38 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.746 0.818 . . . . 74.43 109.337 -170.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.551 ' HB ' ' HB3' ' A' ' 137' ' ' ALA . 44.2 mm -89.51 100.11 10.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-N 115.451 -0.795 . . . . 73.53 110.048 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.35 95.14 7.86 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.939 -1.134 . . . . 54.34 107.939 170.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 167' ' ' PRO . 36.9 p90 -85.56 109.32 18.45 Favored 'General case' 0 C--N 1.348 0.517 0 N-CA-C 108.627 -0.879 . . . . 71.32 108.627 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -100.43 -179.48 4.12 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.855 1.262 . . . . 63.15 108.747 -172.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -124.08 120.59 32.81 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 118.801 0.728 . . . . 75.34 110.408 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -90.08 89.49 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 107.393 -1.336 . . . . 72.43 107.393 170.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 60.56 33.78 20.4 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 114.624 -1.171 . . . . 64.5 111.926 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 111.54 -23.76 17.03 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 119.753 -0.471 . . . . 73.32 113.28 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 54.6 m -86.0 125.24 33.25 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.685 -0.857 . . . . 73.05 108.685 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 34' ' ' HIS . 20.5 tt0 -72.08 121.96 20.13 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.433 0.56 . . . . 72.3 109.723 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.0 p -117.46 90.25 34.34 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.892 1.277 . . . . 75.11 109.037 175.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 158' ' ' TYR . 98.4 Cg_exo -50.2 125.92 16.12 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.226 2.617 . . . . 71.55 112.473 167.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 24.0 m -123.82 115.06 20.72 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.904 -0.776 . . . . 74.52 108.904 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp -76.51 130.7 38.3 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.054 0.942 . . . . 72.35 108.909 177.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.2 ttp -128.14 123.0 33.35 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.06 0.944 . . . . 70.42 109.174 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.427 HD21 ' HA ' ' A' ' 154' ' ' ALA . 95.2 mt -139.11 157.58 45.72 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.341 1.456 . . . . 64.22 107.614 176.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 174' ' ' GLU . 13.6 p -78.25 131.97 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 N-CA-C 108.891 -0.781 . . . . 41.43 108.891 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -52.22 -28.77 19.77 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.637 1.575 . . . . 75.4 111.983 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.419 ' H ' HG22 ' A' ' 172' ' ' VAL . 15.4 tp10 -67.15 -34.95 78.65 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.243 1.017 . . . . 74.11 111.844 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.18 -13.43 15.43 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.224 0.61 . . . . 74.22 112.068 -174.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.513 HG21 ' HB3' ' A' ' 28' ' ' TYR . 11.0 tp -108.93 161.91 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.084 -1.45 . . . . 71.35 107.084 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 42.3 mm -135.79 132.26 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.092 0.957 . . . . 63.33 108.593 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.3 96.95 5.29 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 108.129 -1.063 . . . . 63.13 108.129 174.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.551 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 41.4 tt0 -99.19 102.07 13.62 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.482 -0.933 . . . . 71.42 108.482 -174.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -72.17 134.08 45.5 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.549 0.74 . . . . 75.15 110.546 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 36.7 t -117.76 96.15 5.25 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.239 -1.023 . . . . 65.31 108.239 173.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.07 153.62 42.95 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.312 0.645 . . . . 74.34 109.919 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.253 1.265 0 CA-C-N 115.456 -0.793 . . . . 71.11 108.988 177.258 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.598 0.713 . . . . 73.35 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.47 160.59 29.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.106 0.962 . . . . 65.25 108.431 173.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.599 ' HA ' ' HA ' ' A' ' 15' ' ' SER . 28.1 mt -116.74 118.9 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.573 -1.269 . . . . 72.32 107.573 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -97.92 97.23 8.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.362 -0.977 . . . . 70.22 108.362 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -111.43 110.29 20.67 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.199 0.6 . . . . 75.22 109.679 -175.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 9.8 t70 -83.85 135.93 34.32 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 106.643 -1.614 . . . . 73.32 106.643 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.7 pt -64.04 -17.87 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 118.542 0.61 . . . . 71.31 112.232 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -113.98 -52.07 2.75 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.383 1.073 . . . . 74.22 110.47 178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -90.05 17.46 6.89 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.622 -1.172 . . . . 73.02 111.634 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 29.0 t70 -46.91 -43.84 19.24 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 125.034 1.333 . . . . 74.42 112.671 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -66.24 -19.3 65.78 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.117 -1.401 . . . . 71.31 111.906 -173.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.591 ' HG3' ' HA3' ' A' ' 141' ' ' GLY . 6.9 mm-40 -120.8 12.5 11.35 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.808 1.243 . . . . 74.44 111.403 -174.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.96 -148.34 0.34 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.433 0.693 . . . . 73.42 109.794 -176.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 t -150.07 160.14 43.87 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 118.435 0.562 . . . . 75.45 111.388 -163.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 3' ' ' ILE . 60.0 p -124.38 -160.77 0.95 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.026 0.93 . . . . 73.24 109.573 165.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 74.11 -162.86 0.08 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.073 0.949 . . . . 73.24 110.905 164.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -96.98 58.01 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.549 0.69 . . . . 73.33 110.307 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -81.9 149.27 62.99 Favored Pre-proline 0 N--CA 1.478 0.927 0 CA-C-N 115.427 -0.806 . . . . 74.0 109.007 172.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 31' ' ' LYS . 16.5 Cg_exo -68.02 117.6 5.03 Favored 'Trans proline' 0 C--N 1.377 2.079 0 C-N-CA 121.684 1.589 . . . . 71.25 112.025 -176.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.457 ' SD ' ' CD1' ' A' ' 28' ' ' TYR . 12.6 tmm? -148.98 139.44 22.49 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.042 0.937 . . . . 64.12 109.69 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -139.45 158.28 44.41 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.269 1.028 . . . . 75.53 109.147 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.12 119.76 37.33 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.469 -0.938 . . . . 74.21 108.469 174.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.23 136.15 43.34 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 123.808 0.843 . . . . 74.21 108.93 175.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.6 t70 65.51 8.3 4.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.269 1.028 . . . . 71.22 113.044 171.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 55.42 30.49 15.08 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 124.265 1.026 . . . . 60.32 111.626 -171.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.498 HD11 ' HB ' ' A' ' 120' ' ' ILE . 21.3 tp -132.93 -44.03 0.88 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.881 -0.6 . . . . 73.03 111.076 -172.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.08 140.6 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.967 0.507 . . . . 72.23 109.988 -170.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.457 ' CD1' ' SD ' ' A' ' 20' ' ' MET . 30.2 m-85 -92.47 115.09 27.78 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 109.179 -0.675 . . . . 64.41 109.179 168.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -80.13 126.99 31.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.747 -1.205 . . . . 74.41 107.747 166.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 169' ' ' LEU . 71.5 t80 -117.06 104.93 11.74 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.973 -1.491 . . . . 74.54 106.973 177.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 19' ' ' PRO . 41.0 mmtm -79.48 143.38 34.98 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.377 0.671 . . . . 71.05 111.374 -175.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -139.77 -168.55 11.35 Favored Glycine 0 C--O 1.241 0.582 0 CA-C-N 114.677 -1.147 . . . . 74.45 110.51 172.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -118.97 150.85 39.22 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.36 0.664 . . . . 74.02 110.913 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -80.3 107.73 13.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 107.639 -1.245 . . . . 65.34 107.639 169.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.588 HG12 HD23 ' A' ' 44' ' ' LEU . 29.6 m -132.96 155.8 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.773 0.829 . . . . 74.42 109.159 -173.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 44' ' ' LEU . 3.0 m -94.09 141.14 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 109.446 -0.576 . . . . 62.22 109.446 177.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.757 ' HB2' HD13 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -142.13 110.08 5.86 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.604 -1.258 . . . . 73.31 107.604 -178.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 41' ' ' GLU . 15.6 tptm -89.23 161.66 16.31 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.942 0.897 . . . . 72.12 108.957 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -45.88 -38.62 7.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.64 0.978 . . . . 73.23 113.64 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -134.39 42.29 1.37 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.586 -0.279 . . . . 60.13 112.419 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 11.7 tp10 -164.52 142.51 6.76 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.074 0.55 . . . . 73.43 111.057 -176.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.2 tp -137.83 96.06 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.392 1.077 . . . . 70.02 108.507 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -156.08 110.76 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.121 0.968 . . . . 72.2 109.363 171.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.705 ' HA ' HG22 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -60.42 144.16 51.61 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.912 0.885 . . . . 63.2 111.248 178.02 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -80.69 103.93 10.87 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.212 0.605 . . . . 65.52 110.776 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.02 -36.63 21.16 Favored Glycine 0 C--N 1.347 1.173 0 N-CA-C 111.414 -0.674 . . . . 62.55 111.414 171.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 t -94.81 155.66 16.71 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.338 -0.986 . . . . 71.02 108.338 169.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.8 t30 64.21 99.03 0.04 OUTLIER Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.513 1.125 . . . . 75.12 111.241 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -66.23 115.74 3.65 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.105 2.537 . . . . 61.31 112.743 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 p -98.02 82.92 3.04 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.579 0.752 . . . . 73.34 109.959 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.93 25.43 9.14 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.747 0.819 . . . . 65.44 109.297 174.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -113.41 79.17 1.21 Allowed 'General case' 0 C--N 1.354 0.796 0 C-N-CA 124.281 1.032 . . . . 71.12 109.544 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -74.02 -30.35 62.4 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.098 -0.501 . . . . 55.42 110.12 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -83.71 15.65 35.43 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 115.86 -0.609 . . . . 34.32 113.365 176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.3 87.78 0.3 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.151 0.58 . . . . 64.21 110.829 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -103.38 111.91 24.55 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.247 1.019 . . . . 75.03 109.473 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -147.36 -174.16 4.45 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.322 0.649 . . . . 74.03 110.02 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.23 -39.07 71.95 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.603 1.161 . . . . 64.22 112.183 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.2 107.49 2.33 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.619 -0.719 . . . . 74.1 111.711 -176.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.3 m -66.96 -30.29 70.38 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.495 0.718 . . . . 64.12 112.005 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -134.11 -163.74 1.41 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.416 1.086 . . . . 65.51 108.703 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -79.85 137.3 36.9 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 107.643 -1.243 . . . . 55.31 107.643 168.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -77.12 84.66 3.61 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.497 1.142 . . . . 64.15 111.583 -171.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.34 -88.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 104.179 -2.526 . . . . 63.23 104.179 162.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 77.0 -51.0 0.56 Allowed 'General case' 0 C--N 1.362 1.135 0 C-N-CA 125.198 1.399 . . . . 51.22 113.339 157.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -139.15 158.37 44.29 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.552 0.741 . . . . 65.32 109.613 -164.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.4 -158.06 29.0 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 111.235 -0.746 . . . . 74.45 111.235 160.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.6 pt -110.14 147.3 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 123.375 0.67 . . . . 75.13 109.209 172.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.67 -26.84 68.85 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.885 0.874 . . . . 75.45 111.748 -174.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 169' ' ' LEU . 41.7 mm -54.01 -48.21 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.356 0.662 . . . . 53.21 110.205 176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.5 t -80.71 -51.08 16.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 115.017 -0.992 . . . . 73.12 111.674 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.757 HD13 ' HB2' ' A' ' 37' ' ' ARG . 50.6 mt -64.49 -25.47 68.01 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.809 0.844 . . . . 61.22 112.353 -171.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -91.18 -43.68 9.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.571 0.748 . . . . 64.52 110.526 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -94.9 9.51 38.96 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 112.779 0.659 . . . . 51.12 112.779 -170.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? 64.02 33.77 11.93 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.991 0.807 . . . . 64.33 110.85 168.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 139' ' ' PHE . 72.3 mt -78.5 120.74 23.64 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.543 -0.54 . . . . 55.32 109.543 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -81.18 136.37 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.697 0.799 . . . . 75.24 109.158 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.17 145.69 55.53 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.243 1.017 . . . . 75.14 113.194 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 41.9 mtt -133.06 102.9 5.78 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 105.211 -2.144 . . . . 75.11 105.211 167.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -68.45 125.4 26.36 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 108.892 -0.781 . . . . 72.23 108.892 176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 19.0 m -57.6 -25.17 59.65 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.924 0.869 . . . . 74.41 111.071 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -70.01 -32.77 71.12 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 113.792 -1.549 . . . . 64.11 110.721 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -103.83 -39.72 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.347 0.659 . . . . 75.43 111.02 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.4 -11.89 39.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.063 0.945 . . . . 74.42 112.779 -165.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -37.63 -51.85 1.21 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.391 1.626 . . . . 52.11 115.391 -167.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.5 m -68.86 -45.14 71.83 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.074 0.464 . . . . 72.14 111.374 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 72.9 mtm -67.07 -27.99 67.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.177 -0.919 . . . . 70.31 110.432 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.463 ' HA ' ' CD2' ' A' ' 91' ' ' TYR . 81.0 t80 -70.79 -39.99 72.82 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.73 0.812 . . . . 73.22 110.78 177.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -66.13 -31.06 71.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.671 0.388 . . . . 73.2 110.657 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.7 82.63 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.945 -0.571 . . . . 74.24 110.257 172.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.463 ' CD2' ' HA ' ' A' ' 88' ' ' PHE . 19.4 m-85 -60.81 -41.69 96.2 Favored 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 109.669 -0.493 . . . . 71.33 109.669 173.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.1 mm -61.73 -29.94 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.632 0.773 . . . . 73.32 110.625 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -62.79 -53.43 54.39 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 118.188 0.449 . . . . 73.12 111.381 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -67.11 -47.33 71.49 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 123.252 0.345 . . . . 61.24 110.389 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -45.74 -62.7 1.19 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.61 1.964 . . . . 75.22 112.054 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 39.3 ttp -57.23 -47.99 79.95 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.583 1.153 . . . . 75.31 111.43 -175.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -68.4 -35.7 78.05 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.783 -0.644 . . . . 74.12 111.896 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -47.31 63.29 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.525 0.73 . . . . 74.11 110.251 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 174' ' ' GLU . 19.6 m -71.53 -33.09 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 115.915 -0.584 . . . . 71.11 112.44 -173.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 60.2 mt -74.26 -39.9 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.536 -0.542 . . . . 73.31 109.536 174.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.1 -46.62 75.55 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.023 0.929 . . . . 75.5 111.578 176.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -64.53 -43.98 92.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.501 0.72 . . . . 72.31 110.458 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.756 ' SD ' HG12 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -62.81 -50.1 72.34 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.466 1.106 . . . . 73.44 112.604 -174.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.689 ' HA ' HG11 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -70.03 -32.72 71.0 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.435 0.294 . . . . 71.24 111.68 -172.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -58.47 -21.67 52.25 Favored 'General case' 0 CA--C 1.557 1.217 0 CA-C-O 121.154 0.502 . . . . 70.11 111.596 177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -106.55 -26.1 11.54 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.605 0.762 . . . . 51.21 111.831 -175.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 112' ' ' ASP . 13.3 m120 -146.46 35.12 0.96 Allowed 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 123.11 0.564 . . . . 64.43 112.052 -167.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.538 ' HB2' ' O ' ' A' ' 104' ' ' GLU . 31.1 ttp180 -69.83 7.55 0.88 Allowed 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 124.006 0.922 . . . . 73.3 112.748 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.3 -21.88 26.9 Favored 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.136 0.974 . . . . 72.51 111.248 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' HG22 ' A' ' 113' ' ' VAL . 97.8 mttt 83.26 -8.84 1.1 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.685 1.594 . . . . 63.25 113.029 171.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.34 88.15 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.59 0.632 . . . . 64.44 110.004 168.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 107' ' ' ASN . 15.5 t0 -95.36 -44.54 7.52 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.072 -0.967 . . . . 64.11 110.69 -170.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.756 HG12 ' SD ' ' A' ' 103' ' ' MET . 35.8 m -76.37 -31.72 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 113.114 0.783 . . . . 71.04 113.114 -176.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.32 -40.12 95.3 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.163 0.438 . . . . 63.01 110.158 172.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.81 -51.59 67.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.39 -0.823 . . . . 72.52 110.077 174.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -56.99 -47.13 81.55 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.827 0.851 . . . . 73.02 111.605 -178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? -63.83 -43.9 94.84 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.114 0.966 . . . . 74.11 110.434 -176.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -59.69 -45.73 91.22 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 123.753 0.658 . . . . 70.42 110.433 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.17 -39.31 68.79 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.256 -0.884 . . . . 74.22 111.559 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.498 ' HB ' HD11 ' A' ' 26' ' ' LEU . 10.8 tp -73.49 -38.78 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-N 117.95 0.341 . . . . 63.23 110.105 -175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -66.93 -44.0 81.81 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.041 0.536 . . . . 75.22 109.857 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -61.55 -38.23 95.47 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 124.088 0.867 . . . . 54.33 112.786 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 127' ' ' LEU . 25.5 t90 -66.36 -52.69 44.4 Favored 'General case' 0 C--O 1.215 -0.717 0 C-N-CA 123.874 0.87 . . . . 64.11 110.221 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 29.4 m -69.69 -36.9 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-O 119.152 -0.451 . . . . 74.44 111.842 -176.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.58 -33.95 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.606 0.639 . . . . 63.43 110.372 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 77.2 p -80.52 -34.06 35.92 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 122.497 0.319 . . . . 62.44 111.004 175.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.62 HD21 HG21 ' A' ' 155' ' ' ILE . 17.2 tp -69.53 -27.72 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.856 0.862 . . . . 73.3 110.623 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 124' ' ' VAL . 74.3 mt -94.49 3.53 55.01 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.948 0.899 . . . . 73.25 111.438 178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.01 95.0 4.07 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.046 -0.724 . . . . 31.44 109.046 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -58.3 -19.21 32.95 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.69 1.196 . . . . 72.53 113.774 -170.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.11 -45.91 65.07 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.315 1.046 . . . . 62.33 111.737 -173.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -108.58 -37.57 5.9 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.949 0.9 . . . . 64.14 110.168 175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -77.4 -1.84 32.19 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.664 1.186 . . . . 74.11 113.77 -170.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -58.05 -15.11 8.12 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 122.884 0.473 . . . . 74.11 111.179 164.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -100.22 26.09 6.87 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.019 0.927 . . . . 54.24 110.702 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.6 mt -89.14 155.18 19.59 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.28 -1.007 . . . . 64.52 108.28 164.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.44 ' O ' ' HB ' ' A' ' 156' ' ' ILE . . . -130.03 113.7 14.87 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.977 -1.49 . . . . 71.21 106.977 170.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -86.16 146.8 26.42 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.721 -0.844 . . . . 72.42 108.721 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 76' ' ' LEU . 74.0 m-85 -143.47 162.49 35.66 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 123.405 0.682 . . . . 72.25 109.584 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.3 tt -150.69 154.14 9.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.065 -1.457 . . . . 70.44 107.065 170.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.591 ' HA3' ' HG3' ' A' ' 12' ' ' GLU . . . -57.09 134.55 52.26 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-O 119.717 -0.49 . . . . 50.13 112.28 173.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 146' ' ' GLU . 39.5 tt0 -61.57 -44.55 96.81 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.994 0.517 . . . . 72.34 110.26 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -57.16 -41.5 79.3 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 74.33 111.417 177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.629 ' HA ' ' HB3' ' A' ' 148' ' ' ALA . . . -65.43 -35.14 80.03 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.431 -0.804 . . . . 74.44 111.15 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.77 4.04 48.87 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.555 1.142 . . . . 64.52 112.801 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 142' ' ' GLU . 52.9 mt-10 -110.34 -42.14 4.21 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.427 0.691 . . . . 63.31 110.219 177.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.89 67.91 0.18 Allowed Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.813 -0.631 . . . . 65.21 112.977 -176.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 144' ' ' ALA . . . -155.19 -92.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.405 0.682 . . . . 72.24 109.954 170.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -155.23 152.14 28.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.221 1.008 . . . . 74.25 109.763 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -70.89 -36.86 72.94 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.75 -0.659 . . . . 64.52 109.992 169.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 35.33 -119.73 0.4 Allowed Glycine 0 C--N 1.351 1.402 0 O-C-N 125.516 1.76 . . . . 43.42 116.437 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -94.49 128.53 41.13 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.373 -0.602 . . . . 64.12 109.373 176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.9 t -79.85 131.67 33.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.753 0.821 . . . . 74.12 109.422 172.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -71.3 100.19 2.09 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.209 1.004 . . . . 53.02 109.229 170.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.62 HG21 HD21 ' A' ' 127' ' ' LEU . 86.8 mt -92.11 113.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 109.555 -0.535 . . . . 74.44 109.555 -170.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 137' ' ' ALA . 42.0 mm -101.73 125.12 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 122.624 0.37 . . . . 54.25 110.855 -173.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -119.72 120.28 36.12 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.653 -1.24 . . . . 74.5 107.653 165.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.612 ' HB2' ' HB3' ' A' ' 165' ' ' GLU . 12.0 p90 -95.21 102.73 14.56 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.482 -1.303 . . . . 71.21 107.482 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.462 ' O ' HG22 ' A' ' 166' ' ' VAL . 11.3 tpt180 -87.39 102.52 14.62 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.387 0.675 . . . . 63.0 109.891 -166.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -65.61 109.11 2.26 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.385 1.074 . . . . 71.23 111.803 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.83 117.74 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 123.966 0.906 . . . . 73.41 109.624 176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.3 t70 70.36 -62.13 0.44 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.346 1.858 . . . . 75.34 111.408 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -171.68 21.02 0.07 OUTLIER Glycine 0 CA--C 1.527 0.826 0 CA-C-N 116.013 -0.54 . . . . 73.23 112.513 173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 50.9 m -136.26 127.75 28.63 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.743 0.817 . . . . 71.43 109.227 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 158' ' ' TYR . 4.2 mp0 -81.17 137.7 35.89 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.098 0.559 . . . . 71.32 110.03 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 159' ' ' ARG . 34.2 m -109.42 113.19 58.59 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.4 0.68 . . . . 62.53 109.252 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -59.51 114.84 2.22 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.406 2.737 . . . . 73.35 112.361 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 m -120.68 103.9 9.49 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.127 -1.064 . . . . 74.31 108.127 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 30' ' ' PHE . 26.3 tp -77.59 129.75 36.01 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 108.882 -0.784 . . . . 64.41 108.882 173.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 64.4 mtt -112.17 122.76 48.65 Favored 'General case' 0 C--O 1.25 1.1 0 N-CA-C 108.575 -0.898 . . . . 62.34 108.575 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 97.7 mt -133.71 130.24 37.87 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 106.626 -1.62 . . . . 42.1 106.626 170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 176' ' ' ILE . 14.8 p -66.25 133.75 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 108.617 -0.883 . . . . 64.33 108.617 177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 173' ' ' LYS . 0.0 OUTLIER -63.29 -4.89 2.86 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.183 1.179 . . . . 51.24 114.183 -168.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . 42.0 mm-40 -95.68 -17.59 21.17 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.361 0.875 . . . . 75.3 113.361 177.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -108.62 -0.87 19.97 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.902 0.481 . . . . 64.53 110.49 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 172' ' ' VAL . 5.9 tp -126.88 119.79 54.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 106.653 -1.61 . . . . 72.22 106.653 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 45.8 mm -102.96 110.78 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.339 -0.846 . . . . 72.13 109.392 -172.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.52 96.06 1.89 Allowed 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 114.061 -1.427 . . . . 50.11 109.518 172.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.597 ' HB3' ' HB ' ' A' ' 3' ' ' ILE . 10.5 tp10 -92.31 98.76 11.7 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.079 -1.452 . . . . 74.52 107.079 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -87.98 95.27 10.06 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.151 -0.932 . . . . 63.31 110.959 -165.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 47.2 t -92.79 88.88 6.39 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.261 -1.014 . . . . 74.13 108.261 173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -104.33 54.43 0.73 Allowed 'General case' 0 C--O 1.243 0.74 0 C-N-CA 124.464 1.106 . . . . 73.45 109.691 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--O 1.249 1.073 0 CA-C-N 114.742 -1.117 . . . . 63.34 108.895 177.352 . . . . . . . . 0 0 . 1 stop_ save_